Citrus Sinensis ID: 006211

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650------
Protein Sequence
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHccccccccHHHEEHEEEEccccccccccHHHHHHHHHEEEEEEcccccEEEEcccccccHHcccccccccccccEEEEEEcccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccEEccccccccccHHHHHHHHHHHHcccccccEEEEEcccccccccEEEEccccccccccEEEEEcccccccccccccccccEEcccccccccccccHHHHccccccccEEcccccccccccccccccccccccEEEcccccccccccHHHHHHcccHHHHHHccccccccccEEEEEcccccccEEEEEcccccccHHcccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHEEEccccHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHcccccccccccccHHEEEEEEEccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHcccHcccHHHEHcccEccccccccccccHHHHHHHHHHHHHcccccEEEEEccccccHHHHHHHHHHcccccHHHHHHHHccccccccEEcccccccHHHHHHHcccccHHHHHHHHHHHHHHHHcccccEEcccccccccccHHHHHHHHHHHHHccccHHHHHHHHHEccccccccccHHHHHHHHcEEEEEEHccccccccccccccHHHcccccccccccccccccccccccEEEEcccccccccccccccccccEEEEcccccccccccccccEEEEEEcccccccccccccEcccccccccccccccccccccccccccccccccccccccccccccHEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHcHHHEEEEccccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccEEccccEEEEccccccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccccHHEEEcc
Coil and Loop (DISEMBL)
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGywlagrefplsdiNSALFTHLICAFAevdsstyqLSISSANQQYFSIFAnsvrrknpsIKTLLSIWNGQNSTYQSilgnkninpsvlssmvgdsshrksFIESSIRTARLYGfqgidlfwlwpnstdlnslGILLDEwkasasdqpeltlsmavryspthetvsypidsmkkNLNWAHLVAYdyhmpskenvTGIHAalynpssnistdfgirewlrrgfpanklvlgarasgpgitidgsMGYKFIRAFIQnygygaapvynASYVVNLFTSgatwinfdGVETIKAKISYAKEKNLLgykafqlsnddnWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRrnlrtpgtstpaaeyfdsdtpnlqvfsfsdikaatnnfssanklgeggfgpvykgnlprgqEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYcterdenmliyeylpnksldlylfdpiRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNilldnelnpkisdfgMAKLFRKDvdeantgrivgtygyvppeyvkkgiysmkyDVYSFGVLLLQIISSkrnaryygtsenlnFLEYASI
Flexible Loop (DISEMBL)
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVmiilgrrnlrtpgtstpaaeyfdsdtpNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRkdvdeantgrivgtygyvppeYVKKGIYSMKYDVYSFGVLLLQIISSkrnaryygtsenlnfleyasi
Low Complexity Region (SEG)
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDKDKQRllllillpiglvliliASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI
Disordered region (IsUnstruct)
***KSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNIN****************FIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKAS******LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQI*******KQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRT********EYFDSDTPNLQVFSFSDIKAATNNF*****LGEGGFGPVYKGNLPRGQEFAVKRL******GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE****
Disordered Region (DISOPRED)
***KSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGA*AS***ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW********************LLILLPIGLVLILIASLICYFRRTAI******************************PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI
Disordered Region (DISEMBL)
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI
Disordered Region (DISPRO)
*AIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR**********DKQRLLLLILLPIGLVLILIASLICYFRRTAI****************************DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR*YGT**NLNFLEYASI
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	656	2.2.26 [Sep-21-2011]
Q9LW83	850	G-type lectin S-receptor-	no	no	0.342	0.264	0.608	1e-80
Q9SXB8	842	G-type lectin S-receptor-	yes	no	0.355	0.276	0.592	2e-80
O81905	850	Receptor-like serine/thre	no	no	0.359	0.277	0.618	2e-80
Q9SY89	842	Putative G-type lectin S-	no	no	0.346	0.269	0.607	2e-79
O64793	818	G-type lectin S-receptor-	no	no	0.336	0.270	0.606	3e-79
Q3E9X6	690	Cysteine-rich receptor-li	no	no	0.382	0.363	0.571	9e-79
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.423	0.411	0.505	1e-78
O81906	849	G-type lectin S-receptor-	no	no	0.458	0.354	0.482	6e-78
Q9LDM5	666	Putative cysteine-rich re	no	no	0.346	0.340	0.594	1e-77
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.445	0.350	0.488	2e-77

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  301 bits (770), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 137/225 (60%), Positives = 176/225 (78%)

Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
           LQ+FSF  +  AT+ FS ANKLGEGGFGPVYKG L  G+E A+KRLS  S QGL EFKNE
Sbjct: 512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571

Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
             L A+LQH NL+++LG C E+DE MLIYEY+PNKSLD +LFDP+R+ VLDW+ R  I+E
Sbjct: 572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
           G+ QGLLYL +YS  +VIHRD+KA NILLD ++NPKISDFGMA++F     +ANT R+ G
Sbjct: 632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           T+GY+ PEY ++G++S K DV+SFGVL+L+II  ++N  ++  SE
Sbjct: 692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSE 736

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  300 bits (769), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 138/233 (59%), Positives = 177/233 (75%)

Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
           L +F F  +  +T++FS  NKLG+GGFGPVYKG LP GQE AVKRLS  S QGLEE  NE
Sbjct: 509 LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNE 568

Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           V + ++LQH NL+++LG C E +E ML+YEY+P KSLD YLFDP+++ +LDW+ R NI+E
Sbjct: 569 VVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIME 628

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
           G+ +GLLYL   S  ++IHRDLKASNILLD  LNPKISDFG+A++FR + DEANT R+VG
Sbjct: 629 GICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVG 688

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
           TYGY+ PEY  +G +S K DV+S GV+ L+IIS +RN+  +    NLN L YA
Sbjct: 689 TYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYA 741

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  300 bits (768), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 146/236 (61%), Positives = 178/236 (75%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
           ++D   L +  F ++  ATNNFS+ANKLG+GGFG VYKG L  GQE AVKRLS TS QG 
Sbjct: 505 NTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGT 564

Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +EFKNEV L ARLQH+NL+R+L  C +  E MLIYEYL N SLD +LFD  R   L+WQ 
Sbjct: 565 DEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQM 624

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
           R +II G+ +GLLYL + S FR+IHRDLKASNILLD  + PKISDFGMA++F +D  EAN
Sbjct: 625 RFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEAN 684

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
           T ++VGTYGY+ PEY   GI+SMK DV+SFGVLLL+IISSKRN  +Y +  +LN L
Sbjct: 685 TRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  297 bits (761), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 138/227 (60%), Positives = 175/227 (77%)

Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
           DTP+L +FSF  + +AT +F+  NKLG+GGFG VYKGN   G+E AVKRLS  S QGLEE
Sbjct: 506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565

Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
           FKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKSLD +LFD  ++  LDW+KR 
Sbjct: 566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
            +I G+ +GLLYL   S  ++IHRDLKASNILLD E+NPKISDFGMA++F    D ANT 
Sbjct: 626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685

Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT 644
           R+VGTYGY+ PEY  +GI+S K DVYSFGVL+L+I+S ++N  + GT
Sbjct: 686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGT 732

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  296 bits (759), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 134/221 (60%), Positives = 174/221 (78%)

Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
           LQ+FSF  + +AT++FS  NKLGEGGFGPVYKG L  G+E A+KRLS  S QGL EFKNE
Sbjct: 481 LQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNE 540

Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
             L A+LQH NL++VLG C E+DE MLIYEY+ NKSLD +LFDP+R+ VLDW  R  I+E
Sbjct: 541 AILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIME 600

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
           G+ QGLLYL +YS  +VIHRD+KASNILLD ++NPKISDFG+A++F  +   ANT R+ G
Sbjct: 601 GIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAG 660

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
           T+GY+ PEY ++G++S K DV+SFGVL+L+II  ++N  ++
Sbjct: 661 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFH 701

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9X6|CRK21_ARATH Cysteine-rich receptor-like protein kinase 21 OS=Arabidopsis thaliana GN=CRK21 PE=2 SV=1

 Score =  295 bits (754), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 147/257 (57%), Positives = 189/257 (73%), Gaps = 6/257 (2%)

Query: 397 LGRRNLRTPGTSTP--AAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
           + RR  R  GT++P  A +   + + +L+ F F  IKAAT+NF  +NKLG GGFG VYKG
Sbjct: 322 VSRRPRRPYGTASPDDATDDLTASSGSLR-FDFRAIKAATSNFHKSNKLGHGGFGAVYKG 380

Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
             P G E A KRLS  S QG  EFKNEV L ARLQH NL+ +LG+  E +E +L+YE++P
Sbjct: 381 MFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFVP 440

Query: 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
           NKSLD +LFDPI+R  LDW +R NIIEG+T+G+LYL + S   +IHRDLKASNILLD E+
Sbjct: 441 NKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAEM 500

Query: 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           NPKI+DFG+A+ FR +  EANTGR+VGT+GY+PPEYV  G +S K DVYSFGVL+L+II 
Sbjct: 501 NPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEIIG 560

Query: 635 SKRNARYY---GTSENL 648
            K+N+ ++   G+  NL
Sbjct: 561 GKKNSSFHQIDGSVSNL 577

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  294 bits (753), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 147/291 (50%), Positives = 201/291 (69%), Gaps = 13/291 (4%)

Query: 352 EENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPA 411
           E+   K+   ++  I +P+ + ++L+ ++ C+           ++  RRN +    +   
Sbjct: 275 EKGKGKNLTVIVTAIAVPVSVCVLLLGAM-CW-----------LLARRRNNKLSAETEDL 322

Query: 412 AEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS 471
            E   + T  LQ F FS I+AATN FS +NKLG GGFG VYKG L  G+  A+KRLS  S
Sbjct: 323 DEDGITSTETLQ-FQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGS 381

Query: 472 TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
           TQG EEFKNEV + A+LQH NL ++LGYC + +E +L+YE++PNKSLD +LFD  +R VL
Sbjct: 382 TQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVL 441

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
           DWQ+R  IIEG+ +G+LYL   S   +IHRDLKASNILLD +++PKISDFGMA++F  D 
Sbjct: 442 DWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQ 501

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
            +ANT RIVGTYGY+ PEY   G YS+K DVYSFGVL+L++I+ K+N+ +Y
Sbjct: 502 TQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFY 552

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  292 bits (748), Expect = 6e-78,   Method: Compositional matrix adjust.
 Identities = 153/317 (48%), Positives = 211/317 (66%), Gaps = 16/317 (5%)

Query: 353 ENNDKDKQRLLLLILLPIGLVLILIASLI------------CYFRRTAIKSKVMIILGRR 400
           E  +  K ++ +++ + +G++LI I +L+             Y  +    S V+  L + 
Sbjct: 430 EVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489

Query: 401 NLRTP---GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLP 457
              T    G+     E    +T  L VFS + I  ATN+F   N+LG GGFGPVYKG L 
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549

Query: 458 RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517
            G+E AVKRLS  S QG++EFKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609

Query: 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577
           LD +LFD  ++ ++DW+ R +IIEG+ +GLLYL   S  R+IHRDLK SN+LLD E+NPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669

Query: 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           ISDFGMA++F  + +EANT R+VGTYGY+ PEY  +G++S+K DVYSFGVLLL+I+S KR
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729

Query: 638 NARYYGTSENLNFLEYA 654
           N     +SE+ + + YA
Sbjct: 730 NTSLR-SSEHGSLIGYA 745

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDM5|CRK31_ARATH Putative cysteine-rich receptor-like protein kinase 31 OS=Arabidopsis thaliana GN=CRK31 PE=3 SV=1

 Score =  291 bits (745), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 135/227 (59%), Positives = 174/227 (76%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
           D  +P    F F+ I+ AT+NFS  NKLG+GGFG VYKG LP   E AVKRLS+ S QG 
Sbjct: 318 DMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGT 377

Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +EFKNEV + A+LQH NL+R+LG+C ERDE +L+YE++ NKSLD +LFDP  +  LDW++
Sbjct: 378 QEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKR 437

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
           R NII GVT+GLLYL + S   +IHRD+KASNILLD ++NPKI+DFGMA+ FR D  E  
Sbjct: 438 RYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDQ 497

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
           TGR+VGT+GY+PPEYV  G +S K DVYSFGVL+L+I+  K+N+ ++
Sbjct: 498 TGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFF 544

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  290 bits (743), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 151/309 (48%), Positives = 200/309 (64%), Gaps = 17/309 (5%)

Query: 349 AQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTS 408
           A+   N    K+R+LL+++  I  V++L   L C  R     +        R+  +    
Sbjct: 426 ARWNRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSN--------RHRSSSANF 477

Query: 409 TPAAEYFD---------SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG 459
            P    FD         +    L +F  + I AATNNFSS NKLG GGFGPVYKG L   
Sbjct: 478 APVPFDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNR 537

Query: 460 QEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD 519
            E AVKRLS  S QG+EEFKNEV L ++LQH NL+R+LG C E +E ML+YEYLPNKSLD
Sbjct: 538 MEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLD 597

Query: 520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579
            ++F   +R  LDW KR+ I+ G+ +G+LYL + S  R+IHRDLKASNILLD+E+ PKIS
Sbjct: 598 YFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKIS 657

Query: 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639
           DFGMA++F  +  E  T R+VGT+GY+ PEY  +G +S+K DVYSFGVL+L+II+ K+N+
Sbjct: 658 DFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNS 717

Query: 640 RYYGTSENL 648
            ++  S NL
Sbjct: 718 AFHEESSNL 726

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	656
359484771	781	PREDICTED: G-type lectin S-receptor-like	0.955	0.802	0.607	0.0
359497026	738	PREDICTED: G-type lectin S-receptor-like	0.951	0.845	0.585	0.0
296088199	1130	unnamed protein product [Vitis vinifera]	0.935	0.543	0.552	0.0
356558668	909	PREDICTED: uncharacterized protein LOC10	0.943	0.680	0.547	0.0
224142425	763	predicted protein [Populus trichocarpa]	0.960	0.825	0.532	0.0
255565055	721	conserved hypothetical protein [Ricinus	0.897	0.816	0.514	0.0
5814093	739	receptor-like kinase CHRK1 [Nicotiana ta	0.897	0.797	0.498	1e-179
147787796	658	hypothetical protein VITISV_036051 [Viti	0.830	0.828	0.519	1e-179
296084604	580	unnamed protein product [Vitis vinifera]	0.695	0.786	0.623	1e-176
224142429	375	predicted protein [Populus trichocarpa]	0.528	0.925	0.659	1e-137

>gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera]

 Score =  825 bits (2132), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/665 (60%), Positives = 509/665 (76%), Gaps = 38/665 (5%)

Query: 21  FSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA 80
           +S  +TWIKAGYW AG E P+ DI S LFTHL+CAFA+++ +TYQLSISS+ + YFS F 
Sbjct: 19  YSHGETWIKAGYWYAGSESPIPDIKSGLFTHLLCAFADINPTTYQLSISSSEEHYFSTFT 78

Query: 81  NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTAR 140
           + V+R+NPS+ TLLSIW GQ  T  SILG + +N S++S MV   S+RKSFIES+++TAR
Sbjct: 79  DIVKRRNPSVVTLLSIWGGQGPTGLSILGER-VNSSMVSLMVRQPSYRKSFIESAMKTAR 137

Query: 141 LYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASA------SDQPELTLSMAVRYSPTHET 193
           LYGF G+DLFWLWPN+ +D+ ++G LLDE +A+       S +  L L+MAV Y PT  +
Sbjct: 138 LYGFHGLDLFWLWPNTESDMKNMGALLDELRAAVKLESRNSGKAPLILTMAVHYVPTLYS 197

Query: 194 VSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPA 253
           VSY I+++++NL+WAH+ AYDY++PS+ N T  HAALY+P SN+STDFGIREW+ +GFPA
Sbjct: 198 VSYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNVSTDFGIREWISKGFPA 257

Query: 254 NKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN 294
           +KLVLG                   A  SG  +T DGSM YK+I+ F+++YG  A  +YN
Sbjct: 258 SKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLRSYG--ATSMYN 315

Query: 295 ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEEN 354
           A+YVVN  T G TWI FD V+ I+AKISYAKEK LLGY  FQ+SNDDNWALS+AAQ ++ 
Sbjct: 316 ATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDDNWALSQAAQDDDK 375

Query: 355 NDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNL-----RTPGTST 409
               KQ LL+ IL+PI +++++  S++C + R    S+V+  +G RNL        G+ +
Sbjct: 376 VHHKKQELLIKILVPIAVLILVAGSIMCCYSR----SRVLKAIGTRNLGKISLHEVGSKS 431

Query: 410 PAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSA 469
              E F+S+ PNL+VFSF++IK ATNNFS  NKLGEGGFGPVYKG   +G+E AVKRLS 
Sbjct: 432 SGVENFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFGPVYKGKSQKGEEMAVKRLSK 491

Query: 470 TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY 529
           TS QG EEFKNEV+LTA+LQHVNL+R+ G+CTE +E MLIYEY+PNKSLD YLFDP RRY
Sbjct: 492 TSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSLDFYLFDPTRRY 551

Query: 530 VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
            LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+ PKISDFG+A+ F+K
Sbjct: 552 FLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKISDFGIARAFQK 611

Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
           D  EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIISS+RN+  YG S+NLN
Sbjct: 612 DEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRNSCTYGLSQNLN 671

Query: 650 FLEYA 654
            LEYA
Sbjct: 672 LLEYA 676

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera]

 Score =  789 bits (2038), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/680 (58%), Positives = 506/680 (74%), Gaps = 56/680 (8%)

Query: 1   MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
           MA K+I +L FI   +F    S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 1   MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 57

Query: 61  SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
            S YQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N + +             SS
Sbjct: 58  PSAYQIYISPSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDSTK------------FSS 105

Query: 121 MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
           M+   S+RKSFIESSI+TARLYGFQG+DL   WP + ++  ++GIL DEW+A+ +     
Sbjct: 106 MISQPSYRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 165

Query: 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233
             Q  L L++ V Y PT  +VSY +DS+++N++W H+ AYDY++PS  N T  HAALY+P
Sbjct: 166 PSQSPLILTLEVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSSVNFTHAHAALYDP 225

Query: 234 SSNISTDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMG 274
            S ++TDFGI EW+ RG PA KLVLG                   A ASG  +T DGS+ 
Sbjct: 226 VSRVNTDFGIGEWIGRGLPAGKLVLGLAYHGYAWTLLNPKENGIGAPASGLAMTPDGSVS 285

Query: 275 YKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKA 334
           YK+I+ FI++Y    A VYNA+YVVN  + GATWI +D VE I+ K+SYAKEK LLGY  
Sbjct: 286 YKYIKWFIRSYE--CASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNV 343

Query: 335 FQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVM 394
           +++S+D+NW LS AAQ E+ ++ +KQRLL++ILLPI +V++L++S I +  +T  KS  +
Sbjct: 344 WEVSHDENWVLSLAAQGEDQDEGNKQRLLVIILLPIAIVVLLVSS-IMFMMQTRPKSLPI 402

Query: 395 IILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
            +         G++  +A   +SD PNLQVFSFS IK ATNNFSS N+LGEGGFGPVYKG
Sbjct: 403 KL---------GSNISSA---NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGPVYKG 450

Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
            LP+GQE AVKRLS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +P
Sbjct: 451 KLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMP 510

Query: 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
           NKSLD YLFDP RRY LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+
Sbjct: 511 NKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEM 570

Query: 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            PKISDFG+A+ F+KD  EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIIS
Sbjct: 571 KPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIIS 630

Query: 635 SKRNARYYGTSENLNFLEYA 654
           S+RN+  YG S+NLN LEYA
Sbjct: 631 SRRNSCTYGLSQNLNLLEYA 650

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera]

 Score =  727 bits (1877), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/673 (55%), Positives = 489/673 (72%), Gaps = 59/673 (8%)

Query: 1    MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
            MA K+I +L FI   +F    S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 396  MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 452

Query: 61   SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
             S YQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N + +             SS
Sbjct: 453  PSAYQIYISPSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDSTK------------FSS 500

Query: 121  MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
            M+   S+RKSFIESSI+TARLYGFQG+DL   WP + ++  ++GIL DEW+A+ +     
Sbjct: 501  MISQPSYRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 560

Query: 176  --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSK----ENVTGI--H 227
              Q  L L++ V Y PT  +VSY +DS+++N++W H+ AYDY++PS+    + V G+  H
Sbjct: 561  PSQSPLILTLEVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSRLPAGKLVLGLAYH 620

Query: 228  A---ALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQN 284
                 L NP  N     GI               GA ASG  +T DGS+ YK+I+ FI++
Sbjct: 621  GYAWTLLNPKEN-----GI---------------GAPASGLAMTPDGSVSYKYIKWFIRS 660

Query: 285  YGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344
            Y    A VYNA+YVVN  + GATWI +D VE I+ K+SYAKEK LLGY  +++S+D+NW 
Sbjct: 661  YE--CASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNVWEVSHDENWV 718

Query: 345  LSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRT 404
            LS AAQ E+ ++ +KQRLL++ILLPI +V++L++S++C+  +  +   + +++  R    
Sbjct: 719  LSLAAQGEDQDEGNKQRLLVIILLPIAIVVLLVSSIMCHRWKGRLIFNIKVMMQTRPKSL 778

Query: 405  P---GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQE 461
            P   G++  +A   +SD PNLQVFSFS IK ATNNFSS N+LGEGGFGPVYKG LP+GQE
Sbjct: 779  PIKLGSNISSA---NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGPVYKGKLPKGQE 835

Query: 462  FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY 521
             AVKRLS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +PNKSLD Y
Sbjct: 836  IAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMPNKSLDFY 895

Query: 522  LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581
            LFDP  + +LDW KR++IIEG+TQGLLYLQEYS  R+IHRDLKASNILLD E+ PKI+DF
Sbjct: 896  LFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGEMKPKIADF 955

Query: 582  GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
            G+A++F+KD +EANTGRIVGTYGYV PEYV+KG YS+K DVYSFGVLLLQIIS K+N  +
Sbjct: 956  GIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLLQIISGKKNTCF 1015

Query: 642  YGTSENLNFLEYA 654
            YG  +NL+ LEYA
Sbjct: 1016 YGLDQNLHLLEYA 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max]

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/676 (54%), Positives = 472/676 (69%), Gaps = 57/676 (8%)

Query: 5   SIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTY 64
           +I ++ F FL   + E   AQTW++AGYW +G  FP+SDINSAL+THLICAFAE++SSTY
Sbjct: 6   TIALVLFEFLLCQEFEPLKAQTWLQAGYWYSGSGFPVSDINSALYTHLICAFAELNSSTY 65

Query: 65  QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD 124
           +L +S  ++Q FS F  +V++KNPSI TLLSI  G            N N +VLS MV  
Sbjct: 66  ELYVSPEDEQSFSSFTTTVKQKNPSITTLLSIAGG------------NGNDTVLSLMVSK 113

Query: 125 SSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPE------ 178
            S RK FI+SSIR ARLYGFQG+DL W+    +D+N++G L +EW+A+A  +        
Sbjct: 114 DSSRKYFIQSSIRIARLYGFQGLDLSWVPETISDMNNMGRLFEEWRAAAKSEAANDSTQV 173

Query: 179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIS 238
           L L+ AV + P  ++ SYP++S++ NLNW H++ YDYHMP   N T  HAALY+PSS+++
Sbjct: 174 LILTAAVHFRPGLDSASYPVESIQNNLNWVHILTYDYHMPQLANFTAAHAALYDPSSSVN 233

Query: 239 TDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMGYKFIR 279
           TD GI+EW+  G  A+KLVLG                   A A+GP I   G+M YK I+
Sbjct: 234 TDNGIKEWIGSGVTASKLVLGLPFYGYAWNLRNPEDNAIGASATGPAIGKSGAMNYKDIK 293

Query: 280 AFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
           A+IQ YG      YNA+YVVN F++G+TWI +D VE +K K+SYA+E  LLGY  +Q+  
Sbjct: 294 AYIQRYGGHVK--YNATYVVNYFSNGSTWIGYDDVEVVKMKVSYARENKLLGYAVWQVPY 351

Query: 340 DDNWALSRAA-QIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILG 398
           DDNW LS AA +  + N ++  RLL++IL+   + +IL+  LI Y RR            
Sbjct: 352 DDNWVLSSAAAEHVDQNGRNSWRLLVIILIITAMSVILLGILIYYLRR------------ 399

Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR 458
               R P  ST A+  F S+ P+LQVFSFSDI+ ATN FS  NK+G+GG+GPVYKG L  
Sbjct: 400 ----RFP-KSTDASRLFHSNAPDLQVFSFSDIEQATNRFSIENKVGQGGYGPVYKGILSN 454

Query: 459 GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
            QE AVK+LS  STQG EEFKNEV LTARLQHVNL+R+LG+  + ++ ML+YEY+PNKSL
Sbjct: 455 RQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVYEYMPNKSL 514

Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
           D YLFDPIRRY+LDW+KR+ IIEG+TQGLLYLQEYS   +IHRD+KASNILLDNE+ PKI
Sbjct: 515 DSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILLDNEMKPKI 574

Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638
           SDFGMA++FRKD  EANT +IVGTYGYV PEY  KG+YS K DVYSFGVLLLQI+S +R 
Sbjct: 575 SDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLLQIVSGRRT 634

Query: 639 ARYYGTSENLNFLEYA 654
           A +YG  ENLN +EYA
Sbjct: 635 ACFYGEHENLNLMEYA 650

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa]

 Score =  705 bits (1820), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/676 (53%), Positives = 478/676 (70%), Gaps = 46/676 (6%)

Query: 5   SIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTY 64
           +I +LF +FLS  +L  + AQ WIKAGYW +G + P+SDINS L+THLICAFA ++SS+Y
Sbjct: 6   TIIILFHVFLS-LKLHTAKAQAWIKAGYWFSGSDLPISDINSTLYTHLICAFAGLNSSSY 64

Query: 65  QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD 124
            LSISS++ Q+FS F N+V++KNPSI TLLSI            G  + N S LS+MVG+
Sbjct: 65  HLSISSSDDQFFSAFTNTVKQKNPSITTLLSI------------GGGSANYSTLSAMVGN 112

Query: 125 SSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTD-LNSLGILLDEWKAS------ASDQP 177
           S++RKSFI+ SI+ AR YGFQG+D  W+  N++D ++S+G L +EW+A+       S   
Sbjct: 113 STYRKSFIDDSIKIARHYGFQGLDFSWVSANTSDNMDSMGTLFEEWRAAIALERRKSSLS 172

Query: 178 ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI 237
           EL L+ AV+YSP  ++ S+PIDS++KNLNW H++A+DY+MP+    T   AALY+P S++
Sbjct: 173 ELILTAAVQYSPRLDSGSFPIDSIRKNLNWTHVLAFDYYMPTWAKFTAAFAALYDPDSDV 232

Query: 238 STDFGIREWLRRGFPANKLVL-------------------GARASGPGITIDGSMGYKFI 278
           +TDFGI  W+  G PA+KLVL                   GA A+GP +T DG + YK I
Sbjct: 233 NTDFGIAAWINGGLPASKLVLGLPFYGYAWKLANLNESAIGAPATGPAVTEDGDLSYKDI 292

Query: 279 RAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLS 338
             + +  G    P+YN++YVVN    G  WI+FDGV+ ++ K+SYAKEK LLGY  +++S
Sbjct: 293 NNYFKTNGR-VNPIYNSTYVVNYGIVGPAWISFDGVDVVRTKVSYAKEKALLGYVVWEVS 351

Query: 339 NDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILG 398
            DDNW LS+A    ++  + K R+L++IL     V+IL+     + R   +KSK      
Sbjct: 352 YDDNWVLSQAGVDLKHEGRPKSRILIIILTTTAAVIILLGLAFYFIRNRILKSK------ 405

Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR 458
            +  +    +  AA  FDS+ P+L V+S +DI+ AT+ F+  NKLGEGGFGPVYKG LP 
Sbjct: 406 SKETKLKVNNAAAAGDFDSNNPDLIVYSLADIEKATDQFAFENKLGEGGFGPVYKGVLPG 465

Query: 459 GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
           GQE AVK+LS +STQG +EFKNEV LTA+LQHVNL++VLG+C ER+E +LIYEY+P KSL
Sbjct: 466 GQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIYEYMPKKSL 525

Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
           D YLFDPIRRY+LDW++R  IIEG+TQGLLYLQEYS   +IHRDLKASNILLD ++ PKI
Sbjct: 526 DSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILLDGDMKPKI 585

Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638
           SDFGMA++F KD  EANT R+VGTYGYVPPEYV+ G+YS+K DVYSFG++LL IIS K+N
Sbjct: 586 SDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIVLLHIISGKKN 645

Query: 639 ARYYGTSENLNFLEYA 654
              YG+ E L+ LEYA
Sbjct: 646 GSLYGSDETLSLLEYA 661

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis]

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/659 (51%), Positives = 440/659 (66%), Gaps = 70/659 (10%)

Query: 24  AQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
           A+ WIKA Y+ +    P S +NSALFTH+   FA +D+STYQLS   +N+Q  S F  ++
Sbjct: 2   AKPWIKAAYYDSSGNLPASSVNSALFTHIYYGFAGIDNSTYQLSYPFSNEQDVSTFTATL 61

Query: 84  RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           +RKNPSI TLLSI            G    N S  S+MV   S+RK+FI SSI+ AR YG
Sbjct: 62  KRKNPSIITLLSI------------GLAYRNYSTFSTMVSQPSYRKAFIRSSIKIARRYG 109

Query: 144 FQGIDLFWLWPNST-DLNSLGILLDEWKASA------SDQPELTLSMAVRYSPTHETVSY 196
           F G+DL WLWPN++ D+ ++G+LL+EW+A+       S +P++ L+M     P    +++
Sbjct: 110 FHGLDLAWLWPNTSFDMKNVGVLLEEWRAAVNSESRNSSEPQIILTMMTYRLPVIGNLTF 169

Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKL 256
           P++S+++NLNW +++ +DYH+P KE  TG HAALY+PS +++TDF +R WL RG P +KL
Sbjct: 170 PVESIERNLNWVNILTFDYHLPLKERATGNHAALYDPSGHVNTDFCVRAWLERGLPPSKL 229

Query: 257 VLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
           VLG                   A +SGP +T+DGS+GYK I++ I  YGYG A  YNA+Y
Sbjct: 230 VLGLPYHGYAWTLVNPNDNSVGAPSSGPDLTMDGSIGYKMIQSVISGYGYGVASTYNATY 289

Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDK 357
            VN FT   TWINFD VE I+ KISYA  K LLGY  FQL+NDD+W LSRAA    N++K
Sbjct: 290 AVNYFTIRTTWINFDDVEAIRTKISYAVTKGLLGYFVFQLANDDDWKLSRAAYGVGNDEK 349

Query: 358 DKQ-RLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTS-TPAAEYF 415
            K+ +++++++  + ++L+L A    Y R   +KS+     G       G   T   EY 
Sbjct: 350 KKKSQIIIVLVPIVVVILLLFAPASYYIRCRTLKSRGNTEFGEVPSFELGQPITVVNEYP 409

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
           D + PNLQ                              G LPRGQE AVKRLS TS QGL
Sbjct: 410 DQNAPNLQ------------------------------GKLPRGQEIAVKRLSKTSNQGL 439

Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +EFKNE+ LTA+LQHVNL+R+LGYCTER E MLIYEY+PNKSLD YLFD  RR  L+W+K
Sbjct: 440 KEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYMPNKSLDFYLFDQKRRLELNWEK 499

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
           RV+IIEG+ QGLLYLQEYSN  +IH+D+K+SNILLD+ + PKISDFGMA++F+K+  EAN
Sbjct: 500 RVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSNMKPKISDFGMARIFQKENHEAN 559

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
           T +IVGTYGYVPPEYVK+G+YS KYDVYSFGVLLLQIIS K+N  YYG+  NLN LEYA
Sbjct: 560 TCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQIISGKKNTCYYGSHVNLNLLEYA 618

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|5814093|gb|AAD52097.1|AF088885_1 receptor-like kinase CHRK1 [Nicotiana tabacum]

 Score =  634 bits (1635), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 330/662 (49%), Positives = 456/662 (68%), Gaps = 73/662 (11%)

Query: 22  SDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFAN 81
           SDA  WIK+G+W AG EFP+ +I S +FTH+  AFA +++S+++L +S +++ Y S F+N
Sbjct: 21  SDATAWIKSGFWYAGSEFPVPEIPSTMFTHIHFAFAYINASSFELYVSHSDEPYISTFSN 80

Query: 82  SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
           +V++KNPS+ TLLSIW G++ +           P+  + M    S RKSFI +SI+TAR 
Sbjct: 81  TVKQKNPSVITLLSIWGGRDES-----------PNFFA-MTSQFSRRKSFITTSIKTARQ 128

Query: 142 YGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASDQPE------LTLSMAVRYSPTHETV 194
           YGFQG+DL  + PN+  ++ ++   ++EW+ + + + +      L L+M   YSP  +++
Sbjct: 129 YGFQGLDLIGVNPNTDANMTNMRSFIEEWRTAINSESKSSGTRTLILTMGAYYSPMLDSM 188

Query: 195 SYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
           SYPID++ +N +W HL AY              AALY+P+S ++TD+GI+EW++RG PAN
Sbjct: 189 SYPIDTIIRNFDWVHLKAY--------------AALYDPTSKLNTDYGIKEWIKRGLPAN 234

Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
           K+VLG                     A G  IT DGS+ Y++I+ ++++YG    PVYN+
Sbjct: 235 KIVLGLAYHGYAWTLVNPKHNTVRTPARGLAITQDGSISYRYIKQYMKSYG--VTPVYNS 292

Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD-NWALSRAAQIEEN 354
           ++VVN  T G+ WI +D VE I+ K+SYAK+K LLG+ AFQ+ +DD NW LS+ AQ EE 
Sbjct: 293 TFVVNYVTIGSFWIGYDDVEAIRTKVSYAKDKGLLGFAAFQIPSDDVNWELSKTAQDEEE 352

Query: 355 NDKD--KQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAA 412
            D+    +RLL ++L  + L ++L+++++   ++  ++S+ +  L  R +          
Sbjct: 353 EDQSGSNRRLLAILLPTLTLTILLLSTIVFILKKKTLRSEGIRELNERAI---------- 402

Query: 413 EYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST 472
                   NL+VF F  IKAAT+NFS  NKLGEGGFGPVYKG L  GQE A+KRLSA S 
Sbjct: 403 ------GHNLKVFKFDKIKAATDNFSIKNKLGEGGFGPVYKGRLSDGQEIAIKRLSAYSK 456

Query: 473 QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD 532
           QG+EEF+NEV+L ++LQHVN+L++ G CTER+E +LIYEY+PNKSLD YL+DP++   LD
Sbjct: 457 QGVEEFQNEVTLASKLQHVNVLQLQGCCTEREEKILIYEYMPNKSLDFYLYDPVQSLQLD 516

Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           W+ RV IIEGVTQGLLYLQEYS F VIHRDLKASNILLD+E+ PKISDFG+AKLF+KD  
Sbjct: 517 WETRVRIIEGVTQGLLYLQEYSAFTVIHRDLKASNILLDDEMKPKISDFGIAKLFQKDEK 576

Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
           EANTGRIVGTYG VPPEYVK+G+YS KYDVYSFGVLLLQI+  K+N+  YG   +LN LE
Sbjct: 577 EANTGRIVGTYGCVPPEYVKRGLYSRKYDVYSFGVLLLQILGEKKNSSEYGIKNDLNLLE 636

Query: 653 YA 654
           YA
Sbjct: 637 YA 638

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147787796|emb|CAN60684.1| hypothetical protein VITISV_036051 [Vitis vinifera]

 Score =  634 bits (1635), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 332/639 (51%), Positives = 429/639 (67%), Gaps = 94/639 (14%)

Query: 1   MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
           MA K+I +L FI   +F    S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 1   MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 57

Query: 61  SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
           SSTYQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N +               SS
Sbjct: 58  SSTYQIYISPSDEQYFATFTNIVKKRNPSITTLLSIWAGKNDSTN------------FSS 105

Query: 121 MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
           M+   SHRKSFIESSI+TARLYGFQG+DL   WP + ++  ++GIL DEW+A+ +     
Sbjct: 106 MISQPSHRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 165

Query: 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233
             Q  L L++ V   PT E+VSY +DS+++NL+W H+ AYDY++PS  N T  HAALY+P
Sbjct: 166 PSQSPLILTLKVHCLPTLESVSYEVDSIRRNLDWVHVAAYDYYLPSSVNFTHAHAALYDP 225

Query: 234 SSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVY 293
                                      R +G                +   +G+G   V 
Sbjct: 226 ---------------------------RVTG----------------WEAGFGFGVPWVC 242

Query: 294 NAS-------YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALS 346
             +       Y     + GATWI +D VE I+ K+SYAKEK LLGY  +++S+D+NW LS
Sbjct: 243 MDTLEPQGKWYWSTCISFGATWIGYDDVEAIRTKVSYAKEKGLLGYFVWEVSHDENWVLS 302

Query: 347 RAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPG 406
            AAQ E+ ++ +KQRLL +ILLPI +V++L          T +KS  + +         G
Sbjct: 303 LAAQDEDQDEGNKQRLLAIILLPIAIVVLL----------TTLKSLPIKL---------G 343

Query: 407 TSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR 466
           ++  +A   +SD PNLQVFSF+ IK ATNNFSS NKLGEGGFGPVYKG LP+GQE AVKR
Sbjct: 344 SNISSA---NSDDPNLQVFSFTTIKVATNNFSSENKLGEGGFGPVYKGKLPKGQEIAVKR 400

Query: 467 LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
           LS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +P  SLD YLFDP 
Sbjct: 401 LSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMPXXSLDFYLFDPE 460

Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
            + +LDW KR++IIEG+TQGLLYLQEYS  R+IHRDLKASNILLD E+ PKI+DFG+A++
Sbjct: 461 GQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGEMKPKIADFGIARI 520

Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF 625
           F+KD +EANTGRIVGTYGYV PEYV+KG YS+K D Y  
Sbjct: 521 FQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDAYEL 559

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 306/491 (62%), Positives = 379/491 (77%), Gaps = 35/491 (7%)

Query: 183 MAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFG 242
           MAV Y PT  +VSY I+++++NL+WAH+ AYDY++PS+ N T  HAALY+P SN+STDFG
Sbjct: 1   MAVHYVPTLYSVSYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNVSTDFG 60

Query: 243 IREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQ 283
           IREW+ +GFPA+KLVLG                   A  SG  +T DGSM YK+I+ F++
Sbjct: 61  IREWISKGFPASKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLR 120

Query: 284 NYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW 343
           +YG  A  +YNA+YVVN  T G TWI FD V+ I+AKISYAKEK LLGY  FQ+SNDDNW
Sbjct: 121 SYG--ATSMYNATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDDNW 178

Query: 344 ALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLR 403
           ALS+AAQ ++     KQ LL+ IL+PI +++++  S++C + R    S+V+  +G  ++ 
Sbjct: 179 ALSQAAQDDDKVHHKKQELLIKILVPIAVLILVAGSIMCCYSR----SRVLKAIGNFSV- 233

Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFA 463
                    E F+S+ PNL+VFSF++IK ATNNFS  NKLGEGGFGPVYKG   +G+E A
Sbjct: 234 ---------ENFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFGPVYKGKSQKGEEMA 284

Query: 464 VKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF 523
           VKRLS TS QG EEFKNEV+LTA+LQHVNL+R+ G+CTE +E MLIYEY+PNKSLD YLF
Sbjct: 285 VKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSLDFYLF 344

Query: 524 DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583
           DP RRY LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+ PKISDFG+
Sbjct: 345 DPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKISDFGI 404

Query: 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
           A+ F+KD  EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIISS+RN+  YG
Sbjct: 405 ARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRNSCTYG 464

Query: 644 TSENLNFLEYA 654
            S+NLN LEYA
Sbjct: 465 LSQNLNLLEYA 475

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142429|ref|XP_002324560.1| predicted protein [Populus trichocarpa] gi|222865994|gb|EEF03125.1| predicted protein [Populus trichocarpa]

 Score =  495 bits (1274), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 248/376 (65%), Positives = 295/376 (78%), Gaps = 29/376 (7%)

Query: 1   MAIKSIRVLFF--IFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAE 58
           MAI++  +L F   FLSS Q   S AQ WIKAGYW  G +FP+ DINSALFTHL+CAFA 
Sbjct: 1   MAIRNTIILLFSFAFLSS-QNRCSVAQKWIKAGYWYGGSDFPIPDINSALFTHLLCAFAN 59

Query: 59  VDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVL 118
           V+SSTY+LSI S  QQ FSIF   V+RKNPSI TLLSIWNGQ  TY+SI+G + +N SVL
Sbjct: 60  VNSSTYELSIPSDFQQNFSIFTGIVKRKNPSIVTLLSIWNGQAETYKSIIG-EAVNSSVL 118

Query: 119 SSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQP- 177
           SSM+  SS+RKSFIESS++TAR  GFQGIDLFWLWPNSTDL+++G LLDEW+A+   +P 
Sbjct: 119 SSMLTQSSYRKSFIESSVKTARTLGFQGIDLFWLWPNSTDLSNIGTLLDEWRATVDSEPR 178

Query: 178 -----ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN 232
                +L L+M VRYSP+ ++VSYPI+SMK+NL+WAH+VAYDYHMPS+EN TG HAALYN
Sbjct: 179 NSSVSKLILTMGVRYSPSLQSVSYPINSMKRNLDWAHVVAYDYHMPSRENFTGNHAALYN 238

Query: 233 PSSNISTDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSM 273
           PSSNISTDFGIREWL RG+PANKL+LG                   A ASGPG+TIDGS+
Sbjct: 239 PSSNISTDFGIREWLSRGYPANKLLLGMPYHGYAWKLVDPTDNSLGAPASGPGVTIDGSI 298

Query: 274 GYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK 333
           GY+F+R+FIQNYGYGA  VYN++YVVN F +G+TWINFD VET++AKISYAKEK LLGY 
Sbjct: 299 GYRFVRSFIQNYGYGARSVYNSTYVVNYFVAGSTWINFDDVETVRAKISYAKEKGLLGYN 358

Query: 334 AFQLSNDDNWALSRAA 349
            FQ+ NDDNWALS A 
Sbjct: 359 VFQVINDDNWALSLAG 374

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	656
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.359	0.280	0.590	2.8e-80
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.350	0.270	0.601	8.5e-77
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.376	0.365	0.568	1.3e-76
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.361	0.279	0.586	2.1e-76
TAIR|locus:2121706	690	CRK21 "cysteine-rich RLK (RECE	0.382	0.363	0.571	5.2e-75
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.359	0.277	0.618	9.3e-75
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.359	0.277	0.586	1.4e-74
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.371	0.311	0.570	1.4e-74
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.364	0.281	0.585	4e-74
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.361	0.281	0.586	5.9e-74

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 2.8e-80, Sum P(3) = 2.8e-80
 Identities = 140/237 (59%), Positives = 179/237 (75%)

Query:   418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
             DTP+L +FSF  + +AT +F+  NKLG+GGFG VYKGN   G+E AVKRLS  S QGLEE
Sbjct:   506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565

Query:   478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
             FKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKSLD +LFD  ++  LDW+KR 
Sbjct:   566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625

Query:   538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
              +I G+ +GLLYL   S  ++IHRDLKASNILLD E+NPKISDFGMA++F    D ANT 
Sbjct:   626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685

Query:   598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
             R+VGTYGY+ PEY  +GI+S K DVYSFGVL+L+I+S ++N  + GT    + + YA
Sbjct:   686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYA 741

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 8.5e-77, Sum P(2) = 8.5e-77
 Identities = 139/231 (60%), Positives = 179/231 (77%)

Query:   422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
             LQ+FSF  +  AT+ FS ANKLGEGGFGPVYKG L  G+E A+KRLS  S QGL EFKNE
Sbjct:   512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571

Query:   482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
               L A+LQH NL+++LG C E+DE MLIYEY+PNKSLD +LFDP+R+ VLDW+ R  I+E
Sbjct:   572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631

Query:   542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
             G+ QGLLYL +YS  +VIHRD+KA NILLD ++NPKISDFGMA++F     +ANT R+ G
Sbjct:   632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691

Query:   602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN-LNFL 651
             T+GY+ PEY ++G++S K DV+SFGVL+L+II  ++N  ++  SE  LN +
Sbjct:   692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLI 742

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 725 (260.3 bits), Expect = 1.3e-76, Sum P(3) = 1.3e-76
 Identities = 141/248 (56%), Positives = 182/248 (73%)

Query:   395 IILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
             ++  RRN +    +    E   + T  LQ F FS I+AATN FS +NKLG GGFG VYKG
Sbjct:   306 LLARRRNNKLSAETEDLDEDGITSTETLQ-FQFSAIEAATNKFSESNKLGHGGFGEVYKG 364

Query:   455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
              L  G+  A+KRLS  STQG EEFKNEV + A+LQH NL ++LGYC + +E +L+YE++P
Sbjct:   365 QLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVP 424

Query:   515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
             NKSLD +LFD  +R VLDWQ+R  IIEG+ +G+LYL   S   +IHRDLKASNILLD ++
Sbjct:   425 NKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADM 484

Query:   575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             +PKISDFGMA++F  D  +ANT RIVGTYGY+ PEY   G YS+K DVYSFGVL+L++I+
Sbjct:   485 HPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELIT 544

Query:   635 SKRNARYY 642
              K+N+ +Y
Sbjct:   545 GKKNSSFY 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 2.1e-76, Sum P(3) = 2.1e-76
 Identities = 139/237 (58%), Positives = 177/237 (74%)

Query:   417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE 476
             +D   L +  +  +  ATNNFS+ NKLG+GGFG VYKG L  G+E AVKRLS  S+QG +
Sbjct:   503 TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTD 562

Query:   477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
             EF NEV L A+LQH+NL+R+LG C ++ E MLIYEYL N SLD +LFD  R   L+WQKR
Sbjct:   563 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622

Query:   537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
              +II G+ +GLLYL + S  R+IHRDLKASN+LLD  + PKISDFGMA++F ++  EANT
Sbjct:   623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682

Query:   597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
              R+VGTYGY+ PEY   GI+SMK DV+SFGVLLL+IIS KRN  +Y ++ +LN L +
Sbjct:   683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 739

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2121706 CRK21 "cysteine-rich RLK (RECEPTOR-like protein kinase) 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 738 (264.8 bits), Expect = 5.2e-75, Sum P(2) = 5.2e-75
 Identities = 147/257 (57%), Positives = 189/257 (73%)

Query:   397 LGRRNLRTPGTSTP--AAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
             + RR  R  GT++P  A +   + + +L+ F F  IKAAT+NF  +NKLG GGFG VYKG
Sbjct:   322 VSRRPRRPYGTASPDDATDDLTASSGSLR-FDFRAIKAATSNFHKSNKLGHGGFGAVYKG 380

Query:   455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
               P G E A KRLS  S QG  EFKNEV L ARLQH NL+ +LG+  E +E +L+YE++P
Sbjct:   381 MFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFVP 440

Query:   515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
             NKSLD +LFDPI+R  LDW +R NIIEG+T+G+LYL + S   +IHRDLKASNILLD E+
Sbjct:   441 NKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAEM 500

Query:   575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             NPKI+DFG+A+ FR +  EANTGR+VGT+GY+PPEYV  G +S K DVYSFGVL+L+II 
Sbjct:   501 NPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEIIG 560

Query:   635 SKRNARYY---GTSENL 648
              K+N+ ++   G+  NL
Sbjct:   561 GKKNSSFHQIDGSVSNL 577

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
 Identities = 146/236 (61%), Positives = 178/236 (75%)

Query:   416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
             ++D   L +  F ++  ATNNFS+ANKLG+GGFG VYKG L  GQE AVKRLS TS QG 
Sbjct:   505 NTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGT 564

Query:   476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
             +EFKNEV L ARLQH+NL+R+L  C +  E MLIYEYL N SLD +LFD  R   L+WQ 
Sbjct:   565 DEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQM 624

Query:   536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
             R +II G+ +GLLYL + S FR+IHRDLKASNILLD  + PKISDFGMA++F +D  EAN
Sbjct:   625 RFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEAN 684

Query:   596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
             T ++VGTYGY+ PEY   GI+SMK DV+SFGVLLL+IISSKRN  +Y +  +LN L
Sbjct:   685 TRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 1.4e-74, Sum P(2) = 1.4e-74
 Identities = 139/237 (58%), Positives = 181/237 (76%)

Query:   418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
             +T  L VFS + I  ATN+F   N+LG GGFGPVYKG L  G+E AVKRLS  S QG++E
Sbjct:   510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569

Query:   478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
             FKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKSLD +LFD  ++ ++DW+ R 
Sbjct:   570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629

Query:   538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
             +IIEG+ +GLLYL   S  R+IHRDLK SN+LLD E+NPKISDFGMA++F  + +EANT 
Sbjct:   630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689

Query:   598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
             R+VGTYGY+ PEY  +G++S+K DVYSFGVLLL+I+S KRN     +SE+ + + YA
Sbjct:   690 RVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYA 745

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 724 (259.9 bits), Expect = 1.4e-74, Sum P(2) = 1.4e-74
 Identities = 141/247 (57%), Positives = 181/247 (73%)

Query:   408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
             S+   E  D + P L + + S+   AT+ FS+ NKLG+GGFGPVYKG L  GQE AVKRL
Sbjct:   439 SSRKQEEEDLELPFLDLDTVSE---ATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRL 495

Query:   468 SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR 527
             S TS QG+EEFKNE+ L A+LQH NL+++LGYC + +E MLIYEY PNKSLD ++FD  R
Sbjct:   496 SRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKER 555

Query:   528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
             R  LDW KRV II+G+ +G+LYL E S  R+IHRDLKASN+LLD+++N KISDFG+A+  
Sbjct:   556 RRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTL 615

Query:   588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
               D  EANT R+VGTYGY+ PEY   G +S+K DV+SFGVL+L+I+S +RN  +      
Sbjct:   616 GGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHK 675

Query:   648 LNFLEYA 654
             LN L +A
Sbjct:   676 LNLLGHA 682

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 748 (268.4 bits), Expect = 4.0e-74, P = 4.0e-74
 Identities = 140/239 (58%), Positives = 183/239 (76%)

Query:   416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
             D  +  L+V+S   I+ AT+NFS +NKLGEGGFGPVY G LP G+E AVKRL   S QGL
Sbjct:   509 DGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGL 568

Query:   476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
             EEFKNEV L A+LQH NL+R+LG C  R+E +L+YEY+PNKSLD +LF+P ++ +LDW+K
Sbjct:   569 EEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKK 628

Query:   536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
             R +IIEG+ +GLLYL   S  RV+HRDLKASNILLD ++ PKISDFGMA++F  D ++ N
Sbjct:   629 RFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFN 688

Query:   596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
             T R+VGT+GY+ PEY  +GI+S+K DVY FGVL+L+II+ KR   ++   ++LN   YA
Sbjct:   689 TNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYA 747

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 720 (258.5 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 139/237 (58%), Positives = 176/237 (74%)

Query:   417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE 476
             S+   L +     +  ATNNFS+ NKLG+GGFG VYKG L  G+E AVKRLS  S+QG +
Sbjct:   499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558

Query:   477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
             EF NEV L A+LQH+NL+R+LG C ++ E MLIYEYL N SLD +LFD  R   L+WQKR
Sbjct:   559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618

Query:   537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
              +II G+ +GLLYL + S  R+IHRDLKASN+LLD  + PKISDFGMA++F ++  EANT
Sbjct:   619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query:   597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
              R+VGTYGY+ PEY   GI+SMK DV+SFGVLLL+IIS KRN  +Y ++ +LN L +
Sbjct:   679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 735

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	3.2.1.14	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	656
cd02879	299	cd02879, GH18_plant_chitinase_class_V, The class V	1e-115
smart00636	334	smart00636, Glyco_18, Glyco_18 domain	1e-56
pfam00704	325	pfam00704, Glyco_hydro_18, Glycosyl hydrolases fam	2e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-44
cd02872	362	cd02872, GH18_chitolectin_chitotriosidase, This co	9e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-29
cd06548	322	cd06548, GH18_chitinase, The GH18 (glycosyl hydrol	2e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-22
cd02873	413	cd02873, GH18_IDGF, The IDGF's (imaginal disc grow	2e-21
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-18
cd00598	210	cd00598, GH18_chitinase-like, The GH18 (glycosyl h	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
COG3325	441	COG3325, ChiA, Chitinase [Carbohydrate transport a	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.003

>gnl|CDD|119358 cd02879, GH18_plant_chitinase_class_V, The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes

 Score =  346 bits (890), Expect = e-115
 Identities = 141/334 (42%), Positives = 204/334 (61%), Gaps = 47/334 (14%)

Query: 25  QTWIKAGYWLAG-REFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
            T +K GYW A   EFP S+I+S+LFTHL  AFA++D STY++ IS +++  FS F  +V
Sbjct: 1   STIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVISPSDESEFSTFTETV 60

Query: 84  RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           +RKNPS+KTLLSI  G              + S  ++M  D + RK+FI SSI+ AR YG
Sbjct: 61  KRKNPSVKTLLSIGGG------------GSDSSAFAAMASDPTARKAFINSSIKVARKYG 108

Query: 144 FQGIDLFWLWPNS-TDLNSLGILLDEWKASASD------QPELTLSMAVRYSPT----HE 192
           F G+DL W +P+S  ++ + G LL+EW+A+  D      +P L L+ AV +SP      +
Sbjct: 109 FDGLDLDWEFPSSQVEMENFGKLLEEWRAAVKDEARSSGRPPLLLTAAVYFSPILFLSDD 168

Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFP 252
           +VSYPI+++ KNL+W +++AYDY+   + N TG  AALY+P+SN+STD+GI+ W++ G P
Sbjct: 169 SVSYPIEAINKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNSNVSTDYGIKSWIKAGVP 228

Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
           A KLVLG                      +  YG  A  +Y+ + V +   +G TWI +D
Sbjct: 229 AKKLVLG----------------------LPLYGR-AWTLYDTTTVSSYVYAGTTWIGYD 265

Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDDNWALS 346
            V++I  K+ YAK+K LLGY A+ +  DDN  LS
Sbjct: 266 DVQSIAVKVKYAKQKGLLGYFAWAVGYDDNNWLS 299

The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity. Length = 299

>gnl|CDD|214753 smart00636, Glyco_18, Glyco_18 domain

 Score =  194 bits (496), Expect = 1e-56
 Identities = 100/355 (28%), Positives = 155/355 (43%), Gaps = 65/355 (18%)

Query: 29  KAGYWLA----GREFPLSDINSALFTHLICAFAEVDSS-TYQLSISSANQQYFSIFANSV 83
             GY+      GR FP+ DI ++  TH+I AFA +D   T  +    A+   F     ++
Sbjct: 2   VVGYFTNWGVYGRNFPVDDIPASKLTHIIYAFANIDPDGTVTIGDEWADIGNFGQL-KAL 60

Query: 84  RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           ++KNP +K LLSI     S                SSM+ D + RK FI+S +   + YG
Sbjct: 61  KKKNPGLKVLLSIGGWTESDN-------------FSSMLSDPASRKKFIDSIVSFLKKYG 107

Query: 144 FQGIDLFWLWPNS--TDLNSLGILLDEWKA----SASDQPELTLSMAVRYSPTHETVSYP 197
           F GID+ W +P     D  +   LL E +       ++     L++AV   P      Y 
Sbjct: 108 FDGIDIDWEYPGGRGDDRENYTALLKELREALDKEGAEGKGYLLTIAVPAGPDKIDKGYG 167

Query: 198 -IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN---ISTDFGIREWLRRGFPA 253
            + ++ K L++ +L+ YD+H     N TG +A LY    +    + D+ ++ +L +G P 
Sbjct: 168 DLPAIAKYLDFINLMTYDFHGAW-SNPTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGVPP 226

Query: 254 NKLVLG-------------------ARASGPGITI-----DGSMGYKFIRAFIQNYGYGA 289
           +KLVLG                   A  +GP          G + Y+ I   +     GA
Sbjct: 227 SKLVLGIPFYGRGWTLVDGSNNGPGAPFTGPATGGPGTWEGGVVDYREICKLL-----GA 281

Query: 290 APVYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
             VY+    A Y  N       W+++D   +IKAK  Y K+K L G   ++L  D
Sbjct: 282 TVVYDDTAKAPYAYNP--GTGQWVSYDDPRSIKAKADYVKDKGLGGVMIWELDAD 334

Length = 334

>gnl|CDD|216071 pfam00704, Glyco_hydro_18, Glycosyl hydrolases family 18

 Score =  180 bits (458), Expect = 2e-51
 Identities = 99/345 (28%), Positives = 150/345 (43%), Gaps = 48/345 (13%)

Query: 24  AQTWIKAGYWLAGRE-FPLSDINSALFTHLICAFAEVDSSTYQLSI----SSANQQYFSI 78
            +       W    E FPL DI +   TH+I AFA +D +    +         +  F  
Sbjct: 1   GRIVGYYTQWGNYGEGFPLDDIPTDKLTHIIYAFANIDGNGTFGNNADTEDDGLKGCFEQ 60

Query: 79  FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
             +  + +NP +K LLSI     S                S +  D + RK+F +S I  
Sbjct: 61  LKDLKKCQNPGVKVLLSIGGWTFSGG-------------FSLLASDDAKRKTFADSIIDF 107

Query: 139 ARLYGFQGIDLFWLWPNST--DLNSLGILLDEWKA--SASDQPELTLSMAVRYSPTHETV 194
            + YGF GID+ W +P     D ++   LL E +A      +    LS AV   P     
Sbjct: 108 LKKYGFDGIDIDWEYPGGKGDDKDNYTALLKELRAALKKEAKAGYLLSAAVPAGPDKIDG 167

Query: 195 SYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
              I  + K L++ +L+ YD+H     N+TG +A LY+  S  + D+ ++ +L+ G PA+
Sbjct: 168 -SDIAKIGKYLDFINLMTYDFH--GWSNITGPNAPLYDG-SWQNVDYAVQYYLKAGVPAS 223

Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
           KLVLG                   A A GPG    G + YK I A +++   GA P Y+ 
Sbjct: 224 KLVLGIPFYGRGWTLVNGSGNGGGAPAPGPGTWEGGILSYKEICALLKS---GAGPGYDD 280

Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
           +        G  ++++D   +IKAK  Y K+K L G   + L  D
Sbjct: 281 TAKAPYIYKGKQFVSYDDPRSIKAKAKYVKDKGLGGVMIWSLDQD 325

Length = 325

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (406), Expect = 2e-45
 Identities = 69/194 (35%), Positives = 105/194 (54%), Gaps = 11/194 (5%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEGGFG VY   +   G++ A+K +    S+  LEE   E+ +  +L H N++++ G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            + +   L+ EY    SL   L +   +  L   + + I+  + +GL YL       +IH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 561 RDLKASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           RDLK  NILLD+     K++DFG++KL   D     T  IVGT  Y+ PE +  KG YS 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 619 KYDVYSFGVLLLQI 632
           K D++S GV+L ++
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (399), Expect = 8e-44
 Identities = 75/200 (37%), Positives = 110/200 (55%), Gaps = 13/200 (6%)

Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
           KLGEG FG VYKG L      +  E AVK L    S Q +EEF  E  +  +L H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +LG CTE +  M++ EY+P   L  YL    R   L     ++    + +G+ YL    +
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYL---ES 121

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              IHRDL A N L+   L  KISDFG+++ L+  D  +   G++     ++ PE +K+G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            ++ K DV+SFGVLL +I +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|119351 cd02872, GH18_chitolectin_chitotriosidase, This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases

 Score =  160 bits (407), Expect = 9e-44
 Identities = 101/344 (29%), Positives = 157/344 (45%), Gaps = 60/344 (17%)

Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSAN---QQYFSIFANSVRRKNPSIKTLLS 95
           F   +I+  L TH+I AFA ++     + +   N      +  F N+++ KNP++KTLL+
Sbjct: 18  FVPENIDPFLCTHIIYAFAGLNPDGNIIILDEWNDIDLGLYERF-NALKEKNPNLKTLLA 76

Query: 96  I--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLW 153
           I  WN  ++ +              S+M     +RK+FI+S+I   R YGF G+DL W +
Sbjct: 77  IGGWNFGSAKF--------------SAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEY 122

Query: 154 PNS-----TDLNSLGILLDEWK-ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
           P        D  +   LL E + A   + P L L+ AV         +Y I  + K L++
Sbjct: 123 PGQRGGPPEDKENFVTLLKELREAFEPEAPRLLLTAAVSAGKETIDAAYDIPEISKYLDF 182

Query: 208 AHLVAYDYHMPSKENVTGIHAALYNPSSNI------STDFGIREWLRRGFPANKLVLG-- 259
            +++ YD+H    E VTG ++ LY  S++       + D+ I+ WL +G P  KLVLG  
Sbjct: 183 INVMTYDFHGSW-EGVTGHNSPLYAGSADTGDQKYLNVDYAIKYWLSKGAPPEKLVLGIP 241

Query: 260 -----------------ARASGPG----ITI-DGSMGYKFIRAFIQNYGYGAAPVYNASY 297
                            A ASGPG     T   G + Y  I  F+++   G   V++   
Sbjct: 242 TYGRSFTLASPSNTGVGAPASGPGTAGPYTREAGFLAYYEICEFLKS---GWTVVWDDEQ 298

Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
            V     G  W+ +D  E+I  K+ Y K K L G   + +  DD
Sbjct: 299 KVPYAYKGNQWVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDD 342

The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the large form being converted to the small form by either RNA or post-translational processing. Although the small form, containing the chitinase domain alone, is sufficient for the chitinolytic activity, the additional C-terminal chitin-binding domain of the large form plays a role in processing colloidal chitin. The chitotriosidase gene is nonessential in humans, as about 35% of the population are heterozygous and 6% homozygous for an inactivated form of the gene. HCGP39 is a 39-kDa human cartilage glycoprotein thought to play a role in connective tissue remodeling and defense against pathogens. Length = 362

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  156 bits (397), Expect = 2e-43
 Identities = 72/200 (36%), Positives = 106/200 (53%), Gaps = 14/200 (7%)

Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
           KLGEG FG VYKG        +  E AVK L    S Q +EEF  E  +  +L H N+++
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +LG CTE +   ++ EY+    L  YL     R  L     ++    + +G+ YL    +
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYL---ES 120

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              IHRDL A N L+   L  KISDFG+++ L+  D      G++     ++ PE +K+G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            ++ K DV+SFGVLL +I +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  154 bits (391), Expect = 2e-42
 Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 16/206 (7%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
            KLGEG FG VYKG L          AVK L    S +  ++F  E  +  +L H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +LG CTE +   L+ EY+    L  YL      F    +  L  +  ++    + +G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPP 608
           L   ++ + +HRDL A N L+  +L  KISDFG+++ ++  D     TG  +    ++ P
Sbjct: 121 L---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E +K GI++ K DV+SFGVLL +I +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  150 bits (382), Expect = 2e-41
 Identities = 73/200 (36%), Positives = 103/200 (51%), Gaps = 14/200 (7%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLG 498
           KLG G FG VYK  +   G+  AVK L   S   +  +  + E+ +  RL H N++R++ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
              ++D   L+ EY     L    FD + R   L   +   I   + +GL YL  +SN  
Sbjct: 66  AFEDKDHLYLVMEYCEGGDL----FDYLSRGGPLSEDEAKKIALQILRGLEYL--HSN-G 118

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-Y 616
           +IHRDLK  NILLD     KI+DFG+AK   K      T   VGT  Y+ PE +  G  Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176

Query: 617 SMKYDVYSFGVLLLQIISSK 636
             K DV+S GV+L ++++ K
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  147 bits (373), Expect = 4e-40
 Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 21/204 (10%)

Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLR 495
           KLGEG FG VYKG L         + AVK L   ++ +  EEF  E S+  +L H N++R
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +LG CT+ +   ++ EY+P   L  +L        L  +  + +   + +G+ YL    +
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL---ES 120

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
              +HRDL A N L+   L  KISDFG++    +D+ E +  R     G +P     PE 
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLS----RDIYEDDYYR-KRGGGKLPIKWMAPES 175

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +K G ++ K DV+SFGVLL +I +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (347), Expect = 2e-36
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
            KLGEG FG VY   +   G+  A+K +     +   E    E+ +  +L+H N++R+  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 499 YCTERDENMLIYEYLPNKSLDLYL-----FDP--IRRYVLDWQKRVNIIEGVTQGLLYLQ 551
              + D+  L+ EY     L   L           R Y+            +   L YL 
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ----------ILSALEYLH 114

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
                 ++HRDLK  NILLD + + K++DFG+A+      ++  T   VGT  Y+ PE +
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTT--FVGTPEYMAPEVL 168

Query: 612 KKGIYSMKYDVYSFGVLLLQIISSK 636
               Y    D++S GV+L ++++ K
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (328), Expect = 7e-34
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 25/209 (11%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
             LG G FG VY   +   G+  AVK   LS  S + LE  + E+ + + LQH N++R  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 498 GYCTERDENML-IY-EYLPNKSLD--LYLFDP-----IRRYVLDWQKRVNIIEGVTQGLL 548
           G   + ++N L I+ EY+   SL   L  F       IR+Y             + +GL 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           YL   SN  ++HRD+K +NIL+D++   K++DFG AK          TG + GT  ++ P
Sbjct: 116 YLH--SN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           E ++   Y    D++S G  ++++ + K 
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  126 bits (318), Expect = 1e-32
 Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 6/198 (3%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           F+   KLG G FG V++G        A+K L +      ++F+ EV    RL+H +L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
              C+  +   +I E +   SL  +L  P  + VL     +++   V +G+ YL+E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
             IHRDL A NIL+  +L  K++DFG+A+L ++DV  ++  +I   Y +  PE    G +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 617 SMKYDVYSFGVLLLQIIS 634
           S K DV+SFG+LL ++ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 71/199 (35%), Positives = 111/199 (55%), Gaps = 17/199 (8%)

Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RGQ+ AVK L   ST   + F  E S+   L+H NL+++LG   +
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 503 RDENMLIYEYLPNKSLDLYLFDPIR---RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            +   ++ EY+   SL  YL    R   R V+   +++     V +G+ YL+E  NF  +
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEE-KNF--V 124

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL A N+L+  +L  K+SDFG+AK   +  D   +G++     +  PE +++  +S K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKL--PVKWTAPEALREKKFSTK 179

Query: 620 YDVYSFGVLLLQIISSKRN 638
            DV+SFG+LL +I S  R 
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|119365 cd06548, GH18_chitinase, The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites

 Score =  115 bits (291), Expect = 2e-28
 Identities = 86/332 (25%), Positives = 127/332 (38%), Gaps = 73/332 (21%)

Query: 39  FPLSDINSALFTHLICAFAEVDSST--YQLSISSANQQYFSIFAN--------------- 81
           F   DI +   TH+  AFA++D           +A++   S+                  
Sbjct: 16  FVTDDIPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQL 75

Query: 82  -SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
             +++KNP +K LLSI  W    S                S      + R  F +S++  
Sbjct: 76  RKLKQKNPHLKILLSIGGWT--WSGG-------------FSDAAATEASRAKFADSAVDF 120

Query: 139 ARLYGFQGIDLFWLWPNST----------DLNSLGILLDEW-----KASASDQPELTLSM 183
            R YGF GID+ W +P S           D  +  +LL E         A    +  L++
Sbjct: 121 IRKYGFDGIDIDWEYPGSGGAPGNVARPEDKENFTLLLKELREALDALGAETGRKYLLTI 180

Query: 184 AVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY----NPSSNIST 239
           A    P        +  + K L++ +L+ YD+H     N TG H+ LY    +P    S 
Sbjct: 181 AAPAGPDKLDKLE-VAEIAKYLDFINLMTYDFHGAW-SNTTGHHSNLYASPADPPGGYSV 238

Query: 240 DFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVV 299
           D  +  +L  G P  KLVLG    G              R +   Y      V  A Y+ 
Sbjct: 239 DAAVNYYLSAGVPPEKLVLGVPFYG--------------RGW-TGYTRYWDEVAKAPYLY 283

Query: 300 NLFTSGATWINFDGVETIKAKISYAKEKNLLG 331
           N   S  T+I++D   +IKAK  Y K+K L G
Sbjct: 284 N--PSTKTFISYDDPRSIKAKADYVKDKGLGG 313

The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. Length = 322

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 441 NKLGEGGFGPVYKGNL--PRGQEF---AVKRLSATS-TQGLEEFKNEVSLTARLQHVNLL 494
            +LGEG FG V                AVK L+ +   Q   +F+ E+ +   L H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  G C +       LI EYLP+ SL  YL     R  ++ ++ +     + +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG- 126

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPEY 610
             + R IHRDL A NIL+++E   KISDFG+AK+  +D D            + Y  PE 
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PEC 183

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           ++   +S   DV+SFGV L ++ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 6e-28
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 14/199 (7%)

Query: 443 LGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
           +G G FG V +G   LP  +E   A+K L A S+     +F  E S+  +  H N++R+ 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T+    M+I EY+ N SLD +L +          + V ++ G+  G+ YL   S   
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYVKKGI 615
            +HRDL A NIL+++ L  K+SDFG+++          T  G+I     +  PE +    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           ++   DV+SFG+++ +++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V+ G      + AVK L    T   E F  E  +  +L+H  L+++   C+
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +  L   + V++   + +G+ YL+       IHR
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIHR 127

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR---IVGTYGYVPPEYVKKGIYSM 618
           DL A NIL+   L  KI+DFG+A+L   D   A  G    I  T     PE    G +++
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTI 183

Query: 619 KYDVYSFGVLLLQIISSKR 637
           K DV+SFG+LL +I++  R
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (275), Expect = 8e-27
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           F    K+G+GGFG VYK  +   G+E A+K +   S +  E+  NE+ +  + +H N+++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 496 VLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
             G   ++DE  ++ E+    SL DL          L   +   + + + +GL YL    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              +IHRD+KA+NILL ++   K+ DFG++       D      +VGT  ++ PE +   
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVINGK 172

Query: 615 IYSMKYDVYSFGVLLL 630
            Y  K D++S G+  +
Sbjct: 173 PYDYKADIWSLGITAI 188

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  109 bits (273), Expect = 2e-26
 Identities = 73/229 (31%), Positives = 112/229 (48%), Gaps = 32/229 (13%)

Query: 443 LGEGGFGPVYKGNL--PRGQE----FAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
           LGEG FG VYKG L  P  +      A+K L      +  +EF+ E  L + LQH N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNIIEG 542
           +LG CT+     +++EYL +  L  +L              D   +  LD    ++I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  G+ YL   S+   +HRDL A N L+   L  KISDFG++    +D+  A+  R+   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS----RDIYSADYYRVQSK 185

Query: 603 ----YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
                 ++PPE +  G ++ + D++SFGV+L +I S      YYG S  
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-YYGFSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  108 bits (271), Expect = 3e-26
 Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 30/227 (13%)

Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLR 495
           LGEG FG V+ G   +L    +    AVK L  T++    + F+ E  L    QH N+++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV---------LDWQKRVNIIEGVT 544
             G CTE D  ++++EY+ +  L+ +L    P   ++         L   + + I   + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-- 602
            G++YL   ++   +HRDL   N L+  +L  KI DFGM+    +DV   +  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDVYTTDYYRVGGHTM 185

Query: 603 --YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
               ++PPE +    ++ + DV+SFGV+L +I +  +   +YG S  
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-WYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 8e-26
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 24/204 (11%)

Query: 443 LGEGGFGPVYKGN-LPRGQ----EFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L   TS +  +E  +E  + A + H +++R+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 497 LGYC-TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           LG C + +    LI + +P   L  Y+ +   +  +  Q  +N    + +G+ YL+E   
Sbjct: 75  LGICLSSQ--VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK-- 128

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
            R++HRDL A N+L+    + KI+DFG+AKL   D  E +        G VP      E 
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA-----EGGKVPIKWMALES 182

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +   IY+ K DV+S+GV + ++++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 1e-25
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
              + +  K+GEG  G VYK  +   G+E A+K++     Q  E   NE+ +    +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG--------VT 544
           ++         DE  ++ EY+   SL           ++  Q  V + E         V 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIIT-QNFVRMNEPQIAYVCREVL 126

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           QGL YL    +  VIHRD+K+ NILL  + + K++DFG A    K+  + N+  +VGT  
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           ++ PE +K+  Y  K D++S G++ +++ 
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 79/230 (34%), Positives = 109/230 (47%), Gaps = 36/230 (15%)

Query: 441 NKLGEGGFGPVYKG--NLPRGQEF--AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG G FG V KG   +  G+E   AVK L       G +EF  E S+ A+L H  ++R
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYLQE 552
           ++G C   +  ML+ E  P   L  YL    RR +       ++ E   Q   G+ YL+ 
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKK--RREI----PVSDLKELAHQVAMGMAYLES 113

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP--- 607
             +F  +HRDL A N+LL N    KISDFGM++      D   A T       G  P   
Sbjct: 114 -KHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA------GRWPLKW 164

Query: 608 --PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT---SENLNFLE 652
             PE +  G +S K DV+S+GV L +  S    A+ YG    +E +  LE
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS--YGAKPYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 6/196 (3%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V++G        AVK L    T   ++F  E  +  +L+H  L+++   CT
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
             +   ++ E +   SL  YL     R  L   + +++   V  G+ YL E  N+  IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYL-EAQNY--IHR 127

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+      K++DFG+A++ ++D+ EA  G       +  PE      +S+K D
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREG-AKFPIKWTAPEAALYNRFSIKSD 186

Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I++  R
Sbjct: 187 VWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 8e-25
 Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 6/194 (3%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVLGYC 500
           K+G+G FG VYKG L    E AVK   +T    L  +F  E  +  +  H N+++++G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            ++    ++ E +P  SL  +L     R  L  +K + +      G+ YL E  N   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL-ESKN--CIH 116

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL A N L+      KISDFGM++     +   + G       +  PE +  G Y+ + 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 621 DVYSFGVLLLQIIS 634
           DV+S+G+LL +  S
Sbjct: 177 DVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  103 bits (258), Expect = 2e-24
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 436 NFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL 488
           + +    LG G FG VY+G            + AVK L  + ++  E  F  E  + ++ 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVT 544
            H N++R++G   ER    ++ E +    L  +L +    P R   L  +  +     V 
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAK-LFRKDVDEANTGRI 599
           +G  YL+E      IHRD+ A N LL  +  P    KI+DFGMA+ ++R        GR 
Sbjct: 127 KGCKYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRA 181

Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++PPE    GI++ K DV+SFGVLL +I S
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (252), Expect = 7e-24
 Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 7/196 (3%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V+ G      + A+K L    +   E F  E +L  +LQH  L+R+    T
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
            ++   +I EY+ N SL  +L  P     L   K +++   + +G+ ++ E  N+  IHR
Sbjct: 72  -QEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFI-ERKNY--IHR 126

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  KI+DFG+A+L   +   A  G       +  PE +  G +++K D
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 185

Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I++  R
Sbjct: 186 VWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVN 492
           N+   + +G G FG VYKG NL  G   A+K++S      + L+    E+ L   L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDP-----IRRYVLDWQKRVNIIEGVTQ 545
           +++ +G     D   +I EY  N SL   +  F P     +  Y          +  V Q
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY----------VYQVLQ 110

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL YL E     VIHRD+KA+NIL   +   K++DFG+A        +  +  +VGT  +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           + PE ++    S   D++S G  ++++++  
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  100 bits (252), Expect = 1e-23
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 27/207 (13%)

Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           LG+G FG V    L R        G+  AVK+L  ++ + L +F+ E+ +   LQH N++
Sbjct: 12  LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 495 RVLGYCTE--RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  G C    R    L+ EYLP  SL  YL     R  LD +K +     + +G+ YL  
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGS 126

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYGYVP 607
               R +HRDL   NIL+++E   KI DFG+ K+  +D     V E     I     +  
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYA 179

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE + +  +S+  DV+SFGV+L ++ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (249), Expect = 1e-23
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           ++G G FG V+ G     ++ A+K  R  A S    E+F  E  +  +L H  L+++ G 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           CTER    L++E++ +  L  YL    +R     +  + +   V +G+ YL+  +   VI
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL A N L+      K+SDFGM +    D   ++TG       +  PE      YS K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSK 181

Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFGVL+ ++ S  +
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 67/205 (32%), Positives = 111/205 (54%), Gaps = 24/205 (11%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS-----ATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VY+G NL  G  FAVK +S      T  + +++ + E++L ++LQH N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 497 LGYCTERDE-NMLIY-EYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           LG  TER+E N+ I+ E +P  SL   L  +      V+           +  GL YL  
Sbjct: 68  LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI-----RLYTRQILLGLEYLH- 119

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
             +   +HRD+K +NIL+D     K++DFGMAK   + V+ +      G+  ++ PE + 
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 612 KKGIYSMKYDVYSFGVLLLQIISSK 636
           ++G Y +  D++S G  +L++ + K
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  101 bits (251), Expect = 5e-23
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQH-VNLLRVL 497
           KLGEG FG VY     +    A+K L+       + +E F  E+ + A L H  N++++ 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
            +  +     L+ EY+   SL+  L    R+  L   + + I+  +   L YL       
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 558 VIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDEAN----TGRIVGTYGYVPPEYVK 612
           +IHRD+K  NILLD +    K+ DFG+AKL       ++        VGT GY+ PE + 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 613 ---KGIYSMKYDVYSFGVLLLQIISSKR 637
                  S   D++S G+ L ++++   
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 36/216 (16%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQG-------LEEFKNEVSLTARLQHVN 492
           +G G FG VY G N   G+  AVK+  L + S          L+    E++L   LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 493 LLRVLGYCTERDENMLIYEYLPNKS----LDLY--LFDPIRRYVLDWQKRVNIIEGVTQG 546
           +++ LG   + D   +  EY+P  S    L+ Y    + + R         N +  + +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR------IV 600
           L YL    N  +IHRD+K +NIL+DN+   KISDFG++K  + + +  +T        + 
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQ 173

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           G+  ++ PE VK+  Y+ K D++S G L++++++ K
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 7/193 (3%)

Query: 441 NKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL+++LG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           CT      +I E++   +L  YL +   R  ++    + +   ++  + YL E  NF  I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL-EKKNF--I 126

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL A N L+      K++DFG+++L   D   A+ G       +  PE +    +S+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185

Query: 620 YDVYSFGVLLLQI 632
            DV++FGVLL +I
Sbjct: 186 SDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.8 bits (238), Expect = 5e-22
 Identities = 63/200 (31%), Positives = 110/200 (55%), Gaps = 15/200 (7%)

Query: 443 LGEGGFGPVYKGNL--PRGQE--FAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V++G L  P  +E   A+K L    T+   ++F +E S+  +  H N++R+ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T+    M+I EY+ N +LD YL D    +     + V ++ G+  G+ YL   S+  
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS--YQLVGMLRGIAAGMKYL---SDMN 127

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT---GRIVGTYGYVPPEYVKKG 614
            +HRDL A NIL+++ L  K+SDFG++++   D +   T   G+I     +  PE +   
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYR 185

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            ++   DV+SFG+++ +++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 438 SSANKLGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +   +LG G FG V+ G   RG+ + A+K +   +    ++F  E  +  +L H NL+++
Sbjct: 7   TFLKELGSGQFGVVHLGKW-RGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQL 64

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
            G CT++    ++ EY+ N  L  YL +  R+  L  +  +++   V + + YL+     
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT---YGYVPPEYVKK 613
             IHRDL A N L+  +   K+SDFG+A   R  +D+  T    GT     + PPE    
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSS-QGTKFPVKWAPPEVFDY 175

Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             +S K DV+SFGVL+ ++ S
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 8/194 (4%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V+ G      + AVK L    T  ++ F  E +L   LQH  L+R+    T
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 502 ERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           + +   +I EY+   SL D    D   + +L   K ++    + +G+ Y+ E  N+  IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI-ERKNY--IH 126

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL+A+N+L+   L  KI+DFG+A++   +   A  G       +  PE +  G +++K 
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185

Query: 621 DVYSFGVLLLQIIS 634
           DV+SFG+LL +I++
Sbjct: 186 DVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|119352 cd02873, GH18_IDGF, The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster

 Score = 97.0 bits (242), Expect = 2e-21
 Identities = 93/392 (23%), Positives = 150/392 (38%), Gaps = 104/392 (26%)

Query: 38  EFPLSDINSAL-F-THLICAFAEVDSSTYQLSISSAN-------QQYFSIFANSVRRKNP 88
           +  L D+  AL F THL+  +A +D+ TY+  I S N         Y +I   S++RK P
Sbjct: 18  KMSLEDLEPALQFCTHLVYGYAGIDADTYK--IKSLNEDLDLDKSHYRAI--TSLKRKYP 73

Query: 89  SIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGID 148
            +K LLS+  G +        N+         ++  S  R +FI S+    + YGF G+D
Sbjct: 74  HLKVLLSV--GGDRDTDEEGENEKYL-----LLLESSESRNAFINSAHSLLKTYGFDGLD 126

Query: 149 LFWLWP-------------------------NSTDLNS------LGILLDEWKAS-ASDQ 176
           L W +P                         +  D  +         L+ E K +   D 
Sbjct: 127 LAWQFPKNKPKKVRGTFGSAWHSFKKLFTGDSVVDEKAAEHKEQFTALVRELKNALRPDG 186

Query: 177 PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA-LY---- 231
             LTL++       + T  + + ++  N+++ +L  +D+  P +      + A +Y    
Sbjct: 187 LLLTLTV---LPHVNSTWYFDVPAIANNVDFVNLATFDFLTPERNPEEADYTAPIYELYE 243

Query: 232 -NPSSNISTDFGIREWLRRGFPANKLVLG----AR------------------ASGPG-- 266
            NP  N+  D+ ++ WL +G PA+KL LG     R                    GPG  
Sbjct: 244 RNPHHNV--DYQVKYWLNQGTPASKLNLGIATYGRAWKLTKDSGITGVPPVLETDGPGPA 301

Query: 267 ---ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNL---FTSGA-----------TWI 309
                  G + +  I + + N             V +    F S A            W+
Sbjct: 302 GPQTKTPGLLSWPEICSKLPNPANLKGADAPLRKVGDPTKRFGSYAYRPADENGEHGIWV 361

Query: 310 NFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           +++  +T   K  YAK K L G   F LS DD
Sbjct: 362 SYEDPDTAANKAGYAKAKGLGGVALFDLSLDD 393

The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes. Length = 413

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 68/217 (31%), Positives = 114/217 (52%), Gaps = 31/217 (14%)

Query: 442 KLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLL 494
           +LGE  FG VYKG+L       + Q  A+K L   +   L EEFK+E  + +RLQH N++
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNIIE 541
            +LG  T+     +I+ Y  +  L  +L              D   +  L+    V+I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +  G+ +L   S+  V+H+DL   N+L+ ++LN KISD G   LFR +V  A+  +++G
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLG---LFR-EVYAADYYKLMG 184

Query: 602 T----YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                  ++ PE +  G +S+  D++S+GV+L ++ S
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 37/216 (17%)

Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
           LG+G FG VY+G    + +G+     A+K ++  ++     EF NE S+       +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------------FDPIRRYVLDWQKRVNIIEGV 543
           +LG  +     +++ E +    L  YL              P        QK + +   +
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL-----QKFIQMAAEI 128

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
             G+ YL      + +HRDL A N ++  +L  KI DFGM     +D+ E +  R  G  
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT----RDIYETDYYRKGGK- 180

Query: 604 GYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G +P     PE +K G+++ K DV+SFGV+L ++ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 27/206 (13%)

Query: 443 LGEGGFGPVYKGNL--PRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
           +G G FG V  G L  P  +E   A+K L A  T+    +F +E S+  +  H N++ + 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ----KRVNIIEGVTQGLLYLQEY 553
           G  T+    M++ EY+ N SLD +L    R++  D Q    + V ++ G+  G+ YL   
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKH--DGQFTVIQLVGMLRGIASGMKYL--- 122

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
           S+   +HRDL A NIL+++ L  K+SDFG++++   D + A T R     G +P     P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAP 178

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E +    ++   DV+S+G+++ +++S
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 26/225 (11%)

Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGE  FG +YKG+L        Q  A+K L    + Q   EF+ E SL A L H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLF--------------DPIRRYVLDWQKRVNIIE 541
           +LG  T+     +++EYL    L  +L               D   +  LD    ++I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIV 600
            +  G+ YL   S+F  +H+DL A NIL+  +L+ KISD G+++ ++  D        ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
               ++PPE +  G +S   D++SFGV+L +I S      YYG S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-YYGFS 231

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 35/206 (16%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
            ++G+G FG VY       G+ + +K   LS  S +  E+  NEV +  +L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 496 -----------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGV 543
                      V+ Y    D +  I +             P     +LDW          
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-------KPFPEEQILDW---------F 109

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            Q  L L+   + +++HRD+K  NI L +    K+ DFG++K+    VD A T  +VGT 
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
            Y+ PE  +   Y+ K D++S G +L
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.4 bits (229), Expect = 7e-21
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 11/198 (5%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V+ G      + AVK L    T   E F  E  +  +L+H  L+++    +
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E     ++ EY+   SL  +L D   R  L     V++   V  G+ Y+ E  N+  IHR
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYI-ERMNY--IHR 126

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
           DL+++NIL+ + L  KI+DFG+A+L     D   T R    +   +  PE    G +++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL ++++  R
Sbjct: 184 SDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 9e-21
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQGLE-EFKNEVSLTARLQHVN 492
                 ++LGEG  G V K  L      FA+K ++      L+ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVT 544
           +++  G   +   + +    EY    SLD      I + V     R+       I E V 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           +GL YL      ++IHRD+K SNILL  +   K+ DFG++      +     G   GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSF 168

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           Y+ PE ++   YS+  DV+S G+ LL++
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           KLGEG +G VYK  +   GQ  A+K +       L+E   E+S+  +     +++  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 501 TERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            +  +  ++ EY    S  D+     I    L  ++   I+    +GL YL  +SN + I
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYL--HSN-KKI 121

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRD+KA NILL+ E   K++DFG++      + + NT  ++GT  ++ PE +++  Y+ K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNK 179

Query: 620 YDVYSFGVLLLQIISSK 636
            D++S G+  +++   K
Sbjct: 180 ADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 41/216 (18%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEF----KNEVSLTARLQHVNLLR 495
            ++GEG +G VYK  N   G+  A+K++        E F      E+ L  +L+H N++R
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDL--------YLFDP--IRRYVLDWQKRVNIIEGV 543
           +    T + +    +++EY+ +   DL          F    I+ Y+   Q    ++EG+
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMK--Q----LLEGL 113

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
                YL  +SN  ++HRD+K SNIL++N+   K++DFG+A+ + K      T R++ T 
Sbjct: 114 Q----YL--HSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165

Query: 604 GYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
            Y PPE +    +  Y  + D++S G +L ++   K
Sbjct: 166 WYRPPELLLGATR--YGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 13/196 (6%)

Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG   E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 503 RDENMLIY-EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
               + I  EY+   SL  YL     R VL     +     V + + YL E +NF  +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EANNF--VHR 126

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+  +   K+SDFG+ K      D   TG++     +  PE +++  +S K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALREKKFSTKSD 181

Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I S  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 443 LGEGGFGPVYKGNLPRGQE------FAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLR 495
           LG G FG V+       +E        VK L  T  + L+ EF+ E+ +  +L H N++R
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +LG C E + + +I EY     L  +L       + ++   L  +++V +   +  G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPP 608
           L   SN R +HRDL A N L+ ++   K+S   ++K ++  +  +     I     ++ P
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISS 635
           E V++  +S K DV+SFGVL+ ++ + 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQ 214

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 90.3 bits (224), Expect = 5e-20
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 29/208 (13%)

Query: 443 LGEGGFGPVYKGNLP----RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V +G L     R    A+K L +  T +   +F +E S+  +  H N++ + 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 498 GYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           G  T+    M+I E++ N +LD +L      F  I        + V ++ G+  G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--------QLVGMLRGIAAGMKYLS 123

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP---- 607
           E +    +HRDL A NIL+++ L  K+SDFG+++    D  +      +G  G +P    
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWT 178

Query: 608 -PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            PE +    ++   DV+S+G+++ +++S
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 5e-20
 Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 44/207 (21%)

Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATS---TQGLEEFKNEVSLTARLQH---VN 492
           LG+G FG V    L R    G+ +A+K L        + +E    E ++ +R+ H   V 
Sbjct: 1   LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----- 545
           L     +   + E  L  + EY P   L  +L            K     E   +     
Sbjct: 58  L-----HYAFQTEEKLYLVLEYAPGGELFSHL-----------SKEGRFSEERARFYAAE 101

Query: 546 ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
               L YL       +I+RDLK  NILLD + + K++DFG+AK    +    NT    GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE +    Y    D +S GVLL
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLL 183

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 442 KLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGEG FG V+     NL   Q+    AVK L   S    ++F+ E  L   LQH +++R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV----------LDWQKRVNIIEGV 543
             G CTE    ++++EY+ +  L+ +L    P  + +          L   + + I   +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGT 602
             G++YL   ++   +HRDL   N L+   L  KI DFGM++ ++  D      GR +  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
             ++PPE +    ++ + D++SFGV+L +I +  +   Y
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.9 bits (223), Expect = 7e-20
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 32/238 (13%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLP---RGQEF---AVKRL-SATSTQGLEEFKNEVSLTAR 487
           NN      +G+G FG V++   P     + F   AVK L    S     +F+ E +L A 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD-------------------PIRR 528
             H N++++LG C       L++EY+    L+ +L                      +  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLF 587
             L   +++ I + V  G+ YL E    + +HRDL   N L+   +  KI+DFG++  ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
             D  +A+    +    ++PPE +    Y+ + DV+++GV+L +I S      YYG +
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-YYGMA 237

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.2 bits (221), Expect = 8e-20
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 29/204 (14%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-- 499
            +GEG FG V +G    GQ+ AVK +    T   + F  E ++  +L H NL+R+LG   
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 500 ------CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
                   E      +  +L  +   L     + ++ LD          V +G+ YL+  
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD----------VAEGMEYLESK 119

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              +++HRDL A NIL+  +   K+SDFG+A++    VD +          +  PE +K 
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKH 171

Query: 614 GIYSMKYDVYSFGVLLLQIISSKR 637
             +S K DV+S+GVLL ++ S  R
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 89.2 bits (221), Expect = 9e-20
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 22/207 (10%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS----ATSTQG--LEEFKNEVSLTARLQHVNLLR 495
           LG G F   Y+  ++  G   AVK+++     +S Q   +E  + E+ L ARL H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 496 VLGYCTERDENMLIY-EYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +LG  T  D +  ++ E++   S+   L  +   +  V+     +N  E + +GL YL E
Sbjct: 68  MLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121

Query: 553 YSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEAN--TGRIVGTYGYVPPE 609
               ++IHRD+K +N+L+D+     +I+DFG A         A    G+++GT  ++ PE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSK 636
            ++   Y    DV+S G +++++ ++K
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 24/205 (11%)

Query: 443 LGEGGFGPV--YK---GNLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRV 496
           LGEG FG V  Y     N   G+  AVK L     Q     +K E+++   L H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            G C+E+      LI EY+P  SL  YL     ++ L+  + +   + + +G+ YL    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
               IHRDL A N+LLDN+   KI DFG+A    K V E +    V   G  P      E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLA----KAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            +K+  +S   DV+SFGV L ++++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 22/210 (10%)

Query: 443 LGEGGFGPVYKGN----LPRG---QEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLL 494
           LG G FG VY+G     L  G      AVK L   +T Q  +EF  E  L +   H N++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDP-IRRY---VLDWQKRVNIIEGVTQGLLYL 550
           ++LG C   +   +I E +    L  YL D  + R+   +L  ++ ++I   V +G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 551 QEYSNFRVIHRDLKASNILL-----DNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYG 604
           ++      IHRDL A N L+     D +   KI DFG+A+ +++ D        ++    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           ++ PE +  G ++ + DV+SFGVL+ +I++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 9/197 (4%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG G FG V+     +  + AVK +    +  +E F  E ++   LQH  L+++    T
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 502 ERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            ++   +I E++   SL D    D   +  L   K ++    + +G+ ++ E  N+  IH
Sbjct: 72  -KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI-EQRNY--IH 125

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL+A+NIL+   L  KI+DFG+A++   +   A  G       +  PE +  G +++K 
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184

Query: 621 DVYSFGVLLLQIISSKR 637
           DV+SFG+LL++I++  R
Sbjct: 185 DVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 29/202 (14%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLG- 498
            LG+G  G VYK  + P G+ +A+K++      +  ++   E+      +   +++  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII-EGVT--------QGLLY 549
           +  E + + ++ EY+   SL             D  K+V  I E V         +GL Y
Sbjct: 68  FYKEGEIS-IVLEYMDGGSLA------------DLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L  ++   +IHRD+K SN+L++++   KI+DFG++K+    +D+ NT   VGT  Y+ PE
Sbjct: 115 L--HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170

Query: 610 YVKKGIYSMKYDVYSFGVLLLQ 631
            ++   YS   D++S G+ LL+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 15/197 (7%)

Query: 442 KLGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG G FG V  G   RGQ + A+K +   S    +EF  E  +  +L H  L+++ G C
Sbjct: 11  ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           T++    ++ EY+ N  L  YL +  +R      + + + + V +G+ YL+     + IH
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT---YGYVPPEYVKKGIYS 617
           RDL A N L+D++   K+SDFG++   R  +D+  T   VG+     + PPE +    +S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179

Query: 618 MKYDVYSFGVLLLQIIS 634
            K DV++FGVL+ ++ S
Sbjct: 180 SKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 37/223 (16%)

Query: 442 KLGEGGFGPVY---------------KGNLPRGQE--FAVKRLSATSTQ-GLEEFKNEVS 483
           KLGEG FG V+                 N         AVK L   ++    E+F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--------FDPIRRYVLDWQK 535
           + +RL   N+ R+LG CT      +I EY+ N  L+ +L                L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---V 591
            + +   +  G+ YL+   NF  +HRDL   N L+      KI+DFGM++ L+  D   V
Sbjct: 132 LLYMATQIASGMRYLESL-NF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                GR      ++  E V  G ++ K DV++FGV L +I++
Sbjct: 189 Q----GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQG--------LEEFKNEVSLTARLQHV 491
           +G+G +G VY   N+  G+  AVK+  L AT            ++  ++E+     L H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++ LG+ T  +   +  EY+P  S+   L    R Y   + Q      E V +GL YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
               +  ++HRDLKA N+L+D +   KISDFG++K      D      + G+  ++ PE 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSKR 637
           +      YS K D++S G ++L++ + +R
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 7/193 (3%)

Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G FG V+KG L      AVK       Q L+ +F +E  +  +  H N+++++G CT
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           +R    ++ E +P    D   F   ++  L  ++ V        G+ YL+  +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N L+      KISDFGM++    D   +++G       +  PE +  G YS + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 622 VYSFGVLLLQIIS 634
           V+S+G+LL +  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 30/216 (13%)

Query: 442 KLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGEG FG V+     NL   ++    AVK L   +    ++F+ E  L   LQH ++++
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLDWQKR-----------VNIIEG 542
             G C + D  ++++EY+ +  L+ +L    P    ++D Q R           ++I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG- 601
           +  G++YL   ++   +HRDL   N L+   L  KI DFGM+    +DV   +  R+ G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYRVGGH 184

Query: 602 ---TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                 ++PPE +    ++ + DV+SFGV+L +I +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           +LG G FG V+ G      + A+K ++  +    E+F  E  +  +L H  L+++ G CT
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           ++    ++ E++ N  L  YL    R+  L     +++ + V +G+ YL E ++F  IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYL-ERNSF--IHR 124

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N L+ +    K+SDFGM +    D   +++G       + PPE      YS K D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183

Query: 622 VYSFGVLLLQIISSKR 637
           V+SFGVL+ ++ +  +
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVN 492
           +F   NK+G+G FG V+K       + +A+K+  LS  + +  EE  +E  + A+L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV----TQGLL 548
           ++R      ++ +  ++ EY  N  L         + +   + R    + V     Q LL
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL--------HKLLKMQRGRPLPEDQVWRFFIQILL 112

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
            L    + +++HRD+K+ N+ LD   N KI D G+AKL   + + ANT  IVGT  Y+ P
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSP 170

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           E  +   Y+ K DV++ GV+L +  + K
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRV 496
            +LG G  G V K  + P G+  AVK +           K    E+ +  +     ++  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            G      +  +  EY+   SLD  L      I   +L       I   V +GL YL  +
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYL--H 117

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              ++IHRD+K SNIL+++    K+ DFG++      +  A T   VGT  Y+ PE ++ 
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKT--FVGTSSYMAPERIQG 173

Query: 614 GIYSMKYDVYSFGVLLLQI 632
             YS+K D++S G+ L+++
Sbjct: 174 NDYSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|119349 cd00598, GH18_chitinase-like, The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 18/185 (9%)

Query: 33  WLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           W +GR    +DI  +L TH+I AFAE+ S          +++        +  K P +K 
Sbjct: 8   WSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDKSEEPLKGALEELASKKPGLKV 67

Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           L+SI    +S+                ++  D + R +F  S +   + YGF G+D+ W 
Sbjct: 68  LISIGGWTDSSP--------------FTLASDPASRAAFANSLVSFLKTYGFDGVDIDWE 113

Query: 153 WPNS---TDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAH 209
           +P +   +D  +   LL E + SA       L++AV  S      +Y + ++   +++ +
Sbjct: 114 YPGAADNSDRENFITLLRELR-SALGAANYLLTIAVPASYFDLGYAYDVPAIGDYVDFVN 172

Query: 210 LVAYD 214
           ++ YD
Sbjct: 173 VMTYD 177

Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are included in this alignment model. Length = 210

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 8/198 (4%)

Query: 441 NKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLG 498
             +G G    VY    LP  ++ A+KR+     Q  ++E + EV   ++  H N+++   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                DE  L+  YL   SL   +     R  LD      +++ V +GL YL        
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYVKKGI- 615
           IHRD+KA NILL  + + KI+DFG++       D     R   VGT  ++ PE +++   
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 616 YSMKYDVYSFGVLLLQII 633
           Y  K D++SFG+  +++ 
Sbjct: 184 YDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 13/194 (6%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL 493
           F+    +G+G FG VYK  +    Q  A+K   L     + +E+ + E+   ++ +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +  G   +  +  +I EY    S      D ++   LD      I+  V  GL YL E 
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
                IHRD+KA+NILL  E + K++DFG++      + + NT   VGT  ++ PE +K+
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 614 GIYSMKYDVYSFGV 627
             Y  K D++S G+
Sbjct: 173 SGYDEKADIWSLGI 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 15/197 (7%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVL-GYC 500
           LG+G FG VYK  +   G   A K +   S + LE+F  E+ + +  +H N++ +   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            E    +LI E+    +LD  +   + R + + Q R  +   + + L +L  +   +VIH
Sbjct: 73  YENKLWILI-EFCDGGALD-SIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA NILL  + + K++DFG++   +  + + +T   +GT  ++ PE V     K   
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184

Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K D++S G+ L+++
Sbjct: 185 YDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 30/219 (13%)

Query: 442 KLGEGGFGPVYKGNLPRGQEF---------------AVKRLSATSTQ-GLEEFKNEVSLT 485
           KLGEG FG V+        EF               AVK L A  T+    +F  E+ + 
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT- 544
           +RL++ N++R+LG C   D   +I EY+ N  L+ +L    +R +       N I  V+ 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 545 QGLLY--------LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN 595
             LLY        ++  ++   +HRDL   N L+ N    KI+DFGM++ L+  D     
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            GR V    ++  E +  G ++   DV++FGV L ++ +
Sbjct: 189 -GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 65/235 (27%), Positives = 111/235 (47%), Gaps = 32/235 (13%)

Query: 435 NNFSSANKLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARL 488
           +N     +LGEG FG V+     NL   Q+    AVK L   S    ++F  E  L   L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------------DPIRRYVLDWQKR 536
           QH ++++  G C E D  ++++EY+ +  L+ +L             +      L   + 
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQM 122

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++I + +  G++YL   ++   +HRDL   N L+   L  KI DFGM+    +DV   + 
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS----RDVYSTDY 175

Query: 597 GRIVG----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
            R+ G       ++PPE +    ++ + DV+S GV+L +I +  +   +Y  S N
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-WYQLSNN 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 11/198 (5%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 126

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
           DL+A+NIL+   L  K++DFG+A+L     D   T R    +   +  PE    G +++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL ++ +  R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 40/212 (18%)

Query: 441 NKLGEGGFGPVYK-GNLPRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
             +G+G FG V K      G+    K +     + +  ++  +EV++   L+H N++R  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 496 -------------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
                        V+ YC   D   LI +    K    Y+ +              I   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKC---KKERKYIEEEF------------IWRI 110

Query: 543 VTQGLLYLQE-----YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           +TQ LL L E          V+HRDLK +NI LD   N K+ DFG+AK+   D   A T 
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT- 169

Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             VGT  Y+ PE +    Y  K D++S G L+
Sbjct: 170 -YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           NK+G G FG VY   NL  G+  AVK  R+     + ++E  +E+ +   L+H NL++  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 498 GYCTERDENMLIYEYLPNKSLDLYL----FDP---IRRYVLDWQKRVNIIEGVTQGLLYL 550
           G    R++  +  EY    +L+  L          IR Y L           + +GL YL
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ----------LLEGLAYL 115

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYGYVPP 608
             +    ++HRD+K +NI LD+    K+ DFG A   + +          + GT  Y+ P
Sbjct: 116 HSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 609 EYVKKGIYSMKY---DVYSFGVLLLQIISSKR 637
           E +  G         D++S G ++L++ + KR
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.7 bits (209), Expect = 8e-18
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 32/214 (14%)

Query: 437 FSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQH 490
           F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEG 542
            ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++     
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI----- 118

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIV 600
             +G+ YL+E    R++HRDL A N+L+    + KI+DFG+AKL   D  E  A  G++ 
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV- 173

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 174 -PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLG 498
           K+GEG +G VYK  +   G+  A+K++               E+ L   L H N++++L 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
               + +  L++E++     DLY     R+  L      + +  + QGL +   +    +
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-YVKKGIYS 617
           +HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V T  Y  PE  +    YS
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 618 MKYDVYSFGVLLLQIIS 634
              D++S G +  +++S
Sbjct: 178 TPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 59/198 (29%), Positives = 107/198 (54%), Gaps = 12/198 (6%)

Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L+ T+  +   EF +E  + A + H +L+R+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           LG C       L+ + +P+  L  Y+ +   +  +  Q  +N    + +G++YL+E    
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R++HRDL A N+L+ +  + KI+DFG+A+L   D  E N         ++  E +    +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 617 SMKYDVYSFGVLLLQIIS 634
           + + DV+S+GV + ++++
Sbjct: 189 THQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           F+   ++G G FG VY     R  E  A+K++S +  Q  E++++   EV    R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            +   G         L+ EY    + DL     + +  L   +   I  G  QGL YL  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
           ++   +IHRD+KA NILL      K++DFG A +       AN+   VGT  ++ PE + 
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194

Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              +G Y  K DV+S G+  +++   K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 33/219 (15%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-----LSATSTQGLEEFKNEVSLTARL 488
            N+     LG+G FG VY   ++  G+E AVK+      S  + + +   + E+ L   L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 489 QHVNLLRVLGYCTERDENMLIY-EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT--- 544
           QH  +++  G C   DE + I+ EY+P  S+     D ++ Y         + E VT   
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVK----DQLKAYGA-------LTETVTRKY 109

Query: 545 -----QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR- 598
                +G+ YL  +SN  ++HRD+K +NIL D+  N K+ DFG +K  +  +  + TG  
Sbjct: 110 TRQILEGVEYL--HSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICSSGTGMK 165

Query: 599 -IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            + GT  ++ PE +    Y  K DV+S G  ++++++ K
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)

Query: 443 LGEGGFGPVYKG------NLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVNLL 494
           LGEG FG V K       N       AVK L   +T + L +  +E+ +   + +H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE------------- 541
            +LG CT+     ++ EY  + +L  +L    RR   ++    +                
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA--RRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 542 --GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK------LFRKDVDE 593
              V +G+ +L      + IHRDL A N+L+  +   KI+DFG+A+       +RK  + 
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN- 193

Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              GR+     ++ PE +   +Y+ + DV+SFGVLL +I +
Sbjct: 194 ---GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 11/198 (5%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G      + A+K L    T   E F  E  +  +L+H  L+ +    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ E++   SL  +L +   +Y L   + V++   +  G+ Y+ E  N+  IHR
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYI-ERMNY--IHR 126

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
           DL+A+NIL+ + L  KI+DFG+A+L     D   T R    +   +  PE    G +++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL ++++  R
Sbjct: 184 SDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 28/230 (12%)

Query: 443 LGEGGFGPVYKGNLPRG----QEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRV 496
           LGEG FG V +G L +      + AVK +     +   +EEF +E +      H N++++
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 497 LGYCTERDEN------MLIYEYLPNKSLDLYLF------DPIRRYVLDWQKRVNIIEGVT 544
           +G C E          M+I  ++ +  L  +L        P +   L  Q  +  +  + 
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---LPLQTLLKFMVDIA 123

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-Y 603
            G+ YL   SN   IHRDL A N +L  ++   ++DFG++K      D    GRI     
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
            ++  E +   +Y+ K DV++FGV + +I +  R    Y   EN    +Y
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDY 227

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 10/193 (5%)

Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           K+GEG  G V        G++ AVK +     Q  E   NEV +    QH N++ +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +E  ++ E+L   +L     D + +  L+ ++   + E V Q L YL       VIH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RD+K+ +ILL  +   K+SDFG      KDV +  +  +VGT  ++ PE + +  Y  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 621 DVYSFGVLLLQII 633
           D++S G+++++++
Sbjct: 199 DIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           F+   ++G+G FG VYKG   R +E  A+K +     +  +E+ + E+++ ++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           R  G   +  +  +I EYL   S LDL    P+    +       I+  + +GL YL   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              R IHRD+KA+N+LL  + + K++DFG+A        + NT   VGT  ++ PE +K+
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175

Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 176 SAYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 18/218 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST-QGLEEFK-NEVSLTARLQHVN 492
           +++   K+GEG +G VYKG N   GQ  A+K++   S  +G+      E+SL   LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDL--YLFDPIRR-YVLDWQKRVNIIEGVTQGLLY 549
           ++ +     +     LI+E+L   S+DL  YL D + +   +D +   + +  + QG+L+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
                  RV+HRDLK  N+L+DN+   K++DFG+A+ F   V    T  +V T  Y  PE
Sbjct: 117 CHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVV-TLWYRAPE 171

Query: 610 YVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            +     YS   D++S G +  ++ + K    ++G SE
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK--PLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRV 496
           KLG+G FG V +G  +   G+    AVK L +      +++F  E ++   L H NL+R+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD---WQKRVNIIEGVTQGLLYLQEY 553
            G        M++ E  P  SL   L      + L        V I      G+ YL+  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGM--AKLFRKDVDEANTGRIVGTYGYVPPEYV 611
              R IHRDL A NILL ++   KI DFG+  A    +D         V  + +  PE +
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
           +   +S   DV+ FGV L ++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 17/194 (8%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
            ++G G +G VYK  ++  G+  A+K +        E  + E+S+    +H N++   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 500 CTERDENMLIYEYLPNKSL-DLY--LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
              RD+  ++ EY    SL D+Y     P+    + +     +     +GL YL E    
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYLHE---T 120

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV---KK 613
             IHRD+K +NILL  + + K++DFG++      + +  +   +GT  ++ PE     +K
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERK 178

Query: 614 GIYSMKYDVYSFGV 627
           G Y  K D+++ G+
Sbjct: 179 GGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 59/234 (25%)

Query: 443 LGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
           LGEG FG V K               AVK L   ++   L +  +E +L  ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 496 VLGYCTERDENMLIYEYLPNKSL----------------------DLYLFDPIRRYV--- 530
           + G C++    +LI EY    SL                        YL +P  R +   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 531 ----LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
                 WQ        +++G+ YL E    +++HRDL A N+L+      KISDFG++  
Sbjct: 128 DLISFAWQ--------ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLS-- 174

Query: 587 FRKDVDEANT------GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             +DV E ++      GRI     ++  E +   IY+ + DV+SFGVLL +I++
Sbjct: 175 --RDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 6e-17
 Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 10/201 (4%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           ++   K+G+G  G V+   ++  GQE A+K+++       E   NE+ +   L++ N++ 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
            L      DE  ++ EYL   SL     D +    +D  +   +     Q L +L  ++N
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFL--HAN 134

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            +VIHRD+K+ N+LL  + + K++DFG       +  + +T  +VGT  ++ PE V +  
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 616 YSMKYDVYSFGVLLLQIISSK 636
           Y  K D++S G++ ++++  +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRG----QEFAVKRLSATSTQGLEEF--KNEVSLTARLQ 489
            +     +G G FG V+   L R     +   +K++        E    +NE  +   L 
Sbjct: 1   KYEKIRVVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS 57

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++       E    M++ EY P  +L  Y+        LD      I+    Q LL 
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDED---TILHFFVQILLA 113

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           L       ++HRDLK  NILLD      KI DFG++K+      ++    +VGT  Y+ P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISP 170

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           E  +   Y+ K D+++ G +L ++ S KR
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 27/229 (11%)

Query: 443 LGEGGFGPVYKGNLPRGQ---EFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           LGEG FG V +G L +     + AVK  +++  +   +E+F +E        H N++R++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 498 GYCTERDEN------MLIYEYLPNKSLDLYLF------DPIRRYVLDWQKRVNIIEGVTQ 545
           G C +  E+      ++I  ++ +  L  +L        P     L  Q  V  +  +  
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ---YLPTQMLVKFMTDIAS 123

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-YG 604
           G+ YL   S+   IHRDL A N +L+  +N  ++DFG++K      D    GRI      
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVK 179

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
           ++  E +   +Y+ K DV+SFGV + +I  + R    Y   EN    +Y
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPYPGVENSEIYDY 226

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 80.2 bits (199), Expect = 1e-16
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 50/218 (22%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLTARLQHVN 492
           KLGEG +G VYK  +   G+  A+K++       L+  +         E+SL   L+H N
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL------FDP--IRRYVLDWQKRVNIIEGVT 544
           ++++L       +  L++EY  +  L  YL        P  I+  +  +Q    ++    
Sbjct: 60  IVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM--YQ----LL---- 108

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           +GL Y   +S+ R++HRDLK  NIL++ +   K++DFG+A+ F   +    T  +V T  
Sbjct: 109 RGLAYC--HSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLW 163

Query: 605 YVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSK 636
           Y  PE     I      YS   D++S G +  ++I+ K
Sbjct: 164 YRAPE-----ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNL 493
           LGEG FG V    L R        G++ AVK L   +    + + K E+ +   L H N+
Sbjct: 12  LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           ++  G CTE   N   LI E+LP+ SL  YL  P  +  ++ ++++     + +G+ YL 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPE 609
              + + +HRDL A N+L+++E   KI DFG+ K    D +            + Y P  
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            ++   Y +  DV+SFGV L ++++
Sbjct: 184 LIQSKFY-IASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           ++   K+G+G  G VY   ++  GQE A+K+++       E   NE+ +    +H N++ 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
            L      DE  ++ EYL   SL     D +    +D  +   +     Q L +L  +SN
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFL--HSN 134

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            +VIHRD+K+ NILL  + + K++DFG       +  + +T  +VGT  ++ PE V +  
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 616 YSMKYDVYSFGVLLLQII 633
           Y  K D++S G++ ++++
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 27/202 (13%)

Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLS--ATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
           LG GGFG V       + + FA+K +        G +E   +E  +     H  ++++  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 499 YCTERDEN---MLIYEYLPNKSLDLYLFDPIRRYVL--DWQKRVNIIEGVTQGLLYLQEY 553
           Y T +D+    ML+ EY     L    +  +R   L  ++  R   I  V     YL   
Sbjct: 59  YRTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYL--- 109

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVK 612
            N  +I+RDLK  N+LLD+    K+ DFG AK L         T    GT  YV PE + 
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPEIIL 165

Query: 613 -KGIYSMKYDVYSFGVLLLQII 633
            KG Y    D +S G+LL +++
Sbjct: 166 NKG-YDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           F+   ++G G FG VY   ++   +  A+K++S +  Q  E++++   EV    +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
            +   G C  R+    L+ EY    + D+     + +  L   +   I  G  QGL YL 
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
            +     IHRD+KA NILL      K++DFG A L    V  AN+   VGT  ++ PE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVI 183

Query: 612 ---KKGIYSMKYDVYSFGVLLLQIISSK 636
               +G Y  K DV+S G+  +++   K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL------EEFKNEVSLTARLQH 490
           ++    LG+G +G VY G   +GQ  AVK++   ++  L      E+ + EV L   L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLL 548
           VN+++ LG C + +   +  E++P  S+   L  F P+   V     +  I++GV     
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA---- 116

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK---LFRKDVDEANTGRIV-GTYG 604
           YL       V+HRD+K +N++L      K+ DFG A+           +N  + + GT  
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           ++ PE + +  Y  K D++S G  + ++ + K
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           FS   ++G G FG VY     R  E  A+K++S +  Q  E++++   EV    +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            ++  G         L+ EY    + DL     + +  L   +   +  G  QGL YL  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
             +  +IHRD+KA NILL      K+ DFG A +    +  AN    VGT  ++ PE + 
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX--FVGTPYWMAPEVIL 184

Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              +G Y  K DV+S G+  +++   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 37/242 (15%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSA---TSTQGLEEFKNEVSLTARL-Q 489
           ++F     +GEG F  V         +E+A+K L        + ++  K E  +  RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQG 546
           H  ++++  Y T +DE  L  + EY PN  L       IR+Y  LD +        +   
Sbjct: 61  HPGIIKL--YYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF-RKDVDEANTGRI------ 599
           L YL    +  +IHRDLK  NILLD +++ KI+DFG AK+       E+N G        
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 600 -----------VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
                      VGT  YV PE + +       D+++ G ++ Q+++ K    + G++E L
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYL 229

Query: 649 NF 650
            F
Sbjct: 230 TF 231

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 11/205 (5%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK-NEVSLTARLQHVNL 493
           NF    KLGEG +  VYKG N   G+  A+K +   + +G       E+SL   L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +R+       ++ ML++EY+ +K L  Y+     R  LD     +    + +G+ +  E 
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              RV+HRDLK  N+L++     K++DFG+A+ F   V+  +    V T  Y  P+ V  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE--VVTLWYRAPD-VLL 173

Query: 614 G--IYSMKYDVYSFGVLLLQIISSK 636
           G   YS   D++S G ++ ++I+ +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N   G   A K +   S + LE++  E+ + A   H  ++++LG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
               +  ++ E+ P  ++D  + + + R + + Q +V I   + + L YL    + ++IH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLH---SMKIIH 133

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA N+LL  + + K++DFG++    K +   ++   +GT  ++ PE V     K   
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTP 191

Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K D++S G+ L+++
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 15/216 (6%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHVN 492
           NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           ++++L      ++  L++E+L ++ L  ++   P+    L   K  + +  + QGL +  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH 117

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-Y 610
            +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V T  Y  PE  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEIL 172

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +    YS   D++S G +  ++++  R A + G SE
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 7/195 (3%)

Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGY 499
           ++G G FG V+ G L       AVK    T    L+ +F  E  +  +  H N++R++G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           CT++    ++ E +       +L     R  L  ++ + ++E    G+ YL+       I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL A N L+  +   KISDFGM++     V  +  G       +  PE +  G YS +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 620 YDVYSFGVLLLQIIS 634
            DV+SFG+LL +  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG V+KG  +P G       A+K +   +  Q  +E  + +     L H  ++R+
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           LG C       L+ +  P  SL  ++     R  LD Q+ +N    + +G+ YL+E+   
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R++HR+L A NILL ++   +I+DFG+A L   D  +           ++  E +  G Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 617 SMKYDVYSFGVLLLQIIS 634
           + + DV+S+GV + +++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 13/214 (6%)

Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+K+++       E   NE+
Sbjct: 11  IVSVGDPKKKYTRFE---KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG       +  + +T  +VGT
Sbjct: 124 CLQALDFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ ++++  +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
              +  K+GEG  G V        G++ AVK++     Q  E   NEV +    QH N++
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            +       DE  ++ E+L   +L     D +    ++ ++   +   V + L +L    
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLH--- 132

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRD+K+ +ILL ++   K+SDFG      K+V    +  +VGT  ++ PE + + 
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRL 190

Query: 615 IYSMKYDVYSFGVLLLQII 633
            Y  + D++S G+++++++
Sbjct: 191 PYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 442 KLGEGGFGPVY---------KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
           +LG+G FG VY         +  L   +E  V  L+   T    +   E  L ++L H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK--RVNIIEGVTQGLLYL 550
           +++      ERD   +I EY   + LD      +       +      + E   Q LL +
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLD----CKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                 R++HRDLKA NI L N L  KI DFG+++L     D A T    GT  Y+ PE 
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176

Query: 611 VKKGIYSMKYDVYSFGVLLLQI 632
           +K   Y  K D++S G +L ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 436 NFSSANKLGEGGFGPVYK-GNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVN 492
           +F    KLG+G +G VYK   L   Q +A+K   L + S +  E+  NE+ + A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 493 LLRVLGYCTER-DENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT----- 544
              ++ Y     D N L  + EY P        F  + + +   +K+  +I         
Sbjct: 61  ---IISYKEAFLDGNKLCIVMEYAP--------FGDLSKAISKRKKKRKLIPEQEIWRIF 109

Query: 545 -QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            Q L  LQ     +++HRDLK++NILL      KI D G++K+ +K++  A T   +GT 
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKT--QIGTP 165

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            Y+ PE  K   YS K D++S G LL ++ +
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)

Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG         +++    +VGT
Sbjct: 125 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGT 179

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
             NF    K+G+G F  VYK   L  G+  A+K++        +  ++   E+ L  +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N+++ L    E +E  ++ E      L         R +  ++K+  +I   T    +
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDL--------SRMIKHFKKQKRLIPERTIWKYF 112

Query: 550 LQEYSNF------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           +Q  S        R++HRD+K +N+ +      K+ D G+ + F      A++  +VGT 
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
            Y+ PE + +  Y+ K D++S G LL ++ + +  + +YG   NL
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 12/208 (5%)

Query: 435 NNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN S    LG G FG V +     L +     + AVK L  T+     E   +E+ + + 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           L  H N++ +LG CT     ++I EY     L  +L    R   L  +  ++    V +G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + +L   +    IHRDL A N+LL +    KI DFG+A+    D +    G       ++
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            PE +   +Y+ + DV+S+G+LL +I S
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 442 KLGEGGFGPVYKG--NLPRGQ-EFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVL 497
           +LG G FG V KG   + + Q + A+K L   + + + +E   E  +  +L +  ++R++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G C E +  ML+ E      L+ +L    ++  +     V ++  V+ G+ YL+   NF 
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG-KNF- 116

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGI 615
            +HRDL A N+LL N+   KISDFG++K    D D     R  G +   +  PE +    
Sbjct: 117 -VHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRK 174

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           +S + DV+S+G+ + +  S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 443 LGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G +G VY       Q   A+K +    ++ ++    E++L + L+H N+++ LG  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 502 ERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNII---EGVTQGLLYLQEYSN 555
           E     +  E +P  SL   L   + P++           II   + + +GL YL +   
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLK------DNEQTIIFYTKQILEGLKYLHDN-- 127

Query: 556 FRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
            +++HRD+K  N+L++      KISDFG +K  R       T    GT  Y+ PE + KG
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKG 184

Query: 615 I--YSMKYDVYSFGVLLLQIISSK 636
              Y    D++S G  ++++ + K
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 45/231 (19%)

Query: 442 KLGEGGFGPV---------------YKGNLPRGQEF--AVKRLSATSTQGLE-EFKNEVS 483
           KLGEG FG V               +  N+ +G+    AVK L   + +    +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD----------- 532
           + +RL+  N++R+LG C + D   +I EY+ N  L+ +L      ++ D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 533 --------WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                   +   +++   +  G+ YL   S+   +HRDL   N L+   L  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 585 K-LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           + L+  D      GR V    ++  E +  G ++   DV++FGV L +I+ 
Sbjct: 186 RNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 437 FSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           F   +++G G FG VY   N    +  AVK++S +  Q  E++++   EV    +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            +   G   +     L+ EY    + DL     + +  L   +   I  G  QGL YL  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
           ++   +IHRD+KA NILL      K++DFG A         AN+   VGT  ++ PE + 
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190

Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              +G Y  K DV+S G+  +++   K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N   G   A K +   S + LE++  E+ + A   H N++++L   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   ++ E+    ++D  + + + R + + Q RV + +   + L YL E    ++IH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA NIL   + + K++DFG++    + +   ++   +GT  ++ PE V     K   
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 184

Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K DV+S G+ L+++
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG   R Q+  A+K +     +  +E+ + E+++ ++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P     LD  +   I+  + +GL YL   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              + IHRD+KA+N+LL      K++DFG+A        + N    VGT  ++ PE +K+
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175

Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 176 SAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 42/124 (33%), Positives = 69/124 (55%), Gaps = 13/124 (10%)

Query: 511 EYLPNKSLD--LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           E++   SLD       PI   +L       I   V +GL YL  Y+  R++HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNI 135

Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628
           L+++    K+ DFG++      +  A+T   VGT  Y+ PE ++ G Y++K DV+S G+ 
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSI--ADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191

Query: 629 LLQI 632
           ++++
Sbjct: 192 IIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 19/212 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
           N+     LG+G FG VY   ++  G+E A K++     S  +++ +   + E+ L   LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
           H  +++  G   +R E  L    EY+P  S+     D ++ Y  L           + +G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
           + YL  +SN  ++HRD+K +NIL D+  N K+ DFG +K  +  +  + TG   + GT  
Sbjct: 119 MSYL--HSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICMSGTGIRSVTGTPY 174

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           ++ PE +    Y  K DV+S G  ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV 491
           +F     +G+G FG V         + FA+K ++         +    NE  +   L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH- 59

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQ 545
             L  L Y  + +ENM    YL    +DL L   +R Y L  + + +       I  +  
Sbjct: 60  PFLVNLWYSFQDEENM----YL---VVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVL 111

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL       +IHRD+K  NILLD + +  I+DF +A     D     T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           + PE + +  YS+  D +S GV   + +  KR
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 62/217 (28%), Positives = 119/217 (54%), Gaps = 21/217 (9%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFK-NEVSLTARLQ---HVNLL 494
            ++GEG +G VYK  +L  G+  A+K++    S +G+      E++L  +L+   H N++
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 495 RVLGYC-TERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           R+L  C   R +      L++E++ ++ L  YL     +  L  +   +++  + +G+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L  +S+ R++HRDLK  NIL+ ++   KI+DFG+A+++    + A T  +V T  Y  PE
Sbjct: 123 L--HSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTS-VVVTLWYRAPE 176

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            + +  Y+   D++S G +  ++   +R   + GTSE
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL--FRRRPLFRGTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 8e-15
 Identities = 54/235 (22%), Positives = 110/235 (46%), Gaps = 26/235 (11%)

Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF 462
              +S+ ++    S +      S S+++         N++G G  G VYK  + P G+ +
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLSELE-------RVNRIGSGAGGTVYKVIHRPTGRLY 102

Query: 463 AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY 521
           A+K +       +  +   E+ +   + H N+++         E  ++ E++   SL+  
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-- 160

Query: 522 LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581
                  ++ D Q   ++   +  G+ YL       ++HRD+K SN+L+++  N KI+DF
Sbjct: 161 -----GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF 212

Query: 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY-----DVYSFGVLLLQ 631
           G++++  + +D  N+   VGT  Y+ PE +   +    Y     D++S GV +L+
Sbjct: 213 GVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 54/199 (27%), Positives = 104/199 (52%), Gaps = 13/199 (6%)

Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           F+   ++G+G FG V+KG   R Q+  A+K +     +  +E+ + E+++ ++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P   + +       +++ + +GL YL   
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGLDYLHSE 120

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              + IHRD+KA+N+LL  + + K++DFG+A        + NT   VGT  ++ PE +++
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175

Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 176 SAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 31/220 (14%)

Query: 442 KLGEGGFGPVYKGNLPRGQEF-----------------AVKRLSATSTQGLE-EFKNEVS 483
           KLGEG FG V+       ++F                 AVK L   + +    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------DPIRRYV--LDWQK 535
           + +RL+  N++R+L  C   D   +I EY+ N  L+ +L          +  V  + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEA 594
            + +   +  G+ YL   S+   +HRDL   N L+      KI+DFGM++ L+  D    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             GR V    ++  E +  G ++   DV++FGV L +I++
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 37/226 (16%)

Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGLEEFKNEV 482
           + A    + + +LG+G FG VY+G + +G          A+K ++ A S +   EF NE 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ-------- 534
           S+       +++R+LG  ++    ++I E +    L  YL    R    + +        
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPP 116

Query: 535 ---KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
              K + +   +  G+ YL      + +HRDL A N ++  +   KI DFGM     +D+
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----RDI 169

Query: 592 DEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQI 632
            E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I
Sbjct: 170 YETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 28/223 (12%)

Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG+G FG VY+GN   + +G+     AVK ++ + S +   EF NE S+       +++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLF-------DPIRRYVLDWQKRVNIIEGVTQGL 547
           R+LG  ++    +++ E + +  L  YL        +   R     Q+ + +   +  G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            YL      + +HRDL A N ++ ++   KI DFGM     +D+ E +  R  G  G +P
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT----RDIYETDYYR-KGGKGLLP 184

Query: 608 -----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
                PE +K G+++   D++SFGV+L + I+S     Y G S
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 19/200 (9%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVLGY- 499
           +G G +G VY+G ++P G+  A+K ++  T    + + + EV+L ++L+      +  Y 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 500 -CTERDENM-LIYEYLPNKSL-DLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
               +   + +I EY    S+  L    PI  +Y+        II  V   L Y+ +   
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI------SVIIREVLVALKYIHKVG- 121

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             VIHRD+KA+NIL+ N  N K+ DFG+A L  ++  + +T   VGT  ++ PE + +G 
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGK 177

Query: 616 -YSMKYDVYSFGVLLLQIIS 634
            Y  K D++S G+ + ++ +
Sbjct: 178 YYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKR---LSATSTQGLEEFKNEVSLTARLQHVN 492
            +    K+GEG FG +Y        E  V +   L+    +  E  K EV L A+++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV--------- 543
           ++       E     ++ EY                   D  KR+N   GV         
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGG---------------DLMKRINRQRGVLFSEDQILS 105

Query: 544 --TQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIV 600
              Q  L L+   + +++HRD+K+ NI L  N +  K+ DFG+A+     ++ A T   V
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CV 163

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           GT  Y+ PE  +   Y+ K D++S G +L ++ + K
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-Q 489
           N+    + +GEG FG V K  + +     + A+KR+   +++    +F  E+ +  +L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKR 536
           H N++ +LG C  R    L  EY P+ +L  +L        DP           L  Q+ 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++    V +G+ YL   S  + IHRDL A NIL+      KI+DFG+++     V +   
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-M 182

Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++  E +   +Y+   DV+S+GVLL +I+S
Sbjct: 183 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)

Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    +    AVK L   +T + L +  +E+ L   + +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  +L           FD  +     L ++  V+ 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL+     R IHRDL A N+L+  +   KI+DFG+A+    D+D   + + 
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSN 195

Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   +Y+ + DV+SFG+L+ +I +
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 36/210 (17%)

Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L   TS +  +E  +E  + A +    + R+
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLL 548
           LG C       L+ + +P   L     D +R        + +L+W  ++       +G+ 
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQI------AKGMS 123

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----ANTGRIVGTYG 604
           YL+E    R++HRDL A N+L+ +  + KI+DFG+A+L   D+DE    A+ G++     
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKV--PIK 176

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           ++  E +    ++ + DV+S+GV + ++++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 442 KLGEGGFGPVYKG--NLPRGQE-FAVKRLSATSTQGL--EEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG   + + ++  AVK L   +      +E   E ++  +L +  ++R+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ +L     ++V + +    ++  V+ G+ YL+E +NF
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQK--NKHVTE-KNITELVHQVSMGMKYLEE-TNF 116

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K    D +         T+G  P     PE +
Sbjct: 117 --VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA----KTHGKWPVKWYAPECM 170

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 20/227 (8%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFA---VKRLSATST-QGLEEFKNEVSLTARLQHVNLLRV 496
           +++G G FG V  G   RG   A   VK L A++T      F  EV     L H N+L+ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV--NIIEGVTQGLLYLQEYS 554
           LG C E    +L+ E+ P   L  YL           QK V   +   V  GLL+L + +
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-A 119

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVK- 612
           +F  IH DL   N  L  +L+ KI D+G+A + + +D         V    ++ PE V+ 
Sbjct: 120 DF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 613 -----KGIYSMKY-DVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
                      K  +++S GV + ++       + Y    +   L+ 
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL--FTAADQPYPDLSDEQVLKQ 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 29/206 (14%)

Query: 443 LGEGGFGPVYKG--NLPRGQEFAVK----RLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG + +G   LP  +E  V     R   +  Q    F  E     +  H N++R+
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY--VLDWQKRVNIIEGVTQGLLYLQEYS 554
            G  T  +  M++ EY+ N +LD +L    R++   L   + + ++ G+  G+ YL E  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG------YVPP 608
               +H+ L A  +L++++L  KIS F   +   +D  EA    I  T        +  P
Sbjct: 128 ---YVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEA----IYTTMSGKSPVLWAAP 177

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E ++   +S   DV+SFG+++ +++S
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 437 FSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQ 489
            + ++ L EG FG ++ G L      + +E  VK +   A+  Q +     E  L   L 
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLS 66

Query: 490 HVNLLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYV-------LDWQKRVNIIE 541
           H N+L +L  C E  +   ++Y Y+   +L L+L     R         L  Q+ V++  
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC--RLGEANNPQALSTQQLVHMAI 124

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVD--EANTGR 598
            +  G+ YL +     VIH+D+ A N ++D EL  KI+D  +++ LF  D      N  R
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            V    ++  E +    YS   DV+SFGVLL ++++
Sbjct: 182 PV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           K+GEG  G V        G++ AVK++     Q  E   NEV +     H N++ +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              DE  ++ E+L   +L     D +    ++ ++   +   V + L YL    N  VIH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIH 141

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RD+K+ +ILL ++   K+SDFG      K+V +  +  +VGT  ++ PE + +  Y  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199

Query: 621 DVYSFGVLLLQIISSK 636
           D++S G++++++I  +
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 58/215 (26%), Positives = 111/215 (51%), Gaps = 10/215 (4%)

Query: 437 FSSANKLGEGGFG-PVYKGNLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNL 493
           +    K+GEG FG  +   +   G+++ +K +  S  S +  EE + EV++ + ++H N+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           ++      E     ++ +Y      DLY     +R VL  + +  I++   Q  L L+  
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQ--ILDWFVQICLALKHV 117

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + +++HRD+K+ NI L  +   K+ DFG+A++    V+ A T   +GT  Y+ PE  + 
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICEN 175

Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
             Y+ K D+++ G +L ++ + K +A   G  +NL
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK-HAFEAGNMKNL 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.4 bits (177), Expect = 8e-14
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 10/193 (5%)

Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           K+GEG  G V    +   G+  AVK++     Q  E   NEV +    QH N++ +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              DE  ++ E+L   +L     D +    ++ ++   +   V + L  L       VIH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RD+K+ +ILL ++   K+SDFG      K+V    +  +VGT  ++ PE + +  Y  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEV 197

Query: 621 DVYSFGVLLLQII 633
           D++S G+++++++
Sbjct: 198 DIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGFG V    +   G+ +A K+L        +G +   NE  +  ++     +  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 499 YCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           Y  E +D+  L+   +    L  ++++ +        + +     +  GL +L      R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRR 115

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +++RDLK  N+LLD+  N +ISD G+A   +            GT GY+ PE ++  +Y 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGT 644
              D ++ G  L ++I+ +   R    
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 59/217 (27%), Positives = 116/217 (53%), Gaps = 22/217 (10%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEF-AVKRLSA-TSTQGLE-EFKNEVSLTARLQ---HVNLL 494
           ++GEG +G V+K  +L  G  F A+KR+   T  +G+      EV++   L+   H N++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 495 RVLGYCT----ERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           R+   CT    +R+  + L++E++ ++ L  YL D +    +  +   +++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L  +   RV+HRDLK  NIL+ +    K++DFG+A+++     +     +V T  Y  PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            + +  Y+   D++S G +  ++   +R   + G+S+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 30/217 (13%)

Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDP--IRRYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P  +    L ++  V+ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANT-G 597
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+ +   D  +  T G
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           R+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 203 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 111/218 (50%), Gaps = 29/218 (13%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARLQHV 491
           F    ++GEG +G VYK  +   G+  A+K++   + +  E F      E+ +  +L H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66

Query: 492 NLLRVLGYCTERDENM----------LIYEYLPNKSLDLYLFDPIRRYVLDWQKR--VNI 539
           N++ +    T++ + +          L++EY+     D  L   +   ++ + +    + 
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
           ++ + +GL Y  +  NF  +HRD+K SNILL+N+   K++DFG+A+L+  +     T ++
Sbjct: 122 MKQLLEGLNYCHK-KNF--LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 600 VGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
           + T  Y PPE  + +  Y    DV+S G +L ++ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 19/212 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
           N+     LG+G FG VY   +   G+E AVK++     S  +++ +   + E+ L   L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
           H  +++  G   +  E  L    E++P  S+     D ++ Y  L           + +G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
           + YL  +SN  ++HRD+K +NIL D+  N K+ DFG +K  +  +  + TG   + GT  
Sbjct: 119 VSYL--HSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQT-ICLSGTGMKSVTGTPY 174

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           ++ PE +    Y  K D++S G  ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 28/212 (13%)

Query: 443 LGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-QHVNLLRVL 497
           +GEG FG V +  + +       A+K L   +++    +F  E+ +  +L  H N++ +L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 498 GYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKRVNIIEGVT 544
           G C  R    +  EY P  +L  +L        DP           L  Q+ +     V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
            G+ YL E    + IHRDL A N+L+   L  KI+DFG+++      +E    + +G   
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181

Query: 605 --YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++  E +   +Y+ K DV+SFGVLL +I+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 19/212 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
           N+     LG G FG VY   +   G+E AVK++     S  +++ +   + E+ L   L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
           H  +++  G   + +E  L    EY+P  S+     D ++ Y  L           + QG
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
           + YL  +SN  ++HRD+K +NIL D+  N K+ DFG +K  +  +  + TG   + GT  
Sbjct: 119 VSYL--HSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQT-ICMSGTGIKSVTGTPY 174

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           ++ PE +    Y  K DV+S    ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFK-NEVSLTARLQHVNLLRVL 497
           K+GEG +G VYK  +   G+  A+K  RL  T  +G+      E+SL   L H N++R+L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 498 GYCTERDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
                 ++  L++E+L    LDL  Y+ D      LD     + +  + QG+ Y   +S+
Sbjct: 65  DVVHSENKLYLVFEFL---DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYC--HSH 118

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG- 614
            RV+HRDLK  N+L+D E   K++DFG+A+ F   V    T  +V T  Y  PE +    
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEILLGSR 175

Query: 615 IYSMKYDVYSFGVLLLQIISSK 636
            YS   D++S G +  ++++ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 446 GGFGPVY---KGNLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVNLLRVLGY 499
           G +G V+   K +   G  +A+K +          +++   E  + ++ Q   +++ L Y
Sbjct: 4   GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYY 60

Query: 500 CTERDENM-LIYEYLPNKSLDLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
             +  +N+ L+ EYLP    DL  L + +    LD       I  +   L YL    +  
Sbjct: 61  SFQGKKNLYLVMEYLPGG--DLASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNG 113

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKL------FRKDVDEANTGRIVGTYGYVPPEYV 611
           +IHRDLK  NIL+D+  + K++DFG++K+         + DE    RIVGT  Y+ PE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S   D +S G +L + + 
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|225862 COG3325, ChiA, Chitinase [Carbohydrate transport and metabolism]

 Score = 71.7 bits (176), Expect = 4e-13
 Identities = 78/396 (19%), Positives = 136/396 (34%), Gaps = 111/396 (28%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-------------------QYF 76
            +++   DI     TH+  AF +++S    +    A++                      
Sbjct: 52  RQDYFPGDIPLDQLTHINYAFLDINSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLK 111

Query: 77  SIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFI 132
             F     ++   P +KTL+SI  W+                    S M  D + R++F 
Sbjct: 112 GHFGALFDLKATYPDLKTLISIGGWSDSGG---------------FSDMAADDASRENFA 156

Query: 133 ESSIRTARLYGFQGIDLFWLWPNS-----------------TDLNSLGILLDEWKASASD 175
           +S++   R YGF G+D+ W +P S                   L  L   LD+  A   D
Sbjct: 157 KSAVEFMRTYGFDGVDIDWEYPGSGGDAGNCGRPKDKANYVLLLQELRKKLDK--AGVED 214

Query: 176 QPELTLSMAVRYSPTHETVSY-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234
                L++A     + + +       + + +++ +++ YD+H    E   G HAALY   
Sbjct: 215 GRHYQLTIAA--PASKDKLEGLNHAEIAQYVDYINIMTYDFHGAWNET-LGHHAALYGTP 271

Query: 235 -------------SNISTDFGIREWLRRGFPANKLVLGARASGPGITI------------ 269
                        + +     + E      P +KLVLG    G G               
Sbjct: 272 KDPPLANGGFYVDAEVDGIDWLEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGL 331

Query: 270 ----------DGSMG-----YKFIRAFI--QN------YGYGAAPVYNASYVVNLFTSGA 306
                      G+         + +A+    N      Y      V  A Y+ N      
Sbjct: 332 YQGLDNSGIPKGTWEAGNGDKDYGKAYDLDANNAGKNGYERYWDDVAKAPYLYN--PEKG 389

Query: 307 TWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
            +I++D   ++KAK  Y  + NL G   +++S D+N
Sbjct: 390 VFISYDDPRSVKAKAEYVADNNLGGMMFWEISGDEN 425

Length = 441

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 20/222 (9%)

Query: 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHV 491
           NF    K+G G F  VY+   L   +  A+K++        +  ++   E+ L  +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLD--LYLFDPIRRYVLD---WQKRVNIIEGVTQG 546
           N+++ L    E +E  ++ E      L   +  F   +R + +   W+  V +   V   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV--- 119

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
               +   + RV+HRD+K +N+ +      K+ D G+ + F      A++  +VGT  Y+
Sbjct: 120 ----EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
            PE + +  Y+ K D++S G LL ++  +   + +YG   NL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)

Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQH-VNLLRVLGY 499
           LG G +G V K  ++P G   AVKR+ AT ++Q  +    ++ ++ R       +   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG- 67

Query: 500 CTERDENMLIYEYLPNKSLD-LYLFDPIRRYVLDWQKRV------NIIEGVTQGLLYLQE 552
              R+ ++ I   + + SLD  Y      + V D    +       I   + + L YL  
Sbjct: 68  ALFREGDVWICMEVMDTSLDKFY------KKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
                VIHRD+K SN+L++     K+ DFG++      V  A T    G   Y+ PE + 
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDA-GCKPYMAPERIN 176

Query: 612 ----KKGIYSMKYDVYSFGVLLLQI 632
               +KG Y +K DV+S G+ ++++
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 28/212 (13%)

Query: 443 LGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-QHVNLLRVL 497
           +GEG FG V K  + +     + A+KR+   +++    +F  E+ +  +L  H N++ +L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 498 GYCTERDENMLIYEYLPNKSLDLYL-------FDPI--RRY----VLDWQKRVNIIEGVT 544
           G C  R    L  EY P+ +L  +L        DP           L  Q+ ++    V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           +G+ YL +    + IHRDL A NIL+      KI+DFG+++       E    + +G   
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174

Query: 605 --YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++  E +   +Y+   DV+S+GVLL +I+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +G+G FG VY G L     +    AVK L+  T  + +E+F  E  +     H N+L +L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++        +  +  +     V +G+ YL   ++ 
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL---ASK 117

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD     K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALESLQ 175

Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 28/200 (14%)

Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTAR 487
              ++    KLGEG FG VYK   +  G+  A+K++   + +  + F      E+ +  +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63

Query: 488 LQHVNLLRVLGYCTERDENML-----IYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNII 540
           L+H N++ ++    ER +        +Y   P    DL   L +P     L   +    +
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYM 121

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +G+ YL E     ++HRD+KA+NIL+DN+   KI+DFG+A+ +         G   
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 601 GTYGYV---------PPEYV 611
           GT  Y          PPE +
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 34/209 (16%)

Query: 443 LGEGGFG-PVYKGNLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLLR----- 495
           +GEG FG  +   ++   Q++A+K +    S+  +E+ + E  L A+++H N++      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 496 --------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
                   V+ YC   D    + + +  +   L+  D I    L W           Q  
Sbjct: 68  EADGHLYIVMEYCDGGD----LMQKIKLQRGKLFPEDTI----LQW---------FVQMC 110

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L +Q     RV+HRD+K+ NI L      K+ DFG A+L       A T   VGT  YVP
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVP 168

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           PE  +   Y+ K D++S G +L ++ + K
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 32/218 (14%)

Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    +    AVK L   +T + L +  +E+ +   + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     ++ EY    +L  YL           FD  +     L ++  V+ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+    ++D   +   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH-NIDYYKKTTN 195

Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   +Y+ + DV+SFGVLL +I +
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 20/222 (9%)

Query: 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHV 491
           NF    K+G G F  VY+   L  G   A+K++        +   +   E+ L  +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLD---WQKRVNIIEGVTQG 546
           N+++      E +E  ++ E      L   +  F   +R + +   W+  V +       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA---- 118

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
              L+   + RV+HRD+K +N+ +      K+ D G+ + F      A++  +VGT  Y+
Sbjct: 119 ---LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
            PE + +  Y+ K D++S G LL ++ + +  + +YG   NL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 29/213 (13%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN----EVSLTARLQ 489
           N +     +GEG +G V K  N   G+  A+K+   +     E+ K     EV +  +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDL-----YLFDP--IRRYVLDWQKRVNIIEG 542
           H N++ +      +    L++EY+    L+L         P  +R Y+  WQ        
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYI--WQ-------- 108

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + Q + Y   +S+  +IHRD+K  NIL+      K+ DFG A+  R       T   V T
Sbjct: 109 LLQAIAYC--HSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVAT 164

Query: 603 YGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIIS 634
             Y  PE  V    Y    DV++ G ++ +++ 
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 437 FSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT--STQGLEEFKNEVSLTARLQH 490
           F+    LG+G FG V +  L       Q+ AVK L A   S+  +EEF  E +      H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 491 VNLLRVLGYCTERDEN------MLIYEYLPNKSLDLYLFDPIRR-----YVLDWQKRVNI 539
            N+++++G              M+I  ++  K  DL+ F  + R     + L  Q  V  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGR 598
           +  +  G+ YL   S+   IHRDL A N +L+  +   ++DFG++ K++  D        
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
            +    ++  E +   +Y+   DV++FGV + +I++  R    Y   EN     Y
Sbjct: 176 KLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNY 227

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 2e-12
 Identities = 55/228 (24%), Positives = 108/228 (47%), Gaps = 23/228 (10%)

Query: 413 EYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS 471
           ++FDS     +  + +DI ++       N +  G  G  YKG ++  G +F VK ++  +
Sbjct: 673 QFFDSKV--SKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727

Query: 472 TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
           +       +E++   +LQH N+++++G C       LI+EY+  K+L   L +      L
Sbjct: 728 SIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------L 777

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            W++R  I  G+ + L +L    +  V+  +L    I++D +  P +    +  L   D 
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639
                 +   +  YV PE  +    + K D+Y FG++L+++++ K  A
Sbjct: 837 ------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878

Length = 968

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRV 496
            +GEG FG VY+G    P  ++   AVK     ++  + E+F  E  +  +  H +++++
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G  TE +   ++ E  P   L  YL   + +Y LD    +     ++  L YL E   F
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYL-ESKRF 128

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-VDEANTGRIVGTYGYVPPEYVKKGI 615
             +HRD+ A N+L+ +    K+ DFG+++    +   +A+ G++     ++ PE +    
Sbjct: 129 --VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           ++   DV+ FGV + +I+ 
Sbjct: 185 FTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 31/205 (15%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG--- 498
           LG+G FG V+   L    Q FA+K L       L +   E ++  +       RVL    
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEK-------RVLSLAW 53

Query: 499 --------YCT-ERDENML-IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
                   YCT +  EN+  + EYL    L ++      ++  D  +       +  GL 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHKF--DLPRATFYAAEIICGLQ 110

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +L       +++RDLK  NILLD + + KI+DFGM K     + +A T    GT  Y+ P
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAP 165

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQII 633
           E +    Y+   D +SFGVLL +++
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)

Query: 436 NFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTAR 487
           NF     LG G +G V+     G    G+ +A+K L   +     +  E  + E  +   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           ++    L  L Y  + D  + LI +Y+    L  +L+   R +  + + RV I E V   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIV--- 115

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
            L L       +I+RD+K  NILLD+E +  ++DFG++K F  + +E       GT  Y+
Sbjct: 116 -LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYM 173

Query: 607 PPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
            PE ++ G   +    D +S GVL  ++++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/216 (28%), Positives = 115/216 (53%), Gaps = 21/216 (9%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLE-EFKNEVSLTARLQ---HVNLLR 495
           ++G G +G VYK  +   G   A+K +   T+  GL      EV+L  RL+   H N++R
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 496 VLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
           ++  C    T+R+  + L++E++ ++ L  YL D +    L  +   +++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
             ++N  ++HRDLK  NIL+ +    K++DFG+A+++   +  A T  +V T  Y  PE 
Sbjct: 125 --HAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVV-TLWYRAPEV 178

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           + +  Y+   D++S G +  ++   +R   + G SE
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 19/159 (11%)

Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYE-----YLPNKSLDLYLFDPIRRYVLDWQK 535
           E  L   + H +++R+         + L+        LP+ S DLY +   R   L   +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            + I + + +GL YL      R+IHRD+K  NI +++     I D G A+     V    
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              + GT     PE + +  Y+ K D++S G++L ++++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 33/214 (15%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGL---EEFKNEVSLTARLQHV 491
           +      +G G FG V+       + + A+K ++      L   +   NE  +   + H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 492 NLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            ++R+  + TE D+  L  + EY+P   L  YL +   R+              + GL Y
Sbjct: 62  FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRF------------SNSTGLFY 106

Query: 550 -------LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
                  L+   +  +++RDLK  NILLD E + K++DFG AK   K  D   T  + GT
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWT--LCGT 161

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+ PE ++   ++   D ++ G+L+ +++   
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 31/205 (15%)

Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG--- 498
           LG+G FG V    L    EF A+K L       LE+   E ++  R       RVL    
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVER-------RVLALAW 53

Query: 499 --------YCTERDENMLIY--EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
                   +CT + +  L +  EYL    L ++      R+    + R    E +  GL 
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDEA-RARFYAAE-IICGLQ 110

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +L +     +I+RDLK  N+LLD + + KI+DFGM K       E       GT  Y+ P
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAP 165

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQII 633
           E +K   Y+   D +SFGVLL +++
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 32/218 (14%)

Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K         AVK L   +T+  L +  +E+ +   + +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           +D  R     + ++  V+ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++D   +   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198

Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 199 GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +F    ++G G +G VYK  N+  G+  A+K +     +     + E+ +    +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 495 RVLGYCTERDENMLIYEYLPNKSL-DLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
              G    RD+  +  E+    SL D+Y +  P+    + +  R  +     QGL YL  
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
                 +HRD+K +NILL +  + K++DFG++      +  A     +GT  ++ PE   
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAA 179

Query: 612 --KKGIYSMKYDVYSFGVLLLQI 632
             +KG Y+   D+++ G+  +++
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 29/208 (13%)

Query: 443 LGEGGFGP--VYK----GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG+G FG   +Y+     +L   +E  + RLS    +   +  NE+ + + LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64

Query: 497 LGYCTERDENMLIYEYLPNKSL-------DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
             +  + +  ++  EY    +L          LF+     VL +      +  +   + Y
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWY------LFQIVSAVSY 116

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           + +     ++HRD+K  NI L      K+ DFG++K+   +   A T  +VGT  Y+ PE
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
             +   Y+ K D+++ G +L ++++ KR
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.8 bits (163), Expect = 8e-12
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL      KI DFG+A+   KD D    G     
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+ + DV+SFGVLL +I S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 9e-12
 Identities = 37/94 (39%), Positives = 58/94 (61%), Gaps = 2/94 (2%)

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGTY 603
           Q LL +    +  +IHRD+K++NILL +    K+ DFG +K++   V + + GR   GT 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-DVGRTFCGTP 209

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            YV PE  ++  YS K D++S GVLL ++++ KR
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 49/198 (24%)

Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQ--GLEEFK-NEVSLTARLQHVNLLR 495
            +G G +G VYK    N   G+E+A+K+      Q  G+ +    E++L   L+H N++ 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 496 VLGYCTERDENM--LIYEYLPNKSLDL-----YLFDPIRRYV-------LDWQKRVNIIE 541
           ++    E  +    L+++Y  +   DL     +     R  +       L WQ       
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLWQ------- 116

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK------DV 591
            +  G+ YL  +SN+ V+HRDLK +NIL+  E       KI D G+A+LF        D+
Sbjct: 117 -ILNGVHYL--HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 592 DEANTGRIVGTYGYVPPE 609
           D      +V T  Y  PE
Sbjct: 173 D-----PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.9 bits (166), Expect = 1e-11
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 26/195 (13%)

Query: 459 GQEFAVKRLSATSTQGLEE---FKNEVSLTARLQHVNLLRVL--GYCTERDENMLIYEYL 513
           G E A+K L   + +   +   F+ E +L ARL H N++ +L  G          ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGV---TQGLLYLQEYSNFRVIHRDLKASNILL 570
           P ++L         R VL     +   E      Q L  L    N  ++HRDLK  NI++
Sbjct: 62  PGRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

Query: 571 ---DNELNPKISDFGMAKLFR--KDVDEAN---TGRIVGTYGYVPPEYVKKGIYSMKYDV 622
                  + K+ DFG+  L    +D D A    T  ++GT  Y  PE ++    +   D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 623 YSFGVLLLQIISSKR 637
           Y++G++ L+ ++ +R
Sbjct: 173 YAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 5/103 (4%)

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+GY+
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162

Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
            PE ++KG+ Y    D +S G +L +++      R + T +  
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 5/104 (4%)

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           T+ +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159

Query: 604 GYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           GY+ PE ++KG  Y    D +S G +L +++      R + T +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGFG V    +   G+ +A K+L+       +G E    E  + A++ H   +  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYV---------LDWQKRVNIIEGVTQGLLY 549
           Y  +   ++ +   + N          +R ++             +       +  GL +
Sbjct: 60  YAFQTKTDLCLVMTIMNGG-------DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L +    R+I+RDLK  N+LLDN+ N +ISD G+A +  KD      G   GT G++ PE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKG-YAGTPGFMAPE 167

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
            ++   Y    D ++ GV L ++I+++   R  G
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 32/205 (15%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLG-- 498
           +GEG +G VYK  +   GQ  A+K +     +  EE K E ++  +   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 499 ----YCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVN------IIEGVTQGL 547
                    D+  L+ E     S+ DL       + +    KR+       I+    +GL
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            YL E    +VIHRD+K  NILL      K+ DFG++      +   NT   +GT  ++ 
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMA 181

Query: 608 PEYV-----KKGIYSMKYDVYSFGV 627
           PE +         Y  + DV+S G+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
           F     +G G +G VYKG ++  GQ  A+K +  T  +  EE K E+++  +   H N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 495 RVLGYCTER------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
              G   ++      D+  L+ E+    S+   L    +   L  +    I   + +GL 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +L ++   +VIHRD+K  N+LL      K+ DFG++    + V   NT   +GT  ++ P
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180

Query: 609 EYVK-----KGIYSMKYDVYSFGVLLLQI 632
           E +         Y  K D++S G+  +++
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVNLLRV-- 496
           LG+GGFG V    +   G+ +A K+L     + +++ K E ++L  +  L+ VN   V  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           L Y  E +D   L+   +    L  ++++ +     D ++ V     +T GL  L     
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRE-- 121

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            R+++RDLK  NILLD+  + +ISD G+A    +   E   GR VGT GY+ PE VK   
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGR-VGTVGYMAPEVVKNER 177

Query: 616 YSMKYDVYSFGVLLLQIISSK 636
           Y+   D +  G L+ ++I  K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           +++    ++G G +G VYK  NL  G+  AVK +           + E+ +    +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 494 LRVLGYCTERDENMLIYEYLPNKSL-DLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           +   G    R++  +  EY    SL D+Y +  P+    + +  R  +     QGL YL 
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
                  +HRD+K +NILL +  + K++DFG+A      +  A     +GT  ++ PE  
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVA 178

Query: 612 ---KKGIYSMKYDVYSFGVLLLQI 632
              K G Y+   D+++ G+  +++
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 3e-11
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 26/156 (16%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EV-SLTARLQHVNLLRVL 497
           +LG+G FG VY   N   G+  A+K++        EE  N  EV SL    +H N++++ 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 498 GYCTERDENMLIYEYLPNKSLDLY------LFDP--IRRYVLDWQKRVNIIEGVTQGLLY 549
               E DE   ++EY+      L        F    IR          +II  + QGL +
Sbjct: 65  EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR----------SIIYQILQGLAH 114

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
           + ++  F   HRDLK  N+L+      KI+DFG+A+
Sbjct: 115 IHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 443 LGEGGFGPVYK-GNLPRGQEF-AVKRLSAT----------STQGLEEFKNEVSLT-ARLQ 489
           LG G FG VYK      GQ   A+K ++              + + +  +EV++   +L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           H N++R      E D   ++ + +    L + +     ++     ++  NI   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           YL +    R++HRDL  +NI+L  +    I+DFG+AK   +   E+    +VGT  Y  P
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQI 632
           E VK   Y  K DV++FG +L Q+
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 35/221 (15%)

Query: 437 FSSAN-----KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQ 489
           F++ +     ++G G FG V K  + P G   AVKR+ +T  +   +    ++ +  R  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 490 H-VNLLRVLGYCTERDENMLIYEYLPNKSLD-LYLFDPIRRYVLDWQKRV---NIIEGVT 544
               +++  G    R+ +  I   L + SLD  Y      +YV +  K V    I+  + 
Sbjct: 61  DCPYIVKFYG-ALFREGDCWICMELMDISLDKFY------KYVYEVLKSVIPEEILGKIA 113

Query: 545 ----QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRI 599
               + L YL+E    ++IHRD+K SNILLD   N K+ DFG++ +L    VD     R 
Sbjct: 114 VATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRD 167

Query: 600 VGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSK 636
            G   Y+ PE +    + G Y ++ DV+S G+ L ++ + K
Sbjct: 168 AGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
           LG G  G VYK  +L   +  AVK +    T  L+ +  +E+ +  +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   +  E++   SLD+Y    I  +VL       I   V +GL YL    + +++H
Sbjct: 69  FVENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLW---SLKILH 118

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RD+K SN+L++     K+ DFG++      +  A T   VGT  Y+ PE +    Y +  
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT--YVGTNAYMAPERISGEQYGIHS 174

Query: 621 DVYSFGVLLLQIISSK 636
           DV+S G+  +++   +
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVN--LLRV 496
           LG+GGFG V    +   G+ +A K+L     + +++ K E ++L  +  L+ VN   +  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           L Y  E +D   L+   +    L  ++++ +     D Q+ +     +  GL  LQ    
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYVKK 613
            R+++RDLK  NILLD+  + +ISD G+A      + E  T  GR VGT GY+ PE +  
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGR-VGTVGYMAPEVINN 175

Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYY 642
             Y+   D +  G L+ ++I  +   R  
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL      KI DFG+A+   KD D    G     
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTAR----LQHVN-LLRV 496
           LG+G FG V    L   G+ +AVK L       L++   E ++T +    L   +  L  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           L  C +  + +       N    ++     RR+  D  +       +T  L++L +    
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF--DEARARFYAAEITSALMFLHDKG-- 116

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
            +I+RDLK  N+LLD+E + K++DFGM K      +   T    GT  Y+ PE +++ +Y
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 617 SMKYDVYSFGVLLLQIIS 634
               D ++ GVLL +++ 
Sbjct: 174 GPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 21/200 (10%)

Query: 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV------NLLR 495
           LG+G FG V    L  +G+ FAVK L     + +    ++V  T   + V      N   
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALK----KDVVLIDDDVECTMVEKRVLALAWENPFL 58

Query: 496 VLGYCT--ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
              YCT   ++    + E+L    L  ++ D  R    D  +       +  GL +L   
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSK 115

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
               +I+RDLK  N++LD + + KI+DFGM K       +       GT  Y+ PE ++ 
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 614 GIYSMKYDVYSFGVLLLQII 633
             Y+   D +SFGVLL +++
Sbjct: 171 LKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 21/209 (10%)

Query: 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVN 492
           F     LG+GGFG V    +   G+ +A K+L     + +++ K E ++L  +  L+ VN
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMALNEKQILEKVN 58

Query: 493 --LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
              +  L Y  E +D   L+   +    L  +++  +     +  + V     +  GL  
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLED 117

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVP 607
           L +    R+++RDLK  NILLD+  + +ISD G+A      V E  T  GR VGT GY+ 
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGR-VGTVGYMA 169

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           PE VK   Y+   D ++ G LL ++I+ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 12/172 (6%)

Query: 442 KLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLRVLG 498
           ++GEG  G V+K  +   G+  A+K+++    +G    +   E+      QH  ++++L 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY-LQEYSNFR 557
                   +L+ EY+P+   DL   + +R       +    ++   + LL  +       
Sbjct: 67  VFPHGSGFVLVMEYMPS---DLS--EVLRDEERPLPEA--QVKSYMRMLLKGVAYMHANG 119

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           ++HRDLK +N+L+  +   KI+DFG+A+LF ++     + + V T  Y  PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVG 601
           +  GL +L E     +I+RDLK  N+LLD+E + KI+DFGM K   + +    T     G
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCG 158

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           T  Y+ PE +    Y    D ++ GVLL
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLL 186

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 442 KLGEGGFGPVYKGNLPRGQE-FAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           K+GEG +G VYK       E  A+K  RL             E+SL   +QH N++R+  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 499 YCTERDENMLIYEYL-----------PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
                    L++EYL           P+ + +  L   I+ Y+  +Q        + +G+
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL---IKTYL--YQ--------ILRGI 115

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
            Y   +   RV+HRDLK  N+L+D   N  K++DFG+A+ F   V    T  +V T  Y 
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVV-TLWYR 170

Query: 607 PPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE  +    YS   D++S G +  ++++ K
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 55/232 (23%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-----------EVSLTARL 488
            KLGEG +  VYK  +   G+  A+K++       L E K            E+ L   L
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQEL 59

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLP--------NKSLDLYLFDPIRRYVLDWQKRVNII 540
           +H N++ +L     +    L++E++         +KS+ L   D I+ Y+L         
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLM-------- 110

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI- 599
               +GL YL  +SN+ ++HRDLK +N+L+ ++   K++DFG+A+ F       +  R  
Sbjct: 111 --TLRGLEYL--HSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKM 159

Query: 600 ---VGTYGYVPPE--YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
              V T  Y  PE  +  +  Y +  D++S G +  +++   R     G S+
Sbjct: 160 THQVVTRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELL--LRVPFLPGDSD 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL      KI DFG+A+   KD D    G     
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+ + DV+SFGVLL +I S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 31/217 (14%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQ 489
            + + + +GEG +G V    + P G + A+K++S    Q      L E K    +  R +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61

Query: 490 HVNLLRVLGYCTERD-ENM----LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
           H N++ +L        E+     ++ E +     DLY    I+   L        +  + 
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKL--IKTQHLSNDHIQYFLYQIL 116

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VG 601
           +GL Y+   +N  V+HRDLK SN+LL+   + KI DFG+A++   D +  +TG +   V 
Sbjct: 117 RGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVA 171

Query: 602 TYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSK 636
           T  Y  PE +   KG Y+   D++S G +L +++S++
Sbjct: 172 TRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG+GGFG V    +   G+ +A K     RL   S + +   + E+     L+ VN   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55

Query: 497 --LGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             L Y  E   ++ L+   +    L  ++++   R  L+ ++ ++    +T G+L+L   
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS- 113

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
               +++RD+K  N+LLD++ N ++SD G+A   +   D     +  GT GY+ PE +K+
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKE 168

Query: 614 GIYSMKYDVYSFGVLLLQIISSK 636
             YS   D ++ G  + ++++ +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 34/235 (14%)

Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ---------GLEEFKNEVSLTARLQHVN 492
           LG+G F  +YKG L  +     V      S               F    SL ++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           L+++ G C  RDEN+++ EY+    LD++L        L W  ++++ + +   L YL++
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 553 YSNFRVIHRDLKASNILL----DNELNP---KISDFGMAK-LFRKDVDEANTGRIVGTYG 604
               +++H ++   NIL+     NE      K+SD G+   +  ++       RI     
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RI----P 169

Query: 605 YVPPEYVKKGIYSMKY--DVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYASI 656
           ++ PE ++ G  S+    D +SFG  LL+I S  +       +SE   F +    
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEF-AVKR---------LSATSTQGLEEFKNEVSLT 485
            F   N++GEG +G VY+       E  A+K+         +  +S +       E++L 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-------EITLL 60

Query: 486 ARLQHVNLLRVLGYCTER--DENMLIYEYLPNKSLDL-YLFDPIRRYVLDWQKRVNIIEG 542
             L+H N++ +      +  D   L+ EY      DL  L D +     + Q +  ++  
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKC-LMLQ 116

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + +GL YL E  NF +IHRDLK SN+LL ++   KI+DFG+A+ +     +  T ++V T
Sbjct: 117 LLRGLQYLHE--NF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-T 171

Query: 603 YGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
             Y  PE +       Y+   D+++ G +L ++++ K
Sbjct: 172 LWYRAPELLLGCTT--YTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 42/214 (19%)

Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEE--FKNEVSLTARLQHVNLLR- 495
           +G+G +G V   +L R    G+++ +K+L+  +    E    + E  L ++L+H N++  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 496 -------------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
                        V+G+C   D    +Y  L  +   L         V++W  ++ +   
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQIAM--- 113

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
               L YL E     ++HRDLK  N+ L      K+ D G+A++     D A+T  ++GT
Sbjct: 114 ---ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+ PE      Y+ K DV++ G  + ++ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL +L       +I+RDLK  N++LD+E + KI+DFGM K      D   T    GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           + PE +    Y    D ++FGVLL ++++ +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFK-NEVSLTARLQHVNLLRVLG 498
           K+GEG +G V+K  N    +  A+KR+      +G+      E+ L   L+H N++R+  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                 +  L++EY  ++ L  Y FD     + D +   + +  + +GL +   +    V
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG--IY 616
           +HRDLK  N+L++     K++DFG+A+ F   V    +  +V T  Y PP+ V  G  +Y
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVV-TLWYRPPD-VLFGAKLY 177

Query: 617 SMKYDVYSFGVLLLQIISSKR 637
           S   D++S G +  ++ ++ R
Sbjct: 178 STSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 17/209 (8%)

Query: 436 NFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTAR 487
           NF     LG G +G V+          G+ +A+K L   +     + +E  + E ++   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           ++    L  L Y  + +  + LI +Y+    +  +L+   R    + + R    E +   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEII--- 115

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
            L L+      +++RD+K  NILLD+E +  ++DFG++K F  + ++  T    GT  Y+
Sbjct: 116 -LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-EKERTYSFCGTIEYM 173

Query: 607 PPEYVK-KGIYSMKYDVYSFGVLLLQIIS 634
            PE ++ KG +    D +S G+L+ ++++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 10/156 (6%)

Query: 442 KLGEGGFGPVYKGNLPRG---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVL 497
           ++G G FG V  G +  G    +  VK L  + S Q   +F  E      LQH NLL+ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV--NIIEGVTQGLLYLQEYSN 555
           G CTE    +L+ E+ P   L  YL    +  ++         +   +  GLL+L + +N
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NN 120

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKL-FRKD 590
           F  IH DL   N LL  +L  KI D+G++   +++D
Sbjct: 121 F--IHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
           F     +G G +G VYKG ++  GQ  A+K +  T  +  EE K E+++  +   H N+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 495 RVLGYCTER------DENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
              G   ++      D+  L+ E+    S+ DL           DW     I   + +GL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGL 134

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            +L  +   +VIHRD+K  N+LL      K+ DFG++    + V   NT   +GT  ++ 
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 189

Query: 608 PEYVK-----KGIYSMKYDVYSFGVLLLQI 632
           PE +         Y  + D++S G+  +++
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L       +I+RDLK  N++LD E + KI+DFGM K          T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             Y+ PE +    Y    D ++FGVLL ++++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.4 bits (150), Expect = 3e-10
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 25/196 (12%)

Query: 443 LGEGGFGPV----YKGNLPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLR 495
           LG G FG V    +KG+   G+ +A+K LS       + +E   NE  +   ++H  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 496 VLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           + G   + D N+ L+ EY+P   L         R+      R    + V   L YL    
Sbjct: 66  LYG-SFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEP-VARFYAAQ-VVLALEYLH--- 118

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-KK 613
           +  +++RDLK  N+LLD++   KI+DFG AK  +       T  + GT  Y+ PE +  K
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSK 173

Query: 614 GIYSMKYDVYSFGVLL 629
           G Y    D ++ G+L+
Sbjct: 174 G-YGKAVDWWALGILI 188

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 25/185 (13%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKR-LSATSTQGLEEFK-NEVSLTARLQHVNLLRVL 497
            K+G+G FG V+K  +    Q  A+K+ L     +G       E+ +   L+H N++ ++
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 498 GYCTE--------RDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNIIEGVTQGL 547
             C          +    L++E+  +   DL   L +   ++ L   K+V  ++ +  GL
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKV--MKMLLNGL 132

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF-RKDVDEAN--TGRIVGTYG 604
            Y+  + N +++HRD+KA+NIL+  +   K++DFG+A+ F      + N  T R+V T  
Sbjct: 133 YYI--HRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188

Query: 605 YVPPE 609
           Y PPE
Sbjct: 189 YRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 39/123 (31%), Positives = 71/123 (57%), Gaps = 11/123 (8%)

Query: 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570
           E++   SLD  L     R   +   +++I   V +GL YL+E    +++HRD+K SNIL+
Sbjct: 79  EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133

Query: 571 DNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           ++    K+ DFG++      +D  AN+   VGT  Y+ PE ++   Y+++ D++S G+ L
Sbjct: 134 NSRGEIKLCDFGVSGQL---IDSMANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 630 LQI 632
           +++
Sbjct: 189 VEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 2/92 (2%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             + L  L+    F VI+RDLK  NILLD + +  + DFG+ KL  KD D+ NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             Y+ PE +    Y+   D ++ GVLL ++++
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++ GL +L       +I+RDLK  N++LD+E + KI+DFGM K     VD   T    GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+ PE +    Y    D +++GVLL ++++ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 443 LGEGGFGPVYKGNLPR-------GQEFAVKRLSATSTQGLEEF--KNEVSLTARLQHVNL 493
           LG+G FG V+   L R       GQ +A+K L   + +  +    K E  + A + H  +
Sbjct: 4   LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 494 LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++ L Y  + +  + LI ++L    L    F  + + V+  ++ V     + +  L L  
Sbjct: 61  VK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDH 113

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYV 611
             +  +I+RDLK  NILLD E + K++DFG++K   + +D E       GT  Y+ PE V
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
            +  ++   D +SFGVL+ ++++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
            KLGEG +  V+KG     +   A+K +     +G       EVSL   L+H N++ +  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                    L++EYL +K L  Y+ D     ++        +  + +GL Y       +V
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KV 125

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-YVKKGIYS 617
           +HRDLK  N+L++     K++DFG+A+   K V        V T  Y PP+  +    YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 618 MKYDVYSFGVLLLQIISSK 636
            + D++  G +  ++ S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
           +KLGEG +  VYKG         A+K +     +G       EVSL   L+H N++ +  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                    L++EYL +K L  YL D      ++       +  + +GL Y       +V
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           +HRDLK  N+L++     K++DFG+A+   K +        V T  Y PP+ +     YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 618 MKYDVYSFGVLLLQIISSK 636
            + D++  G +  ++ + +
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 5/105 (4%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++  L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D   T    GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGT 159

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             Y+ PE ++   Y    D ++ GVL+ ++++ +      G+S+N
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 23/226 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-LSATSTQGLEEFK-NEVSLTARLQH- 490
           + +    K+GEG +G VYK  +   G+  A+K+       +G+      E+SL   L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 491 ---VNLLRVLGYCTERDENML--IYEYLPN---KSLDLYLFDPIRRYVLDWQKRVNIIEG 542
              V LL V     +  +  L  ++EYL +   K +D     P R   L  +   + +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQ 118

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVG 601
           + +G+ +  ++    V+HRDLK  N+L+D +    KI+D G+ + F   V ++ T  IV 
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIV- 173

Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           T  Y  PE +     YS   D++S G +  ++  S++   + G SE
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM--SRKQPLFPGDSE 217

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPR-------GQEFAVKRLS-ATSTQGLEEFKNEVSLTAR 487
           NF     LG G +G V+   L R       G+ +A+K L  AT  Q  +  ++  +    
Sbjct: 1   NFELLKVLGTGAYGKVF---LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57

Query: 488 LQHVN---LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           L+H+     L  L Y  + D  + LI +Y+    L  +L    R      ++ V I  G 
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSG- 112

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            + +L L+      +I+RD+K  NILLD+  +  ++DFG++K F +D  E       GT 
Sbjct: 113 -EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTI 170

Query: 604 GYVPPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
            Y+ P+ V+ G   +    D +S GVL+ ++++
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 33/211 (15%)

Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V K  + P G   A K +             E+    R Q +  
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL-----------EIKPAIRNQIIRE 53

Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L +  +R   +   +V+I  
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSI-- 110

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      + ++     VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 442 KLGEGGFGPVYKGNLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           K+G G +G VYK     G++   +A+K++  T          E++L   L+H N++ +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65

Query: 499 -YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL------ 550
            + +  D  + L+++Y  +   DL+      R     +K V +  G+ + LLY       
Sbjct: 66  VFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 551 QEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
             ++N+ V+HRDLK +NIL+  E  P     KI+D G A+LF   +   A+   +V T+ 
Sbjct: 123 YLHANW-VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
           Y  PE +     Y+   D+++ G +  ++++S+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           VT  L++L  +    VI+RDLK  NILLD E + K++DFGM K     ++   T    GT
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGT 159

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+ PE +++  Y    D ++ GVL+ ++++ +
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + + L YL+E     VIHRD+K SNILLD   N K+ DFG++      VD     R  G 
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKTRSAGC 177

Query: 603 YGYVPPEYV----KKGIYSMKYDVYSFGVLLLQI 632
             Y+ PE +        Y ++ DV+S G+ L+++
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 443 LGEGGFGPVYKG--------NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           LG+G F  ++KG              E  +K L  +     E F    S+ ++L H +L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
              G C   DE++++ EY+   SLD YL     + +++   ++ + + +   L +L++  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD------EANTGRIVGTYGYVPP 608
              + H ++ A N+LL  E + K  +    KL    +       E    RI     +VPP
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI----PWVPP 173

Query: 609 EYVKKG-IYSMKYDVYSFGVLLLQIIS 634
           E ++     S+  D +SFG  L +I S
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 11/208 (5%)

Query: 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           F     LG+GGFG V    +   G+ +A KRL     +  +     ++    L+ VN   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 496 V--LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           V  L Y  E +D   L+   +    L  ++++ +     + ++ +     +  GL  L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
            +    ++RDLK  NILLD+  + +ISD G+A   +    E+  GR VGT GY+ PE + 
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLN 174

Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNAR 640
              Y++  D +  G L+ ++I  +   R
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 16/184 (8%)

Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE---YL 513
           P+ +    KR+ A S   ++  +NE+    RL H N+L++        E +L  E   Y+
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILRSEANTYM 240

Query: 514 PNKSLDLYLFDPIRRYVLDWQKR--VNIIEGVTQGLLYLQEYSNFR-VIHRDLKASNILL 570
             +  D  L+  +     DW+ R  +     + + LL   EY + + +IHRD+K  NI L
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300

Query: 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630
           + +    + DFG A  F K+ +  + G  VGT     PE +    Y    D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 631 QIIS 634
            ++S
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFK---NEVSLTAR 487
            +F    ++G+GG+G V+   L +    G+  A+KR+  +    L E +    E  +   
Sbjct: 1   KDFQILTQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT 57

Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
            +   L+++L Y  + DE + L  EY+P       L +     + +   R  + E     
Sbjct: 58  TKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMF--- 111

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
              +        IHRDLK  N L+D   + K++DFG++K     V  AN+  +VG+  Y+
Sbjct: 112 -EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYM 165

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            PE ++   Y    D +S G +L + + 
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
           TN +     +G G FG V    +   GQ  A+K++    +T       ++ E+ L   L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67

Query: 490 HVNLLRVLG-YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           H N++ +   + +  ++   + E L     DL+     R   L+ Q     +  + +GL 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP--LEKQFIQYFLYQILRGLK 122

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           Y+       V+HRDLK SNIL++   + KI DFG+A++     D   TG  V T  Y  P
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYRAP 174

Query: 609 EYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
           E +   +K  Y ++ D++S G +  +++  K
Sbjct: 175 EIMLTWQK--YDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 42/159 (26%), Positives = 79/159 (49%), Gaps = 2/159 (1%)

Query: 479 KNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
           ++E+   A   H  +++        D+ +LI EY     L+  +   ++ ++   +  V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           ++    Q +L L E  + +++HRDLK++NI L      K+ DFG +K +   V       
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
             GT  Y+ PE  ++  YS K D++S GV+L ++++  R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 434 TNNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHV 491
           T+ +     +G+G +G VYK  N   G   AVK L   S    EE + E ++   L  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79

Query: 492 NLLRVLGYCTERDENM-----LIYEYLPNKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQ 545
           N+++  G   + D+ +     L+ E     S+   +   +     LD      I+ G   
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG--- 136

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            LL LQ   N R+IHRD+K +NILL  E   K+ DFG++          NT   VGT  +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194

Query: 606 VPPEYVK-----KGIYSMKYDVYSFGVLLLQI 632
           + PE +         Y  + DV+S G+  +++
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 1e-08
 Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 55/233 (23%)

Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFK-------NEVSLTARLQHVNL 493
            +G+GG G VY    P   +  A+K++     + L E          E  + A L H  +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIR----EDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---------------N 538
           + V   C++ D    +Y  +P   ++ Y    + + V  WQK                 +
Sbjct: 65  VPVYSICSDGD---PVYYTMP--YIEGYTLKSLLKSV--WQKESLSKELAEKTSVGAFLS 117

Query: 539 IIEGVTQGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAK--------LFRK 589
           I   +   +    EY + + V+HRDLK  NILL       I D+G A         L   
Sbjct: 118 IFHKICATI----EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 590 DVDEANT--------GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           DVDE N         G+IVGT  Y+ PE +     S   D+Y+ GV+L Q+++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 443 LGEGGFGPV----YKGNLPRGQEFAVKRLSA---TSTQGLEEFKNE--VSLTA-RLQHVN 492
           LG G FG V    YK     G+ +A+K L      +   +E    E  +  TA   +H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           L+ +   C + ++++  + EY     L ++    I   V    + V     V  GL YL 
Sbjct: 64  LVNLFA-CFQTEDHVCFVMEYAAGGDLMMH----IHTDVFSEPRAVFYAACVVLGLQYLH 118

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAK--LFRKDVDEANTGRIVGTYGYVPPE 609
           E    ++++RDLK  N+LLD E   KI+DFG+ K  +   D     T    GT  ++ PE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFCGTPEFLAPE 171

Query: 610 YVKKGIYSMKYDVYSFGVLLLQII 633
            + +  Y+   D +  GVL+ +++
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 30/91 (32%), Positives = 56/91 (61%), Gaps = 6/91 (6%)

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      + ++     VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 27/230 (11%)

Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK--NEVSLTARLQ 489
           A  ++ +  KLGEG +  VYKG +   GQ  A+K +S  + +G+  F    E SL   L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGV 543
           H N++ +      ++    ++EY+ +  L  Y+        P    +  +Q        +
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ--------L 112

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            +GL Y+       ++HRDLK  N+L+      K++DFG+A+   K +        V T 
Sbjct: 113 LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTL 167

Query: 604 GYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
            Y PP+ +     YS   D++  G + ++++  +    + G S+    LE
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ--PAFPGVSDVFEQLE 215

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
           LD +  ++    V +G+ +L   ++   IHRDL A NILL +    KI DFG+A+  R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +    G       ++ PE +   +Y+ + DV+S+G+LL +I S
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 2/90 (2%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +I+RDLK  N+LLD E + K++D+GM K   +  D  +T    GT  Y+ PE ++   Y 
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST--FCGTPNYIAPEILRGEDYG 174

Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
              D ++ GVL+ ++++ +      G S+N
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVN 492
           +++    KLGEG +  VYKG     G+  A+K +     +G       E SL   L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 493 LLRVLGYCTERDENMLIYEY---------------LPNKSLDLYLFDPIRRYVLDWQKRV 537
           ++ +      ++   L++EY               L  +++ L+LF  +R          
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR---------- 114

Query: 538 NIIEGVTQGLLYL-QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
                   GL Y+ Q Y    ++HRDLK  N+L+ +    K++DFG+A+   K V     
Sbjct: 115 --------GLSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTY 160

Query: 597 GRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
              V T  Y PP+ +     YS   D++  G + +++I
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFK-----NEVSLTARLQHVN 492
           ++LG+G +G VYK  + P G   A+K  RL       L+E K      E+ +  +     
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++   G         +  EY+   SLD      +    +       I   V +GL +L+E
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
             N  +IHRD+K +N+L++     K+ DFG++      + + N    +G   Y+ PE +K
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIK 174

Query: 613 KG------IYSMKYDVYSFGVLLLQI 632
            G       Y+++ DV+S G+ +L++
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 25/213 (11%)

Query: 442 KLGEGGFGPVYKGNLPRGQ---EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           K+G G +G VYK     G+   E+A+K++  T          E++L   L+H N++ +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65

Query: 499 -YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL------ 550
            + +  D  + L+++Y  +   DL+      R     +K + +   + + LLY       
Sbjct: 66  VFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 551 QEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
             ++N+ V+HRDLK +NIL+  E  P     KI+D G A+LF   +   A+   +V T+ 
Sbjct: 123 YLHANW-VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
           Y  PE +     Y+   D+++ G +  ++++S+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           ++S  ++G G +G V    +   G++ A+K+LS    S    +    E++L   +QH N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 494 LRVLGYCTER---DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
           + +L   T     DE    Y  +P    DL     I  + L   K   ++  +  GL Y+
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYI 133

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  +IHRDLK  N+ ++ +   KI DFG+A    +  D   TG +V T  Y  PE 
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVV-TRWYRAPEV 185

Query: 611 VKKGI-YSMKYDVYSFGVLLLQIISSK 636
           +   + Y+   D++S G ++ ++++ K
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 3/96 (3%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V QG+ +L   ++   IHRD+ A N+LL +    KI DFG+A+    D +    G     
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638
             ++ PE +   +Y+++ DV+S+G+LL +I S  ++
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 31/159 (19%)

Query: 442 KLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKN-------EVSLTARLQH--- 490
           K+GEG +G V+K  N   GQ  A+K+   +     E+          E+ +  +L+H   
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 491 VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYV--LDWQKRVNIIEGVTQGL 547
           VNL+ V      R   + L++EY      D  + + + +    +       II    Q +
Sbjct: 63  VNLIEVF----RRKRKLHLVFEYC-----DHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
            +  +++    IHRD+K  NIL+  +   K+ DFG A++
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.3 bits (134), Expect = 4e-08
 Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 41/232 (17%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQH---- 490
            KLG+G +G V+K  +    +  A+K++     +AT  Q    F+ E+     L      
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHPNI 69

Query: 491 VNLLRVLGYCTERDENM----LIYEYLPNKSLDLYLFDPIRRYVL-DWQKRVNIIEGVTQ 545
           V LL V+     + EN     L++EY+     DL+    IR  +L D  KR  I+  + +
Sbjct: 70  VKLLNVI-----KAENDKDIYLVFEYMET---DLHAV--IRANILEDVHKRY-IMYQLLK 118

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----VG 601
            L Y+  +S   VIHRDLK SNILL+++   K++DFG+A+   +  +E     +    V 
Sbjct: 119 ALKYI--HSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL-EENPENPVLTDYVA 174

Query: 602 TYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
           T  Y  PE  +    Y+   D++S G +L +++  K    + GTS  LN LE
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--PLFPGTS-TLNQLE 223

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 26/213 (12%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARLQH 490
            +   N++ EG +G VY+  +   G+  A+K+L     +  E F      E+++  +LQH
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQH 63

Query: 491 VNLLR----VLGYCTERDENMLIYEYLPN--KSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
            N++     V+G  +  D+  ++ EY+ +  KSL   +    + ++    K   ++  + 
Sbjct: 64  PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL---METMKQPFLQSEVK--CLMLQLL 116

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
            G+ +L +  N+ ++HRDLK SN+LL+N    KI DFG+A+ +     +  T ++V T  
Sbjct: 117 SGVAHLHD--NW-ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVTLW 171

Query: 605 YVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
           Y  PE  +    YS   D++S G +  ++++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN----EVSLTARLQ 489
           N F     +GEG +G V K      +E  A+K+     ++  EE K     E+ +   L+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLY-------LFDPIRRYVLDWQKRVNIIEG 542
             N++ +      R +  L++EY+    L+L          + +R Y+    K ++    
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC-- 116

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
                     + N  ++HRD+K  N+L+ +    K+ DFG A+   +  + AN    V T
Sbjct: 117 ----------HKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVAT 164

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y  PE +    Y    D++S G +L
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
           +KLGEG +  V+KG     +   A+K +     +G       EVSL   L+H N++ +  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                    L++EYL +  L  YL D     +     ++ + + + +GL Y  +    ++
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCHKR---KI 124

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           +HRDLK  N+L++ +   K++DFG+A+   K V        V T  Y PP+ +     YS
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++  G +L ++ + +
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.2 bits (131), Expect = 9e-08
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRVLG 498
           +G G +G V      + G++ A+K+LS    Q     K    E+ L   + H N++ +L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 499 YCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
             T         + YL    +   L + ++   L       ++  + +GL Y+    +  
Sbjct: 82  VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAG 138

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-KKGIY 616
           +IHRDLK SNI ++ +   KI DFG+A+      D+  TG  V T  Y  PE +     Y
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTG-YVATRWYRAPEIMLNWMHY 193

Query: 617 SMKYDVYSFGVLLLQIISSK 636
           +   D++S G ++ ++++ K
Sbjct: 194 NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQ-HVNLLRV 496
            K+GEG F  V K  +   G+ +A+K +     + LE+  N  E+    RL  H N+LR+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +    +R      L++E +     D+ L++ I  R+  L  ++  + +  + + L ++  
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPE-Y 610
              F   HRD+K  NIL+ +++  K++DFG  + ++ K      T  I  T  Y  PE  
Sbjct: 119 NGIF---HRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYI-STRWYRAPECL 170

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +  G Y  K D+++ G +  +I+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 28/76 (36%), Positives = 43/76 (56%), Gaps = 5/76 (6%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +I+RDLK  N+LLDN+ + K++DFG AK          T  + GT  Y+ PE ++   + 
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHG 193

Query: 618 MKYDVYSFGVLLLQII 633
              D ++ GVLL + I
Sbjct: 194 KAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 37/212 (17%)

Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVS-LTARLQHVNLLRVLGYC 500
           +G+G +G V+K  N   G + AVK L        EE + E + L A   H N+++  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 501 TERDEN-----MLIYEYLPNKSL-DLY---------LFDPIRRYVLDWQKRVNIIEGVTQ 545
            ++D        L+ E     S+ DL          + +PI  Y+L             +
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH------------E 132

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L+ LQ     + IHRD+K +NILL  E   K+ DFG++          NT   VGT  +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190

Query: 606 VPPEYVK-----KGIYSMKYDVYSFGVLLLQI 632
           + PE +         Y  + DV+S G+  +++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 28/96 (29%), Positives = 52/96 (54%), Gaps = 2/96 (2%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +I+RDLK  N+LLD + + K++D+GM K      D  +T    GT  Y+ PE ++   Y 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRGEEYG 174

Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
              D ++ GVL+ ++++ +        + ++N  +Y
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)

Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRV 496
           LG+G FG V    L R    G+ +A+K L        +E  + V+ +  LQ+     L  
Sbjct: 3   LGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           L Y  +  D    + EY     L    F   R  V   ++       +   L YL     
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 115

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+ PE ++   
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 616 YSMKYDVYSFGVLLLQIISSK 636
           Y    D +  GV++ +++  +
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 4e-07
 Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 46/246 (18%)

Query: 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-----E 481
           + D ++  N +    K+G G FG V+     R QEF   +  A S +GL+E +      E
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIE 62

Query: 482 VSLTARLQHVNLLRVLG-YCTERDENMLI-YEYLPNKSLD------LYLFDPIRRYVLDW 533
           V++   L+H N++R +  +  + ++ + I  E+     L         +F  I  + +  
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-- 120

Query: 534 QKRVNIIEGVTQGLLYLQEYSNF----RVIHRDLKASNILLD-------------NELN- 575
              V+I   +   L Y     +     RV+HRDLK  NI L              N LN 
Sbjct: 121 ---VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 576 ---PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLL 630
               KI DFG++K       E+     VGT  Y  PE +  +   Y  K D+++ G ++ 
Sbjct: 178 RPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 631 QIISSK 636
           ++ S K
Sbjct: 235 ELCSGK 240

Length = 1021

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 38/217 (17%)

Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKN----EVSLTARLQ 489
             + +   +GEG +G V K  +   GQ  A+K+   +     +  K     E+ +  +L+
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLR 58

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLD-LYLF------DPIRRYVLDWQKRVNIIEG 542
           H NL+ ++     +    L++E++ +  LD L  +        +R+Y+  +Q        
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL--FQ-------- 108

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI--- 599
           + +G+ +     +  +IHRD+K  NIL+      K+ DFG A+        A  G +   
Sbjct: 109 ILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------AAPGEVYTD 159

Query: 600 -VGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIIS 634
            V T  Y  PE +     Y    D+++ G L+ ++++
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 27/76 (35%), Positives = 42/76 (55%)

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           +HRDL A N+LL      KI DFG+A+    D +  + G       ++ PE +   +Y+ 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 619 KYDVYSFGVLLLQIIS 634
             DV+S+G+LL +I S
Sbjct: 319 LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           E  +   + H +++++ G  T      LI   LP    DLY +   +R  +     + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             V + + YL E    R+IHRD+KA NI +++  +  + DFG A  F  D++        
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           GT     PE + +  Y    D++S G++L ++
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 43/216 (19%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           +G G FG V+    PR G+  A+K++          F+N VS     + + +L     C 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML-----CF 55

Query: 502 ERDENML-IYEYLPNKSLDLYLFDPIRRYVL------DWQK-------------RVNIIE 541
            + +N+L   + L    +D   F+ I  YV+      D  K             +V + +
Sbjct: 56  FKHDNVLSALDILQPPHIDP--FEEI--YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ 111

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            + +GL YL    +  ++HRD+K  N+L+++    KI DFG+A++   D  +  T  +V 
Sbjct: 112 -ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            Y Y  PE +     Y+   D++S G +  +++  +
Sbjct: 168 QY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 5/88 (5%)

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+    + +++RDLK  NILLD   +  + DFG++K    D    NT    GT  Y+
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYL 163

Query: 607 PPEYV--KKGIYSMKYDVYSFGVLLLQI 632
            PE +  +KG Y+   D +S GVL+ ++
Sbjct: 164 APEVLLDEKG-YTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 66/241 (27%), Positives = 97/241 (40%), Gaps = 67/241 (27%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           ++F     +G G FG V+   L R    GQ +A+K L           K+++    ++ H
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR----------KSDMIKRNQIAH 47

Query: 491 VNLLR-----------VLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLD--WQK 535
           V   R           V  Y + +DE  L  + EY+P   L   L   IR+ V       
Sbjct: 48  VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-A 103

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK---------- 585
           R  I E V    L L        IHRD+K  NIL+D + + K++DFG+ K          
Sbjct: 104 RFYIAELV----LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159

Query: 586 --------LFRKDVDEANTGR---------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628
                   LFR +V                 VGT  Y+ PE ++   Y ++ D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219

Query: 629 L 629
           L
Sbjct: 220 L 220

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 69/205 (33%)

Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV----- 496
           LG G  G V+        +  AVK++  T  Q ++    E+ +  RL H N+++V     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 497 ---------LGYCTERDENMLIYEY-------------LPNKSLDLYLFDPIRRYVLDWQ 534
                    +G  TE +   ++ EY             L  +   L+++  +R       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDE 593
                      GL Y+   +   V+HRDLK +N+ ++ E L  KI DFG+A++       
Sbjct: 126 -----------GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI------- 164

Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSM 618
                       V P Y  KG  S 
Sbjct: 165 ------------VDPHYSHKGYLSE 177

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 49.8 bits (120), Expect = 2e-06
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 49/220 (22%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRVL- 497
           +G G +G V    +   G++ A+K++S      L + K    E+ L   L+H N++ +L 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLD 66

Query: 498 -----GYCTERDENMLIYEYLPNKSLDLY--------LFDPIRRYVLDWQKRVNIIEGVT 544
                      D    +Y        DL+        L D   +Y L +Q        + 
Sbjct: 67  ILRPPSPEDFND----VYIVTELMETDLHKVIKSPQPLTDDHIQYFL-YQ--------IL 113

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----V 600
           +GL YL   +N  VIHRDLK SNIL+++  + KI DFG+A   R    + +        V
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLA---RGVDPDEDEKGFLTEYV 167

Query: 601 GTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
            T  Y  PE +   + S +Y    D++S G +  ++++ K
Sbjct: 168 VTRWYRAPELL---LSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 26/76 (34%), Positives = 43/76 (56%)

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           +HRDL A N+L+      KI DFG+A+   +D +  + G       ++ PE +   +Y+ 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 619 KYDVYSFGVLLLQIIS 634
             DV+SFG+LL +I +
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 12/198 (6%)

Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGY 499
           LG+G FG V        G+ +A+K L        +E  + ++ +  L++     L  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 500 CTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             + +D    + EY+    L    F   R  V    +       +   L YL    + ++
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKI 116

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           ++RDLK  N++LD + + KI+DFG+ K      D A      GT  Y+ PE ++   Y  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 619 KYDVYSFGVLLLQIISSK 636
             D +  GV++ +++  +
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 52/236 (22%), Positives = 102/236 (43%), Gaps = 41/236 (17%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKN------------EVSLT 485
             LGEG +G V K  +   G+  A+K++     S    ++ +             E+ + 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY-LFDPIRRYVLDWQKRVNIIEGVT 544
             ++H N++ ++    E D   L+ + + +   DL  + D  R+  L   +   I+  + 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVD--RKIRLTESQVKCILLQIL 129

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV------------- 591
            GL  L ++     +HRDL  +NI ++++   KI+DFG+A+ +                 
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 592 DEANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            E  T ++V T  Y  PE +     Y    D++S G +  ++++ K    + G +E
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFPGENE 239

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 11/198 (5%)

Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGY 499
           LG+G FG V        G+ +A+K L        +E  + ++    LQ+     L  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 500 CTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             +  + +  + EY     L    F   R  V    +       +   L YL    N  V
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--V 117

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           ++RDLK  N++LD + + KI+DFG+ K   K  D A      GT  Y+ PE ++   Y  
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 619 KYDVYSFGVLLLQIISSK 636
             D +  GV++ +++  +
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 15/197 (7%)

Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVS----LTARLQHVNLLRVL 497
           +G+G FG V          F AVK L   +    +E  + ++    L   L+H  L+  L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61

Query: 498 GYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
            Y  +  E +  + +Y+    L  +L     R  L+ + R    E V   + YL    + 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLH---SL 115

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
            +I+RDLK  NILLD++ +  ++DFG+ K   +   E  T    GT  Y+ PE ++K  Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 617 SMKYDVYSFGVLLLQII 633
               D +  G +L +++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)

Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVNLLRVLGY 499
           +G G +G V    +   G + A+K+L       L  +    E+ L   ++H N++ +L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDP--------IRRYVLDWQKRVN-IIEGVTQGLLYL 550
            T  D ++       ++  D YL  P        + ++    + R+  ++  + +GL Y+
Sbjct: 83  FTP-DLSL-------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  +IHRDLK  N+ ++ +   KI DFG+A    +  D   TG +V T  Y  PE 
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEMTGYVV-TRWYRAPEV 186

Query: 611 VKKGI-YSMKYDVYSFGVLLLQIISSK 636
           +   + Y+   D++S G ++ ++++ K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)

Query: 458 RGQEFAV--KRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
            G+E  V  K L  +       F    SL +++ H++L  V G C    EN+++ E++ +
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----- 570
             LD+ L     R  + W  ++ + + +   L YL++ +   ++H ++ A NILL     
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155

Query: 571 -DNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFG 626
            +    P  K+SD G++  F     E    RI     ++ PE V  G   S   D +SFG
Sbjct: 156 AEGTS-PFIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFG 208

Query: 627 VLLLQI 632
             LL+I
Sbjct: 209 TTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 79  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 178

Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 76/250 (30%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           ++F S   +G G FG V    L +    G  +A+K+L           K+E+    ++ H
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAH 47

Query: 491 VNLLR-----------VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVL-DWQKR 536
           V   R           V  Y + +DEN   LI EYLP   +   L   +++    + + R
Sbjct: 48  VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETR 104

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---- 592
             I E +    L +        IHRD+K  N+LLD + + K+SDFG+    +K       
Sbjct: 105 FYIAETI----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160

Query: 593 ------------------EANTGRI--------------VGTYGYVPPE-YVKKGIYSMK 619
                              ++  +               VGT  Y+ PE +++ G Y+ +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKE 219

Query: 620 YDVYSFGVLL 629
            D +S GV++
Sbjct: 220 CDWWSLGVIM 229

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 42/213 (19%)

Query: 443 LGEGGFGPVYKGNLPRGQE----FAVKRLS----ATSTQGLEEFKNEVSLTARLQH---V 491
           LG+GG+G V++     G +    FA+K L       + +     K E ++   ++H   V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 492 NLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLY 549
           +L+    Y  +    + LI EYL    L ++L            +R  I +E       Y
Sbjct: 64  DLI----YAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTAC--FY 105

Query: 550 LQEYS-------NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVG 601
           L E S          +I+RDLK  NILLD + + K++DFG+ K   + + E   T    G
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFCG 162

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  Y+ PE + +  +    D +S G L+  +++
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 20/153 (13%)

Query: 442 KLGEGGFGPVYKGNL---PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVL 497
           ++G G FG V    +          VK L A  S++   EF  +      LQH N+L+ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR-VNIIE------GVTQGLLYL 550
           G C E    +L++EY     L  YL          W +R   ++        +  G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583
            ++ NF  +H DL   N  L ++L  K+ D+G+
Sbjct: 116 HKH-NF--LHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 25/197 (12%)

Query: 446 GGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV-----NLLRV 496
           G FG VY   L +    G  FA+K L  +      +  N V     +  +      + ++
Sbjct: 7   GAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKL 62

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
                 +D   L+ EYL        L   +     DW K    I  V  G+  L +    
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCA-SLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG-- 117

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
            +IHRD+K  N+L+D   + K++DFG+++         N  + VGT  Y+ PE +     
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENK-KFVGTPDYLAPETILGVGD 170

Query: 617 SMKYDVYSFGVLLLQII 633
               D +S G ++ + +
Sbjct: 171 DKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 20/144 (13%)

Query: 499 YCTERDENML--IYEYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           +C  +D+  L  + EY+P   L   +  +D   ++   +   V         +L L    
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV---------VLALDAIH 159

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
           +  +IHRD+K  N+LLD   + K++DFG   K+    +   +T   VGT  Y+ PE +K 
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKS 217

Query: 614 ----GIYSMKYDVYSFGVLLLQII 633
               G Y  + D +S GV L +++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 34/125 (27%), Positives = 52/125 (41%), Gaps = 4/125 (3%)

Query: 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
           +P    DL+ +   R   L  ++ + I   + + L YL       +IHRD+K  NI LD 
Sbjct: 165 MPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220

Query: 573 ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
             N  + DFG A       D        GT     PE +    Y  K D++S G++L ++
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Query: 633 ISSKR 637
                
Sbjct: 281 SVKNV 285

Length = 392

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 45/213 (21%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK--NEVSLTARLQHVNLLRVLG 498
           KLGEG +  VYKG +   GQ  A+K +     +G   F    E SL   L+H N++ +  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHD 70

Query: 499 YCTERDENMLIYEYL-----------PN----KSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
               +    L++EYL                  ++ L+LF  +R                
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------------- 114

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
             GL Y  +    RV+HRDLK  N+L+      K++DFG+A+   K V        V T 
Sbjct: 115 --GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTL 167

Query: 604 GYVPPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
            Y PP+ V  G   YS   D++  G +  ++ +
Sbjct: 168 WYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 44/181 (24%)

Query: 435 NNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            +F +   +G+G FG V        G+ +A+K L  +     E FK +     +L HV  
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKD-----QLAHVKA 50

Query: 494 LR-----------VLGYCTERDENML--IYEYLPNKSL-------DLYLFDPIRRYVLDW 533
            R           V  Y + +D   L  I E+LP   L       D +  D  R Y+ + 
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110

Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
              V  IE V +             IHRD+K  NIL+D   + K+SDFG++  F K  D 
Sbjct: 111 ---VLAIEAVHK----------LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157

Query: 594 A 594
           A
Sbjct: 158 A 158

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 24/77 (31%), Positives = 45/77 (58%), Gaps = 4/77 (5%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGTYGYVPPEYVKKGIY 616
           V++RDLK  N++LD + + KI+DFG+ K   + + +  T +   GT  Y+ PE ++   Y
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 617 SMKYDVYSFGVLLLQII 633
               D +  GV++ +++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVP 607
           YL       +I+RDLK  NILLD++ +  ++DFG+ K   + ++    T    GT  Y+ 
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLA 164

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE ++K  Y    D +  G +L +++ 
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLGY 499
           +G G +G V    +    Q+ AVK+LS      +   +   E+ L   ++H N++ +L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 500 CTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            T         E YL    +   L + ++   L  +    +I  + +GL Y+       +
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           IHRDLK SN+ ++ +   +I DFG+A    +  D+  TG  V T  Y  PE +   + Y+
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLA----RQADDEMTG-YVATRWYRAPEIMLNWMHYN 194

Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S G ++ +++  K
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL-------------FRKDVDE 593
           +L L+   N+ ++HRDLK  N+L+ +  + K++DFG++K+               KD  E
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
               ++ GT  Y+ PE + +  Y    D ++ G++L + +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 3/79 (3%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYV-KKG 614
           VIHRDLK SN+L++ +   +I DFGMA+       E        V T  Y  PE +    
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP 187

Query: 615 IYSMKYDVYSFGVLLLQII 633
            Y+   D++S G +  +++
Sbjct: 188 EYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 5/79 (6%)

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK----G 614
           IHRD+K  N+LLD   + K++DFG      K+         VGT  Y+ PE +K     G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 615 IYSMKYDVYSFGVLLLQII 633
            Y  + D +S GV L +++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVS----LTARLQHVNLLRVL 497
           +G+G FG V        ++F AVK L   +    +E K+ +S    L   ++H  L+ + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
                 D+   + +Y+    L  +L     R  L+ + R    E +   L YL    +  
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLH---SLN 116

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKKGIY 616
           +++RDLK  NILLD++ +  ++DFG+ K   ++++    T    GT  Y+ PE + K  Y
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 617 SMKYDVYSFGVLLLQII 633
               D +  G +L +++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 3/76 (3%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +IHRDLK SNI++ ++   KI DFG+A+          T  +V  Y Y  PE +    Y 
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYK 195

Query: 618 MKYDVYSFGVLLLQII 633
              D++S G ++ ++I
Sbjct: 196 ENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 25/79 (31%), Positives = 43/79 (54%), Gaps = 2/79 (2%)

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           +  +++RDLK  NILLD++ +  ++DFG+ K      D   T    GT  Y+ PE ++K 
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEVIRKQ 171

Query: 615 IYSMKYDVYSFGVLLLQII 633
            Y    D +  G +L +++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 30/83 (36%), Positives = 47/83 (56%), Gaps = 5/83 (6%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPE-YVKK 613
           V+HRDLK  N+L++ +   KI DFG+A+ F ++  E N G +   V T  Y  PE  +  
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVATRWYRAPEIMLSF 184

Query: 614 GIYSMKYDVYSFGVLLLQIISSK 636
             Y+   DV+S G +L +++  K
Sbjct: 185 QSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 15/161 (9%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL--RVLGY 499
            L  G    VY       +++ +K     S +   + + EV++   L    L   +VL  
Sbjct: 5   LLKGGLTNRVYLLGTK-DEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
                 + L+ E++  ++LD           +  +++ +I E + + L  L +     + 
Sbjct: 62  GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
           H DL   NIL+D+     I D+  A       D A      
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAALLFN 152

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 25/89 (28%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q +L  +   +  +++RDLK  N+LLD +   K++DFG AK+      +  T  + GT  
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y+ PE +    +    D ++ G+ + +I+
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 1/79 (1%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           V+HRDLK SN+LL+   + KI DFG+A+    +  +  T  +V  +   P   +    Y+
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNCSEYT 187

Query: 618 MKYDVYSFGVLLLQIISSK 636
              DV+S G +  +++  K
Sbjct: 188 TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 34/190 (17%)

Query: 459 GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
           G   AVK+LS      T     ++ E+ L   + H N++ +L   T            P 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT------------PQ 92

Query: 516 KSL----DLYL--------FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL 563
           KSL    D+YL           +    LD ++   ++  +  G+ +L       +IHRDL
Sbjct: 93  KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149

Query: 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVY 623
           K SNI++ ++   KI DFG+A+      +   T  +V  Y Y  PE +    Y    D++
Sbjct: 150 KPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIW 206

Query: 624 SFGVLLLQII 633
           S G ++ +++
Sbjct: 207 SVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 36/168 (21%), Positives = 77/168 (45%), Gaps = 16/168 (9%)

Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENM----LIYEYLPNKSLDLYLFDPIRRYV 530
           ++  +NE+    R+   N+L++ G+  +  +++    LI EY     L   L    +   
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKD 118

Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
           L ++ ++++     +GL  L +Y+N    +++L + + L+      KI   G+ K+    
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL--- 173

Query: 591 VDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSK 636
              +   + V    Y   + +      Y++K D+YS GV+L +I + K
Sbjct: 174 --SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 7/80 (8%)

Query: 559 IHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVKK---- 613
           IHRD+K  N+LLD   + K++DFG   K+    +   +T   VGT  Y+ PE +K     
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGD 221

Query: 614 GIYSMKYDVYSFGVLLLQII 633
           G Y  + D +S GV L +++
Sbjct: 222 GYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + + +L +        +HRD+K  N+LLD   + +++DFG      +D     +   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-GTVQSSVAVGT 166

Query: 603 YGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQII 633
             Y+ PE ++      G Y  + D +S GV + +++
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 17/208 (8%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQGLEE---FKNEVSLTARLQHV 491
           +F     +G G FG V    L    + FA+K L+        E   F+ E  +     + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN- 60

Query: 492 NLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             +  L Y  + + N+ L+ +Y     L L L       + +   R  + E V    + +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMV----IAI 115

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                   +HRD+K  NIL+D   + +++DFG      +D     +   VGT  Y+ PE 
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEI 174

Query: 611 VK-----KGIYSMKYDVYSFGVLLLQII 633
           ++     KG Y  + D +S GV + +++
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 42/222 (18%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEE---FKNEVSLTAR 487
            +F   + +G G FG V    + R    G  +A+K +  +     E    F+ E  + + 
Sbjct: 1   KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLP--------NKSLDLYLFDPIRRYVLDWQKRVN 538
             +   +  L Y  +  +N+ L+ EY P        N+  D +  D  + Y+ +      
Sbjct: 58  -SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE------ 110

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTG 597
           ++  +    ++   Y     +HRD+K  N+L+D   + K++DFG A   R   ++  N+ 
Sbjct: 111 LVLAIHS--VHQMGY-----VHRDIKPENVLIDRTGHIKLADFGSAA--RLTANKMVNSK 161

Query: 598 RIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQII 633
             VGT  Y+ PE +       KG Y ++ D +S GV+  ++I
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 437 FSSANKLGEGGFGPV---YKGNLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
           + +   +G G  G V   Y   L R    A+K+LS      T     ++ E+ L   + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 491 VNLLRVLGYCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            N++ +L   T +       + YL  + +D  L   I+   LD ++   ++  +  G+ +
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKH 134

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L       +IHRDLK SNI++ ++   KI DFG+A+          T  +V  Y Y  PE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPE 188

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSK 636
            +    Y    D++S G ++ +++  K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 26/200 (13%)

Query: 443 LGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
             +     + K   P     AVK+  L + S + L+  + E+  + +LQH N+L  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLYLQEYSNFR 557
               E  ++   +   S +    D ++ +  +    +    I++ V   L Y+    +  
Sbjct: 69  IVDSELYVVSPLMAYGSCE----DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKG 121

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG--------YVPPE 609
            IHR +KAS+ILL  +    +S    +      +      R+V  +         ++ PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 610 YVKKGI--YSMKYDVYSFGV 627
            +++ +  Y+ K D+YS G+
Sbjct: 179 VLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---- 612
             +HRD+K  N+LLD   + +++DFG       D     +   VGT  Y+ PE ++    
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGTPDYISPEILQAMED 180

Query: 613 -KGIYSMKYDVYSFGVLLLQII 633
            KG Y  + D +S GV + +++
Sbjct: 181 GKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 34/232 (14%)

Query: 421 NLQVFSFSDIK-AATNNFSSANKLGEGGFGPV---YKGNLPRGQEFAVKRLSATSTQGLE 476
           N       D        + +   +G G  G V   Y   L R    A+K+LS        
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS-------R 59

Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL----DLY----LFDP--- 525
            F+N+       + + L++ + +   ++   L+  + P KSL    D+Y    L D    
Sbjct: 60  PFQNQTHAKRAYRELVLMKCVNH---KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116

Query: 526 -IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
            + +  LD ++   ++  +  G+ +L       +IHRDLK SNI++ ++   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +          T  +V  Y Y  PE +    Y    D++S G ++ ++I   
Sbjct: 174 R--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 55/231 (23%), Positives = 106/231 (45%), Gaps = 48/231 (20%)

Query: 428 SDIKAATN-NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSL 484
           +DI  + N ++   N +G G FG VY+   +   ++ A+K++         ++KN E+ +
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLI 112

Query: 485 TARLQHVNLLRVLGY----CTERDENML----IYEYLP-------------NKSLDLYLF 523
              L H+N++ +  Y    C +++E  +    + E++P             N +L L+L 
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL- 171

Query: 524 DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFG 582
             ++ Y   +Q        + + L Y+  +S F + HRDLK  N+L+D N    K+ DFG
Sbjct: 172 --VKLY--SYQ--------LCRALAYI--HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
            AK       + +   I   +   P   +    Y+   D++S G ++ ++I
Sbjct: 217 SAKNLLA--GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 65/256 (25%), Positives = 99/256 (38%), Gaps = 75/256 (29%)

Query: 436 NFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNE------VSL 484
           +F    KLGEG FG VYK +L      +  ++ +K+  AT    +E + NE       + 
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYGAVEIWMNERVRRACPNS 190

Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL-DL-------YLFDP-IRRYVLDWQK 535
            A   +  L  V     + DE  L++ Y    +L DL       Y  +P +   V D  K
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248

Query: 536 ---RVN-IIEGVTQGLLY-LQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRK 589
              R N II+ + + +L+ L    +  ++HRD+K  NI+        KI D G A   R 
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR- 307

Query: 590 DVDEANTGRIVGTYGYVP------PEYVKKGIYSM------------------------- 618
                     VG   Y+P      P Y     Y M                         
Sbjct: 308 ----------VG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356

Query: 619 --KYDVYSFGVLLLQI 632
             ++D+YS G++ LQ+
Sbjct: 357 PDRFDIYSAGLIFLQM 372

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 12/82 (14%)

Query: 508 LIYEYLPN---KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564
           L+ EYL     KSL L+++        D +  V  I  V   L YL  +    +IHRDLK
Sbjct: 81  LVMEYLIGGDVKSL-LHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLK 131

Query: 565 ASNILLDNELNPKISDFGMAKL 586
             N+L+ NE + K++DFG++K+
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 49/252 (19%)

Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
           DI  +T  F   + LGEG FG V +    + +E+   ++     +   + K E+    ++
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY---VLDW---------QKR 536
           +  +         +R   M I  Y  N++  + +  P  +Y   +LDW         +  
Sbjct: 183 RQADP-------ADRFPLMKIQRYFQNETGHMCIVMP--KYGPCLLDWIMKHGPFSHRHL 233

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNP-------------KISD 580
             II      L Y   ++   ++H DLK  NIL+   D  ++P             +I D
Sbjct: 234 AQIIFQTGVALDYF--HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 581 FGMAKLFRKDVDEANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639
            G         DE ++   IV T  Y  PE V    +    D++S G ++ ++ + K   
Sbjct: 292 LGGC------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK--- 342

Query: 640 RYYGTSENLNFL 651
             Y T +NL  L
Sbjct: 343 LLYDTHDNLEHL 354

Length = 467

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
           F    S+  ++ H +++ + G C    EN+++ E++    LDL++          W  + 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-----DNELNP--KISDFG--MAKLFR 588
            + + +   L YL++     ++H ++   NILL     D E  P  K+SD G  +  L R
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQI 632
           ++  E    RI     ++ PE V+     S+  D +SFG  L +I
Sbjct: 166 QECVE----RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 8/153 (5%)

Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI 539
           +E  L  RL H  +L +L          L+   LP    DLY +   R   L   +    
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261

Query: 540 IEGVTQGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           +  V + LL   +Y +   +IHRD+K  N+L++   +  + DFG A   R          
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQ 631
           I GT     PE +    Y+   D++S G+++ +
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRIVGTYGYVPPEYVKKGIY 616
           V HRDLK  NIL + +   KI DFG+A++   D   A      V T  Y  PE    G +
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC--GSF 181

Query: 617 SMKY----DVYSFGVLLLQIISSK 636
             KY    D++S G +  ++++ K
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 41/116 (35%)

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFR----------------------KDVDEANT 596
           IHRD+K  NIL+D + + K++DFG+   FR                      ++  E + 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 597 GR-------------------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
            R                   +VGT  Y+ PE + +  Y+   D +S GV+L +++
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 52/240 (21%), Positives = 90/240 (37%), Gaps = 53/240 (22%)

Query: 436 NFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEE---FKNEVSLTARLQHV 491
           +F S   +G G FG V        G  +A+K L        E+    + E  +      +
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ-----G 546
            ++++     ++    LI E+LP   +   L            K+  + E  TQ      
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-----------KKDTLTEEETQFYIAET 110

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK----------------- 589
           +L +        IHRD+K  N+LLD++ + K+SDFG+    +K                 
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 590 -DVDEANTGR---------------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
                 N+ R                VGT  Y+ PE   +  Y+   D +S GV++ +++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	656
cd02879	299	GH18_plant_chitinase_class_V The class V plant chi	100.0
cd02873	413	GH18_IDGF The IDGF's (imaginal disc growth factors	100.0
COG3325	441	ChiA Chitinase [Carbohydrate transport and metabol	100.0
cd02872	362	GH18_chitolectin_chitotriosidase This conserved do	100.0
cd06548	322	GH18_chitinase The GH18 (glycosyl hydrolases, fami	100.0
KOG2806	432	consensus Chitinase [Carbohydrate transport and me	100.0
cd02878	345	GH18_zymocin_alpha Zymocin, alpha subunit. Zymocin	100.0
smart00636	334	Glyco_18 Glycosyl hydrolase family 18.	100.0
cd02876	318	GH18_SI-CLP Stabilin-1 interacting chitinase-like	100.0
PF00704	343	Glyco_hydro_18: Glycosyl hydrolases family 18; Int	100.0
cd02875	358	GH18_chitobiase Chitobiase (also known as di-N-ace	100.0
cd02874	313	GH18_CFLE_spore_hydrolase Cortical fragment-lytic	100.0
cd06545	253	GH18_3CO4_chitinase The Bacteroides thetaiotaomicr	100.0
cd06549	298	GH18_trifunctional GH18 domain of an uncharacteriz	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd00598	210	GH18_chitinase-like The GH18 (glycosyl hydrolase,	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06544	253	GH18_narbonin Narbonin is a plant 2S protein from	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06546	256	GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.98
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.98
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.98
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
PHA02988	283	hypothetical protein; Provisional	99.98
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
COG3858	423	Predicted glycosyl hydrolase [General function pre	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd02871	312	GH18_chitinase_D-like GH18 domain of Chitinase D (	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
KOG2091	392	consensus Predicted member of glycosyl hydrolase f	99.91
cd06542	255	GH18_EndoS-like Endo-beta-N-acetylglucosaminidases	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
cd06543	294	GH18_PF-ChiA-like PF-ChiA is an uncharacterized ch	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
cd02877	280	GH18_hevamine_XipI_class_III This conserved domain	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
PLN00181	793	protein SPA1-RELATED; Provisional	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.7
smart00090	237	RIO RIO-like kinase.	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.62
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.54
COG3469	332	Chitinase [Carbohydrate transport and metabolism]	99.52
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.52
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
KOG4701	568	consensus Chitinase [Cell wall/membrane/envelope b	98.86
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.85
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.74
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.64
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.62
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.42
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
PRK09902	216	hypothetical protein; Provisional	98.31
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.15
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.06
cd06547	339	GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENG	98.06
PF01636	239	APH: Phosphotransferase enzyme family This family	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.97
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.96
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.81
PLN02876	822	acyl-CoA dehydrogenase	97.8
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.75
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.74
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.72
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
PRK10593	297	hypothetical protein; Provisional	97.64
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.54
PF03644	311	Glyco_hydro_85: Glycosyl hydrolase family 85 ; Int	97.41
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.37
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.28

>cd02879 GH18_plant_chitinase_class_V The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes

Probab=100.00  E-value=8.7e-66  Score=523.05  Aligned_cols=285  Identities=48%  Similarity=0.876  Sum_probs=255.9

Q ss_pred             ceEEEEEecCCC-CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcc
Q 006211           26 TWIKAGYWLAGR-EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTY  104 (656)
Q Consensus        26 ~~~~~~y~~~~~-~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~  104 (656)
                      +.+++|||++|. .|.|++||+++||||+|||+.++++++.+...+.....+..+.+.+|++||++|+||||        
T Consensus         2 ~~~~~~Y~~~w~~~~~~~~i~~~~~THi~yaf~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lkvlisi--------   73 (299)
T cd02879           2 TIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVISPSDESEFSTFTETVKRKNPSVKTLLSI--------   73 (299)
T ss_pred             CeEEEEEECCCCCCCChhHCCcccCCEEEEEEEEecCCCCEEeeccccHHHHHHHHHHHHHhCCCCeEEEEE--------
Confidence            568899999987 79999999999999999999999988788776655666777777899999999999999        


Q ss_pred             ccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCC-ccCcchHHHHHHHHHhhcCC------CC
Q 006211          105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLNSLGILLDEWKASASD------QP  177 (656)
Q Consensus       105 ~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~-~~d~~~~~~ll~~lr~~l~~------~~  177 (656)
                          |||+.+++.|+.++++++.|++||+++++++++|||||||||||||. ++|+++|+.||++||++|+.      ++
T Consensus        74 ----GG~~~~s~~fs~~~~~~~~R~~fi~siv~~l~~~~fDGidiDWE~P~~~~d~~n~~~ll~elr~~l~~~~~~~~~~  149 (299)
T cd02879          74 ----GGGGSDSSAFAAMASDPTARKAFINSSIKVARKYGFDGLDLDWEFPSSQVEMENFGKLLEEWRAAVKDEARSSGRP  149 (299)
T ss_pred             ----eCCCCCCchhhHHhCCHHHHHHHHHHHHHHHHHhCCCceeecccCCCChhHHHHHHHHHHHHHHHHHHHhhccCCC
Confidence                66666666699999999999999999999999999999999999996 47899999999999999952      24


Q ss_pred             CcEEEEEeecCCCc----cccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCC
Q 006211          178 ELTLSMAVRYSPTH----ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPA  253 (656)
Q Consensus       178 ~~~ls~a~~~~~~~----~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~  253 (656)
                      +++||+++|+.+..    ...+||+++++++||||||||||+||+|....+||+|||+.+.+..+++.+|++|++.|+|+
T Consensus       150 ~~~ls~av~~~~~~~~~~~~~~yd~~~l~~~vD~i~vMtYD~~g~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~  229 (299)
T cd02879         150 PLLLTAAVYFSPILFLSDDSVSYPIEAINKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNSNVSTDYGIKSWIKAGVPA  229 (299)
T ss_pred             cEEEEeecccchhhccccccccCCHHHHHhhCCEEEEEeecccCCCCCCCCCCCCcCCCCCCCCCHHHHHHHHHHcCCCH
Confidence            79999999877654    34568999999999999999999998765567899999998877789999999999999999


Q ss_pred             CceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccce
Q 006211          254 NKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK  333 (656)
Q Consensus       254 ~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~  333 (656)
                      +||+||+|+|||+|+.                       ||+....+|.+.+++||+|||++|++.|++||+++||||+|
T Consensus       230 ~KlvlGvp~YGr~~~~-----------------------~D~~~~~~y~~~~~~wi~ydd~~Si~~K~~~a~~~~lgGv~  286 (299)
T cd02879         230 KKLVLGLPLYGRAWTL-----------------------YDTTTVSSYVYAGTTWIGYDDVQSIAVKVKYAKQKGLLGYF  286 (299)
T ss_pred             HHEEEEeccccccccc-----------------------cCCCcceEEEEECCEEEEeCCHHHHHHHHHHHHhCCCCeEE
Confidence            9999999999999975                       67777888988899999999999999999999999999999


Q ss_pred             eeEeccCccccc
Q 006211          334 AFQLSNDDNWAL  345 (656)
Q Consensus       334 ~W~l~~Dd~~~~  345 (656)
                      +|++++||...+
T Consensus       287 ~W~l~~Dd~~~~  298 (299)
T cd02879         287 AWAVGYDDNNWL  298 (299)
T ss_pred             EEEeecCCcccc
Confidence            999999997654

The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity.

>cd02873 GH18_IDGF The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster

Probab=100.00  E-value=2.3e-61  Score=510.38  Aligned_cols=309  Identities=25%  Similarity=0.417  Sum_probs=250.4

Q ss_pred             EEEEecCC---C----CCCCCCCCCCC--ccEEEEEEEEecCCCcEEecCCcchh---hHHHHHHHHHhhCCCceEEEEe
Q 006211           29 KAGYWLAG---R----EFPLSDINSAL--FTHLICAFAEVDSSTYQLSISSANQQ---YFSIFANSVRRKNPSIKTLLSI   96 (656)
Q Consensus        29 ~~~y~~~~---~----~~~~~~i~~~~--~thi~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~~k~~~~~~kvl~si   96 (656)
                      ++|||.+|   |    .|.|++||+.+  ||||+|||+.|+++++.+...+....   .....+.+||++||++|||+||
T Consensus         2 vvcyy~~~a~~r~~~~~~~~~~i~~~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~~~lk~~~p~lKvllSi   81 (413)
T cd02873           2 LVCYYDSKSYLREGLAKMSLEDLEPALQFCTHLVYGYAGIDADTYKIKSLNEDLDLDKSHYRAITSLKRKYPHLKVLLSV   81 (413)
T ss_pred             EEEEecchhhcCCCCCeeCHHHcCCccccCCeEEEEEEEEeCCCCEEEecCcccchhhhHHHHHHHHHhhCCCCeEEEee
Confidence            47888664   2    57899999876  99999999999998877765443221   2234446799999999999999


Q ss_pred             ecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc--------------------
Q 006211           97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS--------------------  156 (656)
Q Consensus        97 gg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~--------------------  156 (656)
                      |||+.+.-    +   ..++.|+.+++++++|++||+++++|+++|+|||||||||||..                    
T Consensus        82 GGw~~~~~----~---~~s~~fs~~~~~~~~R~~Fi~siv~~l~~~~fDGidiDWEyP~~~~~~~~g~~~~~~~~~~~~~  154 (413)
T cd02873          82 GGDRDTDE----E---GENEKYLLLLESSESRNAFINSAHSLLKTYGFDGLDLAWQFPKNKPKKVRGTFGSAWHSFKKLF  154 (413)
T ss_pred             cCCCCCCC----c---ccchhhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeEeeeeCCCCcccccccccchhhhhhhccc
Confidence            55543221    0   11446999999999999999999999999999999999999952                    


Q ss_pred             -----------cCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCC-cc
Q 006211          157 -----------TDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN-VT  224 (656)
Q Consensus       157 -----------~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~-~~  224 (656)
                                 +|+++|+.||++||++|+ ..+++|++++++.... ...||+++|+++|||||||||||||+|+.+ .+
T Consensus       155 ~g~~~~~~~~~~d~~nf~~Ll~elr~~l~-~~~~~ls~av~~~~~~-~~~~d~~~l~~~vD~inlMtYD~~g~~~~~~~~  232 (413)
T cd02873         155 TGDSVVDEKAAEHKEQFTALVRELKNALR-PDGLLLTLTVLPHVNS-TWYFDVPAIANNVDFVNLATFDFLTPERNPEEA  232 (413)
T ss_pred             ccccccCCCChhHHHHHHHHHHHHHHHhc-ccCcEEEEEecCCchh-ccccCHHHHhhcCCEEEEEEecccCCCCCCCcc
Confidence                       478999999999999994 4478999998654332 234899999999999999999999887664 58


Q ss_pred             ccCCCCCCCC---CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCC---------------------------CCCcc
Q 006211          225 GIHAALYNPS---SNISTDFGIREWLRRGFPANKLVLGARASGPGITI---------------------------DGSMG  274 (656)
Q Consensus       225 g~~apl~~~~---~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~---------------------------~g~~~  274 (656)
                      +|+|||+...   ...+++.+|++|++.|+|++||+||+|+|||+|++                           +|.++
T Consensus       233 ~~~apL~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~l~~~~~~~g~~~~~~~~g~~~~G~~~~~~g~l~  312 (413)
T cd02873         233 DYTAPIYELYERNPHHNVDYQVKYWLNQGTPASKLNLGIATYGRAWKLTKDSGITGVPPVLETDGPGPAGPQTKTPGLLS  312 (413)
T ss_pred             CcCCccCCCccccccccHHHHHHHHHHcCCCHHHeEEEEecceeeeEccCCCCCcCCCCCccCCCCCCCCCCcCCCcccc
Confidence            9999999643   24689999999999999999999999999999952                           14579


Q ss_pred             hHHHHHHHHhcCC------Cccccccccee-eeeeec-------CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          275 YKFIRAFIQNYGY------GAAPVYNASYV-VNLFTS-------GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       275 y~~i~~~~~~~~~------~~~~~~d~~~~-~~~~~~-------~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                      |.|||..+...++      .++..||.... .+|.+.       .++||+|||++|++.|++||+++||||+|+|++++|
T Consensus       313 y~ei~~~~~~~~~~~g~~~~~~~~~d~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgGv~~W~l~~D  392 (413)
T cd02873         313 WPEICSKLPNPANLKGADAPLRKVGDPTKRFGSYAYRPADENGEHGIWVSYEDPDTAANKAGYAKAKGLGGVALFDLSLD  392 (413)
T ss_pred             HHHHHHhhccCccccccccceeEeecccccccceEEeccccCCCCCeEEEeCCHHHHHHHHHHHHhCCCceEEEEeeecC
Confidence            9999987765321      24556777654 366552       257999999999999999999999999999999999


Q ss_pred             cccccc
Q 006211          341 DNWALS  346 (656)
Q Consensus       341 d~~~~~  346 (656)
                      |..+.|
T Consensus       393 D~~g~c  398 (413)
T cd02873         393 DFRGQC  398 (413)
T ss_pred             cCCCCc
Confidence            988876

The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes.

>COG3325 ChiA Chitinase [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-61  Score=478.19  Aligned_cols=306  Identities=24%  Similarity=0.362  Sum_probs=243.8

Q ss_pred             cceEEEEEecCCCC-----CCCCCCCCCCccEEEEEEEEecCCCcEEe-------------------cCCcch--hhHHH
Q 006211           25 QTWIKAGYWLAGRE-----FPLSDINSALFTHLICAFAEVDSSTYQLS-------------------ISSANQ--QYFSI   78 (656)
Q Consensus        25 ~~~~~~~y~~~~~~-----~~~~~i~~~~~thi~~~f~~~~~~~~~~~-------------------~~~~~~--~~~~~   78 (656)
                      .+.+++|||++|++     |.|.+||++++|||+|||+.|+.++....                   .+.+.+  .....
T Consensus        36 ~~~rvvgYY~sWs~~d~~~y~~~DIp~~qlTHInYAF~~I~~~g~~~~~~~~~~~~~~~~~~~~~~e~dp~~~~~~G~~~  115 (441)
T COG3325          36 DQFKVVGYYTSWSQYDRQDYFPGDIPLDQLTHINYAFLDINSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLKGHFG  115 (441)
T ss_pred             CCceEEEEecccccCCCcccccccCCHHHhceeeEEEEEecCCCCccccccccchhhccccCcCceeeccccccccchHH
Confidence            45688999998864     77899999999999999999998874211                   000111  11233


Q ss_pred             HHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc--
Q 006211           79 FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS--  156 (656)
Q Consensus        79 ~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~--  156 (656)
                      ....+|+++|++|+++|||||+.|..             |+.|+.++++|++|++|+++|+++|+|||||||||||++  
T Consensus       116 ~L~~lk~~~~d~k~l~SIGGWs~S~~-------------F~~~aad~a~re~Fa~saVe~~r~~~FDGVDIDWEYP~~~~  182 (441)
T COG3325         116 ALFDLKATYPDLKTLISIGGWSDSGG-------------FSDMAADDASRENFAKSAVEFMRTYGFDGVDIDWEYPGSGG  182 (441)
T ss_pred             HHHHHhhhCCCceEEEeecccccCCC-------------cchhhcCHHHHHHHHHHHHHHHHhcCCCceeeccccCCCCC
Confidence            44789999999999999955555444             999999999999999999999999999999999999954  


Q ss_pred             --------cCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCc
Q 006211          157 --------TDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENV  223 (656)
Q Consensus       157 --------~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~  223 (656)
                              .|+++|+.||++||++|+.     ++++.||+|.|+.+.... +.+..+++++|||||+|||||||+ |..+
T Consensus       183 ~~~~~~~~~d~~ny~~Ll~eLR~~LD~a~~edgr~Y~LTiA~~as~~~l~-~~~~~~~~~~vDyiNiMTYDf~G~-Wn~~  260 (441)
T COG3325         183 DAGNCGRPKDKANYVLLLQELRKKLDKAGVEDGRHYQLTIAAPASKDKLE-GLNHAEIAQYVDYINIMTYDFHGA-WNET  260 (441)
T ss_pred             CCCCCCCcccHHHHHHHHHHHHHHHhhcccccCceEEEEEecCCchhhhh-cccHHHHHHHHhhhheeeeecccc-cccc
Confidence                    4789999999999999943     457999999999988877 589999999999999999999974 8999


Q ss_pred             cccCCCCCCCCCC-------CCH------HHHHHHHHHcCCCCCceeecccCCCCCcCCC--CC----------------
Q 006211          224 TGIHAALYNPSSN-------IST------DFGIREWLRRGFPANKLVLGARASGPGITID--GS----------------  272 (656)
Q Consensus       224 ~g~~apl~~~~~~-------~~~------~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~--g~----------------  272 (656)
                      +|||||||..+.+       +.+      ...++.....++||+|||||+|+|||+|...  +.                
T Consensus       261 ~Gh~a~Ly~~~~d~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~klvlG~p~YgRgw~~v~~~~~~~~~~~~q~~~n~g~  340 (441)
T COG3325         261 LGHHAALYGTPKDPPLANGGFYVDAEVDGIDWLEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGLYQGLDNSGI  340 (441)
T ss_pred             cccccccccCCCCCccccCCeeEEEEechhHHHHhhhccCCCCceEEeeccccccccccccCcccCCCCCcccccCCCCC
Confidence            9999999953321       122      2355666677899999999999999999542  00                


Q ss_pred             -----------cchH--HHHHHHHhcCCCcccccccceeeeeeec--CcEEEeeCCcchhHHHHhhhhhcccccceeeEe
Q 006211          273 -----------MGYK--FIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQL  337 (656)
Q Consensus       273 -----------~~y~--~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l  337 (656)
                                 ..|.  -.......+..++.+.||..+..||.++  ++.||+|||++|+++|++||+++||||+|+|++
T Consensus       341 ~~Gtw~a~n~~~~~~~~~~l~~n~~~~~g~~~~~d~~a~apyL~n~~~~vFiSyDd~rSvkaK~eYv~~n~LGG~m~We~  420 (441)
T COG3325         341 PKGTWEAGNGDKDYGKAYDLDANNAGKNGYERYWDDVAKAPYLYNPEKGVFISYDDPRSVKAKAEYVADNNLGGMMFWEI  420 (441)
T ss_pred             CCCcccccccCccchhhccccccccCCCCeeEecccccccceeecCCCCeEEEccCCcchhhHHHHHhhcCccceEEEEe
Confidence                       0110  0111112233567889999999999775  578999999999999999999999999999999


Q ss_pred             ccCccccc
Q 006211          338 SNDDNWAL  345 (656)
Q Consensus       338 ~~Dd~~~~  345 (656)
                      ++|-+.-+
T Consensus       421 sgD~n~~l  428 (441)
T COG3325         421 SGDENGVL  428 (441)
T ss_pred             cCCcchhH
Confidence            99943333

>cd02872 GH18_chitolectin_chitotriosidase This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases

Probab=100.00  E-value=4.8e-61  Score=505.94  Aligned_cols=303  Identities=31%  Similarity=0.523  Sum_probs=262.7

Q ss_pred             EEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcc--hhhHHHHHHHHHhhCCCceEEEEeecC
Q 006211           29 KAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSAN--QQYFSIFANSVRRKNPSIKTLLSIWNG   99 (656)
Q Consensus        29 ~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~--~~~~~~~~~~~k~~~~~~kvl~sigg~   99 (656)
                      ++|||+.|.       .|.+++||+++||||+|+|+.+++++.........  .......+.++|++||++||++||   
T Consensus         1 v~~y~~~w~~~~~~~~~~~~~~i~~~~~Thv~y~f~~i~~~g~~~~~~~~~d~~~~~~~~~~~lk~~~p~lkvlisi---   77 (362)
T cd02872           1 VVCYFTNWAQYRPGNGKFVPENIDPFLCTHIIYAFAGLNPDGNIIILDEWNDIDLGLYERFNALKEKNPNLKTLLAI---   77 (362)
T ss_pred             CEEEECcchhcCCCCCCcChhHCCcccCCEEEEeeEEECCCCCEEecCchhhhhhhHHHHHHHHHhhCCCceEEEEE---
Confidence            367887643       48899999999999999999999986555443332  233344446799999999999999   


Q ss_pred             CCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----cCcchHHHHHHHHHhhcC
Q 006211          100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASAS  174 (656)
Q Consensus       100 ~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----~d~~~~~~ll~~lr~~l~  174 (656)
                               |||+.++..|+.++++++.|++||+++++++++|+|||||||||||..     +|+++|+.||++||++|+
T Consensus        78 ---------GG~~~~~~~f~~~~~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~p~~~~~~~~d~~~~~~ll~~lr~~l~  148 (362)
T cd02872          78 ---------GGWNFGSAKFSAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEYPGQRGGPPEDKENFVTLLKELREAFE  148 (362)
T ss_pred             ---------cCCCCCcchhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeeeeeeccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence                     777766667999999999999999999999999999999999999974     789999999999999994


Q ss_pred             CC-CCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC------CCCHHHHHHHHH
Q 006211          175 DQ-PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREWL  247 (656)
Q Consensus       175 ~~-~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~------~~~~~~~v~~~~  247 (656)
                      +. ++++||+++|+.+.....+||+++|.++||+|||||||++|+ |+..+||+|||+..+.      ..+++.+|++|+
T Consensus       149 ~~~~~~~ls~av~~~~~~~~~~~d~~~l~~~vD~v~vmtYD~~~~-~~~~~g~~spl~~~~~~~~~~~~~~v~~~v~~~~  227 (362)
T cd02872         149 PEAPRLLLTAAVSAGKETIDAAYDIPEISKYLDFINVMTYDFHGS-WEGVTGHNSPLYAGSADTGDQKYLNVDYAIKYWL  227 (362)
T ss_pred             hhCcCeEEEEEecCChHHHhhcCCHHHHhhhcceEEEecccCCCC-CCCCCCCCCCCCCCCCCccccccccHHHHHHHHH
Confidence            32 379999999988766666799999999999999999999976 6778999999996443      358999999999


Q ss_pred             HcCCCCCceeecccCCCCCcCCC------------------------CCcchHHHHHHHHhcCCCcccccccceeeeeee
Q 006211          248 RRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT  303 (656)
Q Consensus       248 ~~g~p~~Kl~lG~p~yG~~~~~~------------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~  303 (656)
                      +.|+|++||+||+|+||++|+..                        |.++|.|||+.+ .  .+++..||+.+..||.+
T Consensus       228 ~~gvp~~KlvlGlp~YG~~~~~~~~~~~~~g~~~~g~~~~g~~~~~~g~~~y~ei~~~~-~--~~~~~~~D~~~~~~y~~  304 (362)
T cd02872         228 SKGAPPEKLVLGIPTYGRSFTLASPSNTGVGAPASGPGTAGPYTREAGFLAYYEICEFL-K--SGWTVVWDDEQKVPYAY  304 (362)
T ss_pred             HcCCCHHHeEeccccccceeeecCCccCCCCCccCCCCCCCCCcCCCccchHHHHHHhh-c--CCcEEEEeCCcceeEEE
Confidence            99999999999999999998542                        356899999876 3  35899999999999998


Q ss_pred             cCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccch
Q 006211          304 SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR  347 (656)
Q Consensus       304 ~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~  347 (656)
                      .+++||+|||++|++.|++||+++||||+++|++++||..+.|.
T Consensus       305 ~~~~~v~ydd~~Si~~K~~~~~~~~lgGv~iW~l~~DD~~g~cg  348 (362)
T cd02872         305 KGNQWVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDDFRGTCG  348 (362)
T ss_pred             ECCEEEEeCCHHHHHHHHHHHHhCCCceEEEEeeecCcCCCccC
Confidence            89999999999999999999999999999999999999988864

The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the la

>cd06548 GH18_chitinase The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites

Probab=100.00  E-value=1.2e-60  Score=492.48  Aligned_cols=278  Identities=29%  Similarity=0.450  Sum_probs=239.5

Q ss_pred             EEEEecCCCCC----CCC-CCCCCCccEEEEEEEEecCCCcEEecCCc------------------chhhHHHHHHHHHh
Q 006211           29 KAGYWLAGREF----PLS-DINSALFTHLICAFAEVDSSTYQLSISSA------------------NQQYFSIFANSVRR   85 (656)
Q Consensus        29 ~~~y~~~~~~~----~~~-~i~~~~~thi~~~f~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~k~   85 (656)
                      ++|||++|..+    .+. +||+++||||+|||+.|++++..+...+.                  ........+..+|+
T Consensus         1 v~~Y~~~W~~~~~~~~~~~~i~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lk~   80 (322)
T cd06548           1 VVGYFTNWGIYGRNYFVTDDIPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQLRKLKQ   80 (322)
T ss_pred             CEEEeCCCcccCCCCCcccCCChhHCcEEEEEeeeEcCCCCeEccChhhhhhccccCCcccccCCccchhHHHHHHHHHH
Confidence            37899887654    444 69999999999999999998776653321                  11122233467999


Q ss_pred             hCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc---------
Q 006211           86 KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS---------  156 (656)
Q Consensus        86 ~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~---------  156 (656)
                      +||++|||+||            |||+.+ ..|+.++++++.|++||+++++++++|+|||||||||||..         
T Consensus        81 ~~p~lkvl~si------------GG~~~s-~~f~~~~~~~~~r~~Fi~siv~~l~~~~fDGidiDwE~p~~~~~~~~~~~  147 (322)
T cd06548          81 KNPHLKILLSI------------GGWTWS-GGFSDAAATEASRAKFADSAVDFIRKYGFDGIDIDWEYPGSGGAPGNVAR  147 (322)
T ss_pred             hCCCCEEEEEE------------eCCCCC-CCchhHhCCHHHHHHHHHHHHHHHHhcCCCeEEECCcCCCCCCCCCCCCC
Confidence            99999999999            555443 34999999999999999999999999999999999999964         


Q ss_pred             -cCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCC
Q 006211          157 -TDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAAL  230 (656)
Q Consensus       157 -~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl  230 (656)
                       +|+++|+.||++||++|+.     +++++||+++|+.+..... +++++++++||+||||||||||+ |+..+||+|||
T Consensus       148 ~~d~~~~~~ll~~Lr~~l~~~~~~~~~~~~Ls~av~~~~~~~~~-~~~~~l~~~vD~vnlMtYD~~g~-w~~~~g~~spL  225 (322)
T cd06548         148 PEDKENFTLLLKELREALDALGAETGRKYLLTIAAPAGPDKLDK-LEVAEIAKYLDFINLMTYDFHGA-WSNTTGHHSNL  225 (322)
T ss_pred             hhHHHHHHHHHHHHHHHHHHhhhccCCceEEEEEccCCHHHHhc-CCHHHHhhcCCEEEEEEeeccCC-CCCCCCCCCCC
Confidence             6889999999999999954     2469999999987765544 78999999999999999999976 56789999999


Q ss_pred             CCCC----CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecC-
Q 006211          231 YNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSG-  305 (656)
Q Consensus       231 ~~~~----~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~-  305 (656)
                      +...    ...+++.+|++|++.|+|++||+||+|+||++|+.                   +...||+.+..||.+++ 
T Consensus       226 ~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~~~~-------------------~~~~~D~~~~~~y~~~~~  286 (322)
T cd06548         226 YASPADPPGGYSVDAAVNYYLSAGVPPEKLVLGVPFYGRGWTG-------------------YTRYWDEVAKAPYLYNPS  286 (322)
T ss_pred             CCCCCCCCCCccHHHHHHHHHHcCCCHHHeEEEecccccccCC-------------------cEEEEcCCcceeEEEeCC
Confidence            9654    35789999999999999999999999999999986                   56789999999998877 


Q ss_pred             -cEEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          306 -ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       306 -~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                       ++||+|||++||+.|++||+++||||+|+|++++|
T Consensus       287 ~~~~v~ydd~~Si~~K~~~a~~~~LgGv~~W~l~~D  322 (322)
T cd06548         287 TKTFISYDDPRSIKAKADYVKDKGLGGVMFWELSGD  322 (322)
T ss_pred             CCeEEEeCCHHHHHHHHHHHHhcCCccEEEEeccCC
Confidence             89999999999999999999999999999999998

The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel.

>KOG2806 consensus Chitinase [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-60  Score=504.69  Aligned_cols=305  Identities=25%  Similarity=0.445  Sum_probs=266.1

Q ss_pred             EEEEEecCCC-CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcccc
Q 006211           28 IKAGYWLAGR-EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS  106 (656)
Q Consensus        28 ~~~~y~~~~~-~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~  106 (656)
                      .++||++++. ...++++++++|||++|||+.++.++......+.....+....+.+|.+||+||+|+||          
T Consensus        59 ~~~~~~~~~~~~~~~~~~~~~~~TH~vfafa~~~~~~~~~~~~~~~~~~f~~~~~~~k~~n~~vK~llSI----------  128 (432)
T KOG2806|consen   59 SIVGYYPSRIGPETLEDQDPLKCTHLVYAFAKMKRVGYVVFCGARTMNRFSSYNQTAKSSNPTVKVMISI----------  128 (432)
T ss_pred             eeEEEeCCCCCCCCccccChhhcCcceEEEeeecccccEEeccchhhhhhHHHHHHHHhhCCCceEEEEe----------
Confidence            4588888887 88999999999999999999999998888777766778888889999999999999999          


Q ss_pred             ccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCC--CccCcchHHHHHHHHHhhcCCCC------C
Q 006211          107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP--NSTDLNSLGILLDEWKASASDQP------E  178 (656)
Q Consensus       107 ~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p--~~~d~~~~~~ll~~lr~~l~~~~------~  178 (656)
                        |||..+++.|+.|++|++.|++||+|+++|+++|+|||||||||||  ...|+.+|..|++|||++|.+..      .
T Consensus       129 --GG~~~ns~~fs~~~s~~~~r~~FI~Sii~fl~~~~fDGvDL~We~P~~~~~d~~~~~~~i~elr~~~~~~~~~~~~~~  206 (432)
T KOG2806|consen  129 --GGSHGNSGLFSLVLSDRMIRAKFIESVVSFIKDYGFDGVDLAWEWPLFTPSDQLEFSRFIQELRSAFARETLKSPDTA  206 (432)
T ss_pred             --cCCCCCccchhhhhcChHHHHHHHHHHHHHHHHcCCCceeeeeECCCCchhhHHHHHHHHHHHHHHHHHHhhccCCcc
Confidence              4443333349999999999999999999999999999999999999  77899999999999999994321      2


Q ss_pred             cEEEEEeecCCC-ccccccChhhhhhccchhhhhhhcccCCCCCC-ccccCCCCCCCC----CCCCHHHHHHHHHHcCCC
Q 006211          179 LTLSMAVRYSPT-HETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN-VTGIHAALYNPS----SNISTDFGIREWLRRGFP  252 (656)
Q Consensus       179 ~~ls~a~~~~~~-~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~-~~g~~apl~~~~----~~~~~~~~v~~~~~~g~p  252 (656)
                      .+|+.++.+++. ....+||+++|+++|||||||+|||+|+|+++ .+||+||||.+.    ..+|++.++++|++.|.|
T Consensus       207 ~~l~~~v~~~~~~~~~~~ydi~~i~~~~DfiNi~syDf~gpw~~~~~tGp~aPl~~~~~~~~~~~Nvd~~~ky~~~~~~~  286 (432)
T KOG2806|consen  207 KVLEAVVADSKQSAYSDGYDYENLSKYVDFINIMSYDYYGPWSLPCFTGPPSPLYKGPSMTNPKMNVDSLLKYWTEKGLP  286 (432)
T ss_pred             ceeeeccccCccchhhccCCHHHHHhhCCeEEEecccccCCCcCCCcCCCCcccCCCCcccccCcchhhhHHHHhhcCCC
Confidence            245555555544 67888999999999999999999999986553 799999999753    347999999999999999


Q ss_pred             CCceeecccCCCCCcCC------------------------CCCcchHHHHHHHHhcCCCcccccccceeeeeeec--Cc
Q 006211          253 ANKLVLGARASGPGITI------------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GA  306 (656)
Q Consensus       253 ~~Kl~lG~p~yG~~~~~------------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~  306 (656)
                      ++|++||+|+||+.|++                        .|.++|.|||+...+.+   ...||+..+.||.+.  ++
T Consensus       287 ~~Kl~~gip~yg~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~g~ls~~ei~~~~~~~~---~~~~d~~~~~~Y~~~~~~~  363 (432)
T KOG2806|consen  287 PSKLVLALPFYGRSWQLLEDSRSSAAPPFGQAAPVSMRSKGGGYMSYPEICERKINTG---VTHWDEETQTPYLYNIPYD  363 (432)
T ss_pred             chheEEEEecceehhhhcCCcCCCCCccCCCcccCccccccCceeeHHHHHHHhcccC---CceecCCceeeeEEecCCC
Confidence            99999999999999954                        25689999999544333   678999999999999  99


Q ss_pred             EEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccch
Q 006211          307 TWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR  347 (656)
Q Consensus       307 ~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~  347 (656)
                      +||+|||++||+.|++||+++||||+|+|++++||..+.+.
T Consensus       364 ~wvtyen~~Si~~K~~Yvk~~~lGGv~iW~vd~DD~~~~~~  404 (432)
T KOG2806|consen  364 QWVTYENERSIHIKADYAKDEGLGGVAIWNIDQDDESGSLL  404 (432)
T ss_pred             eEEecCCHHHHHHHHHHHHhcCCceEEEEeccCCCCCCccc
Confidence            99999999999999999999999999999999999888744

>cd02878 GH18_zymocin_alpha Zymocin, alpha subunit

Probab=100.00  E-value=2e-57  Score=471.20  Aligned_cols=292  Identities=20%  Similarity=0.303  Sum_probs=231.6

Q ss_pred             EEEEecCCC------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCC
Q 006211           29 KAGYWLAGR------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNS  102 (656)
Q Consensus        29 ~~~y~~~~~------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~  102 (656)
                      ++|||++|.      .|.|++||+++||||+|+|+.++++ +.+...+ ....+..+ .++|    ++|||+|||||+.|
T Consensus         2 ~v~Y~~~w~~~r~~~~~~~~~i~~~~~THi~yaf~~~~~~-g~l~~~~-~~~~~~~~-~~~k----~lkvllsiGG~~~s   74 (345)
T cd02878           2 NIAYFEAYNLDRPCLNMDVTQIDTSKYTHIHFAFANITSD-FSVDVSS-VQEQFSDF-KKLK----GVKKILSFGGWDFS   74 (345)
T ss_pred             EEEEEChhhcCCCCCCCCHhHCCcccCCEEEEEeEeecCC-CeEeecc-cHHHHHHH-Hhhc----CcEEEEEEeCCCCC
Confidence            589998873      4789999999999999999999987 4555432 22333332 2232    39999999555433


Q ss_pred             ccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----------cCcchHHHHHHHHHh
Q 006211          103 TYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----------TDLNSLGILLDEWKA  171 (656)
Q Consensus       103 ~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----------~d~~~~~~ll~~lr~  171 (656)
                      ..    ..   ....|+.++ ++++|++||+++++++++|+|||||||||||..           +|+++|+.||++||+
T Consensus        75 ~~----~~---~~~~f~~~~-~~~~R~~Fi~si~~~~~~~~fDGidiDwE~P~~~~~~~~~~~~~~d~~n~~~ll~elr~  146 (345)
T cd02878          75 TS----PS---TYQIFRDAV-KPANRDTFANNVVNFVNKYNLDGVDFDWEYPGAPDIPGIPAGDPDDGKNYLEFLKLLKS  146 (345)
T ss_pred             CC----Cc---cchhhHhhc-CHHHHHHHHHHHHHHHHHcCCCceeecccCCcccCCCCCCCCChHHHHHHHHHHHHHHH
Confidence            21    00   012488888 999999999999999999999999999999952           478999999999999


Q ss_pred             hcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCC-------CCCCCCHHHHHH
Q 006211          172 SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN-------PSSNISTDFGIR  244 (656)
Q Consensus       172 ~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~-------~~~~~~~~~~v~  244 (656)
                      +|++  +++||+++|+.+... .+||+++++++|||||||||||||+ |+..+++++|...       .....++..+|+
T Consensus       147 ~l~~--~~~ls~a~~~~~~~~-~~yd~~~l~~~vD~i~vMtYD~~g~-w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~v~  222 (345)
T cd02878         147 KLPS--GKSLSIAAPASYWYL-KGFPIKDMAKYVDYIVYMTYDLHGQ-WDYGNKWASPGCPAGNCLRSHVNKTETLDALS  222 (345)
T ss_pred             HhCc--CcEEEEEcCCChhhh-cCCcHHHHHhhCcEEEEEeecccCC-cCccCCcCCCCCCcccccccCCCchhHHHHHH
Confidence            9954  689999998876543 3599999999999999999999976 5655666665221       112235889999


Q ss_pred             HHHHcCCCCCceeecccCCCCCcCCC------------------------CC---cchHHHHHHHHhcCCCcccccccce
Q 006211          245 EWLRRGFPANKLVLGARASGPGITID------------------------GS---MGYKFIRAFIQNYGYGAAPVYNASY  297 (656)
Q Consensus       245 ~~~~~g~p~~Kl~lG~p~yG~~~~~~------------------------g~---~~y~~i~~~~~~~~~~~~~~~d~~~  297 (656)
                      +|+++|+|++||+||+|+|||+|++.                        +.   +.|.|+|...... .+++..||...
T Consensus       223 ~~~~~Gvp~~KlvlGip~YGr~~~l~~~~~~~~~~p~~g~~~~~~~g~~~~~~g~~~~~e~~~~~~~~-~~~~~~~d~~~  301 (345)
T cd02878         223 MITKAGVPSNKVVVGVASYGRSFKMADPGCTGPGCTFTGPGSGAEAGRCTCTAGYGAISEIEIIDISK-SKNKRWYDTDS  301 (345)
T ss_pred             HHHHcCCCHHHeEEeeccccceeeccCCCCCCCCCcccCCCCCCCCCCCCCchhhhhHHHHHHHHhcc-CCCcEEEecCC
Confidence            99999999999999999999999632                        12   2348888755433 35899999999


Q ss_pred             eeeee-ecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          298 VVNLF-TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       298 ~~~~~-~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                      .+||. +.+++||+|||++|++.|++||+++||||+|+|++|+|
T Consensus       302 ~~~y~~~~~~~wv~ydd~~Si~~K~~y~~~~~LgGv~~W~ld~~  345 (345)
T cd02878         302 DSDILVYDDDQWVAYMSPATKAARIEWYKGLNFGGTSDWAVDLQ  345 (345)
T ss_pred             CccEEEEcCCEEEEcCCHHHHHHHHHHHHhCCCceEEEeeccCC
Confidence            99985 56779999999999999999999999999999999987

Zymocin is a heterotrimeric enzyme that inhibits yeast cell cycle progression. The zymocin alpha subunit has a chitinase activity that is essential for holoenzyme action from the cell exterior while the gamma subunit contains the intracellular toxin responsible for G1 phase cell cycle arrest. The zymocin alpha and beta subunits are thought to act from the cell's exterior by docking to the cell wall-associated chitin, thus mediating gamma-toxin translocation. The alpha subunit has an eight-stranded TIM barrel fold similar to that of family 18 glycosyl hydrolases such as hevamine, chitolectin, and chitobiase.

>smart00636 Glyco_18 Glycosyl hydrolase family 18

Probab=100.00  E-value=4.3e-57  Score=471.52  Aligned_cols=291  Identities=32%  Similarity=0.583  Sum_probs=251.7

Q ss_pred             EEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchh--hHHHHHHHHHhhCCCceEEEEeecCCCC
Q 006211           29 KAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ--YFSIFANSVRRKNPSIKTLLSIWNGQNS  102 (656)
Q Consensus        29 ~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~--~~~~~~~~~k~~~~~~kvl~sigg~~~~  102 (656)
                      ++|||.+|.    .|.++++|.++||||+|+|+.+++++ .+...+...+  .+.. +..+|++||++|+|+||      
T Consensus         2 ~~~Y~~~w~~~~~~~~~~~~~~~~~thv~~~~~~~~~~g-~~~~~~~~~~~~~~~~-~~~l~~~~~~~kvl~sv------   73 (334)
T smart00636        2 VVGYFTNWGVYGRNFPVDDIPASKLTHIIYAFANIDPDG-TVTIGDEWADIGNFGQ-LKALKKKNPGLKVLLSI------   73 (334)
T ss_pred             EEEEECchhccCCCCChhHCCcccCcEEEEeeeeeCCCC-CEeeCCcchhhhhHHH-HHHHHHhCCCCEEEEEE------
Confidence            589998876    38899999999999999999999964 4554433332  3444 46799999999999999      


Q ss_pred             ccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc--cCcchHHHHHHHHHhhcCC----C
Q 006211          103 TYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS--TDLNSLGILLDEWKASASD----Q  176 (656)
Q Consensus       103 ~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~--~d~~~~~~ll~~lr~~l~~----~  176 (656)
                            |||.. +..|+.++++++.|++||+++++++++|+|||||||||+|..  +|+++|+.|+++||++|++    +
T Consensus        74 ------gg~~~-s~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGidiDwE~~~~~~~d~~~~~~ll~~lr~~l~~~~~~~  146 (334)
T smart00636       74 ------GGWTE-SDNFSSMLSDPASRKKFIDSIVSFLKKYGFDGIDIDWEYPGARGDDRENYTALLKELREALDKEGAEG  146 (334)
T ss_pred             ------eCCCC-CcchhHHHCCHHHHHHHHHHHHHHHHHcCCCeEEECCcCCCCCccHHHHHHHHHHHHHHHHHHhcccC
Confidence                  55554 244999999999999999999999999999999999999987  6899999999999999964    3


Q ss_pred             CCcEEEEEeecCCCccccccC-hhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC---CCCHHHHHHHHHHcCCC
Q 006211          177 PELTLSMAVRYSPTHETVSYP-IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS---NISTDFGIREWLRRGFP  252 (656)
Q Consensus       177 ~~~~ls~a~~~~~~~~~~~~~-~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~---~~~~~~~v~~~~~~g~p  252 (656)
                      ++++||+++|+.+......|+ +++++++||+||||+||+|++ |+..+||+|||+....   ..+++.+|++|++.|+|
T Consensus       147 ~~~~lsi~v~~~~~~~~~~~~~~~~l~~~vD~v~vm~YD~~~~-~~~~~g~~spl~~~~~~~~~~~v~~~v~~~~~~gvp  225 (334)
T smart00636      147 KGYLLTIAVPAGPDKIDKGYGDLPAIAKYLDFINLMTYDFHGA-WSNPTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGVP  225 (334)
T ss_pred             CceEEEEEecCChHHHHhhhhhHHHHHhhCcEEEEeeeccCCC-CCCCCCCCCcCCCCCCCCCCccHHHHHHHHHHcCCC
Confidence            689999999987665555688 599999999999999999975 6778999999996543   45899999999999999


Q ss_pred             CCceeecccCCCCCcCC------------------------CCCcchHHHHHHHHhcCCCcccccccceeeeeeec-C-c
Q 006211          253 ANKLVLGARASGPGITI------------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS-G-A  306 (656)
Q Consensus       253 ~~Kl~lG~p~yG~~~~~------------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~-~-~  306 (656)
                      ++||+||+|+||+.|+.                        +|.++|.|||...     ++...||+....||.+. + +
T Consensus       226 ~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~y~ei~~~~-----~~~~~~d~~~~~~y~~~~~~~  300 (334)
T smart00636      226 PSKLVLGIPFYGRGWTLVDGSNNGPGAPFTGPATGGPGTWEGGVVDYREICKLL-----GATVVWDDTAKAPYAYNPGTG  300 (334)
T ss_pred             HHHeEEeeccccCccccCCCCcCCCCCcccCCCCCCCCCCcccchhHHHHHhhc-----CcEEEEcCCCceeEEEECCCC
Confidence            99999999999999854                        2457899999864     58899999999999776 3 5


Q ss_pred             EEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          307 TWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       307 ~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                      +||+|||++|++.|++||+++||||+|+|++++|
T Consensus       301 ~~v~ydd~~Si~~K~~~~~~~~lgGv~iW~l~~D  334 (334)
T smart00636      301 QWVSYDDPRSIKAKADYVKDKGLGGVMIWELDAD  334 (334)
T ss_pred             EEEEcCCHHHHHHHHHHHHhCCCCeEEEEeecCC
Confidence            9999999999999999999999999999999998

>cd02876 GH18_SI-CLP Stabilin-1 interacting chitinase-like protein (SI-CLP) is a eukaryotic chitinase-like protein of unknown function that interacts with the endocytic/sorting transmembrane receptor stabilin-1 and is secreted from the lysosome

Probab=100.00  E-value=7.6e-54  Score=441.61  Aligned_cols=287  Identities=17%  Similarity=0.234  Sum_probs=237.6

Q ss_pred             EEEEecCCC--CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEE--EEeecCCCCcc
Q 006211           29 KAGYWLAGR--EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTL--LSIWNGQNSTY  104 (656)
Q Consensus        29 ~~~y~~~~~--~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl--~sigg~~~~~~  104 (656)
                      ++|||+.|.  .|.+.+++.++||||+|+|+.++++++.+...+..+ .-...+..+|++||++||+  +++        
T Consensus         5 ~~~y~~~W~~~~~~~~~~~~~~lthv~~~f~~i~~~g~~~~~~~~~~-~~~~~~~~lk~~~~~lkvlp~i~~--------   75 (318)
T cd02876           5 VLGYVTPWNSHGYDVAKKFAAKFTHVSPVWLQIKRKGNKFVIEGTHD-IDKGWIEEVRKANKNIKILPRVLF--------   75 (318)
T ss_pred             eEEEEcCcCccchHHHHHHhccCCEecceEEEEecCCCeeeeecCcc-hhhHHHHHHHhhCCCcEEEeEEEE--------
Confidence            578998876  467899999999999999999998876555443222 1223457899999999999  566        


Q ss_pred             ccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceee-eeCCCc----cCcchHHHHHHHHHhhcCCCCCc
Q 006211          105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNS----TDLNSLGILLDEWKASASDQPEL  179 (656)
Q Consensus       105 ~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdid-we~p~~----~d~~~~~~ll~~lr~~l~~~~~~  179 (656)
                          |||+.+  .|+.++++++.|++||+++++++++||||||||| ||||..    +|+++|+.||++||++|++ .++
T Consensus        76 ----gg~~~~--~f~~~~~~~~~R~~fi~s~~~~~~~~~~DGidiD~we~p~~~~~~~d~~~~~~~l~el~~~l~~-~~~  148 (318)
T cd02876          76 ----EGWSYQ--DLQSLLNDEQEREKLIKLLVTTAKKNHFDGIVLEVWSQLAAYGVPDKRKELIQLVIHLGETLHS-ANL  148 (318)
T ss_pred             ----CCCCHH--HHHHHHcCHHHHHHHHHHHHHHHHHcCCCcEEEechhhhcccCCHHHHHHHHHHHHHHHHHHhh-cCC
Confidence                565433  4899999999999999999999999999999999 999975    3899999999999999954 478


Q ss_pred             EEEEEeecCCCc-----cccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcC-CCC
Q 006211          180 TLSMAVRYSPTH-----ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRG-FPA  253 (656)
Q Consensus       180 ~ls~a~~~~~~~-----~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g-~p~  253 (656)
                      .+++++|+....     ....||+++|+++||||||||||+||+   +.+||+|||+      +++.+++++++.| +|+
T Consensus       149 ~l~~~v~~~~~~~~~~~~~~~~d~~~l~~~vD~v~lMtYD~~~~---~~~g~~apl~------~v~~~v~~~~~~~~vp~  219 (318)
T cd02876         149 KLILVIPPPREKGNQNGLFTRKDFEKLAPHVDGFSLMTYDYSSP---QRPGPNAPLS------WVRSCLELLLPESGKKR  219 (318)
T ss_pred             EEEEEEcCccccccccccccccCHHHHHhhccEEEEEeeccCCC---CCCCCCCCcH------HHHHHHHHHHhcCCCCH
Confidence            888888765432     233589999999999999999999964   6799999998      8999999999987 999


Q ss_pred             CceeecccCCCCCcCCCC---CcchHHHHHHHHhcCCCcccccccceeee-eeecC---cEEEeeCCcchhHHHHhhhhh
Q 006211          254 NKLVLGARASGPGITIDG---SMGYKFIRAFIQNYGYGAAPVYNASYVVN-LFTSG---ATWINFDGVETIKAKISYAKE  326 (656)
Q Consensus       254 ~Kl~lG~p~yG~~~~~~g---~~~y~~i~~~~~~~~~~~~~~~d~~~~~~-~~~~~---~~~i~yd~~~si~~K~~~~~~  326 (656)
                      +||+||+|+||++|+..+   ..++.+..+.+...  +++..||+.+..+ |.+.+   ++||+|||++|++.|++||++
T Consensus       220 ~KlvlGip~YG~~w~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~~~~~~~y~~~~~~~~v~ydd~~Si~~K~~~a~~  297 (318)
T cd02876         220 AKILLGLNFYGNDYTLPGGGGAITGSEYLKLLKSN--KPKLQWDEKSAEHFFEYKNKGGKHAVFYPTLKSIQLRLDLAKE  297 (318)
T ss_pred             HHeEEeccccccccccCCCCceeehHHHHHHHHhc--CCCceeccCCCcceEEEecCCCcEEEEeCCHHHHHHHHHHHHH
Confidence            999999999999998753   44455555555543  4788999885554 55543   799999999999999999999


Q ss_pred             cccccceeeEeccCccc
Q 006211          327 KNLLGYKAFQLSNDDNW  343 (656)
Q Consensus       327 ~glgGv~~W~l~~Dd~~  343 (656)
                      +|| |+|+|++++++..
T Consensus       298 ~~l-Gv~~W~lg~~~~~  313 (318)
T cd02876         298 LGT-GISIWELGQGLDY  313 (318)
T ss_pred             cCC-cEEEEcccCCchH
Confidence            999 9999999998754

SI-CLP has a glycosyl hydrolase family 18 (GH18) domain but lacks a chitin-binding domain. The catalytic amino acids of the GH18 domain are not conserved in SI-CLP, similar to the chitolectins YKL-39, YKL-40, and YM1/2. Human SI-CLP is sorted to late endosomes and secretory lysosomes in alternatively activated macrophages.

>PF00704 Glyco_hydro_18: Glycosyl hydrolases family 18; InterPro: IPR001223 O-Glycosyl hydrolases 3

Probab=100.00  E-value=1.8e-51  Score=432.44  Aligned_cols=297  Identities=29%  Similarity=0.487  Sum_probs=250.9

Q ss_pred             EEEEEecCCCC-----CCCCCCCCCCccEEEEEEEEecCCCcEEe-----cCCcchhhHHHHHHHHHhhCCCceEEEEee
Q 006211           28 IKAGYWLAGRE-----FPLSDINSALFTHLICAFAEVDSSTYQLS-----ISSANQQYFSIFANSVRRKNPSIKTLLSIW   97 (656)
Q Consensus        28 ~~~~y~~~~~~-----~~~~~i~~~~~thi~~~f~~~~~~~~~~~-----~~~~~~~~~~~~~~~~k~~~~~~kvl~sig   97 (656)
                      +++|||..|+.     |.+++++.++||||+|+|+.+++++....     ............+..+|+++|++|||+|| 
T Consensus         2 ~vv~Y~~~~~~~~~~~~~~~~i~~~~~t~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kvllsi-   80 (343)
T PF00704_consen    2 RVVGYYSNWNSYRPGSYKIEDIPWSKCTHIVYAFAGIDPNGNLNYPWNFDDDNDGDSSGFKNLKELKAKNPGVKVLLSI-   80 (343)
T ss_dssp             EEEEEEEGGGGSSTGCSHGGGSHTTTESEEEEEEEEEETTTTEEEGTTTECSSTTHHHHHHHHHHHHHHHTT-EEEEEE-
T ss_pred             EEEEEECCcCCCCCCCCCHHHCCcccCCEEEEEeeeecCCCceecccccccccCccccchhHHHHHHhhccCceEEEEe-
Confidence            57999988753     66889999999999999999999876642     23334444555667899999999999999 


Q ss_pred             cCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc----CcchHHHHHHHHHhhc
Q 006211           98 NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST----DLNSLGILLDEWKASA  173 (656)
Q Consensus        98 g~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~----d~~~~~~ll~~lr~~l  173 (656)
                                 ||+..+...|..++++++.|++|++++++++++|+|||||||||+|...    ++.+|..||++||++|
T Consensus        81 -----------gg~~~~~~~~~~~~~~~~~r~~f~~~i~~~l~~y~~DGidiD~e~~~~~~~~~~~~~~~~~l~~L~~~l  149 (343)
T PF00704_consen   81 -----------GGWGMSSDGFSQLLSNPAKRQNFINNIVSFLKKYGFDGIDIDWEYPSSSGDPQDKDNYTAFLKELRKAL  149 (343)
T ss_dssp             -----------EETTSSHHHHHHHHHSHHHHHHHHHHHHHHHHHHT-SEEEEEESSTTSTSSTTHHHHHHHHHHHHHHHH
T ss_pred             -----------ccccccccccccccccHHHHHHHHHhhhhhhcccCcceeeeeeeeccccccchhhhhhhhhhhhhhhhh
Confidence                       4444444349999999999999999999999999999999999999886    8999999999999999


Q ss_pred             CCC----CCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC---CCCHHHHHHHH
Q 006211          174 SDQ----PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS---NISTDFGIREW  246 (656)
Q Consensus       174 ~~~----~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~---~~~~~~~v~~~  246 (656)
                      .+.    ++++||+++|+.+..... ++++++.++|||||+|+||++++ |+..++|++||+....   ..+++.++++|
T Consensus       150 ~~~~~~~~~~~ls~a~p~~~~~~~~-~~~~~l~~~vD~v~~m~yD~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~  227 (343)
T PF00704_consen  150 KRANRSGKGYILSVAVPPSPDYYDK-YDYKELAQYVDYVNLMTYDYHGP-WSDVTGPNAPLYDSSWDSNYYSVDSAVQYW  227 (343)
T ss_dssp             HHHHHHHSTSEEEEEEECSHHHHTT-HHHHHHHTTSSEEEEETTSSSST-TSSBETTSSSSSHTTTSGTSSSHHHHHHHH
T ss_pred             cccccccceeEEeeccccccccccc-cccccccccccccccccccCCCC-cccccccccccccCCccCCCceeeeehhhh
Confidence            442    379999999988765544 58999999999999999999975 5668999999997653   67899999999


Q ss_pred             HHcCCCCCceeecccCCCCCcCCC----------------------CCcchHHHHHHHHhcCCCcccccccceeeeeeec
Q 006211          247 LRRGFPANKLVLGARASGPGITID----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS  304 (656)
Q Consensus       247 ~~~g~p~~Kl~lG~p~yG~~~~~~----------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~  304 (656)
                      +..|+|++||+||+|+||+.|+..                      +.++|.++|......+  +...||.....+|.+.
T Consensus       228 ~~~g~p~~Kl~lglp~yg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~y~~~  305 (343)
T PF00704_consen  228 IKAGVPPSKLVLGLPFYGRSWTLVNGSPNGPWGPAYWSPGKGTKNAGILSYYELCALLKSNG--YTVQWDDTAQAPYAYN  305 (343)
T ss_dssp             HHTTSTGGGEEEEEESEEEEEESSSSTTSTTTBBEESEETTTTSBTTEEEHHHHHHHTHHTT--EEEEEETTTTEEEEEE
T ss_pred             ccccCChhheeecCCcccccceecCCcCCCCCCcccccccccccCCCccccccchhhcccCC--cceEEeecccceEEEe
Confidence            999999999999999999987442                      4689999999776444  7888998899999877


Q ss_pred             C--cEEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          305 G--ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       305 ~--~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                      +  ++|++|||++|+++|++||+++||||+++|+|++|
T Consensus       306 ~~~~~~i~~e~~~Si~~K~~~v~~~glgGv~~W~l~~D  343 (343)
T PF00704_consen  306 DDKKHWISYEDPRSIKAKMDYVKEKGLGGVAIWSLDQD  343 (343)
T ss_dssp             TTTTEEEEE--HHHHHHHHHHHHHTT-SEEEEETGGGS
T ss_pred             cCCCeEEEeCCHHHHHHHHHHHHhCCCCEEEEEecCCC
Confidence            6  79999999999999999999999999999999998

2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. Some members of this family, GH18 from CAZY, belong to the chitinase class II group which includes chitinase, chitodextrinase and the killer toxin of Kluyveromyces lactis. The chitinases hydrolyse chitin oligosaccharides. The family also includes various glycoproteins from mammals; cartilage glycoprotein and the oviduct-specific glycoproteins are two examples.; GO: 0004553 hydrolase activity, hydrolyzing O-glycosyl compounds, 0005975 carbohydrate metabolic process; PDB: 1ITX_A 3ALG_A 3ALF_A 1NAR_A 3QOK_A 3G6L_A 3G6M_A 2DT1_A 2B31_A 2O92_A ....

>cd02875 GH18_chitobiase Chitobiase (also known as di-N-acetylchitobiase) is a lysosomal glycosidase that hydrolyzes the reducing-end N-acetylglucosamine from the chitobiose core of oligosaccharides during the ordered degradation of asparagine-linked glycoproteins in eukaryotes

Probab=100.00  E-value=8.5e-50  Score=414.27  Aligned_cols=279  Identities=15%  Similarity=0.200  Sum_probs=228.4

Q ss_pred             ceEEEEEecCCCCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCccc
Q 006211           26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ  105 (656)
Q Consensus        26 ~~~~~~y~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~  105 (656)
                      +..++||..+.  ..-...|++++|||...       +      +.+    .+.+..+|++  ++||+++.         
T Consensus        35 ~~~~~~~~~~~--~~~~~~~~~~~tti~~~-------~------~~~----~~~~~~A~~~--~v~v~~~~---------   84 (358)
T cd02875          35 RFEFLVFSVNS--TNYPNYDWSKVTTIAIF-------G------DID----DELLCYAHSK--GVRLVLKG---------   84 (358)
T ss_pred             ceEEEEEEeCC--CcCcccccccceEEEec-------C------CCC----HHHHHHHHHc--CCEEEEEC---------
Confidence            45678998764  34578999999999874       1      111    2333334444  79999874         


Q ss_pred             cccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc---cCcchHHHHHHHHHhhcCCC-CCcEE
Q 006211          106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS---TDLNSLGILLDEWKASASDQ-PELTL  181 (656)
Q Consensus       106 ~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~---~d~~~~~~ll~~lr~~l~~~-~~~~l  181 (656)
                          +.      ....+++++.|++||+++++++++|||||||||||||..   +|+++|+.||++||++|++. ++++|
T Consensus        85 ----~~------~~~~l~~~~~R~~fi~siv~~~~~~gfDGIdIDwE~p~~~~~~d~~~~t~llkelr~~l~~~~~~~~L  154 (358)
T cd02875          85 ----DV------PLEQISNPTYRTQWIQQKVELAKSQFMDGINIDIEQPITKGSPEYYALTELVKETTKAFKKENPGYQI  154 (358)
T ss_pred             ----cc------CHHHcCCHHHHHHHHHHHHHHHHHhCCCeEEEcccCCCCCCcchHHHHHHHHHHHHHHHhhcCCCcEE
Confidence                11      134678999999999999999999999999999999964   67899999999999999653 47899


Q ss_pred             EEEeecCCCcccc-ccChhhhhhccchhhhhhhcccCCCCC--CccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceee
Q 006211          182 SMAVRYSPTHETV-SYPIDSMKKNLNWAHLVAYDYHMPSKE--NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL  258 (656)
Q Consensus       182 s~a~~~~~~~~~~-~~~~~~l~~~vD~invmtYD~~g~~~~--~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~l  258 (656)
                      |+++|..+..... .||+++|+++||||||||||+|++.|+  ..+|++||+.      +++.+|++|++.|+|++||+|
T Consensus       155 svav~~~p~~~~~~~yd~~~l~~~vD~v~lMtYD~h~~~w~~~~~~g~~ap~~------~v~~~v~~~~~~gvp~~KLvL  228 (358)
T cd02875         155 SFDVAWSPSCIDKRCYDYTGIADASDFLVVMDYDEQSQIWGKECIAGANSPYS------QTLSGYNNFTKLGIDPKKLVM  228 (358)
T ss_pred             EEEEecCcccccccccCHHHHHhhCCEeeEEeecccCCCCCCCCCCCCCCCch------hHHHHHHHHHHcCCCHHHeEE
Confidence            9999977765444 399999999999999999999987676  3588999986      899999999999999999999


Q ss_pred             cccCCCCCcCC--------------------------CCCcchHHHHHHHHhcCCCcccccccceeeeee-ec---C-cE
Q 006211          259 GARASGPGITI--------------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF-TS---G-AT  307 (656)
Q Consensus       259 G~p~yG~~~~~--------------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~-~~---~-~~  307 (656)
                      |+|+||++|+.                          ++.++|.+|+...+..+  +...||+....||. +.   + .+
T Consensus       229 Gip~YGr~w~~~~~~~~~~~~~~~~~p~~g~~~~~~~g~~i~Y~ei~~~~~~~~--~~~~wD~~~~~py~~y~d~~g~~~  306 (358)
T cd02875         229 GLPWYGYDYPCLNGNLEDVVCTIPKVPFRGANCSDAAGRQIPYSEIMKQINSSI--GGRLWDSEQKSPFYNYKDKQGNLH  306 (358)
T ss_pred             EeCCCCCceeCCCCcccCcccCCCCCCcCCCCCcCCCCCccCHHHHHHHHhcCC--CceeeccccccceEEEecCCCcEE
Confidence            99999999952                          12468999998765543  67889999999985 32   2 27


Q ss_pred             EEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccchhhhhh
Q 006211          308 WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIE  352 (656)
Q Consensus       308 ~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~~~~~  352 (656)
                      ||||||++|++.|++||+++||||+|+|++|+||..+.+.+.+..
T Consensus       307 ~V~ydD~~Si~~K~~~a~~~gL~Gv~iW~ld~dD~~g~~~~~~~~  351 (358)
T cd02875         307 QVWYDNPQSLSIKVAYAKNLGLKGIGMWNGDLLDYSGLPIAEKQT  351 (358)
T ss_pred             EEEeCCHHHHHHHHHHHHhCCCCeEEEEeccccccCCCchhhhhh
Confidence            999999999999999999999999999999999999988776443

Chitobiase can only do so if the asparagine that joins the oligosaccharide to protein is previously removed by a glycosylasparaginase. Chitobiase is therefore the final step in the lysosomal degradation of the protein/carbohydrate linkage component of asparagine-linked glycoproteins. The catalytic domain of chitobiase is an eight-stranded alpha/beta barrel fold similar to that of other family 18 glycosyl hydrolases such as hevamine and chitotriosidase.

>cd02874 GH18_CFLE_spore_hydrolase Cortical fragment-lytic enzyme (CFLE) is a peptidoglycan hydrolase involved in bacterial endospore germination

Probab=100.00  E-value=4.5e-48  Score=398.74  Aligned_cols=285  Identities=20%  Similarity=0.295  Sum_probs=233.6

Q ss_pred             EEEEecCCCC--CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcccc
Q 006211           29 KAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS  106 (656)
Q Consensus        29 ~~~y~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~  106 (656)
                      ++||+..|..  +....-..+++|||++.++.++++|. +.  ...   ...++..+|++  ++||+++|||++.+    
T Consensus         4 ~~g~~~~~~~~~~~~~~~~~~~lt~v~p~w~~~~~~g~-~~--~~~---~~~~~~~a~~~--~~kv~~~i~~~~~~----   71 (313)
T cd02874           4 VLGYYTPRNGSDYESLRANAPYLTYIAPFWYGVDADGT-LT--GLP---DERLIEAAKRR--GVKPLLVITNLTNG----   71 (313)
T ss_pred             EEEEEecCCCchHHHHHHhcCCCCEEEEEEEEEcCCCC-CC--CCC---CHHHHHHHHHC--CCeEEEEEecCCCC----
Confidence            5799987765  34445677899999999999998753 22  221   23444445554  79999999655421    


Q ss_pred             ccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEee
Q 006211          107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR  186 (656)
Q Consensus       107 ~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~  186 (656)
                           .++++.|+.++++++.|++||+++++++++|||||||||||+|..+|+++|+.||++||.+|+ .++++|+++++
T Consensus        72 -----~~~~~~~~~~l~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~~~~~d~~~~~~fl~~lr~~l~-~~~~~lsv~~~  145 (313)
T cd02874          72 -----NFDSELAHAVLSNPEARQRLINNILALAKKYGYDGVNIDFENVPPEDREAYTQFLRELSDRLH-PAGYTLSTAVV  145 (313)
T ss_pred             -----CCCHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCcEEEecccCCHHHHHHHHHHHHHHHHHhh-hcCcEEEEEec
Confidence                 145566899999999999999999999999999999999999999999999999999999995 34788998876


Q ss_pred             cCCC-----ccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeeccc
Q 006211          187 YSPT-----HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGAR  261 (656)
Q Consensus       187 ~~~~-----~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p  261 (656)
                      +...     .+...||+++++++||+||||+||+||+ | +.+||+||+.      +++..++++. +|+|++||+||+|
T Consensus       146 p~~~~~~~~~~~~~~~~~~l~~~vD~v~lm~YD~~~~-~-~~~gp~a~~~------~~~~~~~~~~-~gvp~~KlvlGip  216 (313)
T cd02874         146 PKTSADQFGNWSGAYDYAAIGKIVDFVVLMTYDWHWR-G-GPPGPVAPIG------WVERVLQYAV-TQIPREKILLGIP  216 (313)
T ss_pred             CccccccccccccccCHHHHHhhCCEEEEEEeccCCC-C-CCCCccCChH------HHHHHHHHHH-hcCCHHHEEEeec
Confidence            5532     2235689999999999999999999975 3 5689999986      6777777665 8999999999999


Q ss_pred             CCCCCcCCC-------CCcchHHHHHHHHhcCCCcccccccceeeeee-ec----CcEEEeeCCcchhHHHHhhhhhccc
Q 006211          262 ASGPGITID-------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF-TS----GATWINFDGVETIKAKISYAKEKNL  329 (656)
Q Consensus       262 ~yG~~~~~~-------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~-~~----~~~~i~yd~~~si~~K~~~~~~~gl  329 (656)
                      +||++|+..       +.++|.+++..+.+.  ++...||+.+..||. +.    ..+||+|||++|++.|++|++++||
T Consensus       217 ~YG~~w~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~~~~~~~y~~~~g~~~~v~y~d~~Si~~K~~~~~~~~l  294 (313)
T cd02874         217 LYGYDWTLPYKKGGKASTISPQQAINLAKRY--GAEIQYDEEAQSPFFRYVDEQGRRHEVWFEDARSLQAKFELAKEYGL  294 (313)
T ss_pred             ccccccccCCCCCcCccccCHHHHHHHHHHc--CCCeEECcccCCCcEEEEeCCCCEEEEEeCcHHHHHHHHHHHHHcCC
Confidence            999999654       457888888877764  488899999888874 22    3589999999999999999999999


Q ss_pred             ccceeeEeccCcc
Q 006211          330 LGYKAFQLSNDDN  342 (656)
Q Consensus       330 gGv~~W~l~~Dd~  342 (656)
                      ||+++|++++||.
T Consensus       295 gGv~iW~lg~dD~  307 (313)
T cd02874         295 RGVSYWRLGLEDP  307 (313)
T ss_pred             CeEEEEECCCCCc
Confidence            9999999999994

CFLE is expressed as an inactive preprotein (called SleB) in the forespore compartment of sporulating cells. SleB translocates across the forespore inner membrane and is deposited as a mature enzyme in the cortex layer of the spore. As part of a sensory mechanism capable of initiating germination, CFLE degrades a spore-specific peptidoglycan constituent called muramic-acid delta-lactam that comprises the outer cortex. CFLE has a C-terminal glycosyl hydrolase family 18 (GH18) catalytic domain as well as two N-terminal LysM peptidoglycan-binding domains. In addition to SleB, this family includes YaaH, YdhD, and YvbX from Bacillus subtilis.

>cd06545 GH18_3CO4_chitinase The Bacteroides thetaiotaomicron protein represented by pdb structure 3CO4 is an uncharacterized bacterial member of the family 18 glycosyl hydrolases with homologs found in Flavobacterium, Stigmatella, and Pseudomonas

Probab=100.00  E-value=5.3e-47  Score=377.67  Aligned_cols=240  Identities=23%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             EEEEecCCCCCC--CCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcccc
Q 006211           29 KAGYWLAGREFP--LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS  106 (656)
Q Consensus        29 ~~~y~~~~~~~~--~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~  106 (656)
                      ++|||++|..+.  ++++|.++||||+|+|+.++++| .+...+. ...+...++.+|+  +++||++|||         
T Consensus         1 vigyy~~w~~~~~~~~~~~~~~lThv~~~f~~i~~~G-~l~~~~~-~~~~~~~~~~~~~--~~~kvl~sig---------   67 (253)
T cd06545           1 VVGYLPNYDDLNALSPTIDFSKLTHINLAFANPDANG-TLNANPV-RSELNSVVNAAHA--HNVKILISLA---------   67 (253)
T ss_pred             CEEEeCCcccccCCcccCChhhCCeEEEEEEEECCCC-eEEecCc-HHHHHHHHHHHHh--CCCEEEEEEc---------
Confidence            479999998754  89999999999999999999875 4444322 2234444455554  4799999994         


Q ss_pred             ccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEee
Q 006211          107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR  186 (656)
Q Consensus       107 ~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~  186 (656)
                         |+..+.  |+.++++++.|++|++++++++++|+|||||||||+|... +++|..|+++||+++++ .+++||++++
T Consensus        68 ---g~~~~~--~~~~~~~~~~r~~fi~~lv~~~~~~~~DGIdiDwE~~~~~-~~~~~~fv~~Lr~~l~~-~~~~lt~av~  140 (253)
T cd06545          68 ---GGSPPE--FTAALNDPAKRKALVDKIINYVVSYNLDGIDVDLEGPDVT-FGDYLVFIRALYAALKK-EGKLLTAAVS  140 (253)
T ss_pred             ---CCCCCc--chhhhcCHHHHHHHHHHHHHHHHHhCCCceeEEeeccCcc-HhHHHHHHHHHHHHHhh-cCcEEEEEcc
Confidence               443322  5779999999999999999999999999999999999865 78999999999999943 4789999997


Q ss_pred             cCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCC-CCCceeecccCCCC
Q 006211          187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGF-PANKLVLGARASGP  265 (656)
Q Consensus       187 ~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~-p~~Kl~lG~p~yG~  265 (656)
                      +.....   + .+++.++||||||||||++|+|+.+.+|++||+.      +++.++++|++.|+ |++||+||+|+||+
T Consensus       141 ~~~~~~---~-~~~~~~~vD~i~vMtYD~~g~~~~~~~g~~a~~~------~~~~~v~~~~~~g~ip~~KlvlGlp~YG~  210 (253)
T cd06545         141 SWNGGA---V-SDSTLAYFDFINIMSYDATGPWWGDNPGQHSSYD------DAVNDLNYWNERGLASKDKLVLGLPFYGY  210 (253)
T ss_pred             Cccccc---c-cHHHHhhCCEEEEEcCcCCCCCCCCCCCCCCchH------hHHHHHHHHHHcCCCCHHHEEEEeCCccc
Confidence            653322   3 3678899999999999999887666789999986      78999999999998 99999999999998


Q ss_pred             CcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCc
Q 006211          266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD  341 (656)
Q Consensus       266 ~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd  341 (656)
                      +|                                          +|+++.+++.|+++|+++ +||+|+|++++|.
T Consensus       211 ~w------------------------------------------~~~~~~~~~~~~~~~~~~-~gG~~~w~~~~d~  243 (253)
T cd06545         211 GF------------------------------------------YYNGIPTIRNKVAFAKQN-YGGVMIWELSQDA  243 (253)
T ss_pred             cc------------------------------------------cCCCHHHHHHHHHHHHHh-cCeEEEEeccCCC
Confidence            76                                          588888999999999999 9999999999997

>cd06549 GH18_trifunctional GH18 domain of an uncharacterized family of bacterial proteins, which share a common three-domain architecture: an N-terminal glycosyl hydrolase family 18 (GH18) domain, a glycosyl transferase family 2 domain, and a C-terminal polysaccharide deacetylase domain

Probab=100.00  E-value=3.1e-44  Score=365.30  Aligned_cols=284  Identities=14%  Similarity=0.166  Sum_probs=218.8

Q ss_pred             EEEEecCCCC--CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcccc
Q 006211           29 KAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS  106 (656)
Q Consensus        29 ~~~y~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~  106 (656)
                      +.|||..|..  +.--......+|||+..+..++..++.+..  ..+.......+.+|+++|.++++.++          
T Consensus         2 ~l~~~~~w~~~s~~sl~~~~~~l~~vsP~W~~~~~~~g~l~~--~~d~~~~~~~~~~k~~~~~l~~~~~~----------   69 (298)
T cd06549           2 ALAFYTPWDDASFASLKRHAPRLDWLVPEWLNLTGPEGRIDV--FVDPQGVAIIAAAKAHPKVLPLVQNI----------   69 (298)
T ss_pred             eeEEEecCChhhHHHHHHhhccCCEEeceeEEEecCCCceec--cCChHHHHHHHHHHcCCceeEEEEec----------
Confidence            4688877654  333344566899999999999854455542  22222233446678888888888888          


Q ss_pred             ccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEee
Q 006211          107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR  186 (656)
Q Consensus       107 ~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~  186 (656)
                        +|+..++..|+.++++++.|++||+++++++++|||||||||||++..+|+++|+.||++||++|++ .++.|++++|
T Consensus        70 --~~~~~~~~~~~~~l~~~~~R~~fi~~iv~~~~~~~~dGidiD~E~~~~~d~~~~~~fl~eL~~~l~~-~~~~lsv~v~  146 (298)
T cd06549          70 --SGGAWDGKNIARLLADPSARAKFIANIAAYLERNQADGIVLDFEELPADDLPKYVAFLSELRRRLPA-QGKQLTVTVP  146 (298)
T ss_pred             --CCCCCCHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEEecCCCChhHHHHHHHHHHHHHHHhhh-cCcEEEEEec
Confidence              5555555569999999999999999999999999999999999999999999999999999999954 4789999998


Q ss_pred             cCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccCCCCC
Q 006211          187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPG  266 (656)
Q Consensus       187 ~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~  266 (656)
                      +.+.    .||+++++++||+++|||||+|+++  +.+||.+|..      +++..+++. ..|+|++||+||+|+||++
T Consensus       147 ~~~~----~~d~~~l~~~~D~v~lMtYD~~~~~--~~~gp~a~~~------~~~~~~~~~-~~~vp~~KlvlGip~YG~~  213 (298)
T cd06549         147 ADEA----DWNLKALARNADKLILMAYDEHYQG--GAPGPIASQD------WFESNLAQA-VKKLPPEKLIVALGSYGYD  213 (298)
T ss_pred             CCCC----CCCHHHHHHhCCEEEEEEeccCCCC--CCCCCCCChh------hHHHHHHHH-HhCCCHHHEEEEecccCcc
Confidence            7643    4899999999999999999999642  2455666543      566666664 4799999999999999999


Q ss_pred             cCCCC---CcchHHHHHHHHhcCCCcccccccceeee-eee-c--C-cEEEeeCCcchhHHHHhhhhhcccccceeeEec
Q 006211          267 ITIDG---SMGYKFIRAFIQNYGYGAAPVYNASYVVN-LFT-S--G-ATWINFDGVETIKAKISYAKEKNLLGYKAFQLS  338 (656)
Q Consensus       267 ~~~~g---~~~y~~i~~~~~~~~~~~~~~~d~~~~~~-~~~-~--~-~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~  338 (656)
                      |+..+   ..+..+....+...+  ....|++....| |.+ +  | .++|||||++|++.|+++|+++||+|+++|+++
T Consensus       214 w~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~g~~h~Vw~~d~~Sl~~K~~~a~~~~l~Gva~W~lg  291 (298)
T cd06549         214 WTKGGNTKAISSEAAWLLAAHAS--AAVKFDDKASNATYFFYDDEGVSHEVWMLDAVTLFNQLKAVQRLGPAGVALWRLG  291 (298)
T ss_pred             ccCCCCCcccCHHHHHHHHHHcC--CcceecccccCCceEEEcCCCcEEEEEeccHHHHHHHHHHHHHcCCCcEEEEecc
Confidence            98753   344444444344333  566676544444 333 1  2 479999999999999999999999999999999


Q ss_pred             cCcc
Q 006211          339 NDDN  342 (656)
Q Consensus       339 ~Dd~  342 (656)
                      +||.
T Consensus       292 ~ed~  295 (298)
T cd06549         292 SEDP  295 (298)
T ss_pred             CCCC
Confidence            9984

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=365.62  Aligned_cols=231  Identities=47%  Similarity=0.813  Sum_probs=203.0

Q ss_pred             CccccCHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 006211          421 NLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC  500 (656)
Q Consensus       421 ~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  500 (656)
                      ....|++.++..++++|...+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            57789999999999999999999999999999999999999999988776443135599999999999999999999999


Q ss_pred             eeCC-ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEE
Q 006211          501 TERD-ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS  579 (656)
Q Consensus       501 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~  579 (656)
                      .+.+ ..+||+|||++|+|.++|+..... .++|.++++|+.++|+||+|||+...++||||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9988 499999999999999999875444 78999999999999999999999888889999999999999999999999


Q ss_pred             eccCccccccCccccccccc-cccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccccccccc
Q 006211          580 DFGMAKLFRKDVDEANTGRI-VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA  654 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  654 (656)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+++||+||++|.+.....+...+++|+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            99999654321  1111122 7899999999999999999999999999999999999998876555555577764

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=350.07  Aligned_cols=205  Identities=28%  Similarity=0.461  Sum_probs=181.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..+|...+.||+|+||+||+|+. .++..||||.+...  ..+..+.+..|+.+|+.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35688888999999999999965 45789999999776  4566677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC------CcEEEEeccCc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE------LNPKISDFGMA  584 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~------~~~kl~DfGla  584 (656)
                      |||.+|+|..|++.   +..+++..++.++.|++.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999964   336899999999999999999999998   9999999999999875      45899999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCccc
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN  647 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~  647 (656)
                      +.+..   .......+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+..+..+-
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            98763   3334567999999999999999999999999999999999999999985544443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=328.37  Aligned_cols=203  Identities=26%  Similarity=0.392  Sum_probs=180.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++++.||+|+||+|+.++. .+++.+|+|++++..   ..+.+....|..+|.+++||.||++...|++...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            35789999999999999999954 568899999998753   23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      +||+.||.|...|.   +...+++..+..++.+|+.||.|||+.+   ||||||||+|||+|++|+++|+|||+|+....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999998884   3456889999999999999999999998   99999999999999999999999999985433


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                        ....+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.
T Consensus       178 --~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~  230 (357)
T KOG0598|consen  178 --DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV  230 (357)
T ss_pred             --CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence              22344557999999999999999999999999999999999999999976653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-41  Score=345.65  Aligned_cols=206  Identities=26%  Similarity=0.457  Sum_probs=185.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..|...+.||+|+|+.||++.. .+|+.||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999966 88999999999764   3445677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |+|..++|..++.   ++..+++.+++.++.||+.||.|||+.+   |+|||||..|+|++++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999998885   4567999999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL  648 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~  648 (656)
                      .+  +..+.||||.|+|||++.....+..+||||+|||+|.||.|++||+..+-.+..
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety  227 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY  227 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence            33  344589999999999999999999999999999999999999999876554443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=317.92  Aligned_cols=205  Identities=23%  Similarity=0.371  Sum_probs=177.1

Q ss_pred             CCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEE-EeeCCc-eEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGY-CTERDE-NMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~  510 (656)
                      +|++.++||+|+||+||++ +..+|..+|.|.++-.  ..+..+.+..|+.+|++|+|||||+++++ +.++.. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4667899999999999999 6678999999988743  45566789999999999999999999983 444444 88999


Q ss_pred             EecCCCChhhhhhC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          511 EYLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF-RVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       511 e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~-~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+|..|+|...+.. ..++..+++...++++.|++.||..+|+.-+. -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999988854 23455689999999999999999999983321 38999999999999999999999999999886


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...  ......+|||.||+||.+....|+.||||||+||++|||...+.||.+.
T Consensus       180 s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  180 SKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             chh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            543  3445679999999999999999999999999999999999999999765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=317.21  Aligned_cols=197  Identities=28%  Similarity=0.394  Sum_probs=174.7

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-eEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-NMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~  513 (656)
                      .+.++.||+|+.|+||++.+ .+++.+|+|++... .+...+++.+|+++++..+||+||.++|.|..... ..|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            44568999999999999955 56889999999654 34456789999999999999999999999999884 99999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|+.++...   ..+++...-.++.++++||.|||+.+  +||||||||+|||++..|++||||||.++.+...   
T Consensus       161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999998543   45899999999999999999999633  3999999999999999999999999999876543   


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+...
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence             345578999999999999999999999999999999999999999764

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=328.68  Aligned_cols=201  Identities=33%  Similarity=0.568  Sum_probs=174.5

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEEEecCC
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-ENMLIYEYLPN  515 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  515 (656)
                      ..+.||+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            4466999999999999995555599999986532  22568999999999999999999999999887 79999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccccCcccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~~~~~~~  594 (656)
                      |+|..+++.. ++..+++..+++++.+|++||.|||+++.  ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            9999999764 45679999999999999999999999874  99999999999999997 99999999998654321  2


Q ss_pred             cccccccccccccccccc--CCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVK--KGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            222358999999999999  66999999999999999999999999976553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=300.47  Aligned_cols=199  Identities=27%  Similarity=0.393  Sum_probs=179.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+.++.||.|+||.|.+++.+ +|..+|+|+++...   .+..+...+|..+|+.+.||+++++.+.|.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45778899999999999999654 58899999998753   345567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||++||.|..+++..   ..+++..++.++.||+.|++|||+++   |++|||||+|||+|.+|.+||+|||.|+.... 
T Consensus       124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            999999999999543   35899999999999999999999998   99999999999999999999999999987542 


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                          .+-+.||||.|+|||++....++.++|.|||||++|||+.|.+||...+.
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence                35568999999999999999999999999999999999999999976554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-39  Score=318.22  Aligned_cols=204  Identities=25%  Similarity=0.393  Sum_probs=174.4

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChh-------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-------GLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      ..+.|.+.+.||+|+||.|-+| ...+|+.||||++++....       ....+++|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4566788999999999999999 5567999999999764211       2234679999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEEec
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDF  581 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~Df  581 (656)
                      ..||||||++||+|.+.+..   ...+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999988843   445778888999999999999999998   9999999999999876   77999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCC---CccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY---SMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      |+|+...   ......+.|||+.|.|||++.+...   ..++|+||+||+||-+|||.+||....++
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            9998764   2344556899999999999976553   34789999999999999999999765443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=329.04  Aligned_cols=207  Identities=32%  Similarity=0.516  Sum_probs=178.0

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ..+.||+|.||+||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+..++||||||+.|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            458899999999999999888899999997752 3346788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      .++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+....+... ....
T Consensus       289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~~~  363 (468)
T KOG0197|consen  289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-ASEG  363 (468)
T ss_pred             HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-ecCC
Confidence            999976 24456888999999999999999999998   999999999999999999999999999955443222 2223


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCccccccc
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFL  651 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~  651 (656)
                      ..-+..|.|||.+....++.|||||||||+||||+| |+.|+......+...++
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l  417 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL  417 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH
Confidence            345679999999999999999999999999999998 55566766665555444

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.8e-38  Score=339.59  Aligned_cols=212  Identities=30%  Similarity=0.485  Sum_probs=181.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .+.+..+.||+|+||+||+|..      +....||||.++...+. ...+|++|++++..++|||||+|+|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            4455678999999999999954      23457999999887655 6789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          508 LIYEYLPNKSLDLYLFDPIR-----------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      +|+|||..|+|.+||.....           +.+++..+.+.|+.|||.||.||-+.+   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999953211           334889999999999999999999988   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCccccc
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN  649 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  649 (656)
                      ||+|||+++..-..+.....+...-+.+|||||.|..+.||.+||||||||+|||++| |+.|+....+++..+
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            9999999997655444333334456789999999999999999999999999999997 777887666655443

>cd00598 GH18_chitinase-like The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods

Probab=100.00  E-value=3.2e-37  Score=300.49  Aligned_cols=204  Identities=27%  Similarity=0.429  Sum_probs=174.7

Q ss_pred             EEEEecCCCCCC---CCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCccc
Q 006211           29 KAGYWLAGREFP---LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ  105 (656)
Q Consensus        29 ~~~y~~~~~~~~---~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~  105 (656)
                      ++|||..|....   +..++.++||||+|+|+.+++++......+.........+..+|+++|++||++||         
T Consensus         1 vv~y~~~w~~~~~~~~~~~~~~~~thvi~~f~~v~~~~~~~~~~~~~~~~~~~~i~~l~~~~~g~kv~~si---------   71 (210)
T cd00598           1 VICYYDGWSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDKSEEPLKGALEELASKKPGLKVLISI---------   71 (210)
T ss_pred             CEEEEccccccCCCChhhCCcccCCEEEEeeEEECCCCCEecccCcccHHHHHHHHHHHHhCCCCEEEEEE---------
Confidence            379998876543   58999999999999999999887655423333444556667888888999999999         


Q ss_pred             cccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccC---cchHHHHHHHHHhhcCCCCCcEEE
Q 006211          106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTD---LNSLGILLDEWKASASDQPELTLS  182 (656)
Q Consensus       106 ~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d---~~~~~~ll~~lr~~l~~~~~~~ls  182 (656)
                         ||+..+.. | .++++++.|++|++++++++++|+|||||||||+|...+   +++|+.|+++||+++++ .+++||
T Consensus        72 ---gg~~~~~~-~-~~~~~~~~~~~f~~~~~~~v~~~~~DGidiD~E~~~~~~~~~~~~~~~ll~~lr~~l~~-~~~~ls  145 (210)
T cd00598          72 ---GGWTDSSP-F-TLASDPASRAAFANSLVSFLKTYGFDGVDIDWEYPGAADNSDRENFITLLRELRSALGA-ANYLLT  145 (210)
T ss_pred             ---cCCCCCCC-c-hhhcCHHHHHHHHHHHHHHHHHcCCCceEEeeeCCCCcCccHHHHHHHHHHHHHHHhcc-cCcEEE
Confidence               44443433 4 889999999999999999999999999999999998875   89999999999999943 379999


Q ss_pred             EEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccC
Q 006211          183 MAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARA  262 (656)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~  262 (656)
                      +++|+.+.....+|+++++.+++||+|+|+||                                         |+||+|+
T Consensus       146 ~a~~~~~~~~~~~~~~~~l~~~vD~v~vm~Yd-----------------------------------------l~~g~~~  184 (210)
T cd00598         146 IAVPASYFDLGYAYDVPAIGDYVDFVNVMTYD-----------------------------------------LVLGVPF  184 (210)
T ss_pred             EEecCChHHhhccCCHHHHHhhCCEEEEeeec-----------------------------------------ccccchh
Confidence            99998776554458999999999999999998                                         8999999


Q ss_pred             CCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccC
Q 006211          263 SGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND  340 (656)
Q Consensus       263 yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~D  340 (656)
                      |                                                    |++.|++|++++++||+|+|++++|
T Consensus       185 ~----------------------------------------------------s~~~k~~~~~~~~~gGv~~w~~~~d  210 (210)
T cd00598         185 Y----------------------------------------------------SLGAKAKYAKQKGLGGVMIWELDQD  210 (210)
T ss_pred             h----------------------------------------------------hHHHHHHHHHHcCCceEEEEeccCC
Confidence            8                                                    9999999999999999999999987

Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are inclu

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-38  Score=315.28  Aligned_cols=208  Identities=28%  Similarity=0.443  Sum_probs=176.4

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  508 (656)
                      .+.|+.+++||+|.||.||+| +..+|+.||+|+++...  +....-..+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456788899999999999999 56789999999987654  44455678999999999999999999998876  68999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+|||+. +|.-++..+  .-.+++.++..++.|++.||+|+|+++   |+|||||.+|||||++|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 565555432  335899999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL  648 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~  648 (656)
                      ...... ....+-|..|.|||++.+ ..|+.++|+||.||||.||+.|++.+.+.+.-+++
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl  329 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL  329 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence            654333 334567999999998876 56999999999999999999999999876654443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=314.94  Aligned_cols=206  Identities=27%  Similarity=0.408  Sum_probs=178.8

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      +...++|...+.||+|+|++|++|+ ...++.||||++.+.   .+...+-+..|-+.|.+| .||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3445789999999999999999994 457899999999765   222334466788889999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      +|+|+||+++|+|..++...   +.+++...+.++.+|+.+|+|||+++   ||||||||+|||+|.+++++|+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            99999999999999999643   45899999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCccc---------c--ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDE---------A--NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .+......         .  .....+||..|.+||++.....++.+|+|+|||++|+|+.|++||...
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            77543211         1  114579999999999999999999999999999999999999999754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-37  Score=312.45  Aligned_cols=208  Identities=24%  Similarity=0.360  Sum_probs=180.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..++|+++++||+|+||+||.|+. .+|..+|+|+++++.   ..+.+.++.|-.+|....+|.||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999954 569999999998763   3456678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||++||++..+|.   +...|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+|||||.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999984   4567999999999999999999999998   9999999999999999999999999995322


Q ss_pred             cC---------------------cccc-----c-------------------cccccccccccccccccCCCCCccchhH
Q 006211          589 KD---------------------VDEA-----N-------------------TGRIVGTYGYVPPEYVKKGIYSMKYDVY  623 (656)
Q Consensus       589 ~~---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sDvw  623 (656)
                      ..                     .+..     .                   .-..+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                     0000     0                   0124899999999999999999999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCcc
Q 006211          624 SFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       624 slGvil~elltg~~p~~~~~~~~  646 (656)
                      |||||+||||.|.+||...+..+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~  395 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE  395 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999997766544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.3e-38  Score=296.73  Aligned_cols=208  Identities=21%  Similarity=0.318  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      +.|+.+.++|+|+||.|++|+. .+|+.||||++..+.+ +. .+-.++|+++|++++|+|+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4678889999999999999965 4699999999876533 23 3346899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||+..-|+++-..   ...++.+...+++.|+++|+.|+|+++   +|||||||+||||+.++.+||||||+|+.+... 
T Consensus        82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            9988777665433   234788999999999999999999998   999999999999999999999999999987642 


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccccc
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF  650 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  650 (656)
                       .......+.|..|.|||.+.+ .+|...+||||+||++.||++|.+-|.+..+-+++.+
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~  213 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL  213 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence             223344588999999998876 7899999999999999999999999987665554443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=316.82  Aligned_cols=197  Identities=27%  Similarity=0.417  Sum_probs=176.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+..  +++.+.+.+|+++++.++||||+.++++|+.....++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4688889999999999999954 457899999987653  4456779999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+.| +|..++.+   ...++++.+..++.+++.||.|||++.   |+|||+||+|||++.++.+|+||||+|+.+... 
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9977 99988853   456999999999999999999999987   999999999999999999999999999976542 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                       ......+.||+.|||||...+.+|+..+|+|||||++||+++|++||-
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence             233456789999999999999999999999999999999999999994

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=308.95  Aligned_cols=207  Identities=28%  Similarity=0.448  Sum_probs=180.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .+...+.++||+|.||+|.++....+..||||.++...... ..+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34556789999999999999998888999999999875544 47899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |++|+|..++....... +.-....+|+.||+.||+||.+.+   +|||||.++|||++.++++||+|||+++.+-....
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999997653332 455667889999999999999998   99999999999999999999999999997665555


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHH--cCCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII--SSKRNARYYGT  644 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ell--tg~~p~~~~~~  644 (656)
                      ....+..+-+.+|||||.+..+.++.+||+|+||+++||++  +..+|+....+
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~  746 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD  746 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence            55555667789999999999999999999999999999975  56777765544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-36  Score=280.19  Aligned_cols=202  Identities=24%  Similarity=0.438  Sum_probs=173.2

Q ss_pred             cCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-G-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .+|...++||+|.||.||+| +.++|+.||||+++..... . .....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            36778899999999999999 5578999999999865332 1 2356899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||+ .+|+..+.+  +...++..+...++.++++|++|||++.   |+||||||.|+|++++|.+||+|||+++.+.+..
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            996 578888865  3456899999999999999999999998   9999999999999999999999999999887543


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...  ...+-|..|.|||.+.+ ..|+..+||||.||++.||+-|.+-|.+.++
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            332  23377899999998765 5699999999999999999998877665443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=310.38  Aligned_cols=200  Identities=27%  Similarity=0.448  Sum_probs=180.5

Q ss_pred             cCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ..|...++||+|+-|.||.+ +..+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46777889999999999999 55678899999998876666677899999999999999999999999899999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|.+.+    ....+++.++..|++++++||+|||.++   |+|||||..|||++.+|.+||+|||+|..+....  
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--  423 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--  423 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence            999998877    3445899999999999999999999998   9999999999999999999999999998776543  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......+||+.|||||++....|++|+||||||++++||+-|.+||-+.+
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence            34556899999999999999999999999999999999999999997533

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=295.46  Aligned_cols=195  Identities=32%  Similarity=0.514  Sum_probs=165.4

Q ss_pred             CCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEeeCC----ceEEEEE
Q 006211          438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCTERD----ENMLIYE  511 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e  511 (656)
                      +..+.||+|.||.||+|.+ +++.||||++...   ..+.++.|-+|.+.  ++|+||+++++.-....    .++||++
T Consensus       213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            4567899999999999988 5599999999654   34567777777765  48999999998876555    7899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE------YSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~------~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      |.+.|+|.+||    ..+.++|....+++..+++||+|||+      .+.++|+|||||++||||.+|+.+.|+|||+|.
T Consensus       289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999    45679999999999999999999996      334579999999999999999999999999999


Q ss_pred             ccccCccccccccccccccccccccccCCC-CC-----ccchhHHHHHHHHHHHcCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS-----MKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDvwslGvil~elltg~~p~~  640 (656)
                      .+............+||.+|||||++.+.. +.     .+.||||+|.+||||++.-.-+.
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            887665555555689999999999997643 22     36899999999999999876553

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=297.67  Aligned_cols=202  Identities=28%  Similarity=0.456  Sum_probs=170.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  511 (656)
                      .++...+.||+|+||.||++... +|...|||..........+.+.+|+.+|.+++|||||+.+|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34667789999999999999554 48999999987764444677899999999999999999999754444  5899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCcccccc-
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRK-  589 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~-  589 (656)
                      |+++|+|.+++.....  .+++..++.++.||++||.|||+++   |+||||||+|||++. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999865432  5899999999999999999999887   999999999999999 79999999999987653 


Q ss_pred             CccccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...........||+.|||||++..+. ...++|||||||++.||+||++||..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            11122234568999999999998533 34599999999999999999999976

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=304.30  Aligned_cols=201  Identities=26%  Similarity=0.394  Sum_probs=172.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHH--HHHHHHHHHhcC-CCceeeEEEEEeeCC-ceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEE--FKNEVSLTARLQ-HVNLLRVLGYCTERD-ENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  507 (656)
                      ..++|..+++||.|.||.||+|+ ...+..||||+++..-.. .++  =++|+..|++++ ||||+++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            45678899999999999999994 556899999999765322 222  268999999998 999999999998887 899


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|||||+ .+|..++.++  +..+++..++.|+.||++||+|+|..|   +.|||+||+|||+..+..+||+|||+|+.+
T Consensus        87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            9999995 5788887665  567999999999999999999999998   999999999999998889999999999987


Q ss_pred             ccCcccccccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+..   .....+.|..|.|||++. ...|+.+.||||+|||++|+.+.++-|.+..
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s  214 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS  214 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence            6543   334458899999999764 5678999999999999999999999887543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=309.30  Aligned_cols=207  Identities=25%  Similarity=0.367  Sum_probs=180.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      ..-++|...++||+|+||+|+++.. .+++.+|||++++.   .....+....|-.++... +||.+++++.+|++.+.+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3456889999999999999999965 45789999999876   344566778888888777 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+.||++..+.    +...+++..+..++..++.||.|||+++   ||+||||.+|||+|.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999954333    3456899999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCccc
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN  647 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~  647 (656)
                      .-.  ....+++.+||+.|||||++.+..|+..+|.|||||+|||||.|..||.+.+.++.
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~  576 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV  576 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            332  23467789999999999999999999999999999999999999999987665543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=304.43  Aligned_cols=203  Identities=26%  Similarity=0.418  Sum_probs=176.6

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCC----Ch-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT----ST-QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  505 (656)
                      ...+|.+.+.||+|+||.|+.| ...+++.||+|++...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4567889999999999999999 4456899999977653    11 23446678999999999 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMA  584 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla  584 (656)
                      .++||||+.+|+|.+++.+   ...+.+.++..++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999965   345888999999999999999999998   9999999999999999 99999999999


Q ss_pred             cccccCccccccccccccccccccccccCCC-CC-ccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS-MKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....  ........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+-||....
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            87631  223344569999999999999877 75 78999999999999999999998744

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=305.25  Aligned_cols=206  Identities=28%  Similarity=0.512  Sum_probs=175.1

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      .++....+.+.+.+.||+|+||+||+|.+-  ..||||++...  ..+..+.|++|+..+++-+|.||+-++|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555566678899999999999999873  36999999765  44567889999999999999999999999987666


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                       .||+.+|+|-+|..+++...  ..++..+.+.|+.||++||.|||.++   |||||||..||++.+++.|||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999997644  45888999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .-..-..........|...|||||++..   .+|+..+||||||+++|||+||..|+..
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi  595 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI  595 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence            4322112223334467889999999864   5689999999999999999999999983

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=289.23  Aligned_cols=206  Identities=23%  Similarity=0.356  Sum_probs=178.5

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .+.|++.+.||.|..++||+| +.+.+..||||++..+.. ...+.+++|+..|..++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            457889999999999999999 567789999999986533 336789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||.+|++.+++...... .+++..+..|++++++||.|||.++   .||||||+.||||+.+|.|||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999998664443 3889999999999999999999998   9999999999999999999999999876554332


Q ss_pred             cccc--cccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEAN--TGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~--~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+..  ....+||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            2221  145689999999999543  458999999999999999999999997654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=313.05  Aligned_cols=205  Identities=28%  Similarity=0.492  Sum_probs=176.1

Q ss_pred             CCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ...+.++||.|.||+|++|+++    ....||||.++... ++.+.+|+.|..||.+++||||++|.|+........||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3456689999999999999663    34579999998764 455678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|+.+|+...  ..+++.++.-++++|+.||.||.+++   +|||||.++|||++.+..+|++|||+++.+..+
T Consensus       710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999997644  45889999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccccccccc--cccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCcc
Q 006211          591 VDEANTGRI--VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE  646 (656)
Q Consensus       591 ~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~  646 (656)
                      .+ ......  .=+.+|.|||.+....+|.+|||||||+++||.++ |.+|+..+.+.+
T Consensus       785 ~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  785 PE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             CC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            42 222222  22578999999999999999999999999999765 888987665543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-35  Score=279.60  Aligned_cols=204  Identities=24%  Similarity=0.346  Sum_probs=170.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhh--HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  509 (656)
                      ++|+.+++|++|+||.||+|+. .+++.||+|+++...+..  --.-++|+.+|.+++|||||.+..+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4577889999999999999954 568899999998764321  11347899999999999999998877543  568999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||||+. +|...+...  +..+...+...++.|+++|++|||.+.   |+||||||+|+|+...|.+||+|||+|+.+..
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 677777543  245788999999999999999999998   99999999999999999999999999998765


Q ss_pred             CccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      .  .......+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++-|.+.+.-+
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d  285 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID  285 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence            3  233445677999999998876 458999999999999999999999887655433

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-34  Score=304.99  Aligned_cols=203  Identities=23%  Similarity=0.348  Sum_probs=173.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+..+.||+|+||+||++.. .+++.||+|+++...   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688899999999999999954 468899999987532   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999998853   345899999999999999999999987   999999999999999999999999998754321


Q ss_pred             ccc---------------------------------cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCC
Q 006211          591 VDE---------------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR  637 (656)
Q Consensus       591 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~  637 (656)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            000                                 00123479999999999999899999999999999999999999


Q ss_pred             CCCCCC
Q 006211          638 NARYYG  643 (656)
Q Consensus       638 p~~~~~  643 (656)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            997544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-34  Score=300.17  Aligned_cols=198  Identities=29%  Similarity=0.422  Sum_probs=175.1

Q ss_pred             CCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      -|+..+.||.|+-|.|..| +..+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++++++++...+|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3667889999999999999 45689999999987652   2223468899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++|.|.+++.   +++.+++.++.+++.||+.|+.|+|..+   |+|||+||+|+|||..+++||+|||+|.+...  
T Consensus        93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            999999999984   4667999999999999999999999998   99999999999999999999999999976432  


Q ss_pred             cccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .....+.||++.|.|||++.+.+| +.++||||.|||||.||||+.||+..
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd  215 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD  215 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence             233345699999999999999988 57899999999999999999999743

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-35  Score=284.90  Aligned_cols=202  Identities=26%  Similarity=0.441  Sum_probs=180.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ...+|++.+.||+|.||.|-++. ...|+.||||.+++..   ++..-.+.+|++||..|+||||+.++.+|++.+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            45678999999999999999994 4679999999987753   3444568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||..+|.|.+|+.+   +..+++.+++.++.||..++.|+|.+.   ++|||||.+|||+|.|+++||+|||++-++.
T Consensus       131 vMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999954   456999999999999999999999987   9999999999999999999999999998775


Q ss_pred             cCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..   ....++||++-|.+||++.+.+| .+.+|-|||||+||.|+.|.-||++.+
T Consensus       205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence            43   23345799999999999999998 578999999999999999999998765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=285.80  Aligned_cols=204  Identities=26%  Similarity=0.445  Sum_probs=168.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCCh--------------hhHHHHHHHHHHHHhcCCCceeeE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--------------QGLEEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l  496 (656)
                      ..-++|++.+.||+|.||.|-+|+ ..+++.||||++.+...              ...+.+.+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999995 45689999999875411              123578999999999999999999


Q ss_pred             EEEEee--CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          497 LGYCTE--RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       497 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      +.+..+  .+..|||+|||..|.+...   +..+..+++++++.++..+..||+|||.++   ||||||||.|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            998865  4578999999999887532   223333899999999999999999999998   99999999999999999


Q ss_pred             cEEEEeccCccccccCc---cccccccccccccccccccccCCC----CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          575 NPKISDFGMAKLFRKDV---DEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .+||+|||.+..+....   ........+||+.|+|||.+..+.    .+.+.||||+||+||.|+.|+.||..
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999997653221   111222368999999999887632    35679999999999999999999954

>cd06544 GH18_narbonin Narbonin is a plant 2S protein from the globulin fraction of narbon bean (Vicia narbonensis L

Probab=100.00  E-value=1.7e-33  Score=275.88  Aligned_cols=202  Identities=15%  Similarity=0.162  Sum_probs=144.4

Q ss_pred             CCCCCCCCCC--ccEEEEEEE-EecC----CCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCc
Q 006211           39 FPLSDINSAL--FTHLICAFA-EVDS----STYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNK  111 (656)
Q Consensus        39 ~~~~~i~~~~--~thi~~~f~-~~~~----~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~  111 (656)
                      ..+++||.+.  ||||||||+ ..+.    .++.+.....++......+..+|++||++|||+||            |||
T Consensus        13 ~~~~dip~~~~~~thii~aFa~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lK~~~p~lKvllSi------------GG~   80 (253)
T cd06544          13 VTFSDVPINPKVEFHFILSFAIDYDTESNPTNGKFNPYWDTENLTPEAVKSIKAQHPNVKVVISI------------GGR   80 (253)
T ss_pred             ccccccCCCCCeeEEEEEEeeeecccccCCCCCccccccCccccCHHHHHHHHHhCCCcEEEEEe------------CCC
Confidence            4789999999  999999999 3332    13444433334444666778999999999999999            555


Q ss_pred             CCCc-cccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCC
Q 006211          112 NINP-SVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPT  190 (656)
Q Consensus       112 ~~~~-~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~  190 (656)
                      +.+. ..+....+.+..|++|++|+++++++|||||||||||||. .|+++|+.|+++||++|.+. ++++.+++.+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~fv~S~~~~l~~~~fDGiDiDwE~~~-~d~~~f~~ll~~l~~~l~~~-~~lt~a~vap~~~  158 (253)
T cd06544          81 GVQNNPTPFDPSNVDSWVSNAVSSLTSIIQTYNLDGIDIDYEHFP-ADPDTFVECIGQLITELKNN-GVIKVASIAPSED  158 (253)
T ss_pred             CCCCCccccCchhhhhHHHHHHHHHHHHHHHhCCCceeeecccCC-cCHHHHHHHHHHHHHHhhhc-CCeEEEEecCCcc
Confidence            4432 1233344555667778999999999999999999999995 57999999999999999543 4444444443332


Q ss_pred             ccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccCCCCCcC
Q 006211          191 HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGIT  268 (656)
Q Consensus       191 ~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~  268 (656)
                      ... .+.++.+.+++|+|++|+||+++.. .+  ...+         ...+..+.|. .++|++|+++|+|++++.|.
T Consensus       159 ~~~-~~y~~~~~~~~d~id~~~~qfy~~~-~~--~~~~---------~~~~~~~~~~-~~~p~~Kv~lGl~a~~~~~~  222 (253)
T cd06544         159 AEQ-SHYLALYNAYGDYIDYVNYQFYNYG-VP--TTVA---------KYVEFYDEVA-NNYPGKKVLASFSTDGEDGA  222 (253)
T ss_pred             ccc-cccHHHHHHhhCceeEEEhhhhCCC-CC--CCHH---------HHHHHHHHHH-hCCCcccEEEEEecCCCccC
Confidence            213 3558899999999999999999542 11  1000         1123344443 47999999999999997553

) cotyledons with unknown function. Narbonin has a glycosyl hydrolase family 18 (GH18) domain without the conserved catalytic residues and with no known enzymatic activity. Narbonin amounts to up to 3% of the total seed globulins of mature seeds and was thought to be a storage protein but was found to degrade too slowly during germination. This family also includes the VfNOD32 nodulin from Vicia faba.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-34  Score=281.76  Aligned_cols=211  Identities=23%  Similarity=0.305  Sum_probs=180.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +.|+.++.||.|.-|+||+++... +..+|+|++.+...   +...+.+.|-+||..++||.++.|+..++.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456677899999999999997754 58899999987633   33456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||+||+|..+.+. +....+++..++.++.+++.||+|||-+|   ||.|||||+||||.++|++-|+||.++......
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999877654 44556999999999999999999999998   999999999999999999999999988542100


Q ss_pred             --------------------------------c-c---------------------ccccccccccccccccccccCCCC
Q 006211          591 --------------------------------V-D---------------------EANTGRIVGTYGYVPPEYVKKGIY  616 (656)
Q Consensus       591 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  616 (656)
                                                      . .                     ..+....+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011223589999999999999999


Q ss_pred             CccchhHHHHHHHHHHHcCCCCCCCCCCccccc
Q 006211          617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENLN  649 (656)
Q Consensus       617 s~~sDvwslGvil~elltg~~p~~~~~~~~~~~  649 (656)
                      +.++|.|+||+++||||.|+.||.+.+.++++.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~  345 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR  345 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence            999999999999999999999999988877653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=294.13  Aligned_cols=199  Identities=28%  Similarity=0.456  Sum_probs=172.8

Q ss_pred             CccccCHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 006211          421 NLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC  500 (656)
Q Consensus       421 ~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  500 (656)
                      .+-.++|+++..       ++.||.|+.|.||+|++ .++.||||.++...       ..+|+.|++|+||||+.+.|+|
T Consensus       117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee
Confidence            344556666554       48899999999999998 57889999876543       3478899999999999999999


Q ss_pred             eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       501 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                      .....+|||||||..|-|...|..   +..++......+..+||.||.|||...   |||||||.=||||..+..+||+|
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecc
Confidence            999999999999999999999954   445788889999999999999999987   99999999999999999999999


Q ss_pred             ccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ||-++.....   ...-.+.||..|||||++.+.+.+.|+|||||||+|||||||..|+..-+
T Consensus       256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd  315 (904)
T KOG4721|consen  256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD  315 (904)
T ss_pred             ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence            9999875432   22234689999999999999999999999999999999999999996543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-35  Score=268.39  Aligned_cols=203  Identities=30%  Similarity=0.419  Sum_probs=177.7

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|-||.||.|+. +++-.||+|++.++..   +...++.+|+++-..|+||||++++++|.++...|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            4688899999999999999955 4577899999876532   22357889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||...|++...|.+.. ...+++.....++.|+|.|+.|+|..+   +|||||||+|+|++..+.+||+|||.+..-.  
T Consensus       102 Eya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999998886533 335788889999999999999999988   9999999999999999999999999997532  


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                        .......+||..|.+||+..+..++..+|+|++|++.||++.|.+||+....+
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~  228 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS  228 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence              33445679999999999999999999999999999999999999999765533

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=280.20  Aligned_cols=211  Identities=24%  Similarity=0.398  Sum_probs=174.8

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccC--CChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-----CC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-----RD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  504 (656)
                      +...|...+.||+|+||.|+.+ ...+|+.||||.+..  ......++..+|+.+|+.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445666789999999999999 456789999999873  344456678999999999999999999998865     34


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..|+|+|+| +.+|...+..   +..++...+..+++|+++||.|+|+.+   ++||||||.|+|++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            679999999 5678777743   334899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccccc
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF  650 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  650 (656)
                      +...........+..+.|..|.|||++. ...|+...||||+|||+.||++|++-|.+.+.-+++.+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l  239 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL  239 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence            9775432222334457899999999764 56799999999999999999999999987765554443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.2e-34  Score=302.45  Aligned_cols=202  Identities=23%  Similarity=0.344  Sum_probs=171.7

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .|+.++.||+|+||+||+|.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999954 568899999986542   2345578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999988853   335788899999999999999999987   9999999999999999999999999986431100


Q ss_pred             c---------------------------------------------ccccccccccccccccccccCCCCCccchhHHHH
Q 006211          592 D---------------------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG  626 (656)
Q Consensus       592 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG  626 (656)
                      .                                             .......+||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234799999999999988899999999999


Q ss_pred             HHHHHHHcCCCCCCCCC
Q 006211          627 VLLLQIISSKRNARYYG  643 (656)
Q Consensus       627 vil~elltg~~p~~~~~  643 (656)
                      |++|||++|+.||....
T Consensus       236 ~il~elltG~~Pf~~~~  252 (381)
T cd05626         236 VILFEMLVGQPPFLAPT  252 (381)
T ss_pred             hHHHHHHhCCCCCcCCC
Confidence            99999999999997544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-33  Score=295.61  Aligned_cols=207  Identities=29%  Similarity=0.428  Sum_probs=170.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC-
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD-  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  504 (656)
                      .++|++.++||+|+||.||+|..      ..++.||||++.... ....+.+.+|+.++..+ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            45788999999999999999953      235689999987543 23345788999999999 8999999999887644 


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc---------------------------------------------------------
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------  527 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  527 (656)
                      ..+++|||+++|+|..++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999988854211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccc
Q 006211          528 --RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY  605 (656)
Q Consensus       528 --~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  605 (656)
                        ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124778889999999999999999987   999999999999999999999999999865432222222333456789


Q ss_pred             cccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          606 VPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       606 ~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999998889999999999999999997 999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-34  Score=278.68  Aligned_cols=203  Identities=26%  Similarity=0.405  Sum_probs=168.9

Q ss_pred             cCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCC------
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQHVN-LLRVLGYCTERD------  504 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  504 (656)
                      ..|+.+++||+|+||+||+|. ..+|+.||+|+++...++  ......+|+.++++++|+| |+++.+++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            346667889999999999994 456899999998876442  2234588999999999999 999999998877      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ..++|+||++ -+|..++...... ..++......++.||++||.|||+.+   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999995 5788887543321 34677889999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |+.+.-.  .......++|..|.|||++.+. .|+...||||+||++.||+++++-|....
T Consensus       167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            9865422  2224445789999999998775 78999999999999999999988886544

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.1e-35  Score=284.84  Aligned_cols=197  Identities=24%  Similarity=0.384  Sum_probs=159.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  509 (656)
                      .|+..+++|.|+||.||+|.. .+++.||||+.-....-    --+|+++|++++|||||+++-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            456678999999999999965 44789999987554321    146899999999999999998886543     34589


Q ss_pred             EEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCcccc
Q 006211          510 YEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLF  587 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~~~  587 (656)
                      ||||+. +|...+... ..+..++...+.-+..||++||.|||+.+   |+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 666666432 12345777888889999999999999976   9999999999999987 89999999999987


Q ss_pred             ccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..+.....   ..-|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+..
T Consensus       177 ~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s  230 (364)
T KOG0658|consen  177 VKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS  230 (364)
T ss_pred             ccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence            66543322   244789999998765 579999999999999999999999887643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=298.57  Aligned_cols=204  Identities=31%  Similarity=0.455  Sum_probs=171.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC--C--CE-EEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR--G--QE-FAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      .++....++||+|+||.||+|.+..  +  .. ||||..+..   ..+...++.+|.++|++++|||||+++|++..+.+
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3444566899999999999996533  2  23 899998853   35667789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      +++|||+|+||+|.++|.....  .++..+.+.++.+.++||+|||+++   ++||||.++|+|++.++.+||+|||+++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999965322  5899999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .-..  .......-.-+..|+|||.+....|+.++|||||||++||+++ |..|+.....
T Consensus       311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            5431  1111111134679999999999999999999999999999999 7888876553

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-33  Score=285.78  Aligned_cols=200  Identities=26%  Similarity=0.391  Sum_probs=171.3

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      |+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++.+++|+|++++.+.+.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999954 578999999886542   22234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999998777532 2235889999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence              1223468999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-34  Score=302.07  Aligned_cols=203  Identities=24%  Similarity=0.329  Sum_probs=171.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||||++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999954 57889999998653   2233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999988853   345788899999999999999999987   999999999999999999999999999643210


Q ss_pred             ccc------------c---------------------------------ccccccccccccccccccCCCCCccchhHHH
Q 006211          591 VDE------------A---------------------------------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF  625 (656)
Q Consensus       591 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwsl  625 (656)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012468999999999998889999999999


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q 006211          626 GVLLLQIISSKRNARYYG  643 (656)
Q Consensus       626 Gvil~elltg~~p~~~~~  643 (656)
                      ||++|||++|+.||....
T Consensus       235 Gvil~elltG~~Pf~~~~  252 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             chhhhhhhcCCCCCCCCC
Confidence            999999999999996543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=288.63  Aligned_cols=202  Identities=27%  Similarity=0.408  Sum_probs=178.2

Q ss_pred             CCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .|...+.||+|+||.||+| +...++.||+|++... .+...+++++|+.++.+++++||.++++.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4667789999999999999 4557899999999875 3455788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      .+|++.+.+.   ....+++....-+++++..|+.|||..+   .+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999988883   2334577888889999999999999987   999999999999999999999999999877654333


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                        ....+||+.|||||+++...|+.|+||||||++.+||.+|.+|+....+-
T Consensus       168 --r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm  217 (467)
T KOG0201|consen  168 --RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM  217 (467)
T ss_pred             --cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence              35679999999999999889999999999999999999999999765553

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=289.80  Aligned_cols=198  Identities=23%  Similarity=0.336  Sum_probs=172.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   .+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999654 68899999986532   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++.....++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999988853   335888999999999999999999987   999999999999999999999999999765321


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                 123468999999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.6e-34  Score=302.25  Aligned_cols=202  Identities=24%  Similarity=0.358  Sum_probs=171.3

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .|+.+++||+|+||+||+|.. .+++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999954 568899999986532   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++|+|..++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999988853   235788899999999999999999987   9999999999999999999999999975331100


Q ss_pred             c---------------------------------------------ccccccccccccccccccccCCCCCccchhHHHH
Q 006211          592 D---------------------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG  626 (656)
Q Consensus       592 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG  626 (656)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999988999999999999


Q ss_pred             HHHHHHHcCCCCCCCCC
Q 006211          627 VLLLQIISSKRNARYYG  643 (656)
Q Consensus       627 vil~elltg~~p~~~~~  643 (656)
                      |++|||++|+.||....
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=316.29  Aligned_cols=202  Identities=32%  Similarity=0.544  Sum_probs=172.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC--CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR--GQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .+.+..+.||+|.||.||+|...+  +.    .||||.++.. +.+...+|++|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345567889999999999995432  32    5899998765 4566778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          508 LIYEYLPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      |++|||++|+|..+|++..    ....++..+++.++.+||+|+.||++++   +|||||..+|+||++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997642    2456899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      |+.+.............-+.+|||||.+....++.|+|||||||++||++|...+.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P  904 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP  904 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence            99554433333333334467999999999999999999999999999999965544

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=299.73  Aligned_cols=203  Identities=23%  Similarity=0.361  Sum_probs=173.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||++.. .+++.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4688999999999999999965 468899999987532   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999998854   335899999999999999999999987   999999999999999999999999998754321


Q ss_pred             cccc------------------------------------ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc
Q 006211          591 VDEA------------------------------------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS  634 (656)
Q Consensus       591 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt  634 (656)
                      ....                                    .....+||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012468999999999998889999999999999999999


Q ss_pred             CCCCCCCCC
Q 006211          635 SKRNARYYG  643 (656)
Q Consensus       635 g~~p~~~~~  643 (656)
                      |+.||....
T Consensus       235 G~~Pf~~~~  243 (364)
T cd05599         235 GYPPFCSDN  243 (364)
T ss_pred             CCCCCCCCC
Confidence            999996543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=295.49  Aligned_cols=199  Identities=23%  Similarity=0.368  Sum_probs=174.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999664 58899999987542   233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999998843   335788999999999999999999987   99999999999999999999999999975432 


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                          ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  203 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP  203 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence                22335789999999999988999999999999999999999999975443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-33  Score=291.73  Aligned_cols=195  Identities=24%  Similarity=0.313  Sum_probs=167.9

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||++.. .+++.||+|+++...   ......+.+|+.++.+++||||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999955 568899999987532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT  596 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  596 (656)
                      +|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99888753   345889999999999999999999987   999999999999999999999999998753221  1222


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence            34578999999999999899999999999999999999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-33  Score=301.16  Aligned_cols=204  Identities=22%  Similarity=0.341  Sum_probs=172.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688999999999999999954 468899999986532   223456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999998854   335788889999999999999999987   999999999999999999999999997532100


Q ss_pred             c-----------------------------------------cccccccccccccccccccccCCCCCccchhHHHHHHH
Q 006211          591 V-----------------------------------------DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL  629 (656)
Q Consensus       591 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil  629 (656)
                      .                                         ........+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001134789999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCC
Q 006211          630 LQIISSKRNARYYGT  644 (656)
Q Consensus       630 ~elltg~~p~~~~~~  644 (656)
                      |||++|+.||.....
T Consensus       235 yell~G~~Pf~~~~~  249 (376)
T cd05598         235 YEMLVGQPPFLADTP  249 (376)
T ss_pred             eehhhCCCCCCCCCH
Confidence            999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=278.68  Aligned_cols=199  Identities=28%  Similarity=0.460  Sum_probs=162.2

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHH--HHhcCCCceeeEEEEEeeCC--
Q 006211          429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSL--TARLQHVNLLRVLGYCTERD--  504 (656)
Q Consensus       429 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~--  504 (656)
                      -...+..+..+.+.||+|.||+||+|++ .|+.||||++....+..   ..+|.++  -..|+|+||+.+++.-..+.  
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            3345677888999999999999999998 78999999998765543   3445554  45579999999987654432  


Q ss_pred             --ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecccCCCCEEEcCCCcEE
Q 006211          505 --ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-----YSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       505 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-----~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                        +++||.+|.+.|||.+||.    +..++....++++..++.||++||-     ++.+.|.|||||+.|||+..++.+.
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence              5799999999999999993    4679999999999999999999993     6778899999999999999999999


Q ss_pred             EEeccCccccccCcc--ccccccccccccccccccccCCC----C-C-ccchhHHHHHHHHHHHcC
Q 006211          578 ISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPEYVKKGI----Y-S-MKYDVYSFGVLLLQIISS  635 (656)
Q Consensus       578 l~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~-s-~~sDvwslGvil~elltg  635 (656)
                      |+|+|+|........  .......+||.+|||||++....    + + ..+||||||+++||+.-.
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            999999987654422  22344579999999999986432    2 2 248999999999998754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-33  Score=293.43  Aligned_cols=197  Identities=24%  Similarity=0.335  Sum_probs=172.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++.+++||||+++++.+...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46788899999999999999654 58899999986532   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999988854   335788899999999999999999987   999999999999999999999999999765322


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                           .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence                 12347899999999999988999999999999999999999999653

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-33  Score=294.27  Aligned_cols=198  Identities=21%  Similarity=0.304  Sum_probs=171.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC--CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|....  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999996433  368999998643   223445688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999988853   335889999999999999999999987   99999999999999999999999999976532


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            1     223578999999999988889999999999999999999999997543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-33  Score=297.87  Aligned_cols=203  Identities=22%  Similarity=0.312  Sum_probs=172.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..++|++.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999654 5889999998642   22234457889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999988843    24788899999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCC----CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ... ........||+.|+|||++...    .++.++|+|||||++|||++|+.||....
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            321 1122345799999999998654    37889999999999999999999996543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-33  Score=290.61  Aligned_cols=195  Identities=24%  Similarity=0.321  Sum_probs=167.9

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||++.. .+++.||+|++...   .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 46899999998754   2234457788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT  596 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  596 (656)
                      +|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99887743   335889999999999999999999987   999999999999999999999999998753221  1122


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence            33578999999999998889999999999999999999999996544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.4e-33  Score=289.42  Aligned_cols=195  Identities=24%  Similarity=0.315  Sum_probs=167.2

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||++.. .++..||+|+++..   .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999964 46899999998754   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT  596 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  596 (656)
                      +|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence            99887743   335889999999999999999999987   999999999999999999999999998753221  1122


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence            23568999999999998899999999999999999999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-34  Score=290.38  Aligned_cols=205  Identities=23%  Similarity=0.379  Sum_probs=180.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-eEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-NMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  510 (656)
                      ++|..++++|+|+||.++.++. .+++.+++|.+...  .....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5688899999999999999844 45779999988654  33444567899999999999999999999998888 99999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      +||+||++...+.... +..+++++...++.|++.|+.|||+++   |+|||||+.||+++.+..+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999886543 456899999999999999999999887   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .  ......+||+.||+||++.+.+|+.|+|||||||++|||++-+++|...+..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~  212 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS  212 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH
Confidence            3  2445579999999999999999999999999999999999999999765543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-33  Score=286.64  Aligned_cols=192  Identities=24%  Similarity=0.311  Sum_probs=166.3

Q ss_pred             ccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||.||++.. .+++.||+|+++..   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999965 45889999998653   233445678899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            988853   335889999999999999999999987   9999999999999999999999999997543221  22234


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence            57899999999999989999999999999999999999999653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-33  Score=295.31  Aligned_cols=207  Identities=23%  Similarity=0.318  Sum_probs=173.9

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          429 DIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       429 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      ++....++|++.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++.+.+..
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445578999999999999999999654 6889999998642   1223345788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++||||+++|+|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999988843    34788889999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCC----CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +...... ........||+.|+|||++...    .++.++|||||||++|||++|+.||...+
T Consensus       190 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         190 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             eEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            8654321 1122345799999999998653    37889999999999999999999997543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-33  Score=295.79  Aligned_cols=204  Identities=23%  Similarity=0.348  Sum_probs=173.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+..+.||+|+||.||++.. .+++.||+|+++..   .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688889999999999999955 46889999998653   2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999998853   345889999999999999999999987   999999999999999999999999998754221


Q ss_pred             cc---------------------------------ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCC
Q 006211          591 VD---------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR  637 (656)
Q Consensus       591 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~  637 (656)
                      ..                                 .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                 000113478999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 006211          638 NARYYGT  644 (656)
Q Consensus       638 p~~~~~~  644 (656)
                      ||.....
T Consensus       235 Pf~~~~~  241 (360)
T cd05627         235 PFCSETP  241 (360)
T ss_pred             CCCCCCH
Confidence            9975543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-32  Score=300.32  Aligned_cols=205  Identities=20%  Similarity=0.264  Sum_probs=175.7

Q ss_pred             CCCCCCcccccCceEEEEEEe-CC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .|.+.+.||+|++|.||+|.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            378889999999999999954 33 6788999876655555567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          514 PNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       514 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++|+|..++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542 22446889999999999999999999987   99999999999999999999999999987644322


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            222344578999999999998899999999999999999999999996543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-32  Score=285.49  Aligned_cols=200  Identities=24%  Similarity=0.325  Sum_probs=174.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999654 68889999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+  +++||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999998854   235788999999999999999999864  4999999999999999999999999999765322 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence               122346899999999999888999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-32  Score=282.20  Aligned_cols=204  Identities=28%  Similarity=0.439  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-----------------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-----------------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  496 (656)
                      ++|++.++||+|+||.||+|...+                 +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999996432                 3369999987653 3345578999999999999999999


Q ss_pred             EEEEeeCCceEEEEEecCCCChhhhhhCCC----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 006211          497 LGYCTERDENMLIYEYLPNKSLDLYLFDPI----------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH  560 (656)
Q Consensus       497 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH  560 (656)
                      ++++.+.+..++||||+++++|..++....                ....+++.....++.|++.||.|||+.+   ++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999998874321                1124678889999999999999999987   999


Q ss_pred             cccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcC--CCC
Q 006211          561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS--KRN  638 (656)
Q Consensus       561 ~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg--~~p  638 (656)
                      |||||+|||++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765432222222334557889999999888899999999999999999974  456


Q ss_pred             CCC
Q 006211          639 ARY  641 (656)
Q Consensus       639 ~~~  641 (656)
                      |..
T Consensus       242 ~~~  244 (304)
T cd05096         242 YGE  244 (304)
T ss_pred             CCc
Confidence            543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06546 GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase 3), an uncharacterized protein from the human fungal pathogen Coccidioides posadasii

Probab=100.00  E-value=5.4e-32  Score=267.55  Aligned_cols=196  Identities=15%  Similarity=0.226  Sum_probs=143.8

Q ss_pred             EEEEEecCCCC--------CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcc--hh---hHHHHHHHHHhhCCCceEEE
Q 006211           28 IKAGYWLAGRE--------FPLSDINSALFTHLICAFAEVDSSTYQLSISSAN--QQ---YFSIFANSVRRKNPSIKTLL   94 (656)
Q Consensus        28 ~~~~y~~~~~~--------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~--~~---~~~~~~~~~k~~~~~~kvl~   94 (656)
                      ++++||+.|+.        +++..++.++||||+|||+.++++| .+...+..  ..   .+...+..+|  ++++|||+
T Consensus         1 r~v~y~~~~~~~~~~~~~~~~~~~~~~~~~THvi~af~~i~~~G-~l~~~d~~~~~~~~~~~~~~i~~~~--~~g~KVll   77 (256)
T cd06546           1 RLVIYYQTTHPSNGDPISSLLLVTEKGIALTHLIVAALHINDDG-NIHLNDHPPDHPRFTTLWTELAILQ--SSGVKVMG   77 (256)
T ss_pred             CEEEEEccEECCCCCcccccccccCCCCCCceEEEEEEEECCCC-eEEECCCCCCcchhhHHHHHHHHHH--hCCCEEEE
Confidence            35889887643        2234667899999999999999874 45444321  11   2222233344  57899999


Q ss_pred             EeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcC
Q 006211           95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS  174 (656)
Q Consensus        95 sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~  174 (656)
                      ||            |||+.+.  |+.++++++.|++|++++.+++++|+|||||||||||..  ..+|..|+++||+++.
T Consensus        78 Si------------GG~~~~~--fs~~a~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~~--~~~~~~ll~~Lr~~~~  141 (256)
T cd06546          78 ML------------GGAAPGS--FSRLDDDDEDFERYYGQLRDMIRRRGLDGLDLDVEEPMS--LDGIIRLIDRLRSDFG  141 (256)
T ss_pred             EE------------CCCCCCC--cccccCCHHHHHHHHHHHHHHHHHhCCCceEEeeecCCC--HhHHHHHHHHHHHHhC
Confidence            99            5554322  788889999999999999999999999999999999964  5699999999999993


Q ss_pred             CCCCcEEEEEeecCCC----ccccccChhhhhh----ccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHH
Q 006211          175 DQPELTLSMAVRYSPT----HETVSYPIDSMKK----NLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW  246 (656)
Q Consensus       175 ~~~~~~ls~a~~~~~~----~~~~~~~~~~l~~----~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~  246 (656)
                        +++.||+|++....    ....++++.++.+    ++||+|+|.||.+|..        +         + ......|
T Consensus       142 --~~~~lT~Ap~~~~~~~g~~~~~~~~~~~l~~~~~~~~Df~nvQfYn~~g~~--------~---------~-~~~~~~~  201 (256)
T cd06546         142 --PDFIITLAPVASALTGGEANLSGFDYRELEQARGDKIDFYNAQFYNGFGSM--------S---------S-PSDYDAI  201 (256)
T ss_pred             --CCcEEEECCccccccCCcccccccCHHHHHHhhCCceeEEEEcCcCCCCCc--------c---------C-HHHHHHH
Confidence              46889987754311    1222467777764    9999999999976431        0         0 1233456


Q ss_pred             HHcCCCCCceeecccC
Q 006211          247 LRRGFPANKLVLGARA  262 (656)
Q Consensus       247 ~~~g~p~~Kl~lG~p~  262 (656)
                      .+.++|++||++|+|+
T Consensus       202 ~~~~~~~~Kv~iGlpa  217 (256)
T cd06546         202 VAQGWDPERIVIGLLT  217 (256)
T ss_pred             HHcCCCcccEEEEEec
Confidence            6679999999999996

CTS3 has a chitinase-like glycosyl hydrolase family 18 (GH18) domain; and has homologs in bacteria as well as fungi.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-32  Score=286.71  Aligned_cols=198  Identities=26%  Similarity=0.375  Sum_probs=167.0

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHH---HhcCCCceeeEEEEEeeCCceEEE
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLT---ARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      |++.+.||+|+||.||++.. .+++.||||+++...   ....+.+.+|..++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56788999999999999965 468999999987532   22344566676655   456799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++.    ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999987773    245899999999999999999999987   99999999999999999999999999874322


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence            1  122234578999999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-32  Score=285.22  Aligned_cols=196  Identities=24%  Similarity=0.349  Sum_probs=166.6

Q ss_pred             CCcccccCceEEEEEEe----CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          440 ANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++.||+|+||.||++..    ..++.||+|+++...    ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999964    357899999987532    2233457889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+.+..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            9999999888743   345788888999999999999999987   999999999999999999999999998743221 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ........|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence             112223578999999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.9e-33  Score=292.55  Aligned_cols=202  Identities=23%  Similarity=0.313  Sum_probs=170.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||++.. .+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            45788999999999999999965 46889999998643   122334577899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999988743    34788889999999999999999987   99999999999999999999999999976543


Q ss_pred             CccccccccccccccccccccccCC----CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .. ........||+.|+|||++...    .++.++|||||||++|||++|+.||....
T Consensus       195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            21 1122345789999999988643    37889999999999999999999997543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=292.40  Aligned_cols=204  Identities=28%  Similarity=0.457  Sum_probs=176.8

Q ss_pred             CCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------ceEE
Q 006211          437 FSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ENML  508 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  508 (656)
                      +...+.||+|+||.||+++ ...|+.||||.++... ....+...+|+++|++++|||||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4567899999999999996 6679999999998753 344566789999999999999999998765543      5689


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC--C--cEEEEeccCc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--L--NPKISDFGMA  584 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~--~--~~kl~DfGla  584 (656)
                      |||||.+|+|...+.++.+...|++.+.+.+...++.||.|||+++   |+||||||.||++-..  |  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999999988889999999999999999999999887   9999999999999533  3  3699999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      +.+..+.   ......||..|.+||+..+ +.|+..+|.|||||++|+..||..||.....+.
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence            9775432   4456799999999999984 889999999999999999999999997666554

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-33  Score=288.78  Aligned_cols=195  Identities=25%  Similarity=0.313  Sum_probs=166.4

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||++.. .+++.||+|+++..   .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 56889999998753   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      +|..++..   ...+++..+..++.|++.||.|||+ .+   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99887743   3358899999999999999999997 55   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~  200 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  200 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence            223468999999999998899999999999999999999999996544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-32  Score=280.78  Aligned_cols=201  Identities=24%  Similarity=0.375  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|+..++||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4688899999999999999955 4688999999875432 2334678899999999999999999999998899999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++ +|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            975 887777432  234788999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11223467899999998865 568999999999999999999999996544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-32  Score=285.16  Aligned_cols=200  Identities=26%  Similarity=0.327  Sum_probs=168.7

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCC-ceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV-NLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  510 (656)
                      +|++.+.||+|+||.||+|... +++.||+|+++..   .....+.+..|..++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999654 5789999998753   223445678899999999765 5888999999889999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999888743   335788999999999999999999987   999999999999999999999999998643221


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence              112234578999999999999899999999999999999999999996543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-32  Score=285.57  Aligned_cols=200  Identities=26%  Similarity=0.340  Sum_probs=168.6

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +|++.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999654 57899999987542   22334566777887777 5899999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999888743   235889999999999999999999987   999999999999999999999999999753221


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence              112234578999999999999999999999999999999999999997644

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.3e-32  Score=286.04  Aligned_cols=200  Identities=23%  Similarity=0.345  Sum_probs=169.3

Q ss_pred             CCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCC----ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSAT----STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      +|++.+.||+|+||.||++..    .+++.||+|++...    .....+.+..|+.+++.+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999854    35789999998643    122345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++|+|..++..   +..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999988853   345889999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            533221 222345789999999998765 4788999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=292.15  Aligned_cols=203  Identities=24%  Similarity=0.389  Sum_probs=175.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|... +++.||||+++...   ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999654 68999999987542   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++...   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999988543   45889999999999999999999987   999999999999999999999999999765432


Q ss_pred             c---------------------------cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 V---------------------------DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012233578999999999999999999999999999999999999997554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=285.34  Aligned_cols=202  Identities=21%  Similarity=0.298  Sum_probs=170.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999965 45889999998642   2223456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++...  ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999988532  335889999999999999999999987   999999999999999999999999998765432


Q ss_pred             ccccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            11 11223468999999999863     45788999999999999999999999653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-32  Score=284.54  Aligned_cols=194  Identities=21%  Similarity=0.346  Sum_probs=166.4

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++.. .+++.||+|+++..   ..+..+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999965 46889999999753   223345678899999888 799999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999877743   345899999999999999999999987   999999999999999999999999998742211  122


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  199 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  199 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence            23457899999999999989999999999999999999999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-32  Score=282.28  Aligned_cols=195  Identities=28%  Similarity=0.382  Sum_probs=163.7

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHh-cCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTAR-LQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|.. .+++.||+|+++...   ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 457899999987532   2233445566666665 4899999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999888753   335888999999999999999999987   9999999999999999999999999997543221  22


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence            334578999999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.6e-33  Score=290.24  Aligned_cols=198  Identities=25%  Similarity=0.364  Sum_probs=168.9

Q ss_pred             cCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-C-----CceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-H-----VNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~  507 (656)
                      -+|++++.||+|+||.|.+| +..+++.||||+++... ....+-+.|+.+|..++ |     -|+|+++++|..+++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            37899999999999999999 56679999999998753 33455678999999996 4     38999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC--CcEEEEeccCcc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAK  585 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~--~~~kl~DfGla~  585 (656)
                      ||+|.+ .-+|.+++....- ..++....+.++.||+.+|.+||+++   |||+||||+||||.+.  ..+||+|||.|.
T Consensus       265 iVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999998 5689999866433 35899999999999999999999987   9999999999999754  369999999998


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......     ..+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.+
T Consensus       340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            6543222     3466889999999999999999999999999999999977666443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-32  Score=278.97  Aligned_cols=201  Identities=22%  Similarity=0.328  Sum_probs=171.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|+||.||++... +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999664 57899999987542  2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |++++++..+..   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2345888999999999999999999987   9999999999999999999999999998654321


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       ........|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence             11222346889999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.6e-32  Score=283.83  Aligned_cols=193  Identities=22%  Similarity=0.360  Sum_probs=165.3

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++.. .+++.+|+|+++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 45789999998754   223445677888888776 799999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            999877743   345889999999999999999999987   999999999999999999999999999753221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            2345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-32  Score=286.18  Aligned_cols=202  Identities=20%  Similarity=0.284  Sum_probs=171.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999654 5788999998652   1223445788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998542  235788999999999999999999987   999999999999999999999999999765432


Q ss_pred             ccccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            21 12223468999999998865     45788999999999999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=2.7e-32  Score=284.09  Aligned_cols=195  Identities=27%  Similarity=0.364  Sum_probs=165.6

Q ss_pred             CcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|... +++.||+|+++..   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999654 5789999998753   223345567888888866 799999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999888743   335788999999999999999999987   9999999999999999999999999987533221  12


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            233568999999999998889999999999999999999999997544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=4.4e-32  Score=282.41  Aligned_cols=204  Identities=28%  Similarity=0.411  Sum_probs=179.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChh---hHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  507 (656)
                      ....|++.+.||+|.||.||++..+ +|+.+|+|.+.+....   ..+.+.+|+.+|+++. ||||+.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567888899999999999999654 4999999999776432   3468899999999998 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC----CcEEEEeccC
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKISDFGM  583 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~----~~~kl~DfGl  583 (656)
                      +|||++.||.|.+.+...    .+++.++..++.|++.++.|||+.+   ++||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999888654    3899999999999999999999987   9999999999999644    4799999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      +.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...+..+
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~  245 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE  245 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence            987654   334456799999999999999999999999999999999999999998766433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.98  E-value=5.5e-32  Score=279.43  Aligned_cols=201  Identities=24%  Similarity=0.373  Sum_probs=167.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999654 688999999875432 223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |++ ++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 5666666432  345788999999999999999999987   9999999999999999999999999987543211


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              12223467899999998765 45788999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.98  E-value=4.2e-32  Score=282.35  Aligned_cols=195  Identities=26%  Similarity=0.387  Sum_probs=165.7

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|.. .+++.||+|+++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 45889999998753   223345667788888876 699999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            999888743   235889999999999999999999987   999999999999999999999999998753221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            234578999999999998889999999999999999999999997554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.98  E-value=4.4e-32  Score=287.86  Aligned_cols=207  Identities=30%  Similarity=0.446  Sum_probs=170.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+.+++.+ +|+||++++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45788999999999999999853      224579999997643 33455688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCC-----------------------------------------------------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPI-----------------------------------------------------------  526 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  526 (656)
                      .++||||+++|+|..++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998874321                                                           


Q ss_pred             --------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          527 --------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       527 --------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                              ....+++.++.+++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788889999999999999999987   99999999999999999999999999976543222122222


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            335668999999988889999999999999999997 999986543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.98  E-value=5.3e-32  Score=287.52  Aligned_cols=206  Identities=30%  Similarity=0.445  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|..      ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688899999999999999953      235689999987543 33445788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCc----------------------------------------------------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR----------------------------------------------------------  527 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  527 (656)
                      .++||||+++|+|..++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999888854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          528 --------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       528 --------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                                    ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788899999999999999999987   999999999999999999999999999865433222


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ...+...++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            22222344667999999999999999999999999999998 88888543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.98  E-value=8.7e-33  Score=258.33  Aligned_cols=201  Identities=28%  Similarity=0.443  Sum_probs=172.9

Q ss_pred             HHHhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCC-----h---hhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-----T---QGLEEFKNEVSLTARL-QHVNLLRVLGYC  500 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~  500 (656)
                      +...++|...+.||+|..++|.++ ..+++..+|+|++....     +   +-.+.-.+|+.+|+++ .||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            345677888999999999999998 44578899999886431     1   1234567899999998 699999999999


Q ss_pred             eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       501 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                      +.....++|+|.|+.|.|.++|.+   .-.+++++..+|+.|+..|++|||.++   |+||||||+|||++++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            999999999999999999999954   446899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccccCccccccccccccccccccccccC------CCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK------GIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ||.+..+...   ......||||+|+|||.+..      ..|+..+|+|++||++|.|+.|.+||.
T Consensus       167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            9999887643   23345799999999998853      347888999999999999999999984

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.98  E-value=9.1e-32  Score=281.32  Aligned_cols=200  Identities=25%  Similarity=0.338  Sum_probs=173.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.++||+|+||.||++... ++..+|+|++... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999654 5788999988764 23344678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+++.....++.+++.+|.|||+.+  +++||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999998853   335788999999999999999999854  3999999999999999999999999999754322 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               122346889999999999888999999999999999999999999653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.98  E-value=5.4e-32  Score=282.38  Aligned_cols=194  Identities=22%  Similarity=0.335  Sum_probs=166.1

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++.. .+++.+|+|+++...   .+..+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 457899999997642   23445678899999888 699999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999887743   335899999999999999999999987   999999999999999999999999998743221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            23457899999999999999999999999999999999999999643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=6.6e-32  Score=284.94  Aligned_cols=195  Identities=25%  Similarity=0.443  Sum_probs=163.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .+|+..++||+|+||.||++.. .+++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            3456778999999999999965 4689999999865433 3346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|....       ..++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999985432       3466778899999999999999987   99999999999999999999999999986543211


Q ss_pred             ccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        ......||..|+|||.+..     ...+.++|||||||++|||++|+.||..
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence              1223478999999998743     2245689999999999999999999974

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-34  Score=264.17  Aligned_cols=203  Identities=26%  Similarity=0.433  Sum_probs=174.2

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .++|++-+.||+|.|+.|+++ ..++|+.+|+|++...  +....+++.+|+.|.+.++||||+++.+...+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456777889999999999998 6678999999987543  3335678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccCcccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLF  587 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGla~~~  587 (656)
                      |+|.|++|..-+.   .+...++..+..++.||+.+|.|.|.++   |||||+||+|+|+-.   .--+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999864442   2345788899999999999999999998   999999999999954   345999999999877


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .   .........|||+|||||+++..+|+..+|||+.||+||-||.|.+||...+++
T Consensus       164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~  218 (355)
T KOG0033|consen  164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH  218 (355)
T ss_pred             C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence            6   233444568999999999999999999999999999999999999999774443

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=1.2e-31  Score=273.63  Aligned_cols=196  Identities=26%  Similarity=0.410  Sum_probs=166.9

Q ss_pred             ccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||+||++.. .+++.+|+|.+.....   ...+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999954 4688999999865422   2335677899999999999999999999999999999999999999


Q ss_pred             hhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccc
Q 006211          519 DLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG  597 (656)
Q Consensus       519 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~  597 (656)
                      ..++.... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            87774422 2346899999999999999999999987   99999999999999999999999999976543221  222


Q ss_pred             cccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       598 ~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            3468899999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA02988 hypothetical protein; Provisional

Probab=99.98  E-value=1.2e-31  Score=273.72  Aligned_cols=193  Identities=21%  Similarity=0.333  Sum_probs=164.8

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEEEEe
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIYEY  512 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  512 (656)
                      ...||+|+++.||+|.. +++.||||+++......   .+.+.+|+.++.+++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999987 78899999997653322   4678899999999999999999999876    3467899999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|..++..   ...+++.....++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999854   235888999999999999999999852  27899999999999999999999999997653221 


Q ss_pred             ccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ....++..|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence                12357889999999876  678999999999999999999999997654

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.98  E-value=5.1e-32  Score=283.30  Aligned_cols=202  Identities=21%  Similarity=0.292  Sum_probs=170.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.++||+|+||.||++... +++.+|+|++...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999654 4778999998642   1223345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998542  235788999999999999999999987   999999999999999999999999999754322


Q ss_pred             cccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      . ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         156 G-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             C-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            1 11222347899999999885     345788999999999999999999999654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=5.7e-32  Score=281.86  Aligned_cols=195  Identities=24%  Similarity=0.338  Sum_probs=163.1

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||+||+|.. .+++.||+|++....   .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999965 468999999986532   122234455544 56778999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999888743   345888999999999999999999987   999999999999999999999999998753221  122


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            234578999999999999899999999999999999999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.98  E-value=6.6e-32  Score=281.25  Aligned_cols=200  Identities=26%  Similarity=0.345  Sum_probs=168.2

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +|+..+.||+|+||+||++.. .+++.||+|+++...   ....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            366788999999999999954 468899999987532   233455777888888885 577888999999889999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999888743   345889999999999999999999987   999999999999999999999999998753221


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ........||+.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence              112233468999999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=4.5e-32  Score=282.90  Aligned_cols=195  Identities=22%  Similarity=0.319  Sum_probs=163.3

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||+||++.. .+++.+|+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999954 568999999986531   222334555554 56778999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            999877743   345889999999999999999999987   999999999999999999999999998753221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            234578999999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=5.7e-32  Score=280.73  Aligned_cols=195  Identities=28%  Similarity=0.398  Sum_probs=164.2

Q ss_pred             CcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHh-cCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTAR-LQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||+||+|... +++.||||+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 57899999987542   2233455667777776 4899999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence            999988853   235788999999999999999999987   999999999999999999999999998743221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence            234578999999999998889999999999999999999999997544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.7e-32  Score=274.70  Aligned_cols=211  Identities=23%  Similarity=0.339  Sum_probs=183.9

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..-|...+.||+|-|+.|-.++ .-+|..||||++.+....  ....+.+|+..|+.++|||||+++.+...+..+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3457777899999999999994 458999999999876443  3446889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~~~  589 (656)
                      |.-.+|+|.+|+.....  .+++..+.+++.||+.++.|+|+.|   +|||||||+|+.+- .-|-+||+|||++-.+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999976443  4889999999999999999999999   99999999999875 557899999999987654


Q ss_pred             CccccccccccccccccccccccCCCCC-ccchhHHHHHHHHHHHcCCCCCCCCCCcccccccc
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE  652 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  652 (656)
                      .   ......+|+..|.|||++.+..|+ +++||||||||||.|++|++||+..++.+.+.++-
T Consensus       172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm  232 (864)
T KOG4717|consen  172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM  232 (864)
T ss_pred             c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence            3   233456999999999999998886 57999999999999999999999999998887653

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=274.61  Aligned_cols=201  Identities=27%  Similarity=0.394  Sum_probs=171.6

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      +|+..+.||+|+||+||++.. .+++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999965 468899999986532   1223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999998877542 2345889999999999999999999987   9999999999999999999999999997653221


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         ......|+..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence               1123468899999999988889999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=8e-32  Score=294.94  Aligned_cols=208  Identities=24%  Similarity=0.336  Sum_probs=174.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  504 (656)
                      ..++|++.+.||+|+||+||++. ..+++.||||++...  .......+.+|+..+..++|+|++++...+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            35689999999999999999995 457899999998654  3344557889999999999999999887765432     


Q ss_pred             ---ceEEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          505 ---ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       505 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                         ..++||||+++|+|..++.... ....+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               3579999999999999886432 2346889999999999999999999987   99999999999999999999999


Q ss_pred             ccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            999986543322223334578999999999999999999999999999999999999996543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.98  E-value=1.7e-32  Score=286.78  Aligned_cols=203  Identities=23%  Similarity=0.333  Sum_probs=172.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|+++...   .+..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999954 468899999987542   234456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988543  235889999999999999999999987   999999999999999999999999999865432


Q ss_pred             cccccccccccccccccccccc------CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||....
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            211 222346899999999986      4567889999999999999999999996543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=1.3e-31  Score=301.09  Aligned_cols=204  Identities=25%  Similarity=0.356  Sum_probs=172.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.++||+|+||.||+|.. .+++.||+|+++...   ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4788999999999999999965 458899999987542   233457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          511 EYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      ||+++++|..++.....        ....++..++.++.|+++||.|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999988753211        123566778899999999999999987   9999999999999999999999999


Q ss_pred             CccccccCcc----------------ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          583 MAKLFRKDVD----------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       583 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +++.......                .......+||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9986521110                0111234689999999999999999999999999999999999999965

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=8.9e-32  Score=282.40  Aligned_cols=200  Identities=21%  Similarity=0.338  Sum_probs=165.2

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM  507 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  507 (656)
                      +|++.+.||+|+||.||+|.. .+++.||||++...  .......+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999964 56899999998643  2233456889999999999999999999875432     479


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+. ++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 678777743   335889999999999999999999987   999999999999999999999999999754


Q ss_pred             ccCcc-ccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          588 RKDVD-EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       588 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..... ........|++.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            32211 111233578999999999865  67899999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.1e-31  Score=285.80  Aligned_cols=193  Identities=21%  Similarity=0.278  Sum_probs=165.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+|++.+.||+|+||.||++.. .+++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999954 5688999996532      3467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +. ++|..++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence            85 677777643   235789999999999999999999987   999999999999999999999999999753221 1


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            112223578999999999998899999999999999999999998874

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=99.98  E-value=4.1e-32  Score=270.30  Aligned_cols=221  Identities=19%  Similarity=0.253  Sum_probs=187.6

Q ss_pred             CcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEeecCC
Q 006211          110 NKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSP  189 (656)
Q Consensus       110 g~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~  189 (656)
                      +.+++.+.++.++.++..++++++++++.++.+|+.|+.||+|..++.|++.|..|+|++|.+| ++.++.+++|+|+..
T Consensus       174 ~~~f~~ela~~lL~net~~~~~i~~ii~~l~~~Gyrgv~iDfE~v~~~DR~~yt~flR~~r~~l-~~~G~~~siAvaakt  252 (423)
T COG3858         174 GANFGGELAQLLLNNETAKNRLINNIITLLDARGYRGVNIDFENVGPGDRELYTDFLRQVRDAL-HSGGYTVSIAVAAKT  252 (423)
T ss_pred             ccccchHHHHHHHhcHHHHHHHHHHHHHHHHhcCcccEEechhhCCHHHHHHHHHHHHHHHHHh-ccCCeEEEEEecCCC
Confidence            3444556689999999999999999999999999999999999999999999999999999999 455899999999875


Q ss_pred             C-----ccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccCCC
Q 006211          190 T-----HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASG  264 (656)
Q Consensus       190 ~-----~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG  264 (656)
                      .     .+..+||+..+.++||||.|||||.|.+  .+.+|+.||..      .++..+++.+. -+|++|++||+|+||
T Consensus       253 ~~~~~G~W~~~~dy~a~Gkiad~v~lMtYd~h~~--gG~PG~vA~i~------~vr~~ieya~T-~iP~~Kv~mGip~YG  323 (423)
T COG3858         253 SDLQVGSWHGAYDYVALGKIADFVILMTYDWHYS--GGPPGPVASIG------WVRKVIEYALT-VIPAEKVMMGIPLYG  323 (423)
T ss_pred             CCCcCccccchhhhhhhceeeeEEEEEEeccCcC--CCCCCcccCch------hHhhhhhhhhe-ecchHHeEEcccccc
Confidence            3     3556799999999999999999999954  35688888876      67777776666 699999999999999


Q ss_pred             CCcCCC----CCc----chHHHHHHHHhcCCCcccccccceeeeeee----cC-cEEEeeCCcchhHHHHhhhhhccccc
Q 006211          265 PGITID----GSM----GYKFIRAFIQNYGYGAAPVYNASYVVNLFT----SG-ATWINFDGVETIKAKISYAKEKNLLG  331 (656)
Q Consensus       265 ~~~~~~----g~~----~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~----~~-~~~i~yd~~~si~~K~~~~~~~glgG  331 (656)
                      ++|+.+    |..    +..+  .......++++..||..++.|+++    ++ .+++||||.+|+++|.+++|+.||.|
T Consensus       324 YDW~~~y~~~g~~~~a~~~~~--~i~ia~~y~A~Iq~D~~~qsp~F~y~D~eg~~h~VWfeD~~s~~~k~~lik~ygl~G  401 (423)
T COG3858         324 YDWTLPYDPLGYLARAISPDE--AIDIANRYNATIQYDATSQSPFFYYVDKEGRYHEVWFEDARSFQTKLDLIKEYGLRG  401 (423)
T ss_pred             ccccCCCCCCcceeeecCcch--hhhhhcccCCccCcCccccCceEEEEcCCCceEEEEcCchHHHHHHHHHHHHcCCce
Confidence            999875    222    2223  223445577899999999999854    34 68999999999999999999999999


Q ss_pred             ceeeEeccCcc
Q 006211          332 YKAFQLSNDDN  342 (656)
Q Consensus       332 v~~W~l~~Dd~  342 (656)
                      |++|.|++.|.
T Consensus       402 Vs~W~Lg~e~p  412 (423)
T COG3858         402 VSYWVLGQEDP  412 (423)
T ss_pred             EEEEEecCcch
Confidence            99999999983

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=8.5e-32  Score=280.36  Aligned_cols=194  Identities=24%  Similarity=0.338  Sum_probs=162.0

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 468899999986532   122334555544 67889999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|...+..   ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999877743   345788889999999999999999987   999999999999999999999999998753221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            23457899999999999888999999999999999999999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=9.5e-32  Score=280.43  Aligned_cols=195  Identities=23%  Similarity=0.314  Sum_probs=161.7

Q ss_pred             CcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHH-HHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEV-SLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++... +++.+|+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999654 57889999986532   12223344444 456778999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+.+.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999888853   334778888899999999999999987   999999999999999999999999999753221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            334578999999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=1.1e-31  Score=278.72  Aligned_cols=195  Identities=27%  Similarity=0.398  Sum_probs=164.3

Q ss_pred             CcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999654 68899999987532   22334566777777754 899999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.++|+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999888743   345788999999999999999999987   999999999999999999999999998743211  122


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~  200 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD  200 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            234578999999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=273.13  Aligned_cols=203  Identities=26%  Similarity=0.392  Sum_probs=175.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +.|+.-++||+|+||.|+-++. .+|+.+|.|.+.+...   +...-.++|-.+|.+++.+.||.+-..+++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5567778999999999999954 5799999998865432   22334678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ..|.||+|.-++.+... ..++++.++.++.+|+.||++||...   ||.||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999877765433 56999999999999999999999987   999999999999999999999999999876543


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .   .....+||.+|||||++.+..|+...|.|||||++|||+-|+.||..+..
T Consensus       341 ~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  341 K---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             C---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            2   22234899999999999999999999999999999999999999976543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-33  Score=264.17  Aligned_cols=210  Identities=23%  Similarity=0.315  Sum_probs=180.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      -++|+.+++||+|.||.|-.++- .+++.+|+|+++++-   ..+...-+.|-++|...+||.+..+-..|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999954 468999999998762   33445567889999999999999999899999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||..||.|.-.|.   +...+++...+.+-..|+.||.|||+.+   ||.||||.+|.|+|.+|++||+|||+++.-..
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999976663   4556888889999999999999999987   99999999999999999999999999985332


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCccccccc
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL  651 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~  651 (656)
                        ....+...||||.|+|||++....|...+|.|.+||++|||++|+.||...+.+....++
T Consensus       321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence              234456689999999999999999999999999999999999999999765554444433

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=2.4e-31  Score=283.49  Aligned_cols=207  Identities=28%  Similarity=0.407  Sum_probs=171.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  504 (656)
                      ..++|++.+.||+|+||.||+|...      .+..||||+++... ....+.+.+|++++.++. ||||++++++|....
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567889999999999999999642      23479999997543 333467899999999996 999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc---------------------------------------------------------
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------  527 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  527 (656)
                      ..++||||+++|+|..++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999888753210                                                         


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          528 ------------------------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       528 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                                                          ...+++..+..++.|+++||.|||+.+   ++||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124778888999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            999999999999986543322222233456778999999988889999999999999999997 88888653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=2.6e-31  Score=272.62  Aligned_cols=201  Identities=25%  Similarity=0.412  Sum_probs=164.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe--CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEEEee-----
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTE-----  502 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  502 (656)
                      ++|++.+.||+|+||.||+|..  .+++.||+|+++...  ......+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4688999999999999999965  246789999886542  22233456677777665   69999999998852     


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      ....++|+||++ ++|..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346889999996 58887775432 234889999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +++.....   .......|++.|+|||.+....++.++|||||||++|||++|++||....
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            99765432   22234568999999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=5e-32  Score=281.70  Aligned_cols=195  Identities=26%  Similarity=0.336  Sum_probs=167.4

Q ss_pred             CcccccCceEEEEEEe----CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          441 NKLGEGGFGPVYKGNL----PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      +.||+|+||.||++..    .+++.+|+|++.....  .....+..|++++++++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999853    3578999999875422  233456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999888743   345899999999999999999999987   9999999999999999999999999997543221  1


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            2233578999999999988888999999999999999999999997544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=292.83  Aligned_cols=209  Identities=25%  Similarity=0.344  Sum_probs=173.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCC-CEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEE-EEee------CC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRG-QEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLG-YCTE------RD  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~  504 (656)
                      ..++++.+.|.+|+|+.||.|....+ ..+|+|++-..++...+.+.+|+++|+.|+ |+|||.+++ ....      ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567789999999999999977665 999999988778888899999999999997 999999999 3221      13


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      +.+|.||||++|.|-+++..+.... +++.++++|+.++++|+.+||.+. ++|||||||-+||||..+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            5689999999999999987654444 999999999999999999999986 67999999999999999999999999988


Q ss_pred             cccccCccccc-c------ccccccccccccccc---cCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          585 KLFRKDVDEAN-T------GRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       585 ~~~~~~~~~~~-~------~~~~gt~~y~aPE~~---~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .-......... .      -...-|+.|.|||++   .+..++.|+|||+|||+||-|+....||+..+.
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            64322211100 0      011347899999987   577899999999999999999999999987643

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.5e-31  Score=277.87  Aligned_cols=203  Identities=28%  Similarity=0.449  Sum_probs=168.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .+|+..+.||+|+||.||+|... ++.    .||+|.++... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999643 333    48999987543 34456788999999999999999999998764 5689


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++||+++|+|.+++...  ...+++.....++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999988643  234788899999999999999999987   9999999999999999999999999998765


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .............+..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            4322222222234678999999999999999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=1.8e-31  Score=270.28  Aligned_cols=204  Identities=25%  Similarity=0.390  Sum_probs=170.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|...    .+..||+|.++... ....+.+.+|+..+.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888899999999999999542    35689999987653 2334578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999988542  235889999999999999999999987   9999999999999999999999999876432


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ... ........++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus       159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~  213 (266)
T cd05064         159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            211 111112234578999999998999999999999999999875 999986543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.1e-31  Score=276.81  Aligned_cols=195  Identities=28%  Similarity=0.371  Sum_probs=165.7

Q ss_pred             CcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++... +++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999654 57899999987542   23345667888888887 699999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence            999887743   235899999999999999999999987   999999999999999999999999998643221  112


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....+|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~  200 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD  200 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence            233468999999999999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=2e-33  Score=265.72  Aligned_cols=196  Identities=27%  Similarity=0.461  Sum_probs=175.8

Q ss_pred             CCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      |.++++||+|+||.||++ ....|+.+|||.+....  ..+++..|+.++.+.+.|++|+++|.+.....+++|||||--
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            567789999999999999 55679999999887653  457889999999999999999999999888999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+..+.++.  ++.++++++...++...++||+|||.+.   -||||||+.|||++.+|..||+|||.+..+...  -..
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK  185 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK  185 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence            999999854  4567999999999999999999999987   799999999999999999999999999876532  233


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...+.||+.|||||++..-.|+.++||||||++..||.-|++|+..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence            4567899999999999999999999999999999999999999854

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=3.8e-31  Score=270.32  Aligned_cols=206  Identities=31%  Similarity=0.521  Sum_probs=171.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|++.+.||+|+||.||+|....      ...+++|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357888999999999999996532      2579999987543 233457899999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          508 LIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      +++||+++++|..++.....             ...+++.+.+.++.|++.+|.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999988854211             145788999999999999999999987   99999999999999999


Q ss_pred             cEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999976543222222233456788999999988889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.7e-31  Score=270.94  Aligned_cols=207  Identities=29%  Similarity=0.477  Sum_probs=173.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|.+.+.||+|+||.||+|...      ++..||||.++..... ..+.+.+|+++++.++|||++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45778899999999999999653      3478999998765443 4568899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          508 LIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      ++|||+++++|..++....           ....+++.....++.|++.++.+||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999885421           1235788999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999975433222122223345678999999999999999999999999999998 9999865443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=287.57  Aligned_cols=206  Identities=31%  Similarity=0.465  Sum_probs=175.8

Q ss_pred             CCCcccccCceEEEEEE-eCCCC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          439 SANKLGEGGFGPVYKGN-LPRGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..++||+|+||+||+|- .+.++    +||||++... ..+...++++|.-+|.+++|||+++++++|..+. ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            46899999999999994 34444    6899998665 3445678999999999999999999999998766 7899999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++.|+|.++++.  .+..+..+..+.+..||++||.|||++.   ++||||..+|||+.+-..+||.|||+++....+..
T Consensus       779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999976  4456888999999999999999999886   99999999999999999999999999998877665


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCcccccc
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF  650 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~  650 (656)
                      ........-.+.|||-|.+....|+.++|||||||++||++| |.+|+.....++..++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl  912 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL  912 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH
Confidence            555555555789999999999999999999999999999997 6778876655544433

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=275.84  Aligned_cols=209  Identities=26%  Similarity=0.446  Sum_probs=176.0

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEe--C-CCC--EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKGNL--P-RGQ--EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~~~--~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      +...+.....+.||+|.||.||+|..  . .|+  .||||..+.. ..+..+.|++|..+|+.++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            33444555678999999999999943  1 333  6899998874 45567789999999999999999999999985 5


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..+||||.++-|.|..||..  ++..++......++.||+.+|.|||+..   +|||||..+|||+....-+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            78999999999999999964  4556888999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCcc
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE  646 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~  646 (656)
                      +.+..+... ..+...-+..|||||.+.-..++.+||||.|||++||+++ |.+||..-.+.+
T Consensus       539 R~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  539 RYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             hhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            987654332 2234456789999999999999999999999999999765 889997765544

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=283.82  Aligned_cols=199  Identities=27%  Similarity=0.442  Sum_probs=174.3

Q ss_pred             cccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhh
Q 006211          442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL  520 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  520 (656)
                      +||+|.||+||.|+. .+...+|||.+.....+..+.+.+|+.+-++++|.|||+++|.|.+.+..-|.||.++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            599999999999965 4466899999988777777889999999999999999999999999999999999999999999


Q ss_pred             hhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCccccccCccccccccc
Q 006211          521 YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRI  599 (656)
Q Consensus       521 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~  599 (656)
                      ++...-..-.-.+.+.-.+.+||++||.|||+++   |||||||-.|+||+ -.|.+||+|||-++.+..  -.+.+.+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9976544434478888999999999999999998   99999999999997 468899999999987653  34556678


Q ss_pred             cccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          600 VGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       600 ~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .||..|||||++..++  |...+|||||||++.||.||++||-..+.+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp  784 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP  784 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence            8999999999997654  788999999999999999999999766543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=9.2e-31  Score=266.66  Aligned_cols=193  Identities=22%  Similarity=0.396  Sum_probs=163.6

Q ss_pred             ccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||.||++.. .+++.+|+|++.....   .....+..|++++++++||||+++.+.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999965 4589999999864321   1223456799999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            88775432 334788999999999999999999987   9999999999999999999999999997654321   1123


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            46889999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=6.7e-31  Score=269.27  Aligned_cols=206  Identities=28%  Similarity=0.467  Sum_probs=173.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++.+++|||++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35688889999999999999963      234568999988766566678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          508 LIYEYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                      +++||+++++|..++....          ....+++..+..++.|++.+|.|||+.+   ++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999998885321          2234899999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      |+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |+.||...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999976543222122223345678999999988889999999999999999998 88888544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=4.3e-31  Score=270.00  Aligned_cols=205  Identities=31%  Similarity=0.481  Sum_probs=170.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      +.|++.+.||+|+||.||+|..     ..+..+++|.+.... .+....+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3567889999999999999963     346789999987543 3344678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          509 IYEYLPNKSLDLYLFDPI--------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      +|||+++++|..++....              ....+++.+...++.+++.+|.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999998874321              1234788899999999999999999987   99999999999999999


Q ss_pred             cEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999976543222222223345678999999988889999999999999999999 88888543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=4.3e-31  Score=269.13  Aligned_cols=208  Identities=25%  Similarity=0.448  Sum_probs=171.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998542      24679999886532 2344568899999999999999999999999899


Q ss_pred             eEEEEEecCCCChhhhhhCCCc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                      .++||||+++++|..++.....       ...+++..+..++.|++++|.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999998854221       124678889999999999999999987   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~  226 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS  226 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999975543222111222345678999999988889999999999999999999 688886544

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=2.7e-31  Score=267.76  Aligned_cols=201  Identities=36%  Similarity=0.605  Sum_probs=165.8

Q ss_pred             CCCcccccCceEEEEEEeC-----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          439 SANKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+.||.|.||.||+|.+.     .+..|+||.++... .+..+.+.+|++.+++++||||+++++++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3478999999999999765     25689999996643 34467899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+++||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999998654 2346899999999999999999999987   99999999999999999999999999987632222


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+....
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~  210 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD  210 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            222223356778999999998889999999999999999999 678886543

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1e-30  Score=267.49  Aligned_cols=199  Identities=26%  Similarity=0.390  Sum_probs=169.7

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....   ....+.+.+|+.++++++|+|++++.+.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999954 468899999886542   22234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999998887432 2235889999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        ......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence              112346899999999999888999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=6.7e-31  Score=265.14  Aligned_cols=202  Identities=29%  Similarity=0.467  Sum_probs=172.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5688899999999999999988788899999886543 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++... ....+++..+..++.+++++|.|||+.+   ++||||||+||++++++.++|+|||++........ .
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            99999988543 2345788899999999999999999987   99999999999999999999999999986543211 1


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ......++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            1122345678999999988889999999999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=7.5e-31  Score=264.02  Aligned_cols=202  Identities=29%  Similarity=0.442  Sum_probs=171.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3477789999999999999988788899999886442 234578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|+|..++...  ...+++..+..++.+++.+|.|||+.+   ++||||+|+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999888542  235789999999999999999999987   999999999999999999999999999765322111 


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            1112234568999999988889999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=4.4e-31  Score=280.74  Aligned_cols=200  Identities=22%  Similarity=0.354  Sum_probs=166.5

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM  507 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  507 (656)
                      +|++.+.||+|+||.||++.. .+++.||||++...  .....+++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999964 57899999998653  2234457889999999999999999999998766     789


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|+||+. ++|...+..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 466666532   345889999999999999999999987   999999999999999999999999999765


Q ss_pred             ccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            432211 12233578899999988764 47899999999999999999999997544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=279.81  Aligned_cols=195  Identities=30%  Similarity=0.451  Sum_probs=167.9

Q ss_pred             CCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .|+.++.||.|+||.||.++ ..+.+.||||.++-+.   .+...+++.|+.+|++++|||++.+.||+......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            35667889999999999995 4567899999987653   3446689999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||- |+-.+++.  ..+.++.+.++..|+.+.++||.|||+.+   .||||||+.|||+++.|.|||+|||.+....+  
T Consensus       107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            995 45555552  23456888999999999999999999998   89999999999999999999999999976533  


Q ss_pred             ccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                          ...++|||.|||||++.   .+.|+-++||||||++..||.-.++|....
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM  228 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  228 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence                33568999999999874   578999999999999999999999997544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=8.2e-31  Score=274.39  Aligned_cols=204  Identities=30%  Similarity=0.454  Sum_probs=168.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC-Cc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER-DE  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  505 (656)
                      ++|++.+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            4688999999999999999943      235789999987543 23345678899999999 899999999988654 56


Q ss_pred             eEEEEEecCCCChhhhhhCCCc----------------------------------------------------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR----------------------------------------------------------  527 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  527 (656)
                      .++++||+++++|..++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999988743211                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccc
Q 006211          528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP  607 (656)
Q Consensus       528 ~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  607 (656)
                      ...+++..+..++.|++.+|.|||+++   |+||||||+|||++.++.++|+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            125789999999999999999999987   99999999999999999999999999986543322222333455678999


Q ss_pred             cccccCCCCCccchhHHHHHHHHHHHc-CCCCCCC
Q 006211          608 PEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARY  641 (656)
Q Consensus       608 PE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~  641 (656)
                      ||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.9e-31  Score=286.08  Aligned_cols=199  Identities=21%  Similarity=0.333  Sum_probs=160.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--------C
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--------D  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  504 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++.+++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45799999999999999999965 468899999885432    2235799999999999999998876432        2


Q ss_pred             ceEEEEEecCCCChhhhhhC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEecc
Q 006211          505 ENMLIYEYLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFG  582 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfG  582 (656)
                      ..++||||+++ ++..++.. ......+++..+..++.|+++||.|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            36689999985 55555432 123446889999999999999999999987   99999999999999665 69999999


Q ss_pred             CccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +++.+....   ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            998654322   1223467899999998765 468999999999999999999999997543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=8.1e-31  Score=277.36  Aligned_cols=198  Identities=24%  Similarity=0.312  Sum_probs=165.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  504 (656)
                      ..++|++.+.||+|+||.||++.. .++..||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999954 46889999998653  2233456789999999999999999999886543     


Q ss_pred             -ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                       ..++||||++++ |...+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999764 444442     23778889999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++.....   .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9754322   1222346889999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1e-30  Score=268.38  Aligned_cols=206  Identities=27%  Similarity=0.458  Sum_probs=173.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .+|.+.+.||+|+||.||++..      .++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            3577789999999999999953      2345689999877666556778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc
Q 006211          509 IYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN  575 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~  575 (656)
                      ||||+++++|.+++....             ....+++..++.++.|++.++.|||+.+   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1234789999999999999999999987   999999999999999999


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ++|+|||++................++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999976543222222233456788999999988889999999999999999999 999985543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=2.1e-30  Score=264.26  Aligned_cols=193  Identities=24%  Similarity=0.382  Sum_probs=168.0

Q ss_pred             cCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|+..+.||+|+||.||+|. ..+++.+|+|++... .....+++.+|++++.+++|||++++++.+...+..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            357788999999999999995 457889999998654 233445788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..+.       .+++.....++.|++.+|.|||+.+   ++|+||||+|||++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996542       3678888999999999999999987   999999999999999999999999999765322  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence              12234688899999999988899999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=7.2e-31  Score=271.91  Aligned_cols=202  Identities=25%  Similarity=0.393  Sum_probs=167.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|...+.||+|+||.||+|... +++.+|+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888999999999999999654 678899999875432 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++ +|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            975 777666432  234788899999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+.
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  210 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV  210 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence             11223467889999998765 4578999999999999999999999975543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=1.6e-30  Score=265.96  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=170.2

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      |+..+.||+|+||+||++.. .+++.+|+|.+....   ....+.+.+|++++++++|+|++++.+.+..++..++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56778999999999999955 468899999986542   22234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++... ....+++..+..++.|++.+|.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999998877542 2235899999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......|+..|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence              1123468899999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=1.7e-30  Score=263.23  Aligned_cols=201  Identities=23%  Similarity=0.383  Sum_probs=171.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++.+......++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35688999999999999999965 56889999998765544556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++..   ...+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            999999988743   335789999999999999999999987   9999999999999999999999999998654321 


Q ss_pred             cccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......++..|+|||.+.   ...++.++|+|||||++|||++|+.|+...
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence             1122346788999999874   345788999999999999999999998543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.6e-30  Score=262.47  Aligned_cols=204  Identities=27%  Similarity=0.442  Sum_probs=173.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++|||++++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688889999999999999987777889999987643 23466889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++.... ...+++.....++.+++.++.+||+.+   ++||||||+||++++++.++|+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 345889999999999999999999987   999999999999999999999999999876422111


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                       .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence             1111223457999999988889999999999999999999 998886543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=1.8e-30  Score=262.79  Aligned_cols=204  Identities=29%  Similarity=0.467  Sum_probs=171.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|....    ...||||.++... .....++.+|+.++.+++||||+++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            468889999999999999996632    4579999987653 33445788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++....  ..+++..+..++.|++.++.|||+++   ++|+||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999985432  35889999999999999999999987   99999999999999999999999999987642


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~  213 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence            222222222344678999999988889999999999999999998 998885433

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.1e-30  Score=262.83  Aligned_cols=202  Identities=28%  Similarity=0.447  Sum_probs=170.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||.+...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3467889999999999999987777789999887543 234678999999999999999999999998889999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999999885432  25889999999999999999999987   999999999999999999999999998765432211 


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            1112234567999999988889999999999999999999 999986544

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=7.8e-31  Score=280.43  Aligned_cols=199  Identities=21%  Similarity=0.284  Sum_probs=169.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC---CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ...+|++.+.||+|+||.||++...   .+..|++|.+....     ...+|++++++++||||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3457999999999999999999542   35789999886532     346799999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||++. ++|..++.   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.....
T Consensus       165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99986 57777762   3346899999999999999999999987   99999999999999999999999999976544


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...........||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            332223334578999999999998899999999999999999999999996544

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=1.4e-30  Score=265.71  Aligned_cols=203  Identities=28%  Similarity=0.403  Sum_probs=166.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC----EEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|+||+||+|... +++    .+++|.+..... ....++..|+..+.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46778899999999999999653 344    478888754432 33456778888999999999999999875 455788


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++||+++|+|..++...  ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998542  335889999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ............++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            3322222233456778999999988889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.7e-30  Score=265.20  Aligned_cols=205  Identities=28%  Similarity=0.460  Sum_probs=172.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .+++..++||+|+||.||++..      .++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4677889999999999999953      2356899999887666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          509 IYEYLPNKSLDLYLFDPIR------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      ++||+++++|..++.....            ...+++..+..++.|++.|+.|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999988854221            134788999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      +|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            9999999975533221111222345678999999988889999999999999999998 88888543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=248.02  Aligned_cols=208  Identities=24%  Similarity=0.313  Sum_probs=173.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ce
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----EN  506 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  506 (656)
                      ..++|++.+.||+|+|+-|+.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999994 6678999999998877777888999999999999999999998765433     48


Q ss_pred             EEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          507 MLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      |++++|...|+|.+.+.... .+..+++.+.+.++.++++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999988886543 3447999999999999999999999986 479999999999999999999999999987


Q ss_pred             ccccCcccc-------cccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDEA-------NTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...-.....       ......-|..|.|||.+.   +...+.++|||||||+||+|+.|..||+.
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            532111100       011123478899999885   34578999999999999999999999965

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=260.46  Aligned_cols=201  Identities=26%  Similarity=0.419  Sum_probs=170.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|++|.||++.. .+++.+++|.+....     ....+.+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999954 468899999886432     1234568889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++||+++++|..++..   ...+++.....++.+++.+|.|||+.+   ++||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999888743   235788999999999999999999987   9999999999999999999999999997653


Q ss_pred             cCccccc-cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            3211111 1234577899999999988899999999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=7.5e-31  Score=268.17  Aligned_cols=205  Identities=30%  Similarity=0.467  Sum_probs=169.3

Q ss_pred             CCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      +|++.+.||+|+||.||+|...      .+..||+|+++.... ...+.+.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3566789999999999999643      246899999976543 234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc
Q 006211          509 IYEYLPNKSLDLYLFDP-------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN  575 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~  575 (656)
                      ++||+++++|..++...             ..+..+++..+..++.|++.||.|||+.+   ++||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999887421             11234788889999999999999999987   999999999999999999


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +||+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |..||....
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999876543222222233455778999999988889999999999999999998 777876543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1.8e-30  Score=267.08  Aligned_cols=200  Identities=26%  Similarity=0.417  Sum_probs=173.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+|+..+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++.+......++|+||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788889999999999999964 568899999987765555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++..    ..+++.++..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--  170 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence            99999988743    34788999999999999999999987   9999999999999999999999999987643321  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            11223467889999999988888999999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=7.2e-31  Score=264.89  Aligned_cols=204  Identities=31%  Similarity=0.513  Sum_probs=176.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ..+|++.++||.|+||.||+|...++..+++|.+..........+..|+.+++.++|||++++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688899999999999999988779999999998776655677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++.... ...+++.....++.++++|+.|||+.+   ++|+||+|+||++++++.+||+|||.+.........
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999986532 345889999999999999999999987   999999999999999999999999999765432111


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                        .....++..|+|||.+....++.++|+||||+++|+|++ |+.||....
T Consensus       161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence              112345678999999988889999999999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=277.95  Aligned_cols=193  Identities=24%  Similarity=0.323  Sum_probs=159.7

Q ss_pred             ccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc---CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       443 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      ||+|+||+||+|.. .+++.||||++....   ......+..|..++.+.   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999965 468999999986432   12233445566666655   699999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.++|+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999888743   345889999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~  201 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED  201 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence            2345789999999988654 47899999999999999999999996543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=275.27  Aligned_cols=205  Identities=28%  Similarity=0.442  Sum_probs=176.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ...+..+.++||-|.||.||.|.++. ...||||.++... -..++|+.|..+|+.++|||+|+++|+|..+...|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456678999999999999998765 6689999997653 456889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||..|+|.+||.+..+ ..++.-.++.++.||..||+||...+   +|||||..+|+|+.++..+|++|||+++++..+.
T Consensus       344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999977543 45777888999999999999999998   9999999999999999999999999999987654


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .... ....-++.|.|||.+....++.|+|||+|||+|||+.| |-.|+.+-+
T Consensus       420 YTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  420 YTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             eecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            3322 22344678999999999999999999999999999986 666765433

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=2.7e-30  Score=267.45  Aligned_cols=199  Identities=25%  Similarity=0.332  Sum_probs=171.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||.||++.. .++..+|+|.+... ......++.+|++++.+++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999954 46788999988754 233345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++...   ..+++..+..++.|++++|.|||+.+  +++||||||+|||+++++.++|+|||++......  
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999998542   45788999999999999999999843  3999999999999999999999999998754321  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence              122346788999999998888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=3.9e-30  Score=264.14  Aligned_cols=202  Identities=26%  Similarity=0.419  Sum_probs=172.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .+.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            356888999999999999999654 5889999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++...  ...+++..+..++.|+++++.|||+.+   ++||||+|+||+++.++.++|+|||++......  
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            9999998876442  235889999999999999999999987   999999999999999999999999998754321  


Q ss_pred             cccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ........++..|+|||.+.     ...++.++|+|||||++|||++|+.||...
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence            11122346788999999874     445788999999999999999999998654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=2.2e-30  Score=259.94  Aligned_cols=198  Identities=28%  Similarity=0.453  Sum_probs=164.5

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      +.||+|+||.||+|.. .+++.+|+|...... .+....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999965 468899999876543 34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9888532  235789999999999999999999987   99999999999999999999999999875432211111111


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ...+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~  201 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS  201 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            123457999999988889999999999999999998 888885433

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.5e-30  Score=260.24  Aligned_cols=201  Identities=28%  Similarity=0.449  Sum_probs=169.2

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +|++.+.||+|+||.||++....+..+|+|.+..... ....+.+|++++++++||||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4778899999999999999877777899999865422 335678899999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|.+++....  ..+++.....++.|+++++.|||+.+   ++||||||+||++++++.+||+|||+++........ .
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            99999885432  35889999999999999999999987   999999999999999999999999999765322111 1


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence            111123457999999988889999999999999999999 788886543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.7e-30  Score=275.44  Aligned_cols=199  Identities=23%  Similarity=0.294  Sum_probs=166.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  503 (656)
                      ..++|++.+.||+|+||.||++.. ..++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            356899999999999999999954 46889999998754  233345678899999999999999999987543      


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ...++||||+++ +|...+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346999999975 5555552     23778889999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            9764322   11223468899999999999899999999999999999999999996543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.5e-30  Score=261.55  Aligned_cols=204  Identities=25%  Similarity=0.414  Sum_probs=166.9

Q ss_pred             CCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-----
Q 006211          437 FSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  505 (656)
                      |++.+.||+|+||.||+|....    +..||+|+++...  ....+.+.+|+..++.++|||++++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999996532    3679999987542  3345678999999999999999999998866544     


Q ss_pred             -eEEEEEecCCCChhhhhhCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          506 -NMLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       506 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                       .++++||+++++|..++....   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998874422   2235889999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |+++...............++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~  220 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE  220 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            99986543322211222234678999999988889999999999999999999 888885543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.9e-30  Score=279.77  Aligned_cols=195  Identities=22%  Similarity=0.263  Sum_probs=165.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ...|.+.+.||+|+||.||++... .++.||||....      ..+.+|++++++++|+||+++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457888999999999999999654 578899996432      2356899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +. ++|..++...  ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6777776432  235899999999999999999999987   99999999999999999999999999986543322


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ........||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            222223578999999999999999999999999999999999887653

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=3.3e-30  Score=268.03  Aligned_cols=197  Identities=24%  Similarity=0.406  Sum_probs=158.0

Q ss_pred             CCcccccCceEEEEEEeC---CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEEecC
Q 006211          440 ANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLIYEYLP  514 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  514 (656)
                      .++||+|+||+||+|...   +++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999653   467899999865432  2456789999999999999999998854  446789999986


Q ss_pred             CCChhhhhhCC------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE----cCCCcEEEEeccCc
Q 006211          515 NKSLDLYLFDP------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMA  584 (656)
Q Consensus       515 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl----~~~~~~kl~DfGla  584 (656)
                      + +|..++...      .....+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 666665321      11235888999999999999999999987   9999999999999    45678999999999


Q ss_pred             cccccCccc-cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          585 KLFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       585 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876432211 12234578999999998876 45889999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.7e-30  Score=263.06  Aligned_cols=199  Identities=24%  Similarity=0.394  Sum_probs=171.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++|++.+.||+|+||.||+|.. .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4677788999999999999954 468899999987665555566889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++..   ...+++.+...++.|++.++.|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999988743   335889999999999999999999987   9999999999999999999999999987654321  


Q ss_pred             ccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .......|+..|+|||.+.   ...++.++|+|||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            1223346889999999874   45578899999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=6.8e-30  Score=304.52  Aligned_cols=190  Identities=26%  Similarity=0.506  Sum_probs=162.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ...+...+.||+|+||.||+|.. .++..||||+++......    .+|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            44577788999999999999965 578999999987543221    3468899999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|.+++.      .++|.++..++.++++||+|||+.++.+++||||||+||+++.++.+++. ||........  
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999984      27899999999999999999997666679999999999999999888875 6665432211  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                          ....+++.|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence                12257889999999999999999999999999999999999984

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=3.8e-30  Score=274.14  Aligned_cols=208  Identities=27%  Similarity=0.433  Sum_probs=170.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  504 (656)
                      ..++|.+.++||+|+||.||+|...      .+..||+|+++... ....+.+.+|+.++.++. ||||++++++|....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3446778899999999999999642      34689999997653 233456889999999997 999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc---------------------------------------------------------
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------  527 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  527 (656)
                      ..++|+||+++|+|..+++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999988853211                                                         


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEE
Q 006211          528 --------------------------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       528 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NIL  569 (656)
                                                            ...+++.....++.|++.||.|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  123677788899999999999999887   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999986533222122223356788999999988889999999999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=3.2e-30  Score=265.37  Aligned_cols=201  Identities=26%  Similarity=0.410  Sum_probs=174.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+|+..+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46788999999999999999964 57899999998765555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++..    ..+++..+..++.+++.+|.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999988743    34788999999999999999999987   99999999999999999999999999876533221


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1223467889999999988889999999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=252.43  Aligned_cols=199  Identities=23%  Similarity=0.369  Sum_probs=169.2

Q ss_pred             CCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          440 ANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      .+.||+|+|+.|-.+ .+.++..+|||++.+...-.+.++.+|++++.+. .|+||++++++|+++...|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            378999999999988 6788999999999888666677889999999888 59999999999999999999999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEEeccCccccccCcc--
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKLFRKDVD--  592 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~DfGla~~~~~~~~--  592 (656)
                      |...+..   +..+++.++.++.+.|+.||.+||..+   |.|||+||+|||.....   -+|||||.+..-+....+  
T Consensus       163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9888754   345899999999999999999999998   99999999999997554   389999998864432211  


Q ss_pred             ---cccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          593 ---EANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       593 ---~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                         .+...+.+|+..|||||+..     ...|+.+.|.||||||+|-||+|.+||.+...
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence               12223468999999999763     34578899999999999999999999977654

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.8e-30  Score=264.47  Aligned_cols=207  Identities=26%  Similarity=0.439  Sum_probs=172.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||++...      .+..+|+|.+.... ......+.+|+.++..++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999543      24689999986543 23445788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~  579 (656)
                      ++||||+++++|..++.....       ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999998854221       224688899999999999999999987   9999999999999999999999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            9999976543322222233456788999999988889999999999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=4.5e-30  Score=258.13  Aligned_cols=202  Identities=28%  Similarity=0.414  Sum_probs=173.8

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|++|.||++.. .+++.|++|.+...  .....+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999965 46889999998643  334556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++... ....+++.....++.+++.+|.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999988653 2346889999999999999999999987   99999999999999999999999999886543221


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......+++.|+|||++.+..++.++|+|||||+++||++|+.||....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence              1223467889999999998889999999999999999999999996544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-30  Score=262.06  Aligned_cols=198  Identities=31%  Similarity=0.528  Sum_probs=170.6

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHH--HHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE--EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      |++.+.||+|+||+||++... +++.+|+|++.........  ...+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            566789999999999999665 4668999999887544332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.   ....+++..+..++.|++++|.+||+.+   ++|+||||+||++++++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999998885   3456899999999999999999999987   99999999999999999999999999975411  12


Q ss_pred             ccccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .......++..|+|||.+. ...++.++|+||||+++++|++|+.||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2333456788999999998 788999999999999999999999999765

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=3.2e-30  Score=261.51  Aligned_cols=199  Identities=26%  Similarity=0.360  Sum_probs=159.3

Q ss_pred             CcccccCceEEEEEEeCC---CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999995433   3478889876543 233456789999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          517 SLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       517 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|..++.....  ....++.....++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99998865322  223467788899999999999999987   9999999999999999999999999986533221111


Q ss_pred             ccccccccccccccccccC-------CCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            1223345678999998642       356789999999999999999 77777544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=2.8e-30  Score=263.39  Aligned_cols=203  Identities=26%  Similarity=0.437  Sum_probs=167.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .++|+..++||+|+||+||+|.. .+++    .||+|+++... ....+.+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35678889999999999999964 3444    48999987543 3345678899999999999999999999875 4578


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +++||+++|+|..++...  ...+++...+.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999888543  235889999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            43222111222234678999999988889999999999999999998 88888653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.8e-30  Score=274.38  Aligned_cols=198  Identities=23%  Similarity=0.299  Sum_probs=165.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  504 (656)
                      ..++|+..+.||+|+||.||++.. ..++.+|||++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999954 468899999987542  233456788999999999999999999886432     


Q ss_pred             -ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                       ..++||||+++ ++...+.     ..+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46899999976 4544442     23788889999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9764322   1222346889999999999888999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=293.41  Aligned_cols=208  Identities=24%  Similarity=0.352  Sum_probs=169.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      ...++|++.+.||+|+||+||++.. ..+..+|+|.+...  .......+..|+.++.+++||||+++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3456899999999999999999965 45778999988653  233456788999999999999999999988543  468


Q ss_pred             EEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEecccCCCCEEEcCC--------
Q 006211          507 MLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSN----FRVIHRDLKASNILLDNE--------  573 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~----~~iiH~Dikp~NILl~~~--------  573 (656)
                      ++||||+++++|..++.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999998885422 23468999999999999999999998542    349999999999999642        


Q ss_pred             ---------CcEEEEeccCccccccCccccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          574 ---------LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       574 ---------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                               ..+||+|||++..+....   ......||+.|+|||++..  ..++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     348999999997653221   1223478999999998854  45889999999999999999999999643

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=2.7e-30  Score=263.25  Aligned_cols=207  Identities=30%  Similarity=0.449  Sum_probs=169.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|++|.||+|...      .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456888999999999999999654      35678999887543 33345688999999999999999999999988899


Q ss_pred             EEEEEecCCCChhhhhhCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~  579 (656)
                      ++||||+++++|..++.....    ...+++..++.++.||+.+|.|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999998854321    235889999999999999999999987   99999999999998765   59999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |||+++................+..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999986533221111222233567999999988889999999999999999997 988886543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=4e-30  Score=260.36  Aligned_cols=203  Identities=21%  Similarity=0.362  Sum_probs=172.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||||.++..   .......+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688999999999999999965 46899999987542   2333456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++++|..++.... ....+++.....++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988774322 2345788999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...  ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            221  122346788999999998888999999999999999999999998543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=3.9e-30  Score=263.64  Aligned_cols=207  Identities=26%  Similarity=0.455  Sum_probs=169.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567899999999999999998542      24579999886543 2333467889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                      .++||||+++|+|..++.....       ....++.....++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999854211       234567788899999999999999987   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      +|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |+.||...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999976543222112222345678999999988889999999999999999998 67787543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=3.7e-30  Score=264.05  Aligned_cols=205  Identities=27%  Similarity=0.421  Sum_probs=169.2

Q ss_pred             CCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999542      23578999887553 2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCC
Q 006211          509 IYEYLPNKSLDLYLFDPI---------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN  567 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~N  567 (656)
                      ++||+++++|..++....                     ....+++..++.++.|++.+|.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998875321                     1134788999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       568 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999976533222112222345678999999988889999999999999999998 988886543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=5.6e-30  Score=259.68  Aligned_cols=200  Identities=28%  Similarity=0.391  Sum_probs=162.0

Q ss_pred             CcccccCceEEEEEEeCC---CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999996543   45799998876532 33346888999999999999999999999989999999999999


Q ss_pred             ChhhhhhCCC--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          517 SLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       517 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|..++....  .....++..+..++.|++.++.|||+.+   ++||||||+||+++.++.++|+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999885422  1234567788899999999999999987   9999999999999999999999999997543222112


Q ss_pred             ccccccccccccccccccCC-------CCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKG-------IYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||++...       .++.++|+||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  214 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS  214 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            22234567889999988542       35789999999999999996 999996544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=3.7e-30  Score=260.07  Aligned_cols=203  Identities=28%  Similarity=0.441  Sum_probs=170.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+|+..+.||+|++|.||+|.. ..++.+|+|++.... .....+.+|++++++++|||++++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            3467788999999999999955 458899999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.... ...+++..++.++.|++++|.|||+++   ++||||||+||++++++.+||+|||++........ 
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            9999999885432 345889999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ........+..|+|||.+.+..++.++|||||||++|||++ |..|+....
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  210 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  210 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11112234567999999988889999999999999999998 888886533

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=3.6e-30  Score=264.86  Aligned_cols=200  Identities=26%  Similarity=0.437  Sum_probs=174.2

Q ss_pred             cCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+|+..+.||.|++|.||++. ..+++.|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            458888999999999999995 4578999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++..    ..+++.++..++.+++.++.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999988742    34789999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1223467889999999988889999999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=5.1e-30  Score=261.92  Aligned_cols=199  Identities=26%  Similarity=0.430  Sum_probs=170.0

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|||++++++.+......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999654 4778899998776666667889999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++...  ...+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            9998877532  345899999999999999999999987   9999999999999999999999999987543221  12


Q ss_pred             ccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....++..|+|||.+.     ...++.++|+|||||++|||++|++||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence            22346788999999873     345788999999999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=267.43  Aligned_cols=195  Identities=26%  Similarity=0.421  Sum_probs=169.4

Q ss_pred             CCcccccCceEEEEE-EeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          440 ANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      .+.||+|.||+||-| ..++|+.||||++.+..  .+....+++|+.||..++||.||.+.-.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            588999999999999 45679999999987652  334467899999999999999999999999999999999999776


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEEeccCccccccCccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~DfGla~~~~~~~~~  593 (656)
                      -|+.+|..  ++..+++.....+..||+.||.|||.++   |+|+||||+|||+...   -++||||||.|+.+...   
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---  720 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---  720 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence            66666643  4556888888999999999999999998   9999999999999654   46999999999987542   


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ......+||+.|+|||++.++.|+..-|+||.|||+|--|+|..||...
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            3334579999999999999999999999999999999999999999643

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.3e-30  Score=263.57  Aligned_cols=198  Identities=27%  Similarity=0.374  Sum_probs=172.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|++|.||++... +++.+|+|++....   .+..+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999654 68899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++.....++.|++++|.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999988854   245889999999999999999999987   999999999999999999999999999765432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           .....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||....
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                 223467889999999988888999999999999999999999986544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-30  Score=262.56  Aligned_cols=203  Identities=25%  Similarity=0.406  Sum_probs=174.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||.|++|.||++.. .++..+|+|++........+.+.+|++++++++|||++++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            35688899999999999999965 46889999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++...  ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999887542  235889999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......++..|+|||.+.     ...++.++|+||||+++|||++|+.||....
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence             1222346788999999874     3457789999999999999999999996543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-30  Score=264.53  Aligned_cols=204  Identities=27%  Similarity=0.425  Sum_probs=167.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC---------------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR---------------GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLG  498 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~  498 (656)
                      ++|++.+.||+|+||.||++....               ...||+|.++.. .....+.+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999985432               235899998764 2334557899999999999999999999


Q ss_pred             EEeeCCceEEEEEecCCCChhhhhhCCCc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEE
Q 006211          499 YCTERDENMLIYEYLPNKSLDLYLFDPIR---------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       499 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NIL  569 (656)
                      ++......++||||+++++|..++.....         ...+++..+..++.++++||.|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999988854211         123678899999999999999999987   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc--CCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS--SKRNARY  641 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt--g~~p~~~  641 (656)
                      +++++.+||+|||++................++..|+|||.+....++.++|+|||||+++||++  +..||..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999976543222222223345678999999988889999999999999999998  4556644

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-30  Score=271.31  Aligned_cols=198  Identities=24%  Similarity=0.349  Sum_probs=165.8

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----  503 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  503 (656)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3567899999999999999999954 5688999999875422  2345677899999999999999999887543     


Q ss_pred             -CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          504 -DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       504 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                       ...+++++++ +++|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468899987 778877763    235899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +++.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99764321     223468899999999876 56889999999999999999999999653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=3.4e-30  Score=266.55  Aligned_cols=206  Identities=29%  Similarity=0.411  Sum_probs=169.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC--------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      ++|.+.+.||+|+||.||++...        +...+|+|.++... .....++.+|++++..+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56889999999999999998542        23579999997642 33455788899999999 7999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      ..++|+||+++++|..++.....             ...+++.+++.++.|++.+|.|||+.+   ++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999864321             234888999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |+.||....
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            999999999999976532211111112234568999999988889999999999999999998 888875433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=5.2e-30  Score=260.30  Aligned_cols=202  Identities=26%  Similarity=0.439  Sum_probs=163.5

Q ss_pred             CCCCcccccCceEEEEEEeCC-CC--EEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------Cce
Q 006211          438 SSANKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DEN  506 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  506 (656)
                      .+.+.||+|+||.||+|.... +.  .+|+|.++..  .....+.+.+|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            466889999999999997644 32  6899988754  334456788999999999999999999987432      246


Q ss_pred             EEEEEecCCCChhhhhhCC---CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          507 MLIYEYLPNKSLDLYLFDP---IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ++++||+++|+|..++...   .....+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999998876421   12235789999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ++...............+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            986543221111122345678999999998889999999999999999999 78888643

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=2.3e-30  Score=265.95  Aligned_cols=208  Identities=27%  Similarity=0.404  Sum_probs=172.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+... ..+...++.+|+.++.++ +||||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            4457888899999999999999653      2357999998754 233445688999999999 8999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDP-------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      ..+++|||+++++|..++...             .....+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999988532             12345889999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999986543322222222334678999999988889999999999999999998 888886443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=5.5e-30  Score=258.69  Aligned_cols=202  Identities=26%  Similarity=0.435  Sum_probs=169.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.++||+|+||.||+|...+...||+|+++.... ..+++.+|++++++++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            46889999999999999999877777899999975432 3457889999999999999999999875 456799999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++... ....+++..+..++.+++++|.|||+.+   ++||||||+||++++++.++|+|||.++....... .
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            99999998542 2235788999999999999999999987   99999999999999999999999999976543221 1


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||...+..++.++|+|||||++|||++ |+.||....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            1222345678999999988889999999999999999999 777876543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=3.2e-30  Score=266.41  Aligned_cols=207  Identities=27%  Similarity=0.399  Sum_probs=171.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe--------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .++|++.+.||+|+||.||++..        .++..+|+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45678889999999999999953        124579999887542 34456788999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      ...+++|||+++++|..++.....             ...+++.++..++.|+++||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999864321             235788899999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999986543222222222345678999999988889999999999999999998 777775443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=5.3e-30  Score=264.41  Aligned_cols=205  Identities=29%  Similarity=0.429  Sum_probs=171.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|+..+.||+|+||.||++..      ..+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35688899999999999999953      124579999987653 33456789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++++||+++++|..++.... ...+++.+...++.+++.+|.|||+.+   ++|+||||+|||++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999885422 233799999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ...............++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            6543222112222345678999999988889999999999999999998 99988543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=283.62  Aligned_cols=203  Identities=23%  Similarity=0.303  Sum_probs=162.5

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC------CceeeEEEEEe
Q 006211          429 DIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH------VNLLRVLGYCT  501 (656)
Q Consensus       429 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~  501 (656)
                      ++....++|++.++||+|+||+||+|.. ..++.||||+++... ...+....|+.+++.++|      ++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3344567899999999999999999954 467889999986532 223345667777777654      45888888887


Q ss_pred             eC-CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCC-----
Q 006211          502 ER-DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNEL-----  574 (656)
Q Consensus       502 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~-----  574 (656)
                      .. ...++|||++ +++|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            54 4678999987 6777777643   3458899999999999999999997 46   99999999999998765     


Q ss_pred             -----------cEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          575 -----------NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       575 -----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                                 .+||+|||.+....     ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       49999999885422     12234578999999999999999999999999999999999999997654


Q ss_pred             C
Q 006211          644 T  644 (656)
Q Consensus       644 ~  644 (656)
                      .
T Consensus       350 ~  350 (467)
T PTZ00284        350 N  350 (467)
T ss_pred             h
Confidence            3

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4e-30  Score=263.48  Aligned_cols=199  Identities=25%  Similarity=0.419  Sum_probs=161.4

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEeeC-----C
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCTER-----D  504 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  504 (656)
                      +|++.+.||+|+||+||+|.. .+++.||+|.++....  .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            478889999999999999955 4688999998875421  1223455677666655   799999999987642     3


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++++|++++ +|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 777776442 2234889999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +......   ......++..|+|||.+.+..++.++|||||||++|||++|++||...
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            7654321   122346788999999998888999999999999999999999998543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=5.4e-30  Score=261.42  Aligned_cols=206  Identities=26%  Similarity=0.366  Sum_probs=171.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC-----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  506 (656)
                      .++|++.+.||+|+||.||+|....     +..|++|++... .....+.+.+|+.++++++|||++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999997654     678999988754 23345678899999999999999999998766 4678


Q ss_pred             EEEEEecCCCChhhhhhCCCcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRR-----YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      ++++||+++++|..++......     ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999988543222     46889999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            99986543322211222345678999999988889999999999999999999 99998643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=7.1e-30  Score=261.17  Aligned_cols=201  Identities=30%  Similarity=0.427  Sum_probs=167.9

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|++.+.||+|++|.||+|.. .++..||+|.++...  ....+.+.+|+.+++.++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            477889999999999999965 468899999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++ ++|..++........+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 578777754333456899999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......+++.|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             112223567889999987654 4788999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=5.9e-30  Score=263.51  Aligned_cols=203  Identities=29%  Similarity=0.447  Sum_probs=166.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-C--CEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-G--QEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999996643 3  35788888753 334456788999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999885421             1134788999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ||+|||++......   ........+..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999998642211   11111123457999999988889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.9e-30  Score=262.58  Aligned_cols=202  Identities=23%  Similarity=0.374  Sum_probs=170.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||.||++... .+..+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788899999999999999664 6899999988754 333456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++........+++..+..++.+++++|.|||+..  +++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999888865333346899999999999999999999742  39999999999999999999999999997653221 


Q ss_pred             ccccccccccccccccccccCCC------CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                         .....++..|+|||.+.+..      ++.++|+|||||++|||++|+.||...
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence               12235778899999885443      478999999999999999999999543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=7.7e-30  Score=257.28  Aligned_cols=202  Identities=28%  Similarity=0.469  Sum_probs=169.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.++||+|+||.||++....+..+|+|.++.... ..+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999887888999999876433 3456889999999999999999999875 456899999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++... ....+++.++..++.+++.+|.|||+.+   ++||||+|+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999988543 2235789999999999999999999987   999999999999999999999999999765432211 


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            1112234567999999988889999999999999999999 888886533

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=6.6e-30  Score=258.54  Aligned_cols=202  Identities=25%  Similarity=0.389  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      ++|++.+.||+|+||.||++.. .++..||+|.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688899999999999999965 45889999987532     123345788899999999999999999988663  457


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+++++|..++..   ...+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999988753   234788889999999999999999987   99999999999999999999999999976


Q ss_pred             cccCcc-ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            532111 11122345788999999998888899999999999999999999998643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=9.6e-30  Score=257.33  Aligned_cols=201  Identities=26%  Similarity=0.429  Sum_probs=171.2

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +|+..+.||+|+||+||+|...+++.+|+|.+....      .+..+.+.+|++++++++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999987789999999886432      12335688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      +||+++++|..++..   ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999998853   235788999999999999999999987   99999999999999999999999999875432


Q ss_pred             Cc----cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DV----DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..    .........++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence            11    011112345788999999998888999999999999999999999999643

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=8.1e-30  Score=262.28  Aligned_cols=206  Identities=29%  Similarity=0.438  Sum_probs=171.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC-----------------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR-----------------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLR  495 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  495 (656)
                      .++|++.+.||+|+||.||++....                 +..||+|.+.... ....+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999985432                 2458999987653 344567889999999999999999


Q ss_pred             EEEEEeeCCceEEEEEecCCCChhhhhhCCC--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCC
Q 006211          496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPI--------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN  567 (656)
Q Consensus       496 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~N  567 (656)
                      +++++...+..++++|++++++|..++....        ....+++..+..++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999885432        1225889999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc--CCCCCCCC
Q 006211          568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS--SKRNARYY  642 (656)
Q Consensus       568 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt--g~~p~~~~  642 (656)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++|||||||++|||++  +..|+...
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999976543322222333456778999999988889999999999999999998  66666543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=8.7e-30  Score=256.62  Aligned_cols=199  Identities=34%  Similarity=0.530  Sum_probs=170.9

Q ss_pred             CcccccCceEEEEEEeCC----CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||++....    +..+++|.++..... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999996543    789999999876443 367789999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          516 KSLDLYLFDPIR------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       516 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ++|..++.....      ...+++..+..++.|+++||.+||+.+   ++||||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      256899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            322222333456889999999988889999999999999999999 58888654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2e-30  Score=269.25  Aligned_cols=204  Identities=24%  Similarity=0.391  Sum_probs=178.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ....|.+.+.||+|.|+.|..+. ..++..||||.+++...  ...+.+.+|+++|..++|||||+++.+...+..+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            45678899999999999999994 45699999999987643  3345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+.+|.+.+++....   .+.+..+..++.|+.++++|||+.+   |+|||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999996533   3556888899999999999999998   99999999999999999999999999988763


Q ss_pred             CccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                         .......+|++.|.|||++.+..| ++++|+||+|+++|-|++|..||++....
T Consensus       208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk  261 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK  261 (596)
T ss_pred             ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence               233445699999999999988776 68999999999999999999999865543

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=8.7e-30  Score=260.31  Aligned_cols=198  Identities=31%  Similarity=0.439  Sum_probs=164.9

Q ss_pred             CCCCCcccccCceEEEEEE-----eCCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEE
Q 006211          437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML  508 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  508 (656)
                      |+..+.||+|+||+||++.     ..++..||+|.++.... .....+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3788999999999998763     23577899999876532 3456788999999999999999999988654  35789


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      +|||+++++|..++..    ..+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.++|+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999988843    34899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccc-cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ....... .....++..|+|||.+....++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            3221111 1122345679999999888899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=6.4e-30  Score=268.59  Aligned_cols=206  Identities=30%  Similarity=0.448  Sum_probs=167.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC-C
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER-D  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  504 (656)
                      .++|++.+.||+|+||.||+|..      ..++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999952      346789999997643 23345688999999999 689999999988654 4


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc---------------------------------------------------------
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------  527 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  527 (656)
                      ..+++|||+++|+|..++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999988753210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccccc
Q 006211          528 -------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV  600 (656)
Q Consensus       528 -------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  600 (656)
                             ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999987   9999999999999999999999999997653322222222334


Q ss_pred             ccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       601 gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            5678999999988889999999999999999997 88888653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd02871 GH18_chitinase_D-like GH18 domain of Chitinase D (ChiD)

Probab=99.97  E-value=1.4e-29  Score=259.19  Aligned_cols=210  Identities=23%  Similarity=0.331  Sum_probs=144.8

Q ss_pred             EEEEEecCCCCCC-----CCCCCCCCccEEEEEEEEecCCCc-EEe------cCCcchhhHHHHHHHHHhhCCCceEEEE
Q 006211           28 IKAGYWLAGREFP-----LSDINSALFTHLICAFAEVDSSTY-QLS------ISSANQQYFSIFANSVRRKNPSIKTLLS   95 (656)
Q Consensus        28 ~~~~y~~~~~~~~-----~~~i~~~~~thi~~~f~~~~~~~~-~~~------~~~~~~~~~~~~~~~~k~~~~~~kvl~s   95 (656)
                      +++|||.+|....     +.+..++.||||+|||+.+.+++. .+.      ........+...++.+|++  ++|||+|
T Consensus         2 ~~vgY~~~w~~~~~~~~~~~~~~~~~yt~i~~AF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~--G~KVllS   79 (312)
T cd02871           2 VLVGYWHNWDNGAGSGRQDLDDVPSKYNVINVAFAEPTSDGGGEVTFNNGSSPGGYSPAEFKADIKALQAK--GKKVLIS   79 (312)
T ss_pred             eEEEecCcccCCCCCCCCCcccCCCCCCEEEEcceeecCCCceeEeecccCCcccCChHHHHHHHHHHHHC--CCEEEEE
Confidence            5699998875432     223445899999999999987643 222      1222334556666667765  6999999


Q ss_pred             eecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc-----CcchHHHHHHHHH
Q 006211           96 IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST-----DLNSLGILLDEWK  170 (656)
Q Consensus        96 igg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~-----d~~~~~~ll~~lr  170 (656)
                      |            ||+..     +..+++++.|++|++++++++++|+|||||||||+|...     ++++++.||++||
T Consensus        80 i------------GG~~~-----~~~~~~~~~~~~fa~sl~~~~~~~g~DGiDiD~E~~~~~~~~~~~~~~~~~~lk~lr  142 (312)
T cd02871          80 I------------GGANG-----HVDLNHTAQEDNFVDSIVAIIKEYGFDGLDIDLESGSNPLNATPVITNLISALKQLK  142 (312)
T ss_pred             E------------eCCCC-----ccccCCHHHHHHHHHHHHHHHHHhCCCeEEEecccCCccCCcHHHHHHHHHHHHHHH
Confidence            9            44432     224778899999999999999999999999999999654     6799999999999


Q ss_pred             hhcCCCCCcEEEEEeecCCCc--------ccccc--ChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHH
Q 006211          171 ASASDQPELTLSMAVRYSPTH--------ETVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTD  240 (656)
Q Consensus       171 ~~l~~~~~~~ls~a~~~~~~~--------~~~~~--~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~  240 (656)
                      +++.  ++++||+|+......        ....|  .++++.+++||+|+|.||.++..     ++...-+. ....+..
T Consensus       143 ~~~~--~~~~lT~AP~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~D~invqfYn~~~~~-----~~~~~~~~-~~~~~~~  214 (312)
T cd02871         143 DHYG--PNFILTMAPETPYVQGGYAAYGGIWGAYLPLIDNLRDDLTWLNVQYYNSGGMG-----GCDGQSYS-QGTADFL  214 (312)
T ss_pred             HHcC--CCeEEEECCCcccccCcccccccCCcchhHHHHHhhhheeEEEEeeccCCCcc-----cccccCCc-cchhHHH
Confidence            9994  389999986432111        11123  36788899999999999987431     11111110 1111223


Q ss_pred             HHHHHHHHcC-----------CCCCceeecccCCC
Q 006211          241 FGIREWLRRG-----------FPANKLVLGARASG  264 (656)
Q Consensus       241 ~~v~~~~~~g-----------~p~~Kl~lG~p~yG  264 (656)
                      .++...+..|           +|++||++|+|+.-
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~p~~Kv~iG~pa~~  249 (312)
T cd02871         215 VALADMLLTGFPIAGNDRFPPLPADKVVIGLPASP  249 (312)
T ss_pred             HHHHHHHHcCCCccCCcccccCChhhEEEeccCCC
Confidence            3333444445           89999999999863

ChiD, a chitinase found in Bacillus circulans, hydrolyzes the 1,4-beta-linkages of N-acetylglucosamine in chitin and chitodextrins. The domain architecture of ChiD includes a catalytic glycosyl hydrolase family 18 (GH18) domain, a chitin-binding domain, and a fibronectin type III domain. The chitin-binding and fibronectin type III domains are located either N-terminal or C-terminal to the catalytic domain. This family includes exochitinase Chi36 from Bacillus cereus.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-31  Score=235.85  Aligned_cols=205  Identities=25%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             cCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      +.......||+|++|.|-+-+ ..+|...|+|++... ..+...+.++|+.+..+. ..|.+|.++|........++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            344456789999999998874 467999999999765 344556778888876665 79999999999988899999999


Q ss_pred             ecCCCChhhhhhC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      .| ..||+.+-.+ ......+++.-.-+|+..+.+||.|||++-  .+||||+||+||||+.+|++|+||||++..+..+
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            99 4578766533 223456888889999999999999999875  5999999999999999999999999999876543


Q ss_pred             cccccccccccccccccccccc----CCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVK----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~----~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      ....   ...|...|||||.+.    ...|+-+|||||||+.+.||.+++.|++.+.++
T Consensus       203 iAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  203 IAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             hHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            2222   135667899999885    346899999999999999999999999887654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.2e-29  Score=256.88  Aligned_cols=201  Identities=30%  Similarity=0.501  Sum_probs=169.9

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh---------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      +|.+.+.||+|++|.||+|.. .+++.+|+|.+.....         +..+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999954 4678999998865422         123467889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++++||+++++|..++..   ...+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999988843   245788899999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccc----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDE----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ........    .......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            66432111    1112245788999999998888999999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=8.4e-30  Score=262.22  Aligned_cols=204  Identities=26%  Similarity=0.433  Sum_probs=168.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-----------------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-----------------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  496 (656)
                      ++|++.++||+|+||.||++...                 +...+|+|++.... .....++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998432                 23468999987643 3345678999999999999999999


Q ss_pred             EEEEeeCCceEEEEEecCCCChhhhhhCCCc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCE
Q 006211          497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI  568 (656)
Q Consensus       497 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NI  568 (656)
                      ++++...+..+++|||+++++|..++.....        ...+++.+...++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999988854221        124778889999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc--CCCCCCC
Q 006211          569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS--SKRNARY  641 (656)
Q Consensus       569 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt--g~~p~~~  641 (656)
                      |++.++.++|+|||+++.+.........+...++..|+|||......++.++|+|||||++|||++  |..||..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999976543222122222344678999998888889999999999999999998  6677754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=274.91  Aligned_cols=200  Identities=25%  Similarity=0.400  Sum_probs=174.3

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .|.++..||.|+||.||++..+ .+-..|.|++.....+..++++-|++||..++||+||++++.|...+.++|+.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3456678999999999999554 344567899988888889999999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      ||-.+..+.+.  ...+++.++.-+++|++.+|.|||+++   |||||||+.|||++-+|.++|+|||.+-....  ...
T Consensus       113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ  185 (1187)
T ss_pred             CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence            99999887654  346899999999999999999999998   99999999999999999999999998864332  233


Q ss_pred             ccccccccccccccccc-----cCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ....+.|||+|||||+.     +..+|++++||||||++|.||.-+.+|....
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel  238 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL  238 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence            44567999999999976     4567999999999999999999999997543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.3e-29  Score=254.95  Aligned_cols=202  Identities=21%  Similarity=0.342  Sum_probs=173.7

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||.|+||.|+.+.. .+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999854 56889999987654  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++.... ...+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999885432 345889999999999999999999987   99999999999999999999999999986543321


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence              2223467899999999988888999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=1.4e-29  Score=256.25  Aligned_cols=202  Identities=27%  Similarity=0.430  Sum_probs=168.7

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      .+|+..+.||+|+||.||++.. .++..|++|++....     .+..+.+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999955 468899999886432     23345688899999999999999999988653  567


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+++++|..++..   ...+++.....++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999988853   234788999999999999999999887   99999999999999999999999999976


Q ss_pred             cccCc-cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDV-DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..... .........++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            53211 111112245788999999998888999999999999999999999999644

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=255.91  Aligned_cols=202  Identities=24%  Similarity=0.402  Sum_probs=174.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++|+..+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.++++++|||++++++.+......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            5688889999999999999965 457889999998765556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++...  ...+++.++..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999887542  245889999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cccccccccccccccccccCC---CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKG---IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ......++..|+|||.+...   .++.++|+||||+++|||++|+.||....
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence             12234678889999998776   78999999999999999999999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.7e-30  Score=258.67  Aligned_cols=199  Identities=27%  Similarity=0.393  Sum_probs=173.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|+..+.||.|++|.||+|... +++.+|+|++.... ......+.+|+.+++.++|+|++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999654 68899999987553 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++...    .+++.....++.|++.++.|||+.+   ++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999888432    6889999999999999999999987   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......++..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence             1222346788899999998888999999999999999999999999643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.4e-29  Score=258.85  Aligned_cols=201  Identities=31%  Similarity=0.497  Sum_probs=168.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  507 (656)
                      ++|++.+.||+|+||.||++..     .++..||+|.+........+.+.+|++++++++||||+++.+++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999853     3578999999987766666788999999999999999999998754  34678


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|+||+++++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999988542  235889999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          588 RKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       588 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ....... ......++..|+|||.+.+..++.++|+|||||+++||+++..|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            4322211 1111223456999999988889999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=7.1e-30  Score=265.06  Aligned_cols=205  Identities=27%  Similarity=0.413  Sum_probs=168.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeC--------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      .+|.+.+.||+|+||.||++...        ....+|+|+++... .....++.+|+.+++++ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46778899999999999999531        24579999987542 34456788999999999 6999999999999988


Q ss_pred             ceEEEEEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      ..++++||+++|+|..++....             ....+++.+...++.|++.+|.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999885422             1235888999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999986543221111112234467999999988889999999999999999999 88888544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=2.2e-29  Score=252.29  Aligned_cols=196  Identities=29%  Similarity=0.444  Sum_probs=166.0

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChh
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD  519 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  519 (656)
                      +.||+|+||.||+|...+++.+|+|.++.... .....+.+|+++++.++|||++++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999887889999999876543 33446889999999999999999999999999999999999999999


Q ss_pred             hhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccc
Q 006211          520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI  599 (656)
Q Consensus       520 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~  599 (656)
                      .++...  ...+++..+..++.+++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            887542  234789999999999999999999987   999999999999999999999999999754322111 11122


Q ss_pred             cccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       600 ~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            34567999999988889999999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=7.8e-30  Score=258.23  Aligned_cols=202  Identities=22%  Similarity=0.374  Sum_probs=172.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .+|++.+.||+|++|.||++.. .+++.++||.+....   .....++.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3677889999999999999964 578999999876532   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++++|..++... .....+++.....++.+++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 22346899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  208 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence            221  12234678899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.4e-29  Score=256.64  Aligned_cols=205  Identities=25%  Similarity=0.393  Sum_probs=169.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++++|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            345555667899999999999964 4577899999887666666788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~~  590 (656)
                      |+++++|..++.........++..+..++.|++++|.|||+.+   ++||||||+||+++. ++.++|+|||++......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999998864322212377888899999999999999987   999999999999986 678999999998755322


Q ss_pred             ccccccccccccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  .......++..|+|||.+....  ++.++|+||||+++|+|++|+.||...
T Consensus       163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            1  1122235788999999986543  788999999999999999999998643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.1e-29  Score=255.64  Aligned_cols=197  Identities=28%  Similarity=0.422  Sum_probs=167.0

Q ss_pred             CcccccCceEEEEEEeCC--C--CEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLPR--G--QEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|++|.||+|....  +  ..+|+|.++.... ...+++.+|+.++++++||||+++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999996533  3  3689999987655 556789999999999999999999999888 888999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc-
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA-  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~-  594 (656)
                      ++|..++..... ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999998865432 45899999999999999999999987   9999999999999999999999999998764422111 


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            1112356778999999988889999999999999999999 99998543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=7.3e-30  Score=263.52  Aligned_cols=202  Identities=29%  Similarity=0.457  Sum_probs=166.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999653 344  4578877643 233456788999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      +||+++++|..++....             ....+++.+++.++.|++.|+.|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999885422             1235789999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ||+|||++......   ........+..|+|||.+....++.++|||||||++|||+| |..||...
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            99999998642211   11111233567999999988889999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=289.28  Aligned_cols=207  Identities=21%  Similarity=0.302  Sum_probs=178.5

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      .++....++|++++.||+|+||.|..++. .+++.||+|++++-   .......|..|-.+|..-+.+=|+.+.-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            44555568899999999999999999965 45889999999762   233345688999999988899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ..+|+||||++||+|-.++....   .+++..++.++..|+-||..||++|   +|||||||.|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999998885433   4889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccccc----C-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK----K-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +-.+..+ ........+|||-|++||++.    + +.|+...|.||+||++||||.|..||..
T Consensus       222 Clkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  222 CLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             HHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            9776543 233445679999999999985    2 5689999999999999999999999943

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.6e-29  Score=254.15  Aligned_cols=199  Identities=27%  Similarity=0.420  Sum_probs=173.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++|+..+.||+|+||.||++.... ++.+++|.++....  .+++.+|++++++++|||++++++.+......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999997654 78999999876533  578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++...  ...+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999988532  345899999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence             222345788999999998888999999999999999999999998653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-29  Score=255.80  Aligned_cols=203  Identities=30%  Similarity=0.480  Sum_probs=173.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.++||+|+||.||++..+++..+|||.+.... ...+++.+|+.++++++|||++++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788999999999999999987778899999987543 33467889999999999999999999999888999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.... ...+++..+..++.+++.++.|||+++   ++|+||+|+||++++++.++|+|||++..+..... 
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            9999999886532 235889999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ........+..|+|||.+.+..++.++|+||||++++||++ |+.||...
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            11112234568999999988889999999999999999999 99998543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=1.1e-29  Score=255.38  Aligned_cols=201  Identities=25%  Similarity=0.376  Sum_probs=172.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +|++.+.||+|+||.||++.. .+++.+|+|.++.. .....+.+.+|+.+++.++|||++++.+.+..++..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477889999999999999955 46889999988643 2344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++... ....+++.....++.|++.+|.+||+.+   ++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  154 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--  154 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence            999998887532 2345788999999999999999999987   9999999999999999999999999997654321  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence            1122346788999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=1.1e-29  Score=255.76  Aligned_cols=195  Identities=29%  Similarity=0.433  Sum_probs=162.1

Q ss_pred             cccccCceEEEEEEe---CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          442 KLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      .||+|+||.||+|..   .++..+|+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999953   357889999987543  234567899999999999999999999885 45678999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc-c
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA-N  595 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~  595 (656)
                      +|..++..   ...+++..+..++.|++.+|.|||+.+   ++||||||.||++++++.+||+|||+++......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99988843   235889999999999999999999987   9999999999999999999999999998654332211 1


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .....++..|+|||.+....++.++|+|||||++|||++ |+.||....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  203 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK  203 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            112234578999999988888999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=2.1e-29  Score=254.89  Aligned_cols=203  Identities=22%  Similarity=0.375  Sum_probs=173.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|++|.||+|... +++.+|+|.++..   .....+.+.+|++++++++|+|++++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999665 7899999988642   2233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++++|..++... .....+++..+..++.+++++|.|||+.+   ++||||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999887542 22345889999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...  ......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            221  112245788899999998888999999999999999999999998543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=1e-29  Score=262.31  Aligned_cols=201  Identities=26%  Similarity=0.383  Sum_probs=167.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++......++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            4688899999999999999965 4678999999875432 2334677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++ ++|..++...  ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 5787777542  335788999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11222356889999998765 457889999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=1.6e-29  Score=262.90  Aligned_cols=196  Identities=25%  Similarity=0.410  Sum_probs=156.9

Q ss_pred             CcccccCceEEEEEEeC---CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  515 (656)
                      ++||+|+||.||+|...   ++..+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999754   357899998875432  2456789999999999999999998854  4567899999875


Q ss_pred             CChhhhhhCC------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE----cCCCcEEEEeccCcc
Q 006211          516 KSLDLYLFDP------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAK  585 (656)
Q Consensus       516 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl----~~~~~~kl~DfGla~  585 (656)
                       +|..++...      .....+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             555554311      12235788999999999999999999987   9999999999999    566789999999998


Q ss_pred             ccccCccc-cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ........ .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            66433211 12234568899999998876 45789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.4e-29  Score=255.83  Aligned_cols=191  Identities=24%  Similarity=0.357  Sum_probs=158.8

Q ss_pred             CcccccCceEEEEEEeCC-------------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          441 NKLGEGGFGPVYKGNLPR-------------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      +.||+|+||.||+|....             ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999996422             2358999887665555567888999999999999999999999988999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc-------EEEEe
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-------PKISD  580 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~-------~kl~D  580 (656)
                      ++|||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998887532  335889999999999999999999987   999999999999987664       89999


Q ss_pred             ccCccccccCcccccccccccccccccccccc-CCCCCccchhHHHHHHHHHHH-cCCCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQII-SSKRNARYY  642 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~ell-tg~~p~~~~  642 (656)
                      ||++......      ....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+...
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            9998654321      1235678899999886 466899999999999999998 577777543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=8.7e-30  Score=258.63  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=168.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC------C
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER------D  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  504 (656)
                      +...|+..+.||+|+||.||+|.. ..++.+|+|++.... .....+.+|+.++.++ +|||++++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            456688889999999999999965 457899999987543 3345678899999998 699999999998753      3


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++++||+++++|..++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999988542 2345889999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCcccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7653321  1223456889999999885     34578899999999999999999999854

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=3.8e-30  Score=264.79  Aligned_cols=196  Identities=28%  Similarity=0.411  Sum_probs=169.0

Q ss_pred             CCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      ....||+|+||.||++.. .+++.||+|++........+.+.+|+.++..++|||++++++.+...+..++++||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            445799999999999965 4688999999876544455678899999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccc
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG  597 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~  597 (656)
                      |..++..    ..+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++..+....  ....
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            9887632    35789999999999999999999987   9999999999999999999999999987554322  1122


Q ss_pred             cccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       598 ~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...++..|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3468899999999988889999999999999999999999986443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.5e-29  Score=254.75  Aligned_cols=195  Identities=27%  Similarity=0.443  Sum_probs=160.8

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          442 KLGEGGFGPVYKGNLP---RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      .||+|+||.||+|...   .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999543   355799999876533 33456889999999999999999999885 457899999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc-c
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-T  596 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~  596 (656)
                      |..++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.+||+|||++........... .
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99888542  345899999999999999999999987   99999999999999999999999999975543221111 1


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            11223568999999988889999999999999999996 99998644

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.4e-29  Score=255.47  Aligned_cols=203  Identities=31%  Similarity=0.492  Sum_probs=171.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.++||+|+||.||+|...+++.+|+|.+..... ..+.+.+|+.++++++|||++++++++. .+..++++||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999999888889999999875433 3467889999999999999999998864 56789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++.... ...+++.++..++.|++.+|.|||+.+   ++||||||+||++++++.++|+|||++........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999998875432 345889999999999999999999887   99999999999999999999999999976542211 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            11122345678999999988889999999999999999999 999986543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=9.2e-30  Score=260.85  Aligned_cols=206  Identities=27%  Similarity=0.458  Sum_probs=170.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|+..+.||+|+||.||++...      ++..+|+|++.... ......+.+|+.++++++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356888999999999999999653      46789999987653 33446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCC
Q 006211          507 MLIYEYLPNKSLDLYLFDPI-------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN  567 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~N  567 (656)
                      ++++||+++++|..++....                   ....+++..++.++.|++.+|.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999885321                   1234778889999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       568 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999875433221111222234567999999988889999999999999999997 77787543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=2e-29  Score=255.09  Aligned_cols=206  Identities=27%  Similarity=0.424  Sum_probs=175.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||.|+||+||+|.. .++..+++|++.... ......+.+|++.++.++|+|++++++.+......++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999964 467899999987543 23556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++........+++.....++.|++.+|.+||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865333346889999999999999999999987   99999999999999999999999999976654322


Q ss_pred             cc--ccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EA--NTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  ......++..|+|||.+... .++.++|+|||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            21  22334678899999998776 78999999999999999999999996543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=6.1e-30  Score=262.63  Aligned_cols=197  Identities=27%  Similarity=0.407  Sum_probs=170.1

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      |.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|||++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            44456799999999999965 46889999998766555566788999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..    ..+++.+...++.|++.+|.|||+.+   ++||||||+||++++++.++|+|||++.......  ..
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~  174 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK  174 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence            999888732    34788999999999999999999987   9999999999999999999999999987543322  12


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  221 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE  221 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            22346788999999998888999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-29  Score=258.10  Aligned_cols=203  Identities=29%  Similarity=0.460  Sum_probs=169.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC----EEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .+|++.+.||+|+||.||+|... +++    .+|+|.+..... ....++.+|+.++++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46778899999999999999643 232    589998876543 345678899999999999999999999987 78899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+||+++|+|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999988543  234889999999999999999999976   9999999999999999999999999998664


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ............++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence            3322111112233568999999988889999999999999999999 999986644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.3e-29  Score=257.05  Aligned_cols=202  Identities=27%  Similarity=0.488  Sum_probs=167.9

Q ss_pred             CCCCCCcccccCceEEEEEEeCC-C---CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPR-G---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .|++.+.||+|+||.||+|.... +   ..||||++... ......++..|+.++++++||||+++.+++..+...++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46788999999999999996532 3   36999998765 3444567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++...  ...+++.++..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999888543  235789999999999999999999987   999999999999999999999999998765432


Q ss_pred             cccccccccc---ccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          591 VDEANTGRIV---GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ..........   .+..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            2211111111   2357999999988889999999999999999986 99998543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-31  Score=272.41  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=169.6

Q ss_pred             CCCcccccCceEEEEEEeC--CCC--EEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          439 SANKLGEGGFGPVYKGNLP--RGQ--EFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ..++||+|+||.|++|.|.  .|+  .||||+++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4588999999999999663  344  6899999876543 67789999999999999999999999987 6788999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      +.|+|.+.|+. ..+..+-...+..++.||+.||.||.+++   +|||||..+|+|+-..-.+||+|||+.+-+..+.+.
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999977 44556777888999999999999999998   999999999999999889999999999977655443


Q ss_pred             ccc-ccccccccccccccccCCCCCccchhHHHHHHHHHHHcC-CCCCCCCC
Q 006211          594 ANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARYYG  643 (656)
Q Consensus       594 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg-~~p~~~~~  643 (656)
                      ... ....-...|+|||.++...++.+||||+|||++|||+|+ ..||-+..
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            322 223345689999999999999999999999999999985 55665433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.8e-29  Score=266.58  Aligned_cols=192  Identities=22%  Similarity=0.320  Sum_probs=162.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ...+|++.+.||+|+||.||+|... +++.||+|......      ...|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999654 56789999754332      2568999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ++. ++|..++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 577777643  2345899999999999999999999987   999999999999999999999999999743221 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                        .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1122346899999999999889999999999999999999876665

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.6e-31  Score=250.61  Aligned_cols=205  Identities=24%  Similarity=0.392  Sum_probs=166.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC---C--CCEEEEEEccCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEEEee-CCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP---R--GQEFAVKRLSATSTQ-G-LEEFKNEVSLTARLQHVNLLRVLGYCTE-RDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  505 (656)
                      ...|+....||+|.||.||+|...   +  ...+|+|.++.+... . .....+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346889999999999999999322   2  237899999876321 1 2345789999999999999999998877 778


Q ss_pred             eEEEEEecCCCChhhhhh--CCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC----CcEEEE
Q 006211          506 NMLIYEYLPNKSLDLYLF--DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKIS  579 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~--~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~----~~~kl~  579 (656)
                      .++++||.+.. |...++  .......++......|+.||+.|+.|||++.   |+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            99999999764 444442  2223346888999999999999999999999   9999999999999877    899999


Q ss_pred             eccCccccccCcccc-ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       580 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      |+|+++.+....... ....++-|..|.|||.+.+ ..||.+.|||+.|||+.||+|.++-|...
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            999999886543222 3345677999999998876 56999999999999999999999888643

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=1.5e-29  Score=258.90  Aligned_cols=201  Identities=23%  Similarity=0.343  Sum_probs=169.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+..+.||+|++|.||++... +++.||+|++....  ....+.+.+|+.++++++|||++++++++......++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999664 58899999886542  2233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..+...   ...+++..+..++.|++.+|.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999988777632   235899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            1  1223356788999998865 457889999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=1.6e-29  Score=261.30  Aligned_cols=202  Identities=20%  Similarity=0.325  Sum_probs=169.7

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+..+.||+|+||.||++.. ..++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4688899999999999999955 457899999887543   233456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++.....++.++++||.|||+.+   ++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999854   235788999999999999999999987   999999999999999999999999998642110


Q ss_pred             c-------------cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 V-------------DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .             .........++..|+|||.+....++.++|+|||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            0             000111235678899999998888999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=1.4e-29  Score=256.37  Aligned_cols=204  Identities=27%  Similarity=0.472  Sum_probs=169.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-C---CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-R---GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999653 2   3379999987543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++...  ...+++.+...++.|++.++.+||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998543  235788999999999999999999987   99999999999999999999999999986543


Q ss_pred             Cccccc-cccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          590 DVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ...... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence            221111 111223567999999988889999999999999999887 999986543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.9e-29  Score=263.40  Aligned_cols=199  Identities=17%  Similarity=0.251  Sum_probs=163.5

Q ss_pred             CCCccccc--CceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          439 SANKLGEG--GFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       439 ~~~~iG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++++||+|  +|++||++.. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6889999954 578999999987642  233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999998885422 234789999999999999999999987   999999999999999999999999865433211110


Q ss_pred             -----cccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          594 -----ANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       594 -----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                           .......++..|+|||.+.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                 01112346778999999875  4588999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-29  Score=262.03  Aligned_cols=205  Identities=24%  Similarity=0.309  Sum_probs=173.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+..+.||+|++|.||++... +++.+|+|.+.....   ...+.+.+|++++..++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999654 489999999876532   24457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+.+++|..++... ....+++.....++.|++++|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999887532 2346899999999999999999999987   999999999999999999999999998754321


Q ss_pred             ccc---------------------------cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDE---------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112367889999999998889999999999999999999999996544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=2.4e-29  Score=256.23  Aligned_cols=200  Identities=25%  Similarity=0.404  Sum_probs=171.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..|+..+.||.|+||.||+|.. .++..+|+|++.... ......+.+|+.++++++|||++++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            3567788999999999999965 458899999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|.+++..    ..+++.....++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence            999999988742    35788899999999999999999987   9999999999999999999999999997654322 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......++..|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence             11223457888999999988889999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.1e-29  Score=259.97  Aligned_cols=213  Identities=24%  Similarity=0.327  Sum_probs=173.0

Q ss_pred             cCHHHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEe-
Q 006211          425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCT-  501 (656)
Q Consensus       425 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-  501 (656)
                      +.++.+....++|++.+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.++..+ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            33455556778999999999999999999954 4578999998865322 235678899999999 6999999999874 


Q ss_pred             ----eCCceEEEEEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          502 ----ERDENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       502 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                          .+...++||||+++++|..++... .....+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                345689999999999998877532 22345788999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +|+|||+++......  .......|++.|+|||.+..     ..++.++|||||||++|||++|+.|+....
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999997654321  12223468899999998753     447889999999999999999999986543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.5e-29  Score=252.11  Aligned_cols=198  Identities=29%  Similarity=0.463  Sum_probs=166.7

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChh
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD  519 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  519 (656)
                      ++||+|++|.||++...+++.|++|.++..... ..+.+.+|++++++++||||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999997766999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccc
Q 006211          520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI  599 (656)
Q Consensus       520 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~  599 (656)
                      .++...  ...+++..+..++.+++.++.|||+++   ++||||+|+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            888542  235788999999999999999999987   999999999999999999999999999765322111111122


Q ss_pred             cccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       600 ~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ..+..|+|||.+.+..++.++|+||||+++|||+| |..||....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            33567999999988889999999999999999999 788886543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=2.2e-29  Score=257.54  Aligned_cols=200  Identities=29%  Similarity=0.490  Sum_probs=167.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      +.|++.+.||+|+||.||++..     ..+..||+|.++... ....+.+.+|+.++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999963     357889999987553 33456789999999999999999999998775  567


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++++|..++...  ...+++..+..++.+++.+|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999988532  235789999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      +...... .......++..|+|||.+.+..++.++|||||||++|||++++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            5432211 1122345677899999998888999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=2.2e-29  Score=255.10  Aligned_cols=203  Identities=29%  Similarity=0.522  Sum_probs=168.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|+..+.||+|+||.||+|... ++   ..+++|.++... ....+.+.+|++++++++|||++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999654 23   379999987552 34456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++...  ...+++..+..++.+++.|+.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999988542  235789999999999999999999987   99999999999999999999999999976543


Q ss_pred             Ccccccc-ccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          590 DVDEANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ....... .....+..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            2211111 11123457999999988889999999999999999997 99998543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=1.3e-29  Score=265.45  Aligned_cols=206  Identities=28%  Similarity=0.401  Sum_probs=169.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC--------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      .+|++.+.||+|+||.||++...        ....+|+|.++... ....+++.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999531        12368999887543 33456788999999999 7999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      ..++++||+++|+|..++....             ....+++.++..++.|++.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999885421             1234788899999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999976543221111222234567999999998889999999999999999998 888876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2.1e-29  Score=258.86  Aligned_cols=200  Identities=27%  Similarity=0.422  Sum_probs=173.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788899999999999999954 468899999987655555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++..    ..+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999988843    34788899999999999999999987   99999999999999999999999999875543221 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ......+++.|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1223467888999999988889999999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=3.7e-29  Score=251.75  Aligned_cols=202  Identities=21%  Similarity=0.361  Sum_probs=170.0

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  511 (656)
                      +|++.+.||+|++|.||++.. .+++.+|+|.+...  .....+.+.+|++++++++|+|++++.+.+.. ....++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            478889999999999999964 45788999998653  23345568899999999999999999988764 345789999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++... ....+++.++..++.+++.++.+||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888643 2335889999999999999999999987   9999999999999999999999999998654321


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        .......+++.|+|||.+.+..++.++|+||||++++||++|+.||...+
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  206 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD  206 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence              12223467889999999998889999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=3e-29  Score=253.00  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=168.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999987777789999886543 23456889999999999999999998875 456899999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|.+++.... ...+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ .
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            999999886432 234788999999999999999999987   99999999999999999999999999976543211 1


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1112245678999999988889999999999999999999 88888654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=3e-29  Score=252.39  Aligned_cols=198  Identities=29%  Similarity=0.442  Sum_probs=170.5

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+.+++.++|||++++.+++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999665 78999999886543     23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      +||+++++|..++..   ...+++.....++.|+++++.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998853   234788999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            22   122346788999999987766 899999999999999999999998554

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.3e-30  Score=261.30  Aligned_cols=202  Identities=24%  Similarity=0.367  Sum_probs=172.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccC--CChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  509 (656)
                      ....|+++++||+|+-+.||++...+.+.+|+|++..  .+.+....+.+|+..|.+|+ |.+|+++++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3567899999999999999999887888899887643  35666778999999999995 99999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+- +.+|..+|...... ...| .++.+..|+++++.++|..+   |||.||||.|+|+-.+ .+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence            9985 56888888654332 2223 77889999999999999987   9999999999999876 799999999998887


Q ss_pred             CccccccccccccccccccccccCCC-----------CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGI-----------YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +.........+||+.||+||.+....           .+.+|||||||||||+|+.|++||..
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            77766677789999999999885322           56789999999999999999999954

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=256.87  Aligned_cols=205  Identities=26%  Similarity=0.342  Sum_probs=170.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..+|..+.+||+|+||.|-++.. .+.+.+|||++++.-   ....+--..|-++|... +-|.++++..+++.-+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            34677889999999999999954 456789999998752   22233334566666655 57899999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+.||+|--.+..   -..+.+..+..++.+|+-||-+||+.+   ||.||||..|||++.+|++||+|||+++.-.
T Consensus       428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999655533   234677888999999999999999998   9999999999999999999999999997422


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                        .....+.+.+||+.|+|||++...+|+.++|.||+||+||||+.|++||++.+.++
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e  557 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE  557 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence              23445566899999999999999999999999999999999999999998755443

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=1.1e-29  Score=258.71  Aligned_cols=197  Identities=26%  Similarity=0.425  Sum_probs=169.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            355668899999999999954 457889999987543 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.    ...+++.....++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            9999988873    245788999999999999999999987   9999999999999999999999999997654321  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .......++..|+|||.+.+..++.++|+|||||++|||++|+.|+..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence            112224578899999999988899999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=2.8e-29  Score=255.26  Aligned_cols=191  Identities=25%  Similarity=0.354  Sum_probs=157.6

Q ss_pred             cccccCceEEEEEEeCC-------------------------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeE
Q 006211          442 KLGEGGFGPVYKGNLPR-------------------------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  496 (656)
                      .||+|+||.||+|....                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999985311                         13589999876555555678889999999999999999


Q ss_pred             EEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC--
Q 006211          497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL--  574 (656)
Q Consensus       497 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~--  574 (656)
                      ++++......++||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999998888542  335788999999999999999999987   99999999999998653  


Q ss_pred             -----cEEEEeccCccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHH-HcCCCCCCCCC
Q 006211          575 -----NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQI-ISSKRNARYYG  643 (656)
Q Consensus       575 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~el-ltg~~p~~~~~  643 (656)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence                 3799999988643221      12246778999998865 5689999999999999998 47898886544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.1e-29  Score=251.35  Aligned_cols=198  Identities=33%  Similarity=0.513  Sum_probs=171.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||.|+||.||++.. .++.||+|.+..... ..+++.+|+.+++.++|+|++++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35678889999999999999976 478999999977644 4567899999999999999999999999889999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.... ...+++.....++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999885432 225899999999999999999999987   99999999999999999999999999986532211 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                          ....+..|+|||.+....++.++|+||||++++||++ |+.||...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence                1234567999999988889999999999999999997 88888544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=1.6e-29  Score=261.01  Aligned_cols=202  Identities=29%  Similarity=0.498  Sum_probs=166.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCC----EEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|+||.||+|.. .++.    .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4677889999999999999964 3343    578998875432 3334688999999999999999999998754 5678


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999888542  234788999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3322222222345678999999988889999999999999999997 88998653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-30  Score=249.62  Aligned_cols=213  Identities=24%  Similarity=0.309  Sum_probs=174.7

Q ss_pred             HHHHHHHhcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEE
Q 006211          427 FSDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGY  499 (656)
Q Consensus       427 ~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~  499 (656)
                      ..++.....+++....+-+|.||.||+|-+      .+.+.|-+|.++.. +.-....++.|...+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            445555667788889999999999999943      33456778877654 33456678899999999999999999998


Q ss_pred             Eee-CCceEEEEEecCCCChhhhhh-----CCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC
Q 006211          500 CTE-RDENMLIYEYLPNKSLDLYLF-----DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE  573 (656)
Q Consensus       500 ~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~  573 (656)
                      +.+ ....++++.++.-|+|..++.     +......++..+...++.|++.|++|||..+   +||.||..+|++|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            865 456788999999999999997     4445566888899999999999999999987   9999999999999999


Q ss_pred             CcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          574 LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       574 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .++||+|-.+++.+-+.+.......--.+..||+||.+.+..|+..+|||||||++|||+| |+.|+..-
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            9999999999997655444333223345678999999999999999999999999999998 56666443

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.8e-29  Score=258.17  Aligned_cols=200  Identities=25%  Similarity=0.384  Sum_probs=171.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++.+......++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4677889999999999999965 468899999876543 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++..   ...+++..+..++.+++.+|.|||+.+  +++||||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999888743   235889999999999999999999753  3999999999999999999999999998654321  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence              1123468899999999988889999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=2.7e-29  Score=254.39  Aligned_cols=201  Identities=27%  Similarity=0.469  Sum_probs=170.5

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      +|+..+.||+|++|.||++.. .+++.+|+|+++...      ....+.+.+|+.++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999954 568899999987543      1234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCcccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLF  587 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~  587 (656)
                      |+||+++++|..++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999988853   235788999999999999999999987   99999999999998776 5999999999766


Q ss_pred             ccCccc--cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          588 RKDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       588 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ......  .......++..|+|||.+.+..++.++|+||||+++++|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            432111  1122346788999999998888999999999999999999999998643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=3.7e-29  Score=252.30  Aligned_cols=203  Identities=26%  Similarity=0.445  Sum_probs=170.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||++....+..+++|.+... ....+.+.+|++++++++|+|++++.+.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4578889999999999999998777888999988754 2345678899999999999999999999877 7789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++.... ...+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+..+..... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999885432 335788899999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......++..|+|||.+....++.++|+|||||++|++++ |+.||....
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence            11122245677999999988889999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=241.69  Aligned_cols=198  Identities=24%  Similarity=0.400  Sum_probs=164.1

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+.+..||.|+.|.|+++.. ..|...|||.+... ..++.+++++.+.++..- ..|.||+.+|+|......++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34457799999999999965 45889999998765 445667888888887765 4899999999999998899999988


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                       ...++.++..  ...++++.-+-++...+.+||.||.++|  +|+|||+||+|||+|+.|++||||||++..+..+.  
T Consensus       174 -s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  174 -STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             -HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence             3455555543  2345888888899999999999999998  69999999999999999999999999998765432  


Q ss_pred             cccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       ..+...|.+.|||||.+.-   ..|+.++||||||+.++||.||+-||..-
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c  297 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC  297 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence             2334478899999999854   35888999999999999999999999763

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=4.3e-29  Score=254.01  Aligned_cols=203  Identities=26%  Similarity=0.409  Sum_probs=170.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|+..+.||+|+||.||+|...      ..+.+++|.+.....+ ..+.+.+|++++++++|||++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999653      3467999988765443 4567899999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhhCCCcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          508 LIYEYLPNKSLDLYLFDPIRR------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      +||||+++++|..++......      ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998643321      25899999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARY  641 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~  641 (656)
                      |++...... .........++..|+|||.+.+...+.++||||||+++|||++ |..||..
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            998644321 1112223356778999999888888999999999999999999 7778754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=4.7e-29  Score=253.33  Aligned_cols=200  Identities=29%  Similarity=0.454  Sum_probs=167.7

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh----------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST----------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      +|...+.||+|++|.||+|.. .+++.+|+|.++....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466788999999999999954 4688999998764211          11346788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++|+||+++++|..++...   ..+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999888543   45888999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +...............++..|+|||.+....  ++.++|+||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            7643322222223346788999999887654  78999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.4e-29  Score=251.74  Aligned_cols=202  Identities=26%  Similarity=0.403  Sum_probs=168.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      .+|++.+.||+|+||.||++.. .+++.+|+|++...     ..+....+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999964 46889999987532     223445788999999999999999999988664  457


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+++++|..++..   ...+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999888743   234788899999999999999999987   99999999999999999999999999986


Q ss_pred             cccCcc-ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...... ........++..|+|||.+.+..++.++|+|||||+++||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            532111 11112345788999999998888899999999999999999999998643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=6e-29  Score=252.28  Aligned_cols=196  Identities=29%  Similarity=0.467  Sum_probs=161.1

Q ss_pred             CcccccCceEEEEEEeCC-CC--EEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|...+ +.  .+++|.++... ....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999997643 33  46888887542 34456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          516 KSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       516 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      ++|..++....             ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885422             1224788999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ++......   ........+..|+|||.+....++.++|+|||||++|||++ |+.||...
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            98632211   11111223567999999988889999999999999999997 99998543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=227.01  Aligned_cols=196  Identities=26%  Similarity=0.409  Sum_probs=164.3

Q ss_pred             CCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|...++||+|.||+||+++ ..+++.||+|+++....  .-....++|+.+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667899999999999994 55688999999876532  2234578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |. -+|..+.-.  -+..++.+.+..++.|+++||.+.|+.+   +.|||+||+|.||+.+|++|++|||+++-+.-.. 
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence            95 467666532  2345889999999999999999999988   9999999999999999999999999999765432 


Q ss_pred             ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~  639 (656)
                       ...+..+-|..|.+|+++.+. .|+.+.|+||.||++.|+....+|.
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence             233334668999999988764 5899999999999999999877775

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=3.7e-29  Score=251.98  Aligned_cols=189  Identities=26%  Similarity=0.448  Sum_probs=158.0

Q ss_pred             CcccccCceEEEEEEeCCCC-----------EEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          441 NKLGEGGFGPVYKGNLPRGQ-----------EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +.||+|+||.||+|......           .+++|.+...... ...+.+|+.+++.++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999664332           5788877654333 5678899999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-------cEEEEecc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-------NPKISDFG  582 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-------~~kl~DfG  582 (656)
                      +||+++++|..++....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999885432  25889999999999999999999987   99999999999999887       79999999


Q ss_pred             CccccccCccccccccccccccccccccccCC--CCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ++.....      .....++..|+|||.+...  .++.++|||||||++|||++ |..|+...
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            9976432      1123456789999998776  78999999999999999999 46666544

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=3.5e-29  Score=256.94  Aligned_cols=201  Identities=24%  Similarity=0.364  Sum_probs=165.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|.+.+.||+|+||.||+|.. .+++.+++|++..... .....+.+|+.+++.++|+||+++.+++......++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46788999999999999999954 4688999999865432 223356789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+. +++..++...  ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 5665555332  234678888899999999999999987   9999999999999999999999999997543221


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            1  1122356889999998865 34788999999999999999999999643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-31  Score=293.52  Aligned_cols=205  Identities=28%  Similarity=0.414  Sum_probs=173.4

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +-+++....||.|.||.||.| ...+|...|+|.+....  ......+.+|+.++..++|||+|+.+|+-..++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            456777889999999999999 66779999999876543  233456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|.+.+.   ....+++.....+..|++.|+.|||+.|   ||||||||.||+++.+|.+|++|||.|..+...
T Consensus      1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999883   3334677777889999999999999988   999999999999999999999999999887654


Q ss_pred             ccc--cccccccccccccccccccCC---CCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDE--ANTGRIVGTYGYVPPEYVKKG---IYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...  ..-....||+-|||||++.+.   ....++||||||||+.||+||++||...+.
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence            321  122346899999999998653   345689999999999999999999976554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-31  Score=248.92  Aligned_cols=200  Identities=25%  Similarity=0.400  Sum_probs=162.6

Q ss_pred             CCCcccccCceEEEEE-EeCCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          439 SANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      -+..||.|+||+|++- ..+.|+..|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..|+.||.| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            3578999999999998 456799999999987643 4556788888765554 7999999999999999999999999 4


Q ss_pred             CChhhhhhC--CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          516 KSLDLYLFD--PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       516 g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      .+++.+...  ...+..++++-.-.|......||.||.+..  .|||||+||+|||++..|.+||||||++..+..+.. 
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-  223 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-  223 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence            577654321  123456888888889999999999998765  599999999999999999999999999987654322 


Q ss_pred             cccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                        .+.-.|...|||||.+..  ..|+.+|||||||++|+|+.||+.|++.+.+
T Consensus       224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence              223367788999999854  3488999999999999999999999987653

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=1.9e-29  Score=255.66  Aligned_cols=200  Identities=31%  Similarity=0.487  Sum_probs=165.1

Q ss_pred             CcccccCceEEEEEEeCC-------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          441 NKLGEGGFGPVYKGNLPR-------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +.||+|+||.||+|...+       +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999996532       2578999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-----cEEEEeccC
Q 006211          513 LPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-----NPKISDFGM  583 (656)
Q Consensus       513 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-----~~kl~DfGl  583 (656)
                      +++++|..++....    ....+++.+++.++.|++.+|.|||+.+   ++|+||+|+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999886422    2234788999999999999999999887   99999999999999887     899999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~  218 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN  218 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence            976543222222223345678999999998889999999999999999998 999986543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=7.6e-29  Score=250.34  Aligned_cols=201  Identities=26%  Similarity=0.409  Sum_probs=175.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|++|.||++... +++.+++|++..... ...+.+.+|+..+.+++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999665 589999999877644 4456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      +++++|..++...   ..+++.....++.|+++++.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   468999999999999999999999 87   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .....++..|+|||.+....++.++|+||||+++|||++|+.|+...+
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            21  123467889999999998889999999999999999999999996654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=5.1e-29  Score=250.72  Aligned_cols=196  Identities=30%  Similarity=0.454  Sum_probs=165.6

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT-ERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  513 (656)
                      ++|++.+.||+|+||.||++.. .+..+++|.++...  ..+.+.+|+.++++++|+|++++++++. .....++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4678889999999999999976 47889999886543  2456889999999999999999999764 456789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.... ...+++..+..++.+++.+|.|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999886432 234788999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                         .....+..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~  203 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence               12234567999999988889999999999999999997 88888643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=3.7e-30  Score=267.47  Aligned_cols=193  Identities=31%  Similarity=0.474  Sum_probs=162.8

Q ss_pred             CCcccccCceEEEEE-EeCCCCEEE---EEEccC-CChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc--eEEEEEe
Q 006211          440 ANKLGEGGFGPVYKG-NLPRGQEFA---VKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE--NMLIYEY  512 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~-~~~~~~~va---vK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  512 (656)
                      ..+||+|+|-+||+| +..+|-.||   ||.-+. ..++..++|..|+.+|+.|+||||++++..+.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            468999999999999 444577776   332222 234556889999999999999999999999877665  6789999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~~~  591 (656)
                      +..|+|..|+....   .++......+++||++||.|||+.. ++|||||||..||+|+. -|.|||+|+|||...... 
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999986533   4778899999999999999999976 68999999999999985 489999999999986543 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                         .....+|||.|||||+.. ..|+..+||||||++++||.|+.-|+..
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE  245 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE  245 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence               223468999999999887 7899999999999999999999999854

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=4e-29  Score=256.46  Aligned_cols=201  Identities=26%  Similarity=0.384  Sum_probs=166.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999654 688999999865432 2224567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++ +|..++....  ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 8888775432  35789999999999999999999987   99999999999999999999999999875322111


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence              1112246788999998765 457899999999999999999999996443

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=5.5e-29  Score=252.55  Aligned_cols=202  Identities=23%  Similarity=0.387  Sum_probs=167.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|.+.+.||+|+||.||+|...+    ...++||...... .+..+.+.+|+.++++++|||++++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999996533    3468999887654 4455678999999999999999999998875 557899


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|.+++...  ...+++..+..++.+++.+|.|||+.+   ++||||||+||+++.++.++|+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998543  234789999999999999999999987   99999999999999999999999999976543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .... ......++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus       160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            3111 1112234568999999988889999999999999999996 999986543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-29  Score=253.16  Aligned_cols=199  Identities=27%  Similarity=0.456  Sum_probs=170.0

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .|+..+.||+|+||.||+|.. .+++.+++|+++.. ......++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477789999999999999964 56889999998754 2344567888999999986   999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..    ..+++.....++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988743    36889999999999999999999987   999999999999999999999999999866443


Q ss_pred             ccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2  12223468889999998765 446889999999999999999999996543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=4.2e-29  Score=259.45  Aligned_cols=205  Identities=24%  Similarity=0.381  Sum_probs=167.0

Q ss_pred             CCCCCCcccccCceEEEEEEeC---CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENM  507 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  507 (656)
                      +|++.+.||+|++|.||+|...   .++.||+|.+....   ....+.+.+|+.++.+++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999654   47899999987743   33345678899999999999999999999888  7899


Q ss_pred             EEEEecCCCChhhhhhCCC-c-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC----CCcEEEEec
Q 006211          508 LIYEYLPNKSLDLYLFDPI-R-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN----ELNPKISDF  581 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~-~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~----~~~~kl~Df  581 (656)
                      +|+||+++ ++..++.... . ...+++.....++.|++.+|.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 5555543221 1 236889999999999999999999987   999999999999999    899999999


Q ss_pred             cCccccccCcc-ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          582 GMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       582 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      |++........ ........++..|+|||.+.+ ..++.++|||||||+++||++|+.||.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99986543222 112223467889999998765 4578999999999999999999999975543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=7.1e-29  Score=249.78  Aligned_cols=196  Identities=33%  Similarity=0.479  Sum_probs=162.1

Q ss_pred             CcccccCceEEEEEEeC-C---CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP-R---GQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      ++||+|+||.||+|... .   +..+|+|.+..... ...+++.+|+.+++.++|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999542 2   26899999876543 24457889999999999999999999876 4567999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++...   ..+++..+..++.|++.+|.|||..+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999998543   25889999999999999999999987   99999999999999999999999999986543322111


Q ss_pred             -cccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       596 -~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~  203 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK  203 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence             111223467999999988889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=5.7e-29  Score=254.52  Aligned_cols=199  Identities=23%  Similarity=0.360  Sum_probs=169.4

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|++.+.||+|++|.||+|.. .+++.|++|++....  ....+.+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999965 468899999987653  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      + +++|..++....  ..+++.++..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999998875432  45899999999999999999999987   99999999999999999999999999986543321


Q ss_pred             ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                       .......++..|+|||.+.+. .++.++|||||||+++||++|++||..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence             122334688899999987654 468899999999999999999877754

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=7.5e-29  Score=249.37  Aligned_cols=201  Identities=29%  Similarity=0.479  Sum_probs=169.6

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++|||++++++++......++++||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            5677899999999999999877788999998875432 235688999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++...  ...+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++......... .
T Consensus        84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            9999888542  234788999999999999999999987   999999999999999999999999998754322111 1


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            112234568999999988889999999999999999998 899886543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=5.4e-29  Score=252.36  Aligned_cols=198  Identities=23%  Similarity=0.341  Sum_probs=156.6

Q ss_pred             CcccccCceEEEEEEeCCC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          441 NKLGEGGFGPVYKGNLPRG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999964333   356677766543 334567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          517 SLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       517 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      +|..++..... ....++.....++.|+++||.|||+.+   ++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99998864322 234566778899999999999999987   99999999999999999999999999864322111112


Q ss_pred             cccccccccccccccccC-------CCCCccchhHHHHHHHHHHHcC-CCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIISS-KRNARY  641 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslGvil~elltg-~~p~~~  641 (656)
                      .....++..|+|||++..       ..++.++|||||||++|||+++ ..||..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  211 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH  211 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence            223467889999998743       2357899999999999999975 556643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=257.76  Aligned_cols=206  Identities=31%  Similarity=0.460  Sum_probs=170.5

Q ss_pred             HHhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCC-------hhhHHHHHHHHHHHHhcCCCceeeEEEEEe-e
Q 006211          432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-------TQGLEEFKNEVSLTARLQHVNLLRVLGYCT-E  502 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~  502 (656)
                      ...++|-++..||+|+|++||++ ++...+.||||+-....       +...+...+|..|-+.|+||.||++++++. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34567788899999999999999 66678889999754321       111234678999999999999999999985 4


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEE
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKIS  579 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~  579 (656)
                      .+..|-|+|||+|.+|+-||..   ...+++.+++.|+.||+.+|.||.+.. ++|||-||||.|||+.+.   |.+||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            5677899999999999999853   345899999999999999999999985 579999999999999654   789999


Q ss_pred             eccCccccccCccc-----cccccccccccccccccccCC----CCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          580 DFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       580 DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |||+++.+..+...     ..++...||..|++||.+.-+    .++.|+||||+|||+|..+.|++||.-
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            99999988654333     224456799999999987432    378999999999999999999999964

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.2e-29  Score=275.29  Aligned_cols=203  Identities=24%  Similarity=0.351  Sum_probs=158.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCC--CCEEEEE------------------EccCCChhhHHHHHHHHHHHHhcCCC
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPR--GQEFAVK------------------RLSATSTQGLEEFKNEVSLTARLQHV  491 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~  491 (656)
                      ...++|++.+.||+|+||+||++....  +...++|                  .+.. .......+.+|+.++.+++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence            456789999999999999999985422  2222222                  1111 122345678999999999999


Q ss_pred             ceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEE
Q 006211          492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       492 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NIL  569 (656)
                      ||+++++++...+..+++++++. ++|..++.....  ...........++.|++.||.|||+.+   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            99999999999999999999985 455555533211  112345667789999999999999987   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++.
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999987643221 12223578999999999999899999999999999999999986543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-29  Score=261.34  Aligned_cols=213  Identities=23%  Similarity=0.362  Sum_probs=176.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .-|..++.||-|+||+|.+++. .+...+|+|.+++.+   ......++.|-.||..-+.+=||+|+-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            3466678899999999999954 456789999997753   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc-
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK-  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~-  589 (656)
                      +|++||++-.+|.   +-..+.+..++.++.++.+++++.|.++   +|||||||.|||||.+|++||+|||||.-+.- 
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999988873   4556788888999999999999999998   99999999999999999999999999964320 


Q ss_pred             --------Ccc-------------------------------ccccccccccccccccccccCCCCCccchhHHHHHHHH
Q 006211          590 --------DVD-------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL  630 (656)
Q Consensus       590 --------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~  630 (656)
                              ...                               .......+||+.|+|||++....++...|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    000                               00012357999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCccc-cccccc
Q 006211          631 QIISSKRNARYYGTSEN-LNFLEY  653 (656)
Q Consensus       631 elltg~~p~~~~~~~~~-~~~~~~  653 (656)
                      ||+.|+.||-....-+. ...++|
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeeh
Confidence            99999999976665443 344444

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=3.1e-29  Score=256.52  Aligned_cols=199  Identities=22%  Similarity=0.338  Sum_probs=168.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+..+.||+|+||.||+|... +++.+|+|++.....  ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999764 588999999865422  234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..+...   ...+++.....++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999988876632   234889999999999999999999987   9999999999999999999999999997654322


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        .......++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence              12223457889999998865 4468899999999999999999988854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.3e-28  Score=250.83  Aligned_cols=198  Identities=26%  Similarity=0.414  Sum_probs=170.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      -|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++++++|||++++++++......++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999954 468899999886543 334457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++.    ...+++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++..+....  
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            9999998874    235789999999999999999999987   9999999999999999999999999987654321  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .......++..|+|||.+....++.++|+|||||++|+|++|+.|+...
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            1122345788899999998888899999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=5.4e-29  Score=255.56  Aligned_cols=211  Identities=26%  Similarity=0.344  Sum_probs=172.0

Q ss_pred             CHHHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       426 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      ...++....++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3344555678899999999999999999965 468899999986542 2235677899999998 899999999998754


Q ss_pred             -----CceEEEEEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          504 -----DENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       504 -----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                           ...++|+||+++++|..++... .....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3579999999999998887532 22345889999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccCC-----CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-----IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      |+|||++........  ......++..|+|||.+...     .++.++|+|||||++|||++|+.||...
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999876543221  12234678899999987543     2688999999999999999999998654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=1.7e-29  Score=254.40  Aligned_cols=199  Identities=27%  Similarity=0.358  Sum_probs=173.1

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      +|++.+.||.|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999664 58899999987542   2345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++...   ..+++..+..++.+++++|.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999888432   46889999999999999999999987   9999999999999999999999999987654321


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         ......++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence               1223457788999999988889999999999999999999999997654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=8.2e-29  Score=253.16  Aligned_cols=202  Identities=28%  Similarity=0.446  Sum_probs=169.1

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +|+..+.||.|++|.||+|... ++..||||+++.... ...+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999664 688999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++ +|..++........+++..+..++.|++++|.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 77777755444456899999999999999999999987   99999999999999999999999999975533211 


Q ss_pred             cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ......++..|++||.+.+. .++.++|+|||||++|||++|+.||....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11223567889999987653 46889999999999999999999987544

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=6.9e-29  Score=253.53  Aligned_cols=210  Identities=25%  Similarity=0.417  Sum_probs=171.6

Q ss_pred             CHHHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee-
Q 006211          426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE-  502 (656)
Q Consensus       426 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  502 (656)
                      ++.++......|++.+.||.|+||.||+|.. ..++.+|+|++.... ....++..|+.++.++ +|||++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3445555667889999999999999999965 568899999986643 3345678899999998 69999999998853 


Q ss_pred             -----CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          503 -----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       503 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                           ....+++|||+++|+|..++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45679999999999999887542 2345788889999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCcccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      |+|||++.......  .......++..|+|||.+.     ...++.++|+|||||++|||++|+.||...
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            99999987543221  1222346888999999875     345788999999999999999999999543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.1e-28  Score=249.37  Aligned_cols=201  Identities=27%  Similarity=0.461  Sum_probs=171.9

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|+||.||++.. .+++.+++|.++....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477889999999999999965 4688999999876543  3567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|.+++..   ...+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998854   234788899999999999999999987   99999999999999999999999999976543222


Q ss_pred             ccc--cccccccccccccccccCCC---CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EAN--TGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...  .....++..|+|||.+....   ++.++||||||++++||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            111  11245778999999987766   889999999999999999999999643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.2e-28  Score=252.19  Aligned_cols=197  Identities=26%  Similarity=0.403  Sum_probs=170.0

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44557899999999999964 56889999998765555556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..    ..+++..+..++.|++.+|.+||+.+   ++||||+|+||+++.++.++|+|||.+........  .
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999988854    34788999999999999999999987   99999999999999999999999998875433221  1


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~  218 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE  218 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence            22346788999999998888999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=7.4e-29  Score=249.40  Aligned_cols=201  Identities=22%  Similarity=0.406  Sum_probs=171.2

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|+||.+|.+.. .+++.+++|++...  .....+++.+|+.++++++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999954 46889999998643  233445788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++... ....+++.....++.|++.++.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999998887542 2234788999999999999999999987   99999999999999999999999999976543211


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        ......+++.|+|||.+.+..++.++|+|||||++++|++|+.|+...
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG  204 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence              112235788899999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=9.2e-29  Score=248.61  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=171.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|++|.||++.. .+++.+|+|++...  ..+..+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999954 46889999998654  233456788999999999999999999999988999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~~~~~~~  591 (656)
                      +++++|.+++.... ...+++..+..++.+++++|.|||+++   ++|+||+|+||+++++ +.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999985432 335789999999999999999999987   9999999999999865 458999999998654321


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         ......++..|+|||.+....++.++||||||+++|+|++|+.||...+
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence               1223467889999999988888999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=1.3e-28  Score=247.75  Aligned_cols=201  Identities=34%  Similarity=0.530  Sum_probs=168.9

Q ss_pred             CCCCCcccccCceEEEEEEeCC-----CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          437 FSSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +++.+.||.|+||.||++....     +..+|+|++...... ..+.+.+|+.++..++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999996643     378999999765433 5668899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..... ..+++.....++.|++.++.+||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999988854222 12899999999999999999999987   999999999999999999999999999865433


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ..... ....++..|+|||.+....++.++|+||||++++||++ |+.||...
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            11111 12236788999999988889999999999999999998 77777543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=3.2e-29  Score=256.23  Aligned_cols=197  Identities=25%  Similarity=0.407  Sum_probs=163.9

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|+||.||+|.. .+|+.+|+|+++...  ......+.+|++++++++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477889999999999999965 468899999986542  22234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++ +|..++...  ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.++|+|||+++...... 
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            974 676665432  345899999999999999999999987   9999999999999999999999999997653321 


Q ss_pred             ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                       .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence             111223567899999988664 47899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=4.7e-29  Score=252.14  Aligned_cols=198  Identities=26%  Similarity=0.363  Sum_probs=171.7

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +|+..+.||+|++|.||++... +++.+++|++.... .+..+++.+|++++++++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5778889999999999999664 68899999987653 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++++|..++....  ..+++.....++.|++.+|.|||+ .+   ++|+||+|+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999885432  468889999999999999999999 66   99999999999999999999999999875532211


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .    ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            1    146788999999998889999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=8.5e-29  Score=254.97  Aligned_cols=198  Identities=25%  Similarity=0.372  Sum_probs=166.6

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +|+..+.||+|++|.||+|.. .+++.|+||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999965 46889999998765322     234567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+ +++|..++....  ..+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899998885432  35899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...  ......++..|+|||.+.+ ..++.++|+|||||+++||++|.+||..
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            221  1222345778999998754 4578899999999999999999777754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=1.1e-28  Score=250.68  Aligned_cols=203  Identities=26%  Similarity=0.424  Sum_probs=164.1

Q ss_pred             CCCCCcccccCceEEEEEEeC----CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          437 FSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      |++.+.||+|+||.||+|...    +++.+|||++...  .....+++.+|++++++++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999642    3678999998754  2344567889999999999999999999886532      


Q ss_pred             ceEEEEEecCCCChhhhhhCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      ..++++||+++|+|..++....   ....+++.....++.|++.+|.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999987764211   2235788999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      |+++...............+++.|++||.+....++.++|||||||++|||++ |+.||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            99986543221112222345678999999988889999999999999999999 88887544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.2e-28  Score=248.70  Aligned_cols=194  Identities=26%  Similarity=0.431  Sum_probs=156.5

Q ss_pred             CcccccCceEEEEEEeC----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEEEEEecC
Q 006211          441 NKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCT-ERDENMLIYEYLP  514 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  514 (656)
                      +.||+|+||.||+|...    ....+|+|++... .....+.+.+|+.+++.++|||++++++++. .+...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999642    2357999988643 3344567889999999999999999999775 3556789999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc-
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-  593 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~-  593 (656)
                      +++|..++...  ....++.....++.+++.||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998543  223677888899999999999999987   999999999999999999999999999754322111 


Q ss_pred             -cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          594 -ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       594 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                       .......++..|+|||.+....++.++|||||||++|||++|+.|+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~  202 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  202 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCC
Confidence             1111234567899999998888999999999999999999965443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=7.1e-29  Score=254.10  Aligned_cols=200  Identities=24%  Similarity=0.349  Sum_probs=170.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|++|.||+|... +++.|++|+++..  .....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999654 5889999988653  23334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |++++.+..+...   ...+++..+..++.+++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777665532   334889999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      . .......++..|+|||.+... .++.++|+||||+++|||++|+.||..
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2 122234678889999999887 789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=1.2e-28  Score=251.11  Aligned_cols=194  Identities=24%  Similarity=0.394  Sum_probs=164.7

Q ss_pred             ccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||+||++.. .+++.+|+|.+....   ....+.+.+|++++++++|||++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999954 468899999986532   22234567899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++..... ..+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            988854322 35889999999999999999999987   999999999999999999999999998765331   11222


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..++..|+|||.+.+..++.++|+|||||++++|++|+.||....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            356788999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=1.5e-28  Score=250.68  Aligned_cols=192  Identities=27%  Similarity=0.356  Sum_probs=156.5

Q ss_pred             cccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHH---HhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLT---ARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .||+|+||.||++.. .+++.+|+|.+.....   .....+.+|..++   ...+|||++.+.+.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 4688999998865421   1122234444333   33479999999999998899999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++......    
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            9999888753   335899999999999999999999987   999999999999999999999999998754322    


Q ss_pred             cccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......|+..|+|||.+. +..++.++|+||+||++|||++|+.||....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence            112236889999999886 4567899999999999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=1.1e-28  Score=252.22  Aligned_cols=201  Identities=24%  Similarity=0.368  Sum_probs=162.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHH-HHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSL-TARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|+++.... +...++..|+.+ ++.++|||++++++++......++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4688889999999999999965 4689999999876432 223345556665 566789999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |++ ++|..++... .....+++..+..++.|++.||.|||+..  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 6777666432 23356899999999999999999999862  3999999999999999999999999999765322


Q ss_pred             ccccccccccccccccccccccC----CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK----GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .   ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||..
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            1   1122357888999998754    4568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=2.9e-28  Score=246.80  Aligned_cols=198  Identities=24%  Similarity=0.348  Sum_probs=163.4

Q ss_pred             HHHHHHhcCCCCCCcc--cccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          428 SDIKAATNNFSSANKL--GEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~i--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+........     |+.....+ +|||++++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            4445556677777776  9999999999954 5688899999865422211     22222222 799999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEecc
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFG  582 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfG  582 (656)
                      +..++||||+++++|..++...   ..+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++ .++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999988542   26899999999999999999999987   99999999999999998 99999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++......      ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            98754322      1235788999999999888999999999999999999999999743

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=9.9e-29  Score=248.29  Aligned_cols=196  Identities=29%  Similarity=0.471  Sum_probs=165.4

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||++.. +++.+|+|.++...  ..+.+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4578889999999999999864 67889999986543  23578899999999999999999998865 45799999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++.... ...+++..+..++.|++.++.|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999985432 335788999999999999999999987   9999999999999999999999999987543211   


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                        .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  202 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS  202 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence              11233567999999988889999999999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=5.4e-29  Score=250.85  Aligned_cols=190  Identities=26%  Similarity=0.416  Sum_probs=158.1

Q ss_pred             CcccccCceEEEEEEeCC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999995422        234888888665555556788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc--------EEEEeccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--------PKISDFGMA  584 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~--------~kl~DfGla  584 (656)
                      +++|+|..++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986432  35788999999999999999999987   999999999999987765        699999988


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCC-CCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSK-RNARY  641 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~-~p~~~  641 (656)
                      .....      .....++..|+|||.+.+ ..++.++|||||||++|||++|. .|+..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            65432      122356788999999876 45789999999999999999995 45433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.7e-28  Score=251.69  Aligned_cols=200  Identities=25%  Similarity=0.339  Sum_probs=167.5

Q ss_pred             CCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCCh----hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATST----QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      +|++.+.||+|+||.||++..    .++..||+|++.....    ...+.+.+|+.++.++ +|+||+++.+++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999964    3688999999875321    2345678899999999 599999999999988899


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|+||+++++|.+++..   ...+++.....++.|++++|.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999988853   335788899999999999999999987   99999999999999999999999999976


Q ss_pred             cccCccccccccccccccccccccccCC--CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...... .......|+..|+|||.+...  .++.++||||||+++|+|++|+.||...
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  211 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD  211 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence            533211 112234678899999988653  4678999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.1e-28  Score=252.12  Aligned_cols=202  Identities=31%  Similarity=0.462  Sum_probs=169.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-----CCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEee--CCce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  506 (656)
                      ..|+..+.||+|+||.||++...     .+..+|||.++..... ..+.+.+|+++++.++|||++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677899999999999999643     3678999999765443 45678999999999999999999999877  5578


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+++++|..++....  ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999985432  24889999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          587 FRKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ........ ......++..|+|||.+....++.++|+||||++++||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            65322111 11122345679999999888899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=2e-28  Score=248.30  Aligned_cols=201  Identities=27%  Similarity=0.427  Sum_probs=167.8

Q ss_pred             CCCCCCcccccCceEEEEEEeCC--CCEEEEEEccCC----------ChhhHHHHHHHHHHHHh-cCCCceeeEEEEEee
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSAT----------STQGLEEFKNEVSLTAR-LQHVNLLRVLGYCTE  502 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  502 (656)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999997654  678999987532          22234557778888765 799999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      .+..++++||+++++|..++... .....+++..++.++.|++.+|.|||+..  +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998877431 23446889999999999999999999633  3999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |++.......   ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            9997654322   22334678899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.8e-28  Score=247.47  Aligned_cols=206  Identities=25%  Similarity=0.377  Sum_probs=170.8

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  510 (656)
                      +|++.+.||.|+||.||++.. .++..+|+|++...  .....+.+.+|+++++.++|||++++++++..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999954 56789999998653  33445678899999999999999999998754  34578999


Q ss_pred             EecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      ||+++++|..++... .....+++..++.++.+++.+|.|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999888542 22356899999999999999999999332  334999999999999999999999999999876


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....  ......++..|+|||.+....++.++|+||||+++++|++|+.||....
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            43321  1223467889999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=3.5e-28  Score=243.26  Aligned_cols=199  Identities=29%  Similarity=0.475  Sum_probs=174.5

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|||++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999764 688999999987665556788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++....  ..+++.....++.+++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999998875432  45899999999999999999999977   99999999999999999999999999976543321  


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .....++..|+|||.+....++.++|+||||+++++|++|+.||...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             23346788999999998888899999999999999999999998654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=3.1e-28  Score=251.92  Aligned_cols=195  Identities=30%  Similarity=0.429  Sum_probs=164.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++....   .+..+++.+|+++++.++|||++++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4578889999999999999965 468899999886432   233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||++ |++..++...  ...+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 4665555322  235899999999999999999999987   999999999999999999999999998754321


Q ss_pred             cccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence                  1235678899999874   45688899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=2.5e-28  Score=249.97  Aligned_cols=203  Identities=28%  Similarity=0.434  Sum_probs=174.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ..+.|+..+.||+|++|.||++... .+..+++|++..... ..+.+.+|+++++.++|+|++++++.+......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456778889999999999999665 688999999976544 45678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|.+++....  ..+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999986532  36899999999999999999999977   9999999999999999999999999886543321


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            1  1223356788999999988889999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.4e-28  Score=251.41  Aligned_cols=200  Identities=27%  Similarity=0.412  Sum_probs=166.6

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||.|++|.||+|.. .+++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478889999999999999965 468899999886542  22335688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +. ++|..++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 5787777442 2345889999999999999999999987   9999999999999999999999999987653321 


Q ss_pred             ccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             1122235678899999876544 688999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.9e-28  Score=258.70  Aligned_cols=198  Identities=24%  Similarity=0.316  Sum_probs=166.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  503 (656)
                      ..++|+..+.||+|+||.||++.. .+++.||+|++...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999954 47899999998653  233345677899999999999999999988643      


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ...++|+||+.+ +|...+..     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            246899999964 67666532     2788899999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            98654321   122335788999999999989999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=2.2e-28  Score=251.32  Aligned_cols=201  Identities=24%  Similarity=0.367  Sum_probs=166.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  509 (656)
                      ++|+..+.||+|+||.||+|... +++.+++|.++....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999764 588999999875432  2223567899999999999999999998877  789999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      +||+++ +|..++...  ...+++.....++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 887777442  225899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21  112234567889999988654 46889999999999999999999986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2e-28  Score=250.79  Aligned_cols=201  Identities=27%  Similarity=0.388  Sum_probs=169.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  510 (656)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3577889999999999999965 4588999999875433 3456788999999999999999999988654  3679999


Q ss_pred             EecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++++|.+++... .....+++.....++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876431 12345788999999999999999999987   99999999999999999999999999875432


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..    .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21    11235678899999998888999999999999999999999999755

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2.8e-28  Score=246.15  Aligned_cols=192  Identities=28%  Similarity=0.382  Sum_probs=166.2

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||.|++|.||++... +++.+++|++....   ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999664 48899999986542   23346788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            998854   234788999999999999999999987   9999999999999999999999999998654321   2223


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            467889999999988889999999999999999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=240.03  Aligned_cols=196  Identities=23%  Similarity=0.330  Sum_probs=162.8

Q ss_pred             HhcCCCCC-CcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee----CCc
Q 006211          433 ATNNFSSA-NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE----RDE  505 (656)
Q Consensus       433 ~~~~y~~~-~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  505 (656)
                      ++++|++. ++||-|-.|.|..+ +..+++.+|+|++.....     .++|+++--+. .|||||++++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-----ARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-----HHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            56677764 67999999999999 445789999999876532     35677765444 69999999998754    456


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEecc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFG  582 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfG  582 (656)
                      +.+|||.|+||.|...+.++ ....+++.++..|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999998888654 3446899999999999999999999998   999999999999974   4569999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      +|+.-..   .......+-|+.|.|||++....|+...|+||+||++|-||+|.+||.
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            9986432   222334577999999999999999999999999999999999999994

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=3.3e-28  Score=247.92  Aligned_cols=191  Identities=29%  Similarity=0.382  Sum_probs=156.6

Q ss_pred             cccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHH---HHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEV---SLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .||+|+||.||++.. .+++.||+|.+.....   .....+..|.   ..+....|||++++.+.+...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999954 4688999998865421   1112233343   34444579999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999888743   345899999999999999999999987   9999999999999999999999999987553221   


Q ss_pred             ccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .....|+..|+|||.+.+. .++.++|+||+|+++|||++|+.||...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence             1234688999999998754 5889999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=2.2e-28  Score=251.03  Aligned_cols=194  Identities=26%  Similarity=0.392  Sum_probs=167.6

Q ss_pred             CCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ..+||+|+||.||++.. .+++.+|||.+........+.+.+|+.+++.++|+|++++++.+...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999965 56889999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      ..++..    ..+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            887632    34788999999999999999999987   9999999999999999999999999987554321  11223


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..++..|+|||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46788999999998888899999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=4.7e-28  Score=243.40  Aligned_cols=202  Identities=28%  Similarity=0.438  Sum_probs=174.6

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  510 (656)
                      +|+..+.||+|++|.||+|... +++.+++|++.....  ...+.+.+|+..+++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999665 688999999876542  4567789999999999999999999999888  8899999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |++++++|.+++...   ..+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999988543   26899999999999999999999987   999999999999999999999999999876543


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..........++..|+|||.+.....+.++||||||+++++|++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32111233467889999999988889999999999999999999999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=3.5e-28  Score=250.00  Aligned_cols=202  Identities=24%  Similarity=0.344  Sum_probs=164.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCc-----
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  505 (656)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.++....  .....+.+|+.+++.++ |||++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999965 4688999998765422  22356788999999995 6999999999877665     


Q ss_pred             eEEEEEecCCCChhhhhhCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEecc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFG  582 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfG  582 (656)
                      .+++|||+++ +|..++.....  ...+++..+..++.||++||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78777644222  245799999999999999999999987   999999999999998 8899999999


Q ss_pred             CccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +++.+.....  ......+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9976533211  1122356788999998764 45789999999999999999999998653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-28  Score=247.34  Aligned_cols=203  Identities=27%  Similarity=0.408  Sum_probs=169.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC------
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD------  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  504 (656)
                      ..++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3578999999999999999999664 578999999876543 346788999999999 6999999999997644      


Q ss_pred             ceEEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4799999999999988875422 2346889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +.......  .......++..|+|||.+..     ..++.++|||||||+++||++|+.||..
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            87653321  12223467889999998753     3467899999999999999999999964

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-28  Score=257.23  Aligned_cols=200  Identities=25%  Similarity=0.402  Sum_probs=164.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----EN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  506 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999954 568999999986432 234456788999999999999999998876543     47


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+++ +|...+.    ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999964 6666552    335889999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCcccc-ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          587 FRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            54322111 1123467889999998654 5688999999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=2e-28  Score=247.19  Aligned_cols=195  Identities=26%  Similarity=0.377  Sum_probs=166.4

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||.||++... +++.+++|++.....   ...+.+.+|++++++++|||++++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 489999999875533   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc------
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD------  592 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~------  592 (656)
                      ..++...   ..+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9888542   25899999999999999999999987   99999999999999999999999999875432211      


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ........++..|+|||.......+.++|+||||++++||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            112233467889999999988888999999999999999999999986443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=3.1e-28  Score=250.22  Aligned_cols=203  Identities=18%  Similarity=0.218  Sum_probs=151.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCChhhH-----------HHHHHHHHHHHhcCCCceeeEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGL-----------EEFKNEVSLTARLQHVNLLRVLG  498 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  498 (656)
                      .++|++.++||+|+||.||+|....    +..+++|..........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3678999999999999999996543    34667775433221110           01122334455678999999998


Q ss_pred             EEeeCC----ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          499 YCTERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       499 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      ++....    ..++++|++.. ++...+..   ....++..+..++.|++.||.|||+.+   ++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    33667776643 44444422   122467888999999999999999987   99999999999999999


Q ss_pred             cEEEEeccCccccccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          575 NPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .++|+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...+
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999866432111     11123468999999999999999999999999999999999999997664

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-30  Score=257.99  Aligned_cols=199  Identities=25%  Similarity=0.303  Sum_probs=175.1

Q ss_pred             CCCCCcccccCceEEEEEEeCCCC-EEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNLPRGQ-EFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++.+..||-|+||.|-.++..... .+|+|++++.   .....+.+..|-++|...+.|.||+++..|.++...|++||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            445678999999999998765433 4888888764   344556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |-||.+-..+.+   +..++..+...++..+.+|++|||+.+   ||.|||||+|.+++.+|-+||.|||+|+.+..   
T Consensus       502 ClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---  572 (732)
T KOG0614|consen  502 CLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---  572 (732)
T ss_pred             hcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence            999999988865   345788889999999999999999998   99999999999999999999999999998764   


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...+.+.+||+.|.|||++.++..+.++|.||||+++||||+|++||...++
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            3456678999999999999999999999999999999999999999987654

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-28  Score=247.73  Aligned_cols=199  Identities=28%  Similarity=0.419  Sum_probs=165.6

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      |++.+.||.|++|.||+|.. .++..||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56788999999999999965 468999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      + ++|..++.... ...+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 68888774422 235899999999999999999999987   99999999999999999999999999975432211 


Q ss_pred             cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             11223567889999987654 5788999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.2e-29  Score=231.83  Aligned_cols=206  Identities=21%  Similarity=0.435  Sum_probs=173.4

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER--DENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  509 (656)
                      .++|++.+++|+|.+++||.| ...+.+.++||+++....   +.+.+|+.+|+.++ ||||+++++...+.  ....+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467888999999999999999 566788999999976543   46789999999997 99999999998664  456899


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFR  588 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~~~~  588 (656)
                      +||+.+.+...+.      ..++..+...++.+++.||.|+|++|   |+|||+||.|++||.. -.++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998886554      24777888999999999999999998   9999999999999964 569999999998876


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCccccccccccc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAS  655 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  655 (656)
                      +..+   ....+.+..|.-||.+.. ..|+.+-|+|||||++..|+..+.|| |.+.++...++..|+
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF-FhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVKIAK  248 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc-cCCCCCHHHHHHHHH
Confidence            5433   333467888999998865 45789999999999999999999999 567777777777664

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.7e-28  Score=243.62  Aligned_cols=190  Identities=23%  Similarity=0.310  Sum_probs=158.7

Q ss_pred             CcccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHH-HhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLT-ARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|.. .+++.||+|+++....   .....+..|..++ ...+|||++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999965 4588999999875432   1222344454443 445899999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      ++|..++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999998843   235788999999999999999999987   99999999999999999999999999875332      


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            12235778899999998888899999999999999999999999644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=4.3e-28  Score=251.12  Aligned_cols=201  Identities=26%  Similarity=0.390  Sum_probs=164.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35788999999999999999965 4689999999865422  1223456899999999999999999998755  46799


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+||+++ +|..++...  ...+++..+..++.|++++|.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 777776432  245899999999999999999999987   9999999999999999999999999998664


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ....  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3221  1112245778999998865 45789999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=3.5e-28  Score=255.02  Aligned_cols=203  Identities=25%  Similarity=0.384  Sum_probs=166.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--Cce
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  506 (656)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888999999999999999654 5789999988542  223345677899999999 999999999988653  357


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|+||++ ++|..++..    ..+++.....++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588777643    25788899999999999999999987   99999999999999999999999999986


Q ss_pred             cccCccc---cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDE---ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......   .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            5433221   12223467889999998754 557889999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1e-27  Score=240.46  Aligned_cols=199  Identities=29%  Similarity=0.435  Sum_probs=172.6

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|++.+.||+|++|.||++... +++.+++|.+.....  ...+.+.+|++++++++|||++++++++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999554 578999999876643  4556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|.+++...   ..+++..+..++.|++.++.+||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999887532   46899999999999999999999987   99999999999999999999999999986643322


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  .....++..|+|||......++.++|+||||+++++|++|+.|+...
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence            1  22346788999999988877899999999999999999999998643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3.3e-28  Score=251.94  Aligned_cols=203  Identities=22%  Similarity=0.383  Sum_probs=163.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  505 (656)
                      .++|+..+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            34688999999999999999965 468899999886542  2223356789999999999999999999876543     


Q ss_pred             ---eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          506 ---NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       506 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                         .++|+||+.+ +|...+...  ...+++.+...++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999965 676666432  235889999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCccc--cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++.........  .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99765432211  112234567889999987654 4688999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=8.2e-28  Score=247.16  Aligned_cols=201  Identities=25%  Similarity=0.392  Sum_probs=164.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999654 688999999865422  233567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~~  590 (656)
                      |++ ++|..++... .....++..+..++.||+.||.|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4676665332 2223578888899999999999999987   999999999999985 557999999999765332


Q ss_pred             ccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  .......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||...
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  11122356789999998765 45789999999999999999999999643

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=4.1e-28  Score=248.63  Aligned_cols=201  Identities=26%  Similarity=0.410  Sum_probs=162.2

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            345567899999999999954 468999999987543 234457889999999996 99999999999988899999999


Q ss_pred             cCCCChhhhhhC--CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFD--PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      +.. ++..+...  ......+++..+..++.++++||+|||+..  +++||||||+||+++.++.++|+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 44433211  112346889999999999999999999752  3999999999999999999999999999765432


Q ss_pred             ccccccccccccccccccccccCC---CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKG---IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..   .....++..|+|||.+...   .++.++|||||||++|||++|+.||...
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            11   1223578899999998766   6889999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6e-28  Score=253.84  Aligned_cols=203  Identities=23%  Similarity=0.341  Sum_probs=167.8

Q ss_pred             HHHHHHHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          427 FSDIKAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       427 ~~~~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      ..++....++|++.+.||+|+||.||++. ..+++.||+|++....  ....+.+.+|+.++++++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            45566778999999999999999999995 4568899999987542  22345678899999999999999999987543


Q ss_pred             ------CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          504 ------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       504 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                            ...+++++++ +++|..++..    ..+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3367788776 7788777632    34889999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      |+|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999875432     1123467889999998765 56788999999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=1.2e-27  Score=248.66  Aligned_cols=194  Identities=29%  Similarity=0.443  Sum_probs=163.3

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .|+..+.||+|+||.||++.. .++..+|+|++....   .+....+.+|+.++++++|||++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366788999999999999965 468899999986432   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++ ++.+.+..  ....+++.++..++.+++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 66665533  2345889999999999999999999987   99999999999999999999999999865432  


Q ss_pred             ccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                          .....++..|+|||.+.   ...++.++|||||||++|||++|+.||..
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                11235788899999873   45688999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=236.79  Aligned_cols=202  Identities=22%  Similarity=0.353  Sum_probs=173.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  508 (656)
                      -++|..+++||+|+|+.|..+++ ++.+.+|+|+++++   ..+..+-.+.|-.+..+- +||.+|-+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            36788999999999999999965 45788999998765   233444566777777766 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |.||+++|+|--.+   +++..++++.++.+...|+-+|.|||+.+   ||.||||..|+|+|..|++||+|+|+++.-.
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999985444   34456999999999999999999999998   9999999999999999999999999998533


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  ....+++.+||+.|+|||++.+..|..++|.|+|||+++||+.|+.||+--+
T Consensus       403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            2  2334567899999999999999999999999999999999999999996544

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=1.1e-27  Score=240.67  Aligned_cols=203  Identities=24%  Similarity=0.408  Sum_probs=174.9

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|++|.||++... ++..+++|++.....  .....+.+|+++++.++|||++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999654 588999999876532  4556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      +++++|..++.... ....+++.....++.+++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999998886532 1356899999999999999999999987   9999999999999999999999999997654332


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        .......+++.|+|||.+....++.++|+||+|+++++|++|+.||...+
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence              12223467889999999988889999999999999999999999986553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=8.6e-28  Score=245.79  Aligned_cols=200  Identities=27%  Similarity=0.435  Sum_probs=166.6

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEEE
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIYE  511 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  511 (656)
                      |++.+.||+|++|.||+|... +++.+|+|++....  ......+.+|+.++++++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999664 58899999998653  33345688999999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++ +|..++...  ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 787776442  246889999999999999999999987   9999999999999999999999999998654432


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 11222356778999997754 457899999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=5.3e-28  Score=243.21  Aligned_cols=201  Identities=24%  Similarity=0.420  Sum_probs=169.7

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|+..+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999654 57899999986542  23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~~~~  591 (656)
                      +++++|..++... ....+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999888542 2235789999999999999999999987   99999999999999885 46999999997654322


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..  .....|++.|+|||.+....++.++|+||||++++||++|+.||...
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            11  12235788999999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=9.8e-28  Score=247.52  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=165.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----  504 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  504 (656)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999664 58899999987542  223346778999999999999999999887654    


Q ss_pred             ------ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          505 ------ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       505 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                            ..++|+||+++ ++...+...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 565555332  335889999999999999999999987   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +|||++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||..
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999865433221 1122345778999998764 4578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=1.3e-27  Score=243.98  Aligned_cols=196  Identities=23%  Similarity=0.329  Sum_probs=159.8

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CceEEEEE
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER--DENMLIYE  511 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  511 (656)
                      |++.+.||+|+||.||++.. .+++.+|+|+++.... .......+|+..+.++. |||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999964 4688999999875422 22223457888888885 99999999999887  88999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++ ++...+...  ...+++..+..++.|+++||.|||+.+   ++||||+|+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 676666432  245899999999999999999999987   999999999999999 999999999998654322


Q ss_pred             ccccccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..   ....++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            11   1235788999999764 455788999999999999999999999654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=4e-28  Score=247.33  Aligned_cols=203  Identities=28%  Similarity=0.437  Sum_probs=173.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|++|.||++.. .+++.+++|++...   .....+.+.+|.+++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688899999999999999965 46899999998653   2233456788999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||++++++|..++..   ...+++.....++.|++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999988854   236899999999999999999999987   99999999999999999999999999976543


Q ss_pred             Cccc------------------cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDE------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....                  .......++..|+|||.+....++.++|+||||++++++++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            2211                  12223467889999999988889999999999999999999999997544

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=5.3e-28  Score=253.28  Aligned_cols=202  Identities=20%  Similarity=0.343  Sum_probs=166.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  506 (656)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|++....  ......+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36789999999999999999954 468999999987542  2334567889999999999999999987753    3467


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|+||+. ++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 578777643   334899999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCccc--cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVDE--ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            5432211  11123467889999998765 45789999999999999999999999543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=8.2e-28  Score=241.61  Aligned_cols=201  Identities=29%  Similarity=0.430  Sum_probs=172.3

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +|++.+.||+|++|.||++.. .+++.+++|.+....  .....++.+|+.+++.++||||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999954 467899999987542  33445678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      +++++|..++.... ....+++..+..++.++++||.|||+.+   ++|+||+|.||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999998875422 2345889999999999999999999987   999999999999999999999999999876443 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.||...+
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence               1122357889999999988889999999999999999999999997554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.2e-27  Score=251.38  Aligned_cols=198  Identities=22%  Similarity=0.354  Sum_probs=165.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----  504 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  504 (656)
                      ...++|+..+.||+|+||.||++. ..++..||||++....  ....+.+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            356789999999999999999995 4578999999986432  223456789999999999999999999886543    


Q ss_pred             --ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          505 --ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       505 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                        ..++|+||+ +++|..++.    ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              348999998 778877763    235889999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99764321     122356788999998865 45788999999999999999999999643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=1.1e-27  Score=249.95  Aligned_cols=199  Identities=26%  Similarity=0.371  Sum_probs=165.7

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCce
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDEN  506 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  506 (656)
                      ..++++|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.+++.++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34678899999999999999999954 47899999987643  22334567889999999999999999998865 5578


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++++||+ +++|..++.    ...+++.....++.|++++|.|||+.+   ++||||+|+||++++++.++|+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 567877763    234778888899999999999999987   99999999999999999999999999875


Q ss_pred             cccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ....     .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4221     122356788999998765 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=1e-27  Score=245.76  Aligned_cols=199  Identities=25%  Similarity=0.360  Sum_probs=166.7

Q ss_pred             CCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      +|++.+.||+|++|.||++..    .+++.+|||+++...    ....+.+.+|+.++.++ +|||++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999853    356889999986532    22335678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++++|..++..   ...+++.....++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999888743   235788999999999999999999987   99999999999999999999999999876


Q ss_pred             cccCccccccccccccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +..... .......++..|+|||.+.+..  .+.++|+||||+++|||++|+.||..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            543321 1222346788999999987654  78899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=7.2e-28  Score=252.52  Aligned_cols=200  Identities=23%  Similarity=0.372  Sum_probs=165.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  505 (656)
                      .++|++.+.||+|+||+||++.. .+++.||||.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999954 56899999998753  223345677899999999999999999987644     24


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++++||+. ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 677777643   345899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ......  .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            654321  11223357889999998764 46889999999999999999999999653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=4.1e-27  Score=244.15  Aligned_cols=194  Identities=30%  Similarity=0.435  Sum_probs=162.5

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      |...+.||+|+||.||+|.. .+++.+++|++....   ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56678899999999999965 468899999986532   23345688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +. +++..++..  ....+++.++..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 466665533  2345889999999999999999999987   99999999999999999999999999864221   


Q ss_pred             cccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                         .....++..|+|||.+.   ...++.++|||||||++|||++|+.|+...
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence               12346788999999874   456888999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.6e-27  Score=250.37  Aligned_cols=195  Identities=25%  Similarity=0.383  Sum_probs=161.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|...+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999964 468999999986532  223356789999999999999999999886543      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++|+||+.. +|..+.     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999864 665543     234788999999999999999999987   999999999999999999999999998


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            754221     122356788999998866 45889999999999999999999999754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=1.7e-27  Score=249.62  Aligned_cols=203  Identities=22%  Similarity=0.324  Sum_probs=164.2

Q ss_pred             hcCCCC-CCcccccCceEEEEEEe-CCCCEEEEEEccCCChhh--------------HHHHHHHHHHHHhcCCCceeeEE
Q 006211          434 TNNFSS-ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG--------------LEEFKNEVSLTARLQHVNLLRVL  497 (656)
Q Consensus       434 ~~~y~~-~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  497 (656)
                      .++|.. .+.||+|+||.||+|.. ..++.||+|.++......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345554 46799999999999964 468899999886542211              12467899999999999999999


Q ss_pred             EEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       498 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                      +++...+..+++|||+. ++|..++..   ...+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 578777743   345889999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCc------------cccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDV------------DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       578 l~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |+|||++.......            .........++..|+|||.+.+. .++.++|+|||||++|||++|+.||...+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999997654110            01111123467889999988654 46889999999999999999999986544

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=1.8e-27  Score=244.96  Aligned_cols=199  Identities=25%  Similarity=0.422  Sum_probs=161.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|++|.||+|.... ++.||||+++... ......+..|+.++.+.. ||||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999997754 8899999987543 233445667777676664 9999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+. +++..+....  ...+++..+..++.+++++|.|||+.+  +++||||+|+||++++++.+||+|||++..+....
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 4665555332  236889999999999999999999742  39999999999999999999999999997654322


Q ss_pred             cccccccccccccccccccccCCC----CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ..   ....++..|+|||.+.+..    ++.++|+||||+++|||++|+.||..
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            11   1235678899999987543    78899999999999999999999965

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=2.2e-27  Score=246.47  Aligned_cols=198  Identities=20%  Similarity=0.209  Sum_probs=161.1

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.+.+|.|+++.|+++.. +++.||+|++...  ..+..+.+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455556666666554 7899999998754  3445668899999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc----
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD----  592 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~----  592 (656)
                      +|..++.... ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.++|+|||.+........    
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999886432 234788999999999999999999987   99999999999999999999999998875432211    


Q ss_pred             -ccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 -EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 -~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                       ........++..|+|||.+..  ..++.++|+|||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence             111123356778999999865  3578899999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=2.8e-27  Score=247.15  Aligned_cols=198  Identities=22%  Similarity=0.303  Sum_probs=160.4

Q ss_pred             Cccccc--CceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEG--GFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      ..||+|  +||+||++.. ..++.||+|++....  .+..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  8999999965 578999999987542  33456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc-
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA-  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~-  594 (656)
                      +++..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99998875432 234788999999999999999999987   9999999999999999999999998654322111100 


Q ss_pred             ----ccccccccccccccccccCC--CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          595 ----NTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       595 ----~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                          ......++..|+|||.+.+.  .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                01112345679999998763  4788999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=3.5e-27  Score=241.35  Aligned_cols=199  Identities=25%  Similarity=0.431  Sum_probs=162.9

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEeeCCc-----
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  505 (656)
                      |++.+.||+|+||.||++... +++.+|+|+++....  .....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999765 489999999875422  1233456777776665   59999999999988776     


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++++||+.+ +|..++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 7877764322 235899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......   .....++..|+|||.+.+..++.++|+|||||++|||++|++||....
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            6543211   122356788999999988889999999999999999999999886543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=242.43  Aligned_cols=199  Identities=26%  Similarity=0.393  Sum_probs=167.2

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      |+..+.||+|++|.||++... +++.+++|++.....  .....+.+|+.++++++|+|++++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999654 688999999876532  23457788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++ ++..++...  ...+++..+..++.+++++|.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 777766442  246889999999999999999999987   9999999999999999999999999997664432  


Q ss_pred             cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            112223567889999988766 78999999999999999999999986543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=1.4e-27  Score=250.87  Aligned_cols=200  Identities=23%  Similarity=0.351  Sum_probs=163.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC----------
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER----------  503 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----------  503 (656)
                      .+|+..+.||.|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788899999999999999954 56889999998776656667788999999999999999998766543          


Q ss_pred             ----CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEE
Q 006211          504 ----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKI  578 (656)
Q Consensus       504 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl  578 (656)
                          ...++|+||++ ++|..++.    ...+++.....++.|++.||.|||+.+   ++||||||+||+++. ++.++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                34689999997 57877663    235789999999999999999999987   999999999999974 567899


Q ss_pred             EeccCccccccCcccc-ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999997653321111 1122356888999997654 56788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-28  Score=257.27  Aligned_cols=203  Identities=24%  Similarity=0.391  Sum_probs=173.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee-----CC
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE-----RD  504 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~  504 (656)
                      ..++.|++.+.||.|.+|.||+++ ..+++..|+|++..... ..+++..|.++++.. .|||++.++|++..     .+
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            345667888999999999999994 45788999998876533 335678899999988 69999999999854     46


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      .+|||||||.+|+..+++.... ...+.|.....|++.++.|+.+||.+.   ++|||||-.|||++.++.|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence            8999999999999999987654 567899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCC-----CCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKG-----IYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ..+...  ..+....+||+.|||||++...     .|+.++|+||||++..||--|.+|+-.
T Consensus       171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D  230 (953)
T KOG0587|consen  171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD  230 (953)
T ss_pred             eeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence            877653  3344556899999999998643     377899999999999999999999843

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2e-27  Score=248.62  Aligned_cols=201  Identities=25%  Similarity=0.376  Sum_probs=168.9

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM  507 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  507 (656)
                      +|++.+.||.|++|.||+|... +++.+|+|++....  ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999654 48899999987643  334567889999999999999999999987765     789


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      ++|||++ ++|..++..   ...+++..+..++.+++++|.+||+.+   ++||||||.|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 477777743   236899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCccc-cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDE-ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            443210 112234678899999999877 78999999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=3.4e-27  Score=244.26  Aligned_cols=195  Identities=30%  Similarity=0.436  Sum_probs=162.9

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .|+..+.||+|++|.||+|.. .+++.+++|.+...   .....+++.+|+++++.++|+|++++.+++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            366678899999999999965 45788999988643   22334567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+. +++...+...  ...+++.++..++.+++.++.|||+.+   ++||||+|+||+++.++.++|+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 5776665332  335789999999999999999999987   999999999999999999999999998764321 


Q ss_pred             ccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                           ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+...
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence                 1235788999999874   356788999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=1.7e-27  Score=246.71  Aligned_cols=203  Identities=26%  Similarity=0.424  Sum_probs=162.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|++.+.||+|++|.||+|.. .+++.+|+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46788999999999999999965 4688999998865422  22345678999999999999999998875433      


Q ss_pred             --ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          505 --ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       505 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                        ..++|+||+.+ ++...+...  ...+++..+..++.|++++|.|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999875 565555432  335899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCcccc---------ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          583 MAKLFRKDVDEA---------NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       583 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +++.........         ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            997654322111         1122356788999998765 45789999999999999999999998643

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=5.3e-27  Score=245.46  Aligned_cols=200  Identities=24%  Similarity=0.333  Sum_probs=160.9

Q ss_pred             CCCCCCcccccCceEEEEEEeC-C--CCEEEEEEccCCC--hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC----Cc
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-R--GQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER----DE  505 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  505 (656)
                      +|++.+.||+|+||.||++... .  +..+|+|++....  ....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999653 3  6789999986532  22345678899999999 599999999875432    35


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++++|++. ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888885 678777743   345889999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccc--cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .+......  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            65432111  11223468899999998765 46889999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.5e-27  Score=240.13  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=164.1

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      |++.+.||+|++|+||+|... +++.++||++..... .......+|+..+.+++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999764 478899999865432 12223457899999998 999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                       +++|..++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788887775432 235799999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             ccccccccccccccccccc-CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        .....++..|+|||.+. ...++.++|+||||++++||++|+.||...
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence              12235788899999874 455789999999999999999999998654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.7e-27  Score=234.18  Aligned_cols=193  Identities=27%  Similarity=0.383  Sum_probs=165.9

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       443 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ||+|+||.||++... +++.+++|++.....   .....+..|+.++++++|||++++++.+......+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999654 588999999876432   2455788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR  598 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  598 (656)
                      .+++...   ..+++.....++.|+++++.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9888532   35889999999999999999999987   9999999999999999999999999997654321  12233


Q ss_pred             ccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       599 ~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..++..|+|||.+.+...+.++|+||||+++|||++|+.||....
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            467889999999988888999999999999999999999996543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=5.5e-27  Score=239.27  Aligned_cols=198  Identities=28%  Similarity=0.405  Sum_probs=166.8

Q ss_pred             CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      |+..+.||+|.+|.||+|... +++.+++|.+....  ....+.+..|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999654 58999999987653  233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      + ++|..++....  ..+++..+..++.+++++|.+||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 58988885422  35889999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       ......++..|+|||.+... .++.++|||||||+++||++|+.||...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence             12223456789999988766 7899999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-29  Score=234.24  Aligned_cols=206  Identities=23%  Similarity=0.367  Sum_probs=165.8

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEE
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENML  508 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  508 (656)
                      .+..+.||.|+||.||.++. .+|+.||.|.+...  +-...+++-+|+++|..++|.|++..++......     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568899999999999954 56999999988653  2334567889999999999999999988765432     4577


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++|.|. .+|..++..   ...++.....-+.+||++||+|||+.+   |.||||||.|.|++.|..+||||||+++...
T Consensus       135 ~TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            888885 467666643   345777888889999999999999998   9999999999999999999999999999765


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccccc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF  650 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  650 (656)
                      .+.....+ .-+-|..|.|||++.+ ..|+...||||.||++.||+..+--|...+.-+.+.+
T Consensus       208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l  269 (449)
T KOG0664|consen  208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM  269 (449)
T ss_pred             hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence            44333333 3356889999999876 5689999999999999999999988876665554443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=1.2e-27  Score=264.27  Aligned_cols=199  Identities=31%  Similarity=0.484  Sum_probs=156.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-------
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-------  502 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  502 (656)
                      +-.++|+.++.||+|+||.||+++. -+|+.||||++... +.+....+.+|+..+.+|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4456788889999999999999953 48999999998765 33445678899999999999999986532100       


Q ss_pred             --------------------------------------------------------------------------------
Q 006211          503 --------------------------------------------------------------------------------  502 (656)
Q Consensus       503 --------------------------------------------------------------------------------  502 (656)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHH
Q 006211          503 ------------------------R--------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL  550 (656)
Q Consensus       503 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L  550 (656)
                                              +        ..+||-||||+..++..++.+....  -.....++++.+|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                    0        1236788888888887777432211  14577899999999999999


Q ss_pred             HhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc---c-------------CccccccccccccccccccccccCC
Q 006211          551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR---K-------------DVDEANTGRIVGTYGYVPPEYVKKG  614 (656)
Q Consensus       551 h~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~~  614 (656)
                      |+++   +|||||||.||+++++..|||+|||++....   .             .......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9998   9999999999999999999999999998621   0             0111123346899999999999765


Q ss_pred             C---CCccchhHHHHHHHHHHHcC
Q 006211          615 I---YSMKYDVYSFGVLLLQIISS  635 (656)
Q Consensus       615 ~---~s~~sDvwslGvil~elltg  635 (656)
                      .   |+.|+|+||||+|++||+.-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhcc
Confidence            4   99999999999999999853

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=6.3e-27  Score=261.10  Aligned_cols=203  Identities=27%  Similarity=0.401  Sum_probs=167.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC--------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .++..+.+.||+|.||.|++|...        ....||||.++... ..+.+.+..|+++|+.+ +|+|++.++|+|..+
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344456679999999999999532        14579999998653 34567899999999999 599999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCC-----c------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPI-----R------R--YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      ...++|.||++.|+|..++....     .      .  ..++..+.+.++.||+.||+||++.+   ++||||..+|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            99999999999999999997644     0      0  23889999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      .++..+||+|||+++......... ..+...-+..|||||.+....|+.++||||||++|||++|...+.
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            999999999999998654332221 111111355799999999999999999999999999999976554

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=6.8e-27  Score=235.77  Aligned_cols=200  Identities=28%  Similarity=0.401  Sum_probs=163.0

Q ss_pred             CCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999996543 444555555432     122233567789999999999999999999988899999


Q ss_pred             EEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          510 YEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      +||+++++|..++... .....+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.+ .++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~~-~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeecC-CEeecccCceeecC
Confidence            9999999998887532 23346899999999999999999999987   9999999999999864 69999999997654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ....  ......++..|+|||.+....++.++|+||||+++|+|++|+.||..
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3221  12234578899999998888889999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=4.3e-27  Score=247.21  Aligned_cols=197  Identities=24%  Similarity=0.367  Sum_probs=164.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  505 (656)
                      ..++|+..+.||+|++|.||+|... +++.||+|++...  .....+.+.+|+.+++.++|||++++.+++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4568899999999999999999664 5789999998653  22334567789999999999999999987765554    


Q ss_pred             --eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          506 --NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       506 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                        .++|+||+ +++|..++..    ..+++..+..++.|++++|.|||+.+   ++||||+|+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 6688877743    35899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9765322     122356788999998765 46788999999999999999999999644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-28  Score=236.90  Aligned_cols=210  Identities=22%  Similarity=0.305  Sum_probs=174.1

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC--CC----ceeeEEEEEeeCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--HV----NLLRVLGYCTERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~l~~~~~~~~~  505 (656)
                      ..++|.+++.+|+|.||.|-++ +...+..||||+++... ...+.-+-|++++.++.  .|    -++.+.++|.-.+.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            4789999999999999999999 44457899999987652 33455577999999993  22    37888899999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------------  572 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-------------  572 (656)
                      .|||+|.+ |-|+.+++.+. .-.+.+....+.++.|+++++++||++.   ++|.||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999987 56888888553 2335788899999999999999999998   999999999999842             


Q ss_pred             -------CCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          573 -------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       573 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                             +..++|+|||.|..-.     .....++.|..|.|||++.+-.++..+||||+||||.||.||..-|...++-
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   2458999999997532     2235678899999999999999999999999999999999999999888776


Q ss_pred             cccccccc
Q 006211          646 ENLNFLEY  653 (656)
Q Consensus       646 ~~~~~~~~  653 (656)
                      |.+.+++.
T Consensus       316 EHLaMMer  323 (415)
T KOG0671|consen  316 EHLAMMER  323 (415)
T ss_pred             HHHHHHHH
Confidence            76666554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=2e-26  Score=260.92  Aligned_cols=145  Identities=27%  Similarity=0.389  Sum_probs=128.6

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.++||+|+||.||+|... +++.||||+++...   ......+..|+.++..++||||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999654 68899999987542   233457888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      ||+++++|..++..   ...+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999988853   234788899999999999999999987   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=1.4e-26  Score=230.15  Aligned_cols=180  Identities=18%  Similarity=0.147  Sum_probs=151.1

Q ss_pred             cCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhhhhhC
Q 006211          446 GGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD  524 (656)
Q Consensus       446 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  524 (656)
                      |.+|.||++.. .+++.+|+|++.....     +.+|...+....|||++++++++...+..+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999954 5688999999876532     23344455556799999999999999999999999999999888753


Q ss_pred             CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccccccccc
Q 006211          525 PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG  604 (656)
Q Consensus       525 ~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  604 (656)
                      .   ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence            2   34889999999999999999999987   9999999999999999999999999886543221     12245677


Q ss_pred             ccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       605 y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |+|||.+....++.++|+||+|+++|||++|+.|+..
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9999999888889999999999999999999988754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5e-27  Score=245.32  Aligned_cols=196  Identities=25%  Similarity=0.348  Sum_probs=163.2

Q ss_pred             hcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++.|.....+|.|+|+.|..+ ...+++..++|++.....    +..+|+.++... +|||++++.+.+.+....++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567788888999999999998 456788999999977622    234566565555 79999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE-cCCCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl-~~~~~~kl~DfGla~~~~~~  590 (656)
                      .+.++.+...+..   . .....++..|+.+|+.++.|||+.|   ++||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~---~-~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---K-PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---c-chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999888666532   1 2222677789999999999999987   9999999999999 58899999999999876543


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                           ....+-|..|.|||++....+++++|+||||++||+||+|+.||......
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence                 12235578999999999999999999999999999999999999765544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.7e-26  Score=245.25  Aligned_cols=203  Identities=24%  Similarity=0.370  Sum_probs=150.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-----------------CCCCEEEEEEccCCChhhHHHH--------------HHHH
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-----------------PRGQEFAVKRLSATSTQGLEEF--------------KNEV  482 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~  482 (656)
                      .++|++.++||+|+||.||+|..                 ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999843                 2356799999875433222222              3466


Q ss_pred             HHHHhcCCCce-----eeEEEEEee--------CCceEEEEEecCCCChhhhhhCCC---------------------cC
Q 006211          483 SLTARLQHVNL-----LRVLGYCTE--------RDENMLIYEYLPNKSLDLYLFDPI---------------------RR  528 (656)
Q Consensus       483 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~  528 (656)
                      .++.+++|.++     ++++++|..        ....++|+||+++++|.+++....                     ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     667777653        356799999999999998875321                     11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccccccccccccc
Q 006211          529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP  608 (656)
Q Consensus       529 ~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP  608 (656)
                      ..+++..+..++.|++++|.|||+.+   ++||||||+|||++.++.+||+|||++........ .......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            23467788899999999999999987   99999999999999999999999999975433211 111122347899999


Q ss_pred             ccccCCCC----------------------CccchhHHHHHHHHHHHcCCC-CCC
Q 006211          609 EYVKKGIY----------------------SMKYDVYSFGVLLLQIISSKR-NAR  640 (656)
Q Consensus       609 E~~~~~~~----------------------s~~sDvwslGvil~elltg~~-p~~  640 (656)
                      |.+.....                      ..+.||||+||+++||+++.. |+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            98753321                      124699999999999999875 553

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.8e-28  Score=227.10  Aligned_cols=204  Identities=22%  Similarity=0.418  Sum_probs=162.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--------C
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--------R  503 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  503 (656)
                      ..|+...+||+|.||+||+|+. ++++.||+|..-.+  .+.--...++|+.+|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3456678899999999999955 45778898865432  22223345889999999999999999887743        2


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ...++|+++|+. +|.-++.+.  ...++..++.+++.++..||.|+|.+.   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999965 566666543  234788899999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCc--cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          584 AKLFRKDV--DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       584 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ++.+....  ........+-|..|.+||.+.+ ..|+++.|||..||++.||.|+.+-+.....
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence            98664432  2233444566999999998765 6699999999999999999999987765443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=240.60  Aligned_cols=196  Identities=24%  Similarity=0.381  Sum_probs=164.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh--------hHHHHHHHHHHHHhcC---CCceeeEEEEEee
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ--------GLEEFKNEVSLTARLQ---HVNLLRVLGYCTE  502 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  502 (656)
                      ..|...+.+|+|+||.|+.|.. .+...|+||.+.+++--        ..-.+-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4588899999999999999954 45678999988765321        1112556999999997   9999999999999


Q ss_pred             CCceEEEEEecC-CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          503 RDENMLIYEYLP-NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       503 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      ++..+|+||-.. +-+|.+++   ..+..+++.++..|++|++.|+++||+++   |||||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999763 44566666   34556999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~  640 (656)
                      |.+......    .....+||..|.|||++.+..| ...-|||++|++||.++....||.
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999765433    2335689999999999998887 456899999999999999888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.2e-25  Score=219.03  Aligned_cols=199  Identities=30%  Similarity=0.457  Sum_probs=170.2

Q ss_pred             CCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      |+..+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999997654 889999999876544 56788999999999999999999999998899999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++.....  .+++.....++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            9999988854221  1788999999999999999999986   999999999999999999999999999876543211 


Q ss_pred             ccccccccccccccccc-cCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22234677889999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-26  Score=244.38  Aligned_cols=197  Identities=26%  Similarity=0.390  Sum_probs=158.8

Q ss_pred             CCCCCcccccCceE-EEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecC
Q 006211          437 FSSANKLGEGGFGP-VYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       437 y~~~~~iG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      |...+.+|.|+.|+ ||+|.. +++.||||++-.+.   ....++|+..|+.- +||||+++++.-.++...||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44457799999976 789987 68899999985543   23557899999988 5999999998888889999999999 


Q ss_pred             CCChhhhhhCCCcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---C--CcEEEEeccCccccc
Q 006211          515 NKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---E--LNPKISDFGMAKLFR  588 (656)
Q Consensus       515 ~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~--~~~kl~DfGla~~~~  588 (656)
                      ..+|++++...... ........+.+..|++.||++||+.+   ||||||||+||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            56899988553111 11111445788999999999999987   999999999999976   3  468999999999876


Q ss_pred             cCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcC-CCCCCC
Q 006211          589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARY  641 (656)
Q Consensus       589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg-~~p~~~  641 (656)
                      .+... .......||-+|+|||++....-+..+|||||||++|+.++| +.||..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            55333 234556799999999999988888899999999999999998 888853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=3.8e-25  Score=244.45  Aligned_cols=199  Identities=23%  Similarity=0.317  Sum_probs=138.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-C----CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEE------Ee
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-R----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY------CT  501 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  501 (656)
                      ..++|+..+.||+|+||.||+|... +    +..||+|++......  +....|  .+....+.++..+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3467889999999999999999654 4    689999987653321  111111  1111222222222111      24


Q ss_pred             eCCceEEEEEecCCCChhhhhhCCCcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 006211          502 ERDENMLIYEYLPNKSLDLYLFDPIRR-----------------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK  564 (656)
Q Consensus       502 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dik  564 (656)
                      .....++|+||+++++|.+++......                 .......+..++.|++.+|.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999998887542211                 01123345679999999999999987   9999999


Q ss_pred             CCCEEEcC-CCcEEEEeccCccccccCccccccccccccccccccccccCC----------------------CCCccch
Q 006211          565 ASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG----------------------IYSMKYD  621 (656)
Q Consensus       565 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD  621 (656)
                      |+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999996 57899999999986543221 223345789999999965322                      2334569


Q ss_pred             hHHHHHHHHHHHcCCCCC
Q 006211          622 VYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       622 vwslGvil~elltg~~p~  639 (656)
                      ||||||++|||+++..|.
T Consensus       362 VwSlGviL~el~~~~~~~  379 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             cHHHHHHHHHHHhCcCCC
Confidence            999999999999976554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=1.5e-24  Score=215.41  Aligned_cols=186  Identities=29%  Similarity=0.410  Sum_probs=162.3

Q ss_pred             CceEEEEEEeC-CCCEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhhhhhC
Q 006211          447 GFGPVYKGNLP-RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD  524 (656)
Q Consensus       447 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  524 (656)
                      +||.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++|++++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999765 48999999998765444 67889999999999999999999999998999999999999999988854


Q ss_pred             CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccccccccccc
Q 006211          525 PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG  604 (656)
Q Consensus       525 ~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  604 (656)
                      ..   .+++.....++.++++++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2788999999999999999999987   9999999999999999999999999998654332   2223467888


Q ss_pred             ccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       605 y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |++||.+....++.++|+||||+++++|++|+.||..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888889999999999999999999999865

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG2091 consensus Predicted member of glycosyl hydrolase family 18 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=1.5e-24  Score=205.64  Aligned_cols=289  Identities=12%  Similarity=0.172  Sum_probs=220.8

Q ss_pred             EEEEEecCCC--CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCccc
Q 006211           28 IKAGYWLAGR--EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ  105 (656)
Q Consensus        28 ~~~~y~~~~~--~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~  105 (656)
                      .+-||...|+  +|+++.|-.+++|||...+..+...|..+..... .+.-...++++|+++++++++.-+         
T Consensus        80 ~vLayVTPWNs~Gydvakifaskft~iSPVW~ql~~qgs~~~v~G~-hdid~gwiralRk~~~~l~ivPR~---------  149 (392)
T KOG2091|consen   80 TVLAYVTPWNSHGYDVAKIFASKFTYISPVWLQLKDQGSDVGVYGK-HDIDPGWIRALRKSGKDLHIVPRF---------  149 (392)
T ss_pred             ceEEEecCcCccchhHHHHHhcccceecchheeehhcCcceEEeec-ccCChHHHHHHHHhCCCceeecee---------
Confidence            3578887665  6999999999999999999999876644443333 334455668899999999988776         


Q ss_pred             cccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceee-eeCCCc-cCcchHHHHHHHHHhhcCCCCCcEEEE
Q 006211          106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNS-TDLNSLGILLDEWKASASDQPELTLSM  183 (656)
Q Consensus       106 ~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdid-we~p~~-~d~~~~~~ll~~lr~~l~~~~~~~ls~  183 (656)
                       .|..+.  ...|..++.+++.|++..+.++++++++||||+.++ |..-.. -+......|++.|.++++ +..++...
T Consensus       150 -~fd~~~--~~d~ke~l~ke~l~ekv~~tlv~~ck~~~fdGlVlevwsq~a~~i~d~~al~~v~hl~k~Lh-kq~l~~iL  225 (392)
T KOG2091|consen  150 -YFDEFT--SADLKEFLVKEALREKVGQTLVNFCKKHGFDGLVLEVWSQLADVIADKDALELVEHLGKALH-KQELQAIL  225 (392)
T ss_pred             -hhhhcc--chHHHHHhhhHHHHHHHHHHHHHHHHHcCCCeeeHHHHHHHHHHHhhhHHHHHHHHHHHHHH-HhheEEEE
Confidence             334433  334789999999999999999999999999999998 643222 112445577888888884 34666777


Q ss_pred             EeecCCC--ccccc----cChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCcee
Q 006211          184 AVRYSPT--HETVS----YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV  257 (656)
Q Consensus       184 a~~~~~~--~~~~~----~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~  257 (656)
                      .+|+...  +.+..    =++..|.+.+|.+.+|||||.++   ..+|++||++      +++.++....-...-+.|+.
T Consensus       226 vvPp~~~~e~~~~~~ft~ee~~~L~~~~d~fsLmTYd~s~~---~~pg~nap~~------wi~~~l~~l~~~s~~r~KiL  296 (392)
T KOG2091|consen  226 VVPPVIEEENGQLKFFTPEEFSKLVAVYDGFSLMTYDYSLV---QGPGPNAPLE------WIRHCLHHLGGSSAKRPKIL  296 (392)
T ss_pred             EeCCCCcCCCCCcCcCCHHHHHHHHHhhhheeEEEeecccc---cCCCCCCCHH------HHHHHHHHhCCcccccccee
Confidence            7776322  22221    26789999999999999999843   4689999998      88999988776666779999


Q ss_pred             ecccCCCCCcCC---CCCcchHHHHHHHHhcCCCcccccccceeeeee-----ecCcEEEeeCCcchhHHHHhhhhhccc
Q 006211          258 LGARASGPGITI---DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF-----TSGATWINFDGVETIKAKISYAKEKNL  329 (656)
Q Consensus       258 lG~p~yG~~~~~---~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~-----~~~~~~i~yd~~~si~~K~~~~~~~gl  329 (656)
                      +|+.|||..+..   .+.++.....+.++...  -.-.||+.+...+.     .++++-|.|.+..|+..+.++|++.|.
T Consensus       297 lGlNFYG~d~~~gdg~~~IT~~rYL~lLk~~k--~~~~~Dees~EH~f~~k~n~~gkhivfyPTL~Sl~~Ri~lA~~~gv  374 (392)
T KOG2091|consen  297 LGLNFYGNDFNLGDGGEAITAKRYLQLLKGEK--SVFKFDEESKEHFFEYKRNDDGKHIVFYPTLTSLELRIELARELGV  374 (392)
T ss_pred             EeeeccccccccCCCCCceeHHHHHHHHhccC--cceeeccccchhheeeeccCCCceEEEecchHhHHHHHHHHHHhCC
Confidence            999999999977   35666666666666554  45567877765542     235899999999999999999999996


Q ss_pred             ccceeeEeccCcc
Q 006211          330 LGYKAFQLSNDDN  342 (656)
Q Consensus       330 gGv~~W~l~~Dd~  342 (656)
                       ||++|+++|-=+
T Consensus       375 -gISIWe~GqGLD  386 (392)
T KOG2091|consen  375 -GISIWEYGQGLD  386 (392)
T ss_pred             -ceEeeeccCchh
Confidence             999999998543

>cd06542 GH18_EndoS-like Endo-beta-N-acetylglucosaminidases are bacterial chitinases that hydrolyze the chitin core of various asparagine (N)-linked glycans and glycoproteins

Probab=99.91  E-value=1.1e-23  Score=210.86  Aligned_cols=228  Identities=13%  Similarity=0.128  Sum_probs=161.6

Q ss_pred             EEEEEecCCCC------CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCC
Q 006211           28 IKAGYWLAGRE------FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQN  101 (656)
Q Consensus        28 ~~~~y~~~~~~------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~  101 (656)
                      +..|||..|..      ..+.++| +.+++|++.++.++.++...  ...........+..+|++  ++||++|||    
T Consensus         2 ~~~~y~~~~~~~~~~~~~~l~~~p-ds~D~v~lf~~~~~~~~~~~--~~~~~~~~~~~i~~l~~k--G~KVl~sig----   72 (255)
T cd06542           2 ISFGYFEVWDDKGASLQESLLNLP-DSVDMVSLFAANINLDAATA--VQFLLTNKETYIRPLQAK--GTKVLLSIL----   72 (255)
T ss_pred             eEEEEEEecCCcCcccccccccCC-CcceEEEEcccccCcccccc--hhhhhHHHHHHHHHHhhC--CCEEEEEEC----
Confidence            46789988764      4666777 55888888444444331110  111223344555556665  799999994    


Q ss_pred             CccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-------cCcchHHHHHHHHHhhcC
Q 006211          102 STYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------TDLNSLGILLDEWKASAS  174 (656)
Q Consensus       102 ~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-------~d~~~~~~ll~~lr~~l~  174 (656)
                              |+..... | ....+++.|++|++++++++++|||||||||||+|..       .+.++|..|+++||++++
T Consensus        73 --------g~~~~~~-~-~~~~~~~~~~~fa~~l~~~v~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~lv~~Lr~~~~  142 (255)
T cd06542          73 --------GNHLGAG-F-ANNLSDAAAKAYAKAIVDTVDKYGLDGVDFDDEYSGYGKNGTSQPSNEAFVRLIKELRKYMG  142 (255)
T ss_pred             --------CCCCCCC-c-cccCCHHHHHHHHHHHHHHHHHhCCCceEEeeeecccCCCCCCcchHHHHHHHHHHHHHHhC
Confidence                    4433322 3 3566788999999999999999999999999999864       367899999999999994


Q ss_pred             CCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCC
Q 006211          175 DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN  254 (656)
Q Consensus       175 ~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~  254 (656)
                      + .+++|++++++.....    +.+++.+++||+++|+||-.    +...+.    +            ......|+|++
T Consensus       143 ~-~~kllt~~~~~~~~~~----~~~~~~~~vDyv~~~~y~~~----~~~~~~----~------------~~~~~~g~~~~  197 (255)
T cd06542         143 P-TDKLLTIDGYGQALSN----DGEEVSPYVDYVIYQYYGSS----SSSTQR----N------------WNTNSPKIPPE  197 (255)
T ss_pred             c-CCcEEEEEecCCchhc----CHHHHHHhCCEEEeeccCCC----CccCCc----c------------cccccCCCCHH
Confidence            3 4789999987654322    67999999999999999854    221111    0            01113589999


Q ss_pred             ceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhc-ccccce
Q 006211          255 KLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEK-NLLGYK  333 (656)
Q Consensus       255 Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~-glgGv~  333 (656)
                      |+++|+++++....                                           .+..++...++++.+. +.||+|
T Consensus       198 k~i~~~~~~~~~~~-------------------------------------------~~~~~~~~~A~~~~~~~~~gG~~  234 (255)
T cd06542         198 KMVYTESFEEENGG-------------------------------------------NSGSSAEQYARWTPAKGGKGGIG  234 (255)
T ss_pred             HceeeeeeecccCC-------------------------------------------CcchhHHHHHhcCcccCceEEEE
Confidence            99999999973111                                           2344556677778777 999999


Q ss_pred             eeEeccCcc
Q 006211          334 AFQLSNDDN  342 (656)
Q Consensus       334 ~W~l~~Dd~  342 (656)
                      +|.++.|-.
T Consensus       235 ~y~~~~dy~  243 (255)
T cd06542         235 TYALDRDYY  243 (255)
T ss_pred             EEecCCCcc
Confidence            999999864

The endo-beta-N-acetylglucosaminidases have a glycosyl hydrolase family 18 (GH18) catalytic domain. Some members also have an additional C-terminal glycosyl hydrolase family 20 (GH20) domain while others have an N-terminal domain of unknown function (pfam08522). Members of this family include endo-beta-N-acetylglucosaminidase S (EndoS) from Streptococcus pyogenes, EndoF1, EndoF2, EndoF3, and EndoH from Flavobacterium meningosepticum, and EndoE from Enterococcus faecalis. EndoS is a secreted endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes the glycan on human IgG between two core N-acetylglucosamine residues. EndoE is a secreted endoglycosidase, encoded by the ndoE gene in Enterococcus faecalis, that hydrolyzes the glycan on human RNase B.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-25  Score=208.63  Aligned_cols=194  Identities=19%  Similarity=0.345  Sum_probs=154.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEE-EEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLG-YCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~  510 (656)
                      .+.|.+.+.||+|.||.+-++.. +..+.+++|-+..+.. ..++|.+|..---.| .|.||+.-++ .|+..+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            45688889999999999999955 4577899998877543 356788888765555 5889988765 467778888999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc--CCCcEEEEeccCccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NELNPKISDFGMAKLFR  588 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~--~~~~~kl~DfGla~~~~  588 (656)
                      ||++.|+|..-+    ....+.+.....++.|+++|+.|+|+.+   +||||||.+||||-  +...+||||||+.+...
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999997665    3345788899999999999999999998   99999999999994  33479999999997644


Q ss_pred             cCccccccccccccccccccccccCC-----CCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKG-----IYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ......     .-+..|.+||.....     ...+.+|+|.||++++..|||+.||+
T Consensus       175 ~tV~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  175 TTVKYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             ceehhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            322221     234579999976422     24678999999999999999999997

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=1.3e-25  Score=227.31  Aligned_cols=209  Identities=22%  Similarity=0.258  Sum_probs=173.4

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC------CCceeeEEEEEee
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ------HVNLLRVLGYCTE  502 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~  502 (656)
                      .+....+|.+....|+|-|++|.+|. ...|+.||||++..... -.+.=+.|+++|++|.      .-|+++++..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            34566789999999999999999994 44588999999976422 2233467999999994      3479999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEec
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDF  581 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~Df  581 (656)
                      .+++|||+|-+ .-+|.+.|.....+-.|....+..++.|+.-||..|..++   |+|.||||.|||+++.. .+|||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence            99999999987 4578888877777777888999999999999999999987   99999999999999764 5899999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCccc
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN  647 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~  647 (656)
                      |.|.....+   ..+. ..-+..|.|||++.+.+|++..|+||+||+||||.||+-.|.+.++..-
T Consensus       582 GSA~~~~en---eitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M  643 (752)
T KOG0670|consen  582 GSASFASEN---EITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM  643 (752)
T ss_pred             ccccccccc---cccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence            999764322   1121 2335689999999999999999999999999999999999988776543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=8.2e-25  Score=210.13  Aligned_cols=194  Identities=25%  Similarity=0.332  Sum_probs=159.8

Q ss_pred             cCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------c
Q 006211          435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------E  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  505 (656)
                      .+|..++.+|.|.- .|..+ +.-.+++||+|.+..+  .....++..+|...+..+.|+|+++++.++....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46677788999988 55555 4457899999987654  2233456688999999999999999999987654      4


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++|||+|. .+|...+.     ..++-.+...+..|+++|++|||+.+   |+||||||+||++..++.+||.|||+++
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            689999994 56766653     23677889999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .-...   ...+..+.+..|.|||++.+..+.+.+||||+||++.||++|+--|.+
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            54322   233445778899999999988899999999999999999999988864

>cd06543 GH18_PF-ChiA-like PF-ChiA is an uncharacterized chitinase found in the hyperthermophilic archaeon Pyrococcus furiosus with a glycosyl hydrolase family 18 (GH18) catalytic domain as well as a cellulose-binding domain

Probab=99.90  E-value=2.5e-23  Score=208.59  Aligned_cols=149  Identities=15%  Similarity=0.191  Sum_probs=118.5

Q ss_pred             CCCccEEEEEEEEecCCCcEEecCCc---c-hhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccc
Q 006211           46 SALFTHLICAFAEVDSSTYQLSISSA---N-QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSM  121 (656)
Q Consensus        46 ~~~~thi~~~f~~~~~~~~~~~~~~~---~-~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~  121 (656)
                      ...|+|+++||+....+ +.......   . ...+...+..+|+++  +||+||+            |||....  |+. 
T Consensus        23 ~~g~~~v~lAFi~~~~~-~~~~w~g~~~~~~~~~~~~~i~~lk~~G--~kViiS~------------GG~~g~~--~~~-   84 (294)
T cd06543          23 ATGVKAFTLAFIVASGG-CKPAWGGSYPLDQGGWIKSDIAALRAAG--GDVIVSF------------GGASGTP--LAT-   84 (294)
T ss_pred             HcCCCEEEEEEEEcCCC-CcccCCCCCCcccchhHHHHHHHHHHcC--CeEEEEe------------cCCCCCc--ccc-
Confidence            46799999999988754 44443332   1 344556667888885  8999999            4444321  233 


Q ss_pred             cCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCc---chHHHHHHHHHhhcCCCCCcEEEEEeecCCCccc-cccC
Q 006211          122 VGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDL---NSLGILLDEWKASASDQPELTLSMAVRYSPTHET-VSYP  197 (656)
Q Consensus       122 ~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~---~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~-~~~~  197 (656)
                        +...|++|++++.+++.+|+|||||||||+|...|+   +++..+|++|++++   +++.||+++|..+.... .+++
T Consensus        85 --~~~~~~~~~~a~~~~i~~y~~dgiDfDiE~~~~~d~~~~~~~~~al~~Lq~~~---p~l~vs~Tlp~~p~gl~~~g~~  159 (294)
T cd06543          85 --SCTSADQLAAAYQKVIDAYGLTHLDFDIEGGALTDTAAIDRRAQALALLQKEY---PDLKISFTLPVLPTGLTPDGLN  159 (294)
T ss_pred             --CcccHHHHHHHHHHHHHHhCCCeEEEeccCCccccchhHHHHHHHHHHHHHHC---CCcEEEEecCCCCCCCChhHHH
Confidence              678999999999999999999999999999988776   88999999999888   37889999998776554 6678


Q ss_pred             hhhhhh----ccchhhhhhhcccC
Q 006211          198 IDSMKK----NLNWAHLVAYDYHM  217 (656)
Q Consensus       198 ~~~l~~----~vD~invmtYD~~g  217 (656)
                      +.+.++    .+|+||||||||++
T Consensus       160 ~l~~a~~~Gv~~d~VNiMtmDyg~  183 (294)
T cd06543         160 VLEAAAANGVDLDTVNIMTMDYGS  183 (294)
T ss_pred             HHHHHHHcCCCcceeeeeeecCCC
Confidence            899999    99999999999984

Members of this domain family are found not only in archaea but also in eukaryotes and prokaryotes. PF-ChiA exhibits hydrolytic activity toward both colloidal and crystalline (beta/alpha) chitins at high temperature.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=8.5e-24  Score=210.79  Aligned_cols=214  Identities=24%  Similarity=0.379  Sum_probs=171.0

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      +....+.|...++||+|.|++||++...    ..+.||+|.+...+..  .++..|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445677899999999999999999432    4678999998766443  5688999999999 5999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGM  583 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGl  583 (656)
                      ...+|+||++.....++...      ++...+..+++.+..||.++|+++   ||||||||.|+|.+.. +.-.|+|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999988888743      667889999999999999999998   9999999999999864 5678999999


Q ss_pred             ccccccCc------c------------------------------------ccccccccccccccccccccC-CCCCccc
Q 006211          584 AKLFRKDV------D------------------------------------EANTGRIVGTYGYVPPEYVKK-GIYSMKY  620 (656)
Q Consensus       584 a~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~s  620 (656)
                      |.......      .                                    ........||++|.|||++.. ...+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97211000      0                                    000112469999999998865 4468899


Q ss_pred             hhHHHHHHHHHHHcCCCCCCCCCCccccccccccc
Q 006211          621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAS  655 (656)
Q Consensus       621 DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  655 (656)
                      ||||.|||++-+++++.||.. ..++...+.|.++
T Consensus       260 Diws~GVI~Lslls~~~PFf~-a~dd~~al~ei~t  293 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFK-AKDDADALAEIAT  293 (418)
T ss_pred             ceeeccceeehhhcccccccc-CccccchHHHHHH
Confidence            999999999999999999943 4445555555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-24  Score=226.40  Aligned_cols=198  Identities=25%  Similarity=0.408  Sum_probs=172.6

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|+.+.++|.|.||.||+++ ...++..|+|+++........-+++|+-+++..+||||+.+++-+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3568889999999999999995 456889999999988777777788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |.+|+|++.-+   .-.++++.+....+++..+++.|||+++   -+|||||-.|||+++.|.+|++|||.+-.+...  
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence            99999987763   2456889999999999999999999998   799999999999999999999999999766532  


Q ss_pred             ccccccccccccccccccc---cCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      -.......||+.|||||+-   ..+.|..++|+|++|+...|+--.++|.
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            2233456899999999975   4567899999999999999998777775

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=4.8e-22  Score=192.50  Aligned_cols=183  Identities=36%  Similarity=0.579  Sum_probs=156.5

Q ss_pred             ccccCceEEEEEEeCC-CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhh
Q 006211          443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL  520 (656)
Q Consensus       443 iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  520 (656)
                      ||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997654 899999999876443 34678999999999999999999999999899999999999999999


Q ss_pred             hhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCccccccCccccccccc
Q 006211          521 YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRI  599 (656)
Q Consensus       521 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  599 (656)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||++++ ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            885421  35788999999999999999999997   999999999999999 89999999999976543221  12223


Q ss_pred             cccccccccccccCC-CCCccchhHHHHHHHHHH
Q 006211          600 VGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQI  632 (656)
Q Consensus       600 ~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~el  632 (656)
                      .+...|++||.+... ..+.++|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            567889999998877 788999999999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd02877 GH18_hevamine_XipI_class_III This conserved domain family includes xylanase inhibitor Xip-I, and the class III plant chitinases such as hevamine, concanavalin B, and PPL2, all of which have a glycosyl hydrolase family 18 (GH18) domain

Probab=99.88  E-value=7.1e-22  Score=196.68  Aligned_cols=237  Identities=17%  Similarity=0.165  Sum_probs=150.0

Q ss_pred             EEEEecCCC-CCCCCCC-CCCCccEEEEEEEEecCCCcE--EecCC--cch-----hhHHHHHHHHHhhCCCceEEEEee
Q 006211           29 KAGYWLAGR-EFPLSDI-NSALFTHLICAFAEVDSSTYQ--LSISS--ANQ-----QYFSIFANSVRRKNPSIKTLLSIW   97 (656)
Q Consensus        29 ~~~y~~~~~-~~~~~~i-~~~~~thi~~~f~~~~~~~~~--~~~~~--~~~-----~~~~~~~~~~k~~~~~~kvl~sig   97 (656)
                      ++.||-... +-.+... +...++-|+++|+..-++++.  +.+..  ...     ..+...++.+++  +++|||||||
T Consensus         3 v~vyWGq~~~~~~L~~~C~~~~~dii~i~Fl~~~~~~~~p~~n~~~~c~~~~~~~c~~~~~dI~~cq~--~G~KVlLSIG   80 (280)
T cd02877           3 IAVYWGQNSDEGSLREYCDTGNYDIVNISFLNVFGSGGTPGLNFAGHCGGSTYPNCPQLGADIKHCQS--KGKKVLLSIG   80 (280)
T ss_pred             eEEECCCCCCCCCHHHHhCCCCccEEEEEeEcccCCCCCcccCccccCcccccccchhHHHHHHHHHH--CCCEEEEEcc
Confidence            467873322 2222222 234588999999977654221  11111  111     245555555555  4799999995


Q ss_pred             cCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHH------------HHcCCCcceeeeeCCCccCcchHHHH
Q 006211           98 NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA------------RLYGFQGIDLFWLWPNSTDLNSLGIL  165 (656)
Q Consensus        98 g~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~------------~~~~~DGvdidwe~p~~~d~~~~~~l  165 (656)
                      ||+            .+.. |    .+++.|++|++++.++.            .+++|||||||||+|..   .+|..|
T Consensus        81 G~~------------~~~~-~----~s~~~a~~Fa~~l~~~~~~~~~~~~~rp~g~~~lDGiD~D~E~~~~---~~~~~l  140 (280)
T cd02877          81 GAG------------GSYS-L----SSDADAKDFADYLWNAFGGGTDSGVPRPFGDAVVDGFDFDIEHGSP---ENYDAL  140 (280)
T ss_pred             CCC------------CCcC-C----CCHHHHHHHHHHHHHHhCCccccccccccccccccceEEecccCCc---cCHHHH
Confidence            444            3211 3    67899999999998875            26789999999999985   789999


Q ss_pred             HHHHHhhcCCC--CCcEEEEEeecCCCccccccChhhhhh-ccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHH
Q 006211          166 LDEWKASASDQ--PELTLSMAVRYSPTHETVSYPIDSMKK-NLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFG  242 (656)
Q Consensus       166 l~~lr~~l~~~--~~~~ls~a~~~~~~~~~~~~~~~~l~~-~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~  242 (656)
                      +++||+.+...  +++.||+|++...   ...+....+.. ++||||||.||..+..  ...+.++         .....
T Consensus       141 ~~~LR~~~~~~~~~~~~LTaAPq~~~---~d~~~~~~i~~~~~D~i~vqfYn~~~c~--~~~~~~~---------~~~~~  206 (280)
T cd02877         141 AKRLRSLFASDPSKKYYLTAAPQCPY---PDASLGDAIATGLFDFIFVQFYNNPCCS--YASGNAS---------GFNFN  206 (280)
T ss_pred             HHHHHHHhhcccCCceEEEeccccCC---cchhHHHHHccCccCEEEEEEecCcccc--ccccccc---------hhhhH
Confidence            99999999543  6799999966531   12233455654 9999999999975211  0011111         23445


Q ss_pred             HHHHHHcCCCC---CceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHH
Q 006211          243 IREWLRRGFPA---NKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKA  319 (656)
Q Consensus       243 v~~~~~~g~p~---~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~  319 (656)
                      .+.|... +|.   .||+||+|..-.. ...|                                       |=+|..+..
T Consensus       207 ~~~w~~~-~~~~~~~kv~lGlpas~~a-a~~G---------------------------------------yv~p~~l~~  245 (280)
T cd02877         207 WDTWTSW-AKATSNAKVFLGLPASPEA-AGSG---------------------------------------YVDPSELAS  245 (280)
T ss_pred             HHHHHHh-cccCCCceEEEecccCCCC-CCCC---------------------------------------ccCHHHHHH
Confidence            6667654 555   8999999976421 1122                                       334444444


Q ss_pred             HHhhh-hhc-ccccceeeEeccCcc
Q 006211          320 KISYA-KEK-NLLGYKAFQLSNDDN  342 (656)
Q Consensus       320 K~~~~-~~~-glgGv~~W~l~~Dd~  342 (656)
                      -+..+ .+. ++||||+|++.+|..
T Consensus       246 ~v~~~~~~~~~fGGvM~Wd~~~~~~  270 (280)
T cd02877         246 LVLPVKQKSPNFGGVMLWDASQDKQ  270 (280)
T ss_pred             HHHHHhhcCCCCcEEEEEhHhhccC
Confidence            43333 233 699999999999985

Hevamine is a class III endochitinase that hydrolyzes the linear polysaccharide chains of chitin and peptidoglycan and is important for defense against pathogenic bacteria and fungi. PPL2 (Parkia platycephala lectin 2) is a class III chitinase from Parkia platycephala seeds that hydrolyzes beta(1-4) glycosidic bonds linking 2-acetoamido-2-deoxy-beta-D-glucopyranose units in chitin.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-22  Score=203.06  Aligned_cols=132  Identities=23%  Similarity=0.290  Sum_probs=108.0

Q ss_pred             cCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----C---CceeeEEEEEee---
Q 006211          435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----H---VNLLRVLGYCTE---  502 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~---  502 (656)
                      .+|.+.++||.|-|++||++ +.++.+.||+|+.+.. ....+..+.||++|++++     |   .+||+|+++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67888999999999999999 5667889999998764 233455688999999983     3   369999999965   


Q ss_pred             -CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          503 -RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       503 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                       +.+.|+|+|++ |.+|..++....- ..++...+.+|++|++.||.|||..+  +|||.||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             45789999998 6666666644322 34888999999999999999999987  699999999999983

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.1e-22  Score=208.14  Aligned_cols=167  Identities=17%  Similarity=0.216  Sum_probs=128.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC--CCCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP--RGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      ....+|+..+.||+|+||+||+|...  +++.+|||++...     .....+.+.+|++++++++|+|+++.+..   ..
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            45678999999999999999999653  5777899986533     12234568999999999999999864322   24


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc-CCCCEEEcCCCcEEEEeccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL-KASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Di-kp~NILl~~~~~~kl~DfGl  583 (656)
                      ..++||||+++++|...  .  .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~--~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA--R--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHh--C--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            57999999999999622  1  1   11   1467889999999999987   999999 99999999999999999999


Q ss_pred             ccccccCccccc------cccccccccccccccccCC
Q 006211          584 AKLFRKDVDEAN------TGRIVGTYGYVPPEYVKKG  614 (656)
Q Consensus       584 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  614 (656)
                      |+.+........      .....+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            987654321111      1245778889999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=9.4e-21  Score=196.59  Aligned_cols=203  Identities=21%  Similarity=0.256  Sum_probs=164.1

Q ss_pred             CCCCCCcccccCceEEEEEEeCCC--CEEEEEEccCCChhhHHHHHHHHHHHHhcCC----CceeeEEEEE-eeCCceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRG--QEFAVKRLSATSTQGLEEFKNEVSLTARLQH----VNLLRVLGYC-TERDENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  508 (656)
                      +|.+.++||+|+||.||.+.....  ..+|+|............+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999965443  4789998766533322257788888888863    5888898888 47778899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-----CcEEEEeccC
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-----LNPKISDFGM  583 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-----~~~kl~DfGl  583 (656)
                      ||+.+ |.+|.++..... ...++..+...++.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 889988764433 456899999999999999999999998   9999999999999865     3699999999


Q ss_pred             cc--ccccCcc------ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AK--LFRKDVD------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~--~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++  .+.....      ........||..|++++...+...+.+.|+||++.++.|++.|..||....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            98  3222111      111223569999999999999999999999999999999999999996544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=7.5e-21  Score=183.53  Aligned_cols=205  Identities=22%  Similarity=0.283  Sum_probs=168.7

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..-+|++.++||+|+||+++.| .+-+++.||||.-...++  .-++..|....+.| ..++|..++-+..++....||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            3457899999999999999999 567899999996543322  24567788888888 4788988888888888889999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-----CcEEEEeccCcc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-----LNPKISDFGMAK  585 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-----~~~kl~DfGla~  585 (656)
                      |.+ |.+|+++.--+.+  .++.++...++.|++.-++++|+.+   +|.|||||+|+||..-     ..+.|+|||+|+
T Consensus       104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            987 8899887643333  4788999999999999999999998   9999999999999643     358999999999


Q ss_pred             ccccCcccc-----ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          586 LFRKDVDEA-----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       586 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .+.......     ......||.+||+-....+..-+.+.|+-|||-++.+.|-|..||.+..-+
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            876543221     233467999999999888999999999999999999999999999876544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.1e-21  Score=178.24  Aligned_cols=205  Identities=23%  Similarity=0.312  Sum_probs=166.6

Q ss_pred             HhcCCCCCCcccccCceEEEEE-EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  510 (656)
                      ...+|.++++||.|+||.+|.| ...+|..||||.-+....  ...+..|..+.+.+++ ..|..+..+..+.....+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3568999999999999999999 667899999997654322  2346778899998864 56777777888888999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEEeccCcccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLF  587 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~DfGla~~~  587 (656)
                      +.+ |.+|+++..-..+  .++..+.+-++.|++.-++|+|..+   +|||||||+|.|..-+   ..+.++|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            987 8899887744433  3788899999999999999999998   9999999999999644   35889999999976


Q ss_pred             ccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          588 RKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       588 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      ......     .......||.+|.+-....+..-+.+.|+-|+|.+|.++.-|..||+.....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            543222     1223467899999988877777788999999999999999999999876543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=5.2e-19  Score=183.76  Aligned_cols=202  Identities=30%  Similarity=0.443  Sum_probs=168.2

Q ss_pred             CCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChh---hHHHHHHHHHHHHhcCCC-ceeeEEEEEeeCCceEEEEEe
Q 006211          437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQHV-NLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  512 (656)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999765  88999998765332   356789999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccccCc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDV  591 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~~~~  591 (656)
                      +.++++..++........++......+..|++.++.++|+.+   ++|||+||+||+++... .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866643221125888999999999999999999998   99999999999999998 79999999998554332


Q ss_pred             ccc----ccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEA----NTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...    ......|+..|+|||.+..   ...+...|+||+|++++++++|..|+....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            221    2355689999999999887   578889999999999999999999976544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4e-20  Score=177.65  Aligned_cols=172  Identities=12%  Similarity=0.157  Sum_probs=132.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhh---HHH------HHHHHHHHHhcCCCceeeEEEEEee
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG---LEE------FKNEVSLTARLQHVNLLRVLGYCTE  502 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~e~~~l~~l~h~niv~l~~~~~~  502 (656)
                      ...++|+..+.+|.|+||.||.... ++..+|+|+++......   ...      +.+|+..+.++.||+|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4578999999999999999999866 57789999997653222   122      5789999999999999999888653


Q ss_pred             C--------CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          503 R--------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       503 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      .        ...+++|||++|.+|.++.       .+++    ....++++++..+|..+   ++|||++|+||++++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        3578999999999997663       1222    24558999999999987   99999999999999998


Q ss_pred             cEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHH
Q 006211          575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII  633 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ell  633 (656)
                       ++|+|||.......+   ...           ........+..++|+||||+.+..+.
T Consensus       173 -i~liDfg~~~~~~e~---~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQR---KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccch---hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988654211   000           11334445667899999999887654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.81  E-value=1.3e-20  Score=219.10  Aligned_cols=147  Identities=16%  Similarity=0.195  Sum_probs=109.6

Q ss_pred             cCC-CceeeEEEEE-------eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 006211          488 LQH-VNLLRVLGYC-------TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI  559 (656)
Q Consensus       488 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ii  559 (656)
                      ++| +||.++++.|       ......+.++|++ +++|..++...  ...+++.+++.++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            344 4677777766       2234566778877 66999998543  345899999999999999999999987   99


Q ss_pred             ecccCCCCEEEcCCC-------------------cEEEEeccCccccccCcc--------------cccccccccccccc
Q 006211          560 HRDLKASNILLDNEL-------------------NPKISDFGMAKLFRKDVD--------------EANTGRIVGTYGYV  606 (656)
Q Consensus       560 H~Dikp~NILl~~~~-------------------~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~  606 (656)
                      ||||||+||||+..+                   .+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455566666543211000              00011235788899


Q ss_pred             ccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       607 aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      |||++.+..++.++|||||||++|||+++..|+.
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            9999999999999999999999999999988865

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=2.2e-19  Score=170.77  Aligned_cols=139  Identities=18%  Similarity=0.163  Sum_probs=106.5

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChh--h------------------------HHHHHHHHHHHHhcCCCce
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ--G------------------------LEEFKNEVSLTARLQHVNL  493 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  493 (656)
                      .+.||+|++|.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999998778999999998754211  0                        0122359999999987776


Q ss_pred             eeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecccCCCCEEEcC
Q 006211          494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL-QEYSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       494 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~iiH~Dikp~NILl~~  572 (656)
                      ........  ...++||||++++++.....   ....++..+...++.|++.+|.+| |+.+   |+||||||+|||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence            43332222  23489999999887654422   223578899999999999999999 6776   999999999999994


Q ss_pred             CCcEEEEeccCcccc
Q 006211          573 ELNPKISDFGMAKLF  587 (656)
Q Consensus       573 ~~~~kl~DfGla~~~  587 (656)
                       +.++|+|||+|...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             68999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=1.3e-18  Score=166.11  Aligned_cols=140  Identities=20%  Similarity=0.238  Sum_probs=109.6

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChh---------------------h-----HHHHHHHHHHHHhcCCCce
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ---------------------G-----LEEFKNEVSLTARLQHVNL  493 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  493 (656)
                      ...||+|++|.||+|...+|+.||||+++.....                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998768999999998764211                     0     1124578899999999987


Q ss_pred             eeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcC
Q 006211          494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       494 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~  572 (656)
                      .....+...  ..++||||++++++.....   ....++..+...++.+++.++.++|+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3489999999885543321   22346788899999999999999999 76   99999999999999 


Q ss_pred             CCcEEEEeccCccccc
Q 006211          573 ELNPKISDFGMAKLFR  588 (656)
Q Consensus       573 ~~~~kl~DfGla~~~~  588 (656)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.5e-18  Score=159.81  Aligned_cols=185  Identities=18%  Similarity=0.130  Sum_probs=137.5

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChh----hHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEec
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ----GLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ....|++|+||+|+.+.. .+..++.+.+.....-    ....+.+|+++|+++. |+++.+++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999998865 6778888877665331    1225789999999995 5789998886    3469999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc-CCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL-KASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Di-kp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +|.+|.....    .      ....++.|++++|.++|+.+   |+|||| ||.|||+++++.++|+|||++........
T Consensus        81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9988854321    0      12357788999999999998   999999 79999999999999999999985443221


Q ss_pred             c----c-------ccccccccccccccccccCC-CCC-ccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 E----A-------NTGRIVGTYGYVPPEYVKKG-IYS-MKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .    .       .......++.+++|+...-. ..+ ...+.++.|+.+|.++|++.|...
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            0    0       01112356778888753321 223 467889999999999999988754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.75  E-value=3.8e-18  Score=161.11  Aligned_cols=107  Identities=21%  Similarity=0.156  Sum_probs=92.1

Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN  595 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~  595 (656)
                      |+|.+++...  +..+++..+..++.|+++||.|||+.+         ||+|||++.++.+|+  ||+++.....     
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            6788888542  345899999999999999999999875         999999999999999  9998765321     


Q ss_pred             cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       596 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        ...|++.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence              125789999999999999999999999999999999999998543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=5.2e-19  Score=195.00  Aligned_cols=202  Identities=26%  Similarity=0.377  Sum_probs=159.2

Q ss_pred             CCCcccccCceEEEEEEe-CCCCEEEEEEcc-----CCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLS-----ATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~-----~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ....+|.|++|.|+.... ...+..+.|...     ..... ....+..|+.+-..++|||++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457899999997777633 233334444322     11111 12236678888888999999887777766666666699


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||++ +|..++..   ...++..++..++.|++.|+.|+|+.+   +.|||+|++|++++.++.+||+|||.+..+....
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 88877743   235788899999999999999999998   9999999999999999999999999998876655


Q ss_pred             cc--cccccccccccccccccccCCCCCcc-chhHHHHHHHHHHHcCCCCCCCCCCccc
Q 006211          592 DE--ANTGRIVGTYGYVPPEYVKKGIYSMK-YDVYSFGVLLLQIISSKRNARYYGTSEN  647 (656)
Q Consensus       592 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwslGvil~elltg~~p~~~~~~~~~  647 (656)
                      +.  ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||.....++.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN  533 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence            54  45566789999999999999998765 8999999999999999999977665543

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=4.2e-17  Score=156.48  Aligned_cols=138  Identities=22%  Similarity=0.308  Sum_probs=105.6

Q ss_pred             CCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCC---c-eEE
Q 006211          438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-----QHVNLLRVLGYCTERD---E-NML  508 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  508 (656)
                      ...+.||+|+||.||. ...++. .+||+.........+.+.+|+.+++.+     .||||+++++++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996 333444 479988765444556789999999999     5799999999998864   2 237


Q ss_pred             EEEe--cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecccCCCCEEEcC----CCcEEEEe-
Q 006211          509 IYEY--LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL-LYLQEYSNFRVIHRDLKASNILLDN----ELNPKISD-  580 (656)
Q Consensus       509 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~~iiH~Dikp~NILl~~----~~~~kl~D-  580 (656)
                      |+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||+.+   |+||||||+|||++.    +..++|+| 
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  6689999999542    24444  35577777777 8999998   999999999999974    34799999 


Q ss_pred             ccCccc
Q 006211          581 FGMAKL  586 (656)
Q Consensus       581 fGla~~  586 (656)
                      ||....
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            554433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.5e-17  Score=186.72  Aligned_cols=200  Identities=18%  Similarity=0.219  Sum_probs=156.8

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCce
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDEN  506 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~  506 (656)
                      .+.-...|.+.+.||+|+||+||+|...+|+.||+|+-+....-+   |---.+++.+|+   -+.|..+..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            334456788889999999999999988789999999887664322   111122333333   22344455555567778


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-------CCcEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------ELNPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-------~~~~kl~  579 (656)
                      ++|+||.+.|+|.+++.   ....++|.-...++.|+++.++.||..+   |||+||||+|.||..       ...++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999985   4456899999999999999999999998   999999999999953       3458999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN  638 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p  638 (656)
                      |||-+..+.--.+.......++|-.+-.+|+..++.++++.|.|.|+-+++-||.|+-.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999755433333444456788999999999999999999999999999999999743

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-18  Score=180.12  Aligned_cols=186  Identities=25%  Similarity=0.291  Sum_probs=152.4

Q ss_pred             cccccCceEEEEEE----eCCCCEEEEEEccCCChhh--HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEecC
Q 006211          442 KLGEGGFGPVYKGN----LPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       442 ~iG~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .+|+|+||.|+.++    ...+..+|+|++.+.....  ......|..++...+ ||.++++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999873    2347788999887653221  114466788888887 9999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|.|...+..   ....++.....+...++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            9998766643   234566667777888899999999998   99999999999999999999999999986533211  


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                          .+||..|||||++.  .....+|.||||++++||+||-.||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                18899999999988  456789999999999999999999976

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.70  E-value=5.5e-18  Score=159.27  Aligned_cols=195  Identities=21%  Similarity=0.358  Sum_probs=151.1

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      .-+|.+.-.|+.|+|+++ |..+++|++...  .....++|.+|.-.|+.+.||||+.+++.|.....+.++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            356888889999999995 455666776543  22334578999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccc
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG  597 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~  597 (656)
                      |...+++. ..-..+..++.+++..+++|++|||+..+ -|.---|.++.++||++...+|+ .+-.+..     .... 
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfs-----fqe~-  344 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFS-----FQEV-  344 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceee-----eecc-
Confidence            99999764 33456778899999999999999999873 24445788999999999887763 1111110     1111 


Q ss_pred             cccccccccccccccCCCCC---ccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          598 RIVGTYGYVPPEYVKKGIYS---MKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       598 ~~~gt~~y~aPE~~~~~~~s---~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...-.+.||+||.++..+-+   .++|+|||++++|||-|...||....+
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp  394 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP  394 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence            11235789999999876643   468999999999999999999976543

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=4.7e-16  Score=153.06  Aligned_cols=143  Identities=17%  Similarity=0.174  Sum_probs=110.3

Q ss_pred             cCCCCCCcccccCceEEEEEE--eCCCCEEEEEEccCCChh------------------------hHHHHHHHHHHHHhc
Q 006211          435 NNFSSANKLGEGGFGPVYKGN--LPRGQEFAVKRLSATSTQ------------------------GLEEFKNEVSLTARL  488 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  488 (656)
                      .-|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347888999999999999997  568999999998753210                        012356899999999


Q ss_pred             CCCc--eeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCC
Q 006211          489 QHVN--LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKAS  566 (656)
Q Consensus       489 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~  566 (656)
                      .+.+  +.+++..    ...++||||+++++|......   .......+...++.|++.++.+||+.+  +++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7533  3444432    235899999999888655422   223556667889999999999999886  4999999999


Q ss_pred             CEEEcCCCcEEEEeccCcccc
Q 006211          567 NILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       567 NILl~~~~~~kl~DfGla~~~  587 (656)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 789999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=7.1e-16  Score=150.21  Aligned_cols=134  Identities=18%  Similarity=0.300  Sum_probs=111.9

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCCh--h------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--Q------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +.||+|++|.||+|.. .+..+++|+......  .      ....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999977 677899997654321  1      123577899999999999988777777777788999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      +++++|..++...      .. ....++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999998887431      12 77889999999999999987   99999999999999 77899999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=9.5e-16  Score=147.62  Aligned_cols=141  Identities=18%  Similarity=0.195  Sum_probs=109.1

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh----------------------hhHHHHHHHHHHHHhcC
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----------------------QGLEEFKNEVSLTARLQ  489 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~  489 (656)
                      .....|.+.+.||+|+||.||++...+++.||||+++....                      ........|+.++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            33344778899999999999999887899999998654320                      01123567888899887


Q ss_pred             CCc--eeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCC
Q 006211          490 HVN--LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN  567 (656)
Q Consensus       490 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~N  567 (656)
                      |++  +.+.++    ....++||||+++++|.....         ......++.+++.++.++|+.+   ++||||+|+|
T Consensus        92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             HcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            774  444443    245689999999998865431         0234578889999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEeccCccccc
Q 006211          568 ILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       568 ILl~~~~~~kl~DfGla~~~~  588 (656)
                      |++++++.++|+|||++....
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=1.8e-15  Score=145.91  Aligned_cols=131  Identities=21%  Similarity=0.342  Sum_probs=105.7

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEccCCC--h------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATS--T------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .||+|++|.||+|.. ++..+++|+.....  .      ...+++.+|++++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 67889999864321  1      11346778999999999887665555556667779999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      ++++|...+....       .   .++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999987763210       0   78999999999999987   99999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=2.5e-15  Score=166.60  Aligned_cols=138  Identities=19%  Similarity=0.283  Sum_probs=110.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEE-ccCC-Ch------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR-LSAT-ST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      ...|...+.||+|+||.||++...... +++|+ .... ..      ...+++.+|++++..++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344566789999999999999764443 44443 2211 11      123468899999999999999888877777778


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++++|..++.           ....++.+++++|.+||+.+   ++||||||+|||+ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988773           35678999999999999987   9999999999999 56789999999997


Q ss_pred             cc
Q 006211          586 LF  587 (656)
Q Consensus       586 ~~  587 (656)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.62  E-value=1.9e-15  Score=149.90  Aligned_cols=199  Identities=19%  Similarity=0.278  Sum_probs=125.7

Q ss_pred             CCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCC----------CceeeEEEEE---
Q 006211          438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQH----------VNLLRVLGYC---  500 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~---  500 (656)
                      ...+.||.|+++.||.+.. .+++.+|+|++....   ....+++++|.-....+.+          -.++--++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            3567899999999999965 458999999875442   2345566666544444322          1111111111   


Q ss_pred             ------eeCC--------ceEEEEEecCCCChhhhhh---CCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecc
Q 006211          501 ------TERD--------ENMLIYEYLPNKSLDLYLF---DPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRD  562 (656)
Q Consensus       501 ------~~~~--------~~~lv~e~~~~g~L~~~l~---~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~D  562 (656)
                            ....        +.+++|+-+ .++|..++.   .... ...+....++.+..|+++.+++||+.+   ++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence                  1111        235667766 467766542   1111 122344556778899999999999998   99999


Q ss_pred             cCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccC--------CCCCccchhHHHHHHHHHHHc
Q 006211          563 LKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--------GIYSMKYDVYSFGVLLLQIIS  634 (656)
Q Consensus       563 ikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwslGvil~ellt  634 (656)
                      |+|+|++++++|.+.|+||+...........     ...+..|.+||....        ..++.+.|.|+||+++|.|.|
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999877654321111     233567999997643        247889999999999999999


Q ss_pred             CCCCCCCCCCc
Q 006211          635 SKRNARYYGTS  645 (656)
Q Consensus       635 g~~p~~~~~~~  645 (656)
                      ++.||.....+
T Consensus       246 ~~lPf~~~~~~  256 (288)
T PF14531_consen  246 GRLPFGLSSPE  256 (288)
T ss_dssp             SS-STCCCGGG
T ss_pred             ccCCCCCCCcc
Confidence            99999865443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.60  E-value=1.9e-16  Score=174.44  Aligned_cols=196  Identities=20%  Similarity=0.200  Sum_probs=144.7

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC-hhhHHHH---HHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS-TQGLEEF---KNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++...+.||++.|=+|.+|+..+|. |+||++-+.. .-..+.+   +.|++ ...++|||++++.-+-....-.|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4667789999999999999887776 9999886543 2223333   34444 455689999999877666777788888


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+.. +|.+.+.   .+.-+...+.+-|+.|++.|+.-+|..+   |+|||||.+||||+.-..+.|+||..-+..--..
T Consensus       102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8854 5655552   3455777888899999999999999998   9999999999999999999999998665321111


Q ss_pred             cc-cc----cccccccccccccccccCC----------C-CCccchhHHHHHHHHHHHcC-CCCCC
Q 006211          592 DE-AN----TGRIVGTYGYVPPEYVKKG----------I-YSMKYDVYSFGVLLLQIISS-KRNAR  640 (656)
Q Consensus       592 ~~-~~----~~~~~gt~~y~aPE~~~~~----------~-~s~~sDvwslGvil~elltg-~~p~~  640 (656)
                      +. ..    ..+...-..|+|||.+...          . .+++.||||+||++.||++- ++||.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            11 11    1112233579999987531          1 57889999999999999886 55553

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=3e-14  Score=130.38  Aligned_cols=135  Identities=21%  Similarity=0.254  Sum_probs=113.9

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC--CceeeEEEEEeeCCceEEEEEecCCC
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH--VNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      +.+.||+|.++.||++...+ ..+++|+......  ...+..|+..++.++|  .++++++.+...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998744 7899999866543  4568899999999976  58899988888778899999999988


Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      .+..+          +......++.++++++..||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77533          4466677899999999999997655699999999999999988999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=3.4e-14  Score=135.54  Aligned_cols=137  Identities=19%  Similarity=0.230  Sum_probs=97.2

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChh--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ--GLEE----------------------FKNEVSLTARLQHVN--L  493 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  493 (656)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998778999999988653211  1111                      134556666654432  3


Q ss_pred             eeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcC
Q 006211          494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       494 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~  572 (656)
                      .+.+++    ...++||||++++.+........   ... .+...++.+++.++.++|. .+   ++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444432    24589999999965432111100   011 5677899999999999998 65   99999999999999 


Q ss_pred             CCcEEEEeccCccccc
Q 006211          573 ELNPKISDFGMAKLFR  588 (656)
Q Consensus       573 ~~~~kl~DfGla~~~~  588 (656)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.54  E-value=1.4e-15  Score=156.90  Aligned_cols=124  Identities=27%  Similarity=0.428  Sum_probs=108.1

Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++.|++|...+|.+++..+......++...+.++.|++.++.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999766666667888999999999999999   44   899999999999999999999999998


Q ss_pred             cccccCc----cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc
Q 006211          585 KLFRKDV----DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS  634 (656)
Q Consensus       585 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt  634 (656)
                      .......    .........||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7654433    1233455789999999999999999999999999999999998

>COG3469 Chitinase [Carbohydrate transport and metabolism]

Probab=99.52  E-value=1.8e-12  Score=120.25  Aligned_cols=215  Identities=16%  Similarity=0.221  Sum_probs=125.5

Q ss_pred             ccceEEEEEecCCCC--------CCCCCCCC----CCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCce
Q 006211           24 AQTWIKAGYWLAGRE--------FPLSDINS----ALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIK   91 (656)
Q Consensus        24 ~~~~~~~~y~~~~~~--------~~~~~i~~----~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~k   91 (656)
                      ++..+.+|||.+|..        -+..+|-.    ..++-+..+|..-..+=..+.+....+..|...+.+|.++  +--
T Consensus        23 ~~~KvLvGyWHnw~sgaaDgyq~gs~adial~d~~~~ynvv~V~Fmk~~g~iptf~P~~~~daeFr~~v~aLnae--Gka  100 (332)
T COG3469          23 ISNKVLVGYWHNWKSGAADGYQQGSSADIALADTPRNYNVVTVSFMKGAGDIPTFKPYNDPDAEFRAQVGALNAE--GKA  100 (332)
T ss_pred             cccceEEEeeecccccccccccccceeeeEeccCCcccceEEEEEeecCCCCcccCcCCCCHHHHHHHHHHhhcc--CcE
Confidence            445589999987642        12222221    2355566666533322122223333344454444444444  456


Q ss_pred             EEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc---CcchHHHHHHH
Q 006211           92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST---DLNSLGILLDE  168 (656)
Q Consensus        92 vl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~---d~~~~~~ll~~  168 (656)
                      |+||+            ||.+.     +.-+ ....-++|+.+|++++++|||||+|||-|.-...   ...-..+.+|.
T Consensus       101 vllsL------------GGAdg-----hIeL-~~~qE~~fv~eiirlietyGFDGLDiDLEq~ai~~~dnq~v~p~alk~  162 (332)
T COG3469         101 VLLSL------------GGADG-----HIEL-KAGQEQAFVNEIIRLIETYGFDGLDIDLEQSAILAADNQTVIPAALKA  162 (332)
T ss_pred             EEEEc------------cCccc-----eEEe-ccchHHHHHHHHHHHHHHhCCCccccchhhhhhhhcCCeeehHHHHHH
Confidence            78999            54432     1112 2234689999999999999999999999976432   23345677888


Q ss_pred             HHhhcC-CCCCcEEEEEeecCCCcccccc--ChhhhhhccchhhhhhhcccCC-CCCCccccCCCCCCCCCCCCHHHHHH
Q 006211          169 WKASAS-DQPELTLSMAVRYSPTHETVSY--PIDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSNISTDFGIR  244 (656)
Q Consensus       169 lr~~l~-~~~~~~ls~a~~~~~~~~~~~~--~~~~l~~~vD~invmtYD~~g~-~~~~~~g~~apl~~~~~~~~~~~~v~  244 (656)
                      +|+.-. .++++.||+|.-...-.....|  -+.++..+.|||+..-|+--|- -|-  +..+++.-  ..+.-+.+...
T Consensus       163 vk~hyk~~Gk~f~itMAPEfPYl~~~gaY~pyin~l~~~yD~i~pQlYNqGGdg~w~--~~~nawi~--q~nd~~kesfl  238 (332)
T COG3469         163 VKDHYKNQGKNFFITMAPEFPYLQGWGAYIPYINELRDYYDFIAPQLYNQGGDGNWV--TESNAWIA--QNNDMVKESFL  238 (332)
T ss_pred             HHHHHHhcCCceEEEecCCCceecCCcccchHHHHHhhHHhhhhHHHhcCCCCCCCc--Cccccccc--cccHHHHHhHH
Confidence            887663 3568999998754321111112  2578999999999999987542 222  22233322  11112333333


Q ss_pred             HHHH-------c---CCCCCceeecccC
Q 006211          245 EWLR-------R---GFPANKLVLGARA  262 (656)
Q Consensus       245 ~~~~-------~---g~p~~Kl~lG~p~  262 (656)
                      +++.       +   .+|++|+++|+|.
T Consensus       239 y~~~~slanGtr~f~~ipa~k~aiGLPs  266 (332)
T COG3469         239 YYLTFSLANGTRGFEKIPADKFAIGLPS  266 (332)
T ss_pred             HHhhhhhhcCcccceecccceeEEecCC
Confidence            3332       1   3799999999995

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.52  E-value=2.4e-14  Score=150.95  Aligned_cols=157  Identities=26%  Similarity=0.417  Sum_probs=127.8

Q ss_pred             HHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 006211          485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK  564 (656)
Q Consensus       485 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dik  564 (656)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..  ....+++.-...+.+.|+.||.|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999865  3445888888999999999999999865  23999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCC-------CCccchhHHHHHHHHHHHcCCC
Q 006211          565 ASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISSKR  637 (656)
Q Consensus       565 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDvwslGvil~elltg~~  637 (656)
                      +.|++++....+||+|||+....................-|.|||.+....       .+.+.|+||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999997654211111111223445799999987531       4667999999999999999999


Q ss_pred             CCCCCCCc
Q 006211          638 NARYYGTS  645 (656)
Q Consensus       638 p~~~~~~~  645 (656)
                      ||......
T Consensus       157 ~~~~~~~~  164 (484)
T KOG1023|consen  157 PFDLRNLV  164 (484)
T ss_pred             cccccccc
Confidence            99775443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=2.2e-13  Score=134.37  Aligned_cols=136  Identities=23%  Similarity=0.254  Sum_probs=103.3

Q ss_pred             CCccc-ccCceEEEEEEeCCCCEEEEEEccCCC-------------hhhHHHHHHHHHHHHhcCCCce--eeEEEEEeeC
Q 006211          440 ANKLG-EGGFGPVYKGNLPRGQEFAVKRLSATS-------------TQGLEEFKNEVSLTARLQHVNL--LRVLGYCTER  503 (656)
Q Consensus       440 ~~~iG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  503 (656)
                      ...|| .|+.|+||.+... +..++||++....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8889999998774 7789999875321             1223467889999999998775  6666664432


Q ss_pred             Cc----eEEEEEecCC-CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          504 DE----NMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       504 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                      ..    .++|+|++++ .+|..++..    ..++..    .+.++++++.+||+.+   |+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 688877633    234443    3568999999999998   999999999999999989999


Q ss_pred             EeccCcccc
Q 006211          579 SDFGMAKLF  587 (656)
Q Consensus       579 ~DfGla~~~  587 (656)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.49  E-value=1.4e-14  Score=159.90  Aligned_cols=172  Identities=22%  Similarity=0.319  Sum_probs=123.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+|..++.|..|+||.||..+.+ ..+++|+|+-+..      .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence            356888899999999999999654 4667888533221      11111  33333444433                  


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC--
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD--  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~--  590 (656)
                         |+....+...   ..++..        ++.+++|||+.+   |+|||+||.|.+|+.-|++|++|||+++.....  
T Consensus       136 ---gDc~tllk~~---g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNI---GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccC---CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               4444444221   122221        267899999998   999999999999999999999999999753211  


Q ss_pred             -----------ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcccc
Q 006211          591 -----------VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL  648 (656)
Q Consensus       591 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~~~  648 (656)
                                 .........+||+.|.|||++....|...+|+|++|+++||.+-|+.||...+.++.+
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf  267 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF  267 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence                       1111223468999999999999999999999999999999999999999887666544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.6e-14  Score=156.82  Aligned_cols=207  Identities=23%  Similarity=0.335  Sum_probs=162.3

Q ss_pred             CCCCCCcccccCceEEEEEEeC--CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP--RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .|...+.||+|+|+.|-.....  ....+|+|.+....  ....+....|..+-..+. |+|++.+++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4566778999999999887543  34456777665543  223344556777777776 999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-EYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFR  588 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~  588 (656)
                      ++..++++...+.... ....+......++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus       101 ~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             CcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999876663211 113455667788999999999999 666   99999999999999999 99999999998776


Q ss_pred             c-Cccccccccccc-cccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          589 K-DVDEANTGRIVG-TYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       589 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      . ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence            5 333444445678 9999999988774 45678999999999999999999998765543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=2.7e-12  Score=137.76  Aligned_cols=140  Identities=20%  Similarity=0.224  Sum_probs=96.8

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhhHH----------------------------------------HHHH
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE----------------------------------------EFKN  480 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~  480 (656)
                      +.||.|++|.||+|++.+|+.||||+.+....+...                                        ++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            679999999999999999999999998654211100                                        1334


Q ss_pred             HHHHHHhc----CCCceeeEEEEE-eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 006211          481 EVSLTARL----QHVNLLRVLGYC-TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ-GLLYLQEYS  554 (656)
Q Consensus       481 e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~Lh~~~  554 (656)
                      |...+.++    +|.+-+.+-..+ ......++||||++|++|.+.......  ..   ....++..++. .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            55444444    232223332222 224457999999999999876532111  12   23345665555 466778776


Q ss_pred             CCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       555 ~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                         ++|+|++|.||++++++.++++|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=1.4e-12  Score=129.58  Aligned_cols=145  Identities=21%  Similarity=0.295  Sum_probs=103.6

Q ss_pred             CCCceeeEEEEEeeC---------------------------CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHH
Q 006211          489 QHVNLLRVLGYCTER---------------------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE  541 (656)
Q Consensus       489 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  541 (656)
                      +|||||++.++|.++                           ...|+||.-.+ -+|..++...    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence            699999988876442                           23567777653 4677777542    244556677899


Q ss_pred             HHHHHHHHHHhcCCCCcEecccCCCCEEEc--CCC--cEEEEeccCccccccC----ccccccccccccccccccccccC
Q 006211          542 GVTQGLLYLQEYSNFRVIHRDLKASNILLD--NEL--NPKISDFGMAKLFRKD----VDEANTGRIVGTYGYVPPEYVKK  613 (656)
Q Consensus       542 ~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~--~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  613 (656)
                      |+++++.|||..+   +.|||+|+.|||+.  +++  .+.|+|||++---...    ......-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999987   99999999999994  333  4789999987421110    00111112245667899998754


Q ss_pred             CC------CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          614 GI------YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       614 ~~------~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .+      --.|+|.|+.|.+.||+++...||..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            32      12589999999999999999999965

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=6.2e-11  Score=111.01  Aligned_cols=131  Identities=18%  Similarity=0.186  Sum_probs=96.1

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcee-eEEEEEeeCCceEEEEEecCCCCh
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL-RVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      .+.|+.|.++.||++... +..+++|....... ....+..|...++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999864 77899998765432 123457888898888655544 444433  3345899999999877


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ....           .....+..+++++|..||..+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5320           111245678999999999876  23369999999999999 56899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=6.7e-11  Score=128.40  Aligned_cols=146  Identities=17%  Similarity=0.175  Sum_probs=93.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCChhh----------------------------------HH-
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG----------------------------------LE-  476 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-  476 (656)
                      ....|+. +.||+|++|+||+|...+ |+.||||+.++...+.                                  .+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 789999999999998877 9999999987542110                                  11 


Q ss_pred             -----HHHHHHHHHHhc----CCCceeeEEEEEee-CCceEEEEEecCCCChhhhhhCCCcC---CCCCHHHHHHHHHHH
Q 006211          477 -----EFKNEVSLTARL----QHVNLLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRR---YVLDWQKRVNIIEGV  543 (656)
Q Consensus       477 -----~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i  543 (656)
                           ++.+|...+.++    .+.+.+.+-.++.+ ....++||||++|+.+.+...-...+   ..+.......++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 133344444443    23333443333332 45678999999999997642111111   012222222222332


Q ss_pred             HHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEeccCcccccc
Q 006211          544 TQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFGMAKLFRK  589 (656)
Q Consensus       544 ~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfGla~~~~~  589 (656)
                             ...+   ++|+|+||.||+++.++    .++++|||+...+..
T Consensus       277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3344   99999999999999988    999999999986643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=1.6e-10  Score=123.28  Aligned_cols=167  Identities=15%  Similarity=0.175  Sum_probs=125.8

Q ss_pred             EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHH
Q 006211          455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ  534 (656)
Q Consensus       455 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  534 (656)
                      ...++.+|.|...+....+..+...+-++.|+.++||||++++.....++..|+|+|-+.  .|..++.+      +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence            445678888888776655444567788999999999999999999999999999999874  45555532      2345


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCC
Q 006211          535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG  614 (656)
Q Consensus       535 ~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  614 (656)
                      ...-.+.||++||.|||..+  .++|++|.-..|++++.|+.||++|.++........  .......-..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            56667899999999998655  499999999999999999999999988754322111  11111122346677765443


Q ss_pred             CCCccchhHHHHHHHHHHHcC
Q 006211          615 IYSMKYDVYSFGVLLLQIISS  635 (656)
Q Consensus       615 ~~s~~sDvwslGvil~elltg  635 (656)
                      .  -..|.|.|||+++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            3  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=3.2e-09  Score=100.18  Aligned_cols=134  Identities=18%  Similarity=0.167  Sum_probs=96.1

Q ss_pred             CcccccCceEEEEEEeCC-------CCEEEEEEccCCC------------h----------hhHHHH----HHHHHHHHh
Q 006211          441 NKLGEGGFGPVYKGNLPR-------GQEFAVKRLSATS------------T----------QGLEEF----KNEVSLTAR  487 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~e~~~l~~  487 (656)
                      ..||.|--+.||.|...+       +..+|||+.+...            .          ...+.+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999996542       4789999765421            0          001222    378999988


Q ss_pred             cCC--CceeeEEEEEeeCCceEEEEEecCCCChhh-hhhCCCcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEeccc
Q 006211          488 LQH--VNLLRVLGYCTERDENMLIYEYLPNKSLDL-YLFDPIRRYVLDWQKRVNIIEGVTQGLLYL-QEYSNFRVIHRDL  563 (656)
Q Consensus       488 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~iiH~Di  563 (656)
                      +..  -++.+.+++    ...++||||+.++.+.. .+.    ...++..+...+..+++.+|..| |..+   ++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            853  456666654    45689999997654421 121    22345566677889999999988 7776   999999


Q ss_pred             CCCCEEEcCCCcEEEEeccCccc
Q 006211          564 KASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       564 kp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++.|||+++ +.+.|+|||-+..
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCcee
Confidence            999999975 5799999998854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=2.5e-09  Score=104.77  Aligned_cols=142  Identities=17%  Similarity=0.254  Sum_probs=106.9

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCC--ceeeEEEEEeeCC---ceEEEEEecC
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHV--NLLRVLGYCTERD---ENMLIYEYLP  514 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~  514 (656)
                      +.|+.|..+.||++...+|..+++|....... .....+..|.++++.+.+.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999876678999998765432 1345678999999999753  4566777665532   5689999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS----------------------------------------  554 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------  554 (656)
                      +.++...+..    ..++......++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888654421    23566777777888888888887421                                        


Q ss_pred             -------------CCCcEecccCCCCEEEcC--CCcEEEEeccCccc
Q 006211          555 -------------NFRVIHRDLKASNILLDN--ELNPKISDFGMAKL  586 (656)
Q Consensus       555 -------------~~~iiH~Dikp~NILl~~--~~~~kl~DfGla~~  586 (656)
                                   ...++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         234799999999999998  66689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=3.6e-09  Score=95.56  Aligned_cols=144  Identities=19%  Similarity=0.294  Sum_probs=105.5

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEE-ccCC-------ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKR-LSAT-------STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .+..|-+|+-+.|+++.. .|+...||. +.+.       ..-...+..+|.+.+.++.--.|.-..-++.+.....|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456788999999999987 577777774 3222       1112346788999999886555555455666777788999


Q ss_pred             EecCC-CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEeccCccc
Q 006211          511 EYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKL  586 (656)
Q Consensus       511 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~DfGla~~  586 (656)
                      ||+++ .++..++........ ..+....++..|-+.+.-||.++   +||+||..+||++.+++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 467777755333322 22333678888999999999998   999999999999987654   58999999965


Q ss_pred             c
Q 006211          587 F  587 (656)
Q Consensus       587 ~  587 (656)
                      -
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=4.4e-09  Score=95.66  Aligned_cols=131  Identities=21%  Similarity=0.334  Sum_probs=99.8

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEc-cCC--Chh-----hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRL-SAT--STQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~-~~~--~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+++|+-+.++.+.+ -|..+++|.- ++.  .++     ..++..+|..++.+++--.|....-+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4578999999999976 3445667643 222  111     123567899999988766665555566677788999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|..|.+.+...          ...++..+-..+.-||..+   |+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998887432          2456777888888999988   99999999999999875 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=4.5e-10  Score=118.95  Aligned_cols=200  Identities=21%  Similarity=0.273  Sum_probs=150.1

Q ss_pred             cCCCCCCcccc--cCceEEEEEEe---CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          435 NNFSSANKLGE--GGFGPVYKGNL---PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      +.+...+.+|.  |.+|.+|.+..   .++..+|+|+-+....  ....+=.+|..-..++ .|+|.++....+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  99999999854   4578899997443321  2111224455555555 499999988889999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEec
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----GLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDF  581 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~Df  581 (656)
                      ++-+|.|. .+|..+.+..  ...++....+....+..+    |+.++|+.+   ++|-|+||.||+...+ ..++++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999985 6777766543  223566777777777888    999999988   9999999999999999 88999999


Q ss_pred             cCccccccCccccc---cccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          582 GMAKLFRKDVDEAN---TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       582 Gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |+...+........   .-...+...|++||..++ .++..+|+|++|.++.+-.++..++..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence            99987755431111   111246678999998654 568889999999999999988877644

>KOG4701 consensus Chitinase [Cell wall/membrane/envelope biogenesis]

Probab=98.86  E-value=4e-08  Score=96.69  Aligned_cols=80  Identities=16%  Similarity=0.127  Sum_probs=57.5

Q ss_pred             CCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHH-------cC---CCcceeeeeCCCcc
Q 006211           88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL-------YG---FQGIDLFWLWPNST  157 (656)
Q Consensus        88 ~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~-------~~---~DGvdidwe~p~~~  157 (656)
                      .+.|||+|+||+.+                 ...+++++.-+.|++.+-+..-.       +|   +||+|+|-|.-.+ 
T Consensus       102 ~GiKVlLSLGG~~G-----------------nYs~~~d~dA~~fA~~LWn~Fg~G~~S~RPfg~AVvDGfDF~IE~g~~-  163 (568)
T KOG4701|consen  102 NGIKVLLSLGGYNG-----------------NYSLNNDDDATNFAFQLWNIFGSGEDSYRPFGKAVVDGFDFEIEKGTN-  163 (568)
T ss_pred             cCeEEEEeccCccc-----------------ceeeccchhHHHHHHHHHHHhcCCccccCcccchhccceeeeeecCCc-
Confidence            37999999954322                 34566777778888887765422       12   8999999996544 


Q ss_pred             CcchHHHHHHHHHhhcCCC-CCcEEEEEeec
Q 006211          158 DLNSLGILLDEWKASASDQ-PELTLSMAVRY  187 (656)
Q Consensus       158 d~~~~~~ll~~lr~~l~~~-~~~~ls~a~~~  187 (656)
                        ..|.+|-+.||..|.++ +.+-|+.|...
T Consensus       164 --~~ysaLA~~L~~~Fa~~~r~yYLsaAPQC  192 (568)
T KOG4701|consen  164 --TAYSALAKRLLEIFASDPRRYYLSAAPQC  192 (568)
T ss_pred             --chHHHHHHHHHHHHccCCceEEeccCCCC
Confidence              67899999999999554 46777776653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.85  E-value=1.1e-09  Score=116.13  Aligned_cols=196  Identities=20%  Similarity=0.226  Sum_probs=146.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe--CCCCEEEEEEccCCChhhHHH--HHHHHHHHHhc-CCCceeeEEEEEeeCCceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATSTQGLEE--FKNEVSLTARL-QHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  507 (656)
                      ...+|..+..||.|.|+.|+....  .++..+++|.+.........+  -..|+.+...+ .|.++++....+..-+..+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            345678889999999999999843  467889999887653322222  23455555555 5888888777777777778


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKL  586 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~~  586 (656)
                      +-.|||+++++....   .....+++...+++..|++.++.++|++.   ++|+|++|.||++..+ +..++.|||++..
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999987665   22345777888999999999999999887   9999999999999986 7889999999864


Q ss_pred             cccCcccccccccccccccc--ccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYV--PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      +...  .  .. .....+++  +|+......+..+.|++|||.-+.|.+++..-.
T Consensus       417 ~~~~--~--~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  417 LAFS--S--GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccee--c--cc-ccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            2211  0  00 11222344  555666677888999999999999999987544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=4.1e-09  Score=102.93  Aligned_cols=155  Identities=21%  Similarity=0.269  Sum_probs=114.7

Q ss_pred             HHHHhcCCCceeeEEEEEeeCC-----ceEEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006211          483 SLTARLQHVNLLRVLGYCTERD-----ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNF  556 (656)
Q Consensus       483 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~  556 (656)
                      .-+-++.|.||+++..++.+.+     ...++.|||..|++..+|.+-. ....+......+++.||+.||.|||+.. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            3455567999999998886543     4678999999999999996532 2335677778899999999999999975 6


Q ss_pred             CcEecccCCCCEEEcCCCcEEEEeccCccccccCc---cccccccccccccccccccccCCCCCccchhHHHHHHHHHHH
Q 006211          557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV---DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII  633 (656)
Q Consensus       557 ~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ell  633 (656)
                      +|+|+++..+-|++..++-+|+.- +.........   .........+-++|.+||.=.....+..+|||+||...+||-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            799999999999999998888632 2111111110   111122234567899999866666778899999999999998


Q ss_pred             cCCCCC
Q 006211          634 SSKRNA  639 (656)
Q Consensus       634 tg~~p~  639 (656)
                      -+.-..
T Consensus       277 ilEiq~  282 (458)
T KOG1266|consen  277 ILEIQS  282 (458)
T ss_pred             Hheecc
Confidence            876654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=7.3e-08  Score=90.68  Aligned_cols=124  Identities=27%  Similarity=0.317  Sum_probs=79.9

Q ss_pred             EEEEEEeCCCCEEEEEEccCCC-------------h-------------hhHHHHHHHHHHHHhcCCC--ceeeEEEEEe
Q 006211          450 PVYKGNLPRGQEFAVKRLSATS-------------T-------------QGLEEFKNEVSLTARLQHV--NLLRVLGYCT  501 (656)
Q Consensus       450 ~V~~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  501 (656)
                      .||.|...++..+|+|..+...             .             .......+|.+.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899988889999999765420             0             0123467899999999765  456665442 


Q ss_pred             eCCceEEEEEecC--CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          502 ERDENMLIYEYLP--NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY-LQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       502 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                         ...+||||++  +..+..+....     ++......++.+++..+.. +|..+   ++|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4589999998  55554332111     1123445667777775554 56776   9999999999999998 8999


Q ss_pred             EeccCccc
Q 006211          579 SDFGMAKL  586 (656)
Q Consensus       579 ~DfGla~~  586 (656)
                      +|||.+..
T Consensus       148 IDf~qav~  155 (188)
T PF01163_consen  148 IDFGQAVD  155 (188)
T ss_dssp             --GTTEEE
T ss_pred             EecCccee
Confidence            99998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.71  E-value=3.8e-07  Score=91.09  Aligned_cols=141  Identities=19%  Similarity=0.159  Sum_probs=97.6

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChh-hH----------HHHHHHHHHHHhcCCCc--eeeEEEEEee-----
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GL----------EEFKNEVSLTARLQHVN--LLRVLGYCTE-----  502 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  502 (656)
                      +.+-+-....|.+... +|+.+.||+....... ..          ..+.+|...+.++...+  ..+.+.+...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444344444667665 6778999977543211 01          13678888887774333  3444555443     


Q ss_pred             CCceEEEEEecCCC-ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-------CC
Q 006211          503 RDENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------EL  574 (656)
Q Consensus       503 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-------~~  574 (656)
                      ....++|+|++++. +|.+++.+.. ....+......++.+++..+.-||..+   ++|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence            23468999999886 7887764321 123456677789999999999999998   999999999999985       46


Q ss_pred             cEEEEeccCccc
Q 006211          575 NPKISDFGMAKL  586 (656)
Q Consensus       575 ~~kl~DfGla~~  586 (656)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            799999998854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.64  E-value=7e-09  Score=115.63  Aligned_cols=205  Identities=19%  Similarity=0.203  Sum_probs=144.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .+.+.+.+-+-+|+++.++.+.-. .|...++|.....   .....+....+-.++-..++|-+++..--+.......++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345666778889999999887432 3444444443322   111223333444444444566666555445566788999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ++|..+++|...++...   ..+..........+.+.+++||...   +.|+|++|.|+|+..++..+++|||.......
T Consensus       883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence            99999999988876533   3455555666777889999999876   89999999999999999999999984332110


Q ss_pred             ---------------------C----c----cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          590 ---------------------D----V----DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       590 ---------------------~----~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                                           .    .    +........+|+.|.+||...+......+|.|++|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                 0    0    0011223578999999999999888999999999999999999999996


Q ss_pred             CCCC
Q 006211          641 YYGT  644 (656)
Q Consensus       641 ~~~~  644 (656)
                      ....
T Consensus      1037 a~tp 1040 (1205)
T KOG0606|consen 1037 AETP 1040 (1205)
T ss_pred             Ccch
Confidence            5543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.62  E-value=4.4e-07  Score=94.41  Aligned_cols=170  Identities=21%  Similarity=0.299  Sum_probs=126.4

Q ss_pred             CceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEEEEecCC-CChhh
Q 006211          447 GFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIYEYLPN-KSLDL  520 (656)
Q Consensus       447 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  520 (656)
                      .-.+.|++. ..+|..|++|+++............-++.++++.|+|+|++.+++..    +..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346788884 45799999999965444333233456789999999999999998863    3457899999876 45554


Q ss_pred             hhhC------------CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          521 YLFD------------PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       521 ~l~~------------~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      +-+.            ...+...++..++.++.|+..||.++|+.|   +.-+-|.|++||++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            4332            122345788999999999999999999998   8889999999999999999998888776554


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN  638 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p  638 (656)
                      .+..                |-+..   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3220                11111   1256888999999999999765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.55  E-value=6.9e-07  Score=86.40  Aligned_cols=134  Identities=20%  Similarity=0.252  Sum_probs=95.2

Q ss_pred             CCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC----------------------hhhHHHHHHHHHHHHhcCCC--c
Q 006211          437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS----------------------TQGLEEFKNEVSLTARLQHV--N  492 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n  492 (656)
                      ..+..+||-|--+.||.|..+.|.++|||.=+...                      .......++|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34678999999999999999999999999432210                      01123467899999998644  5


Q ss_pred             eeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC
Q 006211          493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       493 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~  572 (656)
                      +.+.+++    +...+|||++++-.|...-        ++....-.++..|++-+.-+-..|   +||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            5565543    4568999999986664221        123333445555555555444555   999999999999999


Q ss_pred             CCcEEEEeccCcc
Q 006211          573 ELNPKISDFGMAK  585 (656)
Q Consensus       573 ~~~~kl~DfGla~  585 (656)
                      +|.+.++||-=+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.42  E-value=3.5e-06  Score=85.61  Aligned_cols=192  Identities=14%  Similarity=0.156  Sum_probs=125.3

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEE------EeeCC-ceEEEE
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGY------CTERD-ENMLIY  510 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv~  510 (656)
                      ..+.||+|+.+.+|-.-.  -.-.+.|+..........+   -+..|... .||-+..-+.+      .-++. ..-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            456799999999996522  1223557776654332222   22233333 46643321111      11112 245667


Q ss_pred             EecCCCChhhhhhC----CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          511 EYLPNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       511 e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      +.+++-.--..+.+    ++.....+|.-+++.+..++.+...||..+   .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            76655422112211    222345789999999999999999999987   89999999999999999999998654433


Q ss_pred             cccCcccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcC-CCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISS-KRNARY  641 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg-~~p~~~  641 (656)
                      ..   ......+.+|...|.+||...     +..-+...|-|.||+++++|+.| +.||.+
T Consensus       167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            21   222334458899999999754     33356789999999999999888 888865

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.7e-06  Score=93.69  Aligned_cols=145  Identities=17%  Similarity=0.244  Sum_probs=92.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhH----------------------------------H----
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL----------------------------------E----  476 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------~----  476 (656)
                      ..|+. +.|+.++-|+||+|.+.+|+.||||+.++.-.+..                                  +    
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34442 67999999999999999999999998876421110                                  0    


Q ss_pred             --HHHHHHHHHHhc----C-CCceeeEEEEE-eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHH-H
Q 006211          477 --EFKNEVSLTARL----Q-HVNLLRVLGYC-TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG-L  547 (656)
Q Consensus       477 --~~~~e~~~l~~l----~-h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l  547 (656)
                        ++..|..-+.++    + .|+ +.+-.++ .-.....++|||++|-.+.+...-..  ...+...   ++..++++ +
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~  278 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFL  278 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHH
Confidence              123344444443    2 233 2332333 33567799999999998887742222  2234222   33333332 2


Q ss_pred             HHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       548 ~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ..+=..   +++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus       279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222223   399999999999999999999999999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.40  E-value=2.9e-06  Score=81.94  Aligned_cols=106  Identities=25%  Similarity=0.295  Sum_probs=80.7

Q ss_pred             HHHHHHHHHHHhcCC--CceeeEEEEEeeCC----ceEEEEEecCCC-ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHH
Q 006211          476 EEFKNEVSLTARLQH--VNLLRVLGYCTERD----ENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL  548 (656)
Q Consensus       476 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~  548 (656)
                      ....+|...+..+..  -.+.+.+++.....    ..++|+|++++. +|..++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            356778877777743  23455666655432    347999999884 78888743211   455677889999999999


Q ss_pred             HHHhcCCCCcEecccCCCCEEEcCCC---cEEEEeccCcccc
Q 006211          549 YLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKLF  587 (656)
Q Consensus       549 ~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~DfGla~~~  587 (656)
                      -||..+   ++|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999998   99999999999999887   8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=9.1e-06  Score=79.53  Aligned_cols=139  Identities=17%  Similarity=0.228  Sum_probs=84.6

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEEEeeCCceEEEEEecCCCC-
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENMLIYEYLPNKS-  517 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  517 (656)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+.+.+....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25567888876533  2345688999998885433  4566777777777789999999863 


Q ss_pred             hhhh---------------------hhCCCcCCCCCHHHHH-HHHHH----------HHH-HHHHHHhc-CCCCcEeccc
Q 006211          518 LDLY---------------------LFDPIRRYVLDWQKRV-NIIEG----------VTQ-GLLYLQEY-SNFRVIHRDL  563 (656)
Q Consensus       518 L~~~---------------------l~~~~~~~~l~~~~~~-~i~~~----------i~~-~l~~Lh~~-~~~~iiH~Di  563 (656)
                      +...                     ++.... ......... .+..+          +.+ ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            2111                     111000 001111100 00000          011 12222211 1234789999


Q ss_pred             CCCCEEEcCCCcEEEEeccCccc
Q 006211          564 KASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       564 kp~NILl~~~~~~kl~DfGla~~  586 (656)
                      .|.||++++++ +.++||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999988 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.31  E-value=1.5e-05  Score=75.47  Aligned_cols=139  Identities=14%  Similarity=0.123  Sum_probs=98.9

Q ss_pred             ccccCceEEEEEEeCCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCC--ceeeEEEEEeeC----CceEEEE
Q 006211          443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHV--NLLRVLGYCTER----DENMLIY  510 (656)
Q Consensus       443 iG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~  510 (656)
                      -|+|+.+-|++-.. +|..+-+|+-..-.      +-....|.+|...+.++..-  .+.+........    ..-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            35688889998876 34478899765211      22446789999998888532  244444222221    1357899


Q ss_pred             EecCC-CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc--EEEEeccCccc
Q 006211          511 EYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMAKL  586 (656)
Q Consensus       511 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~--~kl~DfGla~~  586 (656)
                      |-+.+ -+|..++.+.. ....+......+..++++.+.-||+.+   +.|+|+.++||+++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 47777764321 123567777899999999999999998   999999999999986666  99999987764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.20  E-value=3.5e-05  Score=73.34  Aligned_cols=139  Identities=14%  Similarity=0.200  Sum_probs=90.0

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHH---------HHHHHHHHHhcCC---CceeeEEEE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE---------FKNEVSLTARLQH---VNLLRVLGY  499 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~niv~l~~~  499 (656)
                      ....+|...+.+-......|.+-.. ++..+++|..+.......+.         ..+++..+.+++.   .....++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3456788777787777777777666 57889999887653222111         2233343443422   222232222


Q ss_pred             Eee-----CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          500 CTE-----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       500 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      ...     ....+++|||++|..|.+..       .+++    .+...+.+.+.-||+.|   +.|+|+.|.|++++++ 
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence            221     23456899999998886543       1222    24455777889999987   9999999999999976 


Q ss_pred             cEEEEeccCccc
Q 006211          575 NPKISDFGMAKL  586 (656)
Q Consensus       575 ~~kl~DfGla~~  586 (656)
                      .++++||+..+.
T Consensus       172 ~i~iID~~~k~~  183 (229)
T PF06176_consen  172 GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEEECccccc
Confidence            499999987754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=1.4e-05  Score=86.41  Aligned_cols=141  Identities=15%  Similarity=0.190  Sum_probs=89.1

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhh-------------------------------HH------HHHHHHH
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-------------------------------LE------EFKNEVS  483 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~  483 (656)
                      +.||.-+.|.||+|++++|+.||||+-++.-++.                               .+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999876642111                               01      1333333


Q ss_pred             HHHh----cCCCc---eeeEEEEE-eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006211          484 LTAR----LQHVN---LLRVLGYC-TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN  555 (656)
Q Consensus       484 ~l~~----l~h~n---iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~  555 (656)
                      -.++    ++|-+   -|.+-.++ .-.....|+||||+|..+.+...-  .+..++......-+.+...-+-+-  .  
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~--~--  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFK--T--  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHh--c--
Confidence            3222    34555   12222222 223567999999999888765421  223355554433333322212222  2  


Q ss_pred             CCcEecccCCCCEEEcC----CCcEEEEeccCccccc
Q 006211          556 FRVIHRDLKASNILLDN----ELNPKISDFGMAKLFR  588 (656)
Q Consensus       556 ~~iiH~Dikp~NILl~~----~~~~kl~DfGla~~~~  588 (656)
                       +++|+|-+|.||++++    ++++.+-|||+...+.
T Consensus       321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             4999999999999994    6789999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.06  E-value=5.8e-05  Score=75.10  Aligned_cols=141  Identities=16%  Similarity=0.187  Sum_probs=84.9

Q ss_pred             cccccCc-eEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEecCCCChh
Q 006211          442 KLGEGGF-GPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLD  519 (656)
Q Consensus       442 ~iG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  519 (656)
                      .|-.|.. ..||+.... +..+.+|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 789999764 4788899876543   234567888888773 334556777776666789999999998775


Q ss_pred             hhh-------------------hCCC-cCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 006211          520 LYL-------------------FDPI-RRYVLDW--QKRVNIIE--------------------GVTQGLLYLQE----Y  553 (656)
Q Consensus       520 ~~l-------------------~~~~-~~~~l~~--~~~~~i~~--------------------~i~~~l~~Lh~----~  553 (656)
                      ...                   +... .......  ........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            331                   1100 0001110  00000000                    01112222221    1


Q ss_pred             CCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       554 ~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234599999999999999987788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd06547 GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENGase) hydrolyzes the N-N'-diacetylchitobiosyl core of N-glycosylproteins

Probab=98.06  E-value=3e-05  Score=79.87  Aligned_cols=158  Identities=14%  Similarity=0.087  Sum_probs=100.5

Q ss_pred             HHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCC-hhhHHHHHHHHHHHHHHcCCCcceeeeeCCC--cc
Q 006211           81 NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD-SSHRKSFIESSIRTARLYGFQGIDLFWLWPN--ST  157 (656)
Q Consensus        81 ~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~-~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~--~~  157 (656)
                      ..+|++  +|||+-.|--           .|+.....+..++.+ ++.+..+|+.++++++.|||||+-||+|...  .+
T Consensus        53 daAHkn--GV~Vlgti~~-----------e~~~~~~~~~~lL~~~~~~~~~~a~kLv~lak~yGfDGw~iN~E~~~~~~~  119 (339)
T cd06547          53 NAAHRN--GVPVLGTFIF-----------EWTGQVEWLEDFLKKDEDGSFPVADKLVEVAKYYGFDGWLINIETELGDAE  119 (339)
T ss_pred             HHHHhc--CCeEEEEEEe-----------cCCCchHHHHHHhccCcccchHHHHHHHHHHHHhCCCceEeeeeccCCcHH
Confidence            445555  7999988811           111122336788888 9999999999999999999999999999876  57


Q ss_pred             CcchHHHHHHHHHhhcCCC-CCcEEEE--Eee-cCCCccccccCh--hhhhhccchhhhhhhcccCCCCCCccccCCCCC
Q 006211          158 DLNSLGILLDEWKASASDQ-PELTLSM--AVR-YSPTHETVSYPI--DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY  231 (656)
Q Consensus       158 d~~~~~~ll~~lr~~l~~~-~~~~ls~--a~~-~~~~~~~~~~~~--~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~  231 (656)
                      +++++..|+++|++++++. ++..+.-  ++- .+.-.++...+-  ....+.+|-+.+   +|   +|..         
T Consensus       120 ~~~~l~~F~~~L~~~~~~~~~~~~v~WYDs~t~~G~l~wQn~Ln~~N~~ff~~~D~~Fl---NY---~W~~---------  184 (339)
T cd06547         120 KAKRLIAFLRYLKAKLHENVPGSLVIWYDSMTEDGKLSWQNELNSKNKPFFDVCDGIFL---NY---WWTE---------  184 (339)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCCcEEEEEecCCCCCccchhhhhhHHHHHHHhhhcceeE---ec---CCCc---------
Confidence            8999999999999999542 1222211  110 011111111100  011122221111   22   2332         


Q ss_pred             CCCCCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCC
Q 006211          232 NPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDG  271 (656)
Q Consensus       232 ~~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g  271 (656)
                           ...+.+++.....|..+.+|.+|+-..|++....+
T Consensus       185 -----~~l~~s~~~a~~~g~~~~dvy~GiDv~grg~~~~~  219 (339)
T cd06547         185 -----ESLERSVQLAEGLGRSPYDVYVGVDVWGRGTKGGG  219 (339)
T ss_pred             -----chHHHHHHHHHHcCCCHhHEEEEEEEEcCCcccCC
Confidence                 13456667777889999999999999999876444

The beta-1,4-glycosyl bond located between two N-acetylglucosamine residues is hydrolyzed such that N-acetylglucosamine 1 remains with the protein and N-acetylglucosamine 2 forms the reducing end of the released glycan. ENGase is a key enzyme in the processing of free oligosaccharides in the cytosol of eukaryotes. Oligosaccharides formed in the lumen of the endoplasmic reticulum are transported into the cytosol where they are catabolized by cytosolic ENGases and other enzymes, possibly to maximize the reutilization of the component sugars. ENGases have an eight-stranded alpha/beta barrel topology and are classified as a family 85 glycosyl hydrolase (GH85) domain. The GH85 ENGases are sequence-similar to the family 18 glycosyl hydrolases, also known as GH18 chitinases. An ENGase-like protein is also found in bacteria and is included in this alignment mod

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.03  E-value=5e-05  Score=74.77  Aligned_cols=143  Identities=24%  Similarity=0.245  Sum_probs=82.7

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEEEee---CCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV--NLLRVLGYCTE---RDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  515 (656)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+.+++..+..   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568899999999998866 69999987654  3445677888888887533  34566654432   2346899999999


Q ss_pred             CChhh----------------hh---hCC-CcCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 006211          516 KSLDL----------------YL---FDP-IRRYVLDWQK---------RVNI------------IEGVTQ-GLLYLQE-  552 (656)
Q Consensus       516 g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~Lh~-  552 (656)
                      ..+..                .+   +.. ..........         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87766                11   110 0000001000         0000            111222 2333332 


Q ss_pred             ---cCCCCcEecccCCCCEEEc-CCCcEEEEeccCccc
Q 006211          553 ---YSNFRVIHRDLKASNILLD-NELNPKISDFGMAKL  586 (656)
Q Consensus       553 ---~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~  586 (656)
                         .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               2334599999999999999 566667999998854

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.97  E-value=0.00012  Score=70.38  Aligned_cols=152  Identities=19%  Similarity=0.237  Sum_probs=97.7

Q ss_pred             cCHHHHHHHhcCCCCCC---cccccCceEEEEEEeCCCCEEEEEEccCCChhh-------------------HH-----H
Q 006211          425 FSFSDIKAATNNFSSAN---KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-------------------LE-----E  477 (656)
Q Consensus       425 ~~~~~~~~~~~~y~~~~---~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~  477 (656)
                      .+...+....++..+..   .|..|.-+.||+|...++..+|||+.+......                   .+     -
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455555555555544   456677788999987789999999886542111                   01     1


Q ss_pred             HHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEEEecCCCCh-hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006211          478 FKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS  554 (656)
Q Consensus       478 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~  554 (656)
                      ..+|..-|.++.  +-.+.+-+.+.    ...|||||+..... .-.|    ....+...+...+..++++.+.-|-...
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            245666676663  33444455443    34899999965411 1111    1112233356667777888888776632


Q ss_pred             CCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       555 ~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                        ++||+||+.=|||+. ++.+.|+|+|=|...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              399999999999999 778999999977543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.96  E-value=1.5e-06  Score=93.76  Aligned_cols=96  Identities=20%  Similarity=0.379  Sum_probs=74.7

Q ss_pred             HHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc-------ccccccccccccccccccccCC
Q 006211          542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-------EANTGRIVGTYGYVPPEYVKKG  614 (656)
Q Consensus       542 ~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~  614 (656)
                      +++.|+.++|...  .+||++|.|++|.++.++.+||+.|+.+........       ............|.|||.+...
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3458999999755  699999999999999999999999998865433111       1111122345689999999998


Q ss_pred             CCCccchhHHHHHHHHHHHcCCCCC
Q 006211          615 IYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       615 ~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      ..+.++|+||+||++|.+..|.++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i  209 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSI  209 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcch
Confidence            8899999999999999999555443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.0002  Score=68.01  Aligned_cols=133  Identities=18%  Similarity=0.278  Sum_probs=92.0

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCC----------------hhhHHHHHHHHHHHHhcC------CCceeeEE
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS----------------TQGLEEFKNEVSLTARLQ------HVNLLRVL  497 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~  497 (656)
                      ...||+|+.-.||.  .+.....+||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999996  4566778899887655                112345566666555554      78899999


Q ss_pred             EEEeeCCceEEEEEecCC--C----ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          498 GYCTERDENMLIYEYLPN--K----SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       498 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      |+.+++...-+|+|.+.+  |    +|..++.    ...++. +..+.   +-+-..+|-+.+   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998744  3    3555552    333554 33333   334455666666   99999999999996


Q ss_pred             CCC----cEEEEe-ccCcc
Q 006211          572 NEL----NPKISD-FGMAK  585 (656)
Q Consensus       572 ~~~----~~kl~D-fGla~  585 (656)
                      ...    .+.|+| ||...
T Consensus       153 ~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ecCCCceEEEEEeCCCCcc
Confidence            432    577888 56544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.81  E-value=0.00011  Score=69.42  Aligned_cols=105  Identities=20%  Similarity=0.148  Sum_probs=81.9

Q ss_pred             HHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006211          479 KNEVSLTARLQH-VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR  557 (656)
Q Consensus       479 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  557 (656)
                      ..|.-++..+++ +++.+++|.|-    .+++.|+...+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888875 59999999994    3788999987655321100011123689999999999999999999866556


Q ss_pred             cEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          558 VIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       558 iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +.-.|++|+|+-+++++++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.80  E-value=0.00029  Score=82.53  Aligned_cols=79  Identities=19%  Similarity=0.421  Sum_probs=57.0

Q ss_pred             CCcccccCceEEEEEEeCCC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCce--eeEEEEEeeC---CceEEE
Q 006211          440 ANKLGEGGFGPVYKGNLPRG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNL--LRVLGYCTER---DENMLI  509 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  509 (656)
                      ++.++.|....+|+.....+   ..+++|+..... ......+.+|.++++.+. |+++  .+++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876543   467788765432 123346789999999985 6654  7777777654   357899


Q ss_pred             EEecCCCCh
Q 006211          510 YEYLPNKSL  518 (656)
Q Consensus       510 ~e~~~~g~L  518 (656)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.75  E-value=2.7e-06  Score=90.77  Aligned_cols=182  Identities=18%  Similarity=0.156  Sum_probs=126.2

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCCceEEEEEecCCC-C
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLIYEYLPNK-S  517 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~  517 (656)
                      .+-+++++++.+++.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++..+++++++..+ +
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            3557899999999886544444446655443     23356889999999999 667677677777889999999877 2


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccc
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG  597 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~  597 (656)
                      ...-. . .....+.+.+...+...-.+++++||+..   =+|+|    ||+..+ +..+..||+....+....   ...
T Consensus       322 ~~~~~-~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  322 SALEM-T-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             ccccC-C-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence            21110 0 01111223333445555667788888764   48888    887776 478999999887654432   233


Q ss_pred             cccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       598 ~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      ...+++.++|||+.....+....|+|++|+-..++--|-+|-
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            457899999999999999999999999998777766665554

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.74  E-value=0.00049  Score=64.87  Aligned_cols=137  Identities=23%  Similarity=0.409  Sum_probs=92.5

Q ss_pred             CCCCccccCHHHHHHHhcCCCCCCcccccCc-eEEEEEEeCCCCEEEEEEccC---CCh------------------hhH
Q 006211          418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGF-GPVYKGNLPRGQEFAVKRLSA---TST------------------QGL  475 (656)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~  475 (656)
                      ..|.+..|..     -+.+++.++.||.|.. |.||++++ +|+.+|+|.+..   ...                  ...
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            3455555554     1267888999999999 99999998 678999999321   100                  112


Q ss_pred             HHHHHHHHHHHhcC---CCce--eeEEEEEeeCC------------------ceEEEEEecCCCChhhhhhCCCcCCCCC
Q 006211          476 EEFKNEVSLTARLQ---HVNL--LRVLGYCTERD------------------ENMLIYEYLPNKSLDLYLFDPIRRYVLD  532 (656)
Q Consensus       476 ~~~~~e~~~l~~l~---h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~  532 (656)
                      ..|..|++...+|+   +.++  ++.+||..-..                  ...||.||++...            .++
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~  166 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ  166 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc
Confidence            35778888877774   4455  88888873220                  1246777665532            122


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       533 ~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..    -+.+|.+-+..+|..+   |+-+|+++.|..     .-+|+|||.+
T Consensus       167 ~~----~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 IR----DIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hh----HHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            22    3445666777888887   999999999987     4589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.72  E-value=0.00029  Score=64.13  Aligned_cols=129  Identities=22%  Similarity=0.285  Sum_probs=87.5

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      ..+.|++|.+|.||.|.+ .+..+|+|+-+..+.  ...+..|.++|..+.--++-+=+-.+.   ...+.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence            457899999999999988 456889987766543  357889999999988666554332222   22455999999888


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC-CCCEEEcCCCcEEEEeccCccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK-ASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dik-p~NILl~~~~~~kl~DfGla~~  586 (656)
                      ......      .+.++...    +++.---|..++   |-|+.|. |...+|.++..+.|+||..|+.
T Consensus       100 ~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            765421      12233333    344434455555   8999997 5555555555899999999974

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.69  E-value=0.00042  Score=68.48  Aligned_cols=73  Identities=18%  Similarity=0.258  Sum_probs=44.5

Q ss_pred             CcccccCce-EEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEEEeeC---CceEEEEEec
Q 006211          441 NKLGEGGFG-PVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV---NLLRVLGYCTER---DENMLIYEYL  513 (656)
Q Consensus       441 ~~iG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  513 (656)
                      +.|+.|+.. .||+.    +..+++|..+...  ....+.+|.+++..+...   -+.+++......   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766665 58875    2357778655422  234678899998887532   233444433322   2347899999


Q ss_pred             CCCChh
Q 006211          514 PNKSLD  519 (656)
Q Consensus       514 ~~g~L~  519 (656)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00051  Score=67.79  Aligned_cols=73  Identities=18%  Similarity=0.255  Sum_probs=47.7

Q ss_pred             CcccccCceEEEEEEeCC--CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcee-eEEEEEeeCCceEEEEEecCCCC
Q 006211          441 NKLGEGGFGPVYKGNLPR--GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL-RVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      +.|..|-...+|+....+  +..+++|+........ -...+|+.++..+...+++ +++..+.    ..+++||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467788888999997654  6789999776432221 2235688888888543443 3433322    247999999876


Q ss_pred             h
Q 006211          518 L  518 (656)
Q Consensus       518 L  518 (656)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.64  E-value=0.001  Score=68.11  Aligned_cols=77  Identities=17%  Similarity=0.134  Sum_probs=55.7

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC---CceeeEEEEEeeC---CceEEEEEe
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH---VNLLRVLGYCTER---DENMLIYEY  512 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~  512 (656)
                      ..+.||.|..+.||+....++ .+.+|..+...  ....+..|...++.+..   ..+.+++++|...   +..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            456799999999999876555 46777754311  22467889998888843   3577888877543   568999999


Q ss_pred             cCCCCh
Q 006211          513 LPNKSL  518 (656)
Q Consensus       513 ~~~g~L  518 (656)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.54  E-value=0.00053  Score=68.72  Aligned_cols=139  Identities=17%  Similarity=0.142  Sum_probs=78.9

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCceEEEEEecCCCChhh
Q 006211          442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYLPNKSLDL  520 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~  520 (656)
                      .+..|-...+|+... +++.+++|+.........-...+|..+++.+...++ .+++....    ..+|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            355677888998874 567888887654322211134678888888854333 33333322    378999999876542


Q ss_pred             h-----------------hhCCC-cCCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCcEecccCCCC
Q 006211          521 Y-----------------LFDPI-RRYVLDWQKR-VNIIEG---------VTQGLLYLQEY-----SNFRVIHRDLKASN  567 (656)
Q Consensus       521 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------i~~~l~~Lh~~-----~~~~iiH~Dikp~N  567 (656)
                      .                 ++... .....+.... .....+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 1111222111 111111         11222222221     12348999999999


Q ss_pred             EEEcCCCcEEEEeccCccc
Q 006211          568 ILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       568 ILl~~~~~~kl~DfGla~~  586 (656)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999886 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF03644 Glyco_hydro_85: Glycosyl hydrolase family 85 ; InterPro: IPR005201 O-Glycosyl hydrolases 3

Probab=97.41  E-value=8e-05  Score=75.87  Aligned_cols=152  Identities=17%  Similarity=0.193  Sum_probs=88.8

Q ss_pred             HHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccC-ChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc--
Q 006211           80 ANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVG-DSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS--  156 (656)
Q Consensus        80 ~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~-~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~--  156 (656)
                      +.+++++  +||||=.|-          | .|+.+.+.+..++. +++....+++.++++++.|||||.-|+||.+..  
T Consensus        48 idaAHrn--GV~vLGTii----------f-e~~~~~~~~~~ll~~~~~g~~~~A~kLi~ia~~yGFDGw~iN~E~~~~~~  114 (311)
T PF03644_consen   48 IDAAHRN--GVKVLGTII----------F-EWGGGAEWCEELLEKDEDGSFPYADKLIEIAKYYGFDGWLINIETPLSGP  114 (311)
T ss_dssp             HHHHHHT--T--EEEEEE----------E-EEE--HHHHHHHT---TTS--HHHHHHHHHHHHHT--EEEEEEEESSTTG
T ss_pred             HHHHHhc--CceEEEEEE----------e-cCCchHHHHHHHHcCCcccccHHHHHHHHHHHHcCCCceEEEecccCCch
Confidence            3445554  899998871          1 22222334678888 888999999999999999999999999998865  


Q ss_pred             cCcchHHHHHHHHHhhcCCCCCcEEEE--Eeec-CCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCC
Q 006211          157 TDLNSLGILLDEWKASASDQPELTLSM--AVRY-SPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP  233 (656)
Q Consensus       157 ~d~~~~~~ll~~lr~~l~~~~~~~ls~--a~~~-~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~  233 (656)
                      .+..++..|+++|+++++..++..+.-  ++.. +...++.                           .....+.++...
T Consensus       115 ~~~~~l~~F~~~l~~~~~~~~~~~v~WYDs~t~~G~l~~qn---------------------------~Ln~~N~~f~~~  167 (311)
T PF03644_consen  115 EDAENLIDFLKYLRKEAHENPGSEVIWYDSVTNSGRLSWQN---------------------------ELNDKNKPFFDV  167 (311)
T ss_dssp             GGHHHHHHHHHHHHHHHHHT-T-EEEEES-B-SSSSB---S---------------------------SS-TTTGGGBES
T ss_pred             hHHHHHHHHHHHHHHHhhcCCCcEEEEeecCCcCCccchHH---------------------------HHHhhCcchhhh
Confidence            588999999999999995422333322  1110 0111111                           111122222111


Q ss_pred             CC---------CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCC
Q 006211          234 SS---------NISTDFGIREWLRRGFPANKLVLGARASGPGITIDG  271 (656)
Q Consensus       234 ~~---------~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g  271 (656)
                      ++         ..+...+++...+.|.++.++.+|+-..||+....|
T Consensus       168 ~d~iFlNY~W~~~~l~~s~~~A~~~~~~~~~vy~GiDv~grg~~g~g  214 (311)
T PF03644_consen  168 CDGIFLNYNWNPDSLESSVANAKSRGRDPYDVYAGIDVFGRGTYGGG  214 (311)
T ss_dssp             -SEEEE-S--SHHHHHHHHHHHHHHTS-GGGEEEEEEHHHHT-GGG-
T ss_pred             cceeeEecCCCcccHHHHHHHHHHcCCCHHHEEEEEEEEcCCcccCC
Confidence            11         024678888888999999999999999998743333

2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. This group of endo-beta-N-acetylglucosaminidases belong to the glycoside hydrolase family 85 (GH85 from CAZY). These enzymes work on a broad spectrum of substrates.; GO: 0033925 mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity, 0005737 cytoplasm; PDB: 2W92_A 2W91_A 2VTF_B 3FHQ_B 3FHA_D 3GDB_A.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.37  E-value=0.0027  Score=65.14  Aligned_cols=143  Identities=17%  Similarity=0.143  Sum_probs=83.7

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEE------EeeCCceEEEEE
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGY------CTERDENMLIYE  511 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  511 (656)
                      .+.|..|....+|+....+ ..+++|+....   ....+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778888999986644 47888987652   2345567777777774332  3444331      122345689999


Q ss_pred             ecCCCChhh----h----------hhCC----Cc----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 006211          512 YLPNKSLDL----Y----------LFDP----IR----RYVLDWQKRV----------NIIEGVTQGLLYLQE----YSN  555 (656)
Q Consensus       512 ~~~~g~L~~----~----------l~~~----~~----~~~l~~~~~~----------~i~~~i~~~l~~Lh~----~~~  555 (656)
                      +++|..+..    .          ++..    ..    .....|....          .....+...+.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    0          0100    00    0011111110          011122334444443    122


Q ss_pred             CCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          556 FRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       556 ~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ..++|+|+.|.||+++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3599999999999999987778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.28  E-value=0.0042  Score=65.58  Aligned_cols=75  Identities=16%  Similarity=0.246  Sum_probs=52.5

Q ss_pred             CcccccCceEEEEEEeCCC-CEEEEEEccCC-----C--hhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCceEEE
Q 006211          441 NKLGEGGFGPVYKGNLPRG-QEFAVKRLSAT-----S--TQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  509 (656)
                      +.||.|.+..||++...+| +.++||.-...     .  ....++...|.+.|..+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999988776 48999975321     1  123456677888877762   2356666655  44567899


Q ss_pred             EEecCCCC
Q 006211          510 YEYLPNKS  517 (656)
Q Consensus       510 ~e~~~~g~  517 (656)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	656
3aqu_A	356	Crystal Structure Of A Class V Chitinase From Arabi		3e-72
3alg_A	353	Crystal Structure Of Class V Chitinase (E115q Mutan		2e-60
3alf_A	353	Crystal Structure Of Class V Chitinase From Nicotia		2e-60
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-44
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-36
1lg1_A	365	Crystal Structure Of Human Chitotriosidase In Compl		5e-31
1hki_A	365	Crystal Structure Of Human Chitinase In Complex Wit		5e-31
1hkk_A	364	High Resoultion Crystal Structure Of Human Chitinas		7e-31
1guv_A	366	Structure Of Human Chitotriosidase Length = 366		7e-31
1waw_A	445	Specificity And Affinity Of Natural Product Cyclope		1e-30
1xhg_A	361	Crystal Structure Of A 40 Kda Signalling Protein Fr		6e-26
1syt_A	361	Crystal Structure Of Signalling Protein From Goat S		1e-25
1zbv_A	361	Crystal Structure Of The Goat Signalling Protein (S		1e-25
1ljy_A	361	Crystal Structure Of A Novel Regulatory 40 Kda Mamm		2e-25
2pi6_A	361	Crystal Structure Of The Sheep Signalling Glycoprot		2e-25
1sr0_A	361	Crystal Structure Of Signalling Protein From Sheep(		3e-25
1tfv_A	361	Crystal Structure Of A Buffalo Signaling Glycoprote		4e-25
1hjv_A	362	Crystal Structure Of Hcgp-39 In Complex With Chitin		1e-24
1owq_A	361	Crystal Structure Of A 40 Kda Signalling Protein (S		7e-24
2esc_A	361	Crystal Structure Of A 40 Kda Protective Signalling		2e-23
4ay1_A	365	Human Ykl-39 Is A Pseudo-Chitinase With Retained Ch		7e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
3fxy_A	395	Acidic Mammalian Chinase, Catalytic Domain Length =		1e-20
2ybt_A	381	Crystal Structure Of Human Acidic Chitinase In Comp		1e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1e9l_A	377	The Crystal Structure Of Novel Mammalian Lectin Ym1		3e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-19
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-12
3g6l_A	406	The Crystal Structure Of A Chitinase Crchi1 From Th		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3soa_A	444	Full-Length Human Camkii Length = 444		4e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
1wno_A	395	Crystal Structure Of A Native Chitinase From Asperg		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1w9p_A	433	Specificity And Affinity Of Natural Product Cyclope		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
1jnd_A	420	Crystal Structure Of Imaginal Disc Growth Factor-2		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
1ll7_A	392	Structure Of The E171q Mutant Of C. Immitis Chitina		6e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-09
1d2k_A	392	C. Immitis Chitinase 1 At 2.2 Angstroms Resolution		6e-09
1ll6_A	392	Structure Of The D169n Mutant Of C. Immitis Chitina		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
3b9a_A	584	Crystal Structure Of Vibrio Harveyi Chitinase A Com		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
3b8s_A	584	Crystal Structure Of Wild-Type Chitinase A From Vib		1e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3ars_A	584	Crystal Structure Analysis Of Chitinase A From Vibr		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-06
1itx_A	419	Catalytic Domain Of Chitinase A1 From Bacillus Circ		6e-06
1e6n_B	499	Chitinase B From Serratia Marcescens Inactive Mutan		6e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-06
1ogb_A	499	Chitinase B From Serratia Marcescens Mutant D142n L		7e-06
1h0g_A	499	Complex Of A Chitinase With The Natural Product Cyc		7e-06
1e15_A	499	Chitinase B From Serratia Marcescens Length = 499		8e-06
1e6z_A	498	Chitinase B From Serratia Marcescens Wildtype In Co		8e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-06
1ur9_A	499	Interactions Of A Family 18 Chitinase With The Desi		8e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
1kfw_A	435	Structure Of Catalytic Domain Of Psychrophilic Chit		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-04

>pdb|3AQU|A Chain A, Crystal Structure Of A Class V Chitinase From Arabidopsis Thaliana Length = 356

Iteration: 1
 Score =  270 bits (689), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/352 (42%), Positives = 215/352 (61%), Gaps = 41/352 (11%)
Query: 25  QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVR 84
           QT +KA YW    EFP++DI+S+LFTHL CAFA+++S T Q+++SSANQ  FS F  +V+
Sbjct: 2   QTVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSANQPKFSTFTQTVQ 61
Query: 85  RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGF 144
           R+NPS+KTLLSI            G    + +  +SM  + + RKSFI+SSIR AR YGF
Sbjct: 62  RRNPSVKTLLSI------------GGGIADKTAYASMASNPTSRKSFIDSSIRVARSYGF 109
Query: 145 QGIDLFWLWPNS-TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYP 197
            G+DL W +P+S T++ + G LL EW+      AS+S +P L L+ AV YS  + +V YP
Sbjct: 110 HGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSSGKPRLLLAAAVFYSNNYYSVLYP 169
Query: 198 IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS-SNISTDFGIREWLRRGFPANKL 256
           + ++  +L+W +L+AYD++ P    VTG  AAL++PS +  S D G R W++ G PA K 
Sbjct: 170 VSAVASSLDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGPSGDAGTRSWIQAGLPAKKA 229
Query: 257 VLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
           VLG                   A  +G  I+ DGS+GY  IR FI +   GA  VYN++ 
Sbjct: 230 VLGFPYYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVD--NGATTVYNSTV 287
Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
           V +   +G  WI +D  ++I  K+ YAK++ LLGY ++ +  DDN  LSRAA
Sbjct: 288 VGDYCYAGTNWIGYDDNQSIVTKVRYAKQRGLLGYFSWHVGADDNSGLSRAA 339

>pdb|3ALG|A Chain A, Crystal Structure Of Class V Chitinase (E115q Mutant) From Nicotiana Tobaccum In Complex With Nag4 Length = 353

Iteration: 1
 Score =  230 bits (587), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 139/353 (39%), Positives = 198/353 (56%), Gaps = 46/353 (13%)
Query: 28  IKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
           +K GYW       L++I+S LFTHL CAFA+++    QL IS  NQ  F  F ++V+RKN
Sbjct: 4   VKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKN 63
Query: 88  PSIKTLLSIWNGQ-NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
           PS+KT LSI  G+ NST   I             M    + RKSFI+SSIR AR  GF G
Sbjct: 64  PSVKTFLSIAGGRANSTAYGI-------------MARQPNSRKSFIDSSIRLARQLGFHG 110
Query: 147 IDLFWLWP-NSTDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPID 199
           +DL W +P ++ D+ +LG LL+EW+      A  S +  L L+ AV  SP    ++YP++
Sbjct: 111 LDLDWQYPLSAADMTNLGTLLNEWRTAINTEARNSGRAALLLTAAVSNSPRVNGLNYPVE 170
Query: 200 SMKKNLNWAHLVAYDYHMPS-KENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL 258
           S+ +NL+W +L+AYD++ P+   + T  HA L++P +++S   GI  W++ G P  KLVL
Sbjct: 171 SLARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLVL 230
Query: 259 G----------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNAS 296
           G                      A  S  G   DGSM Y  IR +I      A  VYNA+
Sbjct: 231 GIPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVE--SRATTVYNAT 288
Query: 297 YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
            V +   SG+ WI++D  +T++ K++Y K + LLGY A+ ++ D NW LSR A
Sbjct: 289 IVGDYCYSGSNWISYDDTQTVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTA 341

>pdb|3ALF|A Chain A, Crystal Structure Of Class V Chitinase From Nicotiana Tobaccum Length = 353

Iteration: 1
 Score =  230 bits (587), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 139/353 (39%), Positives = 198/353 (56%), Gaps = 46/353 (13%)
Query: 28  IKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
           +K GYW       L++I+S LFTHL CAFA+++    QL IS  NQ  F  F ++V+RKN
Sbjct: 4   VKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKN 63
Query: 88  PSIKTLLSIWNGQ-NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
           PS+KT LSI  G+ NST   I             M    + RKSFI+SSIR AR  GF G
Sbjct: 64  PSVKTFLSIAGGRANSTAYGI-------------MARQPNSRKSFIDSSIRLARQLGFHG 110
Query: 147 IDLFWLWP-NSTDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPID 199
           +DL W +P ++ D+ +LG LL+EW+      A  S +  L L+ AV  SP    ++YP++
Sbjct: 111 LDLDWEYPLSAADMTNLGTLLNEWRTAINTEARNSGRAALLLTAAVSNSPRVNGLNYPVE 170
Query: 200 SMKKNLNWAHLVAYDYHMPS-KENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL 258
           S+ +NL+W +L+AYD++ P+   + T  HA L++P +++S   GI  W++ G P  KLVL
Sbjct: 171 SLARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLVL 230
Query: 259 G----------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNAS 296
           G                      A  S  G   DGSM Y  IR +I      A  VYNA+
Sbjct: 231 GIPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVE--SRATTVYNAT 288
Query: 297 YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
            V +   SG+ WI++D  +T++ K++Y K + LLGY A+ ++ D NW LSR A
Sbjct: 289 IVGDYCYSGSNWISYDDTQTVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTA 341

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  176 bits (445), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 97/233 (41%), Positives = 139/233 (59%), Gaps = 5/233 (2%)
Query: 408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
             PA E  +     L+ FS  +++ A++NFS+ N LG GGFG VYKG L  G   AVKRL
Sbjct: 11  DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 70
Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD-P 525
                QG E +F+ EV + +   H NLLR+ G+C    E +L+Y Y+ N S+   L + P
Sbjct: 71  KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 130
Query: 526 IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
             +  LDW KR  I  G  +GL YL ++ + ++IHRD+KA+NILLD E    + DFG+AK
Sbjct: 131 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 586 LFRKDVDEANTGRIV-GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           L   D  + +    V GT G++ PEY+  G  S K DV+ +GV+LL++I+ +R
Sbjct: 191 LM--DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 96/233 (41%), Positives = 138/233 (59%), Gaps = 5/233 (2%)
Query: 408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
             PA E  +     L+ FS  +++ A++NF + N LG GGFG VYKG L  G   AVKRL
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL 62
Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD-P 525
               TQG E +F+ EV + +   H NLLR+ G+C    E +L+Y Y+ N S+   L + P
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 526 IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
             +  LDW KR  I  G  +GL YL ++ + ++IHRD+KA+NILLD E    + DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 586 LFRKDVDEANTGRIV-GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           L   D  + +    V G  G++ PEY+  G  S K DV+ +GV+LL++I+ +R
Sbjct: 183 LM--DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/228 (40%), Positives = 131/228 (57%), Gaps = 16/228 (7%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKRLSA- 469
           SDT     FSF ++K  TNNF         NK+GEGGFG VYKG +      AVK+L+A 
Sbjct: 8   SDT-RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 470 ---TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
              T+ +  ++F  E+ + A+ QH NL+ +LG+ ++ D+  L+Y Y+PN SL   L    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L W  R  I +G   G+ +L E  +   IHRD+K++NILLD     KISDFG+A+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             K        RIVGT  Y+ PE + +G  + K D+YSFGV+LL+II+
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/228 (40%), Positives = 131/228 (57%), Gaps = 16/228 (7%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKRLSA- 469
           SDT     FSF ++K  TNNF         NK+GEGGFG VYKG +      AVK+L+A 
Sbjct: 2   SDT-RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 59
Query: 470 ---TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
              T+ +  ++F  E+ + A+ QH NL+ +LG+ ++ D+  L+Y Y+PN SL   L    
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 119
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L W  R  I +G   G+ +L E  +   IHRD+K++NILLD     KISDFG+A+ 
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             K        RIVGT  Y+ PE + +G  + K D+YSFGV+LL+II+
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 223

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/228 (39%), Positives = 141/228 (61%), Gaps = 6/228 (2%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
           D++ ATNNF     +G G FG VYKG L  G + A+KR +  S+QG+EEF+ E+   +  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-DPIRRYVLDWQKRVNIIEGVTQGL 547
           +H +L+ ++G+C ER+E +LIY+Y+ N +L  +L+   +    + W++R+ I  G  +GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV-GTYGYV 606
            YL   +   +IHRD+K+ NILLD    PKI+DFG++K    ++D+ +   +V GT GY+
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYI 208
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
            PEY  KG  + K DVYSFGV+L +++ ++         E +N  E+A
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 93/228 (40%), Positives = 131/228 (57%), Gaps = 16/228 (7%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKRLSA- 469
           SDT     FSF ++K  TNNF         NK+GEGGFG VYKG +      AVK+L+A 
Sbjct: 8   SDT-RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 470 ---TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
              T+ +  ++F  E+ + A+ QH NL+ +LG+ ++ D+  L+Y Y+PN SL   L    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L W  R  I +G   G+ +L E  +   IHRD+K++NILLD     KISDFG+A+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             K        RIVGT  Y+ PE + +G  + K D+YSFGV+LL+II+
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  149 bits (376), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 90/220 (40%), Positives = 125/220 (56%), Gaps = 15/220 (6%)
Query: 425 FSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKRLSA----TSTQG 474
           FSF ++K  TNNF         NK GEGGFG VYKG +      AVK+L+A    T+ + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
            ++F  E+ + A+ QH NL+ +LG+ ++ D+  L+Y Y PN SL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
            R  I +G   G+ +L E  +   IHRD+K++NILLD     KISDFG+A+   K     
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              RIVGT  Y  PE + +G  + K D+YSFGV+LL+II+
Sbjct: 182 XXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIIT 220

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/228 (38%), Positives = 140/228 (61%), Gaps = 6/228 (2%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
           D++ ATNNF     +G G FG VYKG L  G + A+KR +  S+QG+EEF+ E+   +  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-DPIRRYVLDWQKRVNIIEGVTQGL 547
           +H +L+ ++G+C ER+E +LIY+Y+ N +L  +L+   +    + W++R+ I  G  +GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV-GTYGYV 606
            YL   +   +IHRD+K+ NILLD    PKI+DFG++K    ++ + +   +V GT GY+
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYI 208
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
            PEY  KG  + K DVYSFGV+L +++ ++         E +N  E+A
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|1LG1|A Chain A, Crystal Structure Of Human Chitotriosidase In Complex With Chitobiose Length = 365

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 102/342 (29%), Positives = 160/342 (46%), Gaps = 57/342 (16%)
Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           F   D++ +L THLI AFA +  + +QLS +  N +      N +++ NP +KTLL+I  
Sbjct: 20  FLPKDLDPSLCTHLIYAFAGM--TNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI-- 75
Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-- 156
                     G  N      + MV  +++R++F+ S+IR  R Y F G+DL W +P S  
Sbjct: 76  ----------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQG 125
Query: 157 ---TDLNSLGILLD------EWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
               D      L+       + +A  S +  L LS AV    T+    Y +D + +NL++
Sbjct: 126 SPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDF 185
Query: 208 AHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGAR 261
            +L+AYD+H  S E VTG ++ LY        +++++ D  +++WL++G PA+KL+LG  
Sbjct: 186 VNLMAYDFH-GSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMP 244
Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA-----SYVVNLFTSGAT--------- 307
             G   T+  S      R      G G    +       +Y       GAT         
Sbjct: 245 TYGRSFTLASSSD---TRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKV 301
Query: 308 --------WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                   W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>pdb|1HKI|A Chain A, Crystal Structure Of Human Chitinase In Complex With Glucoallosamidin B Length = 365

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 102/342 (29%), Positives = 160/342 (46%), Gaps = 57/342 (16%)
Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           F   D++ +L THLI AFA +  + +QLS +  N +      N +++ NP +KTLL+I  
Sbjct: 20  FLPKDLDPSLCTHLIYAFAGM--TNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI-- 75
Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-- 156
                     G  N      + MV  +++R++F+ S+IR  R Y F G+DL W +P S  
Sbjct: 76  ----------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQG 125
Query: 157 ---TDLNSLGILLD------EWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
               D      L+       + +A  S +  L LS AV    T+    Y +D + +NL++
Sbjct: 126 SPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDF 185
Query: 208 AHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGAR 261
            +L+AYD+H  S E VTG ++ LY        +++++ D  +++WL++G PA+KL+LG  
Sbjct: 186 VNLMAYDFH-GSWEKVTGHNSPLYKRQEQSGAAASLNVDAAVQQWLQKGTPASKLILGMP 244
Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA-----SYVVNLFTSGAT--------- 307
             G   T+  S      R      G G    +       +Y       GAT         
Sbjct: 245 TYGRSFTLASSSD---TRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKV 301
Query: 308 --------WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                   W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>pdb|1HKK|A Chain A, High Resoultion Crystal Structure Of Human Chitinase In Complex With Allosamidin Length = 364

Iteration: 1
 Score =  132 bits (332), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 102/342 (29%), Positives = 160/342 (46%), Gaps = 57/342 (16%)
Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           F   D++ +L THLI AFA +  + +QLS +  N +      N +++ NP +KTLL+I  
Sbjct: 20  FLPKDLDPSLCTHLIYAFAGM--TNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI-- 75
Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-- 156
                     G  N      + MV  +++R++F+ S+IR  R Y F G+DL W +P S  
Sbjct: 76  ----------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQG 125
Query: 157 ---TDLNSLGILLD------EWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
               D      L+       + +A  S +  L LS AV    T+    Y +D + +NL++
Sbjct: 126 SPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDF 185
Query: 208 AHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGAR 261
            +L+AYD+H  S E VTG ++ LY        +++++ D  +++WL++G PA+KL+LG  
Sbjct: 186 VNLMAYDFH-GSWEKVTGHNSPLYKRQEQSGAAASLNVDAAVQQWLQKGTPASKLILGMP 244
Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA-----SYVVNLFTSGAT--------- 307
             G   T+  S      R      G G    +       +Y       GAT         
Sbjct: 245 TYGRSFTLASSSD---TRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKV 301
Query: 308 --------WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                   W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>pdb|1GUV|A Chain A, Structure Of Human Chitotriosidase Length = 366

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 102/342 (29%), Positives = 159/342 (46%), Gaps = 57/342 (16%)
Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           F   D++ +L THLI AFA +  + +QLS +  N +      N +++ NP +KTLL+I  
Sbjct: 20  FLPKDLDPSLCTHLIYAFAGM--TNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI-- 75
Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-- 156
                     G  N      + MV  +++R++F+ S+IR  R Y F G+DL W +P S  
Sbjct: 76  ----------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQG 125
Query: 157 ---TDLNSLGILLD------EWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
               D      L+       + +A  S +  L LS AV    T+    Y +D + +NL++
Sbjct: 126 SPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDF 185
Query: 208 AHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGAR 261
            +L+AYD+H  S E VTG ++ LY        +++++ D  +++WL +G PA+KL+LG  
Sbjct: 186 VNLMAYDFH-GSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLEKGTPASKLILGMP 244
Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA-----SYVVNLFTSGAT--------- 307
             G   T+  S      R      G G    +       +Y       GAT         
Sbjct: 245 TYGRSFTLASSSD---TRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKV 301
Query: 308 --------WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                   W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>pdb|1WAW|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitor Argadin Against Human Chitinase Length = 445

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 101/338 (29%), Positives = 159/338 (47%), Gaps = 57/338 (16%)
Query: 43  DINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNS 102
           D++ +L THLI AFA +  + +QLS +  N +      N +++ NP +KTLL+I      
Sbjct: 24  DLDPSLCTHLIYAFAGM--TNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI------ 75
Query: 103 TYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----T 157
                 G  N      + MV  +++R++F+ S+IR  R Y F G+DL W +P S      
Sbjct: 76  ------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAV 129
Query: 158 DLNSLGILLD------EWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLV 211
           D      L+       + +A  S +  L LS AV    T+    Y +D + +NL++ +L+
Sbjct: 130 DKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLM 189
Query: 212 AYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGARASGP 265
           AYD+H  S E VTG ++ LY        +++++ D  +++WL++G PA+KL+LG    G 
Sbjct: 190 AYDFHG-SWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGR 248
Query: 266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNA-----SYVVNLFTSGAT------------- 307
             T+  S      R      G G    +       +Y       GAT             
Sbjct: 249 SFTLASSSD---TRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIF 305
Query: 308 ----WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
               W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 306 RDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>pdb|1XHG|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein From Porcine (spp-40) At 2.89a Resolution Length = 361

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP + I+  L TH+I +FA +  S  ++     N        N+++ +NP++KTLLS
Sbjct: 18  GSCFPDA-IDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPNLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPQRFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+    + S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGQEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGK 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+Q    GA         V   
Sbjct: 242 SFTLASSKTDVGAPVSGPGIPGQFTKEKGILAYYEICDFLQ----GATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1SYT|A Chain A, Crystal Structure Of Signalling Protein From Goat Spg-40 In The Presense Of N,n',n''-triacetyl-chitotriose At 2.6a Resolution Length = 361

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I +FA +  S  ++     N        N+++ +NP +KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKASASDQPE-----LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA  + + +     L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTALVKEMKAEFAREAQAGTERLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  +S+ S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGNSDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+    +GA         V   
Sbjct: 242 SFTLASSKTDGGAPISGPGIPGRFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1ZBV|A Chain A, Crystal Structure Of The Goat Signalling Protein (Spg-40) Complexed With A Designed Peptide Trp-Pro-Trp At 3.2a Resolution Length = 361

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I +FA +  S  ++     N        N+++ +NP +KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKASASDQPE-----LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA  + + +     L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTALVKEMKAEFAREAQAGTERLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  +S+ S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGNSDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+    +GA         V   
Sbjct: 242 SFTLASSKTDVGAPISGPGIPGRFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1LJY|A Chain A, Crystal Structure Of A Novel Regulatory 40 Kda Mammary Gland Protein (Mgp-40) Secreted During Involution Length = 361

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 151/339 (44%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP + I+  L TH+I +FA +  S  ++     N        N+++ +NP +KTLLS
Sbjct: 18  GSCFPDA-IDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S++   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPERFSAIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKASASDQPE-----LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA  + + +     L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTALVKEMKAEFAREAQAGTERLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  +S+ S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGNSDGSSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+    +GA         V   
Sbjct: 242 SFTLASSKTDGGAPISGPGIPGRFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|2PI6|A Chain A, Crystal Structure Of The Sheep Signalling Glycoprotein (Sps-40) Complex With 2-Methyl-2-4-Pentanediol At 1.65a Resolution Reveals Specific Binding Characteristics Of Sps-40 Length = 361

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 98/339 (28%), Positives = 147/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I  FA +  S  ++     N        N+++ +NP +KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYTFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  + + S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+    +GA         V   
Sbjct: 242 SFTLASSKTDVGAPVSGPGIPGRFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1SR0|A Chain A, Crystal Structure Of Signalling Protein From Sheep(Sps-40) At 3.0a Resolution Using Crystal Grown In The Presence Of Polysaccharides Length = 361

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 97/339 (28%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I +FA +  S  ++     N        N+++ +NP +KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N  P   S++   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGPERFSAIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 RRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  + + S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFAGNEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPG+        G + Y  I  F+    +GA         V   
Sbjct: 242 SFTLASSKTDVGAPVSGPGVPGRFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1TFV|A Chain A, Crystal Structure Of A Buffalo Signaling Glycoprotein (Spb-40) Secreted During Involution Length = 361

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 98/336 (29%), Positives = 151/336 (44%), Gaps = 47/336 (13%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I +FA +  S  ++     N        N+++ +NP++KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPNLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N      S +   +  R++FI+S     R +GF G+DL WLWP 
Sbjct: 75  V------------GGWNYGSQRFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLWPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 WRDKRHLTTLVKEMKAEFVREAQAGTEQLLLSAAVTAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   ++ V G H+ L+  + + S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGAWRQTV-GHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGITIDGSMGYKFIRAF--IQNYGYGAAPVYNASYVVNLFTSG 305
                      GA  SGPGI    +  +K I A+  I ++ +GA         V   T G
Sbjct: 242 SYTLASSKTDVGAPISGPGIPGRFTK-WKGILAYYEICDFLHGATTHRFRDQQVPYATKG 300
Query: 306 ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
             W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 301 NQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|1HJV|A Chain A, Crystal Structure Of Hcgp-39 In Complex With Chitin Tetramer Length = 362

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 96/340 (28%), Positives = 151/340 (44%), Gaps = 54/340 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   ++  L TH+I +FA +  S   +     N        N+++ +NP++KTLLS
Sbjct: 18  GSCFP-DALDRFLCTHIIYSFANI--SNDHIDTWEWNDVTLYGMLNTLKNRNPNLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N      S +  ++  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGSQRFSKIASNTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKAS--ASDQP---ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D      L+ E KA      QP   +L LS A+         SY I  + ++L++  +
Sbjct: 123 RRDKQHFTTLIKEMKAEFIKEAQPGKKQLLLSAALSAGKVTIDSSYDIAKISQHLDFISI 182
Query: 211 VAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVL------ 258
           + YD+H  +    TG H+ L+      +P    +TD+ +   LR G PA+KLV+      
Sbjct: 183 MTYDFH-GAWRGTTGHHSPLFRGQEDASPDRFSNTDYAVGYMLRLGAPASKLVMGIPTFG 241
Query: 259 ------------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNL 301
                       GA  SGPGI        G++ Y  I  F++    GA         V  
Sbjct: 242 RSFTLASSETGVGAPISGPGIPGRFTKEAGTLAYYEICDFLR----GATVHRILGQQVPY 297
Query: 302 FTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
            T G  W+ +D  E++K+K+ Y K++ L G   + L  DD
Sbjct: 298 ATKGNQWVGYDDQESVKSKVQYLKDRQLAGAMVWALDLDD 337

>pdb|1OWQ|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein (Spc-40) Secreted During Involution Length = 361

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 98/339 (28%), Positives = 150/339 (44%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP + I+  L TH+I +FA +  S  ++     N        N+++ +NP++KTLLS
Sbjct: 18  GSCFPDA-IDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPNLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N      S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGSERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 WRDKRHLTTLVKEMKAEFVREAQAGTEQLLLSAAVPAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   +  V G H+ L+  +S+ S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGGWRGTV-GHHSPLFRGNSDGSSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G++ Y  I  F+    +GA         V   
Sbjct: 242 SYTLASSKTDVGAPISGPGIPGQFTKEKGTLAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|2ESC|A Chain A, Crystal Structure Of A 40 Kda Protective Signalling Protein From Bovine (Spc-40) At 2.1 A Resolution Length = 361

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/339 (28%), Positives = 148/339 (43%), Gaps = 53/339 (15%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           G  FP   I+  L TH+I +FA +  S  ++     N        N+++ +NP++KTLLS
Sbjct: 18  GSCFP-DAIDPFLCTHVIYSFANI--SNNEIDTWEWNDVTLYDTLNTLKNRNPNLKTLLS 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           +            G  N      S +   +  R++FI+S     R +GF G+DL WL+P 
Sbjct: 75  V------------GGWNFGSERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG 122
Query: 156 STDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHL 210
             D   L  L+ E KA     + +   +L LS AV          Y I  + ++L++  L
Sbjct: 123 WRDKRHLTTLVKEMKAEFVREAQAGTEQLLLSAAVTAGKIAIDRGYDIAQISRHLDFISL 182
Query: 211 VAYDYHMPSKENVTGIHAALYNPSSNIST-----DFGIREWLRRGFPANKLVL------- 258
           + YD+H   +  V G H+ L+  +S+ S+     D+ +   LR G PANKLV+       
Sbjct: 183 LTYDFHGGWRGTV-GHHSPLFRGNSDGSSRFSNADYAVSYMLRLGAPANKLVMGIPTFGR 241
Query: 259 -----------GARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302
                      GA  SGPGI        G + Y  I  F+    +GA         V   
Sbjct: 242 SYTLASSSTRVGAPISGPGIPGQFTKEKGILAYYEICDFL----HGATTHRFRDQQVPYA 297
Query: 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           T G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 298 TKGNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>pdb|4AY1|A Chain A, Human Ykl-39 Is A Pseudo-Chitinase With Retained Chitooligosaccharide Binding Properties Length = 365

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/340 (25%), Positives = 154/340 (45%), Gaps = 54/340 (15%)
Query: 38  EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIW 97
           +F   +I+  L +HLI +FA ++++   +   S    Y +I  NS++ KNP +K LLSI 
Sbjct: 20  KFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTI--NSLKTKNPKLKILLSIG 77
Query: 98  NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST 157
                    + G+K  +P     MV  S+ R  FI S I   R + F G+D+ W++P+  
Sbjct: 78  G-------YLFGSKGFHP-----MVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQK 125
Query: 158 DLNSLGILLDEWKA------SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLV 211
           +     +L+ E         + S +  L L+  V         SY ++ + K+L++ +L+
Sbjct: 126 ENTHFTVLIHELAEAFQKDFTKSTKERLLLTAGVSAGRQMIDNSYQVEKLAKDLDFINLL 185
Query: 212 AYDYHMP-SKENVTGIHAAL------YNPSSNISTDFGIREWLRRGFPANKLVL------ 258
           ++D+H    K  +TG ++ L        PSS  + ++ +  W+ +G P+ K+V+      
Sbjct: 186 SFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYG 245
Query: 259 ------------GARASGPGIT-----IDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNL 301
                       GA ASGPG         G + Y  I  F++    GA         V  
Sbjct: 246 HSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLK----GAKITRLQDQQVPY 301
Query: 302 FTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
              G  W+ +D V++++ K+ + K  NL G   + +  DD
Sbjct: 302 AVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDD 341

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 125/248 (50%), Gaps = 21/248 (8%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-- 454
            G  +L+ PG  T    +   D P   V  F+    ATN  S    +G G FG V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFED-PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRL 66
Query: 455 NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
            LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M++ E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NIL++
Sbjct: 127 YMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG+A++   D + A T R     G +P     PE +    ++   DV+S+G
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 627 VLLLQIIS 634
           ++L +++S
Sbjct: 238 IVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 27/251 (10%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDT---PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYK 453
            G  +L+ PG  T    Y D  T   P   V  F+    ATN  S    +G G FG V  
Sbjct: 9   FGNGHLKLPGLRT----YVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 63
Query: 454 G--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
           G   LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M+
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           + EY+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NI
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 178
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVY 623
           L+++ L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 624 SFGVLLLQIIS 634
           S+G++L +++S
Sbjct: 235 SYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 27/251 (10%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDT---PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYK 453
            G  +L+ PG  T    Y D  T   P   V  F+    ATN  S    +G G FG V  
Sbjct: 7   FGNGHLKLPGLRT----YVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 61
Query: 454 G--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
           G   LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M+
Sbjct: 62  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 121
Query: 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           + EY+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NI
Sbjct: 122 VTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 176
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVY 623
           L+++ L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+
Sbjct: 177 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVW 232
Query: 624 SFGVLLLQIIS 634
           S+G++L +++S
Sbjct: 233 SYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 27/251 (10%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDT---PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYK 453
            G  +L+ PG  T    Y D  T   P   V  F+    ATN  S    +G G FG V  
Sbjct: 9   FGNGHLKLPGLRT----YVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 63
Query: 454 G--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
           G   LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M+
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           + EY+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NI
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 178
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVY 623
           L+++ L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 624 SFGVLLLQIIS 634
           S+G++L +++S
Sbjct: 235 SYGIVLWEVMS 245

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 61
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 62  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 118
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+ 
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 58
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 59  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 115
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+ 
Sbjct: 116 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 9/214 (4%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLT 485
           S  D +      +   ++G G FG VYKG         +  ++A + Q L+ FKNEV + 
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
            + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I     Q
Sbjct: 64  RKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQ 120
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           G+ YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+  +
Sbjct: 121 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 606 VPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
           + PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 9/211 (4%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
           D +      +   ++G G FG VYKG         +  ++A + Q L+ FKNEV +  + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I     QG+ 
Sbjct: 62  RHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 118
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+  ++ P
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 609 EYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
           E ++   K  YS + DVY+FG++L ++++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 84  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 140
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+ 
Sbjct: 141 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 85  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 141
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+ 
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 125/248 (50%), Gaps = 21/248 (8%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-- 454
            G  +L+ PG  T    +   D P   V  F+    ATN  S    +G G FG V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFED-PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRL 66
Query: 455 NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
            LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M++ E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NIL++
Sbjct: 127 YMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILIN 181
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+S+G
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 627 VLLLQIIS 634
           ++L +++S
Sbjct: 238 IVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 125/248 (50%), Gaps = 21/248 (8%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-- 454
            G  +L+ PG  T    +   D P   V  F+    ATN  S    +G G FG V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFED-PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRL 66
Query: 455 NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
            LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M++ E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NIL++
Sbjct: 127 YMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+S+G
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 627 VLLLQIIS 634
           ++L +++S
Sbjct: 238 IVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 125/248 (50%), Gaps = 21/248 (8%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-- 454
            G  +L+ PG  T    +   D P   V  F+    ATN  S    +G G FG V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTYED-PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRL 66
Query: 455 NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
            LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M++ E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NIL++
Sbjct: 127 YMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+S+G
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 627 VLLLQIIS 634
           ++L +++S
Sbjct: 238 IVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 124/248 (50%), Gaps = 21/248 (8%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-- 454
            G  +L+ PG  T    +   D P   V  F+    ATN  S    +G G FG V  G  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFED-PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRL 66
Query: 455 NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
            LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M++ E
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NIL++
Sbjct: 127 YMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG+ ++   D + A T R     G +P     PE +    ++   DV+S+G
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 627 VLLLQIIS 634
           ++L +++S
Sbjct: 238 IVLWEVMS 245

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 13/213 (6%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTA 486
           D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV +  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           + +HVN+L  +GY T   +  ++ ++    SL  +L   I     +  K ++I     QG
Sbjct: 60  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL   S   +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+  ++
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 607 PPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 114/216 (52%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 77  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 133
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A    +        ++ G+ 
Sbjct: 134 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 114/216 (52%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I    
Sbjct: 85  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQT 141
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            QG+ YL   S   +IHRDLK++NI L  +L  KI DFG+A    +        ++ G+ 
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++   K  YS + DVY+FG++L ++++ +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 9/211 (4%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
           D +      +   ++G G FG VYKG         +  ++A + Q L+ FKNEV +  + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           +HVN+L  +GY T + +  ++ ++    SL  +L   I     +  K ++I     QG+ 
Sbjct: 62  RHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 118
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           YL   S   +IHRDLK++NI L  +L  KI DFG+A    +        ++ G+  ++ P
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175
Query: 609 EYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
           E ++   K  YS + DVY+FG++L ++++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3FXY|A Chain A, Acidic Mammalian Chinase, Catalytic Domain Length = 395

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 90/347 (25%), Positives = 147/347 (42%), Gaps = 60/347 (17%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           GR  P  DIN  L THLI AFA + ++  +++    N        N ++ KN  +KTLL+
Sbjct: 18  GRFMP-DDINPCLCTHLIYAFAGMQNN--EITTIEWNDVTLYQAFNGLKNKNSQLKTLLA 74
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           I            G  N   +  ++MV    +R++FI S I+  R Y F G+D  W +P 
Sbjct: 75  I------------GGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPG 122
Query: 156 S-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
           S      D +   +L+ E +      A   ++P L ++ AV    ++    Y I  + + 
Sbjct: 123 SRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQY 182
Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREWLRRGFPANKLVL 258
           L++ H++ YD H  S E  TG ++ LY   ++      ++ D+ +  W   G PA KL++
Sbjct: 183 LDYIHVMTYDLHG-SWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIV 241
Query: 259 ------------------------GARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN 294
                                   GA  +GP     G   Y  I  F++N   GA   ++
Sbjct: 242 GFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKN---GATQGWD 298
Query: 295 ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           A   V     G  W+ +D V++   K  + K     G   + +  DD
Sbjct: 299 APQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDD 345

>pdb|2YBT|A Chain A, Crystal Structure Of Human Acidic Chitinase In Complex With Bisdionin C Length = 381

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 89/347 (25%), Positives = 147/347 (42%), Gaps = 60/347 (17%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           GR  P  DIN  L THLI AFA + ++  +++    N        N ++ KN  +KTLL+
Sbjct: 22  GRFMP-DDINPCLCTHLIYAFAGMQNN--EITTIEWNDVTLYQAFNGLKNKNSQLKTLLA 78
Query: 96  IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155
           I            G  N   +  ++MV    +R++FI S I+  R Y F G+D  W +P 
Sbjct: 79  I------------GGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPG 126
Query: 156 S-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
           S      D +   +L+ E +      A   ++P L ++ AV    ++    Y I  + + 
Sbjct: 127 SRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQY 186
Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREWLRRGFPANKLVL 258
           L++ H++ YD H  S E  TG ++ LY   ++      ++ D+ +  W   G PA KL++
Sbjct: 187 LDYIHVMTYDLHG-SWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIV 245
Query: 259 ------------------------GARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN 294
                                   GA  +GP     G   Y  I  F++N   GA   ++
Sbjct: 246 GFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKN---GATQGWD 302
Query: 295 ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           A   V     G  W+ +D +++   K  + K     G   + +  DD
Sbjct: 303 APQEVPYAYQGNVWVGYDNIKSFDIKAQWLKHNKFGGAMVWAIDLDD 349

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 125/251 (49%), Gaps = 27/251 (10%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDT---PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYK 453
            G  +L+ PG  T    Y D  T   P   V  F+    ATN  S    +G G FG V  
Sbjct: 9   FGNGHLKLPGLRT----YVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 63
Query: 454 G--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
           G   LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M+
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           + E + N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NI
Sbjct: 124 VTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 178
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVY 623
           L+++ L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 624 SFGVLLLQIIS 634
           S+G++L +++S
Sbjct: 235 SYGIVLWEVMS 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 27/251 (10%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDT---PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYK 453
            G  +L+ PG  T    + D  T   P   V  F+    ATN  S    +G G FG V  
Sbjct: 9   FGNGHLKLPGLRT----FVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 63
Query: 454 G--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
           G   LP  +E   A+K L    T+    +F  E S+  +  H N++R+ G  T+    M+
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
           + E + N SLD +L     ++ +   + V ++ G+  G+ YL   S+   +HRDL A NI
Sbjct: 124 VTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGAVHRDLAARNI 178
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVY 623
           L+++ L  K+SDFG++++   D + A T R     G +P     PE +    ++   DV+
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 624 SFGVLLLQIIS 634
           S+G++L +++S
Sbjct: 235 SYGIVLWEVMS 245

>pdb|1E9L|A Chain A, The Crystal Structure Of Novel Mammalian Lectin Ym1 Suggests A Saccharide Binding Site Length = 377

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/344 (26%), Positives = 146/344 (42%), Gaps = 59/344 (17%)
Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           F   +I+  L THLI AFA + ++    +     + Y ++  N ++ KN  +KTLL+I  
Sbjct: 20  FKPGNIDPCLCTHLIYAFAGMQNNEITYTHEQDLRDYEAL--NGLKDKNTELKTLLAI-- 75
Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-- 156
                     G     P+  S+MV    +R+ FI+S IR  R Y F G++L W +P S  
Sbjct: 76  ----------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRG 125
Query: 157 ---TDLNSLGILLDEWKAS------ASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
               D +   +L+ E + +        D P L L+             Y I  + ++L++
Sbjct: 126 SPPKDKHLFSVLVKEMRKAFEEESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDY 185
Query: 208 AHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFPANKLVLGAR 261
             ++ YD H P K+  TG ++ LY        S++++ D  I  W   G  + KL++G  
Sbjct: 186 IQVMTYDLHDP-KDGYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGAASEKLIVGFP 244
Query: 262 ASG----------------------PGITID--GSMGYKFIRAFIQNYGYGAAPVYNASY 297
           A G                      PG   D  G + Y  +  F+     GA  V++A  
Sbjct: 245 AYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQ 301
Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
            V     G  W+ +D V + K K  + K+ NL G   + L  DD
Sbjct: 302 EVPYAYQGNEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDD 345

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 114/227 (50%), Gaps = 12/227 (5%)
Query: 416 DSDTPNLQVFSFS------DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSA 469
           D D P  +   F       D+     + +   K+G G FG V++     G + AVK L  
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILME 70
Query: 470 TS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR 527
                + + EF  EV++  RL+H N++  +G  T+     ++ EYL   SL   L     
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
           R  LD ++R+++   V +G+ YL    N  ++HRDLK+ N+L+D +   K+ DFG+++L 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL- 188
Query: 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            K      +    GT  ++ PE ++    + K DVYSFGV+L ++ +
Sbjct: 189 -KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 415 FDSDTPNLQVFSFS-DIKAATNNFSSANKLGEGGFGPVYKGNL--PRGQEF--AVKRLSA 469
           F  + PN  V  F+ +I A+         +G G FG V  G L  P  +E   A+K L A
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKV--IGVGEFGEVCSGRLKVPGKREICVAIKTLKA 67
Query: 470 TST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR 528
             T +   +F +E S+  +  H N++ + G  T+    M+I EY+ N SLD +L     R
Sbjct: 68  GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR 127
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
           + +   + V ++ G+  G+ YL   S+   +HRDL A NIL+++ L  K+SDFGM+++  
Sbjct: 128 FTV--IQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 589 KDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            D + A T R     G +P     PE +    ++   DV+S+G+++ +++S
Sbjct: 183 DDPEAAYTTR----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 12/227 (5%)
Query: 416 DSDTPNLQVFSFS------DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSA 469
           D D P  +   F       D+     + +   K+G G FG V++     G + AVK L  
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILME 70
Query: 470 TS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR 527
                + + EF  EV++  RL+H N++  +G  T+     ++ EYL   SL   L     
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
           R  LD ++R+++   V +G+ YL    N  ++HR+LK+ N+L+D +   K+ DFG+++L 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL- 188
Query: 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            K     ++    GT  ++ PE ++    + K DVYSFGV+L ++ +
Sbjct: 189 -KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQ 489
            N S    +G G FG V  G   LP  +E   A+K L    T+    +F  E S+  +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++R+ G  T+    M++ EY+ N SLD +L     ++ +   + V ++ G+  G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKY 133
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L   S+   +HRDL A NIL+++ L  K+SDFG++++   D + A T R     G +P  
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIR 186
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +    ++   DV+S+G++L +++S
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQ 489
            N S    +G G FG V  G   LP  +E   A+K L    T+    +F  E S+  +  
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 92
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++R+ G  T+    M++ EY+ N SLD +L     ++ +   + V ++ G+  G+ Y
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKY 150
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L   S+   +HRDL A NIL+++ L  K+SDFG++++   D + A T R     G +P  
Sbjct: 151 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIR 203
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +    ++   DV+S+G++L +++S
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVL 497
           +G G  G V  G L     R    A+K L A  T+    +F +E S+  +  H N++R+ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T     M++ EY+ N SLD +L     ++ +   + V ++ GV  G+ YL   S+  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A N+L+D+ L  K+SDFG++++   D D A T     T G +P     PE + 
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT----TTGGKIPIRWTAPEAIA 227
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              +S   DV+SFGV++ ++++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 115/216 (53%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L     ++  + +K ++I    
Sbjct: 61  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQT 117
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            +G+ YL   S   +IHRDLK++NI L  +   KI DFG+A +  +        ++ G+ 
Sbjct: 118 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++      YS + DVY+FG++L ++++ +
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 77
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 78  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 132
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 191
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 192 SDVWSFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 131
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 190
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 78
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 79  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 133
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 192
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 193 SDVWSFGILLTEIVTHGR 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 19/202 (9%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVL 497
           +G G  G V  G L     R    A+K L A  T+    +F +E S+  +  H N++R+ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T     M++ EY+ N SLD +L     ++ +   + V ++ GV  G+ YL   S+  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A N+L+D+ L  K+SDFG++++   D D A T     T G +P     PE + 
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT----TTGGKIPIRWTAPEAIA 227
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              +S   DV+SFGV++ ++++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 85
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 86  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 140
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 199
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 200 SDVWSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 84
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 139
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 198
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 199 SDVWSFGILLTEIVTHGR 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 131
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 190
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 82
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 137
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIK 196
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 131
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 190
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 71
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 126
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 185
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 186 SDVWSFGILLTEIVTHGR 203

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 82
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 137
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 196
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 13/216 (6%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVS 483
           S  D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV 
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  + +HVN+L  +GY T + +  ++ ++    SL  +L     ++  + +K ++I    
Sbjct: 73  VLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQT 129
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            +G+ YL   S   +IHRDLK++NI L  +   KI DFG+A    +        ++ G+ 
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            ++ PE ++      YS + DVY+FG++L ++++ +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 81
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 82  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 136
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 195
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 196 SDVWSFGILLTEIVTHGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 86
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 141
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 200
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 201 SDVWSFGILLTEIVTHGR 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 443 LGEGGFGPVYKGNL--PRGQEF--AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V  G L  P  +E   A+K L A  T +   +F +E S+  +  H N++ + 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T+    M+I EY+ N SLD +L     R+ +   + V ++ G+  G+ YL   S+  
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYL---SDMS 130
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A NIL+++ L  K+SDFGM+++   D + A T R     G +P     PE + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIA 186
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++   DV+S+G+++ +++S
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 443 LGEGGFGPVYKGNL--PRGQEF--AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V  G L  P  +E   A+K L A  T +   +F +E S+  +  H N++ + 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T+    M+I EY+ N SLD +L     R+ +   + V ++ G+  G+ YL   S+  
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYL---SDMS 136
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A NIL+++ L  K+SDFGM+++   D + A T R     G +P     PE + 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIA 192
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++   DV+S+G+++ +++S
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMS 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQ 489
            N S    +G G FG V  G   LP  +E   A+K L    T+    +F  E S+  +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++R+ G  T+    M++ E + N SLD +L     ++ +   + V ++ G+  G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKY 133
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L   S+   +HRDL A NIL+++ L  K+SDFG++++   D + A T R     G +P  
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIR 186
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +    ++   DV+S+G++L +++S
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 119/228 (52%), Gaps = 22/228 (9%)
Query: 418 DTPNLQVFSFS-DIKAATNNFSSANKLGEGGFGPVYKG--NLPRGQEF--AVKRLSATST 472
           + PN  V  F+ +I+A+         +G G FG V  G   LP  +E   A+K L    T
Sbjct: 6   EDPNQAVHEFAKEIEASCITIERV--IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 473 QGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
           +    +F  E S+  +  H N++ + G  T+    M++ EY+ N SLD +L     ++ +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
              + V ++ G++ G+ YL   S+   +HRDL A NIL+++ L  K+SDFG++++   D 
Sbjct: 124 --IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 592 DEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           + A T R     G +P     PE +    ++   DV+S+G+++ +++S
Sbjct: 179 EAAYTTR----GGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 114/218 (52%), Gaps = 31/218 (14%)
Query: 441 NKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNL 493
            +LGE  FG VYKG+L       + Q  A+K L   +   L EEF++E  L ARLQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNII 540
           + +LG  T+     +I+ Y  +  L  +L              D   +  L+    V+++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+ YL   S+  V+H+DL   N+L+ ++LN KISD G   LFR +V  A+  +++
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLG---LFR-EVYAADYYKLL 204
Query: 601 G----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G       ++ PE +  G +S+  D++S+GV+L ++ S
Sbjct: 205 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 112/213 (52%), Gaps = 13/213 (6%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTA 486
           D +      +   ++G G FG VYKG      + AVK L+ T  + Q L+ FKNEV +  
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           + +HVN+L  +GY T   +  ++ ++    SL  +L     ++ +  +K ++I     +G
Sbjct: 76  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARG 132
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL   S   +IHRDLK++NI L  +   KI DFG+A    +        ++ G+  ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 607 PPEYVK---KGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++      YS + DVY+FG++L ++++ +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 115/224 (51%), Gaps = 17/224 (7%)
Query: 420 PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQG 474
           PN  V  F+  +   +  +    +G G FG VYKG L      +    A+K L A  T+ 
Sbjct: 30  PNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88
Query: 475 LE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
              +F  E  +  +  H N++R+ G  ++    M+I EY+ N +LD +L +    + +  
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-- 146
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
            + V ++ G+  G+ YL   +N   +HRDL A NIL+++ L  K+SDFG++++   D + 
Sbjct: 147 LQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203
Query: 594 ANT---GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             T   G+I     +  PE +    ++   DV+SFG+++ ++++
Sbjct: 204 TYTTSGGKI--PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L    T  ++ F  E +L   LQH  L+R+   
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 500 CTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            T  +   +I EY+   SL D    D   + +L   K ++    + +G+ Y+ E  N+  
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI-ERKNY-- 131
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDL+A+N+L+   L  KI+DFG+A++   +   A  G       +  PE +  G +++
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTI 190
Query: 619 KYDVYSFGVLLLQIIS 634
           K DV+SFG+LL +I++
Sbjct: 191 KSDVWSFGILLYEIVT 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 114/218 (52%), Gaps = 31/218 (14%)
Query: 441 NKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNL 493
            +LGE  FG VYKG+L       + Q  A+K L   +   L EEF++E  L ARLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNII 540
           + +LG  T+     +I+ Y  +  L  +L              D   +  L+    V+++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+ YL   S+  V+H+DL   N+L+ ++LN KISD G   LFR +V  A+  +++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLG---LFR-EVYAADYYKLL 187
Query: 601 G----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G       ++ PE +  G +S+  D++S+GV+L ++ S
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 108/198 (54%), Gaps = 7/198 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+   
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 72
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  I
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--I 127
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HR+L+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G +++K
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 186
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL +I++  R
Sbjct: 187 SDVWSFGILLTEIVTHGR 204

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 122/248 (49%), Gaps = 32/248 (12%)
Query: 406 GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSA---------NKLGEGGFGPVYKGNL 456
           G  TP  + F      +  F+F D   A   F+             +G G FG V  G+L
Sbjct: 1   GHMTPGMKIF------IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHL 54
Query: 457 --PRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
             P  +E   A+K L +  T+    +F +E S+  +  H N++ + G  T+    M+I E
Sbjct: 55  KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 114
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           ++ N SLD +L     ++ +   + V ++ G+  G+ YL   ++   +HRDL A NIL++
Sbjct: 115 FMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVN 169
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG+++    D  +      +G  G +P     PE ++   ++   DV+S+G
Sbjct: 170 SNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPEAIQYRKFTSASDVWSYG 227
Query: 627 VLLLQIIS 634
           +++ +++S
Sbjct: 228 IVMWEVMS 235

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 110/223 (49%), Gaps = 13/223 (5%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG 474
           D  T NL   S    +    + +  +KLG G +G VY G   +     AVK L    T  
Sbjct: 13  DLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTME 71
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
           +EEF  E ++   ++H NL+++LG CT      ++ EY+P  +L  YL +  R  V    
Sbjct: 72  VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEV---- 127
Query: 535 KRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
             V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D 
Sbjct: 128 TAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 185 YTAHAGAKFPI-KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            +LG G  G V+ G      + AVK L   S    + F  E +L  +LQH  L+R+    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E  N+  IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNY--IH 132
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSM 618
           RDL+A+NIL+ + L+ KI+DFG+A+L     D   T R    +   +  PE +  G +++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE---DAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 619 KYDVYSFGVLLLQIISSKR 637
           K DV+SFG+LL +I++  R
Sbjct: 190 KSDVWSFGILLTEIVTHGR 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 161
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 217
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 137
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 193
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 189
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 136
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 192
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 129
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 185
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 128
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 184
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 135
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 191
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 186
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 133
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 189
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 186
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 65
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL    +R +   +  + +   V +G+ YL+E S
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 179
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 148
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 204
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 134
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 190
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 148
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 204
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 130
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYGYVPP 608
              R IHRDL   NIL++NE   KI DFG+ K+  +D     V E     I     +  P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAP 186
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG G FG V+ G      + AVK L    T  ++ F  E +L   LQH  L+R+    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 501 TERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           T+ +   +I E++   SL D    D   + +L   K ++    + +G+ Y+ E  N+  I
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI-ERKNY--I 131
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+N+L+   L  KI+DFG+A++   +   A  G       +  PE +  G +++K
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIK 190
Query: 620 YDVYSFGVLLLQIIS 634
            +V+SFG+LL +I++
Sbjct: 191 SNVWSFGILLYEIVT 205

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 442 KLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 497 LGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            G C    R    LI E+LP  SL  YL     R  +D  K +     + +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
             R IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 190
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            + +  +S+  DV+SFGV+L ++ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 123/248 (49%), Gaps = 29/248 (11%)
Query: 401 NLRTPGTSTPAAEYFDSDT---PNLQVFSFS-DIKAATNNFSSANKLGEGGFGPVYKGNL 456
           + + PGT T    Y D +T   PN  V  F+ ++ A+         +G G FG V  G L
Sbjct: 11  HFKFPGTKT----YIDPETYEDPNRAVHQFAKELDASCIKIERV--IGAGEFGEVCSGRL 64
Query: 457 P----RGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511
                R    A+K L    T+    +F  E S+  +  H N++ + G  T     M++ E
Sbjct: 65  KLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIE 124
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           ++ N +LD +L     ++ +   + V ++ G+  G+ YL   ++   +HRDL A NIL++
Sbjct: 125 FMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVN 179
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFG 626
           + L  K+SDFG++++   D +   T     T G +P     PE ++   ++   DV+S+G
Sbjct: 180 SNLVCKVSDFGLSRVIEDDPEAVYT----TTGGKIPVRWTAPEAIQYRKFTSASDVWSYG 235
Query: 627 VLLLQIIS 634
           +++ +++S
Sbjct: 236 IVMWEVMS 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 68
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL    +R +   +  + +   V +G+ YL+E  
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 182
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 65
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL    +R +   +  + +   V +G+ YL+E  
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 179
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL    +R +   +  + +   V +G+ YL+E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 177
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 442 KLGEGGFGPVYKGN----LPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGEG FG V+       LP   +   AVK L   S    ++F+ E  L   LQH +++R
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV----------LDWQKRVNIIEGV 543
             G CTE    ++++EY+ +  L+ +L    P  + +          L   + + +   V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGT 602
             G++YL   +    +HRDL   N L+   L  KI DFGM++ ++  D      GR +  
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 223
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
             ++PPE +    ++ + DV+SFGV+L +I +  +   Y
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 430 IKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGL-EEFKNEVSLT 485
           I     +F   N LG+G F  VY+  ++  G E A+K +   A    G+ +  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
            +L+H ++L +  Y  + +   L+ E   N  ++ YL + ++ +  +  +  + +  +  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIIT 123
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           G+LYL  +    ++HRDL  SN+LL   +N KI+DFG+A   +   ++  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           + PE   +  + ++ DV+S G +   ++
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLL 206

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 110/215 (51%), Gaps = 9/215 (4%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           + ++G G FG VYKG         + ++   + +  + F+NEV++  + +HVN+L  +GY
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            T +D   ++ ++    SL  +L   ++       + ++I     QG+ YL   +   +I
Sbjct: 101 MT-KDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN---II 154
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---KGIY 616
           HRD+K++NI L   L  KI DFG+A +  +        +  G+  ++ PE ++      +
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
           S + DVYS+G++L ++++ +    +    + + F+
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 442 KLGEGGFGPVYKGN----LPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGEG FG V+       LP   +   AVK L   S    ++F+ E  L   LQH +++R
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV----------LDWQKRVNIIEGV 543
             G CTE    ++++EY+ +  L+ +L    P  + +          L   + + +   V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGT 602
             G++YL   +    +HRDL   N L+   L  KI DFGM++ ++  D      GR +  
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 194
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
             ++PPE +    ++ + DV+SFGV+L +I +  +   Y
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   S    ++F  E  +  +L H  L+
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLV 85
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL    +R +   +  + +   V +G+ YL+E  
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 199
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 442 KLGEGGFGPVYKGN----LPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +LGEG FG V+       LP   +   AVK L   S    ++F+ E  L   LQH +++R
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV----------LDWQKRVNIIEGV 543
             G CTE    ++++EY+ +  L+ +L    P  + +          L   + + +   V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGT 602
             G++YL   +    +HRDL   N L+   L  KI DFGM++ ++  D      GR +  
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 200
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
             ++PPE +    ++ + DV+SFGV+L +I +  +   Y
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 496 VLGYC--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C    R    LI EYLP  SL  YL     R  +D  K +     + +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 131
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYGYVPP 608
              R IHR+L   NIL++NE   KI DFG+ K+  +D     V E     I     +  P
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G FG VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 69
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 125
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 126 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPES 181
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 406 GTSTPAAEYFDSDTPNL----QVFSFSDIKAAT-NNFSSANKLGEGGFGPVYKG------ 454
           G  T    YF    PN     +  S SD+K     N +    LG G FG VY+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 455 NLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
           N P   + AVK L    ++  E +F  E  + ++L H N++R +G   +     ++ E +
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELM 130
Query: 514 PNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569
               L  +L +    P +   L     +++   +  G  YL+E ++F  IHRD+ A N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCL 187
Query: 570 LDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF 625
           L     P    KI DFGMA+   +       G  +    ++PPE   +GI++ K D +SF
Sbjct: 188 LTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 626 GVLLLQIISSKRNARYYGTSENLNFLEYAS 655
           GVLL +I S       Y +  N   LE+ +
Sbjct: 247 GVLLWEIFS--LGYMPYPSKSNQEVLEFVT 274

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 7/203 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 66
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L+ E++ +  L  YL    +R +   +  + +   V +G+ YL+E  
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D   ++TG       +  PE     
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFS 180
Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ 473
            D  +PN     +   +    + +  +KLG G +G VY+G   +     AVK L    T 
Sbjct: 3   MDPSSPN-----YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM 56
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
            +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +  R+ V   
Sbjct: 57  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--- 113
Query: 534 QKRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
              V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D
Sbjct: 114 -NAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 170 TXTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 7/217 (3%)
Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
           + P+     +   +    + +   +LG G FG V  G   RGQ     ++    +   +E
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDE 65
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
           F  E  +   L H  L+++ G CT++    +I EY+ N  L  YL +   R+    Q+ +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLL 123
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
            + + V + + YL+   + + +HRDL A N L++++   K+SDFG+++    D + ++ G
Sbjct: 124 EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVG 180
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                  + PPE +    +S K D+++FGVL+ +I S
Sbjct: 181 SKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 69
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 125
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 126 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPES 181
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ 473
            D  +PN     +   +    + +  +KLG G +G VY+G   +     AVK L    T 
Sbjct: 3   MDPSSPN-----YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM 56
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
            +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +  R+ V   
Sbjct: 57  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV--- 113
Query: 534 QKRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
              V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D
Sbjct: 114 -NAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 170 TYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           +G GGFG VY+     G E AVK          +Q +E  + E  L A L+H N++ + G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            C +     L+ E+     L+  L    +R   D    VN    + +G+ YL + +   +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPD--ILVNWAVQIARGMNYLHDEAIVPI 129
Query: 559 IHRDLKASNILLDNELNP--------KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
           IHRDLK+SNIL+  ++          KI+DFG+A+ + +    +  G     Y ++ PE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG----AYAWMAPEV 185
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSK 636
           ++  ++S   DV+S+GVLL ++++ +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ 473
            D  +PN     +   +    + +  +KLG G +G VY+G   +     AVK L    T 
Sbjct: 3   MDPSSPN-----YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM 56
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
            +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +  R+ V   
Sbjct: 57  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--- 113
Query: 534 QKRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
              V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D
Sbjct: 114 -NAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 170 TYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ 473
            D  +PN     +   +    + +  +KLG G +G VY+G   +     AVK L    T 
Sbjct: 3   MDPSSPN-----YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM 56
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
            +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +  R+ V   
Sbjct: 57  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--- 113
Query: 534 QKRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
              V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D
Sbjct: 114 -SAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 170 TYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 72
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 73  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 128
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 129 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPES 184
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ 473
            D  +PN     +   +    + +  +KLG G +G VY+G   +     AVK L    T 
Sbjct: 3   MDPSSPN-----YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM 56
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
            +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +  R+ V   
Sbjct: 57  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--- 113
Query: 534 QKRVNIIEGVTQ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
              V ++   TQ    + YL E  NF  IHRDL A N L+      K++DFG+++L   D
Sbjct: 114 -NAVVLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              A+ G       +  PE +    +S+K DV++FGVLL +I +
Sbjct: 170 TYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 120/270 (44%), Gaps = 26/270 (9%)
Query: 406 GTSTPAAEYFDSDTPNL----QVFSFSDIKAAT-NNFSSANKLGEGGFGPVYKG------ 454
           G  T    YF    PN     +  S SD+K     N +    LG G FG VY+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 455 NLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
           N P   + AVK L    ++  E +F  E  + ++  H N++R +G   +     ++ E +
Sbjct: 71  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 130
Query: 514 PNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569
               L  +L +    P +   L     +++   +  G  YL+E ++F  IHRD+ A N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCL 187
Query: 570 LDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF 625
           L     P    KI DFGMA+   +       G  +    ++PPE   +GI++ K D +SF
Sbjct: 188 LTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 626 GVLLLQIISSKRNARYYGTSENLNFLEYAS 655
           GVLL +I S       Y +  N   LE+ +
Sbjct: 247 GVLLWEIFS--LGYMPYPSKSNQEVLEFVT 274

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL--PRGQE--FAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V +G L  P  +E   A+K L    T+    EF +E S+  + +H N++R+ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T     M++ E++ N +LD +L     ++ +   + V ++ G+  G+ YL E S   
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMS--- 138
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A NIL+++ L  K+SDFG+++   ++  +      +G  G +P     PE + 
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG--GKIPIRWTAPEAIA 196
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++   D +S+G+++ +++S
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMS 218

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL--PRGQE--FAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG V +G L  P  +E   A+K L    T+    EF +E S+  + +H N++R+ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T     M++ E++ N +LD +L     ++ +   + V ++ G+  G+ YL E S   
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMS--- 136
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HRDL A NIL+++ L  K+SDFG+++   ++  +      +G  G +P     PE + 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG--GKIPIRWTAPEAIA 194
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++   D +S+G+++ +++S
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMS 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL--PRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
           +G G FG V  G+L  P  +E   A+K L +  T+    +F +E S+  +  H N++ + 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  T+    M+I E++ N SLD +L     ++ +   + V ++ G+  G+ YL   ++  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVK 612
            +HR L A NIL+++ L  K+SDFG+++    D  +      +G  G +P     PE ++
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPEAIQ 187
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++   DV+S+G+++ +++S
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 131
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 132 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 187
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 127
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 128 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 129
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 130 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 185
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            +LG G FG V+ G      + A+K L    T   E F  E  +  +L+H  L+++    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           +E +   ++ EY+   SL  +L D   R  L     V++   V  G+ Y+ E  N+  IH
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYI-ERMNY--IH 128
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL+++NIL+ N L  KI+DFG+A+L   +   A  G       +  PE    G +++K 
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 187
Query: 621 DVYSFGVLLLQIISSKR 637
           DV+SFG+LL ++++  R
Sbjct: 188 DVWSFGILLTELVTKGR 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 69
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL 125
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 126 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPES 181
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 129
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 130 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 185
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 7/217 (3%)
Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
           + P+     +   +    + +   +LG G FG V  G   RGQ     ++    +   +E
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDE 65
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
           F  E  +   L H  L+++ G CT++    +I EY+ N  L  YL +   R+    Q+ +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLL 123
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
            + + V + + YL+   + + +HRDL A N L++++   K+SDFG+++    D   ++ G
Sbjct: 124 EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                  + PPE +    +S K D+++FGVL+ +I S
Sbjct: 181 SKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 114/246 (46%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++L H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 141 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 196
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 254
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 255 VLEFVT 260

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 406 GTSTPAAEYFDSDTPNL----QVFSFSDIKAAT-NNFSSANKLGEGGFGPVYKG------ 454
           G  T    YF    PN     +  S SD+K     N +    LG G FG VY+G      
Sbjct: 11  GIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 70
Query: 455 NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
           N P   + AVK L    S Q   +F  E  + ++  H N++R +G   +     ++ E +
Sbjct: 71  NDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 130
Query: 514 PNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569
               L  +L +    P +   L     +++   +  G  YL+E ++F  IHRD+ A N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCL 187
Query: 570 LDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF 625
           L     P    KI DFGMA+   +       G  +    ++PPE   +GI++ K D +SF
Sbjct: 188 LTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 246
Query: 626 GVLLLQIISSKRNARYYGTSENLNFLEYAS 655
           GVLL +I S       Y +  N   LE+ +
Sbjct: 247 GVLLWEIFSLGYMP--YPSKSNQEVLEFVT 274

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 84
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 140
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A+ G       +  PE 
Sbjct: 141 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPES 196
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G   RGQ     ++    +   +EF  E  +   L H  L+
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 66
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D   ++ G       + PPE +   
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 180
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K D+++FGVL+ +I S
Sbjct: 181 KFSSKSDIWAFGVLMWEIYS 200

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G   RGQ     ++    +   +EF  E  +   L H  L+
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 73
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D   ++ G       + PPE +   
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYS 187
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K D+++FGVL+ +I S
Sbjct: 188 KFSSKSDIWAFGVLMWEIYS 207

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G   RGQ     ++    +   +EF  E  +   L H  L+
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D   ++ G       + PPE +   
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 181
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K D+++FGVL+ +I S
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y++       +HR
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 447 VWSFGILLTELTTKGR 462

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G   RGQ     ++    +   +EF  E  +   L H  L+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D   ++ G       + PPE +   
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 176
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K D+++FGVL+ +I S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 74  E-EPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 128
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 187
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 188 VWSFGILLTELTTKGR 203

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y++       +HR
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 27/227 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARL 488
           +N     +LGEG FG V+     NL   Q+    AVK L   S    ++F  E  L   L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ----------KRVN 538
           QH ++++  G C E D  ++++EY+ +  L+ +L       VL  +          + ++
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           I + +  G++YL   ++   +HRDL   N L+   L  KI DFGM+    +DV   +  R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS----RDVYSTDYYR 185
Query: 599 IVG----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
           + G       ++PPE +    ++ + DV+S GV+L +I +  +   Y
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 304
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG   E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 503 RDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
               + ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHR 132
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+  +   K+SDFG+ K      D   TG++     +  PE +++  +S K D
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALREAAFSTKSD 187
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I S  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G   RGQ     ++    +   +EF  E  +   L H  L+
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D   ++ G       + PPE +   
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYS 181
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K D+++FGVL+ +I S
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGN-LPRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L+ T+  +   EF +E  + A + H +L+R+
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           LG C       L+ + +P+  L  Y+ +   +  +  Q  +N    + +G++YL+E    
Sbjct: 106 LGVCLS-PTIQLVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R++HRDL A N+L+ +  + KI+DFG+A+L   D  E N         ++  E +    +
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 617 SMKYDVYSFGVLLLQIIS 634
           + + DV+S+GV + ++++
Sbjct: 220 THQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGN-LPRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L+ T+  +   EF +E  + A + H +L+R+
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           LG C       L+ + +P+  L  Y+ +   +  +  Q  +N    + +G++YL+E    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R++HRDL A N+L+ +  + KI+DFG+A+L   D  E N         ++  E +    +
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 617 SMKYDVYSFGVLLLQIIS 634
           + + DV+S+GV + ++++
Sbjct: 197 THQSDVWSYGVTIWELMT 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 129
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A  G       +  PE 
Sbjct: 130 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPES 185
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 72
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYL 550
           +++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL 128
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
            E  NF  IHRDL A N L+      K++DFG+++L   D   A  G       +  PE 
Sbjct: 129 -EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPES 184
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S+K DV++FGVLL +I +
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            +LGEG FG V+     NL   ++    AVK L   +    ++F+ E  L   LQH +++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLDWQKR-----------VNIIE 541
           +  G C + D  ++++EY+ +  L+ +L    P    ++D Q R           ++I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +  G++YL   ++   +HRDL   N L+   L  KI DFGM+    +DV   +  R+ G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYRVGG 193
Query: 602 ----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                  ++PPE +    ++ + DV+SFGV+L +I +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 250 E-EPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 304
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 127
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 186
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 187 VWSFGILLTELTTKGR 202

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 140 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 195
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 253
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 254 VLEFVT 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 132 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 187
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 245
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 246 VLEFVT 251

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 129
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 189 VWSFGILLTELTTKGR 204

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 140 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 195
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 253
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 254 VLEFVT 259

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
           ++LG+G FG V    L R        G   AVK+L  +      +F+ E+ +   L H +
Sbjct: 13  SQLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 68
Query: 493 LL---RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            +   R + Y   R E  L+ EYLP+  L  +L     R  LD  + +     + +G+ Y
Sbjct: 69  FIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEY 126
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L    + R +HRDL A NIL+++E + KI+DFG+AKL   D D      +V   G  P  
Sbjct: 127 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIF 179
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +   I+S + DV+SFGV+L ++ +
Sbjct: 180 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 141 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 196
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 254
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 255 VLEFVT 260

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG G FG V+     +  + AVK +   S   +E F  E ++   LQH  L+++    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 501 TERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           T ++   +I E++   SL D    D   +  L   K ++    + +G+ ++ E  N+  I
Sbjct: 80  T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFI-EQRNY--I 133
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+   L  KI+DFG+A++   +   A  G       +  PE +  G +++K
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 192
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL++I++  R
Sbjct: 193 SDVWSFGILLMEIVTYGR 210

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL+
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYLQ 551
           ++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL 
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLYMATQISSAMEYL- 334
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
           E  NF  IHR+L A N L+      K++DFG+++L   D   A+ G       +  PE +
Sbjct: 335 EKKNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESL 391
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S+K DV++FGVLL +I +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 141 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAQDIYR 196
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 254
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 255 VLEFVT 260

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 147 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 202
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 260
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 261 VLEFVT 266

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRL--SATSTQ 473
           S TP++    F+      ++F     LG+G FG VY     +     A+K L  S    +
Sbjct: 10  SGTPDILTRHFT-----IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKE 64
Query: 474 GLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD 532
           G+E + + E+ + A L H N+LR+  Y  +R    LI EY P   L   L    +    D
Sbjct: 65  GVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFD 121
Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG---MAKLFRK 589
            Q+   I+E +   L+Y       +VIHRD+K  N+LL  +   KI+DFG    A   R+
Sbjct: 122 EQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR 178
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
                    + GT  Y+PPE ++  +++ K D++  GVL  +++
Sbjct: 179 KT-------MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 157 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 212
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 270
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 271 VLEFVT 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG G FG V+     +  + AVK +   S   +E F  E ++   LQH  L+++    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 501 TERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           T ++   +I E++   SL D    D   +  L   K ++    + +G+ ++++  N+  I
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ-RNY--I 306
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+   L  KI+DFG+A++   +   A  G       +  PE +  G +++K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 365
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL++I++  R
Sbjct: 366 SDVWSFGILLMEIVTYGR 383

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQ--GLE-EFKNEVSLTARLQ 489
            +F     LG+G FG VY     R  +F  A+K L  T  +  G+E + + EV + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLAR-ERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N+LR+ GY  +     LI EY P  ++   L   + R+  D Q+    I  +   L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRF--DEQRTATYITELANALSY 127
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFG---MAKLFRKDVDEANTGRIVGTYGYV 606
                + RVIHRD+K  N+LL +    KI+DFG    A   R+D        + GT  Y+
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-------LCGTLDYL 177
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQII 633
           PPE ++  ++  K D++S GVL  + +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG   E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 503 RDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
               + ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHR 141
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+  +   K+SDFG+ K      D   TG++     +  PE +++  +S K D
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALREKKFSTKSD 196
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I S  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG---MAKLFRKDVDEANTGRIVGT 602
            L Y     + RVIHRD+K  N+LL +    KI+DFG    A   R+D        + GT
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-------LCGT 170
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 167 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 222
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 280
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 281 VLEFVT 286

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 77  E-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 131
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 190
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 191 VWSFGILLTELTTKGR 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           + +  +KLG G +G VY+G   +     AVK L    T  +EEF  E ++   ++H NL+
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYLQ 551
           ++LG CT      +I E++   +L  YL +  R+ V      V ++   TQ    + YL 
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV----NAVVLLYMATQISSAMEYL- 373
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
           E  NF  IHR+L A N L+      K++DFG+++L   D   A+ G       +  PE +
Sbjct: 374 EKKNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESL 430
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S+K DV++FGVLL +I +
Sbjct: 431 AYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +++H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 181 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 236
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 294
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 295 VLEFVT 300

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 22/246 (8%)
Query: 426 SFSDIKAAT-NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLE-E 477
           S SD+K     N +    LG G FG VY+G      N P   + AVK L    ++  E +
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDW 533
           F  E  + ++  H N++R +G   +     ++ E +    L  +L +    P +   L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK 589
              +++   +  G  YL+E ++F  IHRD+ A N LL     P    KI DFGMA+   +
Sbjct: 158 LDLLHVARDIACGCQYLEE-NHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYR 213
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
                  G  +    ++PPE   +GI++ K D +SFGVLL +I S       Y +  N  
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQE 271
Query: 650 FLEYAS 655
            LE+ +
Sbjct: 272 VLEFVT 277

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
           LGEG FG V    L R        G++ AVK L   S    + + K E+ +   L H N+
Sbjct: 29  LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           ++  G CTE   N   LI E+LP+ SL  YL  P  +  ++ ++++     + +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPE 609
              + + +HRDL A N+L+++E   KI DFG+ K    D +       R    + Y  PE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PE 199
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            + +  + +  DV+SFGV L ++++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG   E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 503 RDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
               + ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+  +   K+SDFG+ K   +     +TG++     +  PE +++  +S K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I S  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVT 544
           + L+H N+LR+ GY  +     LI EY P   +    +  +++    D Q+    I  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELA 123
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGT 602
             L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGT 174
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L Y     + RVIHRD+K  N+LL +    KI+DFG +         +    + GT  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDY 175
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +PPE ++  ++  K D++S GVL  + +  K
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
           LGEG FG V    L R        G++ AVK L   S    + + K E+ +   L H N+
Sbjct: 17  LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           ++  G CTE   N   LI E+LP+ SL  YL  P  +  ++ ++++     + +G+ YL 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 130
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPE 609
              + + +HRDL A N+L+++E   KI DFG+ K    D +       R    + Y  PE
Sbjct: 131 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PE 187
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            + +  + +  DV+SFGV L ++++
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+    L  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG   E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 503 RDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
               + ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--VHR 313
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL A N+L+  +   K+SDFG+ K      D   TG++     +  PE +++  +S K D
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALREKKFSTKSD 368
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL +I S  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+    L  +L   + +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 138
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQ--GLE-EFKNEVSLTARLQ 489
            +F     LG+G FG VY     R  +F  A+K L  T  +  G+E + + EV + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLAR-ERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N+LR+ GY  +     LI EY P  ++   L   + R+  D Q+    I  +   L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRF--DEQRTATYITELANALSY 127
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVP 607
                + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT  Y+P
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWS------VHAPSSRRTTLCGTLDYLP 178
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQII 633
           PE ++  ++  K D++S GVL  + +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 442 KLGEGGFGPVYKGNLPRGQ-EFAVKRLSAT---------STQGLEEFK----NEVSLTAR 487
           KLG G +G V       G  E A+K +  +           + +E+F     NE+SL   
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQG 546
           L H N++++     ++    L+ E+     L    F+ I  R+  D     NI++ +  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSG 158
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           + YL +++   ++HRD+K  NILL+N+   LN KI DFG++  F KD    +    +GT 
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTA 212
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
            Y+ PE +KK  Y+ K DV+S GV++
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIM 237

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 175
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTL 175
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L Y     + RVIHRD+K  N+LL +    KI+DFG +         +    + GT  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDY 172
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +PPE ++  ++  K D++S GVL  + +  K
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTL 171
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTL 172
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 173
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 79
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 136
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 187
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVT 544
           + L+H N+LR+ GY  +     LI EY P   +    +  +++    D Q+    I  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELA 123
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGT 602
             L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLXGT 174
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L Y     + RVIHRD+K  N+LL +    KI+DFG +         +    + GT  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDY 172
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +PPE ++  ++  K D++S GVL  + +  K
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTL 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 123
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 174
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYV-ERMNY--VHR 135
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSD 194
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG---MAKLFRKDVDEANTGRIVGT 602
            L Y     + RVIHRD+K  N+LL +    KI+DFG    A   R+D        + GT
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-------DLCGT 195
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTL 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W   V I 
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWC--VQIA 124
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
           EG+     YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 125 EGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 178 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 127
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 182 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 145
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 196
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+++    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L     +Y L   + V++   +  G+ Y+ E  N+  +HR
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYV-ERMNY--VHR 135
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K D
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 194
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 173
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
             S  K+GEG  G V        G++ AVK +     Q  E   NEV +    QH N++ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +       +E  ++ E+L   +L     D + +  L+ ++   + E V Q L YL     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             VIHRD+K+ +ILL  +   K+SDFG      KDV +     +VGT  ++ PE + + +
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSL 217
Query: 616 YSMKYDVYSFGVLLLQIISSK 636
           Y+ + D++S G+++++++  +
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 129
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 184 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 118
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 169
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 120
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 121 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 175 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 132
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 133 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 187 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 183 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 130
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 185 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTL 173
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTXLCGTL 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTL 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRDDLCGTL 173
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY---LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 116
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 167
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 188 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 129
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 184 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           KLG+G FG V+ G        A+K L        E F  E  +  +L+H  L+++    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E +   ++ EY+   SL  +L   + +Y L   + V++   +  G+ Y++       +HR
Sbjct: 251 E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
           DL+A+NIL+   L  K++DFG+ +L   +   A  G       +  PE    G +++K D
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 364
Query: 622 VYSFGVLLLQIISSKR 637
           V+SFG+LL ++ +  R
Sbjct: 365 VWSFGILLTELTTKGR 380

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           FS   ++G G FG VY     R  E  A+K++S +  Q  E++++   EV    +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            ++  G         L+ EY    + DL     + +  L   +   +  G  QGL YL  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
           ++   +IHRD+KA NILL      K+ DFG A +       A     VGT  ++ PE + 
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              +G Y  K DV+S G+  +++   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 129
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 184 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 118/245 (48%), Gaps = 42/245 (17%)
Query: 416 DSDTPNLQVFSFSDIKAATNN----------FSSANKLGEGGFGPVYKGN-LPRGQEF-- 462
           D D P  +   F     A N           F     LG G FG VYKG  +P G++   
Sbjct: 11  DYDIPTTENLYFQGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 463 --AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD 519
             A+K L  ATS +  +E  +E  + A + + ++ R+LG C       LI + +P   L 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL- 128
Query: 520 LYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
               D +R        +Y+L+W  ++       +G+ YL++    R++HRDL A N+L+ 
Sbjct: 129 ---LDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVK 176
Query: 572 NELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
              + KI+DFG+AKL   +  E  A  G++     ++  E +   IY+ + DV+S+GV +
Sbjct: 177 TPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALESILHRIYTHQSDVWSYGVTV 234
Query: 630 LQIIS 634
            ++++
Sbjct: 235 WELMT 239

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
           FS   ++G G FG VY     R  E  A+K++S +  Q  E++++   EV    +L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            ++  G         L+ EY    + DL     + +  L   +   +  G  QGL YL  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
           ++   +IHRD+KA NILL      K+ DFG A +       A     VGT  ++ PE + 
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              +G Y  K DV+S G+  +++   K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXL----LDYVREHKDNIGSQYLLNWCVQI--- 127
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 182 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 129
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 184 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 183 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 136
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 137 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 191 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L Y     + RVIHRD+K  N+LL +    KI+DFG +         +    + GT  Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDY 173
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
           ++LG+G FG V    L R        G   AVK+L  +      +F+ E+ +   L H +
Sbjct: 16  SQLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 71
Query: 493 LL---RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            +   R + Y   R    L+ EYLP+  L  +L     R  LD  + +     + +G+ Y
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L    + R +HRDL A NIL+++E + KI+DFG+AKL   D D      +V   G  P  
Sbjct: 130 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIF 182
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +   I+S + DV+SFGV+L ++ +
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI+DFG +      V   ++ R  + GT 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTL 175
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++   +  K D++S GVL  + +  K
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
           ++LG+G FG V    L R        G   AVK+L  +      +F+ E+ +   L H +
Sbjct: 29  SQLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 493 LL---RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            +   R + Y   R    L+ EYLP+  L  +L     R  LD  + +     + +G+ Y
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEY 142
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L    + R +HRDL A NIL+++E + KI+DFG+AKL   D D      +V   G  P  
Sbjct: 143 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIF 195
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +   I+S + DV+SFGV+L ++ +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 114/219 (52%), Gaps = 25/219 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQG-------LEEFKNEVSL 484
           A N      ++G+GGFG V+KG L + +   A+K L    ++G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
            + L H N++++ G     +   ++ E++P   L   L D  + + + W  ++ ++  + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLD--NELNP---KISDFGMAKLFRKDVDEANTGRI 599
            G+ Y+Q   N  ++HRDL++ NI L   +E  P   K++DFG+++     V       +
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----GL 186
Query: 600 VGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +G + ++ PE +  ++  Y+ K D YSF ++L  I++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG       +  + +T  +VGT
Sbjct: 125 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG         +++    +VGT
Sbjct: 125 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSEMVGT 179
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
           ++LG+G FG V    L R        G   AVK+L  +      +F+ E+ +   L H +
Sbjct: 17  SQLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 72
Query: 493 LL---RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            +   R + Y   R    L+ EYLP+  L  +L     R  LD  + +     + +G+ Y
Sbjct: 73  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEY 130
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-- 607
           L    + R +HRDL A NIL+++E + KI+DFG+AKL   D D      +V   G  P  
Sbjct: 131 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIF 183
Query: 608 ---PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              PE +   I+S + DV+SFGV+L ++ +
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI--------I 540
            H N++++L      ++  L++E+L   S+DL  F       +D      I        +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKF-------MDASALTGIPLPLIKSYL 112
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 113 FQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 29/231 (12%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLE 476
           VF   + + +    +   +LG+G FG VY+GN   + +G+     AVK ++ + S +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------R 528
           EF NE S+       +++R+LG  ++    +++ E + +  L  YL   +R        R
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
                Q+ + +   +  G+ YL      + +HRDL A N ++ ++   KI DFGM     
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT---- 177
Query: 589 KDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +D+ E +  R  G  G +P     PE +K G+++   D++SFGV+L +I S
Sbjct: 178 RDIXETDXXR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPIRRYVLDWQKRVNI 539
           L QH N++ +LG CT     ++I EY     L  +L        D      L+ +  ++ 
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+    D +    G  
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
                ++ PE +   +Y+++ DV+S+G+LL +I S   N  Y G   N  F
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKF 264

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI--------I 540
            H N++++L      ++  L++E+L   S+DL  F       +D      I        +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKF-------MDASALTGIPLPLIKSYL 110
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 111 FQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 166
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 210

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI--------I 540
            H N++++L      ++  L++E+L   S+DL  F       +D      I        +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDF-------MDASALTGIPLPLIKSYL 112
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 113 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 29/231 (12%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLE 476
           VF   + + +    +   +LG+G FG VY+GN   + +G+     AVK ++ + S +   
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------R 528
           EF NE S+       +++R+LG  ++    +++ E + +  L  YL   +R        R
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 121
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
                Q+ + +   +  G+ YL      + +HRDL A N ++ ++   KI DFGM     
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT---- 174
Query: 589 KDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +D+ E +  R  G  G +P     PE +K G+++   D++SFGV+L +I S
Sbjct: 175 RDIXETDXXR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 112
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +
Sbjct: 113 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEV 165
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 210

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 167
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI++FG +      V   ++ R  + GT 
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS------VHAPSSRRTTLCGTL 172
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--------FDP---IRRYVLDWQK 535
           L QH N++ +LG CT     ++I EY     L  +L         DP   I    L  + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            ++    V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+    D +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            G       ++ PE +   +Y+++ DV+S+G+LL +I S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG         +++    +VGT
Sbjct: 125 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGT 179
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 13  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHRD+K+ NILL  + + K++DFG         +++    +VGT
Sbjct: 126 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGT 180
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 118
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 174
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI--------I 540
            H N++++L      ++  L++E+L   S+DL  F       +D      I        +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDF-------MDASALTGIPLPLIKSYL 111
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 112 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 167
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 211

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K     F    KLGEG +G VYK  +   GQ  A+K++   S   L+E   E+S+  +  
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD 82
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
             ++++  G   +  +  ++ EY    S+   +   +R   L   +   I++   +GL Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEY 140
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L      R IHRD+KA NILL+ E + K++DFG+A      + + N   ++GT  ++ PE
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPE 195
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSK 636
            +++  Y+   D++S G+  +++   K
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 25/219 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQG-------LEEFKNEVSL 484
           A N      ++G+GGFG V+KG L + +   A+K L    ++G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
            + L H N++++ G     +   ++ E++P   L   L D  + + + W  ++ ++  + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLD--NELNP---KISDFGMAKLFRKDVDEANTGRI 599
            G+ Y+Q   N  ++HRDL++ NI L   +E  P   K++DFG ++     V       +
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVS-----GL 186
Query: 600 VGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +G + ++ PE +  ++  Y+ K D YSF ++L  I++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPIRRYVLDWQKRVNI 539
           L QH N++ +LG CT     ++I EY     L  +L        D      L+ +  ++ 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+    D +    G  
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                ++ PE +   +Y+++ DV+S+G+LL +I S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 130
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 185 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE--FKNEVSLTARLQHVNLLRVLGY 499
           LG+G FG V K  +    QE+AVK ++  S +  +      EV L  +L H N++++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             +     ++ E      L    FD I +R          II+ V  G+ Y+ +++   +
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 559 IHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
           +HRDLK  NILL++   + + KI DFG++  F+++    +    +GT  Y+ PE V +G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           Y  K DV+S GV+L  ++S      +YG +E
Sbjct: 199 YDEKCDVWSAGVILYILLSG--TPPFYGKNE 227

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQ 489
           +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++++L      ++  L++E+L     D      +    L   K  + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
              +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V  +   P  
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEI 174
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            +    YS   D++S G +  ++++  R A + G SE
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 118
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 174
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 183 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVS 483
           K   ++F     LG+G FG VY   L R ++     A+K L  S    +G+E + + E+ 
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEG 542
           + + L+H N+LR+  Y  +R    L+ E+ P   L    +  ++++   D Q+    +E 
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEE 122
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IV 600
           +   L Y  E    +VIHRD+K  N+L+  +   KI+DFG +      V   +  R  + 
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMC 173
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           GT  Y+PPE ++   +  K D++  GVL  + +
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 188 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE--FKNEVSLTARLQHVNLLRVLGY 499
           LG+G FG V K  +    QE+AVK ++  S +  +      EV L  +L H N++++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             +     ++ E      L    FD I +R          II+ V  G+ Y+ +++   +
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 559 IHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
           +HRDLK  NILL++   + + KI DFG++  F+++    +    +GT  Y+ PE V +G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           Y  K DV+S GV+L  ++S      +YG +E
Sbjct: 199 YDEKCDVWSAGVILYILLSG--TPPFYGKNE 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEF--AVKRL--SATSTQGLE-EFKNEVSLTAR 487
           A  +F     LG+G FG VY     +  +F  A+K L  +     G+E + + EV + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAR-EKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +   L
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            Y     + +VIHRD+K  N+LL +    KI+DFG +         +    + GT  Y+P
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLP 174
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           PE ++  ++  K D++S GVL  + +  K
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 167
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 167
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE--FKNEVSLTARLQHVNLLRVLGY 499
           LG+G FG V K  +    QE+AVK ++  S +  +      EV L  +L H N++++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             +     ++ E      L    FD I +R          II+ V  G+ Y+ +++   +
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 559 IHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
           +HRDLK  NILL++   + + KI DFG++  F+++    +    +GT  Y+ PE V +G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           Y  K DV+S GV+L  ++S      +YG +E
Sbjct: 199 YDEKCDVWSAGVILYILLSG--TPPFYGKNE 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVS 483
           K   ++F     LG+G FG VY   L R ++     A+K L  S    +G+E + + E+ 
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEG 542
           + + L+H N+LR+  Y  +R    L+ E+ P   L    +  ++++   D Q+    +E 
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEE 123
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IV 600
           +   L Y  E    +VIHRD+K  N+L+  +   KI+DFG +      V   +  R  + 
Sbjct: 124 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMC 174
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           GT  Y+PPE ++   +  K D++  GVL  + +
Sbjct: 175 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 207

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 183 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRL--SATSTQGLE-EFKNEVSLT 485
           A  +F     LG+G FG VY   L R ++     A+K L  +     G+E + + EV + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           + L+H N+LR+ GY  +     LI EY P   L     +  +    D Q+    I  +  
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTY 603
            L Y     + RVIHRD+K  N+LL +    KI++FG +      V   ++ R  + GT 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS------VHAPSSRRTTLCGTL 173
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            Y+PPE ++  ++  K D++S GVL  + +  K
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG+G FG VY+GN   + +G+     AVK ++ + S +   EF NE S+       +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQG 546
           R+LG  ++    +++ E + +  L  YL   +R        R     Q+ + +   +  G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL      + +HRDL A N ++ ++   KI DFGM     +D+ E +  R  G  G +
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT----RDIXETDXXR-KGGKGLL 194
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE +K G+++   D++SFGV+L +I S
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 7/194 (3%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            +LG G FG V  G      + AVK +   S    +EF  E     +L H  L++  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           ++     ++ EY+ N  L  YL    +   L+  + + +   V +G+ +L+ +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL A N L+D +L  K+SDFGM +    D   ++ G       +  PE      YS K 
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV-KWSAPEVFHYFKYSSKS 186
Query: 621 DVYSFGVLLLQIIS 634
           DV++FG+L+ ++ S
Sbjct: 187 DVWAFGILMWEVFS 200

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 19/198 (9%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG G FG V+     +  + AVK +   S   +E F  E ++   LQH  L+++    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 501 TERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           T ++   +I E++   SL D    D   +  L   K ++    + +G+ ++ E  N+  I
Sbjct: 247 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI-EQRNY--I 300
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HRDL+A+NIL+   L  KI+DFG+A++  K               +  PE +  G +++K
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIK 349
Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+SFG+LL++I++  R
Sbjct: 350 SDVWSFGILLMEIVTYGR 367

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     LG G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG AKL   +  E  A  G+
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 183 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 115
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 171
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 167
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     L  G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 188 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E++ ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     L  G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 188 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARL 488
             F     L  G FG VYKG  +P G++     A+K L  ATS +  +E  +E  + A +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNII 540
            + ++ R+LG C       LI + +P   L     D +R        +Y+L+W  ++   
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI--- 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGR 598
               +G+ YL++    R++HRDL A N+L+    + KI+DFG+AKL   +  E  A  G+
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +     ++  E +   IY+ + DV+S+GV + ++++
Sbjct: 181 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQ------- 114
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 115 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 167
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLT 485
           A   N+     LGEG FG V    +   GQ+ A+K      L+ +  QG    + E+S  
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 67
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVT 544
             L+H +++++      +DE +++ EY  N+     LFD I +R  +  Q+     + + 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQII 122
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             + Y   +   +++HRDLK  N+LLD  LN KI+DFG++ +     D        G+  
Sbjct: 123 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPN 176
Query: 605 YVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSK 636
           Y  PE +   +Y+  + DV+S GV+L  ++  +
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 43/255 (16%)
Query: 396 ILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGN 455
           +L  R L  P   TP+ E      PN  +            F     LG G FG VYKG 
Sbjct: 21  LLQERELVEP--LTPSGE-----APNQALLRI----LKETEFKKIKVLGSGAFGTVYKGL 69
Query: 456 -LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509
            +P G++     A+  L  ATS +  +E  +E  + A + + ++ R+LG C       LI
Sbjct: 70  WIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LI 128
Query: 510 YEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
            + +P   L     D +R        +Y+L+W  ++       +G+ YL++    R++HR
Sbjct: 129 TQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHR 175
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMK 619
           DL A N+L+    + KI+DFG+AKL   +  E  A  G++     ++  E +   IY+ +
Sbjct: 176 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALESILHRIYTHQ 233
Query: 620 YDVYSFGVLLLQIIS 634
            DV+S+GV + ++++
Sbjct: 234 SDVWSYGVTVWELMT 248

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLT 485
           A   N+     LGEG FG V    +   GQ+ A+K      L+ +  QG    + E+S  
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 68
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVT 544
             L+H +++++      +DE +++ EY  N+     LFD I +R  +  Q+     + + 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQII 123
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             + Y   +   +++HRDLK  N+LLD  LN KI+DFG++ +     D        G+  
Sbjct: 124 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPN 177
Query: 605 YVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSK 636
           Y  PE +   +Y+  + DV+S GV+L  ++  +
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
           + S  D K     F    K+G+G  G VY   ++  GQE A+++++       E   NE+
Sbjct: 13  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    ++ N++  L      DE  ++ EYL   SL     D +    +D  +   +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             Q L +L  +SN +VIHR++K+ NILL  + + K++DFG       +  + +T  +VGT
Sbjct: 126 CLQALEFL--HSN-QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE V +  Y  K D++S G++ +++I  +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 113/219 (51%), Gaps = 25/219 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQG-------LEEFKNEVSL 484
           A N      ++G+GGFG V+KG L + +   A+K L    ++G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
            + L H N++++ G     +   ++ E++P   L   L D  + + + W  ++ ++  + 
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLD--NELNP---KISDFGMAKLFRKDVDEANTGRI 599
            G+ Y+Q   N  ++HRDL++ NI L   +E  P   K++DF +++     V       +
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVS-----GL 186
Query: 600 VGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +G + ++ PE +  ++  Y+ K D YSF ++L  I++ +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--------FDP---IRRYVLDWQK 535
           L QH N++ +LG CT     ++I EY     L  +L         DP   I       + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            ++    V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+    D +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            G       ++ PE +   +Y+++ DV+S+G+LL +I S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQ 489
           +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNII 540
           H N++++L      ++  L++E+L ++ L  ++            I+ Y+          
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-------- 111
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 112 --LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQ 489
           +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNII 540
           H N++++L      ++  L++E+L ++ L  ++            I+ Y+          
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-------- 111
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 112 --LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLT 485
           A   N+     LGEG FG V    +   GQ+ A+K      L+ +  QG    + E+S  
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVT 544
             L+H +++++      +DE +++ EY  N+     LFD I +R  +  Q+     + + 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQII 117
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             + Y   +   +++HRDLK  N+LLD  LN KI+DFG++ +     D        G+  
Sbjct: 118 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPN 171
Query: 605 YVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSK 636
           Y  PE +   +Y+  + DV+S GV+L  ++  +
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N   G   A K +   S + LE++  E+ + A   H  ++++LG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
               +  ++ E+ P  ++D  + + + R + + Q +V +   + + L +L    + R+IH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLH---SKRIIH 132
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA N+L+  E + +++DFG++    K + + ++   +GT  ++ PE V     K   
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTP 190
Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K D++S G+ L+++
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E +   L  EY     L    FD I   + +           +  G++YL       + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K +  ++ 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 619 KYDVYSFGVLLLQIISSK 636
             DV+S G++L  +++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 113
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 114 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 166
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 211

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 112
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 113 ---LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 165
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQ 489
           +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNII 540
           H N++++L      ++  L++E+L ++ L  ++            I+ Y+          
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-------- 111
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 112 --LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLT 485
           A   N+     LGEG FG V    +   GQ+ A+K      L+ +  QG    + E+S  
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
             L+H +++++      +DE +++ EY  N+  D Y+   ++R  +  Q+     + +  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YI---VQRDKMSEQEARRFFQQIIS 114
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            + Y   +   +++HRDLK  N+LLD  LN KI+DFG++ +     D        G+  Y
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNY 168
Query: 606 VPPEYVKKGIYS-MKYDVYSFGVLLLQIISSK 636
             PE +   +Y+  + DV+S GV+L  ++  +
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 112
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 113 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 165
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 210

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 114
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 115 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 167
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 113
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 114 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 166
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 211

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 113
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 114 ---LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 166
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 211

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQ 489
           +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNII 540
           H N++++L      ++  L++E+L ++ L  ++            I+ Y+          
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-------- 111
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V
Sbjct: 112 --LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 114
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 115 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 167
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N   G   A K +   S + LE++  E+ + A   H  ++++LG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
               +  ++ E+ P  ++D  + + + R + + Q +V +   + + L +L    + R+IH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLH---SKRIIH 140
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA N+L+  E + +++DFG++    K + + ++   +GT  ++ PE V     K   
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTP 198
Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K D++S G+ L+++
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E+L ++ L  ++            I+ Y+         
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ------- 115
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 116 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 168
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 112
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V  
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTL 168
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E +   L  EY     L    FD I   + +           +  G++YL       + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K +  ++ 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 619 KYDVYSFGVLLLQIISSK 636
             DV+S G++L  +++ +
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+ ++   T T+G+      E+SL   L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 167
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHV 491
            NF    K+GEG +G VYK  N   G+  A+ ++   T T+G+      E+SL   L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNIIEG 542
           N++++L      ++  L++E+L ++ L  ++            I+ Y+            
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +V  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTL 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 34/242 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF------AVKRLSATSTQGLE-EFKNEVSLTAR 487
           NN      +GEG FG V++   P    +      AVK L   ++  ++ +F+ E +L A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDP------------IRRYV--- 530
             + N++++LG C       L++EY+    L+ +L    P             R  V   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 531 ----LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK- 585
               L   +++ I   V  G+ YL E    + +HRDL   N L+   +  KI+DFG+++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
           ++  D  +A+ G       ++PPE +    Y+ + DV+++GV+L +I S      YYG +
Sbjct: 224 IYSADYYKAD-GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMA 281
Query: 646 EN 647
Sbjct: 282 HE 283

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 23/243 (9%)
Query: 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQ----EFAVK--RLSATSTQGLEEFKN 480
             D+    N       LGEG FG V +GNL +      + AVK  +L  +S + +EEF +
Sbjct: 26  LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 481 EVSLTARLQHVNLLRVLGYCTERDEN-----MLIYEYLPNKSLDLYLF----DPIRRYVL 531
           E +      H N++R+LG C E         M+I  ++    L  YL     +   +++ 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI- 144
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
             Q  +  +  +  G+ YL   SN   +HRDL A N +L +++   ++DFG++K      
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG- 200
Query: 592 DEANTGRIVGT-YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
           D    GRI      ++  E +   +Y+ K DV++FGV + +I  + R    Y   +N   
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEM 258
Query: 651 LEY 653
            +Y
Sbjct: 259 YDY 261

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLE 476
           VF   + + +    +   +LG+G FG VY+GN   + +G+     AVK ++ + S +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------R 528
           EF NE S+       +++R+LG  ++    +++ E + +  L  YL   +R        R
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
                Q+ + +   +  G+ YL      + +HRDL A N ++ ++   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +       G+ +    ++ PE +K G+++   D++SFGV+L +I S
Sbjct: 182 ETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 29/231 (12%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLE 476
           VF   + + +    +   +LG+G FG VY+GN   + +G+     AVK ++ + S +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------R 528
           EF NE S+       +++R+LG  ++    +++ E + +  L  YL   +R        R
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
                Q+ + +   +  G+ YL      + +HRDL A N ++ ++   KI DFGM     
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT---- 177
Query: 589 KDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +D+ E +  R  G  G +P     PE +K G+++   D++SFGV+L +I S
Sbjct: 178 RDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E +   L  EY     L    FD I   + +           +  G++YL       + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K +  ++ 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 619 KYDVYSFGVLLLQIISSK 636
             DV+S G++L  +++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E +   L  EY     L    FD I   + +           +  G++YL       + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K +  ++ 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 619 KYDVYSFGVLLLQIISSK 636
             DV+S G++L  +++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E +   L  EY     L    FD I   + +           +  G++YL       + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
           HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K +  ++ 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 619 KYDVYSFGVLLLQIISSK 636
             DV+S G++L  +++ +
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 7/197 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
             ++G G FG V+ G L       AVK    T    L+ +F  E  +  +  H N++R++
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G CT++    ++ E +  +  D   F       L  +  + ++     G+ YL+      
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
            IHRDL A N L+  +   KISDFGM++     V  A+ G       +  PE +  G YS
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 618 MKYDVYSFGVLLLQIIS 634
            + DV+SFG+LL +  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 112/237 (47%), Gaps = 37/237 (15%)
Query: 425 FSFSDI------KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-AT 470
           FS +D+      + A    + + +LG+G FG VY+G + +G          A+K ++ A 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAA 61
Query: 471 STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------- 523
           S +   EF NE S+       +++R+LG  ++    ++I E +    L  YL        
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 524 -DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
            +P+        K + +   +  G+ YL      + +HRDL A N ++  +   KI DFG
Sbjct: 122 NNPVLAPP-SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 583 MAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           M     +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 178 MT----RDIXETDXXR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 28/227 (12%)
Query: 443 LGEGGFGPVY-----KGNLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LGEG FG V        N   G+  AVK L A    Q    +K E+ +   L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            G C ++ E    L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH--- 134
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
           +   IHR+L A N+LLDN+   KI DFG+AK     V E +    V   G  P     PE
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA----VPEGHEYYRVREDGDSPVFWYAPE 190
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI 656
            +K+  +    DV+SFGV L ++++   +++    S    FLE   I
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQ----SPPTKFLELIGI 233

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 443 LGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL-QHVNLL 494
           LG G FG V + +          +  AVK L   +T        +E+ +   +  H+N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 495 RVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEG----- 542
            +LG CT+     M+I E+    +L  YL      F P +    D  K    +E      
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 543 --VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G FG   K  +   G+   +K L     +    F  EV +   L+H N+L+ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           +      I EY+   +L   +     +Y   W +RV+  + +  G+ YL    +  +IHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 562 DLKASNILLDNELNPKISDFGMAKLF------------RKDVDEANTGRIVGTYGYVPPE 609
           DL + N L+    N  ++DFG+A+L              K  D      +VG   ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 610 YVKKGIYSMKYDVYSFGVLLLQII 633
            +    Y  K DV+SFG++L +II
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 443 LGEGGFGPVY-----KGNLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LGEG FG V        N   G+  AVK L A    Q    +K E+ +   L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL--QE 552
            G C ++ E    L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL  Q 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQH 137
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
           Y     IHR+L A N+LLDN+   KI DFG+AK     V E +    V   G  P     
Sbjct: 138 Y-----IHRNLAARNVLLDNDRLVKIGDFGLAKA----VPEGHEYYRVREDGDSPVFWYA 188
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI 656
           PE +K+  +    DV+SFGV L ++++   +++    S    FLE   I
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ----SPPTKFLELIGI 233

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARL 488
            +  NF    K+GEG +G VYK  N   G+  A+K++   T T+G+      E+SL   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------FDPIRRYVLDWQKRVNI 539
            H N++++L      ++  L++E++ ++ L  ++            I+ Y+         
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQ------- 114
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
              + QGL +   +   RV+HRDLK  N+L++ E   K++DFG+A+ F   V       +
Sbjct: 115 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEV 167
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           V  +   P   +    YS   D++S G +  ++++  R A + G SE
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 443 LGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL-QHVNLL 494
           LG G FG V + +          +  AVK L   +T        +E+ +   +  H+N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 495 RVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEG----- 542
            +LG CT+     M+I E+    +L  YL      F P +    D  K    +E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 543 --VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +       LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D  K    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 540 IEG-------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +E        V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG+G FG VY+GN   + +G+     AVK ++ + S +   EF NE S+       +++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQG 546
           R+LG  ++    +++ E + +  L  YL   +R        R     Q+ + +   +  G
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL      + +HRDL A N ++ ++   KI DFGM     +D+ E +  R  G  G +
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT----RDIYETDYYR-KGGKGLL 193
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE +K G+++   D++SFGV+L +I S
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 7/197 (3%)
Query: 440 ANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
             ++G G FG V+ G L       AVK    T    L+ +F  E  +  +  H N++R++
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G CT++    ++ E +  +  D   F       L  +  + ++     G+ YL+      
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
            IHRDL A N L+  +   KISDFGM++     V  A+ G       +  PE +  G YS
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 618 MKYDVYSFGVLLLQIIS 634
            + DV+SFG+LL +  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 31/225 (13%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGLEEFKNEV 482
           + A    + + +LG+G FG VY+G + +G          A+K ++ A S +   EF NE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 64
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIRRYVLDWQ 534
           S+       +++R+LG  ++    ++I E +    L  YL         +P+        
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP-SLS 123
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           K + +   +  G+ YL      + +HRDL A N ++  +   KI DFGM     +D+ E 
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIXET 176
Query: 595 NTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 177 DXXR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDW 533
           L QH N++ +LG CT     ++I EY     L  +L           ++P       L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
           +  ++    V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+    D + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              G       ++ PE +   +Y+++ DV+S+G+LL +I S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTA 486
           K     +   +KLG GG   VY   +     + A+K +        + L+ F+ EV  ++
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +L H N++ ++    E D   L+ EY+   +L  Y+        L     +N    +  G
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDG 123
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + +     + R++HRD+K  NIL+D+    KI DFG+AK    +     T  ++GT  Y 
Sbjct: 124 IKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYF 179
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQII 633
            PE  K        D+YS G++L +++
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEML 206

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 108/229 (47%), Gaps = 32/229 (13%)
Query: 443 LGEGGFGPVY-----KGNLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496
           LGEG FG V        N   G+  AVK L A +  Q    +K E+ +   L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL--QE 552
            G C +       L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL  Q 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
           Y     IHRDL A N+LLDN+   KI DFG+AK     V E +    V   G  P     
Sbjct: 155 Y-----IHRDLAARNVLLDNDRLVKIGDFGLAKA----VPEGHEXYRVREDGDSPVFWYA 205
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYASI 656
           PE +K+  +    DV+SFGV L ++++   +++    S    FLE   I
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ----SPPTKFLELIGI 250

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 117/241 (48%), Gaps = 37/241 (15%)
Query: 421 NLQVFSFSDI------KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRL 467
           N + FS +D+      + A    + + +LG+G FG VY+G + +G          A+K +
Sbjct: 5   NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTV 63
Query: 468 S-ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
           + A S +   EF NE S+       +++R+LG  ++    ++I E +    L  YL   +
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-L 122
Query: 527 RRYVLD--------WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
           R  + +          K + +   +  G+ YL   +N + +HRDL A N ++  +   KI
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKI 179
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQII 633
            DFGM     +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I 
Sbjct: 180 GDFGMT----RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 634 S 634
           +
Sbjct: 235 T 235

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +       LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D  K    
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 540 IEG-------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +E        V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +       LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D  K    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 540 IEG-------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +E        V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 32/244 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGN-LPRGQE-----FAVKRLSATSTQGLEE-FKNEVSLTAR 487
           NN      LG G FG V +      G+E      AVK L +T+    +E   +E+ + + 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--------------------FDPI 526
           L QH N++ +LG CT     ++I EY     L  +L                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L+ +  ++    V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
              D +    G       ++ PE +   +Y+++ DV+S+G+LL +I S   N  Y G   
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILV 266
Query: 647 NLNF 650
           N  F
Sbjct: 267 NSKF 270

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHV 491
             ++     LGEG  G V    N    +  AVK +    +    E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
           N+++  G+  E +   L  EY     L    FD I   + +           +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 611 VK-KGIYSMKYDVYSFGVLLLQIISSK 636
           +K +  ++   DV+S G++L  +++ +
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 17/241 (7%)
Query: 398 GRRNLRTPGTSTPAAEYFDSDTPNLQ-VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL 456
           GR NL     S  + E F +    LQ V S  D +    NF    K+GEG  G V     
Sbjct: 13  GRENLYFQSMSRVSHEQFRA---ALQLVVSPGDPREYLANFI---KIGEGSTGIVCIATE 66
Query: 457 PR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
              G++ AVK++     Q  E   NEV +     H N++ +       DE  ++ E+L  
Sbjct: 67  KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575
            +L     D +    ++ ++   +   V + L YL    N  VIHRD+K+ +ILL ++  
Sbjct: 127 GALT----DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGR 179
Query: 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS 635
            K+SDFG      K+V +     +VGT  ++ PE + +  Y  + D++S G++++++I  
Sbjct: 180 IKLSDFGFCAQVSKEVPKRKX--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237
Query: 636 K 636
           +
Sbjct: 238 E 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 21/218 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +  +    LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 540 IE---GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           I     V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 21/218 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +  +    LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 540 IE---GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           I     V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGL 475
           VF   + + A    + + +LG+G FG VY+G + +G          A+K ++ A S +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIR 527
            EF NE S+       +++R+LG  ++    ++I E +    L  YL         +P+ 
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
                  K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFGM    
Sbjct: 124 APP-SLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMT--- 176
Query: 588 RKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 177 -RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 132
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKA----QTHGKWPVKWYAPECI 186
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 37/241 (15%)
Query: 421 NLQVFSFSDI------KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRL 467
           N + FS +D+      + A    + + +LG+G FG VY+G + +G          A+K +
Sbjct: 27  NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTV 85
Query: 468 S-ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--- 523
           + A S +   EF NE S+       +++R+LG  ++    ++I E +    L  YL    
Sbjct: 86  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 145
Query: 524 -----DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
                +P+        K + +   +  G+ YL   +N + +HRDL A N ++  +   KI
Sbjct: 146 PEMENNPVLA-PPSLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKI 201
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQII 633
            DFGM     +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I 
Sbjct: 202 GDFGMT----RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 256
Query: 634 S 634
           +
Sbjct: 257 T 257

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 111/224 (49%), Gaps = 36/224 (16%)
Query: 441 NKLGEGGFG-PVYKGNLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
            K+GEG FG  +   +   G+++ +K +  S  S++  EE + EV++ A ++H N+++  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 496 -----------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
                      V+ YC   D    +++ +  +   L+  D I    LDW           
Sbjct: 90  ESFEENGSLYIVMDYCEGGD----LFKRINAQKGVLFQEDQI----LDW---------FV 132
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q  L L+   + +++HRD+K+ NI L  +   ++ DFG+A++    V+ A     +GT  
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           Y+ PE  +   Y+ K D+++ G +L ++ + K +A   G+ +NL
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLK-HAFEAGSMKNL 233

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 491
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 492 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 545
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 490
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 491 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 544
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 117/241 (48%), Gaps = 37/241 (15%)
Query: 421 NLQVFSFSDI------KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRL 467
           N + FS +D+      + A    + + +LG+G FG VY+G + +G          A+K +
Sbjct: 5   NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTV 63
Query: 468 S-ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
           + A S +   EF NE S+       +++R+LG  ++    ++I E +    L  YL   +
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-L 122
Query: 527 RRYVLD--------WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
           R  + +          K + +   +  G+ YL   +N + +HRDL A N ++  +   KI
Sbjct: 123 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKI 179
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQII 633
            DFGM     +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I 
Sbjct: 180 GDFGMT----RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 634 S 634
           +
Sbjct: 235 T 235

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 443 LGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL-QHVNLL 494
           LG G FG V + +          +  AVK L   +T        +E+ +   +  H+N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 495 RVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEG----- 542
            +LG CT+     M+I E+    +L  YL      F P +    D  K    +E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 543 --VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 443 LGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL-QHVNLL 494
           LG G FG V + +          +  AVK L   +T        +E+ +   +  H+N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 495 RVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEG----- 542
            +LG CT+     M+I E+    +L  YL      F P +    D  K    +E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 543 --VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +       LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D  K    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 540 IEG-------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +E        V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 443 LGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL-QHVNLL 494
           LG G FG V + +          +  AVK L   +T        +E+ +   +  H+N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 495 RVLGYCTERDENMLIY------------------EYLPNKSLDLYLFDPIRRYVLDWQKR 536
            +LG CT+    +++                   E++P K  DLY      +  L  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY------KDFLTLEHL 150
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           +     V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    
Sbjct: 151 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 442 KLGEGGFGPVYKG--NLPRGQ-EFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +LG G FG V +G   + + Q + A+K L   T     EE   E  +  +L +  ++R++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G C + +  ML+ E      L  +L    +R  +       ++  V+ G+ YL+E  NF 
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE-KNF- 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGI 615
            +HRDL A N+LL N    KISDFG++K    D D   T R  G +   +  PE +    
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 189
Query: 616 YSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLE 652
           +S + DV+S+GV + + +S  ++  +     E + F+E
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG+G FG VY+GN   + +G+     AVK ++ + S +   EF NE S+       +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQG 546
           R+LG  ++    +++ E + +  L  YL   +R        R     Q+ + +   +  G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL      + +HR+L A N ++ ++   KI DFGM +    D+ E +  R  G  G +
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 194
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE +K G+++   D++SFGV+L +I S
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 126
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 127 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 180
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG+G FG VY+GN   + +G+     AVK ++ + S +   EF NE S+       +++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQG 546
           R+LG  ++    +++ E + +  L  YL   +R        R     Q+ + +   +  G
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL      + +HR+L A N ++ ++   KI DFGM +    D+ E +  R  G  G +
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 195
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE +K G+++   D++SFGV+L +I S
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 146
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 147 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 200
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +       LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNI 539
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +    D  K    
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 540 IEG-------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +E        V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 184 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 31/232 (13%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGL 475
           V+   + + A    + + +LG+G FG VY+G + +G          A+K ++ A S +  
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 62
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD--- 532
            EF NE S+       +++R+LG  ++    ++I E +    L  YL   +R  + +   
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPAMANNPV 121
Query: 533 -----WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
                  K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFGM    
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMT--- 175
Query: 588 RKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 176 -RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 128
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 129 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 182
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 148
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 149 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 202
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 148
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 149 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 202
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 132
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 186
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTAR 487
           +  +    LG G FG V + +          +  AVK L   +T        +E+ +   
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 488 L-QHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYL------FDPIR------RYVLDW 533
           +  H+N++ +LG CT+     M+I E+    +L  YL      F P +      +  L  
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
           +  +     V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D 
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              G       ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLSA-TSTQGLEEFKNEVSLTARL-Q 489
           N+    + +GEG FG V K  + +     + A+KR+    S     +F  E+ +  +L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKR 536
           H N++ +LG C  R    L  EY P+ +L  +L        DP           L  Q+ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++    V +G+ YL   S  + IHRDL A NIL+      KI+DFG+++     V +   
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTM 190
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++  E +   +Y+   DV+S+GVLL +I+S
Sbjct: 191 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLSA-TSTQGLEEFKNEVSLTARL-Q 489
           N+    + +GEG FG V K  + +     + A+KR+    S     +F  E+ +  +L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKR 536
           H N++ +LG C  R    L  EY P+ +L  +L        DP           L  Q+ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++    V +G+ YL   S  + IHRDL A NIL+      KI+DFG+++     V +   
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTM 200
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++  E +   +Y+   DV+S+GVLL +I+S
Sbjct: 201 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG      + +     + +  A      +E   E ++  +L +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C E +  ML+ E      L+ YL     R+V D +  + ++  V+ G+ YL+E SNF
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKD-KNIIELVHQVSMGMKYLEE-SNF 138
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +         T+G  P     PE +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECI 192
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 114/237 (48%), Gaps = 37/237 (15%)
Query: 425 FSFSDI------KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-AT 470
           FS +D+      + A    + + +LG+G FG VY+G + +G          A+K ++ A 
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAA 61
Query: 471 STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------- 523
           S +   EF NE S+       +++R+LG  ++    ++I E +    L  YL        
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 524 -DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
            +P+        K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFG
Sbjct: 122 NNPVLAPP-SLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 583 MAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           M     +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 178 MT----RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 18/214 (8%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK-NEVSLTARLQ 489
           ++++ F    KLG G +  VYKG N   G   A+K +   S +G       E+SL   L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPN---KSLDLYLFDPIRRYVLDWQKRVNIIE----G 542
           H N++R+       ++  L++E++ N   K +D        R +      +N+++     
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-----ELNLVKYFQWQ 116
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + QGL +  E    +++HRDLK  N+L++     K+ DFG+A+ F   V+  ++  +V  
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-EVVTL 172
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +   P   +    YS   D++S G +L ++I+ K
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGL--EEFKNEVSLTARLQHVNLLRV 496
           +G+G F  V +  N   GQ+FAVK +     TS+ GL  E+ K E S+   L+H +++ +
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLYLQE 552
           L   +      +++E++    L    F+ ++R    +V       + +  + + L Y  +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 553 YSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRI----VGTYGY 605
            +   +IHRD+K  N+LL   +N    K+ DFG+A      +    +G +    VGT  +
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVA------IQLGESGLVAGGRVGTPHF 199
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           + PE VK+  Y    DV+  GV+L  ++S      +YGT E L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTKERL 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGL 475
           V+   + + A    + + +LG+G FG VY+G + +G          A+K ++ A S +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIR 527
            EF NE S+       +++R+LG  ++    ++I E +    L  YL         +P+ 
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
                  K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFGM    
Sbjct: 126 APP-SLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMT--- 178
Query: 588 RKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 179 -RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+  +++G+G FG VYKG     +E  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           R  G   +  +  +I EYL   S LDL    P+    +       I+  + +GL YL   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLH-- 133
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + R IHRD+KA+N+LL  + + K++DFG+A        + N    VGT  ++ PE +K+
Sbjct: 134 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 191 SAYDFKADIWSLGITAIEL 209

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGL 475
           V+   + + A    + + +LG+G FG VY+G + +G          A+K ++ A S +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 65
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIR 527
            EF NE S+       +++R+LG  ++    ++I E +    L  YL         +P+ 
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
                  K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFGM    
Sbjct: 126 APP-SLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMT--- 178
Query: 588 RKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 179 -RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N       A K +   S + LE++  E+ + A   H N++++L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   ++ E+    ++D  + + + R + + Q +V + +     L YL +    ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KIIH 158
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA NIL   + + K++DFG++    + +   ++   +GT  ++ PE V     K   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRP 216
Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K DV+S G+ L+++
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G G FG V K    R ++ A+K++ + S +  + F  E+   +R+ H N++++ G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 503 RDENMLIYEYLPNKSL--DLYLFDPIRRYV----LDWQKRVNIIEGVTQGLLYLQEYSNF 556
            +   L+ EY    SL   L+  +P+  Y     + W  +       +QG+ YL      
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 557 RVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            +IHRDLK  N+LL       KI DFG A     D+    T    G+  ++ PE  +   
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEGSN 180
Query: 616 YSMKYDVYSFGVLLLQIISSKR 637
           YS K DV+S+G++L ++I+ ++
Sbjct: 181 YSEKCDVFSWGIILWEVITRRK 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N       A K +   S + LE++  E+ + A   H N++++L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   ++ E+    ++D  + + + R + + Q +V + +     L YL +    ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KIIH 158
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA NIL   + + K++DFG++    + +   ++   +GT  ++ PE V     K   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 216
Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K DV+S G+ L+++
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           F+P       L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANT-G 597
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+ +   D  +  T G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           R+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 213 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 31/225 (13%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGLEEFKNEV 482
           + A    + + +LG+G FG VY+G + +G          A+K ++ A S +   EF NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIRRYVLDWQ 534
           S+       +++R+LG  ++    ++I E +    L  YL         +P+        
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP-SLS 125
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           K + +   +  G+ YL   +N + +HRDL A N ++  +   KI DFGM     +D+ E 
Sbjct: 126 KMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYET 178
Query: 595 NTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 179 DYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           ++N+    +LG+G F  V +  +   G EFA      K+LSA   Q LE    E  +  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 60
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           LQH N++R+     E   + L+++ +    L     D + R         + I+ + + +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 117
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y   +SN  ++HR+LK  N+LL ++      K++DFG+A     +  EA  G   GT G
Sbjct: 118 AYC--HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 171
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE +KK  YS   D+++ GV+L
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   Y+  ++   + FA K +  +        E+   E+++   L + +++   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  +   +    +    QG+ YL    N RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHK--RRKAVTEPEARYFMRQTIQGVQYLH---NNRV 163
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+++++ KI DFG+A     D +   T  + GT  Y+ PE + K  +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 619 KYDVYSFGVLLLQIISSK 636
           + D++S G +L  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G G FG V K    R ++ A+K++ + S +  + F  E+   +R+ H N++++ G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 503 RDENMLIYEYLPNKSL--DLYLFDPIRRYV----LDWQKRVNIIEGVTQGLLYLQEYSNF 556
            +   L+ EY    SL   L+  +P+  Y     + W  +       +QG+ YL      
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 557 RVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            +IHRDLK  N+LL       KI DFG A     D+    T    G+  ++ PE  +   
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEGSN 179
Query: 616 YSMKYDVYSFGVLLLQIISSKR 637
           YS K DV+S+G++L ++I+ ++
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           ++N+    +LG+G F  V +  +   G EFA      K+LSA   Q LE    E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           LQH N++R+     E   + L+++ +    L     D + R         + I+ + + +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y   +SN  ++HR+LK  N+LL ++      K++DFG+A     +  EA  G   GT G
Sbjct: 119 AYC--HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 172
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE +KK  YS   D+++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           ++N+    +LG+G F  V +  +   G EFA      K+LSA   Q LE    E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           LQH N++R+     E   + L+++ +    L     D + R         + I+ + + +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y   +SN  ++HR+LK  N+LL ++      K++DFG+A     +  EA  G   GT G
Sbjct: 119 AYC--HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 172
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE +KK  YS   D+++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           ++N+    +LG+G F  V +  +   G EFA      K+LSA   Q LE    E  +  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           LQH N++R+     E   + L+++ +    L     D + R         + I+ + + +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 141
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y   +SN  ++HR+LK  N+LL ++      K++DFG+A     +  EA  G   GT G
Sbjct: 142 AYC--HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPG 195
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE +KK  YS   D+++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 431 KAATNNFSSANK---LGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTA 486
           + A N+F + +K   LG G FG V+K      G + A K +     +  EE KNE+S+  
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVT 544
           +L H NL+++      +++ +L+ EY+        LFD I    Y L     +  ++ + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQIC 197
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKLFR-KDVDEANTGRIVG 601
           +G+ ++ +     ++H DLK  NIL  N      KI DFG+A+ ++ ++  + N     G
Sbjct: 198 EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FG 250
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  ++ PE V     S   D++S GV+   ++S
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 443 LGEGGFGPVY-----KGNLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRV 496
           LGEG FG V        N   G+  AVK L       L   ++ E+ +   L H ++++ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL--QE 552
            G C ++ E    L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL  Q 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQH 132
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
           Y     IHR L A N+LLDN+   KI DFG+AK     V E +    V   G  P     
Sbjct: 133 Y-----IHRALAARNVLLDNDRLVKIGDFGLAKA----VPEGHEYYRVREDGDSPVFWYA 183
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K+  +    DV+SFGV L ++++
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 443 LGEGGFGPVY-----KGNLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRV 496
           LGEG FG V        N   G+  AVK L       L   ++ E+ +   L H ++++ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL--QE 552
            G C ++ E    L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL  Q 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQH 131
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
           Y     IHR L A N+LLDN+   KI DFG+AK     V E +    V   G  P     
Sbjct: 132 Y-----IHRALAARNVLLDNDRLVKIGDFGLAKA----VPEGHEYYRVREDGDSPVFWYA 182
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K+  +    DV+SFGV L ++++
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG+G FG VYK  N       A K +   S + LE++  E+ + A   H N++++L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   ++ E+    ++D  + + + R + + Q +V + +     L YL +    ++IH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KIIH 158
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
           RDLKA NIL   + + K++DFG++    + +   +    +GT  ++ PE V     K   
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX--FIGTPYWMAPEVVMCETSKDRP 216
Query: 616 YSMKYDVYSFGVLLLQI 632
           Y  K DV+S G+ L+++
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 40/250 (16%)
Query: 398 GRRNLRTPGTSTPAAEYFDSD---TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
           GR NL           YF  D   TP +  F  S     +  +    KLG G +G V   
Sbjct: 10  GRENL-----------YFQGDLQATPGM--FITSKKGHLSEMYQRVKKLGSGAYGEVL-- 54
Query: 455 NLPRGQ----EFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508
            L R +    E A+K  R ++ ST    +   EV++   L H N++++  +  ++    L
Sbjct: 55  -LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113
Query: 509 IYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567
           + E      L    FD I  R   +      II+ V  G+ YL +++   ++HRDLK  N
Sbjct: 114 VMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPEN 166
Query: 568 ILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYS 624
           +LL+++      KI DFG++ +F    ++      +GT  Y+ PE ++K  Y  K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWS 222
Query: 625 FGVLLLQIIS 634
            GV+L  +++
Sbjct: 223 IGVILFILLA 232

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLS-ATSTQGLEEFK-NEVSLTARLQHVNLL 494
           +    K+GEG +G VYK     G+ FA+K++      +G+      E+S+   L+H N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG----VTQGLLYL 550
           ++      +   +L++E+L                  D +K +++ EG    VT     L
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLL 107
Query: 551 QEYSNF------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q  +        RV+HRDLK  N+L++ E   KI+DFG+A+ F   V +  T  IV  + 
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWY 166
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             P   +    YS   D++S G +  ++++      + G SE
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG--TPLFPGVSE 206

>pdb|3G6L|A Chain A, The Crystal Structure Of A Chitinase Crchi1 From The Nematophagous Fungus Clonostachys Rosea Length = 406

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 95/351 (27%), Positives = 164/351 (46%), Gaps = 64/351 (18%)
Query: 36  GREFPLSDINSALFTHLICAFA--EVDSSTYQLSISSANQQYFS------IFANS----- 82
           GR F  +D+ ++   H++ +F    VD + Y     +  ++++S      I  N+     
Sbjct: 34  GRNFQPADLQASKILHVLYSFMNLRVDGTVYSGDTYADLEKHYSDDSWNDIGTNAYGCVK 93
Query: 83  ----VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
               +++ N S+K +LSI     ST        N  P+  S+     + R +F ++++  
Sbjct: 94  QLYKLKKANRSLKIMLSIGGWTWST--------NF-PAAAST----EATRATFAKTAVEF 140
Query: 139 ARLYGFQGIDLFWLWPNS-TDLNSLGILL-------DEWKASASDQPELTLSMAVRYSPT 190
            + +GF GID+ W +P S TD N++ +LL       D + A+ ++     LS+A    P+
Sbjct: 141 MKDWGFDGIDVDWEYPASETDANNMVLLLQRVRQELDSYSATYANGYHFQLSIAAPAGPS 200
Query: 191 HETVS--YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY----NPSSN-ISTDFGI 243
           H  V     + S+  N+N   L+AYDY   S ++V+G    LY    NPSS   ST   +
Sbjct: 201 HYNVLKLAQLGSVLDNIN---LMAYDY-AGSWDSVSGHQTNLYPSTSNPSSTPFSTKAAV 256
Query: 244 REWLRRGFPANKLVLG----ARA----SGPGITIDGSMGYKFIRAFIQNYGY----GAAP 291
             ++  G PA+K++LG     RA     GPG     ++G     + I +Y      GA  
Sbjct: 257 DAYIAAGVPASKIILGMPIYGRAFVGTDGPGKPYS-TIGEGSWESGIWDYKVLPKAGATV 315
Query: 292 VYN--ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
           + +  A    +  +S  T I++D  + ++ K+SYAK   L G   ++ S D
Sbjct: 316 ITDSAAGATYSYDSSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASAD 366

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFK-NEVSLTARL 488
           +     +    K+GEG +G VYK    +G+  A+KR+   +  +G+      E+SL   L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
            H N++ ++          L++E++  K L   L D  +  + D Q ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +  ++   R++HRDLK  N+L++++   K++DFG+A+ F   V  + T  +V  +   P 
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPD 189
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             +    YS   D++S G +  ++I+ K
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +F     +G GGFG V+K  +   G+ + +KR+   +    E+ + EV   A+L HVN++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 495 RVLGYC--------------TERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRV 537
              G C              + R +   ++   E+    +L+ ++ +  R   LD    +
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
            + E +T+G+ Y+      ++I+RDLK SNI L +    KI DFG+    + D       
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRX 179
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           R  GT  Y+ PE +    Y  + D+Y+ G++L +++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 442 KLGEGGFGPVYKG--NLPRGQ-EFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +LG G FG V +G   + + Q + A+K L   T     EE   E  +  +L +  ++R++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G C + +  ML+ E      L  +L    +R  +       ++  V+ G+ YL+E  NF 
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE-KNF- 457
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGI 615
            +HR+L A N+LL N    KISDFG++K    D D   T R  G +   +  PE +    
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 515
Query: 616 YSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLE 652
           +S + DV+S+GV + + +S  ++  +     E + F+E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 443 LGEGGFGPVYKGN-LPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG V+KG  +P G+   +          +  Q  +   + +     L H +++R+
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY--VLDWQKRVNIIEGVTQGLLYLQEYS 554
           LG C       L+ +YLP  SL     D +R++   L  Q  +N    + +G+ YL+E+ 
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              ++HR+L A N+LL +    +++DFG+A L   D  +           ++  E +  G
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            Y+ + DV+S+GV + ++++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFK-NEVSLTARL 488
           +     +    K+GEG +G VYK    +G+  A+KR+   +  +G+      E+SL   L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
            H N++ ++          L++E++  K L   L D  +  + D Q ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +  ++   R++HRDLK  N+L++++   K++DFG+A+ F   V  + T  +V  +   P 
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPD 189
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             +    YS   D++S G +  ++I+ K
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLSA-TSTQGLEEFKNEVSLTARL-Q 489
           N+    + +GEG FG V K  + +     + A+KR+    S     +F  E+ +  +L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKR 536
           H N++ +LG C  R    L  EY P+ +L  +L        DP           L  Q+ 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++    V +G+ YL   S  + IHR+L A NIL+      KI+DFG+++     V +   
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV-KKTM 197
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++  E +   +Y+   DV+S+GVLL +I+S
Sbjct: 198 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG   R Q+  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P     LD  +   I+  + +GL YL   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH-- 121
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + + IHRD+KA+N+LL      K++DFG+A        + NT   VGT  ++ PE +K+
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 179 SAYDSKADIWSLGITAIEL 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEF-AVKRLSA-TSTQGLE-EFKNEVSLTARL 488
           A   +    ++GEG +G V+K  +L  G  F A+KR+   T  +G+      EV++   L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 489 Q---HVNLLRVLGYCT----ERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R+   CT    +R+  + L++E++ ++ L  YL D +    +  +   +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL +L  +   RV+HRDLK  NIL+ +    K++DFG+A+++     +     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G+S+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 443 LGEGGFGPVYKGN-LPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG V+KG  +P G+   +          +  Q  +   + +     L H +++R+
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY--VLDWQKRVNIIEGVTQGLLYLQEYS 554
           LG C       L+ +YLP  SL     D +R++   L  Q  +N    + +G+ YL+E+ 
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              ++HR+L A N+LL +    +++DFG+A L   D  +           ++  E +  G
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            Y+ + DV+S+GV + ++++
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 31/232 (13%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGL 475
           V+   + + A    + + +LG+G FG VY+G + +G          A+K ++ A S +  
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 59
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIR 527
            EF NE S+       +++R+LG  ++    ++I E +    L  YL         +P+ 
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
                  K + +   +  G+ YL   +N + +HRDL A N  +  +   KI DFGM    
Sbjct: 120 APP-SLSKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCXVAEDFTVKIGDFGMT--- 172
Query: 588 RKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +D+ E +  R  G  G +P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 173 -RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   Y+  ++   + FA K +  +        E+   E+++   L + +++   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  +   +    +    QG+ YL    N RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHK--RRKAVTEPEARYFMRQTIQGVQYLH---NNRV 163
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+++++ KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 619 KYDVYSFGVLLLQIISSK 636
           + D++S G +L  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 16  VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 72
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 73  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 128
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 129 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 183
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 184 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLS-ATSTQGLEEFK-NEVSLTARLQHVNLL 494
           +    K+GEG +G VYK     G+ FA+K++      +G+      E+S+   L+H N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG----VTQGLLYL 550
           ++      +   +L++E+L                  D +K +++ EG    VT     L
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLL 107
Query: 551 QEYSNF------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q  +        RV+HRDLK  N+L++ E   KI+DFG+A+ F   V +  T  +V  + 
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWY 166
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             P   +    YS   D++S G +  ++++
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLS-ATSTQGLEEFK-NEVSLTARLQHVNLL 494
           +    K+GEG +G VYK     G+ FA+K++      +G+      E+S+   L+H N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG----VTQGLLYL 550
           ++      +   +L++E+L                  D +K +++ EG    VT     L
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLL 107
Query: 551 QEYSNF------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q  +        RV+HRDLK  N+L++ E   KI+DFG+A+ F   V +  T  +V  + 
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWY 166
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             P   +    YS   D++S G +  ++++      + G SE
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG--TPLFPGVSE 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 113/226 (50%), Gaps = 23/226 (10%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARL 488
           AT+ +    ++G G +G VYK   P    F   + S     G E        EV+L  RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-SVRVPNGEEGLPISTVREVALLRRL 60
Query: 489 Q---HVNLLRVLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R++  C    T+R+  + L++E++ ++ L  YL D      L  +   +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
               +GL +L  ++N  ++HRDLK  NIL+ +    K++DFG+A+++   +  A    +V
Sbjct: 119 RQFLRGLDFL--HANC-IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VV 172
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G SE
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 23  VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 79
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 80  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 135
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 136 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 190
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 191 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 12  VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 68
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 69  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 125 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 179
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 24/204 (11%)
Query: 443 LGEGGFGPVYKGN-LPRGQ----EFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
           LG G FG VYKG  +P G+      A+K L   TS +  +E  +E  + A +    + R+
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           LG C       L+ + +P   L     D +R  R  L  Q  +N    + +G+ YL+   
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL----LDHVRENRGRLGSQDLLNWCMQIAKGMSYLE--- 136
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----ANTGRIVGTYGYVPPEY 610
           + R++HRDL A N+L+ +  + KI+DFG+A+L   D+DE    A+ G++     ++  E 
Sbjct: 137 DVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKV--PIKWMALES 192
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           + +  ++ + DV+S+GV + ++++
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEF-AVKRLSA-TSTQGLE-EFKNEVSLTARL 488
           A   +    ++GEG +G V+K  +L  G  F A+KR+   T  +G+      EV++   L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 489 Q---HVNLLRVLGYCT----ERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R+   CT    +R+  + L++E++ ++ L  YL D +    +  +   +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL +L  +   RV+HRDLK  NIL+ +    K++DFG+A+++     +     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G+S+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 224

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG   R Q+  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P     LD  +   I+  + +GL YL   
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH-- 141
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + + IHRD+KA+N+LL      K++DFG+A        + NT   VGT  ++ PE +K+
Sbjct: 142 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 199 SAYDSKADIWSLGITAIEL 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEF-AVKRLSA-TSTQGLE-EFKNEVSLTARL 488
           A   +    ++GEG +G V+K  +L  G  F A+KR+   T  +G+      EV++   L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 489 Q---HVNLLRVLGYCT----ERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R+   CT    +R+  + L++E++ ++ L  YL D +    +  +   +++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL +L  +   RV+HRDLK  NIL+ +    K++DFG+A+++     +     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G+S+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   Y+  ++   + FA K +  +        E+   E+++   L + +++   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  +   +    +    QG+ YL    N RV
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHK--RRKAVTEPEARYFMRQTIQGVQYLH---NNRV 163
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+++++ KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 619 KYDVYSFGVLLLQIISSK 636
           + D++S G +L  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +N      +G G +G VYKG+L   +  AVK  S  + Q     KN +     ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 495 R-VLG----YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           R ++G        R E +L+ EY PN SL  YL      +  DW     +   VT+GL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 550 LQ------EYSNFRVIHRDLKASNILLDNELNPKISDFGMA------KLFRKDVDEANTG 597
           L       ++    + HRDL + N+L+ N+    ISDFG++      +L R   ++    
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 598 RIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQI 632
             VGT  Y+ PE ++  +          + D+Y+ G++  +I
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            +LG+G F  V +   +  GQE+A      K+LSA   Q LE    E  +   L+H N++
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIV 84
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+    +E   + LI++ +    L     D + R         + I+ + + +L+  +  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 555 NFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
              V+HRDLK  N+LL ++L     K++DFG+A     + ++       GT GY+ PE +
Sbjct: 142 ---VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 612 KKGIYSMKYDVYSFGVLL 629
           +K  Y    D+++ GV+L
Sbjct: 197 RKDPYGKPVDLWACGVIL 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 21  VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 77
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 78  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 133
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 134 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 188
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 189 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+   ++G+G FG V+KG   R Q+  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P   + +       +++ + +GL YL   
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGLDYLHSE 139
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
              + IHRD+KA+N+LL  + + K++DFG+A        + NT   VGT  ++ PE +++
Sbjct: 140 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 194
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 195 SAYDSKADIWSLGITAIEL 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 106/244 (43%), Gaps = 32/244 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGN------LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTAR 487
            N      LG G FG V               + AVK L   + +   E   +E+ +  +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW-----QKRVNIIE 541
           L  H N++ +LG CT      LI+EY     L  YL     ++  D      QKR+   E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 542 G---------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
                           V +G+ +L+  S    +HRDL A N+L+ +    KI DFG+A+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
              D +    G       ++ PE + +GIY++K DV+S+G+LL +I S   N  Y G   
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 280
Query: 647 NLNF 650
           + NF
Sbjct: 281 DANF 284

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   Y+  ++   + FA K +  +        E+   E+++   L + +++   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  +   +    +    QG+ YL    N RV
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHK--RRKAVTEPEARYFMRQTIQGVQYLH---NNRV 147
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+++++ KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 619 KYDVYSFGVLLLQIISSK 636
           + D++S G +L  ++  K
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           T+ +     +G+G F  V +   L  G E+A      K+LSA   Q LE    E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L+H N++R+    +E   + L+++ +    L     D + R         + I+ + + +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 116
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
           L+  +     V+HRDLK  N+LL ++      K++DFG+A   + D  +A  G   GT G
Sbjct: 117 LHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD-QQAWFG-FAGTPG 171
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE ++K  Y    D+++ GV+L
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
            ++F     LG+G FG V K  N    + +A+K++  T  + L    +EV L A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQY 63
Query: 493 LLRVLGYCTER------------DENMLI-YEYLPNKSLDLYLFDPIRRYVLDWQKRV-- 537
           ++R      ER               + I  EY  N++L    +D I    L+ Q+    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQRDEYW 119
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD----- 592
            +   + + L Y+       +IHRDLK  NI +D   N KI DFG+AK   + +D     
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 593 -------EANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQII 633
                    N    +GT  YV  E +   G Y+ K D+YS G++  ++I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           T  +    +LG+G F  V +   +  GQE+A      K+LSA   Q LE    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L+H N++R+    +E   + LI++ +    L     D + R         + I+ + + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
           L+  +     V+HR+LK  N+LL ++L     K++DFG+A     + ++       GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 178
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE ++K  Y    D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL---DLYLFDPIRRYV-- 530
           ++FKNE+ +   +++   L   G  T  DE  +IYEY+ N S+   D Y F   + Y   
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
           +  Q    II+ V     Y+    N  + HRD+K SNIL+D     K+SDFG ++     
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--- 202
Query: 591 VDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLL 629
           VD+   G   GTY ++PPE+   +      K D++S G+ L
Sbjct: 203 VDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 66  VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 122
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 123 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 178
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 179 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 233
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 89  FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A     D +   T  + GT  Y+ PE + K  +S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A     D +   T  + GT  Y+ PE + K  +S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 23/226 (10%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARL 488
           AT+ +    ++G G +G VYK   P    F   + S     G E        EV+L  RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-SVRVPNGEEGLPISTVREVALLRRL 60
Query: 489 Q---HVNLLRVLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R++  C    T+R+  + L++E++ ++ L  YL D      L  +   +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
               +GL +L  ++N  ++HRDLK  NIL+ +    K++DFG+A+++     +     +V
Sbjct: 119 RQFLRGLDFL--HANC-IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVV 172
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G SE
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 25/239 (10%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG 474
           + + P+LQ      IK    +F     LG+G FG V+     +  Q FA+K L       
Sbjct: 5   NKERPSLQ------IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM 58
Query: 475 LEEFKNEVS----LTARLQHVNLLRVLGYCT-ERDENML-IYEYLPNKSLDLYLFDPIRR 528
            ++ +  +     L+   +H  L  +  +CT +  EN+  + EYL    L +Y      +
Sbjct: 59  DDDVECTMVEKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDL-MYHIQSCHK 115
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
           +  D  +       +  GL +L       +++RDLK  NILLD + + KI+DFGM K   
Sbjct: 116 F--DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--E 168
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             + +A T    GT  Y+ PE +    Y+   D +SFGVLL +++  +  + ++G  E 
Sbjct: 169 NMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 446 GGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505
           G FG V+K  L    +F   ++     +   + + E+  T  ++H NLL+ +    +R  
Sbjct: 26  GRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIA-AEKRGS 82
Query: 506 NMLIYEYLPNKSLDL-YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF-------- 556
           N+ +  +L     D   L D ++  ++ W +  ++ E +++GL YL E   +        
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI- 615
            + HRD K+ N+LL ++L   ++DFG+A  F       +T   VGT  Y+ PE ++  I 
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAIN 202
Query: 616 ----YSMKYDVYSFGVLLLQIISSKRNA 639
                 ++ D+Y+ G++L +++S  + A
Sbjct: 203 FQRDAFLRIDMYAMGLVLWELVSRCKAA 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A     D +   T  + GT  Y+ PE + K  +S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 200
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 201 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 211
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 212 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 203
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 204 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL---FDPIRRYV----------LDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL     P   Y           L  +  V+ 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 196
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 197 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEV 482
           V    D ++  +NF    K+GEG  G V    +   G+  AVK++     Q  E   NEV
Sbjct: 143 VVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEV 199
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            +    QH N++ +       DE  ++ E+L   +L     D +    ++ ++   +   
Sbjct: 200 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLA 255
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V Q L  L       VIHRD+K+ +ILL ++   K+SDFG      K+V       +VGT
Sbjct: 256 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGT 310
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             ++ PE + +  Y  + D++S G+++++++  +
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 204
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 205 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL---FDPIRRYV----------LDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL     P   Y           L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 211
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 212 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 211
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 212 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 24/245 (9%)
Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPV--YKGNL 456
           R      GTS    ++  + TP + V   + I   ++ +     LG+G FG V   K  +
Sbjct: 16  RSRGHAAGTSGGPGDHLHA-TPGMFVQHSTAI--FSDRYKGQRVLGKGSFGEVILCKDKI 72
Query: 457 PRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
             GQE AVK +S    +     E    EV L  +L H N++++  +  ++    L+ E  
Sbjct: 73  T-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 131
Query: 514 PNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
               L    FD I  R          II  V  G+ Y+ +    +++HRDLK  N+LL++
Sbjct: 132 TGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLES 184
Query: 573 ---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
              + N +I DFG++  F       +    +GT  Y+ PE V  G Y  K DV+S GV+L
Sbjct: 185 KSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 240
Query: 630 LQIIS 634
             ++S
Sbjct: 241 YILLS 245

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 24/245 (9%)
Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPV--YKGNL 456
           R      GTS    ++  + TP + V   + I   ++ +     LG+G FG V   K  +
Sbjct: 17  RSRGHAAGTSGGPGDHLHA-TPGMFVQHSTAI--FSDRYKGQRVLGKGSFGEVILCKDKI 73
Query: 457 PRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
             GQE AVK +S    +     E    EV L  +L H N++++  +  ++    L+ E  
Sbjct: 74  T-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 132
Query: 514 PNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
               L    FD I  R          II  V  G+ Y+ +    +++HRDLK  N+LL++
Sbjct: 133 TGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLES 185
Query: 573 ---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
              + N +I DFG++  F       +    +GT  Y+ PE V  G Y  K DV+S GV+L
Sbjct: 186 KSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 241
Query: 630 LQIIS 634
             ++S
Sbjct: 242 YILLS 246

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +F     +G GGFG V+K  +   G+ + ++R+   +    E+ + EV   A+L HVN++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 495 RVLG------YCTE-RDENMLIYEYLP--------NKSLDLYL-------------FDPI 526
              G      Y  E  D+++   +Y P        +K+  L++              +  
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
           R   LD    + + E +T+G+ Y+    + ++IHRDLK SNI L +    KI DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
            + D       R  GT  Y+ PE +    Y  + D+Y+ G++L +++
Sbjct: 186 LKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG   R Q+  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P     LD  +   I+  + +GL YL   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH-- 136
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + + IHRD+KA+N+LL      K++DFG+A        + N    VGT  ++ PE +K+
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 193
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 194 SAYDSKADIWSLGITAIEL 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG   R Q+  A+K +    +   +E+ + E+++ ++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  G   +  +  +I EYL   S LDL    P     LD  +   I+  + +GL YL   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH-- 121
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + + IHRD+KA+N+LL      K++DFG+A        + N    VGT  ++ PE +K+
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 178
Query: 614 GIYSMKYDVYSFGVLLLQI 632
             Y  K D++S G+  +++
Sbjct: 179 SAYDSKADIWSLGITAIEL 197

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 434 TNNFSSANKLGEGGFGPV--YKGNLPRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARL 488
           ++ +     LG+G FG V   K  +  GQE AVK +S    +     E    EV L  +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGL 547
            H N++++  +  ++    L+ E      L    FD I  R          II  V  G+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 548 LYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y+ +    +++HRDLK  N+LL++   + N +I DFG++  F       +    +GT  
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAY 193
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           Y+ PE V  G Y  K DV+S GV+L  ++S
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLS 222

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
           LGEG FG V         K    R  + AVK L + +T+  L +  +E+ +   + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
           ++ +LG CT+     +I EY    +L  YL           ++P       L  +  V+ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
              V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A+     +D   +   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-IDYYKKTTN 252
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           GR+     ++ PE +   IY+ + DV+SFGVLL +I +
Sbjct: 253 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 434 TNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQ 489
           ++ +     LG+G FG V    +   GQE AVK +S    +     E    EV L  +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLL 548
           H N++++  +  ++    L+ E      L    FD I  R          II  V  G+ 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGIT 146
Query: 549 YLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           Y+ +    +++HRDLK  N+LL++   + N +I DFG++  F       +    +GT  Y
Sbjct: 147 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYY 200
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           + PE V  G Y  K DV+S GV+L  ++S
Sbjct: 201 IAPE-VLHGTYDEKCDVWSTGVILYILLS 228

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 23/226 (10%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARL 488
           AT+ +    ++G G +G VYK   P    F   + S     G E        EV+L  RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-SVRVPNGEEGLPISTVREVALLRRL 60
Query: 489 Q---HVNLLRVLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           +   H N++R++  C    T+R+  + L++E++ ++ L  YL D      L  +   +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
               +GL +L  ++N  ++HRDLK  NIL+ +    K++DFG+A+++     +     +V
Sbjct: 119 RQFLRGLDFL--HANC-IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVV 172
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            T  Y  PE + +  Y+   D++S G +  ++   +R   + G SE
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 216

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNL--PRGQE----FAVKRLSA-TSTQGLEEFKNEVSLTAR 487
            N      LGEG FG V K      +G+      AVK L    S   L +  +E ++  +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPI 526
           + H +++++ G C++    +LI EY    SL  +L                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L     ++    ++QG+ YL E S   ++HRDL A NIL+      KISDFG++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIIS 634
             +DV E ++  +  + G +P +++        IY+ + DV+SFGVLL +I++
Sbjct: 198 --RDVYEEDS-XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 25/238 (10%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG 474
           + + P+LQ      IK    +F     LG+G FG V+     +  Q FA+K L       
Sbjct: 4   NKERPSLQ------IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM 57
Query: 475 LEEFKNEVS----LTARLQHVNLLRVLGYCT-ERDENML-IYEYLPNKSLDLYLFDPIRR 528
            ++ +  +     L+   +H  L  +  +CT +  EN+  + EYL    L +Y      +
Sbjct: 58  DDDVECTMVEKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDL-MYHIQSCHK 114
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
           +  D  +       +  GL +L       +++RDLK  NILLD + + KI+DFGM K   
Sbjct: 115 F--DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--E 167
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
             + +A T    GT  Y+ PE +    Y+   D +SFGVLL +++  +  + ++G  E
Sbjct: 168 NMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDE 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 7/160 (4%)
Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIR-RYVLDWQKR 536
           +EV+L   L+H N++R      +R    L  + EY     L   +    + R  LD +  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 537 VNIIEGVTQGLLYLQEYSN--FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           + ++  +T  L      S+    V+HRDLK +N+ LD + N K+ DFG+A++   D   A
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            T   VGT  Y+ PE + +  Y+ K D++S G LL ++ +
Sbjct: 174 KT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 37/229 (16%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
            ++F     LG+G FG V K  N    + +A+K++  T  + L    +EV L A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQY 63
Query: 493 LLRVLGYCTER------------DENMLI-YEYLPNKSLDLYLFDPIRRYVLDWQKRV-- 537
           ++R      ER               + I  EY  N +L    +D I    L+ Q+    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD----- 592
            +   + + L Y+       +IHRDLK  NI +D   N KI DFG+AK   + +D     
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 593 -------EANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQII 633
                    N    +GT  YV  E +   G Y+ K D+YS G++  ++I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G +G VY G +L      A+K +    ++  +    E++L   L+H N+++ LG  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 502 ERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFR 557
           E     +  E +P  SL   L   + P++    D ++ +    + + +GL YL +    +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 558 VIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI- 615
           ++HRD+K  N+L++      KISDFG +K  R       T    GT  Y+ PE + KG  
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 616 -YSMKYDVYSFGVLLLQIISSK 636
            Y    D++S G  ++++ + K
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNL--PRGQE----FAVKRLSA-TSTQGLEEFKNEVSLTAR 487
            N      LGEG FG V K      +G+      AVK L    S   L +  +E ++  +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPI 526
           + H +++++ G C++    +LI EY    SL  +L                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L     ++    ++QG+ YL E    +++HRDL A NIL+      KISDFG++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIIS 634
             +DV E ++  +  + G +P +++        IY+ + DV+SFGVLL +I++
Sbjct: 198 --RDVYEEDS-XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G +G VY G +L      A+K +    ++  +    E++L   L+H N+++ LG  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 502 ERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFR 557
           E     +  E +P  SL   L   + P++    D ++ +    + + +GL YL +    +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 558 VIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI- 615
           ++HRD+K  N+L++      KISDFG +K  R       T    GT  Y+ PE + KG  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 616 -YSMKYDVYSFGVLLLQIISSK 636
            Y    D++S G  ++++ + K
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 7/160 (4%)
Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIR-RYVLDWQKR 536
           +EV+L   L+H N++R      +R    L  + EY     L   +    + R  LD +  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 537 VNIIEGVTQGLLYLQEYSN--FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           + ++  +T  L      S+    V+HRDLK +N+ LD + N K+ DFG+A++   D D A
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                VGT  Y+ PE + +  Y+ K D++S G LL ++ +
Sbjct: 174 K--EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 412 AEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGN-LPRGQ---EFAVKRL 467
           AE  D   P+ +V + SD             +G+G FG VY G  + + Q   + A+K L
Sbjct: 9   AEVKDVLIPHERVVTHSD-----------RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 468 S-ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
           S  T  Q +E F  E  L   L H N+L ++G        ML  E LP+  L       +
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLNHPNVLALIGI-------MLPPEGLPHVLLPYMCHGDL 110
Query: 527 RRYVLDWQKRVNIIE------GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD 580
            +++   Q+   + +       V +G+ YL E    + +HRDL A N +LD     K++D
Sbjct: 111 LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVAD 167
Query: 581 FGMAK--LFRK--DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           FG+A+  L R+   V +    R+   +  +  E ++   ++ K DV+SFGVLL ++++
Sbjct: 168 FGLARDILDREYYSVQQHRHARLPVKWTAL--ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 83  FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           T+ +    +LG+G F  V +   +P GQE+A      K+LSA   Q LE    E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L+H N++R+    +E   + L+++ +    L    F+ I     ++    +    + Q L
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDI--VAREYYSEADASHCIQQIL 113
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
             +       ++HRDLK  N+LL ++      K++DFG+A   + D  +A  G   GT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFG-FAGTPG 171
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE ++K  Y    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 107 FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 35/246 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVN 492
            +F     LG GGFG V++  N      +A+KR+   + +   E+   EV   A+L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGL- 547
           ++R      E++      E L   S  +YL+  +    +  + DW      IE   + + 
Sbjct: 65  IVRYFNAWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 548 --LYLQ-----EYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA----- 594
             ++LQ     E+ + + ++HRDLK SNI    +   K+ DFG+     +D +E      
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 595 ------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII----SSKRNARYYGT 644
                 +TG+ VGT  Y+ PE +    YS K D++S G++L +++    +     R    
Sbjct: 181 MPAYARHTGQ-VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTD 239
Query: 645 SENLNF 650
             NL F
Sbjct: 240 VRNLKF 245

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++ +    +E    ++   S        E+   E+S+   L H +++   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
           +  + D   ++ E    +SL L L    RR  L   +    +  +  G  YL      RV
Sbjct: 109 FFEDNDFVFVVLELCRRRSL-LELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           IHRDLK  N+ L+ +L  KI DFG+A   + + D      + GT  Y+ PE + K  +S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 619 KYDVYSFGVLLLQIISSK 636
           + DV+S G ++  ++  K
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNL--PRGQE----FAVKRLSA-TSTQGLEEFKNEVSLTAR 487
            N      LGEG FG V K      +G+      AVK L    S   L +  +E ++  +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPI 526
           + H +++++ G C++    +LI EY    SL  +L                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
               L     ++    ++QG+ YL E    +++HRDL A NIL+      KISDFG++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIIS 634
             +DV E ++  +  + G +P +++        IY+ + DV+SFGVLL +I++
Sbjct: 198 --RDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSATSTQGLEEFKNEVSLTAR 487
           T+ +    +LG+G F  V +   +P GQE+A      K+LSA   Q LE    E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L+H N++R+    +E   + L+++ +    L    F+ I     ++    +    + Q L
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDI--VAREYYSEADASHCIQQIL 113
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
             +       ++HRDLK  N+LL ++      K++DFG+A   + D  +A  G   GT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFG-FAGTPG 171
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE ++K  Y    D+++ GV+L
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 446 GGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG---YCTE 502
           G FG V+K  L   +  AVK       Q  +  + EV     ++H N+L+ +G     T 
Sbjct: 35  GRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-------YSN 555
            D ++ +      K     L D ++  V+ W +  +I E + +GL YL E          
Sbjct: 93  VDVDLWLITAFHEKG---SLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             + HRD+K+ N+LL N L   I+DFG+A  F       +T   VGT  Y+ PE ++  I
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 616 -----YSMKYDVYSFGVLLLQIIS 634
                  ++ D+Y+ G++L ++ S
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHV 491
           NF    K+G G F  VY+   L  G   A+K++        +   +   E+ L  +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT------Q 545
           N+++   Y +  ++N L      N  L+L     + R +  ++K+  +I   T      Q
Sbjct: 93  NVIKY--YASFIEDNEL------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               L+   + RV+HRD+K +N+ +      K+ D G+ + F      A++  +VGT  Y
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 202
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           + PE + +  Y+ K D++S G LL ++ + +  + +YG   NL
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL 243

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 130
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP 607
           L+     R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 131 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 186
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIR-RYVLDWQKR 536
           +EV+L   L+H N++R      +R    L  + EY     L   +    + R  LD +  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 537 VNIIEGVTQGLLYLQEYSN--FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           + ++  +T  L      S+    V+HRDLK +N+ LD + N K+ DFG+A++   D   A
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                VGT  Y+ PE + +  Y+ K D++S G LL ++ +
Sbjct: 174 KA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 37/229 (16%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
            ++F     LG+G FG V K  N    + +A+K++  T  + L    +EV L A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASLNHQY 63
Query: 493 LLRVLGYCTER------------DENMLI-YEYLPNKSLDLYLFDPIRRYVLDWQKRV-- 537
           ++R      ER               + I  EY  N++L    +D I    L+ Q+    
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQRDEYW 119
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD----- 592
            +   + + L Y+       +IHR+LK  NI +D   N KI DFG+AK   + +D     
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 593 -------EANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQII 633
                    N    +GT  YV  E +   G Y+ K D YS G++  + I
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 434 TNNFSSANKLGEGGFGPV--YKGNLPRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARL 488
           ++ +     LG+G FG V   K  +  GQE AVK +S    +     E    EV L  +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGL 547
            H N+ ++  +  ++    L+ E      L    FD I  R          II  V  G+
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 548 LYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
            Y  +    +++HRDLK  N+LL++   + N +I DFG++  F       +    +GT  
Sbjct: 140 TYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTAY 193
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           Y+ PE V  G Y  K DV+S GV+L  ++S
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLS 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 130
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP 607
           L+   + R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 131 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 186
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 136
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA--NTGRIVGTYGYVP 607
           L+   + R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCA 192
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 31/223 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGL--EEFKNEVSLTARLQHVNLLRV 496
           +G+G F  V +  N   GQ+FAVK +     TS+ GL  E+ K E S+   L+H +++ +
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLYLQE 552
           L   +      +++E++    L    F+ ++R    +V       + +  + + L Y  +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 553 YSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRI----VGTYGY 605
            +   +IHRD+K   +LL   +N    K+  FG+A      +    +G +    VGT  +
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA------IQLGESGLVAGGRVGTPHF 199
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           + PE VK+  Y    DV+  GV+L  ++S      +YGT E L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTKERL 240

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA--NTGRIVGTYGYVP 607
           L+     R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCA 182
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV-- 496
            +LG GGFG V +  +   G++ A+K+     S +  E +  E+ +  +L H N++    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 497 ----LGYCTERDENMLIYEYLPNKSLDLYL--FD--------PIRRYVLDWQKRVNIIEG 542
               L      D  +L  EY     L  YL  F+        PIR  + D          
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD---------- 129
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFRKDVDEANTGRI 599
           ++  L YL E    R+IHRDLK  NI+L      L  KI D G AK    D  E  T   
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCT-EF 183
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           VGT  Y+ PE +++  Y++  D +SFG L  + I+  R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 114/228 (50%), Gaps = 24/228 (10%)
Query: 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEF-----KNEVSLTA 486
           AT+ +    ++G G +G VYK   P    F A+K +   +  G           EV+L  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 487 RLQ---HVNLLRVLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
           RL+   H N++R++  C    T+R+  + L++E++ ++ L  YL D      L  +   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           ++    +GL +L  ++N  ++HRDLK  NIL+ +    K++DFG+A+++     +     
Sbjct: 125 LMRQFLRGLDFL--HANC-IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
           +V T  Y  PE + +  Y+   D++S G +  ++   +R   + G SE
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 224

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 417 SDTP--NLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ 473
           SD+P  +L     S ++     F     +G G +G VYKG ++  GQ  A+K +  T  +
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 474 GLEEFKNEVSLTARL-QHVNLLRVLGYCTER------DENMLIYEYLPNKSLDLYLFDPI 526
             EE K E+++  +   H N+    G   ++      D+  L+ E+    S+   L    
Sbjct: 64  E-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNT 121
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
           +   L  +    I   + +GL +L ++   +VIHRD+K  N+LL      K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQI 632
             + V   NT   +GT  ++ PE +         Y  K D++S G+  +++
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 31/223 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGL--EEFKNEVSLTARLQHVNLLRV 496
           +G+G F  V +  N   GQ+FAVK +     TS+ GL  E+ K E S+   L+H +++ +
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLYLQE 552
           L   +      +++E++    L    F+ ++R    +V       + +  + + L Y  +
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 553 YSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRI----VGTYGY 605
            +   +IHRD+K   +LL   +N    K+  FG+A      +    +G +    VGT  +
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA------IQLGESGLVAGGRVGTPHF 201
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           + PE VK+  Y    DV+  GV+L  ++S      +YGT E L
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLSG--CLPFYGTKERL 242

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 136
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP 607
           L+   + R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 192
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV-- 496
            +LG GGFG V +  +   G++ A+K+     S +  E +  E+ +  +L H N++    
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 497 ----LGYCTERDENMLIYEYLPNKSLDLYL--FD--------PIRRYVLDWQKRVNIIEG 542
               L      D  +L  EY     L  YL  F+        PIR  + D          
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD---------- 130
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFRKDVDEAN-TGR 598
           ++  L YL E    R+IHRDLK  NI+L      L  KI D G AK    ++D+      
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTE 183
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            VGT  Y+ PE +++  Y++  D +SFG L  + I+  R
Sbjct: 184 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 23/196 (11%)
Query: 443 LGEGGFGPV-----YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           LGEG FG V     YK       +F  ++L   S   +   + E+S    L+H +++++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT--QGLLYLQEYSN 555
              T   + +++ EY   +     LFD    Y+++ +KR+   EG    Q ++   EY +
Sbjct: 76  DVITTPTDIVMVIEYAGGE-----LFD----YIVE-KKRMTEDEGRRFFQQIICAIEYCH 125
Query: 556 -FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
             +++HRDLK  N+LLD+ LN KI+DFG++ +     D        G+  Y  PE +   
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVINGK 182
Query: 615 IYS-MKYDVYSFGVLL 629
           +Y+  + DV+S G++L
Sbjct: 183 LYAGPEVDVWSCGIVL 198

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP 607
           L+   + R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 182
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQ--EFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNL 493
            KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR----YVLDWQKRVNIIEGVTQGLLY 549
           +R+ G        M + E  P  SL     D +R+    ++L    R  +   V +G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP 607
           L+   + R IHRDL A N+LL      KI DFG+ +   ++ D       R V  + +  
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 182
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K   +S   D + FGV L ++ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E ++ 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 211
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYL----FDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           G C   + + +++  Y+ +  L  ++     +P  + ++ +  +V       +G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPE 609
            ++ + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALE 266
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            ++   ++ K DV+SFGVLL ++++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 157
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E ++ 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 216
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 150
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E ++ 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 209
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E ++ 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 212
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+ D  +  TG  +    ++  E ++ 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 211
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A    +D+
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDI 207
Query: 592 DEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  +  +   T G +P     PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 208 NNIDXXKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVL 531
             + +H N++ +LG CT+     +I EY    +L  YL              + +    +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A    +D+
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDI 207
Query: 592 DEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  +  +   T G +P     PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 208 NNIDXXKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 491 VNLLRVLGYCTERDENMLI-YEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLL 548
              ++ L +C + DE +     Y  N  L  Y    IR+    D          +   L 
Sbjct: 97  PFFVK-LYFCFQDDEKLYFGLSYAKNGELLKY----IRKIGSFDETCTRFYTAEIVSALE 151
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VGT  YV P
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +       D+++ G ++ Q+++
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 23/191 (12%)
Query: 457 PRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
           P+ ++ A+KR++    Q  ++E   E+   ++  H N++        +DE  L+ + L  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 516 KSLDLYLFDPIRRYV---------LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKAS 566
            S+     D I+  V         LD      I+  V +GL YL +      IHRD+KA 
Sbjct: 93  GSV----LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAG 145
Query: 567 NILLDNELNPKISDFGMAKLFRKDVD-EANTGR--IVGTYGYVPPEYVK--KGIYSMKYD 621
           NILL  + + +I+DFG++       D   N  R   VGT  ++ PE ++  +G Y  K D
Sbjct: 146 NILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKAD 204
Query: 622 VYSFGVLLLQI 632
           ++SFG+  +++
Sbjct: 205 IWSFGITAIEL 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 403 RTPGTSTPAAEYFD----SDTPNLQVFSFSDIKAATNNFS-------SANKLGEGGFGPV 451
           R PG   P  E F+    S TP   + S + I     NF           +LG G +G V
Sbjct: 9   RNPGLKIPK-EAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVV 67
Query: 452 YK-GNLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509
            K  ++P GQ  AVKR+ AT ++Q  +    ++ ++ R               R+ ++ I
Sbjct: 68  EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 127
Query: 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRV------NIIEGVTQGLLYLQEYSNFRVIHRDL 563
              L + SLD +      + V+D  + +       I   + + L +L  +S   VIHRD+
Sbjct: 128 CMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL--HSKLSVIHRDV 180
Query: 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGIYSM 618
           K SN+L++     K+ DFG++      VD        G   Y+ PE +     +KG YS+
Sbjct: 181 KPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQKG-YSV 236
Query: 619 KYDVYSFGVLLLQI 632
           K D++S G+ ++++
Sbjct: 237 KSDIWSLGITMIEL 250

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE---EFKNEVSL 484
           D +    ++   + LG G FG V  G     G + AVK L+    + L+   + + E+  
Sbjct: 10  DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN 69
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
               +H +++++    +   +  ++ EY+    L  Y+    R   LD ++   + + + 
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQIL 126
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
            G+ Y   +    V+HRDLK  N+LLD  +N KI+DFG++ +     D        G+  
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRXSCGSPN 180
Query: 605 YVPPEYVKKGIYS-MKYDVYSFGVLLLQIIS 634
           Y  PE +   +Y+  + D++S GV+L  ++ 
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLC 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 202
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 203 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 199
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 200 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 23/191 (12%)
Query: 457 PRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
           P+ ++ A+KR++    Q  ++E   E+   ++  H N++        +DE  L+ + L  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 516 KSLDLYLFDPIRRYV---------LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKAS 566
            S+     D I+  V         LD      I+  V +GL YL +      IHRD+KA 
Sbjct: 98  GSV----LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAG 150
Query: 567 NILLDNELNPKISDFGMAKLFRKDVD-EANTGR--IVGTYGYVPPEYVK--KGIYSMKYD 621
           NILL  + + +I+DFG++       D   N  R   VGT  ++ PE ++  +G Y  K D
Sbjct: 151 NILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKAD 209
Query: 622 VYSFGVLLLQI 632
           ++SFG+  +++
Sbjct: 210 IWSFGITAIEL 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGL 547
              +++  Y T +D+  L +   Y  N  L  Y    IR+    D          +   L
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKY----IRKIGSFDETCTRFYTAEIVSAL 145
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VGT  YV 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE + +   S   D+++ G ++ Q+++
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFA-----VKRLSA 469
           D  T NL     +     T+++    +LG+G F  V +       QE+A      K+LSA
Sbjct: 12  DLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA 71
Query: 470 TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY 529
              Q LE    E  +   L+H N++R+    +E   + L+++ +    L     D + R 
Sbjct: 72  RDHQKLE---REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVARE 125
Query: 530 VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKL 586
                   + I  + + + ++ ++    ++HRDLK  N+LL ++      K++DFG+A  
Sbjct: 126 YYSEADASHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIE 182
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
            + +  +A  G   GT GY+ PE ++K  Y    D+++ GV+L
Sbjct: 183 VQGE-QQAWFG-FAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 256
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 257 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 434 TNNFSSANKLGEGGFGPVY--KGNLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARL 488
           ++ +    KLG G +G V   K  L  G E A+K   + S T+T       +EV++  +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGL 547
            H N++++  +  ++    L+ E          LFD  I R          I++ V  G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYG 604
            YL +++   ++HRDLK  N+LL+++      KI DFG++  F  +V      R+ GT  
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL-GTAY 171
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+ PE ++K  Y  K DV+S GV+L
Sbjct: 172 YIAPEVLRKK-YDEKCDVWSCGVIL 195

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ +L   ++ 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ +  K+ D  +  TG  +    ++  E ++ 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL-PVKWMALESLQT 212
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+GY+
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 356
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
            PE ++KG+ Y    D +S G +L +++      R + T + 
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 431 KAATNNFSSANKLGEGGFGPVY--KGNLPRGQEFAVK---RLSATSTQGLEEFKNEVSLT 485
           +  ++ +    KLG G +G V   K  L  G E A+K   + S T+T       +EV++ 
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVT 544
            +L H N++++  +  ++    L+ E          LFD  I R          I++ V 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVL 131
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVG 601
            G  YL +++   ++HRDLK  N+LL+++      KI DFG++  F  +V      R+ G
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL-G 185
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           T  Y+ PE ++K  Y  K DV+S GV+L
Sbjct: 186 TAYYIAPEVLRKK-YDEKCDVWSCGVIL 212

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 357
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
            PE ++KG+ Y    D +S G +L +++      R + T + 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D       GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKNTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDI-NNI 197
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 198 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1WNO|A Chain A, Crystal Structure Of A Native Chitinase From Aspergillus Fumigatus Yj- 407 Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 54/275 (19%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSA----NQQY----FSIFANSV---- 83
           GR     D+     TH++ AFA V   T ++ ++ +     + Y    +S   N+V    
Sbjct: 18  GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 77
Query: 84  ------RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
                 +++N ++K LLSI            G    +P+   +   D+  RK+F +++++
Sbjct: 78  KQLYLLKKQNRNLKVLLSI------------GGWTYSPNFAPAASTDAG-RKNFAKTAVK 124
Query: 138 TARLYGFQGIDLFWLWP-NSTDLNSLGIL-------LDEWKASASDQPELTLSMAVRYSP 189
             +  GF G+D+ W +P N    N   +L       LD + A+ +      L++A    P
Sbjct: 125 LLQDLGFDGLDIDWEYPENDQQANDFVLLLREVRTALDSYSAANAGGQHFLLTVASPAGP 184
Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-ISTDFGIREWLR 248
               V + +  M + L++ +L+AYDY   S  +++G  A +YN +SN +ST F  +  L 
Sbjct: 185 DKIKVLH-LKDMDQQLDFWNLMAYDY-AGSFSSLSGHQANVYNDTSNPLSTPFNTQTALD 242
Query: 249 ----RGFPANKLVLG--------ARASGPGITIDG 271
                G PANK+VLG        A   GPG   +G
Sbjct: 243 LYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNG 277

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 357
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
            PE ++KG+ Y    D +S G +L +++      R + T + 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +L L+   N  V++RDLK +NILLD   + +ISD G+A  F K    A+    VGT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 357
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
            PE ++KG+ Y    D +S G +L +++      R + T + 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I EY    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      +I+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1W9P|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitors Against Aspergillus Fumigatus, Human And Bacterial Chitinasefra Length = 433

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 54/275 (19%)
Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSA----NQQY----FSIFANSV---- 83
           GR     D+     TH++ AFA V   T ++ ++ +     + Y    +S   N+V    
Sbjct: 56  GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 115
Query: 84  ------RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
                 +++N ++K LLSI            G    +P+   +   D+  RK+F +++++
Sbjct: 116 KQLYLLKKQNRNLKVLLSI------------GGWTYSPNFAPAASTDAG-RKNFAKTAVK 162
Query: 138 TARLYGFQGIDLFWLWP-NSTDLNSLGIL-------LDEWKASASDQPELTLSMAVRYSP 189
             +  GF G+D+ W +P N    N   +L       LD + A+ +      L++A    P
Sbjct: 163 LLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGP 222
Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-ISTDFGIREWLR 248
               V + +  M + L++ +L+AYDY   S  +++G  A +YN +SN +ST F  +  L 
Sbjct: 223 DKIKVLH-LKDMDQQLDFWNLMAYDY-AGSFSSLSGHQANVYNDTSNPLSTPFNTQTALD 280
Query: 249 ----RGFPANKLVLG--------ARASGPGITIDG 271
                G PANK+VLG        A   GPG   +G
Sbjct: 281 LYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNG 315

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKNEVSL 484
           SD +    N+     +G+G F  V    ++  G+E A+K +  T      L++   EV +
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 64
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           LI EY     +  YL    R    + + +   I    
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 124
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           Q   Y  +    R++HRDLKA N+LLD ++N KI+DFG +       +E   G  + T+ 
Sbjct: 125 Q---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFC 171
Query: 605 YVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
             PP    +     KY     DV+S GV+L  ++S
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+    +  TG  +    ++  E ++ 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV-KWMALESLQT 210
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTA 486
           K    +F     LGEG F  V     L   +E+A+K L          +     E  + +
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 487 RLQHVNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRV 537
           RL H   +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +     
Sbjct: 63  RLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----- 115
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
                +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A   
Sbjct: 116 -----IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             VGT  YV PE + +       D+++ G ++ Q+++
Sbjct: 168 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTA 486
           K    +F     LGEG F  V     L   +E+A+K L          +     E  + +
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 487 RLQHVNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRV 537
           RL H   +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +     
Sbjct: 64  RLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----- 116
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
                +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A   
Sbjct: 117 -----IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             VGT  YV PE + +       D+++ G ++ Q+++
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKN 480
           + S +D +    N+     +G+G F  V    ++  G+E AVK +  T  +   L++   
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           EV +   L H N++++           L+ EY     +  YL    R  + + + R    
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFR 121
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
           + V+      Q+Y    ++HRDLKA N+LLD ++N KI+DFG +       +E   G  +
Sbjct: 122 QIVSAVQYCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFS-------NEFTVGNKL 170
Query: 601 GTYGYVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
            T+   PP    +     KY     DV+S GV+L  ++S
Sbjct: 171 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTA 486
           K    +F     LGEG F  V     L   +E+A+K L          +     E  + +
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 487 RLQHVNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRV 537
           RL H   +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +     
Sbjct: 65  RLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----- 117
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
                +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A   
Sbjct: 118 -----IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             VGT  YV PE + +       D+++ G ++ Q+++
Sbjct: 170 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTA 486
           K    +F     LGEG F  V     L   +E+A+K L          +     E  + +
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 487 RLQHVNLLRVLGYCTERDENMLIY--EYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGV 543
           RL H   +++  Y T +D+  L +   Y  N  L  Y    IR+    D          +
Sbjct: 66  RLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKY----IRKIGSFDETCTRFYTAEI 119
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
              L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VGT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            YV PE + +       D+++ G ++ Q+++
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKN 480
           + S +D +    N+     +G+G F  V    ++  G+E A+K +  T      L++   
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR 63
Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           EV +   L H N++++           LI EY     +  YL    R    + + +   I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
               Q   Y  +    R++HRDLKA N+LLD ++N KI+DFG +  F             
Sbjct: 124 VSAVQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC 174
Query: 601 GTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIIS 634
           G   Y  PE  +   Y   + DV+S GV+L  ++S
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE---EFKNE 481
           S  D +    ++   + LG G FG V  G     G + AVK L+    + L+   + K E
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           +      +H +++++    +   +  ++ EY+    L    FD I ++      RV  +E
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL----FDYICKH-----GRVEEME 112
Query: 542 G--VTQGLLYLQEYSN-FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
              + Q +L   +Y +   V+HRDLK  N+LLD  +N KI+DFG++ +   D +   T  
Sbjct: 113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS- 170
Query: 599 IVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISS 635
             G+  Y  PE +   +Y+  + D++S GV+L  ++  
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGL 547
              +++  Y T +D+  L +   Y  N  L  Y    IR+    D          +   L
Sbjct: 95  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKY----IRKIGSFDETCTRFYTAEIVSAL 148
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VGT  YV 
Sbjct: 149 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE + +       D+++ G ++ Q+++
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 74  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 122
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 123 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 211

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 141
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 142 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 24/216 (11%)
Query: 430 IKAATNNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTAR 487
           ++   ++     +LG G +G V K  ++P GQ  AVKR+ AT ++Q  +    ++ ++ R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV------NIIE 541
                          R+ ++ I   L + SLD +      + V+D  + +       I  
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAV 116
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            + + L +L  +S   VIHRD+K SN+L++     K+ DFG++      VD+       G
Sbjct: 117 SIVKALEHL--HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAG 171
Query: 602 TYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQI 632
              Y+ PE +     +KG YS+K D++S G+ ++++
Sbjct: 172 CKPYMAPERINPELNQKG-YSVKSDIWSLGITMIEL 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 141
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 142 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 137
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 138 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 437 FSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLL 494
           F     LG G F  V        G+ FAVK +   + +G E   +NE+++  +++H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEY 553
            +       +   L+ + +    L    FD I       +K  + +I  V   + YL   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 554 SNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
               ++HRDLK  N+L    D E    ISDFG++K+  K  D  +T    GT GYV PE 
Sbjct: 140 G---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTA--CGTPGYVAPEV 193
Query: 611 VKKGIYSMKYDVYSFGVL 628
           + +  YS   D +S GV+
Sbjct: 194 LAQKPYSKAVDCWSIGVI 211

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 137
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 138 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGP-VYKGNLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F   V    L   +E+A+K L          +     E  + +RL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE---EFKNE 481
           S  D +    ++   + LG G FG V  G     G + AVK L+    + L+   + K E
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           +      +H +++++    +   +  ++ EY+    L    FD I ++      RV  +E
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL----FDYICKH-----GRVEEME 112
Query: 542 G--VTQGLLYLQEYSN-FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
              + Q +L   +Y +   V+HRDLK  N+LLD  +N KI+DFG++ +     D      
Sbjct: 113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRD 169
Query: 599 IVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISS 635
             G+  Y  PE +   +Y+  + D++S GV+L  ++  
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQH 490
            +F     LGEG F  V     L   +E+A+K L          +     E  + +RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 491 VNLLRVLGYCTERDENMLIY--EYLPNKSLDLYL-----FDPI--RRYVLDWQKRVNIIE 541
              +++  Y T +D+  L +   Y  N  L  Y+     FD    R Y  +         
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +   L YL       +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VG
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  YV PE + +       D+++ G ++ Q+++
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I  Y    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------ 488
           N  S    LG G FG V +        + + +  A  T  ++  K    LT R       
Sbjct: 23  NRLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 489 -------QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
                   H+N++ +LG CT     ++I EY      DL  F   +R      K    I 
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIM 135
Query: 542 G-----------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                             V +G+ +L   ++   IHRDL A NILL +    KI DFG+A
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  + D +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 170
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 228
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT 250

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------ 488
           N  S    LG G FG V +        + + +  A  T  ++  K    LT R       
Sbjct: 46  NRLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 489 -------QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
                   H+N++ +LG CT     ++I EY      DL  F   +R      K    I 
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIM 158
Query: 542 G-----------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                             V +G+ +L   ++   IHRDL A NILL +    KI DFG+A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  + D +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G     
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G     
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARL- 488
           +   +NF     LG+G FG V    +   G  +AVK L       L++   E ++T +  
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRI 76
Query: 489 -----QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
                 H  L ++       D    + E++    L ++     RR+  D  +       +
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRF--DEARARFYAAEI 133
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
              L++L +     +I+RDLK  N+LLD+E + K++DFGM K      +   T    GT 
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTP 188
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS 635
            Y+ PE +++ +Y    D ++ GVLL +++  
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 210
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 431 KAATNNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTA 486
           K +  +F     LG G FG V+   +   G+ +A+K L        + +E   +E  + +
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG--VT 544
            + H  ++R+ G   +  +  +I +Y+    L    F  +R+     Q+  N +      
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKS----QRFPNPVAKFYAA 113
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           +  L L+   +  +I+RDLK  NILLD   + KI+DFG AK +  DV    T  + GT  
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDV----TYXLCGTPD 168
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           Y+ PE V    Y+   D +SFG+L+ ++++
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G     
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   +Y+++ DV+SFGVLL +I S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 171
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 229
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT 251

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+    +  TG  +    ++  E ++ 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQT 210
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 150
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 208
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 147
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+    +  TG  +    ++  E ++ 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQT 206
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 144
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 202
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT 224

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 431 KAATNNFSSANKLGEGGFGPVY---KGNLP-RGQEFAVKRLSATSTQGLEEF--KNEVSL 484
           KA  ++F     LG+G FG V+   K   P  G  +A+K L   + +  +    K E  +
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 485 TARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
            A + H  +++ L Y  + +  + LI ++L    L    F  + + V+  ++ V     +
Sbjct: 84  LADVNHPFVVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--L 136
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGT 602
            +  L L    +  +I+RDLK  NILLD E + K++DFG++K   + +D E       GT
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGT 193
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             Y+ PE V +  +S   D +S+GVL+ ++++
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------ 488
           N  S    LG G FG V +        + + +  A  T  ++  K    LT R       
Sbjct: 39  NRLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 93
Query: 489 -------QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
                   H+N++ +LG CT     ++I EY      DL  F   +R      K    I 
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIM 151
Query: 542 G-----------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                             V +G+ +L   ++   IHRDL A NILL +    KI DFG+A
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 208
Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  + D +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S
Sbjct: 209 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN--TGRIVGTYGYVPPEYVKK 613
           + +HRDL A N +LD +   K++DFG+A+ ++ K+    +  TG  +    ++  E ++ 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQT 211
Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             ++ K DV+SFGVLL ++++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVL 497
           +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H N+L +L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           G C   + + +++  Y+ +  L  ++ +      +  +  +     V +G+ YL   ++ 
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 149
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
           + +HRDL A N +LD +   K++DFG+A+ ++ K+   V      ++     ++  E ++
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--PVKWMALESLQ 207
Query: 613 KGIYSMKYDVYSFGVLLLQIIS 634
              ++ K DV+SFGVLL ++++
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT 229

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 435 NNFSSANKLGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +  +    LGEG FG V         K         AVK L   +T+  L +  +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLD--------- 532
             + +H N++ +LG CT+     +I  Y    +L  YL     P   Y  D         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 533 -WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            ++  V+    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A+    ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 592 D---EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           D   +   GR+     ++ PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 211 DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV 491
              +     ++G G +G V K  + P GQ  AVKR+ +T  +     K +  L   L  V
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-----KEQKQLLMDLDVV 74
Query: 492 NLLRVLGYCTE------RDENMLIYEYLPNKSLDLY-------LFDPIRRYVLDWQKRVN 538
                  Y  +      R+ +  I   L + S D +       L D I   +L       
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----K 129
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           I     + L +L+E  N ++IHRD+K SNILLD   N K+ DFG++      VD     R
Sbjct: 130 ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTR 184
Query: 599 IVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQIISSK 636
             G   Y+ PE +     ++G Y ++ DV+S G+ L ++ + +
Sbjct: 185 DAGCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGR 226

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------ 488
           N  S    LG G FG V +        + + +  A  T  ++  K    LT R       
Sbjct: 41  NRLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 95
Query: 489 -------QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
                   H+N++ +LG CT     ++I EY      DL  F   +R      K    I 
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIM 153
Query: 542 G-----------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                             V +G+ +L   ++   IHRDL A NILL +    KI DFG+A
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  + D +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           +          ++G+G +G V+ G   RG++ AVK    T        + E+  T  ++H
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRH 90
Query: 491 VNLLRVLGYCTERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
            N+L  +    +      +  LI +Y  N SL    +D ++   LD +  + +      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 547 LLYLQE-----YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRI 599
           L +L            + HRDLK+ NIL+       I+D G+A  F  D +E +      
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 600 VGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQI 632
           VGT  Y+PPE + + +       Y M  D+YSFG++L ++
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMA-DMYSFGLILWEV 245

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 443 LGEGGFGPVY--KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           LG G F  V+  K  L  G+ FA+K +  +        +NE+++  +++H N++ +    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
                  L+ + +    L    FD I  R V   +    +I+ V   + YL E     ++
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 560 HRDLKASNIL-LDNELNPKI--SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           HRDLK  N+L L  E N KI  +DFG++K+ +  +         GT GYV PE + +  Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPY 184
Query: 617 SMKYDVYSFGVL 628
           S   D +S GV+
Sbjct: 185 SKAVDCWSIGVI 196

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------ 488
           N  S    LG G FG V +        + + +  A  T  ++  K    LT R       
Sbjct: 46  NRLSFGKTLGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 489 -------QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
                   H+N++ +LG CT     ++I EY      DL  F   +R      K    I 
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIM 158
Query: 542 G-----------------VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
                             V +G+ +L   ++   IHRDL A NILL +    KI DFG+A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +  + D +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   S+ + IHRDL A NILL      KI DFG+A+   K+ D    G     
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             ++ PE +   IYS K DV+S+GVLL +I S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVN 492
           N+     +G+G F  V    ++  G+E AVK +  T  ++  L++   EV +   L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++++           L+ EY     +  YL          W K         Q +  +Q 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV------AHGWMKEKEARAKFRQIVSAVQY 121
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
                ++HRDLKA N+LLD ++N KI+DFG +       +E   G  + T+   PP    
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAP 174
Query: 613 KGIYSMKY-----DVYSFGVLLLQIIS 634
           +     KY     DV+S GV+L  ++S
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVS 201

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 437 FSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLL 494
           F    KLG G FG V+       G E  +K ++   +Q  +E+ + E+ +   L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY----- 549
           ++     +     ++ E      L       + R V    +   + EG    L+      
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGEL-------LERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           L  + +  V+H+DLK  NIL   + +P    KI DFG+A+LF+ D    N     GT  Y
Sbjct: 137 LAYFHSQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALY 192
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE  K+ + + K D++S GV++
Sbjct: 193 MAPEVFKRDV-TFKCDIWSAGVVM 215

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 112/236 (47%), Gaps = 23/236 (9%)
Query: 414 YFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST 472
           YF S  P  ++  ++  K     +   + +G G    V +  +   G EFAVK +  T+ 
Sbjct: 73  YFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE 132
Query: 473 QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRR-YVL 531
           +   E   EV    R +   L +V G+       + + +   + S    +FD +R+  + 
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGH----PHIITLIDSYESSSFMFLVFDLMRKGELF 188
Query: 532 DW-QKRVNIIEGVTQGLLY-LQEYSNF----RVIHRDLKASNILLDNELNPKISDFGMAK 585
           D+  ++V + E  T+ ++  L E  +F     ++HRDLK  NILLD+ +  ++SDFG   
Sbjct: 189 DYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG--- 245
Query: 586 LFRKDVDEANTGR-IVGTYGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIIS 634
            F   ++     R + GT GY+ PE +K  +      Y  + D+++ GV+L  +++
Sbjct: 246 -FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 405 PGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQE-FA 463
           PGT++   +Y+            S+  A ++ F   ++LG G    VY+      Q+ +A
Sbjct: 32  PGTASLVPDYW---------IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYA 82
Query: 464 VKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF 523
           +K L  T  + +   + E+ +  RL H N++++        E  L+ E +    L    F
Sbjct: 83  LKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----F 136
Query: 524 DPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKIS 579
           D I  +     +   + ++ + + + YL E     ++HRDLK  N+L      +   KI+
Sbjct: 137 DRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIA 193
Query: 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628
           DFG++K+    V       + GT GY  PE ++   Y  + D++S G++
Sbjct: 194 DFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 431 KAATNNFSSANKLGEGGFGPVY-----KGNLPRGQEFAVKRLSATSTQGLEEF--KNEVS 483
           KA  + F     LG+G FG V+      G+  R Q +A+K L   + +  +    K E  
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMERD 79
Query: 484 LTARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
           +   + H  +++ L Y  + +  + LI ++L    L    F  + + V+  ++ V     
Sbjct: 80  ILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY-- 132
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVG 601
           + +  L L    +  +I+RDLK  NILLD E + K++DFG++K   + +D E       G
Sbjct: 133 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCG 189
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  Y+ PE V +  ++   D +SFGVL+ ++++
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 431 KAATNNFSSANKLGEGGFGPVY-----KGNLPRGQEFAVKRLSATSTQGLEEF--KNEVS 483
           KA  + F     LG+G FG V+      G+  R Q +A+K L   + +  +    K E  
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 484 LTARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
           +   + H  +++ L Y  + +  + LI ++L    L    F  + + V+  ++ V     
Sbjct: 79  ILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY-- 131
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVG 601
           + +  L L    +  +I+RDLK  NILLD E + K++DFG++K   + +D E       G
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCG 188
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  Y+ PE V +  ++   D +SFGVL+ ++++
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 431 KAATNNFSSANKLGEGGFGPVY-----KGNLPRGQEFAVKRLSATSTQGLEEF--KNEVS 483
           KA  + F     LG+G FG V+      G+  R Q +A+K L   + +  +    K E  
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDAR-QLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 484 LTARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
           +   + H  +++ L Y  + +  + LI ++L    L    F  + + V+  ++ V     
Sbjct: 79  ILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY-- 131
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVG 601
           + +  L L    +  +I+RDLK  NILLD E + K++DFG++K   + +D E       G
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCG 188
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T  Y+ PE V +  ++   D +SFGVL+ ++++
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 441 NKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +KLGEG +  VYKG      NL   +E  ++         +     EVSL   L+H N++
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            +           L++EYL +K L  YL D     +++       +  + +GL Y     
Sbjct: 64  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ- 119
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
             +V+HRDLK  N+L++     K++DFG+A+   K +        V T  Y PP+ +   
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 615 I-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
             YS + D++  G +  ++ + +         E L+F+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 65
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 178
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 179 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 212

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPA 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 70
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 183
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 184 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 64
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 177
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 178 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 90
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 203
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 204 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AV+ +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R  + + + R    + V+
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK--LFRKDVDEANTGRIVGT 602
                 Q++    ++HRDLKA N+LLD ++N KI+DFG +    F   +DE       G+
Sbjct: 125 AVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE-----FCGS 175
Query: 603 YGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIIS 634
             Y  PE  +   Y   + DV+S GV+L  ++S
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AVK +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R  + + + R    + V+
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
                 Q++    ++HRDLKA N+LLD ++N KI+DFG +       +E   G  + T+ 
Sbjct: 125 AVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFC 173
Query: 605 YVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
             PP    +     KY     DV+S GV+L  ++S
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 67
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 180
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 181 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTA 486
           ++KA  ++     +LG G +G V K  ++P GQ  AVKR+ AT ++Q  +    ++ ++ 
Sbjct: 30  EVKA--DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISX 87
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV------NII 540
           R               R+ ++ I   L + SLD +      + V+D  + +       I 
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFY-----KQVIDKGQTIPEDILGKIA 142
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + + L +L  +S   VIHRD+K SN+L++     K  DFG++      VD+       
Sbjct: 143 VSIVKALEHL--HSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDA 197
Query: 601 GTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQI 632
           G   Y  PE +     +KG YS+K D++S G+  +++
Sbjct: 198 GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIEL 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AVK +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R    + + +   I    
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 545 QGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           Q       Y + + ++HRDLKA N+LLD ++N KI+DFG +       +E   G  + T+
Sbjct: 127 Q-------YCHQKFIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTF 172
Query: 604 GYVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
              PP    +     KY     DV+S GV+L  ++S
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL +LQ      +I+RDLK  N++LD+E + KI+DFGM K      D   T    GT  Y
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 508
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
           + PE +    Y    D ++FGVLL ++++ +  A + G  E+  F
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELF 551

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH-- 490
           +    KLG+G +G V+K    R G+  AVK++      ST     F+  + LT    H  
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            VNLL VL    +RD   L+++Y+     DL+    IR  +L+   +  ++  + + + Y
Sbjct: 71  IVNLLNVLRADNDRDV-YLVFDYM---ETDLHAV--IRANILEPVHKQYVVYQLIKVIKY 124
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---RK----------------D 590
           L       ++HRD+K SNILL+ E + K++DFG+++ F   R+                D
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            D+      V T  Y  PE +     Y+   D++S G +L +I+  K
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L+E ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG+AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLRVLGYCT 501
           +G+G FG V++G   RG+E AVK  S+   +    F+  E+  T  L+H N   +LG+  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHEN---ILGFIA 103
Query: 502 ERDEN-------MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--- 551
             +++        L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 552 --EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYG 604
                   + HRDLK+ NIL+       I+D G+A   R D     +D A   R VGT  
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR-VGTKR 216
Query: 605 YVPPEYVKKGIYSMKY-------DVYSFGVLLLQI 632
           Y+ PE +   I +MK+       D+Y+ G++  +I
Sbjct: 217 YMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEI 250

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 32/238 (13%)
Query: 425 FSFSDIKAAT--NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFK- 479
            S S   +AT  + +    KLGEG +G VYK  +    +  A+KR+      +G+     
Sbjct: 22  MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI 81
Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI 539
            EVSL   LQH N++ +           LI+EY  N          +++Y+    K  ++
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND---------LKKYM---DKNPDV 129
Query: 540 IEGVTQGLLY-LQEYSNF----RVIHRDLKASNILL---DNELNP--KISDFGMAKLFRK 589
              V +  LY L    NF    R +HRDLK  N+LL   D    P  KI DFG+A+ F  
Sbjct: 130 SMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 590 DVDEANTGRIVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
            + +  T  I+ T  Y PPE  +    YS   D++S   +  +++   +   + G SE
Sbjct: 190 PIRQF-THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML--MKTPLFPGDSE 243

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 57
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 58  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 114
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +DE      VG
Sbjct: 115 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEM-ANEFVG 168
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 128
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 181
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL +LQ      +I+RDLK  N++LD+E + KI+DFGM K      D   T    GT  Y
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 187
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
           + PE +    Y    D ++FGVLL ++++ +  A + G  E+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDED 227

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 128
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 181
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-----EV 482
           D+K+    +   + LGEG F  VYK  +    Q  A+K++        ++  N     E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            L   L H N++ +L     +    L+++++     DL +       VL        +  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
             QGL YL ++    ++HRDLK +N+LLD     K++DFG+AK F    + A   ++V  
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVVTR 176
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           +   P       +Y +  D+++ G +L +++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 106/246 (43%), Gaps = 28/246 (11%)
Query: 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQ----EFAVKRLSA--TSTQGLEEFKN 480
             D+      F+    LG+G FG V +  L +      + AVK L A   ++  +EEF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 481 EVSLTARLQHVNLLRVLGYCTERDEN------MLIYEYLPNKSLDLYLF------DPIRR 528
           E +      H ++ +++G              M+I  ++ +  L  +L       +P   
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP--- 131
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLF 587
           + L  Q  V  +  +  G+ YL   S+   IHRDL A N +L  ++   ++DFG++ K++
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             D         +    ++  E +   +Y++  DV++FGV + +I++  R    Y   EN
Sbjct: 189 SGDYYRQGCASKLPV-KWLALESLADNLYTVHSDVWAFGVTMWEIMT--RGQTPYAGIEN 245
Query: 648 LNFLEY 653
                Y
Sbjct: 246 AEIYNY 251

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AV+ +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R  + + + R    + V+
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVS 124
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
                 Q++    ++HRDLKA N+LLD ++N KI+DFG +       +E   G  + T+ 
Sbjct: 125 AVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFC 173
Query: 605 YVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
             PP    +     KY     DV+S GV+L  ++S
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  FA+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L Y  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  FA+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L Y  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1JND|A Chain A, Crystal Structure Of Imaginal Disc Growth Factor-2 Length = 420

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/393 (20%), Positives = 149/393 (37%), Gaps = 107/393 (27%)
Query: 40  PLSDINSALFTHLICAFAEVDSSTYQLSISSAN----QQYFSIFANSVRRKNPSIKTLLS 95
           P  +I     +HL+  +A +     Q    + N    +  FS    S++RK P +K LLS
Sbjct: 24  PDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSE-VTSLKRKYPHLKVLLS 82
Query: 96  IWNGQNSTYQSILGNKNINPS----VLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFW 151
           +            G+ +I+P      +  + G+   +  FI S+    + YGF G+DL +
Sbjct: 83  VG-----------GDHDIDPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAY 131
Query: 152 LWPNSTDLNSLGILLDEWKA--------------SASDQPELT----------------L 181
            +P +      G L   WK+              +A  + + T                L
Sbjct: 132 QFPKNKPRKVHGDLGLAWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRADGFLL 191
Query: 182 SMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA-LYNPS------ 234
           S+ V  +  + T  + I ++   +++ +L  +D+  P++      ++A +Y+P       
Sbjct: 192 SLTVLPN-VNSTWYFDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYHPDGSKDRL 250
Query: 235 SNISTDFGIREWLRRGFPANKLVLGARASG-----------------PGITIDGSMGYKF 277
           ++++ DF +  WL +GFP+NK+ LG    G                 P  +     G++ 
Sbjct: 251 AHLNADFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQS 310
Query: 278 IRAFIQNYGYGAAPVYNASYVVNLFTSG-----------------------------ATW 308
            +  + +Y      + N     N F  G                               W
Sbjct: 311 QKPGLLSYAEICGKLSNPQ---NQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIW 367
Query: 309 INFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           +++D  ++   K +YA+ KNL G   F LS DD
Sbjct: 368 VSYDDPDSASNKAAYARVKNLGGVALFDLSYDD 400

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     +G G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  FA+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L Y  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AVK +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R    + + +   I    
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 545 QGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           Q       Y + + ++HRDLKA N+LLD ++N KI+DFG +       +E   G  +  +
Sbjct: 127 Q-------YCHQKFIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDAF 172
Query: 604 GYVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
              PP    +     KY     DV+S GV+L  ++S
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     +G G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 17/194 (8%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
            +LG G FG V++      G+ F  K ++          KNE+S+  +L H  L+ +   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
             ++ E +LI E+L        LFD I    Y +   + +N +    +GL ++ E+S   
Sbjct: 117 FEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 558 VIHRDLKASNILLDNEL--NPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           ++H D+K  NI+ + +   + KI DFG+A KL   ++ +  T     T  +  PE V + 
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDRE 225
Query: 615 IYSMKYDVYSFGVL 628
                 D+++ GVL
Sbjct: 226 PVGFYTDMWAIGVL 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L+E ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   +++DFG+AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           + +  +LG G F  V K       L    +F  KR + +S +G+  E+ + EVS+   +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      + + +LI E +    L  +L +   +  L  ++    ++ +  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPK----ISDFGMAKLFRKDVDEANTGR-IVGTYG 604
           L    + ++ H DLK  NI+L +   PK    I DFG+A      +D  N  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KIDFGNEFKNIFGTPE 182
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE V      ++ D++S GV+   ++S
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLS---ATSTQGLEEFKNEVSLTA 486
           +    +F+    LG+G FG V   +    +E +A+K L          +E    E  + A
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 487 RLQHVNLLRVLGYCTER-DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
            L     L  L  C +  D    + EY+    L +Y    + ++     + V     ++ 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKF--KEPQAVFYAAEISI 131
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL +L +     +I+RDLK  N++LD+E + KI+DFGM K     +D   T    GT  Y
Sbjct: 132 GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDY 186
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           + PE +    Y    D +++GVLL ++++ +
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     +G G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 59/105 (56%), Gaps = 5/105 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++  L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D  +T    GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             Y+ PE ++   Y    D ++ GVL+ ++++ +      G+S+N
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 73
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 74  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 130
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      + ++     VG
Sbjct: 131 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 184
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 215

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
           LG G F  V      R Q+  A+K ++  + +G E   +NE+++  +++H N++ +    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEYSNFRVI 559
                  LI + +    L    FD I       ++  + +I  V   + YL    +  ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIV 138
Query: 560 HRDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEANTGRIV----GTYGYVPPEYVK 612
           HRDLK  N+L   LD +    ISDFG++K+        + G ++    GT GYV PE + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 613 KGIYSMKYDVYSFGVL 628
           +  YS   D +S GV+
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1LL7|A Chain A, Structure Of The E171q Mutant Of C. Immitis Chitinase 1 Length = 392

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 53/277 (19%)
Query: 36  GREFPLSDINSALFTHLICAFAEVD-------SSTYQLSISSANQQYFSIFANSV----- 83
           GR     D+ +  FTH++ AFA +        S T+  +        +    N+V     
Sbjct: 16  GRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIK 75
Query: 84  -----RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
                ++ N ++KTLLSI            G    +P+   +       RK F ++S++ 
Sbjct: 76  QMYLLKKNNRNLKTLLSI------------GGWTYSPN-FKTPASTEEGRKKFADTSLKL 122
Query: 139 ARLYGFQGIDLFWLWP-NSTDLNSLGIL-------LDEWKASASDQPELTLSMAVRYSPT 190
            +  GF GID+ W +P +    N   +L       LD + A   +  +  L++A    P 
Sbjct: 123 MKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQ 182
Query: 191 HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTG----IHAALYNPSSN-ISTDFGIRE 245
           +      +  M K L++ +L+AYD+   S + V+G    +  +   P S   S+D  +++
Sbjct: 183 NYN-KLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPSTTKPESTPFSSDKAVKD 240
Query: 246 WLRRGFPANKLVLG--------ARASGPGITIDGSMG 274
           +++ G PANK+VLG        A   G G + +G  G
Sbjct: 241 YIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGG 277

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 116
Query: 494 LRVLGYCTER------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 117 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 173
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 174 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 227
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|1D2K|A Chain A, C. Immitis Chitinase 1 At 2.2 Angstroms Resolution Length = 392

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 53/277 (19%)
Query: 36  GREFPLSDINSALFTHLICAFAEVD-------SSTYQLSISSANQQYFSIFANSV----- 83
           GR     D+ +  FTH++ AFA +        S T+  +        +    N+V     
Sbjct: 16  GRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIK 75
Query: 84  -----RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
                ++ N ++KTLLSI            G    +P+   +       RK F ++S++ 
Sbjct: 76  QMYLLKKNNRNLKTLLSI------------GGWTYSPN-FKTPASTEEGRKKFADTSLKL 122
Query: 139 ARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYSPT 190
            +  GF GID+ W +P            L +    LD + A   +  +  L++A    P 
Sbjct: 123 MKDLGFDGIDIDWEYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQ 182
Query: 191 HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTG----IHAALYNPSSN-ISTDFGIRE 245
           +      +  M K L++ +L+AYD+   S + V+G    +  +   P S   S+D  +++
Sbjct: 183 NYN-KLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPSTTKPESTPFSSDKAVKD 240
Query: 246 WLRRGFPANKLVLG--------ARASGPGITIDGSMG 274
           +++ G PANK+VLG        A   G G + +G  G
Sbjct: 241 YIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGG 277

>pdb|1LL6|A Chain A, Structure Of The D169n Mutant Of C. Immitis Chitinase 1 Length = 392

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 53/277 (19%)
Query: 36  GREFPLSDINSALFTHLICAFAEVD-------SSTYQLSISSANQQYFSIFANSV----- 83
           GR     D+ +  FTH++ AFA +        S T+  +        +    N+V     
Sbjct: 16  GRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIK 75
Query: 84  -----RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
                ++ N ++KTLLSI            G    +P+   +       RK F ++S++ 
Sbjct: 76  QMYLLKKNNRNLKTLLSI------------GGWTYSPN-FKTPASTEEGRKKFADTSLKL 122
Query: 139 ARLYGFQGIDLFWLWP-NSTDLNSLGIL-------LDEWKASASDQPELTLSMAVRYSPT 190
            +  GF GID+ W +P +    N   +L       LD + A   +  +  L++A    P 
Sbjct: 123 MKDLGFDGIDINWEYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQ 182
Query: 191 HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTG----IHAALYNPSSN-ISTDFGIRE 245
           +      +  M K L++ +L+AYD+   S + V+G    +  +   P S   S+D  +++
Sbjct: 183 NYN-KLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPSTTKPESTPFSSDKAVKD 240
Query: 246 WLRRGFPANKLVLG--------ARASGPGITIDGSMG 274
           +++ G PANK+VLG        A   G G + +G  G
Sbjct: 241 YIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGG 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
           LG G F  V      R Q+  A+K ++  + +G E   +NE+++  +++H N++ +    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEYSNFRVI 559
                  LI + +    L    FD I       ++  + +I  V   + YL    +  ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIV 138
Query: 560 HRDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEANTGRIV----GTYGYVPPEYVK 612
           HRDLK  N+L   LD +    ISDFG++K+        + G ++    GT GYV PE + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 613 KGIYSMKYDVYSFGVL 628
           +  YS   D +S GV+
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 440 ANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVN 492
             +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ YL  
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 553 YSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
               ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +V P
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E V      ++ D++S GV+   ++S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 54
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 165
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++  L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D   T    GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGT 184
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             Y+ PE ++   Y    D ++ GVL+ ++++ +      G+S+N
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 229

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 137
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEYLA 192
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 149 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 204 MLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 149
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 150 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 205 MLNSKG-YTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 140
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 141 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 196 MLNSKG-YTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 54
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 165
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 54
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 165
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG---RIVGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG     V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG---RIVGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG     V T  Y  PE 
Sbjct: 149 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 204 MLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 197 MLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
           LG G F  V      R Q+  A+K ++  + +G E   +NE+++  +++H N++ +    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEYSNFRVI 559
                  LI + +    L    FD I       ++  + +I  V   + YL    +  ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIV 138
Query: 560 HRDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEANTGRIV----GTYGYVPPEYVK 612
           HRDLK  N+L   LD +    ISDFG++K+        + G ++    GT GYV PE + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 613 KGIYSMKYDVYSFGVL 628
           +  YS   D +S GV+
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 435 NNFSSANKLGEGGFGPVY---KGNLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARL 488
           ++F     +G+G FG V    K +  +   +A+K ++        E +N   E+ +   L
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKM--YAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG-----V 543
           +H  L+  L Y  + +E+M +        +DL L   +R ++   Q+ V+  E      +
Sbjct: 73  EHPFLVN-LWYSFQDEEDMFMV-------VDLLLGGDLRYHL---QQNVHFKEETVKLFI 121
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            + ++ L    N R+IHRD+K  NILLD   +  I+DF +A +  +   E     + GT 
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTK 178
Query: 604 GYVPPEYV--KKGI-YSMKYDVYSFGVLLLQIISSKR 637
            Y+ PE    +KG  YS   D +S GV   +++  +R
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 197 MLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSL 484
           +D +    N+     +G+G F  V    ++  G+E AVK +  T  ++  L++   EV +
Sbjct: 7   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRI 66
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
              L H N++++           L+ EY     +  YL    R    + + +   I    
Sbjct: 67  XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAV 126
Query: 545 QGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           Q       Y + + ++HRDLKA N+LLD + N KI+DFG +       +E   G  +  +
Sbjct: 127 Q-------YCHQKFIVHRDLKAENLLLDADXNIKIADFGFS-------NEFTFGNKLDAF 172
Query: 604 GYVPPEYVKKGIYSMKY-----DVYSFGVLLLQIIS 634
              PP    +     KY     DV+S GV+L  ++S
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++  L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D   T    GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGT 169
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             Y+ PE ++   Y    D ++ GVL+ ++++ +      G+S+N
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 214

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           ++  L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D   T    GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGT 173
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
             Y+ PE ++   Y    D ++ GVL+ ++++ +      G+S+N
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 440 ANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVN 492
             +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ YL  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 553 YSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
               ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +V P
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E V      ++ D++S GV+   ++S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           +    +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           L      ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEF 184
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           V PE V      ++ D++S GV+   ++S
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
           LG G F  V      R Q+  A+K ++  + +G E   +NE+++  +++H N++ +    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEYSNFRVI 559
                  LI + +    L    FD I       ++  + +I  V   + YL    +  ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIV 138
Query: 560 HRDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEANTGRIV----GTYGYVPPEYVK 612
           HRDLK  N+L   LD +    ISDFG++K+        + G ++    GT GYV PE + 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 613 KGIYSMKYDVYSFGVL 628
           +  YS   D +S GV+
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 81
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 192
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 17/236 (7%)
Query: 409 TPAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVK 465
            P A+Y DS   N  LQ           N F     LG+GGFG V    +   G+ +A K
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 466 RLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYL 522
           +L     +  +     ++    L+ VN   +  L Y  E +D   L+   +    L  ++
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 523 FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
           +  + +      + V     +  G   L++    R+++RDLK  NILLD+  + +ISD G
Sbjct: 276 YH-MGQAGFPEARAVFYAAEICCG---LEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 583 MAKLFRKDVDEANT--GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +A      V E  T  GR VGT GY+ PE VK   Y+   D ++ G LL ++I+ +
Sbjct: 332 LA----VHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 54
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 165
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V+K  + P G   A K +             E+    R Q +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----------EIKPAIRNQIIRE 54
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L    R   +  Q    +  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 165
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQ 489
           +    +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H N++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           L      ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEF 184
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           V PE V      ++ D++S GV+   ++S
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           ++F   ++LG G  G V K  + P G   A K +             E+    R Q +  
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL-----------EIKPAIRNQIIRE 64
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           L+VL  C                E  +  E++   SLD  L +  +R   +   +V+I  
Sbjct: 65  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI-- 121
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +GL YL+E    +++HRD+K SNIL+++    K+ DFG++      +  AN+   VG
Sbjct: 122 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVG 175
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           T  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-LSATSTQGLEEFK-NEVSLTARLQ 489
           +   + +   +GEG +G V K  N   G+  A+K+ L +   + +++    E+ L  +L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLD-LYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           H NL+ +L  C ++    L++E++ +  LD L LF       LD+Q     +  +  G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIG 138
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----VGTYG 604
           +   ++   +IHRD+K  NIL+      K+ DFG A+        A  G +    V T  
Sbjct: 139 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL------AAPGEVYDDEVATRW 189
Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQI 632
           Y  PE +   + Y    DV++ G L+ ++
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 17/236 (7%)
Query: 409 TPAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVK 465
            P A+Y DS   N  LQ           N F     LG+GGFG V    +   G+ +A K
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 466 RLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYL 522
           +L     +  +     ++    L+ VN   +  L Y  E +D   L+   +    L  ++
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 523 FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
           +  + +      + V     +  G   L++    R+++RDLK  NILLD+  + +ISD G
Sbjct: 276 YH-MGQAGFPEARAVFYAAEICCG---LEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 583 MAKLFRKDVDEANT--GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +A      V E  T  GR VGT GY+ PE VK   Y+   D ++ G LL ++I+ +
Sbjct: 332 LA----VHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-CT 501
           +G+G +G V++G L  G+  AVK  S+   Q     + E+  T  L+H N+L  +    T
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 502 ERDENM---LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-----EY 553
            R+ +    LI  Y  + SL    +D ++R  L+    + +      GL +L        
Sbjct: 74  SRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYV 611
               + HRD K+ N+L+ + L   I+D G+A +  +  D  + G    VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 612 KKGIYSMKY------DVYSFGVLLLQI 632
            + I +  +      D+++FG++L +I
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 440 ANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVN 492
             +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ YL  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 553 YSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
               ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +V P
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E V      ++ D++S GV+   ++S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 440 ANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVN 492
             +LG G F  V K       L    +F  KR S  S +G+  EE + EVS+  ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++ +      R + +LI E +    L  +L    ++  L  ++  + I+ +  G+ YL  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 553 YSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
               ++ H DLK  NI+L ++  P    K+ DFG+A      V+  N   I GT  +V P
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E V      ++ D++S GV+   ++S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           ++    +GEG +G V    +  R    A+K++S    Q   +    E+ +  R +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            +           +   Y+    ++  L+  ++   L        +  + +GL Y+   +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG---RIVGTYGYVPPEYV 611
              V+HRDLK SN+L++   + KI DFG+A++   D +  +TG     V T  Y  PE +
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARI--ADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK 636
              KG Y+   D++S G +L +++S++
Sbjct: 220 LNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A++++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 159
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 217
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 136
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     NL + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 148 N---VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 203 MLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIV 144
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 199
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 133
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 191
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 201 MLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 199 MLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-LSATSTQGLEEFK-NEVSLTARLQHV 491
             +    K+GEG +G V+K  N   GQ  A+K+ L +     +++    E+ +  +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT-QGLLYL 550
           NL+ +L     +    L++EY  +  L  +  D  +R V +     ++++ +T Q L  +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPE-----HLVKSITWQTLQAV 115
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE- 609
                   IHRD+K  NIL+      K+ DFG A+L     D  +    V T  Y  PE 
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPEL 173
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            V    Y    DV++ G +  +++S
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 134
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 192
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 152 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 207 MLNSKG-YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 144 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 199 MLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 403 RTPGTSTPAAEYFDS---DTPNLQVFSFSDIKAATNN--------FSSANKLGEGGFGPV 451
           R  G    AA  F+    D+P+L         ++ N         +S   ++G GG   V
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 452 YKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENM 507
           ++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  ++R+  Y      + 
Sbjct: 73  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---EITDQ 129
Query: 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLYLQEYSNFRVIHRDLK 564
            IY  +   ++DL  +   ++ +  W+++    N++E V              ++H DLK
Sbjct: 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV-------HTIHQHGIVHSDLK 182
Query: 565 ASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK---- 619
            +N L+ D  L  K+ DFG+A   + D         VGT  Y+PPE +K    S +    
Sbjct: 183 PANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 240
Query: 620 -------YDVYSFGVLL 629
                   DV+S G +L
Sbjct: 241 KSKISPKSDVWSLGCIL 257

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R+Y LD    +     ++  L YL+   + R
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 186
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 403 RTPGTSTPAAEYFDS---DTPNLQVFSFSDIKAATNN--------FSSANKLGEGGFGPV 451
           R  G    AA  F+    D+P+L         ++ N         +S   ++G GG   V
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 452 YKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENM 507
           ++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  ++R+  Y      + 
Sbjct: 73  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---EITDQ 129
Query: 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLYLQEYSNFRVIHRDLK 564
            IY  +   ++DL  +   ++ +  W+++    N++E V              ++H DLK
Sbjct: 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV-------HTIHQHGIVHSDLK 182
Query: 565 ASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK---- 619
            +N L+ D  L  K+ DFG+A   + D         VGT  Y+PPE +K    S +    
Sbjct: 183 PANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 240
Query: 620 -------YDVYSFGVLL 629
                   DV+S G +L
Sbjct: 241 KSKISPKSDVWSLGCIL 257

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 199 MLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN-EVSLTARL 488
           +A  N+  +  ++G G  G V+K    + G   AVK++  +  +  EE K   + L   L
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVL 78
Query: 489 QHVN---LLRVLGYCTERDENMLIYEYLPN--KSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           +  +   +++  G      +  +  E +    + L   +  PI   +L       +   +
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAI 133
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
            + L YL+E     VIHRD+K SNILLD     K+ DFG++      VD+    R  G  
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCA 188
Query: 604 GYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSK 636
            Y+ PE +      K  Y ++ DV+S G+ L+++ + +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R++ LD    +     ++  L YL+     R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRF 189
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 164 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 219 MLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 144
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 199
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 199 MLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 172
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 227
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 66/267 (24%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVN 492
            +F     +G GGFG V++  N      +A+KR+   + +   E+   EV   A+L+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 493 LLRV----LGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRY---------- 529
           ++R     L    E+ +  +   +L ++S D  L  P         IRR           
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 530 ----------------------VLDWQKRVNIIEGVTQGL---LYLQ-----EYSNFR-V 558
                                 + DW  R   +E    G+   +++Q     E+ + + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----------ANTGRIVGTYGYVPP 608
           +HRDLK SNI    +   K+ DFG+     +D +E          A     VGT  Y+ P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISS 635
           E +    YS K D++S G++L +++ S
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS 272

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVK----RLSATSTQGL--EEFKNEVSLTAR 487
           +++    +LG G F  V K      G+E+A K    R  ++S +G+  EE + EV++   
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           ++H N++ +      + + +LI E +    L  +L +   +  L   +    ++ +  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGV 121
Query: 548 LYLQEYSNFRVIHRDLKASNILL--DNELNPKIS--DFGMAKLFRKDVDEANTGRIVGTY 603
            YL    + R+ H DLK  NI+L   N  NP+I   DFG+A       +  N   I GT 
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 175
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +V PE V      ++ D++S GV+   ++S
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-CT 501
           +G+G +G V++G+  +G+  AVK  S+   +     + E+  T  L+H N+L  +    T
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 102
Query: 502 ERDENM---LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-----EY 553
            R  +    LI  Y    SL    +D ++   LD    + I+  +  GL +L        
Sbjct: 103 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYV 611
               + HRDLK+ NIL+       I+D G+A +  +  ++ + G    VGT  Y+ PE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 612 KKGIYS------MKYDVYSFGVLLLQI 632
            + I         + D+++FG++L ++
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 111/237 (46%), Gaps = 29/237 (12%)
Query: 410 PAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKR-L 467
           PA +Y   + P      F D     + +    K+G+G FG V+K    + GQ+ A+K+ L
Sbjct: 2   PAKQYDSVECP------FCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 52
Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENM--------LIYEYLPNKSL 518
                +G       E+ +   L+H N++ ++  C  +            L++++  +   
Sbjct: 53  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 112
Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
            L L + + ++ L   KRV  ++ +  GL Y+      +++HRD+KA+N+L+  +   K+
Sbjct: 113 GL-LSNVLVKFTLSEIKRV--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 166
Query: 579 SDFGMAKLFR--KDVDEANTGRIVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQI 632
           +DFG+A+ F   K+         V T  Y PPE  + +  Y    D++  G ++ ++
Sbjct: 167 ADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVK----RLSATSTQGL--EEFKNEVSLTAR 487
           +++    +LG G F  V K      G+E+A K    R  ++S +G+  EE + EV++   
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           ++H N++ +      + + +LI E +    L  +L +   +  L   +    ++ +  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGV 128
Query: 548 LYLQEYSNFRVIHRDLKASNILL--DNELNPKIS--DFGMAKLFRKDVDEANTGR-IVGT 602
            YL    + R+ H DLK  NI+L   N  NP+I   DFG+A      ++  N  + I GT
Sbjct: 129 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH----KIEAGNEFKNIFGT 181
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
             +V PE V      ++ D++S GV+   ++S
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-CT 501
           +G+G +G V++G+  +G+  AVK  S+   +     + E+  T  L+H N+L  +    T
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 502 ERDENM---LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-----EY 553
            R  +    LI  Y    SL    +D ++   LD    + I+  +  GL +L        
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYV 611
               + HRDLK+ NIL+       I+D G+A +  +  ++ + G    VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 612 KKGIYS------MKYDVYSFGVLLLQI 632
            + I         + D+++FG++L ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 443 LGEGGFGPVYKGNLPR----GQ----EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           LG+G F  ++KG        GQ    E  +K L        E F    S+ ++L H +L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
              G C   DEN+L+ E++   SLD YL        + W  ++ + + +   + +L+E +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 555 NFRVIHRDLKASNILLDNEL-----NP---KISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
              +IH ++ A NILL  E      NP   K+SD G++  +  KD+ +    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE---RI----PW 183
Query: 606 VPPEYVKKGI-YSMKYDVYSFGVLLLQIIS 634
           VPPE ++     ++  D +SFG  L +I S
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   YL    +   L+  ++   L        +  + +GL Y+   
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 219 MLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-CT 501
           +G+G +G V++G+  +G+  AVK  S+   +     + E+  T  L+H N+L  +    T
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 502 ERDENM---LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-----EY 553
            R  +    LI  Y    SL    +D ++   LD    + I+  +  GL +L        
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYV 611
               + HRDLK+ NIL+       I+D G+A +  +  ++ + G    VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 612 KKGIYS------MKYDVYSFGVLLLQI 632
            + I         + D+++FG++L ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 111/237 (46%), Gaps = 29/237 (12%)
Query: 410 PAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKR-L 467
           PA +Y   + P      F D     + +    K+G+G FG V+K    + GQ+ A+K+ L
Sbjct: 2   PAKQYDSVECP------FCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 52
Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENM--------LIYEYLPNKSL 518
                +G       E+ +   L+H N++ ++  C  +            L++++  +   
Sbjct: 53  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLA 112
Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
            L L + + ++ L   KRV  ++ +  GL Y+      +++HRD+KA+N+L+  +   K+
Sbjct: 113 GL-LSNVLVKFTLSEIKRV--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 166
Query: 579 SDFGMAKLFR--KDVDEANTGRIVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQI 632
           +DFG+A+ F   K+         V T  Y PPE  + +  Y    D++  G ++ ++
Sbjct: 167 ADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 410 PAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLS 468
           PA +Y   + P      F D     + +    K+G+G FG V+K    + GQ+ A+K++ 
Sbjct: 2   PAKQYDSVECP------FCD---EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 52
Query: 469 ATSTQGLEEFK----NEVSLTARLQHVNLLRVLGYCTERDENM--------LIYEYLPNK 516
             + +  E F      E+ +   L+H N++ ++  C  +            L++++  + 
Sbjct: 53  MENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD 110
Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576
              L L + + ++ L   KRV  ++ +  GL Y+      +++HRD+KA+N+L+  +   
Sbjct: 111 LAGL-LSNVLVKFTLSEIKRV--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL 164
Query: 577 KISDFGMAKLFR--KDVDEANTGRIVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQI 632
           K++DFG+A+ F   K+         V T  Y PPE  + +  Y    D++  G ++ ++
Sbjct: 165 KLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
           LGEG    V    NL   QE+AVK +             EV +  + Q H N+L ++ + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            E D   L++E +   S+  ++    RR+  + +  V +++ V   L +L    N  + H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASV-VVQDVASALDFLH---NKGIAH 134
Query: 561 RDLKASNILLD--NELNP-KISDFGMAKLFR--KDVDEANTGRIV---GTYGYVPPEYV- 611
           RDLK  NIL +  N+++P KI DFG+    +   D    +T  ++   G+  Y+ PE V 
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 612 ----KKGIYSMKYDVYSFGVLLLQIIS 634
               +  IY  + D++S GV+L  ++S
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +  R +H N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 144 N---VLHRDLKPSNLLLNTTXDLKIXDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 199 MLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-----STQGLEEFKN----EVSL 484
            N+     LG G    V +  + P  +E+AVK +  T     S + ++E +     EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 485 TARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
             ++  H N++++           L+++ +    L  YL + +    L  ++   I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 133
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGT 602
            + +  L +     ++HRDLK  NILLD+++N K++DFG    F   +D     R + GT
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLRSVCGT 186
Query: 603 YGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIIS 634
             Y+ PE ++  +      Y  + D++S GV++  +++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN-- 492
           +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLY 549
           ++R+  Y      +  IY  +   ++DL  +   ++ +  W+++    N++E V      
Sbjct: 90  IIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 140
Query: 550 LQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
                   ++H DLK +N L+ D  L  K+ DFG+A   + D         VGT  Y+PP
Sbjct: 141 -HTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 609 EYVKKGIYSMK-----------YDVYSFGVLL 629
           E +K    S +            DV+S G +L
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN-- 492
           +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLY 549
           ++R+  Y      +  IY  +   ++DL  +   ++ +  W+++    N++E V      
Sbjct: 71  IIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 121
Query: 550 LQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
                   ++H DLK +N L+ D  L  K+ DFG+A   + D         VGT  Y+PP
Sbjct: 122 -HTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 609 EYVKKGIYSMK-----------YDVYSFGVLL 629
           E +K    S +            DV+S G +L
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-----STQGLEEFKN----EVSL 484
            N+     LG G    V +  + P  +E+AVK +  T     S + ++E +     EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 485 TARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
             ++  H N++++           L+++ +    L  YL + +    L  ++   I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 133
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGT 602
            + +  L +     ++HRDLK  NILLD+++N K++DFG    F   +D     R + GT
Sbjct: 134 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGT 186
Query: 603 YGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIIS 634
             Y+ PE ++  +      Y  + D++S GV++  +++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN-- 492
           +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLY 549
           ++R+  Y      +  IY  +   ++DL  +   ++ +  W+++    N++E V      
Sbjct: 74  IIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 124
Query: 550 LQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
                   ++H DLK +N L+ D  L  K+ DFG+A   + D         VGT  Y+PP
Sbjct: 125 -HTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181
Query: 609 EYVKKGIYSMK-----------YDVYSFGVLL 629
           E +K    S +            DV+S G +L
Sbjct: 182 EAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVK----RLSATSTQGL--EEFKNEVSLTAR 487
           +++    +LG G F  V K      G+E+A K    R   +S +G+  EE + EV++   
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           ++H N++ +      + + +LI E +    L  +L +   +  L   +    ++ +  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGV 142
Query: 548 LYLQEYSNFRVIHRDLKASNILL--DNELNPKIS--DFGMAKLFRKDVDEANTGRIVGTY 603
            YL      R+ H DLK  NI+L   N  NP+I   DFG+A       +  N   I GT 
Sbjct: 143 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 196
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +V PE V      ++ D++S GV+   ++S
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 227

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 441 NKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
            KLGEGGF  V     L  G  +A+KR+     Q  EE + E  +     H N+LR++ Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 500 CTE----RDENMLIYEYLPNKSLDLYLFDPIRRY-----VLDWQKRVNIIEGVTQGL--L 548
           C      + E  L+  +    +    L++ I R       L   + + ++ G+ +GL  +
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV-------G 601
           + + Y+     HRDLK +NILL +E  P + D G        V+ +     +        
Sbjct: 151 HAKGYA-----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 602 TYGYVPPEYV---KKGIYSMKYDVYSFGVLL 629
           T  Y  PE        +   + DV+S G +L
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVL 236

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT-----STQGLEEFKN----EVSL 484
            N+     LG G    V +  + P  +E+AVK +  T     S + ++E +     EV +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 485 TARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
             ++  H N++++           L+++ +    L  YL + +    L  ++   I+  +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 120
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGT 602
            + +  L +     ++HRDLK  NILLD+++N K++DFG    F   +D     R + GT
Sbjct: 121 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGT 173
Query: 603 YGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIIS 634
             Y+ PE ++  +      Y  + D++S GV++  +++
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L + +   +I+RDLK  N+LLD++ N +ISD G+A   +    +  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
            G++ PE +    Y    D ++ GV L ++I+++   R  G
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN-- 492
           +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLY 549
           ++R+  Y      +  IY  +   ++DL  +   ++ +  W+++    N++E V      
Sbjct: 70  IIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 120
Query: 550 LQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
                   ++H DLK +N L+ D  L  K+ DFG+A   + D         VGT  Y+PP
Sbjct: 121 -HTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177
Query: 609 EYVKKGIYSMK-----------YDVYSFGVLL 629
           E +K    S +            DV+S G +L
Sbjct: 178 EAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L + +   +I+RDLK  N+LLD++ N +ISD G+A   +    +  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
            G++ PE +    Y    D ++ GV L ++I+++   R  G
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATST-QGLEEFK-NEVSLTARLQHV 491
             +    K+GEG +G V+K       E  A+KR+      +G+      E+ L   L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           N++R+        +  L++E+  ++ L  Y FD      LD +   + +  + +GL +  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH 118
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
             +   V+HRDLK  N+L++     K++DFG+A+ F   V    +  +V T  Y PP+ +
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVV-TLWYRPPDVL 173
Query: 612 -KKGIYSMKYDVYSFGVLLLQIISSKR 637
               +YS   D++S G +  ++ ++ R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L + +   +I+RDLK  N+LLD++ N +ISD G+A   +    +  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
            G++ PE +    Y    D ++ GV L ++I+++   R  G
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L + +   +I+RDLK  N+LLD++ N +ISD G+A   +    +  T    GT
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
            G++ PE +    Y    D ++ GV L ++I+++   R  G
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    ++  G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 109/257 (42%), Gaps = 42/257 (16%)
Query: 403 RTPGTSTPAAEYFDS---DTPNLQVFSFSDIKAATNN--------FSSANKLGEGGFGPV 451
           R  G    AA  F+    D+P+L         ++ N         +S   ++G GG   V
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 452 YKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENM 507
           ++    + Q +A+K   L     Q L+ ++NE++   +LQ  +  ++R+  Y      + 
Sbjct: 73  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---EITDQ 129
Query: 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLYLQEYSNFRVIHRDLK 564
            IY  +   ++DL  +   ++ +  W+++    N++E V              ++H DLK
Sbjct: 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV-------HTIHQHGIVHSDLK 182
Query: 565 ASNILL-DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK---- 619
            +N L+ D  L  K+ DFG+A   + D         VG   Y+PPE +K    S +    
Sbjct: 183 PANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 620 -------YDVYSFGVLL 629
                   DV+S G +L
Sbjct: 241 KSKISPKSDVWSLGCIL 257

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R++ LD    +     ++  L YL+   + R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+      K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R++ LD    +     ++  L YL+   + R
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+ +    K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 443 LGEGGFGPVYKGNLPR----GQ----EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           LG+G F  ++KG        GQ    E  +K L        E F    S+ ++L H +L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
              G C   DEN+L+ E++   SLD YL        + W  ++ + + +   + +L+E +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 555 NFRVIHRDLKASNILLDNEL-----NP---KISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
              +IH ++ A NILL  E      NP   K+SD G++  +  KD+ +    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE---RI----PW 183
Query: 606 VPPEYVKKGI-YSMKYDVYSFGVLLLQIIS----------SKRNARYYGTSENL 648
           VPPE ++     ++  D +SFG  L +I S          S+R  ++Y     L
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSL 484
           F  +      +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++ 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 485 TARLQHVN--LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NI 539
             +LQ  +  ++R+  Y      +  IY  +   ++DL  +   ++ +  W+++    N+
Sbjct: 80  LNKLQQHSDKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKDVDEANTGR 598
           +E V              ++H DLK +N L+ D  L  K+ DFG+A   + D        
Sbjct: 137 LEAV-------HTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDXXXVVKDS 187
Query: 599 IVGTYGYVPPEYVKKGIYSMK-----------YDVYSFGVLL 629
            VGT  Y+PPE +K    S +            DV+S G +L
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ Q+ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAA 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 12/212 (5%)
Query: 429 DIKAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR 487
           D K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 488 LQHVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
           LQ+     L  L Y  +  D    + EY     L  +L    R  V   ++       + 
Sbjct: 64  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIV 120
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPE 175
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           Y+ PE ++   Y    D +  GV++ +++  +
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR 487
           D +A    +     LG+GGFG V+ G+ L    + A+K +      G     + V+    
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 488 LQ----------HVNLLRVLGYCTERDENMLIYEY-LPNKSLDLYLFDPIRRYVLDWQKR 536
           +           H  ++R+L +   ++  ML+ E  LP + L    FD    Y+    ++
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL----FD----YI---TEK 133
Query: 537 VNIIEGVT-----QGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKD 590
             + EG +     Q +  +Q   +  V+HRD+K  NIL+D      K+ DFG   L    
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-- 191
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISS 635
            DE  T    GT  Y PPE++ +  Y ++   V+S G+LL  ++  
Sbjct: 192 -DEPYTD-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 435 NNFSSANKLGEG-GFGPVYKGNLPRG----QEFAVKRLSATSTQGLE---EFKNEVSLTA 486
           ++ S   +LGE  GFG + + +L R     ++ AVK L A   +       F+ E    A
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 487 RLQHVNLLRVLGYCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVN 538
            L H  ++ V  Y T   E        ++ EY+   +L   ++   P     +  ++ + 
Sbjct: 68  ALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIE 120
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN--- 595
           +I    Q L +  +     +IHRD+K +NI++      K+ DFG+A+      D  N   
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVT 174
Query: 596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            T  ++GT  Y+ PE  +      + DVYS G +L ++++ +
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHV 491
             + S   +G G +G V      R G++ A+K+LS      +  +    E+ L   +QH 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           N++ +L   T            P  SL    D YL  P  +  L     +   E   Q L
Sbjct: 84  NVIGLLDVFT------------PASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 548 LY-----LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +Y     L+   +  V+HRDLK  N+ ++ +   KI DFG+A    +  D   TG +V T
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVV-T 186
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
             Y  PE +   + Y+   D++S G ++ ++++ K
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 11/212 (5%)
Query: 429 DIKAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR 487
           D +   N F     LG+G FG V        G+ +A+K L        +E  + ++    
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 63
Query: 488 LQHVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
           LQ+     L  L Y  +  D    + EY     L  +L    R  V    +       + 
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIV 120
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             L YL    N  V++RDLK  N++LD + + KI+DFG+ K   K  D A      GT  
Sbjct: 121 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 176
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           Y+ PE ++   Y    D +  GV++ +++  +
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 443 LGEGGFGPVYKGNLP--RGQEF--AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           LGEG FG VY+G     +G++   AVK      T    E+F +E  +   L H ++++++
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ------ 551
           G   E +   +I E  P   L  YL           ++  N ++ +T  L  LQ      
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL-----------ERNKNSLKVLTLVLYSLQICKAMA 139
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR-KDVDEANTGRIVGTYGYVPPEY 610
              +   +HRD+   NIL+ +    K+ DFG+++    +D  +A+  R+     ++ PE 
Sbjct: 140 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 197
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++   DV+ F V + +I+S
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHV 491
             + S   +G G +G V      R G++ A+K+LS      +  +    E+ L   +QH 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           N++ +L   T            P  SL    D YL  P  +  L     +   E   Q L
Sbjct: 102 NVIGLLDVFT------------PASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 548 LY-----LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +Y     L+   +  V+HRDLK  N+ ++ +   KI DFG+A    +  D   TG +V T
Sbjct: 150 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVV-T 204
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
             Y  PE +   + Y+   D++S G ++ ++++ K
Sbjct: 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 443 LGEGGFGPVYKGNLP--RGQEF--AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           LGEG FG VY+G     +G++   AVK      T    E+F +E  +   L H ++++++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ------ 551
           G   E +   +I E  P   L  YL           ++  N ++ +T  L  LQ      
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL-----------ERNKNSLKVLTLVLYSLQICKAMA 127
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR-KDVDEANTGRIVGTYGYVPPEY 610
              +   +HRD+   NIL+ +    K+ DFG+++    +D  +A+  R+     ++ PE 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 185
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++   DV+ F V + +I+S
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +    +H N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 146 N---VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 201 MLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 443 LGEGGFGPVYKGNLP--RGQEF--AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
           LGEG FG VY+G     +G++   AVK      T    E+F +E  +   L H ++++++
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ------ 551
           G   E +   +I E  P   L  YL           ++  N ++ +T  L  LQ      
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL-----------ERNKNSLKVLTLVLYSLQICKAMA 123
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR-KDVDEANTGRIVGTYGYVPPEY 610
              +   +HRD+   NIL+ +    K+ DFG+++    +D  +A+  R+     ++ PE 
Sbjct: 124 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPES 181
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++   DV+ F V + +I+S
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 156
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 157 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 208
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVN- 492
           + + + +G G +G V    ++  G + AVK+LS    S    +    E+ L   ++H N 
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 112
Query: 493 --LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-----IIEGVTQ 545
             LL V    T  +E   +Y       L  +L       ++  QK  +     +I  + +
Sbjct: 113 IGLLDVFTPATSLEEFNDVY-------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V T  Y
Sbjct: 166 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YVATRWY 217
Query: 606 VPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
             PE +   + Y+M  D++S G ++ ++++ +
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 156
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 157 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 208
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++     Q 
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY P   +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   K++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           +++    +LG G FG V++      G  FA K +        E  + E+   + L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +     + +E ++IYE++    L   + D   +   D  + V  +  V +GL ++ E 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHE- 273
Query: 554 SNFRVIHRDLKASNILL----DNELNPKISDFGM-AKLFRKDVDEANTGRIVGTYGYVPP 608
           +N+  +H DLK  NI+      NEL  K+ DFG+ A L  K   +  T    GT  +  P
Sbjct: 274 NNY--VHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVTT----GTAEFAAP 325
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E  +        D++S GVL   ++S
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLS 351

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +GEG FG V++G    P     AV   +    TS    E+F  E     +  H ++++++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G  TE +   +I E      L  +L   +R++ LD    +     ++  L YL+   + R
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDV-DEANTGRIVGTYGYVPPEYVKKGIY 616
            +HRD+ A N+L+      K+ DFG+++        +A+ G++     ++ PE +    +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 617 SMKYDVYSFGVLLLQII 633
           +   DV+ FGV + +I+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 155
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 156 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 207
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 156
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 157 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 208
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 155
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 156 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 207
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 114
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 115 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 170
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 171 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 222
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 155
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 156 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 207
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 435 NNFSSANKLGEG-GFGPVYKGNLPRG----QEFAVKRLSATSTQGLE---EFKNEVSLTA 486
           ++ S   +LGE  GFG + + +L R     ++ AVK L A   +       F+ E    A
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 487 RLQHVNLLRVLGYCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVN 538
            L H  ++ V  Y T   E        ++ EY+   +L   ++   P     +  ++ + 
Sbjct: 68  ALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIE 120
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN--- 595
           +I    Q L +  +     +IHRD+K +NIL+      K+ DFG+A+      D  N   
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAI---ADSGNSVX 174
Query: 596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            T  ++GT  Y+ PE  +      + DVYS G +L ++++ +
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 156
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 157 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 208
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 86
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 87  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 143 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 194
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 86
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 87  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 143 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 194
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 143
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 144 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 195
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--AAQIV 172
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 227
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 155
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 156 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 207
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 128
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 129 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 180
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 143
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 144 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 195
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 143
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 144 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 195
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 64  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 119
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 120 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 175
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 176 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 227
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 257

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           ++  N +G G +G V K  + +G     A K++     + ++ FK E+ +   L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+     +  +  L+ E      L   +   + + V        I++ V   + Y  +  
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHK-- 141
Query: 555 NFRVIHRDLKASNILL--DNELNP-KISDFGMAKLFRKDVDEANTGRI----VGTYGYVP 607
              V HRDLK  N L   D+  +P K+ DFG+A  F+        G++    VGT  YV 
Sbjct: 142 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-------PGKMMRTKVGTPYYVS 193
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P+ V +G+Y  + D +S GV++  ++ 
Sbjct: 194 PQ-VLEGLYGPECDEWSAGVMMYVLLC 219

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           +++    +LG G FG V++      G  FA K +        E  + E+   + L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +     + +E ++IYE++    L   + D   +   D  + V  +  V +GL ++ E 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHE- 167
Query: 554 SNFRVIHRDLKASNILL----DNELNPKISDFGM-AKLFRKDVDEANTGRIVGTYGYVPP 608
           +N+  +H DLK  NI+      NEL  K+ DFG+ A L  K   +  T    GT  +  P
Sbjct: 168 NNY--VHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVTT----GTAEFAAP 219
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E  +        D++S GVL   ++S
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLS 245

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 128
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 129 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 180
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 114
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 115 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 170
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 171 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 222
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 51  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 107 FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 162
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 163 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 214
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 434 TNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKR-LSATSTQGLE-EFKNEVSLTARLQH 490
            + +    K+G+G FG V+K    + GQ+ A+K+ L     +G       E+ +   L+H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 491 VNLLRVLGYCTERDENM--------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            N++ ++  C  +            L++++  +    L L + + ++ L   KRV  ++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRV--MQM 132
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR--KDVDEANTGRIV 600
           +  GL Y+      +++HRD+KA+N+L+  +   K++DFG+A+ F   K+         V
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 601 GTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQI 632
            T  Y PPE  + +  Y    D++  G ++ ++
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           ++  N +G G +G V K  + +G     A K++     + ++ FK E+ +   L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+     +  +  L+ E      L   +   + + V        I++ V   + Y  +  
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHK-- 124
Query: 555 NFRVIHRDLKASNILL--DNELNP-KISDFGMAKLFRKDVDEANTGRI----VGTYGYVP 607
              V HRDLK  N L   D+  +P K+ DFG+A  F+        G++    VGT  YV 
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-------PGKMMRTKVGTPYYVS 176
Query: 608 PEYVKKGIYSMKYDVYSFGVLL 629
           P+ V +G+Y  + D +S GV++
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQE----FAVKRLS-ATSTQGLEEFKNEVSLT 485
           K    NF     LG G +G V+      G +    +A+K L  AT  Q  +  ++  +  
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 486 ARLQHVN---LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
             L+H+     L  L Y  + +  + LI +Y+    L  +L    R    + Q  V  I 
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 168
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
                +L L+      +I+RD+K  NILLD+  +  ++DFG++K F  D  E       G
Sbjct: 169 -----VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCG 222
Query: 602 TYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
           T  Y+ P+ V+ G   +    D +S GVL+ ++++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 120
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 175
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 15  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 70
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 71  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 126
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 127 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 178
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 208

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY--AAQIV 146
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 201
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEM 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 128
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 129 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 180
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 123
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 124 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 175
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 437 FSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
           +++ + +GEG +G V     N+ + +  A+K++S    Q   +    E+ +    +H N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +           +   Y+    ++  L+  ++   L        +  + +GL Y+   
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEY 610
           +   V+HRDLK SN+LL+   + KI DFG+A++   D D  +TG +   V T  Y  PE 
Sbjct: 146 N---VLHRDLKPSNLLLNTTSDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSK 636
           +   KG Y+   D++S G +L +++S++
Sbjct: 201 MLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 71
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 72  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 127
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 128 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 179
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 123
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 124 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 175
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLE---EFKNEVSLTARLQHVNLLRVLG 498
           LG GG   V+   +L   ++ AVK L A   +       F+ E    A L H  ++ V  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 499 YCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
           Y T   E        ++ EY+   +L   ++   P     +  ++ + +I    Q L + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 132
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN----TGRIVGTYGYV 606
            +     +IHRD+K +NI++      K+ DFG+A+      D  N    T  ++GT  Y+
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYL 186
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE  +      + DVYS G +L ++++ +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           +   N F     LG+G FG V        G+ +A+K L        +E  + ++    LQ
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V    +       +   
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSA 121
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL    N  V++RDLK  N++LD + + KI+DFG+ K   K  D A      GT  Y+
Sbjct: 122 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYL 177
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           K   N+F     LG+G FG V        G+ +A+K L        +E  + V+ +  LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V   ++       +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL       V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLE---EFKNEVSLTARLQHVNLLRVLG 498
           LG GG   V+   +L   ++ AVK L A   +       F+ E    A L H  ++ V  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 499 YCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
           Y T   E        ++ EY+   +L   ++   P     +  ++ + +I    Q L + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 132
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN----TGRIVGTYGYV 606
            +     +IHRD+K +NI++      K+ DFG+A+      D  N    T  ++GT  Y+
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYL 186
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE  +      + DVYS G +L ++++ +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 152
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 207
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           +   N F     LG+G FG V        G+ +A+K L        +E  + ++    LQ
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V    +       +   
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSA 120
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL    N  V++RDLK  N++LD + + KI+DFG+ K   K  D A      GT  Y+
Sbjct: 121 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYL 176
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLAGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           +   N F     LG+G FG V        G+ +A+K L        +E  + ++    LQ
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V    +       +   
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSA 260
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL    N  V++RDLK  N++LD + + KI+DFG+ K   K  D A      GT  Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYL 316
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 138
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 193
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEM 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 435 NNFSSANKLGEG-GFGPVYKGNLPRG----QEFAVKRLSATSTQGLE---EFKNEVSLTA 486
           ++ S   +LGE  GFG + + +L R     ++ AVK L A   +       F+ E    A
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 487 RLQHVNLLRVLGYCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVN 538
            L H  ++ V  Y T   E        ++ EY+   +L   ++   P     +  ++ + 
Sbjct: 85  ALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIE 137
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN--- 595
           +I    Q L +  +     +IHRD+K +NI++      K+ DFG+A+      D  N   
Sbjct: 138 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVT 191
Query: 596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            T  ++GT  Y+ PE  +      + DVYS G +L ++++ +
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
           LGEG    V    NL   QE+AVK +             EV +  + Q H N+L ++ + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            E D   L++E +   S+  ++    RR+  + +  V +++ V   L +L    N  + H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASV-VVQDVASALDFLH---NKGIAH 134
Query: 561 RDLKASNILLD--NELNP-KISDFGMAKLFR--KDVDEANTGRIV---GTYGYVPPEYV- 611
           RDLK  NIL +  N+++P KI DF +    +   D    +T  ++   G+  Y+ PE V 
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 612 ----KKGIYSMKYDVYSFGVLLLQIIS 634
               +  IY  + D++S GV+L  ++S
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 435 NNFSSANKLGEG-GFGPVYKGNLPRG----QEFAVKRLSATSTQGLE---EFKNEVSLTA 486
           ++ S   +LGE  GFG + + +L R     ++ AVK L A   +       F+ E    A
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 487 RLQHVNLLRVLGYCTERDENM------LIYEYLPNKSLD--LYLFDPIRRYVLDWQKRVN 538
            L H  ++ V  Y T   E        ++ EY+   +L   ++   P     +  ++ + 
Sbjct: 68  ALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIE 120
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN--- 595
           +I    Q L +  +     +IHRD+K +NI++      K+ DFG+A+      D  N   
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVT 174
Query: 596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            T  ++GT  Y+ PE  +      + DVYS G +L ++++ +
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ 489
           +   N F     LG+G FG V        G+ +A+K L        +E  + ++    LQ
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 490 HVN--LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           +     L  L Y  +  D    + EY     L  +L    R  V    +       +   
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSA 263
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L YL    N  V++RDLK  N++LD + + KI+DFG+ K   KD   A      GT  Y+
Sbjct: 264 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYL 319
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            PE ++   Y    D +  GV++ +++  +
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 39  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 94
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 95  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 150
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 151 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 202
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 232

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E  P    DL+ F   R  + +   R     ++E V   
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV--- 123
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 124 ----RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 175
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 442 KLGEGGFGPVYKGNLPRGQ------EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           ++G G F  VYKG            E   ++L+ +  Q    FK E      LQH N++R
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 496 --------VLGY-CTERDENMLIYEYLPNKSLDLYL--FDPIRRYVL-DWQKRVNIIEGV 543
                   V G  C      +L+ E   + +L  YL  F   +  VL  W +++      
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------ 138
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            +GL +L   +   +IHRDLK  NI +       KI D G+A L R    +A    ++GT
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGT 193
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
             +  PE  ++  Y    DVY+FG   L+  +S+
Sbjct: 194 PEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSE 226

>pdb|3B9A|A Chain A, Crystal Structure Of Vibrio Harveyi Chitinase A Complexed With Hexasaccharide Length = 584

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 83/367 (22%), Positives = 137/367 (37%), Gaps = 109/367 (29%)
Query: 62  STYQLSISSANQQYFSIFAN------SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNI 113
           + YQ S   A  +Y +          +++++NP +K + SI  W   +  Y  +      
Sbjct: 211 AAYQKSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGWTLSDPFYDFV------ 264
Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYGF-QGIDLFWLWPNSTD-------------- 158
                     D  +R +F+ S  +  + + F  G+D+ W++P                  
Sbjct: 265 ----------DKKNRDTFVASVKKFLKTWKFYDGVDIDWMFPGGGGAAADKGDPVNDGPA 314
Query: 159 ----LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYD 214
               +  L ++LDE +A      ELT ++ V Y    E V Y  D+++  +++   + YD
Sbjct: 315 YIALMRELRVMLDELEAETGRTYELTSAIGVGYDKI-EDVDY-ADAVQY-MDYIFAMTYD 371
Query: 215 YHMPSKENVTGIHAALYNPS---------------------SNISTDFGIREWLRRGFPA 253
           ++     NV G   ALY  S                        + D GI+  L +G PA
Sbjct: 372 FYG-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPA 430
Query: 254 NKLVLGARASG-------------------------------PGITIDGSMGYKFIRAF- 281
           NKLVLG    G                                G+  DG + YK I++F 
Sbjct: 431 NKLVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFM 490
Query: 282 -------IQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKA 334
                  I  + YG      A +V N  T     I FD   ++ AK +YAK   L G  +
Sbjct: 491 LGANNTGINGFEYGYDAQAEAPWVWNRST--GELITFDDHRSVLAKGNYAKSLGLAGLFS 548
Query: 335 FQLSNDD 341
           +++  D+
Sbjct: 549 WEIDADN 555

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLXGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 172
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GATWTLCGTPEYLA 227
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +    Y+   D ++ GVL+ ++ +
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATST-QGLEEFK-NEVSLTARLQHVNL 493
           +    K+GEG +G V+K       E  A+KR+      +G+      E+ L   L+H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +R+        +  L++E+  ++ L  Y FD      LD +   + +  + +GL +    
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-K 612
           +   V+HRDLK  N+L++     K+++FG+A+ F   V    +  +V T  Y PP+ +  
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVV-TLWYRPPDVLFG 175
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKR 637
             +YS   D++S G +  ++ ++ R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+++D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEM 231

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 66/268 (24%)
Query: 427 FSDIKAATNNFSSANKLGEGGFGPVY--KGNLPRGQE--FAVKRLSATSTQGLEEFKNEV 482
           +  +   +N F   +K+GEG F  VY     L  G E   A+K L  TS        + +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--------HPI 64
Query: 483 SLTARLQHVNLL----RVLG--YCTERDENMLI-YEYLPNKS----LDLYLFDPIRRYVL 531
            + A LQ + +      V+G  YC  ++++++I   YL ++S    L+   F  +R Y+L
Sbjct: 65  RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML 124
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAK----- 585
           +  K              L+    F ++HRD+K SN L +  L    + DFG+A+     
Sbjct: 125 NLFK-------------ALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 586 ---LFRKDVDEANTGRI------------------VGTYGYVPPEYVKKGI-YSMKYDVY 623
              L +    EA   R                    GT G+  PE + K    +   D++
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 624 SFGVLLLQIISSKRNARYYGTSENLNFL 651
           S GV+ L ++S +    +Y  S++L  L
Sbjct: 232 SAGVIFLSLLSGRYP--FYKASDDLTAL 257

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 90  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 189
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 80  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 179
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++     QG + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 76  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 186
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++     QG + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 76  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 186
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++     QG + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           +R+  +      ++DE  L  + +Y+P       ++   R Y    Q    I   +    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 548 LY--LQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYG 604
           L+  L    +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY- 187
Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y  PE +     Y+   DV+S G +L +++
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 104 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 203
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 110 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 220
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 103 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 151 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 202
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 49/250 (19%)
Query: 408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
           S+P+ E  D D         S +     +F   + LG G  G +    +   ++ AVKR+
Sbjct: 3   SSPSLEQDDGDEET------SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI 56
Query: 468 SATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM----------LIYEYLPNK 516
                   +    EV L     +H N++R   +CTE+D              + EY+  K
Sbjct: 57  LPECFSFAD---REVQLLRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQK 111
Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-----D 571
                  +PI            +++  T GL +L    +  ++HRDLK  NIL+      
Sbjct: 112 DFAHLGLEPI-----------TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAH 157
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGR---IVGTYGYVPPEYVKKGIY---SMKYDVYSF 625
            ++   ISDFG+ K  +  V   +  R   + GT G++ PE + +      +   D++S 
Sbjct: 158 GKIKAMISDFGLCK--KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 626 GVLLLQIISS 635
           G +   +IS 
Sbjct: 216 GCVFYYVISE 225

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQH 490
           +++F   + LGEG +G V    + P G+  A+K++         L   + E+ +    +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 491 VNLLRVLGYCTER-------DENMLIYEYLPNK-----SLDLYLFDPIRRYVLDWQKRVN 538
            N++ +     +R       +E  +I E +        S  +   D I+ ++    + V 
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV--DEANT 596
           ++ G           SN  VIHRDLK SN+L+++  + K+ DFG+A++  +    +   T
Sbjct: 127 VLHG-----------SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 597 GRIVGTYGYV-------PPEYVKKGIYSMKYDVYSFGVLLLQI 632
           G+  G   YV       P   +    YS   DV+S G +L ++
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N++ +L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 500 CTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----IIEGVTQG 546
            T            P +SL    D+YL   +       ++  QK  +     +I  + +G
Sbjct: 100 FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V T  Y 
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YVATRWYR 199
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            PE +   + Y+   D++S G ++ ++++ +
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +R+  +     E   +  YL N  LD Y+ + + R    + +    +  +   L   Q +
Sbjct: 76  VRLRYFFYSSGEKKDVV-YL-NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 554 ------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
                  +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   Y   
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRYYRA 190
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQII 633
           P        Y+   DV+S G +L +++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 81  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 134 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 191
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 192 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGX-V 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 443 LGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKN------EVSLTARLQH- 490
           LG GGFG VY G     NLP     A+K +         E  N      EV L  ++   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 71
Query: 491 -VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQG 546
              ++R+L +    D  +LI E +     DL+ F   R  + +   R     ++E V   
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELARSFFWQVLEAV--- 127
Query: 547 LLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
               +   N  V+HRD+K  NIL+D N    K+ DFG   L +  V         GT  Y
Sbjct: 128 ----RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 179
Query: 606 VPPEYVKKGIYSMK-YDVYSFGVLLLQIIS 634
            PPE+++   Y  +   V+S G+LL  ++ 
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 209

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 95  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 148 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 205
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 88  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 198
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 88  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 198
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 24/233 (10%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-----------LE 476
           +++ A  + ++    +  G +G V  G    G   A+KR+  T + G            +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL--DLYLFDPIRRYVLDWQ 534
               E+ L     H N+L +       +E  +   YL  + +  DL      +R V+  Q
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
                +  +  GL  L E     V+HRDL   NILL +  +  I DF +A   R+D  +A
Sbjct: 135 HIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA---REDTADA 188
Query: 595 NTGRIVGTYGYVPPEYVK--KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
           N    V    Y  PE V   KG ++   D++S G ++ ++ +  R A + G++
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKG-FTKLVDMWSAGCVMAEMFN--RKALFRGST 238

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 84  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 137 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 194
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 76  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 186
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 104 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 157 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 214
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 215 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 24/233 (10%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-----------LE 476
           +++ A  + ++    +  G +G V  G    G   A+KR+  T + G            +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL--DLYLFDPIRRYVLDWQ 534
               E+ L     H N+L +       +E  +   YL  + +  DL      +R V+  Q
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
                +  +  GL  L E     V+HRDL   NILL +  +  I DF +A   R+D  +A
Sbjct: 135 HIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA---REDTADA 188
Query: 595 NTGRIVGTYGYVPPEYVK--KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
           N    V    Y  PE V   KG ++   D++S G ++ ++ +  R A + G++
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKG-FTKLVDMWSAGCVMAEMFN--RKALFRGST 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 76  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 186
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 90  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 189
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 77  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 130 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 187
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 112 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 165 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 222
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 223 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 110 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 220
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 80  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 133 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSR 190
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 191 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 96  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 195
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 80  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+   G  V
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAG-FV 179
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3B8S|A Chain A, Crystal Structure Of Wild-Type Chitinase A From Vibrio Harveyi Length = 584

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 83/367 (22%), Positives = 136/367 (37%), Gaps = 109/367 (29%)
Query: 62  STYQLSISSANQQYFSIFAN------SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNI 113
           + YQ S   A  +Y +          +++++NP +K + SI  W   +  Y  +      
Sbjct: 211 AAYQKSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGWTLSDPFYDFV------ 264
Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYGF-QGIDLFWLWPNSTD-------------- 158
                     D  +R +F+ S  +  + + F  G+D+ W +P                  
Sbjct: 265 ----------DKKNRDTFVASVKKFLKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPA 314
Query: 159 ----LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYD 214
               +  L ++LDE +A      ELT ++ V Y    E V Y  D+++  +++   + YD
Sbjct: 315 YIALMRELRVMLDELEAETGRTYELTSAIGVGYDKI-EDVDY-ADAVQY-MDYIFAMTYD 371
Query: 215 YHMPSKENVTGIHAALYNPS---------------------SNISTDFGIREWLRRGFPA 253
           ++     NV G   ALY  S                        + D GI+  L +G PA
Sbjct: 372 FYG-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPA 430
Query: 254 NKLVLGARASG-------------------------------PGITIDGSMGYKFIRAF- 281
           NKLVLG    G                                G+  DG + YK I++F 
Sbjct: 431 NKLVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFM 490
Query: 282 -------IQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKA 334
                  I  + YG      A +V N  T     I FD   ++ AK +YAK   L G  +
Sbjct: 491 LGANNTGINGFEYGYDAQAEAPWVWNRST--GELITFDDHRSVLAKGNYAKSLGLAGLFS 548
Query: 335 FQLSNDD 341
           +++  D+
Sbjct: 549 WEIDADN 555

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 155 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 208 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 265
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 266 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT  Y+ 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P  +    Y+   D ++ GVL+ ++ +
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 89  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 188
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 434 TNNFSSANKLGEGGFGPVYKGNLPRG--QEFAVKRLSATSTQGLEEFKNEVSLTARLQHV 491
           T+ +     +G G +  V K  + +    EFAVK +  +     EE +    L    QH 
Sbjct: 21  TDGYEVKEDIGVGSYS-VCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHP 76
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           N++ +     +     ++ E +    L   L   +R+     ++   ++  +T+ + YL 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 552 EYSNFRVIHRDLKASNIL-LDNELNP---KISDFGMAKLFRKDVDEANTGRIVG---TYG 604
                 V+HRDLK SNIL +D   NP   +I DFG AK  R     A  G ++    T  
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-----AENGLLMTPCYTAN 185
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +V PE +++  Y    D++S GVLL  +++
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLT 215

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+   G  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAG-FV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIRRYVLD-WQKRVNIIEGVTQGLL 548
           + +L   T            P +SL    D+YL   +    L+   K   + +   Q L+
Sbjct: 80  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI 127
Query: 549 Y-----LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           Y     L+   +  +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V T 
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YVATR 182
Query: 604 GYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 91  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 190
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 82  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 129
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 130 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 181
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 89  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 142 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 199
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 114 VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 167 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 224
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
           Y Y  PE +     Y+   DV+S G +L +++
Sbjct: 225 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 81  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 180
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+   G  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAG-FV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 86  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 185
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 80  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 179
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 81  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 180
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 90  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 189
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 96  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 195
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 96  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 195
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 89  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTG-YV 188
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 89  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 188
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 83  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 130
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 131 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 182
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 86  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 185
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 95  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 194
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNL 493
           +++    +G G FG VY+  L   G+  A+K++        + FKN E+ +  +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 494 LRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R+  +      ++DE  L      N  LD Y+ + + R    + +    +  +   L  
Sbjct: 76  VRLRYFFYSSGEKKDEVYL------NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 550 LQEY------SNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGT 602
            Q +       +F + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 186
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           Y   P        Y+   DV+S G +L +++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 86  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 185
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
           +G+G FG VY G         +  +   +   L+ FK EV    + +H N++  +G C  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRD 562
                +I      ++L   + D   + VLD  K   I + + +G+ YL       ++H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 563 LKASNILLDNELNPKISDFGM 583
           LK+ N+  DN     I+DFG+
Sbjct: 156 LKSKNVFYDNG-KVVITDFGL 175

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 104 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 203
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 103 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 151 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 202
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 40/223 (17%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQH 490
           +++F   + LGEG +G V    + P G+  A+K++         L   + E+ +    +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 491 VNLLRVLGYCTER-------DENMLIYEYLPNK-----SLDLYLFDPIRRYVLDWQKRVN 538
            N++ +     +R       +E  +I E +        S  +   D I+ ++    + V 
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV------- 591
           ++ G           SN  VIHRDLK SN+L+++  + K+ DFG+A++  +         
Sbjct: 127 VLHG-----------SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 592 -DEANTGRIVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQI 632
             ++     V T  Y  PE  +    YS   DV+S G +L ++
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQH 490
           +++F   + LGEG +G V    + P G+  A+K++         L   + E+ +    +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 491 VNLLRVLGYCTER-------DENMLIYEYLPNK-----SLDLYLFDPIRRYVLDWQKRVN 538
            N++ +     +R       +E  +I E +        S  +   D I+ ++    + V 
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV--DEANT 596
           ++ G           SN  VIHRDLK SN+L+++  + K+ DFG+A++  +    +   T
Sbjct: 127 VLHG-----------SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 597 GRIVGTYGYV-------PPEYVKKGIYSMKYDVYSFGVLLLQI 632
           G+  G   +V       P   +    YS   DV+S G +L ++
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 92/164 (56%), Gaps = 22/164 (13%)
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLD 532
           +E+   E+++  +L H N+++++    + +E+ L  ++E L N+   + +  P  + + +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE-LVNQGPVMEV--PTLKPLSE 136
Query: 533 WQKRV---NIIEGVTQGLLYLQEYSNF-RVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
            Q R    ++I+G+        EY ++ ++IHRD+K SN+L+  + + KI+DFG++  F+
Sbjct: 137 DQARFYFQDLIKGI--------EYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 589 KDVDEANTGRIVGTYGYVPPEYVK--KGIYSMK-YDVYSFGVLL 629
               +A     VGT  ++ PE +   + I+S K  DV++ GV L
Sbjct: 189 G--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 107 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 155 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 206
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 89  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTG-YV 188
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 12/84 (14%)
Query: 558 VIHRDLKASNIL-LDNELNP---KISDFGMAKLFRKDVDEANTGRIVG---TYGYVPPEY 610
           V+HRDLK SNIL +D   NP   +I DFG AK  R     A  G ++    T  +V PE 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-----AENGLLMTPCYTANFVAPEV 196
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +K+  Y    D++S G+LL  +++
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLA 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLGY 499
           +G G +G V      R  Q+ AVK+LS      +   +   E+ L   L+H N++ +L  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 500 CTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            T         E YL    +   L + ++   L  +    ++  + +GL Y+       +
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG---I 144
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           IHRDLK SN+ ++ +   +I DFG+A    +  DE  TG  V T  Y  PE +   + Y+
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLA----RQADEEMTG-YVATRWYRAPEIMLNWMHYN 199
Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S G ++ +++  K
Sbjct: 200 QTVDIWSVGCIMAELLQGK 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 95  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTG-YV 194
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ARS|A Chain A, Crystal Structure Analysis Of Chitinase A From Vibrio Harveyi With Novel Inhibitors - Apo Structure Of Mutant W275g Length = 584

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 84/367 (22%), Positives = 136/367 (37%), Gaps = 109/367 (29%)
Query: 62  STYQLSISSANQQYFSIFAN------SVRRKNPSIKTLLSIWNGQNST--YQSILGNKNI 113
           + YQ S   A  +Y +          +++++NP +K + SI  G  S   Y  +      
Sbjct: 211 AAYQKSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGGTLSDPFYDFV------ 264
Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYGF-QGIDLFWLWPNSTD-------------- 158
                     D  +R +F+ S  +  + + F  G+D+ W +P                  
Sbjct: 265 ----------DKKNRDTFVASVKKFLKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPA 314
Query: 159 ----LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYD 214
               +  L ++LDE +A      ELT ++ V Y    E V Y  D+++  +++   + YD
Sbjct: 315 YIALMRELRVMLDELEAETGRTYELTSAIGVGYDKI-EDVDY-ADAVQY-MDYIFAMTYD 371
Query: 215 YHMPSKENVTGIHAALYNPS---------------------SNISTDFGIREWLRRGFPA 253
           ++     NV G   ALY  S                        + D GI+  L +G PA
Sbjct: 372 FYG-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPA 430
Query: 254 NKLVLGARASG-------------------------------PGITIDGSMGYKFIRAF- 281
           NKLVLG    G                                G+  DG + YK I++F 
Sbjct: 431 NKLVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFM 490
Query: 282 -------IQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKA 334
                  I  + YG      A +V N  T     I FD   ++ AK +YAK   L G  +
Sbjct: 491 LGANNTGINGFEYGYDAQAEAPWVWNRST--GELITFDDHRSVLAKGNYAKSLGLAGLFS 548
Query: 335 FQLSNDD 341
           +++  D+
Sbjct: 549 WEIDADN 555

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 12/84 (14%)
Query: 558 VIHRDLKASNIL-LDNELNP---KISDFGMAKLFRKDVDEANTGRIVG---TYGYVPPEY 610
           V+HRDLK SNIL +D   NP   +I DFG AK  R     A  G ++    T  +V PE 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-----AENGLLMTPCYTANFVAPEV 196
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +K+  Y    D++S G+LL  +++
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLA 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVS--- 483
           S+  A  ++F     +G+G FG V        + F AVK L   +    +E K+ +S   
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 484 -LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
            L   ++H  L+ +       D+   + +Y+    L  +L     R  L+ + R    E 
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAE- 147
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVG 601
           +   L YL    +  +++RDLK  NILLD++ +  ++DFG+ K   ++++  + T    G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
           T  Y+ PE + K  Y    D +  G +L +++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 432 AATNNFSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
           A  + F     LG G FG V    +   G  +A+K L       L++ ++ ++    LQ 
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 491 VNL--LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           VN   L  L +  + + N+ ++ EY+    +    F  +RR     +          Q +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIV 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           L  +   +  +I+RDLK  N+L+D +   +++DFG AK  +       T  + GT   + 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEALA 206
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQI 632
           PE +    Y+   D ++ GVL+ ++
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 104 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+   G  V
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMXGX-V 203
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 91  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A   R   DE  TG  V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEM-TG-YV 190
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 91  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A   R   DE  TG  V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEM-TG-YV 190
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 91  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A   R   DE  TG  V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEM-TG-YV 190
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 90  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLA----RHTDDEMTG-YV 189
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 86  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+  TG  V
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLA----RHTDDEMTG-YV 185
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLGY 499
           +G G +G V      R  Q+ AVK+LS      +   +   E+ L   L+H N++ +L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 500 CTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            T         E YL    +   L + ++   L  +    ++  + +GL Y+       +
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG---I 152
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           IHRDLK SN+ ++ +   +I DFG+A    +  DE  TG  V T  Y  PE +   + Y+
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLA----RQADEEMTG-YVATRWYRAPEIMLNWMHYN 207
Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S G ++ +++  K
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI D+G+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LGEG F    K  +    Q FAVK +S       +  K   +L     H N++++     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN-IIEGVTQGLLYLQEYSNFRVIH 560
           ++    L+ E L    L    F+ I++     +   + I+  +   + ++ +     V+H
Sbjct: 77  DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVH 129
Query: 561 RDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           RDLK  N+L  +E   L  KI DFG A+L  K  D         T  Y  PE + +  Y 
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S GV+L  ++S +
Sbjct: 188 ESCDLWSLGVILYTMLSGQ 206

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 442 KLGEGGFGPVYKGNLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           K+G G +G VYK     G++   +A+K++  T          E++L   L+H N++ +  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--SACREIALLRELKHPNVISLQK 85
Query: 499 -YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY-----LQ 551
            + +  D  + L+++Y  +   DL+      R     +K V +  G+ + LLY     + 
Sbjct: 86  VFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 552 EYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDE-ANTGRIVGTYGY 605
                 V+HRDLK +NIL+  E  P     KI+D G A+LF   +   A+   +V T+ Y
Sbjct: 143 YLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 606 VPPEYVKKG-IYSMKYDVYSFGVLLLQIISSK 636
             PE +     Y+   D+++ G +  ++++S+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 107 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+A    +  D+   G  V
Sbjct: 155 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMXG-YV 206
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 15/94 (15%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNIL-LDNELNP---KISDFGMAKLFRKDVDEANTGR 598
           +T+ + YL       V+HRDLK SNIL +D   NP   +I DFG AK  R     A  G 
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-----AENGL 176
Query: 599 IVG---TYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           +     T  +V PE +++  Y    D++S GVLL
Sbjct: 177 LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLGY 499
           +G G +G V      R  Q+ AVK+LS      +   +   E+ L   L+H N++ +L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 500 CTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            T         E YL    +   L + ++   L  +    ++  + +GL Y+       +
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG---I 152
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
           IHRDLK SN+ ++ +   +I DFG+A    +  DE  TG  V T  Y  PE +   + Y+
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLA----RQADEEMTG-YVATRWYRAPEIMLNWMHYN 207
Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S G ++ +++  K
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DF +A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 42/222 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST--------QGLEEFKNEVSL 484
           +  +S+ + LG G FG V+   +  + +E  VK +               L +   E+++
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF--------DPIRRYVLDWQKR 536
            +R++H N+++VL     +    L+ E      LDL+ F        +P+  Y+  +++ 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAFIDRHPRLDEPLASYI--FRQL 139
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           V+ +     G L L++     +IHRD+K  NI++  +   K+ DFG A    +       
Sbjct: 140 VSAV-----GYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER------- 182
Query: 597 GRI----VGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQII 633
           G++     GT  Y  PE +    Y   + +++S GV L  ++
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1ITX|A Chain A, Catalytic Domain Of Chitinase A1 From Bacillus Circulans Wl-12 Length = 419

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 71/314 (22%)
Query: 81  NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
           N +++ NP++KT++S+  W   N                 S +   ++ R+ F  S++  
Sbjct: 114 NKLKQTNPNLKTIISVGGWTWSNR---------------FSDVAATAATREVFANSAVDF 158
Query: 139 ARLYGFQGIDLFWLWPNSTDLN----------SLGILLDEWK-----ASASDQPELTLSM 183
            R Y F G+DL W +P S  L+          +  +LL + +     A A D  +  L++
Sbjct: 159 LRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDGKKYLLTI 218
Query: 184 AVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAAL-YNPSSNIS---- 238
           A   S T+   +  +  +   ++W +++ YD++  + + ++  +A L Y+P+++ +    
Sbjct: 219 ASGASATY-AANTELAKIAAIVDWINIMTYDFNG-AWQKISAHNAPLNYDPAASAAGVPD 276
Query: 239 -----TDFGIREWLRRGFPANKLVLGARASGPG--------------ITIDGSMG----- 274
                   G +  L  G PA KLVLG    G G               T   S+G     
Sbjct: 277 ANTFNVAAGAQGHLDAGVPAAKLVLGVPFYGRGWDGCAQAGNGQYQTCTGGSSVGTWEAG 336
Query: 275 ----YKFIRAFIQNYGYGAAPVYNASYVVNLF--TSGATWINFDGVETIKAKISYAKEKN 328
               Y     +I   GY     +N +  V      S   +I++D  E++  K +Y K K 
Sbjct: 337 SFDFYDLEANYINKNGY--TRYWNDTAKVPYLYNASNKRFISYDDAESVGYKTAYIKSKG 394
Query: 329 LLGYKAFQLSNDDN 342
           L G   ++LS D N
Sbjct: 395 LGGAMFWELSGDRN 408

>pdb|1E6N|B Chain B, Chitinase B From Serratia Marcescens Inactive Mutant E144q In Complex With N-Acetylglucosamine-Pentamer Length = 499

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 31  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 90
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 91  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRAKFAQSCVRIMKDYGFDGVDIDWQ 144
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 145 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 204
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D       + +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 205 PLD-------YINLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 256
Query: 249 RGFPA 253
           R FP+
Sbjct: 257 RAFPS 261

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +     +G G +G V      R G + A+K+L          F++E+      + + LL+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLK 79
Query: 496 VLGYCTERDENM--LIYEYLPNKSLD----LYLFDPIRRYVL-DWQKRVNIIEGVTQGLL 548
            +     R EN+  L+  + P+++LD     YL  P     L    K   + E   Q L+
Sbjct: 80  HM-----RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134
Query: 549 YLQEYSNFR------VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           Y Q     R      +IHRDLK  N+ ++ +   KI DFG+A    +  D    G +V T
Sbjct: 135 Y-QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMXGXVV-T 188
Query: 603 YGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
             Y  PE +   + Y+   D++S G ++ ++I+ K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1OGB|A Chain A, Chitinase B From Serratia Marcescens Mutant D142n Length = 499

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 31  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 90
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 91  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRAKFAQSCVRIMKDYGFDGVDINWE 144
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 145 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 204
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D       + +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 205 PLD-------YINLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 256
Query: 249 RGFPA 253
           R FP+
Sbjct: 257 RAFPS 261

>pdb|1H0G|A Chain A, Complex Of A Chitinase With The Natural Product Cyclopentapeptide Argadin From Clonostachys Length = 499

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 31  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 90
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 91  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRTKFAQSCVRIMKDYGFDGVDIDWE 144
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 145 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 204
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D       + +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 205 PLD-------YINLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 256
Query: 249 RGFPA 253
           R FP+
Sbjct: 257 RAFPS 261

>pdb|1E15|A Chain A, Chitinase B From Serratia Marcescens Length = 499

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 31  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 90
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 91  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRAKFAQSCVRIMKDYGFDGVDIDWE 144
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 145 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 204
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D       + +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 205 PLD-------YINLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 256
Query: 249 RGFPA 253
           R FP+
Sbjct: 257 RAFPS 261

>pdb|1E6Z|A Chain A, Chitinase B From Serratia Marcescens Wildtype In Complex With Catalytic Intermediate Length = 498

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 30  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 89
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 90  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRAKFAQSCVRIMKDYGFDGVDIDWE 143
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 144 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 203
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D +       +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 204 PLDYI-------NLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 255
Query: 249 RGFPA 253
           R FP+
Sbjct: 256 RAFPS 260

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 443 LGEGGFGPVYK----GNLPRGQEFAVKRLSAT----STQGLEEFKNEVSLTARLQHVNLL 494
           LG+GG+G V++         G+ FA+K L       + +     K E ++   ++H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            ++       +  LI EYL    L + L    R  +         +  ++  L +L +  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              +I+RDLK  NI+L+++ + K++DFG+ K    D    +T    GT  Y+ PE + + 
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 615 IYSMKYDVYSFGVLLLQIISS 635
            ++   D +S G L+  +++ 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|1UR9|A Chain A, Interactions Of A Family 18 Chitinase With The Designed Inhibitor Hm508, And Its Degradation Product, Chitobiono-Delta-Lactone Length = 499

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 39  FPLSDINSA---LFTHLICAFAEVDS---STYQLSISSANQQYFSIFANSVRRKNPSIKT 92
           FP+S+I  A     TH+  +F +++S     +  + + A  +       +++  NPS++ 
Sbjct: 31  FPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKAHNPSLRI 90
Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           + SI       Y + LG  + N     + V   + R  F +S +R  + YGF G+D+ W 
Sbjct: 91  MFSI---GGWYYSNDLGVSHAN---YVNAVKTPASRAKFAQSCVRIMKDYGFDGVDINWE 144
Query: 153 WPNSTDLNSLGILLDEWKASASDQP----------ELTLSMA------VRYSPTHETVSY 196
           +P + +++     L E +   + Q           +LT++ A       RY      +  
Sbjct: 145 YPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVA 204
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE----W----LR 248
           P+D       + +L+ YD   P  E VT   AAL+  ++  +    +RE    W    L 
Sbjct: 205 PLD-------YINLMTYDLAGP-WEKVTNHQAALFGDAAGPTFYNALREANLGWSWEELT 256
Query: 249 RGFPA 253
           R FP+
Sbjct: 257 RAFPS 261

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 443 LGEGGFGPVYK----GNLPRGQEFAVKRLSAT----STQGLEEFKNEVSLTARLQHVNLL 494
           LG+GG+G V++         G+ FA+K L       + +     K E ++   ++H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            ++       +  LI EYL    L + L    R  +         +  ++  L +L +  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              +I+RDLK  NI+L+++ + K++DFG+ K      D   T    GT  Y+ PE + + 
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 615 IYSMKYDVYSFGVLLLQIISS 635
            ++   D +S G L+  +++ 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
           +L L    +  +IHRD+K  N+LLD   + K++DFG   K+    +   +T   VGT  Y
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDY 241
Query: 606 VPPEYVK----KGIYSMKYDVYSFGVLLLQII 633
           + PE +K     G Y  + D +S GV L +++
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI  FG+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI D G+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV----- 496
           LG GG G V+   +    +  A+K++  T  Q ++    E+ +  RL H N+++V     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 497 ---------LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
                    +G  TE +   ++ EY+     ++    P+    L+   R+ + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL----LEEHARLFMYQ-LLRGL 133
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEANTGR----IVGT 602
            Y+   +   V+HRDLK +N+ ++ E L  KI DFG+A++   D   ++ G     +V  
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHYSHKGHLSEGLVTK 188
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           +   P   +    Y+   D+++ G +  ++++ K
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI DFG+     +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLC----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI D G+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
           +L L    +   IHRD+K  N+LLD   + K++DFG   K+ ++ +   +T   VGT  Y
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDY 240
Query: 606 VPPEYVK----KGIYSMKYDVYSFGVLLLQII 633
           + PE +K     G Y  + D +S GV L +++
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
           + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
           + +L   T            P +SL    D+YL   +       ++  QK  +     +I
Sbjct: 84  IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + +GL Y+       +IHRDLK SN+ ++ +   KI D G+A    +  D+  TG  V
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLA----RHTDDEMTG-YV 183
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +   + Y+   D++S G ++ ++++ +
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
           +L L    +   IHRD+K  N+LLD   + K++DFG   K+ ++ +   +T   VGT  Y
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDY 235
Query: 606 VPPEYVK----KGIYSMKYDVYSFGVLLLQII 633
           + PE +K     G Y  + D +S GV L +++
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|1KFW|A Chain A, Structure Of Catalytic Domain Of Psychrophilic Chitinase B From Arthrobacter Tad20 Length = 435

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 51/243 (20%)
Query: 144 FQGIDLFWLWPNS------------TDLNSLGILLDEWKA-----SASDQPELTLSMAVR 186
           F GID+ W WP +             D  +   LL E++       +++  +  LS  + 
Sbjct: 175 FDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSAFLP 234
Query: 187 YSPTH-ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN-------PSSNIS 238
            +P   +   +   +  K+L++  +  YD H      +TG  A LY+       PS   S
Sbjct: 235 ANPADIDAGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFS 294
Query: 239 TDFGIREWLRRGFPANKLVLGARASGPGIT-----------IDGSMG--------YKFIR 279
            D  ++++L  G    +L LG  A G G T            DG+ G        Y  ++
Sbjct: 295 ADKAVKKYLAAGIDPKQLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKLK 354
Query: 280 AFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
               ++       Y+A+        G  W ++D + T K K  Y   K L G   ++LS 
Sbjct: 355 TLGTDH-------YDAATGSAWRYDGTQWWSYDNIATTKQKTDYIVSKGLGGGMWWELSG 407
Query: 340 DDN 342
           D N
Sbjct: 408 DRN 410

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGY 605
           +L L    +   IHRD+K  N+LLD   + K++DFG   K+ ++ +   +T   VGT  Y
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDY 240
Query: 606 VPPEYVK----KGIYSMKYDVYSFGVLLLQII 633
           + PE +K     G Y  + D +S GV L +++
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 556 FRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            +V HRDLK  N LLD    P  KI DFG +K     V  +     VGT  Y+ PE + K
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 189
Query: 614 GIYSMKY-DVYSFGVLL 629
             Y  K  DV+S GV L
Sbjct: 190 KEYDGKVADVWSCGVTL 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 556 FRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            +V HRDLK  N LLD    P  KI DFG +K     V  +     VGT  Y+ PE + K
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 190
Query: 614 GIYSMKY-DVYSFGVLL 629
             Y  K  DV+S GV L
Sbjct: 191 KEYDGKVADVWSCGVTL 207

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVNLLR 495
           +++   +G G FG V++  L    E A+K++        + FKN E+ +   ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 496 VLGY----CTERDENM--LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV--TQGL 547
           +  +      ++DE    L+ EY+P       ++   R Y    Q    ++  +   Q L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPET-----VYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
             L    +  + HRD+K  N+LLD      K+ DFG AK+      E N   I   Y Y 
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSXICSRY-YR 208
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
            PE +     Y+   D++S G ++ +++  +
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           KL E   G ++KG   +G +  VK L     ST+   +F  E        H N+L VLG 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 500 C--TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           C         LI  ++P  SL   L +    +V+D  + V     + +G+ +L       
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
             H  L + ++++D ++  +IS   +   F+      + GR+     +V PE ++K    
Sbjct: 135 PRHA-LNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP-AWVAPEALQKKPED 186
Query: 618 MKY---DVYSFGVLLLQIIS 634
                 D++SF VLL ++++
Sbjct: 187 TNRRSADMWSFAVLLWELVT 206

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 40/77 (51%), Gaps = 6/77 (7%)
Query: 556 FRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            +V HRDLK  N LLD    P  KI+DFG +K     V  +     VGT  Y+ PE + K
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 614 GIYSMKY-DVYSFGVLL 629
             Y  K  DV+S GV L
Sbjct: 191 KEYDGKVADVWSCGVTL 207

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 555 NFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
           + ++ HRDLK  N LLD    P  KI DFG +K     V  +     VGT  Y+ PE + 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 613 KGIYSMKY-DVYSFGVLL 629
           +  Y  K  DV+S GV L
Sbjct: 191 RQEYDGKIADVWSCGVTL 208

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 474 GLEEFKNEVSLTARLQHVNLLRVLG--YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
           G    K E+ L  RL+H N+++++   Y  E+ +  ++ EY      ++    P +R+ +
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
             Q      + +  GL YL       ++H+D+K  N+LL      KIS  G+A+      
Sbjct: 109 -CQAHGYFCQ-LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYS---MKYDVYSFGVLLLQIISS 635
            +       G+  + PPE +  G+ +    K D++S GV L  I + 
Sbjct: 164 ADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
           L EGGF  VY+  ++  G+E+A+KRL +   +       EV    +L  H N+++   +C
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---FC 92
Query: 501 -----------TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
                      T + E +L+ E    + ++ +L     R  L     + I     + + +
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
           +       +IHRDLK  N+LL N+   K+ DFG A
Sbjct: 152 MHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 435 NNFS--SANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV 491
           NNF   ++ +LG G F  V +  +   GQE+A K L     +G ++ + E+     L  +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RG-QDCRAEI-----LHEI 79
Query: 492 NLLRVLGYCTE----------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
            +L +   C              E +LI EY     +   L  P    ++     + +I+
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIK 138
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTG 597
            + +G+ YL + +   ++H DLK  NILL + + P    KI DFGM+   RK        
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMS---RKIGHACELR 191
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            I+GT  Y+ PE +     +   D+++ G++   +++
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 38/235 (16%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL 488
           ++  N   S   LG G  G V ++G+  +G+  AVKR+        L E K    LT   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESD 84
Query: 489 QHVNLLRVLGYCTERDENML-IYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
            H N++R   YC+E  +  L I   L N +L DL     +    L  QK  N I  + Q 
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPKISDFGMAK-------L 586
              +    + ++IHRDLK  NIL+                L   ISDFG+ K        
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRN 638
           FR +++  +     GT G+  PE ++   K   +   D++S G +   I+S  ++
Sbjct: 203 FRXNLNNPS-----GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 38/235 (16%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL 488
           ++  N   S   LG G  G V ++G+  +G+  AVKR+        L E K    LT   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESD 84
Query: 489 QHVNLLRVLGYCTERDENML-IYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
            H N++R   YC+E  +  L I   L N +L DL     +    L  QK  N I  + Q 
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPKISDFGMAK-------L 586
              +    + ++IHRDLK  NIL+                L   ISDFG+ K        
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRN 638
           FR +++  +     GT G+  PE ++   K   +   D++S G +   I+S  ++
Sbjct: 203 FRXNLNNPS-----GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 442 KLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFK-NEVSLTARLQHVNLLRVLGY 499
           +LG G FG V++  +   G + AVK++       LE F+  E+   A L    ++ + G 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
             E     +  E L   SL   + +   +  L   + +  +    +GL YL    + R++
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH---SRRIL 188
Query: 560 HRDLKASNILLDNE-LNPKISDFGMAKLFRKD---VDEANTGRIVGTYGYVPPEYVKKGI 615
           H D+KA N+LL ++  +  + DFG A   + D    D      I GT  ++ PE V    
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 616 YSMKYDVYSFGVLLLQII 633
              K DV+S   ++L ++
Sbjct: 249 CDAKVDVWSSCCMMLHML 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL ++      KI+DFG +K+      E +  R + 
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLC 183
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL ++      KI+DFG +K+      E +  R + 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLC 177
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL   + +   KI+DFG +K+      E +  R + 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLC 177
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL   + +   KI+DFG +K+      E +  R + 
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLC 176
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL   + +   KI+DFG +K+    + E +  R + 
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI----LGETSLMRTLC 316
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 353

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL   + +   KI+DFG +K+      E +  R + 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLC 177
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGR-IV 600
           Q LL +Q      +IHRDLK  N+LL ++      KI+DFG +K+    + E +  R + 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI----LGETSLMRTLC 302
Query: 601 GTYGYVPPEY---VKKGIYSMKYDVYSFGVLLLQIIS 634
           GT  Y+ PE    V    Y+   D +S GV+L   +S
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 431 KAATNNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL 488
           ++  N   S   LG G  G V ++G+  +G+  AVKR+        L E K    LT   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESD 66
Query: 489 QHVNLLRVLGYCTERDENML-IYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
            H N++R   YC+E  +  L I   L N +L DL     +    L  QK  N I  + Q 
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPKISDFGMAK-------L 586
              +    + ++IHRDLK  NIL+                L   ISDFG+ K        
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-------KGIYSMKYDVYSFGVLLLQIISSKRN 638
           FR +++  +     GT G+  PE ++       K   +   D++S G +   I+S  ++
Sbjct: 185 FRXNLNNPS-----GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
           LGEG +  V    +L  G+E+AVK +   +         EV    + Q + N+L ++ + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            +     L++E L   S+  ++    ++   + ++   ++  V   L +L       + H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 561 RDLKASNILLDN--ELNP-KISDFGMAKLFRKD-----VDEANTGRIVGTYGYVPPEYV- 611
           RDLK  NIL ++  +++P KI DF +    + +     +         G+  Y+ PE V 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 612 ----KKGIYSMKYDVYSFGVLLLQIIS 634
               +   Y  + D++S GV+L  ++S
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLS 221
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	656
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-108
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-108
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-97
3aqu_A	356	AT4G19810; stress response, TIM barrel, hydrolase,	4e-96
3alf_A	353	Chitinase, class V; hydrolase; 1.20A {Nicotiana ta	9e-93
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-73
4ay1_A	365	Chitinase-3-like protein 2; chilectin, lectin, chi	5e-71
1vf8_A	377	YM1, secretory protein; chitinase, CHI-lectin, str	5e-66
3fy1_A	395	Amcase, TSA1902, acidic mammalian chitinase; struc	3e-65
2pi6_A	361	Chitinase-3-like protein 1; complex, signaling pro	3e-65
1wb0_A	445	Chitinase 1, chitotriosidase 1; cyclopentapeptide	7e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-47
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-47
1jnd_A	420	Imaginal DISC growth factor-2; IDGF, chitinase, in	8e-47
1w9p_A	433	Chitinase; peptide inhibitors, argifin, argadin, g	1e-46
3g6m_A	406	Chitinase, crchi1; inhibitor, caffeine, glycosidas	3e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-46
1ll7_A	392	Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {	5e-46
3qok_A	420	Putative chitinase II; structural genomics, PSI-bi	2e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-42
3fnd_A	312	Chitinase; TIM-barrel, structural genomics, PSI-2,	5e-42
1goi_A	499	Chitinase B; chitin degradation, hydrolase, glycos	8e-41
1edq_A	540	Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1	1e-40
3oa5_A	574	CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yers	1e-40
1itx_A	419	Chitinase A1, glycosyl hydrolase; alpha-beta (TIM)	5e-40
1kfw_A	435	Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrob	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
3arx_A	584	Chitinase A; TIM barrel, inhibitor complex, glycos	4e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-32
3cz8_A	319	Putative sporulation-specific glycosylase YDHD; st	6e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-31
3sim_A	275	Protein, family 18 chitinase; family 18 plant chit	1e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
3bxw_B	393	Chitinase domain-containing protein 1; TIM barrel,	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-18
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
3n12_A	333	Chitinase A, chinctu2; zinc atoms, complex, hydrol	5e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-15
1edt_A	271	Endo-beta-N-acetylglucosaminidase H, endo H; hydro	4e-15
2y8v_A	290	CHIC, class III chitinase, putative; afchic, hydro	2e-14
1nar_A	290	Narbonin; plant SEED protein; 1.80A {Vicia narbone	3e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-09
3ebv_A	302	Chinitase A; chitinase A, CHIA, glycosidase, struc	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-09
2ebn_A	289	Endo-beta-N-acetylglucosaminidase F1; hydrolase(gl	1e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3ian_A	321	Chitinase; structural genomics, hydrolase, glycosi	5e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  329 bits (845), Expect = e-108
 Identities = 93/252 (36%), Positives = 135/252 (53%), Gaps = 17/252 (6%)

Query: 413 EYFDSDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKR 466
           +  +        FSF ++K  TNNF         NK+GEGGFG VYKG +      AVK+
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61

Query: 467 LSA----TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL 522
           L+A    T+ +  ++F  E+ + A+ QH NL+ +LG+ ++ D+  L+Y Y+PN SL   L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121

Query: 523 FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
                   L W  R  I +G   G+ +L E      IHRD+K++NILLD     KISDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178

Query: 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
           +A+   K      T RIVGT  Y+ PE + +G  + K D+YSFGV+LL+II+       +
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237

Query: 643 GTSENLNFLEYA 654
              + L  L+  
Sbjct: 238 REPQLL--LDIK 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  329 bits (845), Expect = e-108
 Identities = 98/254 (38%), Positives = 146/254 (57%), Gaps = 11/254 (4%)

Query: 408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
             PA E  +     L+ FS  +++ A++NFS+ N LG GGFG VYKG L  G   AVKRL
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62

Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
               TQG E +F+ EV + +   H NLLR+ G+C    E +L+Y Y+ N S+   L +  
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 527 R-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
             +  LDW KR  I  G  +GL YL ++ + ++IHRD+KA+NILLD E    + DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 586 LFRKDVDEANTG---RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
           L     D  +T     + GT G++ PEY+  G  S K DV+ +GV+LL++I+ +R     
Sbjct: 183 LM----DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238

Query: 643 GTS--ENLNFLEYA 654
             +  +++  L++ 
Sbjct: 239 RLANDDDVMLLDWV 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  300 bits (770), Expect = 4e-97
 Identities = 90/262 (34%), Positives = 142/262 (54%), Gaps = 10/262 (3%)

Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL 456
           +G +  +   +   A                 D++ ATNNF     +G G FG VYKG L
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
             G + A+KR +  S+QG+EEF+ E+   +  +H +L+ ++G+C ER+E +LIY+Y+ N 
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 517 SLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575
           +L  +L+        + W++R+ I  G  +GL YL   +   +IHRD+K+ NILLD    
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177

Query: 576 PKISDFGMAKLFRKDVDEANTG---RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
           PKI+DFG++K      +   T     + GT GY+ PEY  KG  + K DVYSFGV+L ++
Sbjct: 178 PKITDFGISKKG---TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 633 ISSKRNARYYGTSENLNFLEYA 654
           + ++         E +N  E+A
Sbjct: 235 LCARSAIVQSLPREMVNLAEWA 256

>3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana} Length = 356

 Score =  298 bits (766), Expect = 4e-96
 Identities = 151/355 (42%), Positives = 214/355 (60%), Gaps = 45/355 (12%)

Query: 25  QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVR 84
           QT +KA YW    EFP++DI+S+LFTHL CAFA+++S T Q+++SSANQ  FS F  +V+
Sbjct: 2   QTVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSANQPKFSTFTQTVQ 61

Query: 85  RKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLY 142
           R+NPS+KTLLSI       + Y              +SM  + + RKSFI+SSIR AR Y
Sbjct: 62  RRNPSVKTLLSIGGGIADKTAY--------------ASMASNPTSRKSFIDSSIRVARSY 107

Query: 143 GFQGIDLFWLWPNS-TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVS 195
           GF G+DL W +P+S T++ + G LL EW+      AS+S +P L L+ AV YS  + +V 
Sbjct: 108 GFHGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSSGKPRLLLAAAVFYSNNYYSVL 167

Query: 196 YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-ISTDFGIREWLRRGFPAN 254
           YP+ ++  +L+W +L+AYD++ P    VTG  AAL++PS+   S D G R W++ G PA 
Sbjct: 168 YPVSAVASSLDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGPSGDAGTRSWIQAGLPAK 227

Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
           K VLG                   A  +G  I+ DGS+GY  IR FI +   GA  VYN+
Sbjct: 228 KAVLGFPYYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVD--NGATTVYNS 285

Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQ 350
           + V +   +G  WI +D  ++I  K+ YAK++ LLGY ++ +  DDN  LSRAA 
Sbjct: 286 TVVGDYCYAGTNWIGYDDNQSIVTKVRYAKQRGLLGYFSWHVGADDNSGLSRAAS 340

>3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A* Length = 353

 Score =  289 bits (743), Expect = 9e-93
 Identities = 136/352 (38%), Positives = 194/352 (55%), Gaps = 44/352 (12%)

Query: 28  IKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
           +K GYW       L++I+S LFTHL CAFA+++    QL IS  NQ  F  F ++V+RKN
Sbjct: 4   VKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKN 63

Query: 88  PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
           PS+KT LSI                 N +    M    + RKSFI+SSIR AR  GF G+
Sbjct: 64  PSVKTFLSI------------AGGRANSTAYGIMARQPNSRKSFIDSSIRLARQLGFHGL 111

Query: 148 DLFWLWPNS-TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPIDS 200
           DL W +P S  D+ +LG LL+EW+      A  S +  L L+ AV  SP    ++YP++S
Sbjct: 112 DLDWEYPLSAADMTNLGTLLNEWRTAINTEARNSGRAALLLTAAVSNSPRVNGLNYPVES 171

Query: 201 MKKNLNWAHLVAYDYHMPSKE-NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
           + +NL+W +L+AYD++ P+   + T  HA L++P +++S   GI  W++ G P  KLVLG
Sbjct: 172 LARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLVLG 231

Query: 260 -------------------ARASGPGIT---IDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
                              A A+G        DGSM Y  IR +I      A  VYNA+ 
Sbjct: 232 IPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVE--SRATTVYNATI 289

Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
           V +   SG+ WI++D  +T++ K++Y K + LLGY A+ ++ D NW LSR A
Sbjct: 290 VGDYCYSGSNWISYDDTQTVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTA 341

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  236 bits (605), Expect = 8e-73
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 22/244 (9%)

Query: 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSL 484
               ++   +           G FG V+K      +  AVK       Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 485 TARLQHVNLLRVLGYCTERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
              ++H N+L+ +G          +  LI  +    SL  +L    +  V+ W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 541 EGVTQGLLYL-------QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
           E + +GL YL       ++     + HRD+K+ N+LL N L   I+DFG+A  F      
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 594 ANTGRIVGTYGYVPPEYVKKGI-----YSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
            +T   VGT  Y+ PE ++  I       ++ D+Y+ G++L ++ S    A        L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 649 NFLE 652
            F E
Sbjct: 248 PFEE 251

>4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens} Length = 365

 Score =  233 bits (597), Expect = 5e-71
 Identities = 80/354 (22%), Positives = 149/354 (42%), Gaps = 60/354 (16%)

Query: 26  TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
            W  +       +F   +I+  L +HLI +FA ++++   + I   ++       NS++ 
Sbjct: 10  NW--SQDRQEPGKFTPENIDPFLCSHLIYSFASIENNK--VIIKDKSEVMLYQTINSLKT 65

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           KNP +K LLSI  +   +  +                MV  S+ R  FI S I   R + 
Sbjct: 66  KNPKLKILLSIGGYLFGSKGF--------------HPMVDSSTSRLEFINSIILFLRNHN 111

Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYP 197
           F G+D+ W++P+  +     +L+ E         + S +  L L+  V         SY 
Sbjct: 112 FDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTAGVSAGRQMIDNSYQ 171

Query: 198 IDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSN------ISTDFGIREWLRRG 250
           ++ + K+L++ +L+++D+H    K  +TG ++ L     +       + ++ +  W+ +G
Sbjct: 172 VEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKG 231

Query: 251 FPANKLVLG------------------ARASGPGIT-----IDGSMGYKFIRAFIQNYGY 287
            P+ K+V+G                  A ASGPG         G + Y  I  F++    
Sbjct: 232 MPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKI 291

Query: 288 GAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                    Y V     G  W+ +D V++++ K+ + K  NL G   + +  DD
Sbjct: 292 TRLQDQQVPYAVK----GNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDD 341

>1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A Length = 377

 Score =  220 bits (563), Expect = 5e-66
 Identities = 87/359 (24%), Positives = 141/359 (39%), Gaps = 65/359 (18%)

Query: 26  TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
           +W  A        F   +I+  L THLI AFA + ++   ++ +           N ++ 
Sbjct: 9   SW--AKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNE--ITYTHEQDLRDYEALNGLKD 64

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           KN  +KTLL+I  W    + +              S+MV    +R+ FI+S IR  R Y 
Sbjct: 65  KNTELKTLLAIGGWKFGPAPF--------------SAMVSTPQNRQIFIQSVIRFLRQYN 110

Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
           F G++L W +P S      D +   +L+ E +      +   D P L L+          
Sbjct: 111 FDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEKDIPRLLLTSTGAGIIDVI 170

Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI------STDFGIREW 246
              Y I  + ++L++  ++ YD H P  +  TG ++ LY    +I      + D  I  W
Sbjct: 171 KSGYKIPELSQSLDYIQVMTYDLHDPK-DGYTGENSPLYKSPYDIGKSADLNVDSIISYW 229

Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
              G  + KL++G                   A     G         G + Y  +  F+
Sbjct: 230 KDHGAASEKLIVGFPAYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFL 289

Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                GA  V++A   V     G  W+ +D V + K K  + K+ NL G   + L  DD
Sbjct: 290 NE---GATEVWDAPQEVPYAYQGNEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDD 345

>3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A* Length = 395

 Score =  219 bits (560), Expect = 3e-65
 Identities = 92/359 (25%), Positives = 148/359 (41%), Gaps = 65/359 (18%)

Query: 26  TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
            W  A Y      F   DIN  L THLI AFA + ++     I   +   +  F N ++ 
Sbjct: 9   NW--AQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITT-IEWNDVTLYQAF-NGLKN 64

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           KN  +KTLL+I  WN   + +              ++MV    +R++FI S I+  R Y 
Sbjct: 65  KNSQLKTLLAIGGWNFGTAPF--------------TAMVSTPENRQTFITSVIKFLRQYE 110

Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
           F G+D  W +P S      D +   +L+ E +      A   ++P L ++ AV    ++ 
Sbjct: 111 FDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNI 170

Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREW 246
              Y I  + + L++ H++ YD H    E  TG ++ LY   ++      ++ D+ +  W
Sbjct: 171 QSGYEIPQLSQYLDYIHVMTYDLHGSW-EGYTGENSPLYKYPTDTGSNAYLNVDYVMNYW 229

Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
              G PA KL++G                   A  SG G         G   Y  I  F+
Sbjct: 230 KDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFL 289

Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
           +N   GA   ++A   V     G  W+ +D V++   K  + K     G   + +  DD
Sbjct: 290 KN---GATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDD 345

>2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ... Length = 361

 Score =  217 bits (556), Expect = 3e-65
 Identities = 90/351 (25%), Positives = 142/351 (40%), Gaps = 58/351 (16%)

Query: 26  TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
           +W  + Y           I+  L TH+I  FA + ++       +    Y ++  N+++ 
Sbjct: 9   SW--SQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEIDTWEWNDVTLYDTL--NTLKN 64

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           +NP +KTLLS+  WN     +              S +   +  R++FI+S     R +G
Sbjct: 65  RNPKLKTLLSVGGWNFGPERF--------------SKIASKTQSRRTFIKSVPPFLRTHG 110

Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPI 198
           F G+DL WL+P   D   L  L+ E KA     + +   +L LS AV          Y I
Sbjct: 111 FDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDI 170

Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIREWLRRGFPA 253
             + ++L++  L+ YD+H        G H+ L+  + +      + D+ +   LR G PA
Sbjct: 171 AQISRHLDFISLLTYDFHGAW-RQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPA 229

Query: 254 NKLVLG------------------ARASGPGIT-----IDGSMGYKFIRAFIQNYGYGAA 290
           NKLV+G                  A  SGPGI        G + Y  I  F+        
Sbjct: 230 NKLVMGIPTFGRSFTLASSKTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLHGATTHRF 289

Query: 291 PVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                 Y       G  W+ +D  E++K K  Y K + L G   + L  DD
Sbjct: 290 RDQQVPYATK----GNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336

>1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A* Length = 445

 Score =  216 bits (553), Expect = 7e-64
 Identities = 101/359 (28%), Positives = 157/359 (43%), Gaps = 67/359 (18%)

Query: 26  TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
            W  A Y      F   D++ +L THLI AFA + +     S +  N +      N +++
Sbjct: 9   NW--AQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQL--STTEWNDETLYQEFNGLKK 64

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
            NP +KTLL+I  WN     +              + MV  +++R++F+ S+IR  R Y 
Sbjct: 65  MNPKLKTLLAIGGWNFGTQKF--------------TDMVATANNRQTFVNSAIRFLRKYS 110

Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
           F G+DL W +P S      D      L+ +        A  S +  L LS AV    T+ 
Sbjct: 111 FDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYV 170

Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREW 246
              Y +D + +NL++ +L+AYD+H    E VTG ++ LY           ++ D  +++W
Sbjct: 171 DAGYEVDKIAQNLDFVNLMAYDFHGSW-EKVTGHNSPLYKRQEESGAAASLNVDAAVQQW 229

Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
           L++G PA+KL+LG                   A A+G G         G + Y  + ++ 
Sbjct: 230 LQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWK 289

Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                GA         V        W+ FD VE+ K K+SY K+K L G   + L  DD
Sbjct: 290 -----GATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  200 bits (510), Expect = 7e-59
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 34/248 (13%)

Query: 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--V 482
            + S+     +N      +G G +G VYKG+L   +  AVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 483 SLTARLQHVNLLRVLGYCTERDEN-----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
                ++H N+ R +        +     +L+ EY PN SL  YL      +  DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 538 NIIEGVTQGLLYL------QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---- 587
            +   VT+GL YL       ++    + HRDL + N+L+ N+    ISDFG++       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 588 --RKDVDEANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISSKRN 638
             R   ++      VGT  Y+ PE ++  +          + D+Y+ G++  +I     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 639 ARYYGTSE 646
                +  
Sbjct: 235 LFPGESVP 242

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  183 bits (467), Expect = 6e-53
 Identities = 62/191 (32%), Positives = 103/191 (53%), Gaps = 6/191 (3%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
            K+G G FG V++     G + AVK L       + + EF  EV++  RL+H N++  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
             T+     ++ EYL   SL   L     R  LD ++R+++   V +G+ YL    N  +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
           +HR+LK+ N+L+D +   K+ DFG+++L  K     ++    GT  ++ PE ++    + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 619 KYDVYSFGVLL 629
           K DVYSFGV+L
Sbjct: 219 KSDVYSFGVIL 229

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  172 bits (438), Expect = 7e-49
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 11/198 (5%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
             +G G FG V K    R ++ A+K++ + S    + F  E+   +R+ H N++++ G C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +   L+ EY    SL   L              ++     +QG+ YL       +IH
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 561 RDLKASNILLDNELN-PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           RDLK  N+LL       KI DFG A     D+    T    G+  ++ PE  +   YS K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNN-KGSAAWMAPEVFEGSNYSEK 183

Query: 620 YDVYSFGVLLLQIISSKR 637
            DV+S+G++L ++I+ ++
Sbjct: 184 CDVFSWGIILWEVITRRK 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  170 bits (432), Expect = 2e-48
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 21/201 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRL----SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
             +G GGFG VY+     G E AVK          +Q +E  + E  L A L+H N++ +
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
            G C +     L+ E+     L+  L        +     VN    + +G+ YL + +  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 557 RVIHRDLKASNILLDNELNP--------KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
            +IHRDLK+SNIL+  ++          KI+DFG+A+ + +    +      G Y ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183

Query: 609 EYVKKGIYSMKYDVYSFGVLL 629
           E ++  ++S   DV+S+GVLL
Sbjct: 184 EVIRASMFSKGSDVWSYGVLL 204

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  170 bits (434), Expect = 3e-48
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 19/223 (8%)

Query: 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
             LG+G FG   K      G+   +K L     +    F  EV +   L+H N+L+ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
             +      I EY+   +L   +     +    W +RV+  + +  G+ YL    +  +I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL---HSMNII 130

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR------------IVGTYGYVP 607
           HRDL + N L+    N  ++DFG+A+L   +  +    R            +VG   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
           PE +    Y  K DV+SFG++L +II     A        ++F
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN-ADPDYLPRTMDF 232

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  168 bits (427), Expect = 1e-47
 Identities = 52/212 (24%), Positives = 106/212 (50%), Gaps = 25/212 (11%)

Query: 441 NKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQG-------LEEFKNEVSLTARLQHVN 492
            ++G+GGFG V+KG  +      A+K L    ++G        +EF+ EV + + L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++++ G         ++ E++P   L   L D  + + + W  ++ ++  +  G+ Y+Q 
Sbjct: 85  IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 553 YSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
             N  ++HRDL++ NI L +      +  K++DFG+++             ++G + ++ 
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194

Query: 608 PE--YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           PE    ++  Y+ K D YSF ++L  I++ + 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  165 bits (420), Expect = 8e-47
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 17/196 (8%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
            KL E   G ++KG   +G +  VK L     ST+   +F  E        H N+L VLG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 499 YCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
            C         LI  ++P  SL   L +    +V+D  + V     + +G+ +L      
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--- 613
            +    L + ++++D ++  +IS   +   F       + GR+     +V PE ++K   
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRM-YAPAWVAPEALQKKPE 185

Query: 614 GIYSMKYDVYSFGVLL 629
                  D++SF VLL
Sbjct: 186 DTNRRSADMWSFAVLL 201

>1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A* Length = 420

 Score =  169 bits (431), Expect = 8e-47
 Identities = 73/387 (18%), Positives = 129/387 (33%), Gaps = 101/387 (26%)

Query: 43  DINSALFTHLICAFAEVDSSTYQLSI----SSANQQYFSIFANSVRRKNPSIKTLLSI-- 96
           +I     +HL+  +A +     Q           +  FS    S++RK P +K LLS+  
Sbjct: 27  EIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSLKRKYPHLKVLLSVGG 85

Query: 97  WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS 156
            +  +  + +           +  + G+   +  FI S+    + YGF G+DL + +P +
Sbjct: 86  DHDIDPDHPN---------KYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKN 136

Query: 157 TDLNSLGILLDEWKASAS------------------------------DQPELTLSMAVR 186
                 G L   WK+                                       LS+ V 
Sbjct: 137 KPRKVHGDLGLAWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRADGFLLSLTVL 196

Query: 187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSN------IST 239
            +    T  + I ++   +++ +L  +D+  P          A +Y+P  +      ++ 
Sbjct: 197 PNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYHPDGSKDRLAHLNA 255

Query: 240 DFGIREWLRRGFPANKLVLG----------------------ARASGPGIT-----IDGS 272
           DF +  WL +GFP+NK+ LG                         SGP          G 
Sbjct: 256 DFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQKPGL 315

Query: 273 MGYKFIRAFIQNYGYGA------------------APVYNASYVVNLFTSGATWINFDGV 314
           + Y  I   + N                         +           +   W+++D  
Sbjct: 316 LSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQ--ITEGIWVSYDDP 373

Query: 315 ETIKAKISYAKEKNLLGYKAFQLSNDD 341
           ++   K +YA+ KNL G   F LS DD
Sbjct: 374 DSASNKAAYARVKNLGGVALFDLSYDD 400

>1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A* Length = 433

 Score =  169 bits (431), Expect = 1e-46
 Identities = 76/357 (21%), Positives = 136/357 (38%), Gaps = 71/357 (19%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSIS-------------SANQQYFSIFAN- 81
           GR     D+     TH++ AFA V   T ++ ++             S +    +++   
Sbjct: 56  GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 115

Query: 82  ----SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS 135
                ++++N ++K LLSI  W    S                +      + RK+F +++
Sbjct: 116 KQLYLLKKQNRNLKVLLSIGGWTY--SPN-------------FAPAASTDAGRKNFAKTA 160

Query: 136 IRTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRY 187
           ++  +  GF G+D+ W +P +          L  +   LD + A+ +      L++A   
Sbjct: 161 VKLLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPA 220

Query: 188 SPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFG 242
            P        +  M + L++ +L+AYDY   S  +++G  A +YN +SN      +T   
Sbjct: 221 GPDK-IKVLHLKDMDQQLDFWNLMAYDYAG-SFSSLSGHQANVYNDTSNPLSTPFNTQTA 278

Query: 243 IREWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNY 285
           +  +   G PANK+VLG                     G G   +G   YK +       
Sbjct: 279 LDLYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNGVGQGSWENGVWDYKALPQ--AGA 336

Query: 286 GYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
                P   ASY  +   +    I++D  +    K  Y K   L G   +  S+D  
Sbjct: 337 TEHVLPDIMASYSYD--ATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDKT 391

>3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A* Length = 406

 Score =  168 bits (427), Expect = 3e-46
 Identities = 78/356 (21%), Positives = 138/356 (38%), Gaps = 70/356 (19%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSS------------TYQLSISSANQQYFSIFAN-- 81
           GR F  +D+ ++   H++ +F  +                   S  S N    + +    
Sbjct: 34  GRNFQPADLQASKILHVLYSFMNLRVDGTVYSGDTYADLEKHYSDDSWNDIGTNAYGCVK 93

Query: 82  ---SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI 136
               +++ N S+K +LSI  W    ST                +     + R +F ++++
Sbjct: 94  QLYKLKKANRSLKIMLSIGGWTW--STN-------------FPAAASTEATRATFAKTAV 138

Query: 137 RTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYS 188
              + +GF GID+ W +P S          L  +   LD + A+ ++     LS+A    
Sbjct: 139 EFMKDWGFDGIDVDWEYPASETDANNMVLLLQRVRQELDSYSATYANGYHFQLSIAAPAG 198

Query: 189 PTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGI 243
           P+H      +  +   L+  +L+AYDY   S ++V+G    LY  +SN      ST   +
Sbjct: 199 PSH-YNVLKLAQLGSVLDNINLMAYDYAG-SWDSVSGHQTNLYPSTSNPSSTPFSTKAAV 256

Query: 244 REWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNYG 286
             ++  G PA+K++LG                     G G    G   YK +        
Sbjct: 257 DAYIAAGVPASKIILGMPIYGRAFVGTDGPGKPYSTIGEGSWESGIWDYKVLPKAGATVI 316

Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
                   A+Y  +  +S  T I++D  + ++ K+SYAK   L G   ++ S D  
Sbjct: 317 TD--SAAGATYSYD--SSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKT 368

>1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A Length = 392

 Score =  167 bits (424), Expect = 5e-46
 Identities = 74/355 (20%), Positives = 137/355 (38%), Gaps = 70/355 (19%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSS------------TYQLSISSANQQYFSIFAN-- 81
           GR     D+ +  FTH++ AFA +  S                     ++   +++    
Sbjct: 16  GRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIK 75

Query: 82  ---SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI 136
               +++ N ++KTLLSI  W    S                 +       RK F ++S+
Sbjct: 76  QMYLLKKNNRNLKTLLSIGGWT--YSPN-------------FKTPASTEEGRKKFADTSL 120

Query: 137 RTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYS 188
           +  +  GF GID+ W +P            L +    LD + A   +  +  L++A    
Sbjct: 121 KLMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAG 180

Query: 189 PTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGI 243
           P +      +  M K L++ +L+AYD+   S + V+G  + ++  ++       S+D  +
Sbjct: 181 PQN-YNKLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPSTTKPESTPFSSDKAV 238

Query: 244 REWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNYG 286
           +++++ G PANK+VLG                     G G   +G   YK +    Q   
Sbjct: 239 KDYIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGGGSWENGVWDYKDMPQ--QGAQ 296

Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                   ASY  +   +    I++D V+    K  Y  +  + G   ++ S+D 
Sbjct: 297 VTELEDIAASYSYD--KNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDK 349

>3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp} Length = 420

 Score =  166 bits (421), Expect = 2e-45
 Identities = 68/428 (15%), Positives = 131/428 (30%), Gaps = 108/428 (25%)

Query: 7   RVLFFIFLSSFQLEFSDAQTWIKAGYW------LAGREFPLSDINSALFTHLICAFAEVD 60
           R+     L         AQ  +  GY+       AG    +  ++    THL  +F  + 
Sbjct: 6   RLPLLAALPLLCASALSAQPLMSVGYFNGGGDVTAGPGGDIDKLDVRQITHLNYSFGLIY 65

Query: 61  SSTYQLSISSAN-----------QQYFSIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQ 105
           +     + ++              +  +      ++R++NP +K LLS+  W  +     
Sbjct: 66  NDEKDETNAALKDPAHLHEIWLSPKVQADLQKLPALRKQNPDLKVLLSVGGWGARG---- 121

Query: 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLG-- 163
                        S     +  R  FI S+ +  + YG  GIDL W +P +     +   
Sbjct: 122 ------------FSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNGAWGLVASQ 169

Query: 164 --------ILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDY 215
                    LL   + +     +  +++AV  +         + ++   LN+ +L+ YD 
Sbjct: 170 PADRDNFTALLKSLREAV--GEQKLVTIAVGANAESPKSWVDVKAVAPVLNYINLMTYDM 227

Query: 216 HMPSKENVTGIHAALYNPSSN--------ISTDFGIREWLRRGFPANKLVLG-------- 259
                      ++ LY+ S           S DF +  +L  G   +++ LG        
Sbjct: 228 AYG----TQYFNSNLYDSSHWPTVAAADKYSADFVVNNYLAAGLKPSQMNLGIGFYGRVP 283

Query: 260 ---------------------ARASGPGITI-----------DGSMGYKFIRAFIQNYGY 287
                                    GP               D  + Y  I   + N   
Sbjct: 284 KRAVEPGIDWTKADAQNNPVTQPYFGPQQIALFASLGYDLSKDTYVKYNDIVGKLLNDPQ 343

Query: 288 GAAPVY-----NASYVVN--LFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
                +        ++            ++++   ++  K  Y K K L G   ++   D
Sbjct: 344 KRFTEHWDDEAKVPWLSVQSAEGKPLFALSYENPRSVAIKADYIKAKGLAGAMFWEYGAD 403

Query: 341 DNWALSRA 348
           D   L+R 
Sbjct: 404 DQNQLARQ 411

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (409), Expect = 4e-45
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 15/202 (7%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
            ++G G FG VYKG    G + AVK L+ T  + Q L+ FKNEV +  + +HVN+L  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 499 YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           Y T     + ++ ++    SL  +L         + +K ++I     +G+ YL    +  
Sbjct: 88  YSTA--PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYL-HAKSI- 141

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE---YVKKG 614
            IHRDLK++NI L  +   KI DFG+A    +        ++ G+  ++ PE        
Sbjct: 142 -IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 615 IYSMKYDVYSFGVLLLQIISSK 636
            YS + DVY+FG++L ++++ +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  158 bits (401), Expect = 1e-43
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
             +G+G +G V++G+  +G+  AVK  S   ++  + +  E  +  T  L+H N+L  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL---- 550
                  +     LI  Y    SL    +D ++   LD    + I+  +  GL +L    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 551 -QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---RKDVDEANTGRIVGTYGYV 606
                   + HRDLK+ NIL+       I+D G+A +       +D  N  R VGT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184

Query: 607 PPE------YVKKGIYSMKYDVYSFGVLL 629
            PE       V       + D+++FG++L
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVL 213

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  158 bits (401), Expect = 2e-43
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 29/209 (13%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
            ++G+G +G V+ G   RG++ AVK      T     +  E  +  T  ++H N+L  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL---- 550
              +   +     LI +Y  N SL  YL    +   LD +  + +      GL +L    
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 551 -QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---RKDVDEANTGRIVGTYGYV 606
                   + HRDLK+ NIL+       I+D G+A  F     +VD     R VGT  Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYM 213

Query: 607 PPE------YVKKGIYSMKYDVYSFGVLL 629
           PPE              +  D+YSFG++L
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLIL 242

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  156 bits (397), Expect = 4e-43
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
             +G+G FG VY G    G E A++ +     +   L+ FK EV    + +H N++  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            C       +I      ++L   + D   + VLD  K   I + + +G+ YL       +
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL-HAKG--I 151

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEYVK--- 612
           +H+DLK+ N+  DN     I+DFG+  +           ++    G   ++ PE ++   
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 613 ------KGIYSMKYDVYSFGVLLLQIISSK 636
                 K  +S   DV++ G +  ++ + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  155 bits (394), Expect = 2e-42
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 29/209 (13%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
             +G+G FG V++G   RG+E AVK  S   ++    +  E  +  T  L+H N+L  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
              + +       L+ +Y  + SL    FD + RY +  +  + +      GL +L    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 555 NFR-----VIHRDLKASNILLDNELNPKISDFGMAKLFR---KDVDEANTGRIVGTYGYV 606
                   + HRDLK+ NIL+       I+D G+A         +D A   R VGT  Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218

Query: 607 PPE------YVKKGIYSMKYDVYSFGVLL 629
            PE       +K      + D+Y+ G++ 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVF 247

>3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A Length = 312

 Score =  153 bits (389), Expect = 5e-42
 Identities = 51/326 (15%), Positives = 105/326 (32%), Gaps = 63/326 (19%)

Query: 31  GY---WLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
           GY        E     I     TH+  +FA V +    L+I+   ++  S+         
Sbjct: 8   GYLALDDWEFESLFPTIEWKYLTHINASFARVKADG-TLNINPVRKRIESVRE---TAHK 63

Query: 88  PSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQ 145
            ++K L+S+   +                    ++ + D   RK  I+  I   + Y   
Sbjct: 64  HNVKILISLAKNSP----------------GEFTTAINDPKARKELIQQIIAFTKEYKLD 107

Query: 146 GIDLFWLWPNSTDLNSLGILLDEWK-ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
           G D+ +   ++ D N    LL   +    + +  + ++ AV     +          ++ 
Sbjct: 108 GFDIDYEEYDNWDKN-FPSLLVFARGLYLAKEKNMLMTCAVNSRWLNYGT-----EWEQY 161

Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRR-GFPANKLVLG---- 259
            ++ +L++YD    +  +    HA+  +          ++ W  +     +K+V G    
Sbjct: 162 FDYINLMSYDRGAFT--DKPVQHASYDD------FVKDLKYWNEQCRASKSKIVGGLPFY 213

Query: 260 AR----ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVE 315
                 +    +     + Y  I   + N                          ++G  
Sbjct: 214 GYSWEESLQGAVDDVRGIRYSGILKHLGNEAA--------------DKDNIGKTYYNGRP 259

Query: 316 TIKAKISYAKEKNLLGYKAFQLSNDD 341
           TI  K  + KE +  G   +QL  D 
Sbjct: 260 TIANKCKFIKENDYAGVMIWQLFQDA 285

>1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A* Length = 499

 Score =  155 bits (392), Expect = 8e-41
 Identities = 66/400 (16%), Positives = 137/400 (34%), Gaps = 100/400 (25%)

Query: 30  AGYWLAGREFPLSDINSAL---FTHLICAFAEVDSSTY-QLSISSANQQYFSIFA--NSV 83
                +   FP+S+I  A     TH+  +F +++S+       ++ + +   +     ++
Sbjct: 22  TETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTAL 81

Query: 84  RRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
           +  NPS++ + SI  W    S    +            + V   + R  F +S +R  + 
Sbjct: 82  KAHNPSLRIMFSIGGWY--YSNDLGVSHAN------YVNAVKTPASRAKFAQSCVRIMKD 133

Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKA--------SASDQPELTLSMAVRYSPTH-E 192
           YGF G+++ W +P + +++     L E +                  L++A         
Sbjct: 134 YGFDGVNIDWEYPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLS 193

Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN---------------- 236
                +  +   L++ +L+ YD      E VT   AAL+  ++                 
Sbjct: 194 RYYSKLAQIVAPLDYINLMTYDLAG-PWEKVTNHQAALFGDAAGPTFYNALREANLGWSW 252

Query: 237 ------------ISTDFGIRE-WLRRGFPANKLVLG-------------------ARASG 264
                       ++ D  +++  +  G P+ K+V+G                   +  S 
Sbjct: 253 EELTRAFPSPFSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHST 312

Query: 265 PGITI-------------------DGSMGYKFIRAFIQNYGYGAAPVYN----ASYVVNL 301
           PG                           Y+ +   +Q   YG   ++N      Y+ + 
Sbjct: 313 PGEDPYPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYH- 370

Query: 302 FTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                 ++ +D  E+ K K  Y K++ L G   + L  D+
Sbjct: 371 -AQNGLFVTYDDAESFKYKAKYIKQQQLGGVMFWHLGQDN 409

>1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A* Length = 540

 Score =  155 bits (393), Expect = 1e-40
 Identities = 65/379 (17%), Positives = 119/379 (31%), Gaps = 75/379 (19%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
           GR F +  I +   THL+  F  +             +  F     S + +     ++  
Sbjct: 148 GRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHD 207

Query: 96  IWNGQNSTY-------QSILGN-------KNINPSV---LS----------SMVGDSSHR 128
            +                  GN       K  +P +    S            +GD   R
Sbjct: 208 PFAALQKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGWTLSDPFFFMGDKVKR 267

Query: 129 KSFIESSIRTARLYG-FQGIDLFWLWPNSTDLNSLG----------ILLDEWKA-----S 172
             F+ S     + +  F G+D+ W +P     N             +L+ E +A     S
Sbjct: 268 DRFVGSVKEFLQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLS 327

Query: 173 ASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY- 231
                +  L+ A+             +  + +++   L++YD++        G   AL  
Sbjct: 328 VETGRKYELTSAISAGKDK-IDKVAYNVAQNSMDHIFLMSYDFYGAFDLKNLGHQTALNA 386

Query: 232 ---NPSSNISTDFGIREWLRRGFPANKLVLG-----------------------ARASGP 265
               P +  +T  G+   L +G    K+V+G                       A     
Sbjct: 387 PAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMYGRGWTGVNGYQNNIPFTGTATGPVK 446

Query: 266 GITIDGSMGYKFIRAFIQNYGYGAA--PVYNASYVVNLFTSGATWINFDGVETIKAKISY 323
           G   +G + Y+ I     +  +         A YV     S    I FD   +++AK  Y
Sbjct: 447 GTWENGIVDYRQIAGQFMSGEWQYTYDATAEAPYVFK--PSTGDLITFDDARSVQAKGKY 504

Query: 324 AKEKNLLGYKAFQLSNDDN 342
             +K L G  ++++  D+ 
Sbjct: 505 VLDKQLGGLFSWEIDADNG 523

>3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A Length = 574

 Score =  155 bits (394), Expect = 1e-40
 Identities = 50/369 (13%), Positives = 111/369 (30%), Gaps = 77/369 (20%)

Query: 30  AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--NSVRRKN 87
                   +    D + A+   + C F + ++     +     ++   +      +   +
Sbjct: 178 DAIANHKGKTIPVDPDGAVLASINCGFTKWEAG--DANERYNQEKAKGLLGGFRLLHEAD 235

Query: 88  PSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG-F 144
             ++  LSI  W+   S                S +  D   R +F+E      + +  F
Sbjct: 236 KELEFSLSIGGWSM--SGL-------------FSEIAKDEILRTNFVEGIKDFFQRFPMF 280

Query: 145 QGIDLFWLWPNSTDLNSLG---------ILLDEWKASASDQPELTLSMAVRYSPTHETVS 195
             +D+ W +P S    +           IL+ +    A       +S+A    P     +
Sbjct: 281 SHLDIDWEYPGSIGAGNPNSPDDGANFAILIQQITD-AKISNLKGISIASSADPAKIDAA 339

Query: 196 YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY----NPSSNISTDFGIREWLRR-G 250
                M   +   +L+ YD+     +     H  +Y    +  S  S D  +   +    
Sbjct: 340 NIPALMDAGVTGINLMTYDFFTLG-DGKLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKK 398

Query: 251 FPANKLVLG---------------ARASGPGIT-----IDGSMGY-------------KF 277
                + +G               +  S   +       + ++G               +
Sbjct: 399 VDPKAIFIGYAGYTRNAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHY 458

Query: 278 IRAFIQNYGYGAAPVYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK 333
           +         G   V++    A Y+ +   +   +I+ D   +++ K  Y K+K L G  
Sbjct: 459 MDFEKGEGRNGYKLVHDKVAKADYLYS--EATKVFISLDTPRSVRDKGRYVKDKGLGGLF 516

Query: 334 AFQLSNDDN 342
            +    D+ 
Sbjct: 517 IWSGDQDNG 525

>1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1 Length = 419

 Score =  151 bits (382), Expect = 5e-40
 Identities = 81/411 (19%), Positives = 147/411 (35%), Gaps = 117/411 (28%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSIS-------------------------- 69
           GR + ++DI+    TH+  AFA++  +    +                            
Sbjct: 25  GRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTI 84

Query: 70  ----------------SANQQYFSIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQSILG 109
                           + +Q         N +++ NP++KT++S+  W    S       
Sbjct: 85  VLGDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISVGGWTW--SNR----- 137

Query: 110 NKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLG------ 163
                    S +   ++ R+ F  S++   R Y F G+DL W +P S  L+         
Sbjct: 138 --------FSDVAATAATREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDK 189

Query: 164 ----ILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYD 214
               +LL + +       A D  +  L++A   S T+   +  +  +   ++W +++ YD
Sbjct: 190 QNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAA-NTELAKIAAIVDWINIMTYD 248

Query: 215 YHMPSKENVTGIHAALY----------NPSSNISTDFGIREWLRRGFPANKLVLGA---- 260
           ++  + + ++  +A L             ++  +   G +  L  G PA KLVLG     
Sbjct: 249 FNG-AWQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYG 307

Query: 261 RA------------------SGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN----ASYV 298
           R                   S  G    GS  +  + A   N   G    +N      Y+
Sbjct: 308 RGWDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYINKN-GYTRYWNDTAKVPYL 366

Query: 299 VNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
            N   S   +I++D  E++  K +Y K K L G   ++LS D N  L    
Sbjct: 367 YN--ASNKRFISYDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTLQNKL 415

>1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1 Length = 435

 Score =  149 bits (379), Expect = 1e-39
 Identities = 69/421 (16%), Positives = 130/421 (30%), Gaps = 134/421 (31%)

Query: 36  GREFPLSDINS----ALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA----------- 80
           GR F    ++        TH+  +F  +++ T    +++  Q      +           
Sbjct: 22  GRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFG 81

Query: 81  ---------------------------NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNK 111
                                        ++ KNP +K ++S+  W    +         
Sbjct: 82  MGYAADKSVSGKADTWDQPLAGSFNQLKQLKAKNPKLKVMISLGGWTWSKN--------- 132

Query: 112 NINPSVLSSMVGDSSHRKSFIESSIRTARLYG----------------FQGIDLFWLWPN 155
                  S      + R+  + S I                       F GID+ W WP 
Sbjct: 133 ------FSKAAATEASRQKLVSSCIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPG 186

Query: 156 STDLNSLG------------ILLDEWKA-----SASDQPELTLSMAVRYSPTH-ETVSYP 197
           +    +               LL E++       +++  +  LS  +  +P   +   + 
Sbjct: 187 TNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSAFLPANPADIDAGGWD 246

Query: 198 IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-------ISTDFGIREWLRRG 250
             +  K+L++  +  YD H      +TG  A LY+  ++        S D  ++++L  G
Sbjct: 247 DPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAG 306

Query: 251 FPANKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAP 291
               +L LG                   A    PG     +  Y  ++            
Sbjct: 307 IDPKQLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKLKT-------LGTD 359

Query: 292 VYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR 347
            Y+    +++  +    G  W ++D + T K K  Y   K L G   ++LS D N  L  
Sbjct: 360 HYDAATGSAWRYD----GTQWWSYDNIATTKQKTDYIVSKGLGGGMWWELSGDRNGELVG 415

Query: 348 A 348
           A
Sbjct: 416 A 416

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (372), Expect = 5e-39
 Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           ++G G FG V+ G L       AVK            +F  E  +  +  H N++R++G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           CT++    ++ E +       +L        L  +  + ++     G+ YL E      I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL-ESKCC--I 235

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
           HRDL A N L+  +   KISDFGM++     V  A+ G        VP     PE +  G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-----RQVPVKWTAPEALNYG 290

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            YS + DV+SFG+LL +  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  142 bits (360), Expect = 3e-38
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 17/224 (7%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
             + P+     +   +    + +   +LG G FG V  G      + A+K +   S    
Sbjct: 5   SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-E 63

Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +EF  E  +   L H  L+++ G CT++    +I EY+ N  L  YL +   R+    Q+
Sbjct: 64  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQ 121

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            + + + V + + YL E   F  +HRDL A N L++++   K+SDFG+++    D   ++
Sbjct: 122 LLEMCKDVCEAMEYL-ESKQF--LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178

Query: 596 TGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            G         P     PE +    +S K D+++FGVL+ +I S
Sbjct: 179 VG------SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 7e-38
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 7/195 (3%)

Query: 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           +KLG G +G VY+G         AVK L   + + +EEF  E ++   ++H NL+++LG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           CT      +I E++   +L  YL +   R  +     + +   ++  + YL E  NF  I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-EKKNF--I 340

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
           HR+L A N L+      K++DFG+++L   D   A+ G       +  PE +    +S+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 620 YDVYSFGVLLLQIIS 634
            DV++FGVLL +I +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (354), Expect = 1e-37
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            ++G G FG V+ G      + A+K +   +    E+F  E  +  +L H  L+++ G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            E+    L+ E++ +  L  YL    +R +   +  + +   V +G+ YL E +    IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL-EEACV--IH 127

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
           RDL A N L+      K+SDFGM +    D   ++TG         P     PE      
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWASPEVFSFSR 181

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           YS K DV+SFGVL+ ++ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  140 bits (355), Expect = 1e-37
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 19/201 (9%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           +KLG G +G VY+G   +      AVK L   + + +EEF  E ++   ++H NL+++LG
Sbjct: 19  HKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
            CT      +I E++   +L  YL +   R  +     + +   ++  + YL E  NF  
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-EKKNF-- 132

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKK 613
           IHRDL A N L+      K++DFG+++L   D   A+ G         P     PE +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAY 186

Query: 614 GIYSMKYDVYSFGVLLLQIIS 634
             +S+K DV++FGVLL +I +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (356), Expect = 2e-37
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LGEG FG V          G     AVK L +    Q    +K E+ +   L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  G C +       L+ EY+P  SL  YL     R+ +   + +   + + +G+ YL  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
             ++  IHRDL A N+LLDN+   KI DFG+AK   +  +       V   G  P     
Sbjct: 153 -QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE +K+  +    DV+SFGV L ++++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (356), Expect = 3e-37
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 441 NKLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           ++LG+G FG V            G   AVK+L  +      +F+ E+ +   L    +++
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G           L+ EYLP+  L  +L     R  LD  + +     + +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
              R +HRDL A NIL+++E + KI+DFG+AKL   D D      +V   G  P     P
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E +   I+S + DV+SFGV+L ++ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (361), Expect = 6e-37
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG G FG V+     +  + AVK +   S   +E F  E ++   LQH  L+++    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           T+ +   +I E++   SL  +L            K ++    + +G+ ++ E  N+  IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IH 307

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
           RDL+A+NIL+   L  KI+DFG+A++   +   A  G         P     PE +  G 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINFGS 361

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           +++K DV+SFG+LL++I++
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (359), Expect = 9e-37
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG+G FG V+ G        A+K L   +    E F  E  +  +L+H  L+++    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           +E +   ++ EY+   SL  +L        L   + V++   +  G+ Y+ E  N+  +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VH 303

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362

Query: 621 DVYSFGVLLLQIIS 634
           DV+SFG+LL ++ +
Sbjct: 363 DVWSFGILLTELTT 376

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (352), Expect = 1e-36
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 441 NKLGEGGFGPVYKGNL-PRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LG G FG VYKG   P G++     A+K L  ATS +  +E  +E  + A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+LG C       LI + +P   L  Y+ +   +  +  Q  +N    + +G+ YL E  
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL-EDR 136

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
               +HRDL A N+L+    + KI+DFG+AKL   +  E +        G VP      E
Sbjct: 137 RL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            +   IY+ + DV+S+GV + ++++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (348), Expect = 1e-36
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
             +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 501 TERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E      ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--V 139

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
           HRDL A N+L+  +   K+SDFG+     K+             G +P     PE +++ 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDT------GKLPVKWTAPEALREK 189

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K DV+SFG+LL +I S
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (349), Expect = 1e-36
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V            G+  AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C         LI EYLP  SL  YL     +  +D  K +     + +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
             +  IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 133 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 1e-36
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            KLG+G FG V+ G        A+K L   +    E F  E  +  +L+H  L+++    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           +E +   ++ EY+   SL  +L        L   + V++   +  G+ Y+ E  N+  +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VH 386

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
           RDL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G +++K 
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 621 DVYSFGVLLLQIIS 634
           DV+SFG+LL ++ +
Sbjct: 446 DVWSFGILLTELTT 459

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (358), Expect = 1e-36
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
             +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+++LG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 501 TERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            E      ++ EY+   SL  YL     R VL     +     V + + YL E +NF  +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--V 311

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
           HRDL A N+L+  +   K+SDFG+     K+             G +P     PE +++ 
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDT------GKLPVKWTAPEALREK 361

Query: 615 IYSMKYDVYSFGVLLLQIIS 634
            +S K DV+SFG+LL +I S
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (346), Expect = 2e-36
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           +LG G FG V  G      + AVK +   S    +EF  E     +L H  L++  G C+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           +     ++ EY+ N  L  YL        L+  + + +   V +G+ +L E   F  IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL-ESHQF--IHR 128

Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIY 616
           DL A N L+D +L  K+SDFGM +    D   ++ G         P     PE      Y
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG------TKFPVKWSAPEVFHYFKY 182

Query: 617 SMKYDVYSFGVLLLQIIS 634
           S K DV++FG+L+ ++ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (349), Expect = 2e-36
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +LG+G FG V        Q+      AVK+L  ++ + L +F+ E+ +   LQH N+++
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             G C         LI EYLP  SL  YL     +  +D  K +     + +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
             +  IHRDL   NIL++NE   KI DFG+ K+  +D +       V   G  P     P
Sbjct: 164 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E + +  +S+  DV+SFGV+L ++ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (346), Expect = 2e-36
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 17/199 (8%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+R+    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
           T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ ++ E  N+  IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI-EERNY--IH 132

Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
           RDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G         P     PE +  G 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIKWTAPEAINYGT 186

Query: 616 YSMKYDVYSFGVLLLQIIS 634
           +++K DV+SFG+LL +I++
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  137 bits (347), Expect = 3e-36
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LGEG FG V         +      AVK L   +    + + K E+ +   L H N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  G CTE   N   LI E+LP+ SL  YL  P  +  ++ ++++     + +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
              +  +HRDL A N+L+++E   KI DFG+ K    D +       V      P     
Sbjct: 145 -RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWYA 197

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           PE + +  + +  DV+SFGV L ++++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 7e-36
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 20/204 (9%)

Query: 442 KLGEGGFGPVYKG--NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +G G FG VYKG      G++    A+K L +  + +   +F  E  +  +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           + G  ++    M+I EY+ N +LD +L +  +       + V ++ G+  G+ YL    N
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN-MN 167

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
           +  +HRDL A NIL+++ L  K+SDFG++++   D +   T    G  G +P     PE 
Sbjct: 168 Y--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--G--GKIPIRWTAPEA 221

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++   DV+SFG+++ ++++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT 245

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  136 bits (345), Expect = 7e-36
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 19/204 (9%)

Query: 441 NKLGEGGFGPVYKGNL--PRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
             +G G  G V  G L  P  ++   A+K L +  + +   +F +E S+  +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           + G  T     M++ EY+ N SLD +L            + V ++ GV  G+ YL     
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL-SDLG 171

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
           +  +HRDL A N+L+D+ L  K+SDFG++++   D D A T     T G +P     PE 
Sbjct: 172 Y--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT----TTGGKIPIRWTAPEA 225

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S   DV+SFGV++ ++++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (348), Expect = 9e-36
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 441 NKLGEGGFGPVYKG--NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
             +G G FG V  G   LP  +E   A+K L    + +   +F  E S+  +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           + G  T+    M++ EY+ N SLD +L            + V ++ G+  G+ YL     
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYL-SDMG 167

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
           +  +HRDL A NIL+++ L  K+SDFG+ ++   D + A T       G +P     PE 
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT----TRGGKIPIRWTSPEA 221

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    ++   DV+S+G++L +++S
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (345), Expect = 9e-36
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            +LGEG FG V+     NL   Q+    AVK L   S    ++F+ E  L   LQH +++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL------------FDPIRRYVLDWQKRVNIIEG 542
           R  G CTE    ++++EY+ +  L+ +L             + +    L   + + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V  G++YL   +    +HRDL   N L+   L  KI DFGM+    +D+   +  R VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS----RDIYSTDYYR-VGG 218

Query: 603 YGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
              +P     PE +    ++ + DV+SFGV+L +I +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 2e-35
 Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 22/205 (10%)

Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRL---SATSTQGLEEFKNEVSLTARLQHVNLL 494
           KLG+G FG V +G  + P G+    AVK L     +  + +++F  EV+    L H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+ G         ++ E  P  SL   L     +              V +G+ YL E  
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL-ESK 140

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
            F  IHRDL A N+LL      KI DFG+ +   ++ D             VP     PE
Sbjct: 141 RF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH----RKVPFAWCAPE 194

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            +K   +S   D + FGV L ++ +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  133 bits (338), Expect = 3e-35
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +LG G FG V +G     ++    A+K L   T     EE   E  +  +L +  ++R++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G C   +  ML+ E      L  +L    +R  +       ++  V+ G+ YL E  NF 
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL-EEKNF- 131

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP-----PEY 610
            +HRDL A N+LL N    KISDFG++K    D     A +       G  P     PE 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPEC 184

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S + DV+S+GV + + +S
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (338), Expect = 3e-35
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
           +LG G FG V KG     +     AVK L   A      +E   E ++  +L +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G C   +  ML+ E      L+ YL    +   +  +  + ++  V+ G+ YL E SNF
Sbjct: 84  IGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 138

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRDL A N+LL  +   KISDFG++K  R D +           G  P     PE +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH----GKWPVKWYAPECI 192

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               +S K DV+SFGVL+ +  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (338), Expect = 7e-35
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 441 NKLGEGGFGPVYKGNL-PRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LG G FG VYKG   P G++     A+K L  ATS +  +E  +E  + A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+LG C       LI + +P   L  Y+ +   +  +  Q  +N    + +G+ YL++  
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED-R 136

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
               +HRDL A N+L+    + KI+DFG+AKL   +  E +        G VP      E
Sbjct: 137 RL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            +   IY+ + DV+S+GV + ++++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (335), Expect = 8e-35
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 38/215 (17%)

Query: 442 KLGEGGFGPVYKGNL--------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            LG+G F  ++KG              E  +K L        E F    S+ ++L H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +   G C   DEN+L+ E++   SLD YL     +  ++   ++ + + +   + +L E 
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL-EE 131

Query: 554 SNFRVIHRDLKASNILLDNELNP--------KISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           +    IH ++ A NILL  E +         K+SD G++                     
Sbjct: 132 NTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----------DILQ 178

Query: 606 VP-----PEYVKKG-IYSMKYDVYSFGVLLLQIIS 634
                  PE ++     ++  D +SFG  L +I S
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  132 bits (335), Expect = 9e-35
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
            +LGE  FG VYKG       G++    A+K L   +     EEF++E  L ARLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNII 540
           + +LG  T+     +I+ Y  +  L  +L              D   +  L+    V+++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+ YL   S+  V+H+DL   N+L+ ++LN KISD G+     ++V  A+  ++ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF----REVYAADYYKL- 186

Query: 601 GTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
                +P     PE +  G +S+  D++S+GV+L ++ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (337), Expect = 1e-34
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LG G FG V+KG      E       +K +   +  Q  +   + +     L H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+LG C       L+ +YLP  SL  ++     R  L  Q  +N    + +G+ YL E  
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL-EEH 134

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
               +HR+L A N+LL +    +++DFG+A L   D  +             P      E
Sbjct: 135 GM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
            +  G Y+ + DV+S+GV + ++++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (336), Expect = 1e-34
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
             LG G FG VY+G    +P        AVK L    + Q   +F  E  + ++  H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL----FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           +R +G   +     ++ E +    L  +L      P +   L     +++   +  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 550 LQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           L E ++F  IHRD+ A N LL         KI DFGMA    +D+  A+  R  G    +
Sbjct: 156 L-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYR-KGGCAML 207

Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE   +GI++ K D +SFGVLL +I S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 2e-34
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 32/218 (14%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            +LGEG FG V+     NL   ++    AVK L   +    ++F+ E  L   LQH +++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNIIE 541
           +  G C + D  ++++EY+ +  L+ +L                  +  L   + ++I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            +  G++YL   ++   +HRDL   N L+   L  KI DFGM+    +DV   +  R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYR-VG 192

Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            +  +P     PE +    ++ + DV+SFGV+L +I +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 2e-34
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 441 NKLGEGGFGPVYKGNL--PRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
             +G G FG VY G L    G++   AVK L+  +  G + +F  E  +     H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 496 VLGYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           +LG C   + + +++  Y+ +  L  ++ +    +    +  +     V +G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS-K 147

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG-TYGYVP-----P 608
            F  +HRDL A N +LD +   K++DFG+A    +D+ +     +   T   +P      
Sbjct: 148 KF--VHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E ++   ++ K DV+SFGVLL ++++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (330), Expect = 3e-34
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 442 KLGEGGFGPVYKGNL--PRGQEF--AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
            +GEG FG V++G    P       A+K     TS    E+F  E     +  H +++++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G  TE +   +I E      L  +L    R+Y LD    +     ++  L YL E   F
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL-ESKRF 137

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRD+ A N+L+ +    K+ DFG+++          +       G +P     PE +
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESI 189

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               ++   DV+ FGV + +I+ 
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (334), Expect = 5e-34
 Identities = 71/271 (26%), Positives = 108/271 (39%), Gaps = 29/271 (10%)

Query: 383 YFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANK 442
           YF+                LRT    T     +        +    ++     N +    
Sbjct: 21  YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR--KNITLIRG 78

Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLR 495
           LG G FG VY+G    +P        AVK L    + Q   +F  E  + ++  H N++R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL----FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
            +G   +     ++ E +    L  +L      P +   L     +++   +  G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197

Query: 552 EYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP- 607
           E ++F  IHRD+ A N LL         KI DFGMA    +D+  A   R  G    +P 
Sbjct: 198 EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYR-KGGCAMLPV 250

Query: 608 ----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
               PE   +GI++ K D +SFGVLL +I S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (326), Expect = 1e-33
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
            LGEG FG VY+G     +G++   AVK      +    E+F +E  +   L H +++++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G   E +   +I E  P   L  YL     +  L     V     + + + YL E  N 
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYL-ESINC 134

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
             +HRD+   NIL+ +    K+ DFG+++    +     +         +P     PE +
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV------TRLPIKWMSPESI 186

Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
               ++   DV+ F V + +I+S
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (341), Expect = 1e-33
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           +LG G FG V +G     ++    A+K L   T     EE   E  +  +L +  ++R++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           G C   +  ML+ E      L  +L    +R  +       ++  V+ G+ YL E  NF 
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL-EEKNF- 457

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP-----PEY 610
            +HR+L A N+LL N    KISDFG++K    D     A +       G  P     PE 
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPEC 510

Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
           +    +S + DV+S+GV + + +S
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (326), Expect = 2e-33
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LGEG FG V +GNL +        AVK +    +S + +EEF +E +      H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 495 RVLGYCTERD-----ENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNIIEGVTQG 546
           R+LG C E       + M+I  ++    L  YL           +  Q  +  +  +  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL   SN   +HRDL A N +L +++   ++DFG++    K +   +  R  G    +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS----KKIYSGDYYR-QGRIAKM 211

Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P      E +   +Y+ K DV++FGV + +I +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (330), Expect = 2e-33
 Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 21/249 (8%)

Query: 398 GRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL- 456
           G  NL   G +T   +    +   +Q      I  ++        +G G FG VY G L 
Sbjct: 52  GSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111

Query: 457 -PRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDEN-MLIYE 511
              G++   AVK L+  +  G + +F  E  +     H N+L +LG C   + + +++  
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171

Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
           Y+ +  L  ++ +    +    +  +     V +G+ +L     F  +HRDL A N +LD
Sbjct: 172 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS-KKF--VHRDLAARNCMLD 226

Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIV-GTYGYVP-----PEYVKKGIYSMKYDVYSF 625
            +   K++DFG+A    +D+ +     +   T   +P      E ++   ++ K DV+SF
Sbjct: 227 EKFTVKVADFGLA----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282

Query: 626 GVLLLQIIS 634
           GVLL ++++
Sbjct: 283 GVLLWELMT 291

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  129 bits (326), Expect = 2e-33
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
            +LG+G FG VY+G    + + +     A+K ++  ++     EF NE S+       ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPIRRYVLDWQKRVNIIEGVTQG 546
           +R+LG  ++    ++I E +    L  YL        +          K + +   +  G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           + YL   +  + +HRDL A N ++  +   KI DFGM     +D+ E +  R  G  G +
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYR-KGGKGLL 202

Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           P     PE +K G+++   DV+SFGV+L +I +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (324), Expect = 3e-33
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
             +G+G FG VY G      +     A+K L   T  Q +E F  E  L   L H N+L 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 496 VLGYCTERDE-NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++G     +    ++  Y+ +  L  ++  P  +     +  ++    V +G+ YL    
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL-AEQ 143

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVGTYGYVP-----P 608
            F  +HRDL A N +LD     K++DFG+A    +D+ +          +  +P      
Sbjct: 144 KF--VHRDLAARNCMLDESFTVKVADFGLA----RDILDREYYSVQQHRHARLPVKWTAL 197

Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E ++   ++ K DV+SFGVLL ++++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (324), Expect = 4e-33
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLL 494
             LG+G FG V +  L +        AVK L     ++  +EEF  E +      H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 495 RVLGYCTERDEN------MLIYEYLPNKSLDLYLFD---PIRRYVLDWQKRVNIIEGVTQ 545
           +++G              M+I  ++ +  L  +L         + L  Q  V  +  +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           G+ YL    NF  IHRDL A N +L  ++   ++DFG++    + +   +  R  G    
Sbjct: 149 GMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYR-QGCASK 200

Query: 606 VP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +P      E +   +Y++  DV++FGV + +I++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (333), Expect = 2e-32
 Identities = 64/303 (21%), Positives = 112/303 (36%), Gaps = 44/303 (14%)

Query: 364 LLILLPIGLVLILIASLI-CYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNL 422
           L +  P   +   +A LI  Y R     ++  II  ++       S P     +      
Sbjct: 297 LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRS 356

Query: 423 QVFSFSDIKAAT---------------------NNFSSANKLGEGGFGPVYKGNL--PRG 459
              S S+                                  +GEG FG V++G    P  
Sbjct: 357 HTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN 416

Query: 460 QEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
                A+K   + TS    E+F  E     +  H ++++++G  TE +   +I E     
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLG 475

Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576
            L  +L    R++ LD    +     ++  L YL E   F  +HRD+ A N+L+ +    
Sbjct: 476 ELRSFLQV--RKFSLDLASLILYAYQLSTALAYL-ESKRF--VHRDIAARNVLVSSNDCV 530

Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQ 631
           K+ DFG+++          +       G +P     PE +    ++   DV+ FGV + +
Sbjct: 531 KLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584

Query: 632 IIS 634
           I+ 
Sbjct: 585 ILM 587

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  126 bits (319), Expect = 3e-32
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF---AVKRL--SATSTQGLEEFKNEVSLTARL-QHVNLL 494
           + +GEG FG V K  + +       A+KR+   A+      +F  E+ +  +L  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNII 89

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNIIE 541
            +LG C  R    L  EY P+ +L  +L                     L  Q+ ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V +G+ YL   S  + IHRDL A NIL+      KI+DFG++    +  +      +  
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVY----VKK 198

Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           T G +P      E +   +Y+   DV+S+GVLL +I+S
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A* Length = 584

 Score =  130 bits (328), Expect = 4e-32
 Identities = 74/426 (17%), Positives = 131/426 (30%), Gaps = 139/426 (32%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
           GR++ + ++     TH++  F  +      +     N       A               
Sbjct: 151 GRDYTVDNMPVDNLTHILYGFIPICGPNESVKSVGGNSFNALQTACRGVNDYEVVIHDPW 210

Query: 81  -------------------------NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNI 113
                                     +++++NP +K + SI  W    S           
Sbjct: 211 AAYQKSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGWTL--SDP--------- 259

Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYGFQ-GIDLFWLWPNS-----------TDLNS 161
                   V D  +R +F+ S  +  + + F  G+D+ W +P              D  +
Sbjct: 260 ----FYDFV-DKKNRDTFVASVKKFLKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPA 314

Query: 162 LGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH 216
              L+ E +       A       L+ A+                 + +++   + YD++
Sbjct: 315 YIALMRELRVMLDELEAETGRTYELTSAIGVGYDK-IEDVDYADAVQYMDYIFAMTYDFY 373

Query: 217 MPSKENVTGIHAALYNPSSNI---------------------STDFGIREWLRRGFPANK 255
                NV G   ALY  S                        + D GI+  L +G PANK
Sbjct: 374 G-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPANK 432

Query: 256 LVLG-------------------------------ARASGPGITIDGSMGYKFIRAFIQN 284
           LVLG                                 ++  G+  DG + YK I++F+  
Sbjct: 433 LVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFMLG 492

Query: 285 YGYGAAPVYN--------ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQ 336
                   +         A +V N   S    I FD   ++ AK +YAK   L G  +++
Sbjct: 493 ANNTGINGFEYGYDAQAEAPWVWN--RSTGELITFDDHRSVLAKGNYAKSLGLAGLFSWE 550

Query: 337 LSNDDN 342
           +  D+ 
Sbjct: 551 IDADNG 556

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 5e-32
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 36/240 (15%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
             LG G FG V +     + +       AVK L    +        +E+ +   +  H+N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 493 LLRVLGYCTERDE-NMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVN 538
           ++ +LG CT+     M+I E+    +L  YL              + + +  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
               V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A    +D+ +     
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA----RDIYKDPDYV 205

Query: 599 IVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
                  +P     PE +   +Y+++ DV+SFGVLL +I S   +  Y G   +  F   
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRR 263

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  125 bits (317), Expect = 6e-32
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 41/227 (18%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
             +GEG FG V++     L   + F   AVK L   ++     +F+ E +L A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPIRRYVLD 532
           +++LG C       L++EY+    L+ +L                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
             +++ I   V  G+ YL   S  + +HRDL   N L+   +  KI+DFG++    +++ 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIY 225

Query: 593 EANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
            A+  +       +P     PE +    Y+ + DV+++GV+L +I S
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp} Length = 319

 Score =  125 bits (315), Expect = 6e-32
 Identities = 43/334 (12%), Positives = 110/334 (32%), Gaps = 50/334 (14%)

Query: 31  GYWLAGREFP----LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRK 86
            +++          ++D      +  I  +    +      ++ A     +    + +R+
Sbjct: 12  SFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNGDIANQLNDA-----AAIETTWQRR 66

Query: 87  NPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
              + T+ ++             +   +  ++  ++ + + R + + +        G+ G
Sbjct: 67  VTPLATITNL------------TSGGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGG 114

Query: 147 IDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAV---RYSPTHETVSYPIDSMKK 203
           + + +   ++ D +     L + +          L++AV             Y    +  
Sbjct: 115 VTIDFEQVSAADRDLFTGFLRQLRD-RLQAGGYVLTIAVPAKTSDNIPWLRGYDYGGIGA 173

Query: 204 NLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGA--- 260
            +N+  ++AYD+H    E   G  A +      I       E+     P+ K+++G    
Sbjct: 174 VVNYMFIMAYDWHHAGSE--PGPVAPITEIRRTI-------EFTIAQVPSRKIIIGVPLY 224

Query: 261 ----RASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINF 311
                      T+  ++  +          Y A   Y+A Y    F           + F
Sbjct: 225 GYDWIIPYQPGTVASAISNQNAIERAMR--YQAPIQYSAEYQSPFFRYSDQQGRTHEVWF 282

Query: 312 DGVETIKAKISYAKEKNLLGYKAFQLSNDD--NW 343
           +GV ++  K+   +E  L    A+QL+  +  + 
Sbjct: 283 EGVRSMSRKMQIVREYRLQAIGAWQLTLAEGHHH 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  123 bits (312), Expect = 1e-31
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           ++G G F  VYKG +     E A    +    +    + FK E  +   LQH N++R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 499 YC--TERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEY 553
               T + +  +  + E + + +L  YL    +R+ V+  +   +    + +GL +L   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 554 SNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
               +IHRDLK  NI +     + KI D G+A L R    +A    ++GT  ++ PE  +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYE 203

Query: 613 KGIYSMKYDVYSFGVLLLQIISSK 636
           +  Y    DVY+FG+ +L++ +S+
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSE 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  123 bits (312), Expect = 2e-31
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 37/241 (15%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
             LG G FG V +     L +       AVK L  +      E   +E+ + + L  H+N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL---------------FDPIRRYVLDWQKRV 537
           ++ +LG CT     ++I EY     L  +L                       LD +  +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           +    V +G+ +L   ++   IHRDL A NILL +    KI DFG+A    +D+   +  
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIKNDSNY 201

Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
             V     +P     PE +   +Y+ + DV+S+G+ L ++ S   +  Y G   +  F +
Sbjct: 202 V-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYK 259

Query: 653 Y 653
            
Sbjct: 260 M 260

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (310), Expect = 3e-31
 Identities = 57/254 (22%), Positives = 107/254 (42%), Gaps = 16/254 (6%)

Query: 403 RTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQE 461
           ++ G   P    F           ++ +     NF    K+G G F  VY+   L  G  
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVP 59

Query: 462 FAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
            A+K++        +   +   E+ L  +L H N+++      E +E  ++ E      L
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119

Query: 519 DLYLFDPIRRYVLDWQKRV-NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577
              +    ++  L  ++ V      +   L ++      RV+HRD+K +N+ +      K
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176

Query: 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           + D G+ + F      A++  +VGT  Y+ PE + +  Y+ K D++S G LL ++ + + 
Sbjct: 177 LGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234

Query: 638 NARYYGTSENLNFL 651
              +YG   NL  L
Sbjct: 235 P--FYGDKMNLYSL 246

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  122 bits (309), Expect = 8e-31
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
             LGEG FG V         +         AVK L    + + L +  +E+ +   + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
            N++ +LG CT+     +I EY    +L  YL              + +    + ++  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           +    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A    +D++  +  
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDINNIDYY 213

Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +   T G +P     PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 214 K-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (306), Expect = 9e-31
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
            ++F     LG+G FG V K  N    + +A+K++  T  + L    +EV L A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDWQKRV--NII 540
           ++R          N +       K   L+          L+D I    L+ Q+     + 
Sbjct: 64  VVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI- 599
             + + L Y+  +S   +IHRDLK  NI +D   N KI DFG+AK   + +D        
Sbjct: 123 RQILEALSYI--HSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 600 -----------VGTYGYVPPEYVK-KGIYSMKYDVYSFGVLL 629
                      +GT  YV  E +   G Y+ K D+YS G++ 
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221

>3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus} Length = 275

 Score =  120 bits (303), Expect = 1e-30
 Identities = 32/241 (13%), Positives = 79/241 (32%), Gaps = 27/241 (11%)

Query: 30  AGY-WLAGREFPLSDINSALFT-HLICAFAEVDSSTYQLSISSANQQYFSIFA------- 80
            GY   +G +F    IN  +     + +FA   +++   + ++     F   +       
Sbjct: 7   IGYPLFSGVKFSDVPINPHITKFQFVLSFAVDYTASSPHTSTNGKFNVFWDSSILGPDQI 66

Query: 81  NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
           ++++  +P+++  +S+   +  ++T Q                    S   + + S  R 
Sbjct: 67  SAIKSSHPNVRVAVSLGGASVGSNTVQF-------------QAASVDSWVSNAVTSLTRI 113

Query: 139 ARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPI 198
            + Y   GID+ +    +TD N+    +         +  +    ++  SP      Y +
Sbjct: 114 IQRYNLDGIDIDYEHFQNTDKNTFAECIGRLIT-TLKKNGVISFASI--SPFPSVDEYYL 170

Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL 258
               +  N  + + Y +               YN +++      +      G     L +
Sbjct: 171 ALFNEYKNAINHINYQFKAYDSSTSVDKFLGYYNNAASKYKGGNVLISFSTGPHPGGLPV 230

Query: 259 G 259
            
Sbjct: 231 D 231

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (305), Expect = 2e-30
 Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 33/237 (13%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
             LG G FG V +     L +       AVK L S       E   +E+ + + L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIRRYVLDWQKRVNIIE 541
           ++ +LG CT     ++I EY     L  +L              I       +  ++   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
            V QG+ +L   ++   IHRD+ A N+LL N    KI DFG+A    +D+   +    V 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----RDIMNDSNYI-VK 223

Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
               +P     PE +   +Y+++ DV+S+G+LL +I S   N  Y G   N  F + 
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYKL 279

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  120 bits (304), Expect = 2e-30
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 41/227 (18%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
             LGEG FG V K    +L     +   AVK L   ++   L +  +E ++  ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPIRRYVLD 532
           +++ G C++    +LI EY    SL  +L                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
               ++    ++QG+ YL   +  +++HRDL A NIL+      KISDFG++    +DV 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS----RDVY 201

Query: 593 EANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           E ++     + G +P      E +   IY+ + DV+SFGVLL +I++
Sbjct: 202 EEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  120 bits (302), Expect = 3e-30
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 27/219 (12%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
            +F     LG GGFG V++  N      +A+KR+         E+   EV   A+L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 493 LLRVLGYCTERDE---------NMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           ++R      E++           + +Y   +    ++L  ++         +    ++I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-- 598
             + + + +L       ++HRDLK SNI    +   K+ DFG+     +D +E       
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 599 --------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
                    VGT  Y+ PE +    YS K D++S G++L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  121 bits (306), Expect = 3e-30
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
             LGEG FG V         +         AVK L    + + L +  +E+ +   + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
            N++ +LG CT+     +I EY    +L  YL              + +    + ++  V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           +    + +G+ YL   ++ + IHRDL A N+L+      KI+DFG+A    +D++  +  
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDINNIDYY 259

Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +   T G +P     PE +   +Y+ + DV+SFGVL+ +I +
Sbjct: 260 K-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  118 bits (297), Expect = 1e-29
 Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 9/188 (4%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           LG+G +G VY G +L      A+K +    ++  +    E++L   L+H N+++ LG  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
           E     +  E +P  SL   L         + Q      + + +GL YL +    +++HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 562 DLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSM 618
           D+K  N+L++      KISDFG +K          T    GT  Y+ PE + KG   Y  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204

Query: 619 KYDVYSFG 626
             D++S G
Sbjct: 205 AADIWSLG 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (300), Expect = 1e-29
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++  +    + FA K +  S        E    E+S+   L H +++   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQE 552
           +  + D   ++ E    +SL     +  +R     +K +        +  +  G  YL  
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLHR 159

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
               RVIHRDLK  N+ L+ +L  KI DFG+A     D +      + GT  Y+ PE + 
Sbjct: 160 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 214

Query: 613 KGIYSMKYDVYSFGVLL 629
           K  +S + DV+S G ++
Sbjct: 215 KKGHSFEVDVWSIGCIM 231

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  119 bits (301), Expect = 1e-29
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 36/222 (16%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
             LGEG FG V         +         AVK L S  + + L +  +E+ +   + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
            N++ +LG CT+     +I EY    +L  YL                     L  +  V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           +    V +G+ YL   ++ + IHRDL A N+L+  +   KI+DFG+A    +D+   +  
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHIDYY 247

Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
           +   T G +P     PE +   IY+ + DV+SFGVLL +I +
Sbjct: 248 K-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (295), Expect = 2e-29
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
           LG+GGF   ++  +    + FA K +  S        E    E+S+   L H +++   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQE 552
           +  + D   ++ E    +SL     +  +R     +K +        +  +  G  YL  
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLHR 133

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
               RVIHRDLK  N+ L+ +L  KI DFG+A     D +      + GT  Y+ PE + 
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 188

Query: 613 KGIYSMKYDVYSFGVLL 629
           K  +S + DV+S G ++
Sbjct: 189 KKGHSFEVDVWSIGCIM 205

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (297), Expect = 3e-29
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 36/243 (14%)

Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
             LG G FG V       + +       AVK L     +   E   +E+ +  +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLDWQKRVNIIEGVTQGLLY 549
           ++ +LG CT      LI+EY     L  YL    +      ++++ +  + E     +L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 550 LQEYSNF--------------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            ++   F                +HRDL A N+L+ +    KI DFG+A    +D+   +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA----RDIMSDS 226

Query: 596 TGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
               V     +P     PE + +GIY++K DV+S+G+LL +I S   N  Y G   + NF
Sbjct: 227 NYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANF 284

Query: 651 LEY 653
            + 
Sbjct: 285 YKL 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (293), Expect = 3e-29
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVS 483
           + I     +F   N LG+G F  VY+  ++  G E A+K +   A    G+ +  +NEV 
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR---RYVLDWQKRVNII 540
           +  +L+H ++L +  Y  + +   L+ E   N  +       ++   +   + + R + +
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFM 118

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+LYL       ++HRDL  SN+LL   +N KI+DFG+A   +   ++  T  + 
Sbjct: 119 HQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           GT  Y+ PE   +  + ++ DV+S G + 
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMF 202

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 5e-29
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            +F     +G GGFG V+K  +   G+ + +KR+   +    E+ + EV   A+L HVN+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLD--LY----------LFDPIRRY---VLDWQKRVN 538
           +   G     D +        ++S    L+          L   I +     LD    + 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
           + E +T+G+ Y+      ++I+RDLK SNI L +    KI DFG+    + D  +     
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTR-- 180

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             GT  Y+ PE +    Y  + D+Y+ G++L
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  117 bits (295), Expect = 6e-29
 Identities = 49/213 (23%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV 491
             +    K+GEG FG      +   G+++ +K   +S  S++  EE + EV++ A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL----FDPIR-RYVLDW--QKRVNIIEGVT 544
           N+++      E     ++ +Y     L   +        +   +LDW  Q        + 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--------IC 135

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             L ++ +    +++HRD+K+ NI L  +   ++ DFG+A++    V+ A     +GT  
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           Y+ PE  +   Y+ K D+++ G +L ++ + K 
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  115 bits (290), Expect = 7e-29
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 10/196 (5%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
            +G G +G   K      G+    K     + +    +   +EV+L   L+H N++R   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 499 YCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRV-NIIEGVTQGLLYL--QEY 553
              +R    L  + EY     L   +    +      ++ V  ++  +T  L     +  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
               V+HRDLK +N+ LD + N K+ DFG+A++   D   A T   VGT  Y+ PE + +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190

Query: 614 GIYSMKYDVYSFGVLL 629
             Y+ K D++S G LL
Sbjct: 191 MSYNEKSDIWSLGCLL 206

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (289), Expect = 2e-28
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 27/208 (12%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           KLGEGGF  V     L  G  +A+KR+     Q  EE + E  +     H N+LR++ YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 501 TERDENM----LIYEYLPNKSLDLYLFDPIRRYVLDWQ----KRV-NIIEGVTQGLLYLQ 551
                      L+  +    +L    ++ I R           ++  ++ G+ +GL  + 
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV-------GTYG 604
                   HRDLK +NILL +E  P + D G        V+ +     +        T  
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 605 YVPPEYVKKGIYSM---KYDVYSFGVLL 629
           Y  PE      + +   + DV+S G +L
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVL 236

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (284), Expect = 9e-28
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 25/227 (11%)

Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVS 483
            F  +      +S   ++G GG   V++    + Q +A+K   L     Q L+ ++NE++
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 484 LTARLQHVNL--LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNII 540
              +LQ  +   +R+  Y        ++ E   N  L       +++   +D  +R +  
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL----NSWLKKKKSIDPWERKSYW 133

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
           + + + +  + ++    ++H DLK +N L+ +    K+ DFG+A   + D         V
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 601 GTYGYVPPE-----------YVKKGIYSMKYDVYSFGVLLLQIISSK 636
           GT  Y+PPE              K   S K DV+S G +L  +   K
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  110 bits (277), Expect = 4e-27
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQH 490
            +F     LG+G FG VY           A+K L  +     G+E   + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVT 544
            N+LR+ GY  +     LI EY P  ++    +  +++       + +       I  + 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITELA 119

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
             L Y       RVIHRD+K  N+LL +    KI+DFG +         +    + GT  
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLD 172

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y+PPE ++  ++  K D++S GVL 
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLC 197

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  111 bits (279), Expect = 5e-27
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 20/217 (9%)

Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK-NEVSLT 485
            + +   +  +   ++G G FG V++  +   G + AVK++       LE F+  E+   
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 104

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVT 544
           A L    ++ + G   E     +  E L   SL       I++   L   + +  +    
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQAL 160

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGR---IV 600
           +GL YL      R++H D+KA N+LL ++ +   + DFG A   + D    +      I 
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           GT  ++ PE V       K D++S   ++L +++   
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  112 bits (282), Expect = 6e-27
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL--LRV 496
            ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +   +R+
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
             Y        ++ E   N  L+ +L    ++  +D  +R +  + + + +  + ++   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---- 612
            ++H DLK +N L+ +    K+ DFG+A   + D         VG   Y+PPE +K    
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 613 -------KGIYSMKYDVYSFGVLLLQIISSK 636
                  K   S K DV+S G +L  +   K
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  111 bits (279), Expect = 6e-27
 Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL--LRV 496
            ++G GG   V++    + Q +A+K   L     Q L+ ++NE++   +LQ  +   +R+
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEYSN 555
             Y        ++ E   N  L       +++   +D  +R +  + + + +  + ++  
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDL----NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE------ 609
             ++H DLK +N L+ +    K+ DFG+A   + D         VGT  Y+PPE      
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 610 -----YVKKGIYSMKYDVYSFGVLLLQIISSK 636
                   K   S K DV+S G +L  +   K
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (283), Expect = 6e-27
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
           +F   + LG G  G +    +   ++ AVKR+     +       EV L     +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLY---LFDPI--RRYVLDWQKRVNIIEGVTQGLLY 549
           R   +CTE+D       Y+   +++L    L + +  + +     + + +++  T GL +
Sbjct: 82  RY--FCTEKDRQFQ---YI---AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 550 LQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLFRKDVDE-ANTGRIVGTY 603
           L       ++HRDLK  NIL+       ++   ISDFG+ K         +    + GT 
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIIS 634
           G++ PE +    K   +   D++S G +   +IS
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (270), Expect = 5e-26
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 10/198 (5%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           ++   K+G+G  G VY   ++  GQE A+++++       E   NE+ +    ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
            L      DE  ++ EYL   SL     D +    +D  +   +     Q L +L    +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLH---S 134

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
            +VIHRD+K+ NILL  + + K++DFG       +  + +T  +VGT  ++ PE V +  
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 616 YSMKYDVYSFGVLLLQII 633
           Y  K D++S G++ +++I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (271), Expect = 5e-26
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 10/198 (5%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
             S  K+GEG  G V        G++ AVK +     Q  E   NEV +    QH N++ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +       +E  ++ E+L   +L     D + +  L+ ++   + E V Q L YL     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLH---A 159

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             VIHRD+K+ +ILL  +   K+SDFG      KDV +  +  +VGT  ++ PE + + +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217

Query: 616 YSMKYDVYSFGVLLLQII 633
           Y+ + D++S G+++++++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  109 bits (273), Expect = 5e-26
 Identities = 35/288 (12%), Positives = 72/288 (25%), Gaps = 44/288 (15%)

Query: 382 CYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSF-SDIKAATNNFSSA 440
             F R  +K +  +I   R       +        +  P     +  S +          
Sbjct: 8   DSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV 67

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
             L  G    V+   ++ R ++FA+K     +  S   LE         ARL   +    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 497 LGYC-------------------------TERDENMLIYEYLPNKSL----DLYLFDPIR 527
                                             N L+     +  L        F  + 
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
           R          +   + +    LQ      ++H      N+ +  +    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241

Query: 588 RKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQII 633
            K               Y P E++      ++   + +  G+ + ++ 
Sbjct: 242 WKVGTRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (270), Expect = 7e-26
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGY 499
            LG+G    V++G +   G  FA+K  +  S    ++    E  +  +L H N++++   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 500 CTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
             E           E+ P  SL   L +P   Y L   + + ++  V  G+ +L+E    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131

Query: 557 RVIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
            ++HR++K  NI+     D +   K++DFG A+    D ++  +  + GT  Y+ P+  +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS--LYGTEEYLHPDMYE 188

Query: 613 KGI--------YSMKYDVYSFGVLL 629
           + +        Y    D++S GV  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  109 bits (273), Expect = 7e-26
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 19/239 (7%)

Query: 400 RNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS----ANKLGEGGFGPVYKG- 454
             +R         +Y        + +    ++    +         +LG G FG V++  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
               G+ F  K ++          KNE+S+  +L H  L+ +     ++ E +LI E+L 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 515 NKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
                  LFD I    Y +   + +N +    +GL ++ E+    ++H D+K  NI+ + 
Sbjct: 132 GGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184

Query: 573 ELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           +     KI DFG+A     D +         T  +  PE V +       D+++ GVL 
Sbjct: 185 KKASSVKIIDFGLATKLNPD-EIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (278), Expect = 1e-25
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 17/199 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVL-- 497
           +LG GGFG V +  +   G++ A+K+     +    E +  E+ +  +L H N++     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 498 ----GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
                     D  +L  EY     L  YL        L       ++  ++  L YL E 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 554 SNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
              R+IHRDLK  NI+L      L  KI D G AK   +  +       VGT  Y+ PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTE--FVGTLQYLAPEL 194

Query: 611 VKKGIYSMKYDVYSFGVLL 629
           +++  Y++  D +SFG L 
Sbjct: 195 LEQKKYTVTVDYWSFGTLA 213

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (269), Expect = 1e-25
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 435 NNFSSANKLGEGGFGPVY---------------KGNLPRGQEFAVKRLSATSTQGLEE-F 478
           N++     L +G F  +                K  L + ++F        S +   + F
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 479 KNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-----FDPIRRYVLDW 533
           KNE+ +   +++   L   G  T  DE  +IYEY+ N S+  +       D      +  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
           Q    II+ V     Y+  ++   + HRD+K SNIL+D     K+SDFG ++       +
Sbjct: 151 QVIKCIIKSVLNSFSYI--HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KK 206

Query: 594 ANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLL 629
                  GTY ++PPE+   +      K D++S G+ L
Sbjct: 207 IKG--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (270), Expect = 1e-25
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 21/238 (8%)

Query: 403 RTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKG-N 455
           R P  S   +            F    + A     +S         LG G FG V+K   
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110

Query: 456 LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
              G + A K +     +  EE KNE+S+  +L H NL+++      +++ +L+ EY+  
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170

Query: 516 KSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE 573
                 LFD I    Y L     +  ++ + +G+ ++ +     ++H DLK  NIL  N 
Sbjct: 171 GE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNR 223

Query: 574 LNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
                KI DFG+A+ ++   ++       GT  ++ PE V     S   D++S GV+ 
Sbjct: 224 DAKQIKIIDFGLARRYKPR-EKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens} Length = 393

 Score =  108 bits (270), Expect = 2e-25
 Identities = 36/329 (10%), Positives = 105/329 (31%), Gaps = 51/329 (15%)

Query: 39  FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
           + ++ +  + FT +   + ++     ++   +        +  +VR+    +  +  +  
Sbjct: 93  YDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDVDQGWMRAVRKHAKGLHIVPRLLF 152

Query: 99  GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NST 157
                        +       +++      +   ++ ++ A+   F G  +       S 
Sbjct: 153 E------------DWTYDDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLLSQ 200

Query: 158 DLNSLGILLDEWKASASDQ-PELTLSMAVRYSPTHETVS----YPIDSMKKNLNWAHLVA 212
               L  +L     +         L +    +P  + +        + +   L+   L+ 
Sbjct: 201 KRVGLIHMLTHLAEALHQARLLALLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMT 260

Query: 213 YDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASG-----PGI 267
           YDY    +    G +A L            ++    +    +K++LG    G        
Sbjct: 261 YDYSTAHQ---PGPNAPLSW------VRACVQVLDPKSKWRSKILLGLNFYGMDYATSKD 311

Query: 268 TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINFDGVETIKAKIS 322
             +  +G ++I+       +    V+++    + F      SG   + +  +++++ ++ 
Sbjct: 312 AREPVVGARYIQTLKD---HRPRMVWDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLE 368

Query: 323 YAKEKNL------LGYKAFQLSNDDNWAL 345
            A+E  +      LG        D  + L
Sbjct: 369 LARELGVGVSIWELGQ-----GLDYFYDL 392

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  106 bits (266), Expect = 2e-25
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 13/193 (6%)

Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
           KLG GG   VY         + A+K +        + L+ F+ EV  +++L H N++ ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-NF 556
               E D   L+ EY+   +L  Y+        L     +N    +  G+    +++ + 
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGI----KHAHDM 130

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R++HRD+K  NIL+D+    KI DFG+AK    +     T  ++GT  Y  PE  K    
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 617 SMKYDVYSFGVLL 629
               D+YS G++L
Sbjct: 190 DECTDIYSIGIVL 202

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 2e-25
 Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGY 499
            LG+G    V++G +   G  FA+K  +  S     +    E  +  +L H N++++   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 500 CTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
             E           E+ P  SL   L +P   Y L   + + ++  V  G+ +L+E    
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131

Query: 557 RVIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
            ++HR++K  NI+     D +   K++DFG A+    D ++  +  + GT  Y+ P+  +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS--LYGTEEYLHPDMYE 188

Query: 613 KGI--------YSMKYDVYSFGVLL 629
           + +        Y    D++S GV  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (265), Expect = 2e-25
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 11/193 (5%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           F+   K+G+G FG V+KG +    +  A+K +     +  +E+ + E+++ ++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           +  G   +  +  +I EYL   S      D +    LD  +   I+  + +GL YL    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + IHRD+KA+N+LL      K++DFG+A        + NT   VGT  ++ PE +K+ 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 615 IYSMKYDVYSFGV 627
            Y  K D++S G+
Sbjct: 195 AYDSKADIWSLGI 207

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  106 bits (267), Expect = 2e-25
 Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 23/210 (10%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
            L EGGF  VY+  ++  G+E+A+KRL +   +       EV    +L  H N+++    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 500 CTERDENM-------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            +   E         L+   L    L  +L     R  L     + I     + + ++  
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----------VGT 602
                +IHRDLK  N+LL N+   K+ DFG A       D + + +             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 603 YGYVPPEYV---KKGIYSMKYDVYSFGVLL 629
             Y  PE +          K D+++ G +L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 3e-25
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 16/192 (8%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
           LG+G FG VY           A+K L  S    +G+E   + E+ + + L+H N+LR+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
           Y  +R    L+ E+ P   L    +  ++++   D Q+    +E +   L Y  E    +
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCHER---K 134

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           VIHRD+K  N+L+  +   KI+DFG +              + GT  Y+PPE ++   + 
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRTMCGTLDYLPPEMIEGKTHD 190

Query: 618 MKYDVYSFGVLL 629
            K D++  GVL 
Sbjct: 191 EKVDLWCAGVLC 202

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (273), Expect = 4e-25
 Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 19/240 (7%)

Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS----ANKLGEGGFGPVYKG 454
            +     G  T ++ Y +      + +    ++   ++         +LG G FG V++ 
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 455 -NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
                G  FA K +        E  + E+   + L+H  L+ +     + +E ++IYE++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 514 PNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
                   LF+ +      +   + V  +  V +GL ++ E +    +H DLK  NI+  
Sbjct: 237 SGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFT 289

Query: 572 NELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
            + +   K+ DFG+                 GT  +  PE  +        D++S GVL 
Sbjct: 290 TKRSNELKLIDFGLTAHLDPK-QSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (258), Expect = 3e-24
 Identities = 53/265 (20%), Positives = 87/265 (32%), Gaps = 72/265 (27%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
            +F     +G GGFG V++  N      +A+KR+         E+   EV   A+L+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 493 LLRVLGYCTERDENMLIYEYLP------------------------NKSLDLYLFDPIRR 528
           ++R      E        E                            + +D +       
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 529 YVL---------------------DWQKRVN------------IIEGVTQGLLYLQEYSN 555
            +                      DW  R              I   + + + +L    +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HS 182

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG----------RIVGTYGY 605
             ++HRDLK SNI    +   K+ DFG+     +D +E                VGT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLL 630
           + PE +    YS K D++S G++L 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILF 267

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (256), Expect = 4e-24
 Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 17/198 (8%)

Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
            LG GG   V+     R  ++ AVK L    A        F+ E    A L H  ++ V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 498 GYCTERDENMLIY----EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
                      +     EY+   +L   +        +  ++ + +I    Q L     +
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL----NF 131

Query: 554 S-NFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYV 611
           S    +IHRD+K +NI++      K+ DFG+A+ +         T  ++GT  Y+ PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 612 KKGIYSMKYDVYSFGVLL 629
           +      + DVYS G +L
Sbjct: 192 RGDSVDARSDVYSLGCVL 209

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (257), Expect = 5e-24
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 26/224 (11%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG 474
              T   +V    D     ++F   ++LG G  G V+K  + P G   A K +       
Sbjct: 19  AFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP- 72

Query: 475 LEEFK---NEVSLTARLQHVNLLRVLG-YCTERDENMLIYEYLPNKSLDLYL--FDPIRR 528
                    E+ +        ++   G + ++ + ++ + E++   SLD  L     I  
Sbjct: 73  -AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE 130

Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
            +L       +   V +GL YL      +++HRD+K SNIL+++    K+ DFG++    
Sbjct: 131 QIL-----GKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
             +  AN+   VGT  Y+ PE ++   YS++ D++S G+ L+++
Sbjct: 184 DSM--ANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (254), Expect = 7e-24
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
              F    KLGEG +G VYK  +   GQ  A+K++       L+E   E+S+  +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           +++  G   +  +  ++ EY    S+ D+     +R   L   +   I++   +GL YL 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
                R IHRD+KA NILL+ E + K++DFG+A      + + NT  ++GT  ++ PE +
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197

Query: 612 KKGIYSMKYDVYSFGV 627
           ++  Y+   D++S G+
Sbjct: 198 QEIGYNCVADIWSLGI 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  102 bits (255), Expect = 1e-23
 Identities = 41/259 (15%), Positives = 87/259 (33%), Gaps = 32/259 (12%)

Query: 401 NLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG------ 454
            L  P +S P    F+       +   ++ +  +      + LGEG F  VY+       
Sbjct: 33  GLSKPVSSYP--NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90

Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIYE 511
           +    Q+F +K     +     EF     L  RL+       ++       ++ ++L+ E
Sbjct: 91  DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147

Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVN---IIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
                +L     + I  Y    +K +    +I    + L  +++  +  +IH D+K  N 
Sbjct: 148 LYSYGTL----LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203

Query: 569 LLDNELNP-----------KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
           +L N                + D G +   +             T G+   E +    ++
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263

Query: 618 MKYDVYSFGVLLLQIISSK 636
            + D +     +  ++   
Sbjct: 264 YQIDYFGVAATVYCMLFGT 282

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  101 bits (255), Expect = 1e-23
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 23/202 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +G+G F  V +  N   GQ+FAVK     + +++     E+ K E S+   L+H +++ 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK---RV--NIIEGVTQGLLYL 550
           +L   +      +++E++    L       I +           V  + +  + + L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 551 QEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            +     +IHRD+K   +LL ++ N    K+  FG+A    +    A     VGT  ++ 
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 608 PEYVKKGIYSMKYDVYSFGVLL 629
           PE VK+  Y    DV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (253), Expect = 1e-23
 Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 23/198 (11%)

Query: 442 KLGEGGFGPVYKGN---LPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +G GG G VY+       R    A+K +S   ++        + E     RLQ  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +  +     +  +    +    L   L    R+  L   + V I+  +   L    + ++
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSAL----DAAH 151

Query: 556 FR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN---TGRIVGTYGYVPPEYV 611
                HRD+K  NIL+  +    + DFG+A        +      G  VGT  Y+ PE  
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA----TTDEKLTQLGNTVGTLYYMAPERF 207

Query: 612 KKGIYSMKYDVYSFGVLL 629
            +   + + D+Y+   +L
Sbjct: 208 SESHATYRADIYALTCVL 225

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (252), Expect = 2e-23
 Identities = 41/193 (21%), Positives = 83/193 (43%), Gaps = 16/193 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            LG G FG V++       + +  K +           K E+S+    +H N+L +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
              +E ++I+E++    +    F+ I    + L+ ++ V+ +  V + L +L  ++   +
Sbjct: 71  ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---I 123

Query: 559 IHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
            H D++  NI+     +   KI +FG A+  +   D      +     Y  PE  +  + 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRL--LFTAPEYYAPEVHQHDVV 180

Query: 617 SMKYDVYSFGVLL 629
           S   D++S G L+
Sbjct: 181 STATDMWSLGTLV 193

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 2e-23
 Identities = 32/234 (13%), Positives = 71/234 (30%), Gaps = 53/234 (22%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV------- 491
           LG+       +  +   G+ F V     T    +  +++ K EV     L+ +       
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 492 ---------NLLRVLGYCTERDEN--------MLIYEYLPNKSLDLY-LFDPIRRYV--- 530
                    +L++                   +  +   P    +L    + +  +    
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 531 --LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
             L    R+ +   V + L  L  Y    ++H  L+  +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260

Query: 589 KDVDEANTGRIVGTYGYVPPEYV----------KKGIYSMKYDVYSFGVLLLQI 632
               +  +       G+ PPE               + +  +D ++ G+ +  I
Sbjct: 261 ----DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (257), Expect = 2e-23
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 430 IKAATNNFSSA----NKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEV 482
           I +   + S       KLG G +G V    +     E A+K +  ++ ST    +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIE 541
           ++   L H N++++  +  ++    L+ E      L    FD I  R   +      II+
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIK 143

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGR 598
            V  G+ YL +++   ++HRDLK  N+LL++   +   KI DFG++ +F           
Sbjct: 144 QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKE 197

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
            +GT  Y+ PE V +  Y  K DV+S GV+L
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 3e-23
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 430 IKAATNNFSSA----NKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNE 481
           ++ +T  FS        LG+G FG V    +   GQE AVK +S          E    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNII 540
           V L  +L H N++++  +  ++    L+ E      L    FD I  R          II
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARII 132

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTG 597
             V  G+ Y+ +     ++HRDLK  N+LL++   + N +I DFG++  F          
Sbjct: 133 RQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186

Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             +GT  Y+ PE V  G Y  K DV+S GV+L
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (255), Expect = 3e-23
 Identities = 56/235 (23%), Positives = 90/235 (38%), Gaps = 48/235 (20%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVS-LTARLQHVNL 493
           N   S   LG G  G V      +G+  AVKR+        +    E+  LT    H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLY---LFDPI--------RRYVLDWQKRVNIIEG 542
           +R   YC+E  +  L   Y+   +L+L    L D +           +      ++++  
Sbjct: 72  IRY--YCSETTDRFL---YI---ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPKISDFGMAKLFRK 589
           +  G+ +L      ++IHRDLK  NIL+                L   ISDFG+ K    
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 590 DVD--EANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISS 635
                  N     GT G+  PE +++          +   D++S G +   I+S 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVN 492
           +++     +G G    V      P+ ++ A+KR++    Q  ++E   E+   ++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE---------GV 543
           ++        +DE  L+ + L   S+     D I+  V   + +  +++          V
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM-AKLFRKDVDEANTGR--IV 600
            +GL YL +      IHRD+KA NILL  + + +I+DFG+ A L        N  R   V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGV 627
           GT  ++ PE +++   Y  K D++SFG+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGI 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 15/198 (7%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
           +    +LG+G FG VYK  N   G   A K +   S + LE++  E+ + A   H  +++
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 496 VLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           +LG      +  ++ E+ P  ++  + L        L   +   +   + + L +L    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFL---H 134

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV--- 611
           + R+IHRDLKA N+L+  E + +++DFG++    K + + ++   +GT  ++ PE V   
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192

Query: 612 --KKGIYSMKYDVYSFGV 627
             K   Y  K D++S G+
Sbjct: 193 TMKDTPYDYKADIWSLGI 210

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 44/201 (21%), Positives = 71/201 (35%), Gaps = 30/201 (14%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARL-QHVNLLRVL 497
           +LG G +G V+K  +   G+ +AVK         +       EV    ++ QH   +R+ 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 498 GYCTERDENMLIYEYLPNKSLDLYL------F--DPIRRYVLDWQKRVNIIEGVTQGLLY 549
               E     L  E     SL  +            +  Y+ D              L +
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD----------TLLALAH 172

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L       ++H D+K +NI L      K+ DFG+                 G   Y+ PE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEV--QEGDPRYMAPE 226

Query: 610 YVKKGIYSMKYDVYSFGVLLL 630
            ++   Y    DV+S G+ +L
Sbjct: 227 LLQGS-YGTAADVFSLGLTIL 246

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 35/232 (15%), Positives = 74/232 (31%), Gaps = 54/232 (23%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHV------- 491
           LG+       +  +   G+ F V     T       +++ K EV     L+ +       
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 492 ---------NLLRVLG-------YCTERDENM----LIYEYLPNKSLDL--YLFDPIRRY 529
                    +L++             ERD  +     +Y  + +        L      +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 530 -VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
             L    R+ +   V + L  L  Y    ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL---- 253

Query: 589 KDVDEANTGRIVGTYGYVPPEYVK-----------KGIYSMKYDVYSFGVLL 629
             V +        + G+ PPE              + + +  +D ++ G+++
Sbjct: 254 --VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 18/195 (9%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
            LG+G FG V K  +    QE+AVK +  ++   +       EV L  +L H N++++  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
              +     ++ E      L    FD I +R          II+ V  G+ Y+ +++   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141

Query: 558 VIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           ++HRDLK  NILL   + + + KI DFG++  F+++  +      +GT  Y+ PE V +G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD--RIGTAYYIAPE-VLRG 197

Query: 615 IYSMKYDVYSFGVLL 629
            Y  K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 16/193 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            +G G +G V            A K++     + ++ FK E+ +   L H N++R+    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
            +  +  L+ E          LF+ +  + V        I++ V   + Y  +     V 
Sbjct: 76  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 560 HRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           HRDLK  N L      +   K+ DFG+A  F+       T   VGT  YV P+ V +G+Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRT--KVGTPYYVSPQ-VLEGLY 184

Query: 617 SMKYDVYSFGVLL 629
             + D +S GV++
Sbjct: 185 GPECDEWSAGVMM 197

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LEEFKNEVSLTARLQHVNLL 494
           +LG G F  V K      G E+A K +    ++        EE + EVS+  ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +      R + +LI E +    L    FD + ++  L  ++  + I+ +  G+ YL   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
               + H DLK  NI+L ++  P    K+ DFG+A    +D  E     I GT  +V PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN--IFGTPEFVAPE 188

Query: 610 YVKKGIYSMKYDVYSFGVLL 629
            V      ++ D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 33/202 (16%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +         E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLY 549
            E +   L  EY     L    FD I           +R+    Q    ++ GV      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGV------ 118

Query: 550 LQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
              Y     + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 609 EYVKKGIYS-MKYDVYSFGVLL 629
           E +K+  +     DV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LEEFKNEVSLTARLQHVNLL 494
           +LG G F  V K      G E+A K +    ++        EE + EVS+  ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +      R + +LI E +    L    FD + ++  L  ++  + I+ +  G+ YL   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
               + H DLK  NI+L ++  P    K+ DFG+A    +D  E     I GT  +V PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN--IFGTPEFVAPE 188

Query: 610 YVKKGIYSMKYDVYSFGVLL 629
            V      ++ D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 17/195 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           +LG+G F  V +  +   G EFA K +     S +  ++ + E  +  +LQH N++R+  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
              E   + L+++ +    L    F+ I  R         + I+ + + + Y        
Sbjct: 73  SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN---G 125

Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           ++HR+LK  N+LL ++      K++DFG+A     D +  +     GT GY+ PE +KK 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLKKD 182

Query: 615 IYSMKYDVYSFGVLL 629
            YS   D+++ GV+L
Sbjct: 183 PYSKPVDIWACGVIL 197

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 18/196 (9%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
             LG+G FG V K  +    QE+AVK +  ++   +       EV L  +L H N++++ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
               +     ++ E      L    FD I +R          II+ V  G+ Y+ ++   
Sbjct: 88  EILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140

Query: 557 RVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            ++HRDLK  NILL++   + + KI DFG++  F+++  +      +GT  Y+ PE V +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD--RIGTAYYIAPE-VLR 196

Query: 614 GIYSMKYDVYSFGVLL 629
           G Y  K DV+S GV+L
Sbjct: 197 GTYDEKCDVWSAGVIL 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 21/198 (10%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGY 499
           KLG G FG V+       G E  +K ++   +Q  +E+ + E+ +   L H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW-----QKRVNIIEGVTQGLLYLQEYS 554
             +     ++ E      L     + I                 +++ +   L Y     
Sbjct: 89  FEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143

Query: 555 NFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
              V+H+DLK  NIL  +       KI DFG+A+LF+ D + +      GT  Y+ PE V
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTN--AAGTALYMAPE-V 197

Query: 612 KKGIYSMKYDVYSFGVLL 629
            K   + K D++S GV++
Sbjct: 198 FKRDVTFKCDIWSAGVVM 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =   99 bits (249), Expect = 5e-22
 Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 26/197 (13%)

Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVL 497
            +  GG G +Y     N+  G+   +K L  +     +     E    A + H +++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 498 --GYCTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
                T+R  + + Y   EY+  +SL            L   + +  +  +   L YL  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS 200

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
                +++ DLK  NI+L  E   K+ D G        ++    G + GT G+  PE V+
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INS--FGYLYGTPGFQAPEIVR 250

Query: 613 KGIYSMKYDVYSFGVLL 629
            G  ++  D+Y+ G  L
Sbjct: 251 TGP-TVATDIYTVGRTL 266

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 6e-22
 Identities = 47/238 (19%), Positives = 78/238 (32%), Gaps = 54/238 (22%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
            +G+G +G V            A+K     ++   + + +E  K EV L  +L H N+ R
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           +     +     L+ E      L     D +  ++ D   +  +    TQ     +    
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 556 FR--------------------------------------VIHRDLKASNILL--DNELN 575
                                                   + HRD+K  N L   +    
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 576 PKISDFGMAKLFR--KDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLL 629
            K+ DFG++K F    + +        GT  +V PE +      Y  K D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.7 bits (239), Expect = 7e-22
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 16/193 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            LG G F  V+       G+ FA+K +  +        +NE+++  +++H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
                  L+ + +    L    FD I  R V   +    +I+ V   + YL E     ++
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128

Query: 560 HRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           HRDLK  N+L    +      I+DFG++K+              GT GYV PE + +  Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQKPY 184

Query: 617 SMKYDVYSFGVLL 629
           S   D +S GV+ 
Sbjct: 185 SKAVDCWSIGVIT 197

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 33/202 (16%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGYC 500
           LGEG +G V    N    +  AVK +         E  K E+ +   L H N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLY 549
            E +   L  EY     L    FD I           +R+    Q    ++ GV      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGV------ 118

Query: 550 LQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
              Y     + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 609 EYVKKGIYS-MKYDVYSFGVLL 629
           E +K+  +     DV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 98.6 bits (246), Expect = 7e-22
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 29/207 (14%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLS-------------ATSTQGLEEFKNEVSLTA 486
            KLG G +G V          E A+K +                  +  EE  NE+SL  
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQ 545
            L H N++++     ++    L+ E+     L    F+ I  R+  D     NI++ +  
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILS 157

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           G+ YL +++   ++HRD+K  NILL+N    LN KI DFG++  F KD  +      +GT
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRD--RLGT 211

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE V K  Y+ K DV+S GV++
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 97.3 bits (242), Expect = 8e-22
 Identities = 44/228 (19%), Positives = 85/228 (37%), Gaps = 16/228 (7%)

Query: 412 AEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEG--GFGPVYKG-NLPRGQEFAVKR-- 466
           A +      NL     S        +     +G+G      V      P G+   V+R  
Sbjct: 2   AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61

Query: 467 LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
           L A S + +   + E+ ++    H N++         +E  ++  ++   S    L    
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTH 120

Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG-MAK 585
               ++      I++GV + L Y+        +HR +KAS+IL+  +    +S       
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177

Query: 586 LF----RKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGV 627
           +     R+ V        V    ++ PE +++ +  Y  K D+YS G+
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 96.3 bits (240), Expect = 8e-22
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 19/198 (9%)

Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVN 492
           FS   ++G G FG VY   ++   +  A+K++S +  Q     ++   EV    +L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
            ++  G         L+ EY    + DL     + +  L   +   +  G  QGL YL  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 171

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
             +  +IHRD+KA NILL      K+ DFG A +       AN+   VGT  ++ PE + 
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS--FVGTPYWMAPEVIL 223

Query: 612 --KKGIYSMKYDVYSFGV 627
              +G Y  K DV+S G+
Sbjct: 224 AMDEGQYDGKVDVWSLGI 241

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 48/225 (21%), Positives = 88/225 (39%), Gaps = 23/225 (10%)

Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLE 476
           +  L++           +     ++G G +G V K  + P GQ  AVKR+ +T   +  +
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65

Query: 477 EFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +   ++ +  R      +++  G      +  +  E +       Y     +        
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY-----KYVYSVLDD 120

Query: 536 RVN------IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
            +       I     + L +L    N ++IHRD+K SNILLD   N K+ DFG++     
Sbjct: 121 VIPEEILGKITLATVKALNHL--KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178

Query: 590 DVDEANTGRIVGTYGYVPPE----YVKKGIYSMKYDVYSFGVLLL 630
            + +       G   Y+ PE       +  Y ++ DV+S G+ L 
Sbjct: 179 SIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 84/211 (39%), Gaps = 46/211 (21%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARLQHV--NL 493
           LG GGFG VY G  +      A+K +                   EV L  ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEG 542
           +R+L +    D  +LI E  P    DL  FD I           R +   WQ    ++E 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDL--FDFITERGALQEELARSFF--WQ----VLEA 161

Query: 543 VTQGLLYLQEYS-NFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEA-NTGRI 599
           V         +  N  V+HRD+K  NIL+D N    K+ DFG   L +   D        
Sbjct: 162 V--------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTD--F 208

Query: 600 VGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
            GT  Y PPE+++   Y      V+S G+LL
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
           +LG G F  V K      G+E+A K     RLS++      EE + EV++   ++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +      + + +LI E +    L    FD +  +  L   +    ++ +  G+ YL   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127

Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
              R+ H DLK  NI+L ++  P    K+ DFG+A       +E     I GT  +V PE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKN--IFGTPEFVAPE 181

Query: 610 YVKKGIYSMKYDVYSFGVLL 629
            V      ++ D++S GV+ 
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 44/211 (20%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS----ATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
           LGEG +G V +  +       AVK L          G    K E+ L  RL+H N+++  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 496 -VLGYCTERDENMLIY---EYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIE 541
            VL    ++     +Y   EY      ++   D +            Y    Q    +I+
Sbjct: 73  DVLYNEEKQK----MYMVMEYCVCGMQEM--LDSVPEKRFPVCQAHGYF--CQ----LID 120

Query: 542 GVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
           G+        EY  +  ++H+D+K  N+LL      KIS  G+A+       +       
Sbjct: 121 GL--------EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 601 GTYGYVPPEYV--KKGIYSMKYDVYSFGVLL 629
           G+  + PPE           K D++S GV L
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           +LG+G F  V +  +   G EFA K +     S +  ++ + E  +  +LQH N++R+  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
              E   + L+++ +    L    F+ I  R         + I+ + + + Y        
Sbjct: 96  SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSNG--- 148

Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           ++HR+LK  N+LL ++      K++DFG+A       D        GT GY+ PE +KK 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKD 205

Query: 615 IYSMKYDVYSFGVLL 629
            YS   D+++ GV+L
Sbjct: 206 PYSKPVDIWACGVIL 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 29/239 (12%)

Query: 406 GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAV 464
           G+S  + +     T   Q +         N+  +  ++G G  G V+K      G   AV
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55

Query: 465 KRLSATSTQGLEEFKN---EVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL 520
           K++  +  +  EE K    ++  +        +++  G      +  +  E +   +  L
Sbjct: 56  KQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL 113

Query: 521 YL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
                 PI   +L       +   + + L YL       VIHRD+K SNILLD     K+
Sbjct: 114 KKRMQGPIPERIL-----GKMTVAIVKALYYL--KEKHGVIHRDVKPSNILLDERGQIKL 166

Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-----YVKKGIYSMKYDVYSFGVLLLQI 632
            DFG++     D  +  +    G   Y+ PE        K  Y ++ DV+S G+ L+++
Sbjct: 167 CDFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 95.1 bits (237), Expect = 6e-21
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           +LG+G F  V +   +  GQE+A   +     S +  ++ + E  +   L+H N++R+  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
             +E   + LI++ +    L    F+ I  R         + I+ + + +L+  +     
Sbjct: 78  SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMG--- 130

Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           V+HR+LK  N+LL ++L     K++DFG+A     +          GT GY+ PE ++K 
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKD 188

Query: 615 IYSMKYDVYSFGVLL 629
            Y    D+++ GV+L
Sbjct: 189 PYGKPVDLWACGVIL 203

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVL 497
            +LG G +G V K  ++P GQ  AVKR+ AT  +Q  +    ++ ++ R       +   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQ 551
           G      +  +  E + + SLD +      + V+D  + +       I   + + L +L 
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL- 125

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGM-AKLFRKDVDEANTGRIVGTYGYVPPE- 609
            +S   VIHRD+K SN+L++     K+ DFG+   L    VD+       G   Y+ PE 
Sbjct: 126 -HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPER 180

Query: 610 ---YVKKGIYSMKYDVYSFGVLLL 630
               + +  YS+K D++S G+ ++
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMI 204

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARLQHVNLL 494
           +LG G F  V K      G ++A K +      S+      E+ + EVS+   +QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +      + + +LI E +    L    FD +  +  L  ++    ++ +  G+ YL   
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133

Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
               + H DLK  NI+L +   P    KI DFG+A       +  N   I GT  +V PE
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPE 187

Query: 610 YVKKGIYSMKYDVYSFGVLL 629
            V      ++ D++S GV+ 
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG 474
           DS   +L     S ++     F     +G G +G VYKG ++  GQ  A+K +  T    
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DE 63

Query: 475 LEEFKNEVSLTARL-QHVNLLRVLG------YCTERDENMLIYEYLPNKSL-DLYLFDPI 526
            EE K E+++  +   H N+    G           D+  L+ E+    S+ DL      
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNT 121

Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
           +   L  +    I   + +GL +L +    +VIHRD+K  N+LL      K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGV 627
             + V   NT   +GT  ++ PE +         Y  K D++S G+
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 48/213 (22%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARL----QHV 491
           LG+GGFG V+ G  L    + A+K +        +          EV+L  ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNII 540
            ++R+L +   ++  ML+ E  P  + DL  FD I           R +    Q    ++
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDL--FDYITEKGPLGEGPSRCFF--GQ----VV 149

Query: 541 EGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEA-NTG 597
             +        ++  +  V+HRD+K  NIL+D      K+ DFG   L     DE     
Sbjct: 150 AAI--------QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTD- 197

Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
              GT  Y PPE++ +  Y  +   V+S G+LL
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 32/201 (15%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
            LGEG F    K  +    Q FAVK +S    +     + E++     + H N++++   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN--------IIEGVTQGLLYLQ 551
             ++    L+ E L    L    F+ I       +K+ +        I+  +   + ++ 
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERI-------KKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 552 EYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +     V+HRDLK  N+L    ++ L  KI DFG A+L   D     T     T  Y  P
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 609 EYVKKGIYSMKYDVYSFGVLL 629
           E + +  Y    D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 20/196 (10%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLG 498
             +G G +    +  +     EFAVK +  +     EE    + +  R  QH N++ +  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
              +     ++ E +    L     D I R+     ++   ++  +T+ + YL       
Sbjct: 84  VYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHAQ---G 136

Query: 558 VIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
           V+HRDLK SNIL      N  + +I DFG AK  R +     T     T  +V PE +++
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLER 194

Query: 614 GIYSMKYDVYSFGVLL 629
             Y    D++S GVLL
Sbjct: 195 QGYDAACDIWSLGVLL 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 28/206 (13%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL---------EEFKNEVSLTARL-QH 490
            LG G    V +  + P  +E+AVK +  T              E    EV +  ++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLY 549
            N++++           L+++ +    L    FD +  +  L  ++   I+  + + +  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L +     ++HRDLK  NILLD+++N K++DFG +       ++     + GT  Y+ PE
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRE--VCGTPSYLAPE 193

Query: 610 YVKKGI------YSMKYDVYSFGVLL 629
            ++  +      Y  + D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 51/243 (20%), Positives = 104/243 (42%), Gaps = 27/243 (11%)

Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF 462
                     YF S  P  ++  ++  K     +   + +G G    V +  +   G EF
Sbjct: 63  DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122

Query: 463 AVKRLSATSTQG--------LEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYL 513
           AVK +  T+ +          E  + E  +  ++  H +++ ++          L+++ +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182

Query: 514 PNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
               L    FD +  +  L  ++  +I+  + + + +L       ++HRDLK  NILLD+
Sbjct: 183 RKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDD 235

Query: 573 ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFG 626
            +  ++SDFG +       ++     + GT GY+ PE +K  +      Y  + D+++ G
Sbjct: 236 NMQIRLSDFGFSCHLEPG-EKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292

Query: 627 VLL 629
           V+L
Sbjct: 293 VIL 295

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 49/223 (21%), Positives = 83/223 (37%), Gaps = 36/223 (16%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARL-Q 489
           T  F    K+G G FG V+K      G  +A+KR       +   +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 490 HVNLLRVLGYCTERDENMLIY-EYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           H +++R      E D +MLI  EY    SL D    +          +  +++  V +GL
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP-------------------KISDFGMAKLFR 588
            Y+       ++H D+K SNI +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183

Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLL 630
             +         G   ++  E +++   +  K D+++  + ++
Sbjct: 184 --ISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVV 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 36/236 (15%)

Query: 419 TPNLQVFSFSDIKAATNNFSSAN---------KLGEGGFGPVYKG-NLPRGQEFAVKRLS 468
               +VF F D+     +               LG G  G V         ++ A++ +S
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 469 --------ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL 520
                   A         + E+ +  +L H  ++++  +    D   ++ E +    L  
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-- 226

Query: 521 YLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNP 576
             FD +     L           +   + YL E     +IHRDLK  N+LL   + +   
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281

Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE---YVKKGIYSMKYDVYSFGVLL 629
           KI+DFG +K+   +     T  + GT  Y+ PE    V    Y+   D +S GV+L
Sbjct: 282 KITDFGHSKIL-GETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 37/210 (17%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
           LGEG    V    NL   QE+AVK +             EV +  + Q H N+L ++ + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN--------IIEGVTQGLLYLQE 552
            E D   L++E +   S+       I        KR +        +++ V   L +L  
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHI-------HKRRHFNELEASVVVQDVASALDFLH- 128

Query: 553 YSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGR-----IVGTYG 604
             N  + HRDLK  NIL ++       KI DF +    + + D +           G+  
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 605 YVPPEYVKKG-----IYSMKYDVYSFGVLL 629
           Y+ PE V+       IY  + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 58/214 (27%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG G FG V  G +   G + AVK   R    S   + + K E+      +H ++++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK--- 75

Query: 499 YCTERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRV 537
                     +Y+ +   + D +          LFD I           RR     Q   
Sbjct: 76  ----------LYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLF--QQ--- 119

Query: 538 NIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
            I+  V        +Y     V+HRDLK  N+LLD  +N KI+DFG++ +     +   T
Sbjct: 120 -ILSAV--------DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT 169

Query: 597 GRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
               G+  Y  PE +   +Y+  + D++S GV+L
Sbjct: 170 --SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 37/203 (18%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGY 499
           +G+G F  V    ++  G+E A+K +  T  +   L++   EV +   L H N++++   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLL 548
                   LI EY     +    FD +           R      Q    I+  V     
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKF--RQ----IVSAV----- 127

Query: 549 YLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
              +Y    R++HRDLKA N+LLD ++N KI+DFG +  F     + +     G   Y  
Sbjct: 128 ---QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA--FCGAPPYAA 181

Query: 608 PEYVKKGIYS-MKYDVYSFGVLL 629
           PE  +   Y   + DV+S GV+L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 26/201 (12%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV-NLLRVL 497
           +LG G F  V +  +   GQE+A K  +          E  +E+++    +    ++ + 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR------VNIIEGVTQGLLYLQ 551
                  E +LI EY     +    F      + +  +       + +I+ + +G+ YL 
Sbjct: 96  EVYENTSEIILILEYAAGGEI----FSLC---LPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 552 EYSNFRVIHRDLKASNILLDN--ELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           +     ++H DLK  NILL +   L   KI DFGM++       E     I+GT  Y+ P
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPEYLAP 202

Query: 609 EYVKKGIYSMKYDVYSFGVLL 629
           E +     +   D+++ G++ 
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 65/231 (28%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS--------------------------ATSTQGL 475
           +G+G +G V    N      +A+K LS                                +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 476 EEFKNEVSLTARLQHVNLLR---VLGYCTERDENMLIYEYLPNKSLDLYLFDPI------ 526
           E+   E+++  +L H N+++   VL    E D   +++E +    +     +        
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 527 ----RRYVLDWQKRVNIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDF 581
               R Y  D      +I+G+        EY    ++IHRD+K SN+L+  + + KI+DF
Sbjct: 136 EDQARFYFQD------LIKGI--------EYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYS-MKYDVYSFGVLL 629
           G++  F+      +    VGT  ++ PE +   + I+S    DV++ GV L
Sbjct: 182 GVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 34/190 (17%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
            NF    K+GEG +G VYK  N   G+  A+K++       L+            E+SL 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
             L H N++++L      ++  L++E+L     DL      +++ +D      I   + +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL---HQDL------KKF-MDASALTGIPLPLIK 106

Query: 546 GLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
             L+  LQ   +  S+ RV+HRDLK  N+L++ E   K++DFG+A+ F   V    T  +
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEV 164

Query: 600 VGTYGYVPPE 609
           V T  Y  PE
Sbjct: 165 V-TLWYRAPE 173

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 45/216 (20%)

Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN--------EV 482
           +     +    K+GEG +G VYK    +G+  A+KR+       L+            E+
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREI 70

Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLD 532
           SL   L H N++ ++          L++E++     DL   L           I+ Y+  
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYL-- 125

Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +Q        + +G+ +   + + R++HRDLK  N+L++++   K++DFG+A+ F   V 
Sbjct: 126 YQ--------LLRGVAHC--HQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173

Query: 593 EANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFG 626
            + T  +V T  Y  P+ V  G   YS   D++S G
Sbjct: 174 RSYTHEVV-TLWYRAPD-VLMGSKKYSTSVDIWSIG 207

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 57/213 (26%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LGEG FG V    +    Q+ A+K   R     +      + E+S    L+H ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK--- 73

Query: 499 YCTERDENMLIYEYLPNKSLDLY---------LFDPI-----------RRYVLDWQKRVN 538
                     +Y+ +   + D+          LFD I           RR+    Q    
Sbjct: 74  ----------LYDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ---- 116

Query: 539 IIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
           II  +        EY    +++HRDLK  N+LLD+ LN KI+DFG++ +     +   T 
Sbjct: 117 IICAI--------EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT- 166

Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
              G+  Y  PE +   +Y+  + DV+S G++L
Sbjct: 167 -SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.0 bits (219), Expect = 5e-19
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 40/200 (20%)

Query: 429 DIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN------- 480
           D+K+    +   + LGEG F  VYK  +    Q  A+K++         E K+       
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR---SEAKDGINRTAL 60

Query: 481 -EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRY 529
            E+ L   L H N++ +L     +    L+++++     DL   +        P  I+ Y
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAY 117

Query: 530 VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
           +              QGL YL  + +  ++HRDLK +N+LLD     K++DFG+AK F  
Sbjct: 118 M--LM--------TLQGLEYL--HQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSF-G 163

Query: 590 DVDEANTGRIVGTYGYVPPE 609
             + A T ++V T  Y  PE
Sbjct: 164 SPNRAYTHQVV-TRWYRAPE 182

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 45/219 (20%), Positives = 77/219 (35%), Gaps = 62/219 (28%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK--------RLSATSTQGLEEFKNEVSLTARLQHVNL 493
           LG G FG V+   +  + +E  VK                 L +   E+++ +R++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLY-----------LFDPI-----------RRYVL 531
           ++             + +   N+                LF  I                
Sbjct: 92  IK-------------VLDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF- 136

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
             Q    ++  V     YL+      +IHRD+K  NI++  +   K+ DFG A    +  
Sbjct: 137 -RQ----LVSAVG----YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG- 183

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
               T    GT  Y  PE +    Y   + +++S GV L
Sbjct: 184 KLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 42/193 (21%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLTA 486
             +    K+GEG +G VYK     G+ FA+K++       LE+           E+S+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQKR 536
            L+H N++++      +   +L++E+L     DL   L       +    + ++   Q  
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFL--LQ-- 108

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
                 +  G+ Y   +   RV+HRDLK  N+L++ E   KI+DFG+A+ F   V    T
Sbjct: 109 ------LLNGIAYC--HDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158

Query: 597 GRIVGTYGYVPPE 609
             IV T  Y  P+
Sbjct: 159 HEIV-TLWYRAPD 170

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 85.6 bits (213), Expect = 1e-18
 Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 43/194 (22%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
             +    K+GEG +G V+K  N    +  A+KR+       L++           E+ L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQK 535
             L+H N++R+        +  L++E+      DL  Y        DP  ++ ++  +Q 
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFL--FQ- 109

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
                  + +GL +   +S   V+HRDLK  N+L++     K+++FG+A+ F   V    
Sbjct: 110 -------LLKGLGFC--HSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158

Query: 596 TGRIVGTYGYVPPE 609
           +  +V T  Y PP+
Sbjct: 159 SAEVV-TLWYRPPD 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 58/214 (27%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
           LG G FG V  G +   G + AVK   R    S   + + + E+      +H ++++   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK--- 80

Query: 499 YCTERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRV 537
                     +Y+ +   S D++          LFD I           RR     Q   
Sbjct: 81  ----------LYQVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLF--QQ--- 124

Query: 538 NIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
            I+ GV        +Y     V+HRDLK  N+LLD  +N KI+DFG++ +     +   T
Sbjct: 125 -ILSGV--------DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT 174

Query: 597 GRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
               G+  Y  PE +   +Y+  + D++S GV+L
Sbjct: 175 --SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 27/204 (13%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLS--------ATSTQGLEEFKNEVSLTARLQHVN 492
            LG G  G V         ++ A+K +S        A         + E+ +  +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQ 551
           ++++  +    D   ++ E +    L    FD +     L           +   + YL 
Sbjct: 77  IIKIKNFFDAEDYY-IVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 552 EYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
           E     +IHRDLK  N+LL   + +   KI+DFG +K+   +     T  + GT  Y+ P
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLAP 185

Query: 609 E---YVKKGIYSMKYDVYSFGVLL 629
           E    V    Y+   D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 49/197 (24%), Positives = 96/197 (48%), Gaps = 37/197 (18%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
           + +    K+G+G FG V+K  +   GQ+ A+K++       +E  K         E+ + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 486 ARLQHVNLLRVLGYCTERDENM--------LIYEYLPNKSLDL--YLFDPIRRYVLDWQK 535
             L+H N++ ++  C  +            L++++      DL   L + + ++ L   K
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIK 127

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
              +++ +  GL Y+  + N +++HRD+KA+N+L+  +   K++DFG+A+ F    +   
Sbjct: 128 --RVMQMLLNGLYYI--HRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 596 ---TGRIVGTYGYVPPE 609
              T R+V T  Y PPE
Sbjct: 183 NRYTNRVV-TLWYRPPE 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 38/211 (18%)

Query: 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVN 492
              +++   +G G FG V++  L    E A+K++        + FKN E+ +   ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93

Query: 493 LLRVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT-- 544
           ++ +  +     +        L+ EY+P     +Y      R    + K    +  +   
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY------RASRHYAKLKQTMPMLLIK 144

Query: 545 -------QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANT 596
                  + L Y+    +  + HRD+K  N+LLD      K+ DFG AK+      E N 
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNV 199

Query: 597 GRIVGTYGYVPPEYVKKGI-YSMKYDVYSFG 626
             I   Y Y  PE +     Y+   D++S G
Sbjct: 200 SYICSRY-YRAPELIFGATNYTTNIDIWSTG 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 7e-18
 Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 47/198 (23%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
           + +    KLGEG +G VYK  +    +  A+KR+       LE  +         EVSL 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL-----FDP--IRRYVLDWQKR 536
             LQH N++ +           LI+EY      DL  Y+          I+ ++  +Q  
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFL--YQ-- 140

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDV 591
                 +  G+ +   +S  R +HRDLK  N+LL           KI DFG+A+ F   +
Sbjct: 141 ------LINGVNFC--HSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

Query: 592 DEANTGRIVGTYGYVPPE 609
               T  I+ T  Y PPE
Sbjct: 192 -RQFTHEII-TLWYRPPE 207

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 55/214 (25%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
            LG G  G V +  N    ++FA+K L         + + EV L  R     +++R++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122

Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDWQKRVN----------I 539
                    +YE L      L           LF  I       Q R +          I
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEI 166

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEAN 595
           ++ + + + YL   +   + HRD+K  N+L  ++  P    K++DFG AK      +   
Sbjct: 167 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSH-NSLT 221

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           T     T  YV PE +    Y    D++S GV++
Sbjct: 222 T--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 40/206 (19%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
            LG G  G V +  +   GQ+ A+K L  +      + + EV    +     +++ +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89

Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDW---QKRVNIIEGVTQG 546
                    +YE + +    L           LF  I+         ++   I+  +   
Sbjct: 90  ---------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 547 LLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           + +L  ++   + HRD+K  N+L    + +   K++DFG AK   ++     T     T 
Sbjct: 141 IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQT--PCYTP 193

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
            YV PE +    Y    D++S GV++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM 219

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 86.4 bits (213), Expect = 1e-17
 Identities = 88/579 (15%), Positives = 163/579 (28%), Gaps = 160/579 (27%)

Query: 116 SVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD 175
           S+LS    D       I S    +         LFW   +  +   +   ++E      +
Sbjct: 44  SILSKEEIDH-----IIMSKDAVSGTL-----RLFWTLLSKQE-EMVQKFVEE--VLRIN 90

Query: 176 QPELTLSMAVRY-SPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234
              L   +      P+  T  Y I+   +  N   + A  Y++   +    +  AL    
Sbjct: 91  YKFLMSPIKTEQRQPSMMTRMY-IEQRDRLYNDNQVFA-KYNVSRLQPYLKLRQALLE-- 146

Query: 235 SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYG----AA 290
                       LR                  + IDG +            G G    A 
Sbjct: 147 ------------LR--------------PAKNVLIDG-VL-----------GSGKTWVAL 168

Query: 291 PVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQ 350
            V  +  V         W+N     + +  +     + LL    +Q+  +       ++ 
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVL--EMLQKLL----YQIDPNWTSRSDHSSN 222

Query: 351 IEENNDKDKQRLLLLIL---LPIGLVLIL----IASLICYFRRTAIKSKVMIILGRRNLR 403
           I+      +  L  L+        L L+L     A     F    +  K+++        
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCL-LVLLNVQNAKAWNAF---NLSCKILLT------- 271

Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGP------------V 451
                          T   QV  F  + AAT    S +        P             
Sbjct: 272 ---------------TRFKQVTDF--LSAATTTHISLDHH-SMTLTPDEVKSLLLKYLDC 313

Query: 452 YKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN---LLRVLGYCTERD 504
              +LPR         +  ++          ++ ++     +HVN   L  ++       
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAE-------SIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366

Query: 505 ENMLIYEYLPNKSLDLYLFD-----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
           E     +        L +F      P     L W    ++I+      + + +   + ++
Sbjct: 367 EPAEYRKMF----DRLSVFPPSAHIPTILLSLIWF---DVIKSDVM--VVVNKLHKYSLV 417

Query: 560 HRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
            +  K S I + +   EL  K+ +     L R  VD  N  +   +   +PP        
Sbjct: 418 EKQPKESTISIPSIYLELKVKLEN--EYALHRSIVDHYNIPKTFDSDDLIPP-------- 467

Query: 617 SMKYDVYSFGVL---LLQIISSKRNARYYGTSENLNFLE 652
               D Y +  +   L  I   +R   +     +  FLE
Sbjct: 468 --YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 1e-17
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 36/191 (18%)

Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKR-----LSATSTQGLEEFKNEVSLTARLQHVNL 493
           K+G G +G VYK    +    +++A+K+     +S ++ +       E++L   L+H N+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNV 80

Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT------- 544
           + +        +    L+++Y      DL+      R     +K V +  G+        
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 545 -QGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDE-ANTGR 598
             G+ YL  ++N  V+HRDLK +NIL+  E       KI+D G A+LF   +   A+   
Sbjct: 138 LDGIHYL--HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 599 IVGTYGYVPPE 609
           +V T+ Y  PE
Sbjct: 195 VVVTFWYRAPE 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 47/193 (24%), Positives = 87/193 (45%), Gaps = 17/193 (8%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG G    VY+       + +A+K L    T   +  + E+ +  RL H N++++    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
               E  L+ E +    L    FD I  +     +   + ++ + + + YL E     ++
Sbjct: 118 ETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIV 170

Query: 560 HRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           HRDLK  N+L      +   KI+DFG++K+      +     + GT GY  PE ++   Y
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAY 227

Query: 617 SMKYDVYSFGVLL 629
             + D++S G++ 
Sbjct: 228 GPEVDMWSVGIIT 240

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 24/202 (11%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTA------- 486
             + +   +GEG +G V K  N   G+  A+K+          +    V   A       
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78

Query: 487 -RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
            +L+H NL+ +L  C ++    L++E++      +     +    LD+Q     +  +  
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
           G+ +   +S+  +IHRD+K  NIL+      K+ DFG A+      +      +  T  Y
Sbjct: 136 GIGFC--HSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVA-TRWY 190

Query: 606 VPPEY-VKKGIYSMKYDVYSFG 626
             PE  V    Y    DV++ G
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIG 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 23/189 (12%)

Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-----EVSLT 485
           ++++ F    KLG G +  VYKG N   G   A+K +   S +G           E+SL 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNI---I 540
             L+H N++R+       ++  L++E++     DL  Y+            +   +    
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             + QGL +   + N +++HRDLK  N+L++     K+ DFG+A+ F   V    +  +V
Sbjct: 115 WQLLQGLAFC--HEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVV 170

Query: 601 GTYGYVPPE 609
            T  Y  P+
Sbjct: 171 -TLWYRAPD 178

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 44/194 (22%), Positives = 71/194 (36%), Gaps = 43/194 (22%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
             +    K+GEG +G V+K  N   GQ  A+K+          E           E+ + 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56

Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY--------LFDP--IRRYVLDWQK 535
            +L+H NL+ +L     +    L++EY       +               ++     WQ 
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT--WQ- 110

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
                    Q + +   + +   IHRD+K  NIL+      K+ DFG A+L     D   
Sbjct: 111 -------TLQAVNFC--HKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159

Query: 596 TGRIVGTYGYVPPE 609
              +  T  Y  PE
Sbjct: 160 DDEVA-TRWYRSPE 172

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 26/235 (11%)

Query: 409 TPAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEF 462
            P  E+ DS      LQ           + F     LG GGFG V+    K     G+ +
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLY 213

Query: 463 AVKRLS---ATSTQGLEEFKNEVSLTARLQH---VNLLRVLGYCTERDENM-LIYEYLPN 515
           A K+L+       +G +    E  + A++     V+L     Y  E   ++ L+   +  
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA----YAFETKTDLCLVMTIMNG 269

Query: 516 KSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
             +  ++++         + R       +  GL +L +     +I+RDLK  N+LLD++ 
Sbjct: 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDG 326

Query: 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           N +ISD G+A   +    +       GT G++ PE +    Y    D ++ GV L
Sbjct: 327 NVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 3e-17
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 21/230 (9%)

Query: 410 PAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFA 463
           P A+Y DS   N  LQ           N F     LG+GGFG V     +     G+ +A
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYA 213

Query: 464 VKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLD 519
            K+L        +G     NE  +  ++    ++  L Y  E  + + L+   +    L 
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLK 272

Query: 520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579
            +++   +    + +      E +  GL  L      R+++RDLK  NILLD+  + +IS
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRIS 328

Query: 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           D G+A    +          VGT GY+ PE VK   Y+   D ++ G LL
Sbjct: 329 DLGLAVHVPEG-QTIKG--RVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 63/246 (25%), Positives = 92/246 (37%), Gaps = 47/246 (19%)

Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRG 459
           T     P A       P  Q       K    +F     LGEG F  V            
Sbjct: 4   TAAEPRPGAGSLQHAQPPPQ-----PRKKRPEDFKFGKILGEGSFSTVVLARELAT---S 55

Query: 460 QEFAVKRLSATSTQGLEEF---KNEVSLTARLQH---VNLLRVLGYCTERDENML--IYE 511
           +E+A+K L         +      E  + +RL H   V L     Y T +D+  L     
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-----YFTFQDDEKLYFGLS 110

Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ--------GLLYLQEYSNFRVIHRDL 563
           Y  N  L       IR+         +  E  T+         L YL       +IHRDL
Sbjct: 111 YAKNGEL----LKYIRK-----IGSFD--ETCTRFYTAEIVSALEYLHGKG---IIHRDL 156

Query: 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVY 623
           K  NILL+ +++ +I+DFG AK+   +  +A     VGT  YV PE + +       D++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216

Query: 624 SFGVLL 629
           + G ++
Sbjct: 217 ALGCII 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 43/214 (20%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHV 491
             +++    +G G FG VY+      G+  A+K++        + FKN E+ +  +L H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 492 NLLRVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT- 544
           N++R+  +     E        L+ +Y+P     +Y      R    + +    +  +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY------RVARHYSRAKQTLPVIYV 158

Query: 545 --------QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEAN 595
                   + L Y+    +F + HRD+K  N+LLD +    K+ DFG AK   +   E N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPN 213

Query: 596 TGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFG 626
              I   Y Y  PE +       Y+   DV+S G
Sbjct: 214 VSYICSRY-YRAPELIFGATD--YTSSIDVWSAG 244

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 38/191 (19%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN-----EVSLTARL 488
             +   +KLGEG +  VYKG         A+K +     +G           EVSL   L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQKRVN 538
           +H N++ +           L++EYL     DL  YL       +   ++ ++  +Q    
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFL--FQ---- 108

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
               + +GL Y       +V+HRDLK  N+L++     K++DFG+A+       +     
Sbjct: 109 ----LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNE 160

Query: 599 IVGTYGYVPPE 609
           +V T  Y PP+
Sbjct: 161 VV-TLWYRPPD 170

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 58/213 (27%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
           +G G FG      +    +  AVK +   +    E  + E+     L+H N++R      
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVR------ 80

Query: 502 ERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRVNII 540
                    E +   +  L           L++ I           R +    Q    ++
Sbjct: 81  -------FKEVILTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFF--QQ----LL 126

Query: 541 EGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTG 597
            GV         Y  + ++ HRDLK  N LLD    P  KI DFG +K       +  + 
Sbjct: 127 SGV--------SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS- 176

Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
             VGT  Y+ PE + +  Y     DV+S GV L
Sbjct: 177 -TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 34/214 (15%)

Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKN----EVSLTA 486
           AT+ +    ++G G +G VYK  +   G   A+K +       G          EV+L  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 487 RLQ---HVNLLRVLGYCTERDEN-----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
           RL+   H N++R++  C     +      L++E++     DL       R  LD      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDL-------RTYLDKAPPPG 116

Query: 539 IIEGVTQGLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
           +     + L+   L+  ++  +N  ++HRDLK  NIL+ +    K++DFG+A+++     
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQ 173

Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626
            A T  +V T  Y  PE + +  Y+   D++S G
Sbjct: 174 MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVG 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 44/216 (20%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSATSTQGLEEFKN--------EVSL 484
             +    ++GEG +G V+K    +  G+  A+KR+       ++  +         EV++
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 485 TARLQ---H---VNLLRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
              L+   H   V L  V        E    L++E++     DL          LD    
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDL-------TTYLDKVPE 114

Query: 537 VNIIEGVTQGLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
             +     + +++  L+  ++  S+ RV+HRDLK  NIL+ +    K++DFG+A+++   
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--S 171

Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626
              A T  +V T  Y  PE + +  Y+   D++S G
Sbjct: 172 FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVG 206

>3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A* Length = 333

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 57/325 (17%), Positives = 98/325 (30%), Gaps = 67/325 (20%)

Query: 31  GYWLAGRE----FPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSIFANSVR 84
           GYW           L D++   +  +  +F E   D ST + S        F    + ++
Sbjct: 11  GYWHNFDNGTGIIKLKDVSPK-WDVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLK 69

Query: 85  RKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLY 142
            K    K +LSI   NG                     ++ D++ +  FI S       Y
Sbjct: 70  SKG--KKVVLSIGGQNG-------------------VVLLPDNAAKDRFINSIQSLIDKY 108

Query: 143 GFQGIDLFWLWPNS-------------TDLNSLGILLDEWKASASDQPELTLSMA----- 184
           GF GID+                      + +L   +          P+  LSMA     
Sbjct: 109 GFDGIDIDLESGIYLNGNDTNFKNPTTPQIVNLISAIRTISDHYG--PDFLLSMAPETAY 166

Query: 185 -----VRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH--MPSKENVTGIHAALYNPSSNI 237
                  Y          I  +K  L + H+  Y+    +    N      A Y  +   
Sbjct: 167 VQGGYSAYGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGIGMDGNNYNQGTADYEVAMAD 226

Query: 238 -----STDFGIREWLRRGFPANKLVLGARASGP----GITIDGSMGYKFIRAFIQNYGYG 288
                    G    +     ++++++G  A+      G  I  +   K +   I+   +G
Sbjct: 227 MLLHGFPVGGNANNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMKKALNYIIKGVPFG 286

Query: 289 AAPVYNASYVVNLFTSGATW-INFD 312
                +       F    +W IN+D
Sbjct: 287 GKYKLSNQSGYPAFRGLMSWSINWD 311

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 80.7 bits (199), Expect = 6e-16
 Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 37/241 (15%)

Query: 408 STPAAEYFDSDTPNLQVFSF---SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQ 460
                ++ +SD             +I    N+FS    +G GGFG VY          G+
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GK 215

Query: 461 EFAVKRLSATSTQGLEEFKNEVSLTAR----LQHVNLLRV-----LGYCTERDENM-LIY 510
            +A+K L     +     K   +L       L  V+         + Y     + +  I 
Sbjct: 216 MYAMKCLDKKRIKM----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271

Query: 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569
           + +    L       + ++ +  +  +      +  GL ++       V++RDLK +NIL
Sbjct: 272 DLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANIL 324

Query: 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVL 628
           LD   + +ISD G+A     D  +      VGT+GY+ PE ++KG+ Y    D +S G +
Sbjct: 325 LDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380

Query: 629 L 629
           L
Sbjct: 381 L 381

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 14/116 (12%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           V +G+ +L   ++ + IHRDL A NILL  +   KI DFG+A+   KD D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD---- 254

Query: 603 YGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
              +P     PE +   +Y+++ DV+SFGVLL +I S   +  Y G   +  F   
Sbjct: 255 -ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRR 308

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 55/234 (23%), Positives = 82/234 (35%), Gaps = 47/234 (20%)

Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE 477
           + N    +    +   + F      G+G FG V  G     G   A+K++          
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----- 61

Query: 478 FKN----EVSLTARLQHVN---LLRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPI 526
           F+N     +   A L H N   L        ERD       ++ EY+P     L+     
Sbjct: 62  FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRC--C 116

Query: 527 RRYVLDWQKRVNI-----IEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKI 578
           R Y         I     +  + + +  L   S   V HRD+K  N+L++     L  K+
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KL 173

Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFG 626
            DFG AK       E N   I   Y Y  PE     +      Y+   D++S G
Sbjct: 174 CDFGSAKKLSP--SEPNVAYICSRY-YRAPE-----LIFGNQHYTTAVDIWSVG 219

>1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A Length = 271

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 33/247 (13%), Positives = 72/247 (29%), Gaps = 43/247 (17%)

Query: 38  EFPLSDINSALFTHLICAFAEVDSSTY-QLSISSANQQYFSIFANSVRR----KNPSIKT 92
           ++ L+D     F   +   A ++  T  + +    N+    +  N+V +    +   IK 
Sbjct: 27  KYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQGIKV 86

Query: 93  LLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF 150
           LLS+   +                               +F +        YG  G+D  
Sbjct: 87  LLSVLGNHQGAGFAN----------------FPSQQAASAFAKQLSDAVAKYGLDGVDFD 130

Query: 151 WLWPN-------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKK 203
             +           + +S   L+   +A+    P+  +S+     P    +SY    +  
Sbjct: 131 DEYAEYGNNGTAQPNDSSFVHLVTALRAN---MPDKIISLYN-IGPAASRLSYGGVDVSD 186

Query: 204 NLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREWLRRGFPANKLV 257
             ++A      Y+   +     +  A  +P++      + ST   +            L 
Sbjct: 187 KFDYA---WNPYYGTWQVPGIALPKAQLSPAAVEIGRTSRSTVADLARRTVDEGYGVYLT 243

Query: 258 LGARASG 264
                  
Sbjct: 244 YNLDGGD 250

>2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus} Length = 290

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 36/254 (14%), Positives = 75/254 (29%), Gaps = 38/254 (14%)

Query: 25  QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQ--LSISSANQQYFSIFANS 82
           QT             PL   N+   TH+I A   ++       L+    + + ++     
Sbjct: 20  QTLCPNRGD-YVSVLPL-VKNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAE 77

Query: 83  VRR-KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
           V   K   +K +  +      +Y                + GD    + + +  +   R 
Sbjct: 78  VPVLKRSGVKVMGMLGGAAQGSY--------------RCLDGDQEKFERYYQPLLAMVRR 123

Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
           +   G+DL         L  +  L+D  K       +  +++A   +           ++
Sbjct: 124 HQLDGLDLDV--EEEMSLPGIIRLIDRLKLDLG--DDFIITLAPVAA-----------AL 168

Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGAR 261
               N +              ++  +A  YN              + +G+   ++V G  
Sbjct: 169 LGIGNLSGFDYRQLEQQRGSKISWYNAQFYNGWGLAEDPRMYAAIVAQGWSPQRVVYGL- 227

Query: 262 ASGPGITIDGSMGY 275
                   +GS GY
Sbjct: 228 ---LTNPGNGSQGY 238

>1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5 Length = 290

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 44/257 (17%), Positives = 82/257 (31%), Gaps = 43/257 (16%)

Query: 37  REFPLSDINSALFT-HLICAFA-----EVDSSTYQLSISSANQQYFSIFANSVRRKNPSI 90
            +FP   IN+     H I  FA     E    T     S   + +      +++R++P +
Sbjct: 19  HDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEV 78

Query: 91  KTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGID 148
           K ++SI               N   +P+  +  V ++      I             GID
Sbjct: 79  KVVISIGGRGV----------NTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGID 128

Query: 149 LFWLWPNSTD--LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLN 206
           + +    S +     +G L+ E K    D     +S+A    P+    S+         +
Sbjct: 129 IHYEHIRSDEPFATLMGQLITELKKD-DDLNINVVSIA----PSENNSSHYQKLYNAKKD 183

Query: 207 WAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIR---EWLRRGFPANKLVLGARAS 263
           + + V Y +                N    +STD       + L + +  +K++ G    
Sbjct: 184 YINWVDYQF---------------SNQQKPVSTDDAFVEIFKSLEKDYHPHKVLPGFSTD 228

Query: 264 GPGITIDGSMGYKFIRA 280
                 +      FI  
Sbjct: 229 PLDTKHNKITRDIFIGG 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 46/209 (22%)

Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQH---VN 492
           +G+G FG V            + +A+K ++        E +N   E+ +   L+H   VN
Sbjct: 23  IGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ------ 545
           L     Y  + +E+M ++ + L    L         RY L  Q+ V+  E   +      
Sbjct: 80  LW----YSFQDEEDMFMVVDLLLGGDL---------RYHL--QQNVHFKEETVKLFICEL 124

Query: 546 --GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
              L YLQ     R+IHRD+K  NILLD   +  I+DF +A +  ++  +  T  + GT 
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTK 178

Query: 604 GYVPPEYVKKGI---YSMKYDVYSFGVLL 629
            Y+ PE         YS   D +S GV  
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 23/194 (11%), Positives = 48/194 (24%), Gaps = 45/194 (23%)

Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLR 495
             G       ++     L R  + A+  +          L+E  +     +R+    + R
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           VL     R   +++ E++   SL                  +  ++ +            
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR--- 147

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
             V       S +         +S  G   L                   +P        
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------ 179

Query: 616 YSMKYDVYSFGVLL 629
            + + D+   G  L
Sbjct: 180 -NPQDDIRGIGASL 192

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L +L       +I+RDLK  NILLD E + K++DFG++K       +A +    GT  Y
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE V +  ++   D +SFGVL+
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLM 216

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L +L +     +I+RDLK  NI+L+++ + K++DFG+ K    D    +T    GT  Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE + +  ++   D +S G L+
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALM 211

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.2 bits (163), Expect = 4e-12
 Identities = 42/286 (14%), Positives = 75/286 (26%), Gaps = 64/286 (22%)

Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------QG 474
               FS     T       K+GEG FG V++         A+K ++            + 
Sbjct: 9   GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66

Query: 475 LEEFKNEVSLTARLQ---------HVNLLRVLGYC-------------------TERDEN 506
            EE   E+ ++  L              + +                       T+   N
Sbjct: 67  FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126

Query: 507 MLIYEYLPNK-------SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
                +  ++              + +R  +       +I+  +T  L   +    F   
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRF--E 184

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFR-----KDVDEANTGRIVGTYG-------YVP 607
           HRDL   N+LL      K+      K          V   +                   
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
            E +  G    ++D+Y      L    +      Y    N+ +L Y
Sbjct: 245 DEDLFTGDGDYQFDIYR-----LMKKENNNRWGEYHPYSNVLWLHY 285

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +   L++L +     +I+RDLK  N+LLD+E + K++DFGM K    +     T    GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE +++ +Y    D ++ GVLL
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLL 214

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL   +   +++RDLK  NILLD++ +  ++DFG+ K   +     +T    GT  Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE + K  Y    D +  G +L
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVL 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL       V++RD+K  N++LD + + KI+DFG+ K    D     T    GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE ++   Y    D +  GV++
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVM 195

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 4/84 (4%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL  +S   V++RDLK  N++LD + + KI+DFG+ K   KD     T    GT  Y
Sbjct: 260 ALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE ++   Y    D +  GV++
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVM 339

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 6e-12
 Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +LQ      +I+RDLK  N++LD+E + KI+DFGM K    D     T    GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE +    Y    D ++FGVLL
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLL 532

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D  +T    GT  Y
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE ++   Y    D ++ GVL+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLM 200

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +LQ      +I+RDLK  N++LD+E + KI+DFGM K    D     T    GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE +    Y    D ++FGVLL
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLL 211

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           +  GL +L       +++RDLK  NILLD + + KI+DFGM K       + NT    GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE +    Y+   D +SFGVLL
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLL 208

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 29/218 (13%)

Query: 428 SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKN 480
             ++    +F     +G G FG V     K      + FA+K L+        E   F+ 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFRE 123

Query: 481 EVSLTARLQH---VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
           E  +           L     Y  + D N+ L+ +Y     L   L     R   +   R
Sbjct: 124 ERDVLVNGDSKWITTLH----YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-AR 178

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
             + E +   +  + +      +HRD+K  NIL+D   + +++DFG      +D     +
Sbjct: 179 FYLAE-MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQS 233

Query: 597 GRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLL 629
              VGT  Y+ PE ++     KG Y  + D +S GV +
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 31/211 (14%)

Query: 431 KAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSAT---STQGLEEFKNEVS 483
            A  + F     LG G FG V     K +   G  +A+K L        + +E   NE  
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 484 LTARLQH---VNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
           +   +     V L       + +D + L  + EY+    +  +L   I R+      R  
Sbjct: 94  ILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEP-HARFY 146

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
             + +     YL       +I+RDLK  N+L+D +   +++DFG AK   +      T  
Sbjct: 147 AAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-- 197

Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
           + GT   + PE +    Y+   D ++ GVL+
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            L YL E     +I+RDLK  N+LLD+E + K++D+GM K   +  D  +T    GT  Y
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219

Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
           + PE ++   Y    D ++ GVL+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLM 243

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 47/220 (21%), Positives = 97/220 (44%), Gaps = 41/220 (18%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-- 490
            +++    KLG G +  V++  N+   ++  VK L     +   + K E+ +   L++  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKI---LENLR 88

Query: 491 -----VNLLRVLGYCTERDENMLIYEYLPNKSLDLY-LFDP-----IRRYVLDWQKRVNI 539
                + L  ++     R    L++E++ N   D   L+       IR Y+  ++     
Sbjct: 89  GGPNIITLADIVKDPVSRTP-ALVFEHVNN--TDFKQLYQTLTDYDIRFYM--YE----- 138

Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGR 598
              + + L Y   +S   ++HRD+K  N+++D+E    ++ D+G+A+ +     +    R
Sbjct: 139 ---ILKALDYC--HSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190

Query: 599 IVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           +   Y +  PE  V   +Y    D++S G +L  +I  K 
Sbjct: 191 VASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 47/243 (19%), Positives = 92/243 (37%), Gaps = 69/243 (28%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHV 491
           +  +S    LG G FG V +  ++  G+ FA+K++          +KN E+ +   L HV
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60

Query: 492 NLLRVLGYCTERDENM--------------------------------------LIYEYL 513
           N+++++ Y     +                                        +I EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ--------GLLYLQEYSNFRVIHRDLKA 565
           P     L+    ++ ++   +    I   +           + ++    +  + HRD+K 
Sbjct: 121 P---DTLHKV--LKSFIRSGRS---IPMNLISIYIYQLFRAVGFIH---SLGICHRDIKP 169

Query: 566 SNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVY 623
            N+L++++ N  K+ DFG AK       E +   I   + Y  PE +     Y+   D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226

Query: 624 SFG 626
           S G
Sbjct: 227 SIG 229

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 46/205 (22%), Positives = 74/205 (36%), Gaps = 31/205 (15%)

Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKNEVSLTARLQH---VN 492
           +G G F  V     K     GQ +A+K ++        E   F+ E  +           
Sbjct: 69  IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           L     +  + +  + L+ EY     L   L     R   +   R  + E +   +  + 
Sbjct: 126 LH----FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVH 179

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-- 609
                  +HRD+K  NILLD   + +++DFG     R D     +   VGT  Y+ PE  
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEIL 235

Query: 610 -----YVKKGIYSMKYDVYSFGVLL 629
                    G Y  + D ++ GV  
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFA 260

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 43/206 (20%), Positives = 75/206 (36%), Gaps = 60/206 (29%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGY 499
            LG G  G V +  N    ++FA+K L         + + EV L  R  Q  +++R++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78

Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDW---QKRVNIIEGVTQG 546
                    +YE L      L           LF  I+         ++   I++ + + 
Sbjct: 79  ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
           + YL   +   + HRD+K  N+L  ++      K++DFG A                   
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------- 167

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
                E      Y    D++S GV++
Sbjct: 168 ----KE-TTGEKYDKSCDMWSLGVIM 188

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 34/199 (17%), Positives = 77/199 (38%), Gaps = 45/199 (22%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
            + +   + +G G +G V +  +    +  A+K++          F++         E++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 484 LTARLQHVNLLRVLG-YCTERDENM----LIYEYLPNKSLDLY--------LFDPIRRYV 530
           +  RL H ++++VL     +  E      ++ E       D          L +   + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTL 161

Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
           L +         +  G+ Y+   S   ++HRDLK +N L++ + + K+ DFG+A+     
Sbjct: 162 L-YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 591 VDEANTGRIVGTYGYVPPE 609
            +  +   I      +   
Sbjct: 210 ENGNSQLPISPREDDMNLV 228

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 7e-11
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 47/207 (22%)

Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEEF---KNEVSLTARLQH---VN 492
           LG G FG V+    + N   G+ +A+K L       L++     +E  + + + H   + 
Sbjct: 14  LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----- 545
           +     + T +D   +  I +Y+    L   L           +K       V +     
Sbjct: 71  M-----WGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAE 114

Query: 546 ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
               L YL       +I+RDLK  NILLD   + KI+DFG AK      D   T  + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT--LCGT 166

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y+ PE V    Y+   D +SFG+L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILI 193

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 36/220 (16%)

Query: 428 SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKN 480
            D++    ++     +G G FG V     K      + +A+K LS        +   F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE 118

Query: 481 EVSLTARLQH---VNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           E  + A       V L     +   +D+  L  + EY+P   L     + +  Y +  + 
Sbjct: 119 ERDIMAFANSPWVVQL-----FYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKW 169

Query: 536 -RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDE 593
            R    E V   L  +        IHRD+K  N+LLD   + K++DFG    + ++ +  
Sbjct: 170 ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 594 ANTGRIVGTYGYVPPEYVK----KGIYSMKYDVYSFGVLL 629
            +T   VGT  Y+ PE +K     G Y  + D +S GV L
Sbjct: 226 CDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPE---YVKK 613
           +I+RD+K  NILLD+  +  ++DFG++K F  D  E A      GT  Y+ P+       
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDS 237

Query: 614 GIYSMKYDVYSFGVLL 629
           G +    D +S GVL+
Sbjct: 238 G-HDKAVDWWSLGVLM 252

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 41/222 (18%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              + +   +G G  G V    +    +  A+K+LS         F+N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 484 LTARLQHVN---LLRVLGYCTERDENMLIYEYLPNKSLDLY------LFDPIRRYVLDWQ 534
           L   + H N   LL V       +E   +Y  +     +L       L      Y+L +Q
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
                   +  G+ +L  +S   +IHRDLK SNI++ ++   KI DFG+A   R      
Sbjct: 136 --------MLCGIKHL--HSA-GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSF 181

Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
                V T  Y  PE +    Y    D++S G ++ ++I   
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 42/229 (18%), Positives = 88/229 (38%), Gaps = 42/229 (18%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
            + +     LG GG G V+   +    +  A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
           +  RL H N+++V          +        +   +Y+            + +  L  +
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDE 593
                +  + +GL Y+    +  V+HRDLK +N+ ++ E L  KI DFG+A++       
Sbjct: 121 HARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 594 AN--TGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
               +  +V T  Y  P  +   +    Y    D+++ G +  ++++ K
Sbjct: 178 KGHLSEGLV-TKWYRSPRLL---LSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 29/216 (13%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              + +   +G G  G V    +    +  A+K+LS         F+N         E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113

Query: 484 LTARLQHVN---LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           L   + H N   LL V       +E   +Y  +     +L     + +  LD ++   ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLL 170

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+ +L    +  +IHRDLK SNI++ ++   KI DFG+A+          T   V
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-V 224

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
            T  Y  PE +    Y    D++S G ++ +++  K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor} Length = 302

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 39/246 (15%)

Query: 30  AGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
            GYW           +SD+ SA +  +  AFA+  ++   ++ +  +        +  + 
Sbjct: 8   TGYWQNFNNGATVQKISDVPSA-YDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKA 66

Query: 86  -----KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTAR 140
                +    K ++S+  G+  T              ++S    S+   +F  S     R
Sbjct: 67  DVRAKQAAGKKVIISV-GGEKGTVS------------VNS----SASATNFANSVYSVMR 109

Query: 141 LYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR---YSPTHETVSYP 197
            YGF G+D+     N  +   +   L    A A   P++ L+MA +      T       
Sbjct: 110 EYGFDGVDIDLE--NGLNPTYMTQALRALSAKAG--PDMILTMAPQTIDMQSTQGGYFQT 165

Query: 198 IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV 257
             ++K  L   ++  Y+        + G    +Y   +           L  G   +++ 
Sbjct: 166 ALNVKDILTVVNMQYYNSG-----TMLGCDGKVYAQGTVDFLTALACIQLEGGLAPSQVG 220

Query: 258 LGARAS 263
           LG  AS
Sbjct: 221 LGLPAS 226

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 44/229 (19%)

Query: 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE--FKN---------EV 482
            + ++    +  G +G V  G    G   A+KR+  T + G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 483 SLTARLQHVNLLRVLG-YCTERDENM----LIYEYLPN------KSLDLYLFDPIRRYVL 531
            L     H N+L +   +    +  M    L+ E +            + +     +Y +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            +         +  GL  L E +   V+HRDL   NILL +  +  I DF +A   R+D 
Sbjct: 141 -YH--------ILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLA---REDT 185

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
            +AN    V    Y  PE V   +    +    D++S G ++ ++ + K
Sbjct: 186 ADANKTHYVTHRWYRAPELV---MQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 55/231 (23%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              +++ + +GEG +G V    +       A+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 484 LTARLQHVNLLRVLGYCT-ERDENM----LIYEYLPNKSLDLY-------LFDPIRRYVL 531
           +  R +H N++ +         E M    ++ + +     DLY       L +    Y L
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFL 134

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            +Q        + +GL Y+   +N  V+HRDLK SN+LL+   + KI DFG+A++   D 
Sbjct: 135 -YQ--------ILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 592 DEAN--TGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
           D     T   V T  Y  PE +   + S  Y    D++S G +L +++S++
Sbjct: 183 DHTGFLTEY-VATRWYRAPEIM---LNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 13/159 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VN 492
           N +    K+G G FG +Y G ++  G+E A+K     +         E  +   +Q  V 
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  +     E D N+++ E L   SL+       R++ L   K V ++    Q +  ++ 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL---KTVLLL--ADQMISRIEY 120

Query: 553 YSNFRVIHRDLKASNILLDNELNPK---ISDFGMAKLFR 588
             +   IHRD+K  N L+          I DFG+AK +R
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 13/159 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVN 492
           N F    K+G G FG +Y G N+   +E A+K  +  +         E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +  V  +  E D N+L+ + L   SL+       R+  L   K V ++    Q +  ++ 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLML--ADQMINRVEF 118

Query: 553 YSNFRVIHRDLKASNILLDNELNPK---ISDFGMAKLFR 588
             +   +HRD+K  N L+          I DFG+AK +R
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 13/160 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            NF    K+G G FG +  G NL   +  A+K     S       +             +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
            +V  +      N ++ E L   SL+       R + L   K V +I    Q +  ++  
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL---KTVLMI--AIQLISRMEYV 121

Query: 554 SNFRVIHRDLKASNILLDNELNPK-----ISDFGMAKLFR 588
            +  +I+RD+K  N L+    N       I DF +AK + 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 50/226 (22%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              + S   +G G +G V    +   G++ A+K+LS         F++         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 484 LTARLQHVNLLRVLG--YCTERDENM----LIYEYLPNKSLDLY------LFDPIRRYVL 531
           L   +QH N++ +L          N     L+  ++     DL         +   +Y++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQYLV 132

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            +Q        + +GL Y+       V+HRDLK  N+ ++ +   KI DFG+A+      
Sbjct: 133 -YQ--------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----A 176

Query: 592 DEANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
           D   TG  V T  Y  PE +     Y+   D++S G ++ ++++ K
Sbjct: 177 DAEMTGY-VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 13/160 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            ++    ++GEG FG +++G NL   Q+ A+K     S       +             +
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGI 68

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
             V  +  E   N+L+ + L   SL+  L    R++ +   K V +     Q L  +Q  
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV---KTVAMA--AKQMLARVQSI 122

Query: 554 SNFRVIHRDLKASNILLDNELNPK-----ISDFGMAKLFR 588
               +++RD+K  N L+    +       + DFGM K +R
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 46/223 (20%), Positives = 91/223 (40%), Gaps = 43/223 (19%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              +     +G G +G V    +   G + A+K+L          F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
           L   ++H N++ +L        ++   +   +   D YL  P         ++   L   
Sbjct: 77  LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           +   ++  + +GL Y+       +IHRDLK  N+ ++ +   KI DFG+A+    ++   
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185

Query: 595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
                V T  Y  PE +     Y+   D++S G ++ ++I+ K
Sbjct: 186 -----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 Length = 289

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 33/239 (13%), Positives = 73/239 (30%), Gaps = 41/239 (17%)

Query: 38  EFPLSDINSALFTHLICAFAEVDSSTYQLSI---SSANQQYFSIFANSVRR--KNPSIKT 92
            F L +    L   ++   A ++       +   ++ N Q+         +  ++  IK 
Sbjct: 28  NFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKV 87

Query: 93  LLSIW-NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFW 151
           +LSI  N   S   ++                 ++  K+F +    T  LY   G+    
Sbjct: 88  ILSILGNHDRSGIANL----------------STARAKAFAQELKNTCDLYNLDGVFFDD 131

Query: 152 LWPN----------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
            +            +   N+   L  E K +    P   +++ V    +    +    + 
Sbjct: 132 EYSAYQTPPPSGFVTPSNNAAARLAYETKQA---MPNKLVTVYVYSRTSSFPTAVDGVNA 188

Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYN-PSSNISTDFGIREWLRRGFPANKLVLG 259
              +++A    +DY      ++   +  L        S +F    +       N +  G
Sbjct: 189 GSYVDYA---IHDYGGSY--DLATNYPGLAKSGMVMSSQEFNQGRYATAQALRNIVTKG 242

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 54/234 (23%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
           +++F   + LGEG +G V    + P G+  A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 484 LTARLQHVNLLRVLG-YCTERDENM----LIYEYLPNKSLDLY-------LFDPIRRYVL 531
           +    +H N++ +      +  EN     +I E +     DL+       L D   +Y +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHIQYFI 118

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
            +Q          + +  L  + +  VIHRDLK SN+L+++  + K+ DFG+A++  +  
Sbjct: 119 -YQ--------TLRAVKVL--HGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 592 DEANTGRIVGTY--GYV------PPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
            + +      +    +V       PE +     YS   DV+S G +L ++   +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 43/223 (19%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
              + + + +G G +G V    +   G   AVK+LS         F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
           L   ++H N++ +L        ++        +  D+YL            ++   L   
Sbjct: 81  LLKHMKHENVIGLL--------DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
               +I  + +GL Y+  +S   +IHRDLK SN+ ++ +   KI DFG+A+    ++   
Sbjct: 133 HVQFLIYQILRGLKYI--HSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189

Query: 595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
                V T  Y  PE +     Y+   D++S G ++ ++++ +
Sbjct: 190 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 33/179 (18%), Positives = 68/179 (37%), Gaps = 29/179 (16%)

Query: 435 NNFSSANKLGEGGFGPVYKG---------NLPRGQEFAVKRLSATSTQGLEEFK------ 479
             +   +       G +Y+          + P+ Q+F++K L A   +   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 480 --NEVSLTARLQHVNLL---RVLGYCTERDE-NMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
              +V+   +L    LL     +G+   +D+   L+   L  +SL     D   ++VL  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLS- 157

Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
           ++ V  +    + L  L+       +H ++ A NI +D E   ++  + +G A  +   
Sbjct: 158 ERSVLQV--ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

>3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp} Length = 321

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 36/301 (11%), Positives = 87/301 (28%), Gaps = 40/301 (13%)

Query: 30  AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
            GY                +  +  +F +        +    N+      A   +     
Sbjct: 20  DGYKGGSSADFNLSSTQEGYNVINVSFMKTPEGQTLPTFKPYNKTDTEFRAEISKLNAEG 79

Query: 90  IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
              L+++  G ++  +                    S    F+   IR    YGF G+D+
Sbjct: 80  KSVLIAL-GGADAHIEL-----------------KKSQESDFVNEIIRLVDTYGFDGLDI 121

Query: 150 FW------LWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYP--IDSM 201
                      N T + S    + +            ++MA  +     +  Y   I+++
Sbjct: 122 DLEQAAIEAADNQTVIPSALKKVKDHYRKDG--KNFMITMAPEFPYLTSSGKYAPYINNL 179

Query: 202 KKNLNWAHLVAYDYH-MPSKENVTGIHAALYNPSSNISTDFGIREWL------RRGFPAN 254
               ++ +   Y+       ++   +  +  N        +G+ + L          PA+
Sbjct: 180 DSYYDFINPQYYNQGGDGFWDSDLNMWISQSNDEKKEDFLYGLTQRLVTGTDGFIKIPAS 239

Query: 255 KLVLGARAS----GPGITIDGSMGYKFIRAFIQNY-GYGAAPVYNASYVVNLFTSGATWI 309
           K V+G  ++      G   D +     +     +         ++ ++     ++G  + 
Sbjct: 240 KFVIGLPSNNDAAATGYVKDPNAVKNALNRLKASGNEIKGLMTWSVNWDAGTNSNGEKYN 299

Query: 310 N 310
           N
Sbjct: 300 N 300

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 36/212 (16%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATST---QGLEEFK-----NEVSLTARLQH-- 490
           KLG G F  V+   ++      A+K +           +E K     N+   T       
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 491 ---VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLF---DPIRRYVLDWQKRVNIIEGV 543
              + LL    +      ++ +++E L     +L         R   L + K+  I + +
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQ--ISKQL 140

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNP------KISDFGMAKLFRKDVDEANTG 597
             GL Y+  +    +IH D+K  N+L++   +P      KI+D G A       DE  T 
Sbjct: 141 LLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTN 194

Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
            I  T  Y  PE +    +    D++S   L+
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLI 225

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 39/196 (19%), Positives = 77/196 (39%), Gaps = 45/196 (22%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVSLTARLQHV 491
            +G G +G VY   +    +  A+K+++         F++         E+++  RL+  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSD 85

Query: 492 NLLRVL-----GYCTERDENMLIYEYLPNKSLDLY--------LFDPIRRYVLDWQKRVN 538
            ++R+          + DE  ++ E   +   DL         L +   + +L +     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTIL-YN---- 137

Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
               +  G  ++ E S   +IHRDLK +N LL+ + + K+ DFG+A+    + D      
Sbjct: 138 ----LLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 599 IVGTYGYVPPEYVKKG 614
           +       P     K 
Sbjct: 191 LEENEEPGPHNKNLKK 206

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 29/170 (17%), Positives = 60/170 (35%), Gaps = 28/170 (16%)

Query: 442 KLGEGGFGPVYKG-NLPRGQE---FAVKRLSATSTQGLEEFK-----------NEVSLTA 486
           K+G GGFG +Y      + ++     VK     +     E K            +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 487 RLQHVNLLRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
           +L ++ +    G        R    ++ E L    L   +      +       V  +  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKK---STVLQL-- 156

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
             + L  L+       +H D+KA+N+LL  +   ++  +D+G++  +  +
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 31/172 (18%), Positives = 60/172 (34%), Gaps = 29/172 (16%)

Query: 442 KLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEEFK-----NEVSLTARLQH 490
            +G+GGFG +Y        ++       VK   + +     E K      +     +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 491 VNLLRVLGYCT----------ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
              L+ LG              +    +I +      L        +R+     K V  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---KTVLQL 157

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
               + L  L+       +H D+KASN+LL+ +   ++   D+G+A  +  +
Sbjct: 158 --SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 36/207 (17%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHV----- 491
           + +G+G FG V K  +    +  A+K      A   Q       EV L   +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115

Query: 492 -NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR---VNIIEGVTQGL 547
             ++ +  +   R+   L++E L   S +LY  D +R        R   +N+     Q +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML---SYNLY--DLLRNT----NFRGVSLNLTRKFAQQM 166

Query: 548 LY---LQEYSNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGT 602
                        +IH DLK  NILL N      KI DFG +    + +      + + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQS 221

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
             Y  PE +    Y +  D++S G +L
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCIL 248

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 8/62 (12%)

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP--------E 609
           ++HRD+K SNILL+ E + K++DFG+++ F       N   +                 +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189

Query: 610 YV 611
           YV
Sbjct: 190 YV 191

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 50/211 (23%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHV------N 492
           +G+G FG V K  +    Q  A+K +        Q  EE    + +   L+        N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR-------VNIIEGVTQ 545
           ++ +L   T R+   + +E L   S++LY          +  K+       + ++     
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLY----------ELIKKNKFQGFSLPLVRKFAH 207

Query: 546 GLLY-LQEYSNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGT 602
            +L  L      R+IH DLK  NILL  +     K+ DFG +             + V T
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRVYT 258

Query: 603 Y----GYVPPEYVKKGIYSMKYDVYSFGVLL 629
           Y     Y  PE +    Y M  D++S G +L
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	656
3alf_A	353	Chitinase, class V; hydrolase; 1.20A {Nicotiana ta	100.0
3aqu_A	356	AT4G19810; stress response, TIM barrel, hydrolase,	100.0
4ay1_A	365	Chitinase-3-like protein 2; chilectin, lectin, chi	100.0
3fy1_A	395	Amcase, TSA1902, acidic mammalian chitinase; struc	100.0
1vf8_A	377	YM1, secretory protein; chitinase, CHI-lectin, str	100.0
1wb0_A	445	Chitinase 1, chitotriosidase 1; cyclopentapeptide	100.0
1itx_A	419	Chitinase A1, glycosyl hydrolase; alpha-beta (TIM)	100.0
2pi6_A	361	Chitinase-3-like protein 1; complex, signaling pro	100.0
3qok_A	420	Putative chitinase II; structural genomics, PSI-bi	100.0
3g6m_A	406	Chitinase, crchi1; inhibitor, caffeine, glycosidas	100.0
1kfw_A	435	Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrob	100.0
1ll7_A	392	Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {	100.0
1jnd_A	420	Imaginal DISC growth factor-2; IDGF, chitinase, in	100.0
1edq_A	540	Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1	100.0
1w9p_A	433	Chitinase; peptide inhibitors, argifin, argadin, g	100.0
3arx_A	584	Chitinase A; TIM barrel, inhibitor complex, glycos	100.0
1goi_A	499	Chitinase B; chitin degradation, hydrolase, glycos	100.0
3oa5_A	574	CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yers	100.0
3cz8_A	319	Putative sporulation-specific glycosylase YDHD; st	100.0
3bxw_B	393	Chitinase domain-containing protein 1; TIM barrel,	100.0
3fnd_A	312	Chitinase; TIM-barrel, structural genomics, PSI-2,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1nar_A	290	Narbonin; plant SEED protein; 1.80A {Vicia narbone	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3sim_A	275	Protein, family 18 chitinase; family 18 plant chit	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2y8v_A	290	CHIC, class III chitinase, putative; afchic, hydro	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3n12_A	333	Chitinase A, chinctu2; zinc atoms, complex, hydrol	100.0
4axn_A	328	Chitinase C1; hydrolase; 1.68A {Serratia marcescen	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3ebv_A	302	Chinitase A; chitinase A, CHIA, glycosidase, struc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ian_A	321	Chitinase; structural genomics, hydrolase, glycosi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.98
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.98
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.98
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.98
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.98
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.98
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.98
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.98
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.98
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.98
4ac1_X	283	Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, g	99.98
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.98
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.98
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.98
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.98
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.98
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.98
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.98
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.98
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.98
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.98
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2gsj_A	271	Protein PPL-2; mimosoideae, chimerolectin, endochi	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2hvm_A	273	Hevamine; hydrolase, chitinase/lysozyme; 1.80A {He	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1edt_A	271	Endo-beta-N-acetylglucosaminidase H, endo H; hydro	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2uy2_A	294	Endochitinase; carbohydrate metabolism, polysaccha	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
2xtk_A	310	CHIA1, class III chitinase CHIA1; hydrolase, GH18;	99.95
1cnv_A	299	Concanavalin B; plant chitinase, chitin binding pr	99.95
1eok_A	290	Endo-beta-N-acetylglucosaminidase F3; alpha/beta-b	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2ebn_A	289	Endo-beta-N-acetylglucosaminidase F1; hydrolase(gl	99.94
1ta3_A	274	XIP-1, xylanase inhibitor protein I; beta alpha ba	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
3poh_A	451	Endo-beta-N-acetylglucosaminidase F1; TIM barrel,	99.84
3mu7_A	273	XAIP-II, xylanase and alpha-amylase inhibitor prot	99.82
2dsk_A	311	Chitinase; catalytic domain, active domain, crysta	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.82
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.45
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.15
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.65
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.63
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.41
2vtf_A	626	Endo-beta-N-acetylglucosaminidase; hydrolase, fami	97.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.21
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.01
2w91_A	653	Endo-beta-N-acetylglucosaminidase D; hydrolase, N-	96.83
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.78
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.33
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.94
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.31
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.63
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.06
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	91.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	89.2
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.98
3gdb_A	937	Endo-D, putative uncharacterized protein SPR0440;	83.45

>3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A*

Probab=100.00  E-value=2.4e-67  Score=548.99  Aligned_cols=312  Identities=42%  Similarity=0.768  Sum_probs=280.1

Q ss_pred             eEEEEEecCCCCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcccc
Q 006211           27 WIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS  106 (656)
Q Consensus        27 ~~~~~y~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~  106 (656)
                      .+++|||...+.|.|++||+++||||+|||+.++++++.+...+.++..+..+++.+|++||++|||+||          
T Consensus         3 ~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~~~~~~~~~~~~lk~~~~~lkvllsi----------   72 (353)
T 3alf_A            3 NVKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKNPSVKTFLSI----------   72 (353)
T ss_dssp             CEEEEEEEGGGCCCGGGCCGGGCSEEEEEEEEEETTTTEEECCHHHHHHHHHHHHHHHHHCTTCEEEEEE----------
T ss_pred             ceEEEEEecCCCCCHhHCCcccCCEEEEEEEEeeCCCCEEEeCCccHHHHHHHHHHHHhhCCCCeEEEEE----------
Confidence            4678999666789999999999999999999999987888776655566777778899999999999999          


Q ss_pred             ccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCC-CccCcchHHHHHHHHHhhcCC------CCCc
Q 006211          107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NSTDLNSLGILLDEWKASASD------QPEL  179 (656)
Q Consensus       107 ~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p-~~~d~~~~~~ll~~lr~~l~~------~~~~  179 (656)
                        |||+.++..|+.++++++.|++||+++++++++|+||||||||||| .++|+++|+.||++||++|++      ++++
T Consensus        73 --GG~~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~~~~~~  150 (353)
T 3alf_A           73 --AGGRANSTAYGIMARQPNSRKSFIDSSIRLARQLGFHGLDLDWEYPLSAADMTNLGTLLNEWRTAINTEARNSGRAAL  150 (353)
T ss_dssp             --ECTTSCHHHHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECCCCCSHHHHHHHHHHHHHHHHHHHHHHHHHCSCCC
T ss_pred             --CCCCCCchhHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEEeeecCChhHHHHHHHHHHHHHHHHHHhhhhcCCCce
Confidence              6666666679999999999999999999999999999999999999 568999999999999999953      2468


Q ss_pred             EEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCC-CccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceee
Q 006211          180 TLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE-NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL  258 (656)
Q Consensus       180 ~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~-~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~l  258 (656)
                      +||+++|+.+.....+||+++|+++|||||||+||+||+.|+ +.+||+|||+++....+++.+|++|+++|+|++||+|
T Consensus       151 ~Ls~a~~~~~~~~~~~~d~~~l~~~vD~invMtYD~~g~~w~~~~~g~~a~l~~~~~~~~~~~~v~~~~~~gvp~~Klvl  230 (353)
T 3alf_A          151 LLTAAVSNSPRVNGLNYPVESLARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLVL  230 (353)
T ss_dssp             EEEEEEESSSEETTEECCHHHHHHHCSEEEEECCCSSCTTTSTTBCCCSSCSCCTTTCCSHHHHHHHHHHTTCCGGGEEE
T ss_pred             EEEEecccCchhhhcCCCHHHHhhhccEEEEEEeeccCCCCCCCCCCCCCcCcCCCCCccHHHHHHHHHHcCCChHHEEE
Confidence            999999987665556699999999999999999999987577 7899999999877778999999999999999999999


Q ss_pred             cccCCCCCcCCC----------------------CCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcch
Q 006211          259 GARASGPGITID----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVET  316 (656)
Q Consensus       259 G~p~yG~~~~~~----------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~s  316 (656)
                      |+|+|||+|+..                      |.++|.|||..+...+  +...||+.+..||.+.+++||+|||++|
T Consensus       231 Gip~YGr~~~~~~~~~~~~~~~~~g~~~~~~~~~g~~~y~ei~~~~~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~S  308 (353)
T 3alf_A          231 GIPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVESR--ATTVYNATIVGDYCYSGSNWISYDDTQT  308 (353)
T ss_dssp             EEESEEEEEEESCTTCCSTTCBEEEECTTSCTTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHHH
T ss_pred             EeCCceeeeeccCCcCCCCCCCCCCCCCCCCCCCCeEcHHHHHHHHhhCC--CeEEEccccceEEEEeCCEEEEcCCHHH
Confidence            999999999531                      5689999999887655  8999999999999999999999999999


Q ss_pred             hHHHHhhhhhcccccceeeEeccCcccccchhhhhh
Q 006211          317 IKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIE  352 (656)
Q Consensus       317 i~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~~~~~  352 (656)
                      +++|++||+++||||+|+|++++||.|.+.++....
T Consensus       309 i~~K~~~~~~~gLgGv~~W~l~~Dd~~~ll~a~~~~  344 (353)
T 3alf_A          309 VRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTASQT  344 (353)
T ss_dssp             HHHHHHHHHHTTCSEEEEECGGGSSTTHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCEEEEEeccCCCCchHHHHHHHH
Confidence            999999999999999999999999999998887654

>3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana}

Probab=100.00  E-value=3.1e-67  Score=548.33  Aligned_cols=313  Identities=46%  Similarity=0.809  Sum_probs=280.3

Q ss_pred             ceEEEEEecCCCCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCccc
Q 006211           26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ  105 (656)
Q Consensus        26 ~~~~~~y~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~  105 (656)
                      ..+++|||...+.|.|++||+++||||+|||+.++++++.+...+.++..+..+++.+|++||++|||+||         
T Consensus         3 ~~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~~~~~~~~~~~~lk~~~~~lkvllsi---------   73 (356)
T 3aqu_A            3 TVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSANQPKFSTFTQTVQRRNPSVKTLLSI---------   73 (356)
T ss_dssp             CCEEEEEECGGGCCCGGGSCGGGCSEEEEEEEEEETTTTEEECCTTTHHHHHHHHHHHTTTCTTCEEEEEE---------
T ss_pred             ceEEEEEEeCCCCCCHHHCCcccCCEEEEEEEEecCCCCEEEeCCccHHHHHHHHHHHHhhCCCceEEEEE---------
Confidence            35789999555679999999999999999999999987888877666667778878899999999999999         


Q ss_pred             cccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCC-CccCcchHHHHHHHHHhhcCC------CCC
Q 006211          106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NSTDLNSLGILLDEWKASASD------QPE  178 (656)
Q Consensus       106 ~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p-~~~d~~~~~~ll~~lr~~l~~------~~~  178 (656)
                         |||+.++..|+.++++++.|++||+++++++++||||||||||||| .++|+++|+.||++||++|++      +++
T Consensus        74 ---GGw~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~g~~~  150 (356)
T 3aqu_A           74 ---GGGIADKTAYASMASNPTSRKSFIDSSIRVARSYGFHGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSSGKPR  150 (356)
T ss_dssp             ---ECTTSCHHHHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHHHHHHHHHHHCSCC
T ss_pred             ---CCCCCCcchHHHHhcCHHHHHHHHHHHHHHHHHhCCCeEEEEEeecCChhHHHHHHHHHHHHHHHHHHhhhhcCCCc
Confidence               6666666679999999999999999999999999999999999999 568999999999999999953      246


Q ss_pred             cEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC-CCCHHHHHHHHHHcCCCCCcee
Q 006211          179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-NISTDFGIREWLRRGFPANKLV  257 (656)
Q Consensus       179 ~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~-~~~~~~~v~~~~~~g~p~~Kl~  257 (656)
                      ++||+++|+.+.....+||+++|+++|||||||+||+||+.|++.+||+|||+.+.. ..+++.+|++|+++|+|++||+
T Consensus       151 ~~Ls~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~~w~~~~g~~apl~~~~~~~~~v~~~v~~~~~~gvp~~Klv  230 (356)
T 3aqu_A          151 LLLAAAVFYSNNYYSVLYPVSAVASSLDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGPSGDAGTRSWIQAGLPAKKAV  230 (356)
T ss_dssp             CEEEEEEESSSEETTEECCHHHHHHHCSEEEEECCCCCCTTTCSBCCCTTCSCCTTCSSCCHHHHHHHHHHTTCCGGGEE
T ss_pred             eEEEEeccCCchhhhccCCHHHHhhhccEEEEEeeecccCCCCCCcCCCCcCCCCCCCCccHHHHHHHHHHcCCCHHHEE
Confidence            899999998766555669999999999999999999998757889999999996543 5789999999999999999999


Q ss_pred             ecccCCCCCcCCC-------------------CCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhH
Q 006211          258 LGARASGPGITID-------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIK  318 (656)
Q Consensus       258 lG~p~yG~~~~~~-------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~  318 (656)
                      ||+|+|||+|+..                   |.++|.|||..+...+  +...||+.+..||.+.+++||+|||++|++
T Consensus       231 lGip~YGr~~~~~~~~~~~~~~p~~g~~~~~~g~~~y~ei~~~l~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~Si~  308 (356)
T 3aqu_A          231 LGFPYYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVDNG--ATTVYNSTVVGDYCYAGTNWIGYDDNQSIV  308 (356)
T ss_dssp             EEEESEEEEEEESCTTCCSTTCBEEEECSSTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHHHHH
T ss_pred             EEeccceeeeEecCCcCCCCCCCCCCCCCCCCCeeeHHHHHHHHhcCC--CeEEEchhhceEEEEeCCEEEEeCCHHHHH
Confidence            9999999999632                   6789999999887655  899999999999999999999999999999


Q ss_pred             HHHhhhhhcccccceeeEeccCcccccchhhhhh
Q 006211          319 AKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIE  352 (656)
Q Consensus       319 ~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~~~~~  352 (656)
                      +|++||+++||||+|+|++++||.|.+.++....
T Consensus       309 ~K~~~~~~~gLgGv~~W~l~~Dd~~~ll~a~~~~  342 (356)
T 3aqu_A          309 TKVRYAKQRGLLGYFSWHVGADDNSGLSRAASQA  342 (356)
T ss_dssp             HHHHHHHHTTCCEEEEECGGGSSTTHHHHHHHHH
T ss_pred             HHHHHHHhCCCCeEEEEeccCCCCchHHHHHHHH
Confidence            9999999999999999999999999998887655

>4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens}

Probab=100.00  E-value=9.1e-67  Score=548.95  Aligned_cols=302  Identities=25%  Similarity=0.460  Sum_probs=263.2

Q ss_pred             eEEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecC
Q 006211           27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG   99 (656)
Q Consensus        27 ~~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~   99 (656)
                      .++||||++|.       .|.|++||+++||||+|||+.|++++..  ..+..+..+...+.++|++||++||||||   
T Consensus         2 ~rvV~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~~~~~~--~~~~~~~~~~~~~~~lK~~~p~lKvllSi---   76 (365)
T 4ay1_A            2 YKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVI--IKDKSEVMLYQTINSLKTKNPKLKILLSI---   76 (365)
T ss_dssp             CEEEEEEESGGGGSCTTSCCCGGGCCTTTCSEEEEEEEEEETTEEE--CCCTTHHHHHHHHHHHHHHCTTCEEEEEE---
T ss_pred             eEEEEEECCccccCCCCCCCChhHCCcccCCEEEEEeEEecCCeeE--ECCccHHHHHHHHHHHHHHCCCCEEEEEE---
Confidence            46789998763       4789999999999999999999987432  33444555556668899999999999999   


Q ss_pred             CCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcC-----
Q 006211          100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS-----  174 (656)
Q Consensus       100 ~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~-----  174 (656)
                               |||+.+++.|+.+++++++|++||+|+++|+++|+|||||||||||...|+.+|+.|+++||+++.     
T Consensus        77 ---------GGw~~~s~~Fs~~~~~~~~R~~Fi~siv~~~~~~~fDGiDiDWEyP~~~d~~~~~~ll~elr~~~~~~~~~  147 (365)
T 4ay1_A           77 ---------GGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTK  147 (365)
T ss_dssp             ---------EETTTTTGGGTTGGGSHHHHHHHHHHHHHHHHHTTCCEEEEEESCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ---------eCCCCCCchHHHHHcCHHHHHHHHHHHHHHHHhcCCceEEEeeecCCcccccccHHHHHHHHHHHHHHHhh
Confidence                     666666666999999999999999999999999999999999999999999999999999998873     


Q ss_pred             -CCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCC-ccccCCCCCCCCC------CCCHHHHHHHH
Q 006211          175 -DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN-VTGIHAALYNPSS------NISTDFGIREW  246 (656)
Q Consensus       175 -~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~-~~g~~apl~~~~~------~~~~~~~v~~~  246 (656)
                       .++.++||+++|+.+.....+||+++|+++||||||||||+||+|..+ .+||+|||+....      ..+++.+|++|
T Consensus       148 ~~~~~~~lt~a~~~~~~~~~~~~d~~~i~~~vD~inlMtYD~~g~w~~~~~tg~~apL~~~~~~~~~~~~~~v~~av~~~  227 (365)
T 4ay1_A          148 STKERLLLTAGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYW  227 (365)
T ss_dssp             CSSCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEECCCSSCTTCSSCBCCCSSCSSCCTTCCGGGGGSSHHHHHHHH
T ss_pred             hccCceEEEeecCCChhhhhhhcchhhhhhcccEEEEEcccccCcccCCCcCCCCCCCCCCccccCccccccHHHHHHHH
Confidence             245799999999988777777999999999999999999999876543 5899999996543      25799999999


Q ss_pred             HHcCCCCCceeecccCCCCCcCC-----------------------CCCcchHHHHHHHHhcCCCcccccccceeeeeee
Q 006211          247 LRRGFPANKLVLGARASGPGITI-----------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT  303 (656)
Q Consensus       247 ~~~g~p~~Kl~lG~p~yG~~~~~-----------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~  303 (656)
                      +++|+|++||+||+|+|||+|+.                       .|.++|.|+|..+..    ....|+....+||.+
T Consensus       228 ~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~~~~~~~~~~g~~t~~~g~~~y~e~~~~~~~----~~~~~~~~~~~~y~~  303 (365)
T 4ay1_A          228 IHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKG----AKITRLQDQQVPYAV  303 (365)
T ss_dssp             HHTTCCGGGEEEEEESEEEEEEESSSCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHTT----CEEEECTTTCCEEEE
T ss_pred             HHcCCCHHHeeeccCccceeeeecCCCCCCCCcccCCCCCccccccCCeeeHHHHHHHhcC----CceEEecCCeeEEEE
Confidence            99999999999999999999853                       256899999987653    556677778889999


Q ss_pred             cCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccc
Q 006211          304 SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALS  346 (656)
Q Consensus       304 ~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~  346 (656)
                      ++++||+|||++|+++|++||+++||||+|+|++++||..+.+
T Consensus       304 ~~~~~vsydd~~Si~~K~~y~~~~~LgGv~~W~l~~DD~~G~~  346 (365)
T 4ay1_A          304 KGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKS  346 (365)
T ss_dssp             ETTEEEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTSTT
T ss_pred             ECCEEEEeCCHHHHHHHHHHHHhcCCCEEEEEeCCCcCCCCCc
Confidence            9999999999999999999999999999999999999987754

>3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A*

Probab=100.00  E-value=1.5e-64  Score=534.45  Aligned_cols=300  Identities=28%  Similarity=0.490  Sum_probs=264.1

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||.+|.       .|.|++||+++||||+|||+.++ + +.+...++.+......+.+||++||++||||||    
T Consensus         2 ~~v~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~-~-~~i~~~~~~d~~~~~~~~~lK~~~p~lKvllSi----   75 (395)
T 3fy1_A            2 QLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQ-N-NEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAI----   75 (395)
T ss_dssp             EEEEEEETTGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEE-T-TEEECCSTTHHHHHHHHHHGGGSCTTCEEEEEE----
T ss_pred             EEEEEECcccccCCCCCCCChhHCCcccCCEEEEEEEEee-C-CeeEecccccHHHHHHHHHHHHhCCCCEEEEEE----
Confidence            4689998764       47899999999999999999999 4 456555555555555668899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----cCcchHHHHHHHHHhhcCC
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----~d~~~~~~ll~~lr~~l~~  175 (656)
                              |||+.++..|+.++++++.|++||+++++++++|||||||||||||..     +|+++|+.||++||++|++
T Consensus        76 --------GGw~~~s~~f~~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~~  147 (395)
T 3fy1_A           76 --------GGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQ  147 (395)
T ss_dssp             --------ECGGGCSHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHH
T ss_pred             --------cCCCCCCchhhHHhCCHHHHHHHHHHHHHHHHhcCCCeEEEEeEcCCCCCCChhHHHHHHHHHHHHHHHHHH
Confidence                    777766677999999999999999999999999999999999999966     4899999999999999943


Q ss_pred             ------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCC------CCHHHHH
Q 006211          176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGI  243 (656)
Q Consensus       176 ------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~------~~~~~~v  243 (656)
                            +++++||+|+|+.+.....+||+++|+++|||||||+||+||+ |+..+||+|||+..+.+      .+++.+|
T Consensus       148 ~~~~~~~~~~~Lt~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apl~~~~~~~~~~~~~~v~~~v  226 (395)
T 3fy1_A          148 EAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGS-WEGYTGENSPLYKYPTDTGSNAYLNVDYVM  226 (395)
T ss_dssp             HHHHHTSCCCEEEEEECCSHHHHHHHCCHHHHHHHCSEEEECCCCCSCG-GGSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred             hhhccCCCceEEEEEecCChhHhhcchhHHHHHhhcceeeeecccccCC-CCCCCCCCCcCcCCCCCccccccccHHHHH
Confidence                  2358999999987766666799999999999999999999975 78889999999976543      6899999


Q ss_pred             HHHHHcCCCCCceeecccCCCCCcCC------------------------CCCcchHHHHHHHHhcCCCcccccccceee
Q 006211          244 REWLRRGFPANKLVLGARASGPGITI------------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVV  299 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG~~~~~------------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~  299 (656)
                      ++|+++|+|++||+||+|+|||+|+.                        .|.++|.|||..+..   +++..||+.+.+
T Consensus       227 ~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~G~~t~~~G~~~y~ei~~~~~~---g~~~~~D~~~~~  303 (395)
T 3fy1_A          227 NYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKN---GATQGWDAPQEV  303 (395)
T ss_dssp             HHHHHTTCCGGGEEEEEESEEEEEEESSTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTTE
T ss_pred             HHHHHcCCCHHHEEEEeccccceeEecCCCCCCCCCcccCCCCCCcccCCCceeeHHHHHHHhcc---CCeEEEecccce
Confidence            99999999999999999999999953                        246789999987752   578899999999


Q ss_pred             eeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCccccc
Q 006211          300 NLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWAL  345 (656)
Q Consensus       300 ~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~  345 (656)
                      ||.+++++||+|||++|+++|++||+++||||+|+|++++||..+.
T Consensus       304 ~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgG~~~W~ld~DD~~g~  349 (395)
T 3fy1_A          304 PYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGT  349 (395)
T ss_dssp             EEEEETTEEEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCSSST
T ss_pred             EEEEECCEEEEeCCHHHHHHHHHHHHhCCCCEEEEEccccCccCCC
Confidence            9999999999999999999999999999999999999999998773

>1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A

Probab=100.00  E-value=4.8e-64  Score=528.81  Aligned_cols=299  Identities=29%  Similarity=0.486  Sum_probs=262.2

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||++|.       .|.+++||+++||||+|||+.++++  .+...++.+......+.+||++||++|||+||    
T Consensus         2 ~vv~Y~~~w~~~~~~~~~~~~~~i~~~~~Thi~~aF~~i~~~--~~~~~d~~d~~~~~~~~~lk~~~~~lkvllsi----   75 (377)
T 1vf8_A            2 QLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNN--EITYTHEQDLRDYEALNGLKDKNTELKTLLAI----   75 (377)
T ss_dssp             EEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETT--EEECSSTTHHHHHHHHHHGGGTCTTCEEEEEE----
T ss_pred             eEEEEECcchhcCCcCCCCChHHCCcccCCEEEEEeEeeccC--ceeecchhHHHHHHHHHHHHhhCCCCeEEEEE----
Confidence            4689998774       4789999999999999999999987  45544544444445557899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----cCcchHHHHHHHHHhhcCC
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----~d~~~~~~ll~~lr~~l~~  175 (656)
                              |||+.++..|+.++++++.|++||+++++++++|+|||||||||||..     +|+++|+.||++||++|+.
T Consensus        76 --------GG~~~~s~~fs~~~~~~~~R~~fi~si~~~~~~~~fDGiDiDwEyp~~~g~~~~d~~n~~~ll~eLr~~l~~  147 (377)
T 1vf8_A           76 --------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEE  147 (377)
T ss_dssp             --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCchHhHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeeCCCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                    667666666999999999999999999999999999999999999964     5789999999999999952


Q ss_pred             ------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCC------CCHHHHH
Q 006211          176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGI  243 (656)
Q Consensus       176 ------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~------~~~~~~v  243 (656)
                            +++++||+|+|+.+.....+||+++|+++||||||||||+||+ |+..+||+|||+..+.+      .+++.+|
T Consensus       148 ~~~~~~~~~~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apl~~~~~~~~~~~~~~v~~~v  226 (377)
T 1vf8_A          148 ESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHDP-KDGYTGENSPLYKSPYDIGKSADLNVDSII  226 (377)
T ss_dssp             HHHHHTSCCCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSCG-GGSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred             hhhccCCCceEEEEEccCCHHHHhccCCHHHHHhhCcEEEEEeecccCC-CCCCCCCCCCCCCCCCCccccccccHHHHH
Confidence                  4589999999988765555699999999999999999999976 78889999999976533      5899999


Q ss_pred             HHHHHcCCCCCceeecccCCCCCcCCC------------------------CCcchHHHHHHHHhcCCCcccccccceee
Q 006211          244 REWLRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVV  299 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG~~~~~~------------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~  299 (656)
                      ++|+++|+|++||+||+|+|||+|+..                        |.++|.|||..+.   .++...||+....
T Consensus       227 ~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~~~---~g~~~~~D~~~~~  303 (377)
T 1vf8_A          227 SYWKDHGAASEKLIVGFPAYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLN---EGATEVWDAPQEV  303 (377)
T ss_dssp             HHHHHTTCCGGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHH---TTCEEEEETTTTE
T ss_pred             HHHHHcCCCHHHEEEEecccceeeEcccCCCCCCCCcCCCCCCCCCccCcCceecHHHHHHHHh---cCCeEEeccccce
Confidence            999999999999999999999999642                        3479999998764   2589999999999


Q ss_pred             eeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccc
Q 006211          300 NLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA  344 (656)
Q Consensus       300 ~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~  344 (656)
                      ||.+.+++||+|||++|+++|++||+++||||+|+|++++||..+
T Consensus       304 ~y~y~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g  348 (377)
T 1vf8_A          304 PYAYQGNEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDDFSG  348 (377)
T ss_dssp             EEEEETTEEEECCCHHHHHHHHHHHHHTTCCEEEEETGGGSCTTS
T ss_pred             eEEEeCCEEEEecCHHHHHHHHHHHHhCCCceEEEEeeecccCCC
Confidence            999999999999999999999999999999999999999999765

>1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A*

Probab=100.00  E-value=6.2e-64  Score=538.00  Aligned_cols=297  Identities=33%  Similarity=0.544  Sum_probs=261.7

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      .++|||.+|.       .|.+++||+++||||+|||+.++++  .+...++.+..+...+.+||++||++||||||    
T Consensus         2 kvv~Y~~~w~~~r~~~~~~~~~~i~~~~~THi~yaF~~i~~~--~~~~~d~~d~~~~~~~~~lk~~~p~lKvllsi----   75 (445)
T 1wb0_A            2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNH--QLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI----   75 (445)
T ss_dssp             EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETT--EEECSSTTHHHHHHHHHHGGGTCTTCEEEEEE----
T ss_pred             eEEEEECcccccCCCCCCCCHHHCCcccCCEEEEEEEeeccC--ceeecChhHHHHHHHHHHHHHhCCCCeEEEEE----
Confidence            3689998874       4789999999999999999999986  45555554444455568899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----cCcchHHHHHHHHHhhcCC
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----~d~~~~~~ll~~lr~~l~~  175 (656)
                              |||+.++..|+.++++++.|++||+++++++++|||||||||||||..     +|+++|+.||++||++|++
T Consensus        76 --------GGw~~~s~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~~  147 (445)
T 1wb0_A           76 --------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQ  147 (445)
T ss_dssp             --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCchHHHHHcCHHHHHHHHHHHHHHHHHcCCCeEEEeCccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                    777666667999999999999999999999999999999999999964     5789999999999999952


Q ss_pred             ------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCC------CCHHHHH
Q 006211          176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGI  243 (656)
Q Consensus       176 ------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~------~~~~~~v  243 (656)
                            +++++||+|+|+.+.....+||+++|+++|||||||+||+||+ |+..+||+||||....+      .+++.+|
T Consensus       148 ~~~~~~~~~~~Ls~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apL~~~~~~~~~~~~~~v~~av  226 (445)
T 1wb0_A          148 EAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGS-WEKVTGHNSPLYKRQEESGAAASLNVDAAV  226 (445)
T ss_dssp             HHHHHCSCCCEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSSCT-TSSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred             hhhccCCCceEEEEEecCCHHHHHccCCHHHHHHhcceeeeeeeeccCC-CcCCCCCCCCCCCCCCCccccccccHHHHH
Confidence                  4689999999988766555699999999999999999999976 78899999999975533      5899999


Q ss_pred             HHHHHcCCCCCceeecccCCCCCcCCC------------------------CCcchHHHHHHHHhcCCCcccccccceee
Q 006211          244 REWLRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVV  299 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG~~~~~~------------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~  299 (656)
                      ++|+++|+|++||+||+|+|||+|+..                        |.++|.|||..     .++...||+....
T Consensus       227 ~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~-----~g~~~~~D~~~~~  301 (445)
T 1wb0_A          227 QQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKV  301 (445)
T ss_dssp             HHHHHTTCCGGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTC-----TTCEEEEETTTTE
T ss_pred             HHHHHcCCChhHEEEEecccceeeEccCCCCCCCCCcccCCCCCCCccCcCCcccHHHHhhc-----CCcEEEeccccce
Confidence            999999999999999999999999642                        34689999874     2689999999999


Q ss_pred             eeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccc
Q 006211          300 NLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA  344 (656)
Q Consensus       300 ~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~  344 (656)
                      ||.+++++||+|||++|+++|++||+++||||+|+|++++||..+
T Consensus       302 ~y~y~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g  346 (445)
T 1wb0_A          302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAG  346 (445)
T ss_dssp             EEEEETTEEEECCCHHHHHHHHHHHHHTTCCEEEEECGGGSCTTC
T ss_pred             eEEEeCCEEEEeCCHHHHHHHHHHHHHCCCceEEEecccccccCC
Confidence            999999999999999999999999999999999999999999766

>1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1

Probab=100.00  E-value=9.6e-64  Score=532.93  Aligned_cols=310  Identities=24%  Similarity=0.401  Sum_probs=256.7

Q ss_pred             ccceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCC-----------------------------cEEecCC
Q 006211           24 AQTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSST-----------------------------YQLSISS   70 (656)
Q Consensus        24 ~~~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~-----------------------------~~~~~~~   70 (656)
                      +...+++|||.+|.    .|.|++||+++||||+|||+.|+.++                             +.+...+
T Consensus         9 ~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~D   88 (419)
T 1itx_A            9 ADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIVLGD   88 (419)
T ss_dssp             GGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCEEESS
T ss_pred             CCCCEEEEEECchhhcCCCCChhhCCHhhCcEEEEEeecccccccccccccccccccccccccccccccccCCCceeecc
Confidence            44567899998864    58899999999999999999996332                             1122222


Q ss_pred             cc----------------hhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHH
Q 006211           71 AN----------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIES  134 (656)
Q Consensus        71 ~~----------------~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~  134 (656)
                      ..                ...+. .+.+||++||++||||||            |||+.+ ..|+.++++++.|++||++
T Consensus        89 ~~~d~~~~~~~~~w~~~~~g~~~-~l~~lk~~~p~lKvllsi------------GGw~~s-~~fs~~~~~~~~R~~Fi~s  154 (419)
T 1itx_A           89 PWIDTGKTFAGDTWDQPIAGNIN-QLNKLKQTNPNLKTIISV------------GGWTWS-NRFSDVAATAATREVFANS  154 (419)
T ss_dssp             HHHHHTSCCTTCCSSSSCCHHHH-HHHHHHHHSTTCEEEEEE------------ECSSSC-TTHHHHHTSHHHHHHHHHH
T ss_pred             hhhhhhcccCccccchhhhHHHH-HHHHHHHhCCCCEEEEEE------------cCCCCc-chhhHHhcCHHHHHHHHHH
Confidence            11                01233 346799999999999999            555443 2399999999999999999


Q ss_pred             HHHHHHHcCCCcceeeeeCCC----------ccCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChh
Q 006211          135 SIRTARLYGFQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPID  199 (656)
Q Consensus       135 ~~~~~~~~~~DGvdidwe~p~----------~~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~  199 (656)
                      +++++++|+|||||||||||.          ++|+++|+.||++||++|++     +++++||+|+|+.+.... +||++
T Consensus       155 ~v~~l~~~~fDGiDiDwEyP~~~~~~g~~~~~~d~~nf~~ll~eLr~~l~~~~~~~g~~~~Lt~a~~~~~~~~~-~~d~~  233 (419)
T 1itx_A          155 AVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAA-NTELA  233 (419)
T ss_dssp             HHHHHHHHTCSEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHHTSCCEEEEEECCSHHHHH-TSCHH
T ss_pred             HHHHHHHcCCCceEEeeecCCCCCCCCCCCChhHHHHHHHHHHHHHHHHHhhhcccCCceEEEEeccCCHHHhh-cCCHH
Confidence            999999999999999999995          35789999999999999953     457999999988765443 58999


Q ss_pred             hhhhccchhhhhhhcccCCCCCCccccCCCCCCC----------CCCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCC
Q 006211          200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP----------SSNISTDFGIREWLRRGFPANKLVLGARASGPGITI  269 (656)
Q Consensus       200 ~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~----------~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~  269 (656)
                      +|+++|||||||||||||+ |+..+||+||||..          ....+++.+|++|++.|+|++||+||+|+|||+|+.
T Consensus       234 ~l~~~vD~inlMtYD~~g~-w~~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~~  312 (419)
T 1itx_A          234 KIAAIVDWINIMTYDFNGA-WQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYGRGWDG  312 (419)
T ss_dssp             HHHHHSSEEEECCCCSSCT-TSSBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEESEEEEEES
T ss_pred             HHHHhhheeeeecccccCC-CCCCCCCCCcCcCCCCccccCCcccccccHHHHHHHHHHcCCCchhEEEEecccccceee
Confidence            9999999999999999975 78889999999953          234689999999999999999999999999999964


Q ss_pred             ----------------------CCCcchHHHHHHHHhcCCCcccccccceeeeeeec--CcEEEeeCCcchhHHHHhhhh
Q 006211          270 ----------------------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFDGVETIKAKISYAK  325 (656)
Q Consensus       270 ----------------------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~  325 (656)
                                            .|.++|.|||..+.. ..+++..||+....||.+.  +++||+|||++|++.|++||+
T Consensus       313 ~~~~~~g~~~~~~g~~~~G~~~~G~~~y~ei~~~~~~-~~g~~~~~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~y~~  391 (419)
T 1itx_A          313 CAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYIN-KNGYTRYWNDTAKVPYLYNASNKRFISYDDAESVGYKTAYIK  391 (419)
T ss_dssp             CCSGGGGTTCBCSEECSCCSSSTTEEEHHHHHHHTTT-CTTEEEEEETTTTEEEEEETTTCCEEECCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCCCCCCCCcccCCeeeHHHHHHhhcc-cCCcEEEeccccccceEEeCCCCEEEEeCCHHHHHHHHHHHH
Confidence                                  245789999974332 2368899999999999775  579999999999999999999


Q ss_pred             hcccccceeeEeccCcccccchhhh
Q 006211          326 EKNLLGYKAFQLSNDDNWALSRAAQ  350 (656)
Q Consensus       326 ~~glgGv~~W~l~~Dd~~~~~~~~~  350 (656)
                      ++||||+|+|++++|+...+.++..
T Consensus       392 ~~gLgGv~~W~l~~D~~~~Ll~ai~  416 (419)
T 1itx_A          392 SKGLGGAMFWELSGDRNKTLQNKLK  416 (419)
T ss_dssp             HHTCCEEEEECGGGCTTCHHHHHHH
T ss_pred             hCCCCeEEEEeecCCCCcHHHHHHH
Confidence            9999999999999998766665543

>2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ...

Probab=100.00  E-value=9.4e-64  Score=523.96  Aligned_cols=299  Identities=30%  Similarity=0.468  Sum_probs=262.7

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||++|.       .|.+++||+++||||+|+|+.++ + +.+...++.+......+.++|++||++||++||    
T Consensus         2 ~vvgY~~~w~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~-~-g~~~~~~~~d~~~~~~~~~lk~~~p~lkvllsi----   75 (361)
T 2pi6_A            2 KLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANIS-N-NEIDTWEWNDVTLYDTLNTLKNRNPKLKTLLSV----   75 (361)
T ss_dssp             EEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEE-T-TEEECCSTTHHHHHHHHHHHHHHCTTCEEEEEE----
T ss_pred             eEEEEECcccccCCCCCCCChHHCCcccCCEEEEEEEecc-C-CeEEeccHHHHHHHHHHHHHHhcCCCCeEEEEE----
Confidence            5789998874       37899999999999999999999 6 466665543433334446799999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCC-----
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD-----  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~-----  175 (656)
                              |||+.++..|+.++++++.|++||+++++++++|+|||||||||||..+|+++|+.||++||++|++     
T Consensus        76 --------GG~~~~s~~f~~~~~~~~~r~~fi~si~~~~~~~~fDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~~~~~~  147 (361)
T 2pi6_A           76 --------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQAG  147 (361)
T ss_dssp             --------ETTTSCHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCGGGHHHHHHHHHHHHHHHHHHHTTS
T ss_pred             --------CCCCCCchhHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeecCCchHHHHHHHHHHHHHHHHhhhhccc
Confidence                    6666666679999999999999999999999999999999999999999999999999999999942     


Q ss_pred             CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCC-----CCCCHHHHHHHHHHcC
Q 006211          176 QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS-----SNISTDFGIREWLRRG  250 (656)
Q Consensus       176 ~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~-----~~~~~~~~v~~~~~~g  250 (656)
                      +++++||+++|+.+.....+||+++|+++||||||||||+||+ |++.+||+|||+..+     ...+++.+|++|+++|
T Consensus       148 ~~~~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apl~~~~~~~~~~~~~v~~~v~~~~~~g  226 (361)
T 2pi6_A          148 TEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHGA-WRQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLG  226 (361)
T ss_dssp             SCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSCT-TCCBCCCSSCSSCCSSSCSCTTSSHHHHHHHHHHTT
T ss_pred             CCceEEEEEecCCHHHHhccCCHHHHHhhccEEEEEeeeccCC-CCCCCCCCCCCCCCCCCccccCccHHHHHHHHHHcC
Confidence            2467999999988765555699999999999999999999975 778899999999743     3467999999999999


Q ss_pred             CCCCceeecccCCCCCcCCC-----------------------CCcchHHHHHHHHhcCCCcccccccceeeeeeecCcE
Q 006211          251 FPANKLVLGARASGPGITID-----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGAT  307 (656)
Q Consensus       251 ~p~~Kl~lG~p~yG~~~~~~-----------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  307 (656)
                      +|++||+||+|+|||+|+..                       |.++|.|||..+.    ++...||+.+.+||.+.+++
T Consensus       227 ~p~~KlvlGip~YGr~~~~~~~~~~~~~~~~g~~~~g~~t~~~g~~~y~ei~~~~~----g~~~~~D~~~~~~y~~~~~~  302 (361)
T 2pi6_A          227 APANKLVMGIPTFGRSFTLASSKTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLH----GATTHRFRDQQVPYATKGNQ  302 (361)
T ss_dssp             CCGGGEEEEEESEEEEEEESSSCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHTT----TCEEEEETTTTEEEEEETTE
T ss_pred             CCHHHEEEEecccceeeecCCCCCCCCCcCCCCCCCCCcCCCCceeeHHHHHHHhc----CCEEEecccccceEEEECCE
Confidence            99999999999999999643                       4568999998653    58999999999999999999


Q ss_pred             EEeeCCcchhHHHHhhhhhcccccceeeEeccCccccc
Q 006211          308 WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWAL  345 (656)
Q Consensus       308 ~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~  345 (656)
                      ||+|||++|+++|++||+++||||+|+|++++||..+.
T Consensus       303 ~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g~  340 (361)
T 2pi6_A          303 WVAYDDQESVKNKARYLKNRQLAGAMVWALDLDDFRGT  340 (361)
T ss_dssp             EEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCSSSC
T ss_pred             EEEeCCHHHHHHHHHHHHhCCCcEEEEEcccccccCCC
Confidence            99999999999999999999999999999999997765

>3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp}

Probab=100.00  E-value=1.7e-62  Score=525.35  Aligned_cols=308  Identities=21%  Similarity=0.353  Sum_probs=253.4

Q ss_pred             cCccceEEEEEecCCCC------CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcch-hhHHH------------HHHH
Q 006211           22 SDAQTWIKAGYWLAGRE------FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-QYFSI------------FANS   82 (656)
Q Consensus        22 ~~~~~~~~~~y~~~~~~------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-~~~~~------------~~~~   82 (656)
                      .++...+++|||.+|..      +.++++|+++||||+|+|+.+++++.........+ ..+..            .+..
T Consensus        21 ~~~~~~~vvgYy~~~~~~r~~~~~~~~~i~~~~~THi~~af~~i~~~g~~~~~~~~~d~~~~~~~w~~~~~~~~~~~~~~  100 (420)
T 3qok_A           21 LSAQPLMSVGYFNGGGDVTAGPGGDIDKLDVRQITHLNYSFGLIYNDEKDETNAALKDPAHLHEIWLSPKVQADLQKLPA  100 (420)
T ss_dssp             ----CCEEEEEEECSCCSSSCSCCCGGGCCCTTCSEEEEEEEEECCCCTTCCCGGGGCGGGTTSEECCHHHHHHHTTHHH
T ss_pred             ccCCCCEEEEEEcCccccCCCCCCCcccCCcccceEEEEEeEEECCCCcEEecCcccchhhhhhcccccchhhhHHHHHH
Confidence            44566788999988764      78999999999999999999998753222122221 11111            2467


Q ss_pred             HHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCC-------
Q 006211           83 VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-------  155 (656)
Q Consensus        83 ~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~-------  155 (656)
                      +|++||++|||+||            |||+  +..|+.++++++.|++||+++++++++|||||||||||||.       
T Consensus       101 lk~~~p~lkvllsi------------GG~~--s~~f~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~~~~~  166 (420)
T 3qok_A          101 LRKQNPDLKVLLSV------------GGWG--ARGFSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNGAWGLV  166 (420)
T ss_dssp             HHHHCTTCEEEEEE------------ECTT--CCCHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTTHHHHTS
T ss_pred             HHHhCCCCEEEEEE------------CCCC--CcchhhhhCCHHHHHHHHHHHHHHHHhcCCCceEEEEeCCCCCCCCCC
Confidence            99999999999999            5555  33499999999999999999999999999999999999995       


Q ss_pred             ---ccCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCC
Q 006211          156 ---STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN  232 (656)
Q Consensus       156 ---~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~  232 (656)
                         .+|+++|+.||++||++|+  ++++||+|+|+.+.....+||+++++++|||||||+||+||+ |+.   |+|||+.
T Consensus       167 ~~~~~d~~~~~~ll~eLr~~l~--~~~~Ls~a~~~~~~~~~~~~d~~~l~~~~D~inlMtYD~~g~-w~~---~~apL~~  240 (420)
T 3qok_A          167 ASQPADRDNFTALLKSLREAVG--EQKLVTIAVGANAESPKSWVDVKAVAPVLNYINLMTYDMAYG-TQY---FNSNLYD  240 (420)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHHC--SSSEEEEEECSCTHHHHHTSCHHHHGGGCSEEEECCCCCCCT-TCC---CSSCSSC
T ss_pred             CCChhHHHHHHHHHHHHHHHhC--CCcEEEEEecCccccccccccHHHHHhhCCEEEEecccCCCC-CCC---CCCcccC
Confidence               5788999999999999995  689999999988765123699999999999999999999976 454   9999996


Q ss_pred             CC--------CCCCHHHHHHHHHHcCCCCCceeecccCCCCC----------cCCC-----------------------C
Q 006211          233 PS--------SNISTDFGIREWLRRGFPANKLVLGARASGPG----------ITID-----------------------G  271 (656)
Q Consensus       233 ~~--------~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~----------~~~~-----------------------g  271 (656)
                      .+        ...+++.+|++|++.|+|++||+||+|+|||+          |+..                       |
T Consensus       241 ~~~~~~~~~~~~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~~~~~~w~~~~~~~~g~~~~~~g~~~~~~~~~~G  320 (420)
T 3qok_A          241 SSHWPTVAAADKYSADFVVNNYLAAGLKPSQMNLGIGFYGRVPKRAVEPGIDWTKADAQNNPVTQPYFGPQQIALFASLG  320 (420)
T ss_dssp             CSSSCCCSGGGCCCHHHHHHHHHHHTCCGGGEEEEEESEEECCGGGTSCBCCTTSTTGGGSCSBCCCCCHHHHHHHHHTT
T ss_pred             CCcccccCCcccccHHHHHHHHHHcCCCHHHeEEEecccccccccccccccceecCCcccCCCCCCccCCCCCCCCCCCC
Confidence            54        23689999999999999999999999999999          8653                       1


Q ss_pred             -------CcchHHHHHHH-HhcCCCcccccccceeeeeeecCc----E--EEeeCCcchhHHHHhhhhhcccccceeeEe
Q 006211          272 -------SMGYKFIRAFI-QNYGYGAAPVYNASYVVNLFTSGA----T--WINFDGVETIKAKISYAKEKNLLGYKAFQL  337 (656)
Q Consensus       272 -------~~~y~~i~~~~-~~~~~~~~~~~d~~~~~~~~~~~~----~--~i~yd~~~si~~K~~~~~~~glgGv~~W~l  337 (656)
                             .++|.+||..+ ...+.+++..||+.+.+||.+.++    +  ||+|||++|+++|++||+++||||+|+|++
T Consensus       321 ~~~~~~g~~~y~ei~~~~~~~~g~~~~~~~D~~~~~~y~~~~~~~g~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l  400 (420)
T 3qok_A          321 YDLSKDTYVKYNDIVGKLLNDPQKRFTEHWDDEAKVPWLSVQSAEGKPLFALSYENPRSVAIKADYIKAKGLAGAMFWEY  400 (420)
T ss_dssp             CCTTTCCEEEHHHHHHHTTTCTTCCEEEEEETTTTEEEEEEECTTSCEEEEEECCCHHHHHHHHHHHHHHTCSEEEEECG
T ss_pred             ccccCCCccCHHHHHHHhhccCCCceEEEECccccccEEEeCCCCCccceEEEcCCHHHHHHHHHHHHhCCCcEEEEEcc
Confidence                   16899999863 332323889999999999977544    4  999999999999999999999999999999


Q ss_pred             ccCcccccchhh
Q 006211          338 SNDDNWALSRAA  349 (656)
Q Consensus       338 ~~Dd~~~~~~~~  349 (656)
                      ++||...+.++.
T Consensus       401 ~~Dd~~~Ll~a~  412 (420)
T 3qok_A          401 GADDQNQLARQL  412 (420)
T ss_dssp             GGSSTTHHHHHH
T ss_pred             ccCCccHHHHHH
Confidence            999966555444

>3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A*

Probab=100.00  E-value=2.4e-62  Score=520.49  Aligned_cols=300  Identities=24%  Similarity=0.376  Sum_probs=253.1

Q ss_pred             ccCccceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchh------------------hHHH
Q 006211           21 FSDAQTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ------------------YFSI   78 (656)
Q Consensus        21 ~~~~~~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~------------------~~~~   78 (656)
                      ...+...+++|||.+|.    .|.|++||+++||||+|||+.+++++ .+...+...+                  ....
T Consensus        15 ~~~~~~~~~v~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g-~v~~~d~~~d~~~~~~~~~~~~~~~~~~g~~~   93 (406)
T 3g6m_A           15 STRATGSINAVYFTNWGIYGRNFQPADLQASKILHVLYSFMNLRVDG-TVYSGDTYADLEKHYSDDSWNDIGTNAYGCVK   93 (406)
T ss_dssp             ----CCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTS-CEEESCHHHHHTCCCTTCCSCCSSSCCCHHHH
T ss_pred             CcCCCCCEEEEEEChhhccCCCCChhhCChhhCCEEEEEEEEECCCC-cEEecChhhhhhhcccccccccccchhhHHHH
Confidence            34455678899998865    58899999999999999999999986 4544432211                  1233


Q ss_pred             HHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-c
Q 006211           79 FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-T  157 (656)
Q Consensus        79 ~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-~  157 (656)
                      .+..+|++||++|||+|||            ||+.+ ..|+.++++++.|++||+++++++++|||||||||||||.. +
T Consensus        94 ~~~~lk~~~~~lKvllsiG------------Gw~~s-~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwE~p~~~~  160 (406)
T 3g6m_A           94 QLYKLKKANRSLKIMLSIG------------GWTWS-TNFPAAASTEATRATFAKTAVEFMKDWGFDGIDVDWEYPASET  160 (406)
T ss_dssp             HHHHHHHHCTTCEEEEEEE------------CSSSC-TTHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHH
T ss_pred             HHHHHHHHCCCCeEEEEEc------------CCCCC-chHHHHhCCHHHHHHHHHHHHHHHHHcCCcEEEEEEECCCccc
Confidence            4467999999999999994            44433 23999999999999999999999999999999999999986 5


Q ss_pred             CcchHHHHHHHHHhhcCC-------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCC
Q 006211          158 DLNSLGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAAL  230 (656)
Q Consensus       158 d~~~~~~ll~~lr~~l~~-------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl  230 (656)
                      |+++|+.||++||++|++       +++++||+|+|+.+.... .||+++|+++|||||||+|||||+ |+..+||+|||
T Consensus       161 d~~n~~~ll~eLr~~l~~~~~~~~~~~~~~Lsia~p~~~~~~~-~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~a~l  238 (406)
T 3g6m_A          161 DANNMVLLLQRVRQELDSYSATYANGYHFQLSIAAPAGPSHYN-VLKLAQLGSVLDNINLMAYDYAGS-WDSVSGHQTNL  238 (406)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHSTTCCCEEEEEEECSHHHHT-TSCHHHHHHHCSEEEEECCCCSST-TSSSCCCSSCS
T ss_pred             hhhHHHHHHHHHHHHHHHhhhhccCCCCeEEEEEecCCHHHhc-cCCHHHHHhhCCEEEEEcccCCCC-CCCCCCCCCcc
Confidence            889999999999999953       468999999998766554 599999999999999999999976 78899999999


Q ss_pred             CCCCC-----CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCC-----------------CCcchHHHHHHHHhcCCC
Q 006211          231 YNPSS-----NISTDFGIREWLRRGFPANKLVLGARASGPGITID-----------------GSMGYKFIRAFIQNYGYG  288 (656)
Q Consensus       231 ~~~~~-----~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~-----------------g~~~y~~i~~~~~~~~~~  288 (656)
                      +....     ..+++.+|++|++.|+|++||+||+|+|||+|+..                 |.++|.+++.      .+
T Consensus       239 ~~~~~~~~~~~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~~~g~~~~g~~~~t~~~g~~~y~~l~~------~g  312 (406)
T 3g6m_A          239 YPSTSNPSSTPFSTKAAVDAYIAAGVPASKIILGMPIYGRAFVGTDGPGKPYSTIGEGSWESGIWDYKVLPK------AG  312 (406)
T ss_dssp             SCCSSCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEEESCSSTTSCCSBCCCCSSBTTEEEGGGCSC------TT
T ss_pred             cCCCCCCcCCchhHHHHHHHHHHcCCCHHHEEEEecccceeeecCCCCCCCCcCCCCCcCcccceeHHHHHh------cC
Confidence            96643     35899999999999999999999999999999642                 2345777643      46


Q ss_pred             cccccccceeeeeeec--CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcc
Q 006211          289 AAPVYNASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN  342 (656)
Q Consensus       289 ~~~~~d~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~  342 (656)
                      +...||+....||.++  +++||+|||++|++.|++||+++||||+|+|++++||.
T Consensus       313 ~~~~~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~  368 (406)
T 3g6m_A          313 ATVITDSAAGATYSYDSSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKT  368 (406)
T ss_dssp             CEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCCS
T ss_pred             CeEEEecCcccceEEeCCCCEEEEeCCHHHHHHHHHHHHhCCCceEEEEecccCCC
Confidence            8899999999999765  57999999999999999999999999999999999994

>1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1

Probab=100.00  E-value=3.8e-62  Score=520.18  Aligned_cols=301  Identities=24%  Similarity=0.376  Sum_probs=249.7

Q ss_pred             ccceEEEEEecCCC----CCCCCCCCC----CCccEEEEEEEEecCCCcEEecC---------------Cc---------
Q 006211           24 AQTWIKAGYWLAGR----EFPLSDINS----ALFTHLICAFAEVDSSTYQLSIS---------------SA---------   71 (656)
Q Consensus        24 ~~~~~~~~y~~~~~----~~~~~~i~~----~~~thi~~~f~~~~~~~~~~~~~---------------~~---------   71 (656)
                      ....+++|||.+|.    .|.+++||.    ++||||+|||+.|+++++.+...               +.         
T Consensus         6 ~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~~~~~THi~yaFa~i~~~~g~~~~~~~~~~~~~~~~~~~~D~~~d~~~~~~   85 (435)
T 1kfw_A            6 VNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGMGYA   85 (435)
T ss_dssp             BTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTCSBCCCEECCCSSTTTTTTCEEHHHHHTCCCC
T ss_pred             CCCcEEEEEECchhhcCCCCChhhCCcccccccCCEEEEEEEeecCCCCeEEeeccccccccccccccccchhhhhcccc
Confidence            44567899998874    478889984    59999999999999833333221               10         


Q ss_pred             ------------c---hhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHH
Q 006211           72 ------------N---QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI  136 (656)
Q Consensus        72 ------------~---~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~  136 (656)
                                  +   ...+. .+.+||++||++|||+|||||..|.             .|+.|+++++.|++||++++
T Consensus        86 ~~~~~~g~~d~~~~~~~g~~~-~l~~lK~~~p~lKvllSiGGw~~s~-------------~fs~~~~~~~~R~~Fi~siv  151 (435)
T 1kfw_A           86 ADKSVSGKADTWDQPLAGSFN-QLKQLKAKNPKLKVMISLGGWTWSK-------------NFSKAAATEASRQKLVSSCI  151 (435)
T ss_dssp             TTTSSSSSCCCTTCSCCHHHH-HHHHHHTTCTTCEEEEEEECSSSCT-------------THHHHTSSHHHHHHHHHHHH
T ss_pred             ccccccccccccchhhHHHHH-HHHHHHHhCCCCEEEEEEcCCCCcc-------------hhhHHhCCHHHHHHHHHHHH
Confidence                        0   11233 3467999999999999995444332             39999999999999999999


Q ss_pred             HHHHHc----------------CCCcceeeeeCCCc------------cCcchHHHHHHHHHhhcCC-----CCCcEEEE
Q 006211          137 RTARLY----------------GFQGIDLFWLWPNS------------TDLNSLGILLDEWKASASD-----QPELTLSM  183 (656)
Q Consensus       137 ~~~~~~----------------~~DGvdidwe~p~~------------~d~~~~~~ll~~lr~~l~~-----~~~~~ls~  183 (656)
                      +++++|                +|||||||||||..            +|+++|+.||++||++|++     +++++||+
T Consensus       152 ~~l~~~~l~~~~~~g~~g~~~~~fDGiDiDwEyP~~~~g~~g~~~~p~~d~~nf~~ll~eLr~~l~~~~~~~g~~~~Ls~  231 (435)
T 1kfw_A          152 DLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSA  231 (435)
T ss_dssp             HHHTSCCEEEETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHTTCCCEEEE
T ss_pred             HHHHhhcccccccccccccccCCCCceEEeeeCCCCCCCCCCCCCCcHHHHHHHHHHHHHHHHhhhhhhcccCCceEEEE
Confidence            999875                69999999999963            5789999999999999953     36899999


Q ss_pred             EeecCCCccccc-cChhhhhhccchhhhhhhcccCCCCCCc-cccCCCCCCCCC-------CCCHHHHHHHHHHcCCCCC
Q 006211          184 AVRYSPTHETVS-YPIDSMKKNLNWAHLVAYDYHMPSKENV-TGIHAALYNPSS-------NISTDFGIREWLRRGFPAN  254 (656)
Q Consensus       184 a~~~~~~~~~~~-~~~~~l~~~vD~invmtYD~~g~~~~~~-~g~~apl~~~~~-------~~~~~~~v~~~~~~g~p~~  254 (656)
                      |+|+.+.....+ ||+++|+++|||||||+|||||+ |+.. +||+|||+..+.       ..+++.+|++|+++|+|++
T Consensus       232 Avp~~~~~~~~g~~d~~~l~~~vD~invMtYD~~g~-w~~~~tg~~apL~~~~~~~~~~~~~~~v~~av~~~~~~gvp~~  310 (435)
T 1kfw_A          232 FLPANPADIDAGGWDDPANFKSLDFGSIQGYDLHGA-WNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDPK  310 (435)
T ss_dssp             EECSSHHHHHHHTTTCGGGGGTCSEEEECCSCSSCT-TSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCGG
T ss_pred             EccCChhhhccCcccHHHHHhhhheeeeeeecccCC-CCCCCCCCCCcCCCCCCCcccccccccHHHHHHHHHHcCCCHH
Confidence            999876655545 99999999999999999999976 6777 999999996543       3589999999999999999


Q ss_pred             ceeecccCCCCCcCCC-------------------CCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcc
Q 006211          255 KLVLGARASGPGITID-------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVE  315 (656)
Q Consensus       255 Kl~lG~p~yG~~~~~~-------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~  315 (656)
                      ||+||+|+|||+|+..                   |.++|.||     .  .+++..||+....||.+++++||+|||++
T Consensus       311 KlvlGip~YGr~w~~~~~~~~g~~~~~~~~~t~~~G~~~y~ei-----~--~~~~~~~D~~~~~~y~y~~~~~vsydd~~  383 (435)
T 1kfw_A          311 QLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKL-----K--TLGTDHYDAATGSAWRYDGTQWWSYDNIA  383 (435)
T ss_dssp             GEEEEEESEEEEEESCCCSSSSCBCSEECCCSSBTTEEEHHHH-----T--TSSEEEEETTTTEEEEECSSCEEEECCHH
T ss_pred             HEEEEecccceeeecCCCCCCCCCCCCCCCCCCcCCceeHHHh-----c--CCCeEEEccccceeEEEECCEEEEecCHH
Confidence            9999999999999653                   45788887     1  24678999999999999899999999999


Q ss_pred             hhHHHHhhhhhcccccceeeEeccCcccccc
Q 006211          316 TIKAKISYAKEKNLLGYKAFQLSNDDNWALS  346 (656)
Q Consensus       316 si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~  346 (656)
                      |+++|++||+++||||+|+|++++|..+.+.
T Consensus       384 Si~~K~~y~~~~gLgGv~~W~l~~D~~~~Ll  414 (435)
T 1kfw_A          384 TTKQKTDYIVSKGLGGGMWWELSGDRNGELV  414 (435)
T ss_dssp             HHHHHHHHHHHTTCCEEEEECGGGCTTCHHH
T ss_pred             HHHHHHHHHHhCCCCEEEEEecCCCCCchHH
Confidence            9999999999999999999999996544433

>1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A

Probab=100.00  E-value=9.5e-62  Score=513.52  Aligned_cols=293  Identities=24%  Similarity=0.394  Sum_probs=248.8

Q ss_pred             eEEEEEecCC----CCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcc-h-----------------hhHHHHHHHHH
Q 006211           27 WIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISSAN-Q-----------------QYFSIFANSVR   84 (656)
Q Consensus        27 ~~~~~y~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~-~-----------------~~~~~~~~~~k   84 (656)
                      .+++|||.+|    +.|.+++||+++||||+|+|+.+++++ .+...+.. +                 ......+.++|
T Consensus         3 ~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g-~v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~l~~lk   81 (392)
T 1ll7_A            3 FRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSG-EVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQMYLLK   81 (392)
T ss_dssp             BEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTS-CEEESCHHHHTTCCCTTCCSSCSSCCCCHHHHHHHHHH
T ss_pred             cEEEEEECchhhcCCCCChhhCCcccCCEEEEEEEEECCCC-eEEecChhhhhhcccCCccccccchhhhHHHHHHHHHH
Confidence            5679999887    457899999999999999999999875 44433321 1                 01223346799


Q ss_pred             hhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCC-ccCcchHH
Q 006211           85 RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLNSLG  163 (656)
Q Consensus        85 ~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~-~~d~~~~~  163 (656)
                      ++||++|||+||            |||+.+ ..|+.++++++.|++||+++++++++|+|||||||||||. .+|+++|+
T Consensus        82 ~~~~~lKvllsi------------GG~~~s-~~f~~~~~~~~~r~~fi~siv~~l~~~~fDGiDiDwE~p~~~~d~~~~~  148 (392)
T 1ll7_A           82 KNNRNLKTLLSI------------GGWTYS-PNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQANDFV  148 (392)
T ss_dssp             HHCTTCEEEEEE------------EHHHHG-GGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHH
T ss_pred             HhCCCCeEEEEE------------eCCCCC-chHhHHhCCHHHHHHHHHHHHHHHHhcCCCcEEEEeeCCCChHHHHHHH
Confidence            999999999999            555432 3399999999999999999999999999999999999998 57899999


Q ss_pred             HHHHHHHhhcCC-------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC-
Q 006211          164 ILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-  235 (656)
Q Consensus       164 ~ll~~lr~~l~~-------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~-  235 (656)
                      .||++||++|++       +++++||+|+|+.+.... .||+++|+++||||||||||+||+ |+..+||+|||+..+. 
T Consensus       149 ~ll~eLr~~l~~~~~~~~~~~~~~Ls~av~~~~~~~~-~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apl~~~~~~  226 (392)
T 1ll7_A          149 LLLKACREALDAYSAKHPNGKKFLLTIASPAGPQNYN-KLKLAEMDKYLDFWNLMAYDFSGS-WDKVSGHMSNVFPSTTK  226 (392)
T ss_dssp             HHHHHHHHHHHHHHHTSTTSCCCEEEEEEECSHHHHT-TSCHHHHHTTCSEEEEECCCSSST-TSSBCCCSSCSSCCSSC
T ss_pred             HHHHHHHHHHHhhhhcccCCCceEEEEEecCCHHHhc-cCCHHHHHHhhheeeEEeecccCC-CCCCCCCCCcCCCCCCC
Confidence            999999999953       468999999998766555 499999999999999999999976 7888999999996542 


Q ss_pred             ----CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCC-----------------CCcchHHHHHHHHhcCCCcccccc
Q 006211          236 ----NISTDFGIREWLRRGFPANKLVLGARASGPGITID-----------------GSMGYKFIRAFIQNYGYGAAPVYN  294 (656)
Q Consensus       236 ----~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~-----------------g~~~y~~i~~~~~~~~~~~~~~~d  294 (656)
                          ..+++.+|++|++.|+|++||+||+|+|||+|+..                 |.++|.+++.      .|+...||
T Consensus       227 ~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~~~~~~~~g~~~~g~~~g~~~~g~~~y~~l~~------~g~~~~~D  300 (392)
T 1ll7_A          227 PESTPFSSDKAVKDYIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGGGSWENGVWDYKDMPQ------QGAQVTEL  300 (392)
T ss_dssp             GGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEECSCSSTTSBCCCCCCBSSSTTEEEGGGCSC------TTCEEEEE
T ss_pred             CccccccHHHHHHHHHHcCCChhHEEEEecccceeeeccCCCCCcCCCCCCCCCccccccHHHHhh------CCCeEEEe
Confidence                35899999999999999999999999999999653                 2345665432      36889999


Q ss_pred             cceeeeeeec--CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCc
Q 006211          295 ASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD  341 (656)
Q Consensus       295 ~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd  341 (656)
                      +....||.++  +++||+|||++|++.|++||+++||||+|+|++++||
T Consensus       301 ~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd  349 (392)
T 1ll7_A          301 EDIAASYSYDKNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDK  349 (392)
T ss_dssp             TTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHTTCCEEEEECTTSCC
T ss_pred             cccceeEEEECCCCEEEEeCCHHHHHHHHHHHHhCCCCeEEEEeecCCC
Confidence            9999999774  6899999999999999999999999999999999999

>1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A*

Probab=100.00  E-value=1.5e-61  Score=517.57  Aligned_cols=309  Identities=24%  Similarity=0.421  Sum_probs=251.8

Q ss_pred             EEEEEecCCC-------CCCCCCCC--CCCccEEEEEEEEecCCCcEEecCCcc----hhhHHHHHHHHHhhCCCceEEE
Q 006211           28 IKAGYWLAGR-------EFPLSDIN--SALFTHLICAFAEVDSSTYQLSISSAN----QQYFSIFANSVRRKNPSIKTLL   94 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~--~~~~thi~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~~k~~~~~~kvl~   94 (656)
                      +++|||.+|.       .|.+++||  .++||||+|||+.++++++.+...+.+    ...+. .+.++|++||++|||+
T Consensus         3 ~vvgYy~~w~~~r~~~~~~~~~~i~~~~~~~THi~yaFa~i~~~~~~~~~~d~~~d~~~~~~~-~~~~lk~~~p~lKvll   81 (420)
T 1jnd_A            3 NLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFS-EVTSLKRKYPHLKVLL   81 (420)
T ss_dssp             EEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHH-HHHGGGGTSTTCEEEE
T ss_pred             eEEEEEccchhcCCCCCCcCHhHcCCccccCCEEEEEEEEecCCCCEEEecCccchhhhHHHH-HHHHHHhhCCCceEEE
Confidence            5799998764       46788888  478999999999999987777655432    12343 4467999999999999


Q ss_pred             EeecCCCCccccccCCcCCCccccccccCChhhH-HHHHHHHHHHHHHcCCCcceeeeeCCCc-----------------
Q 006211           95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHR-KSFIESSIRTARLYGFQGIDLFWLWPNS-----------------  156 (656)
Q Consensus        95 sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r-~~fi~~~~~~~~~~~~DGvdidwe~p~~-----------------  156 (656)
                      |||||+.+.-        .++..|+.++++++.| ++||+|+++++++|||||||||||||..                 
T Consensus        82 siGGw~~~~~--------~~s~~f~~~~~~~~~R~~~Fi~s~v~~~~~~gfDGiDiDwEyP~~~~~~~~g~~g~~~~~~~  153 (420)
T 1jnd_A           82 SVGGDHDIDP--------DHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSIK  153 (420)
T ss_dssp             EEETTCCCCT--------TSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC------------
T ss_pred             EeCCCcCCCC--------ccchhhhHhhcChHHHHHHHHHHHHHHHHHcCCCceEEeeecCCcccccccccccccccccc
Confidence            9955543210        1144599999999999 9999999999999999999999999963                 


Q ss_pred             --------------cCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCC-
Q 006211          157 --------------TDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE-  221 (656)
Q Consensus       157 --------------~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~-  221 (656)
                                    +|+++|+.||++||++|++ .+++||+++++.... ...||+++|+++||||||||||+||+|+. 
T Consensus       154 ~~~~g~~~~~~~~~~d~~nf~~ll~eLr~~l~~-~~~~Ls~av~~~~~~-~~~~d~~~l~~~vD~inlMtYD~~g~~~~~  231 (420)
T 1jnd_A          154 KLFTGDFIVDPHAALHKEQFTALVRDVKDSLRA-DGFLLSLTVLPNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARNP  231 (420)
T ss_dssp             -------CCCTTHHHHHHHHHHHHHHHHHHHHT-TTCEEEEEECTTCCH-HHHCCHHHHHTTCSEEEECCCCSSCTTTCT
T ss_pred             ccccCCcccccCChhHHHHHHHHHHHHHHHHhh-cCcEEEEEEeCCcch-hhccCHHHHHhhCcEEEEeeeecCCCcCCC
Confidence                          4678999999999999943 479999999876432 24589999999999999999999987654 


Q ss_pred             CccccCCCCCCCCC------CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCC-------------------------
Q 006211          222 NVTGIHAALYNPSS------NISTDFGIREWLRRGFPANKLVLGARASGPGITID-------------------------  270 (656)
Q Consensus       222 ~~~g~~apl~~~~~------~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~-------------------------  270 (656)
                      ..+||+|||+....      ..+++.+|++|+++|+|++||+||+|+|||+|+..                         
T Consensus       232 ~~~g~~apl~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~~~~~~~~~g~~~~~~~~g~~~~g~~t~  311 (420)
T 1jnd_A          232 EEADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQ  311 (420)
T ss_dssp             TCBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEESEEEEEECCGGGCSCCSSCBCSCCSBCCCCTTTC
T ss_pred             CccccCCcccCCccccCccccccHHHHHHHHHHcCCCHHHEEEEecccceeeEecCCCCCCCCCcccccCCCCCCCCCCC
Confidence            47899999996542      46899999999999999999999999999999631                         


Q ss_pred             --CCcchHHHHHHHHhcCC--------Ccccccccc-eeeeeeec-------CcEEEeeCCcchhHHHHhhhhhcccccc
Q 006211          271 --GSMGYKFIRAFIQNYGY--------GAAPVYNAS-YVVNLFTS-------GATWINFDGVETIKAKISYAKEKNLLGY  332 (656)
Q Consensus       271 --g~~~y~~i~~~~~~~~~--------~~~~~~d~~-~~~~~~~~-------~~~~i~yd~~~si~~K~~~~~~~glgGv  332 (656)
                        |.++|.|||..+...+.        ++...||+. ...+|.+.       +++||+|||++|+++|++||+++||||+
T Consensus       312 ~~G~~~y~ei~~~~~~~~~~~~~g~~~~~~~~~D~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgGv  391 (420)
T 1jnd_A          312 KPGLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSYDDPDSASNKAAYARVKNLGGV  391 (420)
T ss_dssp             CTTEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECSBTTBCCCEEEEECCHHHHHHHHHHHHHTTCSEE
T ss_pred             CCceeeHHHHHHhhcccCcccccccccceeEEechhhccceeEEEecccCCCCCEEEEcCCHHHHHHHHHHHHhCCCceE
Confidence              34689999987655331        245667774 34566542       4799999999999999999999999999


Q ss_pred             eeeEeccCcccccch
Q 006211          333 KAFQLSNDDNWALSR  347 (656)
Q Consensus       333 ~~W~l~~Dd~~~~~~  347 (656)
                      |+|++++||..+.|.
T Consensus       392 ~~W~l~~Dd~~g~c~  406 (420)
T 1jnd_A          392 ALFDLSYDDFRGQCS  406 (420)
T ss_dssp             EEECGGGSCTTCTTT
T ss_pred             EEEeeccCCCCCccC
Confidence            999999999888763

>1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A*

Probab=100.00  E-value=5.6e-61  Score=523.59  Aligned_cols=306  Identities=21%  Similarity=0.355  Sum_probs=252.3

Q ss_pred             cceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCC-------------------------CcEEecCCcc---
Q 006211           25 QTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSS-------------------------TYQLSISSAN---   72 (656)
Q Consensus        25 ~~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~-------------------------~~~~~~~~~~---   72 (656)
                      ...+++|||.+|.    .|.+++||+++||||+|||+.++.+                         .+.+...++.   
T Consensus       133 ~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~n~~l~~~~g~~~~~~~~c~~~~~~~v~~~D~~ad~  212 (540)
T 1edq_A          133 SGKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAAL  212 (540)
T ss_dssp             SSCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHHHHH
T ss_pred             CCcEEEEEECcccccCCCCChhHCCHhhCCEEEEeeecccCcccccccccccccchhhhhcccccccCcceEecChhHhh
Confidence            3457789998873    5899999999999999999999741                         1122222210   


Q ss_pred             --------------hhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHH
Q 006211           73 --------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT  138 (656)
Q Consensus        73 --------------~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~  138 (656)
                                    ...+. .+.+||++||++|||+||            |||+.+. .|+.| ++++.|++||+++++|
T Consensus       213 ~~~~~g~~~~~~~~~g~~~-~l~~lK~~~p~lKvllSi------------GGw~~s~-~F~~~-~~~~~R~~Fi~siv~~  277 (540)
T 1edq_A          213 QKAQKGVTAWDDPYKGNFG-QLMALKQAHPDLKILPSI------------GGWTLSD-PFFFM-GDKVKRDRFVGSVKEF  277 (540)
T ss_dssp             TSCBTTBCSTTCSSCHHHH-HHHHHHHHCTTCEEEEEE------------ECSSSCG-GGGGT-TSHHHHHHHHHHHHHH
T ss_pred             ccccCCcccccccchhhHH-HHHHHHHhCCCCeEEEEE------------eCCcCCC-cchhh-cCHHHHHHHHHHHHHH
Confidence                          11233 346799999999999999            5554432 38887 6999999999999999


Q ss_pred             HHHcC-CCcceeeeeCCC----------ccCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChhhhh
Q 006211          139 ARLYG-FQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMK  202 (656)
Q Consensus       139 ~~~~~-~DGvdidwe~p~----------~~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~~l~  202 (656)
                      +++|+ |||||||||||.          ++|+++|+.||++||++|++     +++++||+|+|+.+.... .+|+++|+
T Consensus       278 l~~yg~fDGIDIDWEyP~~~g~~~~~g~~~D~~nf~~ll~eLr~~l~~~~~~~g~~~~LT~Av~a~~~~~~-~~d~~~l~  356 (540)
T 1edq_A          278 LQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVETGRKYELTSAISAGKDKID-KVAYNVAQ  356 (540)
T ss_dssp             HHHCTTCCEEEEECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHHTCCCEEEEEEECSHHHHT-TSCHHHHG
T ss_pred             HHHcCCCceEEEEEEccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhccCCceEEEEEecCChhHhh-cccHHHHH
Confidence            99999 999999999995          46789999999999999953     357999999998765544 38999999


Q ss_pred             hccchhhhhhhcccCCCCCCc-cccCCCCCCCC----CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCC-------
Q 006211          203 KNLNWAHLVAYDYHMPSKENV-TGIHAALYNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITID-------  270 (656)
Q Consensus       203 ~~vD~invmtYD~~g~~~~~~-~g~~apl~~~~----~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~-------  270 (656)
                      ++|||||||+|||||+ |+.. +||+||||...    ...+++.+|++|+++|+|++||+||+|+|||+|+..       
T Consensus       357 ~~vD~inlMtYD~~G~-W~~~~~G~~apLy~~~~~~~~~~~v~~av~~~~~~gvp~~KivlGip~YGr~w~~~~~~~~~~  435 (540)
T 1edq_A          357 NSMDHIFLMSYDFYGA-FDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMYGRGWTGVNGYQNNI  435 (540)
T ss_dssp             GGCSEEEEECCCSSCT-TCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESEEEEEESCBSCSTTC
T ss_pred             hhccEEEEeccccCCC-CCCCCCCCcCCCCCCccCCCCCcCHHHHHHHHHHcCCCHHHEEEEeeccceeEeeccCCCCCC
Confidence            9999999999999976 6766 99999999754    346899999999999999999999999999999632       


Q ss_pred             ----------------CCcchHHHHHHHHhcCCCcccccccceeeeeeec--CcEEEeeCCcchhHHHHhhhhhcccccc
Q 006211          271 ----------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGY  332 (656)
Q Consensus       271 ----------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv  332 (656)
                                      |.++|.|||..+..  .++...||+....||.++  +++||+|||++|+++|++||+++||||+
T Consensus       436 ~~~g~~~G~~~Gt~e~G~~~y~ei~~~~~~--~g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~k~~gLgGv  513 (540)
T 1edq_A          436 PFTGTATGPVKGTWENGIVDYRQIAGQFMS--GEWQYTYDATAEAPYVFKPSTGDLITFDDARSVQAKGKYVLDKQLGGL  513 (540)
T ss_dssp             GGGSBCSEECCCSSBTTEEEHHHHHHHSSS--TTCEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEE
T ss_pred             cccccCCCCccccccCCcccHHHHHHHhhc--CCceEEECCccccceEEECCCCEEEEECCHHHHHHHHHHHHhCCCCEE
Confidence                            34689999987654  358899999999999775  4799999999999999999999999999


Q ss_pred             eeeEeccCcccccchhhh
Q 006211          333 KAFQLSNDDNWALSRAAQ  350 (656)
Q Consensus       333 ~~W~l~~Dd~~~~~~~~~  350 (656)
                      |+|++++||. .+.++..
T Consensus       514 ~~W~l~~Dd~-~Ll~ai~  530 (540)
T 1edq_A          514 FSWEIDADNG-DILNSMN  530 (540)
T ss_dssp             EEECGGGCCS-HHHHHHH
T ss_pred             EEEeccCCCH-HHHHHHH
Confidence            9999999984 3444433

>1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A*

Probab=100.00  E-value=3.2e-61  Score=513.46  Aligned_cols=297  Identities=23%  Similarity=0.349  Sum_probs=250.5

Q ss_pred             cceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchh------------------hHHHHHHH
Q 006211           25 QTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ------------------YFSIFANS   82 (656)
Q Consensus        25 ~~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~------------------~~~~~~~~   82 (656)
                      ...+++|||.+|.    .|.+++|++++||||+|+|+.++++++.+...+...+                  .....+..
T Consensus        41 ~~~~vvgYy~~W~~y~r~~~~~~i~~~~~THI~yaF~~i~~~~g~v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~l~~  120 (433)
T 1w9p_A           41 SGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLYL  120 (433)
T ss_dssp             CCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHHHH
T ss_pred             CCCEEEEEECchhhcCCCCChhHCCHhhCCEEEEEEEEecCCCCeeeecCchhhhhcccCCccccccchhhhHHHHHHHH
Confidence            4567899998764    5789999999999999999999984455554432110                  11233467


Q ss_pred             HHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCC-ccCcch
Q 006211           83 VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLNS  161 (656)
Q Consensus        83 ~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~-~~d~~~  161 (656)
                      +|++||++|||+|||            ||+.+ ..|+.++++++.|++||+++++++++|+|||||||||||. .+|+++
T Consensus       121 lK~~~~~lKvllsiG------------Gw~~s-~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGIDiDwEyP~~~~d~~n  187 (433)
T 1w9p_A          121 LKKQNRNLKVLLSIG------------GWTYS-PNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQAND  187 (433)
T ss_dssp             HHHHCTTCEEEEEEE------------CTTTG-GGHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHH
T ss_pred             HHHhCCCCEEEEEEe------------CCCCC-cchhhHhcCHHHHHHHHHHHHHHHHhcCcCceeEEEEeccChhHHHH
Confidence            999999999999994            44432 2399999999999999999999999999999999999998 478999


Q ss_pred             HHHHHHHHHhhcCC-------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCC
Q 006211          162 LGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS  234 (656)
Q Consensus       162 ~~~ll~~lr~~l~~-------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~  234 (656)
                      |+.||++||++|++       +++++||+|+|+.+..+. .||+++|+++|||||||+||+||+ |+..+||+||||...
T Consensus       188 f~~ll~eLr~~l~~~~~~~~~~~~~~Ls~avp~~~~~~~-~~d~~~l~~~vD~inlMtYD~~G~-w~~~~g~~apL~~~~  265 (433)
T 1w9p_A          188 FVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDKIK-VLHLKDMDQQLDFWNLMAYDYAGS-FSSLSGHQANVYNDT  265 (433)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSTTCCCEEEEEECCSHHHHH-HSCHHHHHTTCSEEEECCCCCSST-TSSSCCCSSCSSCCT
T ss_pred             HHHHHHHHHHHHHhhhhcccCCCceEEEEEccCCHHHhh-hCCHHHHHHhhheeeeeccccCCC-CCCCCCCCCcCCCCC
Confidence            99999999999953       468999999998766554 489999999999999999999965 788899999999654


Q ss_pred             C-----CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCC-----------------CCcchHHHHHHHHhcCCCcccc
Q 006211          235 S-----NISTDFGIREWLRRGFPANKLVLGARASGPGITID-----------------GSMGYKFIRAFIQNYGYGAAPV  292 (656)
Q Consensus       235 ~-----~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~-----------------g~~~y~~i~~~~~~~~~~~~~~  292 (656)
                      .     ..+++.+|++|++.|+|++||+||+|+|||+|+..                 |.+.|.+++.      .|+...
T Consensus       266 ~~~~~~~~~v~~~v~~~~~~Gvp~~KlvlGip~YGr~w~~~~~~g~~~~g~~~g~~~~g~~~y~~l~~------~g~~~~  339 (433)
T 1w9p_A          266 SNPLSTPFNTQTALDLYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNGVGQGSWENGVWDYKALPQ------AGATEH  339 (433)
T ss_dssp             TCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEESSCSSTTSCCCCCCCCSSBTTEEEGGGCSC------TTCEEE
T ss_pred             CCCCCCcccHHHHHHHHHHcCCChhHEEEEecccceeeeccCCCCCcccCCCCCCCccceeeHHHHHh------CCCEEE
Confidence            2     35899999999999999999999999999999653                 2345665432      368889


Q ss_pred             cccceeeeeeec--CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcc
Q 006211          293 YNASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN  342 (656)
Q Consensus       293 ~d~~~~~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~  342 (656)
                      ||+....||.++  +++||+|||++|++.|++||+++||||+|+|++++||.
T Consensus       340 ~D~~~~~~y~yd~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~  391 (433)
T 1w9p_A          340 VLPDIMASYSYDATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDKT  391 (433)
T ss_dssp             EEGGGTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGSCC
T ss_pred             eccccCcceEEECCCCEEEEcCCHHHHHHHHHHHHhCCCCEEEEEeccCCCC
Confidence            999999999774  68999999999999999999999999999999999993

>3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A*

Probab=100.00  E-value=1.1e-60  Score=526.11  Aligned_cols=301  Identities=22%  Similarity=0.369  Sum_probs=249.3

Q ss_pred             cceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCC-----------------------cEEecCCcch----
Q 006211           25 QTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSST-----------------------YQLSISSANQ----   73 (656)
Q Consensus        25 ~~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~-----------------------~~~~~~~~~~----   73 (656)
                      ...+++|||.+|.    .|.+++||+++||||+|||+.++.+.                       +.+...+...    
T Consensus       136 ~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THI~yaF~~i~~~~~~l~~~~~~~~~~~~~~c~~~~~~~v~~~D~~~d~~~  215 (584)
T 3arx_A          136 PSIVMGTYFVEWGIYGRDYTVDNMPVDNLTHILYGFIPICGPNESVKSVGGNSFNALQTACRGVNDYEVVIHDPWAAYQK  215 (584)
T ss_dssp             TTSEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBSSCCGGGGGGCTTHHHHHHHHTTTCCTTCBCCSCHHHHHTS
T ss_pred             CCcEEEEEECcccccCCCCChhHCCHhhCCEEEEEEEEecCCCccccccCccchhhhhhhcccCCCcceEecCchHhhhh
Confidence            3457889998874    58999999999999999999997521                       1222222110    


Q ss_pred             --------------hhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHH
Q 006211           74 --------------QYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA  139 (656)
Q Consensus        74 --------------~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~  139 (656)
                                    ..+ ..+.+||++||++|||+||||            |+.+. .|+.| ++++.|++||+++++|+
T Consensus       216 ~~~~~g~~w~~~~~g~~-~~l~~lK~~np~lKvllSiGG------------w~~s~-~F~~~-~~~~~R~~Fi~siv~~l  280 (584)
T 3arx_A          216 SFPQAGHEYSTPIKGNY-AMLMALKQRNPDLKIIPSIGG------------WTLSD-PFYDF-VDKKNRDTFVASVKKFL  280 (584)
T ss_dssp             CCGGGTCCTTCSSCHHH-HHHHHHHHHCTTCEEEEEEEE------------SSSCG-GGGGG-GSHHHHHHHHHHHHHHH
T ss_pred             ccccCCccccccccchH-HHHHHHHHhCCCCEEEEEEcC------------CcCCc-chhhh-hCHHHHHHHHHHHHHHH
Confidence                          122 334789999999999999954            44432 38887 68999999999999999


Q ss_pred             HHcC-CCcceeeeeCCCc-----------cCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChhhhh
Q 006211          140 RLYG-FQGIDLFWLWPNS-----------TDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMK  202 (656)
Q Consensus       140 ~~~~-~DGvdidwe~p~~-----------~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~~l~  202 (656)
                      ++|+ |||||||||||..           +|+++|+.||++||++|++     +++++||+|+|+...... .+|+++|+
T Consensus       281 ~~yg~fDGIDIDWEyP~~~g~~~~~g~p~~D~~nf~~ll~eLr~~l~~~~~~~g~~~~LT~Av~a~~~~~~-~~d~~~l~  359 (584)
T 3arx_A          281 KTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPAYIALMRELRVMLDELEAETGRTYELTSAIGVGYDKIE-DVDYADAV  359 (584)
T ss_dssp             HHCTTCCEEEEEESCTTSCSSCTTCCCTTTHHHHHHHHHHHHHHHHHHHHHHHSCCCEEEEEECCSHHHHT-TSCHHHHG
T ss_pred             HHcCCcceEeecccCccccCCCCCCCCchHHHHHHHHHHHHHHHhHHhhhhccCCceEEEEEecCChHHhh-ccCHHHHH
Confidence            9999 9999999999962           3889999999999999953     457999999998765544 48999999


Q ss_pred             hccchhhhhhhcccCCCCCCccccCCCCCCCC---------------------CCCCHHHHHHHHHHcCCCCCceeeccc
Q 006211          203 KNLNWAHLVAYDYHMPSKENVTGIHAALYNPS---------------------SNISTDFGIREWLRRGFPANKLVLGAR  261 (656)
Q Consensus       203 ~~vD~invmtYD~~g~~~~~~~g~~apl~~~~---------------------~~~~~~~~v~~~~~~g~p~~Kl~lG~p  261 (656)
                      ++|||||||+|||||+ |+..+||+||||..+                     ...+++.+|++|+++|+|++||+||+|
T Consensus       360 ~~vD~inlMtYD~hG~-W~~~tG~~apLy~~~~~~~~~c~~~~v~~~~~~~~~~~~~v~~av~~~~~~Gvp~~KivLGip  438 (584)
T 3arx_A          360 QYMDYIFAMTYDFYGG-WNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPANKLVLGTA  438 (584)
T ss_dssp             GGCSEEEECCCCSSCT-TSSCCCCSSCSSCCTTSCTTTTTSCSBCTTSCBCCSCCSCHHHHHHHHHHTTCCGGGEEEEEE
T ss_pred             hhCCEEEEecccccCC-CCCCcCCCCCCCCCCCCccccccccccccccccccccceeHHHHHHHHHHcCCCHHHEEEEEc
Confidence            9999999999999976 777899999999643                     236899999999999999999999999


Q ss_pred             CCCCCcCCC-------------------------------CCcchHHHHHHHHhc----CCCcccccccceeeeeeec--
Q 006211          262 ASGPGITID-------------------------------GSMGYKFIRAFIQNY----GYGAAPVYNASYVVNLFTS--  304 (656)
Q Consensus       262 ~yG~~~~~~-------------------------------g~~~y~~i~~~~~~~----~~~~~~~~d~~~~~~~~~~--  304 (656)
                      +|||+|+..                               |.++|.|||..+...    -.++...||+....||.++  
T Consensus       439 ~YGr~w~~~~~~~~~~~~~~~~g~~~G~~~gt~~~~~~~~G~~~y~ei~~~~~~~~~~g~~g~~~~~D~~a~~py~y~~~  518 (584)
T 3arx_A          439 MYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFMLGANNTGINGFEYGYDAQAEAPWVWNRS  518 (584)
T ss_dssp             SEEEEEECCCGGGCSSTTCGGGSCCSEECCCCGGGTCSBTTEEEHHHHHHHTTTTTTSCCTTEEEEEETTTTEEEEEETT
T ss_pred             cccceeeecccccccCCCCccccCCCCCcCCccccccccCCceeHHHHHHHhhcccccccCCcEEEECCccceeEEEECC
Confidence            999999643                               236899999875432    1368889999999999775  


Q ss_pred             CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcc
Q 006211          305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN  342 (656)
Q Consensus       305 ~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~  342 (656)
                      +++||+|||++|+++|++||+++||||+|+|++++||.
T Consensus       519 ~~~~vsyDd~~Si~~K~~y~k~~gLgGv~~W~l~~Dd~  556 (584)
T 3arx_A          519 TGELITFDDHRSVLAKGNYAKSLGLAGLFSWEIDADNG  556 (584)
T ss_dssp             TTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCCS
T ss_pred             CCEEEEeCCHHHHHHHHHHHHhCCCCEEEEEeccCCcH
Confidence            47999999999999999999999999999999999984

>1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A*

Probab=100.00  E-value=1.1e-60  Score=519.45  Aligned_cols=307  Identities=22%  Similarity=0.400  Sum_probs=256.1

Q ss_pred             ceEEEEEec--C--------CC----CCCCCCCC---CCCccEEEEEEEEecCCCcEEecCCc-c---hhhHHHHHHHHH
Q 006211           26 TWIKAGYWL--A--------GR----EFPLSDIN---SALFTHLICAFAEVDSSTYQLSISSA-N---QQYFSIFANSVR   84 (656)
Q Consensus        26 ~~~~~~y~~--~--------~~----~~~~~~i~---~~~~thi~~~f~~~~~~~~~~~~~~~-~---~~~~~~~~~~~k   84 (656)
                      ..+++|||.  +        +.    .|.+++|+   .++||||+|+|+.+++++ .+...+. .   +......+.++|
T Consensus         4 ~~~vvgYy~~~~~~w~~~~~~~~~~~~~~~~~i~~~q~~~~THi~yaF~~i~~~g-~~~~~~~~~d~~~~~~~~~l~~lk   82 (499)
T 1goi_A            4 RKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNL-ECAWDPATNDAKARDVVNRLTALK   82 (499)
T ss_dssp             CCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTS-SEECCTTCCHHHHHHHHHHHHHGG
T ss_pred             CCEEEEEEccCccccccccccCCccCcCCHhHCCCccccCCCEEEEEeEEECCCC-eEEecCcccchhhHHHHHHHHHHH
Confidence            356799998  5        32    58999999   999999999999999875 4554442 1   112233346789


Q ss_pred             hhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHH
Q 006211           85 RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGI  164 (656)
Q Consensus        85 ~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~  164 (656)
                      ++||++|||||||||..|..    .+  .+...|+.++++++.|++||+++++++++|+|||||||||||..+|+++|+.
T Consensus        83 ~~~p~lKvllSiGGw~~s~~----~~--~~~~~f~~~~~~~~~r~~fi~siv~~~~~~gfDGiDiDwE~p~~~d~~~~~~  156 (499)
T 1goi_A           83 AHNPSLRIMFSIGGWYYSND----LG--VSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQAAEVDGFIA  156 (499)
T ss_dssp             GGCTTCEEEEEEECHHHHST----TS--TTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCHHHHHHHHH
T ss_pred             HhCCCCeEEEEECCCCCCCC----cc--cccchhhHhhCCHHHHHHHHHHHHHHHHHcCCCeEEEecccCChhhHHHHHH
Confidence            99999999999965543211    00  1124599999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhcCC-----CC---CcEEEEEeecCCCcccccc-ChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC
Q 006211          165 LLDEWKASASD-----QP---ELTLSMAVRYSPTHETVSY-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS  235 (656)
Q Consensus       165 ll~~lr~~l~~-----~~---~~~ls~a~~~~~~~~~~~~-~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~  235 (656)
                      ||++||++|++     ++   +++||+++|+.+......| |+++|+++||||||||||+||+ |+..+|||||||..+.
T Consensus       157 ll~eLr~~l~~~~~~~g~~~~~~~Ls~a~~~~~~~~~~~y~d~~~l~~~vD~inlMtYD~~g~-w~~~tg~~apL~~~~~  235 (499)
T 1goi_A          157 ALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAGP-WEKVTNHQAALFGDAA  235 (499)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSCT-TSSSCCCTTCSSBCTT
T ss_pred             HHHHHHHHhhhhhhhcccccCceEEEEeccCCHHHHhhhhhhHHHHhhcCCEEEEEeeeccCC-CCCCCCCCCcCcCCCC
Confidence            99999999953     23   7999999998766555444 9999999999999999999976 7888999999985432


Q ss_pred             ----------------------------CCCHHHHHHHHHH-cCCCCCceeecccCCCCCcCCC----------------
Q 006211          236 ----------------------------NISTDFGIREWLR-RGFPANKLVLGARASGPGITID----------------  270 (656)
Q Consensus       236 ----------------------------~~~~~~~v~~~~~-~g~p~~Kl~lG~p~yG~~~~~~----------------  270 (656)
                                                  ..+++.+|++|++ +|+|++||+||+|+|||+|+..                
T Consensus       236 ~~~~~n~l~~~~~~~~~~~~~~~~~~~~~~~v~~av~~~~~~~Gvp~~KlvlGip~YGr~w~~~~~~~~g~~~~~~~~~~  315 (499)
T 1goi_A          236 GPTFYNALREANLGWSWEELTRAFPSPFSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHSTPGE  315 (499)
T ss_dssp             SCCBCCGGGGSSCCCCHHHHHHHCCSSBCCCHHHHHHHHHTSTTCCGGGEEEEEESEEEEEESCCSSSTTTTCCCCCCCC
T ss_pred             CccccccccccccccccccccccccccccccHHHHHHHHHHhcCCCHHHeEEEecccceeeEecCCCCCCCCCcccCCCC
Confidence                                        3489999999999 9999999999999999998542                


Q ss_pred             ----------------------CCcchHHHHHHHHhcCCCcccccccceeeeeee--cCcEEEeeCCcchhHHHHhhhhh
Q 006211          271 ----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT--SGATWINFDGVETIKAKISYAKE  326 (656)
Q Consensus       271 ----------------------g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~--~~~~~i~yd~~~si~~K~~~~~~  326 (656)
                                            |.++|.+||..+.. ..++...||+....||.+  .+++||+|||++|+++|++||++
T Consensus       316 ~~~~~~~~~~~g~~~c~~~~~~g~~~y~ei~~~~~~-~~g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~~~  394 (499)
T 1goi_A          316 DPYPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYHAQNGLFVTYDDAESFKYKAKYIKQ  394 (499)
T ss_dssp             SSCSSSCCCSTTCHHHHHHTCTTEEEHHHHHHHHHT-TSSEEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHH
T ss_pred             CccccccccccccccccccCCCCcccHHHHHHhhhc-CCCceEEEccccceEEEEECCCCEEEEeeCHHHHHHHHHHHHh
Confidence                                  25689999987653 236889999999999977  67899999999999999999999


Q ss_pred             cccccceeeEeccCc
Q 006211          327 KNLLGYKAFQLSNDD  341 (656)
Q Consensus       327 ~glgGv~~W~l~~Dd  341 (656)
                      +||||+|+|+|++||
T Consensus       395 ~gLgGv~~W~l~~Dd  409 (499)
T 1goi_A          395 QQLGGVMFWHLGQDN  409 (499)
T ss_dssp             TTCCEEEEECGGGSC
T ss_pred             cCCCceEEEeeccCC
Confidence            999999999999998

>3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A

Probab=100.00  E-value=7.7e-60  Score=510.25  Aligned_cols=308  Identities=17%  Similarity=0.232  Sum_probs=254.3

Q ss_pred             ccceEEEEEecCCC-----------------CCCCCCC---CCCCccEEEEEEEEecCCC--------------------
Q 006211           24 AQTWIKAGYWLAGR-----------------EFPLSDI---NSALFTHLICAFAEVDSST--------------------   63 (656)
Q Consensus        24 ~~~~~~~~y~~~~~-----------------~~~~~~i---~~~~~thi~~~f~~~~~~~--------------------   63 (656)
                      ...+.++|||.+|.                 .|+++.|   ++..||||||+|++|..+.                    
T Consensus        97 ~~~~~v~~Y~~~W~~yd~r~~~~~~~~~~gr~~d~~~l~~~~p~~~t~ii~~F~~i~gd~~~g~~~~~i~~~~~~~~~d~  176 (574)
T 3oa5_A           97 DDDFNVLCYFTDWSQYDPRIINKEIRDTGGRSADILRLNTPDGRPFKRLIYSFGGLIGDKKYSADGNASIAVRLGVATDP  176 (574)
T ss_dssp             CSSCEEEEEEETTTTCCGGGTCSSCCSSCCCCCCGGGGCCSSSCSCSEEEEEEEEETTCTTTCTTTTHHHHHHHTSCSSH
T ss_pred             CCCceEEEEEcchhhcccccccccccccCCCccCHhhhccCCCccccEEEEEEEeecCCcccCchHHHHHHHHhhhcccc
Confidence            44678899998764                 4588899   8999999999999999765                    


Q ss_pred             --------cEEecCCcch---------------------------hhHHHHHHHHHhhCCCceEEEEeecCCCCcccccc
Q 006211           64 --------YQLSISSANQ---------------------------QYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSIL  108 (656)
Q Consensus        64 --------~~~~~~~~~~---------------------------~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~  108 (656)
                              +.+.+.+...                           ......+.+||++||+|||||||            
T Consensus       177 ~~~~~~~~g~v~~~D~wad~~~~~n~g~~~~~~~~~~~~~~~~~~~G~~~~l~~LK~~np~LKvllSI------------  244 (574)
T 3oa5_A          177 DDAIANHKGKTIPVDPDGAVLASINCGFTKWEAGDANERYNQEKAKGLLGGFRLLHEADKELEFSLSI------------  244 (574)
T ss_dssp             HHHHHHHTTCEEESCHHHHHTCCTTTTCCSCCCCCHHHHCSTTTCCHHHHHHHHHHHHCTTCEEEEEE------------
T ss_pred             cccccCcCCeEeecCchhhhcccccccccccccCCccccccCccchhHHHHHHHHHHHCCCCEEEEEE------------
Confidence                    2333332211                           11234557899999999999999            


Q ss_pred             CCcCCCccccccccCChhhHHHHHHHHHHHHHHcC-CCcceeeeeCCC---------ccCcchHHHHHHHHHhhcCCCCC
Q 006211          109 GNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG-FQGIDLFWLWPN---------STDLNSLGILLDEWKASASDQPE  178 (656)
Q Consensus       109 Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~-~DGvdidwe~p~---------~~d~~~~~~ll~~lr~~l~~~~~  178 (656)
                      |||+.+ ..|+.++++++.|++||+++++|+++|+ |||||||||||.         ++|+++|+.||++||+++  .++
T Consensus       245 GGw~~S-~~Fs~~~s~~~~R~~Fi~siv~~l~~yg~fDGIDIDWEyP~~~g~~n~~~~~D~~nf~~LLkeLR~~~--~~~  321 (574)
T 3oa5_A          245 GGWSMS-GLFSEIAKDEILRTNFVEGIKDFFQRFPMFSHLDIDWEYPGSIGAGNPNSPDDGANFAILIQQITDAK--ISN  321 (574)
T ss_dssp             ECGGGC-TTHHHHHHCHHHHHHHHHHHHHHHHHCTTCCEEEEECSCTTSCTTTCCCCTTHHHHHHHHHHHHHHTC--CTT
T ss_pred             CCCCCc-chhHHHhCCHHHHHHHHHHHHHHHHHcCCCceEEEEEEeccccccCCCCCHHHHHHHHHHHHHHHHhc--cCC
Confidence            555543 2399999999999999999999999998 999999999995         467899999999999965  456


Q ss_pred             cE-EEEEeecCCCccccccChhhhh-hccchhhhhhhcccCCCCCCccccCCCCCCCCC----CCCHHHHHHHHHH-cCC
Q 006211          179 LT-LSMAVRYSPTHETVSYPIDSMK-KNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS----NISTDFGIREWLR-RGF  251 (656)
Q Consensus       179 ~~-ls~a~~~~~~~~~~~~~~~~l~-~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~----~~~~~~~v~~~~~-~g~  251 (656)
                      ++ ||+|+|+.+..... ||+++++ ++|||||||||||||+ |+..+||+|||+..+.    ..+++.+|++|++ +|+
T Consensus       322 ~~~LSiAvpa~~~~~~~-~d~~~l~~~~vD~InlMtYD~~G~-W~~~tG~~apL~~~~~d~~~~~svd~aV~~~l~~~Gv  399 (574)
T 3oa5_A          322 LKGISIASSADPAKIDA-ANIPALMDAGVTGINLMTYDFFTL-GDGKLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKKV  399 (574)
T ss_dssp             CCEEEEEECSSHHHHHH-HTHHHHHHTTCCEEEECCCCCCCT-TSSBCCCSSCSCCCTTCSSSCCCHHHHHHHHHHTTCC
T ss_pred             ceEEEEEccCccccccc-cCHHHHHhhhCCEEEEEccccCCC-CCCCCCCCCCCCCCCCCccccccHHHHHHHHHHhcCC
Confidence            77 99999988765554 8999986 5999999999999975 7788999999997543    4689999999999 999


Q ss_pred             CCCceeecccCCCCCcCC----------------------------CCCcchHHHHHHHH-----hcCCCccccccccee
Q 006211          252 PANKLVLGARASGPGITI----------------------------DGSMGYKFIRAFIQ-----NYGYGAAPVYNASYV  298 (656)
Q Consensus       252 p~~Kl~lG~p~yG~~~~~----------------------------~g~~~y~~i~~~~~-----~~~~~~~~~~d~~~~  298 (656)
                      |++||+||+|+|||+|+.                            +|.++|.+||....     ....|+...||+.+.
T Consensus       400 P~~KLvLGip~YGR~w~~~~~~~~~~~~~p~~G~~~~~g~~~Gt~e~G~l~y~eI~~~~l~~~~~~~~~g~~~~wD~~a~  479 (574)
T 3oa5_A          400 DPKAIFIGYAGYTRNAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHYMDFEKGEGRNGYKLVHDKVAK  479 (574)
T ss_dssp             CGGGEEEEEESBCEEESSEEECCSSTTTSCCCEEESCCTTCCBSSBTTBCBHHHHHHHTEETTTTEESTTCEEEEETTTT
T ss_pred             CHHHEEEEeCccceeeecCCCCcccccCCCCCCccccCCCCCCcccCCceeHHHHHHHhhhhhhhhccCCceEEEchhcC
Confidence            999999999999999853                            14578999986432     134578999999999


Q ss_pred             eeeeec--CcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccchhh
Q 006211          299 VNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA  349 (656)
Q Consensus       299 ~~~~~~--~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~~  349 (656)
                      +||.++  +++||+|||++|+++|++||+++||||+|+|++++| .+.+..+.
T Consensus       480 ~pY~y~~~~~~~VsYDD~~Si~~K~~yak~~gLGGv~iW~ld~D-~g~LlnAi  531 (574)
T 3oa5_A          480 ADYLYSEATKVFISLDTPRSVRDKGRYVKDKGLGGLFIWSGDQD-NGILTNAA  531 (574)
T ss_dssp             EEEEECTTTCCEEEECCHHHHHHHHHHHHHHTCCEEEEETGGGC-CSHHHHHH
T ss_pred             ceEEEECCCCEEEEeCCHHHHHHHHHHHHhcCCCEEEEEeccCC-cHHHHHHH
Confidence            999876  468999999999999999999999999999999999 44444333

>3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp}

Probab=100.00  E-value=7.5e-57  Score=463.49  Aligned_cols=293  Identities=14%  Similarity=0.210  Sum_probs=239.2

Q ss_pred             CccceEEEEEecCCC---CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecC
Q 006211           23 DAQTWIKAGYWLAGR---EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG   99 (656)
Q Consensus        23 ~~~~~~~~~y~~~~~---~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~   99 (656)
                      ...+..++|||..|.   .+...+.+.++||||+++|+.++++| .+..... +.   .+++.+|+  +++||++|||||
T Consensus         4 ~~~~~~vvgYy~~w~~~~~~~~l~~~~~~lthi~~~~~~i~~~g-~l~~~~~-~~---~~~~~~~~--~~~kv~lsigg~   76 (319)
T 3cz8_A            4 SNYIAGTLSFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNG-DIANQLN-DA---AAIETTWQ--RRVTPLATITNL   76 (319)
T ss_dssp             CCSCCEEEEEEEEECGGGC------CCCCCCEEEEEEEEBCTTS-CBCCCCS-CH---HHHHHHHH--TTCEEEEEEECE
T ss_pred             cCCCceEEEEEecCCCccCHHHHHHhhCCCCEEEEeEEEECCCC-CEecCcC-CH---HHHHHHHH--CCCeEEEEEecC
Confidence            345567899998875   35555666899999999999999875 3433321 22   23343443  589999999765


Q ss_pred             CCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCc
Q 006211          100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPEL  179 (656)
Q Consensus       100 ~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~  179 (656)
                      ++         +++++..|+.++++++.|++||+++++++++|||||||||||||.++|+++|+.||++||++|++ +++
T Consensus        77 ~~---------~~~~~~~~~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~-~~~  146 (319)
T 3cz8_A           77 TS---------GGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGGVTIDFEQVSAADRDLFTGFLRQLRDRLQA-GGY  146 (319)
T ss_dssp             ET---------TEECHHHHHHHHTCHHHHHHHHHHHHHHHHHHTCSEEEEECCSCCGGGHHHHHHHHHHHHHHHHH-TTC
T ss_pred             CC---------CCcCHHHHHHHHcCHHHHHHHHHHHHHHHHHhCCCeEEEeccCCCHHHHHHHHHHHHHHHHHHhh-cCc
Confidence            42         22355668999999999999999999999999999999999999999999999999999999943 479


Q ss_pred             EEEEEeecCCCc---cccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCce
Q 006211          180 TLSMAVRYSPTH---ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKL  256 (656)
Q Consensus       180 ~ls~a~~~~~~~---~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl  256 (656)
                      +||+++|+....   ...+||+++++++|||||||+||++|+ |+ .+||+|||+      +++.++++|++ ++|++||
T Consensus       147 ~Ls~av~~~~~~~~~~~~~~d~~~l~~~vD~i~vMtYD~~g~-~~-~~g~~apl~------~v~~~v~~~~~-~vp~~Kl  217 (319)
T 3cz8_A          147 VLTIAVPAKTSDNIPWLRGYDYGGIGAVVNYMFIMAYDWHHA-GS-EPGPVAPIT------EIRRTIEFTIA-QVPSRKI  217 (319)
T ss_dssp             EEEEEEECCSCSCCGGGTTCCHHHHHHHCSEEEEECCCSSCT-TS-CSCCSSCHH------HHHHHHHHHTT-TSCGGGE
T ss_pred             EEEEEecCCcccccchhcccCHHHHHhhCCEEEEEeeccCCC-CC-CCCCCCChH------HHHHHHHHHHh-cCCHHHE
Confidence            999999987642   345699999999999999999999965 43 589999997      79999999887 4999999


Q ss_pred             eecccCCCCCcCC-------CCCcchHHHHHHHHhcCCCcccccccceeeeeeec----C-cEEEeeCCcchhHHHHhhh
Q 006211          257 VLGARASGPGITI-------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS----G-ATWINFDGVETIKAKISYA  324 (656)
Q Consensus       257 ~lG~p~yG~~~~~-------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~----~-~~~i~yd~~~si~~K~~~~  324 (656)
                      +||+|+|||+|+.       .+.++|.|+|+.+...+  +...||+.+..||.+.    + ++||+|||++|++.|++||
T Consensus       218 vlGip~YGr~w~~~~~~g~~~~~~~~~ei~~~~~~~g--~~~~~D~~~~~~y~~~~d~~g~~~~v~ydd~~Si~~K~~~~  295 (319)
T 3cz8_A          218 IIGVPLYGYDWIIPYQPGTVASAISNQNAIERAMRYQ--APIQYSAEYQSPFFRYSDQQGRTHEVWFEGVRSMSRKMQIV  295 (319)
T ss_dssp             EEECCSCEEEEESSCCTTCCCEEECHHHHHHHHHHTT--CCCEEETTTTEEEEEEECTTSCEEEEECCCHHHHHHHHHHH
T ss_pred             EEEecCcCCcccccCCCCCCCCccCHHHHHHHHHHcC--CeEEechhhCCcEEEEEcCCCCEEEEEecCHHHHHHHHHHH
Confidence            9999999999985       35689999999887654  8889999999999642    3 3799999999999999999


Q ss_pred             hhcccccceeeEeccCccc
Q 006211          325 KEKNLLGYKAFQLSNDDNW  343 (656)
Q Consensus       325 ~~~glgGv~~W~l~~Dd~~  343 (656)
                      +++||||+|+|++++||..
T Consensus       296 ~~~~LgGv~~W~l~~dd~~  314 (319)
T 3cz8_A          296 REYRLQAIGAWQLTLAEGH  314 (319)
T ss_dssp             HHTTCSEEEEEEEEEC---
T ss_pred             HhcCCCeEEEEECCCCCcc
Confidence            9999999999999999954

>3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-57  Score=473.20  Aligned_cols=286  Identities=12%  Similarity=0.164  Sum_probs=241.8

Q ss_pred             eEEEEEecCCCC--CCCCCCCCCCccEEEEEEEEecCCC-cEEecCCcchhhHHHHHHHHHhhCCCceEEE--EeecCCC
Q 006211           27 WIKAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSST-YQLSISSANQQYFSIFANSVRRKNPSIKTLL--SIWNGQN  101 (656)
Q Consensus        27 ~~~~~y~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~--sigg~~~  101 (656)
                      .+++|||++|..  +.+.+++.++||||+|+|+.+++++ +.+...+..+.. ...+..+|++||++||++  ||     
T Consensus        79 ~~vvgY~~~W~~~~~~~~~~~~~~lThi~~af~~i~~~g~~~l~~~~~~d~~-~~~~~~lk~~~~~lkvl~~isi-----  152 (393)
T 3bxw_B           79 GDVLGYVTPWNSHGYDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDVD-QGWMRAVRKHAKGLHIVPRLLF-----  152 (393)
T ss_dssp             SCEEEEEBTTBTHHHHHHHHHGGGCSEEEECCEEEEEEETTEEEEECGGGCC-HHHHHHHHHHSSSCEECCEEEE-----
T ss_pred             CcEEEEECCccCCCCChhhcCHhhCCEEEEEEEEEecCCCceEEecCCCccC-HHHHHHHHhhCCCCEEEEEEeE-----
Confidence            467999999875  7889999999999999999999886 455544332222 355678999999999995  78     


Q ss_pred             CccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceee-eeCCCccCcchHHHHHHHHHhhcCCCCCcE
Q 006211          102 STYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNSTDLNSLGILLDEWKASASDQPELT  180 (656)
Q Consensus       102 ~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdid-we~p~~~d~~~~~~ll~~lr~~l~~~~~~~  180 (656)
                             |||+  .+.|+.++++++.|++||+++++++++||||||||| ||||..+|+++|+.||++||++|++ .+++
T Consensus       153 -------GGw~--~~~f~~~~~~~~~R~~fi~siv~~~~~~gfDGidiDfWE~p~~~d~~~~~~ll~eLr~~l~~-~~~~  222 (393)
T 3bxw_B          153 -------EDWT--YDDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLLSQKRVGLIHMLTHLAEALHQ-ARLL  222 (393)
T ss_dssp             -------CSCC--HHHHHHHHTCHHHHHHHHHHHHHHHHHHTCCEEEEECGGGCCC-CHHHHHHHHHHHHHHHHH-TTCE
T ss_pred             -------CCCC--HHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEecccccCChhhHHHHHHHHHHHHHHHhh-cCcE
Confidence                   6665  235899999999999999999999999999999999 9999999999999999999999943 4789


Q ss_pred             EEEEeecCCC----c--cccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCC
Q 006211          181 LSMAVRYSPT----H--ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN  254 (656)
Q Consensus       181 ls~a~~~~~~----~--~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~  254 (656)
                      ||+++|+...    .  +..+||+++++++||||||||||+||+   +.+||+|||+      +++.+|++|+++|+|++
T Consensus       223 Lsiav~~~~~~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~---~~~G~~apL~------~v~~~v~~~~~~gvp~~  293 (393)
T 3bxw_B          223 ALLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMTYDYSTA---HQPGPNAPLS------WVRACVQVLDPKSKWRS  293 (393)
T ss_dssp             EEEEECCSBCTTTSSBCSSCHHHHHHHTTTCSEEEECCCCCCBT---TBCCCSSCHH------HHHHHHHHHSTTCSSGG
T ss_pred             EEEEEcccccccccccccccccCHHHHHhhccEEEEEeeecCCC---CCCCCcCCHH------HHHHHHHHHHHcCCCHH
Confidence            9999988631    1  123589999999999999999999963   6799999998      79999999999999999


Q ss_pred             ceeecccCCCCCcCCC----CCc---chHHHHHHHHhcCCCcccccccceeeee-ee----cCcEEEeeCCcchhHHHHh
Q 006211          255 KLVLGARASGPGITID----GSM---GYKFIRAFIQNYGYGAAPVYNASYVVNL-FT----SGATWINFDGVETIKAKIS  322 (656)
Q Consensus       255 Kl~lG~p~yG~~~~~~----g~~---~y~~i~~~~~~~~~~~~~~~d~~~~~~~-~~----~~~~~i~yd~~~si~~K~~  322 (656)
                      ||+||+|+|||+|+..    +.+   .|.+||.   ..  |+...||+.+..|| .+    .+++||+|||++|+++|++
T Consensus       294 KivlGip~YGr~w~~~~~~g~~~t~~~y~~i~~---~~--g~~~~~D~~~~~~~~~y~d~~~~~~~v~ydd~~Si~~K~~  368 (393)
T 3bxw_B          294 KILLGLNFYGMDYATSKDAREPVVGARYIQTLK---DH--RPRMVWDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLE  368 (393)
T ss_dssp             GEEEEEESSEEEEETTTTEEEEECHHHHHHHHH---HH--CCBCEEETTTTEEEEEEEETTTEEEEEECCCHHHHHHHHH
T ss_pred             HEEEEecccccccccCCCCCCccCHHHHHHHHH---hc--CCceEEccccCCceEEEEecCCCCEEEEeCCHHHHHHHHH
Confidence            9999999999999764    222   4555554   32  48889999999886 34    4579999999999999999


Q ss_pred             hhhhcccccceeeEeccCccc
Q 006211          323 YAKEKNLLGYKAFQLSNDDNW  343 (656)
Q Consensus       323 ~~~~~glgGv~~W~l~~Dd~~  343 (656)
                      ||+++|| |+|+|++++||..
T Consensus       369 ~~~~~gL-Gv~~W~l~~d~~~  388 (393)
T 3bxw_B          369 LARELGV-GVSIWELGQGLDY  388 (393)
T ss_dssp             HHHHHTC-EEEEECTTSSCGG
T ss_pred             HHHHcCC-EEEEEECCCCchh
Confidence            9999999 9999999999854

>3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A

Probab=100.00  E-value=9.6e-55  Score=446.00  Aligned_cols=271  Identities=19%  Similarity=0.246  Sum_probs=224.8

Q ss_pred             ceEEEEEecCCCC--CC-CCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCC
Q 006211           26 TWIKAGYWLAGRE--FP-LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNS  102 (656)
Q Consensus        26 ~~~~~~y~~~~~~--~~-~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~  102 (656)
                      ..+++|||+++..  .. +++||+++||||+|+|+.++++|. +...+ ....+..+++  |+++|++||++|||     
T Consensus         3 ~krvvgY~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~~~g~-~~~~~-~~~~~~~~~~--k~~~~~lkvllsiG-----   73 (312)
T 3fnd_A            3 LKVVIGYLALDDWEFESLFPTIEWKYLTHINASFARVKADGT-LNINP-VRKRIESVRE--TAHKHNVKILISLA-----   73 (312)
T ss_dssp             CCEEEEEEETTCTTHHHHGGGCCGGGCSEEEEEEEEECTTSC-EECTT-TTTTHHHHHH--HHHHTTCEEEEEEE-----
T ss_pred             CceEEEEEeccccccCCChhhCCcccCCEEEEEEEEECCCCe-EEecC-cHHHHHHHHH--HHHcCCCEEEEEEc-----
Confidence            3578999976542  23 799999999999999999999854 44332 2334555544  77789999999994     


Q ss_pred             ccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeee-CCCccCcchHHHHHHHHHh-hcCCCCCcE
Q 006211          103 TYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL-WPNSTDLNSLGILLDEWKA-SASDQPELT  180 (656)
Q Consensus       103 ~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe-~p~~~d~~~~~~ll~~lr~-~l~~~~~~~  180 (656)
                             ||+  ++.|+.++++++.|++||+++++++++||||||||||| ||...  ++|+.|+++||+ +|.++++++
T Consensus        74 -------G~~--~~~~~~~~~~~~~r~~fi~si~~~~~~~~~DGiDiDwE~~p~~~--~~~~~ll~eLr~~~l~~~~~~~  142 (312)
T 3fnd_A           74 -------KNS--PGEFTTAINDPKARKELIQQIIAFTKEYKLDGFDIDYEEYDNWD--KNFPSLLVFARGLYLAKEKNML  142 (312)
T ss_dssp             -------ESS--TTHHHHHHHSHHHHHHHHHHHHHHHHHTTCSEEEECCCCCTTHH--HHHHHHHHHHHHHHHHSCTTCE
T ss_pred             -------CCC--CchhhHHhCCHHHHHHHHHHHHHHHHHcCCCeEEEeeeeCCCch--HHHHHHHHHHHHHHhcccCCcE
Confidence                   443  12378999999999999999999999999999999999 99875  899999999999 993345899


Q ss_pred             EEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHH-HcCCCCCceeec
Q 006211          181 LSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWL-RRGFPANKLVLG  259 (656)
Q Consensus       181 ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~-~~g~p~~Kl~lG  259 (656)
                      ||+++|+.+.    .|+ +++.++|||||||+||+ |+ |++.+||+|||+      +++.++++|+ +.|+|++||+||
T Consensus       143 ls~av~~~~~----~~~-~~~~~~~D~i~vm~YD~-g~-~~~~~g~~apl~------~~~~~v~~~~~~~g~p~~KlvlG  209 (312)
T 3fnd_A          143 MTCAVNSRWL----NYG-TEWEQYFDYINLMSYDR-GA-FTDKPVQHASYD------DFVKDLKYWNEQCRASKSKIVGG  209 (312)
T ss_dssp             EEEEECCSSS----CCT-TTSGGGCSEEEECCCCT-TC-SSSSCCCSSCHH------HHHHHHHHHHHTSCCCGGGEEEE
T ss_pred             EEEEecCCcc----ccc-HHHHhhCCEEEEeeccC-CC-CCCCCCCCCchH------HHHHHHHHHHHHcCCCHHHEEEE
Confidence            9999988432    356 78999999999999999 65 688899999997      7899999999 899999999999


Q ss_pred             ccCCCCCcCC--------CCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhccccc
Q 006211          260 ARASGPGITI--------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLG  331 (656)
Q Consensus       260 ~p~yG~~~~~--------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgG  331 (656)
                      +|+|||+|+.        ++.++|.+||.....     ...++         +++.||+|||++|++.|++||+++||||
T Consensus       210 ip~YGr~w~~~~~g~~~~~~~~~y~ei~~~~~~-----~~~~~---------d~~~~v~ydd~~Si~~K~~~~~~~gLgG  275 (312)
T 3fnd_A          210 LPFYGYSWEESLQGAVDDVRGIRYSGILKHLGN-----EAADK---------DNIGKTYYNGRPTIANKCKFIKENDYAG  275 (312)
T ss_dssp             EESEEEECCGGGTTSSCTTSEEEHHHHHHHHCG-----GGGGC---------SEETTEECCCHHHHHHHHHHHHHTTCCE
T ss_pred             EcccCceeecCCCCCCCCCCceeHHHHHHhcCC-----ceEEe---------cCCeEEEcCCHHHHHHHHHHHHhcCCcE
Confidence            9999999976        367899999985321     11111         1234799999999999999999999999


Q ss_pred             ceeeEeccCccc
Q 006211          332 YKAFQLSNDDNW  343 (656)
Q Consensus       332 v~~W~l~~Dd~~  343 (656)
                      +|+|++++||..
T Consensus       276 v~~W~l~~Dd~~  287 (312)
T 3fnd_A          276 VMIWQLFQDAHN  287 (312)
T ss_dssp             EEEECGGGSCCG
T ss_pred             EEEEeCcCCCCC
Confidence            999999999964

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4e-46  Score=379.32  Aligned_cols=207  Identities=28%  Similarity=0.453  Sum_probs=180.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|.+.++||+|+||+||+|.+.      ++..||||+++....+..++|.+|++++++++|||||+++++|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45777899999999999999753      467899999988777777889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          509 IYEYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                      |||||++|+|.+++....          ....+++.+++.++.||++||.|||+++   |+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999986432          2346999999999999999999999987   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999987654433333444579999999999999999999999999999999999 8999976543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-46  Score=377.98  Aligned_cols=203  Identities=25%  Similarity=0.387  Sum_probs=181.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++..   .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999954 57999999999753   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999853   346999999999999999999999998   999999999999999999999999999987654


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .........+||+.|||||++.+..|+.++|||||||++|||+||+.||...+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  238 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  238 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            44445556799999999999999999999999999999999999999997544

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=378.18  Aligned_cols=207  Identities=29%  Similarity=0.456  Sum_probs=173.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|.+.++||+|+||+||+|.+.      +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999753      467899999988777777889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          509 IYEYLPNKSLDLYLFDPI------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      |||||++|+|.+++....            ....+++.+++.++.||++||.|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            1246899999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      ||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            9999999987654433333445679999999999999999999999999999999999 8999976543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-45  Score=379.86  Aligned_cols=200  Identities=26%  Similarity=0.384  Sum_probs=179.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +.|+..++||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5689999999999999999965 569999999997655555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|..++..    ..+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999998843    35899999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            23345689999999999999999999999999999999999999997543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.5e-45  Score=377.56  Aligned_cols=203  Identities=21%  Similarity=0.385  Sum_probs=173.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+++++||+|+||+||+|.. .+++.||||+++..  .....+.+.+|++++++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999964 56999999999754  34456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||++|+|.+++... +...+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999998542 2345789999999999999999999998   999999999999999999999999999876432 


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence             122334689999999999999999999999999999999999999997644

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.1e-45  Score=374.41  Aligned_cols=205  Identities=30%  Similarity=0.472  Sum_probs=177.1

Q ss_pred             CCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          437 FSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      +++.++||+|+||+||+|.+      .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            45678999999999999975      246789999997643 33457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      ||||++|+|.+++....             .+..+++.++++++.||++||.|||+.+   ||||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence            99999999999996432             1346899999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999987655433344455689999999999999999999999999999999999 8999976543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=367.47  Aligned_cols=201  Identities=28%  Similarity=0.516  Sum_probs=168.4

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      +++++.++||+|+||+||+|.+.  ..||||+++..  ..+..+.|.+|+.++++++|||||+++++|.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            46778899999999999999864  36999998754  34556789999999999999999999998864 568999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |++|+|.+++...  +..+++.++..++.||++||.|||+.+   ||||||||+||||++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999998653  345899999999999999999999987   99999999999999999999999999987654333


Q ss_pred             ccccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......+||+.|||||++..   ..|+.++|||||||++|||+||+.||....
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            333445689999999999863   458999999999999999999999997544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=381.38  Aligned_cols=200  Identities=26%  Similarity=0.384  Sum_probs=180.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +.|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            5689999999999999999965 569999999998765555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|.+++..    ..+++.++..++.||++||.|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            99999998842    35899999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            23345689999999999999999999999999999999999999996543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-44  Score=366.62  Aligned_cols=199  Identities=23%  Similarity=0.290  Sum_probs=171.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +.|+..++||+|+||+||+|.. .+|+.||||+++.....     .+|+.+++.++|||||++++++.+.+..+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4577788999999999999965 56899999999765322     46999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccccCcc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~~~~~  592 (656)
                      ++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999853   346999999999999999999999987   99999999999999987 699999999987654321


Q ss_pred             c---cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          593 E---ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       593 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.....
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~  261 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR  261 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence            1   122346899999999999999999999999999999999999999976543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-44  Score=367.50  Aligned_cols=202  Identities=25%  Similarity=0.329  Sum_probs=169.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|++.+.||+|+||+||+|+.    .+++.||||+++...  .....++.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4689999999999999999964    247799999987542  2223467889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |||||++|+|.+++..   ...+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999853   346899999999999999999999998   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ..  .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.
T Consensus       178 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~  231 (304)
T 3ubd_A          178 DH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR  231 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence            32  2233456899999999999999999999999999999999999999976443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-43  Score=355.10  Aligned_cols=197  Identities=27%  Similarity=0.407  Sum_probs=168.0

Q ss_pred             CCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEEE
Q 006211          438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIY  510 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  510 (656)
                      +..++||+|+||+||+|.. .++..||+|++...  .....+.|.+|++++++++|||||++++++.+    +...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556799999999999965 56889999998654  34455679999999999999999999999865    34579999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~~~  589 (656)
                      |||++|+|..++..   ...+++..+..++.||++||.|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999853   346899999999999999999999875 3599999999999998 478999999999985432


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~  233 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  233 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                22335689999999998865 69999999999999999999999996543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.4e-43  Score=353.08  Aligned_cols=199  Identities=26%  Similarity=0.454  Sum_probs=161.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++...   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999965 569999999997542   234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+ +|+|.+++..   +..+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6788888753   346999999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~  216 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES  216 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence               22334689999999999988876 579999999999999999999997543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-43  Score=364.05  Aligned_cols=215  Identities=28%  Similarity=0.411  Sum_probs=182.6

Q ss_pred             HHHHHHHhcCCCCCCcccccCceEEEEEEeCC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCC-CceeeEEE
Q 006211          427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQH-VNLLRVLG  498 (656)
Q Consensus       427 ~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~  498 (656)
                      .++++...++|++.+.||+|+||+||+|....      ++.||||+++... ....+.|.+|+++|.+++| ||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            34445556789999999999999999996432      3579999997653 3445679999999999965 89999999


Q ss_pred             EEeeC-CceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 006211          499 YCTER-DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK  564 (656)
Q Consensus       499 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dik  564 (656)
                      +|.+. ...++|||||++|+|..++.....             +..+++.+++.++.||++||.|||+++   |||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence            99764 568999999999999999864321             345899999999999999999999997   9999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          565 ASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       565 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655444444556789999999999999999999999999999999998 899997654


Q ss_pred             C
Q 006211          644 T  644 (656)
Q Consensus       644 ~  644 (656)
                      .
T Consensus       293 ~  293 (353)
T 4ase_A          293 I  293 (353)
T ss_dssp             C
T ss_pred             H
Confidence            3

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.9e-42  Score=350.53  Aligned_cols=200  Identities=25%  Similarity=0.428  Sum_probs=161.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-------
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-------  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------  505 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4588999999999999999964 568999999987654 3345678999999999999999999999876543       


Q ss_pred             -----eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          506 -----NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       506 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                           .++|||||++|+|.+++.........++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976544445667788999999999999999998   99999999999999999999999


Q ss_pred             ccCccccccCccc----------cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          581 FGMAKLFRKDVDE----------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       581 fGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ||+|+.+......          ......+||+.|||||++.+..|+.++|||||||++|||++   ||.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9999876543211          11234579999999999999999999999999999999996   664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.3e-42  Score=351.21  Aligned_cols=201  Identities=26%  Similarity=0.374  Sum_probs=163.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----ceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  510 (656)
                      ++|.+.++||+|+||+||+|.+ +|+.||||+++..... ......|+..+.+++|||||+++++|.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4566778999999999999987 6899999999754322 122345666667889999999999998754    479999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      |||++|+|.+++..    ..+++..+.+++.|+++||.|||+.     +.++|+||||||+||||+.++.+||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999853    3589999999999999999999986     23459999999999999999999999999998


Q ss_pred             ccccCccc--cccccccccccccccccccCC------CCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ........  ......+||+.|||||++.+.      .++.++|||||||++|||+||++|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            76543222  123345899999999998654      367899999999999999999887643

>1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5

Probab=100.00  E-value=9e-42  Score=345.06  Aligned_cols=209  Identities=16%  Similarity=0.155  Sum_probs=166.4

Q ss_pred             eEEEEEe-cCCCCCCCCCCC------CCCccEEEEEEEEecCC-----CcEEecCCcchhh-HHHHHHHHHhhCCCceEE
Q 006211           27 WIKAGYW-LAGREFPLSDIN------SALFTHLICAFAEVDSS-----TYQLSISSANQQY-FSIFANSVRRKNPSIKTL   93 (656)
Q Consensus        27 ~~~~~y~-~~~~~~~~~~i~------~~~~thi~~~f~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~k~~~~~~kvl   93 (656)
                      ++-..|+ .+.+.|.+++||      +++||||+|||+.++++     ++.+... +.+.. ....+.++|++||++|||
T Consensus         3 ~~~~~Y~g~~~~~~~~~di~~~~~~~~~~~THi~yaFa~~~~~~~~~~~g~~~~~-~~d~~~~~~~~~~lk~~~~~~Kvl   81 (290)
T 1nar_A            3 PIFREYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEES-WDVELFGPEKVKNLKRRHPEVKVV   81 (290)
T ss_dssp             CEEEEEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEEC-SCHHHHSHHHHHHHHHHCTTCEEE
T ss_pred             cchheeeccCCCCCCHhHCCcccccCcccCcEEEEEeeeecCccccCCCceeccc-ccccccCHHHHHHHHHHCCCceEE
Confidence            3456788 677889999999      88999999999999863     2333322 22322 344557899999999999


Q ss_pred             EEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcC------CCcceeeeeCCCccCcchHHHHHH
Q 006211           94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG------FQGIDLFWLWPNSTDLNSLGILLD  167 (656)
Q Consensus        94 ~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~------~DGvdidwe~p~~~d~~~~~~ll~  167 (656)
                      +|||||..            +. .|+. +++++.|++|++++++++++||      |||||||||||.. | ++|+.|++
T Consensus        82 lSiGG~~~------------s~-~fs~-~~~~~~r~~f~~s~~~~~~~~g~~~~~~fDGiDiDwE~p~~-d-~~~~~ll~  145 (290)
T 1nar_A           82 ISIGGRGV------------NT-PFDP-AEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIRS-D-EPFATLMG  145 (290)
T ss_dssp             EEEEESST------------TS-CBCB-SCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBCS-S-TTHHHHHH
T ss_pred             EEEECCCC------------CC-Ceec-cCCHHHHHHHHHHHHHHHHHhCCCcCCccceEEEeccCCCC-h-HHHHHHHH
Confidence            99955543            32 3787 5788999999999999999999      9999999999874 4 99999999


Q ss_pred             HHHhhcCCCC-CcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHH
Q 006211          168 EWKASASDQP-ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW  246 (656)
Q Consensus       168 ~lr~~l~~~~-~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~  246 (656)
                      +||++|++.. .+++++++++....  .+++++++.+++||||+|+|||||+ |++.             .+++.+|++|
T Consensus       146 ~Lr~~l~~~~~~~~l~a~vap~~~~--~~~~~~~l~~~~D~i~vM~YD~~g~-~~~~-------------~~~~~~v~~~  209 (290)
T 1nar_A          146 QLITELKKDDDLNINVVSIAPSENN--SSHYQKLYNAKKDYINWVDYQFSNQ-QKPV-------------STDDAFVEIF  209 (290)
T ss_dssp             HHHHHHHHCTTSCCCEEEECCCTTT--HHHHHHHHHHHTTTCCEEEEEGGGC-SSCC-------------CSHHHHHHHH
T ss_pred             HHHHHhhhccCceeEEEEeCCCccc--ccCcHHHHHHhCCEEEEEeecCCCC-CCCC-------------CCHHHHHHHH
Confidence            9999995432 33777777654333  5689999999999999999999975 4421             2899999999


Q ss_pred             HHcC--CCCCceeecccCCCCCcC
Q 006211          247 LRRG--FPANKLVLGARASGPGIT  268 (656)
Q Consensus       247 ~~~g--~p~~Kl~lG~p~yG~~~~  268 (656)
                      ++.|  +|++||+||+|+||+.|.
T Consensus       210 ~~~~~gvp~~Ki~lGlp~yg~~~~  233 (290)
T 1nar_A          210 KSLEKDYHPHKVLPGFSTDPLDTK  233 (290)
T ss_dssp             HHHHHHSCTTCEEEEEECCHHHHH
T ss_pred             HHhccCCCHHHEEEEEeccCCccc
Confidence            9854  999999999999997653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=351.01  Aligned_cols=202  Identities=21%  Similarity=0.350  Sum_probs=171.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------Cc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DE  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  505 (656)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999954 579999999997542  33456788999999999999999999987643      56


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .|+|||||+ |+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 678888743   346999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCc--cccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDV--DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            764322  12233456899999999998765 56999999999999999999999997654

>3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus}

Probab=100.00  E-value=4.4e-40  Score=330.04  Aligned_cols=204  Identities=16%  Similarity=0.200  Sum_probs=159.3

Q ss_pred             EEEEec-CCCCCCCCCCCCCC-ccEEEEEEEEecCCCcE--------EecCCcchhh-HHHHHHHHHhhCCCceEEEEee
Q 006211           29 KAGYWL-AGREFPLSDINSAL-FTHLICAFAEVDSSTYQ--------LSISSANQQY-FSIFANSVRRKNPSIKTLLSIW   97 (656)
Q Consensus        29 ~~~y~~-~~~~~~~~~i~~~~-~thi~~~f~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~k~~~~~~kvl~sig   97 (656)
                      ++||-. ..-.+..-+||+.+ ||||||||+ ++.++..        +.. .+++.. ....+..+|++||++|||+|||
T Consensus         6 ~~~~~~~~~~~~~d~pid~~l~ctHliyaFa-i~~~~~~~~~~~~g~~~~-~w~~~~~~~~~~~~lK~~~~~lKvllSiG   83 (275)
T 3sim_A            6 YIGYPLFSGVKFSDVPINPHITKFQFVLSFA-VDYTASSPHTSTNGKFNV-FWDSSILGPDQISAIKSSHPNVRVAVSLG   83 (275)
T ss_dssp             EESCSTTCCCCGGGSCCCTTCSEEEEEEEEE-ESBCSSSSCCBCTTCCEE-CSCTTTSCHHHHHHHHHHCTTEEEEEEEE
T ss_pred             hccccccCCCCCccCCCCCCccccEEEEEEE-ecccCccccCCCCCcccc-ccccccccHHHHHHHHHhCCCCEEEEEEc
Confidence            345432 23357777889999 999999999 8744221        111 222222 2566688999999999999995


Q ss_pred             cCCCCccccccCCcCCCcc-ccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCC
Q 006211           98 NGQNSTYQSILGNKNINPS-VLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQ  176 (656)
Q Consensus        98 g~~~~~~~~~~Gg~~~~~~-~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~  176 (656)
                      |            |+.+.. .|+.++++++.|++|++++++++++|||||||||||||.++|+++|+.|+++||++|++.
T Consensus        84 G------------~~~~~~~~~~~~~~~~~~r~~fi~si~~~l~~~gfDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~~  151 (275)
T 3sim_A           84 G------------ASVGSNTVQFQAASVDSWVSNAVTSLTRIIQRYNLDGIDIDYEHFQNTDKNTFAECIGRLITTLKKN  151 (275)
T ss_dssp             C------------SEETTEECCCCCSCHHHHHHHHHHHHHHHHHHTTCCEEEEECCCCTTSCHHHHHHHHHHHHHHHHHT
T ss_pred             C------------CCCCCcchhhhhhcCHHHHHHHHHHHHHHHHHhCCCeEEEEeecCCcccHHHHHHHHHHHHHHhccC
Confidence            4            444332 257788889999999999999999999999999999999999999999999999999543


Q ss_pred             CCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCC--CCC
Q 006211          177 PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGF--PAN  254 (656)
Q Consensus       177 ~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~--p~~  254 (656)
                       ++ ||+|+++....... ++++++.+++||||+|+||+||  |++.+             +++.++++|++.|+  |++
T Consensus       152 -~~-ls~a~~~p~~~~~~-~~~~~~~~~~D~i~vm~YD~~~--~~~~~-------------~~~~~v~~~~~~g~~~p~~  213 (275)
T 3sim_A          152 -GV-ISFASISPFPSVDE-YYLALFNEYKNAINHINYQFKA--YDSST-------------SVDKFLGYYNNAASKYKGG  213 (275)
T ss_dssp             -TS-CSEEEECCCGGGHH-HHHHHHHHSGGGCCEEECCGGG--SCTTC-------------CHHHHHHHHHHHHHHTTTS
T ss_pred             -Ce-EEEEEcCChHHhhh-ccHHHHHHhCCEEEEEeccCCC--CCCCc-------------cHHHHHHHHHHHhccCChh
Confidence             44 77776655444444 4489999999999999999993  33211             78999999999887  999


Q ss_pred             ceeecccCCC
Q 006211          255 KLVLGARASG  264 (656)
Q Consensus       255 Kl~lG~p~yG  264 (656)
                      ||+||+|+++
T Consensus       214 KlvlGlpa~~  223 (275)
T 3sim_A          214 NVLISFSTGP  223 (275)
T ss_dssp             CEEEEEECSS
T ss_pred             heEEEEeecC
Confidence            9999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-39  Score=341.04  Aligned_cols=198  Identities=25%  Similarity=0.349  Sum_probs=168.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  507 (656)
                      ..++|++.++||+|+||+||+|..    ..++.||||++.....  ..++.+|++++..+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            457899999999999999999954    2467899999866532  35678999999998 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKL  586 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~~  586 (656)
                      +|||||++|+|.+++.      .+++.++..++.|++.||.|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999998872      3889999999999999999999998   9999999999999877 7999999999976


Q ss_pred             cccCccc--------------------------cccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCC
Q 006211          587 FRKDVDE--------------------------ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       587 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      .......                          ......+||+.|||||++.+. .++.++||||+||++|||+||+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            4322110                          112235799999999998775 5899999999999999999999999


Q ss_pred             CC
Q 006211          640 RY  641 (656)
Q Consensus       640 ~~  641 (656)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-39  Score=358.22  Aligned_cols=200  Identities=29%  Similarity=0.372  Sum_probs=170.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHH---HHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEF---KNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++++..   ......+   ..++.++..++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            4688999999999999999955 569999999986531   1112223   34466777789999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|||||+||+|..++..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999853   346899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...    .....+||+.|||||++.+ ..|+.++|+|||||++|||++|+.||...+.
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~  396 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  396 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            432    2334689999999999964 5799999999999999999999999975443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.4e-39  Score=358.03  Aligned_cols=203  Identities=23%  Similarity=0.349  Sum_probs=180.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+....++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36799999999999999999954 57999999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC--CcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~--~~~kl~DfGla~~~~~~  590 (656)
                      |++|+|.+++...  ...+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999888542  345899999999999999999999998   9999999999999854  78999999999876532


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                         ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus       311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~  361 (573)
T 3uto_A          311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND  361 (573)
T ss_dssp             ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence               223345899999999999999999999999999999999999999976543

>2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus}

Probab=100.00  E-value=5.5e-38  Score=317.34  Aligned_cols=206  Identities=15%  Similarity=0.175  Sum_probs=162.1

Q ss_pred             cceEEEEEecCCC----CC---CCCCCCCCCccEEEEEEEEecCCCcEEecCCcch-----hhHHHHHHHHHhhCCCceE
Q 006211           25 QTWIKAGYWLAGR----EF---PLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-----QYFSIFANSVRRKNPSIKT   92 (656)
Q Consensus        25 ~~~~~~~y~~~~~----~~---~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~k~~~~~~kv   92 (656)
                      ...+++|||.+|+    .+   .+++++.++||||+|+|+.++++++.+.+.+..+     ..+...++.+|++  ++||
T Consensus        11 ~~~~vv~Y~~~~~~~~g~~~~~~~~~i~~~~~Thii~af~~i~~~~g~~~~~~~~~~~~~~~~~~~~i~~~k~~--g~kv   88 (290)
T 2y8v_A           11 EHRRVICYHQTLCPNRGDYVSVLPLVKNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAEVPVLKRS--GVKV   88 (290)
T ss_dssp             CCSEEEEEECCCSGGGCSCCCCTHHHHTTCCCCEEEEEEEEECSSTTCEEETTBCTTSGGGHHHHHHHHHHHHT--TCEE
T ss_pred             CCCeEEEEECCEeCCCCceeecChhhcCCccCcEEEEEEEEecCCCCceeecCCCcccchHHHHHHHHHHHHHC--CCEE
Confidence            4567899999886    24   5678899999999999999998756666555322     1345556777777  4999


Q ss_pred             EEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhh
Q 006211           93 LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKAS  172 (656)
Q Consensus        93 l~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~  172 (656)
                      |+||            |||+.++  |+.++++++.|++|++++++++++|+|||||||||||.  ++++|..|+++||++
T Consensus        89 llSi------------GG~~~~~--fs~~~~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~--~~~~~~~ll~~Lr~~  152 (290)
T 2y8v_A           89 MGML------------GGAAQGS--YRCLDGDQEKFERYYQPLLAMVRRHQLDGLDLDVEEEM--SLPGIIRLIDRLKLD  152 (290)
T ss_dssp             EEEE------------ECSSTTT--TGGGSSCHHHHHHHHHHHHHHHHHHTCSEEEEECCSCB--CHHHHHHHHHHHHHH
T ss_pred             EEEE------------CCCCCCC--chhccCCHHHHHHHHHHHHHHHHHhCCCeEEEcccccc--hHHHHHHHHHHHHHH
Confidence            9999            5554222  89999999999999999999999999999999999996  479999999999999


Q ss_pred             cCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCC----ccccCCCCCCCCCCCCHHHHHHHHHH
Q 006211          173 ASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN----VTGIHAALYNPSSNISTDFGIREWLR  248 (656)
Q Consensus       173 l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~----~~g~~apl~~~~~~~~~~~~v~~~~~  248 (656)
                      |+  ++++||+|+++.              .++|++|+|+|||++. |..    .+++++++|+..........++.|++
T Consensus       153 ~~--~~~~lt~A~~~~--------------~~~d~~~~~~yD~~~~-~~~~~~~~d~~~~~~Y~~~~~~~~~~~~~~~~~  215 (290)
T 2y8v_A          153 LG--DDFIITLAPVAA--------------ALLGIGNLSGFDYRQL-EQQRGSKISWYNAQFYNGWGLAEDPRMYAAIVA  215 (290)
T ss_dssp             HC--TTSEEEECCBGG--------------GGGTSCCSSBSCHHHH-HHHHGGGCCEEEEECCTTSCCTTCTHHHHHHHH
T ss_pred             hC--CCEEEEeccccc--------------cccCccccccccHHHH-HhhcccccceeeecccCCCCCCCCchHHHHHHH
Confidence            93  368999988753              2467888888888854 332    56778888865433233457899999


Q ss_pred             cCCCCCceeecccCCCC
Q 006211          249 RGFPANKLVLGARASGP  265 (656)
Q Consensus       249 ~g~p~~Kl~lG~p~yG~  265 (656)
                      +|+|++||+||+|+|..
T Consensus       216 ~g~p~~KivlGlp~~~~  232 (290)
T 2y8v_A          216 QGWSPQRVVYGLLTNPG  232 (290)
T ss_dssp             TTCCGGGEEEEEESSGG
T ss_pred             cCCCHHHEEEeccCCCC
Confidence            99999999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.8e-37  Score=319.24  Aligned_cols=219  Identities=38%  Similarity=0.672  Sum_probs=189.2

Q ss_pred             cCHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       425 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      +++.++....++|+..+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33444555678999999999999999999998889999999998776666778999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ..++||||+++++|..++..... ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999998865322 235899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      ++...............||+.|+|||.+.+..++.++|||||||++|||++|+.||......+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~  248 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE  248 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence            986543322223334568999999999988899999999999999999999999997655443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.8e-36  Score=308.11  Aligned_cols=201  Identities=26%  Similarity=0.415  Sum_probs=178.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999964 57899999998766555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++..    ..+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++....... 
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence            999999998843    35899999999999999999999997   9999999999999999999999999998654332 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             22334578999999999999999999999999999999999999996543

>3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A*

Probab=100.00  E-value=1.3e-36  Score=312.97  Aligned_cols=231  Identities=19%  Similarity=0.282  Sum_probs=167.2

Q ss_pred             ccceEEEEEecCCCC----CCCCCCCCCCccEEEEEEEEecCCCcEEecCC--cchhhHHHHHHHHHhhCCCceEEEEee
Q 006211           24 AQTWIKAGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSISS--ANQQYFSIFANSVRRKNPSIKTLLSIW   97 (656)
Q Consensus        24 ~~~~~~~~y~~~~~~----~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~k~~~~~~kvl~sig   97 (656)
                      ....+++|||..|+.    +.+++|+... |||+|+|+.++.++..+....  ..+..+...++.+|++  ++|||+|| 
T Consensus         4 ~~~~~vvgYy~~~~~~~~~~~~~~i~~~l-thi~~aF~~~~~~~~~~~~~~~~~~~~~~~~~i~~~k~~--g~kvllsi-   79 (333)
T 3n12_A            4 LGSKLLVGYWHNFDNGTGIIKLKDVSPKW-DVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLKSK--GKKVVLSI-   79 (333)
T ss_dssp             CCSSEEEEEEESSCSSSCCCCGGGSCTTC-SEEEEEEEEECTTSCSEECCCSSSCHHHHHHHHHHHHHT--TCEEEEEE-
T ss_pred             CCCCEEEEEECcccCCCCccCHHHCCCCC-cEEEEEEEEecCCCCeEEecCCccchHHHHHHHHHHHhC--CCeEEEEe-
Confidence            345578999998875    8899999765 999999999998765554432  2345566666778887  69999999 


Q ss_pred             cCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc----------cCcchHHHHHH
Q 006211           98 NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------TDLNSLGILLD  167 (656)
Q Consensus        98 g~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~----------~d~~~~~~ll~  167 (656)
                                 |||+     ++.++++++.|++||+++++++++|+|||||||||||..          +|+++|+.|++
T Consensus        80 -----------GG~~-----~s~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~~~d~~~~~~d~~~~~~ll~  143 (333)
T 3n12_A           80 -----------GGQN-----GVVLLPDNAAKDRFINSIQSLIDKYGFDGIDIDLESGIYLNGNDTNFKNPTTPQIVNLIS  143 (333)
T ss_dssp             -----------ESTT-----CCCCCCSHHHHHHHHHHHHHHHHHHCCSEEEEECCTTCCBCTTCCCTTSCCCHHHHHHHH
T ss_pred             -----------cCCC-----CccccCCHHHHHHHHHHHHHHHHHcCCCeEEEeccCCCCCCCCCcCCCcccHHHHHHHHH
Confidence                       5554     367899999999999999999999999999999999842          25679999999


Q ss_pred             HHHhhcCC-CCCcEEEEEeecCCCcc--------cccc--ChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCC
Q 006211          168 EWKASASD-QPELTLSMAVRYSPTHE--------TVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN  236 (656)
Q Consensus       168 ~lr~~l~~-~~~~~ls~a~~~~~~~~--------~~~~--~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~  236 (656)
                      +||+++++ +++++||+|++......        ..+|  +++++.+++||||||+||+||. |+ .+|++.+   .. .
T Consensus       144 eLr~~l~~~g~~~~lT~Ap~~~~~~~~~~~y~~~~~~y~~d~~~i~~~lD~invMtYD~hg~-~g-~~g~~~~---~~-~  217 (333)
T 3n12_A          144 AIRTISDHYGPDFLLSMAPETAYVQGGYSAYGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSG-IG-MDGNNYN---QG-T  217 (333)
T ss_dssp             HHHHHHHHHCTTCEEEECCBGGGTGGGGTCCBBTBTTTHHHHHHTTTTCCEEEEECSSCCEE-EC-TTSCEEE---TT-S
T ss_pred             HHHHHHHhcCCCEEEEEccCcccccccccccccccchhHHHHHHHhcccCEEEeeeecCCCc-CC-CCCcccc---cC-c
Confidence            99999843 45799999987542111        1235  8899999999999999999964 22 2333321   11 1


Q ss_pred             CCHHHHHHHHHHcC-------------CCCCceeecccCCCCCcCCCCCcchHHHHH
Q 006211          237 ISTDFGIREWLRRG-------------FPANKLVLGARASGPGITIDGSMGYKFIRA  280 (656)
Q Consensus       237 ~~~~~~v~~~~~~g-------------~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~  280 (656)
                      .....++..++..|             +|++||+||+|..+..-...|.++-.++..
T Consensus       218 ~~~~~a~~~~l~~g~~~~g~~~~~~~~ip~~KlvlGlPa~~~aa~~~gy~~~~~~~~  274 (333)
T 3n12_A          218 ADYEVAMADMLLHGFPVGGNANNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMKK  274 (333)
T ss_dssp             HHHHHHHHHHHHHEEEETTEEEEEEECCCGGGEEEEEESSGGGSTTSCCCCHHHHHH
T ss_pred             chHHHHHHHHHHhcccccCcccccccccCHHHeeeccccCCCcCCCCCcCCHHHHHH
Confidence            11122333444443             999999999998764332344444444433

>4axn_A Chitinase C1; hydrolase; 1.68A {Serratia marcescens}

Probab=100.00  E-value=3.3e-36  Score=311.15  Aligned_cols=262  Identities=15%  Similarity=0.206  Sum_probs=186.1

Q ss_pred             ccceEEEEEecCCCC-------------CCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCc
Q 006211           24 AQTWIKAGYWLAGRE-------------FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSI   90 (656)
Q Consensus        24 ~~~~~~~~y~~~~~~-------------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~   90 (656)
                      ..+.+++|||.+|+.             ..+++|+ ..||||+|||+.++.+ ..+......+..+...+..+|++  ++
T Consensus        22 ~~~~~~vgY~~~w~~~~~~~~~~~~~~~~~l~~i~-~~~~~i~~aF~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~--g~   97 (328)
T 4axn_A           22 ANKKILMGFWHNWAAGASDGYQQGQFANMNLTDIP-TEYNVVAVAFMKGQGI-PTFKPYNLSDTEFRRQVGVLNSQ--GR   97 (328)
T ss_dssp             TTSCEEEEEEESSCCCSSCSTTSCBCCCCCGGGSC-TTCCEEEEEEEBCSSS-CBCCCSSSCHHHHHHHHHHHHHT--TC
T ss_pred             CCCeEEEEEeCcccccCCCCccCCcCCCCchhhCC-CCCCEEEEEEEccCCC-ceeccCCCCHHHHHHHHHHHHHC--CC
Confidence            345678999988753             2334454 5589999999988765 33444555566777777777776  69


Q ss_pred             eEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc---CcchHHHHHH
Q 006211           91 KTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST---DLNSLGILLD  167 (656)
Q Consensus        91 kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~---d~~~~~~ll~  167 (656)
                      |||||||||.+                  .+..+++.|++|++++++++++|+|||||||||||...   +..+|..+++
T Consensus        98 kvllSiGG~~~------------------~~~~~~~~r~~F~~s~~~~l~~ygfDGiDiDwE~p~~~~~~~~~~~~~~l~  159 (328)
T 4axn_A           98 AVLISLGGADA------------------HIELKTGDEDKLKDEIIRLVEVYGFDGLDIDLEQAAIGAANNKTVLPAALK  159 (328)
T ss_dssp             EEEEEEEETTC------------------CCCCCTTCHHHHHHHHHHHHHHHCCCEEEEEECTTTTTSTTHHHHHHHHHH
T ss_pred             EEEEEeCCCCC------------------CccCChHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCcchHHHHHHHHH
Confidence            99999955432                  23445678999999999999999999999999999653   4566888899


Q ss_pred             HHHhhcCC-CCCcEEEEEeecCCCcccccc--ChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCH---HH
Q 006211          168 EWKASASD-QPELTLSMAVRYSPTHETVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIST---DF  241 (656)
Q Consensus       168 ~lr~~l~~-~~~~~ls~a~~~~~~~~~~~~--~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~---~~  241 (656)
                      +||+.+.. +++++||+|++.........|  +++++.+++||||+|+||++| .|...++++++++........   ..
T Consensus       160 ~l~~~~~~~g~~~~lt~Ap~~~~~~~~~~y~~~~~~~~~~~D~invm~Yd~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T 4axn_A          160 KVKDHYAAQGKNFIISMAPEFPYLRTNGTYLDYINALEGYYDFIAPQYYNQGG-DGIWVDELNAWITQNNDAMKEDFLYY  238 (328)
T ss_dssp             HHHHHHHTTTCCCEEEECCBGGGGBTTCTTHHHHHHTTTTCCEECCBCSSCTT-CEEEETTTTEEEETTCSTTHHHHHHH
T ss_pred             HHHHHHHhcCCceEEEEcccccccCCCcchhhHHHHhhccccEEeeecccCCC-cccCCCCcccccccCCcccchhHHHH
Confidence            99888743 468999999765433322223  467899999999999999995 478888999998754433211   11


Q ss_pred             HHHHHH-----HcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcch
Q 006211          242 GIREWL-----RRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVET  316 (656)
Q Consensus       242 ~v~~~~-----~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~s  316 (656)
                      ....+.     ..|+|++||+||+|+++..-..                  |                     ++..+..
T Consensus       239 ~~~~~~~~~~~~~g~p~~KivlGlPa~~~aa~~------------------G---------------------y~~~~~~  279 (328)
T 4axn_A          239 LTESLVTGTRGYAKIPAAKFVIGLPSNNDAAAT------------------G---------------------YVVNKQA  279 (328)
T ss_dssp             HHHHHHHTCTTBCCCCGGGBEEEEESSTTTCSS------------------C---------------------CCSSTHH
T ss_pred             HHHHHHHHHhhhcCCChhceEEeeccccCCCCC------------------C---------------------cccCHHH
Confidence            112222     2599999999999998742110                  0                     1334444


Q ss_pred             hHHHHhhh--hhcccccceeeEeccCcccccch
Q 006211          317 IKAKISYA--KEKNLLGYKAFQLSNDDNWALSR  347 (656)
Q Consensus       317 i~~K~~~~--~~~glgGv~~W~l~~Dd~~~~~~  347 (656)
                      +...+...  +..++||+|+|+++.||....+.
T Consensus       280 ~~~~~~~~~~k~~~lgGvM~WSi~~Dd~~~~~g  312 (328)
T 4axn_A          280 VYNAFSRLDAKNLSIKGLMTWSINWDNGKSKAG  312 (328)
T ss_dssp             HHHHHHHHHHTTCCCCEEEEECHHHHTCBCTTC
T ss_pred             HHHHHHHHHhcCCCceEEEEEehhhcCCCCcCC
Confidence            54444433  44689999999999999766553

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.3e-36  Score=311.92  Aligned_cols=201  Identities=24%  Similarity=0.323  Sum_probs=176.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5688899999999999999965 46899999998754   2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999888843   345899999999999999999999987   999999999999999999999999999754322


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus       159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence              122344689999999999999999999999999999999999999996543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.6e-36  Score=309.83  Aligned_cols=201  Identities=26%  Similarity=0.416  Sum_probs=176.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788999999999999999965 67999999998654  3345567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999998854   345899999999999999999999987   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccCCCCC-ccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||....
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            2   23345799999999999887764 79999999999999999999997644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-35  Score=305.64  Aligned_cols=211  Identities=28%  Similarity=0.421  Sum_probs=184.1

Q ss_pred             cccCHHHHHHHhcC----------CCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC
Q 006211          423 QVFSFSDIKAATNN----------FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV  491 (656)
Q Consensus       423 ~~~~~~~~~~~~~~----------y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  491 (656)
                      ..++.++++.+.+.          |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34677777776654          666778999999999999765 7999999999876666677889999999999999


Q ss_pred             ceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       492 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      ||+++++++...+..++||||+++++|..++..    ..+++..+..++.|+++||.|||+.+   ++||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999998743    35899999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .++.+||+|||++........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999986644321  223457899999999999999999999999999999999999999654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6e-36  Score=310.89  Aligned_cols=220  Identities=42%  Similarity=0.707  Sum_probs=190.1

Q ss_pred             CCccccCHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEE
Q 006211          420 PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLG  498 (656)
Q Consensus       420 ~~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~  498 (656)
                      .....++..++....++|++.+.||+|+||.||+|...+++.||||++...... ....+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            346678899999999999999999999999999998878999999999765322 2236889999999999999999999


Q ss_pred             EEeeCCceEEEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       499 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                      ++......++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+..+++||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999987643 234589999999999999999999999333499999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      |+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            999999987643322 22334568999999999988889999999999999999999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=316.11  Aligned_cols=203  Identities=25%  Similarity=0.382  Sum_probs=172.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  507 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||+++..   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            346899999999999999999965 46899999998754   223456678899999988 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999988853   345899999999999999999999997   999999999999999999999999999753


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  228 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN  228 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence            322  223344689999999999998889999999999999999999999997654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7e-36  Score=316.87  Aligned_cols=202  Identities=22%  Similarity=0.359  Sum_probs=174.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357889999999999999999654 57889999987542   22234578899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999888853   345899999999999999999999997   9999999999999999999999999997532


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~  257 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  257 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            22  223345689999999999999999999999999999999999999996543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-36  Score=324.85  Aligned_cols=210  Identities=20%  Similarity=0.285  Sum_probs=178.5

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      .++....++|++.++||+|+||+||+|... +++.||+|+++....   ...+.+.+|..++..++||||+++++++.+.
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344445678999999999999999999765 478899999865321   1223478899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      +..++||||+++|+|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence            9999999999999999998652  345899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+
T Consensus       222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            976543222 2233458999999999986     5668999999999999999999999997544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-35  Score=312.03  Aligned_cols=208  Identities=26%  Similarity=0.397  Sum_probs=177.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe--------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .++|++.+.||+|+||.||+|..        .++..||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36788889999999999999964        234579999997653 34456789999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      +..++||||+++|+|.+++....             ....+++.+++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999986432             1235889999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999986654333233334467889999999999999999999999999999999 9999976543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.9e-35  Score=302.49  Aligned_cols=205  Identities=27%  Similarity=0.466  Sum_probs=178.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4678889999999999999965 468999999987777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++...  ...+++.++..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++........
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999998642  345899999999999999999999987   999999999999999999999999999865432211


Q ss_pred             c------------ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          594 A------------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       594 ~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence            1            11145789999999999999999999999999999999999999875443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.6e-35  Score=299.06  Aligned_cols=219  Identities=41%  Similarity=0.653  Sum_probs=189.9

Q ss_pred             CccccCHHHHHHHhcCCCCC------CcccccCceEEEEEEeCCCCEEEEEEccCC----ChhhHHHHHHHHHHHHhcCC
Q 006211          421 NLQVFSFSDIKAATNNFSSA------NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT----STQGLEEFKNEVSLTARLQH  490 (656)
Q Consensus       421 ~~~~~~~~~~~~~~~~y~~~------~~iG~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h  490 (656)
                      ....+++.++..++++|...      +.||+|+||.||+|.. +++.||||++...    ..+..+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999998877      8899999999999986 6889999998653    23345678999999999999


Q ss_pred             CceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       491 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      |||+++++++...+..++||||+++++|.+++........+++..+..++.|+++||.|||+.+   ++||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999876545567899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      +.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999986544332223334578999999998765 478999999999999999999999976543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-36  Score=320.96  Aligned_cols=206  Identities=22%  Similarity=0.306  Sum_probs=175.8

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      +....++|++.+.||+|+||+||+|... +++.||+|+++...   ....+.+.+|+.++..++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3344578999999999999999999654 58899999986531   1122347889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++|+|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999998843    35899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccCCC----CCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...... .......+||+.|+|||++....    ++.++|||||||++|||++|+.||...+
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            654322 12233568999999999987655    7899999999999999999999997544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.4e-35  Score=301.65  Aligned_cols=203  Identities=26%  Similarity=0.435  Sum_probs=172.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45789999999999999999964 56899999998543   234456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999998853   345899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21 122334578999999999999999999999999999999999999997644

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-35  Score=307.89  Aligned_cols=200  Identities=22%  Similarity=0.359  Sum_probs=174.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888999999999999999664 5889999999754   234456688999999988 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999988853   345899999999999999999999987   99999999999999999999999999975332


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  213 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  213 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence            2  12234468999999999999999999999999999999999999999653

>3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor}

Probab=100.00  E-value=3.3e-35  Score=296.53  Aligned_cols=223  Identities=20%  Similarity=0.258  Sum_probs=161.9

Q ss_pred             ceEEEEEecCCC----CCCCCCCCCCCccEEEEEEEEecCCCcEEecC-Cc------chhhHHHHHHHHHhhCCCceEEE
Q 006211           26 TWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSIS-SA------NQQYFSIFANSVRRKNPSIKTLL   94 (656)
Q Consensus        26 ~~~~~~y~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~-~~------~~~~~~~~~~~~k~~~~~~kvl~   94 (656)
                      ..+++|||.+|.    .+.+++|| ++||||+|||+.++++.+.+.+. +.      ....+...++.+|  ++++|||+
T Consensus         4 ~~~vvgY~~~w~~~~~~~~~~~i~-~~~thi~~aFa~~~~~~G~i~~~~~~~~~~~~~~~~~~~~i~~~~--~~g~kvll   80 (302)
T 3ebv_A            4 KHAVTGYWQNFNNGATVQKISDVP-SAYDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKADVRAKQ--AAGKKVII   80 (302)
T ss_dssp             SSEEEEEEESSCSSSCCCCGGGSC-TTCSEEEEEEEEECSSTTCEECCCCTTTTTSCCHHHHHHHHHHHH--HTTCEEEE
T ss_pred             CceEEEEEccccCCCCCCCHHHcC-CCCCEEEEEEEEEECCCCeEEEeeccccccccCHHHHHHHHHHHH--cCCCEEEE
Confidence            446799998765    37899999 89999999999998743444321 11      2334455555444  46899999


Q ss_pred             EeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcC
Q 006211           95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS  174 (656)
Q Consensus        95 sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~  174 (656)
                      |||            ||+     .+.++++++.|++|++++++++++|+|||||||||||..  ..+|..||++||+++ 
T Consensus        81 siG------------G~~-----~s~~~~~~~~r~~f~~~~~~~~~~~~~DGiDiD~E~p~~--~~~~~~~l~~l~~~~-  140 (302)
T 3ebv_A           81 SVG------------GEK-----GTVSVNSSASATNFANSVYSVMREYGFDGVDIDLENGLN--PTYMTQALRALSAKA-  140 (302)
T ss_dssp             EEE------------ETT-----CCCCCCSHHHHHHHHHHHHHHHHHHTCCEEEEEECSCCC--HHHHHHHHHHHHHHH-
T ss_pred             EEE------------CCC-----CCcccCCHHHHHHHHHHHHHHHHHhCCCeEEEecccccC--HHHHHHHHHHHHHhc-
Confidence            994            443     245688999999999999999999999999999999864  678999999999999 


Q ss_pred             CCCCcEEEEEeecCCC-ccccccChh--hhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHH---HHHH
Q 006211          175 DQPELTLSMAVRYSPT-HETVSYPID--SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIR---EWLR  248 (656)
Q Consensus       175 ~~~~~~ls~a~~~~~~-~~~~~~~~~--~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~---~~~~  248 (656)
                       +++++||+|+++... .....|...  ++.+++||||+|+||. |+ |   +++++++|...   +.+..+.   .++.
T Consensus       141 -g~~~~lt~Ap~~~~~~~~~~~y~~~~~~~~~~lD~vnvq~Yd~-g~-~---~~c~~~~y~~~---~~~~~~~~a~~~~~  211 (302)
T 3ebv_A          141 -GPDMILTMAPQTIDMQSTQGGYFQTALNVKDILTVVNMQYYNS-GT-M---LGCDGKVYAQG---TVDFLTALACIQLE  211 (302)
T ss_dssp             -CTTCEEEECCBGGGSSSTTSHHHHHHHHTGGGCCEEEEECSSC-CC-E---ECTTSCEECTT---SHHHHHHHHHHHHT
T ss_pred             -CCCEEEEEeeccccccccchhHHHHHHHhcCcceEEEeecccC-CC-c---CCCCccccCCC---CccHHHHHHHHHHh
Confidence             467999999886421 122223323  3457999999999997 34 4   78888888543   2232222   3456


Q ss_pred             cCCCCCceeecccCCCCCcCCCCCcchHHHHHH
Q 006211          249 RGFPANKLVLGARASGPGITIDGSMGYKFIRAF  281 (656)
Q Consensus       249 ~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~  281 (656)
                      .|+|++||+||+|+|...- ..|.++-.++...
T Consensus       212 ~gvp~~KIvlGlPa~~~aa-g~Gyv~~~~l~~~  243 (302)
T 3ebv_A          212 GGLAPSQVGLGLPASTRAA-GGGYVSPSVVNAA  243 (302)
T ss_dssp             TTCCGGGEEEEEESSTTSC-SSCCCCHHHHHHH
T ss_pred             cCCCHHHEEEecccCCCcC-CCCCcCHHHHHHH
Confidence            7999999999999996432 3455555555443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-35  Score=306.04  Aligned_cols=205  Identities=27%  Similarity=0.415  Sum_probs=175.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357889999999999999999654 789999999875432 233568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999988843   345899999999999999999999987   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence            3333345689999999999987765 7789999999999999999999976543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=313.90  Aligned_cols=203  Identities=16%  Similarity=0.167  Sum_probs=173.6

Q ss_pred             HhcCCCCCCcccccCceEEEEE------EeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTER  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~------~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  503 (656)
                      ..++|++.+.||+|+||+||+|      ....++.||||+++....   .++..|++++++++   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3567888999999999999999      355688999999976543   45677888888776   99999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCC--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---------
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---------  572 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---------  572 (656)
                      +..++||||+++|+|.+++....  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999985321  2346999999999999999999999987   999999999999998         


Q ss_pred             --CCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          573 --ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       573 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        ++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence              899999999999765433333334456799999999999999999999999999999999999999854

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-35  Score=305.06  Aligned_cols=198  Identities=27%  Similarity=0.379  Sum_probs=174.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|+++...   ....+.+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5688899999999999999965 468999999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            99999999999853   345899999999999999999999987   99999999999999999999999999986432 


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  207 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  207 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence                1234578999999999999999999999999999999999999996543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-35  Score=303.49  Aligned_cols=207  Identities=29%  Similarity=0.478  Sum_probs=170.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..++|++.+.||+|+||+||+|.. +++.||||++....  .+..+.+.+|+.++++++||||+++++++......++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356788999999999999999976 68899999987653  344567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++........+++..+..++.|+++||.|||+.+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999865443345899999999999999999999875 24999999999999999999999999999754332


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~  243 (309)
T 3p86_A          193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN  243 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             --ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              122234578999999999999999999999999999999999999997654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.4e-35  Score=307.15  Aligned_cols=201  Identities=26%  Similarity=0.385  Sum_probs=176.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46788999999999999999965 46899999998764321      356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEecc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG  582 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfG  582 (656)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999853   346899999999999999999999987   99999999999998877    79999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~  222 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            998764322   2234579999999999999899999999999999999999999996544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2e-35  Score=308.53  Aligned_cols=204  Identities=27%  Similarity=0.387  Sum_probs=175.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCce
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  506 (656)
                      ...++|++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999764 68899999997542   23445678899999877 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999988853   345899999999999999999999997   99999999999999999999999999975


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....  .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus       168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            4322  122345689999999999999999999999999999999999999997544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=311.82  Aligned_cols=201  Identities=23%  Similarity=0.382  Sum_probs=175.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5688899999999999999965 458899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999988854   345899999999999999999999997   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                         ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||.....
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  222 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS  222 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence               22334689999999999864   4589999999999999999999999975443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-36  Score=319.64  Aligned_cols=210  Identities=20%  Similarity=0.280  Sum_probs=178.3

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      .+.....++|++.+.||+|+||+||++.. .+++.||||+++...   ....+.+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            33444567899999999999999999966 468999999986532   12234578899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      +..++||||+++|+|..++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            9999999999999999998542  235899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccccc-------CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK-------KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            987543221 1223458999999999987       3568999999999999999999999997644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-35  Score=307.77  Aligned_cols=202  Identities=27%  Similarity=0.335  Sum_probs=175.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467899999999999999999765 47899999987542   23456678899999988 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999988853   235899999999999999999999987   9999999999999999999999999997533


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence            22  222344689999999999999999999999999999999999999997543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-34  Score=305.25  Aligned_cols=203  Identities=25%  Similarity=0.414  Sum_probs=176.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456799999999999999999965 46899999998754  23445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEEeccCcc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAK  585 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~DfGla~  585 (656)
                      ||||+++|+|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++   .+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999888853   345899999999999999999999997   99999999999998654   59999999998


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~  234 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  234 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            654321   2234578999999999999899999999999999999999999996543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.1e-35  Score=300.23  Aligned_cols=204  Identities=24%  Similarity=0.371  Sum_probs=172.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||+||+|...+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467899999999999999999888899999999875432  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++ +|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 676666442  345899999999999999999999987   9999999999999999999999999998654321


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                        .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  226 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD  226 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence              22233468999999999876 56899999999999999999999999765544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.7e-35  Score=303.02  Aligned_cols=202  Identities=24%  Similarity=0.338  Sum_probs=166.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||++..    .+++.||+|+++...    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788999999999999999975    478999999997642    2234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999988853   345889999999999999999999997   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          170 ESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence            54322  122234578999999999998889999999999999999999999997543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=300.39  Aligned_cols=201  Identities=25%  Similarity=0.385  Sum_probs=176.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....      ...+.+.+|+.++++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45688999999999999999965 4689999999875432      1356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEecc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG  582 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfG  582 (656)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999853   345899999999999999999999987   99999999999999887    79999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +++......   ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  221 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  221 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            998764322   2233578999999999998899999999999999999999999996543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-35  Score=305.78  Aligned_cols=205  Identities=28%  Similarity=0.389  Sum_probs=172.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----eEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----NMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv  509 (656)
                      .++|++.+.||+|+||+||+|... ++.||||++..... .......|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357889999999999999999874 78999999976533 33455678999999999999999999987543    6999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-------SNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      |||+++|+|..++..    ..+++..+..++.|+++||.|||+.       ++.+|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999843    3489999999999999999999987       11139999999999999999999999999


Q ss_pred             CccccccCccccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      +++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||.....
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            9987655433333444578999999999876     3566789999999999999999999976443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=300.49  Aligned_cols=201  Identities=20%  Similarity=0.307  Sum_probs=175.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788999999999999999965 458899999987653 3445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC--CCcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~--~~~~kl~DfGla~~~~~~  590 (656)
                      +++++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.  ++.+||+|||+++.....
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999988542  335899999999999999999999987   999999999999997  789999999999876432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  207 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence            2   2234578999999999998889999999999999999999999996544

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.6e-35  Score=305.98  Aligned_cols=198  Identities=22%  Similarity=0.288  Sum_probs=175.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            4688899999999999999965 468999999986542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999998853   235899999999999999999999987   999999999999999999999999999865332


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence                 234579999999999999999999999999999999999999996543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=300.29  Aligned_cols=204  Identities=25%  Similarity=0.418  Sum_probs=175.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  509 (656)
                      .++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            356888999999999999999664 58999999987543 334567889999999999999999999988765  67999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE----cCCCcEEEEeccCcc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAK  585 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl----~~~~~~kl~DfGla~  585 (656)
                      |||+++++|..++........+++..+..++.|+++||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999977555556999999999999999999999997   9999999999999    778889999999998


Q ss_pred             ccccCcccccccccccccccccccccc--------CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVK--------KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            764432   222347899999999886        5678999999999999999999999996543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.2e-35  Score=303.09  Aligned_cols=202  Identities=23%  Similarity=0.386  Sum_probs=173.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999965 678999999986532   122356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+ +|+|.+++..   ...+++.++..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 6788777743   345899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCCCcc
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSE  646 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~~~~  646 (656)
                      .   .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+
T Consensus       162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~  215 (336)
T 3h4j_B          162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN  215 (336)
T ss_dssp             B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred             c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence            2   2234579999999999988776 789999999999999999999997654443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-35  Score=305.88  Aligned_cols=203  Identities=24%  Similarity=0.387  Sum_probs=174.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999965 568999999986421     123567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEeccC
Q 006211          508 LIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGM  583 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~DfGl  583 (656)
                      +||||+++++|...+.... ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987774422 2345899999999999999999999987   999999999999987655   99999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            98764322  223345799999999999999999999999999999999999999965

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=306.03  Aligned_cols=202  Identities=24%  Similarity=0.344  Sum_probs=177.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46799999999999999999965 46889999999877665666789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC--CCcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~--~~~~kl~DfGla~~~~~~  590 (656)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999888542  335899999999999999999999987   999999999999974  467999999999876432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  254 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  254 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence            2   2223478999999999999999999999999999999999999997543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-34  Score=300.56  Aligned_cols=203  Identities=25%  Similarity=0.409  Sum_probs=171.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  505 (656)
                      .++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457889999999999999999764 78999999997543 3345678999999999999999999999865432      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCChhhhhhCCCcCCCCCHH
Q 006211          506 ---------------------------------------------------NMLIYEYLPNKSLDLYLFDPIRRYVLDWQ  534 (656)
Q Consensus       506 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  534 (656)
                                                                         .++||||+++++|..++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999776555567778


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc----------ccccccccccc
Q 006211          535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----------ANTGRIVGTYG  604 (656)
Q Consensus       535 ~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  604 (656)
                      .++.++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999987   999999999999999999999999999876543211          12233578999


Q ss_pred             ccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       605 y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      |+|||.+.+..++.++|||||||++|||++|..|+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            99999999999999999999999999999998765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-35  Score=312.69  Aligned_cols=206  Identities=27%  Similarity=0.426  Sum_probs=175.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456788899999999999999765 68999999987653 3334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++|+|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999998542  335889999999999999999999987   9999999999999999999999999998644322


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .........+++.|+|||.+....++.++|||||||++|||+| |+.||.....
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~  321 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN  321 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            2222222345778999999998889999999999999999998 9999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=311.87  Aligned_cols=204  Identities=23%  Similarity=0.369  Sum_probs=175.2

Q ss_pred             HHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ...++|++.+.||+|+||.||+|. ..+++.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            345679999999999999999995 4578899999987653  2345578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc---CCCcEEEEeccCcc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAK  585 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~---~~~~~kl~DfGla~  585 (656)
                      ||||+++|+|.+.+..   +..+++..+..++.|+++||.|||+.+   |+||||||+|||++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999888854   345899999999999999999999997   99999999999998   46789999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~  217 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED  217 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence            654322  22234579999999999999899999999999999999999999996543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-35  Score=309.90  Aligned_cols=202  Identities=22%  Similarity=0.309  Sum_probs=166.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHH-HHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSL-TARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999654 58899999987642   2233455667666 567899999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999988853   345889999999999999999999987   9999999999999999999999999998543


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            22  223345689999999999999999999999999999999999999996543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.4e-35  Score=308.56  Aligned_cols=216  Identities=28%  Similarity=0.421  Sum_probs=180.6

Q ss_pred             CHHHHHHHhcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEE
Q 006211          426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVL  497 (656)
Q Consensus       426 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~  497 (656)
                      .........++|++.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3445555678899999999999999999953      345789999997653 34456789999999999 799999999


Q ss_pred             EEEeeCCc-eEEEEEecCCCChhhhhhCCCc-------------------------------------------------
Q 006211          498 GYCTERDE-NMLIYEYLPNKSLDLYLFDPIR-------------------------------------------------  527 (656)
Q Consensus       498 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------  527 (656)
                      +++...+. .++||||+++|+|..++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999865432                                                 


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          528 --------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       528 --------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                                    +..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          122889999999999999999999997   999999999999999999999999999866443333


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  301 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  301 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence            33445578899999999999999999999999999999998 9999976543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=299.69  Aligned_cols=205  Identities=29%  Similarity=0.476  Sum_probs=173.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|...    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999763    3446999999765 34445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999998543  335899999999999999999999987   9999999999999999999999999998764


Q ss_pred             cCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ..... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  259 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT  259 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence            43221 11222345778999999998899999999999999999999 999996544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-34  Score=316.14  Aligned_cols=204  Identities=24%  Similarity=0.401  Sum_probs=177.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5678889999999999999976 468999999986542   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++|+|..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999998886533 2346899999999999999999999987   99999999999999999999999999987543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            22  22334589999999999999999999999999999999999999997643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=294.85  Aligned_cols=199  Identities=23%  Similarity=0.364  Sum_probs=166.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--------------------------hhHHHHHHHHHHHHh
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--------------------------QGLEEFKNEVSLTAR  487 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~  487 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5788999999999999999965 5688999999865421                          113468899999999


Q ss_pred             cCCCceeeEEEEEee--CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCC
Q 006211          488 LQHVNLLRVLGYCTE--RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA  565 (656)
Q Consensus       488 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp  565 (656)
                      ++||||+++++++.+  ....++||||+++++|..++    ....+++..+..++.|+++||.|||+.+   ++||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence            999999999999986  56789999999999997754    3346899999999999999999999997   99999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCC---CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       566 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      +|||++.++.+||+|||+++......  .......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999998754322  1223357899999999987655   478899999999999999999999653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=309.10  Aligned_cols=207  Identities=29%  Similarity=0.438  Sum_probs=175.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||+|...      +++.||||+++.. .......+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999742      4568999999754 344455788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~  579 (656)
                      ++||||+++|+|..++....    ....+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986432    2245899999999999999999999997   99999999999999555   59999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~  291 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  291 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999986543333333344577899999999998999999999999999999998 999986544

>3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp}

Probab=100.00  E-value=8.2e-35  Score=297.57  Aligned_cols=255  Identities=14%  Similarity=0.224  Sum_probs=176.6

Q ss_pred             ceEEEEEecCCC-------------CCCCCCCCCCCccEEEEEEEEecCCCcEEecC--CcchhhHHHHHHHHHhhCCCc
Q 006211           26 TWIKAGYWLAGR-------------EFPLSDINSALFTHLICAFAEVDSSTYQLSIS--SANQQYFSIFANSVRRKNPSI   90 (656)
Q Consensus        26 ~~~~~~y~~~~~-------------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~k~~~~~~   90 (656)
                      ..+++|||.+|.             .+.+++||++ ||||+|||+.++++++.+...  ...+..+...+..+|++  ++
T Consensus         4 ~~~~vgYy~~w~~~~~~gyr~g~~~~~~~~~i~~~-~thv~~aFa~i~~~~g~~~~~~~~~~~~~~~~~i~~~k~~--g~   80 (321)
T 3ian_A            4 DKVLVGYWHNWKSTGKDGYKGGSSADFNLSSTQEG-YNVINVSFMKTPEGQTLPTFKPYNKTDTEFRAEISKLNAE--GK   80 (321)
T ss_dssp             CBEEEEEEESSCCCSSCSTTSCBCCCCCGGGCCTT-CSEEEEEEEBCCTTCCSCBCCCSSSCHHHHHHHHHHHHHT--TC
T ss_pred             CcEEEEEECcccccccccccCCccCccCHHHCCCC-CCEEEEEEEEecCCCCeEEecCCcccchhHHHHHHHHHHC--CC
Confidence            457799997764             3678999998 889999999998554443322  23345566667788887  49


Q ss_pred             eEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc---cCcchHHHHHH
Q 006211           91 KTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS---TDLNSLGILLD  167 (656)
Q Consensus        91 kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~---~d~~~~~~ll~  167 (656)
                      |||+|||||.            .+   +   ..+++.|++||+++++++++|||||||||||||..   ++..+|..||+
T Consensus        81 kvllsiGG~~------------~~---~---~~~~~~r~~f~~~~~~~~~~~g~DGiDiD~E~p~~~~~~~~~~~~~~l~  142 (321)
T 3ian_A           81 SVLIALGGAD------------AH---I---ELKKSQESDFVNEIIRLVDTYGFDGLDIDLEQAAIEAADNQTVIPSALK  142 (321)
T ss_dssp             EEEEEEEETT------------CC---C---CCCGGGHHHHHHHHHHHHHHHCCCEEEEEECHHHHTSTTHHHHHHHHHH
T ss_pred             EEEEEeccCC------------CC---c---ccChHHHHHHHHHHHHHHHHhCCCeEEEecccCCcccccCHHHHHHHHH
Confidence            9999995543            22   1   12456899999999999999999999999999963   67888999999


Q ss_pred             HHHhhcCC-CCCcEEEEEeecCCCccccccC--hhhhhhccchhhhhhhcccCC-CCCCccccCCCCCCCCCCC----CH
Q 006211          168 EWKASASD-QPELTLSMAVRYSPTHETVSYP--IDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSNI----ST  239 (656)
Q Consensus       168 ~lr~~l~~-~~~~~ls~a~~~~~~~~~~~~~--~~~l~~~vD~invmtYD~~g~-~~~~~~g~~apl~~~~~~~----~~  239 (656)
                      +||+++.+ +++++||+|++.........|+  ++++.+++||||||+||+++. .|...+.   +++......    ..
T Consensus       143 ~lr~~~~~~g~~~~LT~Ap~~~~~~~~~~y~~~i~~l~~~~D~invm~YD~~~~g~~~~~~~---~~~~~~~~~~~~~f~  219 (321)
T 3ian_A          143 KVKDHYRKDGKNFMITMAPEFPYLTSSGKYAPYINNLDSYYDFINPQYYNQGGDGFWDSDLN---MWISQSNDEKKEDFL  219 (321)
T ss_dssp             HHHHHHHTTTCCCEEEECCBGGGCBTTSTTHHHHHHTTTTCCEECCBCSSCTTCEEEETTTT---EEEETTCSTTHHHHH
T ss_pred             HHHHHHhhccCCEEEEEcccCccccccchHHHHHHHHhCCEeEEEEccCCCCCCCCcccccc---hhhccCCCccccchh
Confidence            99999843 4579999997654322333466  788999999999999999742 1222111   232211111    11


Q ss_pred             HHHHHHHHHc-----CCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCc
Q 006211          240 DFGIREWLRR-----GFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGV  314 (656)
Q Consensus       240 ~~~v~~~~~~-----g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~  314 (656)
                      ......+++.     ++|++||+||+|+... ....|.+                                      .++
T Consensus       220 ~~~~~~~l~~~~~~~~iP~~KlvlGlPa~~~-aa~~Gyv--------------------------------------~~~  260 (321)
T 3ian_A          220 YGLTQRLVTGTDGFIKIPASKFVIGLPSNND-AAATGYV--------------------------------------KDP  260 (321)
T ss_dssp             HHHHHHHHHTCTTBCCCCGGGBEEEEESSTT-TCSSCCC--------------------------------------SCH
T ss_pred             HHHHHHHHhccccccCCChHHEEEecccCCC-cCCCCcc--------------------------------------cCH
Confidence            2233445654     8999999999997531 1111111                                      244


Q ss_pred             chhHHHHhhhhh--cccccceeeEeccCccc
Q 006211          315 ETIKAKISYAKE--KNLLGYKAFQLSNDDNW  343 (656)
Q Consensus       315 ~si~~K~~~~~~--~glgGv~~W~l~~Dd~~  343 (656)
                      ..+..-+..+++  .++||||+|++..|+..
T Consensus       261 ~~l~~~l~~~~~~~~~~gGvM~W~~~~d~~n  291 (321)
T 3ian_A          261 NAVKNALNRLKASGNEIKGLMTWSVNWDAGT  291 (321)
T ss_dssp             HHHHHHHHHHHHTTCCCCEEEEECHHHHTCB
T ss_pred             HHHHHHHHHHHhcCCCCceEEEEeeeccccC
Confidence            445555555554  37999999999998744

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-35  Score=301.42  Aligned_cols=204  Identities=23%  Similarity=0.367  Sum_probs=167.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce---
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN---  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  506 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++...   ......+.+|+.++.+++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788999999999999999964 678899999997652   23345788999999999999999999998766544   


Q ss_pred             -EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          507 -MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       507 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                       ++||||+++++|..++..   ...+++..+..++.|++++|.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             999999999999999853   345899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            65433221 22334578999999999999999999999999999999999999997544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-34  Score=292.08  Aligned_cols=202  Identities=29%  Similarity=0.458  Sum_probs=176.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            56888899999999999999888888999999976533 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++...... ..
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            99999998543  345899999999999999999999987   9999999999999999999999999998654321 11


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~  212 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  212 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence            2223456778999999998899999999999999999999 999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-34  Score=293.26  Aligned_cols=200  Identities=25%  Similarity=0.400  Sum_probs=169.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||.||+|...+++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999887899999999875532  2245688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++ +|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            975 887777542  245889999999999999999999987   9999999999999999999999999998654321 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             12223468999999999865 45899999999999999999999999654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-34  Score=299.94  Aligned_cols=204  Identities=19%  Similarity=0.214  Sum_probs=175.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35788999999999999999964 5788999999875432  23578899999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc-----EEEEeccCccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDFGMAKL  586 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~-----~kl~DfGla~~  586 (656)
                      |+ +++|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999988543  346899999999999999999999987   999999999999999887     99999999987


Q ss_pred             cccCcccc-----ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          587 FRKDVDEA-----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       587 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      +.......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence            54332211     123567999999999999999999999999999999999999999875443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-34  Score=304.00  Aligned_cols=205  Identities=29%  Similarity=0.502  Sum_probs=164.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|...    ++..||||+++.. .....+.+.+|+.++.+++||||+++++++......++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999654    5678999999765 34455679999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999998643  335899999999999999999999987   9999999999999999999999999998764


Q ss_pred             cCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ...... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            332111 1122245678999999998999999999999999999998 999996543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.8e-34  Score=292.49  Aligned_cols=198  Identities=24%  Similarity=0.367  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4788899999999999999965 468999999987543  3334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |++++.+..+. .  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99865444333 2  2345899999999999999999999997   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~  640 (656)
                        .......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+.
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence              2223457899999999987765 7999999999999999999998863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-34  Score=316.00  Aligned_cols=203  Identities=26%  Similarity=0.377  Sum_probs=177.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            35688889999999999999965 468999999986532   23345678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999998886532 334899999999999999999999997   99999999999999999999999999987543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            22   2223479999999999999899999999999999999999999997643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-34  Score=305.89  Aligned_cols=208  Identities=29%  Similarity=0.402  Sum_probs=178.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe--------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE  502 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  502 (656)
                      ..++|++.+.||+|+||.||+|..        ..+..||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            346788999999999999999964        223579999997653 34456789999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEE
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NIL  569 (656)
                      .+..++||||+++|+|..++.....             ...+++..++.++.|+++||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999864321             235899999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999986654333233334567889999999999999999999999999999999 999987544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-35  Score=301.33  Aligned_cols=208  Identities=27%  Similarity=0.416  Sum_probs=177.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788899999999999999964      345789999997643 44556789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCC
Q 006211          507 MLIYEYLPNKSLDLYLFDPIR---------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA  565 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp  565 (656)
                      ++||||+++++|.+++.....                     ...+++.++..++.|+++||.|||+.+   ++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999864322                     234889999999999999999999987   99999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       566 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986644333233334467788999999988889999999999999999999 9999976544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.4e-34  Score=297.61  Aligned_cols=204  Identities=27%  Similarity=0.407  Sum_probs=159.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            45789999999999999999965 4689999999875532 234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |++ ++|..++....   ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58888774321   1235889999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...  .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            321  12223478999999999876 468999999999999999999999997544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=301.96  Aligned_cols=209  Identities=27%  Similarity=0.442  Sum_probs=177.7

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD  504 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  504 (656)
                      ...++|++.+.||+|+||.||+|...      +++.||||+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999663      34789999997653 344567899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIR---------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL  563 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Di  563 (656)
                      ..++||||+++++|..++.....                     ...+++.+++.++.|+++||.|||+.+   ++||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999864321                     146899999999999999999999987   999999


Q ss_pred             CCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       564 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986543322223334567889999999988889999999999999999999 99999654


Q ss_pred             C
Q 006211          643 G  643 (656)
Q Consensus       643 ~  643 (656)
                      .
T Consensus       281 ~  281 (343)
T 1luf_A          281 A  281 (343)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5e-34  Score=301.56  Aligned_cols=196  Identities=27%  Similarity=0.409  Sum_probs=167.6

Q ss_pred             CCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      .+.||+|+||.||+|.. .+++.||+|+++.......+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999965 56899999999887666677899999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE--cCCCcEEEEeccCccccccCcccccc
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL--DNELNPKISDFGMAKLFRKDVDEANT  596 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~  596 (656)
                      ..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++......   ..
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            8887542  335899999999999999999999987   9999999999999  567789999999998764322   22


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            23468999999999998899999999999999999999999997544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-34  Score=289.02  Aligned_cols=203  Identities=29%  Similarity=0.428  Sum_probs=176.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||+|...++..||+|+++.... ..+++.+|+.++.+++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            457888999999999999999888888999999976533 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999988542  235899999999999999999999987   999999999999999999999999999865443221


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence             2223356778999999998889999999999999999999 999997544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-34  Score=305.33  Aligned_cols=214  Identities=26%  Similarity=0.321  Sum_probs=182.0

Q ss_pred             CCCccccCHHHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----CCc
Q 006211          419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----HVN  492 (656)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~n  492 (656)
                      ......+++.+.....++|++.++||+|+||.||+|.. .+++.||||+++.. ....+.+..|+.+++.++     |||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            33455566666666788999999999999999999965 56889999999753 334456788999999986     999


Q ss_pred             eeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC
Q 006211          493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       493 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~  572 (656)
                      |+++++++...+..++||||+ +++|..++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~  172 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD  172 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence            999999999999999999999 999998885432 234899999999999999999999987   999999999999975


Q ss_pred             -------------------------CCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHH
Q 006211          573 -------------------------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGV  627 (656)
Q Consensus       573 -------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGv  627 (656)
                                               ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  247 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGC  247 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence                                     78899999999976432     122357899999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCC
Q 006211          628 LLLQIISSKRNARYYG  643 (656)
Q Consensus       628 il~elltg~~p~~~~~  643 (656)
                      ++|||++|+.||....
T Consensus       248 il~ell~g~~pf~~~~  263 (360)
T 3llt_A          248 VLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHCCCCCCCCc
Confidence            9999999999997544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.5e-35  Score=317.68  Aligned_cols=202  Identities=25%  Similarity=0.320  Sum_probs=166.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++..   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36789999999999999999964 56899999998753   233345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |||+++|+|..++..   ...+++..+..++.|+++||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999888843   3458999999999999999999998 66   9999999999999999999999999997543


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  353 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  353 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            22  222334689999999999999999999999999999999999999996544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.8e-34  Score=303.45  Aligned_cols=207  Identities=16%  Similarity=0.234  Sum_probs=176.4

Q ss_pred             hcCCCCCCccccc--CceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEG--GFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|  +||.||+|... +++.||||++....  .+..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568899999999  99999999664 68999999987542  3445678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++.... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999885432 245899999999999999999999987   9999999999999999999999999886543


Q ss_pred             cCcc-----ccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          589 KDVD-----EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       589 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            2211     111223478899999999987  5789999999999999999999999976443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-34  Score=295.16  Aligned_cols=203  Identities=31%  Similarity=0.490  Sum_probs=170.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      .++|++.+.||+|+||.||+|..     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788899999999999999973     36889999999887777777899999999999999999999998653  458


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999998543  234899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            6443221 112233567789999999999999999999999999999999998854

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-34  Score=298.46  Aligned_cols=208  Identities=23%  Similarity=0.412  Sum_probs=160.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCC----CEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce-
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRG----QEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN-  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-  506 (656)
                      .++|++.+.||+|+||.||+|.....    ..||||+++..  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            46789999999999999999965443    27999999765  334567889999999999999999999999877655 


Q ss_pred             -----EEEEEecCCCChhhhhhCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          507 -----MLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       507 -----~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                           ++||||+++++|..++....   ....+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999885322   2225899999999999999999999997   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  245 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN  245 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence            99999986644332222333456788999999999999999999999999999999 8999976544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-34  Score=305.59  Aligned_cols=204  Identities=25%  Similarity=0.404  Sum_probs=162.9

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCC--c
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERD--E  505 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  505 (656)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4567899999999999999999954 56899999998653  3344567889999999997 999999999997544  6


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||++ ++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 578777743    35889999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccCc-------------------cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDV-------------------DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            653210                   0111233579999999999876 678999999999999999999999997654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-34  Score=300.32  Aligned_cols=205  Identities=28%  Similarity=0.461  Sum_probs=167.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|+||+||+|.. .+++    .||+|.+.... ....+.+.+|+.++++++||||++++++|... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            5688899999999999999964 3444    36888886542 34557889999999999999999999999875 4789


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+|++++|+|..++...  ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999988643  345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      ............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  226 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence            4433333334456889999999999999999999999999999999 99999765443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-34  Score=299.86  Aligned_cols=209  Identities=30%  Similarity=0.443  Sum_probs=176.1

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      ..++|++.+.||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            346788999999999999999964      245689999997542 23446789999999999 8999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRR--------------------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK  564 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dik  564 (656)
                      ..++||||+++|+|..++......                    ..+++..+..++.|+++||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999998654321                    24789999999999999999999987   9999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          565 ASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       565 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333344567889999999988899999999999999999998 999997654


Q ss_pred             C
Q 006211          644 T  644 (656)
Q Consensus       644 ~  644 (656)
                      .
T Consensus       280 ~  280 (344)
T 1rjb_A          280 V  280 (344)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5e-34  Score=290.11  Aligned_cols=203  Identities=28%  Similarity=0.447  Sum_probs=173.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||++...++..||+|+++.... ..+++.+|++++.+++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            457888999999999999999888888999999976533 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|..++...  ...+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.+||+|||+++...... .
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence            999999998653  235899999999999999999999987   9999999999999999999999999998654321 1


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~  226 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  226 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence            12223356778999999998889999999999999999998 999997644

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-34  Score=299.55  Aligned_cols=200  Identities=23%  Similarity=0.389  Sum_probs=160.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ..++|++.+.||+|+||.||+|... +++.||||+++...  ..+.+.+|+.++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567999999999999999999765 57899999997653  23567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGla~~~~  588 (656)
                      |+++++|.+++..   ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999988854   345899999999999999999999987   999999999999975   8899999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  254 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER  254 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence            32   12234578999999999999899999999999999999999999996544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.9e-34  Score=299.91  Aligned_cols=200  Identities=24%  Similarity=0.296  Sum_probs=163.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            357889999999999999999654 789999999976533 235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc--EEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~--~kl~DfGla~~~~~~  590 (656)
                      +++|+|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999988853   335899999999999999999999987   999999999999987765  999999999743221


Q ss_pred             ccccccccccccccccccccccCCCCCcc-chhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMK-YDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwslGvil~elltg~~p~~~~~  643 (656)
                         .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence               22234578999999999988877655 899999999999999999997644

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-33  Score=286.86  Aligned_cols=201  Identities=23%  Similarity=0.353  Sum_probs=175.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4567899999999999999999654 577999999987655667789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~~  588 (656)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||+   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999888753   345899999999999999999999987   9999999999999   788899999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...   ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||....
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT  211 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence            322   22334789999999988654 8999999999999999999999997544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=298.34  Aligned_cols=200  Identities=25%  Similarity=0.401  Sum_probs=166.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCC--CceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQH--VNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4568899999999999999998888999999998754  33445678999999999986  9999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      || +.+++|..++..   ...+++.++..++.|+++||.|||+.+   |+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899998854   345899999999999999999999987   99999999999997 56899999999987654


Q ss_pred             CccccccccccccccccccccccC-----------CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            433333345579999999999864           6789999999999999999999999965

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7e-34  Score=293.35  Aligned_cols=207  Identities=28%  Similarity=0.436  Sum_probs=177.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788899999999999999964      3467899999976533 3456789999999999 99999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR---------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      .++||||+++|+|.+++.....               ...+++..+..++.|+++||.|||+.+   ++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999864322               124899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999987654433333334567889999999988899999999999999999999 999987654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-34  Score=312.79  Aligned_cols=204  Identities=26%  Similarity=0.447  Sum_probs=175.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..++|++.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.++++++||||+++++++. ....++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            346788889999999999999998888899999997653 34678999999999999999999999986 5678999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|.+++.... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  338 (454)
T ss_dssp             CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred             cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence            99999999986432 235788999999999999999999987   9999999999999999999999999998654321 


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ........++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~  390 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  390 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence            111222346778999999998899999999999999999999 999997544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3e-34  Score=311.79  Aligned_cols=198  Identities=23%  Similarity=0.310  Sum_probs=164.6

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|++.+.||+|+||.||+|. ..+++.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4679999999999999999995 456889999999764  3344567889999999999999999999996553      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++||||++++ |...+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999865 444442     23889999999999999999999997   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            865432   22334578999999999999999999999999999999999999997644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-33  Score=293.83  Aligned_cols=193  Identities=25%  Similarity=0.334  Sum_probs=150.0

Q ss_pred             CCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      .+.||+|+||.||+|.. .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999965 46899999998653   3356788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEEeccCccccccCcccc
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~DfGla~~~~~~~~~~  594 (656)
                      |..++..   ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            9998854   345899999999999999999999987   99999999999998765   79999999998654322  2


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            2234578999999999999999999999999999999999999997543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-34  Score=300.16  Aligned_cols=211  Identities=25%  Similarity=0.315  Sum_probs=172.7

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      +....++|++.+.||+|+||.||+|.. .++..||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            445677899999999999999999965 56889999998643     234456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCc-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIR-------------------------------------RYVLDWQKRVNIIEGVTQG  546 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~  546 (656)
                      +..++||||+++|+|..++.....                                     ...+++..+..++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999988742100                                     1123567788999999999


Q ss_pred             HHHHHhcCCCCcEecccCCCCEEEcCCC--cEEEEeccCccccccCccc--cccccccccccccccccccC--CCCCccc
Q 006211          547 LLYLQEYSNFRVIHRDLKASNILLDNEL--NPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKK--GIYSMKY  620 (656)
Q Consensus       547 l~~Lh~~~~~~iiH~Dikp~NILl~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~s  620 (656)
                      |.|||+.+   ++||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||.+..  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999997   99999999999998776  8999999999865432211  12334578999999999865  6789999


Q ss_pred             hhHHHHHHHHHHHcCCCCCCCCC
Q 006211          621 DVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       621 DvwslGvil~elltg~~p~~~~~  643 (656)
                      |||||||++|||++|+.||....
T Consensus       258 DiwslG~il~el~~g~~pf~~~~  280 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVN  280 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999996544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3e-34  Score=298.00  Aligned_cols=205  Identities=26%  Similarity=0.412  Sum_probs=169.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCE----EEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQE----FAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|++.+.||+|+||.||+|... +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46788899999999999999653 4443    8888875442 223345678999999999999999999986 466899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+||+++|+|..++...  +..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999998653  335888999999999999999999997   9999999999999999999999999998765


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  224 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA  224 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence            5433333445567889999999998899999999999999999999 99999765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-34  Score=308.18  Aligned_cols=200  Identities=24%  Similarity=0.427  Sum_probs=174.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999654 79999999986542   123467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999853   345899999999999999999999987   999999999999999999999999999875432


Q ss_pred             ccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  220 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH  220 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence            1   2234579999999999988765 689999999999999999999997544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-33  Score=284.74  Aligned_cols=205  Identities=27%  Similarity=0.414  Sum_probs=176.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999654 68999999986543 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999988743   345899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             cccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            2223344578999999999987665 7789999999999999999999976543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=291.09  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=165.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||++.. .++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            4678889999999999999987 4788999998754  34567899999999999999999999876  45899999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc-EEEEeccCccccccCccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~-~kl~DfGla~~~~~~~~~  593 (656)
                      +++|..++........+++..++.++.|+++||.|||+.+..+++||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976544445789999999999999999999954445999999999999998886 799999999754321   


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence              122368999999999999899999999999999999999999997543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-33  Score=293.99  Aligned_cols=207  Identities=27%  Similarity=0.403  Sum_probs=175.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe--------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .++|++.+.||+|+||.||+|..        .++..||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46788999999999999999965        346789999997653 34456789999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      +..++||||+++++|..++.....             ...+++..++.++.|+++||.|||+.+   ++||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999865332             234889999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999986654332223333456788999999988889999999999999999999 999997543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-33  Score=291.97  Aligned_cols=201  Identities=26%  Similarity=0.387  Sum_probs=175.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......      ..+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688999999999999999965 46899999998754321      356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEecc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG  582 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfG  582 (656)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999854   345889999999999999999999987   99999999999999888    79999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  222 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence            998654322   2233468999999999998899999999999999999999999996543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-33  Score=301.04  Aligned_cols=200  Identities=25%  Similarity=0.396  Sum_probs=167.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .+|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            468899999999999999998878999999998654  3445677899999999996  599999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      | +.+++|..++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 678899988854   235889999999999999999999987   99999999999996 578999999999876543


Q ss_pred             ccccccccccccccccccccccC-----------CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .........+||+.|+|||++.+           ..++.++|||||||++|||++|+.||...
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            32223344579999999999865           46889999999999999999999999653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-33  Score=291.70  Aligned_cols=203  Identities=25%  Similarity=0.347  Sum_probs=168.5

Q ss_pred             cCCCCC-CcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~-~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      +.|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 7899999999999964 46899999999876555667889999999885 79999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~DfGla~~~~  588 (656)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999998854   245899999999999999999999997   999999999999998776   9999999997653


Q ss_pred             cCcc-----ccccccccccccccccccccC-----CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVD-----EANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            2211     111223468999999999865     557899999999999999999999997654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-34  Score=297.25  Aligned_cols=211  Identities=25%  Similarity=0.434  Sum_probs=178.2

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE  502 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  502 (656)
                      +....++|++.+.||+|+||.||+|...      .++.||||++.... ......+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3345678999999999999999999543      36789999997653 3345578999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN  575 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~  575 (656)
                      .+..++||||+++++|.+++.....       ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            9999999999999999998854211       135789999999999999999999997   999999999999999999


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            99999999986544322223334467889999999998889999999999999999999 888886543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-33  Score=306.82  Aligned_cols=200  Identities=30%  Similarity=0.444  Sum_probs=171.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-ENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||+|.. .++.||||+++...  ..+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            45678889999999999999987 47899999997654  3467899999999999999999999987765 78999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|.+++... ....+++..++.++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999998643 2234789999999999999999999987   999999999999999999999999999854321  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                         .....++..|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  393 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  393 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence               112356789999999999999999999999999999998 99999765543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-33  Score=284.72  Aligned_cols=200  Identities=30%  Similarity=0.496  Sum_probs=163.6

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh----hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|.. .++.||||++.....    ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            5688889999999999999987 488999999875432    23567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC--------CCcEEEEecc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--------ELNPKISDFG  582 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~--------~~~~kl~DfG  582 (656)
                      ||+++++|..++.    ...+++..+..++.|+++||.|||+.+..+++||||||+|||++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999998883    345899999999999999999999987555899999999999986        6789999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  218 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID  218 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            997654322    123468999999999998889999999999999999999999997544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.1e-34  Score=312.91  Aligned_cols=205  Identities=27%  Similarity=0.440  Sum_probs=177.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ..+|++.+.||+|+||.||+|.... +..||||+++... ...+.+.+|+.++++++||||++++++|......++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4567888999999999999997654 7899999997653 3457799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++|+|..++... ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999998643 2345899999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                       .......++..|+|||.+....++.++|||||||++|||+| |+.||.....
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~  425 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  425 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence             12223356788999999998899999999999999999999 9999876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=285.43  Aligned_cols=204  Identities=25%  Similarity=0.477  Sum_probs=156.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688899999999999999965 578999999986532   12346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999998643  245899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  217 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV  217 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence            221  12234689999999999988899999999999999999999999976543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=289.18  Aligned_cols=197  Identities=23%  Similarity=0.274  Sum_probs=163.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|+..++||+|+||+||+|... +++.||||++....  .........|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999665 78999999986542  23333455566555555 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+ +++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 67888777542  345899999999999999999999987   99999999999999999999999999976543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            21   2233468999999998876 68999999999999999999987764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.9e-33  Score=284.60  Aligned_cols=201  Identities=25%  Similarity=0.424  Sum_probs=174.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46789999999999999999965 46889999998654  3344567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEeccCcccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKLF  587 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~DfGla~~~  587 (656)
                      ||+++++|...+..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999887743   345899999999999999999999997   999999999999987655   999999999765


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence            4322   2223578999999999999999999999999999999999999996543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-33  Score=294.88  Aligned_cols=197  Identities=29%  Similarity=0.434  Sum_probs=169.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999964 578899999987542   23345788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||++ |+|..++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 567666643  2346899999999999999999999997   99999999999999999999999999976532


Q ss_pred             Ccccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                            .....||+.|+|||++.   ...++.++|||||||++|||++|+.||...
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                  12347899999999884   567899999999999999999999998654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=291.15  Aligned_cols=202  Identities=24%  Similarity=0.316  Sum_probs=169.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999664 589999998865432  334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999888743   345899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .  ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  208 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD  208 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            1  2233478999999999875 6689999999999999999999999976543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-34  Score=303.42  Aligned_cols=204  Identities=25%  Similarity=0.420  Sum_probs=174.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356888999999999999999654 58999999987543 234567789999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE----cCCCcEEEEeccCcc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAK  585 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl----~~~~~~kl~DfGla~  585 (656)
                      |||+++|+|..++........+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976555555999999999999999999999997   9999999999999    777889999999998


Q ss_pred             ccccCccccccccccccccccccccccC--------CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKK--------GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......   ......||+.|+|||++..        ..++.++|||||||++|||++|+.||....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            654322   2223578999999998864        567889999999999999999999996543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-33  Score=306.01  Aligned_cols=195  Identities=21%  Similarity=0.364  Sum_probs=152.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  505 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+++.+|+.++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36799999999999999999954 46899999998654  334456789999999999999999999998443     56


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++|||++ +++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5688888753   345899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccCccc-------------------------cccccccccccccccccc-cCCCCCccchhHHHHHHHHHHHcC
Q 006211          586 LFRKDVDE-------------------------ANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISS  635 (656)
Q Consensus       586 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslGvil~elltg  635 (656)
                      ........                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            75432110                         112345789999999976 566799999999999999999994

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.6e-34  Score=321.93  Aligned_cols=203  Identities=27%  Similarity=0.333  Sum_probs=176.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  507 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            346799999999999999999965 46889999998753   223345678899999987 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999988853   245899999999999999999999997   999999999999999999999999999854


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       493 ~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          493 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             CCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence            322  223345689999999999999999999999999999999999999997644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-33  Score=288.24  Aligned_cols=203  Identities=26%  Similarity=0.415  Sum_probs=167.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhc---CCCceeeEEEEEeeC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTER  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~  503 (656)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999975 568999999986432     11123456777777666   499999999999876


Q ss_pred             C-----ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          504 D-----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       504 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                      .     ..++|||++. ++|..++.... ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 59988886532 234899999999999999999999998   999999999999999999999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  223 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  223 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999865432   22234578999999999999999999999999999999999999996543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.6e-34  Score=309.96  Aligned_cols=203  Identities=26%  Similarity=0.440  Sum_probs=169.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||+|....+..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45688889999999999999998877889999997653 235678999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|.+++... ....+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++....... 
T Consensus       261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  335 (452)
T 1fmk_A          261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  335 (452)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence            999999998532 2235889999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence            12223356788999999998899999999999999999999 999997544

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-33  Score=286.74  Aligned_cols=202  Identities=30%  Similarity=0.537  Sum_probs=160.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.++||+|+||.||+|...  ..+|+|+++..  .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            457889999999999999999763  36999998754  334456789999999999999999999965 4567899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999888543  345899999999999999999999987   9999999999999999999999999997654322


Q ss_pred             ccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .........||+.|+|||.+.   ...++.++||||||+++|||++|+.||....
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  229 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  229 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence            233334457899999999986   5678899999999999999999999997644

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.6e-34  Score=296.54  Aligned_cols=198  Identities=24%  Similarity=0.350  Sum_probs=169.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||+++.....    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456799999999999999999965 46889999999765432    35678888887 7999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC----CcEEEEeccCccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKISDFGMAKL  586 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~----~~~kl~DfGla~~  586 (656)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+..+    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999988854   345899999999999999999999997   9999999999998543    3599999999986


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            54332  2223457899999999998888999999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-33  Score=298.20  Aligned_cols=198  Identities=22%  Similarity=0.299  Sum_probs=160.6

Q ss_pred             hcCCCCC-CcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHH-hcCCCceeeEEEEEee----CCce
Q 006211          434 TNNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTA-RLQHVNLLRVLGYCTE----RDEN  506 (656)
Q Consensus       434 ~~~y~~~-~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~  506 (656)
                      .++|.+. +.||+|+||+||++.. .+++.||||+++..     ..+.+|+.++. ..+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3456665 6899999999999965 46889999999643     34567888774 4589999999998875    5578


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccC
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGM  583 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGl  583 (656)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999986532 235899999999999999999999987   999999999999998   78899999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            9865432   12234578999999999999999999999999999999999999996543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-33  Score=287.13  Aligned_cols=203  Identities=20%  Similarity=0.265  Sum_probs=174.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  .+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            45788999999999999999964 6789999999865432  23578899999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc-----EEEEeccCccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDFGMAKL  586 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~-----~kl~DfGla~~  586 (656)
                      |+ +++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999998543  235899999999999999999999987   999999999999987776     99999999987


Q ss_pred             cccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          587 FRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       587 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  223 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  223 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence            6543221     123345789999999999999999999999999999999999999977543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=296.24  Aligned_cols=201  Identities=23%  Similarity=0.367  Sum_probs=173.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--------QGLEEFKNEVSLTARLQHVNLLRVLGYCTE  502 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  502 (656)
                      ...++|++.+.||+|+||.||+|. ..+++.||||+++....        ...+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            346789999999999999999996 45688999999876531        123356789999999999999999999999


Q ss_pred             CCceEEEEEecCCC-ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          503 RDENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       503 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      .+..++||||+.+| +|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 89888854   335899999999999999999999997   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |+++......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus       175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9998754322   2233578999999999988776 8899999999999999999999964

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-34  Score=298.31  Aligned_cols=202  Identities=24%  Similarity=0.343  Sum_probs=171.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      ++|++.+.||+|+||.||++..    .+++.||||+++...    ....+.+.+|+.++.++ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999976    468999999986532    12334567899999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999998854   235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+.... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...+
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            654322 122334579999999999875  347889999999999999999999997544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-33  Score=285.98  Aligned_cols=203  Identities=25%  Similarity=0.377  Sum_probs=170.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            45788999999999999999965 468899999987643 3345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCcccc
Q 006211          512 YLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLF  587 (656)
Q Consensus       512 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~  587 (656)
                      |+++++|..++... .....+++..+..++.|+++||.|||+.+   ++||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999998887542 22356899999999999999999999987   9999999999999   45678999999999765


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....   ......||+.|+|||.+. ..++.++||||||+++|||++|+.||....
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            4322   223356899999999876 568999999999999999999999997543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-33  Score=292.47  Aligned_cols=213  Identities=29%  Similarity=0.431  Sum_probs=179.1

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEE
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGY  499 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~  499 (656)
                      .......++|++.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|+.++.++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34444567899999999999999999963      346789999997653 33456789999999999 79999999999


Q ss_pred             EeeCC-ceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCC
Q 006211          500 CTERD-ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA  565 (656)
Q Consensus       500 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp  565 (656)
                      +...+ ..++||||+++++|..++.....             +..+++..+..++.|+++||.|||+.+   ++||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence            87755 48999999999999999865332             123789999999999999999999987   99999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       566 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999999986654333333444567889999999998899999999999999999998 999997654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-33  Score=287.16  Aligned_cols=198  Identities=26%  Similarity=0.400  Sum_probs=164.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEeeC----CceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCTER----DENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~  507 (656)
                      .++|++.+.||+|+||+||+|.. +++.||||++....   .+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46789999999999999999987 78899999986542   3445566676666  7999999999987543    4578


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecccCCCCEEEcCCCcEEEE
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--------EYSNFRVIHRDLKASNILLDNELNPKIS  579 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~iiH~Dikp~NILl~~~~~~kl~  579 (656)
                      +||||+++|+|.+++.    ...+++..+..++.|+++||.|||        +.+   ++||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999983    345899999999999999999999        655   9999999999999999999999


Q ss_pred             eccCccccccCcccc--ccccccccccccccccccCC------CCCccchhHHHHHHHHHHHcC----------CCCCCC
Q 006211          580 DFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISS----------KRNARY  641 (656)
Q Consensus       580 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslGvil~elltg----------~~p~~~  641 (656)
                      |||+++.........  ......||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997654432211  12234789999999998776      456799999999999999999          788754


Q ss_pred             C
Q 006211          642 Y  642 (656)
Q Consensus       642 ~  642 (656)
                      .
T Consensus       236 ~  236 (301)
T 3q4u_A          236 V  236 (301)
T ss_dssp             T
T ss_pred             c
Confidence            3

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.7e-33  Score=293.58  Aligned_cols=206  Identities=23%  Similarity=0.406  Sum_probs=176.6

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhc-CCCceeeEE
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--------QGLEEFKNEVSLTARL-QHVNLLRVL  497 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~  497 (656)
                      .......++|++.+.||+|+||.||+|... +|+.||||+++....        ...+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999764 699999999875431        1245678899999999 799999999


Q ss_pred             EEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       498 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                      +++......++||||+++++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999998853   345899999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccC------CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK------GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      |+|||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||...
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            99999998764322   2234578999999998853      35788999999999999999999999653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.3e-33  Score=285.05  Aligned_cols=204  Identities=21%  Similarity=0.338  Sum_probs=162.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999996532    4579999987643 344567899999999999999999999985 567899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999998542  345899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .... .......+++.|+|||.+....++.++|||||||++|||++ |+.||.....
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~  223 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  223 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence            3221 12223456788999999988899999999999999999996 9999976543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-33  Score=302.03  Aligned_cols=199  Identities=22%  Similarity=0.377  Sum_probs=165.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  505 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+++.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46799999999999999999965 46889999999764  334456789999999999999999999998766     56


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||++ ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 589888854   345899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccCccc--------------------cccccccccccccccccc-cCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          586 LFRKDVDE--------------------ANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       586 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76432211                    112446789999999986 5667999999999999999999865555

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-33  Score=286.25  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=169.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC-C-------CEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR-G-------QEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|.... +       ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568889999999999999995432 3       4799999987666667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc--------EE
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--------PK  577 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~--------~k  577 (656)
                      .++||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999998643  234889999999999999999999997   999999999999998887        99


Q ss_pred             EEeccCccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      |+|||++.....      .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+.
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence            999999965422      123467889999999887 678999999999999999999655553

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-33  Score=282.75  Aligned_cols=202  Identities=29%  Similarity=0.446  Sum_probs=175.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56788899999999999999888888999999976543 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            99999998542  345889999999999999999999987   9999999999999999999999999998653321 11


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  210 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence            2223456788999999988889999999999999999999 899986543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.8e-33  Score=283.94  Aligned_cols=202  Identities=26%  Similarity=0.388  Sum_probs=175.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357888999999999999999664 5789999998654   234456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++..   ...+++.++..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999988743   345899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  219 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  219 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            22  12233578999999999998889999999999999999999999997543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-33  Score=294.24  Aligned_cols=208  Identities=29%  Similarity=0.412  Sum_probs=176.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD  504 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  504 (656)
                      ..++|++.+.||+|+||.||+|....      ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35678899999999999999996532      2479999997653 34456789999999999 8999999999999999


Q ss_pred             ceEEEEEecCCCChhhhhhCCC-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE  573 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~  573 (656)
                      ..++||||+++|+|.+++....           ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            9999999999999999885421           1335789999999999999999999987   9999999999999999


Q ss_pred             CcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          574 LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       574 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999986654333333334567889999999988889999999999999999999 888986543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-33  Score=296.13  Aligned_cols=203  Identities=17%  Similarity=0.202  Sum_probs=166.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC------CCEEEEEEccCCChhhH-----------HHHHHHHHHHHhcCCCceeeE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATSTQGL-----------EEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l  496 (656)
                      .++|++.+.||+|+||.||+|....      ++.||||++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999997644      47899999876542211           123445667778899999999


Q ss_pred             EEEEeeC----CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-
Q 006211          497 LGYCTER----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-  571 (656)
Q Consensus       497 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-  571 (656)
                      ++++...    ...++||||+ +++|..++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998765    4479999999 99999988542  345899999999999999999999997   99999999999999 


Q ss_pred             -CCCcEEEEeccCccccccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          572 -NELNPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       572 -~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .++.+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence             8899999999999876432211     1113346999999999999999999999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.6e-33  Score=290.30  Aligned_cols=202  Identities=26%  Similarity=0.388  Sum_probs=176.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999654 5789999998654   234456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++..   ...+++.++..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999988743   345899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  245 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  245 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence            22  22234578999999999998889999999999999999999999997543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-33  Score=301.00  Aligned_cols=202  Identities=22%  Similarity=0.331  Sum_probs=163.1

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE  502 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  502 (656)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4568899999999999999999954 568999999986532        1112347899999999999999999999754


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---cEEEE
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS  579 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~~kl~  579 (656)
                       ...++||||+++|+|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             567999999999999888743   345899999999999999999999987   99999999999997554   59999


Q ss_pred             eccCccccccCcccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |||+++.....   .......||+.|+|||++.   ...++.++|||||||++|||++|+.||....
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            99999875432   2223457899999999885   3668889999999999999999999997543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-33  Score=284.12  Aligned_cols=200  Identities=29%  Similarity=0.439  Sum_probs=171.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|.. .++..||+|++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            35688899999999999999955 457799999986532   22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++..   ...+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999988853   245899999999999999999999987   99999999999999999999999999865432


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  211 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  211 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence            2    2233478999999999999899999999999999999999999997544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.4e-33  Score=283.60  Aligned_cols=202  Identities=27%  Similarity=0.412  Sum_probs=170.6

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      |.....||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            44556899999999999964 56889999999876666667889999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-CCcEEEEeccCccccccCcccc
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      ++|..++........+++..+..++.|+++||.|||+.+   ++||||||+||+++. ++.+||+|||++.......  .
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~  178 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--P  178 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--C
Confidence            999999865444445778999999999999999999987   999999999999997 8899999999998654321  1


Q ss_pred             ccccccccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||...+
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            223456899999999987643  7899999999999999999999996543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.3e-33  Score=283.68  Aligned_cols=200  Identities=26%  Similarity=0.411  Sum_probs=176.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35688899999999999999964 568899999987553 3446788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999884    345899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence              2223457899999999999999999999999999999999999999654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.3e-33  Score=281.92  Aligned_cols=201  Identities=24%  Similarity=0.380  Sum_probs=172.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||++... +++.||+|+++....      ...+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356889999999999999999665 689999999875421      1357789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEecc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG  582 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfG  582 (656)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999998853   345899999999999999999999987   99999999999999877    79999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.......   ......+++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  215 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET  215 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence            998654322   1223468999999999998899999999999999999999999997543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=293.33  Aligned_cols=206  Identities=28%  Similarity=0.460  Sum_probs=165.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .++|++.+.||+|+||.||+|.. .+++    .|++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            35788999999999999999964 3444    3578877543 3345678899999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|+|++++|+|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999988643  345899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      .............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  226 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            54333333333456788999999999999999999999999999999 99999765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-33  Score=293.45  Aligned_cols=202  Identities=25%  Similarity=0.372  Sum_probs=163.6

Q ss_pred             HhcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ..++|++.+.||+|+||+||+|. ..+++.||||+++.....  ..+.+.+|+.++++++||||+++++++......++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            45679999999999999999995 457889999999755322  245678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-----CCCcEEEEeccCc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-----NELNPKISDFGMA  584 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-----~~~~~kl~DfGla  584 (656)
                      |||++ ++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++     .++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99997 488888743   335899999999999999999999987   99999999999994     4556999999999


Q ss_pred             cccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +......  .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            8654321  222334679999999998764 48999999999999999999999996543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.8e-33  Score=286.77  Aligned_cols=201  Identities=24%  Similarity=0.379  Sum_probs=172.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ..++|++.+.||+|+||.||++.. .+++.||+|+++.......+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            346788999999999999999965 4689999999987654445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~~  588 (656)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999888743   335899999999999999999999987   9999999999999   788899999999997543


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..    ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  211 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET  211 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            21    2233468999999999999999999999999999999999999996543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-33  Score=294.88  Aligned_cols=197  Identities=23%  Similarity=0.364  Sum_probs=164.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788999999999999999965 56899999998653  3334567889999999999999999999997653      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++||||+ +++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899888743    35899999999999999999999997   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865321     223478999999999876 678999999999999999999999997544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-33  Score=289.33  Aligned_cols=201  Identities=24%  Similarity=0.361  Sum_probs=168.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888999999999999999654 58999999986543  2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999999887643   335899999999999999999999997   9999999999999999999999999997654322


Q ss_pred             cccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                        .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              122334689999999998765 68999999999999999999999997654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-34  Score=294.55  Aligned_cols=201  Identities=26%  Similarity=0.413  Sum_probs=163.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999664 68999999987543221 12355799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      ++ ++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 5787777542  335889999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             22223467999999999876 568999999999999999999999997654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-33  Score=290.60  Aligned_cols=202  Identities=29%  Similarity=0.438  Sum_probs=175.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT--ERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  507 (656)
                      ++|++.+.||+|+||.||+|..     .+++.||||++........+.+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999973     467899999998877777778999999999999999999999886  445688


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+++++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999998542  235899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          588 RKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            433221 122334678889999999988899999999999999999999999853

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-33  Score=294.63  Aligned_cols=200  Identities=25%  Similarity=0.337  Sum_probs=174.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357888999999999999999654 6899999998765 33445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |+++++|..++..   ...+++..+..++.+++++|.|||+. +   ++||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999854   23588999999999999999999986 5   999999999999999999999999999755321


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                2223478999999999999999999999999999999999999997544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-33  Score=281.23  Aligned_cols=200  Identities=27%  Similarity=0.556  Sum_probs=168.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhh-------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG-------LEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5688889999999999999965 578999999986543211       157889999999999999999999986544  


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc-----EEEEec
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDF  581 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~-----~kl~Df  581 (656)
                      ++||||+++++|..++...  ...+++..+..++.|+++||.|||+.+ .+++||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999998887653  345899999999999999999999875 24999999999999988776     999999


Q ss_pred             cCccccccCccccccccccccccccccccc--cCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      |+++....     ......||+.|+|||.+  ....++.++|||||||++|||++|+.||.....
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            99975332     22335789999999998  445678999999999999999999999976543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.3e-33  Score=286.78  Aligned_cols=201  Identities=29%  Similarity=0.471  Sum_probs=170.1

Q ss_pred             cCCCCCCcccccCceEEEEEE-----eCCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN  506 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  506 (656)
                      +.|++.+.||+|+||.||+|.     ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            457888999999999999997     3468899999987543 33457789999999999999999999999876  668


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999998542  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            6543221 22334467888999999998889999999999999999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-33  Score=308.10  Aligned_cols=202  Identities=29%  Similarity=0.450  Sum_probs=171.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-------------hhHHHHHHHHHHHHhcCCCceeeEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-------------QGLEEFKNEVSLTARLQHVNLLRVLG  498 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  498 (656)
                      ..++|++.++||+|+||+||+|.. .+++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            467899999999999999999965 4588999999875421             23467889999999999999999999


Q ss_pred             EEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC---c
Q 006211          499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---N  575 (656)
Q Consensus       499 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~---~  575 (656)
                      ++.+....++||||+++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999888753   345899999999999999999999987   99999999999999776   6


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      +||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.....
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999998764332   223457899999999987 4689999999999999999999999976543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.7e-33  Score=287.29  Aligned_cols=210  Identities=26%  Similarity=0.418  Sum_probs=164.1

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      ...++|.+.+.||+|+||.||+|...    .+..||+|+++..  .....+.+.+|+.++++++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34567888999999999999999543    3448999998754  33445678999999999999999999999977553


Q ss_pred             -----eEEEEEecCCCChhhhhhCC---CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEE
Q 006211          506 -----NMLIYEYLPNKSLDLYLFDP---IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK  577 (656)
Q Consensus       506 -----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~k  577 (656)
                           .++||||+++++|..++...   .....+++..++.++.|+++||.|||+.+   ++||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                 49999999999999988432   22346899999999999999999999987   99999999999999999999


Q ss_pred             EEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  255 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN  255 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence            999999986644322222233456789999999999999999999999999999999 8888866543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.7e-33  Score=282.31  Aligned_cols=203  Identities=31%  Similarity=0.504  Sum_probs=173.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            45788899999999999999988888899999987653 33567899999999999999999999886 45689999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++++|.+++... ....+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||++........ 
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            999999998542 1225899999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  215 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence            12223456788999999988889999999999999999999 899986544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-33  Score=282.03  Aligned_cols=204  Identities=27%  Similarity=0.451  Sum_probs=172.0

Q ss_pred             cCCCCCC-cccccCceEEEEEEe---CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSAN-KLGEGGFGPVYKGNL---PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~-~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|.+.+ .||+|+||.||+|..   .++..||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455665 899999999999964   357789999998753 34566789999999999999999999999 45678999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999998542  345899999999999999999999987   99999999999999999999999999987643


Q ss_pred             Cccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          590 DVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       590 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            3221 12223456789999999988889999999999999999998 9999976543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.3e-33  Score=304.76  Aligned_cols=201  Identities=27%  Similarity=0.441  Sum_probs=172.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            456799999999999999999965 46899999998643  223456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc---CCCcEEEEeccCccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKL  586 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~---~~~~~kl~DfGla~~  586 (656)
                      |||+++++|...+..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999888743   345899999999999999999999997   99999999999995   456799999999986


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            54322   2234578999999999875 58999999999999999999999996544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.7e-33  Score=285.63  Aligned_cols=203  Identities=21%  Similarity=0.277  Sum_probs=165.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            357899999999999999999965 468899999987542   2334678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+||+++++|..++..   ...+++..+..++.|++++|.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999998853   245899999999999999999999987   9999999999999999999999999997654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            321 12223456899999999999989999999999999999999999999653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.3e-33  Score=292.50  Aligned_cols=209  Identities=25%  Similarity=0.336  Sum_probs=169.4

Q ss_pred             CHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh-----------hhHHHHHHHHHHHHhcCCCcee
Q 006211          426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-----------QGLEEFKNEVSLTARLQHVNLL  494 (656)
Q Consensus       426 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv  494 (656)
                      ...++....++|++.+.||+|+||.||+|...+++.||||++.....           ...+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677788899999999999999999999888899999999854321           2236789999999999999999


Q ss_pred             eEEEEEeeC-----CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEE
Q 006211          495 RVLGYCTER-----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       495 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NIL  569 (656)
                      ++++++...     ...++||||++ |+|..++..  ....+++..+..++.|++.||.|||+.+   ++||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998543     35799999998 577777654  2345899999999999999999999997   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.++.+||+|||+++.....   .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999754332   12233578899999998876 678999999999999999999999997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-33  Score=307.09  Aligned_cols=201  Identities=27%  Similarity=0.424  Sum_probs=169.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ..++|++.+.||+|+||+||+|.. .++..||+|++....  ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            455799999999999999999965 468899999987642  23356788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEEeccCccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKL  586 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~DfGla~~  586 (656)
                      |||+++|+|...+..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999887743   345899999999999999999999987   9999999999999764   4599999999987


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  241 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT  241 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            64322   223457999999999876 468999999999999999999999997544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-33  Score=285.27  Aligned_cols=206  Identities=28%  Similarity=0.434  Sum_probs=177.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ..++|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3567888999999999999999664 47889999997643 345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+++++|..++... ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999998543 2345899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      . .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~  218 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  218 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            2 22233466788999999998899999999999999999999 9999876443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.5e-33  Score=287.25  Aligned_cols=209  Identities=22%  Similarity=0.336  Sum_probs=175.0

Q ss_pred             HHHHHHhcCCCCC-CcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcC-CCceeeEEEEEee
Q 006211          428 SDIKAATNNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTE  502 (656)
Q Consensus       428 ~~~~~~~~~y~~~-~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  502 (656)
                      .......+.|.+. +.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.++..++ ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3445566678877 8899999999999965 468999999987542  334567899999999995 6999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEE
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKIS  579 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~  579 (656)
                      ....++||||+++|+|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            99999999999999999887542 2346899999999999999999999987   999999999999998   7899999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |||+++......   ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998654322   2233578999999999999999999999999999999999999996544

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.1e-33  Score=305.62  Aligned_cols=201  Identities=28%  Similarity=0.432  Sum_probs=174.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467899999999999999999654 78999999986542   3346778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCcc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAK  585 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~  585 (656)
                      ||||+.+++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999888854   345899999999999999999999997   9999999999999   567899999999998


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+....   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  231 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN  231 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence            664322   2233578999999999876 68999999999999999999999997644

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-33  Score=290.92  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=165.6

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDE  505 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  505 (656)
                      ...++|++.+.||+|+||.||+|... +++.||||++......     ..+.+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            44578999999999999999999764 5899999998754221     12367899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++ +|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 787777542  345788899999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+....  .......+|+.|+|||.+.+ ..++.++|||||||++|||++|++||....
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~  217 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  217 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            654322  22234578999999999865 458999999999999999999999986543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.3e-33  Score=292.46  Aligned_cols=198  Identities=23%  Similarity=0.295  Sum_probs=161.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35788999999999999999954 46889999998754  3344567889999999999999999999997665      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++||||+++ +|...+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6766663     24889999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865432   12233578999999999999899999999999999999999999997543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-33  Score=295.08  Aligned_cols=197  Identities=24%  Similarity=0.367  Sum_probs=154.2

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------C
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------D  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  504 (656)
                      .++|++.+.||+|+||.||+|. ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4689999999999999999995 456889999998654  334456788999999999999999999998654      5


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++|+|++ +++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999998 6888877732    45899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            764321     223478999999999876 678999999999999999999999997654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.1e-33  Score=288.37  Aligned_cols=207  Identities=29%  Similarity=0.452  Sum_probs=170.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||+|..      .++..||||++... ......++.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999963      35678999999754 334456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~  579 (656)
                      ++||||+++++|..++.....    ...+++..++.++.|+++||.|||+.+   ++||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999864321    245899999999999999999999987   999999999999994   4469999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      |||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  250 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  250 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence            9999976543332233334567889999999988889999999999999999998 889986543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.9e-33  Score=281.88  Aligned_cols=199  Identities=27%  Similarity=0.422  Sum_probs=173.4

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999654 57789999986532   223457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999988853   235899999999999999999999987   999999999999999999999999999754322


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  216 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS  216 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence                1223578999999999999899999999999999999999999997543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.8e-34  Score=302.09  Aligned_cols=202  Identities=16%  Similarity=0.254  Sum_probs=160.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHH---HHHHhcCCCceeeEE-------EE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEV---SLTARLQHVNLLRVL-------GY  499 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  499 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678889999999999999975 56899999998743   334557788999   455556899999998       66


Q ss_pred             EeeCC-----------------ceEEEEEecCCCChhhhhhCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 006211          500 CTERD-----------------ENMLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV  558 (656)
Q Consensus       500 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i  558 (656)
                      +...+                 ..++||||+ +|+|.+++.....    ...+++..+..++.|+++||.|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            66553                 278999999 6899998854211    112345888899999999999999997   9


Q ss_pred             EecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCC-----------CCCccchhHHHHH
Q 006211          559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-----------IYSMKYDVYSFGV  627 (656)
Q Consensus       559 iH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwslGv  627 (656)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2223467 999999999877           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCc
Q 006211          628 LLLQIISSKRNARYYGTS  645 (656)
Q Consensus       628 il~elltg~~p~~~~~~~  645 (656)
                      ++|||++|+.||......
T Consensus       302 il~elltg~~Pf~~~~~~  319 (377)
T 3byv_A          302 VIYWIWCADLPITKDAAL  319 (377)
T ss_dssp             HHHHHHHSSCCC------
T ss_pred             HHHHHHHCCCCCcccccc
Confidence            999999999999765443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.5e-33  Score=291.13  Aligned_cols=203  Identities=22%  Similarity=0.389  Sum_probs=169.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--------
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--------  503 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  503 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.....  .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788999999999999999965 5789999999865432  2245678999999999999999999999773        


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      +..++||||+++ +|...+...  ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            457999999985 666665443  235899999999999999999999997   99999999999999999999999999


Q ss_pred             ccccccCc--cccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDV--DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.+....  .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  233 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  233 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            98654321  1122234578999999998875 558999999999999999999999997644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.9e-33  Score=285.56  Aligned_cols=203  Identities=25%  Similarity=0.421  Sum_probs=170.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467889999999999999999764 5889999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999887542  345899999999999999999999987   999999999999999999999999998643221  


Q ss_pred             ccccccccccccccccccc-----cCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ........|++.|+|||.+     ....++.++||||||+++|||++|+.||....
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            1112234689999999988     46678999999999999999999999997543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-32  Score=285.37  Aligned_cols=198  Identities=30%  Similarity=0.437  Sum_probs=169.1

Q ss_pred             CCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEE
Q 006211          437 FSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML  508 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  508 (656)
                      |++.+.||+|+||.||++..     .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            47889999999999998853     357889999997653 34456789999999999999999999999874  56799


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++..    ..+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999997   9999999999999999999999999998765


Q ss_pred             cCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            43221 122334578889999999988899999999999999999999999854

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-32  Score=277.66  Aligned_cols=199  Identities=23%  Similarity=0.380  Sum_probs=170.0

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|.. +++.||||++....  ....+.+.+|+.++++++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4688889999999999999987 48899999987653  34456789999999999999999999999877  7789999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++|+|.+++.... ...+++..+..++.|+++||.|||+.+ .+++||||||+||+++.++.++|+|||++..... 
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            9999999999996532 235899999999999999999999864 3499999999999999999999999998754221 


Q ss_pred             ccccccccccccccccccccccCCCCCc---cchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSM---KYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvwslGvil~elltg~~p~~~~~  643 (656)
                            ....+|+.|+|||.+.+..++.   ++|||||||++|||++|+.||....
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence                  2246789999999998765544   7999999999999999999997543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.8e-33  Score=295.88  Aligned_cols=200  Identities=20%  Similarity=0.323  Sum_probs=164.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc------eE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------NM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  507 (656)
                      ..+|++.+.||+|+||.||+|....+..+|+|++......    ..+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3468899999999999999998877777999987654322    2469999999999999999999865433      78


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKL  586 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~  586 (656)
                      +||||++++.+............+++..+..++.|+++||.|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655444322223456899999999999999999999987   99999999999999 789999999999987


Q ss_pred             cccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            643322   2234679999999988654 58999999999999999999999997644

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-33  Score=311.69  Aligned_cols=203  Identities=26%  Similarity=0.440  Sum_probs=174.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||.||+|....+..||||+++... ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45678889999999999999998888889999997653 335678999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|.+++... ....+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus       344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            999999998532 2235889999999999999999999987   9999999999999999999999999998654321 1


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      .......++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11222356788999999998899999999999999999999 899997644

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-32  Score=284.41  Aligned_cols=204  Identities=22%  Similarity=0.363  Sum_probs=164.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688999999999999999965 57899999998753   334456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          510 YEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |||+++++|..++.... ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999998885421 2345899999999999999999999987   9999999999999999999999999997654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            322  1222346899999999999989999999999999999999999999643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=291.26  Aligned_cols=201  Identities=18%  Similarity=0.218  Sum_probs=164.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC----CCCEEEEEEccCCChh-----------hHHHHHHHHHHHHhcCCCceeeEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQ-----------GLEEFKNEVSLTARLQHVNLLRVLG  498 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  498 (656)
                      .++|++.+.||+|+||.||+|...    .+..+|||+.......           ..+.+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357889999999999999999764    5778999998765321           1123667888999999999999999


Q ss_pred             EEee----CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC
Q 006211          499 YCTE----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL  574 (656)
Q Consensus       499 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~  574 (656)
                      ++..    ....++||||+ +++|..++...   ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67889999999 99999988542   26899999999999999999999987   99999999999999887


Q ss_pred             --cEEEEeccCccccccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          575 --NPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       575 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              9999999999876432211     112345789999999999998999999999999999999999999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=1.3e-32  Score=286.55  Aligned_cols=204  Identities=27%  Similarity=0.483  Sum_probs=166.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|+||.||+|....     +..||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999996532     2359999997653 3445578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999998542  345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             cCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ..... .......+|+.|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  255 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS  255 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence            33211 11222345778999999998899999999999999999999 999996543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.98  E-value=3.6e-33  Score=313.47  Aligned_cols=198  Identities=27%  Similarity=0.444  Sum_probs=164.9

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCCCC
Q 006211          442 KLGEGGFGPVYKGNLP---RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS  517 (656)
Q Consensus       442 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  517 (656)
                      .||+|+||.||+|...   ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999653   45679999997653 3456789999999999999999999999976 56899999999999


Q ss_pred             hhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc-ccc
Q 006211          518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANT  596 (656)
Q Consensus       518 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~  596 (656)
                      |..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ...
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99998543  345899999999999999999999987   999999999999999999999999999876432211 112


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      ....+++.|+|||++....++.++|||||||++|||++ |+.||......
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~  546 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP  546 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            22345688999999998999999999999999999998 99999765543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.98  E-value=1.3e-32  Score=279.42  Aligned_cols=204  Identities=24%  Similarity=0.381  Sum_probs=169.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||.||+|....    +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3568888999999999999996432    236999998765 33455678999999999999999999999865 45789


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999998542  345899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~  220 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN  220 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred             cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence            3221 12223456788999999988889999999999999999998 9999965443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.98  E-value=2.5e-32  Score=284.04  Aligned_cols=193  Identities=20%  Similarity=0.376  Sum_probs=168.0

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEee--CCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTE--RDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|. ..+++.||||+++...   .+.+.+|+.++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            3678899999999999999995 4678999999997543   356889999999997 9999999999987  5678999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFR  588 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~  588 (656)
                      |||+++++|..++.      .+++..+..++.|+++||.|||+.+   ++||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999988873      2788999999999999999999987   99999999999999776 89999999998654


Q ss_pred             cCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            332   2233478899999999876 6789999999999999999999999953

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.98  E-value=1.1e-32  Score=290.98  Aligned_cols=203  Identities=23%  Similarity=0.347  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  506 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45789999999999999999964 468899999997543 33446789999999999999999999999765     367


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|+|+++ ++|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 588877742    35899999999999999999999997   99999999999999999999999999986


Q ss_pred             cccCcccc-ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          587 FRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  237 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  237 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence            64332211 1234578999999998654 5589999999999999999999999976543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=7.4e-33  Score=288.61  Aligned_cols=207  Identities=24%  Similarity=0.295  Sum_probs=158.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEe--------eC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCT--------ER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~  503 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45788999999999999999965 578999999987766666778899999999996 999999999984        33


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ...++|+||+. |+|.+++........+++..+..++.|++.||.|||+.+ .+++||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            44789999996 788887754334456999999999999999999999874 2499999999999999999999999999


Q ss_pred             ccccccCcccc----------ccccccccccccccccc---cCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          584 AKLFRKDVDEA----------NTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       584 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||...
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            98654322111          11134689999999998   5667899999999999999999999999653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=3e-32  Score=279.01  Aligned_cols=200  Identities=27%  Similarity=0.394  Sum_probs=167.4

Q ss_pred             CCCCCCcccccCceEEEEEEeC-CC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce-EEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP-RG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN-MLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  509 (656)
                      .|+..+.||+|+||.||+|... ++   ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3455688999999999999642 22   279999987643 34556789999999999999999999999876655 999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      +||+.+++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999998653  345789999999999999999999997   99999999999999999999999999986543


Q ss_pred             Cc--cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          590 DV--DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       590 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ..  .........+++.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence            22  1122233467889999999999999999999999999999999666653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.98  E-value=1.8e-32  Score=279.04  Aligned_cols=199  Identities=24%  Similarity=0.330  Sum_probs=168.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  508 (656)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567899999999999999999664 78999999987642  33455788899999999 99999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC--------------
Q 006211          509 IYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--------------  573 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~--------------  573 (656)
                      ||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999854321 245899999999999999999999987   9999999999999844              


Q ss_pred             -----CcEEEEeccCccccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          574 -----LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       574 -----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++|||||||++|||++|++|+.
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                 479999999998654321      23588999999998765 56789999999999999999988764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=1.6e-32  Score=277.94  Aligned_cols=200  Identities=23%  Similarity=0.411  Sum_probs=166.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888999999999999999764 68999999986532   23356788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999998853   235889999999999999999999998   99999999999999999999999999976543


Q ss_pred             CccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..   ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            21   1223468899999999987765 68999999999999999999999654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=7.4e-33  Score=292.47  Aligned_cols=203  Identities=24%  Similarity=0.391  Sum_probs=159.1

Q ss_pred             CCCCCCcccccCceEEEEEEeC--C--CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNLP--R--GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLI  509 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  509 (656)
                      .|+..+.||+|+||.||+|...  +  +..||+|.++... ....+++.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999653  2  2368999987543 3456789999999999999999999998754 4578999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999998643  335789999999999999999999987   99999999999999999999999999986543


Q ss_pred             Cccc--cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          590 DVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       590 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ....  .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||....
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            2211  11223456788999999999999999999999999999999 666665443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=9.9e-33  Score=280.45  Aligned_cols=197  Identities=28%  Similarity=0.486  Sum_probs=170.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee---------
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE---------  502 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  502 (656)
                      ...+|++.+.||+|+||.||+|... +++.||+|++.....    .+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567899999999999999999764 789999999976543    45789999999999999999998854         


Q ss_pred             -------CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc
Q 006211          503 -------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN  575 (656)
Q Consensus       503 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~  575 (656)
                             ....++||||+++++|..++... ....+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34578999999999999998543 2346899999999999999999999987   999999999999999999


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      +||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999999998764332   1223468999999999999899999999999999999999998873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.98  E-value=1e-32  Score=285.18  Aligned_cols=205  Identities=25%  Similarity=0.364  Sum_probs=171.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  508 (656)
                      .++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46789999999999999999965 6789999999877666667789999999999999999999999863    346789


Q ss_pred             EEEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          509 IYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      |+||+++++|..++... .....+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999888542 12356899999999999999999999997   999999999999999999999999998754


Q ss_pred             ccCcccc-------ccccccccccccccccccCCC---CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          588 RKDVDEA-------NTGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       588 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .......       ......||+.|+|||.+....   ++.++|||||||++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            3211110       112245789999999987544   68899999999999999999999854

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.98  E-value=5.5e-33  Score=281.73  Aligned_cols=208  Identities=25%  Similarity=0.396  Sum_probs=171.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  508 (656)
                      .++|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35788899999999999999965 46899999998754  33445678999999999999999999998754  567899


Q ss_pred             EEEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          509 IYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      ||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+  ..+++||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999885422 2345899999999999999999999976  2349999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            654321  11223468899999999998889999999999999999999999997654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=8.4e-33  Score=297.09  Aligned_cols=198  Identities=22%  Similarity=0.349  Sum_probs=160.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------CceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  507 (656)
                      .+|+..+.||+|+||.||+|... +++.||||++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999764 689999999865432    234699999999999999999988542      1357


Q ss_pred             EEEEecCCCChhhhhhC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEeccCcc
Q 006211          508 LIYEYLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAK  585 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfGla~  585 (656)
                      +||||+++ ++...+.. ......+++..+..++.|+++||.|||+.+   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 44444322 123456899999999999999999999987   9999999999999965 568999999998


Q ss_pred             ccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~  261 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  261 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            6543221   2234789999999998664 78999999999999999999999997543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.98  E-value=3.1e-32  Score=281.26  Aligned_cols=202  Identities=28%  Similarity=0.438  Sum_probs=170.4

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+.++..++||||+++++++......++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34568999999999999999999654 58999999997643  2356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++..  ....+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998852  2345899999999999999999999987   999999999999999999999999999765432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            2  1223346899999999999989999999999999999999999999654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.98  E-value=9.9e-33  Score=286.64  Aligned_cols=202  Identities=31%  Similarity=0.495  Sum_probs=173.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-----CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--EN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  506 (656)
                      .++|++.+.||+|+||.||++..     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999973     468899999998776666778999999999999999999999987654  68


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++++|.+++...  ...+++.++..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999998543  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          587 FRKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            65432211 1223356778999999988889999999999999999999998875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.98  E-value=1.7e-32  Score=280.43  Aligned_cols=205  Identities=22%  Similarity=0.307  Sum_probs=168.2

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE-eeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC-TERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  510 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......  +.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999964 67889999987654322  3478899999999988877766655 6667789999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCcccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLF  587 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~  587 (656)
                      ||+ +++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999988532  335899999999999999999999997   9999999999999   78899999999999876


Q ss_pred             ccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          588 RKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       588 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence            543221     1223457899999999999999999999999999999999999999765443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.98  E-value=2.2e-32  Score=280.21  Aligned_cols=202  Identities=25%  Similarity=0.386  Sum_probs=166.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCT-ERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l  508 (656)
                      .+|++.+.||+|+||.||+|...+    ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999996532    2358999987643 345567899999999999999999999865 4557899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999998642  345789999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCccc--cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcC-CCCCCC
Q 006211          589 KDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARY  641 (656)
Q Consensus       589 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg-~~p~~~  641 (656)
                      .....  .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            32211  122234567889999999988999999999999999999995 445543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.98  E-value=2.9e-32  Score=280.15  Aligned_cols=206  Identities=23%  Similarity=0.298  Sum_probs=168.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCT--ERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~  505 (656)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....    ....+.+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            347899999999999999999965 468899999987542    234567899999999999999999999984  4557


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||++++ |..++... ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999877 55555432 2346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccCCC--CCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...............|++.|+|||.+.+..  ++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN  217 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence            764332222333456899999999987644  4789999999999999999999997543

>4ac1_X Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, glycoside hydrolase family 18, deglycosylation; HET: NAG; 1.30A {Hypocrea jecorina}

Probab=99.98  E-value=4.6e-32  Score=271.61  Aligned_cols=201  Identities=14%  Similarity=0.213  Sum_probs=146.7

Q ss_pred             eEEEEEecCCCCC--------CCCCCCCCCccEEEEEEEEecCCCcEEecCC--cchhhHHHH---HHHHHhhCCCceEE
Q 006211           27 WIKAGYWLAGREF--------PLSDINSALFTHLICAFAEVDSSTYQLSISS--ANQQYFSIF---ANSVRRKNPSIKTL   93 (656)
Q Consensus        27 ~~~~~y~~~~~~~--------~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~--~~~~~~~~~---~~~~k~~~~~~kvl   93 (656)
                      +++++||+.|+..        ++..+|...||||+|||+++++++. +...+  +++..+...   ++++|  ++++|||
T Consensus         3 pR~i~Yy~t~~~~~~~~~~~~p~~~~p~~~~THi~~af~~~~~~g~-i~~~d~~p~~~~~~~l~~~i~~~q--~~g~Kvl   79 (283)
T 4ac1_X            3 PRLIVYFQTTHDSSNRPISMLPLITEKGIALTHLIVCSFHINQGGV-VHLNDFPPDDPHFYTLWNETITMK--QAGVKVM   79 (283)
T ss_dssp             SEEEEEECCCBCTTSCBCCSTHHHHSSSCCCCEEEEEEEECCTTSC-CEETTBCTTSGGGHHHHHHHHHHH--HTTCEEE
T ss_pred             CeEEEEEeccccCCCCccccCCcccCCCCCccEEEEEEEEECCCCe-EEECCCCccchHHHHHHHHHHHHH--cCCCEEE
Confidence            5789999887532        2344677889999999999998864 33322  233333333   33344  4579999


Q ss_pred             EEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhc
Q 006211           94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASA  173 (656)
Q Consensus        94 ~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l  173 (656)
                      ||||||+.+.+           ..++...++++.|++|++++++++++|+|||||||||||..  .+++..|+++||+.+
T Consensus        80 lsiGG~~~g~~-----------~~~~~~~~~~~~~~~f~~~~~~~~~~~~~dG~D~d~e~~~~--~~~~~~li~~Lr~~~  146 (283)
T 4ac1_X           80 GMVGGAAPGSF-----------NTQTLDSPDSATFEHYYGQLRDAIVNFQLEGMDLDVEQPMS--QQGIDRLIARLRADF  146 (283)
T ss_dssp             EEEETTSSCSS-----------STTTTTCSSHHHHHHHHHHHHHHHHHTTCSEEEEECCSCBC--HHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCCCC-----------cccccccccHHHHHHHHHHHHHHHHHcCCCceEeecccCCC--HHHHHHHHHHHHHHc
Confidence            99977654332           12567778889999999999999999999999999999964  578999999999999


Q ss_pred             CCCCCcEEEEEeecCCC---ccccccChhh----hhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHH
Q 006211          174 SDQPELTLSMAVRYSPT---HETVSYPIDS----MKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW  246 (656)
Q Consensus       174 ~~~~~~~ls~a~~~~~~---~~~~~~~~~~----l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~  246 (656)
                        ++++.||+|.++...   ....++++..    ...++||+|+|.||..+.+ .                 ...+++.+
T Consensus       147 --g~~~~lT~Ap~~~~~~~~~~~~~~~~~~l~~~~~~~~D~vnvQfYn~~~~~-~-----------------~~~~~~~~  206 (283)
T 4ac1_X          147 --GPDFLITLAPVASALEDSSNLSGFSYTALQQTQGNDIDWYNTQFYSGFGSM-A-----------------DTSDYDRI  206 (283)
T ss_dssp             --CTTSEEEECCBGGGGTTSCCSSBSCHHHHHHHHGGGCCEEEEECCTTSCCS-S-----------------SSHHHHHH
T ss_pred             --CCCceEEEccccccccccccccchhHHHHHHhhcccccEEEecCCCCCCCc-C-----------------CHHHHHHH
Confidence              457899998764321   1122344433    3567999999999986432 1                 12356788


Q ss_pred             HHcCCCCCceeecccCC
Q 006211          247 LRRGFPANKLVLGARAS  263 (656)
Q Consensus       247 ~~~g~p~~Kl~lG~p~y  263 (656)
                      +.+|+|++||+||+|..
T Consensus       207 ~~~g~p~~KivlGlpa~  223 (283)
T 4ac1_X          207 VANGFAPAKVVAGQLTT  223 (283)
T ss_dssp             HHTTCCGGGEEEEEESS
T ss_pred             HHhCCCcccEEEEeecC
Confidence            89999999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.98  E-value=1.6e-32  Score=284.60  Aligned_cols=202  Identities=23%  Similarity=0.333  Sum_probs=167.4

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--------QGLEEFKNEVSLTARLQHVNLLRVLGYCTER  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  503 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            456799999999999999999965 4578999999865321        1233578999999999999999999998765


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEe
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISD  580 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~D  580 (656)
                      . .++||||+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999888843   345899999999999999999999987   999999999999987665   99999


Q ss_pred             ccCccccccCcccccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ||+++.....   .......||+.|+|||++.   ...++.++|||||||++|||++|+.||.....
T Consensus       161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            9999865432   1122346899999999873   56688999999999999999999999975443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.98  E-value=3.5e-32  Score=278.59  Aligned_cols=202  Identities=24%  Similarity=0.390  Sum_probs=173.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---------hhhHHHHHHHHHHHHhcC-CCceeeEEEEEe
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---------TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCT  501 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  501 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||+++...         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            346788999999999999999966 468899999987543         122456789999999995 999999999999


Q ss_pred             eCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       502 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      .....++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999853   345899999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCcccccccccccccccccccccc------CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |++.......   ......+++.|+|||.+.      ...++.++||||||+++|||++|+.||....
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            9998654322   223346899999999885      4567899999999999999999999996543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=1.5e-32  Score=295.87  Aligned_cols=199  Identities=22%  Similarity=0.268  Sum_probs=169.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc------CCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------QHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  506 (656)
                      ..+|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45789999999999999999954 45889999999764 33345677888888877      577999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc--EEEEeccCc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMA  584 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~--~kl~DfGla  584 (656)
                      ++||||+. ++|..++.... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 57877775432 234899999999999999999999997   999999999999999887  999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            75432     1223478999999999999999999999999999999999999997654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=3e-32  Score=281.81  Aligned_cols=202  Identities=23%  Similarity=0.364  Sum_probs=164.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe-----------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT-----------  501 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  501 (656)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999665 48899999998777677788999999999999999999999873           


Q ss_pred             ---eCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEE
Q 006211          502 ---ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPK  577 (656)
Q Consensus       502 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~k  577 (656)
                         .....++||||++ |+|..++.    ...+++..+..++.|+++||.|||+.+   ++||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3457799999997 68988873    345889999999999999999999987   99999999999997 567999


Q ss_pred             EEeccCccccccCcc-ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       578 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |+|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            999999986543211 112233467889999998765 678999999999999999999999997544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.98  E-value=9e-33  Score=286.86  Aligned_cols=206  Identities=25%  Similarity=0.421  Sum_probs=168.0

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee------
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE------  502 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------  502 (656)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            34567899999999999999999965 5789999999876533 346788999999999 79999999999976      


Q ss_pred             CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      ....++||||+++++|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence            45789999999999999998643 2346889999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCcccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.......  .......|++.|+|||++.     ...++.++|||||||++|||++|+.||....
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            997654321  1223347899999999986     5668899999999999999999999996543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=1.3e-32  Score=292.38  Aligned_cols=201  Identities=22%  Similarity=0.330  Sum_probs=164.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-------
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-------  503 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  503 (656)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++......    ..+|+.+++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999954 67899999998654322    24699999999999999999998543       


Q ss_pred             -------------------------------CceEEEEEecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHH
Q 006211          504 -------------------------------DENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQ  551 (656)
Q Consensus       504 -------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh  551 (656)
                                                     ...++||||++ ++|...+... .....+++..+..++.|+++||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           33789999998 4776665431 22346899999999999999999999


Q ss_pred             hcCCCCcEecccCCCCEEEc-CCCcEEEEeccCccccccCccccccccccccccccccccccCC-CCCccchhHHHHHHH
Q 006211          552 EYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLL  629 (656)
Q Consensus       552 ~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil  629 (656)
                      +.+   |+||||||+|||++ .++.+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            987   99999999999998 688999999999986543322   2234679999999988764 489999999999999


Q ss_pred             HHHHcCCCCCCCCC
Q 006211          630 LQIISSKRNARYYG  643 (656)
Q Consensus       630 ~elltg~~p~~~~~  643 (656)
                      |||++|+.||....
T Consensus       233 ~ell~g~~pf~~~~  246 (383)
T 3eb0_A          233 GELILGKPLFSGET  246 (383)
T ss_dssp             HHHHHSSCSSCCSS
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997644

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.98  E-value=4.5e-32  Score=276.73  Aligned_cols=198  Identities=27%  Similarity=0.404  Sum_probs=167.5

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  508 (656)
                      .|++.+.||+|+||.||+|.. .++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            366778899999999999955 56889999998654  34456678999999999999999999998865    345799


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCcccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLF  587 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~  587 (656)
                      ||||+++++|..++..   ...+++..+..++.|+++||.|||+.+ .+++||||||+|||++ +++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999853   245889999999999999999999875 2499999999999998 7889999999999754


Q ss_pred             ccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...    ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||...
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            322    2223468999999998764 5899999999999999999999999653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=1.5e-32  Score=285.50  Aligned_cols=203  Identities=29%  Similarity=0.448  Sum_probs=168.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCCE--EEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQE--FAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||.||+|... ++..  +|+|+++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888999999999999999653 4554  4999887542 33445788999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      |||+++++|.+++....             ....+++..++.++.|+++||.|||+.+   ++||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986532             2346899999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999743221   11223356788999999988889999999999999999998 999996544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.98  E-value=4.7e-33  Score=285.63  Aligned_cols=208  Identities=25%  Similarity=0.410  Sum_probs=157.5

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            356899999999999999999964 468899999987543 234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-----CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          511 EYLPNKSLDLYLFDP-----IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      ||+++++|.+++...     .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999887531     12345899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCcc---ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDVD---EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......   ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  231 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP  231 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence            6543211   111233578999999999865 568999999999999999999999997643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.9e-32  Score=282.59  Aligned_cols=200  Identities=28%  Similarity=0.424  Sum_probs=161.7

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc--CCCceeeEEEEEeeC--
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL--QHVNLLRVLGYCTER--  503 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--  503 (656)
                      .......++|++.+.||+|+||.||+|... ++.||||++.....   .....|.+++..+  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            334456678999999999999999999874 89999999865422   3344555555554  899999999999887  


Q ss_pred             --CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecccCCCCEEEcCCCcE
Q 006211          504 --DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-----NFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       504 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~iiH~Dikp~NILl~~~~~~  576 (656)
                        ...++||||+++|+|..++..    ..+++..+..++.|++.||.|||+..     ..+++||||||+|||++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              678999999999999999843    35899999999999999999999871     1239999999999999999999


Q ss_pred             EEEeccCccccccCcccc--ccccccccccccccccccCCCCCcc------chhHHHHHHHHHHHcC
Q 006211          577 KISDFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKGIYSMK------YDVYSFGVLLLQIISS  635 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDvwslGvil~elltg  635 (656)
                      ||+|||+++.+.......  ......||+.|+|||++.+...+.+      +|||||||++|||++|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999997654332211  1224578999999999987766554      9999999999999999

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.98  E-value=3.6e-32  Score=278.14  Aligned_cols=203  Identities=22%  Similarity=0.308  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE-eeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC-TERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  +.+.+|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46789999999999999999965 67899999998765332  3578999999999988876666555 56677899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~~  588 (656)
                      |+ +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999988532  335899999999999999999999987   9999999999999   588899999999998765


Q ss_pred             cCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          589 KDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       589 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence            43221     112345789999999999999999999999999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.98  E-value=1.2e-32  Score=280.84  Aligned_cols=202  Identities=25%  Similarity=0.334  Sum_probs=156.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-h-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-Q-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++.... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999965 5788999999976522 2 2233455555678889999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       511 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||++ ++|..++... .....+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 4776666431 2345689999999999999999999997 7   9999999999999999999999999997654


Q ss_pred             cCccccccccccccccccccccc----cCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...   ......||+.|+|||.+    ....++.++|||||||++|||++|+.||...
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            322   22234689999999996    5567899999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.98  E-value=3.2e-32  Score=286.83  Aligned_cols=209  Identities=20%  Similarity=0.253  Sum_probs=158.8

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-  505 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  505 (656)
                      .......++|++.+.||+|+||.||+|.. .+++.||||++..... ......+++..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            44556778999999999999999999966 4689999998865432 22345678888899999999999999876443 


Q ss_pred             ------eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEecccCCCCEEEcC-CCcE
Q 006211          506 ------NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--EYSNFRVIHRDLKASNILLDN-ELNP  576 (656)
Q Consensus       506 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~~iiH~Dikp~NILl~~-~~~~  576 (656)
                            .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987543332221223456889999999999999999999  776   999999999999997 8999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence            999999998664332   22234689999999988654 48999999999999999999999997644

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.98  E-value=5.4e-32  Score=282.89  Aligned_cols=208  Identities=25%  Similarity=0.380  Sum_probs=173.1

Q ss_pred             ccCHHHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEe
Q 006211          424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCT  501 (656)
Q Consensus       424 ~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  501 (656)
                      ..++.......++|++.+.||+|+||.||+|.. +++.||||++...   ..+.+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            344445566778999999999999999999987 5899999998653   23567788888887  78999999999998


Q ss_pred             eCC----ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecccCCCCEE
Q 006211          502 ERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ--------EYSNFRVIHRDLKASNIL  569 (656)
Q Consensus       502 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~iiH~Dikp~NIL  569 (656)
                      ...    ..++||||+++|+|..++..    ..+++..+..++.|+++||.|||        +.+   ++||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            776    78999999999999999843    35889999999999999999999        555   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCcccc--ccccccccccccccccccCC------CCCccchhHHHHHHHHHHHcC------
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISS------  635 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslGvil~elltg------  635 (656)
                      ++.++.+||+|||++..........  ......||+.|+|||.+.+.      .++.++|||||||++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998665432211  22345789999999998765      334789999999999999999      


Q ss_pred             ----CCCCCCC
Q 006211          636 ----KRNARYY  642 (656)
Q Consensus       636 ----~~p~~~~  642 (656)
                          +.||...
T Consensus       260 ~~~~~~p~~~~  270 (342)
T 1b6c_B          260 HEDYQLPYYDL  270 (342)
T ss_dssp             CCCCCCTTTTT
T ss_pred             ccccccCcccc
Confidence                6777543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.98  E-value=1.8e-32  Score=287.31  Aligned_cols=202  Identities=26%  Similarity=0.428  Sum_probs=174.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChh-----------------hHHHHHHHHHHHHhcCCCceeeE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-----------------GLEEFKNEVSLTARLQHVNLLRV  496 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~l  496 (656)
                      .++|++.+.||+|+||.||+|.. +++.||||++......                 ..+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35788999999999999999988 8999999998653211                 11678999999999999999999


Q ss_pred             EEEEeeCCceEEEEEecCCCChhhh------hhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEE
Q 006211          497 LGYCTERDENMLIYEYLPNKSLDLY------LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNIL  569 (656)
Q Consensus       497 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NIL  569 (656)
                      ++++.+.+..++||||+++++|..+      +.. .....+++..+..++.|++.||.|||+ .+   ++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999988      432 124568999999999999999999998 76   999999999999


Q ss_pred             EcCCCcEEEEeccCccccccCccccccccccccccccccccccCC-CCCc-cchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSM-KYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       570 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      ++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||.....
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999865432    22335789999999999877 6666 99999999999999999999976543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.98  E-value=5.7e-33  Score=289.62  Aligned_cols=199  Identities=30%  Similarity=0.460  Sum_probs=157.9

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHH--HHhcCCCceeeEEEEEee-----CCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSL--TARLQHVNLLRVLGYCTE-----RDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~~  507 (656)
                      ++|++.+.||+|+||.||+|.. +++.||||++.....   ..+..|.++  +..++||||+++++.+..     ....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5788899999999999999976 689999999975432   333444444  455899999999986543     22568


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS------NFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                      +||||+++|+|..++..    ...++..+..++.|+++||.|||+..      ..+|+||||||+|||++.++.+||+||
T Consensus        89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            99999999999999843    23588999999999999999999981      113999999999999999999999999


Q ss_pred             cCccccccCcc------ccccccccccccccccccccC-------CCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          582 GMAKLFRKDVD------EANTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       582 Gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+..
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99986543211      112223478999999999876       4567889999999999999999887743

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=9.3e-33  Score=282.00  Aligned_cols=203  Identities=30%  Similarity=0.442  Sum_probs=168.4

Q ss_pred             hcCCCCCC-cccccCceEEEEEEe---CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          434 TNNFSSAN-KLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       434 ~~~y~~~~-~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      .++|++.+ .||+|+||.||+|..   ..++.||||+++...  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34677777 899999999999943   346789999987653  23356789999999999999999999999 567789


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999854   335899999999999999999999997   999999999999999999999999999876


Q ss_pred             ccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          588 RKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  225 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  225 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            4432211 1222345788999999988889999999999999999999 999997644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.2e-32  Score=291.38  Aligned_cols=198  Identities=13%  Similarity=0.140  Sum_probs=150.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhc--CCCceeeEE-------EEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARL--QHVNLLRVL-------GYCT  501 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  501 (656)
                      .+|+..+.||+|+||.||+|.. .+++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3578889999999999999975 4788999999987543   3345677885544444  699987754       4444


Q ss_pred             eC-----------------CceEEEEEecCCCChhhhhhCCCcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCc
Q 006211          502 ER-----------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR------VNIIEGVTQGLLYLQEYSNFRV  558 (656)
Q Consensus       502 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~~~~i  558 (656)
                      ..                 ...++||||++ ++|.+++.....  .+.+..+      ..++.|+++||.|||+.+   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            33                 23799999998 899999864322  2344455      678899999999999987   9


Q ss_pred             EecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCC
Q 006211          559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSK  636 (656)
Q Consensus       559 iH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~  636 (656)
                      +||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999865321     113456799999999987  67999999999999999999999


Q ss_pred             CCCCCCC
Q 006211          637 RNARYYG  643 (656)
Q Consensus       637 ~p~~~~~  643 (656)
                      .||....
T Consensus       291 ~Pf~~~~  297 (371)
T 3q60_A          291 LPFGLVT  297 (371)
T ss_dssp             CSTTBCC
T ss_pred             CCCCCcC
Confidence            9997663

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=292.83  Aligned_cols=203  Identities=24%  Similarity=0.396  Sum_probs=153.2

Q ss_pred             cCCCC-CCcccccCceEEEEEEeC---CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Q 006211          435 NNFSS-ANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENML  508 (656)
Q Consensus       435 ~~y~~-~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  508 (656)
                      +.|++ .++||+|+||.||+|...   +++.||||++.....  ...+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44655 468999999999999754   578999999976532  2467899999999999999999999954  667899


Q ss_pred             EEEecCCCChhhhhhCC------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE----cCCCcEEE
Q 006211          509 IYEYLPNKSLDLYLFDP------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKI  578 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl----~~~~~~kl  578 (656)
                      ||||+++ +|..++...      .....+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 666655321      11224899999999999999999999998   9999999999999    77889999


Q ss_pred             EeccCccccccCcc-ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          579 SDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       579 ~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +|||+++.+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999987643211 122334578999999999877 458999999999999999999999996543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=4.9e-32  Score=286.51  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=165.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN----  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  506 (656)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46788999999999999999964 56889999999764  233456788999999999999999999999877655    


Q ss_pred             --EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          507 --MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       507 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                        ++||||+. ++|..++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 57776662     23899999999999999999999997   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            764322     223468999999999877 678999999999999999999999997543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.2e-32  Score=289.15  Aligned_cols=200  Identities=17%  Similarity=0.193  Sum_probs=168.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC---------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceee---------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR---------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR---------  495 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  495 (656)
                      .++|++.+.||+|+||.||+|....         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3578899999999999999996653         789999998754     35688999999999999987         


Q ss_pred             ------EEEEEee-CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCE
Q 006211          496 ------VLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI  568 (656)
Q Consensus       496 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NI  568 (656)
                            +++++.. ....++||||+ +++|..++... ....+++..+..++.|+++||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777766 67889999999 99999998643 1346899999999999999999999997   99999999999


Q ss_pred             EEcCCC--cEEEEeccCccccccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          569 LLDNEL--NPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       569 Ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999866432211     112334789999999999998999999999999999999999999976


Q ss_pred             CC
Q 006211          642 YG  643 (656)
Q Consensus       642 ~~  643 (656)
                      ..
T Consensus       271 ~~  272 (352)
T 2jii_A          271 CL  272 (352)
T ss_dssp             GT
T ss_pred             CC
Confidence            54

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=1.6e-32  Score=308.97  Aligned_cols=197  Identities=30%  Similarity=0.451  Sum_probs=163.9

Q ss_pred             CcccccCceEEEEEEe---CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      +.||+|+||.||+|..   ..++.||||+++...  ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999944   246789999997643  3346789999999999999999999999964 568899999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc-c
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-A  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~-~  594 (656)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999853   345899999999999999999999987   999999999999999999999999999876443221 1


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      ......+|+.|+|||++....++.++|||||||++|||++ |+.||.....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  578 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  578 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            2223356788999999999999999999999999999998 9999976544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=7.6e-32  Score=293.11  Aligned_cols=203  Identities=23%  Similarity=0.310  Sum_probs=171.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.++||+|+||.||+|.. .+++.||||++......  ..+..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999964 57899999987654332  347889999999986 556666667777888899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---cCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---~~~~~~kl~DfGla~~~~  588 (656)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999988532  335899999999999999999999997   9999999999999   688899999999998765


Q ss_pred             cCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          589 KDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       589 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            43221     112246799999999999999999999999999999999999999976544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=1.5e-32  Score=278.48  Aligned_cols=199  Identities=30%  Similarity=0.445  Sum_probs=164.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-DENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||.||++.. +++.||||+++...  ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            35788899999999999999977 58899999997643  346789999999999999999999987654 478999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +++++|.+++... ....+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999988542 1223788999999999999999999987   999999999999999999999999999754322  


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  220 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  220 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence               112356789999999988889999999999999999998 9999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=4.6e-32  Score=289.39  Aligned_cols=200  Identities=22%  Similarity=0.254  Sum_probs=167.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC--------CCceeeEEEEEe---
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--------HVNLLRVLGYCT---  501 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  501 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46799999999999999999954 56889999999754 344567889999999985        788999999987   


Q ss_pred             -eCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCC-----
Q 006211          502 -ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNEL-----  574 (656)
Q Consensus       502 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~-----  574 (656)
                       .....++||||+. +++...+... ....+++..+..++.||++||.|||+. +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             4567899999994 5555554332 224589999999999999999999998 6   99999999999999775     


Q ss_pred             --------------------------------------------cEEEEeccCccccccCcccccccccccccccccccc
Q 006211          575 --------------------------------------------NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY  610 (656)
Q Consensus       575 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  610 (656)
                                                                  .+||+|||++......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999865432     223478999999999


Q ss_pred             ccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       611 ~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      +.+..++.++|||||||++|||++|+.||.....
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  298 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSG  298 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence            9999999999999999999999999999976543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=6e-32  Score=283.92  Aligned_cols=202  Identities=23%  Similarity=0.357  Sum_probs=168.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  506 (656)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467889999999999999999654 68899999997543 33455788999999999999999999988654     678


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+. ++|..++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 588877743    35899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCcccc--------ccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEA--------NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ........        ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            54321111        1223468999999998754 678999999999999999999999997543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=6.7e-32  Score=278.69  Aligned_cols=203  Identities=25%  Similarity=0.390  Sum_probs=167.3

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceE
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDENM  507 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~  507 (656)
                      ...++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++......+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            345678999999999999999998888999999998654  3445567899999999997  599999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||| +.+++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+|||+++ +.+||+|||+++..
T Consensus       105 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999 668899988854   345889999999999999999999987   999999999999975 78999999999876


Q ss_pred             ccCccccccccccccccccccccccC-----------CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .............|++.|+|||.+..           ..++.++||||||+++|||++|+.||...
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            54332222334578999999999865           46888999999999999999999999654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.1e-31  Score=273.35  Aligned_cols=203  Identities=27%  Similarity=0.436  Sum_probs=173.5

Q ss_pred             HHHhcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          431 KAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       431 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ....++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++++++||||+++++++......+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999664 6899999998654  2334677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC---CcEEEEeccCc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMA  584 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~---~~~kl~DfGla  584 (656)
                      +|+||+++++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999888753   235899999999999999999999987   9999999999999764   46999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......   ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||....
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN  226 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence            8654322   22234688999999988654 8999999999999999999999996543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=7e-32  Score=281.36  Aligned_cols=200  Identities=21%  Similarity=0.309  Sum_probs=171.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEe--CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc------eeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN------LLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|..  .+++.||||+++.. ....+.+.+|+.+++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            45789999999999999999965  46889999999754 344567888999999887654      9999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------------  572 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-------------  572 (656)
                      .++||||+ +++|.+++... ....+++..+..++.|+++||.|||+.+   ++||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88998887543 2235889999999999999999999987   999999999999987             


Q ss_pred             ------CCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          573 ------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       573 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                            ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  66899999999976432     12234789999999999998999999999999999999999999976544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=7.9e-32  Score=279.67  Aligned_cols=203  Identities=26%  Similarity=0.418  Sum_probs=168.0

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe--CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEe----
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCT----  501 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  501 (656)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            356899999999999999999976  4578999999864321  1123456677776666   8999999999987    


Q ss_pred             -eCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          502 -ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       502 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                       .....++||||++ ++|..++.... ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 68988875432 234899999999999999999999987   99999999999999999999999


Q ss_pred             ccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ||+++......   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  223 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99997654321   2234578999999999998899999999999999999999999997543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=281.44  Aligned_cols=196  Identities=24%  Similarity=0.374  Sum_probs=164.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  505 (656)
                      .++|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35688899999999999999965 46889999998764  23345678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          506 -NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       506 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                       .++||||++ ++|..++.     ..+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 57776652     24899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....     .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            764321     223468999999998876 678999999999999999999999997644

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=4.8e-32  Score=276.52  Aligned_cols=204  Identities=27%  Similarity=0.388  Sum_probs=162.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC--CCC--EEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP--RGQ--EFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||.||+|...  +++  .||||+++..   ..+..+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357889999999999999999642  333  6899988754   2344567899999999999999999999998654 8


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++|+||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999988542  235889999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  229 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  229 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence            6443221 12223456778999999988889999999999999999999 999996543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.4e-31  Score=277.98  Aligned_cols=201  Identities=24%  Similarity=0.392  Sum_probs=149.4

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+..+.||+|+||.||+|.. .+++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            5788899999999999999966 468899999997653 333345556665 6777899999999999999999999999


Q ss_pred             ecCCCChhhhhhC--CCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFD--PIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      |+++ +|..++..  ......+++..+..++.|+++||.|||+. +   ++||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 67666532  11245689999999999999999999998 7   9999999999999999999999999997654


Q ss_pred             cCccccccccccccccccccccc----cCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ...   ......||+.|+|||.+    .+..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            322   12233689999999998    4566899999999999999999999999754

>2gsj_A Protein PPL-2; mimosoideae, chimerolectin, endochitinase, glycosyl hydrolase family 18, equilibrium sedimentation, X-RAY; 1.73A {Parkia platycephala}

Probab=99.97  E-value=1.4e-31  Score=265.53  Aligned_cols=199  Identities=17%  Similarity=0.173  Sum_probs=138.8

Q ss_pred             EEEEecC-CCCCC-CCCCCCCCccEEEEEEEEecCCCc--EEecCC---cchhhHHHHHHHHHh-hCCCceEEEEeecCC
Q 006211           29 KAGYWLA-GREFP-LSDINSALFTHLICAFAEVDSSTY--QLSISS---ANQQYFSIFANSVRR-KNPSIKTLLSIWNGQ  100 (656)
Q Consensus        29 ~~~y~~~-~~~~~-~~~i~~~~~thi~~~f~~~~~~~~--~~~~~~---~~~~~~~~~~~~~k~-~~~~~kvl~sigg~~  100 (656)
                      +++||-. ...-+ ++..+.++||||+|||+.+.+++.  .+.+.+   ........+...+|+ +++++||||||||  
T Consensus         3 i~~YWg~n~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~lq~~g~KVllSiGG--   80 (271)
T 2gsj_A            3 IVVYWGQNGGEGTLTSTCESGLYQIVNIAFLSQFGGGRRPQINLAGHCDPANNGCRTVSDGIRACQRRGIKVMLSIGG--   80 (271)
T ss_dssp             EEEEESSCTTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECCGGGCCTGGGTTTTHHHHHHHHHTTTCEEEEEEEC--
T ss_pred             EEEEeCCCCCCCChHHhccCCCCCEEEEEEEEecCCCCCcCccccccCCCccccHHHHHHHHHHHHhCCCEEEEEeCC--
Confidence            5889943 22211 122337789999999999987643  233221   111111222233444 5679999999954  


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHH----------HHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHH
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS----------IRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWK  170 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~----------~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr  170 (656)
                                |+.+   |+  +++++.|++|++++          ++++++|+|||||||||||.    ++|..|+++||
T Consensus        81 ----------~~gs---~~--~~s~~~~~~fa~s~~~~f~~~~s~~~~~~~~~~DGiDiDwE~p~----~~~~~l~~~Lr  141 (271)
T 2gsj_A           81 ----------GAGS---YS--LSSVQDARSVADYIWNNFLGGRSSSRPLGDAVLDGVDFDIEHGG----AYYDALARRLS  141 (271)
T ss_dssp             ----------SSSC---BC--CCSHHHHHHHHHHHHHHHSSSCCTTCTTCSCCCSEEEEECCSCC----TTHHHHHHHHH
T ss_pred             ----------CCCc---ee--cCCHHHHHHHHHHHHHHhcCCcchhhhHHHcCCceEEEeecCch----HHHHHHHHHHH
Confidence                      4321   34  56788999999999          56789999999999999997    89999999999


Q ss_pred             hhcCCCCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHc
Q 006211          171 ASASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRR  249 (656)
Q Consensus       171 ~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~  249 (656)
                      +.+..+++++||+|+++. .  ...+....+ .+++||||||+||+++.      .     +......++..+++.|++ 
T Consensus       142 ~~~~~g~~~~LTaAp~~~-~--~~~~~~~~~~~~~~D~invm~Yd~~~~------~-----~~~~~~~~~~~~~~~w~~-  206 (271)
T 2gsj_A          142 EHNRGGKKVFLSAAPQCP-F--PDQSLNKALSTGLFDYVWVQFYNNPQC------E-----FNSGNPSNFRNSWNKWTS-  206 (271)
T ss_dssp             GGGGSSSCCEEEECCBSS-S--SCTTTHHHHHTSCCSEEEEECSSCTTT------S-----CCTTCTHHHHHHHHHHHH-
T ss_pred             HHhhcCCCeEEEEeccCC-c--chhhHHHHHhhccCCeEEEEcccCCCc------c-----CCCCchhHHHHHHHHHHh-
Confidence            988656789999998763 1  122444455 57999999999998732      1     111111257889999998 


Q ss_pred             CCCCCceeecccCCC
Q 006211          250 GFPANKLVLGARASG  264 (656)
Q Consensus       250 g~p~~Kl~lG~p~yG  264 (656)
                      |+|+ ||+||+|++-
T Consensus       207 ~~p~-Kl~lGlp~~~  220 (271)
T 2gsj_A          207 SFNA-KFYVGLPASP  220 (271)
T ss_dssp             HCSS-EEEEEEESSG
T ss_pred             cCCC-cEEEeccCCc
Confidence            6999 9999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.2e-31  Score=272.92  Aligned_cols=196  Identities=29%  Similarity=0.471  Sum_probs=160.7

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee---------
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE---------  502 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  502 (656)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356788999999999999999965 47899999999653 3445678999999999999999999998865         


Q ss_pred             ----CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEE
Q 006211          503 ----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI  578 (656)
Q Consensus       503 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl  578 (656)
                          ....++||||+++++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                34678999999999999998642  234788899999999999999999987   999999999999999999999


Q ss_pred             EeccCccccccCcc------------ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHc
Q 006211          579 SDFGMAKLFRKDVD------------EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIIS  634 (656)
Q Consensus       579 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~ellt  634 (656)
                      +|||++........            ........|++.|+|||.+.+. .++.++|||||||++|||++
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            99999986542210            1122345689999999998764 68999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=1.2e-31  Score=297.85  Aligned_cols=202  Identities=28%  Similarity=0.408  Sum_probs=173.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee------CCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE------RDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  505 (656)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999965 56889999998764 34455678999999999999999999998765      667


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCc---EEEEecc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFG  582 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~---~kl~DfG  582 (656)
                      .++||||+++++|..++........+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            7999999999999999976555556889999999999999999999987   999999999999997765   9999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ++.......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            998654322   22345789999999999999999999999999999999999999954

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=1.9e-31  Score=301.25  Aligned_cols=205  Identities=20%  Similarity=0.331  Sum_probs=169.8

Q ss_pred             HHhcCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          432 AATNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       432 ~~~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      ...++|++.+.||+|+||.||+|....    +..||||+++... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345678888999999999999996532    4579999987643 344567899999999999999999999985 4678


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ++||||+++|+|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            9999999999999998542  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ...... .......+|+.|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  597 (656)
T 2j0j_A          541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  597 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            543221 12223456789999999988899999999999999999997 999987543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=2.3e-31  Score=282.59  Aligned_cols=202  Identities=22%  Similarity=0.266  Sum_probs=168.3

Q ss_pred             HhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CC-----ceeeEEEEEeeCCc
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HV-----NLLRVLGYCTERDE  505 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~  505 (656)
                      ..++|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+..|+.+++.++ |+     +++++.+++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            457899999999999999999965 46789999999754 333456778888888875 54     49999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc--CCCcEEEEeccC
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NELNPKISDFGM  583 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~--~~~~~kl~DfGl  583 (656)
                      .++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 58888875432 23489999999999999999999952 12499999999999995  477899999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865322     223478999999999999999999999999999999999999997644

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=7.2e-32  Score=278.29  Aligned_cols=203  Identities=26%  Similarity=0.421  Sum_probs=162.3

Q ss_pred             HHHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh------hHHHHHHHHHHHHhc----CCCceeeEE
Q 006211          429 DIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARL----QHVNLLRVL  497 (656)
Q Consensus       429 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~  497 (656)
                      +.....++|++.+.||+|+||.||+|.. .+++.||||+++.....      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445677899999999999999999965 56889999999765321      122456789999888    899999999


Q ss_pred             EEEeeCCceEEEEEe-cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCc
Q 006211          498 GYCTERDENMLIYEY-LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELN  575 (656)
Q Consensus       498 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~  575 (656)
                      +++...+..++|+|+ +.+++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            999999999999999 789999998854   335899999999999999999999997   99999999999999 8899


Q ss_pred             EEEEeccCccccccCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCC
Q 006211          576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       576 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +||+|||++.......    .....|+..|+|||.+.+..+ +.++|||||||++|||++|+.||..
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            9999999998754321    223468999999999877665 4589999999999999999999854

>2hvm_A Hevamine; hydrolase, chitinase/lysozyme; 1.80A {Hevea brasiliensis} SCOP: c.1.8.5 PDB: 1hvq_A* 1llo_A 1kr0_A* 1kr1_A* 1kqy_A* 1kqz_A*

Probab=99.97  E-value=6.2e-32  Score=268.27  Aligned_cols=199  Identities=16%  Similarity=0.104  Sum_probs=140.5

Q ss_pred             EEEEe-cCCCC-CCCCCCCCCCccEEEEEEEEecCCCc--EEecCCc------chhhHHHHHHHHHhhCCCceEEEEeec
Q 006211           29 KAGYW-LAGRE-FPLSDINSALFTHLICAFAEVDSSTY--QLSISSA------NQQYFSIFANSVRRKNPSIKTLLSIWN   98 (656)
Q Consensus        29 ~~~y~-~~~~~-~~~~~i~~~~~thi~~~f~~~~~~~~--~~~~~~~------~~~~~~~~~~~~k~~~~~~kvl~sigg   98 (656)
                      ++.|| +++.. .-++..+.+.||||+|||+.+.+++.  .+.+...      ....+...++.+  ++|++||||||| 
T Consensus         3 iavYWg~n~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~--q~~g~KVllSiG-   79 (273)
T 2hvm_A            3 IAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSC--QIQGIKVMLSLG-   79 (273)
T ss_dssp             EEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHH--HHTTCEEEEEEE-
T ss_pred             EEEEcCCCCCCCchHhhcCCCCCCEEEEEEEEEeCCCceeeeeecCCCCcccccHHHHHHHHHHH--HcCCCEEEEEeC-
Confidence            57899 33322 11233346789999999999987642  2222110      012233343434  456899999994 


Q ss_pred             CCCCccccccCCcCCCccccccccCChhhHHHHHHHH----------HHHHHHcCCCcceeeeeCCCccCcchHHHHHHH
Q 006211           99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS----------IRTARLYGFQGIDLFWLWPNSTDLNSLGILLDE  168 (656)
Q Consensus        99 ~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~----------~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~  168 (656)
                                 ||+.+   |+  +++++.|++|++++          ++++++|+|||||||||||.   .++|..|+++
T Consensus        80 -----------G~~g~---~~--~~s~~~~~~fa~~~~~~f~~g~s~~~~~~~~~~DGiDiDwE~p~---~~~~~~l~~~  140 (273)
T 2hvm_A           80 -----------GGIGS---YT--LASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGS---TLYWDDLARY  140 (273)
T ss_dssp             -----------CSSCC---CC--CCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSC---CSSHHHHHHH
T ss_pred             -----------CCCCc---cC--CCCHHHHHHHHHHHHHHhcCCchhhhHHHHcCCceEEeeccCCC---chhHHHHHHH
Confidence                       44321   55  67889999999998          77899999999999999997   4789999999


Q ss_pred             HHhhcCCCCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHH
Q 006211          169 WKASASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWL  247 (656)
Q Consensus       169 lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~  247 (656)
                      ||+.+.++++++||+|+++..   ...|....+ .+++||||||+||+++.      ++++     ....++..+++.|+
T Consensus       141 Lr~~~~~g~~~~LT~A~~~~~---~~~~~~~~l~~~~~D~invm~Yd~~~~------~~~~-----~~~~~~~~~~~~w~  206 (273)
T 2hvm_A          141 LSAYSKQGKKVYLTAAPQCPF---PDRYLGTALNTGLFDYVWVQFYNNPPC------QYSS-----GNINNIINSWNRWT  206 (273)
T ss_dssp             HHHGGGGSSCCEEEECCBSSS---SCTTTHHHHHTTCCSEEEEECSSCGGG------SCBT-----TBCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCeEEEECCCCCC---cchhHHHHHhcccCCEEEEeccCCCCC------cCCC-----CCHHHHHHHHHHHH
Confidence            999885456899999987631   122444555 47999999999999832      1111     01114677888898


Q ss_pred             HcCCCCCceeecccCCC
Q 006211          248 RRGFPANKLVLGARASG  264 (656)
Q Consensus       248 ~~g~p~~Kl~lG~p~yG  264 (656)
                      + |+|++||+||+|++-
T Consensus       207 ~-g~p~~KlvlGlp~~~  222 (273)
T 2hvm_A          207 T-SINAGKIFLGLPAAP  222 (273)
T ss_dssp             H-HCCCSEEEEEEESSG
T ss_pred             h-cCCcccEEEEEecCc
Confidence            7 999999999999973

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=2.9e-31  Score=278.64  Aligned_cols=200  Identities=22%  Similarity=0.306  Sum_probs=167.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CC-CEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc------eeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RG-QEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN------LLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  505 (656)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+.+++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999653 34 68999999754 344567788999999997766      8999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE---------------
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---------------  570 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl---------------  570 (656)
                      .++||||+ ++++..++... ....+++..+..++.|+++||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 55565555432 2235899999999999999999999987   9999999999999               


Q ss_pred             ----cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          571 ----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       571 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                66789999999999764321     2234789999999999999999999999999999999999999976443

>1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A

Probab=99.97  E-value=1.5e-31  Score=266.46  Aligned_cols=172  Identities=15%  Similarity=0.179  Sum_probs=126.6

Q ss_pred             ceEEEEEec--CC-----CCCCCC-CCCCCCccEEEEEEEEecCCC--cEEecCCcch--hhHHHHHHHHHh-hCCCceE
Q 006211           26 TWIKAGYWL--AG-----REFPLS-DINSALFTHLICAFAEVDSST--YQLSISSANQ--QYFSIFANSVRR-KNPSIKT   92 (656)
Q Consensus        26 ~~~~~~y~~--~~-----~~~~~~-~i~~~~~thi~~~f~~~~~~~--~~~~~~~~~~--~~~~~~~~~~k~-~~~~~kv   92 (656)
                      ..+++|||.  .+     +.|.++ +||+..||||+|| +.|+.++  +.........  .......+.+|. ++|++||
T Consensus         8 ~~~~vcY~~~~~~~~~~~g~~~~~~di~~~~~thiiya-a~i~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~Kv   86 (271)
T 1edt_A            8 GPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFA-ANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQGIKV   86 (271)
T ss_dssp             SCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEE-EEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHTTCEE
T ss_pred             CCEEEEEEeccceeccCCceeeecccCCccccEEEEee-cccCCCccccceEEEeCcchhhhhhhHHHHHHHHhcCCCEE
Confidence            456799997  33     247788 8999999999999 8888653  2222221111  111111122222 4579999


Q ss_pred             EEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-------cCcchHHHH
Q 006211           93 LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------TDLNSLGIL  165 (656)
Q Consensus        93 l~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-------~d~~~~~~l  165 (656)
                      |+|||||..+             ..|+.+. +++.|++||+++++++++|+|||||||||||..       .|+.+|+.|
T Consensus        87 llsiGG~~~~-------------~~~~~l~-s~~~r~~f~~s~~~~~~~~~fDGiDiDwE~p~~~~~g~~~~d~~~~~~l  152 (271)
T 1edt_A           87 LLSVLGNHQG-------------AGFANFP-SQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSFVHL  152 (271)
T ss_dssp             EEEEEECTTS-------------CCTTCCS-SHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHHHHH
T ss_pred             EEEECCCCCC-------------CCceecC-CHHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCCCCCCCCHHHHHHH
Confidence            9999554432             2377765 899999999999999999999999999999952       368999999


Q ss_pred             HHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCC
Q 006211          166 LDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPS  219 (656)
Q Consensus       166 l~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~  219 (656)
                      +++||++|+   +++||+++++. .....+||++++.+++||+   +||+||+|
T Consensus       153 l~eLr~~l~---~~~Ls~a~~~~-~~~~~~yd~~~~~~~lD~i---~~d~yg~w  199 (271)
T 1edt_A          153 VTALRANMP---DKIISLYNIGP-AASRLSYGGVDVSDKFDYA---WNPYYGTW  199 (271)
T ss_dssp             HHHHHHHCT---TSEEEEESCHH-HHTCCEETTEECGGGCSEE---ECCSTTEE
T ss_pred             HHHHHHHCC---CCEEEEEecCC-cchhccCCHHHHHhhCCEE---EEcccCCC
Confidence            999999993   48999998752 2333468999999999999   78888653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=2.8e-32  Score=284.42  Aligned_cols=191  Identities=17%  Similarity=0.213  Sum_probs=160.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcC---------CCceeeE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--------TQGLEEFKNEVSLTARLQ---------HVNLLRV  496 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  496 (656)
                      .++|++.+.||+|+||+||+|.. +++.||||++....        ....+.+.+|+.+++.++         |||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999987 78999999987642        223467889999988885         8888888


Q ss_pred             EEEEe------------------------------eCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHH
Q 006211          497 LGYCT------------------------------ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG  546 (656)
Q Consensus       497 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  546 (656)
                      .+.+.                              .....++||||+++|++...+..    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77643                              26789999999999976655522    457999999999999999


Q ss_pred             HHHHH-hcCCCCcEecccCCCCEEEcCCC--------------------cEEEEeccCccccccCccccccccccccccc
Q 006211          547 LLYLQ-EYSNFRVIHRDLKASNILLDNEL--------------------NPKISDFGMAKLFRKDVDEANTGRIVGTYGY  605 (656)
Q Consensus       547 l~~Lh-~~~~~~iiH~Dikp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  605 (656)
                      |.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ..+||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 887   99999999999999887                    8999999999865421       34789999


Q ss_pred             cccccccCCCCCccchhHHHHHH-HHHHHcCCCCCC
Q 006211          606 VPPEYVKKGIYSMKYDVYSFGVL-LLQIISSKRNAR  640 (656)
Q Consensus       606 ~aPE~~~~~~~s~~sDvwslGvi-l~elltg~~p~~  640 (656)
                      +|||++.+.. +.++|||||+++ .+++++|..||.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            9999998766 899999998777 788999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2.6e-31  Score=286.72  Aligned_cols=200  Identities=25%  Similarity=0.290  Sum_probs=155.4

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEecC
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      .|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.++.++ +||||+++++++.+....++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            344567899999999987766789999999986532   34568899999876 89999999999999999999999995


Q ss_pred             CCChhhhhhCCCcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-------------CcEE
Q 006211          515 NKSLDLYLFDPIRRY----VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPK  577 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-------------~~~k  577 (656)
                       |+|.+++.......    ..++..+..++.|++.||.|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999886532211    1123345789999999999999987   9999999999999754             4899


Q ss_pred             EEeccCccccccCcccc--ccccccccccccccccccC-------CCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          578 ISDFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       578 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||...
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            99999998765432211  1234579999999999865       568999999999999999999 89998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=4.5e-31  Score=275.23  Aligned_cols=198  Identities=20%  Similarity=0.255  Sum_probs=145.1

Q ss_pred             hcCCCCCC-cccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceE
Q 006211          434 TNNFSSAN-KLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENM  507 (656)
Q Consensus       434 ~~~y~~~~-~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  507 (656)
                      .++|++.+ .||+|+||.||+|... +++.||||++.... .   ...+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            56788855 6999999999999654 68999999986542 1   11223334566799999999999876    44579


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccCc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMA  584 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGla  584 (656)
                      +||||+++|+|..++.... ...+++.++..++.|+++||.|||+.+   ++||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999986532 245899999999999999999999997   999999999999986   445999999999


Q ss_pred             cccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....    ......+|+.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            765422    2223467999999999988889999999999999999999999996543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=276.45  Aligned_cols=203  Identities=23%  Similarity=0.382  Sum_probs=165.8

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..++|++.+.||+|+||.||+|....  .+|+|+++...  ....+.+.+|+.++++++||||+++++++......++|+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35678899999999999999997643  49999987542  223345778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|..++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||++ ++.+||+|||+++.....
T Consensus       109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999998542  335889999999999999999999987   99999999999998 679999999998754321


Q ss_pred             c---cccccccccccccccccccccC---------CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 V---DEANTGRIVGTYGYVPPEYVKK---------GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   .........|++.|+|||.+..         ..++.++|||||||++|||++|+.||....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  247 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP  247 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            1   1122223468899999999864         457889999999999999999999997543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.5e-31  Score=276.98  Aligned_cols=202  Identities=25%  Similarity=0.387  Sum_probs=169.8

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChh------hHHHHHHHHHHHHhcC--CCceeeEEEEE
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARLQ--HVNLLRVLGYC  500 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~  500 (656)
                      .....++|++.+.||+|+||.||+|.. .+++.||||++......      ..+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            334567899999999999999999964 56889999998654211      1234677999999996  59999999999


Q ss_pred             eeCCceEEEEEecCC-CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEE
Q 006211          501 TERDENMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKI  578 (656)
Q Consensus       501 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl  578 (656)
                      ...+..++|+|++.+ ++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++ +++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999976 899888853   345899999999999999999999987   99999999999999 7889999


Q ss_pred             EeccCccccccCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCC
Q 006211          579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       579 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +|||+++.....    ......||+.|+|||++....+ +.++|||||||++|||++|+.||..
T Consensus       192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            999999875432    2223468999999999877665 6889999999999999999999964

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=3.7e-31  Score=280.04  Aligned_cols=198  Identities=21%  Similarity=0.301  Sum_probs=165.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEEEee
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----------HVNLLRVLGYCTE  502 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  502 (656)
                      .+|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788999999999999999965 56889999999754 334466788999998886           8999999999876


Q ss_pred             CC----ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEc------
Q 006211          503 RD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLD------  571 (656)
Q Consensus       503 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~------  571 (656)
                      ..    ..++|||++ +++|..++.... ...+++..+..++.|++.||.|||+. +   |+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            54    678999999 889988885432 23489999999999999999999997 7   99999999999995      


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            4447999999999865432     223478999999999999999999999999999999999999997543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.9e-31  Score=300.71  Aligned_cols=192  Identities=21%  Similarity=0.363  Sum_probs=165.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC--CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP--RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-----  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  505 (656)
                      .++|++.+.||+|+||.||+|...  +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999764  58899999987543 3445678899999999999999999999987665     


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++++|..++..     .+++.+++.++.||+++|.|||+.+   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999877632     5899999999999999999999987   9999999999999986 89999999998


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .....      ....||+.|+|||++.+.. +.++|||||||++|||++|..|+..
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            65432      3457899999999987654 8899999999999999999988754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=6.1e-31  Score=283.08  Aligned_cols=199  Identities=24%  Similarity=0.349  Sum_probs=157.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .+|+..+.||+|+||+|+.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            467888999999999976665668999999998764332   246799999999 7999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-----CCcEEEEeccCccccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLFR  588 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-----~~~~kl~DfGla~~~~  588 (656)
                      . |+|..++.....  ...+..+..++.|+++||.|||+.+   |+||||||+|||++.     ...+||+|||+++...
T Consensus       101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 589888865322  2444566789999999999999987   999999999999953     3358899999998764


Q ss_pred             cCcc-cccccccccccccccccccc---CCCCCccchhHHHHHHHHHHHc-CCCCCCCC
Q 006211          589 KDVD-EANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIIS-SKRNARYY  642 (656)
Q Consensus       589 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslGvil~ellt-g~~p~~~~  642 (656)
                      .... ........||+.|+|||++.   ...++.++|||||||++|||++ |+.||...
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            3221 12233457999999999987   4567889999999999999999 88888543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=9.7e-31  Score=270.40  Aligned_cols=200  Identities=23%  Similarity=0.366  Sum_probs=149.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-hh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      .++|+..+.||+|+||.||+|... +++.||||++..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888899999999999999664 689999999976532 22 233445556788889999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||+ ++.+..+...  ....+++..+..++.|+++||.|||+. +   ++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4555444422  134589999999999999999999985 6   99999999999999999999999999976543


Q ss_pred             Ccccccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ..   ......+++.|+|||.+.     ...++.++|||||||++|||++|+.||...
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC  232 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence            21   122346899999999984     456889999999999999999999999753

>2uy2_A Endochitinase; carbohydrate metabolism, polysaccharide degradation, glycopr chitin-binding, chitin degradation, CAZY, hydrolase; 1.60A {Saccharomyces cerevisiae} PDB: 2uy3_A* 2uy4_A* 2uy5_A*

Probab=99.97  E-value=8.5e-30  Score=255.70  Aligned_cols=198  Identities=18%  Similarity=0.180  Sum_probs=140.2

Q ss_pred             ceEEEEEecC---CCCCCCCCC-CCCCccEEEEEEEEecCCCcEEecCCc----------chhhHHHHHHHHHhhCCCce
Q 006211           26 TWIKAGYWLA---GREFPLSDI-NSALFTHLICAFAEVDSSTYQLSISSA----------NQQYFSIFANSVRRKNPSIK   91 (656)
Q Consensus        26 ~~~~~~y~~~---~~~~~~~~i-~~~~~thi~~~f~~~~~~~~~~~~~~~----------~~~~~~~~~~~~k~~~~~~k   91 (656)
                      ...+++||..   ...-++.++ +.++||||+|||+.+.+++ .+.+.+.          ....+...++.+|+  +++|
T Consensus         5 ~~~v~~Ywgqn~~~~~~~L~~~c~~~~~t~v~~AF~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~i~~~q~--~g~K   81 (294)
T 2uy2_A            5 NTNIAVYWGQNSAGTQESLATYCESSDADIFLLSFLNQFPTL-GLNFANACSDTFSDGLLHCTQIAEDIETCQS--LGKK   81 (294)
T ss_dssp             CCEEEEEESSCTTSCCCCHHHHHTSSSCSEEEEEEEEEBTTT-EECCGGGCCCBCTTSCBCCHHHHHHHHHHHH--TTCE
T ss_pred             CCCEEEEcCCCCCCCCCCHHHhCCCCCCCEEEEeeEEecCCC-eEEecCcCCCCCCCcccchHHHHHHHHHHHH--CCCE
Confidence            3467899974   333455555 5688999999999998763 4544321          11223334344444  4899


Q ss_pred             EEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHH--------HHHcC---CCcceeeeeCCCccCcc
Q 006211           92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT--------ARLYG---FQGIDLFWLWPNSTDLN  160 (656)
Q Consensus        92 vl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~--------~~~~~---~DGvdidwe~p~~~d~~  160 (656)
                      ||||||||.+            +   ++  .++++.|++|+++++++        ++.||   |||||||||||.   ..
T Consensus        82 VllSiGG~~g------------~---~~--~~s~~~~~~fa~s~~~~f~~~~~~~~r~~g~~~~DGiDiD~E~p~---~~  141 (294)
T 2uy2_A           82 VLLSLGGASG------------S---YL--FSDDSQAETFAQTLWDTFGEGTGASERPFDSAVVDGFDFDIENNN---EV  141 (294)
T ss_dssp             EEEEEECSCC------------C---BC--CSSHHHHHHHHHHHHHHHSSCCSCCCCTTTTCCCSEEEEECCSSC---CT
T ss_pred             EEEEeCCCCC------------C---Cc--CCCHHHHHHHHHHHHHHhcccccccccccCcccccceEEecccCC---cc
Confidence            9999955442            1   11  36788999999999987        47788   999999999997   57


Q ss_pred             hHHHHHHHHHhhcCC-CCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCC
Q 006211          161 SLGILLDEWKASASD-QPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIS  238 (656)
Q Consensus       161 ~~~~ll~~lr~~l~~-~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~  238 (656)
                      +|..|+++||+.+.+ +++++||+|+++...  ...++ +.+ ..++||||||+||+. .      +.+++       ++
T Consensus       142 ~~~~L~~~Lr~~~~~~g~~~~LTaAp~~~~~--~~~~~-~~l~~~~~D~invq~Yd~~-~------~~~~~-------~~  204 (294)
T 2uy2_A          142 GYSALATKLRTLFAEGTKQYYLSAAPQCPYP--DASVG-DLLENADIDFAFIQFYNNY-C------SVSGQ-------FN  204 (294)
T ss_dssp             THHHHHHHHHHHHTTSSSCCEEEECCBSSSS--CTTTH-HHHHHSCCSEEEEECSSST-T------STTSS-------CC
T ss_pred             cHHHHHHHHHHHHhhcCCceEEEECCCcccc--hhhhH-HHHhcCCcCeEEeecccCC-C------CCCCC-------cC
Confidence            999999999999954 468999999876411  11122 233 679999999999983 1      11222       24


Q ss_pred             HHHHHHHHHHc--CCCCCceeecccCCC
Q 006211          239 TDFGIREWLRR--GFPANKLVLGARASG  264 (656)
Q Consensus       239 ~~~~v~~~~~~--g~p~~Kl~lG~p~yG  264 (656)
                      ++ +...|+..  |+|++||+||+|++.
T Consensus       205 ~~-~~~~~~~~~~g~p~~KivlGlPa~~  231 (294)
T 2uy2_A          205 WD-TWLTYAQTVSPNKNIKLFLGLPGSA  231 (294)
T ss_dssp             HH-HHHHHHHHTCSSTTCEEEEEEESST
T ss_pred             HH-HHHHHHHhcCCCCchhEEEeccCCc
Confidence            44 57778875  799999999999974

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=1.1e-29  Score=258.17  Aligned_cols=175  Identities=11%  Similarity=0.058  Sum_probs=151.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      .++|++.+.||+|+||.||+|... +++.||||++....   .+..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999664 48999999997653   33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++++|..++..    . ....+...++.|+++||.|||+.+   |+||||||+|||++.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    1 355678899999999999999997   9999999999999999999997433       


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                                     |++|       ++.++|||||||++|||+||+.||......
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence                           3333       688999999999999999999999765543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=5.6e-30  Score=274.45  Aligned_cols=200  Identities=17%  Similarity=0.230  Sum_probs=151.8

Q ss_pred             cCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCC-Cce---------ee-----
Q 006211          435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQH-VNL---------LR-----  495 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------v~-----  495 (656)
                      .+|...+.||+|+||.||+|. ..+++.||||++.....   ...+.+.+|+.+++.++| +|.         +.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            346667899999999999996 55799999999874322   235678999999999977 221         11     


Q ss_pred             -------EEEEEee-----CCceEEEEEecCCCChhhhhhC----CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 006211          496 -------VLGYCTE-----RDENMLIYEYLPNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI  559 (656)
Q Consensus       496 -------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ii  559 (656)
                             +..++..     ....+++|+.+ +++|.+++..    ......+++..++.++.|+++||.|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     12345666654 6888887731    112345778899999999999999999987   99


Q ss_pred             ecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccc----------cCCCCCccchhHHHHHHH
Q 006211          560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV----------KKGIYSMKYDVYSFGVLL  629 (656)
Q Consensus       560 H~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDvwslGvil  629 (656)
                      ||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999764322     233467 999999998          556688999999999999


Q ss_pred             HHHHcCCCCCCCCCC
Q 006211          630 LQIISSKRNARYYGT  644 (656)
Q Consensus       630 ~elltg~~p~~~~~~  644 (656)
                      |||++|+.||.....
T Consensus       308 ~elltg~~Pf~~~~~  322 (413)
T 3dzo_A          308 YWIWCADLPNTDDAA  322 (413)
T ss_dssp             HHHHHSSCCCCTTGG
T ss_pred             HHHHHCCCCCCCcch
Confidence            999999999976543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=1.4e-28  Score=251.99  Aligned_cols=177  Identities=22%  Similarity=0.321  Sum_probs=149.0

Q ss_pred             hcCCCCC-CcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHH-HhcCCCceeeEEEEEee----CCce
Q 006211          434 TNNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLT-ARLQHVNLLRVLGYCTE----RDEN  506 (656)
Q Consensus       434 ~~~y~~~-~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~  506 (656)
                      .++|.+. +.||+|+||.||++.. .+++.||+|+++..     ..+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3456676 7799999999999965 56899999998653     3456788887 55699999999999876    6678


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccC
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGM  583 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGl  583 (656)
                      ++||||+++++|..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999986532 235899999999999999999999987   999999999999998   78899999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +....                        +..++.++|||||||++|||++|+.||....
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            86432                        1346778999999999999999999996543

>2xtk_A CHIA1, class III chitinase CHIA1; hydrolase, GH18; HET: AZM; 2.00A {Aspergillus fumigatus} PDB: 2xuc_A 2xvp_A 2xvn_A*

Probab=99.95  E-value=7.4e-28  Score=243.19  Aligned_cols=205  Identities=15%  Similarity=0.109  Sum_probs=139.4

Q ss_pred             EEEEecCC-CCCCCCCC-CCCCccEEEEEEEEecCCCc-----EEecC-----------Cc-------chhhHHHHHHHH
Q 006211           29 KAGYWLAG-REFPLSDI-NSALFTHLICAFAEVDSSTY-----QLSIS-----------SA-------NQQYFSIFANSV   83 (656)
Q Consensus        29 ~~~y~~~~-~~~~~~~i-~~~~~thi~~~f~~~~~~~~-----~~~~~-----------~~-------~~~~~~~~~~~~   83 (656)
                      +++||-.. ..-.+.+. +...+++|++||+.+.++++     .+.+.           +.       .-..+...++.+
T Consensus         4 i~vYWGq~~~~~~L~~~c~~~~ydii~laF~~~~~~~~~~~~P~~n~~~~c~~~~~~~~~g~~t~~l~~c~~l~~~I~~~   83 (310)
T 2xtk_A            4 LAIYWGQGPNQLRLSHFCQETSLDIINIGFINYFPDMSPGHWPGSNFGNQCDGSVYVTNDGVVTKLLSGCHQIMEDIPIC   83 (310)
T ss_dssp             EEEEESCCTTCCCHHHHHTCTTCSEEEEEEEEECTTTSGGGSCEECCTTCSCSCEEECTTCCEEEEESCCHHHHHHHHHH
T ss_pred             EEEEECCCCCCCChHHhcCCCCccEEEEeeeeccCCCCCCCCccceeccccCccccccCCCcccccccCcHhHHHHHHHH
Confidence            58898543 33344444 24579999999998865421     11111           00       113345555555


Q ss_pred             HhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHH----------HHHHcC---CCcceee
Q 006211           84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR----------TARLYG---FQGIDLF  150 (656)
Q Consensus        84 k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~----------~~~~~~---~DGvdid  150 (656)
                      |++  ++|||||||||.++.+              +  +++++.|++|++++.+          +++.||   |||||||
T Consensus        84 q~~--g~KVllSiGG~~~~~~--------------~--~~s~~~r~~fa~s~~~~f~~~~~~~~~~r~~g~~~fDGiDiD  145 (310)
T 2xtk_A           84 QAA--GKKVLLSIGGAYPPDQ--------------S--ILSEDSAVAFATFLWGAFGPVAEGWEGPRPFGDVVVDGFDFD  145 (310)
T ss_dssp             HHT--TCEEEEEEEESSCSCC--------------C--CCCHHHHHHHHHHHHHHHSSCCTTCCSCCTTTTCCCSEEEEE
T ss_pred             HhC--CCEEEEEeCCCcCCcc--------------c--cCCHHHHHHHHHHHHHHhcCcccccccccccCCcccceEEEe
Confidence            654  8999999965553222              2  3678999999999986          478899   9999999


Q ss_pred             eeCCCccCcchHHHHHHHHHhhcCC--CCCcEEEEEeecCCCccccccChhhhh-hccchhhhhhhcccCCCCCCccccC
Q 006211          151 WLWPNSTDLNSLGILLDEWKASASD--QPELTLSMAVRYSPTHETVSYPIDSMK-KNLNWAHLVAYDYHMPSKENVTGIH  227 (656)
Q Consensus       151 we~p~~~d~~~~~~ll~~lr~~l~~--~~~~~ls~a~~~~~~~~~~~~~~~~l~-~~vD~invmtYD~~g~~~~~~~g~~  227 (656)
                      ||||.   ..+|..|+++||+.+.+  .++++||+|+++..   ...+...++. .++||||||+||+++-  .... +.
T Consensus       146 wE~p~---~~~~~~L~~~Lr~~~~~~~~~~~~LTaAp~~~~---~~~~~~~~l~~~~lD~invq~Yd~~~~--~~~~-~~  216 (310)
T 2xtk_A          146 IEHNG---GFGYATMVNTFRQYFNQVPERKFYLSAAPQCII---PDAQLSDAIFNAAFDFIWIQYYNTAAC--SAKS-FI  216 (310)
T ss_dssp             ECSSC---CTTHHHHHHHHHHHHHTCTTSCCEEEECCBSSS---SCTTTHHHHHHSCCSEEEEECSSCTTT--CTHH-HH
T ss_pred             ecCCC---chhHHHHHHHHHHhhccccCCCeEEEeCCcCCC---cchHHHHHHHhCCCCceeeeeccCCCC--Cccc-cc
Confidence            99997   46899999999999953  36899999987641   1224557775 6999999999999732  1100 00


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHc-CCCCCceeecccCCC
Q 006211          228 AALYNPSSNISTDFGIREWLRR-GFPANKLVLGARASG  264 (656)
Q Consensus       228 apl~~~~~~~~~~~~v~~~~~~-g~p~~Kl~lG~p~yG  264 (656)
                      .   .....++++.. ..|+.. ++|++||+||+|++-
T Consensus       217 ~---~~~~~~~~~~~-~~~~~~~~~p~~KlvlGlPa~~  250 (310)
T 2xtk_A          217 D---TSLGTFNFDAW-VTVLKASASKDAKLYVGLPASE  250 (310)
T ss_dssp             S---TTSCCCCHHHH-HHHHTTSTTTTCEEEEEEESST
T ss_pred             c---CccccccHHHH-HHHHHhcCCCchhEEEeecCCc
Confidence            0   01122466655 467765 689999999999974

>1cnv_A Concanavalin B; plant chitinase, chitin binding protein, SEED protein; 1.65A {Canavalia ensiformis} SCOP: c.1.8.5

Probab=99.95  E-value=1.5e-28  Score=246.38  Aligned_cols=243  Identities=14%  Similarity=0.142  Sum_probs=160.0

Q ss_pred             EEEEEecCCCCCCC-CCCCCCCccEEEEEEEEecCCCc---EEecCCc-------chhhHHHHHHHHHhhCCCceEEEEe
Q 006211           28 IKAGYWLAGREFPL-SDINSALFTHLICAFAEVDSSTY---QLSISSA-------NQQYFSIFANSVRRKNPSIKTLLSI   96 (656)
Q Consensus        28 ~~~~y~~~~~~~~~-~~i~~~~~thi~~~f~~~~~~~~---~~~~~~~-------~~~~~~~~~~~~k~~~~~~kvl~si   96 (656)
                      .+++||.....=.+ ..-+.+.+|||++||+.+.++|.   .+.+.+.       ....+...++.+|+  +++||||||
T Consensus         6 ~i~~YWg~~~~g~L~~~c~~~~~~~V~~aF~~~~~~G~~~p~~~l~~~~~~~~~~~~~~~~~~Ik~~q~--~g~KVllSi   83 (299)
T 1cnv_A            6 EIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQR--MGVKVFLAL   83 (299)
T ss_dssp             EEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHH--TTCEEEEEE
T ss_pred             cEEEEcCCCCCCCcccccCCCCCCEEEEEEEEecCCCCcchhhhhcccCCcccCcchHhHHHHHHHHHh--CCCEEEEEe
Confidence            46999976111011 11135679999999999876541   2222211       11334445454554  489999999


Q ss_pred             ecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHH---------HHHHHcCCCcceeeeeCCCccCcchHHHHHH
Q 006211           97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI---------RTARLYGFQGIDLFWLWPNSTDLNSLGILLD  167 (656)
Q Consensus        97 gg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~---------~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~  167 (656)
                      |||            +.+   |+  +++++.|++|++++.         +++.+|+|||||||||||..  .++|..|++
T Consensus        84 GG~------------~gs---~~--~~s~~~~~~fa~~~~~~f~~g~~~~~~~~~~~DGiDiD~E~~~~--~~~~~~L~~  144 (299)
T 1cnv_A           84 GGP------------KGT---YS--ACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVD--ELNWDNLLE  144 (299)
T ss_dssp             ECS------------SSE---EC--CCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSC--STTHHHHHH
T ss_pred             cCC------------ccc---cc--cCCHHHHHHHHHHHHHHhcCccccchHHhcCCceEEeeccCCCc--hhHHHHHHH
Confidence            544            321   33  578899999999994         88899999999999999975  389999999


Q ss_pred             HHHhhcCC-CCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHH
Q 006211          168 EWKASASD-QPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE  245 (656)
Q Consensus       168 ~lr~~l~~-~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~  245 (656)
                      +||+.+.+ .++++||+|++....   ..+.-..+ ..++||||||.||..+-      ++++.     ...+...+++.
T Consensus       145 ~Lr~~~~~~g~~~~LTaAp~~~~~---~~~~~~~~~~~~lD~invq~Yn~~~c------~~~~g-----~~~~~~~a~~~  210 (299)
T 1cnv_A          145 ELYQIKDVYQSTFLLSAAPGCLSP---DEYLDNAIQTRHFDYIFVRFYNDRSC------QYSTG-----NIQRIRNAWLS  210 (299)
T ss_dssp             HHHHHHHHHTCCCEEEECCBSSSS---CTTTHHHHTTTCCSEEEEECSSCTTT------SCBTT-----BCHHHHHHHHH
T ss_pred             HHHHhhhhcCCCeEEEEeccCCCc---chhHHHHHhcCCcCEEEEEeecCCCc------CCCCC-----ChhhHHHHHHH
Confidence            99997632 468999999876321   11222233 68999999999997411      11111     01146788999


Q ss_pred             HHHcCC-CCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHH-Hhh
Q 006211          246 WLRRGF-PANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAK-ISY  323 (656)
Q Consensus       246 ~~~~g~-p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K-~~~  323 (656)
                      |++.+. |++||+||+|+....-+..|.+                                       ++..+... ..+
T Consensus       211 w~~~~~~p~~Kl~lGlPa~~~aa~g~Gyv---------------------------------------~~~~l~~~v~~~  251 (299)
T 1cnv_A          211 WTKSVYPRDKNLFLELPASQATAPGGGYI---------------------------------------PPSALIGQVLPY  251 (299)
T ss_dssp             HHHHSSSCSSCEEEEEESSGGGCTTSCCC---------------------------------------CHHHHHHHTGGG
T ss_pred             HHHhCCCCcccEEEEecCCcccCCCCCCc---------------------------------------CHHHHHHHHHHH
Confidence            998764 9999999999975211112222                                       23333222 244


Q ss_pred             hh--hcccccceeeEeccCcccc
Q 006211          324 AK--EKNLLGYKAFQLSNDDNWA  344 (656)
Q Consensus       324 ~~--~~glgGv~~W~l~~Dd~~~  344 (656)
                      ++  ..++||||+|++.+|+...
T Consensus       252 ~~~~~~~~gGvM~W~~~~d~~~~  274 (299)
T 1cnv_A          252 LPDLQTRYAGIALWNRQADKETG  274 (299)
T ss_dssp             STTHHHHEEEEEEECHHHHHHHT
T ss_pred             HhhcCCCCeEEEEEccccccCCC
Confidence            44  4689999999999986443

>1eok_A Endo-beta-N-acetylglucosaminidase F3; alpha/beta-barrel, hydrolase; 1.80A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 PDB: 1eom_A*

Probab=99.95  E-value=3.4e-28  Score=246.06  Aligned_cols=196  Identities=17%  Similarity=0.218  Sum_probs=133.8

Q ss_pred             cceEEEEEecCC---CCCCCCCCCCCCccEEEEEEEE-ecCCCcEEec--CCcch-------hhHHHHHHHHHhhCCCce
Q 006211           25 QTWIKAGYWLAG---REFPLSDINSALFTHLICAFAE-VDSSTYQLSI--SSANQ-------QYFSIFANSVRRKNPSIK   91 (656)
Q Consensus        25 ~~~~~~~y~~~~---~~~~~~~i~~~~~thi~~~f~~-~~~~~~~~~~--~~~~~-------~~~~~~~~~~k~~~~~~k   91 (656)
                      ...+++|||.+.   ..+.+++||. .++||++ |+. +..+ +.+.+  .....       ..+...++.+  +++++|
T Consensus         7 ~~~~vv~Y~~~~~~~~~~~l~~i~~-~~~~i~~-F~~~~~~~-g~~~~~p~~~~~~~~~~~~~~~~~~i~~~--q~~g~K   81 (290)
T 1eok_A            7 SNGVCIAYYITDGRNPTFKLKDIPD-KVDMVIL-FGLKYWSL-QDTTKLPGGTGMMGSFKSYKDLDTQIRSL--QSRGIK   81 (290)
T ss_dssp             -CCEEEEEEECSCSSTTSCGGGCCT-TCCEEEE-ESSCHHHH-HCTTSSCTTSGGGTTCSSHHHHHHHHHHH--HTTTCE
T ss_pred             CCCEEEEEEecCCCCCcccHhHCCC-CCCEEEE-ccccCCCC-CcceeCCCCcccccccccHHHHHHHHHHH--HhCCCE
Confidence            345789999752   2368899985 4667766 763 2211 12211  11101       2233334444  456899


Q ss_pred             EEEEeecCCCCccccccCCcCCCccccccc-cCChhhHHHHHHHHHH-HHHHcCCCcceeeeeCCCc-------------
Q 006211           92 TLLSIWNGQNSTYQSILGNKNINPSVLSSM-VGDSSHRKSFIESSIR-TARLYGFQGIDLFWLWPNS-------------  156 (656)
Q Consensus        92 vl~sigg~~~~~~~~~~Gg~~~~~~~f~~~-~~~~~~r~~fi~~~~~-~~~~~~~DGvdidwe~p~~-------------  156 (656)
                      |||||            ||    +..|+.+ +++.+.|++|++++++ ++++|||||||||||||..             
T Consensus        82 VllSI------------GG----~~~~~~~~~~~~~~r~~fa~s~~~~~l~~yg~DGiDiDwEy~~~~~~~~~~~pg~~~  145 (290)
T 1eok_A           82 VLQNI------------DD----DVSWQSSKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGYAA  145 (290)
T ss_dssp             EEEEE------------EC----CGGGGSSSGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCHHH
T ss_pred             EEEEe------------CC----CcCCCCccccchhHHHHHHHHHHHHHHHhcCCCcEEEecCCCCcccccccccccccc
Confidence            99999            44    1236777 7777899999999999 9999999999999999864             


Q ss_pred             ---------cC--cchHHHHHHHHHhhcCCC--CCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCc
Q 006211          157 ---------TD--LNSLGILLDEWKASASDQ--PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENV  223 (656)
Q Consensus       157 ---------~d--~~~~~~ll~~lr~~l~~~--~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~  223 (656)
                               ++  .++|..||++||+++.+.  ..+.++++.+...  +....+++++.+++||||||+||+++      
T Consensus       146 ~g~~~~~~~~~~~~~~~~~~l~el~~~~~~~a~~~~~l~i~~~~~~--y~~~~~~~~~~~~lD~invm~Yd~~~------  217 (290)
T 1eok_A          146 TGYNGWYSGSMAATPAFLNVISELTKYFGTTAPNNKQLQIASGIDV--YAWNKIMENFRNNFNYIQLQSYGANV------  217 (290)
T ss_dssp             HSCSSCCTTSCCCCHHHHHHHHHHTTTSSTTSSSCCEEEEEECTTS--TTHHHHHHHHTTTCSEEEECCTTCCH------
T ss_pred             cccccccCcchHHHHHHHHHHHHHHHHhCCCCCCceEEEecCCccc--ccchHHHHHHhhccCEEEEecCCCCC------
Confidence                     11  579999999999999542  3567777664321  11112467899999999999999862      


Q ss_pred             cccCCCCCCCCCCCCHHHHHHHHH--HcCCCCCceeecccCC
Q 006211          224 TGIHAALYNPSSNISTDFGIREWL--RRGFPANKLVLGARAS  263 (656)
Q Consensus       224 ~g~~apl~~~~~~~~~~~~v~~~~--~~g~p~~Kl~lG~p~y  263 (656)
                           .        .....++ |.  ..|+|++||+||+|+|
T Consensus       218 -----~--------~~~~~~~-~~~~~~g~p~~Ki~lG~Pa~  245 (290)
T 1eok_A          218 -----S--------RTQLMMN-YATGTNKIPASKMVFGAYAE  245 (290)
T ss_dssp             -----H--------HHHHHHH-HHHHTSCCCGGGEEEEECTT
T ss_pred             -----c--------HHHHHHH-HhhccCCCCHHHEEeccccC
Confidence                 0        2333444 53  1699999999999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.6e-28  Score=270.66  Aligned_cols=185  Identities=17%  Similarity=0.169  Sum_probs=129.2

Q ss_pred             cccccCceEEEEE-EeCCCCEEEEEEccCCC----------hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS----------TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       442 ~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ..+.|+.|.+..+ +.-.|+.+++|++....          +...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3556666655554 23358899999986541          22345799999999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||++|++|.+.+..   ...++..   +|+.||+.||.|+|+++   ||||||||+|||+++++.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999964   3346654   58899999999999998   99999999999999999999999999987644


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN  638 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p  638 (656)
                      ..  ......+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            32  233456899999999998754 56789999999998877655443

>2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5

Probab=99.94  E-value=6.8e-26  Score=223.66  Aligned_cols=220  Identities=14%  Similarity=0.162  Sum_probs=154.3

Q ss_pred             CccceEEEEEecCC-------CCCCC-CCCCCCCccEEEEEEEEecC--CCcEEecCCcch-----hhHHHHHHHHHhhC
Q 006211           23 DAQTWIKAGYWLAG-------REFPL-SDINSALFTHLICAFAEVDS--STYQLSISSANQ-----QYFSIFANSVRRKN   87 (656)
Q Consensus        23 ~~~~~~~~~y~~~~-------~~~~~-~~i~~~~~thi~~~f~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~k~~~   87 (656)
                      ..+.+.+++|+..+       ..|.+ +++++. ||||+++|+.++.  +++.+......+     ......++.+|+  
T Consensus         6 ~~~~~kvVcY~~~~~~~p~~~g~f~l~~~~~p~-~d~vi~~fa~in~d~~~g~~~l~~n~~~~~~~~~~~~~i~~lq~--   82 (289)
T 2ebn_A            6 TKANIKLFSFTEVNDTNPLNNLNFTLKNSGKPL-VDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQD--   82 (289)
T ss_dssp             CCCSCEEEEEEETTTCCGGGGGGEEETTTCCBS-CCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHH--
T ss_pred             cCCCCEEEEEEEecCCCCCcCceEEeccCCCCc-eeEEEEEEEecccCCCCCeeEEecCccccccccchHHHHHHHHh--
Confidence            34567789999744       23777 788775 9999999999863  334444332221     112344466664  


Q ss_pred             CCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc----------c
Q 006211           88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------T  157 (656)
Q Consensus        88 ~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~----------~  157 (656)
                      +++|||||||||..            + ..|..+.  ++.|++|++++++++++|||||||||||||..          .
T Consensus        83 ~glKVllSIGG~~~------------~-~g~~~l~--~~~r~~Fa~sv~~~v~~ygfDGiDiDwEyp~~~~~g~~g~~~~  147 (289)
T 2ebn_A           83 KGIKVILSILGNHD------------R-SGIANLS--TARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTP  147 (289)
T ss_dssp             TTCEEEEEEECCSS------------S-CCTTCBC--HHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCC
T ss_pred             CCCEEEEEeCCCCC------------C-CCeecCC--HHHHHHHHHHHHHHHHHhCCCcEEEeeecCCCCccCCCCCCCc
Confidence            47999999964321            1 1255554  68999999999999999999999999999731          2


Q ss_pred             CcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCC
Q 006211          158 DLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI  237 (656)
Q Consensus       158 d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~  237 (656)
                      |+++|+.||++||++|+   +++||+|+++.+......||.+++++++||+.. +|.    +|+.   ...|+       
T Consensus       148 d~~n~~~Ll~eLR~~l~---~klLT~Av~g~~~~~~~~~d~~~~~~ylDy~~~-~Yg----~~~~---~~~~~-------  209 (289)
T 2ebn_A          148 SNNAAARLAYETKQAMP---NKLVTVYVYSRTSSFPTAVDGVNAGSYVDYAIH-DYG----GSYD---LATNY-------  209 (289)
T ss_dssp             CHHHHHHHHHHHHHHCT---TSEEEEEESGGGSCCCSCBTTBCGGGTCSEEEE-CTT----CCSC---CTTTS-------
T ss_pred             cHHHHHHHHHHHHHHCC---CCEEEEEecCCccccccccCHHHHHhcCCEEEe-ccc----Cccc---CCCcC-------
Confidence            67899999999999992   579999998665554566999999999999766 463    2331   11121       


Q ss_pred             CHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccc
Q 006211          238 STDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN  294 (656)
Q Consensus       238 ~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d  294 (656)
                                 .|+|.+|+..+...++++...    + ....+.+.+.++|+...|+
T Consensus       210 -----------~g~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~gyg~~~~y~  250 (289)
T 2ebn_A          210 -----------PGLAKSGMVMSSQEFNQGRYA----T-AQALRNIVTKGYGGHMIFA  250 (289)
T ss_dssp             -----------TTCCGGGEEEEEEETTTTBCC----C-HHHHHHHHHHTCCEEEEEC
T ss_pred             -----------CCCChhceecceeEecCCCcc----h-HHHHHHHHhCCcceEEEec
Confidence                       389999999988888765443    1 2244456667777766654

>1ta3_A XIP-1, xylanase inhibitor protein I; beta alpha barrel (XIP-I), beta alpha barrel (xylanase), HYD inhibitor-hydrolase complex; HET: NAG; 1.70A {Triticum aestivum} SCOP: c.1.8.5 PDB: 1om0_A* 1te1_A*

Probab=99.92  E-value=6.7e-25  Score=216.77  Aligned_cols=197  Identities=14%  Similarity=0.177  Sum_probs=129.4

Q ss_pred             eEEEEEecCCCCCCCCCCC----CCCccEEEEEEEEecCCCcEE--ecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           27 WIKAGYWLAGREFPLSDIN----SALFTHLICAFAEVDSSTYQL--SISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        27 ~~~~~y~~~~~~~~~~~i~----~~~~thi~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      -.+++||-...  .+..+.    .+.+|||++||+.+.++.+..  .+.......+...++.+++  +++|||||||||.
T Consensus         6 ~~i~~YWGqn~--~~~~L~~~c~~~~~~~V~~AF~~~~~~~G~~~~d~~g~~~~~~~~~I~~cq~--~g~kVlLSiGG~~   81 (274)
T 1ta3_A            6 GQVTVFWGRNK--AEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQS--KGVPVSLSIGGYG   81 (274)
T ss_dssp             CCEEEEESSCG--GGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTCCGGGHHHHHHHHHH--TTCCEEEEEEESS
T ss_pred             CcEEEEeCCCC--CCCchHhhcccCCCcEEEEccEeecCCCCceeeccCCCChHHHHHHHHHHHh--CCCEEEEecCCCc
Confidence            34688994321  233333    567999999999998732322  2222112334444444444  4899999996554


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHH------------HHcCCCcceeeeeCCCccCcchHHHHHHH
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA------------RLYGFQGIDLFWLWPNSTDLNSLGILLDE  168 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~------------~~~~~DGvdidwe~p~~~d~~~~~~ll~~  168 (656)
                      ++.               +  +.+++.+++|++++.+..            .+++|||||||||+|.  +..+|..|+++
T Consensus        82 gs~---------------~--l~s~~~a~~fa~~l~~~f~~g~~~~~~r~~g~~~lDGiDiD~E~~~--~~~~~~~L~~~  142 (274)
T 1ta3_A           82 TGY---------------S--LPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGT--PADRYDVLALE  142 (274)
T ss_dssp             SCB---------------C--CCSHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCC--TTCCHHHHHHH
T ss_pred             Ccc---------------c--cCCHHHHHHHHHHHHHHhcCcccccccccHhhcCcCeEEEeccCCC--CchhHHHHHHH
Confidence            211               1  446678999999998764            4567999999999985  46899999999


Q ss_pred             HHhhcC---CCCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhc-ccCCCCCCccccCCCCCCCCCCCCHHHHH
Q 006211          169 WKASAS---DQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYD-YHMPSKENVTGIHAALYNPSSNISTDFGI  243 (656)
Q Consensus       169 lr~~l~---~~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD-~~g~~~~~~~g~~apl~~~~~~~~~~~~v  243 (656)
                      ||+.+.   ..+++.||+|+...-. ...... ..+ ..++||||||.|| ..+      .+..+         ....++
T Consensus       143 Lr~~~~~~~~g~~~~LTaAPq~p~~-~d~~~~-~~l~~~~~D~v~vqfYdnn~~------c~~~~---------~~~~~~  205 (274)
T 1ta3_A          143 LAKHNIRGGPGKPLHLTATVRCGYP-PAAHVG-RALATGIFERVHVRTYESDKW------CNQNL---------GWEGSW  205 (274)
T ss_dssp             HHTTCCSSSSSCCCEEEEEECSSSS-CCHHHH-HHHTTSCCCEEEEECSSCCTT------SBTTB---------BHHHHH
T ss_pred             HHHHHhhccCCCCEEEEECCcCCCC-CChhHH-HHHhcCCCCeEEeeeecCCCC------Ccccc---------ccHHHH
Confidence            999884   2568999999754211 011011 111 5689999999994 210      11111         124577


Q ss_pred             HHHHHcCCCCCceeecccCCC
Q 006211          244 REWLRRGFPANKLVLGARASG  264 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG  264 (656)
                      +.|++ ++|++||+||+|++.
T Consensus       206 ~~w~~-~~p~~Ki~lGlPa~~  225 (274)
T 1ta3_A          206 DKWTA-AYPATRFYVGLTADD  225 (274)
T ss_dssp             HHHHH-HCTTSEEEEEEECCT
T ss_pred             HHHHh-cCCcccEEEeeecCc
Confidence            78876 699999999999975

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=4.2e-25  Score=243.56  Aligned_cols=185  Identities=18%  Similarity=0.219  Sum_probs=145.8

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..+.||+|+||.||+|.. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            457899999999999954 678899998644321        11345899999999999999996666666778889999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+++++|.+++..           +..++.|++++|.|||+.+   |+||||||+|||++.  .+||+|||+++.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999998843           4589999999999999987   999999999999999  9999999999876442


Q ss_pred             cccc-----ccccccccccccccccccC--CCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          591 VDEA-----NTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       591 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      ....     ......||+.|||||++..  ..|+..+|+||..+-..+.+.++.++.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2111     1235689999999999976  567888999999999999888887763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=5.6e-22  Score=200.46  Aligned_cols=163  Identities=19%  Similarity=0.174  Sum_probs=125.4

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcCCC
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST------------------QGLEEFKNEVSLTARLQHV  491 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  491 (656)
                      +......|++.+.||+|+||.||+|...+++.||+|+++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3334456667799999999999999877799999999865321                  13456889999999999  


Q ss_pred             ceeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc
Q 006211          492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD  571 (656)
Q Consensus       492 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~  571 (656)
                      | +++.+++.. +..++||||+++++|.. +..         .....++.|+++||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 555555443 56699999999999987 311         223469999999999999987   99999999999999


Q ss_pred             CCCcEEEEeccCccccccCccccccccccccccccccccccC----------CCCCccchhHHH
Q 006211          572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK----------GIYSMKYDVYSF  625 (656)
Q Consensus       572 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~~sDvwsl  625 (656)
                       ++.+||+|||+++.               +..++|||.+.+          ..+..++|+|.+
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence             99999999999963               234788998753          334555666653

>3poh_A Endo-beta-N-acetylglucosaminidase F1; TIM barrel, structural genomics, joint center for structural genomics, JCSG; 1.55A {Bacteroides thetaiotaomicron}

Probab=99.84  E-value=1.5e-20  Score=195.45  Aligned_cols=162  Identities=13%  Similarity=0.154  Sum_probs=119.0

Q ss_pred             ceEEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecC--CCcEEecCCcc--hhhH---HHHHHHHHhhCCCce
Q 006211           26 TWIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDS--STYQLSISSAN--QQYF---SIFANSVRRKNPSIK   91 (656)
Q Consensus        26 ~~~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~--~~~~~~~~~~~--~~~~---~~~~~~~k~~~~~~k   91 (656)
                      .+..++|..-..       .|..++ --...+|+++..+.|+-  .++.....-..  ...+   ..+++.++++  ++|
T Consensus       167 ~~~~~~y~evn~~npln~~~y~l~~-~~~~~d~v~lfaanin~d~~~~~~~l~~n~~~~~~L~~~~~~v~~lq~~--glK  243 (451)
T 3poh_A          167 VMQGYLFFEVNDVNPLNTLSFQLEN-GKLLWDVVVLFAANINYDAEAGRPRVQCNPNVQYLLDNNETLLQPLRRR--GVK  243 (451)
T ss_dssp             CCEEEEEEETTTCCGGGGGGCBBTT-SCBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--TCE
T ss_pred             CceEEEEEEeCCCCccccceeEecC-CCceeeEEEEeeeecCCCcccCeEEEEcCCchHHhhhChHHHHHHHHHC--CCE
Confidence            356677774221       255422 22368999999999984  34444432222  2223   4555667776  699


Q ss_pred             EEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc----------cCcch
Q 006211           92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------TDLNS  161 (656)
Q Consensus        92 vl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~----------~d~~~  161 (656)
                      |+||||||+.             ...|+.+  +++.|++|++++++++++|||||||||||||..          .+.++
T Consensus       244 VllSIgGg~~-------------~~gf~~l--s~~~r~~Fa~~v~~~v~~yglDGIDiDwEYp~~~~~g~~~~~~~d~~n  308 (451)
T 3poh_A          244 VLLGLLGNHD-------------ITGLAQL--SEQGAKDFAREVAQYCKAYNLDGVNYDDEYSNSPDLSNPSLTNPSTAA  308 (451)
T ss_dssp             EEEEEECCSS-------------SCCTTCB--CHHHHHHHHHHHHHHHHHTTCCEEEEECCSCCCCCTTSTTBCSCCHHH
T ss_pred             EEEEECcCCC-------------CCCcccC--CHHHHHHHHHHHHHHHHHhCCCcEEEeccCCCCCCCCCCCcCCCCHHH
Confidence            9999954221             1126666  789999999999999999999999999999953          46899


Q ss_pred             HHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhh
Q 006211          162 LGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAH  209 (656)
Q Consensus       162 ~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~in  209 (656)
                      |+.|+++||++|+   +++||+|+|..... ...+|..++.+++||+.
T Consensus       309 f~~Ll~eLR~~lp---~kllT~A~~g~~~~-~~~~d~~~~~~ylDy~~  352 (451)
T 3poh_A          309 AARLCYETKQAMP---DKLVTVFDWGQMYG-VATVDGVDAKEWIDIVV  352 (451)
T ss_dssp             HHHHHHHHHHHCT---TSEEEEECCTTSSC-CCEETTEEGGGTCCEEE
T ss_pred             HHHHHHHHHHhCC---CCEEEEEeccCccc-ccccChhhHhhhceeee
Confidence            9999999999993   57999999988764 44599999999999965

>3mu7_A XAIP-II, xylanase and alpha-amylase inhibitor protein; TIM barell, amylase/xylanase inhibitory protein, hydrolase I; 1.29A {Scadoxus multiflorus} SCOP: c.1.8.0 PDB: 3o9n_A 3oih_A* 3hu7_A 3m7s_A* 3d5h_A*

Probab=99.82  E-value=1.3e-19  Score=176.85  Aligned_cols=198  Identities=18%  Similarity=0.169  Sum_probs=132.0

Q ss_pred             EEEEecCCC-CCCCCC-CCCCCccEEEEEEEEecCCCc--EEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCCCCcc
Q 006211           29 KAGYWLAGR-EFPLSD-INSALFTHLICAFAEVDSSTY--QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTY  104 (656)
Q Consensus        29 ~~~y~~~~~-~~~~~~-i~~~~~thi~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~  104 (656)
                      ++.||-... +-++.. =+...+++|++||+..-.++.  .+.+....+..+...++.++++  ++||||||||+.+   
T Consensus         5 iavYWGqn~~~~~L~~~C~~~~y~~v~laFl~~~g~g~~p~~nl~~~c~~~l~~dI~~cQ~~--G~kVlLSiGG~~g---   79 (273)
T 3mu7_A            5 IAVYWGQSFDERSLEATCDSGNYAYVIIGFLNTFGGGQTPALDISGHSPKGLEPQIKHCQSK--NVKVLLSIGGPAG---   79 (273)
T ss_dssp             EEEEECSCTTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECSTTCCTTTHHHHHHHHHHT--TCEEEEEEEESSC---
T ss_pred             EEEECCCCCCCCCHHHHhcCCCCCEEEEEeEeccCCCCCccccccccchHHHHHHHHHHHHC--CCEEEEEeccCCC---
Confidence            477884322 111211 123568999999998876642  3444443345677777777766  7999999965432   


Q ss_pred             ccccCCcCCCccccccccCChhhHHHHHHHHHHHH----------HHcC---CCcceeeeeCCCccCcchHHHHHHHHHh
Q 006211          105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA----------RLYG---FQGIDLFWLWPNSTDLNSLGILLDEWKA  171 (656)
Q Consensus       105 ~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~----------~~~~---~DGvdidwe~p~~~d~~~~~~ll~~lr~  171 (656)
                                    +.-+.+++.+++|++++.+..          +.+|   |||||||||+|..   ++|..|+++||+
T Consensus        80 --------------~~~l~s~~~a~~fa~~l~~~f~p~~~g~~~~rp~g~~~lDGiD~D~E~~~~---~~~~~l~~~Lr~  142 (273)
T 3mu7_A           80 --------------PYSLDSRNDANDLAVYLHKNFLLPPAGTSESRPFGNAVLDGIDFHIEHGGP---SQYQLLANILSS  142 (273)
T ss_dssp             --------------SBCCCSHHHHHHHHHHHHHHHTSCCCSSCCCCTTTTCCCSEEEEEECSSCS---TTHHHHHHHHHH
T ss_pred             --------------ceecCCHHHHHHHHHHHHHHhccccCCCcccccccccccCceEeecccCCc---hhHHHHHHHHHH
Confidence                          112566788999999999865          4556   9999999999974   689999999999


Q ss_pred             hcCCCCCcEEEEEeecCCCccccccChhhh-hhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcC
Q 006211          172 SASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRG  250 (656)
Q Consensus       172 ~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l-~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g  250 (656)
                      .+...+++.||+|+...-   ...+.-..| ..++||||+|.||-.+-.++           .....+...+...|++ +
T Consensus       143 ~~~~g~~~~LTaAPqcp~---pd~~l~~~l~~~~~D~v~vQfYNn~~C~~~-----------~~~~~~f~~~w~~w~~-~  207 (273)
T 3mu7_A          143 FRLSGSEFALTAAPQCVY---PDPNLGTVINSATFDAIWVQFYNNPQCSYS-----------ASNASALMNAWKEWSM-K  207 (273)
T ss_dssp             HHTTSSCCEEEECCBSSS---SCTTTHHHHHTTCCSEEEEECSSCGGGSCB-----------TTBCHHHHHHHHHHHH-H
T ss_pred             HhccCCceEEEEcccCCC---cchhHHHHhhcCcccEEEEEeccCCCcccc-----------cCChhHHHHHHHHHHh-c
Confidence            986557899999965431   111222233 36899999999985210010           0000122345566664 7


Q ss_pred             CCCCceeecccCC
Q 006211          251 FPANKLVLGARAS  263 (656)
Q Consensus       251 ~p~~Kl~lG~p~y  263 (656)
                      .|+.||++|+|+-
T Consensus       208 ~p~~Kv~lGlPAs  220 (273)
T 3mu7_A          208 ARTDKVFLGFPAH  220 (273)
T ss_dssp             CCSSCEEEEEESS
T ss_pred             CCcceEEEEeecC
Confidence            9999999999974

>2dsk_A Chitinase; catalytic domain, active domain, crystalline CHIT barrel, hydrolase; 1.50A {Pyrococcus furiosus} PDB: 3a4w_A* 3a4x_A* 3afb_A

Probab=99.81  E-value=2.4e-20  Score=186.31  Aligned_cols=150  Identities=13%  Similarity=0.058  Sum_probs=101.9

Q ss_pred             CCCCccEEEEEEEEecCCCcEEecCC-cchhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccC
Q 006211           45 NSALFTHLICAFAEVDSSTYQLSISS-ANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVG  123 (656)
Q Consensus        45 ~~~~~thi~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~  123 (656)
                      ....++|+++||+.....+....... .....+...++.+|++  ++||+||||||.+                 +.++.
T Consensus        31 ~~~g~~~v~lAFl~~~~g~c~p~w~g~~~~~~~~~~I~~~q~~--G~kVllSiGGa~G-----------------s~~~~   91 (311)
T 2dsk_A           31 KLTGTKYFTLAFILYSSVYNGPAWAGSIPLEKFVDEVRELREI--GGEVIIAFGGAVG-----------------PYLCQ   91 (311)
T ss_dssp             HHHSCSEEEEEEEEEETTTTEEEETTTBCGGGGHHHHHHHHTT--TCEEEEEEEESSC-----------------CCHHH
T ss_pred             HhcCCCEEEEEEEeccCCCCcccCCCCCchHHHHHHHHHHHHC--CCeEEEEecCCCC-----------------ccccc
Confidence            34569999999998633333333322 1123455666777766  6999999955443                 22445


Q ss_pred             ChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccc-cccC-hh--
Q 006211          124 DSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHET-VSYP-ID--  199 (656)
Q Consensus       124 ~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~-~~~~-~~--  199 (656)
                      +...+++|+++..+++.+|+|||||||||++...  +.+...|++|++..   +++.+++++|+.+.... .+.. +.  
T Consensus        92 s~~~~~~~a~~~~~~i~~ygldGIDfDiE~~~~~--d~~~~aL~~l~~~~---p~~~vs~TL~~~p~gl~~~g~~~l~~a  166 (311)
T 2dsk_A           92 QASTPEQLAEWYIKVIDTYNATYLDFDIEAGIDA--DKLADALLIVQRER---PWVKFSFTLPSDPGIGLAGGYGIIETM  166 (311)
T ss_dssp             HCSSHHHHHHHHHHHHHHHTCSEEEEEECSCCCH--HHHHHHHHHHHHHS---TTCEEEEEEEEETTTEESTHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHhCCCcEEEeccCCccH--HHHHHHHHHHHhhC---CCcEEEEEeccCCCCCCcchHHHHHHH
Confidence            5567899999999999999999999999999764  46677788887653   35677776665544221 1111 22  


Q ss_pred             -hhhhccchhhhhhhcccCC
Q 006211          200 -SMKKNLNWAHLVAYDYHMP  218 (656)
Q Consensus       200 -~l~~~vD~invmtYD~~g~  218 (656)
                       +....+|+||||+|||+++
T Consensus       167 ~~~g~~ld~VniM~~Df~~~  186 (311)
T 2dsk_A          167 AKKGVRVDRVNPMTMDYYWT  186 (311)
T ss_dssp             HHHTCCCCEEEEECCCCSSS
T ss_pred             HHcCccccEEEEEeeccCCC
Confidence             2233689999999999843

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=6.1e-18  Score=168.69  Aligned_cols=136  Identities=19%  Similarity=0.210  Sum_probs=104.2

Q ss_pred             CCCCCcccccCceEEEEEEe-CCCCE--EEEEEccCCChh------------------------hHHHHHHHHHHHHhcC
Q 006211          437 FSSANKLGEGGFGPVYKGNL-PRGQE--FAVKRLSATSTQ------------------------GLEEFKNEVSLTARLQ  489 (656)
Q Consensus       437 y~~~~~iG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  489 (656)
                      |++.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999976 67888  999987543111                        1135788999999998


Q ss_pred             CCce--eeEEEEEeeCCceEEEEEecCC-C----ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEec
Q 006211          490 HVNL--LRVLGYCTERDENMLIYEYLPN-K----SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-EYSNFRVIHR  561 (656)
Q Consensus       490 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~iiH~  561 (656)
                      |+++  ..++..    ...++||||+.+ |    +|......      .++.....++.|++.+|.+|| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8764  334432    357899999942 4    55544321      123456789999999999999 876   9999


Q ss_pred             ccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          562 DLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       562 Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=8.7e-16  Score=159.17  Aligned_cols=137  Identities=14%  Similarity=0.163  Sum_probs=98.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCCh--------------hhHH--------HHHHHHHHHHhcCCCc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------------QGLE--------EFKNEVSLTARLQHVN  492 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~n  492 (656)
                      .-|++.+.||+|++|.||+|...+|+.||||+++....              ....        ....|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999888999999998754210              0001        1234666677775444


Q ss_pred             eeeEEEEEeeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC
Q 006211          493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN  572 (656)
Q Consensus       493 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~  572 (656)
                      +....-+..  ...+|||||+++++|..+..       .  .....++.|++.+|.+||+.+   ||||||||.|||+++
T Consensus       175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred             CCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence            322111111  23479999999988854431       1  223567899999999999987   999999999999998


Q ss_pred             CC----------cEEEEeccCcc
Q 006211          573 EL----------NPKISDFGMAK  585 (656)
Q Consensus       573 ~~----------~~kl~DfGla~  585 (656)
                      ++          .+.|+||+=+.
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCE
T ss_pred             CCCcccccccccceEEEEeCCcc
Confidence            76          38999999664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=2.4e-11  Score=121.11  Aligned_cols=148  Identities=16%  Similarity=0.119  Sum_probs=113.8

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEE
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENML  508 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  508 (656)
                      +......|+....++.|+.+.||++... ++.+++|+...........+.+|..+++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3444567888888888999999999754 6899999986532122235788999999884 6778889999988888999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS----------------------------------  554 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------  554 (656)
                      |||+++|.+|...+..        ......++.+++++|..||+..                                  
T Consensus        88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999998765311        1223467888999999999821                                  


Q ss_pred             ----------------------CCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          555 ----------------------NFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       555 ----------------------~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                                            ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                  13489999999999998765567999998854

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.03  E-value=2.4e-10  Score=113.47  Aligned_cols=129  Identities=19%  Similarity=0.189  Sum_probs=96.7

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEEEeeCCceEEEEEecCCCChhhh
Q 006211          444 GEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENMLIYEYLPNKSLDLY  521 (656)
Q Consensus       444 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  521 (656)
                      +.|..+.||++...+|+.+++|+.....   ...+..|+.+++.+.+.+  +.+++++....+..++||||++|.++.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            4566799999987778889999976542   234678899988886444  556888888777889999999998884  


Q ss_pred             hhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 006211          522 LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-----------------------------------------------  554 (656)
Q Consensus       522 l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------------------  554 (656)
                      . ..     .+   ...++.++++.|..||+..                                               
T Consensus       104 ~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            2 11     11   1256677778888888643                                               


Q ss_pred             --------CCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          555 --------NFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       555 --------~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                              ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    12299999999999998876667999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.86  E-value=6.1e-09  Score=108.67  Aligned_cols=142  Identities=15%  Similarity=0.277  Sum_probs=106.3

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEcc--CCC-hhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeC---CceEEEE
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLS--ATS-TQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTER---DENMLIY  510 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  510 (656)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567999999999999775 4678888776  322 122346788999999986  45678888888766   3479999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS------------------------------------  554 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------  554 (656)
                      ||++|..+....     ...++..+...++.++++.|..||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998774321     123677888899999999999999731                                    


Q ss_pred             -------------------CCCcEecccCCCCEEEcCCCc--EEEEeccCccc
Q 006211          555 -------------------NFRVIHRDLKASNILLDNELN--PKISDFGMAKL  586 (656)
Q Consensus       555 -------------------~~~iiH~Dikp~NILl~~~~~--~kl~DfGla~~  586 (656)
                                         ...++|+|++|.|||+++++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               245999999999999998753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.82  E-value=2.4e-09  Score=109.08  Aligned_cols=187  Identities=21%  Similarity=0.218  Sum_probs=121.1

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCc--eeeEEEEEeeCC---ceEEEEEec
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVN--LLRVLGYCTERD---ENMLIYEYL  513 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  513 (656)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+++.+. +..  +.+++.......   ..++||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888876432  34567889999998873 332  344444433332   347899999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS---------------------------------------  554 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------------  554 (656)
                      +|.++.....     ..++..++..++.++++.+..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988864332     13566777788888888888888621                                       


Q ss_pred             ----------------CCCcEecccCCCCEEEcC--CCcEEEEeccCccccccCcccccccc------------cccccc
Q 006211          555 ----------------NFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKDVDEANTGR------------IVGTYG  604 (656)
Q Consensus       555 ----------------~~~iiH~Dikp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~  604 (656)
                                      ...++|+|++|.||++++  +..+.|+||+.+.......+......            .....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134899999999999998  55678999999865322111100000            000001


Q ss_pred             ccc-cccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          605 YVP-PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       605 y~a-PE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      ... |+.....  ....+.|+++.++|++.+|..++
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 2222111  12368999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=5.6e-06  Score=83.99  Aligned_cols=137  Identities=20%  Similarity=0.213  Sum_probs=93.8

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEEEe-eCCceEEEEEecCC
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV---NLLRVLGYCT-ERDENMLIYEYLPN  515 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  515 (656)
                      .+.++.|....||+.    +..+++|+..  .......+..|..+++.+.+.   .+.+.+.++. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    5678888743  233456788999999998642   3556666664 34557899999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY------------------------------------------  553 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~------------------------------------------  553 (656)
                      ..+......     .++..+...++.++.+.|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888653211     134444455555555555555542                                          


Q ss_pred             ---------------CCCCcEecccCCCCEEEcC---CCc-EEEEeccCcccc
Q 006211          554 ---------------SNFRVIHRDLKASNILLDN---ELN-PKISDFGMAKLF  587 (656)
Q Consensus       554 ---------------~~~~iiH~Dikp~NILl~~---~~~-~kl~DfGla~~~  587 (656)
                                     ....++|+|++|.||+++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2234799999999999998   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.15  E-value=6.2e-06  Score=81.93  Aligned_cols=135  Identities=18%  Similarity=0.191  Sum_probs=92.6

Q ss_pred             cccccCce-EEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          442 KLGEGGFG-PVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       442 ~iG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.+++.++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445444 68987654 4667899986543   2346788999888874 33467788889888899999999999877


Q ss_pred             hhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 006211          519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY---------------------------------------------  553 (656)
Q Consensus       519 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------------  553 (656)
                      ......       .......+..+++..|..||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            654311       0112223445555555555531                                             


Q ss_pred             ----------CCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          554 ----------SNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       554 ----------~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                                ....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      111379999999999999887777999999865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.03  E-value=7.8e-06  Score=84.84  Aligned_cols=79  Identities=10%  Similarity=0.035  Sum_probs=54.1

Q ss_pred             Ccc-cccCceEEEEEEeC-------CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcC-C--CceeeEEEEEeeC---
Q 006211          441 NKL-GEGGFGPVYKGNLP-------RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQ-H--VNLLRVLGYCTER---  503 (656)
Q Consensus       441 ~~i-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  503 (656)
                      +.| +.|....+|+....       +++.+++|+.....   ......+.+|..+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999998654       26678899765432   001134677888888774 2  3567788777655   


Q ss_pred             CceEEEEEecCCCChh
Q 006211          504 DENMLIYEYLPNKSLD  519 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~  519 (656)
                      ...++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999987764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.65  E-value=0.00011  Score=75.50  Aligned_cols=141  Identities=15%  Similarity=0.200  Sum_probs=77.9

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----CCceeeEE-E--EEeeCCceEEEEEe
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----HVNLLRVL-G--YCTERDENMLIYEY  512 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~  512 (656)
                      +.|+.|..+.||+....++ .+++|+.... .   ..+..|..+++.+.     .|.++... +  +....+..+++++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999977554 5899988753 2   22334455554442     34333310 0  12235667899999


Q ss_pred             cCCCChhh--------------hhhC----C--CcC-----CCCCHHHH-------------------------------
Q 006211          513 LPNKSLDL--------------YLFD----P--IRR-----YVLDWQKR-------------------------------  536 (656)
Q Consensus       513 ~~~g~L~~--------------~l~~----~--~~~-----~~l~~~~~-------------------------------  536 (656)
                      ++|..+..              .++.    .  ...     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99865430              0111    0  000     01122211                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          537 VNIIEGVTQGLLYLQE----------YSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       537 ~~i~~~i~~~l~~Lh~----------~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ..+...+..++.+|+.          ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345566653          1234699999999999998788899999998854

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.63  E-value=0.00013  Score=76.74  Aligned_cols=75  Identities=15%  Similarity=0.209  Sum_probs=48.8

Q ss_pred             CCcccccCceEEEEEEeC-CCCEEEEEEccCCCh-------hhHHHHHHHHHHHHhcCC--Cc-eeeEEEEEeeCCceEE
Q 006211          440 ANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-------QGLEEFKNEVSLTARLQH--VN-LLRVLGYCTERDENML  508 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  508 (656)
                      .+.||.|..+.||++... .++.++||.......       ...+++..|.++++.+..  |. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999654 468899997643211       122456778888887742  33 3455543  3456789


Q ss_pred             EEEecCCC
Q 006211          509 IYEYLPNK  516 (656)
Q Consensus       509 v~e~~~~g  516 (656)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.63  E-value=0.00014  Score=72.92  Aligned_cols=79  Identities=18%  Similarity=0.214  Sum_probs=57.2

Q ss_pred             CCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEEEeeCCceEEEEEe
Q 006211          436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV---NLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ....++.+|.|..+.||+.+..+|+.+++|+...........+..|...|+.+...   -+.+++.+.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34456789999999999999999999999987654433334577899988887421   244455432    34789999


Q ss_pred             cCCCCh
Q 006211          513 LPNKSL  518 (656)
Q Consensus       513 ~~~g~L  518 (656)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.41  E-value=0.0012  Score=66.65  Aligned_cols=138  Identities=19%  Similarity=0.153  Sum_probs=91.3

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCceEEEEEecCCC
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIYEYLPNK  516 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  516 (656)
                      .+.|+.|....+|+... ++..+++|+....   ....+..|...|+.+.   ...+.+++.++...+..++|||++++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999976 5678899987643   2456788988888873   356888888888778899999999987


Q ss_pred             Chhh-----------hhhCCCc-------------------CCCCCHHHHH---HHH----------------HHHHHH-
Q 006211          517 SLDL-----------YLFDPIR-------------------RYVLDWQKRV---NII----------------EGVTQG-  546 (656)
Q Consensus       517 ~L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~i~~~-  546 (656)
                      .+..           .++....                   .-.-+|....   ++.                ..++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1111100                   0012454322   111                111111 


Q ss_pred             HHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEecc
Q 006211          547 LLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFG  582 (656)
Q Consensus       547 l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfG  582 (656)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223321 2245699999999999999987 8999984

>2vtf_A Endo-beta-N-acetylglucosaminidase; hydrolase, family 85, glycosidase, carbohydrat binding; HET: B3P PGE; 1.79A {Arthrobacter protophormiae} PDB: 3fhq_A* 3fha_A*

Probab=97.26  E-value=0.0004  Score=75.89  Aligned_cols=155  Identities=12%  Similarity=0.126  Sum_probs=95.5

Q ss_pred             HHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCcccccccc-CChhhHHHHHHHHHHHHHHcCCCcceeeeeCC--
Q 006211           78 IFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMV-GDSSHRKSFIESSIRTARLYGFQGIDLFWLWP--  154 (656)
Q Consensus        78 ~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~-~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p--  154 (656)
                      ..+.+++++  +++|+-.+.=+ +..+    ||.   ......++ .+++.+..+|+.++++++.|||||+.||+|.+  
T Consensus       113 ~widaAHrn--GV~VlGt~~fe-~~~~----gg~---~~~~~~lL~~~~~~~~~~a~kLv~~a~~yGFDGw~IN~E~~~~  182 (626)
T 2vtf_A          113 DVIDASHRN--GVPILGNVFFP-PTVY----GGQ---LEWLEQMLEQEEDGSFPLADKLLEVADYYGFDGWFINQQTEGA  182 (626)
T ss_dssp             HHHHHHHHT--TCCEEEEEEEC-CGGG----TCC---HHHHHHHTCCCTTCCCHHHHHHHHHHHHHTCCEEEEEECCTTC
T ss_pred             HHHHHHHHc--CCEEEEEEecC-cccC----CcH---HHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeeccccC
Confidence            344556665  79999666100 0011    221   12245666 67777889999999999999999999999984  


Q ss_pred             CccCcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCC--
Q 006211          155 NSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN--  232 (656)
Q Consensus       155 ~~~d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~--  232 (656)
                      ..++.+++..|+++|++....  +..+.-            |            .-|+++-.-.|.+....++.+++.  
T Consensus       183 ~~~~~~~l~~F~~~L~~~~~~--~~~v~W------------Y------------Ds~t~~G~l~wQn~Ln~~N~~ff~~~  236 (626)
T 2vtf_A          183 DEGTAEAMQAFLVYLQEQKPE--GMHIMW------------Y------------DSMIDTGAIAWQNHLTDRNKMYLQNG  236 (626)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCT--TCEEEE------------E------------SCBCTTSCBCCCSSCCTTTGGGTEET
T ss_pred             CHHHHHHHHHHHHHHHHhCCC--CcEEEE------------e------------eccccCCCEeeccccCHHHHHHHhcc
Confidence            346788999999999998722  222211            0            001111110111111222222221  


Q ss_pred             -----------CCCCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCC
Q 006211          233 -----------PSSNISTDFGIREWLRRGFPANKLVLGARASGPGITI  269 (656)
Q Consensus       233 -----------~~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~  269 (656)
                                 -.+. ..+.+++.....|.++..|.+|+-..|+++..
T Consensus       237 ~~~v~D~~FlNY~W~-~l~~S~~~A~~~g~~~~dvy~GiDv~grg~~~  283 (626)
T 2vtf_A          237 STRVADSMFLNFWWR-DQRQSNELAQALGRSPYDLYAGVDVEARGTST  283 (626)
T ss_dssp             TEECCSEEEECSCCS-CCHHHHHHHHHTTCCGGGEEEEEECTTTGGGC
T ss_pred             CCCccceEEEccCCC-ChHHHHHHHHHhCCCHHHEEEEEEEecCccCC
Confidence                       1122 45677777788899999999999999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.21  E-value=0.0012  Score=69.99  Aligned_cols=77  Identities=12%  Similarity=0.119  Sum_probs=45.7

Q ss_pred             CCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccccccccccc--cccccccccccCC---CCCccchhHHHHHHH
Q 006211          555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG--TYGYVPPEYVKKG---IYSMKYDVYSFGVLL  629 (656)
Q Consensus       555 ~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~s~~sDvwslGvil  629 (656)
                      ...++|+|++|.|||+++++ ++|+||+.+..-....+-   .....  ...|++|+.....   .-....++.++...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34599999999999999876 999999988653221111   00010  1245665544211   112234555667777


Q ss_pred             HHHHcC
Q 006211          630 LQIISS  635 (656)
Q Consensus       630 ~elltg  635 (656)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776655

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.11  E-value=0.0013  Score=66.03  Aligned_cols=71  Identities=10%  Similarity=0.143  Sum_probs=43.6

Q ss_pred             CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCceEEEEEec-CCCC
Q 006211          440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYL-PNKS  517 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  517 (656)
                      .+.|+.|....+|+.     ..+++|+........ ....+|...++.+...++ .+++..  ..+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577888999999998     568888876532211 112457777766642223 345543  344457899999 6554


Q ss_pred             h
Q 006211          518 L  518 (656)
Q Consensus       518 L  518 (656)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.01  E-value=0.0024  Score=64.79  Aligned_cols=159  Identities=13%  Similarity=0.114  Sum_probs=86.1

Q ss_pred             cCHHHHHHHhcCCCC-----CCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEE
Q 006211          425 FSFSDIKAATNNFSS-----ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVL  497 (656)
Q Consensus       425 ~~~~~~~~~~~~y~~-----~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  497 (656)
                      .+.+++.....+|..     .+.|+.|....+|+....++ .+++|+......  .+.+..|..++..+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            345566666666665     23466788899999977555 688998865211  123456777766663212  22332


Q ss_pred             EE------EeeCCceEEEEEecCCCChhh--------------hhhCC----CcC--CCC---CHHHHHH----------
Q 006211          498 GY------CTERDENMLIYEYLPNKSLDL--------------YLFDP----IRR--YVL---DWQKRVN----------  538 (656)
Q Consensus       498 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~--~~l---~~~~~~~----------  538 (656)
                      ..      ....+..++++++++|..+..              .++..    ...  ...   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            11      122355689999998865421              01110    000  001   1221100          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          539 --IIEGVTQGLLYLQEY----SNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       539 --i~~~i~~~l~~Lh~~----~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                        +...+.+.+..+++.    .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011133445555432    123599999999999999876568999998754

>2w91_A Endo-beta-N-acetylglucosaminidase D; hydrolase, N-glycan, secreted, oxazoline, NAG-thiazoline, substrate-participation; 1.40A {Streptococcus pneumoniae} PDB: 2w92_A*

Probab=96.83  E-value=0.00048  Score=75.61  Aligned_cols=154  Identities=11%  Similarity=0.132  Sum_probs=94.7

Q ss_pred             HHHHHHHhhCCCceEEEEe---ecCCCCccccccCCcCCCcccccccc-CChhhHHHHHHHHHHHHHHcCCCcceeeeeC
Q 006211           78 IFANSVRRKNPSIKTLLSI---WNGQNSTYQSILGNKNINPSVLSSMV-GDSSHRKSFIESSIRTARLYGFQGIDLFWLW  153 (656)
Q Consensus        78 ~~~~~~k~~~~~~kvl~si---gg~~~~~~~~~~Gg~~~~~~~f~~~~-~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~  153 (656)
                      ..+..++++  +++|+-.+   |..+        ||   .......++ .+++.|..+|+.++++++.|||||+.||+|.
T Consensus       105 ~widaAHrn--GV~VlGT~~fe~~~~--------~~---~~~~~~~lL~~~~~~~~~~a~kLv~la~~yGFDGw~IN~E~  171 (653)
T 2w91_A          105 DVIDAGHRN--GVPVYGTLFFNWSNS--------IA---DQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQET  171 (653)
T ss_dssp             HHHHHHHHT--TCCEEEEEEEEEECC--------HH---HHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEE
T ss_pred             HHHHHHHHC--CCEEEEEEecCcccC--------Cc---HHHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeecc
Confidence            344556665  79999666   1110        11   111245666 5777888999999999999999999999997


Q ss_pred             C---CccCcchHHHHHHHHHhhcCCC-CCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCC
Q 006211          154 P---NSTDLNSLGILLDEWKASASDQ-PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA  229 (656)
Q Consensus       154 p---~~~d~~~~~~ll~~lr~~l~~~-~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~ap  229 (656)
                      +   ..++.+++..|+++|++.+++. .+..+.-                        ..-|+++-.-.|.+....++.+
T Consensus       172 ~~~~~~~~~~~l~~F~~~L~~~~~~~~~~~~v~W------------------------YDs~t~~G~l~wQn~Ln~~N~~  227 (653)
T 2w91_A          172 TGDLVKPLGEKMRQFMLYSKEYAAKVNHPIKYSW------------------------YDAMTYNYGRYHQDGLGEYNYQ  227 (653)
T ss_dssp             CSTTTGGGHHHHHHHHHHHHHHHHHTTCCCEEEE------------------------ESCBCSSSSBCCCSSSCTTTGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhccCCCcEEEE------------------------eeccccCCcEeecccccHhHHH
Confidence            4   4567899999999999998432 1121111                        1112221111122222333333


Q ss_pred             CCCC------C--------CC-CCHHHHHHHHHHcCCCCCceeecccCCC-CCcC
Q 006211          230 LYNP------S--------SN-ISTDFGIREWLRRGFPANKLVLGARASG-PGIT  268 (656)
Q Consensus       230 l~~~------~--------~~-~~~~~~v~~~~~~g~p~~Kl~lG~p~yG-~~~~  268 (656)
                      ++..      +        +. ...+.+++.....|.++..+.+|+-..| .+|.
T Consensus       228 ff~~~~~~~~~D~~FlNY~W~~~~l~~S~~~A~~~g~~~~dvy~GiDV~gggg~~  282 (653)
T 2w91_A          228 FMQPEGDKVPADNFFANFNWDKAKNDYTIATANWIGRNPYDVFAGLELQQGGSYK  282 (653)
T ss_dssp             GTCCBTTBCSCSEEEECSCCCHHHHHHHHHHHHHHTCCGGGEEEEEEHHHHTGGG
T ss_pred             HHhccCCCcccceEEEecCCCcchHHHHHHHHHHhCCCHHHEEEEEEEecCCCCC
Confidence            3322      1        11 1456667776677888899999988777 5543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.80  E-value=0.0039  Score=64.63  Aligned_cols=142  Identities=18%  Similarity=0.229  Sum_probs=81.2

Q ss_pred             CCcccccCceEEEEEEeC--------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCCceEEEE
Q 006211          440 ANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLIY  510 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  510 (656)
                      .+.|..|-...+|++...        +++.+++|+.... ......+.+|..+++.+...+ ..++++.+.+    .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888889998764        2478999986332 233455678998888874222 3556665543    3899


Q ss_pred             EecCCCChhhh-----------------hhCCC---cCCCC-CHHHHHHHHHHHHH-------------------HHHH-
Q 006211          511 EYLPNKSLDLY-----------------LFDPI---RRYVL-DWQKRVNIIEGVTQ-------------------GLLY-  549 (656)
Q Consensus       511 e~~~~g~L~~~-----------------l~~~~---~~~~l-~~~~~~~i~~~i~~-------------------~l~~-  549 (656)
                      ||++|..+..-                 ++...   .+... -+.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665311                 11110   11111 13344444433211                   2222 


Q ss_pred             ---HHhc-CCCCcEecccCCCCEEEcCC----CcEEEEeccCccc
Q 006211          550 ---LQEY-SNFRVIHRDLKASNILLDNE----LNPKISDFGMAKL  586 (656)
Q Consensus       550 ---Lh~~-~~~~iiH~Dikp~NILl~~~----~~~kl~DfGla~~  586 (656)
                         |... ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               3222 22349999999999999886    6899999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.78  E-value=0.0058  Score=62.24  Aligned_cols=33  Identities=36%  Similarity=0.443  Sum_probs=27.9

Q ss_pred             CCCcEecccCCCCEEEcCC----CcEEEEeccCcccc
Q 006211          555 NFRVIHRDLKASNILLDNE----LNPKISDFGMAKLF  587 (656)
Q Consensus       555 ~~~iiH~Dikp~NILl~~~----~~~kl~DfGla~~~  587 (656)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3459999999999999875    67999999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.78  E-value=0.0018  Score=68.58  Aligned_cols=73  Identities=15%  Similarity=0.229  Sum_probs=48.7

Q ss_pred             CCcccccCceEEEEEEeCC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCceEEEE
Q 006211          440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIY  510 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  510 (656)
                      .+.|+.|....+|++...+        ++.+++|+......  .+.+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568888889999997653        57899998844211  1345578888888743333 556665532    3899


Q ss_pred             EecCCCCh
Q 006211          511 EYLPNKSL  518 (656)
Q Consensus       511 e~~~~g~L  518 (656)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.76  E-value=0.016  Score=58.64  Aligned_cols=142  Identities=13%  Similarity=0.182  Sum_probs=80.1

Q ss_pred             CcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEE-----EeeCCceEEEEEec
Q 006211          441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV--NLLRVLGY-----CTERDENMLIYEYL  513 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  513 (656)
                      ..++ |....||+....+|+.+++|+..... ...+.+..|..+++.+...  .+.+++..     ....+..+++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77889999877677789999986431 1234566777777776422  23334332     12234557899999


Q ss_pred             CCCChhh-----h---------hh----CC--CcCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 006211          514 PNKSLDL-----Y---------LF----DP--IRRYVLDWQKR----VNI---------------IEGVTQGLLYLQEY-  553 (656)
Q Consensus       514 ~~g~L~~-----~---------l~----~~--~~~~~l~~~~~----~~i---------------~~~i~~~l~~Lh~~-  553 (656)
                      +|..+..     .         ++    ..  ......++...    ..+               ...+.+.+..+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754421     0         11    00  01111222111    000               11111223333321 


Q ss_pred             ---CCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          554 ---SNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       554 ---~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                         .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999999 4 899999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.33  E-value=0.0073  Score=64.32  Aligned_cols=73  Identities=12%  Similarity=0.161  Sum_probs=46.5

Q ss_pred             CcccccCceEEEEEEeCC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCceEEEEEecCCCCh
Q 006211          441 NKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      +.|+.|-...+|+....+ +..+++|+......... +...|..+++.+...++ .++++.+.  +  .+|+||+++..+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            568888889999997754 47788887744322111 12578888888865444 45666652  2  359999987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.19  E-value=0.008  Score=62.21  Aligned_cols=73  Identities=12%  Similarity=0.124  Sum_probs=43.1

Q ss_pred             CcccccCceEEEEEEeCC---------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCCceEEEE
Q 006211          441 NKLGEGGFGPVYKGNLPR---------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLIY  510 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  510 (656)
                      +.|+.|....+|+....+         ++.+++|+....... ......|..+++.+...+ ..++++..    ..++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            467788888999987643         268888887543221 112356777777774333 34565443    237899


Q ss_pred             EecCCCCh
Q 006211          511 EYLPNKSL  518 (656)
Q Consensus       511 e~~~~g~L  518 (656)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.94  E-value=0.045  Score=55.80  Aligned_cols=31  Identities=32%  Similarity=0.491  Sum_probs=27.5

Q ss_pred             CCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          556 FRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       556 ~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999988764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.61  E-value=0.014  Score=39.02  Aligned_cols=31  Identities=16%  Similarity=0.232  Sum_probs=15.3

Q ss_pred             eeEeehhhHHHHHHHHHHHHHhhhhhcccch
Q 006211          361 RLLLLILLPIGLVLILIASLICYFRRTAIKS  391 (656)
Q Consensus       361 ~~~i~i~~~~~~vl~~~~~~~~~~rr~~~~~  391 (656)
                      .+...+++.+++++++++++++|+|||++++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            3333444434444455555556666665543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.63  E-value=0.22  Score=52.15  Aligned_cols=74  Identities=11%  Similarity=0.110  Sum_probs=47.1

Q ss_pred             CCcccccCceEEEEEEeCC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCCceEEEE
Q 006211          440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLIY  510 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  510 (656)
                      .+.+..|-...+|+....+        ++.+++|+........ -+..+|..+++.+...+ ..++++.+.    .++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778889999997653        5789999865432211 12356777777774222 345554332    37899


Q ss_pred             EecCCCCh
Q 006211          511 EYLPNKSL  518 (656)
Q Consensus       511 e~~~~g~L  518 (656)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.06  E-value=0.049  Score=36.24  Aligned_cols=27  Identities=22%  Similarity=0.225  Sum_probs=11.9

Q ss_pred             eehhhHHHHHHHHHHHHHhhhhhcccc
Q 006211          364 LLILLPIGLVLILIASLICYFRRTAIK  390 (656)
Q Consensus       364 i~i~~~~~~vl~~~~~~~~~~rr~~~~  390 (656)
                      +.+++++.+++++.+++++|.|||+.+
T Consensus        15 a~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           15 ISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            333333444444444444555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=91.66  E-value=0.059  Score=35.94  Aligned_cols=22  Identities=27%  Similarity=0.495  Sum_probs=11.1

Q ss_pred             HHHHHHHHHHHHhhhhhcccch
Q 006211          370 IGLVLILIASLICYFRRTAIKS  391 (656)
Q Consensus       370 ~~~vl~~~~~~~~~~rr~~~~~  391 (656)
                      +++++++++.+++|+|||++++
T Consensus        20 v~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHhhhhhhhh
Confidence            4444444445555566655543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=89.20  E-value=1.1  Score=41.90  Aligned_cols=102  Identities=12%  Similarity=0.010  Sum_probs=64.5

Q ss_pred             ChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccccc
Q 006211          517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT  596 (656)
Q Consensus       517 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  596 (656)
                      +|.+.|..  .+.++++++++.++.|.+..|.-+-.... + ..+=+.|..|++..+|.|.+.+ ..+.           
T Consensus        34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            56667643  35679999999999999988876632111 1 1333457999999999988764 1110           


Q ss_pred             ccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCC
Q 006211          597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN  638 (656)
Q Consensus       597 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p  638 (656)
                         .....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122466888753 3456788999999999987755544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.98  E-value=0.64  Score=48.35  Aligned_cols=29  Identities=28%  Similarity=0.377  Sum_probs=24.8

Q ss_pred             cEecccCCCCEEEc------CCCcEEEEeccCccc
Q 006211          558 VIHRDLKASNILLD------NELNPKISDFGMAKL  586 (656)
Q Consensus       558 iiH~Dikp~NILl~------~~~~~kl~DfGla~~  586 (656)
                      ++|+|+.+.|||+.      ++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            67999999999993      456799999998864

>3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A

Probab=83.45  E-value=0.62  Score=52.46  Aligned_cols=82  Identities=10%  Similarity=0.045  Sum_probs=52.5

Q ss_pred             HHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCC---cccccc-ccCChhhHHHHHHHHHHHHHHcCCCcceeeeeC
Q 006211           78 IFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNIN---PSVLSS-MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLW  153 (656)
Q Consensus        78 ~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~---~~~f~~-~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~  153 (656)
                      ..+.+++++  +|||+=.|           |-.|...   ...|.. +..+++....+++.++++++.|||||.=|+-|.
T Consensus       256 ~winaAHrn--GV~VLGT~-----------i~ew~~~~~~~~~~~~~L~~d~~g~~~~A~KLveiAkyyGFDGWlINiE~  322 (937)
T 3gdb_A          256 DVIDAGHRN--GVPVYGTL-----------FFNWSNSIADQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQET  322 (937)
T ss_dssp             HHHHHHHHT--TCCEEEEE-----------EEEEECCHHHHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEE
T ss_pred             hHHHHHHhc--CCeEEEEE-----------ecCcccchhhHHHHHHHhccCccchhHHHHHHHHHHHHcCcCceEecccc
Confidence            444556665  79999777           1111111   112333 345666677999999999999999999999998


Q ss_pred             CCcc---CcchHHHHHHHHHhh
Q 006211          154 PNST---DLNSLGILLDEWKAS  172 (656)
Q Consensus       154 p~~~---d~~~~~~ll~~lr~~  172 (656)
                      ....   ...++..|++.+++.
T Consensus       323 ~~~~~~~~~~~l~~Fl~yl~e~  344 (937)
T 3gdb_A          323 TGDLVKPLGEKMRQFMLYSKEY  344 (937)
T ss_dssp             CSTTTGGGHHHHHHHHHHHHHH
T ss_pred             ccccchhhHHHHHHHHHHHHHH
Confidence            6542   234455555555543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	656
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-39
d1wb0a1	297	c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Huma	6e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-37
d1goia2	356	c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic	4e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d2pi6a1	292	c.1.8.5 (A:1-239,A:308-361) Signal processing prot	4e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-33
d1w9pa1	333	c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergil	7e-32
d1vf8a1	302	c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin	2e-31
d1jnda1	327	c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth f	2e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-29
d1itxa1	347	c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillu	1e-29
d1edqa2	358	c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalyt	6e-29
d1ll7a1	330	c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (	6e-28
d1kfwa1	374	c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitina	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1nara_	289	c.1.8.5 (A:) Seed storage protein {Vicia narbonens	3e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20
d2ebna_	285	c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl	4e-18
d1edta_	265	c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {St	8e-15
d2hvma_	273	c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para	3e-14
d1ta3a_	274	c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {	6e-11
d1eoka_	282	c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl	2e-06
d1vf8a2	70	d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mo	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-57
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 9/206 (4%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
              +   ++G G FG VYKG         +  ++A + Q L+ FKNEV +  + +HVN+L
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
             +GY T   +  ++ ++    SL  +L         +  K ++I     QG+ YL    
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH--- 121

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-- 612
              +IHRDLK++NI L  +L  KI DFG+A +  +        ++ G+  ++ PE ++  
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 613 -KGIYSMKYDVYSFGVLLLQIISSKR 637
            K  YS + DVY+FG++L ++++ + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-54
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 11/207 (5%)

Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQH 490
             ++F   ++LG G  G V+K  + P G   A K +       +  +   E+ +      
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             ++   G      E  +  E++   SLD  L    +   +  Q    +   V +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                 +++HRD+K SNIL+++    K+ DFG++        ++     VGT  Y+ PE 
Sbjct: 121 --REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR 637
           ++   YS++ D++S G+ L+++   + 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-52
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
                  +LG G FG V+ G      + AVK L   S    + F  E +L  +LQH  L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           R+    T+ +   +I EY+ N SL  +L  P     L   K +++   + +G+ +++E +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
               IHRDL+A+NIL+ + L+ KI+DFG+A+L   +   A  G       +  PE +  G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            +++K DV+SFG+LL +I++  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-52
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 7/203 (3%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +  +   ++G G FG V+ G      + A+K +        E+F  E  +  +L H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G C E+    L++E++ +  L  YL      +    +  + +   V +G+ YL+E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA- 120

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
              VIHRDL A N L+      K+SDFGM +    D    ++        +  PE     
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS 177

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            YS K DV+SFGVL+ ++ S  +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (452), Expect = 1e-51
 Identities = 60/230 (26%), Positives = 111/230 (48%), Gaps = 22/230 (9%)

Query: 425 FSFSDIKAATNNFSSA---------NKLGEGGFGPVYKGNLP----RGQEFAVKRL-SAT 470
           F+F D   A   F+             +G G FG V  G+L     R    A+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 471 STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV 530
           + +   +F +E S+  +  H N++ + G  T+    M+I E++ N SLD +L     ++ 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
               + V ++ G+  G+ YL   ++   +HRDL A NIL+++ L  K+SDFG+++    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 591 VDEANTGRIVG---TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
             +      +G      +  PE ++   ++   DV+S+G+++ +++S   
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-50
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 7/203 (3%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            + +   +LG G FG V  G      + A+K +   S    +EF  E  +   L H  L+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++ G CT++    +I EY+ N  L  YL +   R+    Q+ + + + V + + YL+   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
           + + +HRDL A N L++++   K+SDFG+++    D +  ++        + PPE +   
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYS 176

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            +S K D+++FGVL+ +I S  +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-49
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 7/203 (3%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
            +     KLG+G FG V+ G        A+K L    T   E F  E  +  +L+H  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
           ++    +  +   ++ EY+   SL  +L     +Y+    + V++   +  G+ Y++   
Sbjct: 76  QLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
               +HRDL+A+NIL+   L  K++DFG+A+L   +   A  G       +  PE    G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            +++K DV+SFG+LL ++ +  R
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (438), Expect = 1e-49
 Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 36/247 (14%)

Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATST 472
            P L    +       NN      +GEG FG V++   P           AVK L   ++
Sbjct: 2   NPKLLSLEY-----PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS 56

Query: 473 QGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV- 530
             ++ +F+ E +L A   + N++++LG C       L++EY+    L+ +L       V 
Sbjct: 57  ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116

Query: 531 --------------------LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570
                               L   +++ I   V  G+ YL E    + +HRDL   N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173

Query: 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630
              +  KI+DFG+++           G       ++PPE +    Y+ + DV+++GV+L 
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233

Query: 631 QIISSKR 637
           +I S   
Sbjct: 234 EIFSYGL 240

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-49
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 9/207 (4%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
            ++     LGEG +G V    N    +  AVK +    +    E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           +++  G+  E +   L  EY     L   +        +           +  G++YL  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
                + HRD+K  N+LLD   N KISDFG+A +FR +  E    ++ GT  YV PE +K
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 613 -KGIYSMKYDVYSFGVLLLQIISSKRN 638
            +  ++   DV+S G++L  +++ +  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP 205

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-49
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 13/203 (6%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
            +LG+G FG VYK  N       A K +   S + LE++  E+ + A   H N++++L  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
               +   ++ E+    ++D  + +  R   L   +   + +     L YL +    ++I
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKG 614
           HRDLKA NIL   + + K++DFG++    + +   ++   +GT  ++ PE V     K  
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            Y  K DV+S G+ L+++   + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP 213

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 4e-49
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)

Query: 420 PNL-QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG--- 474
           P++ ++F   D +     FS   ++G G FG VY   ++   +  A+K++S +  Q    
Sbjct: 2   PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58

Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
            ++   EV    +L+H N ++  G         L+ EY    + DL     + +  L   
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEV 115

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
           +   +  G  QGL YL  +    +IHRD+KA NILL      K+ DFG A +        
Sbjct: 116 EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167

Query: 595 NTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKR 637
                VGT  ++ PE +    +G Y  K DV+S G+  +++   K 
Sbjct: 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-49
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 13/204 (6%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
                   +G+G FG V  G+  RG + AVK +   +T   + F  E S+  +L+H NL+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 495 RVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           ++LG   E    + ++ EY+   SL  YL     R VL     +     V + + YL+  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG- 121

Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
                +HRDL A N+L+  +   K+SDFG+ K      D            +  PE +++
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174

Query: 614 GIYSMKYDVYSFGVLLLQIISSKR 637
             +S K DV+SFG+LL +I S  R
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-48
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 10/210 (4%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVN 492
           ++     +G G +G   K      G+    K L   + +    +   +EV+L   L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLY 549
           ++R      +R    L  + EY     L   +    + R  LD +  + ++  +T  L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 550 L--QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
              +      V+HRDLK +N+ LD + N K+ DFG+A++   D   A     VGT  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           PE + +  Y+ K D++S G LL ++ +   
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 212

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (425), Expect = 7e-48
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 12/223 (5%)

Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG 474
           D  +PN   +          + +  +KLG G +G VY+G   +     AVK L   + + 
Sbjct: 3   DPSSPNYDKWEME-----RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 56

Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
           +EEF  E ++   ++H NL+++LG CT      +I E++   +L  YL +   R  +   
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAV 115

Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
             + +   ++  + YL++      IHRDL A N L+      K++DFG+++L   D   A
Sbjct: 116 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172

Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           + G       +  PE +    +S+K DV++FGVLL +I +   
Sbjct: 173 HAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 12/211 (5%)

Query: 433 ATNNFSSAN-KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
             +N   A+ +LG G FG V +G      +  + A+K L   + +   EE   E  +  +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L +  ++R++G C + +  ML+ E      L  +L    +R  +       ++  V+ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVGTYGYV 606
            YL+       +HRDL A N+LL N    KISDFG++K    D               + 
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            PE +    +S + DV+S+GV + + +S  +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-47
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLR 495
            +LG G FG V KG        +  AVK L   +      +E   E ++  +L +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
           ++G C E +  ML+ E      L+ YL        +  +  + ++  V+ G+ YL+    
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---E 125

Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG-RIVGTYGYVPPEYVKKG 614
              +HRDL A N+LL  +   KISDFG++K  R D +             +  PE +   
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 615 IYSMKYDVYSFGVLLLQIISSKR 637
            +S K DV+SFGVL+ +  S  +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ 208

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-47
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 13/216 (6%)

Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNE 481
            + S  D K     ++   K+G+G  G VY   ++  GQE A+++++       E   NE
Sbjct: 11  SIVSVGDPK---KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67

Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
           + +    ++ N++  L      DE  ++ EYL   S    L D +    +D  +   +  
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCR 123

Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
              Q L +L      +VIHRD+K+ NILL  + + K++DFG         +++    +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVG 178

Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           T  ++ PE V +  Y  K D++S G++ +++I  + 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 17/205 (8%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVL 497
            ++G G F  VYKG +     E A   L     +    + FK E  +   LQH N++R  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 498 GYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
                  +     +L+ E + + +L  YL    R  V+  +   +    + +GL +L   
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT- 130

Query: 554 SNFRVIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
               +IHRDLK  NI +       KI D G+A L R          ++GT  ++ PE  +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE 186

Query: 613 KGIYSMKYDVYSFGVLLLQIISSKR 637
           +  Y    DVY+FG+ +L++ +S+ 
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEY 210

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-46
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
            +G+G FG V++G   RG+E AVK  S+   +     + E+  T  L+H N+L  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 502 ERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE----- 552
           + +       L+ +Y  + S    LFD + RY +  +  + +      GL +L       
Sbjct: 68  KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPEY 610
                + HRDLK+ NIL+       I+D G+A       D  +      VGT  Y+ PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 611 ------VKKGIYSMKYDVYSFGVLLLQIIS 634
                 +K      + D+Y+ G++  +I  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIAR 213

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 14/207 (6%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
            +F     LG+G FG VY     +     A+K L            + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
            N+LR+ GY  +     LI EY P  ++   L    +    D Q+    I  +   L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                 RVIHRD+K  N+LL +    KI+DFG +         +    + GT  Y+PPE 
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 175

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR 637
           ++  ++  K D++S GVL  + +  K 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP 202

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 5e-46
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 19/222 (8%)

Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF----AVKRLS-ATSTQGL 475
           L++   ++       F     LG G FG VYKG  +P G++     A+K L  ATS +  
Sbjct: 3   LRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 55

Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
           +E  +E  + A + + ++ R+LG C       LI + +P   L  Y+ +   +  +  Q 
Sbjct: 56  KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQY 112

Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
            +N    + +G+ YL+   + R++HRDL A N+L+    + KI+DFG+AKL   +  E +
Sbjct: 113 LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
                    ++  E +   IY+ + DV+S+GV + ++++   
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-45
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 32/246 (13%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
            N      LG G FG V               + AVK L   +     E   +E+ +  +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY----------------- 529
           L  H N++ +LG CT      LI+EY     L  YL     ++                 
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 530 ---VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
              VL ++  +     V +G+ +L+       +HRDL A N+L+ +    KI DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
              D +    G       ++ PE + +GIY++K DV+S+G+LL +I S   N  Y G   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272

Query: 647 NLNFLE 652
           + NF +
Sbjct: 273 DANFYK 278

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-45
 Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 15/210 (7%)

Query: 436 NFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQH 490
           +F+    +G G FG VY G L     +    AVK L+  +  G + +F  E  +     H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 491 VNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            N+L +LG C   + + +++  Y+ +  L  +       +    +  +     V +G+  
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM-- 143

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVP 607
            +  ++ + +HRDL A N +LD +   K++DFG+A+       ++   +        ++ 
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            E ++   ++ K DV+SFGVLL ++++   
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGA 232

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 9e-45
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 10/211 (4%)

Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTA 486
           K    +F     LGEG F  V     L   +E+A+K L          +     E  + +
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
           RL H   +++     + ++      Y  N  L  Y+         D            + 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTA---EI 117

Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
           +  L+      +IHRDLK  NILL+ +++ +I+DFG AK+   +  +A     VGT  YV
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            PE + +       D+++ G ++ Q+++   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-44
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 12/221 (5%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQE-----FAVKRLSATSTQG-LEEFKNEVSLTARL 488
           +  +    +G G FG VYKG L           A+K L A  T+    +F  E  +  + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
            H N++R+ G  ++    M+I EY+ N +LD +L +  +       + V ++ G+  G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRIVGTYGYVP 607
           Y    +N   +HRDL A NIL+++ L  K+SDFG++++   D +   T         +  
Sbjct: 125 Y---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           PE +    ++   DV+SFG+++ ++++      +  ++  +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 7e-44
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 14/211 (6%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLS---ATSTQGLEEFKNEVSLTAR 487
            +     KLG+G FG V +G       +    AVK L     +  + +++F  EV+    
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
           L H NL+R+ G         ++ E  P  SL   L      ++L    R      V +G+
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYV 606
            YL+     R IHRDL A N+LL      KI DFG+ +   ++ D           + + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            PE +K   +S   D + FGV L ++ +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-43
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLS-ATSTQGLEEFKNEVSLTARL-Q 489
           N+    + +GEG FG V K  + +     + A+KR+    S     +F  E+ +  +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKR 536
           H N++ +LG C  R    L  EY P+ +L  +L                     L  Q+ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
           ++    V +G+ YL +    + IHRDL A NIL+      KI+DFG+++     V     
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
                   ++  E +   +Y+   DV+S+GVLL +I+S   
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 26/237 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
           N  S    LG G FG V +               AVK L  ++     E   +E+ + + 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV---------------L 531
           L  H+N++ +LG CT     ++I EY     L  +L      ++               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
           D +  ++    V +G+ +L        IHRDL A NILL +    KI DFG+A+  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           +    G       ++ PE +   +Y+ + DV+S+G+ L ++ S   +       ++ 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 17/217 (7%)

Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTAR 487
              + + +LG+G FG VY+G              A+K ++ A S +   EF NE S+   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-------DPIRRYVLDWQKRVNII 540
               +++R+LG  ++    ++I E +    L  YL        +          K + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
             +  G+ YL      + +HRDL A N ++  +   KI DFGM +   +       G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
               ++ PE +K G+++   DV+SFGV+L +I +   
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  153 bits (387), Expect = 6e-42
 Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 11/206 (5%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
           +++    +LG G FG V++      G  FA K +        E  + E+   + L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           + +     + +E ++IYE++    L   + D      +   + V  +  V +GL ++ E 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 554 SNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
                +H DLK  NI+   + +   K+ DFG+         + +     GT  +  PE  
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVA 197

Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKR 637
           +        D++S GVL   ++S   
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS 223

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-42
 Identities = 45/212 (21%), Positives = 90/212 (42%), Gaps = 12/212 (5%)

Query: 442 KLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRV 496
            +GEG FG V++G            A+K     ++  + E+F  E     +  H +++++
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
           +G  TE +   +I E      L  +L        LD    +     ++  L YL+     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127

Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
           R +HRD+ A N+L+ +    K+ DFG+++   +D       +      ++ PE +    +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
           +   DV+ FGV + +I+           + ++
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 11/199 (5%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           +LG G FG V++      G+ F  K ++          KNE+S+  +L H  L+ +    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
            ++ E +LI E+L    L   +      Y +   + +N +    +GL ++ E     ++H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 561 RDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
            D+K  NI+ + +     KI DFG+A     D           T  +  PE V +     
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGF 207

Query: 619 KYDVYSFGVLLLQIISSKR 637
             D+++ GVL   ++S   
Sbjct: 208 YTDMWAIGVLGYVLLSGLS 226

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-40
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 13/218 (5%)

Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKN 480
           QVF   D+      +++ + +GEG +G V    +       A+K++S    Q   +    
Sbjct: 2   QVF---DV---GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 55

Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
           E+ +  R +H N++ +           +   YL    +   L+  ++   L        +
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 115

Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRI 599
             + +GL Y+       V+HRDLK SN+LL+   + KI DFG+A++   D D        
Sbjct: 116 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 600 VGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
           V T  Y  PE +     Y+   D++S G +L +++S++
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (369), Expect = 9e-40
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
            +F     LG G FG V+   +   G+ +A+K L        + +E   +E  + + + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             ++R+ G   +  +  +I +Y+    L   L    R      +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
           +   +  +I+RDLK  NILLD   + KI+DFG AK             + GT  Y+ PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR 637
           V    Y+   D +SFG+L+ ++++   
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (362), Expect = 3e-39
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 15/213 (7%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
           ++ +     LG GG   V+   +L   ++ AVK L    A        F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 490 HVNLLRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
           H  ++ V               ++ EY+   +L   +        +  ++ + +I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
            L +  +     +IHRD+K +NI++      K+ DFG+A+      +    T  ++GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
           Y+ PE  +      + DVYS G +L ++++ + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} Length = 297

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitotriosidase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 6e-39
 Identities = 90/329 (27%), Positives = 143/329 (43%), Gaps = 81/329 (24%)

Query: 30  AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
           A Y      F   D++ +L THLI AFA + +  +QLS +  N +      N +++ NP 
Sbjct: 11  AQYRQGEARFLPKDLDPSLCTHLIYAFAGMTN--HQLSTTEWNDETLYQEFNGLKKMNPK 68

Query: 90  IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
           +KTLL+I      T +             + MV  +++R++F+ S+IR  R Y F G+DL
Sbjct: 69  LKTLLAIGGWNFGTQK------------FTDMVATANNRQTFVNSAIRFLRKYSFDGLDL 116

Query: 150 FWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPI 198
            W +P S      D      L+ +        A  S +  L LS AV    T+    Y +
Sbjct: 117 DWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEV 176

Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREWLRRGFP 252
           D + +NL++ +L+AYD+H    E VTG ++ LY          +++ D  +++WL++G P
Sbjct: 177 DKIAQNLDFVNLMAYDFHGSW-EKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTP 235

Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
           A+KL+LG                                                 +  D
Sbjct: 236 ASKLILG-------------------------------------------------MPTD 246

Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDD 341
            VE+ K K+SY K+K L G   + L  DD
Sbjct: 247 DVESFKTKVSYLKQKGLGGAMVWALDLDD 275

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 26/226 (11%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
           +       LGEG FG V              R  + AVK L + +T+  L +  +E+ + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVL 531
             + +H N++ +LG CT+     +I EY    +L  YL                     L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
             +  V+    V +G+ YL      + IHRDL A N+L+  +   KI+DFG+A+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
               T        ++ PE +   IY+ + DV+SFGVLL +I +   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-38
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 26/240 (10%)

Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVS-LTA 486
           +       LG G FG V +            +  AVK L   +T        +E+  L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 487 RLQHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYLF-------------DPIRRYVLD 532
              H+N++ +LG CT+     M+I E+    +L  YL              + + +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
            +  +     V +G+ +L      + IHRDL A NILL  +   KI DFG+A+   KD D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
               G       ++ PE +   +Y+++ DV+SFGVLL +I S   +  Y G   +  F  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR 248

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (360), Expect = 4e-38
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 18/210 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEV---SLTAR 487
           N+FS    +G GGFG VY       G+ +A+K L        QG     NE    SL + 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
                ++ +       D+   I + +    L  +L    +  V            +  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
            ++       V++RDLK +NILLD   + +ISD G+A  F K          VGT+GY+ 
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMA 173

Query: 608 PEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
           PE ++KG+ Y    D +S G +L +++   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 13/208 (6%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVS-LTARLQ 489
            +F     LG+G FG V+        Q FA+K L          +E    E   L+   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
           H  L  +      ++    + EYL    L  ++      +  D  +       +  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           L       +++RDLK  NILLD + + KI+DFGM K       + NT    GT  Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            +    Y+   D +SFGVLL +++  + 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 41/199 (20%), Positives = 83/199 (41%), Gaps = 12/199 (6%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
            LG G FG V++       + +  K +    T      K E+S+    +H N+L +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
              +E ++I+E++    +   +      + L+ ++ V+ +  V + L +L       + H
Sbjct: 71  ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 561 RDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
            D++  NI+     +   KI +FG A+  +      N   +     Y  PE  +  + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 619 KYDVYSFGVLLLQIISSKR 637
             D++S G L+  ++S   
Sbjct: 183 ATDMWSLGTLVYVLLSGIN 201

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 41/199 (20%), Positives = 80/199 (40%), Gaps = 8/199 (4%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
           + LG G F  V    +    +  A+K ++  + +G E   +NE+++  +++H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
                    LI + +    L   +   + +     +    +I  V   + YL +      
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
             +        LD +    ISDFG++K+       +      GT GYV PE + +  YS 
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 619 KYDVYSFGVLLLQIISSKR 637
             D +S GV+   ++    
Sbjct: 189 AVDCWSIGVIAYILLCGYP 207

>d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 356

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase B, catalytic domain
species: Serratia marcescens [TaxId: 615]

 Score =  139 bits (352), Expect = 4e-37
 Identities = 66/342 (19%), Positives = 126/342 (36%), Gaps = 47/342 (13%)

Query: 32  YWLAGREFPLSDINSAL---FTHLICAFAEVDSSTYQLSISSANQQYFSIFAN---SVRR 85
              +   FP+S+I  A     TH+  +F +++S+       + N        N   +++ 
Sbjct: 22  TDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKA 81

Query: 86  KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
            NPS++ + SI  W   N        +  ++ +   + V   + R  F +S +R  + YG
Sbjct: 82  HNPSLRIMFSIGGWYYSN--------DLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYG 133

Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK--------ASASDQPELTLSMAVRYSPTHETVS 195
           F G+++ W +P + +++     L E +                  L++A        +  
Sbjct: 134 FDGVNIDWEYPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRY 193

Query: 196 Y-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
           Y  +  +   L++ +L+ YD   P  E VT   AAL+  ++  +    +R     G+   
Sbjct: 194 YSKLAQIVAPLDYINLMTYDLAGPW-EKVTNHQAALFGDAAGPTFYNALR-EANLGWSWE 251

Query: 255 KLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGV 314
           +L     +            +                V +A  V+         + FD  
Sbjct: 252 ELTRAFPSPFSLTVDAAVQQH-----------LMMEGVPSAKIVM--------GVPFDDA 292

Query: 315 ETIKAKISYAKEKNLLGYKAFQLSNDD-NWALSRAAQIEENN 355
           E+ K K  Y K++ L G   + L  D+ N  L  A     N 
Sbjct: 293 ESFKYKAKYIKQQQLGGVMFWHLGQDNRNGDLLAALDRYFNA 334

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 5e-37
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 9/205 (4%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN 492
           NF    K+GEG +G VYK  N   G+  A+K  RL   +         E+SL   L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++++L      ++  L++E+L            +    +      + +  + QGL +   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
           +   RV+HRDLK  N+L++ E   K++DFG+A+ F        T  +V  +   P   + 
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILLG 176

Query: 613 KGIYSMKYDVYSFGVLLLQIISSKR 637
              YS   D++S G +  ++++ + 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 9e-36
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 15/203 (7%)

Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-----FKNEVSLTARLQHVNLL 494
           + LGEG F  VYK  +    Q  A+K++        ++        E+ L   L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
            +L     +    L+++++      +         VL        +    QGL YL ++ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK- 613
              ++HRDLK +N+LLD     K++DFG+AK F            V T  Y  PE +   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGA 175

Query: 614 GIYSMKYDVYSFGVLLLQIISSK 636
            +Y +  D+++ G +L +++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (336), Expect = 1e-35
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 9/204 (4%)

Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN 492
             +    K+GEG +G VYK     G+ FA+K  RL             E+S+   L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++++      +   +L++E+L      L          L+     + +  +  G+ Y  +
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
               RV+HRDLK  N+L++ E   KI+DFG+A+ F   V +     IV  +   P   + 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174

Query: 613 KGIYSMKYDVYSFGVLLLQIISSK 636
              YS   D++S G +  ++++  
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} Length = 292

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Signal processing protein (SPC-40, MGP-40)
species: Sheep (Ovis aries) [TaxId: 9940]

 Score =  132 bits (333), Expect = 4e-35
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 74/322 (22%)

Query: 30  AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
           + Y           I+  L TH+I  FA + ++       +    Y ++  N+++ +NP 
Sbjct: 11  SQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEIDTWEWNDVTLYDTL--NTLKNRNPK 68

Query: 90  IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
           +KTLLS+                  P   S +   +  R++FI+S     R +GF G+DL
Sbjct: 69  LKTLLSVGGWNFG------------PERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDL 116

Query: 150 FWLWPNSTDLNSLGILLDEW-----KASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
            WL+P   D   L  L+ E      + + +   +L LS AV          Y I  + ++
Sbjct: 117 AWLYPGRRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDIAQISRH 176

Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI-----STDFGIREWLRRGFPANKLVLG 259
           L++  L+ YD+H        G H+ L+  + +      + D+ +   LR G PANKLV+G
Sbjct: 177 LDFISLLTYDFHGAW-RQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMG 235

Query: 260 ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKA 319
                                                            I  D  E++K 
Sbjct: 236 -------------------------------------------------IPTDDQESVKN 246

Query: 320 KISYAKEKNLLGYKAFQLSNDD 341
           K  Y K + L G   + L  DD
Sbjct: 247 KARYLKNRQLAGAMVWALDLDD 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (332), Expect = 4e-35
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 26/218 (11%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL---------EEFKNEVSLT 485
           N+     LG G    V +  + P  +E+AVK +  T              E    EV + 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 486 ARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
            ++  H N++++           L+++ +    L  YL     +  L  ++   I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           + +  L +     ++HRDLK  NILLD+++N K++DFG +              + GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPS 174

Query: 605 YVPPEYV------KKGIYSMKYDVYSFGVLLLQIISSK 636
           Y+ PE +          Y  + D++S GV++  +++  
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 5e-35
 Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)

Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
           +++    +G G FG VY+      G+  A+K++     Q       E+ +  +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76

Query: 495 RVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
           R+  +     E        L+ +Y+P     +       +  L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 549 YLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
           Y+  +    + HRD+K  N+LLD +    K+ DFG AK   +   E N   I   Y   P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAP 191

Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
                   Y+   DV+S G +L +++  + 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  132 bits (332), Expect = 5e-35
 Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 18/229 (7%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
            ++    ++GEG FG +++G NL   Q+ A+K     S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
           +  + Y  +   + ++   L   SL+  L    R+     +      + +   +  + E 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120

Query: 554 SNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDEAN-----TGRIVGTY 603
               +++RD+K  N L+    +       + DFGM K +R  V + +        + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
            Y+          S + D+ + G + +  +      +    + N    E
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-35
 Identities = 51/207 (24%), Positives = 78/207 (37%), Gaps = 20/207 (9%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE------FKNEVSLTARLQ--HVN 492
            LG GGFG VY G  +      A+K +         E         EV L  ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
           ++R+L +    D  +LI E                R  L  +   +    V + + +   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128

Query: 553 YSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
                V+HRD+K  NIL+D N    K+ DFG   L      +       GT  Y PPE++
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181

Query: 612 KKGIY-SMKYDVYSFGVLLLQIISSKR 637
           +   Y      V+S G+LL  ++    
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-34
 Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 12/207 (5%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
           N+F     LG+G FG V        G+ +A+K L      +   +     E  +    +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             L  +       D    + EY     L  +L    R  V   ++         + +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
           +   +  V++RD+K  N++LD + + KI+DFG+ K      D A      GT  Y+ PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEV 176

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR 637
           ++   Y    D +  GV++ +++  + 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-34
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 16/215 (7%)

Query: 433 ATNNFSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARL 488
           A   +    ++GEG +G V+K       G+  A+KR+   + +         EV++   L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 489 ---QHVNLLRVLGYCTERDENMLIYEYLPNKSLD---LYLFDPIRRYVLDWQKRVNIIEG 542
              +H N++R+   CT    +      L  + +D       D +    +  +   +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
           + +GL +L      RV+HRDLK  NIL+ +    K++DFG+A+++     +     +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 178

Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
             Y  PE + +  Y+   D++S G +  ++   K 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-34
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 23/224 (10%)

Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LE 476
           VF   ++    + + +  +LG G F  V K      G ++A K +    T+        E
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
           + + EVS+   +QH N++ +      + + +LI E +    L         +  L  ++ 
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEA 115

Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVD 592
              ++ +   L  +    + ++ H DLK  NI+L +   P    KI DFG+A       +
Sbjct: 116 TEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172

Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
                 I GT  +V PE V      ++ D++S GV+   ++S  
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-34
 Identities = 44/206 (21%), Positives = 83/206 (40%), Gaps = 10/206 (4%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV 491
             +    K+GEG +G V+K  N    +  A+K  RL             E+ L   L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
           N++R+        +  L++E+        +                 +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
              +  V+HRDLK  N+L++     K+++FG+A+ F        +  +V  +   P    
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKR 637
              +YS   D++S G +  ++ ++ R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (324), Expect = 7e-34
 Identities = 42/220 (19%), Positives = 78/220 (35%), Gaps = 16/220 (7%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
           K+G G FG +Y G ++  G+E A+K     +     +   E  +   +Q    +  + +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
               +  ++   L   SL+       R+     +  + + + +   + Y+        IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSK---NFIH 126

Query: 561 RDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEAN-----TGRIVGTYGYVPPEYVK 612
           RD+K  N L           I DFG+AK +R      +        + GT  Y       
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
               S + D+ S G +L+         +    +      E
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 46/217 (21%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHV 491
           + +    K+G+G FG V+K  +   GQ+ A+K++   + +         E+ +   L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 492 NLLRVLGYCTERDENM--------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
           N++ ++  C  +            L++++  +    L   + + ++ L   KRV     +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----M 123

Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVG 601
              L  L      +++HRD+KA+N+L+  +   K++DFG+A+ F    +         V 
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKR 637
           T  Y PPE +     Y    D++  G ++ ++ +   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} Length = 333

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase 1
species: Aspergillus fumigatus [TaxId: 5085]

 Score =  124 bits (312), Expect = 7e-32
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 57/335 (17%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
           GR     D+     TH++ AFA V   T ++ ++ +       +                
Sbjct: 18  GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 77

Query: 81  ---NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
                ++++N ++K LLSI     S                +      + RK+F +++++
Sbjct: 78  KQLYLLKKQNRNLKVLLSIGGWTYSPNF-------------APAASTDAGRKNFAKTAVK 124

Query: 138 TARLYGFQGIDLFWLWPN--------STDLNSLGILLDEWKASASDQPELTLSMAVRYSP 189
             +  GF G+D+ W +P            L  +   LD + A+ +      L++A    P
Sbjct: 125 LLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGP 184

Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIR 244
                   +  M + L++ +L+AYDY      +++G  A +YN +SN      +T   + 
Sbjct: 185 DK-IKVLHLKDMDQQLDFWNLMAYDYAGSF-SSLSGHQANVYNDTSNPLSTPFNTQTALD 242

Query: 245 EWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS 304
            +   G PANK+VLG     P    +   GY      I++ G G A  +++S       S
Sbjct: 243 LYRAGGVPANKIVLGMPLDNPQ-VANLKSGY------IKSLGLGGAMWWDSSSDKTGSDS 295

Query: 305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
             T +    V  +     + + +N L Y   Q  N
Sbjct: 296 LITTV----VNALGGTGVFEQSQNELDYPVSQYDN 326

>d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 302

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase-like lectin ym1, saccharide binding domain
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 75/329 (22%), Positives = 122/329 (37%), Gaps = 81/329 (24%)

Query: 30  AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
           A        F   +I+  L THLI AFA + ++    +     + Y ++  N ++ KN  
Sbjct: 11  AKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNEITYTHEQDLRDYEAL--NGLKDKNTE 68

Query: 90  IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
           +KTLL+I            G     P+  S+MV    +R+ FI+S IR  R Y F G++L
Sbjct: 69  LKTLLAI------------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNL 116

Query: 150 FWLWPNSTDLNS-----LGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPI 198
            W +P S            +L+ E +      +   D P L L+             Y I
Sbjct: 117 DWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEKDIPRLLLTSTGAGIIDVIKSGYKI 176

Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFP 252
             + ++L++  ++ YD H P  +  TG ++ LY        S++++ D  I  W   G  
Sbjct: 177 PELSQSLDYIQVMTYDLHDPK-DGYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGAA 235

Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
           + KL++G                                                    D
Sbjct: 236 SEKLIVG-------------------------------------------------FPAD 246

Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDD 341
            V + K K  + K+ NL G   + L  DD
Sbjct: 247 NVRSFKLKAQWLKDNNLGGAVVWPLDMDD 275

>d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 327

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Imaginal disc growth factor-2
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score =  122 bits (308), Expect = 2e-31
 Identities = 65/355 (18%), Positives = 117/355 (32%), Gaps = 101/355 (28%)

Query: 30  AGYWLAGREFPLSDINSALF--THLICAFAEVDSSTYQLSISS----ANQQYFSIFANSV 83
           +       +    D+  AL   +HL+  +A +     Q    +      +  FS    S+
Sbjct: 11  SYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSL 69

Query: 84  RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
           +RK P +K LLS+    +          +     +  + G+   +  FI S+    + YG
Sbjct: 70  KRKYPHLKVLLSVGGDHDIDP-------DHPNKYIDLLEGEKVRQIGFIRSAYELVKTYG 122

Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK------------------------------ASA 173
           F G+DL + +P +      G L   WK                                +
Sbjct: 123 FDGLDLAYQFPKNKPRKVHGDLGLAWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDS 182

Query: 174 SDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH-MPSKENVTGIHAALYN 232
                  LS+ V  +    T  + I ++   +++ +L  +D+             A +Y+
Sbjct: 183 LRADGFLLSLTVLPNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYH 241

Query: 233 PS------SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYG 286
           P       ++++ DF +  WL +GFP+NK+ L                            
Sbjct: 242 PDGSKDRLAHLNADFQVEYWLSQGFPSNKINL---------------------------- 273

Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
                                 +  D  ++   K +YA+ KNL G   F LS DD
Sbjct: 274 ---------------------GVATDDPDSASNKAAYARVKNLGGVALFDLSYDD 307

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 21/204 (10%)

Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYC 500
           LG G  G V +  N    ++FA+K L     Q   + + EV L  R  Q  +++R++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 501 ----TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
                 R   +++ E L    L   + D   +     ++   I++ + + + YL      
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSI--- 130

Query: 557 RVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
            + HRD+K  N+L  ++      K++DFG AK                T  YV PE +  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 614 GIYSMKYDVYSFGVLLLQIISSKR 637
             Y    D++S GV++  ++    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP 211

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
            +G G +G V    +   G + A+K+L     S    +    E+ L   ++H N++ +L 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 499 YCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
             T  +      + YL    +   L   ++   L   +   ++  + +GL Y+       
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143

Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
             HRDLK  N+ ++ +   KI DFG+A+      D   TG +V  +   P   +    Y+
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYVVTRWYRAPEVILNWMRYT 197

Query: 618 MKYDVYSFGVLLLQIISSK 636
              D++S G ++ ++I+ K
Sbjct: 198 QTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (296), Expect = 1e-29
 Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 15/207 (7%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
           + F     LG G FG V    +   G  +A+K L        + +E   NE  +   +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             L+++     +     ++ EY+    +  +L    R               +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  +I+RDLK  N+L+D +   +++DFG AK       +  T  + GT   + PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209

Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR 637
           +    Y+   D ++ GVL+ ++ +   
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} Length = 347

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase A1
species: Bacillus circulans [TaxId: 1397]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 66/383 (17%), Positives = 125/383 (32%), Gaps = 133/383 (34%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
           GR + ++DI+    TH+  AFA++  +    +   +     +                  
Sbjct: 25  GRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTI 84

Query: 81  -----------------------------NSVRRKNPSIKTLLSIWNGQNSTYQSILGNK 111
                                        N +++ NP++KT++S+     S   S     
Sbjct: 85  VLGDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISVGGWTWSNRFSD---- 140

Query: 112 NINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWK- 170
                    +   ++ R+ F  S++   R Y F G+DL W +P S  L+      ++ + 
Sbjct: 141 ---------VAATAATREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQN 191

Query: 171 --------------ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH 216
                         A A D  +  L++A   S T+   +  +  +   ++W +++ YD++
Sbjct: 192 YTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAA-NTELAKIAAIVDWINIMTYDFN 250

Query: 217 MPSKENVTGIHAALY----------NPSSNISTDFGIREWLRRGFPANKLVLGARASGPG 266
               + ++  +A L             ++  +   G +  L  G PA KLVLG       
Sbjct: 251 GAW-QKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLG------- 302

Query: 267 ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKE 326
                                                     + FD  E++  K +Y K 
Sbjct: 303 ------------------------------------------VPFDDAESVGYKTAYIKS 320

Query: 327 KNLLGYKAFQLSNDDNWALSRAA 349
           K L G   ++LS D N  L    
Sbjct: 321 KGLGGAMFWELSGDRNKTLQNKL 343

>d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 358

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase A, catalytic domain
species: Serratia marcescens [TaxId: 615]

 Score =  116 bits (291), Expect = 6e-29
 Identities = 52/370 (14%), Positives = 113/370 (30%), Gaps = 102/370 (27%)

Query: 28  IKAGYW----LAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
           +   Y+    + GR F +  I +   THL+  F  +             +  F     S 
Sbjct: 27  VVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSC 86

Query: 84  RRKNPSIKTLLSIW--------------NGQNSTYQSILGNKNINPSVL----------- 118
           + +     ++   +              +     +  ++  K  +P +            
Sbjct: 87  QGREDFKVSIHDPFAALQKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGWTLS 146

Query: 119 --SSMVGDSSHRKSFIESSIRTARLYG-FQGIDLFWLWP----------NSTDLNSLGIL 165
                +GD   R  F+ S     + +  F G+D+ W +P          +  D  +  +L
Sbjct: 147 DPFFFMGDKVKRDRFVGSVKEFLQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLL 206

Query: 166 LDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSK 220
           + E +A     S     +  L+ A+  +   +      +  + +++   L++YD++    
Sbjct: 207 MKELRAMLDQLSVETGRKYELTSAI-SAGKDKIDKVAYNVAQNSMDHIFLMSYDFYGAFD 265

Query: 221 ENVTGIHAALY----NPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYK 276
               G   AL      P +  +T  G+   L +G    K+V+G                 
Sbjct: 266 LKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVG----------------- 308

Query: 277 FIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQ 336
                                                  +++AK  Y  +K L G  +++
Sbjct: 309 -----TAMDA----------------------------RSVQAKGKYVLDKQLGGLFSWE 335

Query: 337 LSNDDNWALS 346
           +  D+   L+
Sbjct: 336 IDADNGDILN 345

>d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} Length = 330

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase 1
species: Fungus (Coccidioides immitis) [TaxId: 5501]

 Score =  112 bits (282), Expect = 6e-28
 Identities = 66/335 (19%), Positives = 124/335 (37%), Gaps = 58/335 (17%)

Query: 36  GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
           GR     D+ +  FTH++ AFA +   + ++ +S         +                
Sbjct: 16  GRGHNPQDLKADQFTHILYAFANIRP-SGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCI 74

Query: 81  ---NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
                +++ N ++KTLLSI     S                 +       RK F ++S++
Sbjct: 75  KQMYLLKKNNRNLKTLLSIGGWTYSPN-------------FKTPASTEEGRKKFADTSLK 121

Query: 138 TARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYSP 189
             +  GF GID+ W +P            L +    LD + A   +  +  L++A    P
Sbjct: 122 LMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGP 181

Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIR 244
            +      +  M K L++ +L+AYD+     + V+G  + ++  ++       S+D  ++
Sbjct: 182 QNYN-KLKLAEMDKYLDFWNLMAYDFSGS-WDKVSGHMSNVFPSTTKPESTPFSSDKAVK 239

Query: 245 EWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS 304
           ++++ G PANK+VLG               Y      I   G G    + +S       +
Sbjct: 240 DYIKAGVPANKIVLGMPLDTVK-IAGKKAEY------ITKNGMGGGMWWESSS----DKT 288

Query: 305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
           G   +    V  +       + +N L Y      N
Sbjct: 289 GNESLVGTVVNGLGGTGKLEQRENELSYPESVYDN 323

>d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} Length = 374

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Psychrophilic chitinase B
species: Arthrobacter sp., tad20 [TaxId: 1667]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 65/397 (16%), Positives = 114/397 (28%), Gaps = 145/397 (36%)

Query: 36  GREFPLSDINS----ALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA----------- 80
           GR F    ++        TH+  +F  +++ T    +++  Q      +           
Sbjct: 22  GRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFG 81

Query: 81  ---------------------------NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNI 113
                                        ++ KNP +K ++S+     S           
Sbjct: 82  MGYAADKSVSGKADTWDQPLAGSFNQLKQLKAKNPKLKVMISLGGWTWSKNF-------- 133

Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYG----------------FQGIDLFWLWPNST 157
                S      + R+  + S I                       F GID+ W WP + 
Sbjct: 134 -----SKAAATEASRQKLVSSCIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTN 188

Query: 158 ------------DLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTH-ETVSYPID 199
                       D  +   LL E++       +++  +  LS  +  +P   +   +   
Sbjct: 189 SGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSAFLPANPADIDAGGWDDP 248

Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN-------PSSNISTDFGIREWLRRGFP 252
           +  K+L++  +  YD H      +TG  A LY+       PS   S D  ++++L  G  
Sbjct: 249 ANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGID 308

Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
             +L LG                                                 +  D
Sbjct: 309 PKQLGLG-------------------------------------------------LAAD 319

Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
            + T K K  Y   K L G   ++LS D N  L  A 
Sbjct: 320 NIATTKQKTDYIVSKGLGGGMWWELSGDRNGELVGAM 356

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 4e-27
 Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 18/214 (8%)

Query: 435 NNFSSANKLGEGGFGPVYKG----NLPRGQEFAVKRLS----ATSTQGLEEFKNEVSLTA 486
            NF     LG G +G V+          G+ +A+K L         +  E  + E  +  
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 487 RLQHV-NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
            ++    L+ +        +  LI +Y+    L  +L    R    + Q  V       +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
            +L L+      +I+RD+K  NILLD+  +  ++DFG++K F    +        GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEY 196

Query: 606 VPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKR 637
           + P+ V+ G   +    D +S GVL+ ++++   
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 11/207 (5%)

Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQH 490
              + + + +G G +G V    +   G   AVK+LS    S    +    E+ L   ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 491 VNLLRVLGYCTERDENMLI-YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
            N++ +L   T           YL    +   L + ++   L       +I  + +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
           +         HRDLK SN+ ++ +   KI DFG+A+      D+  TG +   +   P  
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 189

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSK 636
            +    Y+   D++S G ++ ++++ +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 40/208 (19%), Positives = 86/208 (41%), Gaps = 19/208 (9%)

Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVN 492
           +++    KLG G +  V++  N+   ++  VK L        ++ K E+ +   L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 493 LLRVLGYCTERDENM--LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
           ++ +     +       L++E++ N           +   L        +  + + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQT--LTDYDIRFYMYEILKALDYC 145

Query: 551 QEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
                  ++HRD+K  N+++D+E    ++ D+G+A+ +     +    R+   Y   P  
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPEL 200

Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
            V   +Y    D++S G +L  +I  K 
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 5e-25
 Identities = 47/225 (20%), Positives = 90/225 (40%), Gaps = 27/225 (12%)

Query: 427 FSDIKAATNNFSSANK------LGEGGFGPVYKG-NLPRGQEFAVKRLS--ATSTQGLEE 477
           F  ++   + F+   +      +G G  G V    +    +  A+K+LS    +    + 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62

Query: 478 FKNEVSLTARLQHVNLLRVLGYCT------ERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
              E+ L   + H N++ +L   T      E  +  L+ E +      +   +       
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116

Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
           D ++   ++  +  G+ +L        IHRDLK SNI++ ++   KI DFG+A+      
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
                   V T  Y  PE +    Y    D++S G ++ +++  K
Sbjct: 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 1e-23
 Identities = 42/212 (19%), Positives = 84/212 (39%), Gaps = 22/212 (10%)

Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL------- 493
           KLG G F  V+   ++      A+K +        E  ++E+ L  R+   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 494 ----LRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
               L++L +   +  N    ++++E L    L L      R   L + K+  I + +  
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 136

Query: 546 GLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
           GL Y+       +IH D+K  N+L++  +    +    +A L      + +    + T  
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
           Y  PE +    +    D++S   L+ ++I+  
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]} Length = 289

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Seed storage protein
species: Vicia narbonensis, Narbonin [TaxId: 3912]

 Score = 89.4 bits (221), Expect = 3e-20
 Identities = 41/296 (13%), Positives = 87/296 (29%), Gaps = 38/296 (12%)

Query: 32  YWLA-GREFPLSDI------NSALFTHLICAFAEVD-----SSTYQLSISSANQQYFSIF 79
           Y         L D          L  H I  FA          T     S   + +    
Sbjct: 8   YIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEK 67

Query: 80  ANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA 139
             +++R++P +K ++SI     +T           P+  +  V ++      I       
Sbjct: 68  VKNLKRRHPEVKVVISIGGRGVNTPFD--------PAEENVWVSNAKESLKLIIQKYSDD 119

Query: 140 RLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPID 199
                 GID+ +    S +      L+ +         +L +++    +P+    S+   
Sbjct: 120 SGNLIDGIDIHYEHIRSDE--PFATLMGQLITELKKDDDLNINVVS-IAPSENNSSHYQK 176

Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
                 ++ + V Y +    ++ V+   A +            I + L + +  +K++ G
Sbjct: 177 LYNAKKDYINWVDYQFSN-QQKPVSTDDAFVE-----------IFKSLEKDYHPHKVLPG 224

Query: 260 ARASGPGITIDGSMGYKFIRA--FIQNYG-YGAAPVYNASYVVNLFTSGATWINFD 312
                     +      FI     +           +NA+  V     G      +
Sbjct: 225 FSTDPLDTKHNKITRDIFIGGCTRLVQTFSLPGVFFWNANDSVIPKRDGDKPFIVE 280

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 4e-20
 Identities = 35/194 (18%), Positives = 65/194 (33%), Gaps = 25/194 (12%)

Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----------QGLEEFKNEVSLTARLQH 490
             +GEG    V+     +  E  VK      T           G   F      +AR + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
             L ++ G    +      Y +  N ++ + L D    Y +  +    +++ + + +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
                  ++H DL   N+L+  E    I DF  +     +V E     I+         Y
Sbjct: 120 YHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS----VEVGEEGWREILERDVRNIITY 171

Query: 611 VKKGIYSMKYDVYS 624
             +  Y  + D+ S
Sbjct: 172 FSRT-YRTEKDINS 184

>d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]} Length = 285

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]

 Score = 82.9 bits (204), Expect = 4e-18
 Identities = 35/283 (12%), Positives = 78/283 (27%), Gaps = 33/283 (11%)

Query: 38  EFPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSI--FANSVRR-KNPSIKT 92
            F L +    L   ++   A +  D++  ++ +S+       +   A  ++  ++  IK 
Sbjct: 24  NFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKV 83

Query: 93  LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
           +LSI    + +  + L                ++  K+F +    T  LY   G+     
Sbjct: 84  ILSILGNHDRSGIANL---------------STARAKAFAQELKNTCDLYNLDGVFFDDE 128

Query: 153 WPNSTDLNSLGILLDEW-------KASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNL 205
           +         G +             +    P   +++ V    +    +          
Sbjct: 129 YSAYQTPPPSGFVTPSNNAAARLAYETKQAMPNKLVTVYVYSRTSSFPTAV---DGVNAG 185

Query: 206 NWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGP 265
           ++     +DY   S +  T       +     S +F    +       N +  G      
Sbjct: 186 SYVDYAIHDYG-GSYDLATNYPGLAKSGMVMSSQEFNQGRYATAQALRNIVTKGYGGHMI 244

Query: 266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATW 308
                      F    +      A  +Y    V +       W
Sbjct: 245 FAMDPN--RSNFTSGQLPALKLIAKELYGDELVYSNTPYSKDW 285

>d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]} Length = 265

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]

 Score = 72.8 bits (178), Expect = 8e-15
 Identities = 32/240 (13%), Positives = 61/240 (25%), Gaps = 35/240 (14%)

Query: 32  YWLAGREFPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSI--FANSVRR-K 86
             L   ++ L+D     F   +   A +  D+ T    +         +      +R  +
Sbjct: 16  SMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQ 75

Query: 87  NPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
              IK LLS+                       +         +F +        YG  G
Sbjct: 76  QQGIKVLLSVLGNHQGAG--------------FANFPSQQAASAFAKQLSDAVAKYGLDG 121

Query: 147 IDLFWLWP-------NSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPID 199
           +D    +           + +S   L+   +A+  D     +S+     P    +SY   
Sbjct: 122 VDFDDEYAEYGNNGTAQPNDSSFVHLVTALRANMPD---KIISLYN-IGPAASRLSYGGV 177

Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
            +    ++       Y+      V GI       S                     +  G
Sbjct: 178 DVSDKFDY---AWNPYYGTW--QVPGIALPKAQLSPAAVEIGRTSRSTVADLARRTVDEG 232

>d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]} Length = 273

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Hevamine A (chitinase/lysozyme)
species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]

 Score = 71.3 bits (174), Expect = 3e-14
 Identities = 42/280 (15%), Positives = 86/280 (30%), Gaps = 36/280 (12%)

Query: 30  AGYWLA-GREFPLSD-INSALFTHLICAFAEVDSS--TYQLSISSANQQYFS----IFAN 81
           A YW   G E  L+   ++  ++++  AF     +  T Q++++            +   
Sbjct: 4   AIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNG 63

Query: 82  SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
               +   IK +LS+  G  S   +       + +   ++     +     +SS R    
Sbjct: 64  IRSCQIQGIKVMLSLGGGIGSYTLA-------SQADAKNVADYLWNNFLGGKSSSRPLGD 116

Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
               GID      ++   + L   L     + S Q +     A    P  +         
Sbjct: 117 AVLDGIDFDIEHGSTLYWDDLARYLS----AYSKQGKKVYLTAAPQCPFPDR-YLGTALN 171

Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG-- 259
               ++  +  Y+                   S NI+              A K+ LG  
Sbjct: 172 TGLFDYVWVQFYNNPPC------------QYSSGNINNIINSWNRWTTSINAGKIFLGLP 219

Query: 260 --ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
               A+G G      +  + +    ++  YG   +++  Y
Sbjct: 220 AAPEAAGSGYVPPDVLISRILPEIKKSPKYGGVMLWSKFY 259

>d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]} Length = 274

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Xylanase inhibitor protein I, XIP-I
species: Wheat (Triticum aestivum) [TaxId: 4565]

 Score = 61.3 bits (148), Expect = 6e-11
 Identities = 35/272 (12%), Positives = 73/272 (26%), Gaps = 24/272 (8%)

Query: 30  AGYW-LAGREFPLSD-INSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
             +W     E  L +  +S ++T +  +F +V  +  +  +  +     S+ A+    ++
Sbjct: 9   TVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQS 68

Query: 88  PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
             +   LSI             +       L      +S+      S  R        G+
Sbjct: 69  KGVPVSLSIGGYGTGYSLPSNRSALDLFDHL-----WNSYFGGSKPSVPRPFGDAWLDGV 123

Query: 148 DLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
           DLF       D   +  L            +     A                       
Sbjct: 124 DLFLEHGTPADRYDVLALELAKHNIRGGPGKPLHLTATVRCGYPPAAHVGRALATGIFER 183

Query: 208 AHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGI 267
            H+  Y+      +N  G   +    ++               +PA +  +G  A     
Sbjct: 184 VHVRTYESDKWCNQN-LGWEGSWDKWTA--------------AYPATRFYVGLTADDKSH 228

Query: 268 T-IDGSMGYKFIRAFIQNYG-YGAAPVYNASY 297
             +     Y  +    Q    YG   +++  +
Sbjct: 229 QWVHPKNVYYGVAPVAQKKDNYGGIMLWDRYF 260

>d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]} Length = 282

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]

 Score = 47.5 bits (112), Expect = 2e-06
 Identities = 36/276 (13%), Positives = 65/276 (23%), Gaps = 28/276 (10%)

Query: 33  WLAGREFPLSDINSA--LFTHLICAFAEVDSSTYQLSISSANQQYFS--IFANSVRR-KN 87
                 F L DI     +       +  +  +T     +     + S       +R  ++
Sbjct: 11  DGRNPTFKLKDIPDKVDMVILFGLKYWSLQDTTKLPGGTGMMGSFKSYKDLDTQIRSLQS 70

Query: 88  PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
             IK L +I     S   S  G               +S               +   GI
Sbjct: 71  RGIKVLQNID-DDVSWQSSKPGG-------------FASAAAYGDAIKSIVIDKWKLDGI 116

Query: 148 DLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
            L      +                         +     +   E   Y   +   N   
Sbjct: 117 SLDIEHSGAKPNPIPTFPGYAATGYNGWYSGSMAATPAFLNVISELTKYFGTTAPNNKQL 176

Query: 208 AHLVAYDYHMPSKE------NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGAR 261
                 D +  +K       N   I    Y  + + +             PA+K+V GA 
Sbjct: 177 QIASGIDVYAWNKIMENFRNNFNYIQLQSYGANVSRTQLMMNYATGTNKIPASKMVFGAY 236

Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
           A G     + +   +  +        G   +Y  + 
Sbjct: 237 AEGG---TNQANDVEVAKWTPTQGAKGGMMIYTYNS 269

>d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 70

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase-like lectin ym1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 34.8 bits (80), Expect = 0.002
 Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 8/59 (13%)

Query: 258 LGARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311
           +GA     G         G + Y  +  F+     GA  V++A   V     G  W+ +
Sbjct: 15  IGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQEVPYAYQGNEWVGY 70

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	656
d1itxa1	347	Chitinase A1 {Bacillus circulans [TaxId: 1397]}	100.0
d2pi6a1	292	Signal processing protein (SPC-40, MGP-40) {Sheep	100.0
d1kfwa1	374	Psychrophilic chitinase B {Arthrobacter sp., tad20	100.0
d1edqa2	358	Chitinase A, catalytic domain {Serratia marcescens	100.0
d1wb0a1	297	Chitotriosidase {Human (Homo sapiens) [TaxId: 9606	100.0
d1w9pa1	333	Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]}	100.0
d1jnda1	327	Imaginal disc growth factor-2 {Fruit fly (Drosophi	100.0
d1vf8a1	302	Chitinase-like lectin ym1, saccharide binding doma	100.0
d1ll7a1	330	Chitinase 1 {Fungus (Coccidioides immitis) [TaxId:	100.0
d1goia2	356	Chitinase B, catalytic domain {Serratia marcescens	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1nara_	289	Seed storage protein {Vicia narbonensis, Narbonin	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d2hvma_	273	Hevamine A (chitinase/lysozyme) {Para rubber tree	99.96
d2ebna_	285	Endo-beta-N-acetylglucosaminidase {Flavobacterium	99.95
d1edta_	265	Endo-beta-N-acetylglucosaminidase {Streptomyces pl	99.95
d1ta3a_	274	Xylanase inhibitor protein I, XIP-I {Wheat (Tritic	99.92
d1cnva_	283	Seed storage protein {Jack bean (Canavalia ensifor	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1eoka_	282	Endo-beta-N-acetylglucosaminidase {Flavobacterium	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d1vf8a2	70	Chitinase-like lectin ym1 {Mouse (Mus musculus) [T	97.89
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.85
d1wb0a2	68	Chitotriosidase {Human (Homo sapiens) [TaxId: 9606	97.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.3
d2pi6a2	68	Signal processing protein (SPC-40, MGP-40) {Sheep	97.28
d1itxa2	72	Chitinase A1 {Bacillus circulans [TaxId: 1397]}	97.09
d1edqa3	73	Chitinase A {Serratia marcescens [TaxId: 615]}	97.08
d1kfwa2	61	Psychrophilic chitinase B {Arthrobacter sp., tad20	96.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.57
d1jnda2	92	Imaginal disc growth factor-2 {Fruit fly (Drosophi	95.92
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.84
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.59
d1w9pa2	62	Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]}	88.0
d1ll7a2	62	Chitinase 1 {Fungus (Coccidioides immitis) [TaxId:	87.77
d2nt0a2	354	Glucosylceramidase, catalytic domain {Human (Homo	84.62

>d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase A1
species: Bacillus circulans [TaxId: 1397]

Probab=100.00  E-value=3.5e-57  Score=468.23  Aligned_cols=266  Identities=25%  Similarity=0.410  Sum_probs=221.5

Q ss_pred             cCccceEEEEEecCC----CCCCCCCCCCCCccEEEEEEEEecCCCcEEecC----------------------------
Q 006211           22 SDAQTWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSIS----------------------------   69 (656)
Q Consensus        22 ~~~~~~~~~~y~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~----------------------------   69 (656)
                      .+++..+++|||++|    +.|.|++||+++||||+|||+.|+.++.....+                            
T Consensus         7 ~a~~~~rvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (347)
T d1itxa1           7 EAADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIVL   86 (347)
T ss_dssp             CGGGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCEEE
T ss_pred             CCCCCCEEEEEECcccccCCCCChhHCCHhhCCeEEEeeEeecCCcccccCcccccccccccccccccccccCCCceEEe
Confidence            345677889999886    358999999999999999999998664322211                            


Q ss_pred             -Ccch---------------hhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHH
Q 006211           70 -SANQ---------------QYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIE  133 (656)
Q Consensus        70 -~~~~---------------~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~  133 (656)
                       ++..               ......+..||++||++||||||            |||+.+ ..|+.+++++++|++||+
T Consensus        87 ~d~~~d~~~~~~~~~~~~~~~g~~~~~~~lK~~~p~lKvllSi------------GGw~~s-~~Fs~~~~~~~~R~~Fi~  153 (347)
T d1itxa1          87 GDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISV------------GGWTWS-NRFSDVAATAATREVFAN  153 (347)
T ss_dssp             SSHHHHHTSCCTTCCSSSSCCHHHHHHHHHHHHSTTCEEEEEE------------ECSSSC-TTHHHHHTSHHHHHHHHH
T ss_pred             cCchhhhccccccccccccchhHHHHHHHHHHhCCCCEEEEEE------------cCCCCC-cchhhhhcCHHHHHHHHH
Confidence             1100               01233346799999999999999            555543 239999999999999999


Q ss_pred             HHHHHHHHcCCCcceeeeeCCC----------ccCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccCh
Q 006211          134 SSIRTARLYGFQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPI  198 (656)
Q Consensus       134 ~~~~~~~~~~~DGvdidwe~p~----------~~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~  198 (656)
                      ++++|+++|||||||||||||.          .+|+++|+.|+++||++|+.     .+.+++|+++|+.+... ..|++
T Consensus       154 siv~~l~~~~fDGIDiDWE~P~~~g~~~~~~~~~d~~nf~~ll~eLr~~l~~~~~~~~~~~~ls~a~~~~~~~~-~~~d~  232 (347)
T d1itxa1         154 SAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYA-ANTEL  232 (347)
T ss_dssp             HHHHHHHHHTCSEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHHTSCCEEEEEECCSHHHH-HTSCH
T ss_pred             HHHHHHHHhCCCcEEEecccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcCCccceeecccchhhhh-hhccH
Confidence            9999999999999999999994          35788999999999999842     35789999998775444 44999


Q ss_pred             hhhhhccchhhhhhhcccCCCCCCccccCCCCCCC----------CCCCCHHHHHHHHHHcCCCCCceeecccCCCCCcC
Q 006211          199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP----------SSNISTDFGIREWLRRGFPANKLVLGARASGPGIT  268 (656)
Q Consensus       199 ~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~----------~~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~  268 (656)
                      ++++++|||||||||||||+ |++.+||+|||+..          ...++++.+|++|+++|+|++|||||+|       
T Consensus       233 ~~i~~~vD~vnvMtYD~~g~-w~~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~G~p~~KlvlGip-------  304 (347)
T d1itxa1         233 AKIAAIVDWINIMTYDFNGA-WQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVP-------  304 (347)
T ss_dssp             HHHHHHSSEEEECCCCSSCT-TSSBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEE-------
T ss_pred             HHHhhccCEEEeeeccccCC-CCCcccccCCCcCCcccccccCCCCCceeHHHHHHHHHHCCCCHHHeEEEec-------
Confidence            99999999999999999976 78889999999842          2346899999999999999999999987       


Q ss_pred             CCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccchh
Q 006211          269 IDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRA  348 (656)
Q Consensus       269 ~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~  348 (656)
                                                                |||++||+.|++||+++||||+|+|++++||...+.++
T Consensus       305 ------------------------------------------fd~~~si~~K~~y~k~~~LgGvmiW~l~~Dd~~~L~~a  342 (347)
T d1itxa1         305 ------------------------------------------FDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTLQNK  342 (347)
T ss_dssp             ------------------------------------------SCCHHHHHHHHHHHHHHTCCEEEEECGGGCTTCHHHHH
T ss_pred             ------------------------------------------cCCHHHHHHHHHHHHhCCCCEEEEEEecCCCCcHHHHH
Confidence                                                      79999999999999999999999999999998877776


Q ss_pred             hhh
Q 006211          349 AQI  351 (656)
Q Consensus       349 ~~~  351 (656)
                      ...
T Consensus       343 ~~~  345 (347)
T d1itxa1         343 LKA  345 (347)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            553

>d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Signal processing protein (SPC-40, MGP-40)
species: Sheep (Ovis aries) [TaxId: 9940]

Probab=100.00  E-value=1.2e-56  Score=454.88  Aligned_cols=254  Identities=30%  Similarity=0.462  Sum_probs=223.9

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||++|.       .|.|++||+++||||+|||+.+++++..  ..+..+......+.++|++||++|||+||    
T Consensus         2 kvv~Yy~~w~~~r~~~~~~~~~~i~~~~~THiiyafa~i~~~~~~--~~~~~~~~~~~~~~~lk~~~~~lKvllSv----   75 (292)
T d2pi6a1           2 KLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEID--TWEWNDVTLYDTLNTLKNRNPKLKTLLSV----   75 (292)
T ss_dssp             EEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEETTEEE--CCSTTHHHHHHHHHHHHHHCTTCEEEEEE----
T ss_pred             eEEEEEccccccCCCCCCCChhHCCcccCCEEEEEEEEecCCCce--ecccccHHHHHHHHHHHhhCCCceEEEEE----
Confidence            5789998753       3789999999999999999999987533  33334444555568899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcC-----C
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS-----D  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~-----~  175 (656)
                              |||+.+++.|+.++++++.|++||+|+++++++|+|||||||||||+..++.+|+.|+++||++|.     .
T Consensus        76 --------GG~~~~~~~fs~~~~~~~~r~~fi~si~~~l~~~~fDGiDiDwE~p~~~~~~~~~~l~~~lr~~l~~~~~~~  147 (292)
T d2pi6a1          76 --------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQAG  147 (292)
T ss_dssp             --------ETTTSCHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCGGGHHHHHHHHHHHHHHHHHHHTTS
T ss_pred             --------eccccCchHHHHHhccHHHHHHHHHHHHHHHHhcCCCeEEEeccccccccccccchhHHHHHHHHHHHHhcc
Confidence                    777777777999999999999999999999999999999999999999999999999999999982     2


Q ss_pred             CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC-----CCCHHHHHHHHHHcC
Q 006211          176 QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-----NISTDFGIREWLRRG  250 (656)
Q Consensus       176 ~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~-----~~~~~~~v~~~~~~g  250 (656)
                      .+.++++++++..+.....+|+++++.++||||||||||+||+ |+..+||+||||....     ..+++.+|++|+++|
T Consensus       148 ~~~~~~s~~~~~~~~~~~~~~~~~~l~~~vD~invMtYD~~g~-~~~~~g~~apL~~~~~~~~~~~~~v~~~v~~~~~~G  226 (292)
T d2pi6a1         148 TEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHGA-WRQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLG  226 (292)
T ss_dssp             SCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSCT-TCCBCCCSSCSSCCSSSCSCTTSSHHHHHHHHHHTT
T ss_pred             CCCcceecccCchhhHHhccccHHHHHhhCCEEEEecccccCC-CCCccccCCCCCCCCcccCcCCccHHHHHHHHHHCC
Confidence            4468999999988777777799999999999999999999976 6788999999985442     257999999999999


Q ss_pred             CCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccc
Q 006211          251 FPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLL  330 (656)
Q Consensus       251 ~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glg  330 (656)
                      +|++||+||+|                                                 |||++|++.|++||+++|||
T Consensus       227 vp~~KlvlGip-------------------------------------------------ydd~~Si~~K~~~~~~~~lg  257 (292)
T d2pi6a1         227 APANKLVMGIP-------------------------------------------------TDDQESVKNKARYLKNRQLA  257 (292)
T ss_dssp             CCGGGEEEEEE-------------------------------------------------SCCHHHHHHHHHHHHHTTCS
T ss_pred             CCHHHeEEEec-------------------------------------------------CCCHHHHHHHHHHHHHCCCc
Confidence            99999999987                                                 79999999999999999999


Q ss_pred             cceeeEeccCccccc
Q 006211          331 GYKAFQLSNDDNWAL  345 (656)
Q Consensus       331 Gv~~W~l~~Dd~~~~  345 (656)
                      |||+|++++||..+.
T Consensus       258 Gv~iW~l~~DD~~G~  272 (292)
T d2pi6a1         258 GAMVWALDLDDFRGT  272 (292)
T ss_dssp             EEEEECGGGSCSSSC
T ss_pred             eEEEEecccccCCCC
Confidence            999999999998874

>d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Psychrophilic chitinase B
species: Arthrobacter sp., tad20 [TaxId: 1667]

Probab=100.00  E-value=1.5e-56  Score=464.07  Aligned_cols=268  Identities=24%  Similarity=0.370  Sum_probs=222.4

Q ss_pred             cCccceEEEEEecCCCC----CC----CCCCCCCCccEEEEEEEEecCCCcEEecCC-----------------------
Q 006211           22 SDAQTWIKAGYWLAGRE----FP----LSDINSALFTHLICAFAEVDSSTYQLSISS-----------------------   70 (656)
Q Consensus        22 ~~~~~~~~~~y~~~~~~----~~----~~~i~~~~~thi~~~f~~~~~~~~~~~~~~-----------------------   70 (656)
                      +.+...+++|||++|..    +.    +.++++++||||+|||+.|++++.......                       
T Consensus         4 ~~~~g~rvvgYy~~W~~y~r~~~~~~l~~~i~~~~lTHi~YAFa~i~~~~~~~~~~~~~~~~~~~g~~~~~d~~~d~~~~   83 (374)
T d1kfwa1           4 STVNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGMG   83 (374)
T ss_dssp             SSBTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTCSBCCCEECCCSSTTTTTTCEEHHHHHTCC
T ss_pred             CCCCCCEEEEEECcceecCCCCChhhCcCCCChhhCCEEEEeeeeecCCcceeeccccccccCCCCccccCcchhhhccc
Confidence            45566788999998743    33    467888999999999999998765432211                       


Q ss_pred             ----------------cchhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHH
Q 006211           71 ----------------ANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIES  134 (656)
Q Consensus        71 ----------------~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~  134 (656)
                                      .....+.. +.+||++||++||||||            |||+.+. .|+.+++++++|++||+|
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~-l~~lK~~~p~lKvllSi------------GGw~~s~-~F~~~a~~~~~R~~Fi~s  149 (374)
T d1kfwa1          84 YAADKSVSGKADTWDQPLAGSFNQ-LKQLKAKNPKLKVMISL------------GGWTWSK-NFSKAAATEASRQKLVSS  149 (374)
T ss_dssp             CCTTTSSSSSCCCTTCSCCHHHHH-HHHHHTTCTTCEEEEEE------------ECSSSCT-THHHHTSSHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhHHH-HHHHHhhCCCCeEEEEE------------eCCCCCC-ccchhhcCHHHHHHHHHH
Confidence                            11122333 36799999999999999            5555433 399999999999999999


Q ss_pred             HHHHHHHcC----------------CCcceeeeeCCC------------ccCcchHHHHHHHHHhhcC-----CCCCcEE
Q 006211          135 SIRTARLYG----------------FQGIDLFWLWPN------------STDLNSLGILLDEWKASAS-----DQPELTL  181 (656)
Q Consensus       135 ~~~~~~~~~----------------~DGvdidwe~p~------------~~d~~~~~~ll~~lr~~l~-----~~~~~~l  181 (656)
                      +++|+++|+                |||||||||||+            .+|+++|+.||++||++|+     .++.++|
T Consensus       150 ~v~~~~~~~l~~~~~~~~~~~~~~~FDGiDiDWEyP~~~~~~~~~~~~~~~D~~nf~~Ll~eLR~~ld~~~~~~~k~~~L  229 (374)
T d1kfwa1         150 CIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVL  229 (374)
T ss_dssp             HHHHHTSCCEEEETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHTTCCCEE
T ss_pred             HHHHHHHcCCcccccccccccccccccccceeeeecccccCCCCCCCCChhHHHHHHHHHHHHHHHHHHHhcccCceEEE
Confidence            999999999                799999999995            3578999999999999983     3457999


Q ss_pred             EEEeecCCCccc-cccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC-------CCCHHHHHHHHHHcCCCC
Q 006211          182 SMAVRYSPTHET-VSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-------NISTDFGIREWLRRGFPA  253 (656)
Q Consensus       182 s~a~~~~~~~~~-~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~-------~~~~~~~v~~~~~~g~p~  253 (656)
                      |+|+++.+.... .+|+.+++.++|||||||||||||+|....+|||||||..+.       ..|++.+|++|++.|+|+
T Consensus       230 s~A~~~~~~~~~~~~~d~~~i~~~vD~invMtYD~~G~w~~~~tg~~apLy~~~~~~~~~~~~~svd~aV~~~~~~Gvp~  309 (374)
T d1kfwa1         230 SAFLPANPADIDAGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDP  309 (374)
T ss_dssp             EEEECSSHHHHHHHTTTCGGGGGTCSEEEECCSCSSCTTSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCG
T ss_pred             EEEeccccccccccCcchhhhhceeEEEEEEecccccCCCCCCCCccCcCCCCCCCCCCCCCCeeHHHHHHHHHHCCCCH
Confidence            999988765543 358999999999999999999998876677999999996542       258999999999999999


Q ss_pred             CceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccce
Q 006211          254 NKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK  333 (656)
Q Consensus       254 ~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~  333 (656)
                      +||+||+|                                                 |||++|+++|++||+++||||+|
T Consensus       310 ~KlvlGip-------------------------------------------------yd~~~si~~K~~y~~~~glgG~m  340 (374)
T d1kfwa1         310 KQLGLGLA-------------------------------------------------ADNIATTKQKTDYIVSKGLGGGM  340 (374)
T ss_dssp             GGEEEEEE-------------------------------------------------SCCHHHHHHHHHHHHHTTCCEEE
T ss_pred             HHeEEEec-------------------------------------------------CCCHHHHHHHHHHHHhcCCceEE
Confidence            99999976                                                 77899999999999999999999


Q ss_pred             eeEeccCcccccchhhhhh
Q 006211          334 AFQLSNDDNWALSRAAQIE  352 (656)
Q Consensus       334 ~W~l~~Dd~~~~~~~~~~~  352 (656)
                      +|++++|+...++++...+
T Consensus       341 ~W~~~~D~~g~Ll~a~~~~  359 (374)
T d1kfwa1         341 WWELSGDRNGELVGAMSDK  359 (374)
T ss_dssp             EECGGGCTTCHHHHHHHHH
T ss_pred             EEEccCCCCCcHHHHHHHH
Confidence            9999999977777666654

>d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase A, catalytic domain
species: Serratia marcescens [TaxId: 615]

Probab=100.00  E-value=1e-55  Score=455.72  Aligned_cols=258  Identities=21%  Similarity=0.353  Sum_probs=214.6

Q ss_pred             ceEEEEEecCC----CCCCCCCCCCCCccEEEEEEEEecCCCcEEe-------------------------cCC------
Q 006211           26 TWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLS-------------------------ISS------   70 (656)
Q Consensus        26 ~~~~~~y~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~-------------------------~~~------   70 (656)
                      ..+++|||++|    +.|.|++||+++||||+|||+.++++++...                         ..+      
T Consensus        25 ~~~v~~Yy~~W~~y~~~~~~~~I~~~~~THi~YAFa~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  104 (358)
T d1edqa2          25 GKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAALQ  104 (358)
T ss_dssp             SCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHHHHHT
T ss_pred             CCEEEEEeCcccccCCCCChhhCCHhHCCeEEEeeEEecCCCCcccccccccccccccccccccCCCcceeecCchhhhh
Confidence            45788999987    4699999999999999999999987654211                         100      


Q ss_pred             -----------cchhhHHHHHHHHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHH
Q 006211           71 -----------ANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA  139 (656)
Q Consensus        71 -----------~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~  139 (656)
                                 .....+..+ .+||++||++||||||||            |+.+.. |+ ++++++.|++||+|+++||
T Consensus       105 ~~~~~~~~~~~~~~g~~~~~-~~LK~~~p~lKvllSiGG------------w~~s~~-~~-~~a~~~~R~~Fi~svv~~l  169 (358)
T d1edqa2         105 KAQKGVTAWDDPYKGNFGQL-MALKQAHPDLKILPSIGG------------WTLSDP-FF-FMGDKVKRDRFVGSVKEFL  169 (358)
T ss_dssp             SCBTTBCSTTCSSCHHHHHH-HHHHHHCTTCEEEEEEEC------------SSSCGG-GG-GTTSHHHHHHHHHHHHHHH
T ss_pred             ccccCccccccccccHHHHH-HHHHHhCCCCeEEEEEEC------------CCCCCC-cc-cccCHHHHHHHHHHHHHHH
Confidence                       111124444 679999999999999954            444432 54 7789999999999999999


Q ss_pred             HHcC-CCcceeeeeCCC----------ccCcchHHHHHHHHHhhcCC-----CCCcEEEEEeecCCCccccccChhhhhh
Q 006211          140 RLYG-FQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMKK  203 (656)
Q Consensus       140 ~~~~-~DGvdidwe~p~----------~~d~~~~~~ll~~lr~~l~~-----~~~~~ls~a~~~~~~~~~~~~~~~~l~~  203 (656)
                      ++|+ |||||||||||.          ++|+++|+.||++||+++..     ++.+++++++++.+..... ++++++++
T Consensus       170 ~~y~~fDGIDIDWEyP~~~g~~~~~~~~~D~~nf~~Ll~eLR~~l~~~~~~~~~~~~ls~a~~~~~~~~~~-~~~~~l~~  248 (358)
T d1edqa2         170 QTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVETGRKYELTSAISAGKDKIDK-VAYNVAQN  248 (358)
T ss_dssp             HHCTTCCEEEEECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHHTCCCEEEEEEECSHHHHTT-SCHHHHGG
T ss_pred             HHhccCCcccceeeecccccCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcCCccceeeeecCchhhhhh-hhHHHHhh
Confidence            9999 999999999994          36789999999999998843     4578999999988766644 89999999


Q ss_pred             ccchhhhhhhcccCCCCCCccccCCCCCCCC----CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHH
Q 006211          204 NLNWAHLVAYDYHMPSKENVTGIHAALYNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIR  279 (656)
Q Consensus       204 ~vD~invmtYD~~g~~~~~~~g~~apl~~~~----~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~  279 (656)
                      +|||||||||||||+|....+||++||+.+.    ...+++.+|++|+++|+|++|||||+|+|||              
T Consensus       249 ~vD~inlMtYD~~G~w~~~~~g~~t~l~~~~~~~~~~~~v~~~v~~~~~~Gvp~~KlvlGip~YGR--------------  314 (358)
T d1edqa2         249 SMDHIFLMSYDFYGAFDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMDAR--------------  314 (358)
T ss_dssp             GCSEEEEECCCSSCTTCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESCHH--------------
T ss_pred             cCCEEEEeeccccCCCCCCCCCCCCCCCCCccCCCCcccHHHHHHHHHHCCCCHHHeEEEeCccHH--------------
Confidence            9999999999999887667899999998543    3468999999999999999999999999995              


Q ss_pred             HHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccchhh
Q 006211          280 AFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA  349 (656)
Q Consensus       280 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~~~  349 (656)
                                                          |++.|++|++++||||+|+|++++||...++...
T Consensus       315 ------------------------------------s~~~K~~y~~~~~lgG~~~W~~~~D~g~ll~a~~  348 (358)
T d1edqa2         315 ------------------------------------SVQAKGKYVLDKQLGGLFSWEIDADNGDILNSMN  348 (358)
T ss_dssp             ------------------------------------HHHHHHHHHHHHTCCEEEEECGGGCCSHHHHHHH
T ss_pred             ------------------------------------HHHHHHHHHhcCCCceEEEEeccCCccHHHHHHH
Confidence                                                5689999999999999999999999877555433

>d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitotriosidase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=449.44  Aligned_cols=254  Identities=34%  Similarity=0.566  Sum_probs=223.9

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||.+|.       .|.|++||+++||||+|||+.+++++  ......++..+...+.++|++||++||||||    
T Consensus         2 kvvcYy~~w~~~~~~~~~~~~~~i~~~~~THi~yaf~~~~~~~--~~~~~~~~~~~~~~~~~lk~~~p~lKvllSi----   75 (297)
T d1wb0a1           2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQ--LSTTEWNDETLYQEFNGLKKMNPKLKTLLAI----   75 (297)
T ss_dssp             EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETTE--EECSSTTHHHHHHHHHHGGGTCTTCEEEEEE----
T ss_pred             eEEEEECcCcccCCCCCCCChhHCCcccCCEEEEEEEEccCCc--cccCCcccHHHHHHHHHHHHhCCCCeEEEEE----
Confidence            4689998762       37899999999999999999998764  3334455555656668899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-----cCcchHHHHHHHHHhhcCC
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-----~d~~~~~~ll~~lr~~l~~  175 (656)
                              |||+.+++.|+.++++++.|++||+++++|+++|||||||||||||..     .|+.+|+.|+++||++|..
T Consensus        76 --------GG~~~~~~~fs~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~~~d~~n~~~l~~~Lr~~l~~  147 (297)
T d1wb0a1          76 --------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQ  147 (297)
T ss_dssp             --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHH
T ss_pred             --------eccccccchHHHHhhhhHHHHHHHHHHHHHHHHcCCCceeEEEEeccccCCChHHHHHHHHHHHHHHHHHhh
Confidence                    777777777999999999999999999999999999999999999964     5789999999999999842


Q ss_pred             ------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC------CCCHHHHH
Q 006211          176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGI  243 (656)
Q Consensus       176 ------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~------~~~~~~~v  243 (656)
                            ++.+.+++++|+.+.....+|++++++++|||||||+||++|+ |+..+|++||||....      ..+++.+|
T Consensus       148 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~i~~~vD~invmtYD~~g~-~~~~tg~~aply~~~~~~~~~~~~~~d~~v  226 (297)
T d1wb0a1         148 EAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGS-WEKVTGHNSPLYKRQEESGAAASLNVDAAV  226 (297)
T ss_dssp             HHHHHCSCCCEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSSCT-TSSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred             hhhhcCCCceeEEEEccCchhHhhhccCHHHHHhhCCEEEEEecccCCC-CCCCCCCCCcCCCCccccCCCCCCCHHHHH
Confidence                  3578999999988776666799999999999999999999966 7888999999996543      25899999


Q ss_pred             HHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhh
Q 006211          244 REWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISY  323 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~  323 (656)
                      ++|+++|+|++||+||+|                                                 |||++|+++|++|
T Consensus       227 ~~~~~~G~p~~KlvlGip-------------------------------------------------yd~~~si~~K~~~  257 (297)
T d1wb0a1         227 QQWLQKGTPASKLILGMP-------------------------------------------------TDDVESFKTKVSY  257 (297)
T ss_dssp             HHHHHTTCCGGGEEEEEE-------------------------------------------------SCCHHHHHHHHHH
T ss_pred             HHHHHcCCCHHHeEEEec-------------------------------------------------cCCHHHHHHHHHH
Confidence            999999999999999987                                                 6999999999999


Q ss_pred             hhhcccccceeeEeccCccccc
Q 006211          324 AKEKNLLGYKAFQLSNDDNWAL  345 (656)
Q Consensus       324 ~~~~glgGv~~W~l~~Dd~~~~  345 (656)
                      ++++||||||+|++++||..+.
T Consensus       258 ~~~~glgGv~~W~l~~DD~~G~  279 (297)
T d1wb0a1         258 LKQKGLGGAMVWALDLDDFAGF  279 (297)
T ss_dssp             HHHTTCCEEEEECGGGSCTTCS
T ss_pred             HHhcCCceEEEEeCccccCCCC
Confidence            9999999999999999998886

>d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase 1
species: Aspergillus fumigatus [TaxId: 5085]

Probab=100.00  E-value=1.8e-55  Score=452.32  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=218.2

Q ss_pred             ccceEEEEEecCC----CCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchh------------------hHHHHHH
Q 006211           24 AQTWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ------------------YFSIFAN   81 (656)
Q Consensus        24 ~~~~~~~~y~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~------------------~~~~~~~   81 (656)
                      ++..+++|||++|    +.|+|++||+++||||+|||+.++++++.+...++..+                  .....+.
T Consensus         2 ~~g~kvv~Yy~~W~~y~~~~~~~~i~~~~~THI~yaFa~i~~~~g~~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (333)
T d1w9pa1           2 SSGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLY   81 (333)
T ss_dssp             BCCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHHH
T ss_pred             CCCCEEEEEECcccccCCCCChhHCCcccCCeEEEeeEEecCCCCeEEecChHHhhccccCCccccccccchhhHHHHHH
Confidence            3456789999876    45899999999999999999999998888776554221                  1233446


Q ss_pred             HHHhhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-cCcc
Q 006211           82 SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLN  160 (656)
Q Consensus        82 ~~k~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-~d~~  160 (656)
                      ++|++||++||||||            |||+.+ ..|+.++++++.|++||+++++|+++|+|||||||||||.. ++..
T Consensus        82 ~lk~~~p~lKvllSi------------GGw~~s-~~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~~  148 (333)
T d1w9pa1          82 LLKKQNRNLKVLLSI------------GGWTYS-PNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQAN  148 (333)
T ss_dssp             HHHHHCTTCEEEEEE------------ECTTTG-GGHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHH
T ss_pred             HHHhccCCceEEEEE------------eCCcCC-CcccccccCHHHHHHHHHHHHHHHHHhcCCceeeeeeecccccccc
Confidence            799999999999999            555433 33999999999999999999999999999999999999977 5678


Q ss_pred             hHHHHHHHHHhhcC-------CCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCC
Q 006211          161 SLGILLDEWKASAS-------DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP  233 (656)
Q Consensus       161 ~~~~ll~~lr~~l~-------~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~  233 (656)
                      +|+.|+++||++|+       ..+++.||+++|+.+..... ||+++++++|||||||||||+|+ |++.+||+||||..
T Consensus       149 ~~~~llkelr~~L~~~~~~~~~~~~~~ls~a~~~~~~~~~~-~d~~~i~~~vD~invMtYD~~g~-~~~~tg~~aply~~  226 (333)
T d1w9pa1         149 DFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDKIKV-LHLKDMDQQLDFWNLMAYDYAGS-FSSLSGHQANVYND  226 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSTTCCCEEEEEECCSHHHHHH-SCHHHHHTTCSEEEECCCCCSST-TSSSCCCSSCSSCC
T ss_pred             hHHHHHHHHHHHHHhhhhhhccCCceEEEEEccCChhhhhc-cchHHHhhcCCeEEEeeeccCCC-CCCCCCCCccccCC
Confidence            99999999999983       24579999999988765554 89999999999999999999966 78889999999965


Q ss_pred             C-----CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEE
Q 006211          234 S-----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATW  308 (656)
Q Consensus       234 ~-----~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  308 (656)
                      .     ...+++.+|++|+++|+|++|||||+||||+                                           
T Consensus       227 ~~~~~~~~~nv~~av~~~~~~Gvp~~KlvlGiPfyg~-------------------------------------------  263 (333)
T d1w9pa1         227 TSNPLSTPFNTQTALDLYRAGGVPANKIVLGMPLDNP-------------------------------------------  263 (333)
T ss_dssp             TTCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESCCH-------------------------------------------
T ss_pred             CCCCccCCccHHHHHHHHHHCCCCHHHeEEEeCCCch-------------------------------------------
Confidence            4     2368999999999999999999999999985                                           


Q ss_pred             EeeCCcchhHHHHhhhhhcccccceeeEeccCc
Q 006211          309 INFDGVETIKAKISYAKEKNLLGYKAFQLSNDD  341 (656)
Q Consensus       309 i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd  341 (656)
                            .+++.|+.|++++||||+|+|++++|.
T Consensus       264 ------~~~~~k~~y~~~~~lgG~m~We~~~D~  290 (333)
T d1w9pa1         264 ------QVANLKSGYIKSLGLGGAMWWDSSSDK  290 (333)
T ss_dssp             ------HHHHHHHHHHHHHTCCEEEEECGGGSC
T ss_pred             ------HHHHHhHHHHHhCCCceEEEEeccCCC
Confidence                  346789999999999999999999996

>d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Imaginal disc growth factor-2
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=100.00  E-value=4.3e-55  Score=450.25  Aligned_cols=261  Identities=25%  Similarity=0.442  Sum_probs=218.4

Q ss_pred             EEEEEecCCC-------CCCCCCC--CCCCccEEEEEEEEecCCCcEEecCCcch----hhHHHHHHHHHhhCCCceEEE
Q 006211           28 IKAGYWLAGR-------EFPLSDI--NSALFTHLICAFAEVDSSTYQLSISSANQ----QYFSIFANSVRRKNPSIKTLL   94 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i--~~~~~thi~~~f~~~~~~~~~~~~~~~~~----~~~~~~~~~~k~~~~~~kvl~   94 (656)
                      .++|||++|.       .|.+.+|  +.++||||+|||++|++++..+...+...    ..+. .+.++|++||++|++|
T Consensus         2 ~ivcYy~~ws~~r~g~~~~~~~~id~~~~~cTHiiyafa~i~~~~~~~~~~d~~~d~~~~~~~-~~~~lk~~~p~lKvll   80 (327)
T d1jnda1           2 NLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFS-EVTSLKRKYPHLKVLL   80 (327)
T ss_dssp             EEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHH-HHHGGGGTSTTCEEEE
T ss_pred             eEEEEECCCcccCCCCCCcCHhhcCCCcccCCeEEEEEEEecCCCCEEEecCchhhhhHHHHH-HHHHHHHhCCCCeEEE
Confidence            4689998773       3677766  56779999999999998877776555432    2233 3468999999999999


Q ss_pred             EeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc-----------------
Q 006211           95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST-----------------  157 (656)
Q Consensus        95 sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~-----------------  157 (656)
                      |||||+.+.       +...+..|+.+++++++|++||+|+++|+++|+|||||||||||+..                 
T Consensus        81 SiGGw~~~~-------~~~~~~~~~~~~~~~~rr~~Fi~svv~~l~~~~fDGIDiDWEyP~~~~~~~~~~~~~~~~~~~~  153 (327)
T d1jnda1          81 SVGGDHDID-------PDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSIKK  153 (327)
T ss_dssp             EEETTCCCC-------TTSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC-------------
T ss_pred             EEECCCCCC-------CCcccchhHHHhCCHHHHHHHHHHHHHHHHHCCCCceEEEeeccCCCCcccccccchhhhhhhh
Confidence            997766422       22334457888888888899999999999999999999999999642                 


Q ss_pred             --------------CcchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCC-CCC
Q 006211          158 --------------DLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPS-KEN  222 (656)
Q Consensus       158 --------------d~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~-~~~  222 (656)
                                    ++++|..|++++|+++ ...++.|++++++.+.... +||+++++++|||||+|||||+|+| |..
T Consensus       154 ~~~~~~~~~~~~~~d~~~~~~l~~elr~~l-~~~~~~ls~a~~~~~~~~~-~~d~~~l~~~vD~vnlmtYD~~g~~~~~~  231 (327)
T d1jnda1         154 LFTGDFIVDPHAALHKEQFTALVRDVKDSL-RADGFLLSLTVLPNVNSTW-YFDIPALNGLVDFVNLATFDFLTPARNPE  231 (327)
T ss_dssp             ------CCCTTHHHHHHHHHHHHHHHHHHH-HTTTCEEEEEECTTCCHHH-HCCHHHHHTTCSEEEECCCCSSCTTTCTT
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHHhh-ccCCceEEEEecCChHHhh-cccHHHHhhhhhhHhhhhhhhcCccccCC
Confidence                          4678999999999999 4458999999998776543 5999999999999999999999875 457


Q ss_pred             ccccCCCCCCCCC------CCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccc
Q 006211          223 VTGIHAALYNPSS------NISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNAS  296 (656)
Q Consensus       223 ~~g~~apl~~~~~------~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~  296 (656)
                      .+|++|||+.+..      ..+++.+|++|+++|+|++||+||+|                                   
T Consensus       232 ~~g~~apL~~~~~~~~~~~~~~~d~~v~~~~~~G~p~~Kl~lGi~-----------------------------------  276 (327)
T d1jnda1         232 EADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVA-----------------------------------  276 (327)
T ss_dssp             CBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEE-----------------------------------
T ss_pred             cccccCCCCCCCCCCCcccCccHHHHHHHHHHcCCCHHHeEEEEc-----------------------------------
Confidence            8999999995442      35899999999999999999999865                                   


Q ss_pred             eeeeeeecCcEEEeeCCcchhHHHHhhhhhcccccceeeEeccCcccccch
Q 006211          297 YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR  347 (656)
Q Consensus       297 ~~~~~~~~~~~~i~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~~~~~~  347 (656)
                                    |||++||+.|++||+++||||||+|++++||..+.|.
T Consensus       277 --------------ydd~~Si~~K~~~~~~~~lgGv~~W~l~~DDf~G~C~  313 (327)
T d1jnda1         277 --------------TDDPDSASNKAAYARVKNLGGVALFDLSYDDFRGQCS  313 (327)
T ss_dssp             --------------SCCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTCTTT
T ss_pred             --------------CCCHHHHHHHHHHHHhcCCCEEEEEeccCCCCCCccC
Confidence                          8999999999999999999999999999999999873

>d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase-like lectin ym1, saccharide binding domain
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-54  Score=438.07  Aligned_cols=254  Identities=29%  Similarity=0.475  Sum_probs=214.8

Q ss_pred             EEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcchhhHHHHHHHHHhhCCCceEEEEeecCC
Q 006211           28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ  100 (656)
Q Consensus        28 ~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~sigg~~  100 (656)
                      +++|||++|.       .|.|++||+++||||+|+|+.+++++..+ ..+.....+ ..+.++|+++|++|||+||    
T Consensus         2 kvvcYy~~w~~~r~~~~~~~~~~i~~~~cTHiiyaf~~i~~~~~~~-~~~~~~~~~-~~~~~lk~~~p~lKvllSi----   75 (302)
T d1vf8a1           2 QLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNEITY-THEQDLRDY-EALNGLKDKNTELKTLLAI----   75 (302)
T ss_dssp             EEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETTEEEC-SSTTHHHHH-HHHHHGGGTCTTCEEEEEE----
T ss_pred             eEEEEECcccccCCCCCCCChhHCCcccCcEEEEEEEEecCCceEE-cCcccHHHH-HHHHHHHHhCCCcEEEEEE----
Confidence            5799998763       48999999999999999999999874332 223333333 4447899999999999999    


Q ss_pred             CCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCC-----ccCcchHHHHHHHHHhhcCC
Q 006211          101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-----STDLNSLGILLDEWKASASD  175 (656)
Q Consensus       101 ~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~-----~~d~~~~~~ll~~lr~~l~~  175 (656)
                              |||+.++..|+.++++++.|++||+++++++++|||||||||||||+     ++|+++|+.|+++||++|+.
T Consensus        76 --------GG~~~~~~~fs~~~~~~~~R~~fi~si~~~l~~~~fDGIDIDWE~p~~~~~~~~d~~n~~~ll~elr~~l~~  147 (302)
T d1vf8a1          76 --------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEE  147 (302)
T ss_dssp             --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHHHH
T ss_pred             --------ecCCCCCcchHHHhcchHHHHHHHHHHHHHHHHhCCCeeeeeeeecccccccchhHhHHHHHHHHHHHHHHH
Confidence                    77777777799999999999999999999999999999999999996     46789999999999999842


Q ss_pred             ------CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCC------CCCHHHHH
Q 006211          176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGI  243 (656)
Q Consensus       176 ------~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~------~~~~~~~v  243 (656)
                            ....+++.++++.......+||+++++++||||||||||++|+ |+..+||+||||..+.      ..+++.+|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~yd~~~~~~~vD~inlmtYD~~g~-~~~~tg~~apl~~~~~~~~~~~~~~v~~~v  226 (302)
T d1vf8a1         148 ESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHDP-KDGYTGENSPLYKSPYDIGKSADLNVDSII  226 (302)
T ss_dssp             HHHHHTSCCCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSCG-GGSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred             hhhhcCCCceeeeecccchhhhhhhcCcchhhccccCeeeeeccccCCC-CCCCCCCCCCCCCCCCCCCCCCCccHHHHH
Confidence                  2234555556555445556699999999999999999999976 6788999999996543      26799999


Q ss_pred             HHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhh
Q 006211          244 REWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISY  323 (656)
Q Consensus       244 ~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~  323 (656)
                      ++|+++|+|++||+||+|+||                                                 ++|++.|++|
T Consensus       227 ~~~~~~Gvp~~KlvlGip~~g-------------------------------------------------~rs~~~K~~~  257 (302)
T d1vf8a1         227 SYWKDHGAASEKLIVGFPADN-------------------------------------------------VRSFKLKAQW  257 (302)
T ss_dssp             HHHHHTTCCGGGEEEEEESCC-------------------------------------------------HHHHHHHHHH
T ss_pred             HHHHHcCCCHHHeEEEEecCC-------------------------------------------------hHHHHHHHHH
Confidence            999999999999999999764                                                 6799999999


Q ss_pred             hhhcccccceeeEeccCccccc
Q 006211          324 AKEKNLLGYKAFQLSNDDNWAL  345 (656)
Q Consensus       324 ~~~~glgGv~~W~l~~Dd~~~~  345 (656)
                      ++++||||+|+|++++||..+.
T Consensus       258 ~~~~~lgGv~~W~~d~DDf~G~  279 (302)
T d1vf8a1         258 LKDNNLGGAVVWPLDMDDFSGS  279 (302)
T ss_dssp             HHHTTCCEEEEETGGGSCTTST
T ss_pred             HHhCCCeeEEEeccccCCCCCC
Confidence            9999999999999999998874

>d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase 1
species: Fungus (Coccidioides immitis) [TaxId: 5501]

Probab=100.00  E-value=6.8e-54  Score=440.74  Aligned_cols=250  Identities=24%  Similarity=0.423  Sum_probs=211.7

Q ss_pred             eEEEEEecCC----CCCCCCCCCCCCccEEEEEEEEecCCCcEEecCCcch------------------hhHHHHHHHHH
Q 006211           27 WIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ------------------QYFSIFANSVR   84 (656)
Q Consensus        27 ~~~~~y~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~k   84 (656)
                      ..++|||++|    +.|.|++||+++||||+|||+.|++++. +...+...                  ......+..+|
T Consensus         3 ~kvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g~-~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~lk   81 (330)
T d1ll7a1           3 FRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSGE-VYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQMYLLK   81 (330)
T ss_dssp             BEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTSC-EEESCHHHHTTCCCTTCCSSCSSCCCCHHHHHHHHHH
T ss_pred             cEEEEEECcccccCCCCChhHCCcccCceeEEeeEEECCCCC-EEecChhHhhcccCCccccccccchhhHHHHHHHHHH
Confidence            4679999886    4589999999999999999999999754 44332110                  11223346799


Q ss_pred             hhCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-cCcchHH
Q 006211           85 RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLG  163 (656)
Q Consensus        85 ~~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-~d~~~~~  163 (656)
                      ++||+|||||||            |||+. +..|+.++++++.|++||+++++++++|+|||||||||||.. .+..+|.
T Consensus        82 ~~~p~lKvllSv------------GGw~~-s~~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGIDiDWE~p~~~~~~~~~~  148 (330)
T d1ll7a1          82 KNNRNLKTLLSI------------GGWTY-SPNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQANDFV  148 (330)
T ss_dssp             HHCTTCEEEEEE------------EHHHH-GGGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHH
T ss_pred             hcCCCCeEEEEE------------eCCCC-CCCchhhhcCHHHHHHHHHHHHHHHHHhcccccceEEEeeccccccccHH
Confidence            999999999999            55543 233999999999999999999999999999999999999976 5678999


Q ss_pred             HHHHHHHhhcC-------CCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCC--
Q 006211          164 ILLDEWKASAS-------DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS--  234 (656)
Q Consensus       164 ~ll~~lr~~l~-------~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~--  234 (656)
                      .|+++||++|.       ..+.++||+++|+.+.... .|++++++++||||||||||++|+ |+..+||||||+...  
T Consensus       149 ~~l~~lr~~l~~~~~~~~~g~~~~lt~a~~~~~~~~~-~~~~~~l~~~vD~invmtYD~~g~-w~~~tg~~s~l~~~~~~  226 (330)
T d1ll7a1         149 LLLKACREALDAYSAKHPNGKKFLLTIASPAGPQNYN-KLKLAEMDKYLDFWNLMAYDFSGS-WDKVSGHMSNVFPSTTK  226 (330)
T ss_dssp             HHHHHHHHHHHHHHHTSTTSCCCEEEEEEECSHHHHT-TSCHHHHHTTCSEEEEECCCSSST-TSSBCCCSSCSSCCSSC
T ss_pred             HHHHHHHHHHHHHHHHhhcCCceeEEEeccCChHhhc-cccHHHHhhcCCEEEEEEeeccCC-CCCCCCcCcccCCCcCC
Confidence            99999999983       3457899999998776655 499999999999999999999965 788999999999644  


Q ss_pred             ---CCCCHHHHHHHHHHcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEee
Q 006211          235 ---SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF  311 (656)
Q Consensus       235 ---~~~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~y  311 (656)
                         ...+++.+|++|+++|+|++|||||+|+|||.|                                            
T Consensus       227 ~~~~~~sv~~av~~~~~~Gvp~~KlvlGiP~ygr~~--------------------------------------------  262 (330)
T d1ll7a1         227 PESTPFSSDKAVKDYIKAGVPANKIVLGMPLDTVKI--------------------------------------------  262 (330)
T ss_dssp             GGGCSCCHHHHHHHHHHTTCCGGGEEEEEESCCHHH--------------------------------------------
T ss_pred             CCCCCccHHHHHHHHHHCCCCHHHeEEEecCCCchh--------------------------------------------
Confidence               236899999999999999999999999999732                                            


Q ss_pred             CCcchhHHHHhhhhhcccccceeeEeccCc
Q 006211          312 DGVETIKAKISYAKEKNLLGYKAFQLSNDD  341 (656)
Q Consensus       312 d~~~si~~K~~~~~~~glgGv~~W~l~~Dd  341 (656)
                           ++.|++|++++|+||+|+|++++|.
T Consensus       263 -----~~~k~~~~~~~g~gG~m~We~~~D~  287 (330)
T d1ll7a1         263 -----AGKKAEYITKNGMGGGMWWESSSDK  287 (330)
T ss_dssp             -----HHHHHHHHHHTTCCEEEEECTTSCC
T ss_pred             -----hhhhhHhHhhcCCCceEEEeeccCC
Confidence                 3469999999999999999999996

>d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Chitinase B, catalytic domain
species: Serratia marcescens [TaxId: 615]

Probab=100.00  E-value=7.1e-50  Score=416.37  Aligned_cols=289  Identities=21%  Similarity=0.256  Sum_probs=220.5

Q ss_pred             ceEEEEEec-------CCC-------CCCCCCCCC---CCccEEEEEEEEecCCCcEEecCCcchhh---HHHHHHHHHh
Q 006211           26 TWIKAGYWL-------AGR-------EFPLSDINS---ALFTHLICAFAEVDSSTYQLSISSANQQY---FSIFANSVRR   85 (656)
Q Consensus        26 ~~~~~~y~~-------~~~-------~~~~~~i~~---~~~thi~~~f~~~~~~~~~~~~~~~~~~~---~~~~~~~~k~   85 (656)
                      +..++|||.       .+.       .|++++|++   ++||||+|||+.+++++.........+..   +...+.+||+
T Consensus         2 ~~~~~~yy~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~lTHi~yaFa~i~~~g~~~~~~~~~~~~~~~~~~~~~~lK~   81 (356)
T d1goia2           2 RKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKA   81 (356)
T ss_dssp             CCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTSSEECCTTCCHHHHHHHHHHHHHGGG
T ss_pred             CcEEEEEEeCCccCcCcccccCCccCCcChhcCCcchHhhCCeEEEEEEEECCCccEEecCCccchHHHHHHHHHHHHHH
Confidence            346789983       332       366777765   77899999999999986554433333332   3344578999


Q ss_pred             hCCCceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHH
Q 006211           86 KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGIL  165 (656)
Q Consensus        86 ~~~~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~l  165 (656)
                      +||+||||||||||+.|.-      ...+...|+.++++++.|++||+++++|+++|||||||||||||...++.+|..|
T Consensus        82 ~~p~lKvllSiGGW~~s~~------~~~~~~~fs~~~~~~~~R~~Fi~siv~~l~~ygfDGIDIDWE~P~~~~~~~~~~l  155 (356)
T d1goia2          82 HNPSLRIMFSIGGWYYSND------LGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQAAEVDGFIAA  155 (356)
T ss_dssp             GCTTCEEEEEEECHHHHST------TSTTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCHHHHHHHHHH
T ss_pred             HCCCCeEEEEEcCCcCCCC------CcccccchHHHhCCHHHHHHHHHHHHHHHHHhCCCceeeeeccccccccccchhH
Confidence            9999999999966553221      1223456999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcC--------CCCCcEEEEEeecCCCcccc-ccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCC
Q 006211          166 LDEWKASAS--------DQPELTLSMAVRYSPTHETV-SYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN  236 (656)
Q Consensus       166 l~~lr~~l~--------~~~~~~ls~a~~~~~~~~~~-~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~  236 (656)
                      ++++|..+.        ......+++++++.+..... .+|+++|+++|||||||||||||+ |++.+||+|||+..   
T Consensus       156 ~~el~~~~~~~~~~~~~~~~~~~ls~a~~~~~~~~~~~~~d~~~l~~~vD~invMtYD~~g~-w~~~tg~~spLy~~---  231 (356)
T d1goia2         156 LQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAGP-WEKVTNHQAALFGD---  231 (356)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSCT-TSSSCCCTTCSSBC---
T ss_pred             HHHHHHHHHHHHHHhccccccceeEEeccCCHHHHhhhhhHHHHhhcccCeeEEEeecccCC-CCCCCCCCCcccCC---
Confidence            999997662        23367899999877654433 358999999999999999999976 78899999999853   


Q ss_pred             CCHHHHHHHHHHcCCCCCceeecccCCCCCcCC-------CCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEE
Q 006211          237 ISTDFGIREWLRRGFPANKLVLGARASGPGITI-------DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWI  309 (656)
Q Consensus       237 ~~~~~~v~~~~~~g~p~~Kl~lG~p~yG~~~~~-------~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i  309 (656)
                                  .+.|..+.++|.+.||+.|..       .+...+.....           .+......|+ .+..+||
T Consensus       232 ------------~~~p~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~p~-~~~~~~v  287 (356)
T d1goia2         232 ------------AAGPTFYNALREANLGWSWEELTRAFPSPFSLTVDAAVQ-----------QHLMMEGVPS-AKIVMGV  287 (356)
T ss_dssp             ------------TTSCCBCCGGGGSSCCCCHHHHHHHCCSSBCCCHHHHHH-----------HHHTSTTCCG-GGEEEEE
T ss_pred             ------------CCCChhhccccccccccChhhcccccCCCcceeccHHHH-----------HHHHhcCCCc-cceeEEe
Confidence                        356889999999999987742       12233332221           1112222333 3346899


Q ss_pred             eeCCcchhHHHHhhhhhcccccceeeEeccCcc-cccchh
Q 006211          310 NFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN-WALSRA  348 (656)
Q Consensus       310 ~yd~~~si~~K~~~~~~~glgGv~~W~l~~Dd~-~~~~~~  348 (656)
                      +|||++||++|++||+++||||+|+|+|++||. +.+.++
T Consensus       288 sydd~~Si~~K~~y~~~~~LgGv~iW~l~~Dd~~gsLl~a  327 (356)
T d1goia2         288 PFDDAESFKYKAKYIKQQQLGGVMFWHLGQDNRNGDLLAA  327 (356)
T ss_dssp             ESCCHHHHHHHHHHHHHTTCCEEEEECGGGSCTTCHHHHH
T ss_pred             ccCCHHHHHHHHHHHHhCCCCEEEEEecCCCCCCcHHHHH
Confidence            999999999999999999999999999999984 444444

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=357.31  Aligned_cols=203  Identities=27%  Similarity=0.418  Sum_probs=176.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++.... +..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4688999999999999999965 5689999999876532 3345689999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |++|+|.+++..   ...+++.++..++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999988843   346899999999999999999999987   99999999999999999999999999987654433


Q ss_pred             ccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence            334445689999999999988776 578999999999999999999997544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=355.91  Aligned_cols=200  Identities=26%  Similarity=0.417  Sum_probs=178.9

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      ++|++.++||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999964 569999999987665555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|..++..    ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999987742    35899999999999999999999987   9999999999999999999999999998764322  


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ......+||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence            23344579999999999999999999999999999999999999996544

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=348.03  Aligned_cols=199  Identities=29%  Similarity=0.443  Sum_probs=176.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688899999999999999965 468899999986432   233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|..++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999988853   345899999999999999999999987   999999999999999999999999999765432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  208 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  208 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence                2334579999999999999999999999999999999999999997544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=347.82  Aligned_cols=203  Identities=32%  Similarity=0.543  Sum_probs=169.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||+||+|...  ..||||+++..  ..+..+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            457889999999999999999764  46999998754  34556789999999999999999999998754 56899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ||++|+|.+++...  +..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999998643  345899999999999999999999987   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .........||+.|||||++..   ..++.++|||||||++|||+||+.||.....
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence            3334445689999999999864   3589999999999999999999999976443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=353.35  Aligned_cols=203  Identities=25%  Similarity=0.387  Sum_probs=175.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++..   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4688999999999999999965 56899999998653   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|..++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999888743   346899999999999999999999998   999999999999999999999999999876544


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  214 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  214 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence            33334445689999999999999999999999999999999999999997543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-43  Score=352.60  Aligned_cols=203  Identities=25%  Similarity=0.409  Sum_probs=177.7

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      +.|++.+.||+|+||+||+|.. .+++.||||+++.......+.+.+|++++++++||||+++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4588899999999999999965 568999999998776666778899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|..++.+.  ...+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999887542  345899999999999999999999997   9999999999999999999999999997653321  


Q ss_pred             ccccccccccccccccccc-----CCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .......||+.|+|||++.     ...++.++|||||||++|||+||+.||...+.
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~  220 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP  220 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence            2233457999999999883     45689999999999999999999999976543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=349.47  Aligned_cols=207  Identities=26%  Similarity=0.400  Sum_probs=166.3

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  509 (656)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|++++++++||||+++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999965 568999999987653  3445678999999999999999999999865  4567999


Q ss_pred             EEecCCCChhhhhhCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          510 YEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSN--FRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~--~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ||||++|+|.+++.... .+..+++..++.++.|+++||.|||+.+.  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999885422 24568999999999999999999998652  3599999999999999999999999999987


Q ss_pred             cccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +....  .......||+.|||||++.+..++.++|||||||++|||+||+.||...+
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~  218 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  218 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence            65422  22334689999999999999999999999999999999999999997544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-43  Score=358.12  Aligned_cols=200  Identities=25%  Similarity=0.347  Sum_probs=176.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.++||+|+||+||+|.. .+++.||+|+++... ....+.+.+|+.++++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46799999999999999999965 568999999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |+++|+|..++..   ...+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999853   34589999999999999999999975 5   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                2234589999999999999999999999999999999999999997644

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-42  Score=341.49  Aligned_cols=198  Identities=29%  Similarity=0.472  Sum_probs=164.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|+..+.||+|+||+||+|...+++.||||+++... ...+++.+|++++++++||||++++++|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4677889999999999999998888899999997643 345679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|+|.+++...  ...+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            99999988653  345889999999999999999999987   99999999999999999999999999987644322 2


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      ......||+.|+|||++.+..++.++|||||||++|||+|++.|+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence            223357899999999999999999999999999999999965554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=349.15  Aligned_cols=202  Identities=24%  Similarity=0.317  Sum_probs=178.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||.||+|.. .+++.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4688999999999999999965 57999999998754   2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|..++..   ...+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999988853   345899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~  210 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence            2  233446899999999999999999999999999999999999999976543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-42  Score=346.99  Aligned_cols=202  Identities=28%  Similarity=0.447  Sum_probs=176.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||+||+|... +++.||||+++... ...+++.+|+.++++++||||++++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            456888899999999999999664 58899999997653 3456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      |++|+|..++... ....+++..++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999988543 2346899999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                       .......|++.|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus       171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence             222334688999999999999999999999999999999998777643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=340.80  Aligned_cols=200  Identities=32%  Similarity=0.525  Sum_probs=172.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEec
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL  513 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  513 (656)
                      .++|++.+.||+|+||+||+|..++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35688889999999999999998888899999997643 345679999999999999999999998864 5679999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|..++... ....+++..++.++.||++||.|||+.+   |+||||||+||||++++.+||+|||+|+....... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999877543 2335899999999999999999999987   99999999999999999999999999987654322 


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCC
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR  640 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~  640 (656)
                      .......||+.|||||++....++.++|||||||++|||+||+.|+.
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~  211 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY  211 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence            22334578999999999998899999999999999999999766653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=335.08  Aligned_cols=205  Identities=29%  Similarity=0.452  Sum_probs=180.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|+..++||+|+||+||+|..++++.||||+++.... ..+++++|+.++++++||||++++++|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57889999999999999999988888999999986543 34679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|+|..++...  ...+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            99999887543  345889999999999999999999987   99999999999999999999999999986654322 2


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCcc
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE  646 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~~  646 (656)
                      ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            2333578999999999999999999999999999999998 798997665443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-41  Score=351.77  Aligned_cols=202  Identities=23%  Similarity=0.349  Sum_probs=179.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      -++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999965 56899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC--CCcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~--~~~~kl~DfGla~~~~~~  590 (656)
                      |++|+|..++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999888542  345899999999999999999999998   999999999999964  578999999999876432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                         .......||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus       180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  229 (350)
T d1koaa2         180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  229 (350)
T ss_dssp             ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence               22334578999999999999999999999999999999999999997544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-41  Score=350.32  Aligned_cols=202  Identities=24%  Similarity=0.346  Sum_probs=179.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999964 57999999999877666667789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc--CCCcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~--~~~~~kl~DfGla~~~~~~  590 (656)
                      |++|+|.+++..  ....+++.++..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999877643  2345899999999999999999999987   99999999999998  5789999999999876543


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .   ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  232 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  232 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            2   2234578999999999999999999999999999999999999997544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=335.45  Aligned_cols=197  Identities=27%  Similarity=0.407  Sum_probs=167.1

Q ss_pred             CCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEEE
Q 006211          438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIY  510 (656)
Q Consensus       438 ~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  510 (656)
                      +..++||+|+||+||+|.. .+++.||+|++...  .....+.+.+|++++++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4556899999999999965 46889999998654  34445678999999999999999999999865    34578999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc-CCCcEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~-~~~~~kl~DfGla~~~~~  589 (656)
                      ||+++|+|..++..   ...+++..+..++.||++||.|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999998853   346899999999999999999999875 3599999999999996 578999999999976432


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                          ......+||+.|||||++.+ .++.++|||||||++|||++|+.||....
T Consensus       168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~  216 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  216 (270)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence                22334689999999998865 58999999999999999999999996543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-41  Score=344.81  Aligned_cols=205  Identities=26%  Similarity=0.468  Sum_probs=164.1

Q ss_pred             cCCCCCCcccccCceEEEEEEeCC-C---CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPR-G---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||+||+|.... +   ..||||++... .....++|.+|++++++++|||||+++++|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            346667899999999999997642 2   25899998764 344566899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      ||||++|+|..++...  ...+++.++..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999987542  345899999999999999999999987   99999999999999999999999999987654


Q ss_pred             Ccccc---ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          590 DVDEA---NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       590 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      .....   ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence            32221   1122457899999999999999999999999999999998 8999875543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-41  Score=344.99  Aligned_cols=198  Identities=27%  Similarity=0.381  Sum_probs=175.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999965 56899999998653   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999888743   445788999999999999999999987   999999999999999999999999999875432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           ....+||+.|||||++.+..++.++|||||||++|||+||+.||...+
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence                 224589999999999999999999999999999999999999997544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-41  Score=344.95  Aligned_cols=201  Identities=22%  Similarity=0.326  Sum_probs=161.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .+.|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46789999999999999999965 4689999999876532 233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEc---CCCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~---~~~~~kl~DfGla~~~~  588 (656)
                      ||++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999854   346999999999999999999999987   99999999999995   57899999999998654


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..   ......+||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  213 (307)
T d1a06a_         162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN  213 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence            32   22234579999999999999999999999999999999999999996543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-41  Score=343.92  Aligned_cols=197  Identities=29%  Similarity=0.452  Sum_probs=171.8

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ..|+.++.||+|+||+||+|.. .+++.||||+++...   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3488899999999999999964 568899999987653   233457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      |||++|+|..++..   +..+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999766532   346899999999999999999999998   99999999999999999999999999976432 


Q ss_pred             ccccccccccccccccccccccC---CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||....
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence                 223579999999999853   458999999999999999999999996543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=346.06  Aligned_cols=208  Identities=30%  Similarity=0.436  Sum_probs=174.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC-C-----CEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR-G-----QEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.++||+|+||+||+|.... +     ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578889999999999999996532 2     269999986542 33445788999999998 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCC
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIR--------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA  565 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp  565 (656)
                      .++|||||++|+|..++.....                    ...+++..++.++.|+++||.|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999865322                    235899999999999999999999987   99999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       566 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      +|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655444334445678999999999999999999999999999999998 8999976544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-41  Score=338.78  Aligned_cols=205  Identities=27%  Similarity=0.447  Sum_probs=173.1

Q ss_pred             cCCCCCC-cccccCceEEEEEEeC---CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSAN-KLGEGGFGPVYKGNLP---RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|.+.+ +||+|+||+||+|...   ++..||||+++... ....++|.+|++++++++|||||++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455566 4999999999999543   34579999997653 4456789999999999999999999999865 568999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++...  +..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999987542  345899999999999999999999987   99999999999999999999999999987654


Q ss_pred             Cccc-cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          590 DVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       590 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      .... .......||+.|+|||++....++.++|||||||++|||+| |+.||......
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~  219 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP  219 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            3222 22334568899999999999999999999999999999998 89999765543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=335.91  Aligned_cols=201  Identities=25%  Similarity=0.379  Sum_probs=176.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++...      ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999965 578999999986532      12357789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC----cEEEEecc
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG  582 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~----~~kl~DfG  582 (656)
                      ++|||||++|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999998853   346999999999999999999999998   99999999999998776    49999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  220 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  220 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence            998764322   2234578999999999999999999999999999999999999997644

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-41  Score=335.98  Aligned_cols=197  Identities=30%  Similarity=0.452  Sum_probs=165.4

Q ss_pred             CcccccCceEEEEEEeC---CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecCC
Q 006211          441 NKLGEGGFGPVYKGNLP---RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN  515 (656)
Q Consensus       441 ~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  515 (656)
                      ++||+|+||+||+|...   .++.||||+++...  ....+++.+|++++++++||||++++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999653   34689999986542  3345679999999999999999999999865 567899999999


Q ss_pred             CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc-c
Q 006211          516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-A  594 (656)
Q Consensus       516 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~-~  594 (656)
                      |+|..++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999998853   345899999999999999999999987   999999999999999999999999999876543222 2


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT  644 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~  644 (656)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~  216 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  216 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence            2234578999999999999999999999999999999998 8999976543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-40  Score=343.92  Aligned_cols=198  Identities=22%  Similarity=0.288  Sum_probs=176.2

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  510 (656)
                      ++|++++.||+|+||.||+|.. .+|+.||||+++..   .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4689999999999999999965 57999999998643   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccC
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD  590 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~  590 (656)
                      ||+.+|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999888853   345899999999999999999999998   999999999999999999999999999876432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                           .....||+.|||||++.+..++.++|||||||++|||+||+.||...+
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  242 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence                 234589999999999999999999999999999999999999996543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-40  Score=331.57  Aligned_cols=202  Identities=27%  Similarity=0.496  Sum_probs=164.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCC-----CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRG-----QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      ++|+..+.||+|+||+||+|.....     ..||||+++... .....+|.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3566788999999999999965432     369999987653 3445578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+.++++..++...  ...+++.++..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999998877542  345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          589 KDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       589 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ...... ......||+.|||||.+.+..++.++|||||||++|||+|++.|+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            432221 22334688999999999999999999999999999999997776643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-40  Score=330.93  Aligned_cols=200  Identities=27%  Similarity=0.453  Sum_probs=167.8

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEecC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP  514 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  514 (656)
                      ++|++.+.||+|+||+||+|...+++.||||+++... ...+.|.+|+.++++++|||||+++++|. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5688999999999999999998888899999997553 34567999999999999999999999985 456899999999


Q ss_pred             CCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcccc
Q 006211          515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA  594 (656)
Q Consensus       515 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~  594 (656)
                      +|+|..++... ....+++.+++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....... .
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            99998887542 2345899999999999999999999987   99999999999999999999999999987643322 2


Q ss_pred             ccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ......||+.|+|||.+....++.++|||||||++|||+||+.|+..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~  216 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  216 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence            23335789999999999999999999999999999999997777644

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.3e-40  Score=340.18  Aligned_cols=201  Identities=28%  Similarity=0.362  Sum_probs=170.5

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHH---HHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFK---NEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....   ......+.   .|+.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5788999999999999999965 569999999986431   11222333   4466777788999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +|||||++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999998853   345889999999999999999999998   999999999999999999999999999866


Q ss_pred             ccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      ...    ......||+.|+|||++.. ..++.++|||||||++|||+||+.||......
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence            432    2334579999999999865 56899999999999999999999999765443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9e-40  Score=328.72  Aligned_cols=204  Identities=23%  Similarity=0.357  Sum_probs=168.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  505 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++...   .+..+.+.+|+++++.++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999964 579999999997543   3345578999999999999999999999876543    


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+++++|..++..   ...+++.+++.++.||++||.|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999988743   345899999999999999999999987   9999999999999999999999999987


Q ss_pred             ccccCc-cccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          586 LFRKDV-DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       586 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            654322 2223345689999999999999999999999999999999999999997543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-40  Score=334.14  Aligned_cols=201  Identities=27%  Similarity=0.400  Sum_probs=174.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC---ChhhHHHHHHHHHHHH-hcCCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTA-RLQHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++..   .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4688999999999999999955 56899999999653   2233455667777665 68999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccccc
Q 006211          510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK  589 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~  589 (656)
                      |||+++|+|..++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999853   345889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence            2  223334589999999999999999999999999999999999999997644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-39  Score=325.75  Aligned_cols=200  Identities=24%  Similarity=0.400  Sum_probs=174.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh---------hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---------QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER  503 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  503 (656)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999965 5789999999875421         12346889999999997 99999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      +..++|||||++|+|..++..   +..+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999853   346899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccccc------CCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.+....   ......||+.|+|||.+.      ...++.++||||+||++|||++|+.||....
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            98765422   223457999999999885      3346889999999999999999999997654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-40  Score=334.89  Aligned_cols=211  Identities=27%  Similarity=0.437  Sum_probs=177.4

Q ss_pred             HHHHhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 006211          430 IKAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTE  502 (656)
Q Consensus       430 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  502 (656)
                      ++...++|++.+.||+|+||+||+|+..      +++.||||+++.... +..+++.+|+.++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334578999999999999999999653      356899999976543 345679999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhhhhhCCC---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 006211          503 RDENMLIYEYLPNKSLDLYLFDPI---------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR  561 (656)
Q Consensus       503 ~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~  561 (656)
                      ....+++|||+++|+|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            999999999999999999885321                     1234889999999999999999999987   9999


Q ss_pred             ccCCCCEEEcCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCC-CCC
Q 006211          562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NAR  640 (656)
Q Consensus       562 Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~-p~~  640 (656)
                      ||||+|||++.++.+||+|||+|+...............+++.|+|||.+.+..++.++|||||||++|||++|.. ||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999987654433344445678899999999999999999999999999999999965 565


Q ss_pred             CCC
Q 006211          641 YYG  643 (656)
Q Consensus       641 ~~~  643 (656)
                      ...
T Consensus       245 ~~~  247 (301)
T d1lufa_         245 GMA  247 (301)
T ss_dssp             TSC
T ss_pred             CCC
Confidence            443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=334.02  Aligned_cols=205  Identities=28%  Similarity=0.446  Sum_probs=168.3

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .+|+..++||+|+||+||+|... +|+    .||+|+++.. ..+..+++.+|+.++++++|||||+++++|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35889999999999999999653 444    5899988654 344567899999999999999999999999864 5678


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ++|++.+++|..++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999998877542  446899999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      ............||+.|+|||.+.++.++.++|||||||++|||+| |+.||......
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            5433333444578999999999999999999999999999999998 78888765443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-39  Score=330.08  Aligned_cols=202  Identities=21%  Similarity=0.316  Sum_probs=176.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++....+ ...+.+|+++|++++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46799999999999999999965 46889999999776433 35678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC--CcEEEEeccCccccccC
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKLFRKD  590 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~--~~~kl~DfGla~~~~~~  590 (656)
                      |++|+|..++...  ...+++.++..++.||++||.|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999988542  335899999999999999999999987   9999999999999854  47999999999875432


Q ss_pred             ccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCC
Q 006211          591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT  644 (656)
Q Consensus       591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~  644 (656)
                         .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus       158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~  208 (321)
T d1tkia_         158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence               222345789999999999999999999999999999999999999976543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=324.01  Aligned_cols=205  Identities=21%  Similarity=0.348  Sum_probs=163.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML  508 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  508 (656)
                      .++|++.+.||+|+||+||+|....    +..||||.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578889999999999999996532    3468999987543 344567999999999999999999999986 467899


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR  588 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~  588 (656)
                      ||||+++|+|..++..  ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999887653  2346899999999999999999999987   9999999999999999999999999998754


Q ss_pred             cCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                      ... ........||+.|+|||.+.+..++.++|||||||++|||+| |++||......
T Consensus       160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~  216 (273)
T d1mp8a_         160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN  216 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence            332 223334578999999999999999999999999999999998 88888765543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-39  Score=330.90  Aligned_cols=198  Identities=23%  Similarity=0.307  Sum_probs=168.4

Q ss_pred             hcCCCCCC-cccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee----CCce
Q 006211          434 TNNFSSAN-KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE----RDEN  506 (656)
Q Consensus       434 ~~~y~~~~-~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  506 (656)
                      .++|++.+ .||+|+||+||+|.. .+++.||||+++..     ..+.+|+.++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788775 599999999999954 67899999998653     3467899886654 89999999999865    3568


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccC
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGM  583 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGl  583 (656)
                      ++|||||++|+|.+++.... ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999986532 235899999999999999999999998   999999999999985   45799999999


Q ss_pred             ccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |+......   ......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            98765432   2234579999999999999999999999999999999999999996544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-39  Score=328.63  Aligned_cols=197  Identities=25%  Similarity=0.338  Sum_probs=164.7

Q ss_pred             CCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhh-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG-----LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      .+++||+|+||+||+|.. .+++.||||+++......     .+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999965 468999999987543211     23688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +.++++..+..   .+..+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            99887765552   3445888999999999999999999988   9999999999999999999999999998654432 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                       ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence             22233578999999998865 457999999999999999999999986543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-39  Score=327.58  Aligned_cols=208  Identities=29%  Similarity=0.426  Sum_probs=164.9

Q ss_pred             HhcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC-
Q 006211          433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER-  503 (656)
Q Consensus       433 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  503 (656)
                      ..++|++.++||+|+||.||+|...      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++... 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3467899999999999999999642      24689999997543 34455677888888777 689999999988765 


Q ss_pred             CceEEEEEecCCCChhhhhhCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      ...++|||||++|+|..++....             .+..+++.++..++.||++||.|||+++   |+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            46899999999999999985432             1335889999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCC-CCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NARYYG  643 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~-p~~~~~  643 (656)
                      ++++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|+.. ||....
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999987655444444555689999999999999999999999999999999999754 665443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-39  Score=320.49  Aligned_cols=199  Identities=30%  Similarity=0.450  Sum_probs=163.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEec
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLIYEYL  513 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  513 (656)
                      ++|++.+.||+|+||.||+|.. +|..||||+++...  ..+.+.+|++++++++||||++++++|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577889999999999999988 57899999997643  34678999999999999999999999865 45689999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|..++... ....+++..+++++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999998542 2235899999999999999999999987   999999999999999999999999999864332   


Q ss_pred             cccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCCCc
Q 006211          594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTS  645 (656)
Q Consensus       594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~~~  645 (656)
                        .....++..|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence              223467889999999999999999999999999999998 67777655443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-39  Score=320.81  Aligned_cols=203  Identities=27%  Similarity=0.382  Sum_probs=162.7

Q ss_pred             cCCCCCCcccccCceEEEEEEeC--CC--CEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP--RG--QEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM  507 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  507 (656)
                      ++|++.+.||+|+||+||+|...  ++  ..||||+++..   ..+..++|.+|+.++++++||||++++++|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999642  23  36899998754   23445689999999999999999999999975 5678


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      +||||+++|++..++...  ...+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999998877542  345899999999999999999999987   999999999999999999999999999976


Q ss_pred             ccCcccc-ccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          588 RKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      ....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence            5443222 2334467889999999999999999999999999999998 899986544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=322.49  Aligned_cols=201  Identities=26%  Similarity=0.388  Sum_probs=169.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+++++||+|+||+||+|.. .+++.||||+++....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999964 6789999999965432  234678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      |+.++.+......  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976655433322  2345899999999999999999999988   9999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence              2233457999999999877655 578999999999999999999999654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=322.74  Aligned_cols=207  Identities=29%  Similarity=0.392  Sum_probs=172.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeCC--------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER  503 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  503 (656)
                      .++|++.+.||+|+||.||+|+...        +..||||+++... .....++.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578888999999999999995422        2479999997654 34456788899988888 899999999999999


Q ss_pred             CceEEEEEecCCCChhhhhhCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      +..++||||+++|+|..++.....             ...+++.+++.++.||++||.|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999865421             245899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHc-CCCCCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG  643 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~ellt-g~~p~~~~~  643 (656)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||....
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9999999999999987765544444555678999999999999999999999999999999998 677776544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-38  Score=322.21  Aligned_cols=203  Identities=29%  Similarity=0.455  Sum_probs=174.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe------CCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  505 (656)
                      .++|++.++||+|+||.||+|..      ..++.||||+++... ......+.+|+.++.++ +||||++++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            35788889999999999999964      345689999997653 34455789999999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCC---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEE
Q 006211          506 NMLIYEYLPNKSLDLYLFDPI---------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL  570 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl  570 (656)
                      .++|||||++|+|..++....               ....+++..+..++.||++||.|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999885432               2235899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCC
Q 006211          571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA  639 (656)
Q Consensus       571 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~  639 (656)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            999999999999998765544334444568899999999999999999999999999999999955554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.4e-38  Score=317.38  Aligned_cols=200  Identities=25%  Similarity=0.397  Sum_probs=170.6

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEe
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY  512 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  512 (656)
                      ++|++.++||+|+||+||+|...+++.||||+++...  ....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999988889999999997653  22356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCcc
Q 006211          513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD  592 (656)
Q Consensus       513 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~  592 (656)
                      +.++.+..+..   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            98877766653   2456999999999999999999999987   9999999999999999999999999998754322 


Q ss_pred             ccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence             22333468899999998865 45689999999999999999999999654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-38  Score=322.64  Aligned_cols=207  Identities=26%  Similarity=0.432  Sum_probs=176.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEeC------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN  506 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  506 (656)
                      .++|++.++||+|+||+||+|...      .++.||||+++.. ..+....+.+|++++++++||||++++++|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            357788899999999999999542      3578999999764 334455789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEE
Q 006211          507 MLIYEYLPNKSLDLYLFDPI-------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS  579 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~  579 (656)
                      ++||||+++|+|..++....       ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999998875321       1234789999999999999999999987   9999999999999999999999


Q ss_pred             eccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCC-CCCCCCC
Q 006211          580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK-RNARYYG  643 (656)
Q Consensus       580 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~-~p~~~~~  643 (656)
                      |||+++...............+|+.|+|||.+.+..++.++|||||||++|||+||+ .||...+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            999998765544444444557899999999999999999999999999999999995 6665444

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-38  Score=321.10  Aligned_cols=201  Identities=26%  Similarity=0.385  Sum_probs=162.2

Q ss_pred             cCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----ceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  510 (656)
                      ++|.+.++||+|+||.||+|+. +|+.||||+++..... ......|+..+.+++||||++++++|.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4566778999999999999986 6889999998654322 122334555566789999999999998654    478999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      |||++|+|..++..    ..+++..++.++.+++.||.|||+.     +..+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    3589999999999999999999974     23459999999999999999999999999998


Q ss_pred             ccccCccc--cccccccccccccccccccCCC------CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      ........  .......||+.|+|||++....      ++.++|||||||++|||+||..|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            76543222  2234568999999999987543      57789999999999999999988754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=318.51  Aligned_cols=198  Identities=25%  Similarity=0.387  Sum_probs=166.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCCh------hhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCC
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST------QGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERD  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  504 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++....      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35789999999999999999964 5789999999865321      11234678999999986  899999999999999


Q ss_pred             ceEEEEEecCC-CChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCC-CcEEEEecc
Q 006211          505 ENMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFG  582 (656)
Q Consensus       505 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~-~~~kl~DfG  582 (656)
                      ..++||||+.+ +++..++..   +..+++.++..++.|+++||.|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 566666632   346899999999999999999999987   9999999999999854 789999999


Q ss_pred             CccccccCccccccccccccccccccccccCCCC-CccchhHHHHHHHHHHHcCCCCCCC
Q 006211          583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      +|+.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            99865332    2334579999999999987665 5779999999999999999999964

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-37  Score=315.30  Aligned_cols=197  Identities=25%  Similarity=0.414  Sum_probs=167.6

Q ss_pred             CCcccccCceEEEEEEeCCC----CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEec
Q 006211          440 ANKLGEGGFGPVYKGNLPRG----QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-DENMLIYEYL  513 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  513 (656)
                      .++||+|+||+||+|....+    ..||||+++.. .....++|.+|++++++++||||+++++++... ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999976432    25899999753 455567899999999999999999999998764 5789999999


Q ss_pred             CCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCccc
Q 006211          514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE  593 (656)
Q Consensus       514 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~~~  593 (656)
                      ++|+|.+++...  ....++..+++++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999988653  335778899999999999999999987   999999999999999999999999999876543222


Q ss_pred             --cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          594 --ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       594 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                        .......||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence              122235689999999999999999999999999999999998888754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-38  Score=318.52  Aligned_cols=203  Identities=30%  Similarity=0.454  Sum_probs=168.5

Q ss_pred             cCCCCCCcccccCceEEEEEEeC-CCC--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNLP-RGQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI  509 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  509 (656)
                      ++|++.++||+|+||+||+|... ++.  .||||+++.. ..+..+.+.+|++++.++ +||||++++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56778899999999999999654 343  5788887654 334456799999999998 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcE
Q 006211          510 YEYLPNKSLDLYLFDP-------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP  576 (656)
Q Consensus       510 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~  576 (656)
                      |||+++|+|..++...             .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23456899999999999999999999987   9999999999999999999


Q ss_pred             EEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCC-CCCCCC
Q 006211          577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NARYYG  643 (656)
Q Consensus       577 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~-p~~~~~  643 (656)
                      ||+|||+++......   ......||..|+|||.+....++.++|||||||++|||++|.. ||...+
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            999999997654321   2223468999999999999999999999999999999999765 565433

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-38  Score=318.85  Aligned_cols=202  Identities=24%  Similarity=0.377  Sum_probs=166.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhc---CCCceeeEEEEEee----
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PR-GQEFAVKRLSATS--TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTE----  502 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  502 (656)
                      .++|+++++||+|+||+||+|.. .+ ++.||||+++...  ......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999965 34 5679999986432  11223456677776665   79999999999853    


Q ss_pred             -CCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEec
Q 006211          503 -RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF  581 (656)
Q Consensus       503 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~Df  581 (656)
                       ....++++|+++++++......  ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             2467899999998877654432  3445889999999999999999999987   999999999999999999999999


Q ss_pred             cCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       582 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      |+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence            999764332   23344689999999999999999999999999999999999999997543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-36  Score=307.06  Aligned_cols=204  Identities=20%  Similarity=0.264  Sum_probs=172.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++.....  ..+.+|++.+..++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            36799999999999999999964 46889999988654322  346788999999965 899999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC-----CCcEEEEeccCccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKL  586 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~-----~~~~kl~DfGla~~  586 (656)
                      |+ +++|..++...  ...+++.++..++.|++.||.|||+++   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 68888877542  335899999999999999999999998   999999999999974     56899999999987


Q ss_pred             cccCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          587 FRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       587 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      +......     .......||+.|||||++.+..++.++|||||||++|||+||+.||......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence            6433211     1233467999999999999999999999999999999999999999765544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=314.58  Aligned_cols=203  Identities=24%  Similarity=0.346  Sum_probs=167.5

Q ss_pred             hcCCCCCCcccccCceEEEEEE-eCCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----ceE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENM  507 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  507 (656)
                      +++|+++++||+|+||+||+|. ..+++.||||+++... ....+++.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3578999999999999999995 4679999999997643 344567899999999999999999999987643    235


Q ss_pred             EEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcccc
Q 006211          508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF  587 (656)
Q Consensus       508 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~  587 (656)
                      ++++++.+|+|.+++..    ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667789999998843    35899999999999999999999997   999999999999999999999999999865


Q ss_pred             ccCccc-cccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            443221 22344678999999999854 557889999999999999999999996543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=312.60  Aligned_cols=203  Identities=21%  Similarity=0.378  Sum_probs=166.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--------C
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--------R  503 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  503 (656)
                      ++|+++++||+|+||+||+|.. .+|+.||||++...  .....+++.+|+++|++++|||++++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6789999999999999999965 57999999998654  23344678899999999999999999998855        3


Q ss_pred             CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccC
Q 006211          504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM  583 (656)
Q Consensus       504 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGl  583 (656)
                      ...++|||+++++.+..+..   ....+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            45789999998887765542   2345888999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCcc--ccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          584 AKLFRKDVD--EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       584 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ++.+.....  .......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence            976543221  1222335799999999998754 68999999999999999999999997543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=315.63  Aligned_cols=198  Identities=22%  Similarity=0.356  Sum_probs=163.2

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------CceEE
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DENML  508 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  508 (656)
                      +|+..++||+|+||+||+|.. .+++.||||++......    ..+|++++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            477788999999999999965 56999999999765322    24799999999999999999998543      24689


Q ss_pred             EEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCcccc
Q 006211          509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLF  587 (656)
Q Consensus       509 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~  587 (656)
                      |||||+++.+..+.........+++..+..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755444332234456999999999999999999999987   99999999999999775 8999999999876


Q ss_pred             ccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ....   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence            4332   2233578999999998764 568999999999999999999999996543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=313.51  Aligned_cols=197  Identities=23%  Similarity=0.364  Sum_probs=162.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------  504 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  504 (656)
                      .++|+++++||+|+||+||+|.. .+|+.||||+++..  .....+.+.+|+++|++++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46799999999999999999964 56999999999754  3344567899999999999999999999997654      


Q ss_pred             ceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCc
Q 006211          505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA  584 (656)
Q Consensus       505 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla  584 (656)
                      ..++||||+ +.+|..+..    ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 556666552    345999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCccccccccccccccccccccccC-CCCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      +.....     .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence            865432     233578999999998865 456899999999999999999999997543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=311.58  Aligned_cols=204  Identities=24%  Similarity=0.351  Sum_probs=171.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe----CCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDE  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  505 (656)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4589999999999999999954    247899999986532    2234567889999999976 899999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .+++|||+.+|+|..++..   ...+.+.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999988853   334678899999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCccccccccccccccccccccccCC--CCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .+..... .......|++.|+|||.+...  .++.++|||||||++|||++|+.||...+..
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~  238 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK  238 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            7644322 223345789999999998654  4688999999999999999999999765443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=301.57  Aligned_cols=199  Identities=24%  Similarity=0.354  Sum_probs=171.6

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE  511 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  511 (656)
                      ++|+++++||+|+||+||+|.. .+++.||||+++...  ....+++.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4789999999999999999965 578899999986543  3345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCccccccCc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV  591 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~~~~~~  591 (656)
                      ++.++++..++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999988877643   345789999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccccCCC-CCccchhHHHHHHHHHHHcCCCCCCC
Q 006211          592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARY  641 (656)
Q Consensus       592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslGvil~elltg~~p~~~  641 (656)
                      .  ......+++.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            2  222335678899999887654 68999999999999999999999743

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-35  Score=305.30  Aligned_cols=194  Identities=20%  Similarity=0.350  Sum_probs=166.1

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CceEEEE
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER--DENMLIY  510 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  510 (656)
                      ++|+++++||+|+||+||+|.. .+++.||||+++...   .+++.+|+++|+.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999965 578999999997643   356789999999995 99999999998754  4689999


Q ss_pred             EecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCC-cEEEEeccCcccccc
Q 006211          511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRK  589 (656)
Q Consensus       511 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~-~~kl~DfGla~~~~~  589 (656)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987653      24899999999999999999999998   99999999999998655 699999999987643


Q ss_pred             CccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCCC
Q 006211          590 DVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYG  643 (656)
Q Consensus       590 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~~  643 (656)
                      ..   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||....
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            32   23345789999999997764 47999999999999999999999996543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-36  Score=303.25  Aligned_cols=204  Identities=22%  Similarity=0.262  Sum_probs=164.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceee-EEEEEeeCCceEEEEE
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR-VLGYCTERDENMLIYE  511 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e  511 (656)
                      .++|++.+.||+|+||+||+|.. .+++.||||++......  +++..|+++++.++|+|++. +..+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999965 56889999988764322  35788999999998776554 5555677788899999


Q ss_pred             ecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcC---CCcEEEEeccCccccc
Q 006211          512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFR  588 (656)
Q Consensus       512 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~---~~~~kl~DfGla~~~~  588 (656)
                      |+. +++...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.+.
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            995 555555432  2345899999999999999999999998   999999999999864   4579999999998765


Q ss_pred             cCccc-----cccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCCCCc
Q 006211          589 KDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS  645 (656)
Q Consensus       589 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~~~~  645 (656)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||+||+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~  219 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  219 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence            43221     1234568999999999999999999999999999999999999999765543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-35  Score=304.83  Aligned_cols=196  Identities=23%  Similarity=0.308  Sum_probs=159.0

Q ss_pred             cCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------Cc
Q 006211          435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DE  505 (656)
Q Consensus       435 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  505 (656)
                      ++|+++++||+|+||+||+|.. .+|+.||||++...  ......++.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999965 46999999999754  334456788999999999999999999999643      57


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .++||||+.++.+....      ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999776554332      24789999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .....   .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            65432   2233457899999999999999999999999999999999999999654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-35  Score=304.39  Aligned_cols=197  Identities=23%  Similarity=0.334  Sum_probs=164.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Q 006211          434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE  505 (656)
Q Consensus       434 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  505 (656)
                      .++|++.++||+|+||+||+|.. .+++.||||+++...  ....+++.+|++++++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45799999999999999999964 579999999997643  33456788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEeccCcc
Q 006211          506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK  585 (656)
Q Consensus       506 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~  585 (656)
                      .+++++++.+|+|..++..    ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4677788899999998842    35899999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCccccccccccccccccccccccCC-CCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      ....     ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            5432     22335789999999987665 4688999999999999999999999654

>d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Seed storage protein
species: Vicia narbonensis, Narbonin [TaxId: 3912]

Probab=100.00  E-value=1.5e-35  Score=296.77  Aligned_cols=216  Identities=15%  Similarity=0.160  Sum_probs=156.6

Q ss_pred             eEEEEEecC-CCCCCCCCCCCCCc------cEEEEEEEEecCC-----CcEEecCCcchhhHHHHHHHHHhhCCCceEEE
Q 006211           27 WIKAGYWLA-GREFPLSDINSALF------THLICAFAEVDSS-----TYQLSISSANQQYFSIFANSVRRKNPSIKTLL   94 (656)
Q Consensus        27 ~~~~~y~~~-~~~~~~~~i~~~~~------thi~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~   94 (656)
                      ++.-.||-. .+....+++|...+      +|+||+|+.....     .+.+...........+.++++|++||++||||
T Consensus         3 ~~~r~Y~g~~~~~~~~~d~p~~~~~~~~~~~h~i~aFa~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~lK~~~~~~Kvll   82 (289)
T d1nara_           3 PIFREYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEVKVVI   82 (289)
T ss_dssp             CEEEEEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEECSCHHHHSHHHHHHHHHHCTTCEEEE
T ss_pred             cchhhhcCCCCCCCccccCChhhcCCCceEEEEEEecccccCCCCCCCCCeeccccccccccHHHHHHHHHHCCCCeEEE
Confidence            344567743 23355666665554      4999999965422     12222332233334566788999999999999


Q ss_pred             EeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcC
Q 006211           95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS  174 (656)
Q Consensus        95 sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~  174 (656)
                      |||||+.+..        +++..++.++++...|.+|+.++++++++++|||||||||||..  .++|..|+++||+.|+
T Consensus        83 SiGG~~~~~~--------f~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~DGiDiDwE~p~~--~~~~~~ll~~Lr~~l~  152 (289)
T d1nara_          83 SIGGRGVNTP--------FDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIRS--DEPFATLMGQLITELK  152 (289)
T ss_dssp             EEEESSTTSC--------BCBSCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBCS--STTHHHHHHHHHHHHH
T ss_pred             EecCCCCCCc--------cChhhhHHHHhCHHHHHHHHHHHHHHHHhcCCCceeeeeeecCC--HHHHHHHHHHHHHHHh
Confidence            9987764322        23344788899999999999999999999999999999999874  5789999999999996


Q ss_pred             CCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCC
Q 006211          175 DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN  254 (656)
Q Consensus       175 ~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~  254 (656)
                      +...+.++++.++. ......++++.+.+++||||+|+||++|. |+..+||+++++          ..+.| ..|+|++
T Consensus       153 ~~~~~~~~~~~~ap-~~~~~~~~~~~~~~~~D~in~m~ydfyg~-w~~~~g~~~~~~----------~~~~~-~~~~p~~  219 (289)
T d1nara_         153 KDDDLNINVVSIAP-SENNSSHYQKLYNAKKDYINWVDYQFSNQ-QKPVSTDDAFVE----------IFKSL-EKDYHPH  219 (289)
T ss_dssp             HCTTSCCCEEEECC-CTTTHHHHHHHHHHHTTTCCEEEEEGGGC-SSCCCSHHHHHH----------HHHHH-HHHSCTT
T ss_pred             hCCCcEEEEEEecC-cCccccchHHHHHhhCCEEEEEEEeccCC-CCCCCChhHHHH----------HHHHh-hcCCChh
Confidence            54444444443322 22334466788999999999999999965 788889988753          33344 3479999


Q ss_pred             ceeecccCCCC
Q 006211          255 KLVLGARASGP  265 (656)
Q Consensus       255 Kl~lG~p~yG~  265 (656)
                      ||+||+|+++.
T Consensus       220 Kv~lG~pa~~~  230 (289)
T d1nara_         220 KVLPGFSTDPL  230 (289)
T ss_dssp             CEEEEEECCHH
T ss_pred             heEEeeecchh
Confidence            99999998774

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=1.5e-30  Score=271.74  Aligned_cols=198  Identities=20%  Similarity=0.258  Sum_probs=158.1

Q ss_pred             CCCCCCcccccCceEEEEEEe-CCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEEEeeC
Q 006211          436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----------HVNLLRVLGYCTER  503 (656)
Q Consensus       436 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~  503 (656)
                      +|+++++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            589999999999999999965 579999999997643 23456788888888775           57899999887653


Q ss_pred             --CceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCC------
Q 006211          504 --DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNEL------  574 (656)
Q Consensus       504 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~------  574 (656)
                        ...+++++++..+..............+++..+..++.|+++||.|||+ .+   |+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              4556677776655443333333345568899999999999999999998 54   99999999999998665      


Q ss_pred             cEEEEeccCccccccCccccccccccccccccccccccCCCCCccchhHHHHHHHHHHHcCCCCCCCC
Q 006211          575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY  642 (656)
Q Consensus       575 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslGvil~elltg~~p~~~~  642 (656)
                      .++++|||.+.....     ......||+.|+|||++....++.++|+||+||+++||++|+.||...
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            399999999975432     223357899999999999999999999999999999999999998643

>d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Hevamine A (chitinase/lysozyme)
species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]

Probab=99.96  E-value=8.2e-31  Score=261.26  Aligned_cols=211  Identities=17%  Similarity=0.062  Sum_probs=138.4

Q ss_pred             EEEEecCC-CCCCCC-CCCCCCccEEEEEEEEecCCCcEEecCC--------cchhhHHHHHHHHHhhCCCceEEEEeec
Q 006211           29 KAGYWLAG-REFPLS-DINSALFTHLICAFAEVDSSTYQLSISS--------ANQQYFSIFANSVRRKNPSIKTLLSIWN   98 (656)
Q Consensus        29 ~~~y~~~~-~~~~~~-~i~~~~~thi~~~f~~~~~~~~~~~~~~--------~~~~~~~~~~~~~k~~~~~~kvl~sigg   98 (656)
                      +++||-.+ .+..+. ..+.+.||||++||+.+.+++......-        .....+...++.+|+  +++||||||||
T Consensus         3 ~~~YWg~~~~~~~l~~~c~~~~~~~I~laF~~~~~~g~~~~~~~~~~~~~~~~~~~~l~~~I~~~q~--~g~KVllSiGG   80 (273)
T d2hvma_           3 IAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQI--QGIKVMLSLGG   80 (273)
T ss_dssp             EEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHHHH--TTCEEEEEEEC
T ss_pred             EEEEcCCCCCCCchHHHcCCCCCCEEEEEEEeEECCCCeeeccccccCCCccCchhhHHHHHHHHHh--CCCEEEEEEec
Confidence            58898332 222222 2345789999999999987754433221        111234444455554  47999999977


Q ss_pred             CCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCCCCC
Q 006211           99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPE  178 (656)
Q Consensus        99 ~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~~~~  178 (656)
                      |+++..       -.+...+..++.+...|..|++++++++++|+|||||||||+|..   .++..|+++||+.++..+.
T Consensus        81 ~~~~~~-------~~s~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~DGiDiD~E~~~~---~~~~~li~~Lr~~~~~~~~  150 (273)
T d2hvma_          81 GIGSYT-------LASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGST---LYWDDLARYLSAYSKQGKK  150 (273)
T ss_dssp             SSCCCC-------CCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSCC---SSHHHHHHHHHHGGGGSSC
T ss_pred             CCCCcc-------ccCHHHHHHHHHhHHHHhccchhhhhhhhcccccceeeccccCcc---hhHHHHHHHHHhhhccCCe
Confidence            653211       112223455666666666777777788999999999999999975   5799999999999976667


Q ss_pred             cEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCCCCceee
Q 006211          179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL  258 (656)
Q Consensus       179 ~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p~~Kl~l  258 (656)
                      +++|+|... +.. ...+.......++||||+|+||+++++ ....+..          .......+|. .|+|++||+|
T Consensus       151 ~~it~ap~~-~~~-~~~~~~~~~~~~~D~invq~Yn~~~~~-~~~~~~~----------~~~~~~~~~~-~g~~~~Kivl  216 (273)
T d2hvma_         151 VYLTAAPQC-PFP-DRYLGTALNTGLFDYVWVQFYNNPPCQ-YSSGNIN----------NIINSWNRWT-TSINAGKIFL  216 (273)
T ss_dssp             CEEEECCBS-SSS-CTTTHHHHHTTCCSEEEEECSSCGGGS-CBTTBCH----------HHHHHHHHHH-HHCCCSEEEE
T ss_pred             EEEEecccc-ccc-hhhhHHHhhcCcccEEEEEeecCCCcc-ccccchh----------HHHHHHHHHh-hcCCcccEEE
Confidence            777766532 221 222333444688999999999998653 3222221          1233444444 5999999999


Q ss_pred             cccCCCC
Q 006211          259 GARASGP  265 (656)
Q Consensus       259 G~p~yG~  265 (656)
                      |+|+++.
T Consensus       217 Glp~~~~  223 (273)
T d2hvma_         217 GLPAAPE  223 (273)
T ss_dssp             EEESSGG
T ss_pred             EEecCCC
Confidence            9999875

>d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]

Probab=99.95  E-value=2.3e-30  Score=258.94  Aligned_cols=179  Identities=14%  Similarity=0.155  Sum_probs=132.4

Q ss_pred             CccceEEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCCc--EEecCC-cch-hh---HHHHHHHHHhhCC
Q 006211           23 DAQTWIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTY--QLSISS-ANQ-QY---FSIFANSVRRKNP   88 (656)
Q Consensus        23 ~~~~~~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~--~~~~~~-~~~-~~---~~~~~~~~k~~~~   88 (656)
                      .++.+..++||.-..       .|.+++++...|||++++|+.++.++.  ...... ... ..   ....++.+++  +
T Consensus         2 ~~~~~~~~~y~~~~~~n~~n~~~~~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~--~   79 (285)
T d2ebna_           2 TKANIKLFSFTEVNDTNPLNNLNFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQD--K   79 (285)
T ss_dssp             CCCSCEEEEEEETTTCCGGGGGGEEETTTCCBSCCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHH--T
T ss_pred             CcCCceEEEEEEccCCCccccccceeecCCCCcccEEEEEeeeccCCcCCceeeeccCcchhhhhhhHHHHHHHHHh--C
Confidence            466778899996432       478999999999999999999985533  222211 111 11   2333344554  4


Q ss_pred             CceEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc----------cC
Q 006211           89 SIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------TD  158 (656)
Q Consensus        89 ~~kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~----------~d  158 (656)
                      ++|||||||||+.            +. .|+.+  +++.|++|++++++++++|||||||||||||..          .+
T Consensus        80 g~KvllsigG~~~------------~~-~~~~~--~~~~~~~F~~~~~~~~~~y~lDGiDiD~Ey~~~~~~~~~~~~~~~  144 (285)
T d2ebna_          80 GIKVILSILGNHD------------RS-GIANL--STARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTPS  144 (285)
T ss_dssp             TCEEEEEEECCSS------------SC-CTTCB--CHHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCCC
T ss_pred             CCEEEEEeccCCC------------Cc-ccccC--CHHHHHHHHHHHHHHHHHcCCcEEeccccCccccCCCccccCcch
Confidence            7999999965542            22 16655  678899999999999999999999999999842          57


Q ss_pred             cchHHHHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccc
Q 006211          159 LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTG  225 (656)
Q Consensus       159 ~~~~~~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g  225 (656)
                      +++|..|++|||++|+   +++||++++.........++   ..+++|+||+|+||++|+ |+..++
T Consensus       145 ~~~~~~li~eLr~~~~---~~~lt~a~~~~~~~~~~~~~---~~~~~d~id~m~Yd~~g~-w~~~~~  204 (285)
T d2ebna_         145 NNAAARLAYETKQAMP---NKLVTVYVYSRTSSFPTAVD---GVNAGSYVDYAIHDYGGS-YDLATN  204 (285)
T ss_dssp             HHHHHHHHHHHHHHCT---TSEEEEEESGGGSCCCSCBT---TBCGGGTCSEEEECTTCC-SCCTTT
T ss_pred             HHHHHHHHHHHHHHCC---CCeEEEEEecccccccccch---HHHHhhheeEEeecccCc-cCCCCC
Confidence            8899999999999993   56899999876555444444   567899999999999965 565444

>d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]

Probab=99.95  E-value=9.1e-29  Score=242.91  Aligned_cols=174  Identities=15%  Similarity=0.129  Sum_probs=126.5

Q ss_pred             cceEEEEEecCCC-------CCCCCCCCCCCccEEEEEEEEecCCC--cEEecCC-cc-hh---hHHHHHHHHHhhCCCc
Q 006211           25 QTWIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSST--YQLSISS-AN-QQ---YFSIFANSVRRKNPSI   90 (656)
Q Consensus        25 ~~~~~~~y~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~--~~~~~~~-~~-~~---~~~~~~~~~k~~~~~~   90 (656)
                      +.+..++|+..+.       .|.+++++...||||+++|+.++.++  ....... .+ ..   .....++.+|+  +++
T Consensus         2 ~~p~~v~y~~~~~~~~~n~g~y~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~--~g~   79 (265)
T d1edta_           2 QGPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQ--QGI   79 (265)
T ss_dssp             CSCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHH--TTC
T ss_pred             CCCEEEEEEEeccccCCcCCeeeeccCCCcceeEEEEeeeecccCCCCCeeEEecCcchhhhhhhHHHHHHHHHh--CCC
Confidence            3466788986543       38899999999999999999887542  2222211 11 11   12233344555  479


Q ss_pred             eEEEEeecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCc-------cCcchHH
Q 006211           91 KTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------TDLNSLG  163 (656)
Q Consensus        91 kvl~sigg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~-------~d~~~~~  163 (656)
                      |||||||||+.+..             |+.++ +++.|++|++++++++++|+|||||||||||..       .|+++|+
T Consensus        80 KvllsiGG~~~~~~-------------f~~~~-s~~~~~~Fa~~~~~~~~~~~~DGiDiD~Eyp~~~~~~~~~~d~~~~~  145 (265)
T d1edta_          80 KVLLSVLGNHQGAG-------------FANFP-SQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSFV  145 (265)
T ss_dssp             EEEEEEEECTTSCC-------------TTCCS-SHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHHH
T ss_pred             EEEEEEccCcCCCC-------------ceecC-CHHHHHHHHHHHHHHHHhcCCCceEeccccCcccCCCCCcccHHHHH
Confidence            99999965543322             77764 688999999999999999999999999999942       5789999


Q ss_pred             HHHHHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCC
Q 006211          164 ILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN  222 (656)
Q Consensus       164 ~ll~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~  222 (656)
                      .|+++||++|+   +++||++++..+.. ...++..   +.+||||+|+||+||+ |++
T Consensus       146 ~ll~~lR~~l~---~~~is~a~~~~~~~-~~~~~~~---~~~d~id~m~YD~~g~-w~~  196 (265)
T d1edta_         146 HLVTALRANMP---DKIISLYNIGPAAS-RLSYGGV---DVSDKFDYAWNPYYGT-WQV  196 (265)
T ss_dssp             HHHHHHHHHCT---TSEEEEESCHHHHT-CCEETTE---ECGGGCSEEECCSTTE-ECC
T ss_pred             HHHHHHHHhhh---hcEEEEEecCChhh-hcCcCHh---HhcCeEEEEeccCCCc-CCC
Confidence            99999999993   46888887754332 2335544   4568899999999976 454

>d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Xylanase inhibitor protein I, XIP-I
species: Wheat (Triticum aestivum) [TaxId: 4565]

Probab=99.92  E-value=3.2e-26  Score=227.25  Aligned_cols=204  Identities=16%  Similarity=0.135  Sum_probs=130.7

Q ss_pred             EEEEEecC-CCCCCCCC-CCCCCccEEEEEEEEecCCCcEEecCC--cchhhHHHHHHHHHhhCCCceEEEEeecCCCCc
Q 006211           28 IKAGYWLA-GREFPLSD-INSALFTHLICAFAEVDSSTYQLSISS--ANQQYFSIFANSVRRKNPSIKTLLSIWNGQNST  103 (656)
Q Consensus        28 ~~~~y~~~-~~~~~~~~-i~~~~~thi~~~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~k~~~~~~kvl~sigg~~~~~  103 (656)
                      .+++||-. ..+..+.+ .+.+.+|||++||+.+.++++......  .....+...++.+|++  ++|||||||||+++.
T Consensus         7 ~i~~YWGq~~~~~~L~~~c~~~~~~~I~laF~~~~~~~~~~~~~~~~~~~~~~~~~I~~~q~~--g~KVllSiGG~~~~~   84 (274)
T d1ta3a_           7 QVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQSK--GVPVSLSIGGYGTGY   84 (274)
T ss_dssp             CEEEEESSCGGGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTCCGGGHHHHHHHHHHT--TCCEEEEEEESSSCB
T ss_pred             cEEEEcCCCCCCCChHHHcCCCCCCEEEEEEEEEcCCCCeeeccCCCCChhHHHHHHHHHHhC--CCEEEEEEcCCCCCc
Confidence            46889933 22233333 235679999999999877655444322  2234455555556554  799999996654322


Q ss_pred             cccccCCcCCCccccccccCChhh--------HHHHHHHHHHHHHHcCCCcceeeeeCCCccCcchHHHHHHHHHhhcCC
Q 006211          104 YQSILGNKNINPSVLSSMVGDSSH--------RKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD  175 (656)
Q Consensus       104 ~~~~~Gg~~~~~~~f~~~~~~~~~--------r~~fi~~~~~~~~~~~~DGvdidwe~p~~~d~~~~~~ll~~lr~~l~~  175 (656)
                      .             |.........        |..|+.++++++.+|+|||||||||+|..  ..++..|+++||+.+.+
T Consensus        85 ~-------------~~~~~~~~~~a~~l~~~~~~~~~~s~~~~~~~~~~DGiDiD~E~~~~--~~~~~~li~~Lr~~~~~  149 (274)
T d1ta3a_          85 S-------------LPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGTP--ADRYDVLALELAKHNIR  149 (274)
T ss_dssp             C-------------CCSHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCCT--TCCHHHHHHHHHTTCCS
T ss_pred             c-------------ccchhHHHHHHHHHHHhhcccchhhHHHHhhccceeeEEeccccCCC--cchHHHHHHHHHHHHhh
Confidence            1             2222221111        22234466779999999999999999975  45899999999987733


Q ss_pred             ---CCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHHHHcCCC
Q 006211          176 ---QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFP  252 (656)
Q Consensus       176 ---~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~~~~g~p  252 (656)
                         .+.++||+|....... ...+.......++|+||+|.||.++. +...             .....+++.|. +|+|
T Consensus       150 ~~~~~~~litaAp~~~~~~-~~~~~~~~~~~~fD~i~vq~Yn~~~~-~~~~-------------~~~~~s~~~w~-~~~p  213 (274)
T d1ta3a_         150 GGPGKPLHLTATVRCGYPP-AAHVGRALATGIFERVHVRTYESDKW-CNQN-------------LGWEGSWDKWT-AAYP  213 (274)
T ss_dssp             SSSSCCCEEEEEECSSSSC-CHHHHHHHTTSCCCEEEEECSSCCTT-SBTT-------------BBHHHHHHHHH-HHCT
T ss_pred             ccCCCceEEEecccCccCc-hhhhhhhhhccccceEEEEEecCCCC-CCCC-------------hHHHHHHHHHH-hcCC
Confidence               3467888877543211 11122233445789999999998743 2211             14566778886 5899


Q ss_pred             CCceeecccCCC
Q 006211          253 ANKLVLGARASG  264 (656)
Q Consensus       253 ~~Kl~lG~p~yG  264 (656)
                      ++||+||+|+..
T Consensus       214 ~~Ki~lGlPa~~  225 (274)
T d1ta3a_         214 ATRFYVGLTADD  225 (274)
T ss_dssp             TSEEEEEEECCT
T ss_pred             CceEEEeeccCc
Confidence            999999999743

>d1cnva_ c.1.8.5 (A:) Seed storage protein {Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Seed storage protein
species: Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]

Probab=99.90  E-value=1.8e-24  Score=215.64  Aligned_cols=244  Identities=13%  Similarity=0.091  Sum_probs=152.2

Q ss_pred             EEEEEecCCCCCCCCCC-CCCCccEEEEEEEEecCCCcE---EecC-------CcchhhHHHHHHHHHhhCCCceEEEEe
Q 006211           28 IKAGYWLAGREFPLSDI-NSALFTHLICAFAEVDSSTYQ---LSIS-------SANQQYFSIFANSVRRKNPSIKTLLSI   96 (656)
Q Consensus        28 ~~~~y~~~~~~~~~~~i-~~~~~thi~~~f~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~k~~~~~~kvl~si   96 (656)
                      .++.||-....=.+.+. +...+|||++||+...+++..   +...       ......+...+..+|++  ++||||||
T Consensus         6 ~v~vYWgq~~~g~L~~~c~~~~~diI~laF~~~~~~~~~~p~~n~~~~~~~~~~~~~~~l~~dI~~~q~~--G~KVllSl   83 (283)
T d1cnva_           6 EIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQRM--GVKVFLAL   83 (283)
T ss_dssp             EEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHHT--TCEEEEEE
T ss_pred             CEEEECCCCCCCCHHHHccCCCCCEEEEEEEeeeCCCCCCcceecccCCCcccCCchHHHHHHHHHHHhC--CCEEEEEe
Confidence            34669843221122222 235699999999976544321   1111       11224566666667665  79999999


Q ss_pred             ecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHH---------HHHcCCCcceeeeeCCCc-cCcchHHHHH
Q 006211           97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT---------ARLYGFQGIDLFWLWPNS-TDLNSLGILL  166 (656)
Q Consensus        97 gg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~---------~~~~~~DGvdidwe~p~~-~d~~~~~~ll  166 (656)
                      |||++                 ..-..+.+..+.|++++.+.         +.+++|||||||||+|.. ....++..++
T Consensus        84 GG~~~-----------------~~~~~~~~~a~~fa~~~~~~~~~~~~~~~~~~~~lDGiDiD~E~p~~~~~~~~~~~~l  146 (283)
T d1cnva_          84 GGPKG-----------------TYSACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVDELNWDNLLEEL  146 (283)
T ss_dssp             ECSSS-----------------EECCCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSCSTTHHHHHHHH
T ss_pred             cCCCC-----------------CcccccHHHHHHHHHHHHHhhcCccccccccccccCcccccccCCCCcccHHHHHHHH
Confidence            65442                 22233556678888888665         578899999999999965 4568899999


Q ss_pred             HHHHhhcCCCCCcEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCCCCCCCCCCHHHHHHHH
Q 006211          167 DEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW  246 (656)
Q Consensus       167 ~~lr~~l~~~~~~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl~~~~~~~~~~~~v~~~  246 (656)
                      +++|+.+  ++.+.||+|+... .. ...+.......++||||+|.||.++.+     +++.+..      ....+...|
T Consensus       147 ~~l~~~~--~~~~~it~AP~~~-~~-d~~~~~~~~~~~~D~i~vq~Yn~~~~~-----~~~~~~~------~~~~~~~~~  211 (283)
T d1cnva_         147 YQIKDVY--QSTFLLSAAPGCL-SP-DEYLDNAIQTRHFDYIFVRFYNDRSCQ-----YSTGNIQ------RIRNAWLSW  211 (283)
T ss_dssp             HHHHHHH--TCCCEEEECCBSS-SS-CTTTHHHHTTTCCSEEEEECSSCTTTS-----CBTTBCH------HHHHHHHHH
T ss_pred             HHHHHhc--CCCeEEEeccCCc-cC-chhhHHHhhcccccEEEEEeccCCccc-----CCCccHH------HHHHHHHHH
Confidence            9999998  4478888875432 11 111222223468999999999987431     2222211      223344445


Q ss_pred             H-HcCCCCCceeecccCCCCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEeeCCcchhHHHHhh-h
Q 006211          247 L-RRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISY-A  324 (656)
Q Consensus       247 ~-~~g~p~~Kl~lG~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~yd~~~si~~K~~~-~  324 (656)
                      + ..+.|++|+++|+|++...-...|                                       |..+..+..++.. +
T Consensus       212 ~~~~~~~~~k~~lGlp~~~~~a~~~g---------------------------------------y~~~~~~~~~v~~~~  252 (283)
T d1cnva_         212 TKSVYPRDKNLFLELPASQATAPGGG---------------------------------------YIPPSALIGQVLPYL  252 (283)
T ss_dssp             HHHSSSCSSCEEEEEESSGGGCTTSC---------------------------------------CCCHHHHHHHTGGGS
T ss_pred             HHhcCCCccceEEEecCCCcccCCCC---------------------------------------CcCHHHHHHHHHHHH
Confidence            4 567899999999998765333333                                       3334444444332 2


Q ss_pred             hh--cccccceeeEeccCcccc
Q 006211          325 KE--KNLLGYKAFQLSNDDNWA  344 (656)
Q Consensus       325 ~~--~glgGv~~W~l~~Dd~~~  344 (656)
                      ++  .++||||+|++++|+...
T Consensus       253 ~~~~~~~GGvM~W~~~~D~~~g  274 (283)
T d1cnva_         253 PDLQTRYAGIALWNRQADKETG  274 (283)
T ss_dssp             TTHHHHEEEEEEECHHHHHHHT
T ss_pred             HhcCCCCCEEEEEeCccccCCC
Confidence            22  359999999999998654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.3e-21  Score=183.84  Aligned_cols=162  Identities=19%  Similarity=0.217  Sum_probs=118.5

Q ss_pred             CCCcccccCceEEEEEEeCCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 006211          439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST------------------QGLEEFKNEVSLTARLQHVNLLRVLGYC  500 (656)
Q Consensus       439 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~~  500 (656)
                      +.++||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999888899999998753210                  0112345688899999999999887653


Q ss_pred             eeCCceEEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCCEEEcCCCcEEEEe
Q 006211          501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD  580 (656)
Q Consensus       501 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iiH~Dikp~NILl~~~~~~kl~D  580 (656)
                          ..+++|||+++..+..          ++......++.|+++++.|||+.+   |+||||||+|||++++ .++|+|
T Consensus        84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence                2479999998865532          233445678999999999999987   9999999999999976 599999


Q ss_pred             ccCccccccCcccccccccccccccccc------ccccCCCCCccchhHHHHHHH
Q 006211          581 FGMAKLFRKDVDEANTGRIVGTYGYVPP------EYVKKGIYSMKYDVYSFGVLL  629 (656)
Q Consensus       581 fGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDvwslGvil  629 (656)
                      ||+|.....+...          .|...      |.+ .+.|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            9999754321110          11111      111 35578899999975443

>d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: Type II chitinase
domain: Endo-beta-N-acetylglucosaminidase
species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]

Probab=99.80  E-value=7.9e-20  Score=182.69  Aligned_cols=199  Identities=18%  Similarity=0.142  Sum_probs=128.8

Q ss_pred             EEEEEecCCCC---CCCCCCCCCCccEEEEEEEEec--CCCc------EEecCCcchhhHHHHHHHHHhhCCCceEEEEe
Q 006211           28 IKAGYWLAGRE---FPLSDINSALFTHLICAFAEVD--SSTY------QLSISSANQQYFSIFANSVRRKNPSIKTLLSI   96 (656)
Q Consensus        28 ~~~~y~~~~~~---~~~~~i~~~~~thi~~~f~~~~--~~~~------~~~~~~~~~~~~~~~~~~~k~~~~~~kvl~si   96 (656)
                      ++++||..+..   +.++++| +.++.|+++|+.+.  +++.      .+.........+...+..++++  ++||++||
T Consensus         3 ~~~~y~~~~~~~~~~~l~~~p-~~~d~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~--g~kVllSi   79 (282)
T d1eoka_           3 VCIAYYITDGRNPTFKLKDIP-DKVDMVILFGLKYWSLQDTTKLPGGTGMMGSFKSYKDLDTQIRSLQSR--GIKVLQNI   79 (282)
T ss_dssp             EEEEEEECSCSSTTSCGGGCC-TTCCEEEEESSCHHHHHCTTSSCTTSGGGTTCSSHHHHHHHHHHHHTT--TCEEEEEE
T ss_pred             eEEEEEeccCCCCceeeccCC-CCCCEEEEEccccccccccccccCCcceeecccchhHHHHHHHHHhhc--CceEEEEE
Confidence            57999977653   6777886 55899999887542  1111      1111112234455555666666  79999999


Q ss_pred             ecCCCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeCCCcc-------------------
Q 006211           97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST-------------------  157 (656)
Q Consensus        97 gg~~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~p~~~-------------------  157 (656)
                      ||+.....              .....+.+.++.+.+++.+++.+|||||||||||+|...                   
T Consensus        80 GG~~~~~~--------------~~~~~~~~~~~~~~~~~~~~i~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~~~~~~  145 (282)
T d1eoka_          80 DDDVSWQS--------------SKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGYAATGYNGWY  145 (282)
T ss_dssp             ECCGGGGS--------------SSGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCHHHHSCSSCC
T ss_pred             ecCCCCCc--------------cCCccHHHHHHHHHHHHHHHHHHhCCCceeecccCCcccCCchhhhhhhhhhhhhhhh
Confidence            66542111              223334456777888888999999999999999998531                   


Q ss_pred             -----CcchHHHHHHHHHhhcCCCCC--cEEEEEeecCCCccccccChhhhhhccchhhhhhhcccCCCCCCccccCCCC
Q 006211          158 -----DLNSLGILLDEWKASASDQPE--LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAAL  230 (656)
Q Consensus       158 -----d~~~~~~ll~~lr~~l~~~~~--~~ls~a~~~~~~~~~~~~~~~~l~~~vD~invmtYD~~g~~~~~~~g~~apl  230 (656)
                           ...++...+.+++..+.....  ..+....+  .........+..+...+||+++|+|+..+             
T Consensus       146 ~~~~~~~~~~~~~~a~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~v~~q~Y~~~~-------------  210 (282)
T d1eoka_         146 SGSMAATPAFLNVISELTKYFGTTAPNNKQLQIASG--IDVYAWNKIMENFRNNFNYIQLQSYGANV-------------  210 (282)
T ss_dssp             TTSCCCCHHHHHHHHHHTTTSSTTSSSCCEEEEEEC--TTSTTHHHHHHHHTTTCSEEEECCTTCCH-------------
T ss_pred             hcccccchhcchhHHHHHHhhccccCcceEEEeecC--ccccccccchhccccccceeeeeeecccC-------------
Confidence                 135688888899888854332  22332222  22222224467788999999999998641             


Q ss_pred             CCCCCCCCHHHHHHHHH--HcCCCCCceeecccCCCC
Q 006211          231 YNPSSNISTDFGIREWL--RRGFPANKLVLGARASGP  265 (656)
Q Consensus       231 ~~~~~~~~~~~~v~~~~--~~g~p~~Kl~lG~p~yG~  265 (656)
                             +....+..|.  ..++|++|+++|+|+++.
T Consensus       211 -------~~~~~~~~~~~~~~~~pa~k~~~G~~~~~~  240 (282)
T d1eoka_         211 -------SRTQLMMNYATGTNKIPASKMVFGAYAEGG  240 (282)
T ss_dssp             -------HHHHHHHHHHHHTSCCCGGGEEEEECTTTC
T ss_pred             -------CchhhHHhhhhccCCCCccceEeeecCCCC
Confidence                   2233344444  358999999999998874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=1.8e-07  Score=90.33  Aligned_cols=150  Identities=15%  Similarity=0.124  Sum_probs=101.0

Q ss_pred             HHHHHHhcCCCCCCcccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Q 006211          428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDEN  506 (656)
Q Consensus       428 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  506 (656)
                      +++...-..|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666677788776665566678999865 56678888876554333345677888877764 43466778888888889


Q ss_pred             EEEEEecCCCChhhhhhCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 006211          507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY---------------------------------  553 (656)
Q Consensus       507 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------------------------------  553 (656)
                      ++||+++++.++.......     .   ....++.++++.+..||+.                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998775433111     0   1122334444444444431                                 


Q ss_pred             -----------------------CCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          554 -----------------------SNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       554 -----------------------~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                                             ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   112278999999999999876667999998864

>d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase-like lectin ym1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.89  E-value=2.7e-06  Score=62.97  Aligned_cols=55  Identities=24%  Similarity=0.431  Sum_probs=43.0

Q ss_pred             CceeecccCCCC-----CcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEee
Q 006211          254 NKLVLGARASGP-----GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF  311 (656)
Q Consensus       254 ~Kl~lG~p~yG~-----~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~y  311 (656)
                      ++--+|.|+-|+     ....+|.++|.|||+++++   +++..||....+||.+++++||+|
T Consensus        11 ~~~~~gap~~g~g~~G~~t~~~G~l~y~EIc~~~~~---~~~~~~D~~~~~~y~~~~~qWisY   70 (70)
T d1vf8a2          11 SKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQEVPYAYQGNEWVGY   70 (70)
T ss_dssp             TCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTTEEEEEETTEEEEC
T ss_pred             ccCCCCCccccCCCCCCccCCCCeEeHHHHHHHHhC---CCeEEEeCCCCccEEEECCEEEeC
Confidence            333445554444     4456799999999998763   588899999999999999999998

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.85  E-value=3.4e-05  Score=73.26  Aligned_cols=75  Identities=20%  Similarity=0.180  Sum_probs=53.1

Q ss_pred             cccccC-ceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEEEecCCCCh
Q 006211          442 KLGEGG-FGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIYEYLPNKSL  518 (656)
Q Consensus       442 ~iG~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  518 (656)
                      .+..|. -+.||+....++..+++|........   .+..|...++.+.  .-.+.+++.++.+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344444 36799998878888999987654332   3566777777663  23356678888888888999999988665


Q ss_pred             h
Q 006211          519 D  519 (656)
Q Consensus       519 ~  519 (656)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1wb0a2 d.26.3.1 (A:267-336) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitotriosidase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.38  E-value=1.2e-05  Score=58.97  Aligned_cols=53  Identities=23%  Similarity=0.389  Sum_probs=40.8

Q ss_pred             CceeecccCCCCC-----cCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEee
Q 006211          254 NKLVLGARASGPG-----ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF  311 (656)
Q Consensus       254 ~Kl~lG~p~yG~~-----~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~y  311 (656)
                      ++--+|.|+-|++     ...+|.++|.|||+.     .+++..||+...+||.+.+++||+|
T Consensus        11 ~~~~~gap~~Gpg~~G~~T~~~G~l~y~EIc~~-----~~~~~~~d~~~~~py~~~~~qWisY   68 (68)
T d1wb0a2          11 SDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKVPYIFRDNQWVGF   68 (68)
T ss_dssp             TCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTC-----TTCEEEEETTTTEEEEEETTEEEEC
T ss_pred             CCCCCCCccccCCCCCCccCCCeeEEhHHhhhh-----cCCcEEEeccccccEEEECCEEEeC
Confidence            3334455555544     456799999999964     2478899999999999999999998

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.30  E-value=0.00032  Score=71.06  Aligned_cols=76  Identities=16%  Similarity=0.192  Sum_probs=47.8

Q ss_pred             CCcccccCceEEEEEEeCC-CCEEEEEEccCC-------ChhhHHHHHHHHHHHHhcC-C--CceeeEEEEEeeCCceEE
Q 006211          440 ANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT-------STQGLEEFKNEVSLTARLQ-H--VNLLRVLGYCTERDENML  508 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  508 (656)
                      .+.||.|....||+....+ ++.++||.-...       .....++...|.+.++.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999997654 678999964321       1112234456777777662 2  335555543  4556789


Q ss_pred             EEEecCCCC
Q 006211          509 IYEYLPNKS  517 (656)
Q Consensus       509 v~e~~~~g~  517 (656)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d2pi6a2 d.26.3.1 (A:240-307) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Signal processing protein (SPC-40, MGP-40)
species: Sheep (Ovis aries) [TaxId: 9940]

Probab=97.28  E-value=7.5e-05  Score=54.55  Aligned_cols=44  Identities=23%  Similarity=0.340  Sum_probs=36.5

Q ss_pred             CCCcCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEee
Q 006211          264 GPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF  311 (656)
Q Consensus       264 G~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~y  311 (656)
                      |+....+|.++|.|||.++.+    +...||....+||.+++++||+|
T Consensus        25 G~~T~~~G~lay~EIc~~~~~----~~~~~d~~~~~pyay~g~qWi~Y   68 (68)
T d2pi6a2          25 GRFTKEKGILAYYEICDFLHG----ATTHRFRDQQVPYATKGNQWVAY   68 (68)
T ss_dssp             CTTTCCTTEEEHHHHHHHTTT----CEEEEETTTTEEEEEETTEEEEC
T ss_pred             CCccCCCceEEHHHHHHHHhC----CcEEEecCccccEEEECCEEEcC
Confidence            444556799999999987653    66678888899999999999998

>d1itxa2 d.26.3.1 (A:338-409) Chitinase A1 {Bacillus circulans [TaxId: 1397]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase A1
species: Bacillus circulans [TaxId: 1397]

Probab=97.09  E-value=4.5e-05  Score=56.64  Aligned_cols=42  Identities=19%  Similarity=0.250  Sum_probs=35.1

Q ss_pred             CCCCcchHHHHHHHHhcCCCcccccccceeeeeeec--CcEEEee
Q 006211          269 IDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINF  311 (656)
Q Consensus       269 ~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~i~y  311 (656)
                      .+|.++|.|||+.+... .+++..||+.++.||.++  .++||+|
T Consensus        29 e~G~~~Y~ei~~~~~~~-~g~~~~~D~~a~apY~y~~~~~~~isY   72 (72)
T d1itxa2          29 EAGSFDFYDLEANYINK-NGYTRYWNDTAKVPYLYNASNKRFISY   72 (72)
T ss_dssp             STTEEEHHHHHHHTTTC-TTEEEEEETTTTEEEEEETTTCCEEEC
T ss_pred             ccccChHHHHHHHhccC-CCCEEEEcCCCccceEEeCCCCeEEeC
Confidence            46899999999976543 379999999999999876  4589997

>d1edqa3 d.26.3.1 (A:444-516) Chitinase A {Serratia marcescens [TaxId: 615]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase A
species: Serratia marcescens [TaxId: 615]

Probab=97.08  E-value=3.7e-05  Score=57.33  Aligned_cols=44  Identities=18%  Similarity=0.170  Sum_probs=36.4

Q ss_pred             cCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeec--CcEEEeeC
Q 006211          267 ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFD  312 (656)
Q Consensus       267 ~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~i~yd  312 (656)
                      ...+|.+.|.+||..+.+  .+++..||+.+.+||.++  .++||+||
T Consensus        28 t~e~G~~~Y~~l~~~~~~--~g~~~~wD~~a~apY~Y~~~~~~~isYD   73 (73)
T d1edqa3          28 TWENGIVDYRQIAGQFMS--GEWQYTYDATAEAPYVFKPSTGDLITFD   73 (73)
T ss_dssp             SSBTTEEEHHHHHHHSSS--TTCEEEEETTTTEEEEEETTTTEEEECC
T ss_pred             ccccchhHHHHHHHHhcc--CCeeEEEeccccccEEEeCCCCeEEeCC
Confidence            335689999999987754  359999999999999886  46899997

>d1kfwa2 d.26.3.1 (A:328-388) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Psychrophilic chitinase B
species: Arthrobacter sp., tad20 [TaxId: 1667]

Probab=96.98  E-value=5.4e-05  Score=53.87  Aligned_cols=38  Identities=13%  Similarity=0.236  Sum_probs=33.3

Q ss_pred             cCCCCCcchHHHHHHHHhcCCCcccccccceeeeeeecCcEEEee
Q 006211          267 ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF  311 (656)
Q Consensus       267 ~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~i~y  311 (656)
                      ...+|.+.|++||.       +++..||+..+.||.+++.+||+|
T Consensus        24 t~e~G~~~Y~~l~~-------~~~~~~D~~a~a~Y~y~g~~wisY   61 (61)
T d1kfwa2          24 TYETANEDYDKLKT-------LGTDHYDAATGSAWRYDGTQWWSY   61 (61)
T ss_dssp             SSBTTEEEHHHHTT-------SSEEEEETTTTEEEEECSSCEEEE
T ss_pred             cccchhhhHHhhcC-------CCEEEeeCCCcEeEEEeCCEEEeC
Confidence            34568999999972       689999999999999999999998

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.57  E-value=0.0038  Score=61.01  Aligned_cols=136  Identities=15%  Similarity=0.141  Sum_probs=77.3

Q ss_pred             ceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce--eeEE-----EEEeeCCceEEEEEecCCCChhh
Q 006211          448 FGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL--LRVL-----GYCTERDENMLIYEYLPNKSLDL  520 (656)
Q Consensus       448 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~~  520 (656)
                      --.||++...+|+.+++|+.+... ...+++..|...+..|...++  +..+     .........+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            358999999899999999886542 234567788888877742222  1111     12234556788999987644321


Q ss_pred             -----h------h-------h--CCCcCCCCCH----------------------HHHHHHHHHHHHHHHHH-HhcCCCC
Q 006211          521 -----Y------L-------F--DPIRRYVLDW----------------------QKRVNIIEGVTQGLLYL-QEYSNFR  557 (656)
Q Consensus       521 -----~------l-------~--~~~~~~~l~~----------------------~~~~~i~~~i~~~l~~L-h~~~~~~  557 (656)
                           +      +       .  ....+...+.                      ......+..+...+.-+ .+..+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                 0      0       0  0011111111                      11122222232222222 1222345


Q ss_pred             cEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          558 VIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       558 iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      +||+|+.+.|||++++  ..++||+.+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  56899998864

>d1jnda2 d.26.3.1 (A:279-370) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Imaginal disc growth factor-2
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=95.92  E-value=0.0031  Score=48.26  Aligned_cols=53  Identities=15%  Similarity=0.197  Sum_probs=35.6

Q ss_pred             cccCCCCCcCCCCCcchHHHHHHHHhcCCCcc--------ccccccee-eeeee-------cCcEEEee
Q 006211          259 GARASGPGITIDGSMGYKFIRAFIQNYGYGAA--------PVYNASYV-VNLFT-------SGATWINF  311 (656)
Q Consensus       259 G~p~yG~~~~~~g~~~y~~i~~~~~~~~~~~~--------~~~d~~~~-~~~~~-------~~~~~i~y  311 (656)
                      |-..-|+....+|.++|.|||..+.+..+.+.        .++|.... .||++       .+++||+|
T Consensus        24 g~g~~G~~t~~~G~lsy~EIC~~l~~~~~~~~~~~~a~lrrV~D~~~~~g~YAyr~~d~~~~~~qWVsY   92 (92)
T d1jnda2          24 GPAPEGFQSQKPGLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSY   92 (92)
T ss_dssp             SBCCCCTTTCCTTEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECSBTTBCCCEEEEE
T ss_pred             CCCCCCcccCCcceEEHHHHHHHhccCCcceeecccCceeEecCcccceeeeEEecccCCCcCCEeecC
Confidence            34444666677899999999999987663322        23444433 27766       46899998

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.84  E-value=0.0078  Score=60.44  Aligned_cols=73  Identities=14%  Similarity=0.211  Sum_probs=47.8

Q ss_pred             CCcccccCceEEEEEEeCC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCceEEEE
Q 006211          440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIY  510 (656)
Q Consensus       440 ~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  510 (656)
                      ++.|+.|---.+|++...+        .+.|.+++.-.. . ......+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578888889999997643        245666665432 2 22345678888888743344 467776642    6889


Q ss_pred             EecCCCCh
Q 006211          511 EYLPNKSL  518 (656)
Q Consensus       511 e~~~~g~L  518 (656)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.59  E-value=0.019  Score=55.31  Aligned_cols=159  Identities=13%  Similarity=0.044  Sum_probs=81.9

Q ss_pred             cCHHHHHHHhcCCCCCCc-----ccccCceEEEEEEeCCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce--eeEE
Q 006211          425 FSFSDIKAATNNFSSANK-----LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL--LRVL  497 (656)
Q Consensus       425 ~~~~~~~~~~~~y~~~~~-----iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~  497 (656)
                      .+.++++....+|.+.+.     |..|---+.|+....+|+ +++|+......  .+++..|++++..+...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            355778888888877543     446666788999876654 89998865322  1344556666666632221  1111


Q ss_pred             E------EEeeCCceEEEEEecCCCChhhh--------------hh----C--CCcCCCC------------------CH
Q 006211          498 G------YCTERDENMLIYEYLPNKSLDLY--------------LF----D--PIRRYVL------------------DW  533 (656)
Q Consensus       498 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~--~~~~~~l------------------~~  533 (656)
                      .      +.........++.++.+......              ++    .  .......                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            0      11223445566666665433110              00    0  0000000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCCEEEcCCCcEEEEeccCccc
Q 006211          534 QKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKL  586 (656)
Q Consensus       534 ~~~~~i~~~i~~~l~~Lh~-~~~~~iiH~Dikp~NILl~~~~~~kl~DfGla~~  586 (656)
                      ......+......+.-.+. .-+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111122222222222221 1234599999999999999987778999998863

>d1w9pa2 d.26.3.1 (A:299-360) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase 1
species: Aspergillus fumigatus [TaxId: 5085]

Probab=88.00  E-value=0.054  Score=37.79  Aligned_cols=37  Identities=16%  Similarity=0.185  Sum_probs=28.3

Q ss_pred             CCCCcchHHHHHHHHhcCCCcccccccceeeeeeecC--cEEEee
Q 006211          269 IDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSG--ATWINF  311 (656)
Q Consensus       269 ~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~--~~~i~y  311 (656)
                      .+|...|++|-      ..|+...||+.++.+|.++.  +.+|+|
T Consensus        24 e~Gv~dYk~L~------~~G~~~~~D~~a~aay~Yd~~~~~~isY   62 (62)
T d1w9pa2          24 ENGVWDYKALP------QAGATEHVLPDIMASYSYDATNKFLISY   62 (62)
T ss_dssp             BTTEEEGGGCS------CTTCEEEEEGGGTEEEEEETTTTEEEEC
T ss_pred             ccceEEHHHcC------cCCceEEEcCCceEEEEEeCCCCeEeeC
Confidence            35778888762      34689999999999997754  679987

>d1ll7a2 d.26.3.1 (A:293-354) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]}

class: Alpha and beta proteins (a+b)
fold: FKBP-like
superfamily: Chitinase insertion domain
family: Chitinase insertion domain
domain: Chitinase 1
species: Fungus (Coccidioides immitis) [TaxId: 5501]

Probab=87.77  E-value=0.054  Score=37.78  Aligned_cols=37  Identities=16%  Similarity=0.102  Sum_probs=28.4

Q ss_pred             CCCCcchHHHHHHHHhcCCCcccccccceeeeeeecC--cEEEee
Q 006211          269 IDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSG--ATWINF  311 (656)
Q Consensus       269 ~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~~~~~~--~~~i~y  311 (656)
                      ..|...|++|      +..|+...||+.+..+|.++.  +.+|+|
T Consensus        24 e~Gv~dYk~L------~~~g~~~~~D~~a~A~y~yd~~~~~fiSY   62 (62)
T d1ll7a2          24 ENGVWDYKDM------PQQGAQVTELEDIAASYSYDKNKRYLISY   62 (62)
T ss_dssp             STTEEEGGGC------SCTTCEEEEETTTTEEEEEETTTTEEEEC
T ss_pred             cccEEEHHHC------CCCCceEEEcCCceEEEEEeCCCCeEeeC
Confidence            3577888875      334689999999999997654  679987

>d2nt0a2 c.1.8.3 (A:78-431) Glucosylceramidase, catalytic domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: TIM beta/alpha-barrel
superfamily: (Trans)glycosidases
family: beta-glycanases
domain: Glucosylceramidase, catalytic domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.62  E-value=0.59  Score=45.18  Aligned_cols=91  Identities=5%  Similarity=0.073  Sum_probs=57.9

Q ss_pred             HHHHHHH-hhCCCceEEEEeecC---CCCccccccCCcCCCccccccccCChhhHHHHHHHHHHHHHHcCCCcceeeeeC
Q 006211           78 IFANSVR-RKNPSIKTLLSIWNG---QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLW  153 (656)
Q Consensus        78 ~~~~~~k-~~~~~~kvl~sigg~---~~~~~~~~~Gg~~~~~~~f~~~~~~~~~r~~fi~~~~~~~~~~~~DGvdidwe~  153 (656)
                      .++++++ ..+|++|++.+-|..   -.+... .-||..      ..---.++..+.|++=++++++.|.=.||+||.=-
T Consensus        82 ~~l~~a~~~~~~~l~i~aspWSpP~wMk~n~~-~~~~~~------~~~~l~~~~~~~yA~Yl~~~v~~y~~~Gi~i~~is  154 (354)
T d2nt0a2          82 PLIHRALQLAQRPVSLLASPWTSPTWLKTNGA-VNGKGS------LKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVT  154 (354)
T ss_dssp             HHHHHHHHHCSSCCEEEEEESCCCGGGBTTCS-SSSSCB------BSSCTTSHHHHHHHHHHHHHHHHHHHTTCCCSEEE
T ss_pred             HHHHHHHHhcCCCeEEEEcCCCCchhhhcCCc-ccCCCC------cCCccchhHHHHHHHHHHHHHHHHHHcCCCceEec
Confidence            3444444 458999999999743   221111 111111      11123457899999999999999988899998865


Q ss_pred             CCcc----------------CcchHHHHHHH-HHhhcCC
Q 006211          154 PNST----------------DLNSLGILLDE-WKASASD  175 (656)
Q Consensus       154 p~~~----------------d~~~~~~ll~~-lr~~l~~  175 (656)
                      |.++                ..+....|+++ |+.+|.+
T Consensus       155 p~NEP~~~~~~~~~~~~~~~t~~~~~~fi~~~L~~~l~~  193 (354)
T d2nt0a2         155 AENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLAN  193 (354)
T ss_dssp             SCSSGGGGGSTTCCSSCCBCCHHHHHHHHHHTHHHHHHT
T ss_pred             cCcCcCcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Confidence            5332                13456788875 8888844